,category,over_represented_pvalue,under_represented_pvalue,numDEInCat,numInCat,term,ontology,foreground_genes
5118,GO:0014003,3.28395000215819e-09,0.99999999992813,7,38,oligodendrocyte development,BP,MAG;PLP1;MYRF;NKX6-2;SOX11;CNTN2;LPAR1
11118,GO:0043209,4.19553872848087e-09,0.999999999711985,11,158,myelin sheath,CC,CLDN11;MAG;SEPT4;PLP1;PACSIN1;HSPA2;GFAP;ERMN;MOBP;CNTN2;MBP
3706,GO:0007272,5.35412706705966e-09,0.999999999685922,10,113,ensheathment of neurons,BP,CLDN11;MAG;PLP1;MYRF;NKX6-2;KLK6;MAL;CNTN2;MBP;LPAR1
4056,GO:0008366,5.35412706705966e-09,0.999999999685922,10,113,axon ensheathment,BP,CLDN11;MAG;PLP1;MYRF;NKX6-2;KLK6;MAL;CNTN2;MBP;LPAR1
136,GO:0000280,1.92639617928375e-08,0.999999997556079,15,367,nuclear division,BP,KIFC1;ASPM;TPX2;BIRC5;MYBL2;NCAPG;CENPF;HSPA2;TOP2A;ESPL1;NUSAP1;MKI67;BUB1B;BUB1;UBE2C
7005,GO:0022010,5.42547882201332e-08,0.999999999344094,5,17,central nervous system myelination,BP,MAG;PLP1;MYRF;NKX6-2;CNTN2
8297,GO:0032291,5.42547882201332e-08,0.999999999344094,5,17,axon ensheathment in central nervous system,BP,MAG;PLP1;MYRF;NKX6-2;CNTN2
10780,GO:0042552,7.08161423249801e-08,0.999999995443516,9,111,myelination,BP,MAG;PLP1;MYRF;NKX6-2;KLK6;MAL;CNTN2;MBP;LPAR1
12992,GO:0048285,7.57531663243357e-08,0.999999989267283,15,407,organelle fission,BP,KIFC1;ASPM;TPX2;BIRC5;MYBL2;NCAPG;CENPF;HSPA2;TOP2A;ESPL1;NUSAP1;MKI67;BUB1B;BUB1;UBE2C
13186,GO:0048709,9.27479538796094e-08,0.999999995134171,8,87,oligodendrocyte differentiation,BP,MAG;PLP1;MYRF;DAAM2;NKX6-2;SOX11;CNTN2;LPAR1
13819,GO:0051301,1.29548047465317e-07,0.999999978037328,17,561,cell division,BP,KIFC1;ASPM;TPX2;BIRC5;SEPT4;NCAPG;FGF1;CENPF;PACSIN1;TOP2A;ESPL1;NUSAP1;SFRP2;BUB1B;BUB1;CDK1;UBE2C
18483,GO:0140014,1.29674219898121e-07,0.999999985571367,12,252,mitotic nuclear division,BP,KIFC1;TPX2;BIRC5;MYBL2;NCAPG;CENPF;ESPL1;NUSAP1;MKI67;BUB1B;BUB1;UBE2C
6890,GO:0021782,2.03142979762885e-07,0.999999988091498,8,92,glial cell development,BP,MAG;PLP1;MYRF;GFAP;NKX6-2;SOX11;CNTN2;LPAR1
19529,GO:1903047,2.10788003154473e-07,0.99999995690809,20,802,mitotic cell cycle process,BP,USH1C;KIFC1;MCM10;TPX2;BIRC5;MYBL2;SEPT4;NCAPG;FOXM1;CENPF;TOP2A;ESPL1;NUSAP1;DTL;MKI67;BUB1B;BUB1;CDK1;RRM2;UBE2C
6702,GO:0019911,2.37932908770321e-07,0.999999998368666,4,10,structural constituent of myelin sheath,MF,PLP1;MOBP;MAL;MBP
3759,GO:0007417,2.84048829109762e-07,0.999999938348786,21,870,central nervous system development,BP,ASPM;DCX;MAG;SEPT4;CENPF;PLP1;MYRF;GFAP;HAPLN2;MOG;SFRP2;DAAM2;NKX6-2;S100A1;KLK6;EMX2;MAL;SOX11;CNTN2;MBP;LPAR1
4659,GO:0010001,5.49621510924125e-07,0.999999945530659,10,190,glial cell differentiation,BP,MAG;PLP1;MYRF;GFAP;DAAM2;NKX6-2;CDK1;SOX11;CNTN2;LPAR1
135,GO:0000278,1.03598272221562e-06,0.999999755236765,21,971,mitotic cell cycle,BP,USH1C;KIFC1;MCM10;TPX2;BIRC5;MYBL2;SEPT4;NCAPG;FOXM1;CENPF;TOP2A;ESPL1;NUSAP1;DTL;MKI67;BUB1B;PBK;BUB1;CDK1;RRM2;UBE2C
310,GO:0000819,2.462939543838e-06,0.999999709664639,10,223,sister chromatid segregation,BP,KIFC1;BIRC5;NCAPG;CENPF;TOP2A;ESPL1;NUSAP1;BUB1B;BUB1;UBE2C
5125,GO:0014013,3.65824468504713e-06,0.999999744800446,7,98,regulation of gliogenesis,BP,MAG;GFAP;DAAM2;NKX6-2;CDK1;SOX11;CNTN2
7017,GO:0022402,4.99538274276575e-06,0.999998607245586,23,1257,cell cycle process,BP,USH1C;KIFC1;MCM10;ASPM;TPX2;BIRC5;MYBL2;SEPT4;NCAPG;FOXM1;CENPF;PACSIN1;HSPA2;TOP2A;ESPL1;NUSAP1;DTL;MKI67;BUB1B;BUB1;CDK1;RRM2;UBE2C
10540,GO:0042063,5.23725602727095e-06,0.99999932540219,10,244,gliogenesis,BP,MAG;PLP1;MYRF;GFAP;DAAM2;NKX6-2;CDK1;SOX11;CNTN2;LPAR1
35,GO:0000070,5.88905658671131e-06,0.999999443518464,8,143,mitotic sister chromatid segregation,BP,KIFC1;NCAPG;CENPF;ESPL1;NUSAP1;BUB1B;BUB1;UBE2C
13822,GO:0051304,1.02309307298504e-05,0.999999369887577,6,75,chromosome separation,BP,CENPF;TOP2A;ESPL1;BUB1B;BUB1;UBE2C
3586,GO:0007059,1.12474132661787e-05,0.999998222792825,11,328,chromosome segregation,BP,KIFC1;BIRC5;NCAPG;CENPF;TOP2A;ESPL1;NUSAP1;MKI67;BUB1B;BUB1;UBE2C
7138,GO:0030071,1.56396075427401e-05,0.999999294946411,5,48,regulation of mitotic metaphase/anaphase transition,BP,CENPF;ESPL1;BUB1B;BUB1;UBE2C
19140,GO:1902099,1.56396075427401e-05,0.999999294946411,5,48,regulation of metaphase/anaphase transition of cell cycle,BP,CENPF;ESPL1;BUB1B;BUB1;UBE2C
18044,GO:0098813,1.63386347379404e-05,0.999997590160374,10,279,nuclear chromosome segregation,BP,KIFC1;BIRC5;NCAPG;CENPF;TOP2A;ESPL1;NUSAP1;BUB1B;BUB1;UBE2C
3600,GO:0007091,2.17003964392817e-05,0.999998947845907,5,51,metaphase/anaphase transition of mitotic cell cycle,BP,CENPF;ESPL1;BUB1B;BUB1;UBE2C
11743,GO:0044784,2.17003964392817e-05,0.999998947845907,5,51,metaphase/anaphase transition of cell cycle,BP,CENPF;ESPL1;BUB1B;BUB1;UBE2C
5085,GO:0010965,2.33714229870933e-05,0.999998847574521,5,52,regulation of mitotic sister chromatid separation,BP,CENPF;ESPL1;BUB1B;BUB1;UBE2C
17010,GO:0072686,2.57334049216426e-05,0.99999812009804,6,85,mitotic spindle,CC,KIFC1;ASPM;TPX2;ESPL1;NUSAP1;CDK1
13824,GO:0051306,2.78523880408471e-05,0.999998571604571,5,54,mitotic sister chromatid separation,BP,CENPF;ESPL1;BUB1B;BUB1;UBE2C
20796,GO:1905818,3.09035708122361e-05,0.999998378206651,5,55,regulation of chromosome separation,BP,CENPF;ESPL1;BUB1B;BUB1;UBE2C
14181,GO:0051983,3.3637270115604e-05,0.999997415130876,6,90,regulation of chromosome segregation,BP,CENPF;ESPL1;MKI67;BUB1B;BUB1;UBE2C
3748,GO:0007399,3.36875068440122e-05,0.999987877165009,30,2088,nervous system development,BP,USH1C;CLDN11;ASPM;DCX;CPNE6;MAG;SEPT4;CENPF;PLP1;PACSIN1;MYRF;GFAP;HAPLN2;MOG;SFRP2;DAAM2;CRB2;NKX6-2;S100A1;KLK6;MOBP;CDK1;EMX2;MAL;SOX11;S1PR5;CNTN2;MBP;LPAR1;ZNF536
2782,GO:0005819,3.4364536581843e-05,0.999994454540505,10,304,spindle,CC,KIFC1;ASPM;TPX2;BIRC5;CENPF;HSPA2;ESPL1;NUSAP1;BUB1B;CDK1
13462,GO:0050768,4.49976971185124e-05,0.999993364600809,9,245,negative regulation of neurogenesis,BP,ASPM;MAG;GFAP;DAAM2;NKX6-2;SOX11;CNTN2;LPAR1;ZNF536
12125,GO:0045685,4.53707218726609e-05,0.999997402601865,5,61,regulation of glial cell differentiation,BP,MAG;DAAM2;NKX6-2;CDK1;CNTN2
291,GO:0000793,4.57228966198591e-05,0.999994188094993,8,194,condensed chromosome,CC,BIRC5;NCAPG;CENPF;HSPA2;TOP2A;MKI67;BUB1B;BUB1
14164,GO:0051960,5.78577366127078e-05,0.999984839860515,16,765,regulation of nervous system development,BP,ASPM;CPNE6;MAG;PACSIN1;MYRF;GFAP;SFRP2;DAAM2;NKX6-2;KLK6;CDK1;SOX11;S1PR5;CNTN2;LPAR1;ZNF536
8815,GO:0033047,5.84040306872443e-05,0.999996472186594,5,61,regulation of mitotic sister chromatid segregation,BP,CENPF;ESPL1;BUB1B;BUB1;UBE2C
7262,GO:0030261,5.84926072981946e-05,0.999997931975208,4,27,chromosome condensation,BP,NCAPG;TOP2A;NUSAP1;CDK1
13461,GO:0050767,6.33285906986208e-05,0.999984058044842,15,687,regulation of neurogenesis,BP,ASPM;CPNE6;MAG;PACSIN1;GFAP;SFRP2;DAAM2;NKX6-2;KLK6;CDK1;SOX11;S1PR5;CNTN2;LPAR1;ZNF536
3598,GO:0007088,6.72655847849232e-05,0.999992479946388,7,151,regulation of mitotic nuclear division,BP,CENPF;ESPL1;NUSAP1;MKI67;BUB1B;BUB1;UBE2C
14165,GO:0051961,7.93076024699232e-05,0.999987382746886,9,264,negative regulation of nervous system development,BP,ASPM;MAG;GFAP;DAAM2;NKX6-2;SOX11;CNTN2;LPAR1;ZNF536
343,GO:0000940,7.97657389067195e-05,0.999998699395473,3,13,condensed chromosome outer kinetochore,CC,CENPF;BUB1B;BUB1
8813,GO:0033045,0.000108313361356877,0.999992485113986,5,70,regulation of sister chromatid segregation,BP,CENPF;ESPL1;BUB1B;BUB1;UBE2C
8814,GO:0033046,0.000110591665689848,0.99999525036011,4,37,negative regulation of sister chromatid segregation,BP,CENPF;ESPL1;BUB1B;BUB1
14183,GO:0051985,0.000110591665689848,0.99999525036011,4,37,negative regulation of chromosome segregation,BP,CENPF;ESPL1;BUB1B;BUB1
4898,GO:0010721,0.000111688989510028,0.999981388074041,9,277,negative regulation of cell development,BP,ASPM;MAG;GFAP;DAAM2;NKX6-2;SOX11;CNTN2;LPAR1;ZNF536
11736,GO:0044772,0.00011724257333069,0.999973829764433,12,515,mitotic cell cycle phase transition,BP,USH1C;MCM10;TPX2;FOXM1;CENPF;ESPL1;DTL;BUB1B;BUB1;CDK1;RRM2;UBE2C
14065,GO:0051783,0.000142898066939766,0.999981897603345,7,171,regulation of nuclear division,BP,CENPF;ESPL1;NUSAP1;MKI67;BUB1B;BUB1;UBE2C
11734,GO:0044770,0.000198800595248989,0.99995295714871,12,545,cell cycle phase transition,BP,USH1C;MCM10;TPX2;FOXM1;CENPF;ESPL1;DTL;BUB1B;BUB1;CDK1;RRM2;UBE2C
19420,GO:1902850,0.000205977196877525,0.999977698266268,6,125,microtubule cytoskeleton organization involved in mitosis,BP,KIFC1;TPX2;BIRC5;MYBL2;ESPL1;NUSAP1
3580,GO:0007049,0.000217245583527746,0.999919889818054,24,1708,cell cycle,BP,USH1C;KIFC1;MCM10;ASPM;TPX2;BIRC5;MYBL2;SEPT4;NCAPG;FOXM1;CENPF;PACSIN1;HSPA2;TOP2A;ESPL1;NUSAP1;DTL;MKI67;BUB1B;PBK;BUB1;CDK1;RRM2;UBE2C
14052,GO:0051754,0.000234962992251226,0.999999027029322,2,4,meiotic sister chromatid cohesion, centromeric,BP,BUB1B;BUB1
8930,GO:0033269,0.000239152656076238,0.999999000818607,2,4,internode region of axon,CC,ERMN;MBP
14646,GO:0060284,0.000252409034736188,0.999927604225558,15,782,regulation of cell development,BP,ASPM;CPNE6;MAG;PACSIN1;GFAP;SFRP2;DAAM2;NKX6-2;KLK6;CDK1;SOX11;S1PR5;CNTN2;LPAR1;ZNF536
13777,GO:0051246,0.000305051176851651,0.999874142673478,30,2450,regulation of protein metabolic process,BP,CRLF1;HHATL;FGFR3;TPX2;BIRC5;SNTA1;SEPT4;FOXM1;FGF1;FBXO2;NECAB1;HSPA2;GFAP;PPP1R1B;APLNR;PDGFRA;ENPP2;DTL;SFRP2;CRB2;CNDP1;PI16;PPP1R14A;PBK;CDK1;UBE2C;CNTN2;MBP;LPAR1;FXYD1
18482,GO:0140013,0.000323261284544609,0.999961789979821,6,143,meiotic nuclear division,BP,ASPM;HSPA2;TOP2A;ESPL1;BUB1B;BUB1
13831,GO:0051321,0.00034327845605142,0.999949581132109,7,202,meiotic cell cycle,BP,ASPM;HSPA2;TOP2A;ESPL1;BUB1B;BUB1;CDK1
17011,GO:0072687,0.000438582259303501,0.999997110723692,2,5,meiotic spindle,CC,ASPM;HSPA2
36,GO:0000075,0.000449196055364304,0.999930933249648,7,211,cell cycle checkpoint,BP,CENPF;TOP2A;DTL;BUB1B;BUB1;CDK1;SOX11
12113,GO:0045664,0.000460671962911522,0.999880175876636,12,566,regulation of neuron differentiation,BP,ASPM;CPNE6;MAG;PACSIN1;GFAP;SFRP2;KLK6;SOX11;S1PR5;CNTN2;LPAR1;ZNF536
19528,GO:1903046,0.000528713535629462,0.999931274031016,6,156,meiotic cell cycle process,BP,ASPM;HSPA2;TOP2A;ESPL1;BUB1B;BUB1
13735,GO:0051177,0.000530591287101771,0.999995812453472,2,6,meiotic sister chromatid cohesion,BP,BUB1B;BUB1
278,GO:0000779,0.000631415403208766,0.999934716849401,5,107,condensed chromosome, centromeric region,CC,BIRC5;NCAPG;CENPF;BUB1B;BUB1
3732,GO:0007346,0.000638583146771243,0.999827452299506,12,612,regulation of mitotic cell cycle,BP,TPX2;BIRC5;CENPF;TOP2A;ESPL1;NUSAP1;DTL;MKI67;BUB1B;BUB1;CDK1;UBE2C
19103,GO:1901992,0.000642966487964212,0.999954773526036,4,61,positive regulation of mitotic cell cycle phase transition,BP,ESPL1;DTL;CDK1;UBE2C
14041,GO:0051726,0.000657639511786675,0.999776903957442,17,1088,regulation of cell cycle,BP,ASPM;TPX2;BIRC5;MYBL2;FOXM1;CENPF;TOP2A;ESPL1;NUSAP1;DTL;MKI67;BUB1B;BUB1;CDK1;RRM2;UBE2C;SOX11
21157,GO:2000026,0.000689368375993689,0.999727943390068,23,1706,regulation of multicellular organismal development,BP,ASPM;CPNE6;MAG;FGF1;CENPF;PACSIN1;MYRF;GFAP;APLNR;ENPP2;SFRP2;DAAM2;CRB2;NKX6-2;S100A1;KLK6;CDK1;SOX11;S1PR5;CNTN2;MBP;LPAR1;ZNF536
5470,GO:0015630,0.000727840506679356,0.999750780791328,17,1069,microtubule cytoskeleton,CC,KIFC1;ASPM;DCX;TPX2;BIRC5;SEPT4;CENPF;HSPA2;TOP2A;ESPL1;NUSAP1;DTL;AK5;BUB1B;KIF6;CDK1;DNAH17
11884,GO:0045144,0.000734747778250854,0.999992780408703,2,7,meiotic sister chromatid segregation,BP,BUB1B;BUB1
13764,GO:0051225,0.000739728105657153,0.999920820838894,5,105,spindle assembly,BP,KIFC1;ASPM;TPX2;BIRC5;MYBL2
17373,GO:0090307,0.000785569465933048,0.999941653148743,4,62,mitotic spindle assembly,BP,KIFC1;TPX2;BIRC5;MYBL2
11641,GO:0044430,0.000787183155557024,0.999705062605242,20,1378,cytoskeletal part,CC,KIFC1;ASPM;DCX;TPX2;BIRC5;SEPT4;CENPF;HSPA2;GFAP;TOP2A;ESPL1;NUSAP1;DTL;AK5;BUB1B;KIF6;MOBP;CDK1;DNAH17;MYBPC1
3582,GO:0007051,0.000839993913498607,0.999880587036255,6,162,spindle organization,BP,KIFC1;ASPM;TPX2;BIRC5;MYBL2;ESPL1
13482,GO:0050793,0.000918878216659153,0.999605765870407,27,2200,regulation of developmental process,BP,ASPM;FGFR3;CPNE6;MAG;FOXM1;FGF1;CENPF;PACSIN1;MYRF;GFAP;APLNR;PDGFRA;ERMN;ENPP2;SFRP2;DAAM2;CRB2;NKX6-2;S100A1;KLK6;CDK1;SOX11;S1PR5;CNTN2;MBP;LPAR1;ZNF536
3614,GO:0007135,0.000999213103804275,0.99998808124252,2,8,meiosis II,BP,BUB1B;BUB1
15508,GO:0061983,0.000999213103804275,0.99998808124252,2,8,meiosis II cell cycle process,BP,BUB1B;BUB1
11569,GO:0044304,0.00101956476908072,0.999918761672697,4,62,main axon,CC,MAG;ERMN;CNTN2;MBP
3554,GO:0007010,0.00102500435942032,0.999626688493095,18,1179,cytoskeleton organization,BP,USH1C;KIFC1;ASPM;TPX2;BIRC5;MYBL2;SEPT4;PACSIN1;GFAP;PDGFRA;ESPL1;ERMN;NUSAP1;DAAM2;CDK1;CNTN2;MYBPC1;LPAR1
19830,GO:1903672,0.00106662909769566,0.999952782220812,3,31,positive regulation of sprouting angiogenesis,BP,FGF1;APLNR;S100A1
13185,GO:0048708,0.001088029030542,0.99991150221179,4,67,astrocyte differentiation,BP,MAG;PLP1;GFAP;CNTN2
11877,GO:0045132,0.00108992785418586,0.999911163999707,4,70,meiotic chromosome segregation,BP,TOP2A;ESPL1;BUB1B;BUB1
3602,GO:0007094,0.00111206874488004,0.999950050805866,3,31,mitotic spindle assembly checkpoint,BP,CENPF;BUB1B;BUB1
16155,GO:0071173,0.00111206874488004,0.999950050805866,3,31,spindle assembly checkpoint,BP,CENPF;BUB1B;BUB1
16156,GO:0071174,0.00111206874488004,0.999950050805866,3,31,mitotic spindle checkpoint,BP,CENPF;BUB1B;BUB1
4762,GO:0010470,0.00117472958110954,0.999946101636685,3,32,regulation of gastrulation,BP,SFRP2;CRB2;MBP
19100,GO:1901989,0.00118828186077344,0.999900757131794,4,72,positive regulation of cell cycle phase transition,BP,ESPL1;DTL;CDK1;UBE2C
7840,GO:0031399,0.00118967926174158,0.999527972776853,21,1575,regulation of protein modification process,BP,CRLF1;HHATL;FGFR3;TPX2;SNTA1;SEPT4;FOXM1;FGF1;FBXO2;HSPA2;PPP1R1B;APLNR;PDGFRA;ENPP2;SFRP2;PPP1R14A;PBK;CDK1;UBE2C;LPAR1;FXYD1
21828,GO:2001251,0.0012095542095892,0.999855084750864,5,116,negative regulation of chromosome organization,BP,CENPF;TOP2A;ESPL1;BUB1B;BUB1
12205,GO:0045841,0.00122147796645064,0.999943189467376,3,32,negative regulation of mitotic metaphase/anaphase transition,BP,CENPF;BUB1B;BUB1
19141,GO:1902100,0.00122147796645064,0.999943189467376,3,32,negative regulation of metaphase/anaphase transition of cell cycle,BP,CENPF;BUB1B;BUB1
8278,GO:0032268,0.00123621526529226,0.999457894957987,27,2288,regulation of cellular protein metabolic process,BP,CRLF1;HHATL;FGFR3;TPX2;BIRC5;SNTA1;SEPT4;FOXM1;FGF1;FBXO2;HSPA2;PPP1R1B;APLNR;PDGFRA;ENPP2;SFRP2;CRB2;CNDP1;PI16;PPP1R14A;PBK;CDK1;UBE2C;CNTN2;MBP;LPAR1;FXYD1
2814,GO:0005874,0.00123673019193982,0.999711187348223,9,379,microtubule,CC,KIFC1;ASPM;DCX;TPX2;BIRC5;NUSAP1;KIF6;CDK1;DNAH17
20797,GO:1905819,0.00131027022452552,0.999937422145358,3,33,negative regulation of chromosome separation,BP,CENPF;BUB1B;BUB1
21652,GO:2000816,0.00131027022452552,0.999937422145358,3,33,negative regulation of mitotic sister chromatid separation,BP,CENPF;BUB1B;BUB1
3588,GO:0007062,0.00134498643465916,0.999834723306921,5,123,sister chromatid cohesion,BP,BIRC5;CENPF;ESPL1;BUB1B;BUB1
2283,GO:0004865,0.00139948428632534,0.999979180697719,2,10,protein serine/threonine phosphatase inhibitor activity,MF,PPP1R1B;PPP1R14A
7934,GO:0031577,0.00142288024852869,0.999929925121451,3,34,spindle checkpoint,BP,CENPF;BUB1B;BUB1
4803,GO:0010564,0.00143393107080462,0.999573640761993,12,670,regulation of cell cycle process,BP,TPX2;FOXM1;CENPF;ESPL1;NUSAP1;DTL;MKI67;BUB1B;BUB1;CDK1;RRM2;UBE2C
4749,GO:0010454,0.00146759636347035,0.999977633854702,2,10,negative regulation of cell fate commitment,BP,SFRP2;NKX6-2
7967,GO:0031641,0.0014857270045924,0.999925716346133,3,34,regulation of myelination,BP,MAG;MYRF;NKX6-2
7003,GO:0022008,0.00148846443264131,0.99941072255891,20,1439,neurogenesis,BP,USH1C;ASPM;DCX;CPNE6;MAG;PLP1;PACSIN1;MYRF;GFAP;SFRP2;DAAM2;NKX6-2;KLK6;CDK1;EMX2;SOX11;S1PR5;CNTN2;LPAR1;ZNF536
13774,GO:0051239,0.00165109485436544,0.999243284893862,29,2551,regulation of multicellular organismal process,BP,ASPM;CPNE6;SNTA1;MAG;PTGDS;FGF1;CENPF;PACSIN1;MYRF;GFAP;SPX;APLNR;PDGFRA;ENPP2;MOG;SFRP2;DAAM2;CRB2;NKX6-2;S100A1;KLK6;CDK1;SOX11;S1PR5;CNTN2;MBP;LPAR1;ZNF536;FXYD1
5126,GO:0014014,0.00166640842416887,0.999912965386439,3,36,negative regulation of gliogenesis,BP,DAAM2;NKX6-2;SOX11
13178,GO:0048699,0.00167556141322694,0.999344852638527,19,1346,generation of neurons,BP,USH1C;ASPM;DCX;CPNE6;MAG;PLP1;PACSIN1;GFAP;SFRP2;DAAM2;NKX6-2;KLK6;CDK1;EMX2;SOX11;S1PR5;CNTN2;LPAR1;ZNF536
15879,GO:0070601,0.00169399491090419,0.999972229787216,2,10,centromeric sister chromatid cohesion,BP,BUB1B;BUB1
7817,GO:0031344,0.00173997613412848,0.999501208690726,11,570,regulation of cell projection organization,BP,USH1C;CPNE6;MAG;PACSIN1;GFAP;ERMN;ENPP2;SFRP2;KLK6;CNTN2;LPAR1
12253,GO:0045931,0.0017630524153737,0.999769380270205,5,129,positive regulation of mitotic cell cycle,BP,ESPL1;NUSAP1;DTL;CDK1;UBE2C
8816,GO:0033048,0.00180599660837246,0.999902977446373,3,36,negative regulation of mitotic sister chromatid segregation,BP,CENPF;BUB1B;BUB1
2567,GO:0005372,0.00190296443575689,0.99996632656081,2,11,water transmembrane transporter activity,MF,SLC14A1;AQP4
6874,GO:0021762,0.00193192402241125,0.99989324729048,3,39,substantia nigra development,BP,PLP1;S100A1;MBP
7577,GO:0030901,0.00194770964360354,0.999813102315593,4,82,midbrain development,BP,PLP1;SFRP2;S100A1;MBP
8691,GO:0032873,0.00209287551508734,0.999881055595659,3,39,negative regulation of stress-activated MAPK cascade,BP,FOXM1;SFRP2;PBK
15706,GO:0070303,0.00209287551508734,0.999881055595659,3,39,negative regulation of stress-activated protein kinase signaling cascade,BP,FOXM1;SFRP2;PBK
572,GO:0001673,0.00210663245105644,0.99996074060092,2,11,male germ cell nucleus,CC,HSPA2;KIF6
11430,GO:0043949,0.00212609341626198,0.999878333332389,3,40,regulation of cAMP-mediated signaling,BP,APLNR;GPR62;LPAR1
12114,GO:0045665,0.00217852949392741,0.999625484601271,6,196,negative regulation of neuron differentiation,BP,ASPM;MAG;GFAP;CNTN2;LPAR1;ZNF536
8477,GO:0032536,0.00224796734027006,0.99995669631571,2,11,regulation of cell projection size,BP,USH1C;CNTN2
277,GO:0000778,0.00225236627667182,0.999955956857199,2,12,condensed nuclear chromosome kinetochore,CC,BUB1B;BUB1
102,GO:0000212,0.0023187800571718,0.999955392680567,2,10,meiotic spindle organization,BP,ASPM;ESPL1
13049,GO:0048468,0.00243444669584004,0.998936062375926,23,1841,cell development,BP,USH1C;ASPM;CPNE6;MAG;SEPT4;PLP1;PACSIN1;MYRF;HSPA2;GFAP;HAPLN2;PDGFRA;SFRP2;DAAM2;NKX6-2;KLK6;CDK1;SOX11;S1PR5;CNTN2;MYBPC1;LPAR1;ZNF536
2803,GO:0005856,0.00245041118258109,0.998928488862596,23,1846,cytoskeleton,CC,USH1C;KIFC1;ASPM;DCX;TPX2;BIRC5;SNTA1;SEPT4;CENPF;HSPA2;GFAP;TOP2A;ESPL1;ERMN;NUSAP1;DTL;AK5;BUB1B;KIF6;MOBP;CDK1;DNAH17;MYBPC1
13999,GO:0051653,0.00246143103936604,0.99985209419821,3,38,spindle localization,BP,ASPM;ESPL1;NUSAP1
11037,GO:0043073,0.00248713018288275,0.999948842641038,2,12,germ cell nucleus,CC,HSPA2;KIF6
19101,GO:1901990,0.00293590417336345,0.999291365043718,8,376,regulation of mitotic cell cycle phase transition,BP,TPX2;CENPF;ESPL1;DTL;BUB1B;BUB1;CDK1;UBE2C
4464,GO:0009263,0.00302714399154439,0.999929674456751,2,14,deoxyribonucleotide biosynthetic process,BP,AK5;RRM2
11122,GO:0043218,0.00302901137192943,0.999930292106026,2,13,compact myelin,CC,MAG;MBP
7969,GO:0031643,0.00322238282125306,0.999923456044652,2,13,positive regulation of myelination,BP,MAG;MYRF
4782,GO:0010518,0.00322887950539339,0.999784607181184,3,45,positive regulation of phospholipase activity,BP,FGFR3;PDGFRA;LPAR1
5070,GO:0010948,0.00331363886900673,0.999275361232796,7,304,negative regulation of cell cycle process,BP,CENPF;ESPL1;DTL;BUB1B;BUB1;CDK1;RRM2
15183,GO:0061134,0.00337086855904134,0.999486045648874,5,159,peptidase regulator activity,MF,BIRC5;SFRP2;CRB2;PI16;MAL
276,GO:0000777,0.00337289333191897,0.999621724080115,4,96,condensed chromosome kinetochore,CC,BIRC5;CENPF;BUB1B;BUB1
12203,GO:0045839,0.00343487781370871,0.999765548107459,3,46,negative regulation of mitotic nuclear division,BP,CENPF;BUB1B;BUB1
4005,GO:0008284,0.00344942468273747,0.998857165200087,12,755,positive regulation of cell proliferation,BP,CRLF1;ASPM;FGFR3;BIRC5;FOXM1;FGF1;GFAP;APLNR;PDGFRA;SFRP2;CDK1;SOX11
11872,GO:0045125,0.00346673361344466,0.999912952545005,2,15,bioactive lipid receptor activity,MF,S1PR5;LPAR1
3601,GO:0007093,0.0034794825367346,0.999465666236226,5,157,mitotic cell cycle checkpoint,BP,CENPF;TOP2A;BUB1B;BUB1;CDK1
8931,GO:0033270,0.00348376039947435,0.999914864333628,2,12,paranode region of axon,CC,MAG;ERMN
12204,GO:0045840,0.00350208700301053,0.999759547395554,3,45,positive regulation of mitotic nuclear division,BP,ESPL1;NUSAP1;UBE2C
2815,GO:0005875,0.0035262933026626,0.999457842924757,5,141,microtubule associated complex,CC,KIFC1;DCX;BIRC5;KIF6;DNAH17
11684,GO:0044548,0.00359563730920271,0.999908773642539,2,14,S100 protein binding,MF,FGF1;S100A1
18223,GO:0099513,0.00360598153078775,0.99893296033674,10,539,polymeric cytoskeletal fiber,CC,KIFC1;ASPM;DCX;TPX2;BIRC5;GFAP;NUSAP1;KIF6;CDK1;DNAH17
13092,GO:0048546,0.00362825577784121,0.99974773052357,3,45,digestive tract morphogenesis,BP,PDGFRA;SFRP2;SOX11
11087,GO:0043168,0.00363229376794801,0.998251415714644,28,2524,anion binding,MF,KIFC1;FGFR3;TPX2;CPNE6;MAG;PTGDS;SEPT4;FGF1;PACSIN1;HSPA2;TOP2A;IQCA1;HAPLN2;PDGFRA;MKI67;AK5;BUB1B;ETNPPL;KIF6;PBK;BUB1;CDK1;CARNS1;UBE2C;AIFM3;DNAH17;NWD1;LPAR1
12175,GO:0045786,0.00368507150289728,0.998905764994741,10,570,negative regulation of cell cycle,BP,FOXM1;CENPF;TOP2A;ESPL1;DTL;BUB1B;BUB1;CDK1;RRM2;SOX11
13676,GO:0051094,0.00371009125649647,0.998552296453813,16,1157,positive regulation of developmental process,BP,ASPM;CPNE6;MAG;FGF1;PACSIN1;MYRF;GFAP;APLNR;ENPP2;SFRP2;CRB2;NKX6-2;S100A1;CDK1;SOX11;LPAR1
3443,GO:0006833,0.00374464336276636,0.999902184662065,2,15,water transport,BP,SLC14A1;AQP4
8812,GO:0033044,0.00376172735749953,0.999158525766192,7,295,regulation of chromosome organization,BP,CENPF;TOP2A;ESPL1;MKI67;BUB1B;BUB1;UBE2C
13775,GO:0051240,0.00384207199045114,0.998412694855508,18,1389,positive regulation of multicellular organismal process,BP,ASPM;CPNE6;MAG;FGF1;PACSIN1;MYRF;GFAP;SPX;APLNR;ENPP2;SFRP2;CRB2;NKX6-2;S100A1;CDK1;SOX11;MBP;LPAR1
14166,GO:0051962,0.00392115288629339,0.998911316990818,9,458,positive regulation of nervous system development,BP,ASPM;CPNE6;MAG;PACSIN1;MYRF;GFAP;NKX6-2;SOX11;LPAR1
9399,GO:0034501,0.00411576311548702,0.999886336997931,2,16,protein localization to kinetochore,BP,BUB1B;CDK1
19098,GO:1901987,0.00427621719184178,0.998901274424671,8,400,regulation of cell cycle phase transition,BP,TPX2;CENPF;ESPL1;DTL;BUB1B;BUB1;CDK1;UBE2C
42,GO:0000086,0.0043132431265214,0.999146664241598,6,237,G2/M transition of mitotic cell cycle,BP,USH1C;TPX2;FOXM1;CENPF;DTL;CDK1
13699,GO:0051128,0.00464664461089743,0.997794061439326,25,2210,regulation of cellular component organization,BP,USH1C;TPX2;TF;CPNE6;MAG;CENPF;PACSIN1;HSPA2;GFAP;TOP2A;PDGFRA;ESPL1;ERMN;ENPP2;NUSAP1;SFRP2;MKI67;BUB1B;KLK6;FAM107A;BUB1;UBE2C;CNTN2;MYBPC1;LPAR1
14099,GO:0051861,0.00465154748624152,0.999862347092078,2,17,glycolipid binding,MF,MAG;HSPA2
2481,GO:0005198,0.00470603680756832,0.998552687384017,10,587,structural molecule activity,MF,CLDN11;SNTA1;SEPT4;PLP1;GFAP;HAPLN2;MOBP;MAL;MYBPC1;MBP
12058,GO:0045596,0.00480807603084762,0.998516942133439,10,575,negative regulation of cell differentiation,BP,ASPM;MAG;GFAP;SFRP2;DAAM2;NKX6-2;SOX11;CNTN2;LPAR1;ZNF536
13096,GO:0048557,0.00495116488312516,0.999849644396738,2,16,embryonic digestive tract morphogenesis,BP,PDGFRA;SOX11
13825,GO:0051307,0.00496559441666416,0.999848980218509,2,16,meiotic chromosome separation,BP,TOP2A;ESPL1
18450,GO:0120035,0.00496746124787705,0.998460824007614,10,561,regulation of plasma membrane bounded cell projection organization,BP,USH1C;CPNE6;MAG;PACSIN1;GFAP;ENPP2;SFRP2;KLK6;CNTN2;LPAR1
4781,GO:0010517,0.00505799787424233,0.999601626169517,3,52,regulation of phospholipase activity,BP,FGFR3;PDGFRA;LPAR1
13265,GO:0048869,0.00506503143194554,0.99734481769581,36,3636,cellular developmental process,BP,USH1C;ASPM;FGFR3;DCX;CPNE6;MYBL2;MAG;SEPT4;FOXM1;FGF1;CENPF;PLP1;PACSIN1;MYRF;HSPA2;GFAP;TOP2A;HAPLN2;APLNR;PDGFRA;ERMN;ENPP2;SFRP2;DAAM2;CRB2;NKX6-2;KLK6;CDK1;EMX2;MAL;SOX11;S1PR5;CNTN2;MYBPC1;LPAR1;ZNF536
18222,GO:0099512,0.00508726800525037,0.998229555978625,12,742,supramolecular fiber,CC,KIFC1;ASPM;DCX;TPX2;BIRC5;GFAP;NUSAP1;S100A1;KIF6;CDK1;DNAH17;MYBPC1
14591,GO:0060193,0.00512267143521999,0.999594111475083,3,54,positive regulation of lipase activity,BP,FGFR3;PDGFRA;LPAR1
13675,GO:0051093,0.00520446168274359,0.998183020087223,12,775,negative regulation of developmental process,BP,ASPM;FGFR3;MAG;FOXM1;GFAP;SFRP2;DAAM2;NKX6-2;SOX11;CNTN2;LPAR1;ZNF536
5127,GO:0014015,0.00521924822496695,0.999583679943845,3,54,positive regulation of gliogenesis,BP,MAG;GFAP;NKX6-2
14066,GO:0051784,0.00530354323473197,0.999574517055801,3,54,negative regulation of nuclear division,BP,CENPF;BUB1B;BUB1
5080,GO:0010959,0.00530974581051199,0.998733663794123,7,322,regulation of metal ion transport,BP,TF;SNTA1;HSPA2;APLNR;S100A1;NKAIN2;FXYD1
11432,GO:0043951,0.00534816563285456,0.999829949160513,2,17,negative regulation of cAMP-mediated signaling,BP,APLNR;LPAR1
18178,GO:0099081,0.00554861403727575,0.99804719375453,12,749,supramolecular polymer,CC,KIFC1;ASPM;DCX;TPX2;BIRC5;GFAP;NUSAP1;S100A1;KIF6;CDK1;DNAH17;MYBPC1
8036,GO:0031751,0.00557455613942391,1,1,1,D4 dopamine receptor binding,MF,PPP1R1B
17723,GO:0097367,0.00557606950303335,0.997381887591976,23,1979,carbohydrate derivative binding,MF,KIFC1;FGFR3;TPX2;MAG;SEPT4;FGF1;HSPA2;TOP2A;IQCA1;HAPLN2;PDGFRA;MKI67;AK5;BUB1B;KIF6;PBK;BUB1;CDK1;CARNS1;UBE2C;DNAH17;NWD1;LPAR1
7339,GO:0030382,0.0056120273882165,1,1,1,sperm mitochondrion organization,BP,SEPT4
270,GO:0000741,0.00561409485164198,1,1,1,karyogamy,BP,CDK1
3731,GO:0007344,0.00561409485164198,1,1,1,pronuclear fusion,BP,CDK1
10133,GO:0036094,0.00562123778003525,0.997287904333059,25,2242,small molecule binding,MF,KIFC1;FGFR3;TPX2;MAG;PTGDS;SEPT4;HSPA2;TOP2A;IQCA1;HAPLN2;PDGFRA;MKI67;AK5;BUB1B;ETNPPL;KIF6;ALDH1A1;PBK;BUB1;CDK1;CARNS1;UBE2C;AIFM3;DNAH17;NWD1
18177,GO:0099080,0.00562845516761808,0.998015420107117,12,750,supramolecular complex,CC,KIFC1;ASPM;DCX;TPX2;BIRC5;GFAP;NUSAP1;S100A1;KIF6;CDK1;DNAH17;MYBPC1
13256,GO:0048857,0.00563213775464755,0.999537683799054,3,56,neural nucleus development,BP,PLP1;S100A1;MBP
14626,GO:0060254,0.0056487260395534,1,1,1,regulation of N-terminal protein palmitoylation,BP,HHATL
14631,GO:0060262,0.0056487260395534,1,1,1,negative regulation of N-terminal protein palmitoylation,BP,HHATL
19538,GO:1903060,0.0056487260395534,1,1,1,negative regulation of protein lipidation,BP,HHATL
11768,GO:0044839,0.00573132416396648,0.99879684262901,6,252,cell cycle G2/M phase transition,BP,USH1C;TPX2;FOXM1;CENPF;DTL;CDK1
15209,GO:0061185,0.00573866230533917,1,1,1,negative regulation of dermatome development,BP,SFRP2
2615,GO:0005524,0.00576251406470368,0.997520694225435,18,1372,ATP binding,MF,KIFC1;FGFR3;TPX2;HSPA2;TOP2A;IQCA1;PDGFRA;MKI67;AK5;BUB1B;KIF6;PBK;BUB1;CDK1;CARNS1;UBE2C;DNAH17;NWD1
3583,GO:0007052,0.00581966511929398,0.999237502839667,4,106,mitotic spindle organization,BP,KIFC1;TPX2;BIRC5;MYBL2
17768,GO:0097453,0.00595605838846526,1,1,1,mesaxon,CC,MAG
20856,GO:1990015,0.00595605838846526,1,1,1,ensheathing process,CC,MAG
19828,GO:1903670,0.00595991765513624,0.999501042922622,3,55,regulation of sprouting angiogenesis,BP,FGF1;APLNR;S100A1
4838,GO:0010625,0.0059784885895568,1,1,1,positive regulation of Schwann cell proliferation,BP,GFAP
111,GO:0000226,0.00601878773748013,0.998213691029256,9,487,microtubule cytoskeleton organization,BP,KIFC1;ASPM;TPX2;BIRC5;MYBL2;ESPL1;NUSAP1;CDK1;CNTN2
14067,GO:0051785,0.00601915679371075,0.999494285617694,3,55,positive regulation of nuclear division,BP,ESPL1;NUSAP1;UBE2C
2708,GO:0005694,0.00612658451352933,0.997718235669822,13,898,chromosome,CC,MCM10;BIRC5;MYBL2;NCAPG;CENPF;HSPA2;TOP2A;NUSAP1;DTL;MKI67;BUB1B;BUB1;CDK1
20044,GO:1904106,0.00613651695442452,1,1,1,protein localization to microvillus,BP,USH1C
13341,GO:0050459,0.00614936097313637,1,1,1,ethanolamine-phosphate phospho-lyase activity,MF,ETNPPL
824,GO:0002030,0.00621069583006305,1,1,1,inhibitory G-protein coupled receptor phosphorylation,BP,APLNR
20139,GO:1904323,0.00621069583006305,1,1,1,regulation of inhibitory G-protein coupled receptor phosphorylation,BP,APLNR
20140,GO:1904325,0.00621069583006305,1,1,1,positive regulation of inhibitory G-protein coupled receptor phosphorylation,BP,APLNR
11898,GO:0045177,0.00627419921029083,0.998456566877915,7,322,apical part of cell,CC,USH1C;ASPM;TF;CRB2;MAL;TMEM235;FXYD1
13463,GO:0050769,0.00629158879238874,0.998274913626691,8,404,positive regulation of neurogenesis,BP,ASPM;CPNE6;MAG;PACSIN1;GFAP;NKX6-2;SOX11;LPAR1
20248,GO:1904565,0.00632468523686473,1,1,1,response to 1-oleoyl-sn-glycerol 3-phosphate,BP,LPAR1
20249,GO:1904566,0.00632468523686473,1,1,1,cellular response to 1-oleoyl-sn-glycerol 3-phosphate,BP,LPAR1
13700,GO:0051129,0.00637592959330674,0.997950561841132,10,599,negative regulation of cellular component organization,BP,MAG;CENPF;PACSIN1;HSPA2;GFAP;TOP2A;ESPL1;BUB1B;BUB1;LPAR1
12292,GO:0045995,0.00638476808774255,0.999140806984537,4,108,regulation of embryonic development,BP,SFRP2;CRB2;CDK1;MBP
20195,GO:1904427,0.00641325277136476,0.999447686159752,3,58,positive regulation of calcium ion transmembrane transport,BP,HSPA2;APLNR;S100A1
16328,GO:0071459,0.00649013592372552,0.999768591847247,2,20,protein localization to chromosome, centromeric region,BP,BUB1B;CDK1
2996,GO:0006173,0.00656574824346741,1,1,1,dADP biosynthetic process,BP,AK5
9766,GO:0035498,0.00675084274110947,1,1,1,carnosine metabolic process,BP,CARNS1
9767,GO:0035499,0.00675084274110947,1,1,1,carnosine biosynthetic process,BP,CARNS1
12840,GO:0047730,0.00675084274110947,1,1,1,carnosine synthase activity,MF,CARNS1
18315,GO:0102102,0.00675084274110947,1,1,1,homocarnosine synthase activity,MF,CARNS1
279,GO:0000780,0.0067816026298016,0.999752648187227,2,20,condensed nuclear chromosome, centromeric region,CC,BUB1B;BUB1
19169,GO:1902178,0.00692757585521423,1,1,1,fibroblast growth factor receptor apoptotic signaling pathway,BP,FGFR3
274,GO:0000775,0.00696247292206858,0.99873749102433,5,181,chromosome, centromeric region,CC,BIRC5;NCAPG;CENPF;BUB1B;BUB1
2696,GO:0005680,0.00711868180596485,0.999732715870286,2,21,anaphase-promoting complex,CC,BUB1B;UBE2C
8492,GO:0032559,0.00737192275784283,0.996746745621826,18,1407,adenyl ribonucleotide binding,MF,KIFC1;FGFR3;TPX2;HSPA2;TOP2A;IQCA1;PDGFRA;MKI67;AK5;BUB1B;KIF6;PBK;BUB1;CDK1;CARNS1;UBE2C;DNAH17;NWD1
7182,GO:0030154,0.00745282889418943,0.996024646781205,34,3453,cell differentiation,BP,USH1C;ASPM;FGFR3;DCX;CPNE6;MYBL2;MAG;SEPT4;FOXM1;FGF1;CENPF;PLP1;PACSIN1;MYRF;HSPA2;GFAP;TOP2A;HAPLN2;APLNR;PDGFRA;SFRP2;DAAM2;CRB2;NKX6-2;KLK6;CDK1;EMX2;MAL;SOX11;S1PR5;CNTN2;MYBPC1;LPAR1;ZNF536
20037,GO:1904064,0.00748257204392101,0.998944896123153,4,116,positive regulation of cation transmembrane transport,BP,HSPA2;APLNR;S100A1;FXYD1
14442,GO:0055111,0.00763260478541508,1,1,1,ingression involved in gastrulation with mouth forming second,BP,CRB2
6395,GO:0019035,0.00767243881714218,1,1,1,viral integration complex,CC,TOP2A
12217,GO:0045870,0.00767243881714218,1,1,1,positive regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,TOP2A
20684,GO:1905463,0.00767243881714218,1,1,1,negative regulation of DNA duplex unwinding,BP,TOP2A
3589,GO:0007063,0.00771621236563758,0.999700416196312,2,19,regulation of sister chromatid cohesion,BP,ESPL1;BUB1
10531,GO:0042044,0.00785433414734228,0.999689690309567,2,21,fluid transport,BP,SLC14A1;AQP4
7412,GO:0030554,0.00794496567592095,0.996466372472972,18,1419,adenyl nucleotide binding,MF,KIFC1;FGFR3;TPX2;HSPA2;TOP2A;IQCA1;PDGFRA;MKI67;AK5;BUB1B;KIF6;PBK;BUB1;CDK1;CARNS1;UBE2C;DNAH17;NWD1
5090,GO:0010971,0.00795947610482005,0.999683361654933,2,21,positive regulation of G2/M transition of mitotic cell cycle,BP,DTL;CDK1
12126,GO:0045686,0.00808088149505855,0.999675999330752,2,21,negative regulation of glial cell differentiation,BP,DAAM2;NKX6-2
2384,GO:0005018,0.00812520255580196,1,1,1,platelet-derived growth factor alpha-receptor activity,MF,PDGFRA
8458,GO:0032501,0.00813929646477047,0.99540313448585,51,5878,multicellular organismal process,BP,CRLF1;USH1C;CLDN11;KIFC1;ASPM;FGFR3;DCX;BIRC5;TF;CPNE6;SNTA1;MAG;PTGDS;SEPT4;FGF1;CENPF;PLP1;PACSIN1;MYRF;HSPA2;GFAP;TOP2A;PPP1R1B;HAPLN2;SPX;APLNR;PDGFRA;ERMN;ENPP2;MOG;SFRP2;DAAM2;CRB2;NKX6-2;FREM2;S100A1;KLK6;MOBP;NTSR2;CDK1;EMX2;AQP4;MAL;SOX11;S1PR5;CNTN2;MYBPC1;MBP;LPAR1;ZNF536;FXYD1
12704,GO:0046934,0.00819350847986274,0.999227634558261,3,61,phosphatidylinositol-4,5-bisphosphate 3-kinase activity,MF,FGFR3;FGF1;PDGFRA
13195,GO:0048731,0.0082409991013052,0.995480850288502,38,3992,system development,BP,CRLF1;USH1C;CLDN11;ASPM;FGFR3;DCX;CPNE6;MAG;SEPT4;FGF1;CENPF;PLP1;PACSIN1;MYRF;GFAP;TOP2A;HAPLN2;APLNR;PDGFRA;ENPP2;MOG;SFRP2;DAAM2;CRB2;NKX6-2;FREM2;S100A1;KLK6;MOBP;CDK1;EMX2;MAL;SOX11;S1PR5;CNTN2;MBP;LPAR1;ZNF536
7205,GO:0030182,0.00824996168761314,0.996488418539928,16,1223,neuron differentiation,BP,USH1C;ASPM;CPNE6;MAG;PLP1;PACSIN1;GFAP;SFRP2;NKX6-2;KLK6;EMX2;SOX11;S1PR5;CNTN2;LPAR1;ZNF536
7970,GO:0031644,0.0085164359110755,0.999184606212015,3,64,regulation of neurological system process,BP,MAG;MYRF;SPX
4004,GO:0008283,0.0085611462526622,0.996009560395539,20,1764,cell proliferation,BP,CRLF1;MCM10;ASPM;FGFR3;TPX2;BIRC5;FOXM1;FGF1;FBXO2;CENPF;GFAP;APLNR;PDGFRA;SFRP2;MKI67;BUB1B;BUB1;CDK1;EMX2;SOX11
3558,GO:0007017,0.00863164336780238,0.99693033375059,11,701,microtubule-based process,BP,KIFC1;ASPM;TPX2;BIRC5;MYBL2;ESPL1;NUSAP1;KIF6;CDK1;CNTN2;DNAH17
4748,GO:0010453,0.00867232328906587,0.999636876097253,2,23,regulation of cell fate commitment,BP,SFRP2;NKX6-2
16160,GO:0071206,0.00867739531709904,1,1,1,establishment of protein localization to juxtaparanode region of axon,BP,CNTN2
3593,GO:0007076,0.00911004013614872,0.999620776679442,2,16,mitotic chromosome condensation,BP,NCAPG;NUSAP1
275,GO:0000776,0.00912834055541471,0.998635226563223,4,125,kinetochore,CC,BIRC5;CENPF;BUB1B;BUB1
5814,GO:0016324,0.00916425517267062,0.997875815523805,6,265,apical plasma membrane,CC,ASPM;TF;CRB2;MAL;TMEM235;FXYD1
14317,GO:0052813,0.0093306657599679,0.999076425351902,3,64,phosphatidylinositol bisphosphate kinase activity,MF,FGFR3;FGF1;PDGFRA
5092,GO:0010975,0.00935473507778956,0.9972527976246,8,427,regulation of neuron projection development,BP,CPNE6;MAG;PACSIN1;GFAP;SFRP2;KLK6;CNTN2;LPAR1
137,GO:0000281,0.00942803016375665,0.999063245148298,3,64,mitotic cytokinesis,BP,SEPT4;ESPL1;NUSAP1
16628,GO:0072001,0.00961000840174178,0.99775013780417,6,262,renal system development,BP,CRLF1;FGF1;CENPF;PDGFRA;EMX2;SOX11
7714,GO:0031145,0.00992922062763773,0.998989468073341,3,77,anaphase-promoting complex-dependent catabolic process,BP,BUB1B;CDK1;UBE2C
7972,GO:0031646,0.0100403686767757,0.999546331647694,2,23,positive regulation of neurological system process,BP,MAG;MYRF
21169,GO:2000050,0.0101142760922767,0.999542703187615,2,22,regulation of non-canonical Wnt signaling pathway,BP,SFRP2;DAAM2
3918,GO:0008144,0.0102604182584211,0.995217591466934,19,1585,drug binding,MF,KIFC1;FGFR3;TPX2;HSPA2;TOP2A;IQCA1;PDGFRA;MKI67;AK5;BUB1B;ETNPPL;KIF6;PBK;BUB1;CDK1;CARNS1;UBE2C;DNAH17;NWD1
12167,GO:0045769,0.0103504410787375,1,1,1,negative regulation of asymmetric cell division,BP,ASPM
9529,GO:0034767,0.0103616609542764,0.998392514917566,4,127,positive regulation of ion transmembrane transport,BP,HSPA2;APLNR;S100A1;FXYD1
2138,GO:0004667,0.0106497373404109,0.99997178203471,1,2,prostaglandin-D synthase activity,MF,PTGDS
14589,GO:0060191,0.0107782468257651,0.998872424117916,3,70,regulation of lipase activity,BP,FGFR3;PDGFRA;LPAR1
4907,GO:0010731,0.0108778715153405,0.999970556719289,1,2,protein glutathionylation,BP,FXYD1
4908,GO:0010732,0.0108778715153405,0.999970556719289,1,2,regulation of protein glutathionylation,BP,FXYD1
4909,GO:0010734,0.0108778715153405,0.999970556719289,1,2,negative regulation of protein glutathionylation,BP,FXYD1
19396,GO:1902751,0.0109974008834334,0.99947603803083,2,25,positive regulation of cell cycle G2/M phase transition,BP,DTL;CDK1
17598,GO:0097125,0.0113737931448981,0.99996780275618,1,2,cyclin B1-CDK1 complex,CC,CDK1
6363,GO:0018479,0.0113979454331584,0.99996766547125,1,2,benzaldehyde dehydrogenase (NAD+) activity,MF,ALDH1A1
3200,GO:0006500,0.0114313439595924,0.999967475145451,1,2,N-terminal protein palmitoylation,BP,HHATL
10488,GO:0040001,0.0116462432885266,0.999429788768665,2,24,establishment of mitotic spindle localization,BP,ESPL1;NUSAP1
8035,GO:0031750,0.0117037718488265,0.999965901698046,1,2,D3 dopamine receptor binding,MF,PPP1R1B
4403,GO:0009183,0.0117547539368248,0.999965603090399,1,2,purine deoxyribonucleoside diphosphate biosynthetic process,BP,AK5
15637,GO:0070194,0.0119376238840749,0.999964521226707,1,2,synaptonemal complex disassembly,BP,HSPA2
2779,GO:0005815,0.0119826808055261,0.995765082109815,10,655,microtubule organizing center,CC,KIFC1;ASPM;TPX2;CENPF;TOP2A;ESPL1;DTL;AK5;BUB1B;CDK1
9558,GO:0035004,0.012071080167291,0.998684015287285,3,69,phosphatidylinositol 3-kinase activity,MF,FGFR3;FGF1;PDGFRA
13800,GO:0051276,0.0121675230556632,0.994883585273394,14,1085,chromosome organization,BP,KIFC1;BIRC5;NCAPG;CENPF;HSPA2;TOP2A;PPP1R1B;ESPL1;NUSAP1;MKI67;BUB1B;BUB1;CDK1;UBE2C
20083,GO:1904207,0.0122197209275633,0.999962819276954,1,2,regulation of chemokine (C-C motif) ligand 2 secretion,BP,MBP
20084,GO:1904209,0.0122197209275633,0.999962819276954,1,2,positive regulation of chemokine (C-C motif) ligand 2 secretion,BP,MBP
5885,GO:0016492,0.0123432689301205,0.999962061252362,1,2,G-protein coupled neurotensin receptor activity,MF,NTSR2
16883,GO:0072395,0.01239627776772,0.998632702793651,3,74,signal transduction involved in cell cycle checkpoint,BP,DTL;CDK1;SOX11
2995,GO:0006172,0.0124195295404924,0.999961589515772,1,2,ADP biosynthetic process,BP,AK5
15143,GO:0061054,0.0124230089124483,0.999961567922938,1,2,dermatome development,BP,SFRP2
15207,GO:0061183,0.0124230089124483,0.999961567922938,1,2,regulation of dermatome development,BP,SFRP2
19099,GO:1901988,0.0125149401330587,0.997376203294432,5,219,negative regulation of cell cycle phase transition,BP,CENPF;DTL;BUB1B;BUB1;CDK1
12316,GO:0046056,0.0126751393582525,0.999959986957157,1,2,dADP metabolic process,BP,AK5
21161,GO:2000040,0.012712085933307,0.999959752592082,1,2,regulation of planar cell polarity pathway involved in axis elongation,BP,SFRP2
21162,GO:2000041,0.012712085933307,0.999959752592082,1,2,negative regulation of planar cell polarity pathway involved in axis elongation,BP,SFRP2
3887,GO:0008092,0.0128794761685402,0.994927054427867,12,839,cytoskeletal protein binding,MF,USH1C;KIFC1;DCX;BIRC5;SNTA1;PACSIN1;ERMN;NUSAP1;DAAM2;KIF6;MOBP;MYBPC1
4897,GO:0010720,0.0129161985589453,0.995983191085682,8,461,positive regulation of cell development,BP,ASPM;CPNE6;MAG;PACSIN1;GFAP;NKX6-2;SOX11;LPAR1
5132,GO:0014028,0.0130932356310738,0.999957294612695,1,2,notochord formation,BP,CRB2
12155,GO:0045745,0.0131101856840556,0.999312082757257,2,27,positive regulation of G-protein coupled receptor protein signaling pathway,BP,KLK6;CNTN2
20312,GO:1904685,0.0131135861260556,0.999957161312972,1,2,positive regulation of metalloendopeptidase activity,BP,MBP
14623,GO:0060251,0.0132439301905583,0.999304621872761,2,25,regulation of glial cell proliferation,BP,GFAP;SOX11
3761,GO:0007420,0.0135193134341367,0.99513289021477,10,649,brain development,BP,ASPM;SEPT4;CENPF;PLP1;SFRP2;S100A1;EMX2;CNTN2;MBP;LPAR1
13187,GO:0048710,0.0137744327276704,0.999258267777585,2,27,regulation of astrocyte differentiation,BP,MAG;CNTN2
3081,GO:0006323,0.0141210183601756,0.99759741772804,4,142,DNA packaging,BP,NCAPG;TOP2A;NUSAP1;CDK1
15142,GO:0061053,0.0141308756074063,0.998364668605811,3,73,somite development,BP,SFRP2;CRB2;SOX11
4486,GO:0009330,0.0142643820607252,0.999949282927519,1,2,DNA topoisomerase complex (ATP-hydrolyzing),CC,TOP2A
20683,GO:1905462,0.0144421106739696,0.999948006506567,1,2,regulation of DNA duplex unwinding,BP,TOP2A
9551,GO:0034986,0.014532611957228,0.999947350398869,1,2,iron chaperone activity,MF,TF
9963,GO:0035790,0.0147640861221011,0.999945653421376,1,2,platelet-derived growth factor receptor-alpha signaling pathway,BP,PDGFRA
17620,GO:0097166,0.0149058648515264,0.999944600623574,1,2,lens epithelial cell proliferation,BP,SOX11
21746,GO:2001109,0.0149058648515264,0.999944600623574,1,2,regulation of lens epithelial cell proliferation,BP,SOX11
21747,GO:2001111,0.0149058648515264,0.999944600623574,1,2,positive regulation of lens epithelial cell proliferation,BP,SOX11
5634,GO:0015949,0.0149883288303379,0.999148687493104,2,32,nucleobase-containing small molecule interconversion,BP,AK5;RRM2
1688,GO:0003918,0.0150238799297438,0.999943716524589,1,2,DNA topoisomerase type II (ATP-hydrolyzing) activity,MF,TOP2A
15314,GO:0061505,0.0150238799297438,0.999943716524589,1,2,DNA topoisomerase II activity,MF,TOP2A
15381,GO:0061640,0.0150381122254918,0.998216635345858,3,77,cytoskeleton-dependent cytokinesis,BP,SEPT4;ESPL1;NUSAP1
16611,GO:0071944,0.0151665183774383,0.99125606412491,39,4325,cell periphery,CC,USH1C;CLDN11;ASPM;FGFR3;SLCO1A2;TF;CPNE6;SNTA1;MAG;SEPT4;FGF1;PLP1;PACSIN1;HSPA2;APLNR;PDGFRA;ERMN;ENPP2;MOG;SLC14A1;CRB2;FREM2;SLC5A11;PAQR6;MOBP;NTSR2;AQP4;MAL;UBE2C;S1PR5;GPR62;CALN1;CNTN2;NKAIN2;OPALIN;MBP;LPAR1;TMEM235;FXYD1
12166,GO:0045766,0.0151846165465487,0.997359944891096,4,144,positive regulation of angiogenesis,BP,FGF1;APLNR;SFRP2;S100A1
7911,GO:0031523,0.0151982274132289,0.999942397509979,1,2,Myb complex,CC,MYBL2
11563,GO:0044297,0.0156590885839943,0.99495747093346,8,487,cell body,CC,TPX2;CPNE6;GFAP;PPP1R1B;ERMN;CNTN2;MBP;LPAR1
16810,GO:0072275,0.0157390443381399,0.99993820801894,1,2,metanephric glomerulus morphogenesis,BP,PDGFRA
16811,GO:0072276,0.0157390443381399,0.99993820801894,1,2,metanephric glomerulus vasculature morphogenesis,BP,PDGFRA
16812,GO:0072277,0.0157390443381399,0.99993820801894,1,2,metanephric glomerular capillary formation,BP,PDGFRA
4463,GO:0009262,0.0158504832568032,0.999071508837848,2,33,deoxyribonucleotide metabolic process,BP,AK5;RRM2
557,GO:0001655,0.0160034954442906,0.995811341987209,6,294,urogenital system development,BP,CRLF1;FGF1;CENPF;PDGFRA;EMX2;SOX11
17982,GO:0098687,0.0165158611155936,0.995645081576022,6,310,chromosomal region,CC,BIRC5;NCAPG;CENPF;BUB1B;BUB1;CDK1
1574,GO:0003401,0.0166623080892744,0.999004407959992,2,29,axis elongation,BP,FGF1;SFRP2
822,GO:0002028,0.0167607627811998,0.997928564544342,3,80,regulation of sodium ion transport,BP,SNTA1;NKAIN2;FXYD1
2282,GO:0004864,0.0167682763757794,0.998991253635577,2,31,protein phosphatase inhibitor activity,MF,PPP1R1B;PPP1R14A
9868,GO:0035639,0.0168314657790327,0.991732235439475,19,1677,purine ribonucleoside triphosphate binding,MF,KIFC1;FGFR3;TPX2;SEPT4;HSPA2;TOP2A;IQCA1;PDGFRA;MKI67;AK5;BUB1B;KIF6;PBK;BUB1;CDK1;CARNS1;UBE2C;DNAH17;NWD1
13079,GO:0048523,0.0168671378209736,0.990267595857227,37,4114,negative regulation of cellular process,BP,CRLF1;HHATL;ASPM;FGFR3;BIRC5;SNTA1;MAG;FOXM1;FBXO2;CENPF;PACSIN1;HSPA2;GFAP;TOP2A;PPP1R1B;APLNR;PDGFRA;ESPL1;DTL;SFRP2;DAAM2;CRB2;NKX6-2;BUB1B;S100A1;PI16;PPP1R14A;PBK;BUB1;CDK1;RRM2;SOX11;CNTN2;MBP;LPAR1;ZNF536;FXYD1
17558,GO:0097058,0.0168768924410074,0.999905302813331,1,3,CRLF-CLCF1 complex,CC,CRLF1
18713,GO:1900390,0.016999630025113,0.999903915069815,1,3,regulation of iron ion import,BP,TF
6079,GO:0016838,0.0170505459272783,0.999903336399262,1,3,carbon-oxygen lyase activity, acting on phosphates,MF,ETNPPL
15278,GO:0061386,0.0170796491457843,0.999927183295588,1,2,closure of optic fissure,BP,SOX11
5335,GO:0015144,0.0172329976819914,0.998946616995816,2,32,carbohydrate transmembrane transporter activity,MF,SLC5A11;TMEM144
7842,GO:0031401,0.0172690023920189,0.992647350086846,13,1036,positive regulation of protein modification process,BP,CRLF1;FGFR3;TPX2;SEPT4;FGF1;HSPA2;APLNR;PDGFRA;ENPP2;SFRP2;CDK1;UBE2C;LPAR1
11331,GO:0043552,0.0172774369826095,0.998945861163152,2,30,positive regulation of phosphatidylinositol 3-kinase activity,BP,FGFR3;PDGFRA
4377,GO:0009153,0.0174608567542288,0.999898609211004,1,3,purine deoxyribonucleotide biosynthetic process,BP,AK5
7383,GO:0030510,0.0175435049799982,0.997795205122801,3,79,regulation of BMP signaling pathway,BP,SFRP2;CRB2;SOX11
4360,GO:0009136,0.0175782666437501,0.999897235601209,1,3,purine nucleoside diphosphate biosynthetic process,BP,AK5
4400,GO:0009180,0.0175782666437501,0.999897235601209,1,3,purine ribonucleoside diphosphate biosynthetic process,BP,AK5
4407,GO:0009188,0.0175782666437501,0.999897235601209,1,3,ribonucleoside diphosphate biosynthetic process,BP,AK5
20725,GO:1905576,0.0177276074155757,0.999895474961609,1,3,ganglioside GT1b binding,MF,MAG
4111,GO:0008453,0.0177337156607731,0.999895402628095,1,3,alanine-glyoxylate transaminase activity,MF,ETNPPL
9691,GO:0035332,0.0177473338713707,0.999921351985259,1,2,positive regulation of hippo signaling,BP,SOX11
4402,GO:0009182,0.0178325546724038,0.999894228675674,1,3,purine deoxyribonucleoside diphosphate metabolic process,BP,AK5
6194,GO:0017080,0.017840229106349,0.998889397990306,2,32,sodium channel regulator activity,MF,SNTA1;FXYD1
6654,GO:0019828,0.0179208200162253,0.999893174728527,1,3,aspartic-type endopeptidase inhibitor activity,MF,CRB2
83,GO:0000166,0.0179865513968585,0.990817927024193,21,1948,nucleotide binding,MF,KIFC1;FGFR3;TPX2;SEPT4;HSPA2;TOP2A;IQCA1;PDGFRA;MKI67;AK5;BUB1B;KIF6;ALDH1A1;PBK;BUB1;CDK1;CARNS1;UBE2C;AIFM3;DNAH17;NWD1
16470,GO:0071673,0.0180230936449878,0.999891946924874,1,3,positive regulation of smooth muscle cell chemotaxis,BP,LPAR1
18854,GO:1901265,0.0180608234671637,0.990776072821756,21,1949,nucleoside phosphate binding,MF,KIFC1;FGFR3;TPX2;SEPT4;HSPA2;TOP2A;IQCA1;PDGFRA;MKI67;AK5;BUB1B;KIF6;ALDH1A1;PBK;BUB1;CDK1;CARNS1;UBE2C;AIFM3;DNAH17;NWD1
13102,GO:0048566,0.0181404123710214,0.998860720551135,2,32,embryonic digestive tract development,BP,PDGFRA;SOX11
12801,GO:0047391,0.0182212193833274,0.999889548283347,1,3,alkylglycerophosphoethanolamine phosphodiesterase activity,MF,ENPP2
5001,GO:0010863,0.018227215096921,0.998854159505413,2,31,positive regulation of phospholipase C activity,BP,PDGFRA;LPAR1
8034,GO:0031749,0.0184381986503225,0.99988689092518,1,3,D2 dopamine receptor binding,MF,PPP1R1B
5389,GO:0015265,0.0186161086540054,0.999884688282533,1,3,urea channel activity,MF,SLC14A1
6461,GO:0019212,0.0186906899162917,0.998805752058071,2,33,phosphatase inhibitor activity,MF,PPP1R1B;PPP1R14A
6959,GO:0021912,0.018694549783595,0.999883710325418,1,3,regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification,BP,NKX6-2
3872,GO:0008065,0.0188040447554356,0.99988233824306,1,3,establishment of blood-nerve barrier,BP,HAPLN2
292,GO:0000794,0.0188545050780132,0.997563521483984,3,82,condensed nuclear chromosome,CC,HSPA2;BUB1B;BUB1
18767,GO:1901021,0.0188700599736428,0.998791823496768,2,31,positive regulation of calcium ion transmembrane transporter activity,BP,HSPA2;S100A1
17306,GO:0090218,0.0191390792178998,0.998763478513858,2,32,positive regulation of lipid kinase activity,BP,FGFR3;PDGFRA
14676,GO:0060322,0.0192898791436567,0.992655861461224,10,688,head development,BP,ASPM;SEPT4;CENPF;PLP1;SFRP2;S100A1;EMX2;CNTN2;MBP;LPAR1
2322,GO:0004930,0.0193813912614753,0.994700243531635,6,347,G-protein coupled receptor activity,MF,APLNR;SFRP2;NTSR2;S1PR5;GPR62;LPAR1
5305,GO:0015091,0.0196192480259167,0.999871867683191,1,3,ferric iron transmembrane transporter activity,MF,TF
16909,GO:0072510,0.0196192480259167,0.999871867683191,1,3,trivalent inorganic cation transmembrane transporter activity,MF,TF
10993,GO:0043005,0.0196763584141648,0.991203186638874,14,1134,neuron projection,CC,USH1C;DCX;TPX2;CPNE6;MAG;FBXO2;PACSIN1;ERMN;S100A1;FAM107A;LGI3;CNTN2;MBP;LPAR1
5117,GO:0014002,0.0197193273069902,0.99870770219028,2,31,astrocyte development,BP,PLP1;GFAP
13776,GO:0051241,0.0197407458970239,0.991742255862303,12,946,negative regulation of multicellular organismal process,BP,ASPM;MAG;GFAP;SPX;PDGFRA;SFRP2;DAAM2;NKX6-2;SOX11;CNTN2;LPAR1;ZNF536
7386,GO:0030513,0.0197956851781624,0.998700041292396,2,31,positive regulation of BMP signaling pathway,BP,CRB2;SOX11
7932,GO:0031572,0.0198613395931174,0.998691417451115,2,32,G2 DNA damage checkpoint,BP,DTL;CDK1
2198,GO:0004748,0.0199238350925169,0.999867839981635,1,3,ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor,MF,RRM2
2872,GO:0005971,0.0199238350925169,0.999867839981635,1,3,ribonucleoside-diphosphate reductase complex,CC,RRM2
6014,GO:0016728,0.0199238350925169,0.999867839981635,1,3,oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor,MF,RRM2
15421,GO:0061731,0.0199238350925169,0.999867839981635,1,3,ribonucleoside-diphosphate reductase activity,MF,RRM2
13135,GO:0048640,0.0200764499123429,0.997341573925187,3,85,negative regulation of developmental growth,BP,FGFR3;MAG;SFRP2
14575,GO:0060168,0.0201067968178412,0.999865390351628,1,3,positive regulation of adenosine receptor signaling pathway,BP,CNTN2
8037,GO:0031752,0.0203844280832522,0.999861629850501,1,3,D5 dopamine receptor binding,MF,PPP1R1B
5896,GO:0016504,0.0204242185174103,0.998628667973843,2,35,peptidase activator activity,MF,SFRP2;MAL
5929,GO:0016572,0.0204597851132965,0.998626772334055,2,34,histone phosphorylation,BP,PPP1R1B;CDK1
18694,GO:1900274,0.0206409956420727,0.998610013710954,2,33,regulation of phospholipase C activity,BP,PDGFRA;LPAR1
3831,GO:0007621,0.0208638904105783,0.999855012408854,1,3,negative regulation of female receptivity,BP,PPP1R1B
4647,GO:0009967,0.0208861550423047,0.990091524673847,16,1422,positive regulation of signal transduction,BP,CRLF1;ASPM;FGFR3;SEPT4;FGF1;PDGFRA;SFRP2;DAAM2;CRB2;KLK6;CDK1;MAL;SOX11;GPR62;CNTN2;LPAR1
8488,GO:0032555,0.0209319693331908,0.98946943267675,19,1716,purine ribonucleotide binding,MF,KIFC1;FGFR3;TPX2;SEPT4;HSPA2;TOP2A;IQCA1;PDGFRA;MKI67;AK5;BUB1B;KIF6;PBK;BUB1;CDK1;CARNS1;UBE2C;DNAH17;NWD1
20466,GO:1904970,0.0210951759022983,0.999851764459374,1,3,brush border assembly,BP,USH1C
2383,GO:0005017,0.0211415267249893,0.999851109184035,1,3,platelet-derived growth factor-activated receptor activity,MF,PDGFRA
5140,GO:0014038,0.0215334005388169,0.999845510823038,1,3,regulation of Schwann cell differentiation,BP,CDK1
328,GO:0000910,0.0215737798282007,0.995829508190757,4,157,cytokinesis,BP,SEPT4;PACSIN1;ESPL1;NUSAP1
3969,GO:0008219,0.0216821676138899,0.988873295860247,20,1940,cell death,BP,CRLF1;FGFR3;TPX2;BIRC5;MYBL2;MAG;SEPT4;TOP2A;PDGFRA;ESPL1;SFRP2;BUB1B;SLC5A11;KLK6;BUB1;CDK1;MAL;SOX11;AIFM3;LPAR1
3321,GO:0006650,0.021686280963091,0.993921307261473,6,331,glycerophospholipid metabolic process,BP,FGFR3;CPNE6;FGF1;PDGFRA;ENPP2;ETNPPL
7402,GO:0030544,0.0218824120474002,0.99847419742877,2,36,Hsp70 protein binding,MF,FGF1;CDK1
20007,GO:1904018,0.0220709894739786,0.995702518320781,4,161,positive regulation of vasculature development,BP,FGF1;APLNR;SFRP2;S100A1
10374,GO:0038086,0.0221636650004966,0.999836287877722,1,3,VEGF-activated platelet-derived growth factor receptor signaling pathway,BP,PDGFRA
10376,GO:0038091,0.0221636650004966,0.999836287877722,1,3,positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway,BP,PDGFRA
6746,GO:0021510,0.0222145830526805,0.996941065772168,3,89,spinal cord development,BP,DAAM2;NKX6-2;SOX11
8486,GO:0032553,0.0222670699105793,0.98872050962447,19,1728,ribonucleotide binding,MF,KIFC1;FGFR3;TPX2;SEPT4;HSPA2;TOP2A;IQCA1;PDGFRA;MKI67;AK5;BUB1B;KIF6;PBK;BUB1;CDK1;CARNS1;UBE2C;DNAH17;NWD1
7920,GO:0031536,0.0222721172335761,0.999814125218824,1,4,positive regulation of exit from mitosis,BP,UBE2C
7373,GO:0030496,0.0222912307116,0.995646966593793,4,160,midbody,CC,ASPM;BIRC5;CENPF;CDK1
2597,GO:0005497,0.0223279956801115,0.999813186903195,1,4,androgen binding,MF,ALDH1A1
6192,GO:0017076,0.0224210184077551,0.988633782717049,19,1730,purine nucleotide binding,MF,KIFC1;FGFR3;TPX2;SEPT4;HSPA2;TOP2A;IQCA1;PDGFRA;MKI67;AK5;BUB1B;KIF6;PBK;BUB1;CDK1;CARNS1;UBE2C;DNAH17;NWD1
10846,GO:0042662,0.0224254322305363,0.999811545034893,1,4,negative regulation of mesodermal cell fate specification,BP,SFRP2
20783,GO:1905771,0.0224254322305363,0.999811545034893,1,4,negative regulation of mesodermal cell differentiation,BP,SFRP2
20826,GO:1905903,0.0224254322305363,0.999811545034893,1,4,negative regulation of mesoderm formation,BP,SFRP2
20674,GO:1905448,0.0224957367282846,0.999810355854544,1,4,positive regulation of mitochondrial ATP synthesis coupled electron transport,BP,CDK1
14141,GO:0051928,0.0225269872192757,0.996878853906427,3,93,positive regulation of calcium ion transport,BP,HSPA2;APLNR;S100A1
19621,GO:1903276,0.0225785004724336,0.999808951090157,1,4,regulation of sodium ion export across plasma membrane,BP,FXYD1
19622,GO:1903278,0.0225785004724336,0.999808951090157,1,4,positive regulation of sodium ion export across plasma membrane,BP,FXYD1
5121,GO:0014009,0.0227060754569793,0.998389381576216,2,34,glial cell proliferation,BP,GFAP;SOX11
17199,GO:0090068,0.0227505319665688,0.994450147743898,5,244,positive regulation of cell cycle process,BP,ESPL1;NUSAP1;DTL;CDK1;UBE2C
4858,GO:0010647,0.0228037673461391,0.988830319087155,17,1558,positive regulation of cell communication,BP,CRLF1;ASPM;FGFR3;SEPT4;FGF1;GFAP;PDGFRA;SFRP2;DAAM2;CRB2;KLK6;CDK1;MAL;SOX11;GPR62;CNTN2;LPAR1
896,GO:0002141,0.0229549211191844,0.9998243265495,1,3,stereocilia ankle link,CC,USH1C
897,GO:0002142,0.0229549211191844,0.9998243265495,1,3,stereocilia ankle link complex,CC,USH1C
15145,GO:0061056,0.0230665889802577,0.999800560206394,1,4,sclerotome development,BP,SFRP2
12127,GO:0045687,0.0231099113846081,0.998339308719752,2,37,positive regulation of glial cell differentiation,BP,MAG;NKX6-2
4408,GO:0009189,0.0231400345549393,0.999799281816735,1,4,deoxyribonucleoside diphosphate biosynthetic process,BP,AK5
751,GO:0001934,0.023346960619302,0.990389178605631,11,852,positive regulation of protein phosphorylation,BP,CRLF1;FGFR3;TPX2;FGF1;HSPA2;APLNR;PDGFRA;ENPP2;SFRP2;CDK1;LPAR1
7031,GO:0022603,0.0235259894947057,0.989908135953709,12,943,regulation of anatomical structure morphogenesis,BP,CPNE6;MAG;FGF1;APLNR;ERMN;ENPP2;SFRP2;CRB2;S100A1;CNTN2;MBP;LPAR1
12165,GO:0045765,0.0235917925351037,0.994190793427468,5,245,regulation of angiogenesis,BP,FGF1;APLNR;ENPP2;SFRP2;S100A1
21546,GO:2000648,0.0236313965701411,0.998285563414928,2,35,positive regulation of stem cell proliferation,BP,ASPM;SOX11
7092,GO:0023056,0.0236668288545839,0.988356284492586,17,1565,positive regulation of signaling,BP,CRLF1;ASPM;FGFR3;SEPT4;FGF1;GFAP;PDGFRA;SFRP2;DAAM2;CRB2;KLK6;CDK1;MAL;SOX11;GPR62;CNTN2;LPAR1
3610,GO:0007127,0.0237281886350236,0.996645056584613,3,96,meiosis I,BP,HSPA2;TOP2A;ESPL1
75,GO:0000152,0.0237592587910382,0.998265429001796,2,38,nuclear ubiquitin ligase complex,CC,BUB1B;UBE2C
345,GO:0000942,0.0237794506946282,0.999787977862608,1,4,condensed nuclear chromosome outer kinetochore,CC,BUB1
6287,GO:0018108,0.0238300839055606,0.993176463399677,6,334,peptidyl-tyrosine phosphorylation,BP,CRLF1;FGFR3;FGF1;PDGFRA;ENPP2;SFRP2
7841,GO:0031400,0.0238432487255657,0.991702013293235,8,536,negative regulation of protein modification process,BP,HHATL;SNTA1;FOXM1;PPP1R1B;SFRP2;PPP1R14A;PBK;FXYD1
2893,GO:0006001,0.0238926127660725,0.999785944741041,1,4,fructose catabolic process,BP,ALDH1A1
15373,GO:0061624,0.0238926127660725,0.999785944741041,1,4,fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate,BP,ALDH1A1
13813,GO:0051293,0.0239358530600952,0.998253826186918,2,34,establishment of spindle localization,BP,ESPL1;NUSAP1
7861,GO:0031430,0.0240251512253721,0.998257381881764,2,29,M band,CC,S100A1;MYBPC1
9832,GO:0035594,0.0240576716114995,0.999782961643385,1,4,ganglioside binding,MF,MAG
11009,GO:0043025,0.0240727199675171,0.992291557321339,7,425,neuronal cell body,CC,TPX2;CPNE6;PPP1R1B;ERMN;CNTN2;MBP;LPAR1
6960,GO:0021913,0.0242600376180871,0.9997792758342,1,4,regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification,BP,NKX6-2
11891,GO:0045163,0.0242837701074768,0.99980327916891,1,3,clustering of voltage-gated potassium channels,BP,CNTN2
17765,GO:0097450,0.0243535180688456,0.999777562632319,1,4,astrocyte end-foot,CC,GFAP
5173,GO:0014075,0.0245307875931432,0.998182373512064,2,36,response to amine,BP,PPP1R1B;CDK1
13892,GO:0051445,0.0246201728853235,0.998168178905139,2,38,regulation of meiotic cell cycle,BP,ASPM;CDK1
21568,GO:2000672,0.0246594533382037,0.999771909007661,1,4,negative regulation of motor neuron apoptotic process,BP,CRLF1
12658,GO:0046854,0.0246837385040526,0.996460977171891,3,91,phosphatidylinositol phosphorylation,BP,FGFR3;FGF1;PDGFRA
6319,GO:0018212,0.0247127589159585,0.99286467890696,6,337,peptidyl-tyrosine modification,BP,CRLF1;FGFR3;FGF1;PDGFRA;ENPP2;SFRP2
13778,GO:0051247,0.0249910760443659,0.987880340875415,16,1452,positive regulation of protein metabolic process,BP,CRLF1;FGFR3;TPX2;SEPT4;FGF1;HSPA2;APLNR;PDGFRA;ENPP2;DTL;SFRP2;CDK1;UBE2C;CNTN2;MBP;LPAR1
12057,GO:0045595,0.0250779675768458,0.987577183131956,17,1540,regulation of cell differentiation,BP,ASPM;CPNE6;MAG;PACSIN1;GFAP;PDGFRA;SFRP2;DAAM2;CRB2;NKX6-2;KLK6;CDK1;SOX11;S1PR5;CNTN2;LPAR1;ZNF536
15507,GO:0061982,0.025086222925497,0.996375898550142,3,98,meiosis I cell cycle process,BP,HSPA2;TOP2A;ESPL1
3740,GO:0007369,0.02524392118363,0.994879282182591,4,164,gastrulation,BP,APLNR;SFRP2;CRB2;MBP
16596,GO:0071918,0.025348902444505,0.999758905185256,1,4,urea transmembrane transport,BP,SLC14A1
14574,GO:0060167,0.0255032728773428,0.999755943644159,1,4,regulation of adenosine receptor signaling pathway,BP,CNTN2
18919,GO:1901509,0.02557725569671,0.999754517831817,1,4,regulation of endothelial tube morphogenesis,BP,FGF1
5653,GO:0016013,0.0256041313207722,0.999753998839585,1,4,syntrophin complex,CC,SNTA1
8292,GO:0032286,0.0256296381548865,0.999753505767447,1,4,central nervous system myelin maintenance,BP,MYRF
833,GO:0002040,0.0259452222878961,0.996206479375076,3,94,sprouting angiogenesis,BP,FGF1;APLNR;S100A1
18968,GO:1901618,0.0260437732685373,0.99800125139458,2,39,organic hydroxy compound transmembrane transporter activity,MF,SLCO1A2;SLC5A11
14919,GO:0060681,0.0260813921620022,0.999744690207035,1,4,branch elongation involved in ureteric bud branching,BP,FGF1
6230,GO:0017145,0.0261422673591647,0.997993823513586,2,37,stem cell division,BP,ASPM;SFRP2
13448,GO:0050748,0.0262393101132641,0.999741571639505,1,4,negative regulation of lipoprotein metabolic process,BP,HHATL
9863,GO:0035633,0.0267077900717635,0.999732207424852,1,4,maintenance of permeability of blood-brain barrier,BP,MBP
7264,GO:0030263,0.0270244560269189,0.99972578225461,1,4,apoptotic chromosome condensation,BP,TOP2A
11583,GO:0044323,0.0273251067794639,0.999719610718247,1,4,retinoic acid-responsive element binding,MF,ZNF536
7711,GO:0031133,0.0273631386449424,0.999718825077411,1,4,regulation of axon diameter,BP,CNTN2
9526,GO:0034764,0.0276409762871898,0.994233451129238,4,169,positive regulation of transmembrane transport,BP,HSPA2;APLNR;S100A1;FXYD1
671,GO:0001822,0.0276446249183746,0.99290774667848,5,246,kidney development,BP,CRLF1;FGF1;CENPF;PDGFRA;SOX11
17323,GO:0090244,0.0280409206543542,0.99970463727905,1,4,Wnt signaling pathway involved in somitogenesis,BP,SFRP2
8210,GO:0032133,0.0281596138041787,0.999682409981227,1,5,chromosome passenger complex,CC,BIRC5
18003,GO:0098742,0.0282733439411257,0.994062760200129,4,164,cell-cell adhesion via plasma-membrane adhesion molecules,BP,CLDN11;MAG;CRB2;MBP
5801,GO:0016303,0.028274814742584,0.997737228823834,2,37,1-phosphatidylinositol-3-kinase activity,MF,FGFR3;FGF1
16038,GO:0070925,0.028285861624956,0.988539337065494,10,747,organelle assembly,BP,KIFC1;ASPM;TPX2;BIRC5;MYBL2;SEPT4;CENPF;PDGFRA;CDK1;MYBPC1
8928,GO:0033267,0.0286184694148896,0.991455460885203,6,338,axon part,CC,TPX2;MAG;PACSIN1;ERMN;CNTN2;MBP
17372,GO:0090306,0.0286642628757885,0.999691277001263,1,4,spindle assembly involved in meiosis,BP,ASPM
20672,GO:1905446,0.0287005789344821,0.99967001694865,1,5,regulation of mitochondrial ATP synthesis coupled electron transport,BP,CDK1
10668,GO:0042325,0.028728496504182,0.986142607138635,15,1340,regulation of phosphorylation,BP,CRLF1;FGFR3;TPX2;FOXM1;FGF1;HSPA2;PPP1R1B;APLNR;PDGFRA;ENPP2;SFRP2;PPP1R14A;PBK;CDK1;LPAR1
9979,GO:0035814,0.0287416016068289,0.999669067365135,1,5,negative regulation of renal sodium excretion,BP,SPX
13116,GO:0048598,0.0287640958800166,0.98962966944092,8,539,embryonic morphogenesis,BP,USH1C;APLNR;PDGFRA;SFRP2;CRB2;FREM2;SOX11;MBP
13255,GO:0048856,0.0289226608591349,0.982290765168234,42,4897,anatomical structure development,BP,CRLF1;USH1C;CLDN11;ASPM;FGFR3;DCX;CPNE6;MAG;SEPT4;FOXM1;FGF1;CENPF;PLP1;PACSIN1;MYRF;HSPA2;GFAP;TOP2A;HAPLN2;APLNR;PDGFRA;ERMN;ENPP2;MOG;SFRP2;DAAM2;CRB2;NKX6-2;FREM2;S100A1;KLK6;MOBP;CDK1;EMX2;MAL;SOX11;S1PR5;CNTN2;MYBPC1;MBP;LPAR1;ZNF536
4658,GO:0009996,0.0289705630851741,0.999663742059116,1,5,negative regulation of cell fate specification,BP,SFRP2
4405,GO:0009186,0.0291485161966443,0.999659573422731,1,5,deoxyribonucleoside diphosphate metabolic process,BP,AK5
4591,GO:0009786,0.0292226890793102,0.999679053974316,1,4,regulation of asymmetric cell division,BP,ASPM
16034,GO:0070915,0.0292885020279263,0.999656275923119,1,5,lysophosphatidic acid receptor activity,MF,LPAR1
749,GO:0001932,0.0293439253763326,0.986163685094703,14,1227,regulation of protein phosphorylation,BP,CRLF1;FGFR3;TPX2;FOXM1;FGF1;HSPA2;PPP1R1B;APLNR;PDGFRA;ENPP2;SFRP2;PBK;CDK1;LPAR1
3498,GO:0006915,0.0296523334404427,0.984734894231473,18,1746,apoptotic process,BP,CRLF1;FGFR3;TPX2;BIRC5;MYBL2;MAG;SEPT4;TOP2A;PDGFRA;ESPL1;SFRP2;BUB1B;SLC5A11;BUB1;CDK1;MAL;AIFM3;LPAR1
11330,GO:0043551,0.0297328354991345,0.997548119821598,2,40,regulation of phosphatidylinositol 3-kinase activity,BP,FGFR3;PDGFRA
20462,GO:1904956,0.0299051456603292,0.999641558748316,1,5,regulation of midbrain dopaminergic neuron differentiation,BP,SFRP2
5107,GO:0010994,0.0299411169183952,0.999640690596598,1,5,free ubiquitin chain polymerization,BP,UBE2C
17929,GO:0098574,0.0299808017596972,0.999639731585684,1,5,cytoplasmic side of lysosomal membrane,CC,GFAP
16695,GO:0072103,0.0300040583346452,0.999661547638684,1,4,glomerulus vasculature morphogenesis,BP,PDGFRA
16696,GO:0072104,0.0300040583346452,0.999661547638684,1,4,glomerular capillary formation,BP,PDGFRA
9925,GO:0035727,0.0300118658942966,0.999638979997078,1,5,lysophosphatidic acid binding,MF,LPAR1
7884,GO:0031461,0.0300379038976421,0.99356652314442,4,180,cullin-RING ubiquitin ligase complex,CC,FBXO2;DTL;BUB1B;UBE2C
19071,GO:1901896,0.0301204432599181,0.999658899777783,1,4,positive regulation of calcium-transporting ATPase activity,BP,HSPA2
8280,GO:0032270,0.0301211895926254,0.985380290288582,15,1363,positive regulation of cellular protein metabolic process,BP,CRLF1;FGFR3;TPX2;SEPT4;FGF1;HSPA2;APLNR;PDGFRA;ENPP2;SFRP2;CDK1;UBE2C;CNTN2;MBP;LPAR1
20131,GO:1904304,0.0302292005308486,0.99963369946177,1,5,regulation of gastro-intestinal system smooth muscle contraction,BP,SPX
20132,GO:1904306,0.0302292005308486,0.99963369946177,1,5,positive regulation of gastro-intestinal system smooth muscle contraction,BP,SPX
19858,GO:1903727,0.030356245405521,0.997464191491869,2,42,positive regulation of phospholipid metabolic process,BP,FGFR3;PDGFRA
3847,GO:0008017,0.0306819410468219,0.991912292903,5,243,microtubule binding,MF,KIFC1;DCX;BIRC5;NUSAP1;KIF6
9520,GO:0034756,0.0307670121353001,0.999620465446031,1,5,regulation of iron ion transport,BP,TF
12214,GO:0045861,0.030809682733151,0.991861185089548,5,273,negative regulation of proteolysis,BP,BIRC5;SFRP2;CRB2;PI16;PBK
2576,GO:0005412,0.0308360886097488,0.999618748434603,1,5,glucose:sodium symporter activity,MF,SLC5A11
10034,GO:0035926,0.0309048920861357,0.999617034307577,1,5,chemokine (C-C motif) ligand 2 secretion,BP,MBP
13841,GO:0051346,0.031009336557595,0.990563860416394,6,364,negative regulation of hydrolase activity,BP,BIRC5;PPP1R1B;SFRP2;CRB2;PI16;PPP1R14A
21567,GO:2000671,0.0311426838769352,0.999611080123239,1,5,regulation of motor neuron apoptotic process,BP,CRLF1
3176,GO:0006468,0.0311483282553708,0.98387185445605,18,1712,protein phosphorylation,BP,CRLF1;FGFR3;TPX2;BIRC5;FOXM1;FGF1;HSPA2;PPP1R1B;APLNR;PDGFRA;ENPP2;SFRP2;BUB1B;PBK;BUB1;CDK1;MBP;LPAR1
894,GO:0002139,0.0312982167434206,0.99963151606038,1,4,stereocilia coupling link,CC,USH1C
10670,GO:0042327,0.031542560567952,0.986394894841013,11,891,positive regulation of phosphorylation,BP,CRLF1;FGFR3;TPX2;FGF1;HSPA2;APLNR;PDGFRA;ENPP2;SFRP2;CDK1;LPAR1
7888,GO:0031465,0.0316342412154072,0.999598624266008,1,5,Cul4B-RING E3 ubiquitin ligase complex,CC,DTL
19791,GO:1903589,0.0316755859705403,0.999597567538815,1,5,positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,APLNR
4738,GO:0010389,0.0318663998184228,0.993046792229293,4,186,regulation of G2/M transition of mitotic cell cycle,BP,TPX2;CENPF;DTL;CDK1
17660,GO:0097227,0.0319084240271786,0.999591590165829,1,5,sperm annulus,CC,SEPT4
19537,GO:1903059,0.0323978760402755,0.999578879449496,1,5,regulation of protein lipidation,BP,HHATL
12248,GO:0045924,0.0324822424202896,0.999576668570538,1,5,regulation of female receptivity,BP,PPP1R1B
18883,GO:1901342,0.0328041184224604,0.99119169313914,5,268,regulation of vasculature development,BP,FGF1;APLNR;ENPP2;SFRP2;S100A1
2436,GO:0005127,0.0328854552870104,0.999566021070834,1,5,ciliary neurotrophic factor receptor binding,MF,CRLF1
9950,GO:0035766,0.0329182362568022,0.999565149543386,1,5,cell chemotaxis to fibroblast growth factor,BP,FGF1
9952,GO:0035768,0.0329182362568022,0.999565149543386,1,5,endothelial cell chemotaxis to fibroblast growth factor,BP,FGF1
20399,GO:1904847,0.0329182362568022,0.999565149543386,1,5,regulation of cell chemotaxis to fibroblast growth factor,BP,FGF1
21474,GO:2000544,0.0329182362568022,0.999565149543386,1,5,regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,FGF1
12219,GO:0045875,0.0330838046783621,0.999587955323307,1,4,negative regulation of sister chromatid cohesion,BP,ESPL1
15182,GO:0061133,0.0330931004232039,0.99954234502804,1,6,endopeptidase activator activity,MF,SFRP2
12035,GO:0045542,0.033122770939571,0.999559691690242,1,5,positive regulation of cholesterol biosynthetic process,BP,FGF1
3205,GO:0006508,0.0332556421385769,0.983282205740794,16,1519,proteolysis,BP,BIRC5;FBXO2;MYRF;ESPL1;DTL;SFRP2;CRB2;CNDP1;BUB1B;PI16;KLK6;PBK;CDK1;UBE2C;CNTN2;MBP
13111,GO:0048589,0.0332961842642749,0.987655301087213,8,542,developmental growth,BP,ASPM;FGFR3;CPNE6;MAG;FGF1;SFRP2;KLK6;CDK1
12252,GO:0045930,0.0332976611040293,0.991020317245283,5,281,negative regulation of mitotic cell cycle,BP,CENPF;TOP2A;BUB1B;BUB1;CDK1
6925,GO:0021853,0.0333753545911206,0.999552904065936,1,5,cerebral cortex GABAergic interneuron migration,BP,CNTN2
20452,GO:1904936,0.0333753545911206,0.999552904065936,1,5,interneuron migration,BP,CNTN2
2378,GO:0005007,0.0335152064203015,0.999549123217198,1,5,fibroblast growth factor-activated receptor activity,MF,FGFR3
7027,GO:0022414,0.0335533631804852,0.984332705455822,13,1144,reproductive process,BP,CLDN11;KIFC1;ASPM;SEPT4;HSPA2;TOP2A;PPP1R1B;PDGFRA;ESPL1;SFRP2;BUB1B;BUB1;CDK1
16683,GO:0072089,0.0337767338770616,0.99452537049816,3,104,stem cell proliferation,BP,ASPM;SFRP2;SOX11
3038,GO:0006260,0.0337956439793409,0.990852167741895,5,274,DNA replication,BP,MCM10;PDGFRA;DTL;CDK1;RRM2
8467,GO:0032515,0.0339533672161938,0.996980471109905,2,45,negative regulation of phosphoprotein phosphatase activity,BP,PPP1R1B;PPP1R14A
12647,GO:0046834,0.0340739666398618,0.994459379896945,3,103,lipid phosphorylation,BP,FGFR3;FGF1;PDGFRA
1562,GO:0003357,0.0340773291985129,0.999533763557104,1,5,noradrenergic neuron differentiation,BP,SOX11
2,GO:0000003,0.0340806317731358,0.984050773379757,13,1147,reproduction,BP,CLDN11;KIFC1;ASPM;SEPT4;HSPA2;TOP2A;PPP1R1B;PDGFRA;ESPL1;SFRP2;BUB1B;BUB1;CDK1
7125,GO:0030046,0.0341444422104922,0.999531912300927,1,5,parallel actin filament bundle assembly,BP,USH1C
7662,GO:0031072,0.0342682142469092,0.994409362101825,3,110,heat shock protein binding,MF,FGF1;HSPA2;CDK1
13074,GO:0048518,0.0342709138217083,0.978717859429613,42,5037,positive regulation of biological process,BP,CRLF1;ASPM;FGFR3;TPX2;BIRC5;TF;CPNE6;MYBL2;MAG;SEPT4;FOXM1;FGF1;PLP1;PACSIN1;MYRF;HSPA2;GFAP;TOP2A;SPX;APLNR;PDGFRA;ESPL1;ENPP2;MOG;NUSAP1;DTL;SFRP2;DAAM2;CRB2;NKX6-2;S100A1;KLK6;CDK1;MAL;UBE2C;SOX11;GPR62;CNTN2;MYBPC1;MBP;LPAR1;FXYD1
19926,GO:1903862,0.0345015605873405,0.999502277993416,1,6,positive regulation of oxidative phosphorylation,BP,CDK1
4357,GO:0009133,0.0345629528441124,0.99950049277539,1,6,nucleoside diphosphate biosynthetic process,BP,AK5
10373,GO:0038085,0.0346799999686356,0.999517006073116,1,5,vascular endothelial growth factor binding,MF,PDGFRA
4758,GO:0010466,0.0347282957486724,0.992214053453439,4,194,negative regulation of peptidase activity,BP,BIRC5;SFRP2;CRB2;PI16
5542,GO:0015798,0.0349673797538152,0.999539327349124,1,4,myo-inositol transport,BP,SLC5A11
12198,GO:0045834,0.0350464420395667,0.994232485715706,3,110,positive regulation of lipid metabolic process,BP,FGFR3;FGF1;PDGFRA
5658,GO:0016021,0.0351430318150227,0.978600885086242,35,4090,integral component of membrane,CC,HHATL;CLDN11;FGFR3;SLCO1A2;MAG;PLP1;MYRF;HSPA2;EVI2A;APLNR;PDGFRA;ENPP2;MOG;SLC14A1;SFRP2;CRB2;FREM2;SLC5A11;PAQR6;TMEM144;NTSR2;AQP4;MAL;TMEM125;S1PR5;GPR62;HS3ST4;CALN1;CNTN2;NKAIN2;OPALIN;LPAR1;TMEM235;TMEM88B;FXYD1
4121,GO:0008467,0.0351840247243923,0.999482250448392,1,6,[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity,MF,HS3ST4
19052,GO:1901857,0.0354707022665644,0.999473718122108,1,6,positive regulation of cellular respiration,BP,CDK1
11447,GO:0043987,0.0355183490994767,0.999472293164163,1,6,histone H3-S10 phosphorylation,BP,PPP1R1B
4750,GO:0010455,0.0355344702948976,0.999471810590506,1,6,positive regulation of cell fate commitment,BP,NKX6-2
20035,GO:1904062,0.0356225352533571,0.990222674284745,5,273,regulation of cation transmembrane transport,BP,SNTA1;HSPA2;APLNR;S100A1;FXYD1
3951,GO:0008199,0.0357782808428984,0.999464485059919,1,6,ferric iron binding,MF,TF
16468,GO:0071671,0.0357825295306303,0.999464356950171,1,6,regulation of smooth muscle cell chemotaxis,BP,LPAR1
5570,GO:0015840,0.0358594195134109,0.999462035817368,1,6,urea transport,BP,SLC14A1
14472,GO:0060023,0.0358769027017734,0.999482835443477,1,5,soft palate development,BP,SOX11
2399,GO:0005047,0.0359681239849116,0.999458745591096,1,6,signal recognition particle binding,MF,TF
10153,GO:0036128,0.0359985331760585,0.999457823355448,1,6,CatSper complex,CC,HSPA2
5366,GO:0015204,0.0360569892049393,0.999456048291418,1,6,urea transmembrane transporter activity,MF,SLC14A1
10766,GO:0042531,0.0361831430198013,0.996662949023801,2,48,positive regulation of tyrosine phosphorylation of STAT protein,BP,CRLF1;FGFR3
10975,GO:0042982,0.0362436629758651,0.996658779221804,2,46,amyloid precursor protein metabolic process,BP,NECAB1;KLK6
10845,GO:0042661,0.0362691434841199,0.999449581330312,1,6,regulation of mesodermal cell fate specification,BP,SFRP2
20782,GO:1905770,0.0362691434841199,0.999449581330312,1,6,regulation of mesodermal cell differentiation,BP,SFRP2
20825,GO:1905902,0.0362691434841199,0.999449581330312,1,6,regulation of mesoderm formation,BP,SFRP2
14303,GO:0052742,0.036712725892539,0.99659949275103,2,43,phosphatidylinositol kinase activity,MF,FGFR3;FGF1
13548,GO:0050885,0.0368828652740317,0.996575174336427,2,43,neuromuscular process controlling balance,BP,USH1C;NKX6-2
8474,GO:0032532,0.0371008259875549,0.999423855617837,1,6,regulation of microvillus length,BP,USH1C
17264,GO:0090166,0.0371528122550976,0.999422227768344,1,6,Golgi disassembly,BP,CDK1
19137,GO:1902083,0.0377390405253411,0.999427314711759,1,5,negative regulation of peptidyl-cysteine S-nitrosylation,BP,SNTA1
2039,GO:0004528,0.0380569483188966,0.999393543565722,1,6,phosphodiesterase I activity,MF,ENPP2
10341,GO:0038023,0.0380766725970209,0.98378147367241,10,817,signaling receptor activity,MF,FGFR3;EVI2A;APLNR;PDGFRA;SFRP2;PAQR6;NTSR2;S1PR5;GPR62;LPAR1
14529,GO:0060089,0.0380766725970209,0.98378147367241,10,817,molecular transducer activity,MF,FGFR3;EVI2A;APLNR;PDGFRA;SFRP2;PAQR6;NTSR2;S1PR5;GPR62;LPAR1
14585,GO:0060180,0.0384338372928227,0.999381378165797,1,6,female mating behavior,BP,PPP1R1B
6949,GO:0021894,0.0384606841178762,0.999380506910338,1,6,cerebral cortex GABAergic interneuron development,BP,CNTN2
9941,GO:0035749,0.0387839887566792,0.999369965855754,1,6,myelin sheath adaxonal region,CC,MAG
15398,GO:0061676,0.03889698033748,0.999366260567403,1,6,importin-alpha family protein binding,MF,TPX2
6897,GO:0021796,0.0389977268411738,0.999362947520979,1,6,cerebral cortex regionalization,BP,EMX2
13540,GO:0050877,0.0391274645683262,0.983258091665481,10,800,nervous system process,BP,USH1C;BIRC5;MAG;MYRF;PPP1R1B;SPX;NKX6-2;NTSR2;CNTN2;MBP
17298,GO:0090205,0.039146154821058,0.999358050484408,1,6,positive regulation of cholesterol metabolic process,BP,FGF1
11329,GO:0043550,0.0393098300548507,0.99621057361251,2,47,regulation of lipid kinase activity,BP,FGFR3;PDGFRA
2477,GO:0005178,0.0393927203206091,0.9932148173267,3,111,integrin binding,MF,FGF1;GFAP;SFRP2
10131,GO:0036092,0.0396780512399796,0.996163809095042,2,44,phosphatidylinositol-3-phosphate biosynthetic process,BP,FGFR3;FGF1
7990,GO:0031672,0.0396791537250532,0.996180029249758,2,39,A band,CC,S100A1;MYBPC1
10498,GO:0040016,0.0397474477660939,0.999338017300473,1,6,embryonic cleavage,BP,TOP2A
1686,GO:0003916,0.0399117187596477,0.999332489912361,1,6,DNA topoisomerase activity,MF,TOP2A
9681,GO:0035308,0.0399761773940978,0.996106090165156,2,49,negative regulation of protein dephosphorylation,BP,PPP1R1B;PPP1R14A
13183,GO:0048705,0.040024829772577,0.990620527270607,4,192,skeletal system morphogenesis,BP,FGFR3;PDGFRA;SFRP2;SOX11
620,GO:0001758,0.0402079176374237,0.999303334901208,1,7,retinal dehydrogenase activity,MF,ALDH1A1
3198,GO:0006498,0.0402725716947738,0.99932026593595,1,6,N-terminal protein lipidation,BP,HHATL
19394,GO:1902749,0.0408654454246019,0.990355678054281,4,202,regulation of cell cycle G2/M phase transition,BP,TPX2;CENPF;DTL;CDK1
14005,GO:0051661,0.0409361200150404,0.999325278328947,1,5,maintenance of centrosome location,BP,ASPM
5112,GO:0012501,0.0411667624801462,0.977951865897244,18,1816,programmed cell death,BP,CRLF1;FGFR3;TPX2;BIRC5;MYBL2;MAG;SEPT4;TOP2A;PDGFRA;ESPL1;SFRP2;BUB1B;SLC5A11;BUB1;CDK1;MAL;AIFM3;LPAR1
13442,GO:0050730,0.0412280657125267,0.990242996775486,4,202,regulation of peptidyl-tyrosine phosphorylation,BP,CRLF1;FGFR3;ENPP2;SFRP2
1575,GO:0003402,0.0412320709025699,0.999287214111752,1,6,planar cell polarity pathway involved in axis elongation,BP,SFRP2
2299,GO:0004888,0.0413839344802948,0.982987429630207,9,719,transmembrane signaling receptor activity,MF,FGFR3;EVI2A;APLNR;PDGFRA;SFRP2;NTSR2;S1PR5;GPR62;LPAR1
19102,GO:1901991,0.0414060330138869,0.990185662640215,4,206,negative regulation of mitotic cell cycle phase transition,BP,CENPF;BUB1B;BUB1;CDK1
3240,GO:0006548,0.0414378183818296,0.999259702646199,1,7,histidine catabolic process,BP,CARNS1
14313,GO:0052805,0.0414378183818296,0.999259702646199,1,7,imidazole-containing compound catabolic process,BP,CARNS1
2397,GO:0005044,0.0414908461709465,0.995876031839204,2,49,scavenger receptor activity,MF,ENPP2;CRB2
14471,GO:0060022,0.041519805623963,0.999277147030437,1,6,hard palate development,BP,SOX11
11130,GO:0043228,0.0417926732298318,0.974494415379749,32,3648,non-membrane-bounded organelle,CC,USH1C;KIFC1;MCM10;ASPM;DCX;TPX2;BIRC5;MYBL2;SNTA1;SEPT4;NCAPG;FGF1;CENPF;HSPA2;GFAP;TOP2A;ESPL1;ERMN;NUSAP1;SLC14A1;DTL;MKI67;AK5;BUB1B;S100A1;KIF6;KLK6;MOBP;BUB1;CDK1;DNAH17;MYBPC1
11134,GO:0043232,0.0417926732298318,0.974494415379749,32,3648,intracellular non-membrane-bounded organelle,CC,USH1C;KIFC1;MCM10;ASPM;DCX;TPX2;BIRC5;MYBL2;SNTA1;SEPT4;NCAPG;FGF1;CENPF;HSPA2;GFAP;TOP2A;ESPL1;ERMN;NUSAP1;SLC14A1;DTL;MKI67;AK5;BUB1B;S100A1;KIF6;KLK6;MOBP;BUB1;CDK1;DNAH17;MYBPC1
11114,GO:0043203,0.0418527226891085,0.999244679505952,1,7,axon hillock,CC,TPX2
4837,GO:0010624,0.0419647759357509,0.999261437323973,1,6,regulation of Schwann cell proliferation,BP,GFAP
11117,GO:0043208,0.0420641957924579,0.999236963312067,1,7,glycosphingolipid binding,MF,MAG
20509,GO:1905050,0.0420923280033085,0.999235933824153,1,7,positive regulation of metallopeptidase activity,BP,MBP
11679,GO:0044539,0.0421961446444335,0.999232128585274,1,7,long-chain fatty acid import,BP,SPX
13593,GO:0050957,0.0422446450678337,0.999251468530327,1,6,equilibrioception,BP,USH1C
16159,GO:0071205,0.0422604559891362,0.999280519442643,1,5,protein localization to juxtaparanode region of axon,BP,CNTN2
1762,GO:0004028,0.0423903685816521,0.999224983796042,1,7,3-chloroallyl aldehyde dehydrogenase activity,MF,ALDH1A1
13133,GO:0048638,0.0425003195137055,0.987769599684899,5,278,regulation of developmental growth,BP,FGFR3;CPNE6;MAG;SFRP2;CDK1
13075,GO:0048519,0.0427080100933215,0.973252695565557,38,4543,negative regulation of biological process,BP,CRLF1;HHATL;ASPM;FGFR3;BIRC5;SNTA1;MAG;FOXM1;FBXO2;CENPF;PACSIN1;HSPA2;GFAP;TOP2A;PPP1R1B;SPX;APLNR;PDGFRA;ESPL1;DTL;SFRP2;DAAM2;CRB2;NKX6-2;BUB1B;S100A1;PI16;PPP1R14A;PBK;BUB1;CDK1;RRM2;SOX11;CNTN2;MBP;LPAR1;ZNF536;FXYD1
727,GO:0001895,0.0427942549278309,0.995669232762285,2,51,retina homeostasis,BP,USH1C;TF
15292,GO:0061438,0.0428878628186043,0.999228299751301,1,6,renal system vasculature morphogenesis,BP,PDGFRA
15293,GO:0061439,0.0428878628186043,0.999228299751301,1,6,kidney vasculature morphogenesis,BP,PDGFRA
14854,GO:0060563,0.0429334415114392,0.995649923975893,2,50,neuroepithelial cell differentiation,BP,USH1C;SOX11
7113,GO:0030029,0.0431131179874008,0.982148412368754,9,674,actin filament-based process,BP,USH1C;SNTA1;PACSIN1;PDGFRA;ERMN;DAAM2;MOBP;MYBPC1;LPAR1
5909,GO:0016530,0.043227990936008,0.999193785182052,1,7,metallochaperone activity,MF,TF
20984,GO:1990459,0.0435658199492813,0.999181024950955,1,7,transferrin receptor binding,MF,TF
17550,GO:0097049,0.0436355021756448,0.999178380284333,1,7,motor neuron apoptotic process,BP,CRLF1
12150,GO:0045740,0.0437535023356691,0.995518334337448,2,51,positive regulation of DNA replication,BP,PDGFRA;CDK1
8033,GO:0031748,0.043776482700043,0.999173016350763,1,7,D1 dopamine receptor binding,MF,PPP1R1B
20310,GO:1904683,0.0439329958099824,0.999189887474589,1,6,regulation of metalloendopeptidase activity,BP,MBP
21604,GO:2000739,0.0439997884400026,0.999187400329819,1,6,regulation of mesenchymal stem cell differentiation,BP,PDGFRA
21042,GO:1990712,0.0440063231947575,0.999164233457413,1,7,HFE-transferrin receptor complex,CC,TF
15184,GO:0061135,0.0440723967967101,0.992052672237477,3,126,endopeptidase regulator activity,MF,BIRC5;SFRP2;CRB2
5106,GO:0010992,0.0441258878468995,0.999159645867696,1,7,ubiquitin recycling,BP,UBE2C
21170,GO:2000051,0.044140063207246,0.999182164311972,1,6,negative regulation of non-canonical Wnt signaling pathway,BP,SFRP2
3503,GO:0006928,0.0443201171022553,0.976048290893105,18,1741,movement of cell or subcellular component,BP,KIFC1;ASPM;DCX;SNTA1;MAG;FGF1;PDGFRA;ENPP2;SFRP2;CRB2;KIF6;MOBP;CDK1;EMX2;CNTN2;DNAH17;MYBPC1;LPAR1
4000,GO:0008277,0.0443755891221511,0.991979115582734,3,123,regulation of G-protein coupled receptor protein signaling pathway,BP,APLNR;KLK6;CNTN2
7349,GO:0030414,0.0449700580117906,0.991827145322077,3,125,peptidase inhibitor activity,MF,BIRC5;CRB2;PI16
3746,GO:0007389,0.044996211593082,0.985049567098785,6,390,pattern specification process,BP,FGF1;SFRP2;DAAM2;CRB2;NKX6-2;EMX2
21341,GO:2000343,0.0450325345210677,0.999106448783812,1,8,positive regulation of chemokine (C-X-C motif) ligand 2 production,BP,MBP
14477,GO:0060028,0.0450747319607103,0.999122786361551,1,7,convergent extension involved in axis elongation,BP,SFRP2
6694,GO:0019900,0.0452180475193758,0.981109554855935,9,695,kinase binding,MF,ASPM;FGFR3;DCX;TPX2;MAG;FOXM1;GFAP;TOP2A;PDGFRA
7741,GO:0031232,0.0453895596297036,0.999110378378089,1,7,extrinsic component of external side of plasma membrane,CC,TF
434,GO:0001135,0.0454670123687113,0.999107312214138,1,7,transcription factor activity, RNA polymerase II transcription factor recruiting,MF,MYBL2
16791,GO:0072239,0.0454901324391936,0.999106395906446,1,7,metanephric glomerulus vasculature development,BP,PDGFRA
12489,GO:0046486,0.0454975922632002,0.984841425552344,6,396,glycerolipid metabolic process,BP,FGFR3;CPNE6;FGF1;PDGFRA;ENPP2;ETNPPL
13108,GO:0048584,0.0455334598599402,0.974934810026011,19,1967,positive regulation of response to stimulus,BP,CRLF1;ASPM;FGFR3;SEPT4;FOXM1;FGF1;PDGFRA;MOG;SFRP2;DAAM2;CRB2;S100A1;KLK6;CDK1;MAL;SOX11;GPR62;CNTN2;LPAR1
6011,GO:0016725,0.0457179777511519,0.999097340213709,1,7,oxidoreductase activity, acting on CH or CH2 groups,MF,RRM2
21472,GO:2000542,0.0458379899658579,0.999092551646369,1,7,negative regulation of gastrulation,BP,SFRP2
9186,GO:0034115,0.0459782894434624,0.999068178055646,1,8,negative regulation of heterotypic cell-cell adhesion,BP,MBP
15875,GO:0070587,0.0459782894434624,0.999068178055646,1,8,regulation of cell-cell adhesion involved in gastrulation,BP,MBP
2761,GO:0005785,0.0460587818732712,0.999064883140296,1,8,signal recognition particle receptor complex,CC,TF
3433,GO:0006814,0.0461406494250525,0.988687285160373,4,197,sodium ion transport,BP,SNTA1;SLC5A11;NKAIN2;FXYD1
13483,GO:0050794,0.0461834069647408,0.970996258545026,68,9109,regulation of cellular process,BP,CRLF1;USH1C;HHATL;ASPM;FGFR3;DCX;TPX2;BIRC5;TF;CPNE6;MYBL2;SNTA1;MAG;SEPT4;FOXM1;FGF1;FBXO2;CENPF;NECAB1;PLP1;PACSIN1;MYRF;HSPA2;EVI2A;GFAP;TOP2A;PPP1R1B;SPX;APLNR;PDGFRA;ESPL1;ERMN;ENPP2;MOG;NUSAP1;DTL;SFRP2;DAAM2;CRB2;MKI67;NKX6-2;CNDP1;HSPB8;BUB1B;S100A1;PAQR6;PI16;PPP1R14A;KLK6;PBK;FAM107A;LGI3;NTSR2;BUB1;CDK1;EMX2;RRM2;MAL;UBE2C;SOX11;S1PR5;GPR62;CNTN2;MYBPC1;MBP;LPAR1;ZNF536;FXYD1
9427,GO:0034605,0.0471996232128135,0.991260749616276,3,121,cellular response to heat,BP,FGF1;HSPA2;HSPB8
9446,GO:0034638,0.0473303523073296,0.999012046195973,1,8,phosphatidylcholine catabolic process,BP,ENPP2
21384,GO:2000394,0.0473456733941053,0.999031294468679,1,7,positive regulation of lamellipodium morphogenesis,BP,ENPP2
18904,GO:1901387,0.0474382278505384,0.999007495635551,1,8,positive regulation of voltage-gated calcium channel activity,BP,S100A1
10765,GO:0042509,0.0476223961272305,0.994878000918193,2,56,regulation of tyrosine phosphorylation of STAT protein,BP,CRLF1;FGFR3
10351,GO:0038036,0.0476372560028133,0.998999071990503,1,8,sphingosine-1-phosphate receptor activity,MF,S1PR5
17757,GO:0097435,0.047782462507024,0.980978505078517,8,588,supramolecular fiber organization,BP,USH1C;PACSIN1;GFAP;PDGFRA;ERMN;SFRP2;MYBPC1;LPAR1
20329,GO:1904714,0.0477832544678283,0.998992869710022,1,8,regulation of chaperone-mediated autophagy,BP,GFAP
17334,GO:0090263,0.0479091551297522,0.99107183490189,3,126,positive regulation of canonical Wnt signaling pathway,BP,ASPM;SFRP2;DAAM2
5805,GO:0016310,0.0480143895561857,0.973039749081526,20,2076,phosphorylation,BP,CRLF1;FGFR3;TPX2;BIRC5;FOXM1;FGF1;HSPA2;PPP1R1B;APLNR;PDGFRA;ENPP2;SFRP2;AK5;BUB1B;PPP1R14A;PBK;BUB1;CDK1;MBP;LPAR1
11899,GO:0045178,0.048099668999677,0.994817368675471,2,49,basal part of cell,CC,CLDN11;TF
2939,GO:0006069,0.0481747791846356,0.998976140666117,1,8,ethanol oxidation,BP,ALDH1A1
19122,GO:1902041,0.0483175062199933,0.994764263117042,2,55,regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,SFRP2;MAL
21373,GO:2000381,0.0485777050658162,0.998958777851136,1,8,negative regulation of mesoderm development,BP,SFRP2
13827,GO:0051310,0.0486179761434236,0.994713773906386,2,55,metaphase plate congression,BP,KIFC1;CENPF
12059,GO:0045597,0.0487881278900905,0.978313117756416,10,831,positive regulation of cell differentiation,BP,ASPM;CPNE6;MAG;PACSIN1;GFAP;SFRP2;CRB2;NKX6-2;SOX11;LPAR1
21159,GO:2000035,0.0491237351411763,0.998935010946815,1,8,regulation of stem cell division,BP,SFRP2
6708,GO:0019933,0.0492206759345436,0.990729889257313,3,125,cAMP-mediated signaling,BP,APLNR;GPR62;LPAR1
16467,GO:0071670,0.0492342863665075,0.998930165733876,1,8,smooth muscle cell chemotaxis,BP,LPAR1
6936,GO:0021873,0.0492841789037054,0.998949535313844,1,7,forebrain neuroblast division,BP,ASPM
5122,GO:0014010,0.049432868833169,0.998943124648673,1,7,Schwann cell proliferation,BP,GFAP
1754,GO:0004017,0.0495176796988069,0.998917694033063,1,8,adenylate kinase activity,MF,AK5
19577,GO:1903169,0.0495328951986286,0.990648730547272,3,124,regulation of calcium ion transmembrane transport,BP,HSPA2;APLNR;S100A1
2387,GO:0005021,0.0496497140580032,0.998933739861555,1,7,vascular endothelial growth factor-activated receptor activity,MF,PDGFRA
2277,GO:0004857,0.0496831475207998,0.985070361698015,5,314,enzyme inhibitor activity,MF,BIRC5;PPP1R1B;CRB2;PI16;PPP1R14A
7734,GO:0031224,0.0498223104292004,0.968677907808765,35,4199,intrinsic component of membrane,CC,HHATL;CLDN11;FGFR3;SLCO1A2;MAG;PLP1;MYRF;HSPA2;EVI2A;APLNR;PDGFRA;ENPP2;MOG;SLC14A1;SFRP2;CRB2;FREM2;SLC5A11;PAQR6;TMEM144;NTSR2;AQP4;MAL;TMEM125;S1PR5;GPR62;HS3ST4;CALN1;CNTN2;NKAIN2;OPALIN;LPAR1;TMEM235;TMEM88B;FXYD1
6942,GO:0021885,0.049866731760311,0.994510303000596,2,52,forebrain cell migration,BP,EMX2;CNTN2
294,GO:0000796,0.0498731401410221,0.998924026007229,1,7,condensin complex,CC,NCAPG
10852,GO:0042670,0.0498752186875629,0.998901854160665,1,8,retinal cone cell differentiation,BP,USH1C
12528,GO:0046549,0.0498752186875629,0.998901854160665,1,8,retinal cone cell development,BP,USH1C
2812,GO:0005871,0.0500086623316518,0.994492167689597,2,50,kinesin complex,CC,KIFC1;KIF6
13101,GO:0048565,0.0500578364706002,0.990512218735426,3,122,digestive tract development,BP,PDGFRA;SFRP2;SOX11
14469,GO:0060020,0.0501501519717575,0.998889594120199,1,8,Bergmann glial cell differentiation,BP,GFAP
1367,GO:0003002,0.050186975144198,0.984880843849081,5,304,regionalization,BP,FGF1;SFRP2;CRB2;NKX6-2;EMX2
15635,GO:0070192,0.050321052152021,0.994424263407314,2,55,chromosome organization involved in meiotic cell cycle,BP,BUB1B;BUB1
13039,GO:0048387,0.0504722904863672,0.998875140757053,1,8,negative regulation of retinoic acid receptor signaling pathway,BP,ZNF536
10919,GO:0042802,0.050514020416068,0.97371078228971,15,1486,identical protein binding,MF,CLDN11;MCM10;FGFR3;BIRC5;MAG;SEPT4;CENPF;PACSIN1;GFAP;TOP2A;PDGFRA;HSPB8;S100A1;ETNPPL;CNTN2
21230,GO:2000169,0.0506542335035286,0.998889713377875,1,7,regulation of peptidyl-cysteine S-nitrosylation,BP,SNTA1
16694,GO:0072102,0.0508321979144712,0.998881818720832,1,7,glomerulus morphogenesis,BP,PDGFRA
15235,GO:0061303,0.0509884671836722,0.998851782733429,1,8,cornea development in camera-type eye,BP,SOX11
3696,GO:0007260,0.0510391604606612,0.99429284633986,2,58,tyrosine phosphorylation of STAT protein,BP,CRLF1;FGFR3
10900,GO:0042770,0.0510544415543787,0.990241871284088,3,127,signal transduction in response to DNA damage,BP,FOXM1;DTL;CDK1
3708,GO:0007275,0.0510583408319076,0.967503160890747,38,4496,multicellular organism development,BP,CRLF1;USH1C;CLDN11;ASPM;FGFR3;DCX;CPNE6;MAG;SEPT4;FGF1;CENPF;PLP1;PACSIN1;MYRF;GFAP;TOP2A;HAPLN2;APLNR;PDGFRA;ENPP2;MOG;SFRP2;DAAM2;CRB2;NKX6-2;FREM2;S100A1;KLK6;MOBP;CDK1;EMX2;MAL;SOX11;S1PR5;CNTN2;MBP;LPAR1;ZNF536
7254,GO:0030246,0.0511481492274632,0.987025424508979,4,222,carbohydrate binding,MF,MAG;FBXO2;ENPP2;CNTN2
4753,GO:0010459,0.0511616287022659,0.998825828443432,1,9,negative regulation of heart rate,BP,SPX
12206,GO:0045842,0.0512848498606372,0.998838260154849,1,8,positive regulation of mitotic metaphase/anaphase transition,BP,ESPL1
19087,GO:1901970,0.0512848498606372,0.998838260154849,1,8,positive regulation of mitotic sister chromatid separation,BP,ESPL1
19142,GO:1902101,0.0512848498606372,0.998838260154849,1,8,positive regulation of metaphase/anaphase transition of cell cycle,BP,ESPL1
3649,GO:0007186,0.0513954512938298,0.9780043846915,9,761,G-protein coupled receptor signaling pathway,BP,APLNR;ENPP2;SFRP2;KLK6;NTSR2;S1PR5;GPR62;CNTN2;LPAR1
6913,GO:0021826,0.0516296663285321,0.998822426114066,1,8,substrate-independent telencephalic tangential migration,BP,CNTN2
6916,GO:0021830,0.0516296663285321,0.998822426114066,1,8,interneuron migration from the subpallium to the cortex,BP,CNTN2
6921,GO:0021843,0.0516296663285321,0.998822426114066,1,8,substrate-independent telencephalic tangential interneuron migration,BP,CNTN2
15874,GO:0070586,0.0518072256311006,0.998795706716175,1,9,cell-cell adhesion involved in gastrulation,BP,MBP
17120,GO:0086036,0.0518973349185201,0.998810059317389,1,8,regulation of cardiac muscle cell membrane potential,BP,FXYD1
4009,GO:0008289,0.0519200966561453,0.978979037149023,8,622,lipid binding,MF,CPNE6;MAG;PTGDS;PACSIN1;HSPA2;PAQR6;MAL;LPAR1
17771,GO:0097458,0.0520612376190484,0.9727948742469,15,1418,neuron part,CC,USH1C;DCX;TPX2;CPNE6;MAG;FBXO2;PACSIN1;PPP1R1B;ERMN;S100A1;FAM107A;LGI3;CNTN2;MBP;LPAR1
14917,GO:0060677,0.0521318199496852,0.99882330076755,1,7,ureteric bud elongation,BP,FGF1
4801,GO:0010562,0.052155161567224,0.975595799960736,11,971,positive regulation of phosphorus metabolic process,BP,CRLF1;FGFR3;TPX2;FGF1;HSPA2;APLNR;PDGFRA;ENPP2;SFRP2;CDK1;LPAR1
12259,GO:0045937,0.052155161567224,0.975595799960736,11,971,positive regulation of phosphate metabolic process,BP,CRLF1;FGFR3;TPX2;FGF1;HSPA2;APLNR;PDGFRA;ENPP2;SFRP2;CDK1;LPAR1
11161,GO:0043270,0.0522882120870418,0.986646517541471,4,214,positive regulation of ion transport,BP,HSPA2;APLNR;S100A1;FXYD1
6619,GO:0019755,0.052505726965285,0.998762678171866,1,9,one-carbon compound transport,BP,SLC14A1
8279,GO:0032269,0.0525410769228465,0.975384843292415,11,974,negative regulation of cellular protein metabolic process,BP,HHATL;BIRC5;SNTA1;FOXM1;PPP1R1B;SFRP2;CRB2;PI16;PPP1R14A;PBK;FXYD1
12455,GO:0046427,0.0526469698055965,0.994011788970784,2,58,positive regulation of JAK-STAT cascade,BP,CRLF1;FGFR3
2281,GO:0004862,0.0526772363734129,0.998754498646489,1,9,cAMP-dependent protein kinase inhibitor activity,MF,PPP1R1B
112,GO:0000228,0.0527521915462425,0.980042086822781,7,511,nuclear chromosome,CC,MCM10;BIRC5;HSPA2;TOP2A;BUB1B;BUB1;CDK1
5342,GO:0015166,0.0527781729349973,0.998768897368391,1,8,polyol transmembrane transporter activity,MF,SLC5A11
1370,GO:0003008,0.0528640993312637,0.972314993434037,15,1444,system process,BP,USH1C;BIRC5;SNTA1;MAG;MYRF;PPP1R1B;SPX;NKX6-2;S100A1;NTSR2;AQP4;CNTN2;MYBPC1;MBP;FXYD1
3318,GO:0006644,0.0529978161672368,0.981676044488327,6,414,phospholipid metabolic process,BP,FGFR3;CPNE6;FGF1;PDGFRA;ENPP2;ETNPPL
625,GO:0001766,0.0530502473782672,0.998736614268837,1,9,membrane raft polarization,BP,MAL
7936,GO:0031580,0.0530502473782672,0.998736614268837,1,9,membrane raft distribution,BP,MAL
3239,GO:0006547,0.0533238680891845,0.998723412511776,1,9,histidine metabolic process,BP,CARNS1
13106,GO:0048570,0.0534214117343893,0.998738387056328,1,8,notochord morphogenesis,BP,CRB2
8459,GO:0032502,0.0538419660572492,0.965162388953477,43,5253,developmental process,BP,CRLF1;USH1C;CLDN11;ASPM;FGFR3;DCX;CPNE6;MYBL2;MAG;SEPT4;FOXM1;FGF1;CENPF;PLP1;PACSIN1;MYRF;HSPA2;GFAP;TOP2A;HAPLN2;APLNR;PDGFRA;ERMN;ENPP2;MOG;SFRP2;DAAM2;CRB2;NKX6-2;FREM2;S100A1;KLK6;MOBP;CDK1;EMX2;MAL;SOX11;S1PR5;CNTN2;MYBPC1;MBP;LPAR1;ZNF536
18445,GO:0120025,0.0538856819989996,0.970153704707571,18,1793,plasma membrane bounded cell projection,CC,USH1C;DCX;TPX2;CPNE6;MAG;SEPT4;FBXO2;CENPF;PACSIN1;GFAP;ERMN;S100A1;FAM107A;LGI3;CNTN2;DNAH17;MBP;LPAR1
20432,GO:1904894,0.0540900102654409,0.993752737898536,2,59,positive regulation of STAT cascade,BP,CRLF1;FGFR3
18277,GO:0099612,0.0542432878816484,0.998724976671058,1,7,protein localization to axon,BP,CNTN2
19232,GO:1902305,0.0543348686619019,0.993719829253708,2,55,regulation of sodium ion transmembrane transport,BP,SNTA1;FXYD1
12118,GO:0045669,0.0543682175882268,0.993710942104897,2,56,positive regulation of osteoblast differentiation,BP,SFRP2;SOX11
19069,GO:1901894,0.0544663657602301,0.998688009206551,1,8,regulation of calcium-transporting ATPase activity,BP,HSPA2
13051,GO:0048471,0.0545564294281464,0.977689025266802,8,626,perinuclear region of cytoplasm,CC,HHATL;TF;PTGDS;CENPF;PACSIN1;BUB1B;MOBP;CALN1
1633,GO:0003779,0.0547979567085392,0.980908918611963,6,380,actin binding,MF,USH1C;SNTA1;ERMN;DAAM2;MOBP;MYBPC1
1632,GO:0003777,0.0551505385045106,0.989154208410226,3,109,microtubule motor activity,MF,KIFC1;KIF6;DNAH17
10270,GO:0036449,0.0552181880709509,0.99867821811463,1,7,microtubule minus-end,CC,ASPM
7781,GO:0031298,0.0555935340681353,0.998611202144643,1,9,replication fork protection complex,CC,MCM10
98,GO:0000187,0.0558170841430225,0.988938850733403,3,133,activation of MAPK activity,BP,FGF1;CDK1;LPAR1
16900,GO:0072497,0.0558572119870561,0.998619391961317,1,8,mesenchymal stem cell differentiation,BP,PDGFRA
9087,GO:0033691,0.0559164623933157,0.998616429151548,1,8,sialic acid binding,MF,MAG
1403,GO:0003084,0.0561953484394538,0.998580638845084,1,9,positive regulation of systemic arterial blood pressure,BP,SPX
20143,GO:1904338,0.0564243791249803,0.998568918147949,1,9,regulation of dopaminergic neuron differentiation,BP,SFRP2
21339,GO:2000341,0.0566131363099068,0.99854152843853,1,10,regulation of chemokine (C-X-C motif) ligand 2 production,BP,MBP
7127,GO:0030048,0.0566208838023618,0.988733669324486,3,118,actin filament-based movement,BP,SNTA1;MOBP;MYBPC1
19789,GO:1903587,0.0566364385240529,0.998558022039374,1,9,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,APLNR
14123,GO:0051897,0.0566529929270182,0.988708455730357,3,131,positive regulation of protein kinase B signaling,BP,FGFR3;FGF1;PDGFRA
16684,GO:0072091,0.05683686549085,0.993259197955417,2,57,regulation of stem cell proliferation,BP,ASPM;SOX11
2816,GO:0005876,0.0569092721254694,0.993245858544865,2,57,spindle microtubule,CC,NUSAP1;CDK1
3041,GO:0006265,0.0571769691457488,0.998530057221847,1,9,DNA topological change,BP,TOP2A
7129,GO:0030050,0.0573728485519193,0.998542581665585,1,8,vesicle transport along actin filament,BP,MOBP
14851,GO:0060560,0.0575447372699794,0.984847507442599,4,207,developmental growth involved in morphogenesis,BP,CPNE6;MAG;FGF1;SFRP2
16131,GO:0071103,0.0575501356241701,0.984836516825258,4,221,DNA conformation change,BP,NCAPG;TOP2A;NUSAP1;CDK1
5386,GO:0015250,0.0578219281499571,0.998477872295825,1,10,water channel activity,MF,AQP4
4375,GO:0009151,0.057930606433312,0.998472081082549,1,10,purine deoxyribonucleotide metabolic process,BP,AK5
14449,GO:0055123,0.0580132539153278,0.988328063031551,3,130,digestive system development,BP,PDGFRA;SFRP2;SOX11
6710,GO:0019935,0.05818967964408,0.988273703425618,3,134,cyclic-nucleotide-mediated signaling,BP,APLNR;GPR62;LPAR1
857,GO:0002072,0.0583722302031014,0.998490770621358,1,8,optic cup morphogenesis involved in camera-type eye development,BP,SOX11
6695,GO:0019901,0.0584918015237504,0.975739518424368,8,620,protein kinase binding,MF,ASPM;FGFR3;DCX;TPX2;MAG;FOXM1;TOP2A;PDGFRA
14312,GO:0052803,0.0587678456484823,0.998427089499334,1,10,imidazole-containing compound metabolic process,BP,CARNS1
14007,GO:0051665,0.0588802317008777,0.998420999262126,1,10,membrane raft localization,BP,MAL
13832,GO:0051336,0.0589638309482733,0.970899600823842,12,1106,regulation of hydrolase activity,BP,FGFR3;BIRC5;HSPA2;PPP1R1B;PDGFRA;SFRP2;CRB2;PI16;ALDH1A1;PPP1R14A;MBP;LPAR1
17523,GO:0097001,0.0591174315336258,0.998408105811296,1,10,ceramide binding,MF,MAG
21508,GO:2000587,0.059134463678684,0.998450631514796,1,8,negative regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,PDGFRA
20798,GO:1905820,0.0593003652795072,0.9984175413551,1,9,positive regulation of chromosome separation,BP,ESPL1
618,GO:0001756,0.0593175009962198,0.992796671861451,2,57,somitogenesis,BP,SFRP2;CRB2
14389,GO:0055015,0.0595664251724316,0.998383553042888,1,10,ventricular cardiac muscle cell development,BP,CDK1
12481,GO:0046474,0.0596331803601728,0.984104035225091,4,223,glycerophospholipid biosynthetic process,BP,FGFR3;CPNE6;FGF1;ETNPPL
3846,GO:0008016,0.0597933539705888,0.984050638183361,4,218,regulation of heart contraction,BP,SNTA1;SPX;S100A1;FXYD1
506,GO:0001553,0.0598461334117599,0.998387935902666,1,9,luteinization,BP,PDGFRA
2827,GO:0005890,0.0599667271534921,0.998361500804611,1,10,sodium:potassium-exchanging ATPase complex,CC,FXYD1
10976,GO:0042983,0.0606276300949627,0.998324757663264,1,10,amyloid precursor protein biosynthetic process,BP,NECAB1
10977,GO:0042984,0.0606276300949627,0.998324757663264,1,10,regulation of amyloid precursor protein biosynthetic process,BP,NECAB1
17291,GO:0090197,0.0606838091652807,0.998321615136552,1,10,positive regulation of chemokine secretion,BP,MBP
17764,GO:0097449,0.0609740025173075,0.998305334392916,1,10,astrocyte projection,CC,GFAP
6947,GO:0021892,0.061015001463782,0.998303027739847,1,10,cerebral cortex GABAergic interneuron differentiation,BP,CNTN2
16208,GO:0071281,0.061168494872574,0.998294377743193,1,10,cellular response to iron ion,BP,TF
2569,GO:0005381,0.061189216520454,0.998293208266793,1,10,iron ion transmembrane transporter activity,MF,TF
4466,GO:0009265,0.0612497574569165,0.998272846971227,1,11,2'-deoxyribonucleotide biosynthetic process,BP,AK5
12442,GO:0046385,0.0612497574569165,0.998272846971227,1,11,deoxyribose phosphate biosynthetic process,BP,AK5
1477,GO:0003211,0.0613739587745468,0.998303564025413,1,9,cardiac ventricle formation,BP,SOX11
10875,GO:0042733,0.062372980730508,0.992201864310778,2,60,embryonic digit morphogenesis,BP,SFRP2;FREM2
3818,GO:0007605,0.0626724279516395,0.986988790481291,3,133,sensory perception of sound,BP,USH1C;BIRC5;MBP
7353,GO:0030424,0.0629161074408654,0.975247508167058,7,514,axon,CC,TPX2;CPNE6;MAG;PACSIN1;ERMN;CNTN2;MBP
11243,GO:0043408,0.0634766984343109,0.973220676866746,8,652,regulation of MAPK cascade,BP,FGFR3;FOXM1;FGF1;PDGFRA;SFRP2;PBK;CDK1;LPAR1
5094,GO:0010977,0.0634889138309998,0.98674895390898,3,134,negative regulation of neuron projection development,BP,MAG;GFAP;LPAR1
13078,GO:0048522,0.0635332258870194,0.958849626845464,37,4509,positive regulation of cellular process,BP,CRLF1;ASPM;FGFR3;TPX2;BIRC5;TF;CPNE6;MYBL2;MAG;SEPT4;FOXM1;FGF1;PACSIN1;MYRF;HSPA2;GFAP;TOP2A;APLNR;PDGFRA;ESPL1;ENPP2;NUSAP1;DTL;SFRP2;DAAM2;CRB2;NKX6-2;KLK6;CDK1;MAL;UBE2C;SOX11;GPR62;CNTN2;MYBPC1;MBP;LPAR1
591,GO:0001707,0.0635657831925153,0.991962502460711,2,62,mesoderm formation,BP,SFRP2;CRB2
11664,GO:0044459,0.0636991956065288,0.962168298126078,22,2392,plasma membrane part,CC,ASPM;FGFR3;SLCO1A2;TF;SNTA1;MAG;PACSIN1;HSPA2;APLNR;PDGFRA;ENPP2;MOG;SLC14A1;CRB2;SLC5A11;NTSR2;AQP4;MAL;CNTN2;LPAR1;TMEM235;FXYD1
13820,GO:0051302,0.063952414625094,0.986608020321915,3,138,regulation of cell division,BP,ASPM;FGF1;SFRP2
6522,GO:0019371,0.0640793361773943,0.998107526554821,1,11,cyclooxygenase pathway,BP,PTGDS
6935,GO:0021872,0.0641330750528873,0.991853596509113,2,61,forebrain generation of neurons,BP,ASPM;CNTN2
13050,GO:0048469,0.0642063101771931,0.986528653239728,3,142,cell maturation,BP,SEPT4;PLP1;CNTN2
11124,GO:0043220,0.064385800795948,0.998107881265968,1,10,Schmidt-Lanterman incisure,CC,MAG
8192,GO:0032096,0.0645039662208244,0.998082049044435,1,11,negative regulation of response to food,BP,SPX
8195,GO:0032099,0.0645039662208244,0.998082049044435,1,11,negative regulation of appetite,BP,SPX
623,GO:0001764,0.0648208246316175,0.986362208931998,3,130,neuron migration,BP,ASPM;DCX;CNTN2
11852,GO:0045091,0.0650996663887538,0.998046013105625,1,11,regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,TOP2A
6756,GO:0021521,0.0655344271087088,0.998038896032991,1,10,ventral spinal cord interneuron specification,BP,NKX6-2
14858,GO:0060573,0.0655344271087088,0.998038896032991,1,10,cell fate specification involved in pattern specification,BP,NKX6-2
541,GO:0001618,0.0656580960674845,0.991540867117695,2,64,virus receptor activity,MF,MOG;CDK1
18382,GO:0104005,0.0656580960674845,0.991540867117695,2,64,hijacked molecular function,MF,MOG;CDK1
17290,GO:0090196,0.0665092430128446,0.997959372885639,1,11,regulation of chemokine secretion,BP,MBP
5223,GO:0014831,0.0667744869814589,0.997942854029946,1,11,gastro-intestinal system smooth muscle contraction,BP,SPX
18019,GO:0098772,0.0671012066681313,0.963643987228753,15,1531,molecular function regulator,MF,CRLF1;FGFR3;BIRC5;SNTA1;FGF1;PPP1R1B;SPX;PDGFRA;SFRP2;CRB2;PI16;ALDH1A1;PPP1R14A;MAL;FXYD1
11244,GO:0043409,0.0672449658030497,0.985623125518373,3,143,negative regulation of MAPK cascade,BP,FOXM1;SFRP2;PBK
4850,GO:0010639,0.0672756070867116,0.978005119309468,5,327,negative regulation of organelle organization,BP,CENPF;TOP2A;ESPL1;BUB1B;BUB1
6860,GO:0021700,0.0674799898424433,0.981266699099001,4,228,developmental maturation,BP,FGFR3;SEPT4;PLP1;CNTN2
335,GO:0000922,0.0675255663208043,0.985541118665504,3,141,spindle pole,CC,ASPM;TPX2;CENPF
14377,GO:0055002,0.0676015974750533,0.985528616646693,3,133,striated muscle cell development,BP,PDGFRA;CDK1;MYBPC1
13017,GO:0048332,0.0680313957819772,0.99105966544851,2,64,mesoderm morphogenesis,BP,SFRP2;CRB2
15511,GO:0062009,0.0680857459713973,0.997881130511491,1,10,secondary palate development,BP,SOX11
6111,GO:0016887,0.0681023586823045,0.974955899946902,6,407,ATPase activity,MF,KIFC1;HSPA2;TOP2A;KIF6;CARNS1;DNAH17
5539,GO:0015791,0.0684010511106174,0.997861198006333,1,10,polyol transport,BP,SLC5A11
16949,GO:0072567,0.0686073316023285,0.997809125483421,1,12,chemokine (C-X-C motif) ligand 2 production,BP,MBP
17213,GO:0090084,0.0688048205530781,0.997835533170062,1,10,negative regulation of inclusion body assembly,BP,HSPA2
6770,GO:0021537,0.0688348561496306,0.980767214417112,4,225,telencephalon development,BP,ASPM;EMX2;CNTN2;LPAR1
10843,GO:0042659,0.0693154194311426,0.99778114486373,1,11,regulation of cell fate specification,BP,SFRP2
15587,GO:0070106,0.0694565452954305,0.997771979225087,1,11,interleukin-27-mediated signaling pathway,BP,CRLF1
20851,GO:1990001,0.0699212533977877,0.997763750717163,1,10,inhibition of cysteine-type endopeptidase activity involved in apoptotic process,BP,BIRC5
487,GO:0001525,0.0700093227413196,0.974067498817014,6,432,angiogenesis,BP,FGF1;APLNR;PDGFRA;ENPP2;SFRP2;S100A1
17818,GO:0097539,0.0700537248547126,0.997755153455833,1,10,ciliary transition fiber,CC,CENPF
6693,GO:0019899,0.0700593401157579,0.958805118580618,20,2123,enzyme binding,MF,MCM10;ASPM;FGFR3;DCX;TPX2;BIRC5;SNTA1;MAG;FOXM1;FGF1;HSPA2;GFAP;TOP2A;PDGFRA;DAAM2;CRB2;S100A1;MOBP;UBE2C;MBP
18026,GO:0098789,0.0700946840958048,0.997730292052366,1,11,pre-mRNA cleavage required for polyadenylation,BP,FIP1L1
11559,GO:0044291,0.0701855463273066,0.990620940738851,2,62,cell-cell contact zone,CC,OPALIN;FXYD1
19856,GO:1903725,0.0703187304289731,0.990580344637803,2,66,regulation of phospholipid metabolic process,BP,FGFR3;PDGFRA
10481,GO:0039692,0.0703254955009043,0.997696501823114,1,12,single stranded viral RNA replication via double stranded DNA intermediate,BP,TOP2A
12176,GO:0045787,0.0703854760750173,0.976688773081628,5,336,positive regulation of cell cycle,BP,ESPL1;NUSAP1;DTL;CDK1;UBE2C
11637,GO:0044425,0.070527519829329,0.953308009275973,42,5327,membrane part,CC,HHATL;CLDN11;ASPM;FGFR3;SLCO1A2;TF;SNTA1;MAG;PTGDS;PLP1;PACSIN1;MYRF;HSPA2;EVI2A;GFAP;APLNR;PDGFRA;ENPP2;MOG;SLC14A1;SFRP2;CRB2;FREM2;SLC5A11;PAQR6;TMEM144;NTSR2;CDK1;AQP4;MAL;TMEM125;S1PR5;GPR62;HS3ST4;CALN1;CNTN2;NKAIN2;OPALIN;LPAR1;TMEM235;TMEM88B;FXYD1
11638,GO:0044427,0.0706263532002543,0.967882763362466,9,784,chromosomal part,CC,MCM10;BIRC5;MYBL2;NCAPG;CENPF;HSPA2;BUB1B;BUB1;CDK1
14387,GO:0055013,0.0706345879440881,0.990541859885649,2,58,cardiac muscle cell development,BP,PDGFRA;CDK1
17356,GO:0090287,0.0706513826361414,0.980085500103329,4,230,regulation of cellular response to growth factor stimulus,BP,FGF1;SFRP2;CRB2;SOX11
13443,GO:0050731,0.0708346304725915,0.984525719792434,3,148,positive regulation of peptidyl-tyrosine phosphorylation,BP,CRLF1;FGFR3;ENPP2
1570,GO:0003376,0.0710119299018114,0.997650696131935,1,12,sphingosine-1-phosphate signaling pathway,BP,S1PR5
17448,GO:0090520,0.0710119299018114,0.997650696131935,1,12,sphingolipid mediated signaling pathway,BP,S1PR5
13779,GO:0051248,0.071124632354153,0.964917639326931,11,1027,negative regulation of protein metabolic process,BP,HHATL;BIRC5;SNTA1;FOXM1;PPP1R1B;SFRP2;CRB2;PI16;PPP1R14A;PBK;FXYD1
7382,GO:0030509,0.0711481666444566,0.984440599398389,3,139,BMP signaling pathway,BP,SFRP2;CRB2;SOX11
20302,GO:1904668,0.0712779730726509,0.997632818510247,1,12,positive regulation of ubiquitin protein ligase activity,BP,UBE2C
786,GO:0001973,0.0712863525663853,0.997632254292323,1,12,adenosine receptor signaling pathway,BP,CNTN2
14624,GO:0060252,0.0713095724089806,0.997649830457309,1,11,positive regulation of glial cell proliferation,BP,GFAP
8173,GO:0032060,0.0713576581877807,0.997646616122753,1,11,bleb assembly,BP,LPAR1
2824,GO:0005886,0.0715638643268265,0.95341023110707,35,4229,plasma membrane,CC,USH1C;CLDN11;ASPM;FGFR3;SLCO1A2;TF;CPNE6;SNTA1;MAG;PLP1;PACSIN1;HSPA2;APLNR;PDGFRA;ENPP2;MOG;SLC14A1;CRB2;FREM2;SLC5A11;PAQR6;NTSR2;AQP4;MAL;UBE2C;S1PR5;GPR62;CALN1;CNTN2;NKAIN2;OPALIN;MBP;LPAR1;TMEM235;FXYD1
15400,GO:0061684,0.0716959752198035,0.997604588857683,1,12,chaperone-mediated autophagy,BP,GFAP
11528,GO:0044224,0.0718115175917438,0.997639469078523,1,10,juxtaparanode region of axon,CC,CNTN2
6990,GO:0021978,0.0719790116110466,0.997585376430443,1,12,telencephalon regionalization,BP,EMX2
7887,GO:0031464,0.0721292791473591,0.997575144260317,1,12,Cul4A-RING E3 ubiquitin ligase complex,CC,DTL
1631,GO:0003774,0.0721937537511183,0.984139054828325,3,125,motor activity,MF,KIFC1;KIF6;DNAH17
10984,GO:0042995,0.0722667031664461,0.958414265365788,18,1861,cell projection,CC,USH1C;DCX;TPX2;CPNE6;MAG;SEPT4;FBXO2;CENPF;PACSIN1;GFAP;ERMN;S100A1;FAM107A;LGI3;CNTN2;DNAH17;MBP;LPAR1
13192,GO:0048715,0.0724499307609856,0.997572993935342,1,11,negative regulation of oligodendrocyte differentiation,BP,DAAM2
17610,GO:0097154,0.0725227764913199,0.997548244468558,1,12,GABAergic neuron differentiation,BP,CNTN2
1473,GO:0003207,0.072604138107284,0.997562506013847,1,11,cardiac chamber formation,BP,SOX11
21382,GO:2000392,0.0727561790624361,0.997552142668731,1,11,regulation of lamellipodium morphogenesis,BP,ENPP2
9729,GO:0035404,0.0730979583211552,0.997508650082574,1,12,histone-serine phosphorylation,BP,PPP1R1B
16783,GO:0072224,0.0731001356309399,0.997528614633698,1,11,metanephric glomerulus development,BP,PDGFRA
6688,GO:0019888,0.0734200468632734,0.989911887904234,2,70,protein phosphatase regulator activity,MF,PPP1R1B;PPP1R14A
14002,GO:0051657,0.0734770269436286,0.997527099340628,1,10,maintenance of organelle location,BP,ASPM
21507,GO:2000586,0.0736783088188983,0.997513337041916,1,10,regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,PDGFRA
5471,GO:0015631,0.0737598099842599,0.975252682007333,5,319,tubulin binding,MF,KIFC1;DCX;BIRC5;NUSAP1;KIF6
16891,GO:0072425,0.0739082464799101,0.997472881040967,1,11,signal transduction involved in G2 DNA damage checkpoint,BP,DTL
11160,GO:0043269,0.0739221656694474,0.969826601866903,7,554,regulation of ion transport,BP,TF;SNTA1;HSPA2;APLNR;S100A1;NKAIN2;FXYD1
18225,GO:0099515,0.0740827119212427,0.997485567885789,1,10,actin filament-based transport,BP,MOBP
6786,GO:0021554,0.0740900808077794,0.997460252217406,1,11,optic nerve development,BP,LPAR1
2854,GO:0005940,0.074579390843553,0.997405168704184,1,12,septin ring,CC,SEPT4
7689,GO:0031105,0.074579390843553,0.997405168704184,1,12,septin complex,CC,SEPT4
8225,GO:0032160,0.074579390843553,0.997405168704184,1,12,septin filament array,CC,SEPT4
9591,GO:0035090,0.074867529837607,0.997384789872971,1,12,maintenance of apical/basal cell polarity,BP,CRB2
11914,GO:0045199,0.074867529837607,0.997384789872971,1,12,maintenance of epithelial cell apical/basal polarity,BP,CRB2
14580,GO:0060174,0.0749734243170737,0.997398440977035,1,11,limb bud formation,BP,SOX11
6755,GO:0021520,0.0753005585409763,0.997354009338086,1,12,spinal cord motor neuron cell fate specification,BP,NKX6-2
13446,GO:0050746,0.0754845231966624,0.9973408766727,1,12,regulation of lipoprotein metabolic process,BP,HHATL
13821,GO:0051303,0.0757680453118105,0.98940341933302,2,70,establishment of chromosome localization,BP,KIFC1;CENPF
14260,GO:0052547,0.0758413791143109,0.974333085688489,5,358,regulation of peptidase activity,BP,BIRC5;SFRP2;CRB2;PI16;MBP
9400,GO:0034502,0.0759104908140861,0.989372270528944,2,70,protein localization to chromosome,BP,BUB1B;CDK1
2892,GO:0006000,0.0759271401910438,0.99729078441686,1,13,fructose metabolic process,BP,ALDH1A1
4594,GO:0009790,0.076113520593394,0.963350515365795,10,888,embryo development,BP,USH1C;TOP2A;APLNR;PDGFRA;SFRP2;CRB2;FREM2;CDK1;SOX11;MBP
9602,GO:0035107,0.0762908335063728,0.982828247836215,3,142,appendage morphogenesis,BP,SFRP2;FREM2;SOX11
9603,GO:0035108,0.0762908335063728,0.982828247836215,3,142,limb morphogenesis,BP,SFRP2;FREM2;SOX11
2171,GO:0004714,0.0766044960998832,0.989239959077999,2,64,transmembrane receptor protein tyrosine kinase activity,MF,FGFR3;PDGFRA
8201,GO:0032105,0.0767572170953579,0.997230343762004,1,13,negative regulation of response to extracellular stimulus,BP,SPX
8204,GO:0032108,0.0767572170953579,0.997230343762004,1,13,negative regulation of response to nutrient levels,BP,SPX
3778,GO:0007501,0.0767795026276971,0.997228711615841,1,13,mesodermal cell fate specification,BP,SFRP2
8473,GO:0032530,0.076977092651508,0.997233089077667,1,12,regulation of microvillus organization,BP,USH1C
13281,GO:0050000,0.0779142401122344,0.988927403545331,2,71,chromosome localization,BP,KIFC1;CENPF
3782,GO:0007512,0.0779751397517589,0.997159783184272,1,12,adult heart development,BP,APLNR
11294,GO:0043508,0.0783676579506913,0.997111123102651,1,13,negative regulation of JUN kinase activity,BP,SFRP2
11800,GO:0045017,0.0784398762033904,0.977095930265248,4,246,glycerolipid biosynthetic process,BP,FGFR3;CPNE6;FGF1;ETNPPL
17289,GO:0090195,0.0784611655688453,0.997104121249422,1,13,chemokine secretion,BP,MBP
7250,GO:0030239,0.0785010397969768,0.988828284276998,2,62,myofibril assembly,BP,PDGFRA;MYBPC1
13591,GO:0050954,0.0786437481901691,0.982069106172677,3,147,sensory perception of mechanical stimulus,BP,USH1C;BIRC5;MBP
1474,GO:0003208,0.0788132835601927,0.988739982678472,2,67,cardiac ventricle morphogenesis,BP,SFRP2;SOX11
21632,GO:2000781,0.0788624999923577,0.997093777676491,1,12,positive regulation of double-strand break repair,BP,FOXM1
18544,GO:1900006,0.0788757808609482,0.988733155208699,2,65,positive regulation of dendrite development,BP,PACSIN1;LPAR1
5321,GO:0015125,0.078974520523168,0.997065525635658,1,13,bile acid transmembrane transporter activity,MF,SLCO1A2
5916,GO:0016540,0.0794622486247983,0.99702861279005,1,13,protein autoprocessing,BP,KLK6
13047,GO:0048407,0.0795014041759171,0.997069569083521,1,11,platelet-derived growth factor binding,MF,PDGFRA
10893,GO:0042759,0.079978815801451,0.997009631220108,1,12,long-chain fatty acid biosynthetic process,BP,PLP1
13689,GO:0051117,0.0803845892871278,0.988367133553832,2,73,ATPase binding,MF,SNTA1;S100A1
5028,GO:0010893,0.0806314133615117,0.996939157945096,1,13,positive regulation of steroid biosynthetic process,BP,FGF1
17688,GO:0097286,0.0806375218704033,0.996938686980159,1,13,iron ion import,BP,TF
11897,GO:0045176,0.0806479339556991,0.996983092760301,1,11,apical protein localization,BP,MAL
9689,GO:0035330,0.0807434748523642,0.996975828094447,1,11,regulation of hippo signaling,BP,SOX11
6455,GO:0019206,0.0807511166023927,0.996912125779299,1,14,nucleoside kinase activity,MF,AK5
11665,GO:0044463,0.0808215692822834,0.956886919519491,13,1252,cell projection part,CC,USH1C;TPX2;CPNE6;MAG;SEPT4;FBXO2;CENPF;PACSIN1;ERMN;CNTN2;DNAH17;MBP;LPAR1
18452,GO:0120038,0.0808215692822834,0.956886919519491,13,1252,plasma membrane bounded cell projection part,CC,USH1C;TPX2;CPNE6;MAG;SEPT4;FBXO2;CENPF;PACSIN1;ERMN;CNTN2;DNAH17;MBP;LPAR1
11868,GO:0045120,0.0808598121853366,0.996942348383448,1,12,pronucleus,CC,CENPF
8224,GO:0032156,0.0809593206628397,0.996913823521318,1,13,septin cytoskeleton,CC,SEPT4
16885,GO:0072401,0.0809736848488254,0.988233426643873,2,73,signal transduction involved in DNA integrity checkpoint,BP,DTL;CDK1
16889,GO:0072422,0.0809736848488254,0.988233426643873,2,73,signal transduction involved in DNA damage checkpoint,BP,DTL;CDK1
334,GO:0000921,0.0812301268534407,0.996892819588806,1,13,septin ring assembly,BP,SEPT4
13474,GO:0050780,0.0812641817674226,0.996890173063595,1,13,dopamine receptor binding,MF,PPP1R1B
6468,GO:0019220,0.081380913858629,0.954642502072996,15,1549,regulation of phosphate metabolic process,BP,CRLF1;FGFR3;TPX2;FOXM1;FGF1;HSPA2;PPP1R1B;APLNR;PDGFRA;ENPP2;SFRP2;PPP1R14A;PBK;CDK1;LPAR1
13479,GO:0050789,0.0814786660192594,0.946508764822524,70,9666,regulation of biological process,BP,CRLF1;USH1C;HHATL;ASPM;FGFR3;DCX;TPX2;BIRC5;TF;CPNE6;MYBL2;SNTA1;MAG;PTGDS;SEPT4;FOXM1;FGF1;FBXO2;CENPF;NECAB1;PLP1;PACSIN1;MYRF;HSPA2;EVI2A;GFAP;TOP2A;PPP1R1B;SPX;APLNR;PDGFRA;ESPL1;ERMN;ENPP2;MOG;NUSAP1;DTL;SFRP2;DAAM2;CRB2;MKI67;NKX6-2;CNDP1;HSPB8;BUB1B;S100A1;PAQR6;PI16;PPP1R14A;KLK6;PBK;FAM107A;LGI3;NTSR2;BUB1;CDK1;EMX2;RRM2;MAL;UBE2C;SOX11;S1PR5;GPR62;CNTN2;NKAIN2;MYBPC1;MBP;LPAR1;ZNF536;FXYD1
14380,GO:0055006,0.0815816188640834,0.988130392236094,2,63,cardiac cell development,BP,PDGFRA;CDK1
21192,GO:2000095,0.081667480307576,0.996858742962434,1,13,regulation of Wnt signaling pathway, planar cell polarity pathway,BP,SFRP2
7721,GO:0031175,0.0822008366155879,0.959850545219929,10,885,neuron projection development,BP,USH1C;CPNE6;MAG;PLP1;PACSIN1;GFAP;SFRP2;KLK6;CNTN2;LPAR1
8811,GO:0033043,0.0823647996624192,0.957052287055241,12,1156,regulation of organelle organization,BP,TPX2;CENPF;TOP2A;PDGFRA;ESPL1;NUSAP1;MKI67;BUB1B;BUB1;UBE2C;MYBPC1;LPAR1
13610,GO:0050998,0.0824649669053473,0.99681777461528,1,12,nitric-oxide synthase binding,MF,SNTA1
252,GO:0000712,0.0827548449234265,0.996773189191181,1,13,resolution of meiotic recombination intermediates,BP,TOP2A
1433,GO:0003151,0.0828428289997325,0.98781182401686,2,71,outflow tract morphogenesis,BP,SFRP2;SOX11
20507,GO:1905048,0.0829221051178083,0.996759923895405,1,13,regulation of metallopeptidase activity,BP,MBP
15041,GO:0060900,0.0829263579100985,0.996781491643146,1,12,embryonic camera-type eye formation,BP,SOX11
8874,GO:0033160,0.0831983397984381,0.996786073259742,1,11,positive regulation of protein import into nucleus, translocation,BP,CDK1
7930,GO:0031570,0.0832378612529363,0.980557795804706,3,157,DNA integrity checkpoint,BP,TOP2A;DTL;CDK1
7684,GO:0031099,0.0836080972454542,0.980431574647076,3,160,regeneration,BP,GFAP;KLK6;CDK1
592,GO:0001708,0.0836177847170578,0.987623074443903,2,74,cell fate specification,BP,SFRP2;NKX6-2
7865,GO:0031434,0.0838574401055798,0.987587750531333,2,68,mitogen-activated protein kinase kinase binding,MF,FGFR3;PDGFRA
16512,GO:0071772,0.0839361801416428,0.980336366734258,3,150,response to BMP,BP,SFRP2;CRB2;SOX11
16513,GO:0071773,0.0839361801416428,0.980336366734258,3,150,cellular response to BMP stimulus,BP,SFRP2;CRB2;SOX11
15119,GO:0061029,0.0839737821641583,0.996675872386338,1,13,eyelid development in camera-type eye,BP,SOX11
17452,GO:0090533,0.0839866823669997,0.996655581099131,1,14,cation-transporting ATPase complex,CC,FXYD1
7642,GO:0031045,0.0841433799702003,0.996662213829861,1,13,dense core granule,CC,SPX
17573,GO:0097090,0.0842447244914264,0.996676646972843,1,12,presynaptic membrane organization,BP,CNTN2
7032,GO:0022604,0.0842838400386901,0.967272883966374,6,441,regulation of cell morphogenesis,BP,CPNE6;MAG;ERMN;ENPP2;CNTN2;LPAR1
7114,GO:0030030,0.0843039590994849,0.95369450777237,14,1381,cell projection organization,BP,USH1C;CPNE6;MAG;SEPT4;PLP1;PACSIN1;GFAP;ERMN;ENPP2;SFRP2;KLK6;CDK1;CNTN2;LPAR1
1602,GO:0003688,0.0844331492148491,0.996619351389247,1,14,DNA replication origin binding,MF,MCM10
13010,GO:0048313,0.0846286709469821,0.996603421813127,1,14,Golgi inheritance,BP,CDK1
2937,GO:0006067,0.0846454649843673,0.996585107447167,1,15,ethanol metabolic process,BP,ALDH1A1
13736,GO:0051179,0.0849658727697701,0.942564955331362,44,5638,localization,BP,USH1C;KIFC1;ASPM;DCX;SLCO1A2;BIRC5;TF;CPNE6;SNTA1;MAG;SEPT4;FGF1;CENPF;PACSIN1;HSPA2;GFAP;SPX;APLNR;PDGFRA;ESPL1;ENPP2;NUSAP1;SLC14A1;FIP1L1;SFRP2;CRB2;BUB1B;SLC5A11;S100A1;TMEM144;MOBP;LGI3;CDK1;EMX2;AQP4;MAL;SOX11;CNTN2;DNAH17;NKAIN2;MYBPC1;MBP;LPAR1;FXYD1
6160,GO:0017014,0.0849964737038619,0.996593071254603,1,13,protein nitrosylation,BP,SNTA1
6290,GO:0018119,0.0849964737038619,0.996593071254603,1,13,peptidyl-cysteine S-nitrosylation,BP,SNTA1
10543,GO:0042074,0.0851267275389995,0.996582449850939,1,13,cell migration involved in gastrulation,BP,CRB2
18261,GO:0099568,0.0852977709110861,0.966778146371629,6,439,cytoplasmic region,CC,SEPT4;FGF1;CENPF;ERMN;MOBP;DNAH17
3319,GO:0006646,0.0855610885184774,0.996526923723302,1,14,phosphatidylethanolamine biosynthetic process,BP,ETNPPL
4209,GO:0008625,0.0855854295630756,0.987154392143976,2,77,extrinsic apoptotic signaling pathway via death domain receptors,BP,SFRP2;MAL
11889,GO:0045161,0.0858491455147782,0.996546710696129,1,12,neuronal ion channel clustering,BP,CNTN2
13188,GO:0048711,0.0858910230807337,0.996499644177666,1,14,positive regulation of astrocyte differentiation,BP,MAG
10248,GO:0036376,0.0860509361126611,0.996486382627556,1,14,sodium ion export across plasma membrane,BP,FXYD1
11471,GO:0044057,0.0861485517926306,0.966352461376554,6,462,regulation of system process,BP,SNTA1;MAG;MYRF;SPX;S100A1;FXYD1
13733,GO:0051174,0.0864785534395205,0.951361160390289,15,1563,regulation of phosphorus metabolic process,BP,CRLF1;FGFR3;TPX2;FOXM1;FGF1;HSPA2;PPP1R1B;APLNR;PDGFRA;ENPP2;SFRP2;PPP1R14A;PBK;CDK1;LPAR1
14376,GO:0055001,0.0866951545035696,0.979418721721329,3,148,muscle cell development,BP,PDGFRA;CDK1;MYBPC1
4508,GO:0009408,0.0867493222147432,0.979384744162738,3,159,response to heat,BP,FGF1;HSPA2;HSPB8
7203,GO:0030177,0.0875494559447791,0.979113702084804,3,160,positive regulation of Wnt signaling pathway,BP,ASPM;SFRP2;DAAM2
10268,GO:0036445,0.087616861940222,0.996376107640811,1,13,neuronal stem cell division,BP,ASPM
14405,GO:0055057,0.087616861940222,0.996376107640811,1,13,neuroblast division,BP,ASPM
13396,GO:0050679,0.0876872990716715,0.97906983111599,3,158,positive regulation of epithelial cell proliferation,BP,FGF1;APLNR;SOX11
18025,GO:0098787,0.0877065291203347,0.996347561170987,1,14,mRNA cleavage involved in mRNA processing,BP,FIP1L1
17274,GO:0090179,0.0877999290243014,0.996360691197645,1,13,planar cell polarity pathway involved in neural tube closure,BP,SFRP2
17707,GO:0097340,0.0879289098900811,0.996349809142574,1,13,inhibition of cysteine-type endopeptidase activity,BP,BIRC5
17708,GO:0097341,0.0879289098900811,0.996349809142574,1,13,zymogen inhibition,BP,BIRC5
17638,GO:0097194,0.0880029352773796,0.986580843486142,2,77,execution phase of apoptosis,BP,TOP2A;AIFM3
14864,GO:0060579,0.0883960410267749,0.996288925195572,1,14,ventral spinal cord interneuron fate commitment,BP,NKX6-2
14866,GO:0060581,0.0883960410267749,0.996288925195572,1,14,cell fate commitment involved in pattern specification,BP,NKX6-2
10069,GO:0035988,0.0886012242612316,0.996271383212629,1,14,chondrocyte proliferation,BP,FGFR3
13037,GO:0048385,0.0893699848508887,0.996186386423451,1,15,regulation of retinoic acid receptor signaling pathway,BP,ZNF536
864,GO:0002082,0.0893785874160861,0.996185639653112,1,15,regulation of oxidative phosphorylation,BP,CDK1
82,GO:0000165,0.0895801156259683,0.957295734168549,9,824,MAPK cascade,BP,FGFR3;FOXM1;FGF1;PDGFRA;SFRP2;PBK;CDK1;MBP;LPAR1
1479,GO:0003214,0.0896184956436168,0.996205707091476,1,13,cardiac left ventricle morphogenesis,BP,SFRP2
16347,GO:0071481,0.089660047556609,0.99620212682382,1,13,cellular response to X-ray,BP,SFRP2
11907,GO:0045187,0.0899452312708313,0.996119544640936,1,16,regulation of circadian sleep/wake cycle, sleep,BP,PTGDS
1437,GO:0003159,0.0899653608545889,0.9961345245599,1,15,morphogenesis of an endothelium,BP,FGF1
15197,GO:0061154,0.0899653608545889,0.9961345245599,1,15,endothelial tube morphogenesis,BP,FGF1
13007,GO:0048308,0.0902626353934637,0.996108493978199,1,15,organelle inheritance,BP,CDK1
13954,GO:0051580,0.0903839620349669,0.996097844142971,1,15,regulation of neurotransmitter uptake,BP,GFAP
13858,GO:0051382,0.0904383706704097,0.996112410120725,1,14,kinetochore assembly,BP,CENPF
14492,GO:0060047,0.0905662855323317,0.972241425749707,4,248,heart contraction,BP,SNTA1;SPX;S100A1;FXYD1
7818,GO:0031345,0.0905866295206258,0.978082749161946,3,158,negative regulation of cell projection organization,BP,MAG;GFAP;LPAR1
823,GO:0002029,0.0908839029387418,0.996036710336766,1,16,desensitization of G-protein coupled receptor protein signaling pathway,BP,APLNR
7016,GO:0022401,0.0908839029387418,0.996036710336766,1,16,negative adaptation of signaling pathway,BP,APLNR
9394,GO:0034483,0.090948183993498,0.9960676856764,1,14,heparan sulfate sulfotransferase activity,MF,HS3ST4
14064,GO:0051782,0.0912426420018208,0.996041733071844,1,14,negative regulation of cell division,BP,ASPM
1763,GO:0004029,0.091528846372265,0.995996606355118,1,15,aldehyde dehydrogenase (NAD) activity,MF,ALDH1A1
9964,GO:0035791,0.0916749392588151,0.996026417992788,1,13,platelet-derived growth factor receptor-beta signaling pathway,BP,PDGFRA
21372,GO:2000380,0.0916989447221718,0.995981450666594,1,15,regulation of mesoderm development,BP,SFRP2
7863,GO:0031432,0.0919994440407395,0.995974625323589,1,14,titin binding,MF,MYBPC1
12927,GO:0048148,0.0923148198413798,0.995926328406333,1,15,behavioral response to cocaine,BP,PPP1R1B
14034,GO:0051716,0.0930206407529187,0.936366675270962,47,6151,cellular response to stimulus,BP,CRLF1;MCM10;ASPM;FGFR3;DCX;TPX2;BIRC5;TF;CPNE6;MYBL2;MAG;SEPT4;FOXM1;FGF1;FBXO2;PLP1;HSPA2;EVI2A;GFAP;TOP2A;PPP1R1B;SPX;APLNR;PDGFRA;ENPP2;MOG;DTL;SFRP2;DAAM2;CRB2;HSPB8;S100A1;PAQR6;PPP1R14A;KLK6;PBK;NTSR2;CDK1;AQP4;MAL;SOX11;S1PR5;GPR62;CNTN2;MBP;LPAR1;ZNF536
2462,GO:0005161,0.0930871014012053,0.995877156117796,1,14,platelet-derived growth factor receptor binding,MF,PDGFRA
7847,GO:0031406,0.0930998418578452,0.97719907583632,3,170,carboxylic acid binding,MF,MAG;PTGDS;HAPLN2
2050,GO:0004551,0.0931679586477978,0.995831365781131,1,16,nucleotide diphosphatase activity,MF,ENPP2
4223,GO:0008654,0.0931741912316161,0.971152710308454,4,263,phospholipid biosynthetic process,BP,FGFR3;CPNE6;FGF1;ETNPPL
18765,GO:1901019,0.0932931328064588,0.985292784996414,2,77,regulation of calcium ion transmembrane transporter activity,BP,HSPA2;S100A1
20455,GO:1904948,0.0932998771287783,0.995837354776518,1,15,midbrain dopaminergic neuron differentiation,BP,SFRP2
14625,GO:0060253,0.0933486896060784,0.995853533946621,1,14,negative regulation of glial cell proliferation,BP,SOX11
14386,GO:0055012,0.0933510976478322,0.995832701132961,1,15,ventricular cardiac muscle cell differentiation,BP,CDK1
12561,GO:0046625,0.0934891841318738,0.995802055553123,1,16,sphingolipid binding,MF,MAG
8393,GO:0032426,0.0935344989146851,0.995816016107845,1,15,stereocilium tip,CC,USH1C
2767,GO:0005791,0.0936133773346495,0.985194578536928,2,83,rough endoplasmic reticulum,CC,TF;PTGDS
4894,GO:0010717,0.0936552071230922,0.985202986619047,2,77,regulation of epithelial to mesenchymal transition,BP,SFRP2;CRB2
3762,GO:0007422,0.0939930327006515,0.985133359119755,2,73,peripheral nervous system development,BP,HAPLN2;CDK1
7690,GO:0031106,0.0940618590594391,0.995767846754565,1,15,septin ring organization,BP,SEPT4
1377,GO:0003015,0.0941271035027519,0.970766248977282,4,251,heart process,BP,SNTA1;SPX;S100A1;FXYD1
9977,GO:0035812,0.0941709676690786,0.995739493609152,1,16,renal sodium excretion,BP,SPX
9978,GO:0035813,0.0941709676690786,0.995739493609152,1,16,regulation of renal sodium excretion,BP,SPX
6059,GO:0016805,0.0942393306571386,0.995733194019902,1,16,dipeptidase activity,MF,CNDP1
4049,GO:0008353,0.0942511553760855,0.995732103893201,1,16,RNA polymerase II carboxy-terminal domain kinase activity,MF,CDK1
2049,GO:0004550,0.094258642889962,0.995715195135516,1,17,nucleoside diphosphate kinase activity,MF,AK5
17273,GO:0090178,0.0942727522809844,0.995769528424929,1,14,regulation of establishment of planar polarity involved in neural tube closure,BP,SFRP2
6775,GO:0021542,0.0946549135414052,0.995713335434837,1,15,dentate gyrus development,BP,EMX2
3553,GO:0007009,0.0949674592288297,0.984890352591435,2,73,plasma membrane organization,BP,PACSIN1;MYRF
3604,GO:0007096,0.0949963741388695,0.995663110616931,1,16,regulation of exit from mitosis,BP,UBE2C
19746,GO:1903522,0.0951548580100289,0.970331374602874,4,258,regulation of blood circulation,BP,SNTA1;SPX;S100A1;FXYD1
836,GO:0002043,0.0951715570818878,0.995665552749932,1,15,blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,APLNR
7014,GO:0022038,0.0952704222357226,0.995656377730624,1,15,corpus callosum development,BP,LPAR1
14475,GO:0060026,0.0953833181570651,0.995645888307715,1,15,convergent extension,BP,SFRP2
12171,GO:0045778,0.0955674449847295,0.984721833187262,2,78,positive regulation of ossification,BP,SFRP2;SOX11
14607,GO:0060219,0.0960761116607945,0.995581231942333,1,15,camera-type eye photoreceptor cell differentiation,BP,USH1C
9057,GO:0033630,0.0961699891861883,0.995553292654139,1,16,positive regulation of cell adhesion mediated by integrin,BP,SFRP2
6981,GO:0021953,0.0962088506521317,0.976123683402638,3,161,central nervous system neuron differentiation,BP,SFRP2;NKX6-2;CNTN2
11861,GO:0045109,0.0962852393462362,0.995561617549896,1,15,intermediate filament organization,BP,GFAP
7837,GO:0031396,0.096311076687096,0.976074945274436,3,170,regulation of protein ubiquitination,BP,SEPT4;FBXO2;UBE2C
7094,GO:0023058,0.0963774832516638,0.99551677208149,1,17,adaptation of signaling pathway,BP,APLNR
10886,GO:0042749,0.0965499651711762,0.995500414657277,1,17,regulation of circadian sleep/wake cycle,BP,PTGDS
16861,GO:0072359,0.0968184482297012,0.95122027404073,10,916,circulatory system development,BP,FGF1;APLNR;PDGFRA;ENPP2;SFRP2;CRB2;FREM2;S100A1;CDK1;SOX11
13266,GO:0048870,0.0968996104214822,0.946755919967413,13,1309,cell motility,BP,ASPM;DCX;MAG;FGF1;PDGFRA;ENPP2;SFRP2;CRB2;CDK1;EMX2;CNTN2;DNAH17;LPAR1
14011,GO:0051674,0.0968996104214822,0.946755919967413,13,1309,localization of cell,BP,ASPM;DCX;MAG;FGF1;PDGFRA;ENPP2;SFRP2;CRB2;CDK1;EMX2;CNTN2;DNAH17;LPAR1
11095,GO:0043177,0.0969973069052522,0.975829837610289,3,172,organic acid binding,MF,MAG;PTGDS;HAPLN2
17212,GO:0090083,0.0971591857142782,0.99547916108449,1,15,regulation of inclusion body assembly,BP,HSPA2
10234,GO:0036342,0.097521045456802,0.995444789205493,1,15,post-anal tail morphogenesis,BP,SFRP2
9185,GO:0034114,0.0976606882197754,0.995394338249849,1,17,regulation of heterotypic cell-cell adhesion,BP,MBP
14700,GO:0060349,0.0976985500608827,0.984179040108991,2,79,bone morphogenesis,BP,FGFR3;SFRP2
8191,GO:0032095,0.0980374346755437,0.995358066886007,1,17,regulation of response to food,BP,SPX
3556,GO:0007015,0.0983478670229428,0.964110237715724,5,359,actin filament organization,BP,USH1C;PACSIN1;ERMN;MYBPC1;LPAR1
594,GO:0001710,0.098463854337263,0.9953168350729,1,17,mesodermal cell fate commitment,BP,SFRP2
2796,GO:0005847,0.0987429367507675,0.995307547675011,1,16,mRNA cleavage and polyadenylation specificity factor complex,CC,FIP1L1
15030,GO:0060850,0.0989228037921738,0.995290111768501,1,16,regulation of transcription involved in cell fate commitment,BP,NKX6-2
17272,GO:0090177,0.0991143665441065,0.995291836821509,1,15,establishment of planar polarity involved in neural tube closure,BP,SFRP2
8231,GO:0032185,0.099638344807159,0.995220416323268,1,16,septin cytoskeleton organization,BP,SEPT4
12962,GO:0048240,0.0997446518424084,0.995191852544881,1,17,sperm capacitation,BP,SEPT4
2575,GO:0005402,0.100077365321356,0.995177391455294,1,16,carbohydrate:cation symporter activity,MF,SLC5A11
17736,GO:0097386,0.100381796998295,0.995147438965919,1,16,glial cell projection,CC,GFAP
5876,GO:0016477,0.100514205431947,0.945770664689304,12,1193,cell migration,BP,ASPM;DCX;MAG;FGF1;PDGFRA;ENPP2;SFRP2;CRB2;CDK1;EMX2;CNTN2;LPAR1
575,GO:0001676,0.100536907845087,0.983426547789772,2,86,long-chain fatty acid metabolic process,BP,PTGDS;PLP1
6750,GO:0021514,0.101085514336218,0.995077832663615,1,16,ventral spinal cord interneuron differentiation,BP,NKX6-2
5821,GO:0016338,0.101361398269093,0.995014975725029,1,18,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules,BP,CLDN11
9618,GO:0035173,0.101603809394152,0.995026237451586,1,16,histone kinase activity,MF,CDK1
19457,GO:1902932,0.101615393713087,0.995006228572988,1,17,positive regulation of alcohol biosynthetic process,BP,FGF1
10342,GO:0038024,0.102001605018266,0.983064460518925,2,80,cargo receptor activity,MF,ENPP2;CRB2
7579,GO:0030903,0.102305108939627,0.99495597927756,1,16,notochord development,BP,CRB2
13099,GO:0048562,0.102394973078623,0.967253559498077,4,266,embryonic organ morphogenesis,BP,USH1C;PDGFRA;CRB2;SOX11
6457,GO:0019208,0.102480986962942,0.982928531119581,2,83,phosphatase regulator activity,MF,PPP1R1B;PPP1R14A
11083,GO:0043161,0.102665663767462,0.962040086427026,5,387,proteasome-mediated ubiquitin-dependent protein catabolic process,BP,FBXO2;BUB1B;PBK;CDK1;UBE2C
13612,GO:0051000,0.102734630756577,0.99489342492911,1,17,positive regulation of nitric-oxide synthase activity,BP,S100A1
2480,GO:0005184,0.102882740250202,0.994832037468967,1,20,neuropeptide hormone activity,MF,SPX
11081,GO:0043154,0.102914945964246,0.982804794132921,2,86,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,BIRC5;SFRP2
4132,GO:0008483,0.103316372656342,0.994834275897741,1,17,transaminase activity,MF,ETNPPL
5897,GO:0016505,0.103530727045698,0.994812391950873,1,17,peptidase activator activity involved in apoptotic process,MF,MAL
621,GO:0001759,0.104131647819885,0.994733191416334,1,18,organ induction,BP,FGF1
3421,GO:0006796,0.104360440846635,0.933075192523156,24,2851,phosphate-containing compound metabolic process,BP,CRLF1;FGFR3;TPX2;BIRC5;CPNE6;FOXM1;FGF1;HSPA2;PPP1R1B;APLNR;PDGFRA;ENPP2;SFRP2;AK5;BUB1B;ETNPPL;ALDH1A1;PPP1R14A;PBK;BUB1;CDK1;RRM2;MBP;LPAR1
3210,GO:0006516,0.104467991879073,0.994716139085465,1,17,glycoprotein catabolic process,BP,FBXO2
4794,GO:0010544,0.104621911360598,0.99470024424434,1,17,negative regulation of platelet activation,BP,PDGFRA
13198,GO:0048736,0.104815865435826,0.973025257743533,3,164,appendage development,BP,SFRP2;FREM2;SOX11
14579,GO:0060173,0.104815865435826,0.973025257743533,3,164,limb development,BP,SFRP2;FREM2;SOX11
2167,GO:0004709,0.10505118136766,0.982271055294371,2,77,MAP kinase kinase kinase activity,MF,FGFR3;PDGFRA
11121,GO:0043217,0.105310015852759,0.994698334322622,1,14,myelin maintenance,BP,MYRF
4853,GO:0010642,0.105310973125816,0.994649032734157,1,16,negative regulation of platelet-derived growth factor receptor signaling pathway,BP,PDGFRA
20300,GO:1904666,0.105657413334337,0.994558346331552,1,19,regulation of ubiquitin protein ligase activity,BP,UBE2C
16945,GO:0072562,0.105899058224163,0.981993941127029,2,92,blood microparticle,CC,TF;HSPA2
7078,GO:0023014,0.106345493294553,0.94749440029404,9,852,signal transduction by protein phosphorylation,BP,FGFR3;FOXM1;FGF1;PDGFRA;SFRP2;PBK;CDK1;MBP;LPAR1
15884,GO:0070613,0.107115781589027,0.981685015591443,2,86,regulation of protein processing,BP,BIRC5;CNTN2
21716,GO:2001026,0.10723332800673,0.994447778568068,1,16,regulation of endothelial cell chemotaxis,BP,FGF1
8194,GO:0032098,0.107266863061063,0.994387849339672,1,19,regulation of appetite,BP,SPX
6752,GO:0021516,0.107277928630657,0.994403373028512,1,18,dorsal spinal cord development,BP,DAAM2
2105,GO:0004622,0.107368023157333,0.994393774964245,1,18,lysophospholipase activity,MF,ENPP2
13575,GO:0050920,0.107405083552235,0.972047009506701,3,180,regulation of chemotaxis,BP,FGF1;PDGFRA;LPAR1
17697,GO:0097320,0.107657034291258,0.994381735394255,1,17,plasma membrane tubulation,BP,PACSIN1
9669,GO:0035282,0.10784401071967,0.981498506769302,2,83,segmentation,BP,SFRP2;CRB2
3827,GO:0007617,0.107889407331311,0.994338061969634,1,18,mating behavior,BP,PPP1R1B
4020,GO:0008301,0.107920919031936,0.994334685561227,1,18,DNA binding, bending,MF,TOP2A
6106,GO:0016881,0.108243589900136,0.994300051754677,1,18,acid-amino acid ligase activity,MF,CARNS1
3616,GO:0007141,0.108533893451311,0.994268798104598,1,18,male meiosis I,BP,HSPA2
2560,GO:0005355,0.108599331260177,0.994261740869141,1,18,glucose transmembrane transporter activity,MF,SLC5A11
8929,GO:0033268,0.108716821516512,0.994314290761536,1,15,node of Ranvier,CC,CNTN2
16998,GO:0072673,0.109280353390647,0.99420740606624,1,17,lamellipodium morphogenesis,BP,ENPP2
12421,GO:0046337,0.109451633419935,0.994169409685751,1,18,phosphatidylethanolamine metabolic process,BP,ETNPPL
7189,GO:0030162,0.109487060849972,0.95096804583558,7,633,regulation of proteolysis,BP,BIRC5;SFRP2;CRB2;PI16;PBK;CNTN2;MBP
19124,GO:1902043,0.109643014138266,0.994168080184262,1,17,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,MAL
11431,GO:0043950,0.109709467626168,0.994123854671952,1,19,positive regulation of cAMP-mediated signaling,BP,GPR62
14122,GO:0051896,0.109722349274014,0.971192189347663,3,174,regulation of protein kinase B signaling,BP,FGFR3;FGF1;PDGFRA
7191,GO:0030165,0.109899625314637,0.980942387978823,2,82,PDZ domain binding,MF,SNTA1;LPAR1
13651,GO:0051050,0.109996759199324,0.945309954760455,9,856,positive regulation of transport,BP,TF;HSPA2;APLNR;S100A1;CDK1;SOX11;MYBPC1;MBP;FXYD1
13842,GO:0051347,0.110150630424112,0.950605070035184,7,612,positive regulation of transferase activity,BP,FGFR3;TPX2;FGF1;PDGFRA;CDK1;UBE2C;LPAR1
871,GO:0002089,0.110204645889924,0.994129083666635,1,16,lens morphogenesis in camera-type eye,BP,SOX11
6574,GO:0019538,0.110643974251831,0.923871085006357,39,5052,protein metabolic process,BP,CRLF1;HHATL;FGFR3;TPX2;BIRC5;TF;SNTA1;SEPT4;FOXM1;FGF1;FBXO2;NECAB1;MYRF;HSPA2;GFAP;TOP2A;PPP1R1B;APLNR;PDGFRA;ESPL1;ENPP2;DTL;SFRP2;CRB2;CNDP1;BUB1B;PI16;PPP1R14A;KLK6;PBK;BUB1;CDK1;UBE2C;SOX11;HS3ST4;CNTN2;MBP;LPAR1;FXYD1
2797,GO:0005849,0.110783656395733,0.994023570412337,1,18,mRNA cleavage factor complex,CC,FIP1L1
5075,GO:0010954,0.110840433657719,0.994017312285708,1,18,positive regulation of protein processing,BP,CNTN2
12262,GO:0045940,0.111148487440844,0.993965364371228,1,19,positive regulation of steroid metabolic process,BP,FGF1
10623,GO:0042249,0.111209934357412,0.993996572507402,1,17,establishment of planar polarity of embryonic epithelium,BP,SFRP2
16073,GO:0070977,0.111302270895408,0.994034656562885,1,15,bone maturation,BP,FGFR3
19647,GO:1903317,0.111433180011363,0.980499045060851,2,88,regulation of protein maturation,BP,BIRC5;CNTN2
3662,GO:0007200,0.111559591479824,0.980445267803733,2,94,phospholipase C-activating G-protein coupled receptor signaling pathway,BP,NTSR2;LPAR1
2170,GO:0004713,0.111611358460958,0.970490114183273,3,169,protein tyrosine kinase activity,MF,FGFR3;FGF1;PDGFRA
6449,GO:0019199,0.111838248589107,0.980420663653593,2,79,transmembrane receptor protein kinase activity,MF,FGFR3;PDGFRA
13650,GO:0051049,0.111968822196901,0.934474665999058,15,1627,regulation of transport,BP,TF;SNTA1;PACSIN1;HSPA2;GFAP;SPX;APLNR;S100A1;LGI3;CDK1;SOX11;NKAIN2;MYBPC1;MBP;FXYD1
11474,GO:0044062,0.111983658256689,0.99387237144311,1,19,regulation of excretion,BP,SPX
12482,GO:0046475,0.112846831372328,0.993775480701291,1,19,glycerophospholipid catabolic process,BP,ENPP2
15230,GO:0061298,0.112975785270447,0.993823490804638,1,16,retina vasculature development in camera-type eye,BP,PDGFRA
7103,GO:0030011,0.113035070085701,0.993793530130834,1,17,maintenance of cell polarity,BP,CRB2
3711,GO:0007283,0.113347170894641,0.956829992884343,5,394,spermatogenesis,BP,CLDN11;KIFC1;ASPM;SEPT4;HSPA2
10289,GO:0036477,0.11347282740134,0.945756070599968,8,721,somatodendritic compartment,CC,TPX2;CPNE6;FBXO2;PPP1R1B;ERMN;CNTN2;MBP;LPAR1
6033,GO:0016769,0.113555486137479,0.993695341427538,1,19,transferase activity, transferring nitrogenous groups,MF,ETNPPL
13488,GO:0050802,0.113669380878401,0.993665533577014,1,20,circadian sleep/wake cycle, sleep,BP,PTGDS
708,GO:0001871,0.113718106602814,0.993676875751274,1,19,pattern binding,MF,ENPP2
7255,GO:0030247,0.113718106602814,0.993676875751274,1,19,polysaccharide binding,MF,ENPP2
13988,GO:0051640,0.113750361888515,0.948591648319455,7,613,organelle localization,BP,KIFC1;ASPM;CENPF;ESPL1;NUSAP1;MOBP;CDK1
13395,GO:0050678,0.113761481611388,0.962255083525256,4,277,regulation of epithelial cell proliferation,BP,FGF1;APLNR;SFRP2;SOX11
5073,GO:0010951,0.113863143041187,0.969609306515653,3,187,negative regulation of endopeptidase activity,BP,BIRC5;SFRP2;CRB2
8382,GO:0032414,0.1139006721625,0.979826649590489,2,84,positive regulation of ion transmembrane transporter activity,BP,HSPA2;S100A1
5337,GO:0015149,0.113935885591612,0.993652102619813,1,19,hexose transmembrane transporter activity,MF,SLC5A11
4874,GO:0010667,0.114243818843038,0.993616987797873,1,19,negative regulation of cardiac muscle cell apoptotic process,BP,SFRP2
4052,GO:0008356,0.114488407440603,0.993608053437786,1,18,asymmetric cell division,BP,ASPM
15636,GO:0070193,0.114687012132139,0.993566271167036,1,19,synaptonemal complex organization,BP,HSPA2
19395,GO:1902750,0.114702395548304,0.979561407540772,2,96,negative regulation of cell cycle G2/M phase transition,BP,DTL;CDK1
21629,GO:2000778,0.114718156441565,0.993562699298491,1,19,positive regulation of interleukin-6 secretion,BP,MBP
13182,GO:0048704,0.114783957644745,0.979564038454116,2,88,embryonic skeletal system morphogenesis,BP,PDGFRA;SOX11
19925,GO:1903861,0.114846571102978,0.993588515957737,1,17,positive regulation of dendrite extension,BP,CPNE6
6132,GO:0016925,0.11495048124433,0.979517127890641,2,88,protein sumoylation,BP,BIRC5;TOP2A
13928,GO:0051537,0.115058449015827,0.993506311073034,1,20,2 iron, 2 sulfur cluster binding,MF,AIFM3
2423,GO:0005104,0.11509000676664,0.993519972656379,1,19,fibroblast growth factor receptor binding,MF,FGF1
13622,GO:0051015,0.115619427024379,0.968974390840608,3,164,actin filament binding,MF,USH1C;ERMN;MYBPC1
19234,GO:1902307,0.115871375074962,0.993449202127426,1,18,positive regulation of sodium ion transmembrane transport,BP,FXYD1
7119,GO:0030036,0.116019498414092,0.947319628852617,7,595,actin cytoskeleton organization,BP,USH1C;PACSIN1;PDGFRA;ERMN;DAAM2;MYBPC1;LPAR1
821,GO:0002027,0.116468150027472,0.979094975598964,2,86,regulation of heart rate,BP,SNTA1;SPX
4435,GO:0009220,0.116552152237362,0.993316737524853,1,21,pyrimidine ribonucleotide biosynthetic process,BP,AK5
2143,GO:0004674,0.116571743859334,0.950700443235653,6,474,protein serine/threonine kinase activity,MF,FGFR3;PDGFRA;BUB1B;PBK;BUB1;CDK1
6713,GO:0019953,0.116896243426243,0.946811389872761,7,634,sexual reproduction,BP,CLDN11;KIFC1;ASPM;SEPT4;HSPA2;PPP1R1B;CDK1
16306,GO:0071425,0.11693775352335,0.993305470171244,1,19,hematopoietic stem cell proliferation,BP,SFRP2
10489,GO:0040007,0.116996694557404,0.941076222544505,9,854,growth,BP,ASPM;FGFR3;CPNE6;MAG;FGF1;SFRP2;KLK6;FAM107A;CDK1
20596,GO:1905276,0.117069948732984,0.993309881696934,1,18,regulation of epithelial tube formation,BP,SFRP2
21573,GO:2000678,0.117317048167871,0.993260986576913,1,19,negative regulation of transcription regulatory region DNA binding,BP,SOX11
10572,GO:0042127,0.117373643035227,0.933387471489821,13,1403,regulation of cell proliferation,BP,CRLF1;ASPM;FGFR3;BIRC5;FOXM1;FGF1;FBXO2;GFAP;APLNR;PDGFRA;SFRP2;CDK1;SOX11
2825,GO:0005887,0.117378331415873,0.933386514609855,13,1382,integral component of plasma membrane,CC,FGFR3;SLCO1A2;MAG;APLNR;PDGFRA;ENPP2;SLC14A1;SLC5A11;NTSR2;AQP4;CNTN2;LPAR1;FXYD1
14664,GO:0060307,0.117486746185817,0.993261074504624,1,18,regulation of ventricular cardiac muscle cell membrane repolarization,BP,SNTA1
6599,GO:0019682,0.117600452423378,0.993193239151823,1,21,glyceraldehyde-3-phosphate metabolic process,BP,ALDH1A1
16481,GO:0071688,0.117848608835741,0.993366051252502,1,13,striated muscle myosin thick filament assembly,BP,MYBPC1
2141,GO:0004672,0.118198547058171,0.946085645503855,7,596,protein kinase activity,MF,FGFR3;FGF1;PDGFRA;BUB1B;PBK;BUB1;CDK1
11306,GO:0043523,0.118727885333685,0.967741651965741,3,184,regulation of neuron apoptotic process,BP,CRLF1;MYBL2;MAG
12191,GO:0045822,0.119033753830979,0.99305772419967,1,19,negative regulation of heart contraction,BP,SPX
14884,GO:0060602,0.119388385697688,0.993015340991182,1,19,branch elongation of an epithelium,BP,FGF1
8768,GO:0032982,0.119518417638366,0.993043692300707,1,17,myosin filament,CC,MYBPC1
9828,GO:0035588,0.119552738410007,0.992960090656772,1,21,G-protein coupled purinergic receptor signaling pathway,BP,CNTN2
21210,GO:2000117,0.119882417041453,0.978084686216299,2,95,negative regulation of cysteine-type endopeptidase activity,BP,BIRC5;SFRP2
13561,GO:0050905,0.119952748429934,0.978092278718035,2,87,neuromuscular process,BP,USH1C;NKX6-2
13859,GO:0051383,0.119972482987084,0.992945239299414,1,19,kinetochore organization,BP,CENPF
5054,GO:0010923,0.119988973596918,0.978078021111282,2,88,negative regulation of phosphatase activity,BP,PPP1R1B;PPP1R14A
7024,GO:0022410,0.120103646091173,0.992893556085614,1,21,circadian sleep/wake cycle process,BP,PTGDS
11869,GO:0045121,0.120149054101372,0.959357572599823,4,285,membrane raft,CC,MAG;CRB2;MAL;FXYD1
74,GO:0000151,0.120849885351323,0.959033186506852,4,289,ubiquitin ligase complex,CC,FBXO2;DTL;BUB1B;UBE2C
18071,GO:0098857,0.121303557701698,0.958827749979648,4,286,membrane microdomain,CC,MAG;CRB2;MAL;FXYD1
5336,GO:0015145,0.121316950393915,0.992763259317235,1,20,monosaccharide transmembrane transporter activity,MF,SLC5A11
2623,GO:0005540,0.121369856827771,0.992776042795423,1,19,hyaluronic acid binding,MF,HAPLN2
4080,GO:0008406,0.121509440046864,0.966656663416844,3,183,gonad development,BP,ASPM;PDGFRA;SFRP2
8872,GO:0033158,0.121614609728466,0.99276766595737,1,18,regulation of protein import into nucleus, translocation,BP,CDK1
3533,GO:0006978,0.121707045905853,0.992734900801967,1,19,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,FOXM1
778,GO:0001965,0.122066438765637,0.992653840165564,1,21,G-protein alpha-subunit binding,MF,LPAR1
4652,GO:0009986,0.122148301991964,0.943821298126102,7,632,cell surface,CC,FGFR3;TF;HSPA2;MOG;AQP4;CNTN2;LPAR1
12888,GO:0048018,0.122423888898136,0.95828510294359,4,320,receptor ligand activity,MF,CRLF1;FGF1;SPX;SFRP2
3603,GO:0007095,0.122460843848096,0.9926424837251,1,19,mitotic G2 DNA damage checkpoint,BP,CDK1
19649,GO:1903319,0.122760565173186,0.992585878761838,1,20,positive regulation of protein maturation,BP,CNTN2
4640,GO:0009952,0.122866364078345,0.966122385359058,3,183,anterior/posterior pattern specification,BP,SFRP2;CRB2;EMX2
847,GO:0002062,0.122869085230775,0.977234504437932,2,89,chondrocyte differentiation,BP,FGFR3;SFRP2
480,GO:0001516,0.122949432687575,0.992528404298837,1,22,prostaglandin biosynthetic process,BP,PTGDS
12467,GO:0046457,0.122949432687575,0.992528404298837,1,22,prostanoid biosynthetic process,BP,PTGDS
16860,GO:0072358,0.123137424076327,0.943259661664871,7,615,cardiovascular system development,BP,FGF1;APLNR;PDGFRA;ENPP2;SFRP2;CRB2;S100A1
13058,GO:0048485,0.123207978369461,0.992550279463323,1,19,sympathetic nervous system development,BP,SOX11
10887,GO:0042752,0.123411585880999,0.977067490650225,2,91,regulation of circadian rhythm,BP,PTGDS;TOP2A
6592,GO:0019637,0.123437122851819,0.934767261680778,10,1039,organophosphate metabolic process,BP,FGFR3;CPNE6;FGF1;PDGFRA;ENPP2;AK5;ETNPPL;ALDH1A1;CDK1;RRM2
7640,GO:0031034,0.123691360960868,0.992633214977461,1,14,myosin filament assembly,BP,MYBPC1
13212,GO:0048762,0.124196054751659,0.965592964129597,3,185,mesenchymal cell differentiation,BP,SFRP2;CRB2;SOX11
3950,GO:0008198,0.124598216159962,0.992338476891498,1,21,ferrous iron binding,MF,TF
3850,GO:0008022,0.124894380007128,0.965318700658182,3,183,protein C-terminus binding,MF,CENPF;TOP2A;MKI67
3710,GO:0007281,0.125118738669463,0.965221527054128,3,188,germ cell development,BP,ASPM;SEPT4;HSPA2
10902,GO:0042772,0.126367799461208,0.992132797343787,1,20,DNA damage response, signal transduction resulting in transcription,BP,FOXM1
7839,GO:0031398,0.126404536526528,0.976157813749529,2,97,positive regulation of protein ubiquitination,BP,SEPT4;UBE2C
19311,GO:1902533,0.12679572705981,0.93503768122913,9,897,positive regulation of intracellular signal transduction,BP,CRLF1;FGFR3;SEPT4;FGF1;PDGFRA;CDK1;SOX11;GPR62;LPAR1
15984,GO:0070841,0.126838530105485,0.992072631629287,1,20,inclusion body assembly,BP,HSPA2
7935,GO:0031579,0.127199292735365,0.991989857113644,1,22,membrane raft organization,BP,MAL
4433,GO:0009218,0.127399990477893,0.991948022550388,1,23,pyrimidine ribonucleotide metabolic process,BP,AK5
6162,GO:0017016,0.127419808946373,0.944794815952503,6,486,Ras GTPase binding,MF,FGFR3;BIRC5;FGF1;PDGFRA;DAAM2;MOBP
3663,GO:0007202,0.12750477823662,0.991950387852159,1,22,activation of phospholipase C activity,BP,LPAR1
11265,GO:0043457,0.12758788476653,0.991957118837672,1,21,regulation of cellular respiration,BP,CDK1
3780,GO:0007507,0.127706285300972,0.944634895008896,6,490,heart development,BP,APLNR;PDGFRA;SFRP2;FREM2;CDK1;SOX11
559,GO:0001657,0.127997339224493,0.975697001371016,2,92,ureteric bud development,BP,CRLF1;FGF1
18451,GO:0120036,0.128142719762185,0.926175342134567,13,1351,plasma membrane bounded cell projection organization,BP,USH1C;CPNE6;MAG;SEPT4;PLP1;PACSIN1;GFAP;ENPP2;SFRP2;KLK6;CDK1;CNTN2;LPAR1
17913,GO:0098533,0.128189938373864,0.991879145202977,1,21,ATPase dependent transmembrane transport complex,CC,FXYD1
11880,GO:0045137,0.128264223355781,0.963961510382968,3,188,development of primary sexual characteristics,BP,ASPM;PDGFRA;SFRP2
6934,GO:0021871,0.128580008000935,0.99182841531058,1,21,forebrain regionalization,BP,EMX2
839,GO:0002052,0.128757540949814,0.991824864970255,1,20,positive regulation of neuroblast proliferation,BP,ASPM
7639,GO:0031033,0.128781298888354,0.991959098115275,1,15,myosin filament organization,BP,MYBPC1
1584,GO:0003416,0.129446941220541,0.991715073380653,1,21,endochondral bone growth,BP,FGFR3
1376,GO:0003014,0.129454953767903,0.975241385167611,2,96,renal system process,BP,SPX;AQP4
5650,GO:0016010,0.129767696005357,0.991692832586917,1,20,dystrophin-associated glycoprotein complex,CC,SNTA1
17496,GO:0090665,0.129767696005357,0.991692832586917,1,20,glycoprotein complex,CC,SNTA1
16089,GO:0070997,0.130257958157209,0.954650866615801,4,295,neuron death,BP,CRLF1;MYBL2;MAG;KLK6
10882,GO:0042745,0.13028721188773,0.991569554525444,1,23,circadian sleep/wake cycle,BP,PTGDS
6303,GO:0018193,0.130386380832433,0.928198622540865,11,1143,peptidyl-amino acid modification,BP,CRLF1;FGFR3;BIRC5;SNTA1;FGF1;TOP2A;PPP1R1B;PDGFRA;ENPP2;SFRP2;CDK1
19923,GO:1903859,0.130390620280082,0.991610859045282,1,20,regulation of dendrite extension,BP,CPNE6
3042,GO:0006266,0.130405303761471,0.991553880166457,1,23,DNA ligation,BP,TOP2A
19650,GO:1903320,0.130443349980727,0.963069049424871,3,195,regulation of protein modification by small protein conjugation or removal,BP,SEPT4;FBXO2;UBE2C
18517,GO:0140115,0.130749518868688,0.991524868997449,1,22,export across plasma membrane,BP,FXYD1
3713,GO:0007286,0.130987295210751,0.974770649421061,2,97,spermatid development,BP,SEPT4;HSPA2
16637,GO:0072012,0.13110225087381,0.991496380360853,1,21,glomerulus vasculature development,BP,PDGFRA
11040,GO:0043085,0.131396653972788,0.9256420125277,12,1274,positive regulation of catalytic activity,BP,FGFR3;TPX2;FGF1;HSPA2;PDGFRA;SFRP2;S100A1;ALDH1A1;CDK1;UBE2C;MBP;LPAR1
13119,GO:0048609,0.131438915639539,0.938436928694987,7,651,multicellular organismal reproductive process,BP,CLDN11;KIFC1;ASPM;SEPT4;HSPA2;PPP1R1B;PDGFRA
17938,GO:0098589,0.131468764379634,0.954079203550807,4,294,membrane region,CC,MAG;CRB2;MAL;FXYD1
2599,GO:0005501,0.131516073385785,0.991405698469081,1,23,retinoid binding,MF,PTGDS
12959,GO:0048232,0.131644518773716,0.94751618002188,5,413,male gamete generation,BP,CLDN11;KIFC1;ASPM;SEPT4;HSPA2
4871,GO:0010664,0.131746380262695,0.991391825499685,1,22,negative regulation of striated muscle cell apoptotic process,BP,SFRP2
3801,GO:0007569,0.131759333587532,0.97453748552548,2,96,cell aging,BP,FOXM1;CDK1
8379,GO:0032411,0.131934952812443,0.974494693475504,2,93,positive regulation of transporter activity,BP,HSPA2;S100A1
16729,GO:0072163,0.132029613071017,0.974465599544441,2,93,mesonephric epithelium development,BP,CRLF1;FGF1
16730,GO:0072164,0.132029613071017,0.974465599544441,2,93,mesonephric tubule development,BP,CRLF1;FGF1
2853,GO:0005938,0.132361791148273,0.953669390355947,4,280,cell cortex,CC,SEPT4;FGF1;ERMN;MOBP
3420,GO:0006793,0.132823566697645,0.912186657941388,24,2937,phosphorus metabolic process,BP,CRLF1;FGFR3;TPX2;BIRC5;CPNE6;FOXM1;FGF1;HSPA2;PPP1R1B;APLNR;PDGFRA;ENPP2;SFRP2;AK5;BUB1B;ETNPPL;ALDH1A1;PPP1R14A;PBK;BUB1;CDK1;RRM2;MBP;LPAR1
6749,GO:0021513,0.132980550503831,0.991225599971524,1,22,spinal cord dorsal/ventral patterning,BP,NKX6-2
2602,GO:0005504,0.133039600745493,0.99118434099468,1,24,fatty acid binding,MF,PTGDS
8625,GO:0032770,0.133062075673758,0.991197198370325,1,23,positive regulation of monooxygenase activity,BP,S100A1
7638,GO:0031032,0.133168005321566,0.96198547847426,3,178,actomyosin structure organization,BP,PDGFRA;MYBPC1;LPAR1
9527,GO:0034765,0.133210700209195,0.946705660528579,5,401,regulation of ion transmembrane transport,BP,SNTA1;HSPA2;APLNR;S100A1;FXYD1
5422,GO:0015347,0.133256522004361,0.991188201642158,1,22,sodium-independent organic anion transmembrane transporter activity,MF,SLCO1A2
6225,GO:0017134,0.133355210691191,0.991193911217098,1,21,fibroblast growth factor binding,MF,FGFR3
622,GO:0001763,0.133839071847743,0.961697437178666,3,185,morphogenesis of a branching structure,BP,FGF1;ERMN;SFRP2
9567,GO:0035025,0.133960641874791,0.991092403473395,1,22,positive regulation of Rho protein signal transduction,BP,LPAR1
9678,GO:0035305,0.133991200437386,0.973855865120747,2,94,negative regulation of dephosphorylation,BP,PPP1R1B;PPP1R14A
13072,GO:0048514,0.134076244053247,0.941083392253806,6,513,blood vessel morphogenesis,BP,FGF1;APLNR;PDGFRA;ENPP2;SFRP2;S100A1
8200,GO:0032104,0.134120831547629,0.991052893002243,1,23,regulation of response to extracellular stimulus,BP,SPX
8203,GO:0032107,0.134120831547629,0.991052893002243,1,23,regulation of response to nutrient levels,BP,SPX
13833,GO:0051338,0.134284567461779,0.930351931498234,9,896,regulation of transferase activity,BP,FGFR3;TPX2;FGF1;PPP1R1B;PDGFRA;SFRP2;CDK1;UBE2C;LPAR1
17225,GO:0090100,0.134692880847097,0.97363015809353,2,96,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,CRB2;SOX11
17399,GO:0090344,0.134779097728885,0.990999878230493,1,21,negative regulation of cell aging,BP,FOXM1
13228,GO:0048799,0.134881641988753,0.991031093762524,1,19,animal organ maturation,BP,FGFR3
850,GO:0002065,0.135403788974095,0.973401047206008,2,98,columnar/cuboidal epithelial cell differentiation,BP,USH1C;SOX11
15521,GO:0065007,0.135536916040409,0.90697401667194,72,10209,biological regulation,BP,CRLF1;USH1C;HHATL;ASPM;FGFR3;DCX;TPX2;BIRC5;TF;CPNE6;MYBL2;SNTA1;MAG;PTGDS;SEPT4;FOXM1;FGF1;FBXO2;CENPF;NECAB1;PLP1;PACSIN1;MYRF;HSPA2;EVI2A;GFAP;TOP2A;PPP1R1B;SPX;APLNR;PDGFRA;ESPL1;ERMN;ENPP2;MOG;NUSAP1;DTL;SFRP2;DAAM2;CRB2;MKI67;NKX6-2;CNDP1;HSPB8;BUB1B;S100A1;PAQR6;PI16;ALDH1A1;PPP1R14A;KLK6;PBK;FAM107A;LGI3;NTSR2;BUB1;CDK1;EMX2;RRM2;AQP4;MAL;UBE2C;SOX11;S1PR5;GPR62;CNTN2;NKAIN2;MYBPC1;MBP;LPAR1;ZNF536;FXYD1
4173,GO:0008543,0.136393246244874,0.973091081695813,2,98,fibroblast growth factor receptor signaling pathway,BP,FGFR3;FGF1
8690,GO:0032872,0.136452660475498,0.960604445981115,3,193,regulation of stress-activated MAPK cascade,BP,FOXM1;SFRP2;PBK
15983,GO:0070840,0.136471584211822,0.990788358443213,1,20,dynein complex binding,MF,CENPF
8460,GO:0032504,0.136813239850961,0.935273181683157,7,659,multicellular organism reproduction,BP,CLDN11;KIFC1;ASPM;SEPT4;HSPA2;PPP1R1B;PDGFRA
6660,GO:0019840,0.136839929363889,0.990659794598887,1,24,isoprenoid binding,MF,PTGDS
6950,GO:0021895,0.137388492453547,0.990618234032399,1,22,cerebral cortex neuron differentiation,BP,CNTN2
13690,GO:0051119,0.137516487208739,0.990581732846781,1,23,sugar transmembrane transporter activity,MF,SLC5A11
672,GO:0001823,0.137659166895959,0.972699959313021,2,96,mesonephros development,BP,CRLF1;FGF1
15705,GO:0070302,0.137890848080342,0.96000441673701,3,194,regulation of stress-activated protein kinase signaling cascade,BP,FOXM1;SFRP2;PBK
2698,GO:0005682,0.138436392252036,0.990470692161554,1,22,U5 snRNP,CC,NWD1
3757,GO:0007413,0.138824784689134,0.990459182307174,1,20,axonal fasciculation,BP,CNTN2
18396,GO:0106030,0.138824784689134,0.990459182307174,1,20,neuron projection fasciculation,BP,CNTN2
18282,GO:0099625,0.138885066107028,0.990407148735494,1,22,ventricular cardiac muscle cell membrane repolarization,BP,SNTA1
8697,GO:0032879,0.14014444173585,0.909614027928758,20,2357,regulation of localization,BP,TF;SNTA1;FGF1;PACSIN1;HSPA2;GFAP;SPX;APLNR;PDGFRA;ENPP2;SFRP2;S100A1;LGI3;CDK1;SOX11;NKAIN2;MYBPC1;MBP;LPAR1;FXYD1
10924,GO:0042813,0.14066962448026,0.990152204681076,1,22,Wnt-activated receptor activity,MF,SFRP2
5813,GO:0016323,0.140722192028701,0.958822699925144,3,191,basolateral plasma membrane,CC,TF;SLC14A1;AQP4
8219,GO:0032147,0.140837332160268,0.949570144370044,4,303,activation of protein kinase activity,BP,TPX2;FGF1;CDK1;LPAR1
19390,GO:1902745,0.141032356623144,0.990099952752114,1,22,positive regulation of lamellipodium organization,BP,ENPP2
18074,GO:0098868,0.141077610716393,0.990073905432473,1,23,bone growth,BP,FGFR3
7096,GO:0030001,0.141333194410732,0.928954137164944,8,772,metal ion transport,BP,TF;SNTA1;HSPA2;APLNR;SLC5A11;S100A1;NKAIN2;FXYD1
2804,GO:0005858,0.141528101393735,0.990161288680992,1,17,axonemal dynein complex,CC,DNAH17
14139,GO:0051924,0.141549188310462,0.958460518627494,3,199,regulation of calcium ion transport,BP,HSPA2;APLNR;S100A1
13655,GO:0051054,0.14164921298474,0.958415071607317,3,201,positive regulation of DNA metabolic process,BP,FOXM1;PDGFRA;CDK1
11391,GO:0043666,0.141669534027758,0.971406690599869,2,100,regulation of phosphoprotein phosphatase activity,BP,PPP1R1B;PPP1R14A
4851,GO:0010640,0.141705814099955,0.990002553398797,1,22,regulation of platelet-derived growth factor receptor signaling pathway,BP,PDGFRA
4896,GO:0010719,0.141914549386977,0.989917760965461,1,25,negative regulation of epithelial to mesenchymal transition,BP,SFRP2
13073,GO:0048515,0.141966192334455,0.971303932244319,2,102,spermatid differentiation,BP,SEPT4;HSPA2
3207,GO:0006511,0.142250662327035,0.936450341787567,6,539,ubiquitin-dependent protein catabolic process,BP,FBXO2;DTL;BUB1B;PBK;CDK1;UBE2C
15291,GO:0061437,0.142655987874608,0.98984431964606,1,23,renal system vasculature development,BP,PDGFRA
15294,GO:0061440,0.142655987874608,0.98984431964606,1,23,kidney vasculature development,BP,PDGFRA
18280,GO:0099623,0.143017055516433,0.989811468897192,1,22,regulation of cardiac muscle cell membrane repolarization,BP,SNTA1
7172,GO:0030137,0.143271289446618,0.989718649635198,1,25,COPI-coated vesicle,CC,PACSIN1
14490,GO:0060045,0.143313993467159,0.98976793132529,1,22,positive regulation of cardiac muscle cell proliferation,BP,CDK1
12918,GO:0048103,0.143314869021832,0.989767802804877,1,22,somatic stem cell division,BP,ASPM
13730,GO:0051171,0.144157819798754,0.897768995421092,40,5276,regulation of nitrogen compound metabolic process,BP,CRLF1;HHATL;FGFR3;TPX2;BIRC5;MYBL2;SNTA1;SEPT4;FOXM1;FGF1;FBXO2;CENPF;NECAB1;MYRF;HSPA2;GFAP;TOP2A;PPP1R1B;APLNR;PDGFRA;ENPP2;DTL;SFRP2;CRB2;NKX6-2;CNDP1;S100A1;PI16;PPP1R14A;PBK;CDK1;EMX2;RRM2;UBE2C;SOX11;CNTN2;MBP;LPAR1;ZNF536;FXYD1
9246,GO:0034219,0.144527032803443,0.970481553397856,2,100,carbohydrate transmembrane transport,BP,SLC5A11;TMEM144
17606,GO:0097150,0.144984403838128,0.989543766541678,1,21,neuronal stem cell population maintenance,BP,ASPM
9951,GO:0035767,0.145150268726967,0.989475851295687,1,23,endothelial cell chemotaxis,BP,FGF1
16146,GO:0071156,0.145192551139661,0.9702393694954,2,107,regulation of cell cycle arrest,BP,FOXM1;CDK1
7736,GO:0031226,0.145245838978853,0.91445064001031,13,1436,intrinsic component of plasma membrane,CC,FGFR3;SLCO1A2;MAG;APLNR;PDGFRA;ENPP2;SLC14A1;SLC5A11;NTSR2;AQP4;CNTN2;LPAR1;FXYD1
14541,GO:0060122,0.145360852400884,0.989444424943635,1,23,inner ear receptor cell stereocilium organization,BP,USH1C
13113,GO:0048593,0.145720847483972,0.970099427513921,2,98,camera-type eye morphogenesis,BP,USH1C;SOX11
4646,GO:0009966,0.145853319218815,0.903050967868847,23,2820,regulation of signal transduction,BP,CRLF1;ASPM;FGFR3;TPX2;BIRC5;SEPT4;FOXM1;FGF1;SPX;APLNR;PDGFRA;SFRP2;DAAM2;CRB2;KLK6;PBK;CDK1;MAL;SOX11;GPR62;CNTN2;LPAR1;ZNF536
12617,GO:0046718,0.146123828097459,0.969941073826318,2,105,viral entry into host cell,BP,MOG;CDK1
8472,GO:0032528,0.14634693551067,0.989296607902224,1,23,microvillus organization,BP,USH1C
17635,GO:0097191,0.147004623775269,0.956123027097357,3,206,extrinsic apoptotic signaling pathway,BP,FGFR3;SFRP2;MAL
7403,GO:0030545,0.147460343842597,0.946279269199282,4,343,receptor regulator activity,MF,CRLF1;FGF1;SPX;SFRP2
13149,GO:0048666,0.147555276078053,0.919159604656337,10,1002,neuron development,BP,USH1C;CPNE6;MAG;PLP1;PACSIN1;GFAP;SFRP2;KLK6;CNTN2;LPAR1
13913,GO:0051482,0.14755810964485,0.989059376539998,1,26,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,BP,LPAR1
6747,GO:0021511,0.148214990707611,0.988993852801928,1,24,spinal cord patterning,BP,NKX6-2
10524,GO:0042026,0.148527450227676,0.988910979719986,1,26,protein refolding,BP,HSPA2
5509,GO:0015721,0.148906280306143,0.98886961502888,1,25,bile acid and bile salt transport,BP,SLCO1A2
16074,GO:0070979,0.149007535903734,0.9888214074725,1,27,protein K11-linked ubiquitination,BP,UBE2C
11148,GO:0043252,0.149230855961341,0.988819624315552,1,25,sodium-independent organic anion transport,BP,SLCO1A2
4770,GO:0010498,0.149376425594165,0.938048912343537,5,436,proteasomal protein catabolic process,BP,FBXO2;BUB1B;PBK;CDK1;UBE2C
14381,GO:0055007,0.149468994583707,0.968879427975469,2,94,cardiac muscle cell differentiation,BP,PDGFRA;CDK1
788,GO:0001975,0.150025008260393,0.988715417460162,1,24,response to amphetamine,BP,PPP1R1B
11738,GO:0044774,0.150386224634481,0.968525167548781,2,106,mitotic DNA integrity checkpoint,BP,TOP2A;CDK1
6711,GO:0019941,0.150433237709178,0.931735141151408,6,549,modification-dependent protein catabolic process,BP,FBXO2;DTL;BUB1B;PBK;CDK1;UBE2C
14001,GO:0051656,0.150647188900261,0.937364525702138,5,422,establishment of organelle localization,BP,KIFC1;CENPF;ESPL1;NUSAP1;MOBP
848,GO:0002063,0.150713705122072,0.988628922956473,1,23,chondrocyte development,BP,SFRP2
13852,GO:0051371,0.150746382741089,0.988760114695038,1,18,muscle alpha-actinin binding,MF,MYBPC1
9071,GO:0033674,0.151030687424155,0.931391706762566,6,541,positive regulation of kinase activity,BP,FGFR3;TPX2;FGF1;PDGFRA;CDK1;LPAR1
14069,GO:0051787,0.15123327094836,0.988491138579474,1,26,misfolded protein binding,MF,HSPA2
689,GO:0001841,0.151508394132981,0.968172067435353,2,100,neural tube formation,BP,SFRP2;SOX11
14182,GO:0051984,0.151602169411065,0.988469796388664,1,24,positive regulation of chromosome segregation,BP,ESPL1
4564,GO:0009653,0.151622932711669,0.901103630095485,20,2334,anatomical structure morphogenesis,BP,USH1C;FGFR3;CPNE6;MAG;FOXM1;FGF1;PACSIN1;APLNR;PDGFRA;ERMN;ENPP2;SFRP2;CRB2;FREM2;S100A1;SOX11;CNTN2;MYBPC1;MBP;LPAR1
12491,GO:0046488,0.151623753274682,0.95412840451349,3,201,phosphatidylinositol metabolic process,BP,FGFR3;FGF1;PDGFRA
17221,GO:0090092,0.151681540617638,0.954103159612505,3,201,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,SFRP2;CRB2;SOX11
17790,GO:0097493,0.151836597073137,0.988629457704242,1,17,structural molecule activity conferring elasticity,MF,MYBPC1
10792,GO:0042572,0.15231554250937,0.988304507540201,1,27,retinol metabolic process,BP,ALDH1A1
15993,GO:0070851,0.152374045520459,0.967853976559442,2,107,growth factor receptor binding,MF,FGF1;PDGFRA
15673,GO:0070252,0.152859717048247,0.967738758291651,2,95,actin-mediated cell contraction,BP,SNTA1;MYBPC1
6809,GO:0021591,0.15317825103772,0.988221541156937,1,24,ventricular system development,BP,CENPF
12289,GO:0045992,0.15330992049249,0.988181242842353,1,25,negative regulation of embryonic development,BP,SFRP2
10482,GO:0039694,0.153404117113706,0.988148323173769,1,26,viral RNA genome replication,BP,TOP2A
12453,GO:0046425,0.153601815174944,0.967431677994589,2,109,regulation of JAK-STAT cascade,BP,CRLF1;FGFR3
13870,GO:0051402,0.153667920757831,0.953222355118278,3,207,neuron apoptotic process,BP,CRLF1;MYBL2;MAG
772,GO:0001958,0.153672008714354,0.988123666735913,1,25,endochondral ossification,BP,FGFR3
10124,GO:0036075,0.153672008714354,0.988123666735913,1,25,replacement ossification,BP,FGFR3
13667,GO:0051085,0.153781200111703,0.988071526324999,1,27,chaperone cofactor-dependent protein refolding,BP,HSPA2
19194,GO:1902230,0.153882331073247,0.98803983119543,1,28,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,SFRP2
11240,GO:0043405,0.153968575366617,0.943045564321374,4,315,regulation of MAP kinase activity,BP,FGF1;SFRP2;CDK1;LPAR1
3622,GO:0007155,0.15402213513467,0.912398743720313,11,1156,cell adhesion,BP,CLDN11;MAG;HAPLN2;PDGFRA;MOG;SFRP2;CRB2;FREM2;CNTN2;MYBPC1;MBP
11541,GO:0044255,0.154084234729614,0.917641255356504,9,951,cellular lipid metabolic process,BP,FGFR3;CPNE6;PTGDS;FGF1;PLP1;PDGFRA;ENPP2;ETNPPL;ALDH1A1
6451,GO:0019201,0.154129680199678,0.988050679400284,1,25,nucleotide kinase activity,MF,AK5
4498,GO:0009394,0.15439292325158,0.987943380508997,1,29,2'-deoxyribonucleotide metabolic process,BP,AK5
13990,GO:0051642,0.154622764371288,0.988036480848231,1,22,centrosome localization,BP,ASPM
2608,GO:0005516,0.15473770385121,0.952796289672805,3,183,calmodulin binding,MF,ASPM;SNTA1;MBP
7550,GO:0030867,0.155071136913582,0.98784868979135,1,28,rough endoplasmic reticulum membrane,CC,TF
14627,GO:0060255,0.155355672929117,0.888732347901871,41,5463,regulation of macromolecule metabolic process,BP,CRLF1;HHATL;FGFR3;TPX2;BIRC5;MYBL2;SNTA1;SEPT4;FOXM1;FGF1;FBXO2;CENPF;NECAB1;PLP1;MYRF;HSPA2;GFAP;TOP2A;PPP1R1B;APLNR;PDGFRA;ENPP2;DTL;SFRP2;CRB2;NKX6-2;CNDP1;S100A1;PI16;PPP1R14A;PBK;CDK1;EMX2;RRM2;UBE2C;SOX11;CNTN2;MBP;LPAR1;ZNF536;FXYD1
7315,GO:0030330,0.155532091719867,0.966781753774883,2,107,DNA damage response, signal transduction by p53 class mediator,BP,FOXM1;CDK1
18037,GO:0098801,0.155569013136325,0.987784032803472,1,27,regulation of renal system process,BP,SPX
20430,GO:1904892,0.155571375847732,0.966757533544012,2,110,regulation of STAT cascade,BP,CRLF1;FGFR3
12116,GO:0045667,0.155682543645814,0.966737867650202,2,105,regulation of osteoblast differentiation,BP,SFRP2;SOX11
2852,GO:0005930,0.156075689679647,0.966627919617234,2,99,axoneme,CC,CENPF;DNAH17
3115,GO:0006379,0.156309466013925,0.987663897887208,1,27,mRNA cleavage,BP,FIP1L1
11032,GO:0043065,0.156370480406563,0.928259678382782,6,561,positive regulation of apoptotic process,BP,MYBL2;SEPT4;TOP2A;SFRP2;MAL;LPAR1
13480,GO:0050790,0.156621982345605,0.900541800587712,17,2006,regulation of catalytic activity,BP,FGFR3;TPX2;BIRC5;FGF1;HSPA2;PPP1R1B;PDGFRA;SFRP2;CRB2;S100A1;PI16;ALDH1A1;PPP1R14A;CDK1;UBE2C;MBP;LPAR1
781,GO:0001968,0.156678557747246,0.98763985142483,1,25,fibronectin binding,MF,SFRP2
15379,GO:0061631,0.157817334740124,0.987417322246938,1,27,ubiquitin conjugating enzyme activity,MF,UBE2C
4752,GO:0010458,0.158098274109668,0.987371094801259,1,27,exit from mitosis,BP,UBE2C
7035,GO:0022610,0.15820501093628,0.909541162257746,11,1163,biological adhesion,BP,CLDN11;MAG;HAPLN2;PDGFRA;MOG;SFRP2;CRB2;FREM2;CNTN2;MYBPC1;MBP
11378,GO:0043632,0.158234545315352,0.927162802315643,6,558,modification-dependent macromolecule catabolic process,BP,FBXO2;DTL;BUB1B;PBK;CDK1;UBE2C
4627,GO:0009897,0.158370877211719,0.951127106862766,3,214,external side of plasma membrane,CC,TF;MOG;AQP4
17531,GO:0097014,0.158396389112494,0.965825513649879,2,100,ciliary plasm,CC,CENPF;DNAH17
5057,GO:0010927,0.158404632681312,0.965845585857313,2,95,cellular component assembly involved in morphogenesis,BP,PDGFRA;MYBPC1
3050,GO:0006275,0.159412609028306,0.965444900387831,2,107,regulation of DNA replication,BP,PDGFRA;CDK1
12600,GO:0046688,0.159476158475532,0.987096370919884,1,30,response to copper ion,BP,CDK1
8402,GO:0032435,0.159579625148323,0.987125853756235,1,27,negative regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,PBK
11282,GO:0043491,0.159756542429059,0.950518925705645,3,207,protein kinase B signaling,BP,FGFR3;FGF1;PDGFRA
11328,GO:0043549,0.159941891689847,0.91721865110291,8,801,regulation of kinase activity,BP,FGFR3;TPX2;FGF1;PPP1R1B;PDGFRA;SFRP2;CDK1;LPAR1
14261,GO:0052548,0.159943892940463,0.939985497907242,4,335,regulation of endopeptidase activity,BP,BIRC5;SFRP2;CRB2;MBP
11760,GO:0044818,0.160257012558668,0.987031015582847,1,26,mitotic G2/M transition checkpoint,BP,CDK1
14378,GO:0055003,0.160407838842114,0.987186780662856,1,19,cardiac myofibril assembly,BP,PDGFRA
1436,GO:0003158,0.160468574179492,0.965081346473948,2,106,endothelium development,BP,FGF1;HAPLN2
10372,GO:0038084,0.160539737698865,0.987003434214412,1,25,vascular endothelial growth factor signaling pathway,BP,PDGFRA
13036,GO:0048384,0.161171374243986,0.986842504120368,1,28,retinoic acid receptor signaling pathway,BP,ZNF536
9827,GO:0035587,0.161322405570461,0.986801165140746,1,29,purinergic receptor signaling pathway,BP,CNTN2
2805,GO:0005859,0.161626077293854,0.986920075531918,1,21,muscle myosin complex,CC,MYBPC1
11035,GO:0043068,0.162276565957568,0.924762683862864,6,567,positive regulation of programmed cell death,BP,MYBL2;SEPT4;TOP2A;SFRP2;MAL;LPAR1
15389,GO:0061650,0.16231559851538,0.986649028655147,1,28,ubiquitin-like protein conjugating enzyme activity,MF,UBE2C
41,GO:0000083,0.162783526494,0.986569474108575,1,28,regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,RRM2
6996,GO:0021987,0.162789063800936,0.964280859577872,2,103,cerebral cortex development,BP,ASPM;EMX2
13840,GO:0051345,0.162997396717829,0.919365320174401,7,680,positive regulation of hydrolase activity,BP,FGFR3;HSPA2;PDGFRA;SFRP2;ALDH1A1;MBP;LPAR1
19652,GO:1903322,0.163443428209828,0.964007656179934,2,114,positive regulation of protein modification by small protein conjugation or removal,BP,SEPT4;UBE2C
17755,GO:0097431,0.163671019934175,0.986474823411602,1,25,mitotic spindle pole,CC,ASPM
14680,GO:0060326,0.164352921804738,0.948414325945957,3,225,cell chemotaxis,BP,FGF1;PDGFRA;LPAR1
6922,GO:0021846,0.164414054730445,0.986347738580539,1,25,cell proliferation in forebrain,BP,EMX2
6426,GO:0019098,0.164445975893972,0.986284797084407,1,28,reproductive behavior,BP,PPP1R1B
6600,GO:0019692,0.164518933729828,0.986225866691244,1,31,deoxyribose phosphate metabolic process,BP,AK5
15469,GO:0061842,0.164656527582881,0.986328544062265,1,24,microtubule organizing center localization,BP,ASPM
587,GO:0001702,0.164717557016801,0.986295646901385,1,25,gastrulation with mouth forming second,BP,CRB2
16974,GO:0072604,0.165083538059989,0.986174777072901,1,28,interleukin-6 secretion,BP,MBP
3023,GO:0006221,0.165199847154547,0.986107907263738,1,31,pyrimidine nucleotide biosynthetic process,BP,AK5
21270,GO:2000241,0.165642749159923,0.963224030451951,2,115,regulation of reproductive process,BP,ASPM;CDK1
7263,GO:0030262,0.165987630765119,0.986017960141008,1,28,apoptotic nuclear changes,BP,TOP2A
3509,GO:0006936,0.166069625455645,0.936836388440246,4,317,muscle contraction,BP,SNTA1;SPX;MYBPC1;FXYD1
4872,GO:0010665,0.166102643104528,0.985997943377371,1,28,regulation of cardiac muscle cell apoptotic process,BP,SFRP2
12250,GO:0045926,0.166319124758304,0.947528589862752,3,218,negative regulation of growth,BP,FGFR3;MAG;SFRP2
7760,GO:0031267,0.166346849384677,0.922350560895914,6,528,small GTPase binding,MF,FGFR3;BIRC5;FGF1;PDGFRA;DAAM2;MOBP
3775,GO:0007498,0.166550342400829,0.962911008046268,2,112,mesoderm development,BP,SFRP2;CRB2
5800,GO:0016301,0.166758733597552,0.912831033414379,8,784,kinase activity,MF,FGFR3;FGF1;PDGFRA;AK5;BUB1B;PBK;BUB1;CDK1
4467,GO:0009266,0.167215283546793,0.947121470329746,3,216,response to temperature stimulus,BP,FGF1;HSPA2;HSPB8
13391,GO:0050673,0.167459111536761,0.93610506428579,4,323,epithelial cell proliferation,BP,FGF1;APLNR;SFRP2;SOX11
7381,GO:0030507,0.167588181544355,0.985797710814945,1,25,spectrin binding,MF,USH1C
6757,GO:0021522,0.1678437549069,0.985693053666707,1,28,spinal cord motor neuron differentiation,BP,NKX6-2
7709,GO:0031128,0.167872202931344,0.98568804297859,1,28,developmental induction,BP,FGF1
4183,GO:0008569,0.168068093560217,0.985931680241491,1,18,ATP-dependent microtubule motor activity, minus-end-directed,MF,DNAH17
3837,GO:0007628,0.168154521532842,0.985676780110191,1,26,adult walking behavior,BP,CNTN2
13148,GO:0048665,0.168399931582182,0.985577610748302,1,29,neuron fate specification,BP,NKX6-2
433,GO:0001134,0.169127009340368,0.985484853109744,1,27,transcription factor activity, transcription factor recruiting,MF,MYBL2
6941,GO:0021884,0.169315163544358,0.985451457387919,1,27,forebrain neuron development,BP,CNTN2
7824,GO:0031365,0.169316394559607,0.98543243965208,1,28,N-terminal protein amino acid modification,BP,HHATL
5880,GO:0016485,0.169614698017553,0.94600550716175,3,223,protein processing,BP,BIRC5;KLK6;CNTN2
3814,GO:0007600,0.170058388355088,0.926499413235159,5,451,sensory perception,BP,USH1C;BIRC5;SPX;NTSR2;MBP
7359,GO:0030431,0.170208056834344,0.985255735811388,1,29,sleep,BP,PTGDS
7090,GO:0023051,0.170325116874518,0.882913833867765,25,3154,regulation of signaling,BP,CRLF1;ASPM;FGFR3;TPX2;BIRC5;SEPT4;FOXM1;FGF1;GFAP;SPX;APLNR;PDGFRA;SFRP2;DAAM2;CRB2;KLK6;PBK;CDK1;MAL;SOX11;GPR62;CNTN2;LPAR1;ZNF536;FXYD1
19747,GO:1903523,0.17042744932542,0.985253198865965,1,27,negative regulation of blood circulation,BP,SPX
3309,GO:0006633,0.171133050920808,0.961232700217184,2,119,fatty acid biosynthetic process,BP,PTGDS;PLP1
13114,GO:0048596,0.171624920764326,0.985081430368707,1,25,embryonic camera-type eye morphogenesis,BP,SOX11
588,GO:0001704,0.171680951140087,0.961066663701684,2,110,formation of primary germ layer,BP,SFRP2;CRB2
10741,GO:0042462,0.171965157231802,0.984957357506069,1,28,eye photoreceptor cell development,BP,USH1C
556,GO:0001654,0.172131418080869,0.933653895922223,4,318,eye development,BP,USH1C;PDGFRA;FREM2;SOX11
460,GO:0001227,0.172664690348047,0.944596911515309,3,219,transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding,MF,FOXM1;NKX6-2;ZNF536
19370,GO:1902692,0.172980546329109,0.984792696641012,1,27,regulation of neuroblast proliferation,BP,ASPM
2284,GO:0004866,0.173233807151226,0.960461346543494,2,120,endopeptidase inhibitor activity,MF,BIRC5;CRB2
12284,GO:0045987,0.173698185799061,0.984606505435196,1,30,positive regulation of smooth muscle contraction,BP,SPX
11788,GO:0044877,0.17377452395248,0.908251037402668,8,804,protein-containing complex binding,MF,USH1C;TF;FGF1;CENPF;GFAP;ERMN;SFRP2;MYBPC1
4684,GO:0010092,0.173779261473555,0.984608840567586,1,29,specification of animal organ identity,BP,FGF1
5171,GO:0014072,0.173873251201183,0.984574393634069,1,30,response to isoquinoline alkaloid,BP,PPP1R1B
11167,GO:0043278,0.173873251201183,0.984574393634069,1,30,response to morphine,BP,PPP1R1B
8380,GO:0032412,0.174056923262008,0.943957400107898,3,213,regulation of ion transmembrane transporter activity,BP,HSPA2;S100A1;FXYD1
12115,GO:0045666,0.174253249861073,0.932527979854041,4,319,positive regulation of neuron differentiation,BP,CPNE6;PACSIN1;SOX11;LPAR1
17492,GO:0090659,0.175385488945733,0.984351983839515,1,27,walking behavior,BP,CNTN2
16098,GO:0071011,0.175471471038503,0.984263175584768,1,31,precatalytic spliceosome,CC,NWD1
3500,GO:0006921,0.175703218440237,0.984236583221039,1,30,cellular component disassembly involved in execution phase of apoptosis,BP,TOP2A
14999,GO:0060795,0.175894442736905,0.984184573588491,1,31,cell fate commitment involved in formation of primary germ layer,BP,SFRP2
16378,GO:0071542,0.175933403712699,0.984193813828591,1,30,dopaminergic neuron differentiation,BP,SFRP2
12170,GO:0045777,0.17607878053808,0.984150251991001,1,31,positive regulation of blood pressure,BP,SPX
5067,GO:0010941,0.176250581216068,0.89247143918711,13,1515,regulation of cell death,BP,CRLF1;FGFR3;BIRC5;MYBL2;MAG;SEPT4;TOP2A;PDGFRA;SFRP2;CDK1;MAL;SOX11;LPAR1
8190,GO:0032094,0.176307029230575,0.984107699487563,1,31,response to food,BP,SPX
13184,GO:0048706,0.176391109063293,0.959314068455065,2,115,embryonic skeletal system development,BP,PDGFRA;SOX11
19786,GO:1903580,0.176648176878942,0.984078384706253,1,29,positive regulation of ATP metabolic process,BP,CDK1
4869,GO:0010662,0.176784215491297,0.984035190780677,1,30,regulation of striated muscle cell apoptotic process,BP,SFRP2
8220,GO:0032148,0.176870133167991,0.98403694429721,1,29,activation of protein kinase B activity,BP,FGF1
1472,GO:0003206,0.176957171832591,0.959115610357857,2,112,cardiac chamber morphogenesis,BP,SFRP2;SOX11
7317,GO:0030332,0.177742159373175,0.983855578688536,1,30,cyclin binding,MF,CDK1
5872,GO:0016462,0.177906306881318,0.905532222128104,8,806,pyrophosphatase activity,MF,KIFC1;SEPT4;HSPA2;TOP2A;ENPP2;KIF6;CARNS1;DNAH17
13018,GO:0048333,0.178186243514223,0.983771948718683,1,30,mesodermal cell differentiation,BP,SFRP2
18902,GO:1901385,0.178191136071649,0.983754109563179,1,31,regulation of voltage-gated calcium channel activity,BP,S100A1
4866,GO:0010659,0.178344702814618,0.983742051591684,1,30,cardiac muscle cell apoptotic process,BP,SFRP2
4793,GO:0010543,0.17842507024634,0.983726877086526,1,30,regulation of platelet activation,BP,PDGFRA
1491,GO:0003231,0.178619225112992,0.958503934795407,2,110,cardiac ventricle development,BP,SFRP2;SOX11
4499,GO:0009395,0.178781753256852,0.98364241003454,1,31,phospholipid catabolic process,BP,ENPP2
10756,GO:0042491,0.178831967095945,0.983668148745208,1,29,inner ear auditory receptor cell differentiation,BP,USH1C
4187,GO:0008584,0.17914701761697,0.958281757093107,2,116,male gonad development,BP,ASPM;SFRP2
6067,GO:0016817,0.179183057157366,0.904687990153413,8,808,hydrolase activity, acting on acid anhydrides,MF,KIFC1;SEPT4;HSPA2;TOP2A;ENPP2;KIF6;CARNS1;DNAH17
6068,GO:0016818,0.179183057157366,0.904687990153413,8,808,hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,MF,KIFC1;SEPT4;HSPA2;TOP2A;ENPP2;KIF6;CARNS1;DNAH17
21059,GO:1990752,0.179228208344315,0.983680976331024,1,25,microtubule end,CC,ASPM
12416,GO:0046329,0.179972495928105,0.983433220889585,1,30,negative regulation of JNK cascade,BP,SFRP2
19310,GO:1902532,0.180040511304158,0.920735154498742,5,458,negative regulation of intracellular signal transduction,BP,FOXM1;APLNR;SFRP2;PBK;LPAR1
293,GO:0000795,0.180160511632384,0.983380057045668,1,31,synaptonemal complex,CC,HSPA2
18182,GO:0099086,0.180160511632384,0.983380057045668,1,31,synaptonemal structure,CC,HSPA2
17783,GO:0097484,0.180944844352349,0.983265904493493,1,29,dendrite extension,BP,CPNE6
472,GO:0001504,0.181149335028177,0.983208004727529,1,30,neurotransmitter uptake,BP,GFAP
9677,GO:0035304,0.181162268458436,0.95751527996783,2,118,regulation of protein dephosphorylation,BP,PPP1R1B;PPP1R14A
5770,GO:0016247,0.181207778306472,0.957486952775499,2,121,channel regulator activity,MF,SNTA1;FXYD1
7075,GO:0022898,0.181410441289428,0.940471234559072,3,218,regulation of transmembrane transporter activity,BP,HSPA2;S100A1;FXYD1
12526,GO:0046546,0.181770538083331,0.957288978355288,2,117,development of primary male sexual characteristics,BP,ASPM;SFRP2
5963,GO:0016620,0.182285332279128,0.982954761174595,1,32,oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor,MF,ALDH1A1
1434,GO:0003156,0.182576325368466,0.982898321613562,1,32,regulation of animal organ formation,BP,FGF1
5745,GO:0016202,0.182722541966769,0.956935735761895,2,115,regulation of striated muscle tissue development,BP,CENPF;CDK1
13666,GO:0051084,0.182723383249147,0.982869760903563,1,32,'de novo' posttranslational protein folding,BP,HSPA2
1405,GO:0003091,0.182921676511732,0.982884801209258,1,29,renal water homeostasis,BP,AQP4
7908,GO:0031514,0.183570345883826,0.956593503754638,2,120,motile cilium,CC,SEPT4;DNAH17
469,GO:0001501,0.183722852517375,0.918588015847617,5,447,skeletal system development,BP,FGFR3;HAPLN2;PDGFRA;SFRP2;SOX11
2605,GO:0005509,0.183786716560174,0.911697308849397,6,553,calcium ion binding,MF,CPNE6;NECAB1;ENPP2;CRB2;S100A1;CALN1
6346,GO:0018345,0.183875095505362,0.982645196879622,1,32,protein palmitoylation,BP,HHATL
13890,GO:0051443,0.183912798817889,0.982637818827465,1,32,positive regulation of ubiquitin-protein transferase activity,BP,UBE2C
3828,GO:0007618,0.184093654779715,0.982602404226039,1,32,mating,BP,PPP1R1B
7261,GO:0030260,0.184557286246453,0.956212723176436,2,121,entry into host cell,BP,MOG;CDK1
11626,GO:0044409,0.184557286246453,0.956212723176436,2,121,entry into host,BP,MOG;CDK1
14084,GO:0051806,0.184557286246453,0.956212723176436,2,121,entry into cell of other organism involved in symbiotic interaction,BP,MOG;CDK1
14091,GO:0051828,0.184557286246453,0.956212723176436,2,121,entry into other organism involved in symbiotic interaction,BP,MOG;CDK1
10974,GO:0042981,0.184800773224994,0.888462890706643,12,1390,regulation of apoptotic process,BP,CRLF1;FGFR3;BIRC5;MYBL2;MAG;SEPT4;TOP2A;PDGFRA;SFRP2;CDK1;MAL;LPAR1
516,GO:0001569,0.184886136182832,0.982463835261326,1,31,branching involved in blood vessel morphogenesis,BP,SFRP2
4936,GO:0010765,0.184899174181505,0.982479483295776,1,30,positive regulation of sodium ion transport,BP,FXYD1
14142,GO:0051930,0.184921589506115,0.982456861585796,1,31,regulation of sensory perception of pain,BP,SPX
14143,GO:0051931,0.184921589506115,0.982456861585796,1,31,regulation of sensory perception,BP,SPX
14395,GO:0055023,0.185259540128298,0.982428142552551,1,29,positive regulation of cardiac muscle tissue growth,BP,CDK1
11585,GO:0044325,0.185299419184834,0.955951898409301,2,115,ion channel binding,MF,SNTA1;FXYD1
4672,GO:0010039,0.185325523419415,0.982360152069132,1,32,response to iron ion,BP,TF
14663,GO:0060306,0.185551178532876,0.982370722820749,1,29,regulation of membrane repolarization,BP,SNTA1
7283,GO:0030291,0.186379083069416,0.982135243815839,1,33,protein serine/threonine kinase inhibitor activity,MF,PPP1R1B
16588,GO:0071900,0.186501506827721,0.916938294005117,5,465,regulation of protein serine/threonine kinase activity,BP,FGF1;PPP1R1B;SFRP2;CDK1;LPAR1
6232,GO:0017147,0.186572240415555,0.982130527328739,1,31,Wnt-protein binding,MF,SFRP2
8775,GO:0032991,0.186766813509585,0.865319352301759,34,4539,protein-containing complex,CC,CRLF1;USH1C;KIFC1;MCM10;FGFR3;DCX;BIRC5;TF;MYBL2;SNTA1;SEPT4;NCAPG;FBXO2;CENPF;HSPA2;TOP2A;PDGFRA;DTL;FIP1L1;CRB2;BUB1B;S100A1;KIF6;BUB1;CDK1;RRM2;UBE2C;GPR62;CNTN2;DNAH17;NWD1;MYBPC1;MBP;FXYD1
17090,GO:0085029,0.186861769573542,0.982091554396965,1,30,extracellular matrix assembly,BP,HAPLN2
13130,GO:0048634,0.187025319990632,0.955279594516996,2,117,regulation of muscle organ development,BP,CENPF;CDK1
13141,GO:0048646,0.187130854412051,0.895513293486119,9,937,anatomical structure formation involved in morphogenesis,BP,FGF1;APLNR;PDGFRA;ENPP2;SFRP2;CRB2;S100A1;SOX11;MYBPC1
19193,GO:1902229,0.187254301016987,0.981930719080933,1,35,regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,SFRP2
3357,GO:0006692,0.187381905559759,0.981919776045464,1,34,prostanoid metabolic process,BP,PTGDS
3358,GO:0006693,0.187381905559759,0.981919776045464,1,34,prostaglandin metabolic process,BP,PTGDS
4863,GO:0010656,0.187558156899836,0.981916502115979,1,32,negative regulation of muscle cell apoptotic process,BP,SFRP2
4823,GO:0010604,0.188142509719029,0.871323169342078,22,2755,positive regulation of macromolecule metabolic process,BP,CRLF1;FGFR3;TPX2;MYBL2;SEPT4;FOXM1;FGF1;PLP1;MYRF;HSPA2;TOP2A;APLNR;PDGFRA;ENPP2;DTL;SFRP2;CDK1;UBE2C;SOX11;CNTN2;MBP;LPAR1
7819,GO:0031346,0.188309807920163,0.924923443372356,4,326,positive regulation of cell projection organization,BP,CPNE6;PACSIN1;ENPP2;LPAR1
13769,GO:0051233,0.188359491157591,0.981773537131246,1,31,spindle midzone,CC,BUB1B
19056,GO:1901861,0.188459481306489,0.954724575190065,2,117,regulation of muscle tissue development,BP,CENPF;CDK1
4865,GO:0010658,0.188871025766873,0.981652850228799,1,32,striated muscle cell apoptotic process,BP,SFRP2
19123,GO:1902042,0.189382901242838,0.981516848096334,1,34,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,SFRP2
17879,GO:0097718,0.190091660639539,0.981443167673248,1,30,disordered domain specific binding,MF,HSPA2
17070,GO:0080090,0.190427196041775,0.860621402307933,40,5408,regulation of primary metabolic process,BP,CRLF1;HHATL;FGFR3;TPX2;BIRC5;MYBL2;SNTA1;SEPT4;FOXM1;FGF1;FBXO2;CENPF;NECAB1;MYRF;HSPA2;GFAP;TOP2A;PPP1R1B;APLNR;PDGFRA;ENPP2;DTL;SFRP2;CRB2;NKX6-2;CNDP1;S100A1;PI16;PPP1R14A;PBK;CDK1;EMX2;RRM2;UBE2C;SOX11;CNTN2;MBP;LPAR1;ZNF536;FXYD1
6087,GO:0016853,0.190765107297239,0.953770942361649,2,132,isomerase activity,MF,PTGDS;TOP2A
14647,GO:0060285,0.190803541839438,0.981298589455471,1,30,cilium-dependent cell motility,BP,DNAH17
686,GO:0001838,0.191377612388512,0.953582375401444,2,118,embryonic epithelial tube formation,BP,SFRP2;SOX11
3543,GO:0006996,0.191387970194354,0.86497863184488,27,3463,organelle organization,BP,USH1C;KIFC1;ASPM;TPX2;BIRC5;MYBL2;SEPT4;NCAPG;CENPF;PACSIN1;HSPA2;GFAP;TOP2A;PPP1R1B;PDGFRA;ESPL1;ERMN;NUSAP1;DAAM2;MKI67;BUB1B;BUB1;CDK1;UBE2C;CNTN2;MYBPC1;LPAR1
10490,GO:0040008,0.191499370348009,0.906861217682376,6,589,regulation of growth,BP,FGFR3;CPNE6;MAG;SFRP2;FAM107A;CDK1
17096,GO:0086005,0.191503092432291,0.981176811478788,1,29,ventricular cardiac muscle cell action potential,BP,SNTA1
5177,GO:0014706,0.19190344638578,0.922937849475128,4,329,striated muscle tissue development,BP,CENPF;PDGFRA;CDK1;SOX11
12023,GO:0045494,0.191978307818645,0.981039048112604,1,31,photoreceptor cell maintenance,BP,USH1C
3695,GO:0007259,0.192352520901296,0.95317211133891,2,125,JAK-STAT cascade,BP,CRLF1;FGFR3
11034,GO:0043067,0.192425354326184,0.882934340187056,12,1402,regulation of programmed cell death,BP,CRLF1;FGFR3;BIRC5;MYBL2;MAG;SEPT4;TOP2A;PDGFRA;SFRP2;CDK1;MAL;LPAR1
13190,GO:0048713,0.192472326265641,0.980901696970167,1,33,regulation of oligodendrocyte differentiation,BP,DAAM2
10657,GO:0042307,0.192535478483304,0.980944318133296,1,30,positive regulation of protein import into nucleus,BP,CDK1
7218,GO:0030201,0.192652922603724,0.980900395347206,1,31,heparan sulfate proteoglycan metabolic process,BP,HS3ST4
16589,GO:0071901,0.192719384105203,0.953027631594306,2,125,negative regulation of protein serine/threonine kinase activity,BP,PPP1R1B;SFRP2
11857,GO:0045104,0.193140646753947,0.980799814621297,1,31,intermediate filament cytoskeleton organization,BP,GFAP
5270,GO:0014911,0.193570991646511,0.980730788326222,1,30,positive regulation of smooth muscle cell migration,BP,LPAR1
13071,GO:0048513,0.193658344708246,0.866102552922905,23,2884,animal organ development,BP,CRLF1;USH1C;ASPM;FGFR3;SEPT4;FGF1;CENPF;PLP1;TOP2A;APLNR;PDGFRA;SFRP2;DAAM2;CRB2;NKX6-2;FREM2;S100A1;CDK1;EMX2;SOX11;CNTN2;MBP;LPAR1
12251,GO:0045927,0.19398583605614,0.934346108721351,3,224,positive regulation of growth,BP,CPNE6;SFRP2;CDK1
17871,GO:0097696,0.194397540824828,0.952360654305095,2,126,STAT cascade,BP,CRLF1;FGFR3
11600,GO:0044344,0.19443961408711,0.952351487026532,2,124,cellular response to fibroblast growth factor stimulus,BP,FGFR3;FGF1
18279,GO:0099622,0.194478198391802,0.980503632119368,1,32,cardiac muscle cell membrane repolarization,BP,SNTA1
4845,GO:0010634,0.194631381321472,0.952291246494592,2,120,positive regulation of epithelial cell migration,BP,FGF1;ENPP2
685,GO:0001837,0.194666739455423,0.952265272470643,2,123,epithelial to mesenchymal transition,BP,SFRP2;CRB2
11832,GO:0045070,0.195116429112595,0.980370434678105,1,32,positive regulation of viral genome replication,BP,TOP2A
2155,GO:0004693,0.196064443886829,0.98013669192224,1,34,cyclin-dependent protein serine/threonine kinase activity,MF,CDK1
2809,GO:0005865,0.196120683438576,0.980221449569205,1,29,striated muscle thin filament,CC,MYBPC1
14805,GO:0060485,0.19643295819027,0.933118962100198,3,231,mesenchyme development,BP,SFRP2;CRB2;SOX11
10703,GO:0042398,0.196580599217407,0.979996582455367,1,36,cellular modified amino acid biosynthetic process,BP,CARNS1
17425,GO:0090407,0.196810944095766,0.903494314428212,6,610,organophosphate biosynthetic process,BP,FGFR3;CPNE6;FGF1;AK5;ETNPPL;RRM2
9021,GO:0033572,0.19700257744957,0.979922465522809,1,35,transferrin transport,BP,TF
2777,GO:0005813,0.197169964993979,0.910569338366268,5,464,centrosome,CC,ASPM;CENPF;ESPL1;DTL;CDK1
8363,GO:0032391,0.197469547738674,0.979875109453561,1,32,photoreceptor connecting cilium,CC,USH1C
10945,GO:0042887,0.198051392023467,0.979684176276856,1,36,amide transmembrane transporter activity,MF,SLC14A1
11856,GO:0045103,0.198389704325628,0.979679604093654,1,32,intermediate filament-based process,BP,GFAP
17061,GO:0080008,0.199425351856364,0.979422140260095,1,34,Cul4-RING E3 ubiquitin ligase complex,CC,DTL
3795,GO:0007548,0.199449753775949,0.931611204962252,3,231,sex differentiation,BP,ASPM;PDGFRA;SFRP2
5870,GO:0016460,0.199646562239117,0.979525180555432,1,27,myosin II complex,CC,MYBPC1
12026,GO:0045503,0.199729460571728,0.979599051289136,1,24,dynein light chain binding,MF,DNAH17
2718,GO:0005730,0.199943587518553,0.890711502828017,8,876,nucleolus,CC,MCM10;FGF1;TOP2A;NUSAP1;SLC14A1;DTL;MKI67;KLK6
495,GO:0001539,0.199999566275325,0.979355066591152,1,31,cilium or flagellum-dependent cell motility,BP,DNAH17
1865,GO:0004180,0.200528446191878,0.979152113861731,1,36,carboxypeptidase activity,MF,CNDP1
2160,GO:0004702,0.200551557645862,0.94993274935899,2,117,signal transducer, downstream of receptor, with serine/threonine kinase activity,MF,FGFR3;PDGFRA
17776,GO:0097472,0.20102542654387,0.979060341971303,1,35,cyclin-dependent protein kinase activity,MF,CDK1
21273,GO:2000249,0.201179153972316,0.979027008059729,1,35,regulation of actin cytoskeleton reorganization,BP,PDGFRA
10250,GO:0036379,0.201458677398627,0.979062018564361,1,30,myofilament,CC,MYBPC1
8377,GO:0032409,0.202353256484122,0.930148854003713,3,231,regulation of transporter activity,BP,HSPA2;S100A1;FXYD1
12466,GO:0046456,0.202485524602561,0.978696811795915,1,38,icosanoid biosynthetic process,BP,PTGDS
10899,GO:0042769,0.202645033381212,0.978676320755614,1,37,DNA damage response, detection of DNA damage,BP,DTL
13732,GO:0051173,0.203539165155087,0.860170767973273,21,2654,positive regulation of nitrogen compound metabolic process,BP,CRLF1;FGFR3;TPX2;MYBL2;SEPT4;FOXM1;FGF1;MYRF;HSPA2;TOP2A;APLNR;PDGFRA;ENPP2;DTL;SFRP2;CDK1;UBE2C;SOX11;CNTN2;MBP;LPAR1
40,GO:0000082,0.203721220770472,0.929439664424409,3,240,G1/S transition of mitotic cell cycle,BP,MCM10;CDK1;RRM2
13803,GO:0051281,0.203743873427003,0.978466642531349,1,35,positive regulation of release of sequestered calcium ion into cytosol,BP,APLNR
4511,GO:0009411,0.204157212903715,0.94841509147545,2,129,response to UV,BP,DTL;PBK
11660,GO:0044454,0.204315881611016,0.906217450389127,5,479,nuclear chromosome part,CC,MCM10;HSPA2;BUB1B;BUB1;CDK1
16514,GO:0071774,0.204584489568447,0.948243684895389,2,128,response to fibroblast growth factor,BP,FGFR3;FGF1
4218,GO:0008643,0.204661926843292,0.948215792085728,2,127,carbohydrate transport,BP,SLC5A11;TMEM144
7311,GO:0030326,0.20466623107982,0.948234438944671,2,122,embryonic limb morphogenesis,BP,SFRP2;FREM2
9605,GO:0035113,0.20466623107982,0.948234438944671,2,122,embryonic appendage morphogenesis,BP,SFRP2;FREM2
515,GO:0001568,0.204894124035819,0.898341476686708,6,583,blood vessel development,BP,FGF1;APLNR;PDGFRA;ENPP2;SFRP2;S100A1
19309,GO:1902531,0.205091380019119,0.86911998651452,14,1666,regulation of intracellular signal transduction,BP,CRLF1;FGFR3;TPX2;SEPT4;FOXM1;FGF1;APLNR;PDGFRA;SFRP2;PBK;CDK1;SOX11;GPR62;LPAR1
9578,GO:0035051,0.20521042454351,0.948028596115594,2,118,cardiocyte differentiation,BP,PDGFRA;CDK1
5068,GO:0010942,0.206878902264925,0.897044955634458,6,614,positive regulation of cell death,BP,MYBL2;SEPT4;TOP2A;SFRP2;MAL;LPAR1
14756,GO:0060421,0.207658404918546,0.977632855938355,1,33,positive regulation of heart growth,BP,CDK1
20269,GO:1904591,0.207688457113641,0.977626109357252,1,33,positive regulation of protein import,BP,CDK1
16263,GO:0071363,0.207810855594133,0.896451637144089,6,597,cellular response to growth factor stimulus,BP,FGFR3;FGF1;PDGFRA;SFRP2;CRB2;SOX11
16923,GO:0072528,0.208176804630553,0.977416343937928,1,39,pyrimidine-containing compound biosynthetic process,BP,AK5
4798,GO:0010559,0.208419265911847,0.977407415777949,1,36,regulation of glycoprotein biosynthetic process,BP,NECAB1
7390,GO:0030517,0.208587210362712,0.977404638158246,1,34,negative regulation of axon extension,BP,MAG
4168,GO:0008536,0.208677073998631,0.977403553291408,1,33,Ran GTPase binding,MF,BIRC5
11245,GO:0043410,0.208752307498767,0.903490521161521,5,482,positive regulation of MAPK cascade,BP,FGFR3;FGF1;PDGFRA;CDK1;LPAR1
11509,GO:0044183,0.208853735324801,0.977277589254536,1,38,protein binding involved in protein folding,MF,HSPA2
16741,GO:0072175,0.209787444233927,0.946098182549835,2,126,epithelial tube formation,BP,SFRP2;SOX11
9055,GO:0033628,0.210339896769998,0.976954793758836,1,37,regulation of cell adhesion mediated by integrin,BP,SFRP2
11307,GO:0043524,0.210459323522241,0.945797475271464,2,131,negative regulation of neuron apoptotic process,BP,CRLF1;MAG
4623,GO:0009893,0.210504670566726,0.852677291553068,23,2947,positive regulation of metabolic process,BP,CRLF1;FGFR3;TPX2;MYBL2;SEPT4;FOXM1;FGF1;PLP1;MYRF;HSPA2;TOP2A;APLNR;PDGFRA;ENPP2;DTL;SFRP2;S100A1;CDK1;UBE2C;SOX11;CNTN2;MBP;LPAR1
4200,GO:0008610,0.210680798832717,0.894576349789538,6,624,lipid biosynthetic process,BP,FGFR3;CPNE6;PTGDS;FGF1;PLP1;ETNPPL
11653,GO:0044447,0.210930862080842,0.976983788781134,1,29,axoneme part,CC,DNAH17
364,GO:0000979,0.211343299474825,0.976741545260624,1,36,RNA polymerase II core promoter sequence-specific DNA binding,MF,SOX11
9524,GO:0034762,0.211582231760724,0.901748220501918,5,472,regulation of transmembrane transport,BP,SNTA1;HSPA2;APLNR;S100A1;FXYD1
5508,GO:0015718,0.211758970567553,0.945244849770763,2,133,monocarboxylic acid transport,BP,SLCO1A2;SPX
12693,GO:0046915,0.212046680550441,0.976563098565557,1,37,transition metal ion transmembrane transporter activity,MF,TF
11109,GO:0043198,0.212070760281002,0.976591913345277,1,35,dendritic shaft,CC,LPAR1
4857,GO:0010646,0.212093356819873,0.850524439650333,24,3103,regulation of cell communication,BP,CRLF1;ASPM;FGFR3;TPX2;BIRC5;SEPT4;FOXM1;FGF1;GFAP;SPX;APLNR;PDGFRA;SFRP2;DAAM2;CRB2;KLK6;PBK;CDK1;MAL;SOX11;GPR62;CNTN2;LPAR1;ZNF536
13871,GO:0051403,0.212240423107087,0.925066186527476,3,242,stress-activated MAPK cascade,BP,FOXM1;SFRP2;PBK
15014,GO:0060828,0.212375158999161,0.924994508596705,3,243,regulation of canonical Wnt signaling pathway,BP,ASPM;SFRP2;DAAM2
14837,GO:0060537,0.212388114628668,0.911317685495934,4,343,muscle tissue development,BP,CENPF;PDGFRA;CDK1;SOX11
4698,GO:0010165,0.212414764134819,0.976512633127037,1,35,response to X-ray,BP,SFRP2
17939,GO:0098590,0.212477693196519,0.877788966502166,9,967,plasma membrane region,CC,ASPM;TF;PACSIN1;SLC14A1;CRB2;AQP4;MAL;TMEM235;FXYD1
5076,GO:0010955,0.21261755430352,0.976465829145047,1,35,negative regulation of protein processing,BP,BIRC5
19648,GO:1903318,0.21261755430352,0.976465829145047,1,35,negative regulation of protein maturation,BP,BIRC5
3858,GO:0008038,0.212785087491269,0.976487150318023,1,32,neuron recognition,BP,CNTN2
13713,GO:0051146,0.213092340383151,0.92464509030038,3,231,striated muscle cell differentiation,BP,PDGFRA;CDK1;MYBPC1
5488,GO:0015682,0.213314950880665,0.976253703598773,1,38,ferric iron transport,BP,TF
16911,GO:0072512,0.213314950880665,0.976253703598773,1,38,trivalent inorganic cation transport,BP,TF
4634,GO:0009925,0.213591966054059,0.976279323455841,1,33,basal plasma membrane,CC,TF
10493,GO:0040011,0.213602723612076,0.864852067231925,13,1518,locomotion,BP,ASPM;DCX;MAG;FGF1;PDGFRA;ENPP2;SFRP2;CRB2;CDK1;EMX2;CNTN2;DNAH17;LPAR1
7259,GO:0030258,0.21444742778397,0.923916978829115,3,243,lipid modification,BP,FGFR3;FGF1;PDGFRA
13070,GO:0048512,0.214514931346976,0.975974106091971,1,38,circadian behavior,BP,PTGDS
3311,GO:0006636,0.214522059963144,0.975942492001572,1,40,unsaturated fatty acid biosynthetic process,BP,PTGDS
4761,GO:0010469,0.215025062988036,0.90973357412301,4,393,regulation of signaling receptor activity,BP,CRLF1;FGF1;SPX;SFRP2
644,GO:0001786,0.215916776554845,0.975661617227642,1,37,phosphatidylserine binding,MF,CPNE6
14749,GO:0060412,0.216056704761194,0.975664342576358,1,35,ventricular septum morphogenesis,BP,SOX11
14846,GO:0060548,0.216103204295214,0.879542627428551,8,891,negative regulation of cell death,BP,CRLF1;FGFR3;BIRC5;MAG;PDGFRA;SFRP2;CDK1;SOX11
15260,GO:0061351,0.216148307747498,0.943411341616723,2,127,neural precursor cell proliferation,BP,ASPM;EMX2
7128,GO:0030049,0.216183629366008,0.975696436705222,1,32,muscle filament sliding,BP,MYBPC1
8934,GO:0033275,0.216183629366008,0.975696436705222,1,32,actin-myosin filament sliding,BP,MYBPC1
6730,GO:0019985,0.216208216455169,0.975576534758231,1,38,translesion synthesis,BP,DTL
21178,GO:2000059,0.21643589821472,0.9755392854933,1,37,negative regulation of ubiquitin-dependent protein catabolic process,BP,PBK
13381,GO:0050662,0.216684264847875,0.922721557602455,3,258,coenzyme binding,MF,ETNPPL;ALDH1A1;AIFM3
7576,GO:0030900,0.2167221321998,0.9087922150427,4,347,forebrain development,BP,ASPM;EMX2;CNTN2;LPAR1
14763,GO:0060429,0.217089446619002,0.874491139763742,9,996,epithelium development,BP,CRLF1;USH1C;FGF1;HAPLN2;SFRP2;CRB2;FREM2;CDK1;SOX11
14488,GO:0060043,0.217208883891962,0.97537403254825,1,36,regulation of cardiac muscle cell proliferation,BP,CDK1
6659,GO:0019838,0.217430498978985,0.94285966824637,2,128,growth factor binding,MF,FGFR3;PDGFRA
9684,GO:0035315,0.217709567943616,0.97525532916327,1,36,hair cell differentiation,BP,USH1C
405,GO:0001078,0.218049322863244,0.942570392303684,2,134,transcriptional repressor activity, RNA polymerase II proximal promoter sequence-specific DNA binding,MF,NKX6-2;ZNF536
16773,GO:0072210,0.218182984241906,0.975142804170657,1,36,metanephric nephron development,BP,PDGFRA
21820,GO:2001242,0.218454510912796,0.942360507232052,2,144,regulation of intrinsic apoptotic signaling pathway,BP,SEPT4;SFRP2
740,GO:0001917,0.218590278614934,0.975045772669294,1,36,photoreceptor inner segment,CC,USH1C
15715,GO:0070317,0.218647545140159,0.975032113282946,1,36,negative regulation of G0 to G1 transition,BP,RRM2
3832,GO:0007622,0.219387243052877,0.974804446078284,1,39,rhythmic behavior,BP,PTGDS
3174,GO:0006464,0.219411423700817,0.841629847585886,28,3680,cellular protein modification process,BP,CRLF1;HHATL;FGFR3;TPX2;BIRC5;TF;SNTA1;SEPT4;FOXM1;FGF1;FBXO2;HSPA2;TOP2A;PPP1R1B;APLNR;PDGFRA;ENPP2;DTL;SFRP2;BUB1B;PPP1R14A;PBK;BUB1;CDK1;UBE2C;MBP;LPAR1;FXYD1
10182,GO:0036211,0.219411423700817,0.841629847585886,28,3680,protein modification process,BP,CRLF1;HHATL;FGFR3;TPX2;BIRC5;TF;SNTA1;SEPT4;FOXM1;FGF1;FBXO2;HSPA2;TOP2A;PPP1R1B;APLNR;PDGFRA;ENPP2;DTL;SFRP2;BUB1B;PPP1R14A;PBK;BUB1;CDK1;UBE2C;MBP;LPAR1;FXYD1
510,GO:0001558,0.219503267740459,0.907141909799173,4,365,regulation of cell growth,BP,CPNE6;MAG;SFRP2;FAM107A
14486,GO:0060041,0.21959255855871,0.941935792135468,2,127,retina development in camera-type eye,BP,USH1C;PDGFRA
16631,GO:0072006,0.219803557990523,0.941844875412321,2,127,nephron development,BP,FGF1;PDGFRA
18514,GO:0140104,0.219947855949284,0.97465440220223,1,40,molecular carrier activity,MF,TF
13611,GO:0050999,0.220017148252724,0.97465305865134,1,39,regulation of nitric-oxide synthase activity,BP,S100A1
154,GO:0000307,0.220161460467913,0.974618305884795,1,39,cyclin-dependent protein kinase holoenzyme complex,CC,CDK1
2632,GO:0005575,0.220536210779496,0.94392430803746,98,14935,cellular_component,CC,CRLF1;USH1C;HHATL;CLDN11;KIFC1;BCAS1;MCM10;ASPM;FGFR3;DCX;SLCO1A2;TPX2;BIRC5;TF;CPNE6;MYBL2;SNTA1;MAG;PTGDS;SEPT4;NCAPG;FOXM1;FGF1;FBXO2;CENPF;NECAB1;PLP1;PACSIN1;MYRF;HSPA2;EVI2A;GFAP;TOP2A;PPP1R1B;HAPLN2;SPX;APLNR;PDGFRA;ESPL1;ERMN;ENPP2;MOG;NUSAP1;SLC14A1;DTL;FIP1L1;SFRP2;DAAM2;CRB2;MKI67;NKX6-2;CNDP1;FREM2;HSPB8;AK5;BUB1B;SLC5A11;S100A1;PAQR6;ETNPPL;TMEM144;PI16;KIF6;ALDH1A1;PPP1R14A;KLK6;PBK;FAM107A;MOBP;LGI3;NTSR2;BUB1;CDK1;EMX2;RRM2;AQP4;MAL;CARNS1;UBE2C;SOX11;TMEM125;S1PR5;GPR62;HS3ST4;CALN1;AIFM3;CNTN2;DNAH17;NWD1;NKAIN2;MYBPC1;OPALIN;MBP;LPAR1;ZNF536;TMEM235;TMEM88B;FXYD1
14539,GO:0060119,0.220624339124014,0.974558100654974,1,36,inner ear receptor cell development,BP,USH1C
6520,GO:0019369,0.221008577789958,0.974383575237972,1,41,arachidonic acid metabolic process,BP,PTGDS
10699,GO:0042383,0.221277537024168,0.941221579033955,2,124,sarcolemma,CC,SNTA1;FXYD1
9404,GO:0034508,0.22130939258706,0.974325415190692,1,40,centromere complex assembly,BP,CENPF
12154,GO:0045744,0.221543720356011,0.974268561081847,1,40,negative regulation of G-protein coupled receptor protein signaling pathway,BP,APLNR
7398,GO:0030534,0.221646094945491,0.941039717847396,2,129,adult behavior,BP,PPP1R1B;CNTN2
12907,GO:0048048,0.22236491676747,0.974176667060107,1,34,embryonic eye morphogenesis,BP,SOX11
14615,GO:0060236,0.223204401886025,0.97393210122711,1,36,regulation of mitotic spindle organization,BP,TPX2
3943,GO:0008188,0.223273800140765,0.973817333761942,1,42,neuropeptide receptor activity,MF,NTSR2
3037,GO:0006259,0.223754168660745,0.874165758991343,8,896,DNA metabolic process,BP,MCM10;FOXM1;CENPF;TOP2A;PDGFRA;DTL;CDK1;RRM2
12028,GO:0045505,0.223998335291345,0.973934892298277,1,28,dynein intermediate chain binding,MF,DNAH17
16671,GO:0072073,0.224097182517923,0.939968603204115,2,130,kidney epithelium development,BP,CRLF1;FGF1
11136,GO:0043235,0.22422646112342,0.904369398558695,4,351,receptor complex,CC,FGFR3;TF;PDGFRA;GPR62
11769,GO:0044843,0.224592368756137,0.9185456305751,3,252,cell cycle G1/S phase transition,BP,MCM10;CDK1;RRM2
2286,GO:0004869,0.224655184459122,0.973491905833062,1,41,cysteine-type endopeptidase inhibitor activity,MF,BIRC5
12886,GO:0048016,0.224693666780535,0.973566973135868,1,36,inositol phosphate-mediated signaling,BP,GPR62
13975,GO:0051603,0.225961550949406,0.884516769118625,6,627,proteolysis involved in cellular protein catabolic process,BP,FBXO2;DTL;BUB1B;PBK;CDK1;UBE2C
7246,GO:0030234,0.226003146533967,0.872575280132635,8,895,enzyme regulator activity,MF,BIRC5;PPP1R1B;SFRP2;CRB2;PI16;ALDH1A1;PPP1R14A;MAL
3823,GO:0007612,0.226106546779054,0.939092288485434,2,129,learning,BP,PPP1R1B;CNTN2
19511,GO:1903018,0.226170376714463,0.97313191951779,1,40,regulation of glycoprotein metabolic process,BP,NECAB1
6035,GO:0016773,0.226174515074071,0.877847915028843,7,720,phosphotransferase activity, alcohol group as acceptor,MF,FGFR3;FGF1;PDGFRA;BUB1B;PBK;BUB1;CDK1
6753,GO:0021517,0.226873354655931,0.972973174944268,1,39,ventral spinal cord development,BP,NKX6-2
9923,GO:0035725,0.227248009519739,0.93858960254665,2,129,sodium ion transmembrane transport,BP,SNTA1;FXYD1
6092,GO:0016860,0.227293812966558,0.972807327424954,1,43,intramolecular oxidoreductase activity,MF,PTGDS
11241,GO:0043406,0.227586016794273,0.916945743133333,3,249,positive regulation of MAP kinase activity,BP,FGF1;CDK1;LPAR1
6125,GO:0016903,0.227896303266624,0.972685363263372,1,41,oxidoreductase activity, acting on the aldehyde or oxo group of donors,MF,ALDH1A1
19388,GO:1902743,0.228015060922502,0.972705048369087,1,38,regulation of lamellipodium organization,BP,ENPP2
616,GO:0001754,0.228225205324793,0.972652356953085,1,38,eye photoreceptor cell differentiation,BP,USH1C
3615,GO:0007140,0.228426521652067,0.972584420251716,1,39,male meiotic nuclear division,BP,HSPA2
13467,GO:0050773,0.228518269786195,0.93803719107916,2,127,regulation of dendrite development,BP,PACSIN1;LPAR1
17397,GO:0090342,0.228583046150887,0.972545073756261,1,39,regulation of cell aging,BP,FOXM1
13056,GO:0048483,0.22860126533866,0.972557925036435,1,38,autonomic nervous system development,BP,SOX11
760,GO:0001944,0.228802648420913,0.882630746352689,6,607,vasculature development,BP,FGF1;APLNR;PDGFRA;ENPP2;SFRP2;S100A1
10740,GO:0042461,0.228980471134514,0.97246252256022,1,38,photoreceptor cell development,BP,USH1C
7108,GO:0030018,0.229851859517356,0.937485115345839,2,119,Z disc,CC,S100A1;MYBPC1
11354,GO:0043596,0.229922315372264,0.972174466284411,1,41,nuclear replication fork,CC,MCM10
3022,GO:0006220,0.230092974830891,0.97207447763752,1,45,pyrimidine nucleotide metabolic process,BP,AK5
14419,GO:0055078,0.230225563050064,0.972113523906705,1,40,sodium ion homeostasis,BP,SPX
13848,GO:0051353,0.230368737748612,0.972061194625339,1,41,positive regulation of oxidoreductase activity,BP,S100A1
8198,GO:0032102,0.230427820963358,0.915394759793122,3,258,negative regulation of response to external stimulus,BP,SPX;PDGFRA;PBK
3046,GO:0006270,0.230724106626716,0.971955568554899,1,42,DNA replication initiation,BP,MCM10
6038,GO:0016776,0.231004320839746,0.971899491406186,1,41,phosphotransferase activity, phosphate group as acceptor,MF,AK5
3114,GO:0006378,0.231605735649549,0.971762174891786,1,40,mRNA polyadenylation,BP,FIP1L1
2414,GO:0005088,0.231728259776785,0.914736286291512,3,234,Ras guanyl-nucleotide exchange factor activity,MF,FGFR3;FGF1;PDGFRA
13112,GO:0048592,0.231755808540917,0.936573866876787,2,132,eye morphogenesis,BP,USH1C;SOX11
3486,GO:0006898,0.232177629028131,0.91445380454212,3,253,receptor-mediated endocytosis,BP,TF;ENPP2;CNTN2
16189,GO:0071248,0.232336540567794,0.936277099541697,2,141,cellular response to metal ion,BP,TF;CPNE6
3330,GO:0006661,0.232504729302974,0.936221512306417,2,136,phosphatidylinositol biosynthetic process,BP,FGFR3;FGF1
9636,GO:0035239,0.23281406289066,0.873240150750729,7,732,tube morphogenesis,BP,FGF1;APLNR;PDGFRA;ENPP2;SFRP2;S100A1;SOX11
7213,GO:0030195,0.233305218223685,0.971279308287071,1,43,negative regulation of blood coagulation,BP,PDGFRA
18570,GO:1900047,0.233305218223685,0.971279308287071,1,43,negative regulation of hemostasis,BP,PDGFRA
7030,GO:0022602,0.233357942899229,0.971329890863718,1,39,ovulation cycle process,BP,PDGFRA
14163,GO:0051959,0.233717520400948,0.971476117635958,1,29,dynein light intermediate chain binding,MF,DNAH17
7664,GO:0031076,0.233879163773199,0.971232970395742,1,37,embryonic camera-type eye development,BP,SOX11
15991,GO:0070848,0.233953823587317,0.879161022504445,6,621,response to growth factor,BP,FGFR3;FGF1;PDGFRA;SFRP2;CRB2;SOX11
14397,GO:0055025,0.233986551247596,0.971186021520794,1,38,positive regulation of cardiac muscle tissue development,BP,CDK1
7634,GO:0031018,0.234055431657432,0.971132608674391,1,40,endocrine pancreas development,BP,NKX6-2
15513,GO:0062013,0.234468714798776,0.935310439105405,2,143,positive regulation of small molecule metabolic process,BP,FGF1;CDK1
16842,GO:0072331,0.234544235461036,0.913151739453941,3,259,signal transduction by p53 class mediator,BP,TPX2;FOXM1;CDK1
12588,GO:0046661,0.234982731205484,0.935093844729363,2,139,male sex differentiation,BP,ASPM;SFRP2
5139,GO:0014037,0.23538795412797,0.970863028691512,1,36,Schwann cell differentiation,BP,CDK1
8388,GO:0032420,0.23553008037813,0.970767522982609,1,39,stereocilium,CC,USH1C
3664,GO:0007204,0.235925912451779,0.912402013427166,3,255,positive regulation of cytosolic calcium ion concentration,BP,APLNR;PDGFRA;LPAR1
12149,GO:0045739,0.236566417032149,0.970446450066466,1,42,positive regulation of DNA repair,BP,FOXM1
9430,GO:0034614,0.237029092158817,0.934135703677398,2,147,cellular response to reactive oxygen species,BP,PDGFRA;CDK1
10779,GO:0042551,0.237210452976272,0.970328351032937,1,39,neuron maturation,BP,CNTN2
13069,GO:0048511,0.237214237577199,0.911695848813403,3,254,rhythmic process,BP,PTGDS;TOP2A;PDGFRA
11649,GO:0044441,0.237665384764049,0.896267898247555,4,369,ciliary part,CC,USH1C;SEPT4;CENPF;DNAH17
13624,GO:0051017,0.238185767753894,0.933639562456202,2,139,actin filament bundle assembly,BP,USH1C;LPAR1
15347,GO:0061572,0.238185767753894,0.933639562456202,2,139,actin filament bundle organization,BP,USH1C;LPAR1
11713,GO:0044703,0.239081687496328,0.868835343009333,7,777,multi-organism reproductive process,BP,CLDN11;KIFC1;ASPM;SEPT4;HSPA2;PPP1R1B;CDK1
15714,GO:0070316,0.239157278147178,0.969796914765114,1,40,regulation of G0 to G1 transition,BP,RRM2
17100,GO:0086009,0.239460587248723,0.969716459044864,1,40,membrane repolarization,BP,SNTA1
17310,GO:0090224,0.239500272502829,0.969724092602963,1,39,regulation of spindle organization,BP,TPX2
3596,GO:0007080,0.23960193019131,0.969614471086487,1,44,mitotic metaphase plate congression,BP,KIFC1
10612,GO:0042220,0.239777752013177,0.96961488113356,1,41,response to cocaine,BP,PPP1R1B
2287,GO:0004871,0.239782456328095,0.853981091349179,10,1181,signal transducer activity,MF,FGFR3;EVI2A;APLNR;PDGFRA;SFRP2;PAQR6;NTSR2;S1PR5;GPR62;LPAR1
16485,GO:0071695,0.239980005885743,0.932827238243851,2,137,anatomical structure maturation,BP,FGFR3;CNTN2
13868,GO:0051393,0.24025325932697,0.969656954680494,1,33,alpha-actinin binding,MF,MYBPC1
5093,GO:0010976,0.240306921061623,0.91000768510895,3,244,positive regulation of neuron projection development,BP,CPNE6;PACSIN1;LPAR1
6778,GO:0021545,0.240792882980647,0.969344190762944,1,41,cranial nerve development,BP,LPAR1
13061,GO:0048488,0.240951184943254,0.969337738332279,1,39,synaptic vesicle endocytosis,BP,PACSIN1
12255,GO:0045933,0.241125515877452,0.969207446155518,1,44,positive regulation of muscle contraction,BP,SPX
12033,GO:0045540,0.241231563459747,0.969226804751866,1,41,regulation of cholesterol biosynthetic process,BP,FGF1
21239,GO:2000179,0.241632167378911,0.969136980051321,1,40,positive regulation of neural precursor cell proliferation,BP,ASPM
17722,GO:0097366,0.241916179425944,0.969026326736421,1,42,response to bronchodilator,BP,PPP1R1B
4509,GO:0009409,0.242132984573245,0.968951965714988,1,43,response to cold,BP,HSPA2
21814,GO:2001236,0.242134033242654,0.931800049984006,2,146,regulation of extrinsic apoptotic signaling pathway,BP,SFRP2;MAL
10032,GO:0035924,0.242372362644407,0.968920381547958,1,41,cellular response to vascular endothelial growth factor stimulus,BP,PDGFRA
7170,GO:0030135,0.242703430595168,0.908646074529279,3,259,coated vesicle,CC,TF;CPNE6;PACSIN1
7026,GO:0022412,0.243136519472114,0.908400840297746,3,261,cellular process involved in reproduction in multicellular organism,BP,ASPM;SEPT4;HSPA2
11377,GO:0043631,0.24334331543922,0.968641274485978,1,42,RNA polyadenylation,BP,FIP1L1
7196,GO:0030170,0.24397500248631,0.968423343502075,1,45,pyridoxal phosphate binding,MF,ETNPPL
15690,GO:0070279,0.24397500248631,0.968423343502075,1,45,vitamin B6 binding,MF,ETNPPL
12183,GO:0045806,0.244295465739912,0.968336136032923,1,45,negative regulation of endocytosis,BP,PACSIN1
9614,GO:0035148,0.244879763192663,0.930551375274752,2,140,tube formation,BP,SFRP2;SOX11
750,GO:0001933,0.245144237293942,0.89165797022234,4,387,negative regulation of protein phosphorylation,BP,FOXM1;PPP1R1B;SFRP2;PBK
11912,GO:0045197,0.24552399698685,0.968047836572206,1,42,establishment or maintenance of epithelial cell apical/basal polarity,BP,CRB2
13444,GO:0050732,0.246222579011583,0.967824028675471,1,44,negative regulation of peptidyl-tyrosine phosphorylation,BP,SFRP2
7295,GO:0030307,0.246334340923624,0.929864893061284,2,142,positive regulation of cell growth,BP,CPNE6;SFRP2
13502,GO:0050819,0.24639745524484,0.967746350089719,1,46,negative regulation of coagulation,BP,PDGFRA
32,GO:0000060,0.246656936086468,0.967720463127027,1,43,protein import into nucleus, translocation,BP,CDK1
6284,GO:0018105,0.24720364675557,0.906134913263022,3,254,peptidyl-serine phosphorylation,BP,PPP1R1B;SFRP2;CDK1
9688,GO:0035329,0.24734911938914,0.967622175146612,1,38,hippo signaling,BP,SOX11
3594,GO:0007077,0.247766656260901,0.967431118439307,1,42,mitotic nuclear envelope disassembly,BP,CDK1
19034,GO:1901799,0.248159812502314,0.967289421820039,1,44,negative regulation of proteasomal protein catabolic process,BP,PBK
2410,GO:0005080,0.248280926965859,0.967271923629524,1,43,protein kinase C binding,MF,TOP2A
15099,GO:0060999,0.248464195805101,0.967293814602149,1,39,positive regulation of dendritic spine development,BP,LPAR1
3613,GO:0007131,0.248637786232298,0.967156769059871,1,44,reciprocal meiotic recombination,BP,TOP2A
9983,GO:0035825,0.248637786232298,0.967156769059871,1,44,homologous recombination,BP,TOP2A
21822,GO:2001244,0.248722382893328,0.967075424948178,1,48,positive regulation of intrinsic apoptotic signaling pathway,BP,SEPT4
38,GO:0000077,0.24902809919344,0.92858121113146,2,147,DNA damage checkpoint,BP,DTL;CDK1
5657,GO:0016020,0.249367505553262,0.810083837072039,53,7580,membrane,CC,USH1C;HHATL;CLDN11;KIFC1;ASPM;FGFR3;SLCO1A2;TF;CPNE6;SNTA1;MAG;PTGDS;NCAPG;FBXO2;PLP1;PACSIN1;MYRF;HSPA2;EVI2A;GFAP;APLNR;PDGFRA;ENPP2;MOG;SLC14A1;DTL;SFRP2;CRB2;MKI67;FREM2;SLC5A11;PAQR6;TMEM144;NTSR2;BUB1;CDK1;AQP4;MAL;UBE2C;TMEM125;S1PR5;GPR62;HS3ST4;CALN1;AIFM3;CNTN2;NKAIN2;OPALIN;MBP;LPAR1;TMEM235;TMEM88B;FXYD1
14487,GO:0060042,0.249696695143032,0.966913026671154,1,41,retina morphogenesis in camera-type eye,BP,USH1C
2828,GO:0005891,0.249962277267771,0.966877532338775,1,39,voltage-gated calcium channel complex,CC,HSPA2
6308,GO:0018198,0.249977214624672,0.966767873095025,1,45,peptidyl-cysteine modification,BP,SNTA1
9658,GO:0035265,0.25008294105195,0.928108097457315,2,141,organ growth,BP,FGFR3;CDK1
6751,GO:0021515,0.250398640842783,0.966665513141069,1,44,cell differentiation in spinal cord,BP,NKX6-2
11803,GO:0045023,0.250890202412392,0.966561286612166,1,42,G0 to G1 transition,BP,RRM2
12978,GO:0048260,0.251277786721532,0.966418731403369,1,44,positive regulation of receptor-mediated endocytosis,BP,TF
18828,GO:1901214,0.251857686260486,0.903481664730468,3,264,regulation of neuron death,BP,CRLF1;MYBL2;MAG
3624,GO:0007157,0.252380116649451,0.966124495238111,1,43,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,BP,CRB2
21572,GO:2000677,0.252449081642985,0.966088375019847,1,44,regulation of transcription regulatory region DNA binding,BP,SOX11
367,GO:0000982,0.252562343867975,0.887041126711273,4,387,transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding,MF,MYBL2;NKX6-2;SOX11;ZNF536
5817,GO:0016331,0.252638303489364,0.926888338739826,2,143,morphogenesis of embryonic epithelium,BP,SFRP2;SOX11
5072,GO:0010950,0.254528534747976,0.925943315769848,2,154,positive regulation of endopeptidase activity,BP,SFRP2;MBP
13209,GO:0048754,0.254742363784155,0.925888577062218,2,142,branching morphogenesis of an epithelial tube,BP,FGF1;SFRP2
13179,GO:0048701,0.255257959431724,0.96530583827834,1,43,embryonic cranial skeleton morphogenesis,BP,PDGFRA
7992,GO:0031674,0.255338728019866,0.925659585355418,2,130,I band,CC,S100A1;MYBPC1
15082,GO:0060976,0.255559500958955,0.965256007597641,1,41,coronary vasculature development,BP,APLNR
3709,GO:0007276,0.255613842413289,0.873326791340212,5,523,gamete generation,BP,CLDN11;KIFC1;ASPM;SEPT4;HSPA2
11308,GO:0043525,0.256172255494933,0.965010001721916,1,45,positive regulation of neuron apoptotic process,BP,MYBL2
6499,GO:0019320,0.256863806083694,0.964779864384765,1,47,hexose catabolic process,BP,ALDH1A1
9810,GO:0035567,0.25696413955665,0.924788936212813,2,150,non-canonical Wnt signaling pathway,BP,SFRP2;DAAM2
3919,GO:0008146,0.257049684318477,0.964741209797514,1,46,sulfotransferase activity,MF,HS3ST4
11883,GO:0045143,0.257363140780537,0.964650528766724,1,46,homologous chromosome segregation,BP,ESPL1
7387,GO:0030514,0.258528773998532,0.964362206742453,1,43,negative regulation of BMP signaling pathway,BP,SFRP2
7683,GO:0031098,0.258543927330527,0.899642354454086,3,268,stress-activated protein kinase signaling cascade,BP,FOXM1;SFRP2;PBK
8389,GO:0032421,0.258773819849232,0.964273477210954,1,44,stereocilium bundle,CC,USH1C
15523,GO:0065009,0.258961075094783,0.814074616683784,22,2919,regulation of molecular function,BP,CRLF1;FGFR3;TPX2;BIRC5;SNTA1;FGF1;HSPA2;PPP1R1B;SPX;PDGFRA;SFRP2;CRB2;S100A1;PI16;ALDH1A1;PPP1R14A;CDK1;UBE2C;SOX11;MBP;LPAR1;FXYD1
9008,GO:0033554,0.259138359944171,0.827080667328178,14,1782,cellular response to stress,BP,MCM10;FOXM1;FGF1;FBXO2;HSPA2;GFAP;TOP2A;PDGFRA;DTL;SFRP2;HSPB8;PBK;CDK1;AQP4
13532,GO:0050866,0.259348841619261,0.923613419328393,2,156,negative regulation of cell activation,BP,PDGFRA;SOX11
9673,GO:0035295,0.259527419831482,0.848294341623778,8,895,tube development,BP,CRLF1;FGF1;APLNR;PDGFRA;ENPP2;SFRP2;S100A1;SOX11
9589,GO:0035088,0.259970879079628,0.963907215771053,1,45,establishment or maintenance of apical/basal cell polarity,BP,CRB2
15227,GO:0061245,0.259970879079628,0.963907215771053,1,45,establishment or maintenance of bipolar cell polarity,BP,CRB2
3172,GO:0006458,0.260092288967796,0.963825303301353,1,48,'de novo' protein folding,BP,HSPA2
9184,GO:0034113,0.260876994203719,0.963625127598162,1,46,heterotypic cell-cell adhesion,BP,MBP
8633,GO:0032781,0.260895879816882,0.963561182583835,1,50,positive regulation of ATPase activity,BP,HSPA2
12558,GO:0046622,0.26114518783825,0.963579442660089,1,44,positive regulation of organ growth,BP,CDK1
7216,GO:0030199,0.261244112984004,0.963568128708713,1,43,collagen fibril organization,BP,SFRP2
7296,GO:0030308,0.261381016859969,0.922632319356373,2,154,negative regulation of cell growth,BP,MAG;SFRP2
12535,GO:0046579,0.261537785357014,0.963446778030568,1,45,positive regulation of Ras protein signal transduction,BP,LPAR1
6211,GO:0017111,0.261569621599957,0.852790436722392,7,764,nucleoside-triphosphatase activity,MF,KIFC1;SEPT4;HSPA2;TOP2A;KIF6;CARNS1;DNAH17
424,GO:0001105,0.262205205952815,0.963284731345023,1,43,RNA polymerase II transcription coactivator activity,MF,SOX11
4895,GO:0010718,0.262493148977122,0.963181617938828,1,44,positive regulation of epithelial to mesenchymal transition,BP,CRB2
11086,GO:0043167,0.262612326361948,0.800023893799904,40,5495,ion binding,MF,KIFC1;MCM10;FGFR3;TPX2;BIRC5;TF;CPNE6;MAG;PTGDS;SEPT4;FGF1;NECAB1;PACSIN1;HSPA2;TOP2A;IQCA1;HAPLN2;PDGFRA;ENPP2;CRB2;MKI67;CNDP1;FREM2;AK5;BUB1B;S100A1;ETNPPL;KIF6;PBK;BUB1;CDK1;RRM2;CARNS1;UBE2C;CALN1;AIFM3;DNAH17;NWD1;LPAR1;ZNF536
9276,GO:0034308,0.262978747100686,0.962944679810186,1,50,primary alcohol metabolic process,BP,ALDH1A1
12503,GO:0046503,0.263753670231213,0.962742430228062,1,48,glycerolipid catabolic process,BP,ENPP2
4788,GO:0010524,0.263898265844223,0.962699300198491,1,48,positive regulation of calcium ion transport into cytosol,BP,APLNR
13976,GO:0051604,0.264014543533879,0.896438090567323,3,283,protein maturation,BP,BIRC5;KLK6;CNTN2
3068,GO:0006301,0.264630721133336,0.96248039608969,1,48,postreplication repair,BP,DTL
11033,GO:0043066,0.264666651744178,0.85052209479907,7,807,negative regulation of apoptotic process,BP,CRLF1;FGFR3;BIRC5;MAG;PDGFRA;SFRP2;CDK1
7173,GO:0030139,0.265032023246149,0.895859302364161,3,274,endocytic vesicle,CC,TF;CPNE6;LPAR1
3854,GO:0008028,0.265619253889147,0.962169035730485,1,49,monocarboxylic acid transmembrane transporter activity,MF,SLCO1A2
1471,GO:0003205,0.265682803349659,0.920558603471969,2,145,cardiac chamber development,BP,SFRP2;SOX11
4618,GO:0009888,0.265708096639441,0.82438539528845,13,1600,tissue development,BP,CRLF1;USH1C;FGFR3;FGF1;CENPF;HAPLN2;PDGFRA;SFRP2;CRB2;FREM2;KLK6;CDK1;SOX11
3508,GO:0006935,0.265996992956951,0.866321611993633,5,526,chemotaxis,BP,FGF1;PDGFRA;ENPP2;CNTN2;LPAR1
6104,GO:0016879,0.266242668293914,0.962011623486561,1,47,ligase activity, forming carbon-nitrogen bonds,MF,CARNS1
4172,GO:0008542,0.266261651709005,0.962056629627391,1,44,visual learning,BP,PPP1R1B
8623,GO:0032768,0.266569264056293,0.961882692235172,1,49,regulation of monooxygenase activity,BP,S100A1
4484,GO:0009314,0.266908332516652,0.877914143898331,4,402,response to radiation,BP,PPP1R1B;DTL;SFRP2;PBK
10672,GO:0042330,0.267031704614471,0.865616610866584,5,527,taxis,BP,FGF1;PDGFRA;ENPP2;CNTN2;LPAR1
13627,GO:0051020,0.267232184774844,0.856135922161422,6,622,GTPase binding,MF,FGFR3;BIRC5;FGF1;PDGFRA;DAAM2;MOBP
21816,GO:2001238,0.267346919628209,0.961647401774437,1,49,positive regulation of extrinsic apoptotic signaling pathway,BP,MAL
7345,GO:0030397,0.267417365827483,0.961672982025777,1,46,membrane disassembly,BP,CDK1
13663,GO:0051081,0.267417365827483,0.961672982025777,1,46,nuclear envelope disassembly,BP,CDK1
1374,GO:0003012,0.26771124553849,0.877411322045848,4,390,muscle system process,BP,SNTA1;SPX;MYBPC1;FXYD1
13921,GO:0051496,0.267912261500434,0.961506577756493,1,47,positive regulation of stress fiber assembly,BP,LPAR1
6454,GO:0019205,0.267970990114466,0.961457996228844,1,49,nucleobase-containing compound kinase activity,MF,AK5
11108,GO:0043197,0.268627739803683,0.919086645573684,2,148,dendritic spine,CC,FBXO2;LPAR1
8592,GO:0032722,0.268691555438833,0.961224129427475,1,50,positive regulation of chemokine production,BP,MBP
11759,GO:0044815,0.268866355206415,0.961118011250573,1,54,DNA packaging complex,CC,NCAPG
4514,GO:0009416,0.268998794511912,0.893525486015309,3,275,response to light stimulus,BP,PPP1R1B;DTL;PBK
14483,GO:0060038,0.269197249821127,0.961131865591058,1,46,cardiac muscle cell proliferation,BP,CDK1
13104,GO:0048568,0.269750812383272,0.876087902012854,4,396,embryonic organ development,BP,USH1C;PDGFRA;CRB2;SOX11
10621,GO:0042246,0.269750866821754,0.960900299506935,1,50,tissue regeneration,BP,KLK6
21547,GO:2000649,0.269810932243716,0.960944312768912,1,46,regulation of sodium ion transmembrane transporter activity,BP,FXYD1
21813,GO:2001235,0.269881008174161,0.918400032167442,2,164,positive regulation of apoptotic signaling pathway,BP,SEPT4;MAL
12925,GO:0048146,0.270020984825312,0.960847437199159,1,48,positive regulation of fibroblast proliferation,BP,PDGFRA
14701,GO:0060350,0.27023135836885,0.960798876716698,1,47,endochondral bone morphogenesis,BP,FGFR3
15504,GO:0061971,0.27023135836885,0.960798876716698,1,47,replacement bone morphogenesis,BP,FGFR3
8945,GO:0033293,0.270871441002605,0.960541921668268,1,51,monocarboxylic acid binding,MF,PTGDS
13267,GO:0048871,0.270961006504149,0.892360949278053,3,277,multicellular organismal homeostasis,BP,USH1C;TF;AQP4
14409,GO:0055065,0.271635453179386,0.862462337139894,5,536,metal ion homeostasis,BP,TF;SPX;APLNR;PDGFRA;LPAR1
10656,GO:0042306,0.271985516192586,0.960258785025494,1,47,regulation of protein import into nucleus,BP,CDK1
3807,GO:0007588,0.273698168146496,0.959680345659036,1,50,excretion,BP,SPX
7190,GO:0030163,0.273846374969881,0.843802351566557,7,806,protein catabolic process,BP,FBXO2;GFAP;DTL;BUB1B;PBK;CDK1;UBE2C
14393,GO:0055021,0.273964390138779,0.959644539803972,1,47,regulation of cardiac muscle tissue growth,BP,CDK1
5607,GO:0015909,0.274149692541825,0.959539460364323,1,50,long-chain fatty acid transport,BP,SPX
11574,GO:0044309,0.274564636048815,0.916100966469699,2,150,neuron spine,CC,FBXO2;LPAR1
11036,GO:0043069,0.275418138134054,0.842638379460769,7,818,negative regulation of programmed cell death,BP,CRLF1;FGFR3;BIRC5;MAG;PDGFRA;SFRP2;CDK1
18228,GO:0099518,0.275594875761017,0.959151786818775,1,46,vesicle cytoskeletal trafficking,BP,MOBP
14760,GO:0060425,0.275653169544004,0.959083643019422,1,49,lung morphogenesis,BP,SOX11
20892,GO:1990138,0.275662524054499,0.915562947298966,2,146,neuron projection extension,BP,CPNE6;MAG
6962,GO:0021915,0.275914965853089,0.915421522567101,2,149,neural tube development,BP,SFRP2;SOX11
10921,GO:0042805,0.276378884976719,0.95902817128867,1,40,actinin binding,MF,MYBPC1
16045,GO:0070936,0.276544536598183,0.958802996253439,1,49,protein K48-linked ubiquitination,BP,UBE2C
12258,GO:0045936,0.27675736861724,0.858932660960318,5,538,negative regulation of phosphate metabolic process,BP,FOXM1;PPP1R1B;SFRP2;PPP1R14A;PBK
13889,GO:0051438,0.277735898238284,0.958395798361647,1,51,regulation of ubiquitin-protein transferase activity,BP,UBE2C
4653,GO:0009987,0.277807250726565,0.815798245437253,88,13224,cellular process,BP,CRLF1;USH1C;HHATL;CLDN11;KIFC1;MCM10;ASPM;FGFR3;DCX;TPX2;BIRC5;TF;CPNE6;MYBL2;SNTA1;MAG;PTGDS;SEPT4;NCAPG;FOXM1;FGF1;FBXO2;CENPF;NECAB1;PLP1;PACSIN1;MYRF;HSPA2;EVI2A;GFAP;TOP2A;PPP1R1B;HAPLN2;SPX;APLNR;PDGFRA;ESPL1;ERMN;ENPP2;MOG;NUSAP1;DTL;FIP1L1;SFRP2;DAAM2;CRB2;MKI67;NKX6-2;CNDP1;FREM2;HSPB8;AK5;BUB1B;SLC5A11;S100A1;PAQR6;ETNPPL;PI16;KIF6;ALDH1A1;PPP1R14A;KLK6;PBK;FAM107A;MOBP;LGI3;NTSR2;BUB1;CDK1;EMX2;RRM2;AQP4;MAL;CARNS1;UBE2C;SOX11;S1PR5;GPR62;HS3ST4;AIFM3;CNTN2;DNAH17;NWD1;MYBPC1;MBP;LPAR1;ZNF536;FXYD1
4802,GO:0010563,0.277883522366561,0.858152397245868,5,539,negative regulation of phosphorus metabolic process,BP,FOXM1;PPP1R1B;SFRP2;PPP1R14A;PBK
7686,GO:0031102,0.277884889572838,0.958378961297279,1,49,neuron projection regeneration,BP,GFAP
11041,GO:0043086,0.278000098965108,0.848406631901454,6,684,negative regulation of catalytic activity,BP,BIRC5;PPP1R1B;SFRP2;CRB2;PI16;PPP1R14A
15114,GO:0061024,0.278987448325584,0.840005066524341,7,803,membrane organization,BP,TF;PACSIN1;MYRF;CDK1;MAL;CNTN2;MBP
13006,GO:0048306,0.279324392513972,0.957848216022327,1,54,calcium-dependent protein binding,MF,S100A1
11542,GO:0044257,0.279739032388709,0.84715803818262,6,676,cellular protein catabolic process,BP,FBXO2;DTL;BUB1B;PBK;CDK1;UBE2C
11548,GO:0044267,0.280486973597679,0.78724548931706,33,4601,cellular protein metabolic process,BP,CRLF1;HHATL;FGFR3;TPX2;BIRC5;TF;SNTA1;SEPT4;FOXM1;FGF1;FBXO2;HSPA2;TOP2A;PPP1R1B;APLNR;PDGFRA;ENPP2;DTL;SFRP2;CRB2;CNDP1;BUB1B;PI16;PPP1R14A;PBK;BUB1;CDK1;UBE2C;SOX11;CNTN2;MBP;LPAR1;FXYD1
4023,GO:0008307,0.281030094673587,0.957529381158688,1,41,structural constituent of muscle,MF,MYBPC1
8773,GO:0032989,0.281844519349292,0.826245693064981,9,1030,cellular component morphogenesis,BP,CPNE6;MAG;PACSIN1;PDGFRA;ERMN;ENPP2;CNTN2;MYBPC1;LPAR1
11229,GO:0043392,0.282370008005403,0.956910868055514,1,51,negative regulation of DNA binding,BP,SOX11
5175,GO:0014704,0.282472056974386,0.956943434114984,1,47,intercalated disc,CC,FXYD1
13911,GO:0051480,0.282587081896531,0.885377631279396,3,281,regulation of cytosolic calcium ion concentration,BP,APLNR;PDGFRA;LPAR1
18033,GO:0098797,0.282696697368784,0.854811428559689,5,532,plasma membrane protein complex,CC,TF;SNTA1;HSPA2;CNTN2;FXYD1
13134,GO:0048639,0.283029825069731,0.911769152274938,2,151,positive regulation of developmental growth,BP,CPNE6;CDK1
12598,GO:0046686,0.283063530253817,0.956617044770658,1,56,response to cadmium ion,BP,CDK1
14537,GO:0060113,0.283508752370914,0.956590013603001,1,48,inner ear receptor cell differentiation,BP,USH1C
4054,GO:0008360,0.283693181858771,0.911412880051432,2,154,regulation of cell shape,BP,ERMN;LPAR1
11924,GO:0045214,0.283764609286579,0.956602988124943,1,43,sarcomere organization,BP,MYBPC1
5052,GO:0010921,0.283874089536461,0.91131492109264,2,155,regulation of phosphatase activity,BP,PPP1R1B;PPP1R14A
10280,GO:0036465,0.284229883138162,0.956355427998984,1,48,synaptic vesicle recycling,BP,PACSIN1
7301,GO:0030315,0.284265611210202,0.95641919752629,1,44,T-tubule,CC,FXYD1
4550,GO:0009628,0.285006702688318,0.823775077867062,9,1095,response to abiotic stimulus,BP,MAG;FGF1;HSPA2;PPP1R1B;DTL;SFRP2;HSPB8;PBK;LPAR1
17093,GO:0086002,0.285655225225716,0.955926079299357,1,46,cardiac muscle cell action potential involved in contraction,BP,SNTA1
16165,GO:0071214,0.285808433055671,0.883401856614969,3,288,cellular response to abiotic stimulus,BP,MAG;SFRP2;PBK
18381,GO:0104004,0.285808433055671,0.883401856614969,3,288,cellular response to environmental stimulus,BP,MAG;SFRP2;PBK
21630,GO:2000779,0.285926187273865,0.955767253615397,1,50,regulation of double-strand break repair,BP,FOXM1
10997,GO:0043010,0.286111420060656,0.883243928178457,3,274,camera-type eye development,BP,USH1C;PDGFRA;SOX11
16184,GO:0071241,0.286698951296861,0.909813264046205,2,163,cellular response to inorganic substance,BP,TF;CPNE6
4867,GO:0010660,0.286859378589119,0.955429070758555,1,52,regulation of muscle cell apoptotic process,BP,SFRP2
17275,GO:0090181,0.28699747087293,0.955398801157168,1,51,regulation of cholesterol metabolic process,BP,FGF1
7319,GO:0030335,0.287078072897674,0.864697665720172,4,409,positive regulation of cell migration,BP,FGF1;PDGFRA;ENPP2;LPAR1
13808,GO:0051287,0.287366660960886,0.955205725455059,1,56,NAD binding,MF,ALDH1A1
7011,GO:0022029,0.288169462063641,0.955043903941852,1,49,telencephalon cell migration,BP,CNTN2
6776,GO:0021543,0.288608315520058,0.90885105155074,2,154,pallium development,BP,ASPM;EMX2
16344,GO:0071478,0.288659878768043,0.908782911453623,2,164,cellular response to radiation,BP,SFRP2;PBK
15830,GO:0070527,0.288847730028487,0.954770494100136,1,52,platelet aggregation,BP,PDGFRA
20267,GO:1904589,0.289791999186651,0.954471417161617,1,51,regulation of protein import,BP,CDK1
12878,GO:0048008,0.289859381690617,0.954499622268906,1,48,platelet-derived growth factor receptor signaling pathway,BP,PDGFRA
3440,GO:0006826,0.290883546327811,0.954060883972365,1,54,iron ion transport,BP,TF
6405,GO:0019058,0.290892599226497,0.880272557724624,3,291,viral life cycle,BP,TOP2A;MOG;CDK1
7309,GO:0030324,0.290900938229587,0.90762768583806,2,158,lung development,BP,FGF1;SOX11
6938,GO:0021879,0.291746160359628,0.953816512447204,1,51,forebrain neuron differentiation,BP,CNTN2
3839,GO:0007632,0.291922816747362,0.953790625620102,1,49,visual behavior,BP,PPP1R1B
17920,GO:0098552,0.292143419642088,0.861289075979194,4,425,side of membrane,CC,TF;GFAP;MOG;AQP4
9054,GO:0033627,0.292355868420447,0.953595233286167,1,52,cell adhesion mediated by integrin,BP,SFRP2
10669,GO:0042326,0.292534220286559,0.861031975347843,4,420,negative regulation of phosphorylation,BP,FOXM1;PPP1R1B;SFRP2;PBK
11895,GO:0045171,0.292555880911936,0.953497711312637,1,54,intercellular bridge,CC,TPX2
100,GO:0000209,0.29267498769993,0.879171752999793,3,290,protein polyubiquitination,BP,FBXO2;DTL;UBE2C
12435,GO:0046365,0.293728817551702,0.953072324340146,1,56,monosaccharide catabolic process,BP,ALDH1A1
15876,GO:0070588,0.293761113635022,0.878527824851617,3,275,calcium ion transmembrane transport,BP,HSPA2;APLNR;S100A1
6392,GO:0019005,0.293906657183692,0.953025683204966,1,55,SCF ubiquitin ligase complex,CC,FBXO2
12062,GO:0045600,0.294027875383961,0.952998795308064,1,54,positive regulation of fat cell differentiation,BP,SFRP2
5074,GO:0010952,0.294075522382424,0.905894317545149,2,171,positive regulation of peptidase activity,BP,SFRP2;MBP
6034,GO:0016772,0.295020763564316,0.821444186413667,8,934,transferase activity, transferring phosphorus-containing groups,MF,FGFR3;FGF1;PDGFRA;AK5;BUB1B;PBK;BUB1;CDK1
13731,GO:0051172,0.295097558185341,0.793223577230492,16,2098,negative regulation of nitrogen compound metabolic process,BP,HHATL;BIRC5;SNTA1;FOXM1;CENPF;PPP1R1B;SFRP2;CRB2;NKX6-2;S100A1;PI16;PPP1R14A;PBK;SOX11;ZNF536;FXYD1
3513,GO:0006941,0.295320021517873,0.905286760333761,2,157,striated muscle contraction,BP,SNTA1;MYBPC1
11246,GO:0043412,0.295856477903876,0.777087632279794,28,3845,macromolecule modification,BP,CRLF1;HHATL;FGFR3;TPX2;BIRC5;TF;SNTA1;SEPT4;FOXM1;FGF1;FBXO2;HSPA2;TOP2A;PPP1R1B;APLNR;PDGFRA;ENPP2;DTL;SFRP2;BUB1B;PPP1R14A;PBK;BUB1;CDK1;UBE2C;MBP;LPAR1;FXYD1
3512,GO:0006940,0.296435239323279,0.952161796484134,1,55,regulation of smooth muscle contraction,BP,SPX
13551,GO:0050891,0.296799256132968,0.952082159478384,1,52,multicellular organismal water homeostasis,BP,AQP4
13758,GO:0051216,0.298914579332307,0.903330014517455,2,164,cartilage development,BP,FGFR3;SFRP2
11654,GO:0044448,0.299579541372642,0.903001252022409,2,157,cell cortex part,CC,SEPT4;MOBP
19946,GO:1903902,0.299996995699952,0.950929786949411,1,55,positive regulation of viral life cycle,BP,TOP2A
10732,GO:0042445,0.30001167500777,0.902689130066034,2,177,hormone metabolic process,BP,ALDH1A1;KLK6
6316,GO:0018209,0.300163058267713,0.874506366801263,3,285,peptidyl-serine modification,BP,PPP1R1B;SFRP2;CDK1
14512,GO:0060070,0.30053652831155,0.874257638627611,3,292,canonical Wnt signaling pathway,BP,ASPM;SFRP2;DAAM2
13484,GO:0050795,0.30059604649171,0.950735793892264,1,54,regulation of behavior,BP,PTGDS
7308,GO:0030323,0.300635709196146,0.902409125749569,2,162,respiratory tube development,BP,FGF1;SOX11
810,GO:0002011,0.300642239629026,0.950785539262821,1,50,morphogenesis of an epithelial sheet,BP,SOX11
12516,GO:0046530,0.300688894106449,0.950735048738278,1,52,photoreceptor cell differentiation,BP,USH1C
3431,GO:0006812,0.300696055801468,0.817036035291351,8,966,cation transport,BP,TF;SNTA1;HSPA2;APLNR;SLC5A11;S100A1;NKAIN2;FXYD1
13658,GO:0051057,0.30122261878888,0.950548548792846,1,52,positive regulation of small GTPase mediated signal transduction,BP,LPAR1
21224,GO:2000147,0.30147444487718,0.854973445254738,4,420,positive regulation of cell motility,BP,FGF1;PDGFRA;ENPP2;LPAR1
4864,GO:0010657,0.301711402064471,0.950330437315606,1,55,muscle cell apoptotic process,BP,SFRP2
717,GO:0001885,0.302150083048996,0.950207218692179,1,53,endothelial cell development,BP,HAPLN2
726,GO:0001894,0.302279453430233,0.901485869613935,2,170,tissue homeostasis,BP,USH1C;TF
12934,GO:0048168,0.302989700221546,0.949928219789417,1,52,regulation of neuronal synaptic plasticity,BP,CNTN2
21710,GO:2001020,0.30300674167494,0.901086503137854,2,171,regulation of response to DNA damage stimulus,BP,FOXM1;SFRP2
20621,GO:1905330,0.303088610612866,0.901041931413102,2,171,regulation of morphogenesis of an epithelium,BP,FGF1;SFRP2
7273,GO:0030278,0.30362243242597,0.900766693894255,2,167,regulation of ossification,BP,SFRP2;SOX11
14755,GO:0060420,0.303731684502621,0.949649975538032,1,53,regulation of heart growth,BP,CDK1
1368,GO:0003006,0.303794502030948,0.839834756598323,5,554,developmental process involved in reproduction,BP,ASPM;SEPT4;HSPA2;PDGFRA;SFRP2
496,GO:0001540,0.303887468783049,0.949563739979638,1,55,amyloid-beta binding,MF,FBXO2
3470,GO:0006879,0.304143057413917,0.949444235348056,1,57,cellular iron ion homeostasis,BP,TF
1578,GO:0003407,0.305606533603857,0.948984844888225,1,53,neural retina development,BP,USH1C
18943,GO:1901565,0.305618379411354,0.807582702589768,9,1129,organonitrogen compound catabolic process,BP,FBXO2;GFAP;ENPP2;DTL;BUB1B;PBK;CDK1;CARNS1;UBE2C
10755,GO:0042490,0.306209685107349,0.948769812237597,1,53,mechanoreceptor differentiation,BP,USH1C
5216,GO:0014823,0.306758367941532,0.948557585410254,1,54,response to activity,BP,CDK1
7797,GO:0031323,0.307146593741672,0.761489151523928,39,5530,regulation of cellular metabolic process,BP,CRLF1;HHATL;FGFR3;TPX2;BIRC5;MYBL2;SNTA1;SEPT4;FOXM1;FGF1;FBXO2;CENPF;NECAB1;MYRF;HSPA2;GFAP;TOP2A;PPP1R1B;APLNR;PDGFRA;ENPP2;SFRP2;CRB2;NKX6-2;CNDP1;S100A1;PI16;PPP1R14A;PBK;CDK1;EMX2;RRM2;UBE2C;SOX11;CNTN2;MBP;LPAR1;ZNF536;FXYD1
13242,GO:0048839,0.307319486199879,0.898750250894189,2,165,inner ear development,BP,USH1C;FREM2
560,GO:0001658,0.307733505260146,0.948207985610502,1,54,branching involved in ureteric bud morphogenesis,BP,FGF1
7171,GO:0030136,0.307917730408994,0.898408593767716,2,168,clathrin-coated vesicle,CC,TF;CPNE6
19531,GO:1903051,0.308548732650485,0.947883730270506,1,56,negative regulation of proteolysis involved in cellular protein catabolic process,BP,PBK
11970,GO:0045334,0.308566872053446,0.947862529046104,1,57,clathrin-coated endocytic vesicle,CC,CPNE6
1611,GO:0003707,0.308605910049555,0.947894073837097,1,54,steroid hormone receptor activity,MF,PAQR6
3752,GO:0007405,0.308866265441701,0.947816569025678,1,53,neuroblast proliferation,BP,ASPM
8262,GO:0032233,0.309304781933197,0.947610722990112,1,56,positive regulation of actin filament bundle assembly,BP,LPAR1
2622,GO:0005539,0.309320364665092,0.897614732697252,2,173,glycosaminoglycan binding,MF,FGF1;HAPLN2
12680,GO:0046889,0.309372301376273,0.947557338761892,1,58,positive regulation of lipid biosynthetic process,BP,FGF1
12933,GO:0048167,0.310541087921351,0.89697518437641,2,164,regulation of synaptic plasticity,BP,GFAP;CNTN2
2405,GO:0005057,0.31063992050076,0.896929047708756,2,162,signal transducer activity, downstream of receptor,MF,FGFR3;PDGFRA
21834,GO:2001259,0.310971853828283,0.947037307117284,1,54,positive regulation of cation channel activity,BP,S100A1
13140,GO:0048645,0.312019287861946,0.946594360924952,1,58,animal organ formation,BP,FGF1
7280,GO:0030286,0.312724865025903,0.946508641912505,1,48,dynein complex,CC,DNAH17
2267,GO:0004842,0.313698039098951,0.846541292648941,4,422,ubiquitin-protein transferase activity,MF,BIRC5;FBXO2;DTL;UBE2C
13146,GO:0048663,0.313895275881725,0.945905815098314,1,58,neuron fate commitment,BP,NKX6-2
7948,GO:0031594,0.314341797579281,0.945803186267695,1,54,neuromuscular junction,CC,SNTA1
13464,GO:0050770,0.31445442892299,0.894803709640513,2,162,regulation of axonogenesis,BP,MAG;CNTN2
18942,GO:1901564,0.314654868907636,0.754265720631311,41,5941,organonitrogen compound metabolic process,BP,CRLF1;HHATL;FGFR3;TPX2;BIRC5;TF;SNTA1;SEPT4;FOXM1;FGF1;FBXO2;NECAB1;MYRF;HSPA2;GFAP;TOP2A;PPP1R1B;APLNR;PDGFRA;ESPL1;ENPP2;DTL;SFRP2;CRB2;CNDP1;AK5;BUB1B;PI16;PPP1R14A;KLK6;PBK;BUB1;CDK1;CARNS1;UBE2C;SOX11;HS3ST4;CNTN2;MBP;LPAR1;FXYD1
3430,GO:0006811,0.315313813322338,0.79078831044823,11,1404,ion transport,BP,SLCO1A2;TF;SNTA1;HSPA2;SPX;APLNR;SLC5A11;S100A1;AQP4;NKAIN2;FXYD1
7148,GO:0030104,0.315388142521248,0.945384372672206,1,56,water homeostasis,BP,AQP4
8679,GO:0032835,0.315924401178136,0.945218006122509,1,54,glomerulus development,BP,PDGFRA
11368,GO:0043621,0.316306003463184,0.945129922353917,1,51,protein self-association,MF,CNTN2
14699,GO:0060348,0.316357074942806,0.893714356195668,2,167,bone development,BP,FGFR3;SFRP2
10920,GO:0042803,0.316484920753487,0.81994620770059,6,727,protein homodimerization activity,MF,MAG;SEPT4;CENPF;TOP2A;PDGFRA;S100A1
17807,GO:0097525,0.316499526028052,0.944899900538815,1,61,spliceosomal snRNP complex,CC,NWD1
4671,GO:0010038,0.316864128270691,0.863792476229282,3,304,response to metal ion,BP,TF;CPNE6;CDK1
13107,GO:0048583,0.316955612065467,0.760391732929891,26,3621,regulation of response to stimulus,BP,CRLF1;ASPM;FGFR3;TPX2;BIRC5;SEPT4;FOXM1;FGF1;SPX;APLNR;PDGFRA;MOG;SFRP2;DAAM2;CRB2;HSPB8;S100A1;KLK6;PBK;CDK1;MAL;SOX11;GPR62;CNTN2;LPAR1;ZNF536
6166,GO:0017022,0.317433623182773,0.944608367133255,1,57,myosin binding,MF,MOBP
13927,GO:0051536,0.317503786598511,0.94452521596324,1,61,iron-sulfur cluster binding,MF,AIFM3
13931,GO:0051540,0.317503786598511,0.94452521596324,1,61,metal cluster binding,MF,AIFM3
9804,GO:0035556,0.317714571255984,0.768455930533824,19,2545,intracellular signal transduction,BP,CRLF1;FGFR3;DCX;TPX2;SEPT4;FOXM1;FGF1;PPP1R1B;APLNR;PDGFRA;DTL;SFRP2;S100A1;PBK;CDK1;SOX11;GPR62;MBP;LPAR1
6707,GO:0019932,0.318120484952119,0.8629869086185,3,298,second-messenger-mediated signaling,BP,APLNR;GPR62;LPAR1
13799,GO:0051272,0.318277400040138,0.84332886466497,4,431,positive regulation of cellular component movement,BP,FGF1;PDGFRA;ENPP2;LPAR1
10152,GO:0036126,0.318314797904124,0.944221570991275,1,61,sperm flagellum,CC,SEPT4
17884,GO:0097729,0.318314797904124,0.944221570991275,1,61,9+2 motile cilium,CC,SEPT4
5816,GO:0016328,0.318617421762271,0.944180990862182,1,56,lateral plasma membrane,CC,SNTA1
18829,GO:1901215,0.318771867356828,0.892319462779717,2,175,negative regulation of neuron death,BP,CRLF1;MAG
3532,GO:0006977,0.318947272955946,0.943997758017295,1,60,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,BP,CDK1
5484,GO:0015672,0.318961812487528,0.84284241361023,4,436,monovalent inorganic cation transport,BP,SNTA1;SLC5A11;NKAIN2;FXYD1
10003,GO:0035869,0.319015827296703,0.944000710036899,1,58,ciliary transition zone,CC,USH1C
12640,GO:0046824,0.320210875367615,0.943598007130612,1,55,positive regulation of nucleocytoplasmic transport,BP,CDK1
19455,GO:1902930,0.322402079721254,0.942705165825407,1,59,regulation of alcohol biosynthetic process,BP,FGF1
8681,GO:0032838,0.322601024394737,0.890175773920303,2,167,plasma membrane bounded cell projection cytoplasm,CC,CENPF;DNAH17
15134,GO:0061045,0.322802412967411,0.942538182156286,1,60,negative regulation of wound healing,BP,PDGFRA
2422,GO:0005102,0.322929448130656,0.788764737447041,10,1300,signaling receptor binding,MF,CRLF1;TF;MAG;FGF1;GFAP;PPP1R1B;SPX;PDGFRA;MOG;SFRP2
7629,GO:0031012,0.323155415382898,0.839899908030636,4,425,extracellular matrix,CC,FGF1;HAPLN2;SFRP2;FREM2
5269,GO:0014910,0.324276195861523,0.942052713068089,1,55,regulation of smooth muscle cell migration,BP,LPAR1
3643,GO:0007178,0.324665671624198,0.858700661757041,3,297,transmembrane receptor protein serine/threonine kinase signaling pathway,BP,SFRP2;CRB2;SOX11
21128,GO:1990939,0.326305738671995,0.941410905141863,1,48,ATP-dependent microtubule motor activity,MF,DNAH17
10856,GO:0042698,0.326894717112928,0.940965192136032,1,60,ovulation cycle,BP,PDGFRA
16894,GO:0072431,0.326932749416494,0.940936129909432,1,61,signal transduction involved in mitotic G1 DNA damage checkpoint,BP,CDK1
19262,GO:1902400,0.326932749416494,0.940936129909432,1,61,intracellular signal transduction involved in G1 DNA damage checkpoint,BP,CDK1
2478,GO:0005179,0.327150534385996,0.940763107589669,1,68,hormone activity,MF,SPX
6077,GO:0016835,0.327280563757752,0.940736007112567,1,66,carbon-oxygen lyase activity,MF,ETNPPL
13160,GO:0048678,0.328495628772504,0.940314724331897,1,62,response to axon injury,BP,CDK1
15186,GO:0061138,0.328906903187015,0.886526270251429,2,172,morphogenesis of a branching epithelium,BP,FGF1;SFRP2
2633,GO:0005576,0.329251948121403,0.749572665971839,26,3750,extracellular region,CC,CRLF1;CLDN11;BCAS1;FGFR3;TPX2;TF;CPNE6;PTGDS;FGF1;FBXO2;HSPA2;HAPLN2;SPX;ERMN;ENPP2;SFRP2;DAAM2;CRB2;CNDP1;FREM2;S100A1;PI16;ALDH1A1;KLK6;LGI3;CDK1
6470,GO:0019222,0.32954762650264,0.740984639254844,41,5893,regulation of metabolic process,BP,CRLF1;HHATL;FGFR3;TPX2;BIRC5;MYBL2;SNTA1;SEPT4;FOXM1;FGF1;FBXO2;CENPF;NECAB1;PLP1;MYRF;HSPA2;GFAP;TOP2A;PPP1R1B;APLNR;PDGFRA;ENPP2;DTL;SFRP2;CRB2;NKX6-2;CNDP1;S100A1;PI16;PPP1R14A;PBK;CDK1;EMX2;RRM2;UBE2C;SOX11;CNTN2;MBP;LPAR1;ZNF536;FXYD1
5238,GO:0014855,0.329638556844622,0.939911882356392,1,59,striated muscle cell proliferation,BP,CDK1
19294,GO:1902495,0.330213650414433,0.85502864954554,3,295,transmembrane transporter complex,CC,HSPA2;CNTN2;FXYD1
5673,GO:0016049,0.330253198919653,0.834837279993864,4,437,cell growth,BP,CPNE6;MAG;SFRP2;FAM107A
17382,GO:0090316,0.330289082700332,0.885695155879855,2,179,positive regulation of intracellular protein transport,BP,CDK1;MYBPC1
3833,GO:0007623,0.330445566219638,0.885608049548098,2,178,circadian rhythm,BP,PTGDS;TOP2A
13701,GO:0051130,0.330690410509831,0.787416099776953,9,1121,positive regulation of cellular component organization,BP,TF;CPNE6;PACSIN1;ESPL1;ENPP2;NUSAP1;UBE2C;MYBPC1;LPAR1
15146,GO:0061061,0.331021821475939,0.819838358470987,5,556,muscle structure development,BP,CENPF;PDGFRA;CDK1;SOX11;MYBPC1
16887,GO:0072413,0.331158071167586,0.939271501607515,1,62,signal transduction involved in mitotic cell cycle checkpoint,BP,CDK1
19263,GO:1902402,0.331158071167586,0.939271501607515,1,62,signal transduction involved in mitotic DNA damage checkpoint,BP,CDK1
19264,GO:1902403,0.331158071167586,0.939271501607515,1,62,signal transduction involved in mitotic DNA integrity checkpoint,BP,CDK1
11916,GO:0045202,0.331733654802844,0.799589972950984,7,828,synapse,CC,USH1C;SNTA1;FBXO2;PACSIN1;LGI3;CNTN2;LPAR1
8613,GO:0032755,0.332132204446984,0.938859939153115,1,64,positive regulation of interleukin-6 production,BP,MBP
17094,GO:0086003,0.332455155600257,0.938853175100709,1,56,cardiac muscle cell contraction,BP,SNTA1
14915,GO:0060675,0.333104638275922,0.93854680752761,1,59,ureteric bud morphogenesis,BP,FGF1
5430,GO:0015370,0.333370834544495,0.938441237652921,1,59,solute:sodium symporter activity,MF,SLC5A11
3559,GO:0007018,0.33347758198431,0.852863507176844,3,288,microtubule-based movement,BP,KIFC1;KIF6;DNAH17
6043,GO:0016782,0.334040264501063,0.938089690900011,1,65,transferase activity, transferring sulfur-containing groups,MF,HS3ST4
16205,GO:0071277,0.33461184542631,0.937947688390262,1,59,cellular response to calcium ion,BP,CPNE6
12212,GO:0045859,0.334826388187339,0.805886709432865,6,719,regulation of protein kinase activity,BP,TPX2;FGF1;PPP1R1B;SFRP2;CDK1;LPAR1
8744,GO:0032945,0.334915510715267,0.937753751331416,1,64,negative regulation of mononuclear cell proliferation,BP,SOX11
13390,GO:0050672,0.334915510715267,0.937753751331416,1,64,negative regulation of lymphocyte proliferation,BP,SOX11
14853,GO:0060562,0.334999291754154,0.851818762887956,3,299,epithelial tube morphogenesis,BP,FGF1;SFRP2;SOX11
10028,GO:0035914,0.335094764434371,0.937724419261761,1,61,skeletal muscle cell differentiation,BP,SOX11
7091,GO:0023052,0.335200919277352,0.736850695309492,38,5421,signaling,BP,CRLF1;ASPM;FGFR3;DCX;TPX2;BIRC5;CPNE6;SEPT4;FOXM1;FGF1;PLP1;EVI2A;GFAP;PPP1R1B;SPX;APLNR;PDGFRA;ENPP2;MOG;DTL;SFRP2;DAAM2;CRB2;S100A1;PAQR6;KLK6;PBK;NTSR2;CDK1;MAL;SOX11;S1PR5;GPR62;CNTN2;MBP;LPAR1;ZNF536;FXYD1
21094,GO:1990837,0.335356049718043,0.805478152589246,6,715,sequence-specific double-stranded DNA binding,MF,MCM10;MYBL2;FOXM1;NKX6-2;SOX11;ZNF536
870,GO:0002088,0.335669341912678,0.937525325753768,1,59,lens development in camera-type eye,BP,SOX11
3360,GO:0006695,0.33573926881675,0.93745201334725,1,62,cholesterol biosynthetic process,BP,FGF1
20427,GO:1904888,0.336279310265952,0.937280952188535,1,59,cranial skeletal system development,BP,PDGFRA
5168,GO:0014068,0.336751606996043,0.937075649416167,1,60,positive regulation of phosphatidylinositol 3-kinase signaling,BP,PDGFRA
16737,GO:0072171,0.336913806147572,0.937010445696207,1,60,mesonephric tubule morphogenesis,BP,FGF1
12215,GO:0045862,0.337680317887123,0.849971581789804,3,320,positive regulation of proteolysis,BP,SFRP2;CNTN2;MBP
12208,GO:0045844,0.338624734296883,0.936320275944466,1,60,positive regulation of striated muscle tissue development,BP,CDK1
13132,GO:0048636,0.338624734296883,0.936320275944466,1,60,positive regulation of muscle organ development,BP,CDK1
18649,GO:1900182,0.339149233948486,0.936077516837593,1,62,positive regulation of protein localization to nucleus,BP,CDK1
3632,GO:0007165,0.339406062138558,0.734329596437055,35,4994,signal transduction,BP,CRLF1;ASPM;FGFR3;DCX;TPX2;BIRC5;SEPT4;FOXM1;FGF1;PLP1;EVI2A;PPP1R1B;SPX;APLNR;PDGFRA;ENPP2;MOG;DTL;SFRP2;DAAM2;CRB2;S100A1;PAQR6;KLK6;PBK;NTSR2;CDK1;MAL;SOX11;S1PR5;GPR62;CNTN2;MBP;LPAR1;ZNF536
11067,GO:0043130,0.339454614525986,0.93591154519683,1,65,ubiquitin binding,MF,TOP2A
8543,GO:0032642,0.339504523220568,0.935865329854578,1,67,regulation of chemokine production,BP,MBP
19357,GO:1902653,0.339619021529858,0.935872327066833,1,63,secondary alcohol biosynthetic process,BP,FGF1
16852,GO:0072347,0.340073903123415,0.935673253090568,1,64,response to anesthetic,BP,PPP1R1B
3621,GO:0007154,0.340088824596924,0.732458458747645,38,5433,cell communication,BP,CRLF1;ASPM;FGFR3;DCX;TPX2;BIRC5;CPNE6;SEPT4;FOXM1;FGF1;PLP1;EVI2A;GFAP;PPP1R1B;SPX;APLNR;PDGFRA;ENPP2;MOG;DTL;SFRP2;DAAM2;CRB2;FREM2;S100A1;PAQR6;KLK6;PBK;NTSR2;CDK1;MAL;SOX11;S1PR5;GPR62;CNTN2;MBP;LPAR1;ZNF536
7715,GO:0031146,0.340167234145592,0.935559325614003,1,70,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,BP,FBXO2
13465,GO:0050771,0.340715831787634,0.935470833098417,1,60,negative regulation of axonogenesis,BP,MAG
1551,GO:0003341,0.340752487854553,0.935455884557854,1,60,cilium movement,BP,DNAH17
21711,GO:2001021,0.341118968228599,0.935233222780393,1,65,negative regulation of response to DNA damage stimulus,BP,SFRP2
18072,GO:0098858,0.341251081782347,0.879256759996041,2,174,actin-based cell projection,CC,USH1C;ERMN
11485,GO:0044093,0.342380623539853,0.764445704260266,12,1577,positive regulation of molecular function,BP,FGFR3;TPX2;FGF1;HSPA2;PDGFRA;SFRP2;S100A1;ALDH1A1;CDK1;UBE2C;MBP;LPAR1
4849,GO:0010638,0.342651752587772,0.811035751655994,5,587,positive regulation of organelle organization,BP,ESPL1;NUSAP1;UBE2C;MYBPC1;LPAR1
20940,GO:1990351,0.3429035849903,0.846460526243929,3,303,transporter complex,CC,HSPA2;CNTN2;FXYD1
19058,GO:1901863,0.343928720201359,0.934137134675815,1,61,positive regulation of muscle tissue development,BP,CDK1
14022,GO:0051701,0.344167781037298,0.877453531371182,2,188,interaction with host,BP,MOG;CDK1
10499,GO:0040017,0.344665624785988,0.824398109971801,4,449,positive regulation of locomotion,BP,FGF1;PDGFRA;ENPP2;LPAR1
2943,GO:0006081,0.344902811330797,0.93362370363419,1,69,cellular aldehyde metabolic process,BP,ALDH1A1
3111,GO:0006369,0.345060381825902,0.9335707539586,1,68,termination of RNA polymerase II transcription,BP,FIP1L1
7799,GO:0031325,0.345167122196886,0.742926578622365,20,2752,positive regulation of cellular metabolic process,BP,CRLF1;FGFR3;TPX2;MYBL2;SEPT4;FOXM1;FGF1;MYRF;HSPA2;TOP2A;APLNR;PDGFRA;ENPP2;SFRP2;CDK1;UBE2C;SOX11;CNTN2;MBP;LPAR1
3836,GO:0007626,0.345190249398367,0.876882454073693,2,177,locomotory behavior,BP,PPP1R1B;CNTN2
7415,GO:0030574,0.345290773288381,0.933589610947889,1,60,collagen catabolic process,BP,KLK6
139,GO:0000287,0.34531998064803,0.876771683345202,2,185,magnesium ion binding,MF,SEPT4;TOP2A
5908,GO:0016529,0.34573482809239,0.933421885129496,1,59,sarcoplasmic reticulum,CC,S100A1
11267,GO:0043462,0.346174030185051,0.933083074330869,1,70,regulation of ATPase activity,BP,HSPA2
2680,GO:0005657,0.347619557370989,0.932516901969835,1,67,replication fork,CC,MCM10
6636,GO:0019787,0.347944952618447,0.821997151043117,4,446,ubiquitin-like protein transferase activity,MF,BIRC5;FBXO2;DTL;UBE2C
5576,GO:0015850,0.348018591364086,0.875125221269449,2,189,organic hydroxy compound transport,BP,SLCO1A2;SLC5A11
3208,GO:0006513,0.34823920388337,0.932313415102766,1,63,protein monoubiquitination,BP,DTL
6388,GO:0018995,0.348769940161265,0.932061554794537,1,65,host,CC,TOP2A
11390,GO:0043657,0.348769940161265,0.932061554794537,1,65,host cell,CC,TOP2A
11242,GO:0043407,0.348834116949012,0.932007221177426,1,67,negative regulation of MAP kinase activity,BP,SFRP2
7397,GO:0030532,0.349568063011456,0.931685016550603,1,68,small nuclear ribonucleoprotein complex,CC,NWD1
12478,GO:0046470,0.349823285884277,0.931552164068413,1,70,phosphatidylcholine metabolic process,BP,ENPP2
16848,GO:0072341,0.350771521251185,0.931176363926529,1,68,modified amino acid binding,MF,CPNE6
7211,GO:0030193,0.350967073747301,0.931080657461525,1,69,regulation of blood coagulation,BP,PDGFRA
18569,GO:1900046,0.350967073747301,0.931080657461525,1,69,regulation of hemostasis,BP,PDGFRA
15909,GO:0070664,0.351062551234867,0.931053027375446,1,68,negative regulation of leukocyte proliferation,BP,SOX11
10853,GO:0042692,0.351143474086941,0.840794905550182,3,306,muscle cell differentiation,BP,PDGFRA;CDK1;MYBPC1
5669,GO:0016043,0.351717066723225,0.721608730125192,39,5560,cellular component organization,BP,USH1C;KIFC1;ASPM;TPX2;BIRC5;TF;CPNE6;MYBL2;MAG;SEPT4;NCAPG;CENPF;PLP1;PACSIN1;MYRF;HSPA2;GFAP;TOP2A;PPP1R1B;HAPLN2;PDGFRA;ESPL1;ERMN;ENPP2;NUSAP1;SFRP2;DAAM2;MKI67;BUB1B;KLK6;FAM107A;BUB1;CDK1;MAL;UBE2C;CNTN2;MYBPC1;MBP;LPAR1
7152,GO:0030111,0.351871262245506,0.840264734957145,3,319,regulation of Wnt signaling pathway,BP,ASPM;SFRP2;DAAM2
16345,GO:0071479,0.352076260700679,0.930649450388111,1,66,cellular response to ionizing radiation,BP,SFRP2
9676,GO:0035303,0.352434308435803,0.872458201345651,2,183,regulation of dephosphorylation,BP,PPP1R1B;PPP1R14A
16585,GO:0071897,0.352709884189708,0.872261709741014,2,190,DNA biosynthetic process,BP,CENPF;DTL
15152,GO:0061077,0.352899144373093,0.930233861959451,1,71,chaperone-mediated protein folding,BP,HSPA2
13054,GO:0048477,0.353147177317845,0.930179204731146,1,67,oogenesis,BP,ASPM
403,GO:0001076,0.353204933139924,0.87198589778257,2,183,transcription factor activity, RNA polymerase II transcription factor binding,MF,MYBL2;SOX11
14840,GO:0060541,0.35389011800308,0.871565266312753,2,183,respiratory system development,BP,FGF1;SOX11
11339,GO:0043565,0.354351481458518,0.774052578110126,8,1019,sequence-specific DNA binding,MF,MCM10;MYBL2;FOXM1;MYRF;NKX6-2;EMX2;SOX11;ZNF536
3530,GO:0006974,0.354408665857313,0.790494503906592,6,745,cellular response to DNA damage stimulus,BP,MCM10;FOXM1;TOP2A;DTL;SFRP2;CDK1
1517,GO:0003281,0.354431114131324,0.929719807834789,1,61,ventricular septum development,BP,SOX11
19667,GO:1903363,0.354473026847403,0.929611578137561,1,67,negative regulation of cellular protein catabolic process,BP,PBK
9492,GO:0034704,0.354567297242328,0.929695626213918,1,59,calcium channel complex,CC,HSPA2
7215,GO:0030198,0.35505331174785,0.838080147351857,3,306,extracellular matrix organization,BP,GFAP;HAPLN2;SFRP2
14748,GO:0060411,0.355152204491918,0.92937824906512,1,63,cardiac septum morphogenesis,BP,SOX11
6464,GO:0019216,0.355666939425603,0.837619928726938,3,322,regulation of lipid metabolic process,BP,FGFR3;FGF1;PDGFRA
4843,GO:0010632,0.356104135906465,0.870197491600615,2,184,regulation of epithelial cell migration,BP,FGF1;ENPP2
2820,GO:0005882,0.356499186261088,0.928738944662499,1,67,intermediate filament,CC,GFAP
10905,GO:0042775,0.357214274745805,0.928278153789186,1,80,mitochondrial ATP synthesis coupled electron transport,BP,CDK1
5715,GO:0016126,0.358550147042503,0.927835424730702,1,68,sterol biosynthetic process,BP,FGF1
5268,GO:0014909,0.358697286909417,0.927844779577281,1,63,smooth muscle cell migration,BP,LPAR1
7361,GO:0030433,0.360495919349707,0.926958516248398,1,70,ubiquitin-dependent ERAD pathway,BP,FBXO2
7632,GO:0031016,0.361134766848936,0.926718786290899,1,67,pancreas development,BP,NKX6-2
10903,GO:0042773,0.361184639157303,0.926532403477005,1,81,ATP synthesis coupled electron transport,BP,CDK1
16590,GO:0071902,0.361587032332811,0.833458560548242,3,327,positive regulation of protein serine/threonine kinase activity,BP,FGF1;CDK1;LPAR1
448,GO:0001190,0.361889950055927,0.926431344915204,1,64,transcriptional activator activity, RNA polymerase II transcription factor binding,MF,SOX11
615,GO:0001750,0.361956091720088,0.926371890260961,1,66,photoreceptor outer segment,CC,USH1C
9180,GO:0034109,0.36224308132744,0.926230885527153,1,67,homotypic cell-cell adhesion,BP,PDGFRA
7685,GO:0031100,0.362310939941341,0.926159907487608,1,70,animal organ regeneration,BP,CDK1
7931,GO:0031571,0.362345786704818,0.926157811420989,1,69,mitotic G1 DNA damage checkpoint,BP,CDK1
11761,GO:0044819,0.362345786704818,0.926157811420989,1,69,mitotic G1/S transition checkpoint,BP,CDK1
265,GO:0000731,0.362778144888312,0.925980540693603,1,68,DNA synthesis involved in DNA repair,BP,DTL
15747,GO:0070374,0.363206478015641,0.865729242349665,2,196,positive regulation of ERK1 and ERK2 cascade,BP,FGFR3;PDGFRA
5135,GO:0014032,0.363431970521324,0.92569123239405,1,68,neural crest cell development,BP,SOX11
14396,GO:0055024,0.363473986960547,0.925701395442012,1,66,regulation of cardiac muscle tissue development,BP,CDK1
551,GO:0001649,0.36454294760674,0.864908519828381,2,191,osteoblast differentiation,BP,SFRP2;SOX11
2759,GO:0005783,0.364957379983672,0.745097303759476,12,1645,endoplasmic reticulum,CC,HHATL;FGFR3;TF;PTGDS;FBXO2;MYRF;S100A1;KLK6;CDK1;MAL;AIFM3;TMEM235
3845,GO:0008015,0.365274829582999,0.809074346187952,4,458,blood circulation,BP,SNTA1;SPX;S100A1;FXYD1
8515,GO:0032602,0.365379875361776,0.92474761035429,1,74,chemokine production,BP,MBP
12282,GO:0045981,0.365921617238282,0.924530083420429,1,72,positive regulation of nucleotide metabolic process,BP,CDK1
18732,GO:1900544,0.365921617238282,0.924530083420429,1,72,positive regulation of purine nucleotide metabolic process,BP,CDK1
14390,GO:0055017,0.366262838701968,0.924445350774802,1,67,cardiac muscle tissue growth,BP,CDK1
2411,GO:0005085,0.366413416747421,0.830087188984694,3,305,guanyl-nucleotide exchange factor activity,MF,FGFR3;FGF1;PDGFRA
11742,GO:0044783,0.366494573186481,0.924299672598296,1,70,G1 DNA damage checkpoint,BP,CDK1
13501,GO:0050818,0.367107738692406,0.923986097199762,1,73,regulation of coagulation,BP,PDGFRA
15098,GO:0060998,0.367162937136238,0.924104525215213,1,63,regulation of dendritic spine development,BP,LPAR1
486,GO:0001523,0.367401533245533,0.923892807513248,1,70,retinoid metabolic process,BP,ALDH1A1
5414,GO:0015318,0.367592206191637,0.779936210152828,6,740,inorganic molecular entity transmembrane transporter activity,MF,SLCO1A2;TF;SLC14A1;SLC5A11;AQP4;FXYD1
4022,GO:0008306,0.367652292882667,0.923822329152281,1,67,associative learning,BP,PPP1R1B
11170,GO:0043281,0.367702622620681,0.862864411668694,2,204,regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,BIRC5;SFRP2
3702,GO:0007268,0.367720146241933,0.791631398197603,5,598,chemical synaptic transmission,BP,CPNE6;PLP1;GFAP;CNTN2;MBP
18106,GO:0098916,0.367720146241933,0.791631398197603,5,598,anterograde trans-synaptic signaling,BP,CPNE6;PLP1;GFAP;CNTN2;MBP
11347,GO:0043583,0.367939277311407,0.86276298560795,2,191,ear development,BP,USH1C;FREM2
3467,GO:0006875,0.368228111064367,0.806824116057373,4,472,cellular metal ion homeostasis,BP,TF;APLNR;PDGFRA;LPAR1
14063,GO:0051781,0.368976897136446,0.923169664589049,1,71,positive regulation of cell division,BP,FGF1
11522,GO:0044215,0.369041842699989,0.92315369970426,1,70,other organism,CC,TOP2A
11523,GO:0044216,0.369041842699989,0.92315369970426,1,70,other organism cell,CC,TOP2A
11524,GO:0044217,0.369041842699989,0.92315369970426,1,70,other organism part,CC,TOP2A
18948,GO:1901570,0.369224728058593,0.923007630008784,1,75,fatty acid derivative biosynthetic process,BP,PTGDS
5606,GO:0015908,0.369238899023354,0.923051227567741,1,71,fatty acid transport,BP,SPX
150,GO:0000302,0.369992880098986,0.861401832438961,2,206,response to reactive oxygen species,BP,PDGFRA;CDK1
362,GO:0000977,0.370034754717511,0.789799379664466,5,608,RNA polymerase II regulatory region sequence-specific DNA binding,MF,MYBL2;FOXM1;NKX6-2;SOX11;ZNF536
17092,GO:0086001,0.370049730570232,0.922803645546792,1,63,cardiac muscle cell action potential,BP,SNTA1
14420,GO:0055080,0.370686145678245,0.789281052463313,5,613,cation homeostasis,BP,TF;SPX;APLNR;PDGFRA;LPAR1
21712,GO:2001022,0.371469247777075,0.92202547377001,1,72,positive regulation of response to DNA damage stimulus,BP,FOXM1
6982,GO:0021954,0.371926428713614,0.921886926981566,1,67,central nervous system neuron development,BP,CNTN2
18242,GO:0099537,0.372168009796859,0.788119532885621,5,601,trans-synaptic signaling,BP,CPNE6;PLP1;GFAP;CNTN2;MBP
1375,GO:0003013,0.372565478356848,0.803537981463874,4,462,circulatory system process,BP,SNTA1;SPX;S100A1;FXYD1
13193,GO:0048729,0.373179558799914,0.787328095147174,5,590,tissue morphogenesis,BP,FGF1;SFRP2;CRB2;FREM2;SOX11
18241,GO:0099536,0.37383266499263,0.786800009959065,5,602,synaptic signaling,BP,CPNE6;PLP1;GFAP;CNTN2;MBP
10603,GO:0042176,0.373989393053958,0.824607921462635,3,333,regulation of protein catabolic process,BP,GFAP;DTL;PBK
8463,GO:0032508,0.374042499324893,0.920874435515744,1,70,DNA duplex unwinding,BP,TOP2A
383,GO:0001012,0.374252831102287,0.786459182538357,5,611,RNA polymerase II regulatory region DNA binding,MF,MYBL2;FOXM1;NKX6-2;SOX11;ZNF536
2838,GO:0005905,0.374280760466345,0.920824069270355,1,66,clathrin-coated pit,CC,TF
1400,GO:0003073,0.374415705961231,0.920662583021621,1,73,regulation of systemic arterial blood pressure,BP,SPX
16676,GO:0072078,0.374420615749296,0.920729248084749,1,68,nephron tubule morphogenesis,BP,FGF1
19521,GO:1903035,0.374587490363604,0.920596478048968,1,72,negative regulation of response to wounding,BP,PDGFRA
19975,GO:1903955,0.37509607545587,0.920336181611926,1,74,positive regulation of protein targeting to mitochondrion,BP,MYBPC1
13801,GO:0051279,0.375418242932495,0.920269384080348,1,68,regulation of release of sequestered calcium ion into cytosol,BP,APLNR
7107,GO:0030017,0.375604827836714,0.857904418003977,2,181,sarcomere,CC,S100A1;MYBPC1
16922,GO:0072527,0.375648600922248,0.920044609980481,1,77,pyrimidine-containing compound metabolic process,BP,AK5
2514,GO:0005254,0.37671172349986,0.919627768271922,1,71,chloride channel activity,MF,FXYD1
13199,GO:0048738,0.37745361455389,0.85669645655518,2,184,cardiac muscle tissue development,BP,PDGFRA;CDK1
12224,GO:0045892,0.37869650615185,0.753722862143023,8,1044,negative regulation of transcription, DNA-templated,BP,BIRC5;FOXM1;CENPF;SFRP2;NKX6-2;S100A1;SOX11;ZNF536
5401,GO:0015291,0.380449518129651,0.854691973315857,2,198,secondary active transmembrane transporter activity,MF,SLCO1A2;SLC5A11
12977,GO:0048259,0.380473925961156,0.917857005855031,1,72,regulation of receptor-mediated endocytosis,BP,TF
13261,GO:0048864,0.380950736467512,0.917632693575946,1,72,stem cell development,BP,SOX11
2038,GO:0004527,0.381037439271217,0.917578393968088,1,73,exonuclease activity,MF,ENPP2
5134,GO:0014031,0.381875672462665,0.91719652938705,1,72,mesenchymal cell development,BP,SOX11
13110,GO:0048588,0.382287016192015,0.853524564867822,2,190,developmental cell growth,BP,CPNE6;MAG
16682,GO:0072088,0.382741579906137,0.916815309811536,1,70,nephron epithelium morphogenesis,BP,FGF1
17830,GO:0097581,0.383299213080515,0.916536584889922,1,71,lamellipodium organization,BP,ENPP2
21811,GO:2001233,0.384321147722328,0.817057482490942,3,355,regulation of apoptotic signaling pathway,BP,SEPT4;SFRP2;MAL
18508,GO:0140096,0.384880060273229,0.71808324241849,15,2047,catalytic activity, acting on a protein,MF,FGFR3;BIRC5;FGF1;FBXO2;MYRF;PDGFRA;ESPL1;DTL;CNDP1;BUB1B;KLK6;PBK;BUB1;CDK1;UBE2C
5869,GO:0016459,0.385081133970932,0.915855491768496,1,61,myosin complex,CC,MYBPC1
6839,GO:0021675,0.3852537797788,0.915620629930072,1,70,nerve development,BP,LPAR1
2836,GO:0005902,0.385652922185798,0.915401114222419,1,72,microvillus,CC,USH1C
18018,GO:0098771,0.385828057894688,0.777194255682132,5,624,inorganic ion homeostasis,BP,TF;SPX;APLNR;PDGFRA;LPAR1
19885,GO:1903779,0.385920977053387,0.915316674342827,1,69,regulation of cardiac conduction,BP,FXYD1
13836,GO:0051341,0.386211743786967,0.915067989407062,1,77,regulation of oxidoreductase activity,BP,S100A1
16196,GO:0071260,0.386444924981304,0.914968550688616,1,76,cellular response to mechanical stimulus,BP,MAG
12213,GO:0045860,0.386511548048805,0.792770477284565,4,478,positive regulation of protein kinase activity,BP,TPX2;FGF1;CDK1;LPAR1
21237,GO:2000177,0.386973181838811,0.91478243908519,1,71,regulation of neural precursor cell proliferation,BP,ASPM
2484,GO:0005201,0.387353277480155,0.914677765326704,1,66,extracellular matrix structural constituent,MF,HAPLN2
8855,GO:0033138,0.387760521808682,0.914335805930959,1,76,positive regulation of peptidyl-serine phosphorylation,BP,SFRP2
568,GO:0001667,0.387878142640914,0.814483806584602,3,332,ameboidal-type cell migration,BP,FGF1;ENPP2;CRB2
14650,GO:0060291,0.388112415024021,0.91424886963048,1,70,long-term synaptic potentiation,BP,GFAP
9450,GO:0034644,0.388233089116032,0.914133955082181,1,74,cellular response to UV,BP,PBK
5907,GO:0016528,0.388671604723075,0.914009928868693,1,68,sarcoplasm,CC,S100A1
6877,GO:0021766,0.389603587526079,0.913498727605052,1,72,hippocampus development,BP,EMX2
8197,GO:0032101,0.389753605465893,0.774009077478504,5,643,regulation of response to external stimulus,BP,FGF1;SPX;PDGFRA;PBK;LPAR1
14413,GO:0055072,0.390410836934709,0.913039946253627,1,77,iron ion homeostasis,BP,TF
18479,GO:0120114,0.390474138259266,0.912984742027089,1,79,Sm-like protein family complex,CC,NWD1
13379,GO:0050660,0.390563247290465,0.912965799972165,1,77,flavin adenine dinucleotide binding,MF,AIFM3
16648,GO:0072028,0.391681549999975,0.91248798874275,1,72,nephron morphogenesis,BP,FGF1
12924,GO:0048145,0.392784232531903,0.911893868002877,1,76,regulation of fibroblast proliferation,BP,PDGFRA
15250,GO:0061333,0.392819387950713,0.9119315651019,1,72,renal tubule morphogenesis,BP,FGF1
14424,GO:0055085,0.392833626216584,0.72960654813333,10,1347,transmembrane transport,BP,SLCO1A2;SNTA1;HSPA2;APLNR;SLC14A1;SLC5A11;S100A1;TMEM144;AQP4;FXYD1
18830,GO:1901216,0.39297973792902,0.911811200557685,1,75,positive regulation of neuron death,BP,MYBL2
13495,GO:0050810,0.393216055066314,0.911669190331364,1,77,regulation of steroid biosynthetic process,BP,FGF1
8476,GO:0032535,0.393569176341098,0.810258865234757,3,335,regulation of cellular component size,BP,USH1C;MAG;CNTN2
5700,GO:0016101,0.393959762413195,0.911303634309677,1,77,diterpenoid metabolic process,BP,ALDH1A1
7798,GO:0031324,0.394311188012818,0.707046003287797,16,2239,negative regulation of cellular metabolic process,BP,HHATL;BIRC5;SNTA1;FOXM1;CENPF;PPP1R1B;SFRP2;CRB2;NKX6-2;S100A1;PI16;PPP1R14A;PBK;SOX11;ZNF536;FXYD1
3655,GO:0007193,0.395326166842652,0.910642649814733,1,76,adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,BP,LPAR1
5136,GO:0014033,0.395476887054467,0.910581485994653,1,75,neural crest cell differentiation,BP,SOX11
14754,GO:0060419,0.395523633650274,0.910572090204263,1,74,heart growth,BP,CDK1
7168,GO:0030133,0.395736248943432,0.808605479598856,3,354,transport vesicle,CC,FGFR3;SPX;LGI3
517,GO:0001570,0.395983515780596,0.910358638463707,1,73,vasculogenesis,BP,APLNR
3307,GO:0006629,0.39638227990233,0.732053418900993,9,1238,lipid metabolic process,BP,FGFR3;CPNE6;PTGDS;FGF1;PLP1;PDGFRA;ENPP2;ETNPPL;ALDH1A1
2596,GO:0005496,0.396820107397635,0.909889266447715,1,77,steroid binding,MF,PAQR6
12923,GO:0048144,0.396889323689286,0.909854874857403,1,77,fibroblast proliferation,BP,PDGFRA
19288,GO:1902476,0.397495994036334,0.909579730224194,1,75,chloride transmembrane transport,BP,FXYD1
8506,GO:0032588,0.397954519381598,0.909299284557764,1,79,trans-Golgi network membrane,CC,CALN1
18558,GO:1900034,0.398360643490011,0.90914870091825,1,75,regulation of cellular response to heat,BP,HSPB8
2851,GO:0005929,0.399481097203016,0.782575121380436,4,480,cilium,CC,USH1C;SEPT4;CENPF;DNAH17
8221,GO:0032153,0.399890528344264,0.908369391464928,1,76,cell division site,CC,SEPT4
471,GO:0001503,0.400323984321352,0.805184515448241,3,342,ossification,BP,FGFR3;SFRP2;SOX11
2835,GO:0005901,0.400417725949733,0.90814679649411,1,73,caveola,CC,FXYD1
3676,GO:0007218,0.400495602895893,0.907946120377232,1,86,neuropeptide signaling pathway,BP,NTSR2
13917,GO:0051492,0.40168941120517,0.907477821992536,1,75,regulation of stress fiber assembly,BP,LPAR1
3763,GO:0007423,0.40182488029805,0.780717746858015,4,476,sensory organ development,BP,USH1C;PDGFRA;FREM2;SOX11
4044,GO:0008344,0.402101988925768,0.907255658764232,1,76,adult locomotory behavior,BP,CNTN2
5209,GO:0014812,0.404002870469517,0.906320102264191,1,74,muscle cell migration,BP,LPAR1
7547,GO:0030864,0.404711142355257,0.905989458596495,1,72,cortical actin cytoskeleton,CC,MOBP
7069,GO:0022857,0.405515654761741,0.738737401165733,7,921,transmembrane transporter activity,MF,SLCO1A2;TF;SLC14A1;SLC5A11;TMEM144;AQP4;FXYD1
5091,GO:0010972,0.405760075070688,0.905273191376988,1,86,negative regulation of G2/M transition of mitotic cell cycle,BP,CDK1
11831,GO:0045069,0.406327083394887,0.905040138862714,1,81,regulation of viral genome replication,BP,TOP2A
3355,GO:0006690,0.40649619064271,0.904895775477245,1,86,icosanoid metabolic process,BP,PTGDS
9012,GO:0033559,0.406883262939237,0.904696956185927,1,86,unsaturated fatty acid metabolic process,BP,PTGDS
11292,GO:0043506,0.40695688191152,0.904768483368739,1,77,regulation of JUN kinase activity,BP,SFRP2
19602,GO:1903214,0.406965885004487,0.904700125453957,1,82,regulation of protein targeting to mitochondrion,BP,MYBPC1
10786,GO:0042562,0.407697734434259,0.904323587382527,1,82,hormone binding,MF,ALDH1A1
19316,GO:1902554,0.40899543241136,0.903678492938984,1,80,serine/threonine protein kinase complex,CC,CDK1
755,GO:0001938,0.409032066249033,0.903685598151973,1,78,positive regulation of endothelial cell proliferation,BP,APLNR
15704,GO:0070301,0.409939693158407,0.903164522038946,1,82,cellular response to hydrogen peroxide,BP,CDK1
1869,GO:0004197,0.410267247766975,0.903006783361732,1,81,cysteine-type endopeptidase activity,MF,ESPL1
4617,GO:0009887,0.411155115672633,0.733893430232068,7,905,animal organ morphogenesis,BP,USH1C;FGFR3;FGF1;PDGFRA;SFRP2;CRB2;SOX11
8364,GO:0032392,0.412734830433293,0.90173287889753,1,80,DNA geometric change,BP,TOP2A
2635,GO:0005578,0.413226934666149,0.795368137606145,3,337,proteinaceous extracellular matrix,CC,FGF1;HAPLN2;FREM2
3972,GO:0008233,0.413254719798279,0.771505764827654,4,510,peptidase activity,MF,MYRF;ESPL1;CNDP1;KLK6
7145,GO:0030100,0.413372797369606,0.832390890748543,2,215,regulation of endocytosis,BP,TF;PACSIN1
11655,GO:0044449,0.413711095103553,0.832231414548452,2,196,contractile fiber part,CC,S100A1;MYBPC1
3889,GO:0008094,0.41489579286823,0.900624579766604,1,78,DNA-dependent ATPase activity,MF,TOP2A
3911,GO:0008135,0.415218562259362,0.900377772452815,1,84,translation factor activity, RNA binding,MF,SOX11
19734,GO:1903507,0.415364770586865,0.72213624888293,8,1081,negative regulation of nucleic acid-templated transcription,BP,BIRC5;FOXM1;CENPF;SFRP2;NKX6-2;S100A1;SOX11;ZNF536
16148,GO:0071158,0.41539111789672,0.900286660162297,1,84,positive regulation of cell cycle arrest,BP,CDK1
3545,GO:0006998,0.415508631498672,0.900261525237817,1,81,nuclear envelope organization,BP,CDK1
2103,GO:0004620,0.415889028999245,0.900035510407929,1,83,phospholipase activity,MF,ENPP2
19364,GO:1902679,0.417062481962826,0.72064556626086,8,1083,negative regulation of RNA biosynthetic process,BP,BIRC5;FOXM1;CENPF;SFRP2;NKX6-2;S100A1;SOX11;ZNF536
17978,GO:0098662,0.417449918759042,0.751191798075806,5,637,inorganic cation transmembrane transport,BP,SNTA1;HSPA2;APLNR;S100A1;FXYD1
9491,GO:0034703,0.417993020612174,0.829188389907201,2,204,cation channel complex,CC,HSPA2;CNTN2
21209,GO:2000116,0.420290303996492,0.827476367631592,2,227,regulation of cysteine-type endopeptidase activity,BP,BIRC5;SFRP2
15299,GO:0061448,0.4204671723119,0.827390076670852,2,216,connective tissue development,BP,FGFR3;SFRP2
11634,GO:0044421,0.420859543752226,0.671314393241844,22,3280,extracellular region part,CC,CRLF1;CLDN11;BCAS1;TPX2;TF;CPNE6;PTGDS;FGF1;FBXO2;HSPA2;HAPLN2;SPX;ERMN;ENPP2;SFRP2;DAAM2;CRB2;FREM2;PI16;ALDH1A1;KLK6;CDK1
8228,GO:0032182,0.421433046324475,0.897076878696597,1,83,ubiquitin-like protein binding,MF,TOP2A
18453,GO:0120039,0.421933263856489,0.747445198913883,5,611,plasma membrane bounded cell projection morphogenesis,BP,CPNE6;MAG;PACSIN1;ENPP2;CNTN2
3376,GO:0006721,0.421989273588103,0.89675267219751,1,85,terpenoid metabolic process,BP,ALDH1A1
13653,GO:0051052,0.422218808045406,0.788353303111157,3,358,regulation of DNA metabolic process,BP,FOXM1;PDGFRA;CDK1
7077,GO:0022904,0.422377451743448,0.896417301100145,1,97,respiratory electron transport chain,BP,CDK1
13257,GO:0048858,0.423088198452842,0.746469863731202,5,612,cell projection morphogenesis,BP,CPNE6;MAG;PACSIN1;ENPP2;CNTN2
2513,GO:0005253,0.42341246276468,0.896007826102907,1,83,anion channel activity,MF,FXYD1
3466,GO:0006874,0.423539815704072,0.787314478845044,3,361,cellular calcium ion homeostasis,BP,APLNR;PDGFRA;LPAR1
3783,GO:0007517,0.424540430926606,0.786563824011544,3,344,muscle organ development,BP,CENPF;CDK1;SOX11
20915,GO:1990204,0.424601991202433,0.895229203172581,1,95,oxidoreductase complex,CC,RRM2
3881,GO:0008081,0.424603308706647,0.895374267882624,1,82,phosphoric diester hydrolase activity,MF,ENPP2
7955,GO:0031623,0.424745785486497,0.895259142663583,1,85,receptor internalization,BP,CNTN2
5314,GO:0015108,0.425508864776676,0.894881147676729,1,82,chloride transmembrane transporter activity,MF,FXYD1
2837,GO:0005903,0.425793660403674,0.894752558456886,1,80,brush border,CC,USH1C
7106,GO:0030016,0.425930695156239,0.823553014922584,2,201,myofibril,CC,S100A1;MYBPC1
6476,GO:0019233,0.425951381892914,0.8946141333593,1,84,sensory perception of pain,BP,SPX
21821,GO:2001243,0.426060977434325,0.894484464149913,1,90,negative regulation of intrinsic apoptotic signaling pathway,BP,SFRP2
2972,GO:0006119,0.426105252253465,0.894380498621314,1,98,oxidative phosphorylation,BP,CDK1
17948,GO:0098609,0.426222051529491,0.743788138410542,5,647,cell-cell adhesion,BP,CLDN11;MAG;PDGFRA;CRB2;MBP
12304,GO:0046034,0.426699648018844,0.822875870771597,2,234,ATP metabolic process,BP,AK5;CDK1
1604,GO:0003690,0.426777040119813,0.730417234234383,6,793,double-stranded DNA binding,MF,MCM10;MYBL2;FOXM1;NKX6-2;SOX11;ZNF536
9518,GO:0034754,0.427328549323788,0.893779278197395,1,91,cellular hormone metabolic process,BP,ALDH1A1
12446,GO:0046394,0.427667219413415,0.78404828253697,3,374,carboxylic acid biosynthetic process,BP,PTGDS;PLP1;CARNS1
4641,GO:0009953,0.427879187311236,0.89353338919034,1,86,dorsal/ventral pattern formation,BP,NKX6-2
12556,GO:0046620,0.428169691614615,0.893424010544359,1,82,regulation of organ growth,BP,CDK1
13961,GO:0051588,0.42843166509513,0.893254068526943,1,84,regulation of neurotransmitter transport,BP,GFAP
437,GO:0001158,0.429047546968974,0.892902212932287,1,85,enhancer sequence-specific DNA binding,MF,SOX11
2486,GO:0005215,0.42907593972638,0.710028930909405,8,1089,transporter activity,MF,SLCO1A2;TF;CPNE6;SLC14A1;SLC5A11;TMEM144;AQP4;FXYD1
809,GO:0002009,0.429229763269952,0.758453086108148,4,496,morphogenesis of an epithelium,BP,FGF1;SFRP2;FREM2;SOX11
4820,GO:0010595,0.429244647395123,0.892818751596161,1,83,positive regulation of endothelial cell migration,BP,FGF1
7705,GO:0031124,0.429267191427347,0.892745222542009,1,88,mRNA 3'-end processing,BP,FIP1L1
5677,GO:0016053,0.42929309349908,0.782763146819312,3,375,organic acid biosynthetic process,BP,PTGDS;PLP1;CARNS1
19784,GO:1903578,0.429637717972386,0.892601702432966,1,83,regulation of ATP metabolic process,BP,CDK1
5826,GO:0016358,0.429653249909632,0.820850629397889,2,206,dendrite development,BP,PACSIN1;LPAR1
558,GO:0001656,0.429689167944098,0.892599874794933,1,81,metanephros development,BP,PDGFRA
11484,GO:0044092,0.429854655160275,0.717569975532025,7,962,negative regulation of molecular function,BP,BIRC5;PPP1R1B;SFRP2;CRB2;PI16;PPP1R14A;SOX11
18425,GO:0110020,0.431005977026105,0.891870832281332,1,81,regulation of actomyosin structure organization,BP,LPAR1
2279,GO:0004860,0.432079761835223,0.891173814149265,1,89,protein kinase inhibitor activity,MF,PPP1R1B
8746,GO:0032947,0.432775450816172,0.890900415774078,1,80,protein-containing complex scaffold activity,MF,SEPT4
11892,GO:0045165,0.434649804457065,0.817152456246058,2,223,cell fate commitment,BP,SFRP2;NKX6-2
3921,GO:0008150,0.434906685124986,0.716940509721398,93,14255,biological_process,BP,CRLF1;USH1C;HHATL;CLDN11;KIFC1;MCM10;ASPM;FGFR3;DCX;SLCO1A2;TPX2;BIRC5;TF;CPNE6;MYBL2;SNTA1;MAG;PTGDS;SEPT4;NCAPG;FOXM1;FGF1;FBXO2;CENPF;NECAB1;PLP1;PACSIN1;MYRF;HSPA2;EVI2A;GFAP;TOP2A;PPP1R1B;HAPLN2;SPX;APLNR;PDGFRA;ESPL1;ERMN;ENPP2;MOG;NUSAP1;SLC14A1;DTL;FIP1L1;SFRP2;DAAM2;CRB2;MKI67;NKX6-2;CNDP1;FREM2;HSPB8;AK5;BUB1B;SLC5A11;S100A1;PAQR6;ETNPPL;TMEM144;PI16;KIF6;ALDH1A1;PPP1R14A;KLK6;PBK;FAM107A;MOBP;LGI3;NTSR2;BUB1;CDK1;EMX2;RRM2;AQP4;MAL;CARNS1;UBE2C;SOX11;TMEM125;S1PR5;GPR62;HS3ST4;AIFM3;CNTN2;DNAH17;NWD1;NKAIN2;MYBPC1;MBP;LPAR1;ZNF536;FXYD1
3877,GO:0008076,0.434985471031156,0.889583524622384,1,86,voltage-gated potassium channel complex,CC,CNTN2
11030,GO:0043062,0.435124240498055,0.7781761636948,3,352,extracellular structure organization,BP,GFAP;HAPLN2;SFRP2
2911,GO:0006029,0.436126268037102,0.88897989573619,1,83,proteoglycan metabolic process,BP,HS3ST4
4188,GO:0008585,0.436279582115848,0.888867322290641,1,85,female gonad development,BP,PDGFRA
5404,GO:0015294,0.43650005009716,0.888755790814571,1,84,solute:cation symporter activity,MF,SLC5A11
8361,GO:0032388,0.437010373966404,0.815420210569318,2,224,positive regulation of intracellular transport,BP,CDK1;MYBPC1
10312,GO:0036503,0.437323893752408,0.888228207159215,1,89,ERAD pathway,BP,FBXO2
13555,GO:0050896,0.437387558570016,0.640249227679738,49,7357,response to stimulus,BP,CRLF1;MCM10;ASPM;FGFR3;DCX;TPX2;BIRC5;TF;CPNE6;MYBL2;MAG;SEPT4;FOXM1;FGF1;FBXO2;CENPF;PLP1;HSPA2;EVI2A;GFAP;TOP2A;PPP1R1B;SPX;APLNR;PDGFRA;ENPP2;MOG;DTL;SFRP2;DAAM2;CRB2;HSPB8;S100A1;PAQR6;PPP1R14A;KLK6;PBK;NTSR2;CDK1;EMX2;AQP4;MAL;SOX11;S1PR5;GPR62;CNTN2;MBP;LPAR1;ZNF536
1595,GO:0003674,0.437833182373384,0.714486465400247,93,14275,molecular_function,MF,CRLF1;USH1C;CLDN11;KIFC1;MCM10;ASPM;FGFR3;DCX;SLCO1A2;TPX2;BIRC5;TF;CPNE6;MYBL2;SNTA1;MAG;PTGDS;SEPT4;NCAPG;FOXM1;FGF1;FBXO2;CENPF;NECAB1;PLP1;PACSIN1;MYRF;HSPA2;EVI2A;GFAP;TOP2A;PPP1R1B;IQCA1;HAPLN2;SPX;APLNR;PDGFRA;ESPL1;ERMN;ENPP2;MOG;NUSAP1;SLC14A1;DTL;FIP1L1;SFRP2;DAAM2;CRB2;MKI67;NKX6-2;CNDP1;FREM2;HSPB8;AK5;BUB1B;SLC5A11;S100A1;PAQR6;ETNPPL;TMEM144;PI16;KIF6;ALDH1A1;PPP1R14A;KLK6;PBK;FAM107A;MOBP;LGI3;NTSR2;BUB1;CDK1;EMX2;RRM2;AQP4;MAL;CARNS1;UBE2C;SOX11;TMEM125;S1PR5;GPR62;HS3ST4;CALN1;AIFM3;CNTN2;DNAH17;NWD1;MYBPC1;MBP;LPAR1;ZNF536;FXYD1
21158,GO:2000027,0.437933009156624,0.814717379474585,2,231,regulation of organ morphogenesis,BP,FGF1;SFRP2
13669,GO:0051087,0.437996663303499,0.887846819991136,1,89,chaperone binding,MF,BIRC5
13260,GO:0048863,0.438564267651025,0.814245940421588,2,233,stem cell differentiation,BP,PDGFRA;SOX11
2786,GO:0005829,0.439643694931565,0.644237681478428,31,4599,cytosol,CC,CRLF1;USH1C;DCX;TPX2;BIRC5;NCAPG;FGF1;FBXO2;CENPF;NECAB1;PACSIN1;MYRF;HSPA2;GFAP;PPP1R1B;ESPL1;DTL;CNDP1;HSPB8;AK5;BUB1B;ALDH1A1;PPP1R14A;BUB1;CDK1;RRM2;CARNS1;UBE2C;AIFM3;NWD1;MYBPC1
14470,GO:0060021,0.440523242825151,0.886483589048026,1,83,roof of mouth development,BP,SOX11
14415,GO:0055074,0.44079937534972,0.773590962172514,3,371,calcium ion homeostasis,BP,APLNR;PDGFRA;LPAR1
394,GO:0001046,0.441046388135377,0.886157650184532,1,85,core promoter sequence-specific DNA binding,MF,SOX11
7389,GO:0030516,0.441488690569061,0.885944743774625,1,82,regulation of axon extension,BP,MAG
18959,GO:1901606,0.442473312169278,0.885211184802175,1,96,alpha-amino acid catabolic process,BP,CARNS1
10824,GO:0042623,0.443331485402395,0.771593640166196,3,348,ATPase activity, coupled,MF,HSPA2;TOP2A;DNAH17
3053,GO:0006282,0.443358907128017,0.884778400954661,1,89,regulation of DNA repair,BP,FOXM1
6782,GO:0021549,0.443489579558455,0.884753237463535,1,85,cerebellum development,BP,LPAR1
4786,GO:0010522,0.443595468296722,0.88466641520817,1,87,regulation of calcium ion transport into cytosol,BP,APLNR
4332,GO:0009100,0.443899137248992,0.771088899084578,3,371,glycoprotein metabolic process,BP,FBXO2;NECAB1;HS3ST4
7121,GO:0030038,0.444193102199787,0.884333823862658,1,86,contractile actin filament bundle assembly,BP,LPAR1
11078,GO:0043149,0.444193102199787,0.884333823862658,1,86,stress fiber assembly,BP,LPAR1
8505,GO:0032587,0.444346673712645,0.884258040704185,1,85,ruffle membrane,CC,PACSIN1
16678,GO:0072080,0.44455688485211,0.884136388643178,1,85,nephron tubule development,BP,FGF1
10744,GO:0042472,0.44457701087031,0.884098912881077,1,87,inner ear morphogenesis,BP,USH1C
8774,GO:0032990,0.444977884931629,0.727719693290027,5,630,cell part morphogenesis,BP,CPNE6;MAG;PACSIN1;ENPP2;CNTN2
4942,GO:0010771,0.445940083648444,0.883320805164026,1,86,negative regulation of cell morphogenesis involved in differentiation,BP,MAG
8260,GO:0032231,0.446029170154167,0.883269000611471,1,86,regulation of actin filament bundle assembly,BP,LPAR1
691,GO:0001843,0.446338309657312,0.88310228591373,1,85,neural tube closure,BP,SFRP2
17886,GO:0097731,0.446454281909379,0.883008733177939,1,87,9+0 non-motile cilium,CC,USH1C
17888,GO:0097733,0.446454281909379,0.883008733177939,1,87,photoreceptor cell cilium,CC,USH1C
6459,GO:0019210,0.447521163760378,0.882314655953452,1,93,kinase inhibitor activity,MF,PPP1R1B
16550,GO:0071840,0.448313501916256,0.631733904542433,39,5763,cellular component organization or biogenesis,BP,USH1C;KIFC1;ASPM;TPX2;BIRC5;TF;CPNE6;MYBL2;MAG;SEPT4;NCAPG;CENPF;PLP1;PACSIN1;MYRF;HSPA2;GFAP;TOP2A;PPP1R1B;HAPLN2;PDGFRA;ESPL1;ERMN;ENPP2;NUSAP1;SFRP2;DAAM2;MKI67;BUB1B;KLK6;FAM107A;BUB1;CDK1;MAL;UBE2C;CNTN2;MYBPC1;MBP;LPAR1
11172,GO:0043292,0.448348471942086,0.807049960726615,2,212,contractile fiber,CC,S100A1;MYBPC1
14887,GO:0060606,0.449142335915066,0.881449734742896,1,86,tube closure,BP,SFRP2
3581,GO:0007050,0.449385045769203,0.806186182106476,2,234,cell cycle arrest,BP,FOXM1;CDK1
5166,GO:0014066,0.449544024243531,0.881187950060196,1,88,regulation of phosphatidylinositol 3-kinase signaling,BP,PDGFRA
12525,GO:0046545,0.450032738689457,0.880887887482582,1,89,development of primary female sexual characteristics,BP,PDGFRA
2483,GO:0005200,0.450234037253981,0.880769298026932,1,89,structural constituent of cytoskeleton,MF,GFAP
15093,GO:0060993,0.450688043697397,0.88053998467795,1,86,kidney morphogenesis,BP,FGF1
3434,GO:0006816,0.451118480201136,0.765219040886646,3,368,calcium ion transport,BP,HSPA2;APLNR;S100A1
3977,GO:0008238,0.451238162465383,0.880117943874328,1,94,exopeptidase activity,MF,CNDP1
3177,GO:0006469,0.451416772845702,0.804646960927039,2,236,negative regulation of protein kinase activity,BP,PPP1R1B;SFRP2
15249,GO:0061326,0.452531073947162,0.879436399808151,1,87,renal tubule development,BP,FGF1
13487,GO:0050801,0.454086033706391,0.719735926328925,5,676,ion homeostasis,BP,TF;SPX;APLNR;PDGFRA;LPAR1
15096,GO:0060996,0.45426016359176,0.878448600951968,1,84,dendritic spine development,BP,LPAR1
7902,GO:0031503,0.454345306154801,0.802437892870126,2,233,protein-containing complex localization,BP,BIRC5;FIP1L1
11395,GO:0043687,0.454638742396137,0.762285719360427,3,392,post-translational protein modification,BP,TF;FBXO2;DTL
21086,GO:1990823,0.454679146554197,0.878095391376384,1,92,response to leukemia inhibitory factor,BP,MYBL2
21090,GO:1990830,0.454679146554197,0.878095391376384,1,92,cellular response to leukemia inhibitory factor,BP,MYBL2
17471,GO:0090596,0.455160712365525,0.801839607268944,2,227,sensory organ morphogenesis,BP,USH1C;SOX11
3822,GO:0007611,0.455690539140319,0.801451409700848,2,223,learning or memory,BP,PPP1R1B;CNTN2
10613,GO:0042221,0.455953071956594,0.634339883332593,25,3737,response to chemical,BP,CRLF1;FGFR3;BIRC5;TF;CPNE6;MYBL2;FGF1;FBXO2;CENPF;HSPA2;PPP1R1B;SPX;PDGFRA;ENPP2;SFRP2;CRB2;PAQR6;PPP1R14A;CDK1;EMX2;AQP4;SOX11;CNTN2;MBP;LPAR1
13998,GO:0051651,0.456168723606785,0.877252902264639,1,88,maintenance of location in cell,BP,ASPM
13761,GO:0051222,0.45680444288504,0.760517410176816,3,382,positive regulation of protein transport,BP,CDK1;MYBPC1;MBP
7276,GO:0030282,0.45804492005535,0.876062180450362,1,93,bone mineralization,BP,FGFR3
8565,GO:0032675,0.458119905844803,0.875972070661319,1,97,regulation of interleukin-6 production,BP,MBP
4824,GO:0010605,0.458895432743836,0.647449254361153,16,2346,negative regulation of macromolecule metabolic process,BP,HHATL;BIRC5;SNTA1;FOXM1;CENPF;PPP1R1B;SFRP2;CRB2;NKX6-2;S100A1;PI16;PPP1R14A;PBK;SOX11;ZNF536;FXYD1
7539,GO:0030855,0.459515792534659,0.732834421628766,4,525,epithelial cell differentiation,BP,USH1C;HAPLN2;CDK1;SOX11
18647,GO:1900180,0.459792959965538,0.875004095686141,1,93,regulation of protein localization to nucleus,BP,CDK1
1608,GO:0003697,0.460154003251741,0.874750590250455,1,96,single-stranded DNA binding,MF,MCM10
6714,GO:0019955,0.460373650528957,0.874617064729312,1,96,cytokine binding,MF,CRLF1
3511,GO:0006939,0.460417553397192,0.874612991907562,1,94,smooth muscle contraction,BP,SPX
16100,GO:0071013,0.460609893775766,0.874462379863436,1,97,catalytic step 2 spliceosome,CC,NWD1
12694,GO:0046916,0.461040058371258,0.874179100623025,1,99,cellular transition metal ion homeostasis,BP,TF
12015,GO:0045446,0.461085853030855,0.874254602132791,1,90,endothelial cell differentiation,BP,HAPLN2
21815,GO:2001237,0.461367108337158,0.874023262956883,1,95,negative regulation of extrinsic apoptotic signaling pathway,BP,SFRP2
9493,GO:0034705,0.461578414110993,0.873917571922042,1,93,potassium channel complex,CC,CNTN2
17977,GO:0098661,0.461933796251766,0.873724889587714,1,91,inorganic anion transmembrane transport,BP,FXYD1
19449,GO:1902911,0.462927866996212,0.873092477263834,1,93,protein kinase complex,CC,CDK1
20299,GO:1904659,0.463128202729908,0.872981768409745,1,92,glucose transmembrane transport,BP,SLC5A11
12626,GO:0046777,0.463129359456524,0.795732723907859,2,225,protein autophosphorylation,BP,FGFR3;PDGFRA
17634,GO:0097190,0.464101569310675,0.728837195736117,4,552,apoptotic signaling pathway,BP,FGFR3;SEPT4;SFRP2;MAL
1369,GO:0003007,0.464779277179966,0.794462568257366,2,223,heart morphogenesis,BP,SFRP2;SOX11
13118,GO:0048608,0.464912778897884,0.753782159153789,3,379,reproductive structure development,BP,ASPM;PDGFRA;SFRP2
6466,GO:0019218,0.464990052666616,0.871778961920689,1,97,regulation of steroid metabolic process,BP,FGF1
3725,GO:0007338,0.465762218178832,0.871259621114945,1,101,single fertilization,BP,CDK1
21215,GO:2000134,0.466640692310828,0.870769763115371,1,96,negative regulation of G1/S transition of mitotic cell cycle,BP,CDK1
13440,GO:0050728,0.467992717019123,0.869886326327886,1,100,negative regulation of inflammatory response,BP,PBK
361,GO:0000976,0.468557591263688,0.706928547437834,5,679,transcription regulatory region sequence-specific DNA binding,MF,MYBL2;FOXM1;NKX6-2;SOX11;ZNF536
7013,GO:0022037,0.468873347948198,0.86942942114033,1,92,metencephalon development,BP,LPAR1
4213,GO:0008630,0.469068665961631,0.86922626056996,1,99,intrinsic apoptotic signaling pathway in response to DNA damage,BP,SFRP2
15301,GO:0061458,0.469658711670952,0.74979092137801,3,382,reproductive system development,BP,ASPM;PDGFRA;SFRP2
21207,GO:2000113,0.469864875689645,0.665931105438033,9,1278,negative regulation of cellular macromolecule biosynthetic process,BP,HHATL;BIRC5;FOXM1;CENPF;SFRP2;NKX6-2;S100A1;SOX11;ZNF536
13429,GO:0050715,0.469914910316082,0.868686503992858,1,100,positive regulation of cytokine secretion,BP,MBP
326,GO:0000902,0.470174094297816,0.681350898868846,7,939,cell morphogenesis,BP,CPNE6;MAG;PACSIN1;ERMN;ENPP2;CNTN2;LPAR1
2625,GO:0005543,0.470241696669879,0.749304922757246,3,379,phospholipid binding,MF,CPNE6;PACSIN1;LPAR1
8871,GO:0033157,0.47055721246191,0.789889514938488,2,240,regulation of intracellular protein transport,BP,CDK1;MYBPC1
5130,GO:0014020,0.471008893528236,0.868093283332521,1,92,primary neural tube formation,BP,SFRP2
22,GO:0000041,0.471146114656721,0.867914359752373,1,100,transition metal ion transport,BP,TF
3437,GO:0006821,0.47122665202591,0.867919920619558,1,95,chloride transport,BP,FXYD1
16904,GO:0072503,0.472628080487292,0.747263789227366,3,392,cellular divalent inorganic cation homeostasis,BP,APLNR;PDGFRA;LPAR1
13080,GO:0048524,0.472732478356487,0.866915283283958,1,100,positive regulation of viral process,BP,TOP2A
4648,GO:0009968,0.473239999170826,0.669908330121103,8,1142,negative regulation of signal transduction,BP,FGFR3;FOXM1;APLNR;PDGFRA;SFRP2;PBK;LPAR1;ZNF536
11168,GO:0043279,0.473246226789327,0.866635545271679,1,96,response to alkaloid,BP,PPP1R1B
7201,GO:0030175,0.473445571503982,0.866584304475645,1,90,filopodium,CC,ERMN
3701,GO:0007267,0.473840141369514,0.65620391062252,10,1434,cell-cell signaling,BP,ASPM;FGFR3;CPNE6;PLP1;GFAP;SFRP2;DAAM2;SOX11;CNTN2;MBP
11773,GO:0044853,0.474119032589559,0.866119441137216,1,93,plasma membrane raft,CC,FXYD1
10996,GO:0043009,0.474909398167753,0.719417963605995,4,527,chordate embryonic development,BP,PDGFRA;SFRP2;CRB2;SOX11
3685,GO:0007229,0.475978184536065,0.864925828922168,1,94,integrin-mediated signaling pathway,BP,PLP1
19408,GO:1902807,0.476175169926918,0.864741787947903,1,99,negative regulation of cell cycle G1/S phase transition,BP,CDK1
4219,GO:0008645,0.476246269211133,0.864730816025079,1,96,hexose transmembrane transport,BP,SLC5A11
20456,GO:1904949,0.476844405778157,0.86436099313169,1,95,ATPase complex,CC,FXYD1
7454,GO:0030665,0.477621641382127,0.863817328827506,1,99,clathrin-coated vesicle membrane,CC,TF
8409,GO:0032446,0.477965055141217,0.684828235547733,6,844,protein modification by small protein conjugation,BP,BIRC5;SEPT4;FBXO2;TOP2A;DTL;UBE2C
7098,GO:0030003,0.478314496064582,0.716389815577473,4,547,cellular cation homeostasis,BP,TF;APLNR;PDGFRA;LPAR1
17877,GO:0097711,0.478772902751519,0.863113425530692,1,96,ciliary basal body-plasma membrane docking,BP,CDK1
11737,GO:0044773,0.478899843799499,0.862985986949587,1,100,mitotic DNA damage checkpoint,BP,CDK1
19293,GO:1902494,0.47939568446507,0.657015765003318,9,1316,catalytic complex,CC,FBXO2;DTL;BUB1B;CDK1;RRM2;UBE2C;DNAH17;NWD1;FXYD1
12301,GO:0046031,0.479783758039133,0.862439457223324,1,98,ADP metabolic process,BP,AK5
19504,GO:1903008,0.480110382358912,0.86220625791221,1,100,organelle disassembly,BP,CDK1
6873,GO:0021761,0.48038811163979,0.862073103938289,1,96,limbic system development,BP,EMX2
19864,GO:1903749,0.480448350738568,0.861945482270445,1,104,positive regulation of establishment of protein localization to mitochondrion,BP,MYBPC1
5526,GO:0015749,0.480632342084034,0.861903465117604,1,97,monosaccharide transmembrane transport,BP,SLC5A11
9070,GO:0033673,0.481295799212855,0.78133628171324,2,250,negative regulation of kinase activity,BP,PPP1R1B;SFRP2
4842,GO:0010631,0.481435129876163,0.781266653466544,2,238,epithelial cell migration,BP,FGF1;ENPP2
3375,GO:0006720,0.481442087327772,0.861312873513973,1,103,isoprenoid metabolic process,BP,ALDH1A1
1516,GO:0003279,0.482507320342635,0.860738125510606,1,93,cardiac septum development,BP,SOX11
9686,GO:0035326,0.482726428622726,0.860522934480466,1,99,enhancer binding,MF,SOX11
12638,GO:0046822,0.483033815811847,0.860346269810139,1,97,regulation of nucleocytoplasmic transport,BP,CDK1
17243,GO:0090132,0.483141773963286,0.779892296122995,2,239,epithelium migration,BP,FGF1;ENPP2
4421,GO:0009205,0.483966360756967,0.779151244653421,2,262,purine ribonucleoside triphosphate metabolic process,BP,AK5;CDK1
3097,GO:0006353,0.484903402983963,0.85901773115492,1,107,DNA-templated transcription, termination,BP,FIP1L1
8538,GO:0032635,0.486332236653499,0.858100386604021,1,105,interleukin-6 production,BP,MBP
13664,GO:0051082,0.486438059856052,0.858000818755378,1,108,unfolded protein binding,MF,HSPA2
7918,GO:0031532,0.486827710752139,0.857828468175875,1,100,actin cytoskeleton reorganization,BP,PDGFRA
366,GO:0000981,0.487575801934449,0.6652166947155,7,1002,RNA polymerase II transcription factor activity, sequence-specific DNA binding,MF,MYBL2;FOXM1;MYRF;NKX6-2;EMX2;SOX11;ZNF536
9423,GO:0034599,0.488144016409212,0.775783010862991,2,258,cellular response to oxidative stress,BP,PDGFRA;CDK1
10758,GO:0042493,0.488467330845235,0.675144895579619,6,869,response to drug,BP,CENPF;PPP1R1B;SFRP2;PPP1R14A;CDK1;EMX2
12534,GO:0046578,0.490125645606793,0.774262569677666,2,232,regulation of Ras protein signal transduction,BP,FOXM1;LPAR1
13784,GO:0051253,0.49043139508159,0.653830051024041,8,1156,negative regulation of RNA metabolic process,BP,BIRC5;FOXM1;CENPF;SFRP2;NKX6-2;S100A1;SOX11;ZNF536
2657,GO:0005604,0.49052051594848,0.855541804192374,1,88,basement membrane,CC,FREM2
15279,GO:0061387,0.491906572215219,0.854508834335062,1,96,regulation of extent of cell growth,BP,MAG
2664,GO:0005615,0.492002735519254,0.6070184746233,20,3093,extracellular space,CC,CRLF1;CLDN11;BCAS1;TF;CPNE6;PTGDS;FGF1;FBXO2;HSPA2;SPX;ERMN;ENPP2;SFRP2;DAAM2;CRB2;FREM2;PI16;ALDH1A1;KLK6;CDK1
5798,GO:0016298,0.492315743696808,0.854131831459925,1,105,lipase activity,MF,ENPP2
17241,GO:0090130,0.492524893830036,0.772256136211612,2,244,tissue migration,BP,FGF1;ENPP2
6161,GO:0017015,0.492866824973131,0.853841883683949,1,98,regulation of transforming growth factor beta receptor signaling pathway,BP,SOX11
7057,GO:0022838,0.493291853094298,0.729483905341629,3,389,substrate-specific channel activity,MF,SLC14A1;AQP4;FXYD1
10119,GO:0036064,0.493474088345793,0.853399429946919,1,101,ciliary basal body,CC,CENPF
4307,GO:0009063,0.493541646365155,0.853259698180841,1,110,cellular amino acid catabolic process,BP,CARNS1
4163,GO:0008528,0.494291457604846,0.852727321086643,1,113,G-protein coupled peptide receptor activity,MF,NTSR2
14513,GO:0060071,0.49442710288993,0.852704289043342,1,106,Wnt signaling pathway, planar cell polarity pathway,BP,SFRP2
3465,GO:0006873,0.49484563296026,0.701591964813849,4,558,cellular ion homeostasis,BP,TF;APLNR;PDGFRA;LPAR1
363,GO:0000978,0.49543089219915,0.727587908351975,3,401,RNA polymerase II proximal promoter sequence-specific DNA binding,MF,MYBL2;NKX6-2;ZNF536
3134,GO:0006406,0.495605162671073,0.851931086855231,1,104,mRNA export from nucleus,BP,FIP1L1
16308,GO:0071427,0.495605162671073,0.851931086855231,1,104,mRNA-containing ribonucleoprotein complex export from nucleus,BP,FIP1L1
16634,GO:0072009,0.495654389072345,0.85195488270063,1,99,nephron epithelium development,BP,FGF1
4415,GO:0009199,0.49624639708137,0.769116525095574,2,268,ribonucleoside triphosphate metabolic process,BP,AK5;CDK1
6416,GO:0019079,0.496563854603333,0.851261201446718,1,106,viral genome replication,BP,TOP2A
11863,GO:0045111,0.497122693090793,0.850937465363071,1,101,intermediate filament cytoskeleton,CC,GFAP
4368,GO:0009144,0.497331858650983,0.768216613339293,2,269,purine nucleoside triphosphate metabolic process,BP,AK5;CDK1
555,GO:0001653,0.497595190101611,0.850483126207312,1,114,peptide receptor activity,MF,NTSR2
5829,GO:0016363,0.49788672273986,0.850407096670211,1,102,nuclear matrix,CC,CENPF
4715,GO:0010256,0.498198008922034,0.72517292101477,3,391,endomembrane system organization,BP,PACSIN1;MYRF;CDK1
12678,GO:0046887,0.498563381786876,0.849861888930993,1,110,positive regulation of hormone secretion,BP,SOX11
19916,GO:1903844,0.498779119458991,0.849822861749111,1,100,regulation of cellular response to transforming growth factor beta stimulus,BP,SOX11
8853,GO:0033135,0.49884130939984,0.849723846465639,1,105,regulation of peptidyl-serine phosphorylation,BP,SFRP2
283,GO:0000784,0.499295237174038,0.849414092078004,1,105,nuclear chromosome, telomeric region,CC,CDK1
17974,GO:0098657,0.499373887037768,0.678887371607973,5,706,import into cell,BP,TF;PACSIN1;GFAP;ENPP2;CNTN2
12587,GO:0046660,0.499646329602263,0.849207638518218,1,102,female sex differentiation,BP,PDGFRA
423,GO:0001104,0.499734273089,0.849159111418328,1,101,RNA polymerase II transcription cofactor activity,MF,SOX11
14707,GO:0060359,0.499835349648952,0.84903427104672,1,106,response to ammonium ion,BP,PPP1R1B
8754,GO:0032963,0.500377388774892,0.848696111727841,1,103,collagen metabolic process,BP,KLK6
16348,GO:0071482,0.500590936284103,0.84851691957749,1,106,cellular response to light stimulus,BP,PBK
16907,GO:0072507,0.500829738798248,0.722818006382135,3,408,divalent inorganic cation homeostasis,BP,APLNR;PDGFRA;LPAR1
10604,GO:0042177,0.501011332184349,0.848239352135204,1,105,negative regulation of protein catabolic process,BP,PBK
17270,GO:0090175,0.501144195201315,0.848116430485052,1,108,regulation of establishment of planar polarity,BP,SFRP2
4596,GO:0009792,0.501360712278158,0.695689587582381,4,545,embryo development ending in birth or egg hatching,BP,PDGFRA;SFRP2;CRB2;SOX11
3718,GO:0007292,0.501373737364814,0.847990520871377,1,105,female gamete generation,BP,ASPM
17226,GO:0090101,0.502049426317746,0.847571282274391,1,101,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,SFRP2
5662,GO:0016032,0.502065713691176,0.676367774253879,5,736,viral process,BP,TOP2A;PDGFRA;MOG;BUB1;CDK1
15901,GO:0070647,0.502109254426928,0.651545267618814,7,1010,protein modification by small protein conjugation or removal,BP,BIRC5;SEPT4;FBXO2;TOP2A;DTL;CDK1;UBE2C
10932,GO:0042826,0.502182661571821,0.847445186588681,1,104,histone deacetylase binding,MF,TOP2A
17371,GO:0090305,0.502430611667783,0.76399074646658,2,265,nucleic acid phosphodiester bond hydrolysis,BP,ENPP2;FIP1L1
13756,GO:0051209,0.502460703172106,0.847312207994936,1,99,release of sequestered calcium ion into cytosol,BP,APLNR
13805,GO:0051283,0.502460703172106,0.847312207994936,1,99,negative regulation of sequestering of calcium ion,BP,APLNR
7318,GO:0030334,0.50453282205128,0.674102684661239,5,697,regulation of cell migration,BP,FGF1;PDGFRA;ENPP2;SFRP2;LPAR1
12902,GO:0048037,0.504693115298911,0.719347668337563,3,433,cofactor binding,MF,ETNPPL;ALDH1A1;AIFM3
15130,GO:0061041,0.505300815095167,0.845245091170509,1,108,regulation of wound healing,BP,PDGFRA
10700,GO:0042391,0.505495265339809,0.718692668043209,3,398,regulation of membrane potential,BP,SNTA1;NTSR2;FXYD1
13804,GO:0051282,0.505716460944506,0.845046446573707,1,100,regulation of sequestering of calcium ion,BP,APLNR
15745,GO:0070372,0.505725140931632,0.761246286754335,2,260,regulation of ERK1 and ERK2 cascade,BP,FGFR3;PDGFRA
4544,GO:0009611,0.506264680829394,0.691182392450252,4,562,response to wounding,BP,GFAP;PDGFRA;KLK6;CDK1
10743,GO:0042471,0.506763429608047,0.844247889760895,1,106,ear morphogenesis,BP,USH1C
753,GO:0001936,0.507038371449466,0.844066970933711,1,105,regulation of endothelial cell proliferation,BP,APLNR
11005,GO:0043021,0.507693106789317,0.843566363676864,1,109,ribonucleoprotein complex binding,MF,TF
404,GO:0001077,0.508191484093897,0.759181750233437,2,256,transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding,MF,MYBL2;SOX11
21601,GO:2000736,0.509036614692858,0.842565228578773,1,115,regulation of stem cell differentiation,BP,PDGFRA
17637,GO:0097193,0.510844545354965,0.756893135334318,2,269,intrinsic apoptotic signaling pathway,BP,SEPT4;SFRP2
13683,GO:0051101,0.510992984926586,0.841235678129852,1,110,regulation of DNA binding,BP,SOX11
20458,GO:1904951,0.511456151382333,0.713321647873186,3,417,positive regulation of establishment of protein localization,BP,CDK1;MYBPC1;MBP
2989,GO:0006165,0.511515538343409,0.840876592607267,1,109,nucleoside diphosphate phosphorylation,BP,AK5
8909,GO:0033218,0.51314147112052,0.754932810869912,2,271,amide binding,MF,MAG;FBXO2
2839,GO:0005911,0.513231019712263,0.711755169557001,3,399,cell-cell junction,CC,CLDN11;OPALIN;FXYD1
17976,GO:0098660,0.514169722122881,0.665062081916907,5,710,inorganic ion transmembrane transport,BP,SNTA1;HSPA2;APLNR;S100A1;FXYD1
16841,GO:0072330,0.514213746260967,0.754026970472185,2,268,monocarboxylic acid biosynthetic process,BP,PTGDS;PLP1
13755,GO:0051208,0.515534093356804,0.838084342645349,1,103,sequestering of calcium ion,BP,APLNR
19755,GO:1903533,0.515925862852836,0.83768519386232,1,114,regulation of protein targeting,BP,MYBPC1
3739,GO:0007368,0.516283374595066,0.837490614892746,1,108,determination of left/right symmetry,BP,DAAM2
19862,GO:1903747,0.51676558511221,0.837072894409989,1,115,regulation of establishment of protein localization to mitochondrion,BP,MYBPC1
4390,GO:0009167,0.5175042001889,0.751179190066723,2,277,purine ribonucleoside monophosphate metabolic process,BP,AK5;CDK1
12060,GO:0045598,0.518324886713997,0.835990018648761,1,111,regulation of fat cell differentiation,BP,SFRP2
369,GO:0000987,0.518489476585443,0.70696605460106,3,414,proximal promoter sequence-specific DNA binding,MF,MYBL2;NKX6-2;ZNF536
7546,GO:0030863,0.519030261070425,0.835594788941756,1,101,cortical cytoskeleton,CC,MOBP
15981,GO:0070838,0.519089466829655,0.706429152265738,3,409,divalent metal ion transport,BP,HSPA2;APLNR;S100A1
4350,GO:0009126,0.519144857793939,0.749763351047923,2,278,purine nucleoside monophosphate metabolic process,BP,AK5;CDK1
8401,GO:0032434,0.519442592917267,0.835161737085005,1,113,regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,PBK
5390,GO:0015267,0.520021557314229,0.705583901402261,3,407,channel activity,MF,SLC14A1;AQP4;FXYD1
7048,GO:0022803,0.520021557314229,0.705583901402261,3,407,passive transmembrane transporter activity,MF,SLC14A1;AQP4;FXYD1
13550,GO:0050890,0.520598300583605,0.748589806368633,2,253,cognition,BP,PPP1R1B;CNTN2
17972,GO:0098655,0.520651978200619,0.658922747307943,5,719,cation transmembrane transport,BP,SNTA1;HSPA2;APLNR;S100A1;FXYD1
3800,GO:0007568,0.520953591430591,0.748234737694383,2,267,aging,BP,FOXM1;CDK1
7732,GO:0031214,0.522973665628412,0.832602621876298,1,112,biomineral tissue development,BP,FGFR3
16910,GO:0072511,0.523665876268564,0.702244267551428,3,412,divalent inorganic cation transport,BP,HSPA2;APLNR;S100A1
11268,GO:0043467,0.523820343953145,0.832025806610075,1,108,regulation of generation of precursor metabolites and energy,BP,CDK1
13397,GO:0050680,0.524005273380301,0.831879157711448,1,109,negative regulation of epithelial cell proliferation,BP,SFRP2
12019,GO:0045471,0.524022237555423,0.831794522655847,1,116,response to ethanol,BP,CDK1
2847,GO:0005923,0.524693873634928,0.83139611397093,1,107,bicellular tight junction,CC,CLDN11
4797,GO:0010558,0.525232113324925,0.613113071298471,9,1339,negative regulation of macromolecule biosynthetic process,BP,HHATL;BIRC5;FOXM1;CENPF;SFRP2;NKX6-2;S100A1;SOX11;ZNF536
13541,GO:0050878,0.525395387761393,0.700636192157639,3,424,regulation of body fluid levels,BP,APLNR;PDGFRA;AQP4
6152,GO:0016999,0.525715845176043,0.830484711948202,1,123,antibiotic metabolic process,BP,ALDH1A1
13781,GO:0051250,0.52583123326198,0.830454316327921,1,117,negative regulation of lymphocyte activation,BP,SOX11
6662,GO:0019842,0.526597421477637,0.829869780038042,1,119,vitamin binding,MF,ETNPPL
5575,GO:0015849,0.526802707112684,0.743138138040157,2,269,organic acid transport,BP,SLCO1A2;SPX
12708,GO:0046942,0.526802707112684,0.743138138040157,2,269,carboxylic acid transport,BP,SLCO1A2;SPX
13576,GO:0050921,0.527280335442061,0.829355299405546,1,120,positive regulation of chemotaxis,BP,LPAR1
17885,GO:0097730,0.527305808630092,0.829425569260238,1,111,non-motile cilium,CC,USH1C
2668,GO:0005635,0.52761124059288,0.69860338333921,3,420,nuclear envelope,CC,PTGDS;CENPF;DTL
13843,GO:0051348,0.528746594499171,0.741414893813261,2,275,negative regulation of transferase activity,BP,PPP1R1B;SFRP2
14009,GO:0051668,0.528753399751667,0.828341004769517,1,112,localization within membrane,BP,MAL
12706,GO:0046939,0.528921276212793,0.828185267809575,1,115,nucleotide phosphorylation,BP,AK5
11115,GO:0043204,0.529416584920242,0.827826696933589,1,114,perikaryon,CC,CPNE6
3857,GO:0008037,0.530240384959137,0.827212337920564,1,114,cell recognition,BP,CNTN2
609,GO:0001736,0.530447550588651,0.827027612903942,1,117,establishment of planar polarity,BP,SFRP2
3631,GO:0007164,0.530447550588651,0.827027612903942,1,117,establishment of tissue polarity,BP,SFRP2
14289,GO:0052689,0.531297798125402,0.826353762166879,1,121,carboxylic ester hydrolase activity,MF,ENPP2
4554,GO:0009636,0.531967506951622,0.694536836165064,3,442,response to toxic substance,BP,PPP1R1B;CDK1;MBP
815,GO:0002020,0.532102961875756,0.825860796680218,1,110,protease binding,MF,MBP
7735,GO:0031225,0.532239938190858,0.825647046949624,1,121,anchored component of membrane,CC,CNTN2
7704,GO:0031123,0.532735156741253,0.825284076903934,1,120,RNA 3'-end processing,BP,FIP1L1
4359,GO:0009135,0.532800750557387,0.825304164510635,1,113,purine nucleoside diphosphate metabolic process,BP,AK5
4399,GO:0009179,0.532800750557387,0.825304164510635,1,113,purine ribonucleoside diphosphate metabolic process,BP,AK5
11392,GO:0043679,0.534362840369023,0.824095859892761,1,116,axon terminus,CC,PACSIN1
15611,GO:0070160,0.534587798132525,0.823989500006516,1,110,occluding junction,CC,CLDN11
4365,GO:0009141,0.535023520682698,0.735826610849036,2,289,nucleoside triphosphate metabolic process,BP,AK5;CDK1
4963,GO:0010817,0.535344665288555,0.691403558327451,3,436,regulation of hormone levels,BP,ALDH1A1;KLK6;SOX11
9662,GO:0035270,0.535463136546147,0.82325331157261,1,117,endocrine system development,BP,NKX6-2
6286,GO:0018107,0.53796778603408,0.821400630634161,1,112,peptidyl-threonine phosphorylation,BP,CDK1
13158,GO:0048675,0.538042764750022,0.821400571794579,1,107,axon extension,BP,MAG
4404,GO:0009185,0.538227834384891,0.821170196401336,1,115,ribonucleoside diphosphate metabolic process,BP,AK5
20917,GO:1990234,0.538736028350183,0.641546308135014,5,744,transferase complex,CC,FBXO2;DTL;BUB1B;CDK1;UBE2C
7130,GO:0030054,0.539090015449272,0.606894554752665,8,1169,cell junction,CC,CLDN11;FGFR3;SNTA1;PACSIN1;PDGFRA;LGI3;OPALIN;FXYD1
15744,GO:0070371,0.539386632858112,0.731971029964618,2,276,ERK1 and ERK2 cascade,BP,FGFR3;PDGFRA
3606,GO:0007098,0.539742451083949,0.820021453056794,1,114,centrosome cycle,BP,CDK1
4384,GO:0009161,0.539805725950708,0.731556090805449,2,289,ribonucleoside monophosphate metabolic process,BP,AK5;CDK1
4612,GO:0009855,0.539873466656236,0.81990010167592,1,116,determination of bilateral symmetry,BP,DAAM2
3955,GO:0008203,0.540230832118963,0.819605581986104,1,118,cholesterol metabolic process,BP,FGF1
14417,GO:0055076,0.540528663150316,0.81932911750781,1,123,transition metal ion homeostasis,BP,TF
10776,GO:0042542,0.540644953287478,0.81923967758184,1,123,response to hydrogen peroxide,BP,CDK1
4940,GO:0010769,0.54225616896724,0.729449747156884,2,259,regulation of cell morphogenesis involved in differentiation,BP,MAG;CNTN2
4599,GO:0009799,0.542485574106423,0.817878102643935,1,117,specification of symmetry,BP,DAAM2
2936,GO:0006066,0.543106879464093,0.728609421640602,2,281,alcohol metabolic process,BP,FGF1;ALDH1A1
5403,GO:0015293,0.543735502337701,0.816910160339118,1,117,symporter activity,MF,SLC5A11
13965,GO:0051592,0.544356919985187,0.816481075351989,1,112,response to calcium ion,BP,CPNE6
2539,GO:0005319,0.544898266297564,0.816006656377658,1,117,lipid transporter activity,MF,SLCO1A2
16307,GO:0071426,0.548343207283892,0.813262744136922,1,122,ribonucleoprotein complex export from nucleus,BP,FIP1L1
3882,GO:0008083,0.548822185187331,0.812806008879472,1,131,growth factor activity,MF,FGF1
752,GO:0001935,0.549240600460084,0.812585868875007,1,119,endothelial cell proliferation,BP,APLNR
1140,GO:0002576,0.549281261062088,0.812553829725205,1,119,platelet degranulation,BP,TF
19944,GO:1903900,0.549422153223851,0.812385365213141,1,125,regulation of viral life cycle,BP,TOP2A
5165,GO:0014065,0.549835271117729,0.812147909447264,1,116,phosphatidylinositol 3-kinase signaling,BP,PDGFRA
59,GO:0000122,0.550305492629952,0.630245213484757,5,746,negative regulation of transcription by RNA polymerase II,BP,FOXM1;NKX6-2;S100A1;SOX11;ZNF536
16152,GO:0071166,0.551003938451608,0.811153948822782,1,123,ribonucleoprotein complex localization,BP,FIP1L1
19356,GO:1902652,0.5517036489326,0.810608824072295,1,122,secondary alcohol metabolic process,BP,FGF1
939,GO:0002224,0.55263279863813,0.809842300097154,1,125,toll-like receptor signaling pathway,BP,S100A1
2778,GO:0005814,0.552941976477574,0.809674991382042,1,117,centriole,CC,TOP2A
1872,GO:0004252,0.554071622414145,0.808633885014451,1,132,serine-type endopeptidase activity,MF,KLK6
21222,GO:2000145,0.55439498238558,0.626219675727903,5,739,regulation of cell motility,BP,FGF1;PDGFRA;ENPP2;SFRP2;LPAR1
8116,GO:0031965,0.555272129700073,0.717511822159467,2,278,nuclear membrane,CC,PTGDS;DTL
2603,GO:0005506,0.556105119791623,0.807030021315082,1,129,iron ion binding,MF,TF
18946,GO:1901568,0.556152674491281,0.806966167046754,1,132,fatty acid derivative metabolic process,BP,PTGDS
12374,GO:0046165,0.556634480126004,0.806631260211911,1,126,alcohol biosynthetic process,BP,FGF1
17824,GO:0097553,0.556683806941498,0.806702284726907,1,115,calcium ion transmembrane import into cytosol,BP,APLNR
17443,GO:0090501,0.55705658682833,0.806264478453997,1,129,RNA phosphodiester bond hydrolysis,BP,FIP1L1
12184,GO:0045807,0.55735632640977,0.80607814952631,1,123,positive regulation of endocytosis,BP,TF
18073,GO:0098862,0.557486658460899,0.806023438156694,1,118,cluster of actin-based cell projections,CC,USH1C
17079,GO:0080135,0.558225319409183,0.64176007421723,4,602,regulation of cellular response to stress,BP,FOXM1;SFRP2;HSPB8;PBK
4532,GO:0009566,0.558988049014205,0.804704170306524,1,129,fertilization,BP,CDK1
12737,GO:0046983,0.559235598841702,0.595810695357719,7,1103,protein dimerization activity,MF,CRLF1;MAG;SEPT4;CENPF;TOP2A;PDGFRA;S100A1
12595,GO:0046683,0.559385279025985,0.804437859705707,1,123,response to organophosphorus,BP,LPAR1
11623,GO:0044403,0.560372399446303,0.620258315861941,5,786,symbiont process,BP,TOP2A;PDGFRA;MOG;BUB1;CDK1
3178,GO:0006470,0.56088548769226,0.712290800991154,2,281,protein dephosphorylation,BP,PPP1R1B;PPP1R14A
5925,GO:0016567,0.561921009059759,0.618733176559325,5,762,protein ubiquitination,BP,BIRC5;SEPT4;FBXO2;DTL;UBE2C
4859,GO:0010648,0.564147547967877,0.58185403271371,8,1234,negative regulation of cell communication,BP,FGFR3;FOXM1;APLNR;PDGFRA;SFRP2;PBK;LPAR1;ZNF536
9490,GO:0034702,0.5643716054485,0.709052929822012,2,273,ion channel complex,CC,HSPA2;CNTN2
16357,GO:0071496,0.565035899995217,0.70837101898528,2,291,cellular response to external stimulus,BP,MAG;SFRP2
4347,GO:0009123,0.565471165817654,0.707924102236379,2,304,nucleoside monophosphate metabolic process,BP,AK5;CDK1
7637,GO:0031023,0.565675132588545,0.799303515895712,1,122,microtubule organizing center organization,BP,CDK1
3305,GO:0006626,0.566077282627448,0.798852875787218,1,135,protein targeting to mitochondrion,BP,MYBPC1
14493,GO:0060048,0.567649939983068,0.797711753064221,1,118,cardiac muscle contraction,BP,SNTA1
7093,GO:0023057,0.567689403117348,0.578268885040978,8,1238,negative regulation of signaling,BP,FGFR3;FOXM1;APLNR;PDGFRA;SFRP2;PBK;LPAR1;ZNF536
3953,GO:0008201,0.569091344275974,0.796395022852987,1,130,heparin binding,MF,FGF1
18799,GO:1901135,0.569201790115902,0.585760145308371,7,1114,carbohydrate derivative metabolic process,BP,FBXO2;NECAB1;AK5;ALDH1A1;CDK1;RRM2;HS3ST4
13770,GO:0051234,0.570231261654724,0.517579724661484,29,4516,establishment of localization,BP,KIFC1;SLCO1A2;TF;CPNE6;SNTA1;CENPF;PACSIN1;HSPA2;GFAP;SPX;APLNR;ESPL1;ENPP2;NUSAP1;SLC14A1;FIP1L1;SLC5A11;S100A1;TMEM144;MOBP;LGI3;CDK1;AQP4;SOX11;CNTN2;NKAIN2;MYBPC1;MBP;FXYD1
3464,GO:0006869,0.57088916951645,0.702850081522768,2,286,lipid transport,BP,SLCO1A2;SPX
16183,GO:0071236,0.572430796802932,0.793618262580669,1,128,cellular response to antibiotic,BP,CDK1
3197,GO:0006497,0.573959474188547,0.792276217591389,1,134,protein lipidation,BP,HHATL
17357,GO:0090288,0.574062814097358,0.792281743639738,1,124,negative regulation of cellular response to growth factor stimulus,BP,SFRP2
14894,GO:0060627,0.574159480434517,0.654074187035701,3,451,regulation of vesicle-mediated transport,BP,TF;PACSIN1;LGI3
11175,GO:0043296,0.574326467572787,0.792079407433354,1,122,apical junction complex,CC,CLDN11
17656,GO:0097223,0.574503312517352,0.791808013965374,1,135,sperm part,CC,SEPT4
17197,GO:0090066,0.574528576978299,0.653713700696766,3,448,regulation of anatomical structure size,BP,USH1C;MAG;CNTN2
3290,GO:0006606,0.577284118935089,0.789509774834031,1,128,protein import into nucleus,BP,CDK1
3108,GO:0006366,0.57806716801924,0.536243915587543,14,2184,transcription by RNA polymerase II,BP,MYBL2;FOXM1;FGF1;MYRF;TOP2A;FIP1L1;SFRP2;CRB2;NKX6-2;S100A1;CDK1;EMX2;SOX11;ZNF536
19520,GO:1903034,0.578117326088233,0.788761887095821,1,132,regulation of response to wounding,BP,PDGFRA
610,GO:0001738,0.578372292492482,0.788543987666814,1,132,morphogenesis of a polarized epithelium,BP,SFRP2
4388,GO:0009165,0.578924489809768,0.695090826624879,2,306,nucleotide biosynthetic process,BP,AK5;RRM2
9342,GO:0034399,0.579211080540847,0.787872806441339,1,127,nuclear periphery,CC,CENPF
7022,GO:0022408,0.579304274409442,0.78771979623755,1,135,negative regulation of cell-cell adhesion,BP,MBP
11571,GO:0044306,0.580306719035106,0.786894865846617,1,131,neuron projection terminus,CC,PACSIN1
2434,GO:0005125,0.58040690452641,0.786670839856593,1,148,cytokine activity,MF,CRLF1
11633,GO:0044420,0.58046460776765,0.786938311357095,1,114,extracellular matrix component,CC,FREM2
7801,GO:0031327,0.580562361120666,0.557668373314901,9,1402,negative regulation of cellular biosynthetic process,BP,HHATL;BIRC5;FOXM1;CENPF;SFRP2;NKX6-2;S100A1;SOX11;ZNF536
4669,GO:0010035,0.580693317601149,0.647554862274416,3,464,response to inorganic substance,BP,TF;CPNE6;CDK1
5714,GO:0016125,0.581274788332737,0.786043607220616,1,133,sterol metabolic process,BP,FGF1
4148,GO:0008509,0.583114408365385,0.691055268567842,2,297,anion transmembrane transporter activity,MF,SLCO1A2;FXYD1
11632,GO:0044419,0.583740722948791,0.59666817590725,5,809,interspecies interaction between organisms,BP,TOP2A;PDGFRA;MOG;BUB1;CDK1
1207,GO:0002695,0.584187117220004,0.783480159392998,1,138,negative regulation of leukocyte activation,BP,SOX11
18220,GO:0099504,0.585223971634281,0.782678126912646,1,127,synaptic vesicle cycle,BP,PACSIN1
3567,GO:0007030,0.585262243955905,0.782644785343086,1,127,Golgi organization,BP,CDK1
18859,GO:1901293,0.585325659972971,0.688861692406086,2,310,nucleoside phosphate biosynthetic process,BP,AK5;RRM2
8123,GO:0031981,0.58558490436799,0.507272347198904,24,3766,nuclear lumen,CC,MCM10;TPX2;BIRC5;MYBL2;SEPT4;FOXM1;FGF1;CENPF;NECAB1;MYRF;HSPA2;TOP2A;NUSAP1;SLC14A1;DTL;FIP1L1;MKI67;HSPB8;BUB1B;KLK6;FAM107A;BUB1;CDK1;UBE2C
10590,GO:0042158,0.585825912908263,0.782052920757561,1,138,lipoprotein biosynthetic process,BP,HHATL
13771,GO:0051235,0.585883592496893,0.688387729108654,2,286,maintenance of location,BP,ASPM;APLNR
3133,GO:0006405,0.585913056228266,0.782002610210972,1,135,RNA export from nucleus,BP,FIP1L1
4356,GO:0009132,0.586202551815076,0.781758629741676,1,134,nucleoside diphosphate metabolic process,BP,AK5
4819,GO:0010594,0.586429507057482,0.781597083688663,1,130,regulation of endothelial cell migration,BP,FGF1
7578,GO:0030902,0.586747768964495,0.781328331543647,1,129,hindbrain development,BP,LPAR1
21177,GO:2000058,0.587042651448868,0.781014924267117,1,135,regulation of ubiquitin-dependent protein catabolic process,BP,PBK
9565,GO:0035023,0.587685006551914,0.78056817886653,1,123,regulation of Rho protein signal transduction,BP,LPAR1
4351,GO:0009127,0.589277358412043,0.779034387046534,1,137,purine nucleoside monophosphate biosynthetic process,BP,AK5
4391,GO:0009168,0.589277358412043,0.779034387046534,1,137,purine ribonucleoside monophosphate biosynthetic process,BP,AK5
2551,GO:0005342,0.5898013976624,0.778572268060172,1,137,organic acid transmembrane transporter activity,MF,SLCO1A2
12709,GO:0046943,0.5898013976624,0.778572268060172,1,137,carboxylic acid transmembrane transporter activity,MF,SLCO1A2
3634,GO:0007167,0.590184616664972,0.575571039783557,6,923,enzyme linked receptor protein signaling pathway,BP,FGFR3;FGF1;PDGFRA;SFRP2;CRB2;SOX11
11639,GO:0044428,0.591210642282772,0.499062497034745,26,4087,nuclear part,CC,MCM10;TPX2;BIRC5;MYBL2;PTGDS;SEPT4;FOXM1;FGF1;CENPF;NECAB1;MYRF;HSPA2;TOP2A;NUSAP1;SLC14A1;DTL;FIP1L1;MKI67;HSPB8;BUB1B;KLK6;FAM107A;BUB1;CDK1;UBE2C;NWD1
280,GO:0000781,0.591607995822506,0.776991614421942,1,135,chromosome, telomeric region,CC,CDK1
6317,GO:0018210,0.592051396881691,0.776635029422928,1,131,peptidyl-threonine modification,BP,CDK1
3544,GO:0006997,0.593209647973586,0.775595626600147,1,132,nucleus organization,BP,CDK1
13511,GO:0050839,0.594168653199012,0.633954707259554,3,459,cell adhesion molecule binding,MF,FGF1;GFAP;SFRP2
16247,GO:0071346,0.594187431122822,0.774612136851647,1,145,cellular response to interferon-gamma,BP,AQP4
11666,GO:0044464,0.594739085680337,0.543849442276324,90,13950,cell part,CC,CRLF1;USH1C;HHATL;CLDN11;KIFC1;BCAS1;MCM10;ASPM;FGFR3;DCX;SLCO1A2;TPX2;BIRC5;TF;CPNE6;MYBL2;SNTA1;MAG;PTGDS;SEPT4;NCAPG;FOXM1;FGF1;FBXO2;CENPF;NECAB1;PLP1;PACSIN1;MYRF;HSPA2;GFAP;TOP2A;PPP1R1B;SPX;APLNR;PDGFRA;ESPL1;ERMN;ENPP2;MOG;NUSAP1;SLC14A1;DTL;FIP1L1;CRB2;MKI67;NKX6-2;CNDP1;FREM2;HSPB8;AK5;BUB1B;SLC5A11;S100A1;PAQR6;ETNPPL;KIF6;ALDH1A1;PPP1R14A;KLK6;PBK;FAM107A;MOBP;LGI3;NTSR2;BUB1;CDK1;EMX2;RRM2;AQP4;MAL;CARNS1;UBE2C;SOX11;S1PR5;GPR62;HS3ST4;CALN1;AIFM3;CNTN2;DNAH17;NWD1;NKAIN2;MYBPC1;OPALIN;MBP;LPAR1;ZNF536;TMEM235;FXYD1
9434,GO:0034620,0.59505921662485,0.773872853695866,1,140,cellular response to unfolded protein,BP,HSPA2
4620,GO:0009890,0.596402870522383,0.541285390908605,9,1422,negative regulation of biosynthetic process,BP,HHATL;BIRC5;FOXM1;CENPF;SFRP2;NKX6-2;S100A1;SOX11;ZNF536
7076,GO:0022900,0.597079019607514,0.771924592067593,1,158,electron transport chain,BP,CDK1
3485,GO:0006897,0.597224918470039,0.602392567397623,4,629,endocytosis,BP,TF;PACSIN1;ENPP2;CNTN2
3039,GO:0006261,0.59778173755874,0.771417464459834,1,141,DNA-dependent DNA replication,BP,MCM10
14743,GO:0060402,0.598108856234168,0.771212089461832,1,131,calcium ion transport into cytosol,BP,APLNR
6017,GO:0016740,0.598575317912773,0.515056397408424,14,2201,transferase activity,MF,FGFR3;BIRC5;FGF1;FBXO2;PDGFRA;DTL;AK5;BUB1B;ETNPPL;PBK;BUB1;CDK1;UBE2C;HS3ST4
3052,GO:0006281,0.59891574452054,0.62906911610887,3,475,DNA repair,BP,FOXM1;DTL;CDK1
13109,GO:0048585,0.599312503433553,0.538248411515999,9,1434,negative regulation of response to stimulus,BP,FGFR3;FOXM1;SPX;APLNR;PDGFRA;SFRP2;PBK;LPAR1;ZNF536
13634,GO:0051028,0.600606589034357,0.768893611144372,1,137,mRNA transport,BP,FIP1L1
4622,GO:0009892,0.600857876938429,0.506627328139928,16,2548,negative regulation of metabolic process,BP,HHATL;BIRC5;SNTA1;FOXM1;CENPF;PPP1R1B;SFRP2;CRB2;NKX6-2;S100A1;PI16;PPP1R14A;PBK;SOX11;ZNF536;FXYD1
6609,GO:0019725,0.601539546063709,0.578275113331992,5,805,cellular homeostasis,BP,TF;APLNR;PDGFRA;UBE2C;LPAR1
4366,GO:0009142,0.601841963751423,0.767717185047824,1,143,nucleoside triphosphate biosynthetic process,BP,AK5
13232,GO:0048812,0.60232236179544,0.597134146504719,4,597,neuron projection morphogenesis,BP,CPNE6;MAG;PACSIN1;CNTN2
18150,GO:0099003,0.602431292966286,0.76725803836964,1,134,vesicle-mediated transport in synapse,BP,PACSIN1
3862,GO:0008047,0.602986580133922,0.624888466557251,3,465,enzyme activator activity,MF,SFRP2;ALDH1A1;MAL
2667,GO:0005634,0.603050014369817,0.477304006076559,41,6455,nucleus,CC,KIFC1;MCM10;ASPM;FGFR3;TPX2;BIRC5;MYBL2;PTGDS;SEPT4;NCAPG;FOXM1;FGF1;CENPF;NECAB1;MYRF;HSPA2;TOP2A;PPP1R1B;PDGFRA;ESPL1;NUSAP1;SLC14A1;DTL;FIP1L1;MKI67;NKX6-2;HSPB8;BUB1B;S100A1;KIF6;KLK6;PBK;FAM107A;BUB1;CDK1;EMX2;UBE2C;SOX11;NWD1;MBP;ZNF536
13421,GO:0050707,0.603806586191543,0.765895617508556,1,146,regulation of cytokine secretion,BP,MBP
21369,GO:2000377,0.603961760921289,0.765761209492809,1,145,regulation of reactive oxygen species metabolic process,BP,FOXM1
13272,GO:0048878,0.604529508333514,0.560613831643723,6,961,chemical homeostasis,BP,TF;SPX;APLNR;PDGFRA;AQP4;LPAR1
15530,GO:0070011,0.6055919393809,0.622157188565437,3,486,peptidase activity, acting on L-amino acid peptides,MF,ESPL1;CNDP1;KLK6
475,GO:0001508,0.606128943783842,0.763911756913678,1,129,action potential,BP,SNTA1
4706,GO:0010212,0.606936629900161,0.76304465911746,1,142,response to ionizing radiation,BP,SFRP2
15522,GO:0065008,0.60727585889423,0.489263164069885,21,3311,regulation of biological quality,BP,USH1C;ASPM;TF;SNTA1;MAG;GFAP;PPP1R1B;SPX;APLNR;PDGFRA;ERMN;ALDH1A1;KLK6;NTSR2;AQP4;UBE2C;SOX11;CNTN2;MBP;LPAR1;FXYD1
2748,GO:0005769,0.607285440809543,0.666963110088281,2,307,early endosome,CC,KIFC1;TF
14410,GO:0055067,0.607572558405168,0.762455779089484,1,142,monovalent inorganic cation homeostasis,BP,SPX
2666,GO:0005623,0.608283055992138,0.53014016797169,90,13967,cell,CC,CRLF1;USH1C;HHATL;CLDN11;KIFC1;BCAS1;MCM10;ASPM;FGFR3;DCX;SLCO1A2;TPX2;BIRC5;TF;CPNE6;MYBL2;SNTA1;MAG;PTGDS;SEPT4;NCAPG;FOXM1;FGF1;FBXO2;CENPF;NECAB1;PLP1;PACSIN1;MYRF;HSPA2;GFAP;TOP2A;PPP1R1B;SPX;APLNR;PDGFRA;ESPL1;ERMN;ENPP2;MOG;NUSAP1;SLC14A1;DTL;FIP1L1;CRB2;MKI67;NKX6-2;CNDP1;FREM2;HSPB8;AK5;BUB1B;SLC5A11;S100A1;PAQR6;ETNPPL;KIF6;ALDH1A1;PPP1R14A;KLK6;PBK;FAM107A;MOBP;LGI3;NTSR2;BUB1;CDK1;EMX2;RRM2;AQP4;MAL;CARNS1;UBE2C;SOX11;S1PR5;GPR62;HS3ST4;CALN1;AIFM3;CNTN2;DNAH17;NWD1;NKAIN2;MYBPC1;OPALIN;MBP;LPAR1;ZNF536;TMEM235;FXYD1
7049,GO:0022804,0.608956100328824,0.665271154575478,2,303,active transmembrane transporter activity,MF,SLCO1A2;SLC5A11
395,GO:0001047,0.609584773884872,0.760620692461693,1,138,core promoter binding,MF,SOX11
5679,GO:0016055,0.609720904059403,0.617880073336862,3,471,Wnt signaling pathway,BP,ASPM;SFRP2;DAAM2
9895,GO:0035690,0.610180739437649,0.663989716738888,2,313,cellular response to drug,BP,PPP1R14A;CDK1
3308,GO:0006631,0.610505729260465,0.663621677689344,2,326,fatty acid metabolic process,BP,PTGDS;PLP1
3967,GO:0008217,0.610868365859664,0.759346006299175,1,147,regulation of blood pressure,BP,SPX
3510,GO:0006937,0.611797970423474,0.758516757083743,1,142,regulation of muscle contraction,BP,SPX
18540,GO:0198738,0.6125730243475,0.614891049596282,3,473,cell-cell signaling by wnt,BP,ASPM;SFRP2;DAAM2
8748,GO:0032956,0.612578454241929,0.661552613916099,2,305,regulation of actin cytoskeleton organization,BP,PDGFRA;LPAR1
12256,GO:0045934,0.6128979862756,0.531444099549605,8,1282,negative regulation of nucleobase-containing compound metabolic process,BP,BIRC5;FOXM1;CENPF;SFRP2;NKX6-2;S100A1;SOX11;ZNF536
21165,GO:2000045,0.613140511038486,0.757230345860526,1,145,regulation of G1/S transition of mitotic cell cycle,BP,CDK1
21832,GO:2001257,0.613802633104936,0.756640607148241,1,141,regulation of cation channel activity,BP,S100A1
5311,GO:0015103,0.613984472994956,0.756469128191293,1,141,inorganic anion transmembrane transporter activity,MF,FXYD1
13682,GO:0051100,0.614322780690037,0.756099491247552,1,147,negative regulation of binding,BP,SOX11
6100,GO:0016874,0.615588133840905,0.754886624473194,1,149,ligase activity,MF,CARNS1
1862,GO:0004175,0.616262928391235,0.657686237964305,2,328,endopeptidase activity,MF,ESPL1;KLK6
2747,GO:0005768,0.616392248317266,0.56262190903565,5,810,endosome,CC,KIFC1;TF;CPNE6;PACSIN1;LPAR1
13492,GO:0050806,0.616507053286827,0.75409030573611,1,140,positive regulation of synaptic transmission,BP,GFAP
15251,GO:0061337,0.616743220802794,0.753893339431399,1,137,cardiac conduction,BP,FXYD1
11969,GO:0045333,0.616957302810776,0.753492350255241,1,162,cellular respiration,BP,CDK1
4380,GO:0009156,0.618485384522438,0.752130234858336,1,149,ribonucleoside monophosphate biosynthetic process,BP,AK5
7821,GO:0031348,0.619024018610817,0.75159969451321,1,151,negative regulation of defense response,BP,PBK
11557,GO:0044283,0.61931001589196,0.57916109594278,4,673,small molecule biosynthetic process,BP,PTGDS;FGF1;PLP1;CARNS1
13647,GO:0051046,0.619347282028798,0.579140828394661,4,652,regulation of secretion,BP,SPX;LGI3;SOX11;MBP
6229,GO:0017144,0.619450926178994,0.579000381718701,4,685,drug metabolic process,BP,AK5;ALDH1A1;CDK1;CARNS1
12885,GO:0048015,0.620666104007428,0.750108516520558,1,141,phosphatidylinositol-mediated signaling,BP,PDGFRA
3975,GO:0008236,0.622135506666603,0.748565426454801,1,157,serine-type peptidase activity,MF,KLK6
19754,GO:1903532,0.622407738668591,0.651301650138445,2,322,positive regulation of secretion by cell,BP,SOX11;MBP
5012,GO:0010876,0.622849328210925,0.650855480291737,2,316,lipid localization,BP,SLCO1A2;SPX
2616,GO:0005525,0.622869543078418,0.650783640182272,2,335,GTP binding,MF,TPX2;SEPT4
12681,GO:0046890,0.623003103356243,0.747772374541318,1,151,regulation of lipid biosynthetic process,BP,FGF1
5301,GO:0015081,0.62417640842766,0.746738130602163,1,139,sodium ion transmembrane transporter activity,MF,SLC5A11
14742,GO:0060401,0.624256531976695,0.746642139574208,1,141,cytosolic calcium ion transport,BP,APLNR
13918,GO:0051493,0.625728585847474,0.600948989786872,3,473,regulation of cytoskeleton organization,BP,TPX2;PDGFRA;LPAR1
6072,GO:0016829,0.625876339616394,0.744915699396148,1,160,lyase activity,MF,ETNPPL
7194,GO:0030168,0.62669817332314,0.744196671113043,1,149,platelet activation,BP,PDGFRA
10494,GO:0040012,0.626721322294411,0.551580228599543,5,802,regulation of locomotion,BP,FGF1;PDGFRA;ENPP2;SFRP2;LPAR1
3785,GO:0007519,0.626808087552884,0.744097450880211,1,148,skeletal muscle tissue development,BP,SOX11
13729,GO:0051170,0.627200442209385,0.743705658276507,1,149,import into nucleus,BP,CDK1
3266,GO:0006575,0.627397968778531,0.74343618539889,1,159,cellular modified amino acid metabolic process,BP,CARNS1
8483,GO:0032550,0.627586633883567,0.645807838186875,2,338,purine ribonucleoside binding,MF,TPX2;SEPT4
12887,GO:0048017,0.628265090323586,0.742704803834574,1,144,inositol lipid-mediated signaling,BP,PDGFRA
11519,GO:0044212,0.629527978691193,0.548549231129881,5,810,transcription regulatory region DNA binding,MF,MYBL2;FOXM1;NKX6-2;SOX11;ZNF536
13490,GO:0050804,0.630066381647142,0.643237097399946,2,316,modulation of chemical synaptic transmission,BP,GFAP;CNTN2
18208,GO:0099177,0.630066381647142,0.643237097399946,2,316,regulation of trans-synaptic signaling,BP,GFAP;CNTN2
399,GO:0001067,0.630756469787908,0.547221105319986,5,811,regulatory region nucleic acid binding,MF,MYBL2;FOXM1;NKX6-2;SOX11;ZNF536
3496,GO:0006913,0.630826485223053,0.642406349535667,2,324,nucleocytoplasmic transport,BP,FIP1L1;CDK1
947,GO:0002244,0.631040381326038,0.739859650329022,1,158,hematopoietic progenitor cell differentiation,BP,TOP2A
6248,GO:0017171,0.631951908165771,0.738935649967517,1,161,serine hydrolase activity,MF,KLK6
715,GO:0001883,0.632172380349002,0.640927960780704,2,341,purine nucleoside binding,MF,TPX2;SEPT4
4968,GO:0010822,0.634430640092981,0.736506651709826,1,156,positive regulation of mitochondrion organization,BP,MYBPC1
9292,GO:0034341,0.634724640365884,0.736162435615944,1,163,response to interferon-gamma,BP,AQP4
8482,GO:0032549,0.634928661070334,0.637976567613694,2,342,ribonucleoside binding,MF,TPX2;SEPT4
13728,GO:0051169,0.635291770154294,0.637625540813231,2,327,nuclear transport,BP,FIP1L1;CDK1
6653,GO:0019827,0.635345106998216,0.735665274008552,1,147,stem cell population maintenance,BP,ASPM
10056,GO:0035967,0.63546954135383,0.735468355391345,1,156,cellular response to topologically incorrect protein,BP,HSPA2
15339,GO:0061564,0.637760861564313,0.587952518205419,3,471,axon development,BP,MAG;PLP1;CNTN2
21829,GO:2001252,0.638276686541653,0.73267937456087,1,152,positive regulation of chromosome organization,BP,ESPL1
19911,GO:1903829,0.638469473720475,0.634207222281688,2,326,positive regulation of cellular protein localization,BP,CDK1;MYBPC1
11416,GO:0043902,0.638973634031253,0.73192930265757,1,158,positive regulation of multi-organism process,BP,TOP2A
11061,GO:0043123,0.639403596520181,0.731479799378576,1,160,positive regulation of I-kappaB kinase/NF-kappaB signaling,BP,LPAR1
4348,GO:0009124,0.640430437738502,0.730446753797653,1,159,nucleoside monophosphate biosynthetic process,BP,AK5
14838,GO:0060538,0.64064561027255,0.730266578279558,1,154,skeletal muscle organ development,BP,SOX11
17996,GO:0098727,0.640684494092322,0.730267883955225,1,149,maintenance of cell number,BP,ASPM
14401,GO:0055037,0.640721754633486,0.730205266230807,1,152,recycling endosome,CC,TF
19407,GO:1902806,0.641119767583828,0.729769350328307,1,156,regulation of cell cycle G1/S phase transition,BP,CDK1
14622,GO:0060249,0.641696532454161,0.630693263161284,2,333,anatomical structure homeostasis,BP,USH1C;TF
17219,GO:0090090,0.641933466665336,0.728911244554846,1,160,negative regulation of canonical Wnt signaling pathway,BP,SFRP2
13797,GO:0051270,0.64247565142996,0.534459324033995,5,811,regulation of cellular component movement,BP,FGF1;PDGFRA;ENPP2;SFRP2;LPAR1
9247,GO:0034220,0.643005031129346,0.519370066760121,6,980,ion transmembrane transport,BP,SNTA1;HSPA2;APLNR;S100A1;AQP4;FXYD1
3359,GO:0006694,0.643131768557611,0.72768107610219,1,161,steroid biosynthetic process,BP,FGF1
16014,GO:0070887,0.643336500467496,0.459175765071686,17,2789,cellular response to chemical stimulus,BP,CRLF1;FGFR3;BIRC5;TF;CPNE6;MYBL2;FGF1;HSPA2;PDGFRA;SFRP2;CRB2;PAQR6;PPP1R14A;CDK1;AQP4;SOX11;LPAR1
714,GO:0001882,0.645809777611634,0.626166838357317,2,349,nucleoside binding,MF,TPX2;SEPT4
14422,GO:0055082,0.646235492100243,0.54995314232139,4,674,cellular chemical homeostasis,BP,TF;APLNR;PDGFRA;LPAR1
17615,GO:0097159,0.646349835568856,0.434869306918177,34,5402,organic cyclic compound binding,MF,KIFC1;MCM10;FGFR3;TPX2;MYBL2;SEPT4;FOXM1;MYRF;HSPA2;TOP2A;IQCA1;PDGFRA;ENPP2;NUSAP1;FIP1L1;MKI67;NKX6-2;AK5;BUB1B;PAQR6;ETNPPL;KIF6;ALDH1A1;PBK;BUB1;CDK1;EMX2;CARNS1;UBE2C;SOX11;AIFM3;DNAH17;NWD1;ZNF536
11053,GO:0043112,0.647586147476873,0.723122397599414,1,158,receptor metabolic process,BP,CNTN2
937,GO:0002221,0.648001070272307,0.722677742423037,1,160,pattern recognition receptor signaling pathway,BP,S100A1
1600,GO:0003682,0.649404042620618,0.575106277991359,3,494,chromatin binding,MF,CENPF;TOP2A;CDK1
8494,GO:0032561,0.649775373570464,0.621803490737157,2,351,guanyl ribonucleotide binding,MF,TPX2;SEPT4
3976,GO:0008237,0.650563982911895,0.720013420345125,1,160,metallopeptidase activity,MF,CNDP1
6389,GO:0019001,0.651340324664284,0.620072041754657,2,352,guanyl nucleotide binding,MF,TPX2;SEPT4
6691,GO:0019897,0.6514478239349,0.719097817570974,1,159,extrinsic component of plasma membrane,CC,TF
2773,GO:0005798,0.652236194919363,0.718250029322583,1,162,Golgi-associated vesicle,CC,PACSIN1
7452,GO:0030662,0.652612414887399,0.717855521375794,1,162,coated vesicle membrane,CC,TF
5499,GO:0015698,0.652621704893456,0.717891608247318,1,156,inorganic anion transport,BP,FXYD1
3973,GO:0008234,0.652719516357772,0.71778109957519,1,157,cysteine-type peptidase activity,MF,ESPL1
12415,GO:0046328,0.653184296722641,0.717293065136258,1,157,regulation of JNK cascade,BP,SFRP2
11547,GO:0044265,0.65377629353994,0.507488377905176,6,1024,cellular macromolecule catabolic process,BP,FBXO2;DTL;BUB1B;PBK;CDK1;UBE2C
13648,GO:0051047,0.653948580321926,0.617203411114766,2,342,positive regulation of secretion,BP,SOX11;MBP
18800,GO:1901136,0.654183263124935,0.716175076883957,1,166,carbohydrate derivative catabolic process,BP,FBXO2
15185,GO:0061136,0.658073250778788,0.712061119592657,1,165,regulation of proteasomal protein catabolic process,BP,PBK
3849,GO:0008021,0.658158613026816,0.711963044924943,1,166,synaptic vesicle,CC,LGI3
18730,GO:1900542,0.658249991374281,0.711887395120704,1,163,regulation of purine nucleotide metabolic process,BP,CDK1
13382,GO:0050663,0.659492582531258,0.710518305967471,1,169,cytokine secretion,BP,MBP
5676,GO:0016052,0.660139306014644,0.709869001042024,1,163,carbohydrate catabolic process,BP,ALDH1A1
16985,GO:0072655,0.660256294436328,0.7096673494524,1,174,establishment of protein localization to mitochondrion,BP,MYBPC1
10589,GO:0042157,0.661419716560274,0.708466131783092,1,167,lipoprotein metabolic process,BP,HHATL
19219,GO:1902275,0.661494586288063,0.708460948146656,1,157,regulation of chromatin organization,BP,MKI67
3538,GO:0006986,0.662761289575821,0.707000415538101,1,170,response to unfolded protein,BP,HSPA2
11656,GO:0044450,0.665280154288267,0.704354280662887,1,159,microtubule organizing center part,CC,TOP2A
19031,GO:1901796,0.665352879138975,0.704215211645587,1,167,regulation of signal transduction by p53 class mediator,BP,TPX2
601,GO:0001726,0.665471067958489,0.7041628183222,1,157,ruffle,CC,PACSIN1
4055,GO:0008361,0.666598344289528,0.702935771953862,1,157,regulation of cell size,BP,MAG
15873,GO:0070585,0.66703363749542,0.702316873281454,1,177,protein localization to mitochondrion,BP,MYBPC1
3651,GO:0007188,0.667162959201582,0.702222217704521,1,170,adenylate cyclase-modulating G-protein coupled receptor signaling pathway,BP,LPAR1
18446,GO:0120031,0.667261776983391,0.554985594141597,3,506,plasma membrane bounded cell projection assembly,BP,SEPT4;CDK1;LPAR1
14638,GO:0060271,0.667776076096522,0.601634079580386,2,338,cilium assembly,BP,SEPT4;CDK1
13590,GO:0050953,0.668115420270942,0.701201841940013,1,167,sensory perception of light stimulus,BP,USH1C
8781,GO:0033002,0.669316948886077,0.699884043333418,1,167,muscle cell proliferation,BP,CDK1
13657,GO:0051056,0.669538422582384,0.59965739822842,2,324,regulation of small GTPase mediated signal transduction,BP,FOXM1;LPAR1
7034,GO:0022607,0.669765857083134,0.433061087380191,16,2621,cellular component assembly,BP,USH1C;KIFC1;ASPM;TPX2;BIRC5;MYBL2;SEPT4;CENPF;HSPA2;GFAP;HAPLN2;PDGFRA;CDK1;UBE2C;MYBPC1;LPAR1
2979,GO:0006140,0.670217159238994,0.698879561298952,1,169,regulation of nucleotide metabolic process,BP,CDK1
7752,GO:0031256,0.670664008745371,0.698470323627282,1,158,leading edge membrane,CC,PACSIN1
7025,GO:0022411,0.670719684064035,0.550999979018703,3,526,cellular component disassembly,BP,HSPA2;TOP2A;CDK1
3644,GO:0007179,0.670803487006952,0.698284941088425,1,162,transforming growth factor beta receptor signaling pathway,BP,SOX11
7480,GO:0030705,0.672055241860055,0.696925464290184,1,159,cytoskeleton-dependent intracellular transport,BP,MOBP
17618,GO:0097164,0.672423075573137,0.696375632097003,1,179,ammonium ion metabolic process,BP,ENPP2
3436,GO:0006820,0.672967525093528,0.54841962385933,3,523,anion transport,BP,SLCO1A2;SPX;FXYD1
17693,GO:0097305,0.67491563144018,0.69365708286407,1,171,response to alcohol,BP,CDK1
13518,GO:0050852,0.674940945638427,0.693556730884215,1,182,T cell receptor signaling pathway,BP,MOG
15821,GO:0070507,0.675673967658668,0.692876488783881,1,162,regulation of microtubule cytoskeleton organization,BP,TPX2
2697,GO:0005681,0.676464741318121,0.691865070563815,1,180,spliceosomal complex,CC,NWD1
13481,GO:0050792,0.677232710424645,0.691016304996372,1,178,regulation of viral process,BP,TOP2A
18496,GO:0140056,0.678829989967665,0.689272971095629,1,170,organelle localization by membrane tethering,BP,CDK1
12991,GO:0048284,0.678990591769536,0.689063931395494,1,174,organelle fusion,BP,CDK1
3293,GO:0006611,0.679469429111263,0.688530080978808,1,173,protein export from nucleus,BP,FIP1L1
13388,GO:0050670,0.679950822040711,0.687926763035709,1,182,regulation of lymphocyte proliferation,BP,SOX11
11321,GO:0043542,0.680211713190441,0.687718759255527,1,169,endothelial cell migration,BP,FGF1
4840,GO:0010628,0.680934712232032,0.443666270643813,10,1676,positive regulation of gene expression,BP,MYBL2;FOXM1;FGF1;PLP1;MYRF;TOP2A;SFRP2;CDK1;SOX11;CNTN2
4630,GO:0009913,0.681138595401833,0.686639677589304,1,173,epidermal cell differentiation,BP,USH1C
13649,GO:0051048,0.681249086371398,0.686480605265427,1,178,negative regulation of secretion,BP,SPX
8743,GO:0032944,0.681882398364998,0.685728958476847,1,183,regulation of mononuclear cell proliferation,BP,SOX11
11741,GO:0044782,0.683989892424452,0.582804106817242,2,349,cilium organization,BP,SEPT4;CDK1
15554,GO:0070062,0.684105256102126,0.423067280539259,14,2418,extracellular exosome,CC,CLDN11;BCAS1;TF;CPNE6;PTGDS;FBXO2;HSPA2;ERMN;DAAM2;CRB2;FREM2;PI16;ALDH1A1;CDK1
18029,GO:0098793,0.684168488572477,0.582578800155985,2,355,presynapse,CC,PACSIN1;LGI3
12264,GO:0045944,0.684207817344658,0.473195351067229,6,1028,positive regulation of transcription by RNA polymerase II,BP,MYBL2;FOXM1;FGF1;TOP2A;SFRP2;SOX11
3109,GO:0006367,0.684303339973964,0.683017605845262,1,175,transcription initiation from RNA polymerase II promoter,BP,CDK1
6239,GO:0017157,0.68438252837946,0.682933762019779,1,174,regulation of exocytosis,BP,LGI3
7115,GO:0030031,0.684558589407614,0.534951147058949,3,520,cell projection assembly,BP,SEPT4;CDK1;LPAR1
8760,GO:0032970,0.686495768215848,0.579853161435738,2,346,regulation of actin filament-based process,BP,PDGFRA;LPAR1
3101,GO:0006357,0.686721090793989,0.427510837361721,12,2015,regulation of transcription by RNA polymerase II,BP,MYBL2;FOXM1;FGF1;MYRF;TOP2A;SFRP2;CRB2;NKX6-2;S100A1;EMX2;SOX11;ZNF536
6687,GO:0019887,0.687679546927347,0.679086835656131,1,182,protein kinase regulator activity,MF,PPP1R1B
6313,GO:0018205,0.688145141620356,0.577870396241982,2,357,peptidyl-lysine modification,BP,BIRC5;TOP2A
15752,GO:0070382,0.688517865546811,0.678129404455445,1,180,exocytic vesicle,CC,LGI3
11536,GO:0044242,0.688867609420508,0.677692295391387,1,185,cellular lipid catabolic process,BP,ENPP2
3821,GO:0007610,0.689186713221188,0.529498240425155,3,523,behavior,BP,PTGDS;PPP1R1B;CNTN2
18038,GO:0098802,0.689766942276295,0.676720002375143,1,174,plasma membrane receptor complex,CC,TF
19446,GO:1902905,0.689975812936364,0.67644978605163,1,178,positive regulation of supramolecular fiber organization,BP,LPAR1
6170,GO:0017038,0.689997003105959,0.67641849894143,1,179,protein import,BP,CDK1
18509,GO:0140097,0.691538903143467,0.674614065942398,1,180,catalytic activity, acting on DNA,MF,TOP2A
4301,GO:0009057,0.691683132585189,0.453593825249236,7,1229,macromolecule catabolic process,BP,FBXO2;GFAP;DTL;BUB1B;PBK;CDK1;UBE2C
18891,GO:1901363,0.692734470643926,0.385551252135936,33,5338,heterocyclic compound binding,MF,KIFC1;MCM10;FGFR3;TPX2;MYBL2;SEPT4;FOXM1;MYRF;HSPA2;TOP2A;IQCA1;PDGFRA;ENPP2;NUSAP1;FIP1L1;MKI67;NKX6-2;AK5;BUB1B;ETNPPL;KIF6;ALDH1A1;PBK;BUB1;CDK1;EMX2;CARNS1;UBE2C;SOX11;AIFM3;DNAH17;NWD1;ZNF536
11237,GO:0043401,0.693623480245257,0.672211957679995,1,174,steroid hormone mediated signaling pathway,BP,PAQR6
15908,GO:0070663,0.6936532904886,0.672079719159703,1,189,regulation of leukocyte proliferation,BP,SOX11
6175,GO:0017048,0.694011537556662,0.671838407384762,1,163,Rho GTPase binding,MF,DAAM2
6227,GO:0017137,0.694220407034632,0.6715387156983,1,170,Rab GTPase binding,MF,MOBP
19772,GO:1903561,0.694678526173554,0.411268042288297,14,2434,extracellular vesicle,CC,CLDN11;BCAS1;TF;CPNE6;PTGDS;FBXO2;HSPA2;ERMN;DAAM2;CRB2;FREM2;PI16;ALDH1A1;CDK1
13376,GO:0050657,0.694904215244617,0.670669810816748,1,179,nucleic acid transport,BP,FIP1L1
13377,GO:0050658,0.694904215244617,0.670669810816748,1,179,RNA transport,BP,FIP1L1
11132,GO:0043230,0.695712047550977,0.410109269556379,14,2436,extracellular organelle,CC,CLDN11;BCAS1;TF;CPNE6;PTGDS;FBXO2;HSPA2;ERMN;DAAM2;CRB2;FREM2;PI16;ALDH1A1;CDK1
7020,GO:0022406,0.696888455704328,0.668322915898059,1,179,membrane docking,BP,CDK1
11556,GO:0044282,0.697758437360387,0.566276682373806,2,389,small molecule catabolic process,BP,ALDH1A1;CARNS1
11662,GO:0044456,0.699524343625047,0.488897725199348,4,697,synapse part,CC,FBXO2;PACSIN1;LGI3;LPAR1
10055,GO:0035966,0.70013622803995,0.66439557800916,1,188,response to topologically incorrect protein,BP,HSPA2
15518,GO:0065004,0.700369911858113,0.664091804090666,1,192,protein-DNA complex assembly,BP,CENPF
13772,GO:0051236,0.702768224120451,0.661271652840515,1,182,establishment of RNA localization,BP,FIP1L1
8359,GO:0032386,0.704227435580498,0.558439694251339,2,371,regulation of intracellular transport,BP,CDK1;MYBPC1
3804,GO:0007584,0.708357879686381,0.654415940561263,1,192,response to nutrient,BP,SFRP2
3534,GO:0006979,0.708782390661181,0.552792164810919,2,390,response to oxidative stress,BP,PDGFRA;CDK1
2030,GO:0004518,0.709274302694512,0.653285996853502,1,193,nuclease activity,MF,ENPP2
849,GO:0002064,0.709766064773202,0.652771120217655,1,179,epithelial cell development,BP,HAPLN2
4796,GO:0010557,0.709961924219849,0.416625730312087,9,1558,positive regulation of macromolecule biosynthetic process,BP,MYBL2;FOXM1;FGF1;MYRF;TOP2A;PDGFRA;SFRP2;CDK1;SOX11
2435,GO:0005126,0.711369488912269,0.650654190918481,1,202,cytokine receptor binding,MF,CRLF1
19530,GO:1903050,0.71236154620608,0.649496225482186,1,190,regulation of proteolysis involved in cellular protein catabolic process,BP,PBK
3691,GO:0007254,0.712362973150573,0.64951958417545,1,186,JNK cascade,BP,SFRP2
7204,GO:0030178,0.712966408794953,0.64872811882476,1,193,negative regulation of Wnt signaling pathway,BP,SFRP2
21812,GO:2001234,0.713803381563376,0.647664854621909,1,197,negative regulation of apoptotic signaling pathway,BP,SFRP2
11650,GO:0044444,0.713950421655931,0.358410809910487,53,8577,cytoplasmic part,CC,CRLF1;USH1C;HHATL;KIFC1;FGFR3;DCX;TPX2;BIRC5;TF;CPNE6;PTGDS;SEPT4;NCAPG;FGF1;FBXO2;CENPF;NECAB1;PACSIN1;MYRF;HSPA2;GFAP;TOP2A;PPP1R1B;SPX;ESPL1;ERMN;DTL;CNDP1;HSPB8;AK5;BUB1B;S100A1;ETNPPL;ALDH1A1;PPP1R14A;KLK6;MOBP;LGI3;BUB1;CDK1;RRM2;MAL;CARNS1;UBE2C;HS3ST4;CALN1;AIFM3;DNAH17;NWD1;MYBPC1;OPALIN;LPAR1;TMEM235
3650,GO:0007187,0.71405059414785,0.647363008091139,1,196,G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,BP,LPAR1
2765,GO:0005789,0.71407715175191,0.452310602155472,5,930,endoplasmic reticulum membrane,CC,HHATL;TF;PTGDS;MYRF;CDK1
4344,GO:0009117,0.714741559559201,0.498594256845795,3,587,nucleotide metabolic process,BP,AK5;CDK1;RRM2
3069,GO:0006302,0.714998055331932,0.646224249878535,1,189,double-strand break repair,BP,FOXM1
18958,GO:1901605,0.715080655284201,0.646050639983128,1,201,alpha-amino acid metabolic process,BP,CARNS1
2775,GO:0005802,0.715636914389634,0.645426234944822,1,189,trans-Golgi network,CC,CALN1
461,GO:0001228,0.715976885243805,0.543857636951353,2,379,transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding,MF,MYBL2;SOX11
13652,GO:0051051,0.716110798423615,0.543663877344972,2,391,negative regulation of transport,BP,PACSIN1;SPX
17926,GO:0098562,0.716518569851264,0.644310163732772,1,191,cytoplasmic side of membrane,CC,GFAP
13989,GO:0051641,0.716865924262255,0.383225836571491,15,2541,cellular localization,BP,KIFC1;ASPM;SEPT4;CENPF;PACSIN1;APLNR;ESPL1;NUSAP1;FIP1L1;BUB1B;MOBP;CDK1;MAL;CNTN2;MYBPC1
18051,GO:0098827,0.717568358098623,0.448114703533113,5,934,endoplasmic reticulum subcompartment,CC,HHATL;TF;PTGDS;MYRF;CDK1
7354,GO:0030425,0.718048820585175,0.494565976388027,3,541,dendrite,CC,CPNE6;FBXO2;LPAR1
13727,GO:0051168,0.718056659511802,0.64237813258078,1,191,nuclear export,BP,FIP1L1
17763,GO:0097447,0.71895977375069,0.493436048483377,3,542,dendritic tree,CC,CPNE6;FBXO2;LPAR1
2738,GO:0005759,0.719462567817134,0.539388976436277,2,420,mitochondrial matrix,CC,ETNPPL;CDK1
11417,GO:0043903,0.719792252581931,0.64012917850135,1,201,regulation of symbiosis, encompassing mutualism through parasitism,BP,TOP2A
12013,GO:0045444,0.720028362885886,0.639876863711578,1,193,fat cell differentiation,BP,SFRP2
3397,GO:0006753,0.721823179122796,0.489815744118142,3,594,nucleoside phosphate metabolic process,BP,AK5;CDK1;RRM2
17666,GO:0097237,0.725859784328952,0.632369530175821,1,204,cellular response to toxic substance,BP,CDK1
4152,GO:0008514,0.726408591429059,0.631696487699509,1,198,organic anion transmembrane transporter activity,MF,SLCO1A2
6456,GO:0019207,0.726995720956361,0.630916089884757,1,202,kinase regulator activity,MF,PPP1R1B
4063,GO:0008380,0.729024519865259,0.527225931660508,2,405,RNA splicing,BP,FIP1L1;NWD1
3700,GO:0007266,0.730327041277424,0.626685140065492,1,187,Rho protein signal transduction,BP,LPAR1
8701,GO:0032886,0.730582344130612,0.626339194308199,1,189,regulation of microtubule-based process,BP,TPX2
565,GO:0001664,0.730965428332002,0.625712035525234,1,211,G-protein coupled receptor binding,MF,PPP1R1B
12736,GO:0046982,0.731341352816193,0.524240554351749,2,403,protein heterodimerization activity,MF,CRLF1;TOP2A
10602,GO:0042175,0.731379612742011,0.43132965514845,5,947,nuclear outer membrane-endoplasmic reticulum membrane network,CC,HHATL;TF;PTGDS;MYRF;CDK1
13920,GO:0051495,0.731806014339398,0.624678756198225,1,199,positive regulation of cytoskeleton organization,BP,LPAR1
12145,GO:0045732,0.7327109041043,0.623498437885443,1,198,positive regulation of protein catabolic process,BP,DTL
12257,GO:0045935,0.732916552696658,0.389741975009241,9,1589,positive regulation of nucleobase-containing compound metabolic process,BP,MYBL2;FOXM1;FGF1;MYRF;TOP2A;PDGFRA;SFRP2;CDK1;SOX11
16323,GO:0071453,0.733008008651918,0.623073931324568,1,204,cellular response to oxygen levels,BP,LPAR1
3633,GO:0007166,0.73463712664161,0.362858798815643,15,2588,cell surface receptor signaling pathway,BP,CRLF1;ASPM;FGFR3;BIRC5;FGF1;PLP1;PDGFRA;MOG;SFRP2;DAAM2;CRB2;NTSR2;MAL;SOX11;CNTN2
4586,GO:0009755,0.736864926978399,0.618013458568619,1,198,hormone-mediated signaling pathway,BP,PAQR6
19007,GO:1901681,0.737556657150489,0.617059047095694,1,204,sulfur compound binding,MF,FGF1
4545,GO:0009612,0.738499858864668,0.61585484798362,1,195,response to mechanical stimulus,BP,MAG
17329,GO:0090257,0.738947662663961,0.615232729010081,1,199,regulation of muscle system process,BP,SPX
5506,GO:0015711,0.739315713928438,0.513851664608507,2,399,organic anion transport,BP,SLCO1A2;SPX
11651,GO:0044445,0.739458390844287,0.614404563557477,1,227,cytosolic part,CC,RRM2
11544,GO:0044260,0.739757737165681,0.32976590115557,45,7344,cellular macromolecule metabolic process,BP,CRLF1;HHATL;MCM10;FGFR3;TPX2;BIRC5;TF;MYBL2;SNTA1;SEPT4;FOXM1;FGF1;FBXO2;CENPF;NECAB1;MYRF;HSPA2;TOP2A;PPP1R1B;APLNR;PDGFRA;ENPP2;DTL;FIP1L1;SFRP2;CRB2;NKX6-2;CNDP1;BUB1B;S100A1;PI16;PPP1R14A;PBK;BUB1;CDK1;EMX2;RRM2;UBE2C;SOX11;HS3ST4;CNTN2;MBP;LPAR1;ZNF536;FXYD1
11060,GO:0043122,0.740143713033467,0.613580695531904,1,208,regulation of I-kappaB kinase/NF-kappaB signaling,BP,LPAR1
4967,GO:0010821,0.74020902261569,0.613487710992821,1,209,regulation of mitochondrion organization,BP,MYBPC1
9866,GO:0035637,0.740234437206469,0.613565888567342,1,190,multicellular organismal signaling,BP,FXYD1
1638,GO:0003824,0.74172775039277,0.332489295372152,31,5189,catalytic activity,MF,KIFC1;FGFR3;BIRC5;PTGDS;SEPT4;FGF1;FBXO2;MYRF;HSPA2;TOP2A;PDGFRA;ESPL1;ENPP2;DTL;CNDP1;AK5;BUB1B;ETNPPL;KIF6;ALDH1A1;KLK6;PBK;LGI3;BUB1;CDK1;RRM2;CARNS1;UBE2C;HS3ST4;AIFM3;DNAH17
13428,GO:0050714,0.743793574744813,0.608665819089257,1,207,positive regulation of protein secretion,BP,MBP
12456,GO:0046434,0.74460318748653,0.607561842116095,1,208,organophosphate catabolic process,BP,ENPP2
3630,GO:0007163,0.744799002034623,0.607365418765743,1,196,establishment or maintenance of cell polarity,BP,CRB2
13517,GO:0050851,0.745806188647136,0.605862680930295,1,220,antigen receptor-mediated signaling pathway,BP,MOG
6497,GO:0019318,0.746512529050827,0.60495553216515,1,209,hexose metabolic process,BP,ALDH1A1
18967,GO:1901617,0.747891771873267,0.603041168632147,1,214,organic hydroxy compound biosynthetic process,BP,FGF1
3432,GO:0006813,0.748071863480354,0.602831715186766,1,207,potassium ion transport,BP,FXYD1
16968,GO:0072593,0.748719701027636,0.601899123296708,1,215,reactive oxygen species metabolic process,BP,FOXM1
7804,GO:0031330,0.748969025156146,0.601599072112672,1,207,negative regulation of cellular catabolic process,BP,PBK
7986,GO:0031667,0.750624076897624,0.498780573041343,2,416,response to nutrient levels,BP,SPX;SFRP2
16542,GO:0071824,0.751264474114212,0.598367212236894,1,219,protein-DNA complex subunit organization,BP,CENPF
3171,GO:0006457,0.751478164125197,0.598041994530747,1,225,protein folding,BP,HSPA2
9435,GO:0034622,0.752112157384888,0.405550153112041,5,968,cellular protein-containing complex assembly,BP,USH1C;SEPT4;CENPF;UBE2C;MYBPC1
12581,GO:0046651,0.752239500828349,0.597000004741599,1,222,lymphocyte proliferation,BP,SOX11
11089,GO:0043170,0.752544605193076,0.315285938326083,50,8159,macromolecule metabolic process,BP,CRLF1;HHATL;MCM10;FGFR3;TPX2;BIRC5;TF;MYBL2;SNTA1;SEPT4;FOXM1;FGF1;FBXO2;CENPF;NECAB1;PLP1;MYRF;HSPA2;GFAP;TOP2A;PPP1R1B;APLNR;PDGFRA;ESPL1;ENPP2;DTL;FIP1L1;SFRP2;CRB2;NKX6-2;CNDP1;BUB1B;S100A1;PI16;PPP1R14A;KLK6;PBK;BUB1;CDK1;EMX2;RRM2;UBE2C;SOX11;HS3ST4;CNTN2;NWD1;MBP;LPAR1;ZNF536;FXYD1
20531,GO:1905114,0.752823709946439,0.450191993282169,3,583,cell surface receptor signaling pathway involved in cell-cell signaling,BP,ASPM;SFRP2;DAAM2
2951,GO:0006091,0.75341229932061,0.494987567568559,2,433,generation of precursor metabolites and energy,BP,ALDH1A1;CDK1
5884,GO:0016491,0.754984875712182,0.447289683227434,3,642,oxidoreductase activity,MF,ALDH1A1;RRM2;AIFM3
8742,GO:0032943,0.755348607884584,0.592651877497643,1,224,mononuclear cell proliferation,BP,SOX11
5113,GO:0012505,0.756608663065046,0.322789015786989,23,3945,endomembrane system,CC,HHATL;KIFC1;FGFR3;TF;CPNE6;PTGDS;FBXO2;CENPF;PACSIN1;MYRF;SPX;DTL;S100A1;KLK6;LGI3;CDK1;MAL;HS3ST4;CALN1;AIFM3;OPALIN;LPAR1;TMEM235
2749,GO:0005770,0.757114202353803,0.590195122191687,1,219,late endosome,CC,TF
3131,GO:0006403,0.757521810052348,0.589641002514809,1,215,RNA localization,BP,FIP1L1
11322,GO:0043543,0.757727240694715,0.589351118978522,1,215,protein acylation,BP,HHATL
16393,GO:0071560,0.757824389074347,0.589251864689151,1,208,cellular response to transforming growth factor beta stimulus,BP,SOX11
4006,GO:0008285,0.758955457727841,0.442074622875183,3,608,negative regulation of cell proliferation,BP,FBXO2;SFRP2;SOX11
14025,GO:0051704,0.760891434376603,0.345779790486169,11,2025,multi-organism process,BP,CLDN11;KIFC1;ASPM;SEPT4;HSPA2;TOP2A;PPP1R1B;PDGFRA;MOG;BUB1;CDK1
13977,GO:0051606,0.761517740625651,0.583944982005986,1,220,detection of stimulus,BP,DTL
15512,GO:0062012,0.762274381262869,0.4828996956896,2,424,regulation of small molecule metabolic process,BP,FGF1;CDK1
3429,GO:0006810,0.762897244142721,0.31232873499229,26,4422,transport,BP,SLCO1A2;TF;CPNE6;SNTA1;CENPF;PACSIN1;HSPA2;GFAP;SPX;APLNR;ENPP2;SLC14A1;FIP1L1;SLC5A11;S100A1;TMEM144;MOBP;LGI3;CDK1;AQP4;SOX11;CNTN2;NKAIN2;MYBPC1;MBP;FXYD1
19752,GO:1903530,0.762938216283789,0.436774484285184,3,607,regulation of secretion by cell,BP,LGI3;SOX11;MBP
2607,GO:0005515,0.763428455732725,0.30618507115875,63,10177,protein binding,MF,CRLF1;USH1C;CLDN11;KIFC1;MCM10;ASPM;FGFR3;DCX;TPX2;BIRC5;TF;CPNE6;MYBL2;SNTA1;MAG;PTGDS;SEPT4;NCAPG;FOXM1;FGF1;FBXO2;CENPF;PLP1;PACSIN1;HSPA2;GFAP;TOP2A;PPP1R1B;SPX;PDGFRA;ESPL1;ERMN;ENPP2;MOG;NUSAP1;DTL;FIP1L1;SFRP2;DAAM2;CRB2;MKI67;HSPB8;BUB1B;SLC5A11;S100A1;ETNPPL;KIF6;KLK6;PBK;MOBP;BUB1;CDK1;EMX2;RRM2;AQP4;MAL;UBE2C;CNTN2;DNAH17;MYBPC1;MBP;LPAR1;FXYD1
15378,GO:0061630,0.763915127570008,0.580552636930835,1,212,ubiquitin protein ligase activity,MF,UBE2C
5625,GO:0015931,0.763961409344798,0.580444151869522,1,220,nucleobase-containing compound transport,BP,FIP1L1
5806,GO:0016311,0.765407872394046,0.478588289705994,2,412,dephosphorylation,BP,PPP1R1B;PPP1R14A
19666,GO:1903362,0.765895733804226,0.577654972976635,1,220,regulation of cellular protein catabolic process,BP,PBK
16392,GO:0071559,0.766170381020728,0.577299747520115,1,212,response to transforming growth factor beta,BP,SOX11
13762,GO:0051223,0.768439494328767,0.429386855637998,3,611,regulation of protein transport,BP,CDK1;MYBPC1;MBP
5297,GO:0015075,0.768721683362738,0.402375400521989,4,783,ion transmembrane transporter activity,MF,SLCO1A2;TF;SLC5A11;FXYD1
7987,GO:0031668,0.768923546283839,0.573241624852769,1,223,cellular response to extracellular stimulus,BP,SFRP2
4667,GO:0010033,0.769184240164064,0.319940502617761,16,2846,response to organic substance,BP,CRLF1;FGFR3;BIRC5;MYBL2;FGF1;FBXO2;HSPA2;PPP1R1B;PDGFRA;SFRP2;CRB2;PAQR6;CDK1;AQP4;SOX11;LPAR1
7802,GO:0031328,0.769362000736809,0.345730742119744,9,1652,positive regulation of cellular biosynthetic process,BP,MYBL2;FOXM1;FGF1;MYRF;TOP2A;PDGFRA;SFRP2;CDK1;SOX11
7320,GO:0030336,0.769487427801476,0.572453963930046,1,216,negative regulation of cell migration,BP,SFRP2
1276,GO:0002793,0.76969782517998,0.572100640437786,1,225,positive regulation of peptide secretion,BP,MBP
3096,GO:0006352,0.769966815332791,0.571716896042817,1,223,DNA-templated transcription, initiation,BP,CDK1
15391,GO:0061659,0.771228626020713,0.569897079958637,1,217,ubiquitin-like protein ligase activity,MF,UBE2C
15906,GO:0070661,0.771958280975903,0.568736433937456,1,235,leukocyte proliferation,BP,SOX11
10809,GO:0042592,0.773228727907916,0.347492828780005,8,1500,homeostatic process,BP,USH1C;TF;SPX;APLNR;PDGFRA;AQP4;UBE2C;LPAR1
18965,GO:1901615,0.773314532553138,0.467484009319239,2,433,organic hydroxy compound metabolic process,BP,FGF1;ALDH1A1
3629,GO:0007162,0.773442012528141,0.566608452191335,1,222,negative regulation of cell adhesion,BP,MBP
16989,GO:0072659,0.775301456340583,0.563860654628193,1,220,protein localization to plasma membrane,BP,PACSIN1
16223,GO:0071310,0.776507038709731,0.3194033721281,13,2351,cellular response to organic substance,BP,CRLF1;FGFR3;BIRC5;MYBL2;FGF1;HSPA2;PDGFRA;SFRP2;CRB2;PAQR6;AQP4;SOX11;LPAR1
12665,GO:0046873,0.779833787223921,0.45825681074587,2,412,metal ion transmembrane transporter activity,MF,TF;SLC5A11
5927,GO:0016570,0.779928365258895,0.458109852434874,2,418,histone modification,BP,PPP1R1B;CDK1
4374,GO:0009150,0.779956631234089,0.458012939874003,2,450,purine ribonucleotide metabolic process,BP,AK5;CDK1
4376,GO:0009152,0.780230467354757,0.556401745538543,1,235,purine ribonucleotide biosynthetic process,BP,AK5
9401,GO:0034504,0.780270325566426,0.556384059700968,1,226,protein localization to nucleus,BP,CDK1
1252,GO:0002757,0.78063126802468,0.457051213998769,2,447,immune response-activating signal transduction,BP,MOG;S100A1
5642,GO:0015980,0.780950314854865,0.555274318673843,1,244,energy derivation by oxidation of organic compounds,BP,CDK1
4510,GO:0009410,0.780971630294139,0.55528145829123,1,235,response to xenobiotic stimulus,BP,PPP1R1B
4621,GO:0009891,0.781478884356615,0.330713094367471,9,1673,positive regulation of biosynthetic process,BP,MYBL2;FOXM1;FGF1;MYRF;TOP2A;PDGFRA;SFRP2;CDK1;SOX11
4655,GO:0009991,0.781878042021269,0.455266007898451,2,444,response to extracellular stimulus,BP,SPX;SFRP2
2888,GO:0005996,0.782556225462338,0.552882389845468,1,234,monosaccharide metabolic process,BP,ALDH1A1
12674,GO:0046883,0.78275410534639,0.552590687090744,1,232,regulation of hormone secretion,BP,SOX11
10641,GO:0042277,0.783707479785139,0.551106258924396,1,239,peptide binding,MF,FBXO2
3445,GO:0006836,0.784386483654607,0.55012000160498,1,228,neurotransmitter transport,BP,GFAP
3077,GO:0006310,0.784530460298907,0.549880729767258,1,232,DNA recombination,BP,TOP2A
18950,GO:1901575,0.784666719687646,0.321373537111777,10,1889,organic substance catabolic process,BP,FBXO2;GFAP;ENPP2;DTL;BUB1B;ALDH1A1;PBK;CDK1;CARNS1;UBE2C
7973,GO:0031647,0.784889526931303,0.549321858759456,1,234,regulation of protein stability,BP,TF
2988,GO:0006164,0.785486326161276,0.54838449408711,1,239,purine nucleotide biosynthetic process,BP,AK5
21223,GO:2000146,0.785781539881996,0.547982383323131,1,228,negative regulation of cell motility,BP,SFRP2
8199,GO:0032103,0.785975960160769,0.547602619007167,1,246,positive regulation of response to external stimulus,BP,LPAR1
11534,GO:0044238,0.786772293630325,0.277153636797412,56,9218,primary metabolic process,BP,CRLF1;HHATL;MCM10;FGFR3;TPX2;BIRC5;TF;CPNE6;MYBL2;SNTA1;PTGDS;SEPT4;FOXM1;FGF1;FBXO2;CENPF;NECAB1;PLP1;MYRF;HSPA2;GFAP;TOP2A;PPP1R1B;APLNR;PDGFRA;ESPL1;ENPP2;DTL;FIP1L1;SFRP2;CRB2;NKX6-2;CNDP1;AK5;BUB1B;S100A1;ETNPPL;PI16;ALDH1A1;PPP1R14A;KLK6;PBK;BUB1;CDK1;EMX2;RRM2;CARNS1;UBE2C;SOX11;HS3ST4;CNTN2;NWD1;MBP;LPAR1;ZNF536;FXYD1
12225,GO:0045893,0.787930364616561,0.336768012134137,7,1329,positive regulation of transcription, DNA-templated,BP,MYBL2;FOXM1;FGF1;MYRF;TOP2A;SFRP2;SOX11
19735,GO:1903508,0.787930364616561,0.336768012134137,7,1329,positive regulation of nucleic acid-templated transcription,BP,MYBL2;FOXM1;FGF1;MYRF;TOP2A;SFRP2;SOX11
5926,GO:0016569,0.788525305744042,0.445669905960453,2,426,covalent chromatin modification,BP,PPP1R1B;CDK1
19365,GO:1902680,0.788536639971546,0.335988848759042,7,1330,positive regulation of RNA biosynthetic process,BP,MYBL2;FOXM1;FGF1;MYRF;TOP2A;SFRP2;SOX11
3687,GO:0007249,0.789665348883151,0.541922758522069,1,241,I-kappaB kinase/NF-kappaB signaling,BP,LPAR1
5678,GO:0016054,0.790695155951561,0.540281809104457,1,250,organic acid catabolic process,BP,CARNS1
12447,GO:0046395,0.790695155951561,0.540281809104457,1,250,carboxylic acid catabolic process,BP,CARNS1
14444,GO:0055114,0.792686283909688,0.370202338437591,4,870,oxidation-reduction process,BP,ALDH1A1;CDK1;RRM2;AIFM3
17216,GO:0090087,0.792827509664653,0.395737473951822,3,639,regulation of peptide transport,BP,CDK1;MYBPC1;MBP
1253,GO:0002758,0.794548061415771,0.534259737654892,1,245,innate immune response-activating signal transduction,BP,S100A1
4460,GO:0009259,0.79486545882176,0.436288550715803,2,465,ribonucleotide metabolic process,BP,AK5;CDK1
14425,GO:0055086,0.794925691065024,0.392746553344695,3,670,nucleobase-containing small molecule metabolic process,BP,AK5;CDK1;RRM2
18433,GO:0110053,0.795865625576701,0.532216517091162,1,236,regulation of actin filament organization,BP,LPAR1
2987,GO:0006163,0.796276530348814,0.434194102090159,2,467,purine nucleotide metabolic process,BP,AK5;CDK1
13531,GO:0050865,0.796442875911162,0.433951724506072,2,464,regulation of cell activation,BP,PDGFRA;SOX11
17973,GO:0098656,0.796727761327882,0.530858158630663,1,234,anion transmembrane transport,BP,FXYD1
6047,GO:0016787,0.797024851304529,0.297688966766294,12,2218,hydrolase activity,MF,KIFC1;SEPT4;MYRF;HSPA2;TOP2A;ESPL1;ENPP2;CNDP1;KIF6;KLK6;CARNS1;DNAH17
16275,GO:0071383,0.797146753578963,0.530173734988488,1,238,cellular response to steroid hormone stimulus,BP,PAQR6
4461,GO:0009260,0.797420171669908,0.529695172732165,1,248,ribonucleotide biosynthetic process,BP,AK5
11478,GO:0044085,0.798125527093162,0.285217532417785,16,2879,cellular component biogenesis,BP,USH1C;KIFC1;ASPM;TPX2;BIRC5;MYBL2;SEPT4;CENPF;HSPA2;GFAP;HAPLN2;PDGFRA;CDK1;UBE2C;MYBPC1;LPAR1
2722,GO:0005737,0.798687108945608,0.265232715553793,62,10141,cytoplasm,CC,CRLF1;USH1C;HHATL;KIFC1;BCAS1;ASPM;FGFR3;DCX;TPX2;BIRC5;TF;CPNE6;SNTA1;MAG;PTGDS;SEPT4;NCAPG;FGF1;FBXO2;CENPF;NECAB1;PACSIN1;MYRF;HSPA2;GFAP;TOP2A;PPP1R1B;SPX;PDGFRA;ESPL1;ERMN;NUSAP1;DTL;CNDP1;HSPB8;AK5;BUB1B;S100A1;ETNPPL;KIF6;ALDH1A1;PPP1R14A;KLK6;MOBP;LGI3;BUB1;CDK1;RRM2;AQP4;MAL;CARNS1;UBE2C;SOX11;HS3ST4;CALN1;AIFM3;DNAH17;NWD1;MYBPC1;OPALIN;LPAR1;TMEM235
16917,GO:0072522,0.799742165909445,0.525976805169688,1,250,purine-containing compound biosynthetic process,BP,AK5
3699,GO:0007265,0.801005288647459,0.427183931642005,2,438,Ras protein signal transduction,BP,FOXM1;LPAR1
12444,GO:0046390,0.801084783607655,0.523815089120054,1,251,ribose phosphate biosynthetic process,BP,AK5
18030,GO:0098794,0.801668072291779,0.426202852416009,2,430,postsynapse,CC,FBXO2;LPAR1
4625,GO:0009895,0.802765708317945,0.521139191178448,1,242,negative regulation of catabolic process,BP,PBK
13997,GO:0051650,0.802768489853932,0.521152631294044,1,238,establishment of vesicle localization,BP,MOBP
18219,GO:0099503,0.804344229956491,0.354124159358155,4,865,secretory vesicle,CC,TF;SPX;KLK6;LGI3
15643,GO:0070201,0.804903726966146,0.378508570691067,3,653,regulation of establishment of protein localization,BP,CDK1;MYBPC1;MBP
6601,GO:0019693,0.807897878381313,0.416695077687335,2,479,ribose phosphate metabolic process,BP,AK5;CDK1
10539,GO:0042060,0.808448770857924,0.415885047458209,2,459,wound healing,BP,PDGFRA;KLK6
13789,GO:0051258,0.809133259968665,0.510691304026399,1,250,protein polymerization,BP,UBE2C
1259,GO:0002764,0.809778958386939,0.413825804972182,2,476,immune response-regulating signaling pathway,BP,MOG;S100A1
3754,GO:0007409,0.810476753719943,0.412822465069767,2,435,axonogenesis,BP,MAG;CNTN2
3636,GO:0007169,0.810714412802549,0.370089942154247,3,645,transmembrane receptor protein tyrosine kinase signaling pathway,BP,FGFR3;FGF1;PDGFRA
3954,GO:0008202,0.812001521853542,0.505894554313501,1,259,steroid metabolic process,BP,FGF1
15405,GO:0061695,0.812028297167008,0.505882024980833,1,251,transferase complex, transferring phosphorus-containing groups,CC,CDK1
5936,GO:0016579,0.812145740246604,0.505694503540576,1,249,protein deubiquitination,BP,CDK1
2677,GO:0005654,0.812297672450138,0.264084599463414,18,3238,nucleoplasm,CC,MCM10;TPX2;BIRC5;MYBL2;SEPT4;FOXM1;CENPF;NECAB1;MYRF;TOP2A;DTL;FIP1L1;MKI67;HSPB8;FAM107A;BUB1;CDK1;UBE2C
2595,GO:0005488,0.814003553845742,0.262005606092251,79,12653,binding,MF,CRLF1;USH1C;CLDN11;KIFC1;MCM10;ASPM;FGFR3;DCX;TPX2;BIRC5;TF;CPNE6;MYBL2;SNTA1;MAG;PTGDS;SEPT4;NCAPG;FOXM1;FGF1;FBXO2;CENPF;NECAB1;PLP1;PACSIN1;MYRF;HSPA2;GFAP;TOP2A;PPP1R1B;IQCA1;HAPLN2;SPX;PDGFRA;ESPL1;ERMN;ENPP2;MOG;NUSAP1;DTL;FIP1L1;SFRP2;DAAM2;CRB2;MKI67;NKX6-2;CNDP1;FREM2;HSPB8;AK5;BUB1B;SLC5A11;S100A1;PAQR6;ETNPPL;KIF6;ALDH1A1;KLK6;PBK;MOBP;BUB1;CDK1;EMX2;RRM2;AQP4;MAL;CARNS1;UBE2C;SOX11;CALN1;AIFM3;CNTN2;DNAH17;NWD1;MYBPC1;MBP;LPAR1;ZNF536;FXYD1
18032,GO:0098796,0.814511390786401,0.323278871732931,5,1047,membrane protein complex,CC,TF;SNTA1;HSPA2;CNTN2;FXYD1
9547,GO:0034976,0.815837745664371,0.499454338600881,1,260,response to endoplasmic reticulum stress,BP,FBXO2
17078,GO:0080134,0.816326222344551,0.308781617141932,6,1232,regulation of response to stress,BP,FOXM1;PDGFRA;SFRP2;HSPB8;S100A1;PBK
16969,GO:0072594,0.816620897408252,0.403242690091078,2,493,establishment of protein localization to organelle,BP,CDK1;MYBPC1
3755,GO:0007411,0.817063370243196,0.497483710677166,1,236,axon guidance,BP,CNTN2
1694,GO:0003924,0.817115241945474,0.49725220650767,1,271,GTPase activity,MF,SEPT4
8124,GO:0031982,0.817153409890234,0.253745147555527,21,3801,vesicle,CC,CLDN11;KIFC1;BCAS1;FGFR3;TF;CPNE6;PTGDS;FBXO2;PACSIN1;HSPA2;SPX;ERMN;DAAM2;CRB2;FREM2;PI16;ALDH1A1;KLK6;LGI3;CDK1;LPAR1
935,GO:0002218,0.81761121902045,0.496443965406014,1,262,activation of innate immune response,BP,S100A1
21075,GO:1990778,0.81848335905256,0.495004903302871,1,251,protein localization to cell periphery,BP,PACSIN1
13995,GO:0051648,0.818981689178081,0.494159844883398,1,250,vesicle localization,BP,MOBP
6698,GO:0019904,0.819315270522686,0.357434849563465,3,653,protein domain specific binding,MF,SNTA1;HSPA2;LPAR1
17784,GO:0097485,0.819524229273274,0.493286729323933,1,238,neuron projection guidance,BP,CNTN2
5668,GO:0016042,0.820797478425478,0.490975656515901,1,270,lipid catabolic process,BP,ENPP2
7394,GO:0030522,0.821428138405958,0.489945780392491,1,256,intracellular receptor signaling pathway,BP,ZNF536
16916,GO:0072521,0.821468910769323,0.395655685351596,2,494,purine-containing compound metabolic process,BP,AK5;CDK1
3447,GO:0006839,0.821937101847572,0.488991934299329,1,277,mitochondrial transport,BP,MYBPC1
18539,GO:0150034,0.822874621596128,0.487465070902496,1,253,distal axon,CC,PACSIN1
13798,GO:0051271,0.823830627666849,0.485802733718432,1,255,negative regulation of cellular component movement,BP,SFRP2
16356,GO:0071495,0.82474931517764,0.297301640069053,6,1205,cellular response to endogenous stimulus,BP,FGFR3;FGF1;SFRP2;CRB2;PAQR6;SOX11
1609,GO:0003700,0.825428490608109,0.287393796214546,7,1401,DNA binding transcription factor activity,MF,MYBL2;FOXM1;MYRF;NKX6-2;EMX2;SOX11;ZNF536
18801,GO:1901137,0.825442390121739,0.348265467607262,3,685,carbohydrate derivative biosynthetic process,BP,NECAB1;AK5;RRM2
5469,GO:0015629,0.825568326106664,0.389231438265011,2,454,actin cytoskeleton,CC,MOBP;MYBPC1
19909,GO:1903827,0.825961084298375,0.388573199366085,2,476,regulation of cellular protein localization,BP,CDK1;MYBPC1
15900,GO:0070646,0.829463614123518,0.475913225113477,1,264,protein modification by small protein removal,BP,CDK1
6692,GO:0019898,0.830421414737369,0.474219135205165,1,264,extrinsic component of membrane,CC,TF
13996,GO:0051649,0.83048281505586,0.262997513328203,10,1938,establishment of localization in cell,BP,KIFC1;CENPF;PACSIN1;APLNR;ESPL1;NUSAP1;FIP1L1;MOBP;CDK1;MYBPC1
13785,GO:0051254,0.830587756886895,0.280404608673842,7,1398,positive regulation of RNA metabolic process,BP,MYBL2;FOXM1;FGF1;MYRF;TOP2A;SFRP2;SOX11
3549,GO:0007005,0.831517787030735,0.379623103331756,2,513,mitochondrion organization,BP,SEPT4;MYBPC1
2764,GO:0005788,0.832443945386362,0.470612512034782,1,267,endoplasmic reticulum lumen,CC,TF
3082,GO:0006325,0.832801110189808,0.337143148433802,3,674,chromatin organization,BP,PPP1R1B;MKI67;CDK1
13439,GO:0050727,0.83394843193679,0.467865758744785,1,283,regulation of inflammatory response,BP,PBK
954,GO:0002253,0.834326114778962,0.375090170613717,2,504,activation of immune response,BP,MOG;S100A1
9533,GO:0034774,0.83661834394316,0.463021905050951,1,294,secretory granule lumen,CC,TF
10495,GO:0040013,0.836647163697534,0.463061417241551,1,267,negative regulation of locomotion,BP,SFRP2
12670,GO:0046879,0.837583178594589,0.461339555883879,1,274,hormone secretion,BP,SOX11
4174,GO:0008544,0.837709811361401,0.461116795386263,1,272,epidermis development,BP,USH1C
2421,GO:0005096,0.840290215315298,0.456447376180429,1,262,GTPase activator activity,MF,ALDH1A1
4841,GO:0010629,0.844349011553828,0.254759597843223,8,1630,negative regulation of gene expression,BP,BIRC5;FOXM1;CENPF;SFRP2;NKX6-2;S100A1;SOX11;ZNF536
12593,GO:0046677,0.84610233992101,0.445591334877655,1,290,response to antibiotic,BP,CDK1
4631,GO:0009914,0.846671819010183,0.444548331616175,1,283,hormone transport,BP,SOX11
13494,GO:0050808,0.848024093105139,0.442080851269575,1,263,synapse organization,BP,CNTN2
7175,GO:0030141,0.849098584153489,0.311827235740672,3,736,secretory granule,CC,TF;SPX;KLK6
473,GO:0001505,0.850732079103422,0.436886543192967,1,283,regulation of neurotransmitter levels,BP,GFAP
7957,GO:0031625,0.85107185676491,0.436211117315839,1,292,ubiquitin protein ligase binding,MF,UBE2C
2723,GO:0005739,0.851388559706366,0.251651258844146,7,1555,mitochondrion,CC,SEPT4;HSPA2;ETNPPL;KLK6;MOBP;CDK1;AIFM3
3810,GO:0007596,0.852045655793094,0.434354767734825,1,292,blood coagulation,BP,PDGFRA
14598,GO:0060205,0.852114757064031,0.434169416513375,1,310,cytoplasmic vesicle lumen,CC,TF
13791,GO:0051260,0.852172085152126,0.434107026368604,1,294,protein homooligomerization,BP,SEPT4
8125,GO:0031983,0.853024583330173,0.432425924067371,1,311,vesicle lumen,CC,TF
8639,GO:0032787,0.853252308624786,0.343576579488477,2,530,monocarboxylic acid metabolic process,BP,PTGDS;PLP1
13500,GO:0050817,0.854148393755739,0.430317878244896,1,294,coagulation,BP,PDGFRA
16286,GO:0071396,0.854721377293944,0.341086744358632,2,514,cellular response to lipid,BP,PAQR6;LPAR1
16246,GO:0071345,0.855802063582347,0.279049912404207,4,951,cellular response to cytokine stimulus,BP,CRLF1;BIRC5;MYBL2;AQP4
3813,GO:0007599,0.856493645719258,0.425776914864493,1,297,hemostasis,BP,PDGFRA
4773,GO:0010506,0.857295822340835,0.424233490522333,1,292,regulation of autophagy,BP,GFAP
8126,GO:0031984,0.859661489679147,0.239986519880341,7,1491,organelle subcompartment,CC,HHATL;TF;PTGDS;MYRF;CDK1;HS3ST4;CALN1
174,GO:0000377,0.860357251739549,0.418185548801809,1,311,RNA splicing, via transesterification reactions with bulged adenosine as nucleophile,BP,FIP1L1
186,GO:0000398,0.860357251739549,0.418185548801809,1,311,mRNA splicing, via spliceosome,BP,FIP1L1
173,GO:0000375,0.862846133721054,0.413256114554121,1,314,RNA splicing, via transesterification reactions,BP,FIP1L1
11851,GO:0045089,0.863186588808972,0.412601801027814,1,306,positive regulation of innate immune response,BP,S100A1
11618,GO:0044389,0.863202230417115,0.412573572438336,1,305,ubiquitin-like protein ligase binding,MF,UBE2C
4540,GO:0009605,0.864980118799898,0.221060904574047,9,1859,response to external stimulus,BP,MAG;FGF1;SPX;PDGFRA;ENPP2;SFRP2;PBK;CNTN2;LPAR1
8806,GO:0033036,0.865556719759729,0.204341089893069,14,2693,macromolecule localization,BP,USH1C;SLCO1A2;TF;SEPT4;CENPF;PACSIN1;SPX;FIP1L1;BUB1B;CDK1;MAL;CNTN2;MYBPC1;MBP
7073,GO:0022890,0.86667806361855,0.320289344883257,2,517,inorganic cation transmembrane transporter activity,MF,TF;SLC5A11
1053,GO:0002429,0.867900687198558,0.403109419971481,1,318,immune response-activating cell surface receptor signaling pathway,BP,MOG
7476,GO:0030695,0.868879380450603,0.401199730303991,1,292,GTPase regulator activity,MF,ALDH1A1
11128,GO:0043226,0.870753305295785,0.184142557516065,72,11807,organelle,CC,USH1C;HHATL;CLDN11;KIFC1;BCAS1;MCM10;ASPM;FGFR3;DCX;TPX2;BIRC5;TF;CPNE6;MYBL2;SNTA1;PTGDS;SEPT4;NCAPG;FOXM1;FGF1;FBXO2;CENPF;NECAB1;PACSIN1;MYRF;HSPA2;GFAP;TOP2A;PPP1R1B;SPX;PDGFRA;ESPL1;ERMN;NUSAP1;SLC14A1;DTL;FIP1L1;DAAM2;CRB2;MKI67;NKX6-2;FREM2;HSPB8;AK5;BUB1B;S100A1;ETNPPL;PI16;KIF6;ALDH1A1;KLK6;PBK;FAM107A;MOBP;LGI3;BUB1;CDK1;EMX2;MAL;UBE2C;SOX11;HS3ST4;CALN1;AIFM3;DNAH17;NWD1;MYBPC1;OPALIN;MBP;LPAR1;ZNF536;TMEM235
8121,GO:0031974,0.871184721293069,0.18215929894397,26,4759,membrane-enclosed lumen,CC,MCM10;TPX2;BIRC5;TF;MYBL2;SEPT4;FOXM1;FGF1;CENPF;NECAB1;MYRF;HSPA2;TOP2A;NUSAP1;SLC14A1;DTL;FIP1L1;MKI67;HSPB8;BUB1B;ETNPPL;KLK6;FAM107A;BUB1;CDK1;UBE2C
11135,GO:0043233,0.871184721293069,0.18215929894397,26,4759,organelle lumen,CC,MCM10;TPX2;BIRC5;TF;MYBL2;SEPT4;FOXM1;FGF1;CENPF;NECAB1;MYRF;HSPA2;TOP2A;NUSAP1;SLC14A1;DTL;FIP1L1;MKI67;HSPB8;BUB1B;ETNPPL;KLK6;FAM107A;BUB1;CDK1;UBE2C
15532,GO:0070013,0.871184721293069,0.18215929894397,26,4759,intracellular organelle lumen,CC,MCM10;TPX2;BIRC5;TF;MYBL2;SEPT4;FOXM1;FGF1;CENPF;NECAB1;MYRF;HSPA2;TOP2A;NUSAP1;SLC14A1;DTL;FIP1L1;MKI67;HSPB8;BUB1B;ETNPPL;KLK6;FAM107A;BUB1;CDK1;UBE2C
1614,GO:0003713,0.871221958426121,0.396384838934653,1,303,transcription coactivator activity,MF,SOX11
7750,GO:0031253,0.872959410848267,0.392831627573518,1,296,cell projection membrane,CC,PACSIN1
666,GO:0001817,0.875219001766421,0.304959322578265,2,561,regulation of cytokine production,BP,MOG;MBP
4333,GO:0009101,0.87528580013417,0.387967107767798,1,310,glycoprotein biosynthetic process,BP,NECAB1
19444,GO:1902903,0.87676644674411,0.384879900914096,1,308,regulation of supramolecular fiber organization,BP,LPAR1
3212,GO:0006518,0.87886377156434,0.263197076518686,3,803,peptide metabolic process,BP,GFAP;CARNS1;SOX11
3213,GO:0006520,0.879287976639326,0.379489224378928,1,340,cellular amino acid metabolic process,BP,CARNS1
16492,GO:0071704,0.879918586733197,0.165982588790128,56,9506,organic substance metabolic process,BP,CRLF1;HHATL;MCM10;FGFR3;TPX2;BIRC5;TF;CPNE6;MYBL2;SNTA1;PTGDS;SEPT4;FOXM1;FGF1;FBXO2;CENPF;NECAB1;PLP1;MYRF;HSPA2;GFAP;TOP2A;PPP1R1B;APLNR;PDGFRA;ESPL1;ENPP2;DTL;FIP1L1;SFRP2;CRB2;NKX6-2;CNDP1;AK5;BUB1B;S100A1;ETNPPL;PI16;ALDH1A1;PPP1R14A;KLK6;PBK;BUB1;CDK1;EMX2;RRM2;CARNS1;UBE2C;SOX11;HS3ST4;CNTN2;NWD1;MBP;LPAR1;ZNF536;FXYD1
11643,GO:0044432,0.880402351629082,0.227046009108824,5,1172,endoplasmic reticulum part,CC,HHATL;TF;PTGDS;MYRF;CDK1
3517,GO:0006950,0.881622654889574,0.177704897337049,17,3316,response to stress,BP,MCM10;FOXM1;FGF1;FBXO2;PLP1;HSPA2;GFAP;TOP2A;PDGFRA;DTL;SFRP2;HSPB8;S100A1;KLK6;PBK;CDK1;AQP4
8966,GO:0033365,0.882120282626365,0.257682024529547,3,778,protein localization to organelle,BP,BUB1B;CDK1;MYBPC1
14693,GO:0060341,0.884407819205046,0.253781368099369,3,760,regulation of cellular localization,BP,APLNR;CDK1;MYBPC1
10797,GO:0042578,0.884959438533701,0.367398399933762,1,321,phosphoric ester hydrolase activity,MF,ENPP2
11414,GO:0043900,0.885068063368875,0.367118991286028,1,339,regulation of multi-organism process,BP,TOP2A
7021,GO:0022407,0.885168549440777,0.366908367160134,1,336,regulation of cell-cell adhesion,BP,MBP
3520,GO:0006954,0.885962833158974,0.285162989103596,2,589,inflammatory response,BP,PLP1;PBK
3891,GO:0008104,0.886306324496281,0.18110197418504,12,2415,protein localization,BP,USH1C;TF;SEPT4;CENPF;PACSIN1;FIP1L1;BUB1B;CDK1;MAL;CNTN2;MYBPC1;MBP
1597,GO:0003677,0.887210564870923,0.182630637968296,11,2234,DNA binding,MF,MCM10;MYBL2;FOXM1;MYRF;TOP2A;NUSAP1;MKI67;NKX6-2;EMX2;SOX11;ZNF536
5298,GO:0015077,0.887981730686959,0.360795087722761,1,329,monovalent inorganic cation transmembrane transporter activity,MF,SLC5A11
13680,GO:0051098,0.889287720224919,0.357915196560379,1,333,regulation of binding,BP,SOX11
1262,GO:0002768,0.891088908715034,0.353898806911368,1,347,immune response-regulating cell surface receptor signaling pathway,BP,MOG
11129,GO:0043227,0.891262270825398,0.154697730132823,66,11041,membrane-bounded organelle,CC,HHATL;CLDN11;KIFC1;BCAS1;MCM10;ASPM;FGFR3;TPX2;BIRC5;TF;CPNE6;MYBL2;PTGDS;SEPT4;NCAPG;FOXM1;FGF1;FBXO2;CENPF;NECAB1;PACSIN1;MYRF;HSPA2;GFAP;TOP2A;PPP1R1B;SPX;PDGFRA;ESPL1;ERMN;NUSAP1;SLC14A1;DTL;FIP1L1;DAAM2;CRB2;MKI67;NKX6-2;FREM2;HSPB8;BUB1B;S100A1;ETNPPL;PI16;KIF6;ALDH1A1;KLK6;PBK;FAM107A;MOBP;LGI3;BUB1;CDK1;EMX2;MAL;UBE2C;SOX11;HS3ST4;CALN1;AIFM3;NWD1;OPALIN;MBP;LPAR1;ZNF536;TMEM235
2744,GO:0005765,0.891368850374868,0.353301982752526,1,336,lysosomal membrane,CC,GFAP
18068,GO:0098852,0.891368850374868,0.353301982752526,1,336,lytic vacuole membrane,CC,GFAP
4300,GO:0009056,0.89224412454783,0.175555139945097,11,2305,catabolic process,BP,FBXO2;GFAP;ENPP2;DTL;BUB1B;ALDH1A1;KLK6;PBK;CDK1;CARNS1;UBE2C
13150,GO:0048667,0.893869117037709,0.270246288565046,2,537,cell morphogenesis involved in neuron differentiation,BP,MAG;CNTN2
3698,GO:0007264,0.894259499624187,0.269484254385788,2,550,small GTPase mediated signal transduction,BP,FOXM1;LPAR1
9174,GO:0034097,0.895564620226607,0.215587066074563,4,1030,response to cytokine,BP,CRLF1;BIRC5;MYBL2;AQP4
3095,GO:0006351,0.896951022171232,0.155957443007021,18,3476,transcription, DNA-templated,BP,BIRC5;MYBL2;FOXM1;FGF1;CENPF;MYRF;TOP2A;PPP1R1B;FIP1L1;SFRP2;CRB2;NKX6-2;S100A1;CDK1;EMX2;RRM2;SOX11;ZNF536
13557,GO:0050900,0.897663451946008,0.339074279838276,1,357,leukocyte migration,BP,MAG
4032,GO:0008324,0.897721711460792,0.262783738295272,2,570,cation transmembrane transporter activity,MF,TF;SLC5A11
14873,GO:0060589,0.898099429896489,0.338133464890614,1,332,nucleoside-triphosphatase regulator activity,MF,ALDH1A1
12174,GO:0045785,0.899016919717658,0.335984935887122,1,352,positive regulation of cell adhesion,BP,SFRP2
3426,GO:0006807,0.899486461256663,0.140836680544275,51,8813,nitrogen compound metabolic process,BP,CRLF1;HHATL;MCM10;FGFR3;TPX2;BIRC5;TF;MYBL2;SNTA1;SEPT4;FOXM1;FGF1;FBXO2;CENPF;NECAB1;MYRF;HSPA2;GFAP;TOP2A;PPP1R1B;APLNR;PDGFRA;ESPL1;ENPP2;DTL;FIP1L1;SFRP2;CRB2;NKX6-2;CNDP1;AK5;BUB1B;S100A1;PI16;PPP1R14A;KLK6;PBK;BUB1;CDK1;EMX2;RRM2;CARNS1;UBE2C;SOX11;HS3ST4;CNTN2;NWD1;MBP;LPAR1;ZNF536;FXYD1
17859,GO:0097659,0.900512621793691,0.151165204135275,18,3490,nucleic acid-templated transcription,BP,BIRC5;MYBL2;FOXM1;FGF1;CENPF;MYRF;TOP2A;PPP1R1B;FIP1L1;SFRP2;CRB2;NKX6-2;S100A1;CDK1;EMX2;RRM2;SOX11;ZNF536
8118,GO:0031967,0.900940830325653,0.206553909308701,4,1053,organelle envelope,CC,PTGDS;CENPF;DTL;AIFM3
8122,GO:0031975,0.900940830325653,0.206553909308701,4,1053,envelope,CC,PTGDS;CENPF;DTL;AIFM3
15808,GO:0070482,0.901765919045817,0.329629722170882,1,353,response to oxygen levels,BP,LPAR1
7183,GO:0030155,0.901835277954923,0.254736000292529,2,582,regulation of cell adhesion,BP,SFRP2;MBP
668,GO:0001819,0.902347070784505,0.328258208847313,1,362,positive regulation of cytokine production,BP,MBP
2769,GO:0005794,0.903288026283266,0.182121745924731,6,1379,Golgi apparatus,CC,FGFR3;PTGDS;MYRF;HS3ST4;CALN1;OPALIN
8628,GO:0032774,0.903659319487834,0.146911225628128,18,3503,RNA biosynthetic process,BP,BIRC5;MYBL2;FOXM1;FGF1;CENPF;MYRF;TOP2A;PPP1R1B;FIP1L1;SFRP2;CRB2;NKX6-2;S100A1;CDK1;EMX2;RRM2;SOX11;ZNF536
13091,GO:0048545,0.904022512293766,0.324352040678681,1,355,response to steroid hormone,BP,PAQR6
11850,GO:0045088,0.904619236092782,0.322936317754985,1,361,regulation of innate immune response,BP,S100A1
13780,GO:0051249,0.905492070618136,0.320859006471685,1,370,regulation of lymphocyte activation,BP,SOX11
1195,GO:0002683,0.907344498435824,0.316464274186039,1,368,negative regulation of immune system process,BP,SOX11
665,GO:0001816,0.907981435413397,0.242489921091354,2,618,cytokine production,BP,MOG;MBP
3910,GO:0008134,0.908505489617535,0.241456047993537,2,593,transcription factor binding,MF,CENPF;ENPP2
5957,GO:0016607,0.908843212172833,0.312891734918155,1,361,nuclear speck,CC,FAM107A
7820,GO:0031347,0.909561800198285,0.239303629457219,2,622,regulation of defense response,BP,S100A1;PBK
371,GO:0000989,0.911232337586089,0.235937121302983,2,599,transcription factor activity, transcription factor binding,MF,MYBL2;SOX11
11555,GO:0044281,0.911965783824514,0.157281986624978,8,1868,small molecule metabolic process,BP,PTGDS;FGF1;PLP1;AK5;ALDH1A1;CDK1;RRM2;CARNS1
11479,GO:0044087,0.912507532452379,0.203698585801862,3,806,regulation of cellular component biogenesis,BP,HSPA2;GFAP;LPAR1
13472,GO:0050778,0.912714826753483,0.232892683633677,2,631,positive regulation of immune response,BP,MOG;S100A1
370,GO:0000988,0.913145054974712,0.23203416987874,2,603,transcription factor activity, protein binding,MF,MYBL2;SOX11
3289,GO:0006605,0.914200154711871,0.299805376733461,1,394,protein targeting,BP,MYBPC1
13422,GO:0050708,0.915413942427804,0.296847645150554,1,371,regulation of protein secretion,BP,MBP
5170,GO:0014070,0.917334027716417,0.194668552195,3,837,response to organic cyclic compound,BP,PPP1R1B;PAQR6;CDK1
11640,GO:0044429,0.91734746009839,0.194615057789372,3,909,mitochondrial part,CC,ETNPPL;CDK1;AIFM3
4626,GO:0009896,0.917613363437427,0.291380761902718,1,365,positive regulation of catabolic process,BP,DTL
11326,GO:0043547,0.918781422152108,0.288452943860282,1,362,positive regulation of GTPase activity,BP,ALDH1A1
7822,GO:0031349,0.921052087226572,0.282644132442124,1,394,positive regulation of defense response,BP,S100A1
11533,GO:0044237,0.921886630826493,0.112291411277411,54,9385,cellular metabolic process,BP,CRLF1;HHATL;MCM10;FGFR3;TPX2;BIRC5;TF;CPNE6;MYBL2;SNTA1;PTGDS;SEPT4;FOXM1;FGF1;FBXO2;CENPF;NECAB1;PLP1;MYRF;HSPA2;GFAP;TOP2A;PPP1R1B;APLNR;PDGFRA;ENPP2;DTL;FIP1L1;SFRP2;CRB2;NKX6-2;CNDP1;AK5;BUB1B;S100A1;ETNPPL;PI16;ALDH1A1;PPP1R14A;PBK;BUB1;CDK1;EMX2;RRM2;CARNS1;UBE2C;SOX11;HS3ST4;CNTN2;NWD1;MBP;LPAR1;ZNF536;FXYD1
21206,GO:2000112,0.922000327799474,0.12075974804447,19,3735,regulation of cellular macromolecule biosynthetic process,BP,HHATL;BIRC5;MYBL2;FOXM1;FGF1;CENPF;NECAB1;MYRF;TOP2A;PDGFRA;SFRP2;CRB2;NKX6-2;S100A1;CDK1;EMX2;RRM2;SOX11;ZNF536
2752,GO:0005774,0.922157727359771,0.279829379610234,1,388,vacuolar membrane,CC,GFAP
4572,GO:0009719,0.922367711267551,0.151369186339517,6,1435,response to endogenous stimulus,BP,FGFR3;FGF1;SFRP2;CRB2;PAQR6;SOX11
9429,GO:0034613,0.922382635823018,0.145656384728415,7,1643,cellular protein localization,BP,SEPT4;PACSIN1;FIP1L1;BUB1B;CDK1;CNTN2;MYBPC1
11022,GO:0043043,0.922420017221536,0.212683188654064,2,671,peptide biosynthetic process,BP,CARNS1;SOX11
11539,GO:0044248,0.922680030343543,0.137067481476799,9,2055,cellular catabolic process,BP,FBXO2;GFAP;ENPP2;DTL;BUB1B;PBK;CDK1;CARNS1;UBE2C
2849,GO:0005925,0.923634024507055,0.276044630853695,1,381,focal adhesion,CC,FGFR3
2727,GO:0005743,0.923737528140059,0.275695612968319,1,435,mitochondrial inner membrane,CC,AIFM3
4624,GO:0009894,0.924301357626144,0.18139987289892,3,852,regulation of catabolic process,BP,GFAP;DTL;PBK
16491,GO:0071702,0.924342354439987,0.129022733607257,11,2399,organic substance transport,BP,SLCO1A2;TF;CENPF;SPX;SLC14A1;FIP1L1;SLC5A11;TMEM144;CDK1;MYBPC1;MBP
2848,GO:0005924,0.925054016265679,0.272360157502107,1,384,cell-substrate adherens junction,CC,FGFR3
15939,GO:0070727,0.925156453191236,0.14119728796301,7,1653,cellular macromolecule localization,BP,SEPT4;PACSIN1;FIP1L1;BUB1B;CDK1;CNTN2;MYBPC1
11635,GO:0044422,0.92546345966783,0.107262894928072,47,8301,organelle part,CC,USH1C;HHATL;KIFC1;MCM10;ASPM;DCX;TPX2;BIRC5;TF;MYBL2;PTGDS;SEPT4;NCAPG;FOXM1;FGF1;FBXO2;CENPF;NECAB1;PACSIN1;MYRF;HSPA2;GFAP;TOP2A;ESPL1;NUSAP1;SLC14A1;DTL;FIP1L1;MKI67;HSPB8;AK5;BUB1B;S100A1;ETNPPL;KIF6;KLK6;FAM107A;MOBP;BUB1;CDK1;UBE2C;HS3ST4;CALN1;AIFM3;DNAH17;NWD1;MYBPC1
7749,GO:0031252,0.926400728913928,0.268877237931821,1,366,cell leading edge,CC,PACSIN1
4712,GO:0010243,0.926597907567905,0.1769595124491,3,855,response to organonitrogen compound,BP,FBXO2;PPP1R1B;CDK1
7131,GO:0030055,0.926874578306884,0.26759766412096,1,387,cell-substrate junction,CC,FGFR3
2487,GO:0005216,0.927595829916618,0.265711982761824,1,380,ion channel activity,MF,FXYD1
1274,GO:0002791,0.928283841073701,0.263867203175628,1,397,regulation of peptide secretion,BP,MBP
8698,GO:0032880,0.928399523156089,0.173449039147219,3,864,regulation of protein localization,BP,CDK1;MYBPC1;MBP
9458,GO:0034654,0.929579757762052,0.109382940272167,20,3968,nucleobase-containing compound biosynthetic process,BP,BIRC5;MYBL2;FOXM1;FGF1;CENPF;MYRF;TOP2A;PPP1R1B;DTL;FIP1L1;SFRP2;CRB2;NKX6-2;AK5;S100A1;CDK1;EMX2;RRM2;SOX11;ZNF536
6469,GO:0019221,0.930045168648111,0.196277257717031,2,686,cytokine-mediated signaling pathway,BP,CRLF1;BIRC5
7095,GO:0023061,0.930818068829708,0.257116426463347,1,397,signal release,BP,SOX11
11540,GO:0044249,0.93142803943659,0.101811633821647,30,5674,cellular biosynthetic process,BP,HHATL;MCM10;FGFR3;BIRC5;CPNE6;MYBL2;PTGDS;FOXM1;FGF1;CENPF;NECAB1;PLP1;MYRF;TOP2A;PPP1R1B;PDGFRA;DTL;FIP1L1;SFRP2;CRB2;NKX6-2;AK5;S100A1;ETNPPL;CDK1;EMX2;RRM2;CARNS1;SOX11;ZNF536
11149,GO:0043254,0.931929446186303,0.254118541481487,1,402,regulation of protein complex assembly,BP,GFAP
7849,GO:0031410,0.934268965859493,0.119040320468178,9,2073,cytoplasmic vesicle,CC,KIFC1;FGFR3;TF;CPNE6;PACSIN1;SPX;KLK6;LGI3;LPAR1
1618,GO:0003723,0.934307743257443,0.131365590659205,6,1531,RNA binding,MF,TOP2A;NUSAP1;FIP1L1;MKI67;SOX11;NWD1
6618,GO:0019752,0.93489678949281,0.160592027470645,3,928,carboxylic acid metabolic process,BP,PTGDS;PLP1;CARNS1
17875,GO:0097708,0.934993461810103,0.117896897103024,9,2076,intracellular vesicle,CC,KIFC1;FGFR3;TF;CPNE6;PACSIN1;SPX;KLK6;LGI3;LPAR1
11131,GO:0043229,0.936898129436795,0.094527735383326,65,11050,intracellular organelle,CC,USH1C;HHATL;KIFC1;MCM10;ASPM;FGFR3;DCX;TPX2;BIRC5;TF;CPNE6;MYBL2;SNTA1;PTGDS;SEPT4;NCAPG;FOXM1;FGF1;FBXO2;CENPF;NECAB1;PACSIN1;MYRF;HSPA2;GFAP;TOP2A;PPP1R1B;SPX;PDGFRA;ESPL1;ERMN;NUSAP1;SLC14A1;DTL;FIP1L1;MKI67;NKX6-2;HSPB8;AK5;BUB1B;S100A1;ETNPPL;KIF6;KLK6;PBK;FAM107A;MOBP;LGI3;BUB1;CDK1;EMX2;MAL;UBE2C;SOX11;HS3ST4;CALN1;AIFM3;DNAH17;NWD1;MYBPC1;OPALIN;MBP;LPAR1;ZNF536;TMEM235
1206,GO:0002694,0.93711853601312,0.2398666260438,1,431,regulation of leukocyte activation,BP,SOX11
4795,GO:0010556,0.937339821966603,0.0992195704022165,19,3815,regulation of macromolecule biosynthetic process,BP,HHATL;BIRC5;MYBL2;FOXM1;FGF1;CENPF;NECAB1;MYRF;TOP2A;PDGFRA;SFRP2;CRB2;NKX6-2;S100A1;CDK1;EMX2;RRM2;SOX11;ZNF536
18040,GO:0098805,0.937585503318228,0.125764492775127,6,1513,whole membrane,CC,TF;MAG;GFAP;CRB2;MAL;FXYD1
4661,GO:0010008,0.938909288670948,0.234870346462042,1,425,endosome membrane,CC,TF
6293,GO:0018130,0.939393360589631,0.0955630510868184,20,4024,heterocycle biosynthetic process,BP,BIRC5;MYBL2;FOXM1;FGF1;CENPF;MYRF;TOP2A;PPP1R1B;DTL;FIP1L1;SFRP2;CRB2;NKX6-2;AK5;S100A1;CDK1;EMX2;RRM2;SOX11;ZNF536
3922,GO:0008152,0.940060002776084,0.0885821489372742,57,9943,metabolic process,BP,CRLF1;HHATL;MCM10;FGFR3;TPX2;BIRC5;TF;CPNE6;MYBL2;SNTA1;PTGDS;SEPT4;FOXM1;FGF1;FBXO2;CENPF;NECAB1;PLP1;MYRF;HSPA2;GFAP;TOP2A;PPP1R1B;APLNR;PDGFRA;ESPL1;ENPP2;DTL;FIP1L1;SFRP2;CRB2;NKX6-2;CNDP1;AK5;BUB1B;S100A1;ETNPPL;PI16;ALDH1A1;PPP1R14A;KLK6;PBK;BUB1;CDK1;EMX2;RRM2;CARNS1;UBE2C;SOX11;HS3ST4;AIFM3;CNTN2;NWD1;MBP;LPAR1;ZNF536;FXYD1
6547,GO:0019438,0.940709157435615,0.0936905302316706,20,4031,aromatic compound biosynthetic process,BP,BIRC5;MYBL2;FOXM1;FGF1;CENPF;MYRF;TOP2A;PPP1R1B;DTL;FIP1L1;SFRP2;CRB2;NKX6-2;AK5;S100A1;CDK1;EMX2;RRM2;SOX11;ZNF536
68,GO:0000139,0.941438115076345,0.170775401540366,2,681,Golgi membrane,CC,HS3ST4;CALN1
9263,GO:0034248,0.941705762352297,0.226942713587597,1,429,regulation of cellular amide metabolic process,BP,GFAP
11357,GO:0043603,0.942221864550198,0.145732320249679,3,963,cellular amide metabolic process,BP,GFAP;CARNS1;SOX11
18951,GO:1901576,0.94387552522137,0.08484425193321,30,5750,organic substance biosynthetic process,BP,HHATL;MCM10;FGFR3;BIRC5;CPNE6;MYBL2;PTGDS;FOXM1;FGF1;CENPF;NECAB1;PLP1;MYRF;TOP2A;PPP1R1B;PDGFRA;DTL;FIP1L1;SFRP2;CRB2;NKX6-2;AK5;S100A1;ETNPPL;CDK1;EMX2;RRM2;CARNS1;SOX11;ZNF536
6676,GO:0019866,0.9456388103047,0.215504801004367,1,485,organelle inner membrane,CC,AIFM3
3125,GO:0006397,0.946701543265564,0.212413019812663,1,455,mRNA processing,BP,FIP1L1
327,GO:0000904,0.94686810448561,0.158152518109138,2,659,cell morphogenesis involved in differentiation,BP,MAG;CNTN2
11358,GO:0043604,0.948690096967733,0.153793907901428,2,749,amide biosynthetic process,BP,CARNS1;SOX11
18515,GO:0140110,0.949259831762915,0.101051850785162,7,1741,transcription regulator activity,MF,MYBL2;FOXM1;MYRF;NKX6-2;EMX2;SOX11;ZNF536
5955,GO:0016604,0.949781247308707,0.151210551063651,2,702,nuclear body,CC,MKI67;FAM107A
11849,GO:0045087,0.950077657573698,0.150482969092902,2,742,innate immune response,BP,S100A1;AQP4
7450,GO:0030659,0.950218567342567,0.150160838793577,2,706,cytoplasmic vesicle membrane,CC,TF;PACSIN1
3497,GO:0006914,0.950694532771806,0.200480648876081,1,456,autophagy,BP,GFAP
15495,GO:0061919,0.950694532771806,0.200480648876081,1,456,process utilizing autophagic mechanism,BP,GFAP
284,GO:0000785,0.950776060592772,0.200240158698764,1,450,chromatin,CC,CENPF
11042,GO:0043087,0.952059715876223,0.196349948430019,1,435,regulation of GTPase activity,BP,ALDH1A1
4302,GO:0009058,0.952127667875006,0.0733794732009407,30,5810,biosynthetic process,BP,HHATL;MCM10;FGFR3;BIRC5;CPNE6;MYBL2;PTGDS;FOXM1;FGF1;CENPF;NECAB1;PLP1;MYRF;TOP2A;PPP1R1B;PDGFRA;DTL;FIP1L1;SFRP2;CRB2;NKX6-2;AK5;S100A1;ETNPPL;CDK1;EMX2;RRM2;CARNS1;SOX11;ZNF536
11648,GO:0044440,0.952181440924611,0.195949154752838,1,461,endosomal part,CC,TF
19014,GO:1901701,0.95325291145286,0.122507525549559,3,950,cellular response to oxygen-containing compound,BP,PDGFRA;CDK1;LPAR1
13790,GO:0051259,0.954072122031586,0.190117150421452,1,469,protein complex oligomerization,BP,SEPT4
10944,GO:0042886,0.955197887579832,0.0907053532532963,7,1805,amide transport,BP,TF;CENPF;SLC14A1;FIP1L1;CDK1;MYBPC1;MBP
5114,GO:0012506,0.955503520029682,0.137292333784495,2,725,vesicle membrane,CC,TF;PACSIN1
19011,GO:1901698,0.956097863708932,0.116323634018005,3,957,response to nitrogen compound,BP,FBXO2;PPP1R1B;CDK1
9451,GO:0034645,0.95668588637164,0.0691122532523276,23,4656,cellular macromolecule biosynthetic process,BP,HHATL;MCM10;BIRC5;MYBL2;FOXM1;FGF1;CENPF;NECAB1;MYRF;TOP2A;PPP1R1B;PDGFRA;DTL;FIP1L1;SFRP2;CRB2;NKX6-2;S100A1;CDK1;EMX2;RRM2;SOX11;ZNF536
7142,GO:0030097,0.957109657897735,0.133300606611939,2,744,hemopoiesis,BP,TOP2A;SFRP2
11481,GO:0044089,0.957180766693425,0.180371215640418,1,464,positive regulation of cellular component biogenesis,BP,LPAR1
4477,GO:0009306,0.957441828859491,0.17953244313555,1,474,protein secretion,BP,MBP
7800,GO:0031326,0.957938478607953,0.0692330697045871,19,3955,regulation of cellular biosynthetic process,BP,HHATL;BIRC5;MYBL2;FOXM1;FGF1;CENPF;NECAB1;MYRF;TOP2A;PDGFRA;SFRP2;CRB2;NKX6-2;S100A1;CDK1;EMX2;RRM2;SOX11;ZNF536
11260,GO:0043436,0.957988824079102,0.112153413310826,3,1015,oxoacid metabolic process,BP,PTGDS;PLP1;CARNS1
18890,GO:1901362,0.957999548641594,0.0685857244321594,20,4153,organic cyclic compound biosynthetic process,BP,BIRC5;MYBL2;FOXM1;FGF1;CENPF;MYRF;TOP2A;PPP1R1B;DTL;FIP1L1;SFRP2;CRB2;NKX6-2;AK5;S100A1;CDK1;EMX2;RRM2;SOX11;ZNF536
3476,GO:0006886,0.958574735102286,0.110860227627328,3,1001,intracellular protein transport,BP,FIP1L1;CDK1;MYBPC1
12687,GO:0046903,0.959849490255761,0.0909183361194067,5,1426,secretion,BP,TF;SPX;LGI3;SOX11;MBP
2944,GO:0006082,0.960168386648463,0.107309536764398,3,1026,organic acid metabolic process,BP,PTGDS;PLP1;CARNS1
5741,GO:0016192,0.960365804471238,0.0815265001991834,7,1807,vesicle-mediated transport,BP,TF;CPNE6;PACSIN1;HSPA2;ENPP2;LGI3;CNTN2
11904,GO:0045184,0.96209907877772,0.0784048407814622,7,1843,establishment of protein localization,BP,TF;CENPF;FIP1L1;CDK1;CNTN2;MYBPC1;MBP
11652,GO:0044446,0.962586546137149,0.0571027651337945,44,8105,intracellular organelle part,CC,HHATL;KIFC1;MCM10;ASPM;DCX;TPX2;BIRC5;TF;MYBL2;PTGDS;SEPT4;NCAPG;FOXM1;FGF1;CENPF;NECAB1;PACSIN1;MYRF;HSPA2;GFAP;TOP2A;ESPL1;NUSAP1;SLC14A1;DTL;FIP1L1;MKI67;HSPB8;AK5;BUB1B;ETNPPL;KIF6;KLK6;FAM107A;MOBP;BUB1;CDK1;UBE2C;HS3ST4;CALN1;AIFM3;DNAH17;NWD1;MYBPC1
7803,GO:0031329,0.963109252663403,0.118068096069755,2,760,regulation of cellular catabolic process,BP,GFAP;PBK
15517,GO:0065003,0.963165417407032,0.0799003990751362,6,1652,protein-containing complex assembly,BP,USH1C;SEPT4;CENPF;GFAP;UBE2C;MYBPC1
18027,GO:0098791,0.96416903612888,0.115316129174309,2,765,Golgi subcompartment,CC,HS3ST4;CALN1
4619,GO:0009889,0.965068523003803,0.0584935078712262,19,4015,regulation of biosynthetic process,BP,HHATL;BIRC5;MYBL2;FOXM1;FGF1;CENPF;NECAB1;MYRF;TOP2A;PDGFRA;SFRP2;CRB2;NKX6-2;S100A1;CDK1;EMX2;RRM2;SOX11;ZNF536
1273,GO:0002790,0.965137864506814,0.154276815498646,1,505,peptide secretion,BP,MBP
13084,GO:0048534,0.965245311056897,0.112497608629239,2,782,hematopoietic or lymphoid organ development,BP,TOP2A;SFRP2
3099,GO:0006355,0.966396288688203,0.0589240084363608,15,3325,regulation of transcription, DNA-templated,BP,BIRC5;MYBL2;FOXM1;FGF1;CENPF;MYRF;TOP2A;SFRP2;CRB2;NKX6-2;S100A1;EMX2;RRM2;SOX11;ZNF536
17370,GO:0090304,0.966552052920381,0.0545958740134658,23,4746,nucleic acid metabolic process,BP,MCM10;BIRC5;MYBL2;FOXM1;FGF1;CENPF;MYRF;TOP2A;PPP1R1B;PDGFRA;ENPP2;DTL;FIP1L1;SFRP2;CRB2;NKX6-2;S100A1;CDK1;EMX2;RRM2;SOX11;NWD1;ZNF536
16987,GO:0072657,0.967411732931001,0.14648758471686,1,528,protein localization to membrane,BP,PACSIN1
3518,GO:0006952,0.967802410390271,0.0809978070048275,4,1305,defense response,BP,PLP1;S100A1;PBK;AQP4
11645,GO:0044437,0.968202275326643,0.143749729361674,1,525,vacuolar part,CC,GFAP
19733,GO:1903506,0.968412035802362,0.0557212055415286,15,3344,regulation of nucleic acid-templated transcription,BP,BIRC5;MYBL2;FOXM1;FGF1;CENPF;MYRF;TOP2A;SFRP2;CRB2;NKX6-2;S100A1;EMX2;RRM2;SOX11;ZNF536
4303,GO:0009059,0.968758452452773,0.0512935247689033,23,4765,macromolecule biosynthetic process,BP,HHATL;MCM10;BIRC5;MYBL2;FOXM1;FGF1;CENPF;NECAB1;MYRF;TOP2A;PPP1R1B;PDGFRA;DTL;FIP1L1;SFRP2;CRB2;NKX6-2;S100A1;CDK1;EMX2;RRM2;SOX11;ZNF536
21755,GO:2001141,0.968888504590046,0.0549608113154561,15,3349,regulation of RNA biosynthetic process,BP,BIRC5;MYBL2;FOXM1;FGF1;CENPF;MYRF;TOP2A;SFRP2;CRB2;NKX6-2;S100A1;EMX2;RRM2;SOX11;ZNF536
2840,GO:0005912,0.969282295568772,0.13998550928952,1,508,adherens junction,CC,FGFR3
13470,GO:0050776,0.969352062212079,0.101555070156912,2,828,regulation of immune response,BP,MOG;S100A1
3477,GO:0006887,0.969804399421468,0.100336580594965,2,808,exocytosis,BP,TF;LGI3
11657,GO:0044451,0.970155152058112,0.0843507737460949,3,1030,nucleoplasm part,CC,FIP1L1;MKI67;FAM107A
9142,GO:0033993,0.970161771109222,0.0993647658594797,2,815,response to lipid,BP,PAQR6;LPAR1
11636,GO:0044424,0.97120581133063,0.0486270388264935,74,12539,intracellular part,CC,CRLF1;USH1C;HHATL;KIFC1;BCAS1;MCM10;ASPM;FGFR3;DCX;TPX2;BIRC5;TF;CPNE6;MYBL2;SNTA1;MAG;PTGDS;SEPT4;NCAPG;FOXM1;FGF1;FBXO2;CENPF;NECAB1;PACSIN1;MYRF;HSPA2;GFAP;TOP2A;PPP1R1B;SPX;PDGFRA;ESPL1;ERMN;NUSAP1;SLC14A1;DTL;FIP1L1;MKI67;NKX6-2;CNDP1;HSPB8;AK5;BUB1B;S100A1;ETNPPL;KIF6;ALDH1A1;PPP1R14A;KLK6;PBK;FAM107A;MOBP;LGI3;BUB1;CDK1;EMX2;RRM2;AQP4;MAL;CARNS1;UBE2C;SOX11;HS3ST4;CALN1;AIFM3;DNAH17;NWD1;MYBPC1;OPALIN;MBP;LPAR1;ZNF536;TMEM235
1613,GO:0003712,0.971290720319916,0.132845332706633,1,527,transcription cofactor activity,MF,SOX11
12664,GO:0046872,0.97135025043654,0.0498068904288981,17,3657,metal ion binding,MF,MCM10;BIRC5;TF;CPNE6;SEPT4;NECAB1;TOP2A;ENPP2;CRB2;CNDP1;FREM2;S100A1;RRM2;CARNS1;CALN1;AIFM3;ZNF536
2873,GO:0005975,0.971477810033213,0.132165408230256,1,541,carbohydrate metabolic process,BP,ALDH1A1
15612,GO:0070161,0.972320905423918,0.12913726352542,1,522,anchoring junction,CC,FGFR3
1110,GO:0002520,0.972487450000824,0.0929850800306701,2,821,immune system development,BP,TOP2A;SFRP2
11427,GO:0043933,0.973030131286985,0.0581796522207397,7,1932,protein-containing complex subunit organization,BP,USH1C;SEPT4;CENPF;GFAP;SFRP2;UBE2C;MYBPC1
16294,GO:0071407,0.973159909033412,0.126080471251836,1,530,cellular response to organic cyclic compound,BP,PAQR6
11133,GO:0043231,0.973639571465347,0.0414826081944885,53,9620,intracellular membrane-bounded organelle,CC,HHATL;KIFC1;MCM10;ASPM;FGFR3;TPX2;BIRC5;TF;MYBL2;PTGDS;SEPT4;NCAPG;FOXM1;FGF1;FBXO2;CENPF;NECAB1;MYRF;HSPA2;GFAP;TOP2A;PPP1R1B;PDGFRA;ESPL1;NUSAP1;SLC14A1;DTL;FIP1L1;MKI67;NKX6-2;HSPB8;BUB1B;S100A1;ETNPPL;KIF6;KLK6;PBK;FAM107A;MOBP;BUB1;CDK1;EMX2;MAL;UBE2C;SOX11;HS3ST4;CALN1;AIFM3;NWD1;OPALIN;MBP;ZNF536;TMEM235
12580,GO:0046649,0.975533726122774,0.117275576172644,1,568,lymphocyte activation,BP,SOX11
8740,GO:0032940,0.975830912410926,0.0633847355087979,4,1322,secretion by cell,BP,TF;LGI3;SOX11;MBP
5283,GO:0015031,0.975838881440161,0.0553202240451352,6,1750,protein transport,BP,TF;CENPF;FIP1L1;CDK1;MYBPC1;MBP
8117,GO:0031966,0.977503771607551,0.109783884530211,1,618,mitochondrial membrane,CC,AIFM3
3124,GO:0006396,0.977644043074473,0.0783781524064349,2,891,RNA processing,BP,FIP1L1;NWD1
11088,GO:0043169,0.977780333218377,0.0395174004908791,17,3736,cation binding,MF,MCM10;BIRC5;TF;CPNE6;SEPT4;NECAB1;TOP2A;ENPP2;CRB2;CNDP1;FREM2;S100A1;RRM2;CARNS1;CALN1;AIFM3;ZNF536
1196,GO:0002684,0.977905465845394,0.0776219318277724,2,882,positive regulation of immune system process,BP,MOG;S100A1
2665,GO:0005622,0.978287905584561,0.0379790557259619,75,12743,intracellular,CC,CRLF1;USH1C;HHATL;KIFC1;BCAS1;MCM10;ASPM;FGFR3;DCX;TPX2;BIRC5;TF;CPNE6;MYBL2;SNTA1;MAG;PTGDS;SEPT4;NCAPG;FOXM1;FGF1;FBXO2;CENPF;NECAB1;PACSIN1;MYRF;HSPA2;GFAP;TOP2A;PPP1R1B;SPX;PDGFRA;ESPL1;ERMN;NUSAP1;SLC14A1;DTL;FIP1L1;MKI67;NKX6-2;CNDP1;HSPB8;AK5;BUB1B;S100A1;ETNPPL;KIF6;ALDH1A1;PPP1R14A;KLK6;PBK;FAM107A;MOBP;LGI3;BUB1;CDK1;EMX2;RRM2;AQP4;MAL;CARNS1;UBE2C;SOX11;GPR62;HS3ST4;CALN1;AIFM3;DNAH17;NWD1;MYBPC1;OPALIN;MBP;LPAR1;ZNF536;TMEM235
11642,GO:0044431,0.9783631342486,0.0762969732418519,2,849,Golgi apparatus part,CC,HS3ST4;CALN1
5567,GO:0015833,0.979148905780799,0.0486088129920588,6,1784,peptide transport,BP,TF;CENPF;FIP1L1;CDK1;MYBPC1;MBP
11550,GO:0044271,0.979669155745485,0.035088841700481,21,4581,cellular nitrogen compound biosynthetic process,BP,BIRC5;MYBL2;FOXM1;FGF1;CENPF;MYRF;TOP2A;PPP1R1B;DTL;FIP1L1;SFRP2;CRB2;NKX6-2;AK5;S100A1;CDK1;EMX2;RRM2;CARNS1;SOX11;ZNF536
12607,GO:0046700,0.980725022181503,0.0971818995451701,1,615,heterocycle catabolic process,BP,CARNS1
6467,GO:0019219,0.980767569802864,0.0346364587884779,17,3836,regulation of nucleobase-containing compound metabolic process,BP,BIRC5;MYBL2;FOXM1;FGF1;CENPF;MYRF;TOP2A;PDGFRA;SFRP2;CRB2;NKX6-2;S100A1;CDK1;EMX2;RRM2;SOX11;ZNF536
11549,GO:0044270,0.980947693172243,0.0962903155256788,1,617,cellular nitrogen compound catabolic process,BP,CARNS1
1031,GO:0002376,0.981792972909599,0.0382350308326396,9,2461,immune system process,BP,MAG;TOP2A;ENPP2;MOG;SFRP2;S100A1;AQP4;SOX11;MBP
2724,GO:0005740,0.981873083330248,0.0925457845962318,1,654,mitochondrial envelope,CC,AIFM3
6548,GO:0019439,0.982636754048246,0.0894376465383804,1,632,aromatic compound catabolic process,BP,CARNS1
3138,GO:0006412,0.983420570590413,0.0861970063254184,1,651,translation,BP,SOX11
162,GO:0000323,0.983803416968912,0.0846118718639897,1,626,lytic vacuole,CC,GFAP
2743,GO:0005764,0.983803416968912,0.0846118718639897,1,626,lysosome,CC,GFAP
19013,GO:1901700,0.984110448668747,0.0441258227041576,4,1404,response to oxygen-containing compound,BP,PPP1R1B;PDGFRA;CDK1;LPAR1
16493,GO:0071705,0.984283232572235,0.0360707315126386,7,2055,nitrogen compound transport,BP,TF;CENPF;SLC14A1;FIP1L1;CDK1;MYBPC1;MBP
13783,GO:0051252,0.984907991455873,0.0284736455180776,15,3546,regulation of RNA metabolic process,BP,BIRC5;MYBL2;FOXM1;FGF1;CENPF;MYRF;TOP2A;SFRP2;CRB2;NKX6-2;S100A1;EMX2;RRM2;SOX11;ZNF536
18889,GO:1901361,0.985079995267365,0.0792193408833706,1,656,organic cyclic compound catabolic process,BP,CARNS1
8689,GO:0032870,0.985089945332259,0.0791881994748028,1,621,cellular response to hormone stimulus,BP,PAQR6
5684,GO:0016070,0.985167772120641,0.0267277158798729,19,4304,RNA metabolic process,BP,BIRC5;MYBL2;FOXM1;FGF1;CENPF;MYRF;TOP2A;PPP1R1B;FIP1L1;SFRP2;CRB2;NKX6-2;S100A1;CDK1;EMX2;RRM2;SOX11;NWD1;ZNF536
3521,GO:0006955,0.985186767285639,0.0382557742496935,5,1692,immune response,BP,ENPP2;MOG;S100A1;AQP4;MBP
12692,GO:0046914,0.985890341602127,0.0534168063421776,2,926,transition metal ion binding,MF,TF;ENPP2
4760,GO:0010468,0.987040724981395,0.0238522041929505,18,4126,regulation of gene expression,BP,BIRC5;MYBL2;FOXM1;FGF1;CENPF;PLP1;MYRF;TOP2A;SFRP2;CRB2;NKX6-2;S100A1;CDK1;EMX2;RRM2;SOX11;CNTN2;ZNF536
6048,GO:0016788,0.987414042380322,0.0690758628280346,1,660,hydrolase activity, acting on ester bonds,MF,ENPP2
12487,GO:0046483,0.98786788378409,0.0212070885112611,25,5424,heterocycle metabolic process,BP,MCM10;BIRC5;MYBL2;FOXM1;FGF1;CENPF;MYRF;TOP2A;PPP1R1B;PDGFRA;ENPP2;DTL;FIP1L1;SFRP2;CRB2;NKX6-2;AK5;S100A1;CDK1;EMX2;RRM2;CARNS1;SOX11;NWD1;ZNF536
21111,GO:1990904,0.989086231199908,0.0615232139690864,1,717,ribonucleoprotein complex,CC,NWD1
4759,GO:0010467,0.9891848114522,0.0194596652370128,22,4917,gene expression,BP,BIRC5;MYBL2;FOXM1;FGF1;CENPF;PLP1;MYRF;TOP2A;PPP1R1B;FIP1L1;SFRP2;CRB2;NKX6-2;S100A1;KLK6;CDK1;EMX2;RRM2;SOX11;CNTN2;NWD1;ZNF536
18944,GO:1901566,0.989229207891468,0.028888586311501,5,1757,organonitrogen compound biosynthetic process,BP,HHATL;NECAB1;AK5;CARNS1;SOX11
2978,GO:0006139,0.989286430886011,0.0190177068729866,24,5285,nucleobase-containing compound metabolic process,BP,MCM10;BIRC5;MYBL2;FOXM1;FGF1;CENPF;MYRF;TOP2A;PPP1R1B;PDGFRA;ENPP2;DTL;FIP1L1;SFRP2;CRB2;NKX6-2;AK5;S100A1;CDK1;EMX2;RRM2;SOX11;NWD1;ZNF536
3378,GO:0006725,0.989363378170653,0.0187729421426023,25,5463,cellular aromatic compound metabolic process,BP,MCM10;BIRC5;MYBL2;FOXM1;FGF1;CENPF;MYRF;TOP2A;PPP1R1B;PDGFRA;ENPP2;DTL;FIP1L1;SFRP2;CRB2;NKX6-2;AK5;S100A1;CDK1;EMX2;RRM2;CARNS1;SOX11;NWD1;ZNF536
1194,GO:0002682,0.989521259140218,0.034551432668848,3,1276,regulation of immune system process,BP,MOG;S100A1;SOX11
11820,GO:0045055,0.990622417584223,0.0543652838641977,1,706,regulated exocytosis,BP,TF
2751,GO:0005773,0.99114774384412,0.0518566945193461,1,715,vacuole,CC,GFAP
3993,GO:0008270,0.992353111281695,0.0459783712831383,1,715,zinc ion binding,MF,ENPP2
5685,GO:0016071,0.992949175318609,0.042991124894445,1,771,mRNA metabolic process,BP,FIP1L1
7677,GO:0031090,0.993156381634808,0.0158042642265301,9,2671,organelle membrane,CC,TF;PTGDS;FBXO2;PACSIN1;GFAP;DTL;HS3ST4;CALN1;AIFM3
1596,GO:0003676,0.993838683164718,0.0127172821179094,14,3624,nucleic acid binding,MF,MCM10;MYBL2;FOXM1;MYRF;TOP2A;ENPP2;NUSAP1;FIP1L1;MKI67;NKX6-2;EMX2;SOX11;NWD1;ZNF536
18888,GO:1901360,0.994233211364756,0.0106254128047269,25,5637,organic cyclic compound metabolic process,BP,MCM10;BIRC5;MYBL2;FOXM1;FGF1;CENPF;MYRF;TOP2A;PPP1R1B;PDGFRA;ENPP2;DTL;FIP1L1;SFRP2;CRB2;NKX6-2;AK5;S100A1;CDK1;EMX2;RRM2;CARNS1;SOX11;NWD1;ZNF536
12689,GO:0046907,0.994926378349662,0.0161856622278252,4,1614,intracellular transport,BP,FIP1L1;MOBP;CDK1;MYBPC1
9448,GO:0034641,0.995951995483477,0.00758918139253602,26,5915,cellular nitrogen compound metabolic process,BP,MCM10;BIRC5;MYBL2;FOXM1;FGF1;CENPF;MYRF;GFAP;TOP2A;PPP1R1B;PDGFRA;ENPP2;DTL;FIP1L1;SFRP2;CRB2;NKX6-2;AK5;S100A1;CDK1;EMX2;RRM2;CARNS1;SOX11;NWD1;ZNF536
633,GO:0001775,0.996799470799068,0.0149826195357129,2,1199,cell activation,BP,PDGFRA;SOX11
4574,GO:0009725,0.99727613851817,0.0193567479106958,1,876,response to hormone,BP,PAQR6
17937,GO:0098588,0.998865373433204,0.00422289467798058,4,1879,bounding membrane of organelle,CC,TF;GFAP;HS3ST4;CALN1
11644,GO:0044433,0.998929972672433,0.00571537148354617,2,1360,cytoplasmic vesicle part,CC,TF;PACSIN1
11963,GO:0045321,0.999110544840318,0.00738677628230015,1,1066,leukocyte activation,BP,SOX11
17378,GO:0090312,0.999999999999989,0.874150637437259,0,20,positive regulation of protein deacetylation,BP,
7179,GO:0030149,0.99999999999999,0.873601976190058,0,22,sphingolipid catabolic process,BP,
8327,GO:0032350,0.99999999999999,0.820281107618022,0,31,regulation of hormone metabolic process,BP,
4821,GO:0010596,0.999999999999991,0.752544683924795,0,42,negative regulation of endothelial cell migration,BP,
5148,GO:0014047,0.999999999999996,0.756798421088142,0,41,glutamate secretion,BP,
2594,GO:0005484,0.999999999999998,0.801257313105172,0,36,SNAP receptor activity,MF,
5590,GO:0015872,0.999999999999998,0.80679132565904,0,34,dopamine transport,BP,
15977,GO:0070830,0.999999999999999,0.729965721092451,0,47,bicellular tight junction assembly,BP,
6019,GO:0016742,0.999999999999999,0.950199294403314,0,8,hydroxymethyl-, formyl- and related transferase activity,MF,
2758,GO:0005782,0.999999999999999,0.780302084654995,0,41,peroxisomal matrix,CC,
8087,GO:0031907,0.999999999999999,0.780302084654995,0,41,microbody lumen,CC,
5873,GO:0016469,0.999999999999999,0.846960412539784,0,28,proton-transporting two-sector ATPase complex,CC,
1,GO:0000002,1,0.844483209523065,0,26,mitochondrial genome maintenance,BP,
3,GO:0000009,1,0.994060962845764,0,1,alpha-1,6-mannosyltransferase activity,MF,
4,GO:0000010,1,0.987941967495655,0,2,trans-hexaprenyltranstransferase activity,MF,
5,GO:0000011,1,0.993850639026861,0,1,vacuole inheritance,BP,
6,GO:0000012,1,0.949805046214219,0,8,single strand break repair,BP,
7,GO:0000014,1,0.953889422258299,0,7,single-stranded DNA endodeoxyribonuclease activity,MF,
8,GO:0000015,1,0.976942291739695,0,4,phosphopyruvate hydratase complex,CC,
9,GO:0000018,1,0.645271908744966,0,66,regulation of DNA recombination,BP,
10,GO:0000019,1,0.97444030688396,0,4,regulation of mitotic recombination,BP,
11,GO:0000022,1,0.936773151050425,0,10,mitotic spindle elongation,BP,
12,GO:0000023,1,0.978408579250214,0,3,maltose metabolic process,BP,
13,GO:0000026,1,0.980034921583196,0,3,alpha-1,2-mannosyltransferase activity,MF,
14,GO:0000027,1,0.855846548744786,0,26,ribosomal large subunit assembly,BP,
15,GO:0000028,1,0.914064763132303,0,17,ribosomal small subunit assembly,BP,
16,GO:0000030,1,0.867409086234144,0,23,mannosyltransferase activity,MF,
17,GO:0000032,1,0.994371949535733,0,1,cell wall mannoprotein biosynthetic process,BP,
18,GO:0000033,1,0.982793716544882,0,3,alpha-1,3-mannosyltransferase activity,MF,
19,GO:0000035,1,0.983710207732543,0,3,acyl binding,MF,
20,GO:0000036,1,0.989925940293056,0,2,acyl carrier activity,MF,
21,GO:0000038,1,0.834855573985989,0,29,very long-chain fatty acid metabolic process,BP,
23,GO:0000045,1,0.56087275939402,0,87,autophagosome assembly,BP,
24,GO:0000048,1,0.988098669344387,0,2,peptidyltransferase activity,MF,
25,GO:0000049,1,0.70812246470112,0,55,tRNA binding,MF,
26,GO:0000050,1,0.928684981615707,0,12,urea cycle,BP,
27,GO:0000052,1,0.946015899880365,0,8,citrulline metabolic process,BP,
28,GO:0000053,1,0.994344812759299,0,1,argininosuccinate metabolic process,BP,
29,GO:0000054,1,0.92661279222441,0,13,ribosomal subunit export from nucleus,BP,
30,GO:0000055,1,0.954069649659957,0,8,ribosomal large subunit export from nucleus,BP,
31,GO:0000056,1,0.959918989845104,0,7,ribosomal small subunit export from nucleus,BP,
33,GO:0000062,1,0.898272749675629,0,18,fatty-acyl-CoA binding,MF,
34,GO:0000064,1,0.959752942175762,0,6,L-ornithine transmembrane transporter activity,MF,
37,GO:0000076,1,0.90522485308962,0,16,DNA replication checkpoint,BP,
39,GO:0000079,1,0.589656806406159,0,83,regulation of cyclin-dependent protein serine/threonine kinase activity,BP,
43,GO:0000095,1,0.994137348650146,0,1,S-adenosyl-L-methionine transmembrane transporter activity,MF,
44,GO:0000096,1,0.790727911465697,0,37,sulfur amino acid metabolic process,BP,
45,GO:0000097,1,0.904435611396467,0,16,sulfur amino acid biosynthetic process,BP,
46,GO:0000098,1,0.939927550817582,0,10,sulfur amino acid catabolic process,BP,
47,GO:0000099,1,0.958787148249896,0,6,sulfur amino acid transmembrane transporter activity,MF,
48,GO:0000101,1,0.96819072989751,0,5,sulfur amino acid transport,BP,
49,GO:0000103,1,0.982035640981287,0,3,sulfate assimilation,BP,
50,GO:0000104,1,0.977407007262679,0,4,succinate dehydrogenase activity,MF,
51,GO:0000105,1,0.987605395304781,0,2,histidine biosynthetic process,BP,
52,GO:0000109,1,0.93866259332874,0,10,nucleotide-excision repair complex,CC,
53,GO:0000110,1,0.979964136980124,0,3,nucleotide-excision repair factor 1 complex,CC,
54,GO:0000111,1,0.99342374861696,0,1,nucleotide-excision repair factor 2 complex,CC,
55,GO:0000117,1,0.986150848079354,0,2,regulation of transcription involved in G2/M transition of mitotic cell cycle,BP,
56,GO:0000118,1,0.652340859973228,0,60,histone deacetylase complex,CC,
57,GO:0000120,1,0.97036050652128,0,5,RNA polymerase I transcription factor complex,CC,
58,GO:0000121,1,0.993671987568872,0,1,glycerol-1-phosphatase activity,MF,
60,GO:0000123,1,0.612279876451326,0,75,histone acetyltransferase complex,CC,
61,GO:0000124,1,0.936063147680044,0,11,SAGA complex,CC,
62,GO:0000125,1,0.976627604486909,0,3,PCAF complex,CC,
63,GO:0000126,1,0.9830363070633,0,2,transcription factor TFIIIB complex,CC,
64,GO:0000127,1,0.961392111921014,0,6,transcription factor TFIIIC complex,CC,
65,GO:0000132,1,0.873466630472097,0,20,establishment of mitotic spindle orientation,BP,
66,GO:0000137,1,0.902413562456971,0,16,Golgi cis cisterna,CC,
67,GO:0000138,1,0.959003996842164,0,7,Golgi trans cisterna,CC,
69,GO:0000145,1,0.887088249390341,0,18,exocyst,CC,
70,GO:0000146,1,0.865701904426661,0,17,microfilament motor activity,MF,
71,GO:0000147,1,0.966747208102071,0,5,actin cortical patch assembly,BP,
72,GO:0000149,1,0.446870167147225,0,121,SNARE binding,MF,
73,GO:0000150,1,0.953434697731185,0,8,recombinase activity,MF,
76,GO:0000153,1,0.931708764838101,0,11,cytoplasmic ubiquitin ligase complex,CC,
77,GO:0000154,1,0.832168176585874,0,31,rRNA modification,BP,
78,GO:0000155,1,0.958391677727332,0,6,phosphorelay sensor kinase activity,MF,
79,GO:0000159,1,0.885642324045877,0,19,protein phosphatase type 2A complex,CC,
80,GO:0000160,1,0.952041137173964,0,7,phosphorelay signal transduction system,BP,
81,GO:0000164,1,0.931253435881023,0,11,protein phosphatase type 1 complex,CC,
84,GO:0000170,1,0.994563677288245,0,1,sphingosine hydroxylase activity,MF,
85,GO:0000171,1,0.9869147761947,0,2,ribonuclease MRP activity,MF,
86,GO:0000172,1,0.964779924663236,0,6,ribonuclease MRP complex,CC,
87,GO:0000173,1,0.994435780261902,0,1,inactivation of MAPK activity involved in osmosensory signaling pathway,BP,
88,GO:0000175,1,0.823828626851432,0,30,3'-5'-exoribonuclease activity,MF,
89,GO:0000176,1,0.928302622409135,0,13,nuclear exosome (RNase complex),CC,
90,GO:0000177,1,0.911955412626927,0,15,cytoplasmic exosome (RNase complex),CC,
91,GO:0000178,1,0.873364543421499,0,22,exosome (RNase complex),CC,
92,GO:0000179,1,0.976892874250939,0,4,rRNA (adenine-N6,N6-)-dimethyltransferase activity,MF,
93,GO:0000182,1,0.929461763821249,0,10,rDNA binding,MF,
94,GO:0000183,1,0.895024053634784,0,18,chromatin silencing at rDNA,BP,
95,GO:0000184,1,0.512317837584717,0,117,nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
96,GO:0000185,1,0.88752258149784,0,18,activation of MAPKKK activity,BP,
97,GO:0000186,1,0.691218727230305,0,53,activation of MAPKK activity,BP,
99,GO:0000188,1,0.861368005934567,0,24,inactivation of MAPK activity,BP,
101,GO:0000210,1,0.993489813350026,0,1,NAD+ diphosphatase activity,MF,
103,GO:0000213,1,0.977063503606876,0,4,tRNA-intron endonuclease activity,MF,
104,GO:0000214,1,0.977169172640525,0,4,tRNA-intron endonuclease complex,CC,
105,GO:0000215,1,0.988651008636103,0,2,tRNA 2'-phosphotransferase activity,MF,
106,GO:0000217,1,0.85717499349212,0,24,DNA secondary structure binding,MF,
107,GO:0000220,1,0.962761581154045,0,6,vacuolar proton-transporting V-type ATPase, V0 domain,CC,
108,GO:0000221,1,0.980315891085441,0,3,vacuolar proton-transporting V-type ATPase, V1 domain,CC,
109,GO:0000224,1,0.993977449418163,0,1,peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity,MF,
110,GO:0000225,1,0.994692841324421,0,1,N-acetylglucosaminylphosphatidylinositol deacetylase activity,MF,
113,GO:0000229,1,0.989212075389812,0,2,cytoplasmic chromosome,CC,
114,GO:0000235,1,0.945533815213159,0,8,astral microtubule,CC,
115,GO:0000242,1,0.863550815917211,0,20,pericentriolar material,CC,
116,GO:0000243,1,0.954961666275727,0,8,commitment complex,CC,
117,GO:0000244,1,0.924855616610571,0,12,spliceosomal tri-snRNP complex assembly,BP,
118,GO:0000245,1,0.698541423151602,0,57,spliceosomal complex assembly,BP,
119,GO:0000246,1,0.993077609375079,0,1,delta24(24-1) sterol reductase activity,MF,
120,GO:0000247,1,0.994691808092006,0,1,C-8 sterol isomerase activity,MF,
121,GO:0000248,1,0.986902802350349,0,2,C-5 sterol desaturase activity,MF,
122,GO:0000250,1,0.99309393640295,0,1,lanosterol synthase activity,MF,
123,GO:0000252,1,0.99446187876287,0,1,C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity,MF,
124,GO:0000253,1,0.983931966772225,0,3,3-keto sterol reductase activity,MF,
125,GO:0000254,1,0.982384201767219,0,3,C-4 methylsterol oxidase activity,MF,
126,GO:0000255,1,0.973558856839603,0,4,allantoin metabolic process,BP,
127,GO:0000256,1,0.994539908597864,0,1,allantoin catabolic process,BP,
128,GO:0000257,1,0.994583828338402,0,1,nitrilase activity,MF,
129,GO:0000262,1,0.994464462703399,0,1,mitochondrial chromosome,CC,
130,GO:0000266,1,0.791443618862683,0,34,mitochondrial fission,BP,
131,GO:0000268,1,0.975262443198641,0,4,peroxisome targeting sequence binding,MF,
132,GO:0000270,1,0.989601139464883,0,2,peptidoglycan metabolic process,BP,
133,GO:0000271,1,0.624407333480214,0,69,polysaccharide biosynthetic process,BP,
134,GO:0000272,1,0.837158599156617,0,26,polysaccharide catabolic process,BP,
138,GO:0000285,1,0.974286540465067,0,4,1-phosphatidylinositol-3-phosphate 5-kinase activity,MF,
140,GO:0000288,1,0.612571416604948,0,74,nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
141,GO:0000289,1,0.77767377216493,0,36,nuclear-transcribed mRNA poly(A) tail shortening,BP,
142,GO:0000290,1,0.94924481358613,0,8,deadenylation-dependent decapping of nuclear-transcribed mRNA,BP,
143,GO:0000291,1,0.810710943620301,0,34,nuclear-transcribed mRNA catabolic process, exonucleolytic,BP,
144,GO:0000293,1,0.980865202620292,0,3,ferric-chelate reductase activity,MF,
145,GO:0000294,1,0.986448981910745,0,2,nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay,BP,
146,GO:0000295,1,0.934925837413143,0,11,adenine nucleotide transmembrane transporter activity,MF,
147,GO:0000296,1,0.994105340371777,0,1,spermine transport,BP,
148,GO:0000298,1,0.975932507390272,0,4,endopolyphosphatase activity,MF,
149,GO:0000301,1,0.975984901260599,0,4,retrograde transport, vesicle recycling within Golgi,BP,
151,GO:0000303,1,0.850170135630864,0,27,response to superoxide,BP,
152,GO:0000305,1,0.834428353285227,0,30,response to oxygen radical,BP,
153,GO:0000306,1,0.973549031393814,0,4,extrinsic component of vacuolar membrane,CC,
155,GO:0000308,1,0.986029759302394,0,2,cytoplasmic cyclin-dependent protein kinase holoenzyme complex,CC,
156,GO:0000309,1,0.980217341223609,0,3,nicotinamide-nucleotide adenylyltransferase activity,MF,
157,GO:0000313,1,0.638047902671466,0,82,organellar ribosome,CC,
158,GO:0000314,1,0.863660848347316,0,27,organellar small ribosomal subunit,CC,
159,GO:0000315,1,0.759689357589286,0,50,organellar large ribosomal subunit,CC,
160,GO:0000320,1,0.986199052877486,0,2,re-entry into mitotic cell cycle,BP,
161,GO:0000322,1,0.981357131219034,0,3,storage vacuole,CC,
163,GO:0000333,1,0.985375458132307,0,2,telomerase catalytic core complex,CC,
164,GO:0000334,1,0.994623095407419,0,1,3-hydroxyanthranilate 3,4-dioxygenase activity,MF,
165,GO:0000338,1,0.943614788009772,0,10,protein deneddylation,BP,
166,GO:0000339,1,0.906321439419851,0,15,RNA cap binding,MF,
167,GO:0000340,1,0.953208722245895,0,7,RNA 7-methylguanosine cap binding,MF,
168,GO:0000346,1,0.923248617379723,0,13,transcription export complex,CC,
169,GO:0000347,1,0.964737886464433,0,6,THO complex,CC,
170,GO:0000349,1,0.988020624633362,0,2,generation of catalytic spliceosome for first transesterification step,BP,
171,GO:0000350,1,0.983065109483989,0,3,generation of catalytic spliceosome for second transesterification step,BP,
172,GO:0000354,1,0.985184245588072,0,2,cis assembly of pre-catalytic spliceosome,BP,
175,GO:0000379,1,0.982687042312866,0,3,tRNA-type intron splice site recognition and cleavage,BP,
176,GO:0000380,1,0.701224564464331,0,54,alternative mRNA splicing, via spliceosome,BP,
177,GO:0000381,1,0.757671409787673,0,42,regulation of alternative mRNA splicing, via spliceosome,BP,
178,GO:0000384,1,0.988906824632997,0,2,first spliceosomal transesterification activity,MF,
179,GO:0000386,1,0.979481362905662,0,3,second spliceosomal transesterification activity,MF,
180,GO:0000387,1,0.795806890592937,0,38,spliceosomal snRNP assembly,BP,
181,GO:0000389,1,0.963092596536491,0,6,mRNA 3'-splice site recognition,BP,
182,GO:0000390,1,0.988494217877921,0,2,spliceosomal complex disassembly,BP,
183,GO:0000393,1,0.971286582382787,0,5,spliceosomal conformational changes to generate catalytic conformation,BP,
184,GO:0000394,1,0.905093203650621,0,17,RNA splicing, via endonucleolytic cleavage and ligation,BP,
185,GO:0000395,1,0.964114009247793,0,6,mRNA 5'-splice site recognition,BP,
187,GO:0000400,1,0.904217741187637,0,16,four-way junction DNA binding,MF,
188,GO:0000403,1,0.958698724682928,0,6,Y-form DNA binding,MF,
189,GO:0000404,1,0.980112421699873,0,3,heteroduplex DNA loop binding,MF,
190,GO:0000405,1,0.953661568731495,0,7,bubble DNA binding,MF,
191,GO:0000406,1,0.98660144182806,0,2,double-strand/single-strand DNA junction binding,MF,
192,GO:0000407,1,0.802595173141885,0,33,phagophore assembly site,CC,
193,GO:0000408,1,0.971701097352097,0,5,EKC/KEOPS complex,CC,
194,GO:0000409,1,0.991709621950676,0,1,regulation of transcription by galactose,BP,
195,GO:0000411,1,0.991709621950676,0,1,positive regulation of transcription by galactose,BP,
196,GO:0000412,1,0.993797510803126,0,1,histone peptidyl-prolyl isomerization,BP,
197,GO:0000413,1,0.829692701894083,0,31,protein peptidyl-prolyl isomerization,BP,
198,GO:0000414,1,0.968254971384465,0,4,regulation of histone H3-K36 methylation,BP,
199,GO:0000415,1,0.991988822893849,0,1,negative regulation of histone H3-K36 methylation,BP,
200,GO:0000416,1,0.993367865685556,0,1,positive regulation of histone H3-K36 methylation,BP,
201,GO:0000417,1,0.993210510248544,0,1,HIR complex,CC,
202,GO:0000421,1,0.828657944903869,0,30,autophagosome membrane,CC,
203,GO:0000422,1,0.592469529097879,0,80,autophagy of mitochondrion,BP,
204,GO:0000423,1,0.884281077599314,0,18,mitophagy,BP,
205,GO:0000428,1,0.426377199559416,0,132,DNA-directed RNA polymerase complex,CC,
206,GO:0000429,1,0.974808701750783,0,4,carbon catabolite regulation of transcription from RNA polymerase II promoter,BP,
207,GO:0000430,1,0.982959213894053,0,3,regulation of transcription from RNA polymerase II promoter by glucose,BP,
208,GO:0000431,1,0.991709621950676,0,1,regulation of transcription from RNA polymerase II promoter by galactose,BP,
209,GO:0000432,1,0.982959213894053,0,3,positive regulation of transcription from RNA polymerase II promoter by glucose,BP,
210,GO:0000435,1,0.991709621950676,0,1,positive regulation of transcription from RNA polymerase II promoter by galactose,BP,
211,GO:0000436,1,0.974808701750783,0,4,carbon catabolite activation of transcription from RNA polymerase II promoter,BP,
212,GO:0000438,1,0.983273606543947,0,3,core TFIIH complex portion of holo TFIIH complex,CC,
213,GO:0000439,1,0.951401706665991,0,8,core TFIIH complex,CC,
214,GO:0000444,1,0.971646040681036,0,4,MIS12/MIND type complex,CC,
215,GO:0000445,1,0.964737886464433,0,6,THO complex part of transcription export complex,CC,
216,GO:0000447,1,0.945962804532241,0,9,endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
217,GO:0000448,1,0.991809108318657,0,1,cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
218,GO:0000451,1,0.992626873870278,0,1,rRNA 2'-O-methylation,BP,
219,GO:0000453,1,0.992626873870278,0,1,enzyme-directed rRNA 2'-O-methylation,BP,
220,GO:0000454,1,0.984170764324828,0,3,snoRNA guided rRNA pseudouridine synthesis,BP,
221,GO:0000455,1,0.988601019988912,0,2,enzyme-directed rRNA pseudouridine synthesis,BP,
222,GO:0000459,1,0.960151218483466,0,7,exonucleolytic trimming involved in rRNA processing,BP,
223,GO:0000460,1,0.82047177847386,0,32,maturation of 5.8S rRNA,BP,
224,GO:0000461,1,0.989819507397441,0,2,endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
225,GO:0000462,1,0.797864448427457,0,37,maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
226,GO:0000463,1,0.948018010857572,0,9,maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
227,GO:0000466,1,0.877240299253891,0,21,maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
228,GO:0000467,1,0.960151218483466,0,7,exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
229,GO:0000469,1,0.855814695069619,0,25,cleavage involved in rRNA processing,BP,
230,GO:0000470,1,0.87579547200596,0,22,maturation of LSU-rRNA,BP,
231,GO:0000472,1,0.978642507468991,0,3,endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
232,GO:0000478,1,0.911544376998958,0,14,endonucleolytic cleavage involved in rRNA processing,BP,
233,GO:0000479,1,0.917028055102197,0,13,endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
234,GO:0000480,1,0.96074019881321,0,6,endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
235,GO:0000481,1,0.993425285784331,0,1,maturation of 5S rRNA,BP,
236,GO:0000491,1,0.95294638875101,0,8,small nucleolar ribonucleoprotein complex assembly,BP,
237,GO:0000492,1,0.96430677907601,0,6,box C/D snoRNP assembly,BP,
238,GO:0000493,1,0.988223412995303,0,2,box H/ACA snoRNP assembly,BP,
239,GO:0000494,1,0.994685092053482,0,1,box C/D snoRNA 3'-end processing,BP,
240,GO:0000495,1,0.993956590534699,0,1,box H/ACA snoRNA 3'-end processing,BP,
241,GO:0000502,1,0.69608288550429,0,62,proteasome complex,CC,
242,GO:0000506,1,0.950024680933607,0,9,glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex,CC,
243,GO:0000578,1,0.811954879344103,0,31,embryonic axis specification,BP,
244,GO:0000700,1,0.976760589167835,0,4,mismatch base pair DNA N-glycosylase activity,MF,
245,GO:0000701,1,0.988963837680313,0,2,purine-specific mismatch base pair DNA N-glycosylase activity,MF,
246,GO:0000702,1,0.972997862369595,0,5,oxidized base lesion DNA N-glycosylase activity,MF,
247,GO:0000703,1,0.989243423513685,0,2,oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity,MF,
248,GO:0000706,1,0.980757289985986,0,3,meiotic DNA double-strand break processing,BP,
249,GO:0000707,1,0.953224223931777,0,8,meiotic DNA recombinase assembly,BP,
250,GO:0000710,1,0.973461032904006,0,4,meiotic mismatch repair,BP,
251,GO:0000711,1,0.994555668369956,0,1,meiotic DNA repair synthesis,BP,
253,GO:0000715,1,0.871324045812332,0,23,nucleotide-excision repair, DNA damage recognition,BP,
254,GO:0000717,1,0.873005971377726,0,22,nucleotide-excision repair, DNA duplex unwinding,BP,
255,GO:0000718,1,0.994396242376035,0,1,nucleotide-excision repair, DNA damage removal,BP,
256,GO:0000720,1,0.981617013287939,0,3,pyrimidine dimer repair by nucleotide-excision repair,BP,
257,GO:0000722,1,0.905825584275667,0,14,telomere maintenance via recombination,BP,
258,GO:0000723,1,0.384775614571652,0,144,telomere maintenance,BP,
259,GO:0000724,1,0.499613331520588,0,104,double-strand break repair via homologous recombination,BP,
260,GO:0000725,1,0.496519483548663,0,105,recombinational repair,BP,
261,GO:0000726,1,0.650554007038547,0,64,non-recombinational repair,BP,
262,GO:0000727,1,0.970306868902894,0,5,double-strand break repair via break-induced replication,BP,
263,GO:0000729,1,0.862610513244193,0,22,DNA double-strand break processing,BP,
264,GO:0000730,1,0.941581758366975,0,10,DNA recombinase assembly,BP,
266,GO:0000732,1,0.840706219318362,0,25,strand displacement,BP,
267,GO:0000733,1,0.943624329317732,0,9,DNA strand renaturation,BP,
268,GO:0000737,1,0.848453678174776,0,26,DNA catabolic process, endonucleolytic,BP,
269,GO:0000738,1,0.975433065242557,0,4,DNA catabolic process, exonucleolytic,BP,
271,GO:0000768,1,0.774240132466257,0,37,syncytium formation by plasma membrane fusion,BP,
272,GO:0000773,1,0.99477549658101,0,1,phosphatidyl-N-methylethanolamine N-methyltransferase activity,MF,
273,GO:0000774,1,0.934983961117001,0,11,adenyl-nucleotide exchange factor activity,MF,
281,GO:0000782,1,0.934072367053967,0,11,telomere cap complex,CC,
282,GO:0000783,1,0.934072367053967,0,11,nuclear telomere cap complex,CC,
285,GO:0000786,1,0.769615923803868,0,47,nucleosome,CC,
286,GO:0000788,1,0.925749798542511,0,14,nuclear nucleosome,CC,
287,GO:0000789,1,0.994718671777653,0,1,cytoplasmic chromatin,CC,
288,GO:0000790,1,0.131017191232701,0,304,nuclear chromatin,CC,
289,GO:0000791,1,0.834935986239109,0,29,euchromatin,CC,
290,GO:0000792,1,0.636120767998677,0,68,heterochromatin,CC,
295,GO:0000797,1,0.992794852338925,0,1,condensin core heterodimer,CC,
296,GO:0000798,1,0.968452320867054,0,5,nuclear cohesin complex,CC,
297,GO:0000799,1,0.978291261099413,0,3,nuclear condensin complex,CC,
298,GO:0000800,1,0.914894055575737,0,13,lateral element,CC,
299,GO:0000801,1,0.9644528352769,0,6,central element,CC,
300,GO:0000803,1,0.845988899986986,0,25,sex chromosome,CC,
301,GO:0000805,1,0.950988495485071,0,7,X chromosome,CC,
302,GO:0000806,1,0.98680479079975,0,2,Y chromosome,CC,
303,GO:0000808,1,0.945810949375612,0,9,origin recognition complex,CC,
304,GO:0000811,1,0.981690598260269,0,3,GINS complex,CC,
305,GO:0000812,1,0.933598998941991,0,10,Swr1 complex,CC,
306,GO:0000813,1,0.941413472139902,0,10,ESCRT I complex,CC,
307,GO:0000814,1,0.982487212079375,0,3,ESCRT II complex,CC,
308,GO:0000815,1,0.930689347390074,0,12,ESCRT III complex,CC,
309,GO:0000818,1,0.988157409177469,0,2,nuclear MIS12/MIND complex,CC,
311,GO:0000820,1,0.966817279607134,0,5,regulation of glutamine family amino acid metabolic process,BP,
312,GO:0000821,1,0.984883472013363,0,2,regulation of arginine metabolic process,BP,
313,GO:0000822,1,0.975555735256343,0,3,inositol hexakisphosphate binding,MF,
314,GO:0000823,1,0.994361611814873,0,1,inositol-1,4,5-trisphosphate 6-kinase activity,MF,
315,GO:0000824,1,0.994361611814873,0,1,inositol tetrakisphosphate 3-kinase activity,MF,
316,GO:0000825,1,0.994361611814873,0,1,inositol tetrakisphosphate 6-kinase activity,MF,
317,GO:0000827,1,0.966899096663535,0,5,inositol-1,3,4,5,6-pentakisphosphate kinase activity,MF,
318,GO:0000828,1,0.966899096663535,0,5,inositol hexakisphosphate kinase activity,MF,
319,GO:0000829,1,0.966899096663535,0,5,inositol heptakisphosphate kinase activity,MF,
320,GO:0000831,1,0.993863226124155,0,1,inositol hexakisphosphate 6-kinase activity,MF,
321,GO:0000832,1,0.966899096663535,0,5,inositol hexakisphosphate 5-kinase activity,MF,
322,GO:0000835,1,0.959890030922908,0,6,ER ubiquitin ligase complex,CC,
323,GO:0000836,1,0.966756557410865,0,5,Hrd1p ubiquitin ligase complex,CC,
324,GO:0000839,1,0.980170025598752,0,3,Hrd1p ubiquitin ligase ERAD-L complex,CC,
325,GO:0000900,1,0.914173474728187,0,13,translation repressor activity, mRNA regulatory element binding,MF,
329,GO:0000912,1,0.958978704384256,0,6,assembly of actomyosin apparatus involved in cytokinesis,BP,
330,GO:0000915,1,0.958978704384256,0,6,actomyosin contractile ring assembly,BP,
331,GO:0000916,1,0.994161620261592,0,1,actomyosin contractile ring contraction,BP,
332,GO:0000917,1,0.994333182567743,0,1,division septum assembly,BP,
333,GO:0000920,1,0.90315098888143,0,17,cell separation after cytokinesis,BP,
336,GO:0000923,1,0.96705779729755,0,5,equatorial microtubule organizing center,CC,
337,GO:0000928,1,0.993850639026861,0,1,gamma-tubulin small complex, spindle pole body,CC,
338,GO:0000930,1,0.877539198184297,0,19,gamma-tubulin complex,CC,
339,GO:0000931,1,0.952116697527692,0,7,gamma-tubulin large complex,CC,
340,GO:0000932,1,0.590906795887797,0,79,P-body,CC,
341,GO:0000938,1,0.973033063621586,0,4,GARP complex,CC,
342,GO:0000939,1,0.982646707354368,0,3,condensed chromosome inner kinetochore,CC,
344,GO:0000941,1,0.994123924412939,0,1,condensed nuclear chromosome inner kinetochore,CC,
346,GO:0000956,1,0.292992051105269,0,200,nuclear-transcribed mRNA catabolic process,BP,
347,GO:0000957,1,0.966304347292295,0,5,mitochondrial RNA catabolic process,BP,
348,GO:0000958,1,0.980282748261761,0,3,mitochondrial mRNA catabolic process,BP,
349,GO:0000959,1,0.770152239404997,0,41,mitochondrial RNA metabolic process,BP,
350,GO:0000960,1,0.972890031512252,0,4,regulation of mitochondrial RNA catabolic process,BP,
351,GO:0000961,1,0.98574328627614,0,2,negative regulation of mitochondrial RNA catabolic process,BP,
352,GO:0000962,1,0.98696272796186,0,2,positive regulation of mitochondrial RNA catabolic process,BP,
353,GO:0000963,1,0.907075207659554,0,16,mitochondrial RNA processing,BP,
354,GO:0000964,1,0.975724371407652,0,4,mitochondrial RNA 5'-end processing,BP,
355,GO:0000965,1,0.970042291399656,0,5,mitochondrial RNA 3'-end processing,BP,
356,GO:0000966,1,0.879130487242358,0,21,RNA 5'-end processing,BP,
357,GO:0000967,1,0.978642507468991,0,3,rRNA 5'-end processing,BP,
358,GO:0000972,1,0.956176750671898,0,7,transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery,BP,
359,GO:0000973,1,0.980772825495909,0,3,posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery,BP,
360,GO:0000974,1,0.923462806007829,0,13,Prp19 complex,CC,
365,GO:0000980,1,0.646210587972633,0,66,RNA polymerase II distal enhancer sequence-specific DNA binding,MF,
368,GO:0000983,1,0.865709160478431,0,21,transcription factor activity, RNA polymerase II core promoter sequence-specific DNA binding,MF,
372,GO:0000990,1,0.943806873202123,0,8,transcription factor activity, core RNA polymerase binding,MF,
373,GO:0000991,1,0.986811034121865,0,2,transcription factor activity, core RNA polymerase II binding,MF,
374,GO:0000992,1,0.985670199455507,0,2,polymerase III regulatory region sequence-specific DNA binding,MF,
375,GO:0000993,1,0.83383220529545,0,28,RNA polymerase II core binding,MF,
376,GO:0000994,1,0.994369882005025,0,1,RNA polymerase III core binding,MF,
377,GO:0000995,1,0.96869097792484,0,4,transcription factor activity, core RNA polymerase III binding,MF,
378,GO:0001002,1,0.985670199455507,0,2,RNA polymerase III type 1 promoter sequence-specific DNA binding,MF,
379,GO:0001003,1,0.985670199455507,0,2,RNA polymerase III type 2 promoter sequence-specific DNA binding,MF,
380,GO:0001007,1,0.969178766481481,0,4,transcription factor activity, RNA polymerase III transcription factor binding,MF,
381,GO:0001010,1,0.884115069371921,0,18,transcription factor activity, sequence-specific DNA binding transcription factor recruiting,MF,
382,GO:0001011,1,0.990966646083256,0,1,transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting,MF,
384,GO:0001013,1,0.947171629331565,0,8,RNA polymerase I regulatory region DNA binding,MF,
385,GO:0001016,1,0.952715763106129,0,7,RNA polymerase III regulatory region DNA binding,MF,
386,GO:0001018,1,0.988000558510492,0,2,mitochondrial promoter sequence-specific DNA binding,MF,
387,GO:0001025,1,0.972390354502296,0,3,RNA polymerase III transcription factor binding,MF,
388,GO:0001026,1,0.9830363070633,0,2,TFIIIB-type transcription factor activity,MF,
389,GO:0001030,1,0.963123841425327,0,5,RNA polymerase III type 1 promoter DNA binding,MF,
390,GO:0001031,1,0.963123841425327,0,5,RNA polymerase III type 2 promoter DNA binding,MF,
391,GO:0001032,1,0.971526999517815,0,4,RNA polymerase III type 3 promoter DNA binding,MF,
392,GO:0001034,1,0.994356184454288,0,1,RNA polymerase III transcription factor activity, sequence-specific DNA binding,MF,
393,GO:0001042,1,0.965005065802484,0,5,RNA polymerase I core binding,MF,
396,GO:0001054,1,0.935939650441184,0,11,RNA polymerase I activity,MF,
397,GO:0001055,1,0.937500373809761,0,11,RNA polymerase II activity,MF,
398,GO:0001056,1,0.914740106569409,0,15,RNA polymerase III activity,MF,
400,GO:0001069,1,0.985526944967299,0,2,regulatory region RNA binding,MF,
401,GO:0001074,1,0.993951184084783,0,1,transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding involved in preinitiation complex assembly,MF,
402,GO:0001075,1,0.950784621419391,0,7,transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly,MF,
406,GO:0001079,1,0.994178148773045,0,1,nitrogen catabolite regulation of transcription from RNA polymerase II promoter,BP,
407,GO:0001080,1,0.994178148773045,0,1,nitrogen catabolite activation of transcription from RNA polymerase II promoter,BP,
408,GO:0001083,1,0.956145742183318,0,6,transcription factor activity, RNA polymerase II basal transcription factor binding,MF,
409,GO:0001084,1,0.993951184084783,0,1,transcription factor activity, TFIID-class binding,MF,
410,GO:0001085,1,0.39618526817446,0,138,RNA polymerase II transcription factor binding,MF,
411,GO:0001087,1,0.990966646083256,0,1,transcription factor activity, TFIIB-class binding,MF,
412,GO:0001091,1,0.897243081157578,0,16,RNA polymerase II basal transcription factor binding,MF,
413,GO:0001093,1,0.977492800817152,0,3,TFIIB-class transcription factor binding,MF,
414,GO:0001094,1,0.942802541660965,0,9,TFIID-class transcription factor binding,MF,
415,GO:0001096,1,0.993394021082405,0,1,TFIIF-class transcription factor binding,MF,
416,GO:0001097,1,0.980099820639857,0,3,TFIIH-class transcription factor binding,MF,
417,GO:0001098,1,0.754953319283297,0,43,basal transcription machinery binding,MF,
418,GO:0001099,1,0.754953319283297,0,43,basal RNA polymerase II transcription machinery binding,MF,
419,GO:0001100,1,0.993850639026861,0,1,negative regulation of exit from mitosis,BP,
420,GO:0001101,1,0.134085016103943,0,307,response to acid chemical,BP,
421,GO:0001102,1,0.729107340229412,0,47,RNA polymerase II activating transcription factor binding,MF,
422,GO:0001103,1,0.812989731302038,0,32,RNA polymerase II repressing transcription factor binding,MF,
425,GO:0001106,1,0.833338595540414,0,28,RNA polymerase II transcription corepressor activity,MF,
426,GO:0001112,1,0.993723702109128,0,1,DNA-templated transcriptional open complex formation,BP,
427,GO:0001113,1,0.993723702109128,0,1,transcriptional open complex formation at RNA polymerase II promoter,BP,
428,GO:0001120,1,0.993723702109128,0,1,protein-DNA complex remodeling,BP,
429,GO:0001128,1,0.9945931286254,0,1,RNA polymerase II transcription coactivator activity involved in preinitiation complex assembly,MF,
430,GO:0001129,1,0.97073841331234,0,4,RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly,MF,
431,GO:0001132,1,0.97073841331234,0,4,RNA polymerase II transcription factor activity, TBP-class protein binding,MF,
432,GO:0001133,1,0.88965931327282,0,17,RNA polymerase II transcription factor activity, sequence-specific transcription regulatory region DNA binding,MF,
435,GO:0001147,1,0.983157069609533,0,2,transcription termination site sequence-specific DNA binding,MF,
436,GO:0001156,1,0.972390354502296,0,3,TFIIIC-class transcription factor binding,MF,
438,GO:0001160,1,0.983157069609533,0,2,transcription termination site DNA binding,MF,
439,GO:0001161,1,0.923341243839522,0,12,intronic transcription regulatory region sequence-specific DNA binding,MF,
440,GO:0001162,1,0.934915173755886,0,10,RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding,MF,
441,GO:0001163,1,0.947171629331565,0,8,RNA polymerase I regulatory region sequence-specific DNA binding,MF,
442,GO:0001164,1,0.947171629331565,0,8,RNA polymerase I CORE element sequence-specific DNA binding,MF,
443,GO:0001165,1,0.992923747115393,0,1,RNA polymerase I upstream control element sequence-specific DNA binding,MF,
444,GO:0001172,1,0.985146994671852,0,2,transcription, RNA-templated,BP,
445,GO:0001179,1,0.994326979806852,0,1,RNA polymerase I transcription factor binding,MF,
446,GO:0001181,1,0.993352472450903,0,1,transcription factor activity, core RNA polymerase I binding,MF,
447,GO:0001188,1,0.947171629331565,0,8,RNA polymerase I transcriptional preinitiation complex assembly,BP,
449,GO:0001191,1,0.741082638301347,0,46,transcriptional repressor activity, RNA polymerase II transcription factor binding,MF,
450,GO:0001192,1,0.994838000999417,0,1,maintenance of transcriptional fidelity during DNA-templated transcription elongation,BP,
451,GO:0001193,1,0.994838000999417,0,1,maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter,BP,
452,GO:0001205,1,0.821366148741804,0,30,transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific DNA binding,MF,
453,GO:0001206,1,0.933625729132774,0,9,transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding,MF,
454,GO:0001221,1,0.75650673625726,0,40,transcription cofactor binding,MF,
455,GO:0001222,1,0.910912336833449,0,14,transcription corepressor binding,MF,
456,GO:0001223,1,0.864266174670489,0,20,transcription coactivator binding,MF,
457,GO:0001224,1,0.977072545606904,0,3,RNA polymerase II transcription cofactor binding,MF,
458,GO:0001225,1,0.983375425833644,0,2,RNA polymerase II transcription coactivator binding,MF,
459,GO:0001226,1,0.993591646691022,0,1,RNA polymerase II transcription corepressor binding,MF,
462,GO:0001300,1,0.987367086486301,0,2,chronological cell aging,BP,
463,GO:0001302,1,0.96212897608749,0,6,replicative cell aging,BP,
464,GO:0001306,1,0.994759999181943,0,1,age-dependent response to oxidative stress,BP,
465,GO:0001315,1,0.994759999181943,0,1,age-dependent response to reactive oxygen species,BP,
466,GO:0001325,1,0.911480212789203,0,14,formation of extrachromosomal circular DNA,BP,
467,GO:0001401,1,0.987996799704909,0,2,mitochondrial sorting and assembly machinery complex,CC,
468,GO:0001405,1,0.9703038568255,0,5,presequence translocase-associated import motor,CC,
470,GO:0001502,1,0.897912057815544,0,16,cartilage condensation,BP,
474,GO:0001507,1,0.987725477089946,0,2,acetylcholine catabolic process in synaptic cleft,BP,
476,GO:0001510,1,0.702476063529239,0,57,RNA methylation,BP,
477,GO:0001512,1,0.994699040695356,0,1,dihydronicotinamide riboside quinone reductase activity,MF,
478,GO:0001514,1,0.948043040273952,0,8,selenocysteine incorporation,BP,
479,GO:0001515,1,0.97772797177654,0,4,opioid peptide activity,MF,
481,GO:0001517,1,0.959410918149064,0,6,N-acetylglucosamine 6-O-sulfotransferase activity,MF,
482,GO:0001518,1,0.891257851414064,0,14,voltage-gated sodium channel complex,CC,
483,GO:0001519,1,0.993366583143387,0,1,peptide amidation,BP,
484,GO:0001520,1,0.980502554553808,0,3,outer dense fiber,CC,
485,GO:0001522,1,0.901170296362494,0,18,pseudouridine synthesis,BP,
488,GO:0001527,1,0.928458475587139,0,10,microfibril,CC,
489,GO:0001530,1,0.872008379765026,0,23,lipopolysaccharide binding,MF,
490,GO:0001532,1,0.993603414634137,0,1,interleukin-21 receptor activity,MF,
491,GO:0001533,1,0.846323844539628,0,25,cornified envelope,CC,
492,GO:0001534,1,0.975137144157987,0,4,radial spoke,CC,
493,GO:0001536,1,0.981165792759181,0,3,radial spoke stalk,CC,
494,GO:0001537,1,0.969503394890316,0,5,N-acetylgalactosamine 4-O-sulfotransferase activity,MF,
497,GO:0001541,1,0.727772168429289,0,49,ovarian follicle development,BP,
498,GO:0001542,1,0.934942591753893,0,9,ovulation from ovarian follicle,BP,
499,GO:0001543,1,0.991373420884148,0,1,ovarian follicle rupture,BP,
500,GO:0001544,1,0.991492275024838,0,1,initiation of primordial ovarian follicle growth,BP,
501,GO:0001545,1,0.993198904248925,0,1,primary ovarian follicle growth,BP,
502,GO:0001546,1,0.982868438038362,0,3,preantral ovarian follicle growth,BP,
503,GO:0001547,1,0.958207340597084,0,6,antral ovarian follicle growth,BP,
504,GO:0001550,1,0.985369738147513,0,2,ovarian cumulus expansion,BP,
505,GO:0001552,1,0.994285629224291,0,1,ovarian follicle atresia,BP,
507,GO:0001554,1,0.964769093729648,0,5,luteolysis,BP,
508,GO:0001555,1,0.98199023521442,0,3,oocyte growth,BP,
509,GO:0001556,1,0.879289550178455,0,20,oocyte maturation,BP,
511,GO:0001560,1,0.976920227324438,0,3,regulation of cell growth by extracellular stimulus,BP,
512,GO:0001561,1,0.952876286500019,0,8,fatty acid alpha-oxidation,BP,
513,GO:0001562,1,0.894093242541764,0,18,response to protozoan,BP,
514,GO:0001567,1,0.994579694837941,0,1,cholesterol 25-hydroxylase activity,MF,
518,GO:0001572,1,0.992803212983447,0,1,lactosylceramide biosynthetic process,BP,
519,GO:0001573,1,0.894879138590234,0,17,ganglioside metabolic process,BP,
520,GO:0001574,1,0.936453372390251,0,10,ganglioside biosynthetic process,BP,
521,GO:0001575,1,0.988546291105088,0,2,globoside metabolic process,BP,
522,GO:0001576,1,0.99420914570589,0,1,globoside biosynthetic process,BP,
523,GO:0001578,1,0.584791926422123,0,77,microtubule bundle formation,BP,
524,GO:0001579,1,0.987260089435837,0,2,medium-chain fatty acid transport,BP,
525,GO:0001580,1,0.890018747112762,0,21,detection of chemical stimulus involved in sensory perception of bitter taste,BP,
526,GO:0001581,1,0.993708337644235,0,1,detection of chemical stimulus involved in sensory perception of sour taste,BP,
527,GO:0001582,1,0.993966632638298,0,1,detection of chemical stimulus involved in sensory perception of sweet taste,BP,
528,GO:0001587,1,0.992837163368111,0,1,Gq/11-coupled serotonin receptor activity,MF,
529,GO:0001588,1,0.977090536012908,0,4,dopamine neurotransmitter receptor activity, coupled via Gs,MF,
530,GO:0001591,1,0.982517386477716,0,3,dopamine neurotransmitter receptor activity, coupled via Gi/Go,MF,
531,GO:0001595,1,0.9835602541253,0,3,angiotensin receptor activity,MF,
532,GO:0001596,1,0.994086760543214,0,1,angiotensin type I receptor activity,MF,
533,GO:0001601,1,0.981735803322824,0,3,peptide YY receptor activity,MF,
534,GO:0001602,1,0.97694683524152,0,4,pancreatic polypeptide receptor activity,MF,
535,GO:0001604,1,0.989233167599541,0,2,urotensin II receptor activity,MF,
536,GO:0001605,1,0.982288250426447,0,3,adrenomedullin receptor activity,MF,
537,GO:0001607,1,0.987860544115187,0,2,neuromedin U receptor activity,MF,
538,GO:0001608,1,0.931542395744587,0,12,G-protein coupled nucleotide receptor activity,MF,
539,GO:0001609,1,0.965095075875545,0,6,G-protein coupled adenosine receptor activity,MF,
540,GO:0001614,1,0.893798544530123,0,19,purinergic nucleotide receptor activity,MF,
542,GO:0001621,1,0.994521048025353,0,1,ADP receptor activity,MF,
543,GO:0001626,1,0.993597786461588,0,1,nociceptin receptor activity,MF,
544,GO:0001631,1,0.965547907791118,0,6,cysteinyl leukotriene receptor activity,MF,
545,GO:0001632,1,0.98802955865895,0,2,leukotriene B4 receptor activity,MF,
546,GO:0001635,1,0.981533016544427,0,3,calcitonin gene-related peptide receptor activity,MF,
547,GO:0001637,1,0.865940592427586,0,24,G-protein coupled chemoattractant receptor activity,MF,
548,GO:0001640,1,0.956955209383906,0,6,adenylate cyclase inhibiting G-protein coupled glutamate receptor activity,MF,
549,GO:0001641,1,0.987059119330678,0,2,group II metabotropic glutamate receptor activity,MF,
550,GO:0001642,1,0.978797388759026,0,3,group III metabotropic glutamate receptor activity,MF,
552,GO:0001650,1,0.438663599577421,0,126,fibrillar center,CC,
553,GO:0001651,1,0.994685092053482,0,1,dense fibrillar component,CC,
554,GO:0001652,1,0.970691888057795,0,5,granular component,CC,
561,GO:0001659,1,0.799105230057527,0,35,temperature homeostasis,BP,
562,GO:0001660,1,0.938268283834761,0,10,fever generation,BP,
563,GO:0001661,1,0.967219281085846,0,5,conditioned taste aversion,BP,
564,GO:0001662,1,0.796793401108345,0,35,behavioral fear response,BP,
566,GO:0001665,1,0.965549221938463,0,6,alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity,MF,
567,GO:0001666,1,0.12089535503681,0,323,response to hypoxia,BP,
569,GO:0001669,1,0.600711432993385,0,80,acrosomal vesicle,CC,
570,GO:0001671,1,0.859375531871636,0,25,ATPase activator activity,MF,
571,GO:0001672,1,0.93669279538159,0,9,regulation of chromatin assembly or disassembly,BP,
573,GO:0001674,1,0.994133217907939,0,1,female germ cell nucleus,CC,
574,GO:0001675,1,0.944166002137883,0,8,acrosome assembly,BP,
576,GO:0001678,1,0.449688566640598,0,121,cellular glucose homeostasis,BP,
577,GO:0001680,1,0.994112567016873,0,1,tRNA 3'-terminal CCA addition,BP,
578,GO:0001681,1,0.99382060087495,0,1,sialate O-acetylesterase activity,MF,
579,GO:0001682,1,0.932656477997271,0,12,tRNA 5'-leader removal,BP,
580,GO:0001692,1,0.983210657989274,0,3,histamine metabolic process,BP,
581,GO:0001694,1,0.994042910162818,0,1,histamine biosynthetic process,BP,
582,GO:0001695,1,0.994821471152595,0,1,histamine catabolic process,BP,
583,GO:0001696,1,0.90686297930843,0,16,gastric acid secretion,BP,
584,GO:0001697,1,0.993832151157774,0,1,histamine-induced gastric acid secretion,BP,
585,GO:0001698,1,0.988885975507958,0,2,gastrin-induced gastric acid secretion,BP,
586,GO:0001701,1,0.136050153886532,0,293,in utero embryonic development,BP,
589,GO:0001705,1,0.986745068601576,0,2,ectoderm formation,BP,
590,GO:0001706,1,0.695596197310829,0,53,endoderm formation,BP,
593,GO:0001709,1,0.784364182943194,0,37,cell fate determination,BP,
595,GO:0001711,1,0.91092818898097,0,15,endodermal cell fate commitment,BP,
596,GO:0001712,1,0.986745068601576,0,2,ectodermal cell fate commitment,BP,
597,GO:0001714,1,0.954633919110682,0,8,endodermal cell fate specification,BP,
598,GO:0001715,1,0.993306253802084,0,1,ectodermal cell fate specification,BP,
599,GO:0001716,1,0.994226455243127,0,1,L-amino-acid oxidase activity,MF,
600,GO:0001725,1,0.693693454877216,0,52,stress fiber,CC,
602,GO:0001727,1,0.966629537783672,0,5,lipid kinase activity,MF,
603,GO:0001729,1,0.986809581762351,0,2,ceramide kinase activity,MF,
604,GO:0001730,1,0.97444721297105,0,4,2'-5'-oligoadenylate synthetase activity,MF,
605,GO:0001731,1,0.948273840579225,0,8,formation of translation preinitiation complex,BP,
606,GO:0001732,1,0.986858469139577,0,2,formation of cytoplasmic translation initiation complex,BP,
607,GO:0001733,1,0.976664049410022,0,4,galactosylceramide sulfotransferase activity,MF,
608,GO:0001735,1,0.986524947083108,0,2,prenylcysteine oxidase activity,MF,
611,GO:0001739,1,0.969638082897981,0,5,sex chromatin,CC,
612,GO:0001740,1,0.979368898053899,0,3,Barr body,CC,
613,GO:0001741,1,0.927168937858353,0,12,XY body,CC,
614,GO:0001743,1,0.97911703881518,0,3,optic placode formation,BP,
617,GO:0001755,1,0.735048964828693,0,46,neural crest cell migration,BP,
619,GO:0001757,1,0.969449336926087,0,5,somite specification,BP,
624,GO:0001765,1,0.946830890362393,0,9,membrane raft assembly,BP,
626,GO:0001767,1,0.933268072260076,0,10,establishment of lymphocyte polarity,BP,
627,GO:0001768,1,0.941165607516296,0,9,establishment of T cell polarity,BP,
628,GO:0001770,1,0.991613884020134,0,1,establishment of natural killer cell polarity,BP,
629,GO:0001771,1,0.919691476049915,0,13,immunological synapse formation,BP,
630,GO:0001772,1,0.815013490156107,0,32,immunological synapse,CC,
631,GO:0001773,1,0.866187411918142,0,24,myeloid dendritic cell activation,BP,
632,GO:0001774,1,0.845114782764452,0,25,microglial cell activation,BP,
634,GO:0001776,1,0.596983921621675,0,80,leukocyte homeostasis,BP,
635,GO:0001777,1,0.983222171910965,0,3,T cell homeostatic proliferation,BP,
636,GO:0001778,1,0.963699888911787,0,5,plasma membrane repair,BP,
637,GO:0001779,1,0.895773585458807,0,17,natural killer cell differentiation,BP,
638,GO:0001780,1,0.912629912189195,0,14,neutrophil homeostasis,BP,
639,GO:0001781,1,0.955997011100438,0,7,neutrophil apoptotic process,BP,
640,GO:0001782,1,0.830417489002268,0,28,B cell homeostasis,BP,
641,GO:0001783,1,0.86945907059305,0,22,B cell apoptotic process,BP,
642,GO:0001784,1,0.783252697086806,0,35,phosphotyrosine residue binding,MF,
643,GO:0001785,1,0.987660423643538,0,2,prostaglandin J receptor activity,MF,
645,GO:0001787,1,0.957696508594459,0,7,natural killer cell proliferation,BP,
646,GO:0001788,1,0.994459036414026,0,1,antibody-dependent cellular cytotoxicity,BP,
647,GO:0001791,1,0.994394691806086,0,1,IgM binding,MF,
648,GO:0001792,1,0.993083311995591,0,1,polymeric immunoglobulin receptor activity,MF,
649,GO:0001794,1,0.982182772207278,0,3,type IIa hypersensitivity,BP,
650,GO:0001796,1,0.982182772207278,0,3,regulation of type IIa hypersensitivity,BP,
651,GO:0001797,1,0.994459036414026,0,1,negative regulation of type IIa hypersensitivity,BP,
652,GO:0001798,1,0.987656023470213,0,2,positive regulation of type IIa hypersensitivity,BP,
653,GO:0001802,1,0.988945933996337,0,2,type III hypersensitivity,BP,
654,GO:0001803,1,0.988945933996337,0,2,regulation of type III hypersensitivity,BP,
655,GO:0001805,1,0.988945933996337,0,2,positive regulation of type III hypersensitivity,BP,
656,GO:0001806,1,0.982609406486721,0,3,type IV hypersensitivity,BP,
657,GO:0001807,1,0.988834307240707,0,2,regulation of type IV hypersensitivity,BP,
658,GO:0001808,1,0.994233431237293,0,1,negative regulation of type IV hypersensitivity,BP,
659,GO:0001809,1,0.99456987767494,0,1,positive regulation of type IV hypersensitivity,BP,
660,GO:0001810,1,0.98346560635127,0,3,regulation of type I hypersensitivity,BP,
661,GO:0001811,1,0.994459036414026,0,1,negative regulation of type I hypersensitivity,BP,
662,GO:0001812,1,0.988945933996337,0,2,positive regulation of type I hypersensitivity,BP,
663,GO:0001813,1,0.994459036414026,0,1,regulation of antibody-dependent cellular cytotoxicity,BP,
664,GO:0001814,1,0.994459036414026,0,1,negative regulation of antibody-dependent cellular cytotoxicity,BP,
667,GO:0001818,1,0.260632705740843,0,213,negative regulation of cytokine production,BP,
669,GO:0001820,1,0.941610629345559,0,10,serotonin secretion,BP,
670,GO:0001821,1,0.949043523403496,0,9,histamine secretion,BP,
673,GO:0001824,1,0.705090233572174,0,54,blastocyst development,BP,
674,GO:0001825,1,0.850200538787231,0,25,blastocyst formation,BP,
675,GO:0001826,1,0.957398537072707,0,6,inner cell mass cell differentiation,BP,
676,GO:0001827,1,0.985310749067753,0,2,inner cell mass cell fate commitment,BP,
677,GO:0001828,1,0.979473332262249,0,3,inner cell mass cellular morphogenesis,BP,
678,GO:0001829,1,0.92566659539221,0,12,trophectodermal cell differentiation,BP,
679,GO:0001831,1,0.986027364953558,0,2,trophectodermal cellular morphogenesis,BP,
680,GO:0001832,1,0.895739895300906,0,16,blastocyst growth,BP,
681,GO:0001833,1,0.928157805720125,0,11,inner cell mass cell proliferation,BP,
682,GO:0001834,1,0.985428007138424,0,2,trophectodermal cell proliferation,BP,
683,GO:0001835,1,0.993611601194332,0,1,blastocyst hatching,BP,
684,GO:0001836,1,0.723924740135406,0,54,release of cytochrome c from mitochondria,BP,
687,GO:0001839,1,0.961599704469426,0,6,neural plate morphogenesis,BP,
688,GO:0001840,1,0.939425817298194,0,9,neural plate development,BP,
690,GO:0001842,1,0.955700385994515,0,7,neural fold formation,BP,
692,GO:0001844,1,0.822920219032451,0,32,protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,
693,GO:0001845,1,0.925348205769024,0,12,phagolysosome assembly,BP,
694,GO:0001846,1,0.919503439388854,0,12,opsonin binding,MF,
695,GO:0001847,1,0.973124409615008,0,4,opsonin receptor activity,MF,
696,GO:0001848,1,0.901305116519946,0,15,complement binding,MF,
697,GO:0001849,1,0.959543004029588,0,6,complement component C1q binding,MF,
698,GO:0001850,1,0.994344037413837,0,1,complement component C3a binding,MF,
699,GO:0001851,1,0.971697493331867,0,4,complement component C3b binding,MF,
700,GO:0001855,1,0.984980518155495,0,2,complement component C4b binding,MF,
701,GO:0001856,1,0.99408056826141,0,1,complement component C5a binding,MF,
702,GO:0001861,1,0.990458391802756,0,1,complement component C4b receptor activity,MF,
703,GO:0001865,1,0.948362136112867,0,8,NK T cell differentiation,BP,
704,GO:0001866,1,0.970932948066357,0,5,NK T cell proliferation,BP,
705,GO:0001867,1,0.947911719387766,0,9,complement activation, lectin pathway,BP,
706,GO:0001868,1,0.98722349382016,0,2,regulation of complement activation, lectin pathway,BP,
707,GO:0001869,1,0.98722349382016,0,2,negative regulation of complement activation, lectin pathway,BP,
709,GO:0001872,1,0.994288730402198,0,1,(1->3)-beta-D-glucan binding,MF,
710,GO:0001875,1,0.968347802817436,0,5,lipopolysaccharide receptor activity,MF,
711,GO:0001878,1,0.977021694820813,0,4,response to yeast,BP,
712,GO:0001880,1,0.979460539363999,0,3,Mullerian duct regression,BP,
713,GO:0001881,1,0.819975064796746,0,30,receptor recycling,BP,
716,GO:0001884,1,0.986400320868373,0,2,pyrimidine nucleoside binding,MF,
718,GO:0001886,1,0.931743607390493,0,10,endothelial cell morphogenesis,BP,
719,GO:0001887,1,0.969319963986011,0,5,selenium compound metabolic process,BP,
720,GO:0001888,1,0.98594827110713,0,2,glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,MF,
721,GO:0001889,1,0.417826774040009,0,131,liver development,BP,
722,GO:0001890,1,0.405769119874911,0,136,placenta development,BP,
723,GO:0001891,1,0.878418759296522,0,20,phagocytic cup,CC,
724,GO:0001892,1,0.58067100812987,0,81,embryonic placenta development,BP,
725,GO:0001893,1,0.818877969573716,0,30,maternal placenta development,BP,
728,GO:0001897,1,0.988054531763341,0,2,cytolysis by symbiont of host cells,BP,
729,GO:0001905,1,0.977527641789882,0,3,activation of membrane attack complex,BP,
730,GO:0001906,1,0.535431097807964,0,105,cell killing,BP,
731,GO:0001907,1,0.970452333081335,0,5,killing by symbiont of host cells,BP,
732,GO:0001909,1,0.628139729839739,0,76,leukocyte mediated cytotoxicity,BP,
733,GO:0001910,1,0.728976086299493,0,52,regulation of leukocyte mediated cytotoxicity,BP,
734,GO:0001911,1,0.918900227937332,0,14,negative regulation of leukocyte mediated cytotoxicity,BP,
735,GO:0001912,1,0.82226027948002,0,32,positive regulation of leukocyte mediated cytotoxicity,BP,
736,GO:0001913,1,0.84957158571525,0,27,T cell mediated cytotoxicity,BP,
737,GO:0001914,1,0.887486720112667,0,20,regulation of T cell mediated cytotoxicity,BP,
738,GO:0001915,1,0.963044073433683,0,6,negative regulation of T cell mediated cytotoxicity,BP,
739,GO:0001916,1,0.93190455924521,0,12,positive regulation of T cell mediated cytotoxicity,BP,
741,GO:0001919,1,0.866371992441703,0,22,regulation of receptor recycling,BP,
742,GO:0001920,1,0.9753143993486,0,4,negative regulation of receptor recycling,BP,
743,GO:0001921,1,0.916899261884595,0,13,positive regulation of receptor recycling,BP,
744,GO:0001922,1,0.978752807410769,0,3,B-1 B cell homeostasis,BP,
745,GO:0001923,1,0.980635867058484,0,3,B-1 B cell differentiation,BP,
746,GO:0001927,1,0.979902654551589,0,3,exocyst assembly,BP,
747,GO:0001928,1,0.994121859321931,0,1,regulation of exocyst assembly,BP,
748,GO:0001931,1,0.919334732682793,0,13,uropod,CC,
754,GO:0001937,1,0.809691716860563,0,31,negative regulation of endothelial cell proliferation,BP,
756,GO:0001939,1,0.960724473937826,0,6,female pronucleus,CC,
757,GO:0001940,1,0.963361230113504,0,5,male pronucleus,CC,
758,GO:0001941,1,0.793963148798181,0,33,postsynaptic membrane organization,BP,
759,GO:0001942,1,0.578664716403545,0,81,hair follicle development,BP,
761,GO:0001945,1,0.841220418307335,0,24,lymph vessel development,BP,
762,GO:0001946,1,0.898803389471033,0,15,lymphangiogenesis,BP,
763,GO:0001947,1,0.693220919629072,0,55,heart looping,BP,
764,GO:0001949,1,0.99403465917182,0,1,sebaceous gland cell differentiation,BP,
765,GO:0001951,1,0.973907182179835,0,4,intestinal D-glucose absorption,BP,
766,GO:0001952,1,0.499748813841379,0,98,regulation of cell-matrix adhesion,BP,
767,GO:0001953,1,0.804727881041797,0,31,negative regulation of cell-matrix adhesion,BP,
768,GO:0001954,1,0.730680249928467,0,45,positive regulation of cell-matrix adhesion,BP,
769,GO:0001955,1,0.94768410311623,0,8,blood vessel maturation,BP,
770,GO:0001956,1,0.914566492562265,0,13,positive regulation of neurotransmitter secretion,BP,
771,GO:0001957,1,0.959778930397291,0,6,intramembranous ossification,BP,
773,GO:0001959,1,0.399808894136509,0,142,regulation of cytokine-mediated signaling pathway,BP,
774,GO:0001960,1,0.755147159667488,0,44,negative regulation of cytokine-mediated signaling pathway,BP,
775,GO:0001961,1,0.75772431973295,0,43,positive regulation of cytokine-mediated signaling pathway,BP,
776,GO:0001963,1,0.853398577792345,0,26,synaptic transmission, dopaminergic,BP,
777,GO:0001964,1,0.844176863389507,0,24,startle response,BP,
779,GO:0001966,1,0.994585895079447,0,1,thigmotaxis,BP,
780,GO:0001967,1,0.929127288742164,0,11,suckling behavior,BP,
782,GO:0001969,1,0.977527641789882,0,3,regulation of activation of membrane attack complex,BP,
783,GO:0001970,1,0.986093492866658,0,2,positive regulation of activation of membrane attack complex,BP,
784,GO:0001971,1,0.991314570010609,0,1,negative regulation of activation of membrane attack complex,BP,
785,GO:0001972,1,0.924042372250782,0,12,retinoic acid binding,MF,
787,GO:0001974,1,0.764703254572839,0,39,blood vessel remodeling,BP,
789,GO:0001976,1,0.93109014485927,0,11,neurological system process involved in regulation of systemic arterial blood pressure,BP,
790,GO:0001977,1,0.928973565680957,0,12,renal system process involved in regulation of blood volume,BP,
791,GO:0001978,1,0.99416084554766,0,1,regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback,BP,
792,GO:0001979,1,0.994410455703393,0,1,regulation of systemic arterial blood pressure by chemoreceptor signaling,BP,
793,GO:0001980,1,0.994853497591436,0,1,regulation of systemic arterial blood pressure by ischemic conditions,BP,
794,GO:0001983,1,0.99416084554766,0,1,baroreceptor response to increased systemic arterial blood pressure,BP,
795,GO:0001985,1,0.99416084554766,0,1,negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure,BP,
796,GO:0001990,1,0.834513833123119,0,29,regulation of systemic arterial blood pressure by hormone,BP,
797,GO:0001991,1,0.920602133047591,0,13,regulation of systemic arterial blood pressure by circulatory renin-angiotensin,BP,
798,GO:0001992,1,0.974942305063468,0,4,regulation of systemic arterial blood pressure by vasopressin,BP,
799,GO:0001993,1,0.945048731845324,0,9,regulation of systemic arterial blood pressure by norepinephrine-epinephrine,BP,
800,GO:0001994,1,0.976471302365876,0,4,norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure,BP,
801,GO:0001996,1,0.973671918750052,0,4,positive regulation of heart rate by epinephrine-norepinephrine,BP,
802,GO:0001997,1,0.988010533122713,0,2,positive regulation of the force of heart contraction by epinephrine-norepinephrine,BP,
803,GO:0001998,1,0.994297000326347,0,1,angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure,BP,
804,GO:0001999,1,0.974773793015987,0,4,renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure,BP,
805,GO:0002001,1,0.974773793015987,0,4,renin secretion into blood stream,BP,
806,GO:0002002,1,0.944440369507518,0,9,regulation of angiotensin levels in blood,BP,
807,GO:0002003,1,0.944440369507518,0,9,angiotensin maturation,BP,
808,GO:0002007,1,0.994410455703393,0,1,detection of hypoxic conditions in blood by chemoreceptor signaling,BP,
811,GO:0002016,1,0.96415476246725,0,6,regulation of blood volume by renin-angiotensin,BP,
812,GO:0002017,1,0.994317158818065,0,1,regulation of blood volume by renal aldosterone,BP,
813,GO:0002018,1,0.988078472238273,0,2,renin-angiotensin regulation of aldosterone production,BP,
814,GO:0002019,1,0.982544441182829,0,3,regulation of renal output by angiotensin,BP,
816,GO:0002021,1,0.883836206303808,0,19,response to dietary excess,BP,
817,GO:0002023,1,0.994222579812237,0,1,reduction of food intake in response to dietary excess,BP,
818,GO:0002024,1,0.951086293216122,0,8,diet induced thermogenesis,BP,
819,GO:0002025,1,0.982081324541278,0,3,norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP,
820,GO:0002026,1,0.846111955264128,0,24,regulation of the force of heart contraction,BP,
825,GO:0002031,1,0.925447230926429,0,13,G-protein coupled receptor internalization,BP,
826,GO:0002032,1,0.988572751934036,0,2,desensitization of G-protein coupled receptor protein signaling pathway by arrestin,BP,
827,GO:0002034,1,0.97666224649165,0,4,regulation of blood vessel diameter by renin-angiotensin,BP,
828,GO:0002035,1,0.981158150656809,0,3,brain renin-angiotensin system,BP,
829,GO:0002036,1,0.966719661050646,0,5,regulation of L-glutamate import across plasma membrane,BP,
830,GO:0002037,1,0.994191063274847,0,1,negative regulation of L-glutamate import across plasma membrane,BP,
831,GO:0002038,1,0.994118245529178,0,1,positive regulation of L-glutamate import across plasma membrane,BP,
832,GO:0002039,1,0.628487516580374,0,68,p53 binding,MF,
834,GO:0002041,1,0.994104824206991,0,1,intussusceptive angiogenesis,BP,
835,GO:0002042,1,0.738467336990029,0,45,cell migration involved in sprouting angiogenesis,BP,
837,GO:0002046,1,0.994784794930311,0,1,opsin binding,MF,
838,GO:0002051,1,0.969435149877386,0,4,osteoblast fate commitment,BP,
840,GO:0002053,1,0.836099435829526,0,27,positive regulation of mesenchymal cell proliferation,BP,
841,GO:0002054,1,0.977172135538962,0,4,nucleobase binding,MF,
842,GO:0002055,1,0.994907218248437,0,1,adenine binding,MF,
843,GO:0002058,1,0.99418951346472,0,1,uracil binding,MF,
844,GO:0002059,1,0.99418951346472,0,1,thymine binding,MF,
845,GO:0002060,1,0.982884164604224,0,3,purine nucleobase binding,MF,
846,GO:0002061,1,0.99418951346472,0,1,pyrimidine nucleobase binding,MF,
851,GO:0002066,1,0.71028675065006,0,51,columnar/cuboidal epithelial cell development,BP,
852,GO:0002067,1,0.758979586522798,0,42,glandular epithelial cell differentiation,BP,
853,GO:0002068,1,0.856496917334813,0,23,glandular epithelial cell development,BP,
854,GO:0002069,1,0.965340400754002,0,6,columnar/cuboidal epithelial cell maturation,BP,
855,GO:0002070,1,0.911533410671909,0,14,epithelial cell maturation,BP,
856,GO:0002071,1,0.988421151900139,0,2,glandular epithelial cell maturation,BP,
858,GO:0002074,1,0.965023658429594,0,5,extraocular skeletal muscle development,BP,
859,GO:0002076,1,0.890821412656322,0,17,osteoblast development,BP,
860,GO:0002077,1,0.994581244903492,0,1,acrosome matrix dispersal,BP,
861,GO:0002079,1,0.978704536199918,0,3,inner acrosomal membrane,CC,
862,GO:0002080,1,0.897356698842372,0,17,acrosomal membrane,CC,
863,GO:0002081,1,0.984993995758831,0,2,outer acrosomal membrane,CC,
865,GO:0002083,1,0.994440689979797,0,1,4-hydroxybenzoate decaprenyltransferase activity,MF,
866,GO:0002084,1,0.946560196957411,0,9,protein depalmitoylation,BP,
867,GO:0002085,1,0.973058931441419,0,4,inhibition of neuroepithelial cell differentiation,BP,
868,GO:0002086,1,0.988392302328961,0,2,diaphragm contraction,BP,
869,GO:0002087,1,0.923411929433685,0,12,regulation of respiratory gaseous exchange by neurological system process,BP,
872,GO:0002090,1,0.796378185023802,0,35,regulation of receptor internalization,BP,
873,GO:0002091,1,0.943584324098613,0,9,negative regulation of receptor internalization,BP,
874,GO:0002092,1,0.863941469242921,0,22,positive regulation of receptor internalization,BP,
875,GO:0002093,1,0.92186342106921,0,12,auditory receptor cell morphogenesis,BP,
876,GO:0002094,1,0.988062770904423,0,2,polyprenyltransferase activity,MF,
877,GO:0002097,1,0.906558650170675,0,16,tRNA wobble base modification,BP,
878,GO:0002098,1,0.930725402454235,0,12,tRNA wobble uridine modification,BP,
879,GO:0002100,1,0.992051244950117,0,1,tRNA wobble adenosine to inosine editing,BP,
880,GO:0002101,1,0.981859074610876,0,3,tRNA wobble cytosine modification,BP,
881,GO:0002102,1,0.804601724178721,0,32,podosome,CC,
882,GO:0002113,1,0.994107405063373,0,1,interleukin-33 binding,MF,
883,GO:0002114,1,0.987471859287327,0,2,interleukin-33 receptor activity,MF,
884,GO:0002115,1,0.900451721570314,0,16,store-operated calcium entry,BP,
885,GO:0002116,1,0.915019397277733,0,11,semaphorin receptor complex,CC,
886,GO:0002118,1,0.957306511556463,0,7,aggressive behavior,BP,
887,GO:0002121,1,0.987215556577041,0,2,inter-male aggressive behavior,BP,
888,GO:0002125,1,0.987526325652282,0,2,maternal aggressive behavior,BP,
889,GO:0002127,1,0.994546625925015,0,1,tRNA wobble base cytosine methylation,BP,
890,GO:0002133,1,0.980761560899415,0,2,polycystin complex,CC,
891,GO:0002134,1,0.986400320868373,0,2,UTP binding,MF,
892,GO:0002135,1,0.993973843574546,0,1,CTP binding,MF,
893,GO:0002138,1,0.953303307518656,0,8,retinoic acid biosynthetic process,BP,
895,GO:0002140,1,0.991462676802844,0,1,stereocilia tip link,CC,
898,GO:0002143,1,0.977100228979394,0,4,tRNA wobble position uridine thiolation,BP,
899,GO:0002144,1,0.994201395804769,0,1,cytosolic tRNA wobble base thiouridylase complex,CC,
900,GO:0002148,1,0.993626439905363,0,1,hypochlorous acid metabolic process,BP,
901,GO:0002149,1,0.993626439905363,0,1,hypochlorous acid biosynthetic process,BP,
902,GO:0002151,1,0.953862480587151,0,6,G-quadruplex RNA binding,MF,
903,GO:0002152,1,0.993522314306743,0,1,bile acid conjugation,BP,
904,GO:0002153,1,0.994038011007675,0,1,steroid receptor RNA activator RNA binding,MF,
905,GO:0002154,1,0.96294170272334,0,5,thyroid hormone mediated signaling pathway,BP,
906,GO:0002155,1,0.980041808237939,0,3,regulation of thyroid hormone mediated signaling pathway,BP,
907,GO:0002158,1,0.96925191787841,0,5,osteoclast proliferation,BP,
908,GO:0002159,1,0.971460573653861,0,4,desmosome assembly,BP,
909,GO:0002161,1,0.931365862577429,0,11,aminoacyl-tRNA editing activity,MF,
910,GO:0002162,1,0.939368962482511,0,8,dystroglycan binding,MF,
911,GO:0002169,1,0.987402682592774,0,2,3-methylcrotonyl-CoA carboxylase complex, mitochondrial,CC,
912,GO:0002174,1,0.993772895529134,0,1,mammary stem cell proliferation,BP,
913,GO:0002175,1,0.969668234383294,0,4,protein localization to paranode region of axon,BP,
914,GO:0002176,1,0.966462931483902,0,6,male germ cell proliferation,BP,
915,GO:0002177,1,0.959934856274725,0,7,manchette,CC,
916,GO:0002178,1,0.933785137171325,0,11,palmitoyltransferase complex,CC,
917,GO:0002181,1,0.610226269770938,0,84,cytoplasmic translation,BP,
918,GO:0002182,1,0.937474686481404,0,10,cytoplasmic translational elongation,BP,
919,GO:0002183,1,0.889680541356351,0,18,cytoplasmic translational initiation,BP,
920,GO:0002184,1,0.985451657290783,0,2,cytoplasmic translational termination,BP,
921,GO:0002188,1,0.976696818070402,0,3,translation reinitiation,BP,
922,GO:0002189,1,0.993977706987904,0,1,ribose phosphate diphosphokinase complex,CC,
923,GO:0002190,1,0.972006984189796,0,5,cap-independent translational initiation,BP,
924,GO:0002191,1,0.981278322127622,0,3,cap-dependent translational initiation,BP,
925,GO:0002192,1,0.989314290456522,0,2,IRES-dependent translational initiation of linear mRNA,BP,
926,GO:0002193,1,0.977033652039538,0,3,MAML1-RBP-Jkappa- ICN1 complex,CC,
927,GO:0002194,1,0.993704753095749,0,1,hepatocyte cell migration,BP,
928,GO:0002196,1,0.994307596375763,0,1,Ser-tRNA(Ala) hydrolase activity,MF,
929,GO:0002199,1,0.953705267588997,0,8,zona pellucida receptor complex,CC,
930,GO:0002200,1,0.680582512434825,0,57,somatic diversification of immune receptors,BP,
931,GO:0002204,1,0.776548863429577,0,39,somatic recombination of immunoglobulin genes involved in immune response,BP,
932,GO:0002208,1,0.776548863429577,0,39,somatic diversification of immunoglobulins involved in immune response,BP,
933,GO:0002209,1,0.796793401108345,0,35,behavioral defense response,BP,
934,GO:0002215,1,0.988368271261048,0,2,defense response to nematode,BP,
936,GO:0002220,1,0.508248250193758,0,108,innate immune response activating cell surface receptor signaling pathway,BP,
938,GO:0002223,1,0.516915074379494,0,105,stimulatory C-type lectin receptor signaling pathway,BP,
940,GO:0002225,1,0.988874411811437,0,2,positive regulation of antimicrobial peptide production,BP,
941,GO:0002227,1,0.936986107675354,0,12,innate immune response in mucosa,BP,
942,GO:0002228,1,0.724775797104911,0,52,natural killer cell mediated immunity,BP,
943,GO:0002230,1,0.872737880104725,0,21,positive regulation of defense response to virus by host,BP,
944,GO:0002232,1,0.988604617304338,0,2,leukocyte chemotaxis involved in inflammatory response,BP,
945,GO:0002237,1,0.139041690248064,0,311,response to molecule of bacterial origin,BP,
946,GO:0002238,1,0.986666017720341,0,2,response to molecule of fungal origin,BP,
948,GO:0002246,1,0.96410594544431,0,6,wound healing involved in inflammatory response,BP,
949,GO:0002248,1,0.969451507384632,0,5,connective tissue replacement involved in inflammatory response wound healing,BP,
950,GO:0002249,1,0.967906402248133,0,5,lymphocyte anergy,BP,
951,GO:0002250,1,0.139580593207984,0,310,adaptive immune response,BP,
952,GO:0002251,1,0.893248375951857,0,20,organ or tissue specific immune response,BP,
953,GO:0002252,1,0.00147922386429506,0,994,immune effector process,BP,
955,GO:0002254,1,0.982611958053055,0,3,kinin cascade,BP,
956,GO:0002260,1,0.679900319405015,0,60,lymphocyte homeostasis,BP,
957,GO:0002262,1,0.421251230188972,0,133,myeloid cell homeostasis,BP,
958,GO:0002263,1,0.0174601528301495,0,625,cell activation involved in immune response,BP,
959,GO:0002265,1,0.973464804431075,0,3,astrocyte activation involved in immune response,BP,
960,GO:0002266,1,0.982590034901445,0,3,follicular dendritic cell activation,BP,
961,GO:0002268,1,0.988065532720912,0,2,follicular dendritic cell differentiation,BP,
962,GO:0002274,1,0.0238734943638181,0,581,myeloid leukocyte activation,BP,
963,GO:0002275,1,0.0395816456662519,0,505,myeloid cell activation involved in immune response,BP,
964,GO:0002276,1,0.987367421246343,0,2,basophil activation involved in immune response,BP,
965,GO:0002277,1,0.981304499861035,0,3,myeloid dendritic cell activation involved in immune response,BP,
966,GO:0002278,1,0.976747389335865,0,4,eosinophil activation involved in immune response,BP,
967,GO:0002279,1,0.765258182020599,0,42,mast cell activation involved in immune response,BP,
968,GO:0002281,1,0.944251644987963,0,9,macrophage activation involved in immune response,BP,
969,GO:0002282,1,0.987607998993651,0,2,microglial cell activation involved in immune response,BP,
970,GO:0002283,1,0.0542948032085754,0,457,neutrophil activation involved in immune response,BP,
971,GO:0002285,1,0.423628118973055,0,132,lymphocyte activation involved in immune response,BP,
972,GO:0002286,1,0.625653468218448,0,73,T cell activation involved in immune response,BP,
973,GO:0002287,1,0.723590175704532,0,50,alpha-beta T cell activation involved in immune response,BP,
974,GO:0002290,1,0.993809823819756,0,1,gamma-delta T cell activation involved in immune response,BP,
975,GO:0002291,1,0.952658192930155,0,8,T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
976,GO:0002292,1,0.700563620688877,0,55,T cell differentiation involved in immune response,BP,
977,GO:0002293,1,0.723590175704532,0,50,alpha-beta T cell differentiation involved in immune response,BP,
978,GO:0002294,1,0.728063054535322,0,49,CD4-positive, alpha-beta T cell differentiation involved in immune response,BP,
979,GO:0002295,1,0.921121893173067,0,13,T-helper cell lineage commitment,BP,
980,GO:0002296,1,0.985009745115863,0,2,T-helper 1 cell lineage commitment,BP,
981,GO:0002298,1,0.994424668622026,0,1,CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response,BP,
982,GO:0002299,1,0.994481774791152,0,1,alpha-beta intraepithelial T cell differentiation,BP,
983,GO:0002300,1,0.994481774791152,0,1,CD8-positive, alpha-beta intraepithelial T cell differentiation,BP,
984,GO:0002302,1,0.993876074210983,0,1,CD8-positive, alpha-beta T cell differentiation involved in immune response,BP,
985,GO:0002304,1,0.994481774791152,0,1,gamma-delta intraepithelial T cell differentiation,BP,
986,GO:0002305,1,0.994481774791152,0,1,CD8-positive, gamma-delta intraepithelial T cell differentiation,BP,
987,GO:0002309,1,0.977068568257894,0,4,T cell proliferation involved in immune response,BP,
988,GO:0002312,1,0.671418554902247,0,61,B cell activation involved in immune response,BP,
989,GO:0002313,1,0.895020103153272,0,17,mature B cell differentiation involved in immune response,BP,
990,GO:0002314,1,0.982041990955635,0,3,germinal center B cell differentiation,BP,
991,GO:0002315,1,0.937118887002031,0,9,marginal zone B cell differentiation,BP,
992,GO:0002316,1,0.987585958824528,0,2,follicular B cell differentiation,BP,
993,GO:0002317,1,0.983819754046083,0,3,plasma cell differentiation,BP,
994,GO:0002318,1,0.967618712686573,0,5,myeloid progenitor cell differentiation,BP,
995,GO:0002320,1,0.882038450420349,0,18,lymphoid progenitor cell differentiation,BP,
996,GO:0002322,1,0.966428360158125,0,5,B cell proliferation involved in immune response,BP,
997,GO:0002323,1,0.951290748845657,0,8,natural killer cell activation involved in immune response,BP,
998,GO:0002325,1,0.989261116642694,0,2,natural killer cell differentiation involved in immune response,BP,
999,GO:0002326,1,0.974915192430587,0,3,B cell lineage commitment,BP,
1000,GO:0002327,1,0.944812286846172,0,7,immature B cell differentiation,BP,
1001,GO:0002328,1,0.92645081708344,0,10,pro-B cell differentiation,BP,
1002,GO:0002329,1,0.967023697020453,0,4,pre-B cell differentiation,BP,
1003,GO:0002331,1,0.981516454900181,0,2,pre-B cell allelic exclusion,BP,
1004,GO:0002332,1,0.992373423518007,0,1,transitional stage B cell differentiation,BP,
1005,GO:0002333,1,0.992373423518007,0,1,transitional one stage B cell differentiation,BP,
1006,GO:0002335,1,0.871490614912416,0,21,mature B cell differentiation,BP,
1007,GO:0002337,1,0.987853069360017,0,2,B-1a B cell differentiation,BP,
1008,GO:0002339,1,0.983053523809536,0,3,B cell selection,BP,
1009,GO:0002343,1,0.993932652264156,0,1,peripheral B cell selection,BP,
1010,GO:0002344,1,0.993932652264156,0,1,B cell affinity maturation,BP,
1011,GO:0002347,1,0.902452250877097,0,17,response to tumor cell,BP,
1012,GO:0002349,1,0.965998942112799,0,6,histamine production involved in inflammatory response,BP,
1013,GO:0002351,1,0.981592536740055,0,3,serotonin production involved in inflammatory response,BP,
1014,GO:0002352,1,0.989055130833895,0,2,B cell negative selection,BP,
1015,GO:0002353,1,0.982611958053055,0,3,plasma kallikrein-kinin cascade,BP,
1016,GO:0002355,1,0.994035690486941,0,1,detection of tumor cell,BP,
1017,GO:0002357,1,0.981809343561369,0,3,defense response to tumor cell,BP,
1018,GO:0002358,1,0.99487002715562,0,1,B cell homeostatic proliferation,BP,
1019,GO:0002360,1,0.870093405077383,0,21,T cell lineage commitment,BP,
1020,GO:0002361,1,0.976689343815831,0,4,CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation,BP,
1021,GO:0002362,1,0.994082116283792,0,1,CD4-positive, CD25-positive, alpha-beta regulatory T cell lineage commitment,BP,
1022,GO:0002363,1,0.904339826925251,0,16,alpha-beta T cell lineage commitment,BP,
1023,GO:0002366,1,0.0179592379239769,0,622,leukocyte activation involved in immune response,BP,
1024,GO:0002367,1,0.622382028156233,0,76,cytokine production involved in immune response,BP,
1025,GO:0002368,1,0.988060059686461,0,2,B cell cytokine production,BP,
1026,GO:0002369,1,0.831843693866331,0,30,T cell cytokine production,BP,
1027,GO:0002370,1,0.986955119560294,0,2,natural killer cell cytokine production,BP,
1028,GO:0002371,1,0.959634356356201,0,6,dendritic cell cytokine production,BP,
1029,GO:0002373,1,0.994803908005211,0,1,plasmacytoid dendritic cell cytokine production,BP,
1030,GO:0002374,1,0.902966293367096,0,16,cytokine secretion involved in immune response,BP,
1032,GO:0002377,1,0.578599706571501,0,86,immunoglobulin production,BP,
1033,GO:0002378,1,0.979657777606882,0,3,immunoglobulin biosynthetic process,BP,
1034,GO:0002380,1,0.992969046672609,0,1,immunoglobulin secretion involved in immune response,BP,
1035,GO:0002381,1,0.75374296720276,0,44,immunoglobulin production involved in immunoglobulin mediated immune response,BP,
1036,GO:0002384,1,0.987872529588302,0,2,hepatic immune response,BP,
1037,GO:0002385,1,0.904225440862757,0,18,mucosal immune response,BP,
1038,GO:0002386,1,0.987417052157684,0,2,immune response in mucosal-associated lymphoid tissue,BP,
1039,GO:0002396,1,0.973224550034082,0,5,MHC protein complex assembly,BP,
1040,GO:0002397,1,0.99429906783134,0,1,MHC class I protein complex assembly,BP,
1041,GO:0002399,1,0.978805861305835,0,4,MHC class II protein complex assembly,BP,
1042,GO:0002407,1,0.87252681378842,0,22,dendritic cell chemotaxis,BP,
1043,GO:0002408,1,0.976592240672297,0,4,myeloid dendritic cell chemotaxis,BP,
1044,GO:0002414,1,0.981864979972703,0,3,immunoglobulin transcytosis in epithelial cells,BP,
1045,GO:0002415,1,0.987417052157684,0,2,immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor,BP,
1046,GO:0002416,1,0.994377893642252,0,1,IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor,BP,
1047,GO:0002418,1,0.91850577372418,0,14,immune response to tumor cell,BP,
1048,GO:0002420,1,0.946612638855203,0,9,natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1049,GO:0002423,1,0.946612638855203,0,9,natural killer cell mediated immune response to tumor cell,BP,
1050,GO:0002424,1,0.987652884988298,0,2,T cell mediated immune response to tumor cell,BP,
1051,GO:0002426,1,0.994658227399849,0,1,immunoglobulin production in mucosal tissue,BP,
1052,GO:0002428,1,0.982514965893426,0,3,antigen processing and presentation of peptide antigen via MHC class Ib,BP,
1054,GO:0002430,1,0.950730994649453,0,8,complement receptor mediated signaling pathway,BP,
1055,GO:0002431,1,0.614674121476709,0,75,Fc receptor mediated stimulatory signaling pathway,BP,
1056,GO:0002432,1,0.993012206548101,0,1,granuloma formation,BP,
1057,GO:0002433,1,0.633797111526142,0,70,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,BP,
1058,GO:0002434,1,0.988488992593771,0,2,immune complex clearance,BP,
1059,GO:0002436,1,0.988488992593771,0,2,immune complex clearance by monocytes and macrophages,BP,
1060,GO:0002437,1,0.788407691276044,0,39,inflammatory response to antigenic stimulus,BP,
1061,GO:0002438,1,0.892789188084349,0,19,acute inflammatory response to antigenic stimulus,BP,
1062,GO:0002439,1,0.977719728263362,0,4,chronic inflammatory response to antigenic stimulus,BP,
1063,GO:0002440,1,0.379233237635232,0,153,production of molecular mediator of immune response,BP,
1064,GO:0002441,1,0.965998942112799,0,6,histamine secretion involved in inflammatory response,BP,
1065,GO:0002442,1,0.981592536740055,0,3,serotonin secretion involved in inflammatory response,BP,
1066,GO:0002443,1,0.0127262419473717,0,680,leukocyte mediated immunity,BP,
1067,GO:0002444,1,0.0389189659891266,0,508,myeloid leukocyte mediated immunity,BP,
1068,GO:0002445,1,0.982182772207278,0,3,type II hypersensitivity,BP,
1069,GO:0002446,1,0.0509855181497062,0,467,neutrophil mediated immunity,BP,
1070,GO:0002447,1,0.976747389335865,0,4,eosinophil mediated immunity,BP,
1071,GO:0002448,1,0.755697565511473,0,44,mast cell mediated immunity,BP,
1072,GO:0002449,1,0.295397226033626,0,194,lymphocyte mediated immunity,BP,
1073,GO:0002450,1,0.994459036414026,0,1,B cell antigen processing and presentation,BP,
1074,GO:0002455,1,0.797029716423246,0,37,humoral immune response mediated by circulating immunoglobulin,BP,
1075,GO:0002456,1,0.63181052854302,0,74,T cell mediated immunity,BP,
1076,GO:0002457,1,0.968806401980087,0,5,T cell antigen processing and presentation,BP,
1077,GO:0002458,1,0.988312089830476,0,2,peripheral T cell tolerance induction,BP,
1078,GO:0002460,1,0.280958454206955,0,200,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,
1079,GO:0002461,1,0.982469311665666,0,3,tolerance induction dependent upon immune response,BP,
1080,GO:0002465,1,0.988312089830476,0,2,peripheral tolerance induction,BP,
1081,GO:0002467,1,0.905308163760306,0,15,germinal center formation,BP,
1082,GO:0002468,1,0.945864611684157,0,9,dendritic cell antigen processing and presentation,BP,
1083,GO:0002474,1,0.592939202072024,0,88,antigen processing and presentation of peptide antigen via MHC class I,BP,
1084,GO:0002475,1,0.956546092140752,0,7,antigen processing and presentation via MHC class Ib,BP,
1085,GO:0002476,1,0.987671623003946,0,2,antigen processing and presentation of endogenous peptide antigen via MHC class Ib,BP,
1086,GO:0002477,1,0.994779629188806,0,1,antigen processing and presentation of exogenous peptide antigen via MHC class Ib,BP,
1087,GO:0002478,1,0.36702303223075,0,163,antigen processing and presentation of exogenous peptide antigen,BP,
1088,GO:0002479,1,0.672102622839263,0,69,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,BP,
1089,GO:0002480,1,0.955671013001562,0,8,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent,BP,
1090,GO:0002481,1,0.994779629188806,0,1,antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent,BP,
1091,GO:0002483,1,0.950037234804802,0,8,antigen processing and presentation of endogenous peptide antigen,BP,
1092,GO:0002488,1,0.993213088589486,0,1,antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway,BP,
1093,GO:0002489,1,0.993213088589486,0,1,antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent,BP,
1094,GO:0002495,1,0.541377020980502,0,96,antigen processing and presentation of peptide antigen via MHC class II,BP,
1095,GO:0002501,1,0.978411198820374,0,4,peptide antigen assembly with MHC protein complex,BP,
1096,GO:0002502,1,0.99429906783134,0,1,peptide antigen assembly with MHC class I protein complex,BP,
1097,GO:0002503,1,0.984021952392624,0,3,peptide antigen assembly with MHC class II protein complex,BP,
1098,GO:0002504,1,0.537174505650358,0,97,antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1099,GO:0002505,1,0.989370909577331,0,2,antigen processing and presentation of polysaccharide antigen via MHC class II,BP,
1100,GO:0002506,1,0.989370909577331,0,2,polysaccharide assembly with MHC class II protein complex,BP,
1101,GO:0002507,1,0.864370077312061,0,23,tolerance induction,BP,
1102,GO:0002508,1,0.988157856121971,0,2,central tolerance induction,BP,
1103,GO:0002509,1,0.994195971127795,0,1,central tolerance induction to self antigen,BP,
1104,GO:0002510,1,0.993926991213386,0,1,central B cell tolerance induction,BP,
1105,GO:0002513,1,0.969395675945451,0,5,tolerance induction to self antigen,BP,
1106,GO:0002514,1,0.986851827910538,0,2,B cell tolerance induction,BP,
1107,GO:0002517,1,0.927354249442779,0,12,T cell tolerance induction,BP,
1108,GO:0002518,1,0.994668043425921,0,1,lymphocyte chemotaxis across high endothelial venule,BP,
1109,GO:0002519,1,0.988546118871379,0,2,natural killer cell tolerance induction,BP,
1111,GO:0002521,1,0.0609316957651968,0,422,leukocyte differentiation,BP,
1112,GO:0002522,1,0.988250256792955,0,2,leukocyte migration involved in immune response,BP,
1113,GO:0002523,1,0.936619870820545,0,11,leukocyte migration involved in inflammatory response,BP,
1114,GO:0002524,1,0.953644450537013,0,8,hypersensitivity,BP,
1115,GO:0002525,1,0.982413789549227,0,3,acute inflammatory response to non-antigenic stimulus,BP,
1116,GO:0002526,1,0.461390808428568,0,125,acute inflammatory response,BP,
1117,GO:0002528,1,0.984946747843549,0,2,regulation of vascular permeability involved in acute inflammatory response,BP,
1118,GO:0002532,1,0.743668252066902,0,47,production of molecular mediator involved in inflammatory response,BP,
1119,GO:0002534,1,0.825491526042105,0,30,cytokine production involved in inflammatory response,BP,
1120,GO:0002536,1,0.983413456099217,0,3,respiratory burst involved in inflammatory response,BP,
1121,GO:0002537,1,0.983799318902863,0,2,nitric oxide production involved in inflammatory response,BP,
1122,GO:0002538,1,0.987661661578452,0,2,arachidonic acid metabolite production involved in inflammatory response,BP,
1123,GO:0002540,1,0.987661661578452,0,2,leukotriene production involved in inflammatory response,BP,
1124,GO:0002541,1,0.982523166164944,0,3,activation of plasma proteins involved in acute inflammatory response,BP,
1125,GO:0002542,1,0.988381653550293,0,2,Factor XII activation,BP,
1126,GO:0002543,1,0.986934882153212,0,2,activation of blood coagulation via clotting cascade,BP,
1127,GO:0002544,1,0.901386554710258,0,17,chronic inflammatory response,BP,
1128,GO:0002545,1,0.99431612503496,0,1,chronic inflammatory response to non-antigenic stimulus,BP,
1129,GO:0002548,1,0.791628119545267,0,40,monocyte chemotaxis,BP,
1130,GO:0002551,1,0.939206591335969,0,10,mast cell chemotaxis,BP,
1131,GO:0002553,1,0.965998942112799,0,6,histamine secretion by mast cell,BP,
1132,GO:0002554,1,0.981592536740055,0,3,serotonin secretion by platelet,BP,
1133,GO:0002560,1,0.993129923835772,0,1,basophil mediated immunity,BP,
1134,GO:0002561,1,0.993129923835772,0,1,basophil degranulation,BP,
1135,GO:0002562,1,0.709537125962842,0,51,somatic diversification of immune receptors via germline recombination within a single locus,BP,
1136,GO:0002566,1,0.924143369565907,0,12,somatic diversification of immune receptors via somatic mutation,BP,
1137,GO:0002568,1,0.960733738130492,0,5,somatic diversification of T cell receptor genes,BP,
1138,GO:0002572,1,0.986988044790275,0,2,pro-T cell differentiation,BP,
1139,GO:0002573,1,0.328716993099735,0,169,myeloid leukocyte differentiation,BP,
1141,GO:0002577,1,0.903545382648838,0,17,regulation of antigen processing and presentation,BP,
1142,GO:0002578,1,0.957991412999614,0,7,negative regulation of antigen processing and presentation,BP,
1143,GO:0002579,1,0.948561731722258,0,9,positive regulation of antigen processing and presentation,BP,
1144,GO:0002580,1,0.970283996799377,0,5,regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1145,GO:0002581,1,0.980483952108707,0,3,negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1146,GO:0002582,1,0.989599081196691,0,2,positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1147,GO:0002583,1,0.966742589421754,0,6,regulation of antigen processing and presentation of peptide antigen,BP,
1148,GO:0002584,1,0.976905694771416,0,4,negative regulation of antigen processing and presentation of peptide antigen,BP,
1149,GO:0002585,1,0.989599081196691,0,2,positive regulation of antigen processing and presentation of peptide antigen,BP,
1150,GO:0002586,1,0.977829536953935,0,4,regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
1151,GO:0002587,1,0.988108004896466,0,2,negative regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
1152,GO:0002588,1,0.989599081196691,0,2,positive regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
1153,GO:0002589,1,0.988664231885716,0,2,regulation of antigen processing and presentation of peptide antigen via MHC class I,BP,
1154,GO:0002590,1,0.988664231885716,0,2,negative regulation of antigen processing and presentation of peptide antigen via MHC class I,BP,
1155,GO:0002604,1,0.945864611684157,0,9,regulation of dendritic cell antigen processing and presentation,BP,
1156,GO:0002605,1,0.986786474683769,0,2,negative regulation of dendritic cell antigen processing and presentation,BP,
1157,GO:0002606,1,0.958535630615137,0,7,positive regulation of dendritic cell antigen processing and presentation,BP,
1158,GO:0002622,1,0.994459036414026,0,1,regulation of B cell antigen processing and presentation,BP,
1159,GO:0002625,1,0.988655494374454,0,2,regulation of T cell antigen processing and presentation,BP,
1160,GO:0002626,1,0.994283044929331,0,1,negative regulation of T cell antigen processing and presentation,BP,
1161,GO:0002634,1,0.941294874029656,0,9,regulation of germinal center formation,BP,
1162,GO:0002635,1,0.983589207198308,0,2,negative regulation of germinal center formation,BP,
1163,GO:0002636,1,0.984066890519668,0,3,positive regulation of germinal center formation,BP,
1164,GO:0002637,1,0.721297351598578,0,52,regulation of immunoglobulin production,BP,
1165,GO:0002638,1,0.935775163705761,0,10,negative regulation of immunoglobulin production,BP,
1166,GO:0002639,1,0.810483588730011,0,34,positive regulation of immunoglobulin production,BP,
1167,GO:0002640,1,0.993850639026861,0,1,regulation of immunoglobulin biosynthetic process,BP,
1168,GO:0002642,1,0.993850639026861,0,1,positive regulation of immunoglobulin biosynthetic process,BP,
1169,GO:0002643,1,0.901752354752358,0,16,regulation of tolerance induction,BP,
1170,GO:0002644,1,0.994197779329583,0,1,negative regulation of tolerance induction,BP,
1171,GO:0002645,1,0.942606306928729,0,9,positive regulation of tolerance induction,BP,
1172,GO:0002646,1,0.993926991213386,0,1,regulation of central tolerance induction,BP,
1173,GO:0002648,1,0.993926991213386,0,1,positive regulation of central tolerance induction,BP,
1174,GO:0002649,1,0.992882043020951,0,1,regulation of tolerance induction to self antigen,BP,
1175,GO:0002651,1,0.992882043020951,0,1,positive regulation of tolerance induction to self antigen,BP,
1176,GO:0002652,1,0.988205571202277,0,2,regulation of tolerance induction dependent upon immune response,BP,
1177,GO:0002654,1,0.994082116283792,0,1,positive regulation of tolerance induction dependent upon immune response,BP,
1178,GO:0002658,1,0.994082116283792,0,1,regulation of peripheral tolerance induction,BP,
1179,GO:0002660,1,0.994082116283792,0,1,positive regulation of peripheral tolerance induction,BP,
1180,GO:0002661,1,0.986851827910538,0,2,regulation of B cell tolerance induction,BP,
1181,GO:0002663,1,0.986851827910538,0,2,positive regulation of B cell tolerance induction,BP,
1182,GO:0002664,1,0.938477325920807,0,10,regulation of T cell tolerance induction,BP,
1183,GO:0002666,1,0.956971826813891,0,7,positive regulation of T cell tolerance induction,BP,
1184,GO:0002667,1,0.967906402248133,0,5,regulation of T cell anergy,BP,
1185,GO:0002669,1,0.980684994470107,0,3,positive regulation of T cell anergy,BP,
1186,GO:0002673,1,0.638626699645197,0,72,regulation of acute inflammatory response,BP,
1187,GO:0002674,1,0.943358051615018,0,9,negative regulation of acute inflammatory response,BP,
1188,GO:0002675,1,0.859736221034502,0,25,positive regulation of acute inflammatory response,BP,
1189,GO:0002676,1,0.953267295058404,0,8,regulation of chronic inflammatory response,BP,
1190,GO:0002677,1,0.974759346412505,0,4,negative regulation of chronic inflammatory response,BP,
1191,GO:0002678,1,0.977957061609911,0,4,positive regulation of chronic inflammatory response,BP,
1192,GO:0002679,1,0.956920017635154,0,7,respiratory burst involved in defense response,BP,
1193,GO:0002681,1,0.960733738130492,0,5,somatic recombination of T cell receptor gene segments,BP,
1197,GO:0002685,1,0.378584938440468,0,159,regulation of leukocyte migration,BP,
1198,GO:0002686,1,0.815249298094052,0,33,negative regulation of leukocyte migration,BP,
1199,GO:0002687,1,0.504516624041151,0,113,positive regulation of leukocyte migration,BP,
1200,GO:0002688,1,0.55105214432847,0,100,regulation of leukocyte chemotaxis,BP,
1201,GO:0002689,1,0.917959194503393,0,14,negative regulation of leukocyte chemotaxis,BP,
1202,GO:0002690,1,0.627160110782693,0,79,positive regulation of leukocyte chemotaxis,BP,
1203,GO:0002691,1,0.86963867347591,0,22,regulation of cellular extravasation,BP,
1204,GO:0002692,1,0.949549847857612,0,8,negative regulation of cellular extravasation,BP,
1205,GO:0002693,1,0.926223168687383,0,12,positive regulation of cellular extravasation,BP,
1208,GO:0002696,1,0.17549876374197,0,275,positive regulation of leukocyte activation,BP,
1209,GO:0002697,1,0.14758669246007,0,300,regulation of immune effector process,BP,
1210,GO:0002698,1,0.552824631501217,0,93,negative regulation of immune effector process,BP,
1211,GO:0002699,1,0.370818255189758,0,158,positive regulation of immune effector process,BP,
1212,GO:0002700,1,0.518944695510588,0,104,regulation of production of molecular mediator of immune response,BP,
1213,GO:0002701,1,0.826129056935939,0,30,negative regulation of production of molecular mediator of immune response,BP,
1214,GO:0002702,1,0.654635520152012,0,68,positive regulation of production of molecular mediator of immune response,BP,
1215,GO:0002703,1,0.385340710444156,0,152,regulation of leukocyte mediated immunity,BP,
1216,GO:0002704,1,0.775989899902899,0,41,negative regulation of leukocyte mediated immunity,BP,
1217,GO:0002705,1,0.56979874798283,0,90,positive regulation of leukocyte mediated immunity,BP,
1218,GO:0002706,1,0.504028773347634,0,110,regulation of lymphocyte mediated immunity,BP,
1219,GO:0002707,1,0.827140357270191,0,31,negative regulation of lymphocyte mediated immunity,BP,
1220,GO:0002708,1,0.641720653548291,0,71,positive regulation of lymphocyte mediated immunity,BP,
1221,GO:0002709,1,0.747586428360938,0,48,regulation of T cell mediated immunity,BP,
1222,GO:0002710,1,0.914592831276635,0,15,negative regulation of T cell mediated immunity,BP,
1223,GO:0002711,1,0.837364034927155,0,29,positive regulation of T cell mediated immunity,BP,
1224,GO:0002712,1,0.770208686687348,0,41,regulation of B cell mediated immunity,BP,
1225,GO:0002713,1,0.943705815317092,0,9,negative regulation of B cell mediated immunity,BP,
1226,GO:0002714,1,0.838214825911056,0,28,positive regulation of B cell mediated immunity,BP,
1227,GO:0002715,1,0.815420337721241,0,33,regulation of natural killer cell mediated immunity,BP,
1228,GO:0002716,1,0.935489518971215,0,11,negative regulation of natural killer cell mediated immunity,BP,
1229,GO:0002717,1,0.877159746024363,0,21,positive regulation of natural killer cell mediated immunity,BP,
1230,GO:0002718,1,0.68704423947875,0,60,regulation of cytokine production involved in immune response,BP,
1231,GO:0002719,1,0.877731178086814,0,21,negative regulation of cytokine production involved in immune response,BP,
1232,GO:0002720,1,0.803126654160949,0,35,positive regulation of cytokine production involved in immune response,BP,
1233,GO:0002721,1,0.993932652264156,0,1,regulation of B cell cytokine production,BP,
1234,GO:0002724,1,0.878683758342102,0,21,regulation of T cell cytokine production,BP,
1235,GO:0002725,1,0.965713672590548,0,6,negative regulation of T cell cytokine production,BP,
1236,GO:0002726,1,0.915873327906154,0,14,positive regulation of T cell cytokine production,BP,
1237,GO:0002727,1,0.986955119560294,0,2,regulation of natural killer cell cytokine production,BP,
1238,GO:0002728,1,0.992986473589009,0,1,negative regulation of natural killer cell cytokine production,BP,
1239,GO:0002729,1,0.993926476606755,0,1,positive regulation of natural killer cell cytokine production,BP,
1240,GO:0002730,1,0.966780171494803,0,5,regulation of dendritic cell cytokine production,BP,
1241,GO:0002731,1,0.987313837382522,0,2,negative regulation of dendritic cell cytokine production,BP,
1242,GO:0002732,1,0.992972688877791,0,1,positive regulation of dendritic cell cytokine production,BP,
1243,GO:0002736,1,0.994803908005211,0,1,regulation of plasmacytoid dendritic cell cytokine production,BP,
1244,GO:0002737,1,0.994803908005211,0,1,negative regulation of plasmacytoid dendritic cell cytokine production,BP,
1245,GO:0002739,1,0.921668051329241,0,13,regulation of cytokine secretion involved in immune response,BP,
1246,GO:0002740,1,0.970901499148362,0,5,negative regulation of cytokine secretion involved in immune response,BP,
1247,GO:0002741,1,0.955409141869209,0,7,positive regulation of cytokine secretion involved in immune response,BP,
1248,GO:0002752,1,0.988887733413856,0,2,cell surface pattern recognition receptor signaling pathway,BP,
1249,GO:0002753,1,0.711276904795846,0,51,cytoplasmic pattern recognition receptor signaling pathway,BP,
1250,GO:0002755,1,0.797237278441218,0,35,MyD88-dependent toll-like receptor signaling pathway,BP,
1251,GO:0002756,1,0.828993811452968,0,30,MyD88-independent toll-like receptor signaling pathway,BP,
1254,GO:0002759,1,0.976782044674652,0,4,regulation of antimicrobial humoral response,BP,
1255,GO:0002760,1,0.988874411811437,0,2,positive regulation of antimicrobial humoral response,BP,
1256,GO:0002761,1,0.529771269204438,0,96,regulation of myeloid leukocyte differentiation,BP,
1257,GO:0002762,1,0.759658178814996,0,41,negative regulation of myeloid leukocyte differentiation,BP,
1258,GO:0002763,1,0.762563016509321,0,42,positive regulation of myeloid leukocyte differentiation,BP,
1260,GO:0002765,1,0.964697892351331,0,6,immune response-inhibiting signal transduction,BP,
1261,GO:0002767,1,0.970294865127825,0,5,immune response-inhibiting cell surface receptor signaling pathway,BP,
1263,GO:0002769,1,0.99417556603647,0,1,natural killer cell inhibitory signaling pathway,BP,
1264,GO:0002774,1,0.981407336620655,0,3,Fc receptor mediated inhibitory signaling pathway,BP,
1265,GO:0002775,1,0.977248599994043,0,4,antimicrobial peptide production,BP,
1266,GO:0002777,1,0.994812173040639,0,1,antimicrobial peptide biosynthetic process,BP,
1267,GO:0002778,1,0.977248599994043,0,4,antibacterial peptide production,BP,
1268,GO:0002780,1,0.994812173040639,0,1,antibacterial peptide biosynthetic process,BP,
1269,GO:0002784,1,0.982345755381875,0,3,regulation of antimicrobial peptide production,BP,
1270,GO:0002785,1,0.993398635151442,0,1,negative regulation of antimicrobial peptide production,BP,
1271,GO:0002786,1,0.982345755381875,0,3,regulation of antibacterial peptide production,BP,
1272,GO:0002787,1,0.993398635151442,0,1,negative regulation of antibacterial peptide production,BP,
1275,GO:0002792,1,0.504790999078526,0,107,negative regulation of peptide secretion,BP,
1277,GO:0002803,1,0.988874411811437,0,2,positive regulation of antibacterial peptide production,BP,
1278,GO:0002812,1,0.994812173040639,0,1,biosynthetic process of antibacterial peptides active against Gram-negative bacteria,BP,
1279,GO:0002818,1,0.994841358605342,0,1,intracellular defense response,BP,
1280,GO:0002819,1,0.47200226692715,0,120,regulation of adaptive immune response,BP,
1281,GO:0002820,1,0.806241446755382,0,34,negative regulation of adaptive immune response,BP,
1282,GO:0002821,1,0.636124526507226,0,73,positive regulation of adaptive immune response,BP,
1283,GO:0002822,1,0.505187373465055,0,109,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,
1284,GO:0002823,1,0.820986978251585,0,31,negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,
1285,GO:0002824,1,0.652883319404686,0,69,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,
1286,GO:0002825,1,0.891775044384121,0,19,regulation of T-helper 1 type immune response,BP,
1287,GO:0002826,1,0.957573868790542,0,7,negative regulation of T-helper 1 type immune response,BP,
1288,GO:0002827,1,0.931229285100355,0,12,positive regulation of T-helper 1 type immune response,BP,
1289,GO:0002828,1,0.848125712684459,0,27,regulation of type 2 immune response,BP,
1290,GO:0002829,1,0.93419265732276,0,11,negative regulation of type 2 immune response,BP,
1291,GO:0002830,1,0.913162514507921,0,15,positive regulation of type 2 immune response,BP,
1292,GO:0002831,1,0.496012878726671,0,109,regulation of response to biotic stimulus,BP,
1293,GO:0002832,1,0.785824751616492,0,38,negative regulation of response to biotic stimulus,BP,
1294,GO:0002833,1,0.803180268805795,0,34,positive regulation of response to biotic stimulus,BP,
1295,GO:0002834,1,0.93491826227223,0,11,regulation of response to tumor cell,BP,
1296,GO:0002835,1,0.987624876738849,0,2,negative regulation of response to tumor cell,BP,
1297,GO:0002836,1,0.952813797122074,0,8,positive regulation of response to tumor cell,BP,
1298,GO:0002837,1,0.93491826227223,0,11,regulation of immune response to tumor cell,BP,
1299,GO:0002838,1,0.987624876738849,0,2,negative regulation of immune response to tumor cell,BP,
1300,GO:0002839,1,0.952813797122074,0,8,positive regulation of immune response to tumor cell,BP,
1301,GO:0002840,1,0.987652884988298,0,2,regulation of T cell mediated immune response to tumor cell,BP,
1302,GO:0002842,1,0.99409192116475,0,1,positive regulation of T cell mediated immune response to tumor cell,BP,
1303,GO:0002849,1,0.994082116283792,0,1,regulation of peripheral T cell tolerance induction,BP,
1304,GO:0002851,1,0.994082116283792,0,1,positive regulation of peripheral T cell tolerance induction,BP,
1305,GO:0002855,1,0.946612638855203,0,9,regulation of natural killer cell mediated immune response to tumor cell,BP,
1306,GO:0002856,1,0.987624876738849,0,2,negative regulation of natural killer cell mediated immune response to tumor cell,BP,
1307,GO:0002857,1,0.958478986859034,0,7,positive regulation of natural killer cell mediated immune response to tumor cell,BP,
1308,GO:0002858,1,0.946612638855203,0,9,regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1309,GO:0002859,1,0.987624876738849,0,2,negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1310,GO:0002860,1,0.958478986859034,0,7,positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1311,GO:0002861,1,0.893965604064612,0,19,regulation of inflammatory response to antigenic stimulus,BP,
1312,GO:0002862,1,0.949764934512192,0,9,negative regulation of inflammatory response to antigenic stimulus,BP,
1313,GO:0002863,1,0.941279015752801,0,10,positive regulation of inflammatory response to antigenic stimulus,BP,
1314,GO:0002864,1,0.935979836297252,0,11,regulation of acute inflammatory response to antigenic stimulus,BP,
1315,GO:0002865,1,0.976883971865246,0,4,negative regulation of acute inflammatory response to antigenic stimulus,BP,
1316,GO:0002866,1,0.958137636592936,0,7,positive regulation of acute inflammatory response to antigenic stimulus,BP,
1317,GO:0002870,1,0.967906402248133,0,5,T cell anergy,BP,
1318,GO:0002874,1,0.98351922602533,0,3,regulation of chronic inflammatory response to antigenic stimulus,BP,
1319,GO:0002875,1,0.994446891662628,0,1,negative regulation of chronic inflammatory response to antigenic stimulus,BP,
1320,GO:0002876,1,0.989011928343116,0,2,positive regulation of chronic inflammatory response to antigenic stimulus,BP,
1321,GO:0002877,1,0.982413789549227,0,3,regulation of acute inflammatory response to non-antigenic stimulus,BP,
1322,GO:0002878,1,0.993652794239666,0,1,negative regulation of acute inflammatory response to non-antigenic stimulus,BP,
1323,GO:0002879,1,0.988689927074066,0,2,positive regulation of acute inflammatory response to non-antigenic stimulus,BP,
1324,GO:0002880,1,0.99431612503496,0,1,regulation of chronic inflammatory response to non-antigenic stimulus,BP,
1325,GO:0002882,1,0.99431612503496,0,1,positive regulation of chronic inflammatory response to non-antigenic stimulus,BP,
1326,GO:0002883,1,0.959687688714434,0,7,regulation of hypersensitivity,BP,
1327,GO:0002884,1,0.988724098768938,0,2,negative regulation of hypersensitivity,BP,
1328,GO:0002885,1,0.970635760984184,0,5,positive regulation of hypersensitivity,BP,
1329,GO:0002886,1,0.764904546922178,0,43,regulation of myeloid leukocyte mediated immunity,BP,
1330,GO:0002887,1,0.939796381946409,0,10,negative regulation of myeloid leukocyte mediated immunity,BP,
1331,GO:0002888,1,0.87826567553343,0,21,positive regulation of myeloid leukocyte mediated immunity,BP,
1332,GO:0002889,1,0.770208686687348,0,41,regulation of immunoglobulin mediated immune response,BP,
1333,GO:0002890,1,0.943705815317092,0,9,negative regulation of immunoglobulin mediated immune response,BP,
1334,GO:0002891,1,0.838214825911056,0,28,positive regulation of immunoglobulin mediated immune response,BP,
1335,GO:0002892,1,0.982182772207278,0,3,regulation of type II hypersensitivity,BP,
1336,GO:0002893,1,0.994459036414026,0,1,negative regulation of type II hypersensitivity,BP,
1337,GO:0002894,1,0.987656023470213,0,2,positive regulation of type II hypersensitivity,BP,
1338,GO:0002895,1,0.993926991213386,0,1,regulation of central B cell tolerance induction,BP,
1339,GO:0002897,1,0.993926991213386,0,1,positive regulation of central B cell tolerance induction,BP,
1340,GO:0002901,1,0.977974121649504,0,4,mature B cell apoptotic process,BP,
1341,GO:0002902,1,0.897898238423394,0,17,regulation of B cell apoptotic process,BP,
1342,GO:0002903,1,0.933522510715326,0,11,negative regulation of B cell apoptotic process,BP,
1343,GO:0002904,1,0.981308977924415,0,3,positive regulation of B cell apoptotic process,BP,
1344,GO:0002905,1,0.977974121649504,0,4,regulation of mature B cell apoptotic process,BP,
1345,GO:0002906,1,0.977974121649504,0,4,negative regulation of mature B cell apoptotic process,BP,
1346,GO:0002911,1,0.967906402248133,0,5,regulation of lymphocyte anergy,BP,
1347,GO:0002913,1,0.980684994470107,0,3,positive regulation of lymphocyte anergy,BP,
1348,GO:0002920,1,0.730425496087613,0,51,regulation of humoral immune response,BP,
1349,GO:0002921,1,0.934775268815629,0,10,negative regulation of humoral immune response,BP,
1350,GO:0002922,1,0.932470748759481,0,12,positive regulation of humoral immune response,BP,
1351,GO:0002923,1,0.946284867898558,0,9,regulation of humoral immune response mediated by circulating immunoglobulin,BP,
1352,GO:0002924,1,0.967517963723049,0,5,negative regulation of humoral immune response mediated by circulating immunoglobulin,BP,
1353,GO:0002925,1,0.978061297254258,0,4,positive regulation of humoral immune response mediated by circulating immunoglobulin,BP,
1354,GO:0002930,1,0.986937818140861,0,2,trabecular meshwork development,BP,
1355,GO:0002931,1,0.807846415995179,0,32,response to ischemia,BP,
1356,GO:0002933,1,0.98273595367857,0,3,lipid hydroxylation,BP,
1357,GO:0002934,1,0.936750542506549,0,9,desmosome organization,BP,
1358,GO:0002940,1,0.98804420764928,0,2,tRNA N2-guanine methylation,BP,
1359,GO:0002943,1,0.976880984589888,0,4,tRNA dihydrouridine synthesis,BP,
1360,GO:0002944,1,0.985162152400776,0,2,cyclin K-CDK12 complex,CC,
1361,GO:0002945,1,0.985880069841092,0,2,cyclin K-CDK13 complex,CC,
1362,GO:0002946,1,0.994546625925015,0,1,tRNA C5-cytosine methylation,BP,
1363,GO:0002947,1,0.993162501211265,0,1,tumor necrosis factor receptor superfamily complex,CC,
1364,GO:0002949,1,0.983012529151404,0,3,tRNA threonylcarbamoyladenosine modification,BP,
1365,GO:0002950,1,0.980101803823174,0,3,ceramide phosphoethanolamine synthase activity,MF,
1366,GO:0002951,1,0.988098669344387,0,2,leukotriene-C(4) hydrolase,MF,
1371,GO:0003009,1,0.798839006109962,0,36,skeletal muscle contraction,BP,
1372,GO:0003010,1,0.9672308495559,0,5,voluntary skeletal muscle contraction,BP,
1373,GO:0003011,1,0.981164472965818,0,3,involuntary skeletal muscle contraction,BP,
1378,GO:0003016,1,0.827471209512794,0,29,respiratory system process,BP,
1379,GO:0003017,1,0.990541106691751,0,1,lymph circulation,BP,
1380,GO:0003018,1,0.399942201176102,0,143,vascular process in circulatory system,BP,
1381,GO:0003025,1,0.977842215129901,0,3,regulation of systemic arterial blood pressure by baroreceptor feedback,BP,
1382,GO:0003026,1,0.993850639026861,0,1,regulation of systemic arterial blood pressure by aortic arch baroreceptor feedback,BP,
1383,GO:0003027,1,0.994410455703393,0,1,regulation of systemic arterial blood pressure by carotid body chemoreceptor signaling,BP,
1384,GO:0003029,1,0.994410455703393,0,1,detection of hypoxic conditions in blood by carotid body chemoreceptor signaling,BP,
1385,GO:0003032,1,0.987805237232685,0,2,detection of oxygen,BP,
1386,GO:0003044,1,0.784453043994508,0,39,regulation of systemic arterial blood pressure mediated by a chemical signal,BP,
1387,GO:0003050,1,0.992730013648294,0,1,regulation of systemic arterial blood pressure by atrial natriuretic peptide,BP,
1388,GO:0003051,1,0.981158150656809,0,3,angiotensin-mediated drinking behavior,BP,
1389,GO:0003056,1,0.952918846076709,0,7,regulation of vascular smooth muscle contraction,BP,
1390,GO:0003057,1,0.970887794609722,0,5,regulation of the force of heart contraction by chemical signal,BP,
1391,GO:0003058,1,0.994647894618283,0,1,hormonal regulation of the force of heart contraction,BP,
1392,GO:0003062,1,0.959804931790833,0,6,regulation of heart rate by chemical signal,BP,
1393,GO:0003064,1,0.988013215822508,0,2,regulation of heart rate by hormone,BP,
1394,GO:0003065,1,0.99436367937158,0,1,positive regulation of heart rate by epinephrine,BP,
1395,GO:0003068,1,0.994759999181943,0,1,regulation of systemic arterial blood pressure by acetylcholine,BP,
1396,GO:0003069,1,0.994759999181943,0,1,acetylcholine-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP,
1397,GO:0003070,1,0.994759999181943,0,1,regulation of systemic arterial blood pressure by neurotransmitter,BP,
1398,GO:0003071,1,0.895874470240788,0,18,renal system process involved in regulation of systemic arterial blood pressure,BP,
1399,GO:0003072,1,0.97666224649165,0,4,renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure,BP,
1401,GO:0003081,1,0.894227039596699,0,18,regulation of systemic arterial blood pressure by renin-angiotensin,BP,
1402,GO:0003083,1,0.994933045122769,0,1,negative regulation of renal output by angiotensin,BP,
1404,GO:0003085,1,0.921476665124608,0,13,negative regulation of systemic arterial blood pressure,BP,
1406,GO:0003093,1,0.939557886171846,0,10,regulation of glomerular filtration,BP,
1407,GO:0003094,1,0.906686685164015,0,15,glomerular filtration,BP,
1408,GO:0003095,1,0.994393141231139,0,1,pressure natriuresis,BP,
1409,GO:0003096,1,0.967752286905804,0,5,renal sodium ion transport,BP,
1410,GO:0003097,1,0.969953021638837,0,5,renal water transport,BP,
1411,GO:0003099,1,0.982721953469172,0,3,positive regulation of the force of heart contraction by chemical signal,BP,
1412,GO:0003100,1,0.96428805021112,0,6,regulation of systemic arterial blood pressure by endothelin,BP,
1413,GO:0003104,1,0.975499535891487,0,4,positive regulation of glomerular filtration,BP,
1414,GO:0003105,1,0.976367813573953,0,4,negative regulation of glomerular filtration,BP,
1415,GO:0003106,1,0.994933045122769,0,1,negative regulation of glomerular filtration by angiotensin,BP,
1416,GO:0003127,1,0.98334138911002,0,2,detection of nodal flow,BP,
1417,GO:0003128,1,0.934258208179947,0,10,heart field specification,BP,
1418,GO:0003129,1,0.977273366910947,0,4,heart induction,BP,
1419,GO:0003130,1,0.988066935959303,0,2,BMP signaling pathway involved in heart induction,BP,
1420,GO:0003131,1,0.993828043976683,0,1,mesodermal-endodermal cell signaling,BP,
1421,GO:0003133,1,0.988066935959303,0,2,endodermal-mesodermal cell signaling,BP,
1422,GO:0003134,1,0.988066935959303,0,2,endodermal-mesodermal cell signaling involved in heart induction,BP,
1423,GO:0003137,1,0.994690774858455,0,1,Notch signaling pathway involved in heart induction,BP,
1424,GO:0003138,1,0.99202642772236,0,1,primary heart field specification,BP,
1425,GO:0003139,1,0.939563534110157,0,9,secondary heart field specification,BP,
1426,GO:0003140,1,0.950604445270535,0,8,determination of left/right asymmetry in lateral mesoderm,BP,
1427,GO:0003142,1,0.994076440360544,0,1,cardiogenic plate morphogenesis,BP,
1428,GO:0003143,1,0.660122386422516,0,61,embryonic heart tube morphogenesis,BP,
1429,GO:0003147,1,0.994748117708665,0,1,neural crest cell migration involved in heart formation,BP,
1430,GO:0003148,1,0.840589279997162,0,25,outflow tract septum morphogenesis,BP,
1431,GO:0003149,1,0.943236948051951,0,9,membranous septum morphogenesis,BP,
1432,GO:0003150,1,0.966169846198397,0,5,muscular septum morphogenesis,BP,
1435,GO:0003157,1,0.928036415806121,0,11,endocardium development,BP,
1438,GO:0003160,1,0.961817821655136,0,6,endocardium morphogenesis,BP,
1439,GO:0003161,1,0.9219738481187,0,12,cardiac conduction system development,BP,
1440,GO:0003162,1,0.977255793503776,0,3,atrioventricular node development,BP,
1441,GO:0003163,1,0.980116788344118,0,3,sinoatrial node development,BP,
1442,GO:0003164,1,0.967899382316468,0,5,His-Purkinje system development,BP,
1443,GO:0003165,1,0.986699685703474,0,2,Purkinje myocyte development,BP,
1444,GO:0003166,1,0.975352378677668,0,4,bundle of His development,BP,
1445,GO:0003167,1,0.992835335895731,0,1,atrioventricular bundle cell differentiation,BP,
1446,GO:0003168,1,0.994295966577254,0,1,Purkinje myocyte differentiation,BP,
1447,GO:0003169,1,0.983996277928067,0,2,coronary vein morphogenesis,BP,
1448,GO:0003170,1,0.762501713019192,0,38,heart valve development,BP,
1449,GO:0003171,1,0.850195513628224,0,23,atrioventricular valve development,BP,
1450,GO:0003172,1,0.99202642772236,0,1,sinoatrial valve development,BP,
1451,GO:0003174,1,0.927949242618116,0,10,mitral valve development,BP,
1452,GO:0003175,1,0.95808079395793,0,6,tricuspid valve development,BP,
1453,GO:0003176,1,0.962511009953324,0,6,aortic valve development,BP,
1454,GO:0003177,1,0.924901102962582,0,11,pulmonary valve development,BP,
1455,GO:0003179,1,0.782392088646604,0,34,heart valve morphogenesis,BP,
1456,GO:0003180,1,0.962511009953324,0,6,aortic valve morphogenesis,BP,
1457,GO:0003181,1,0.859990122939199,0,21,atrioventricular valve morphogenesis,BP,
1458,GO:0003183,1,0.927949242618116,0,10,mitral valve morphogenesis,BP,
1459,GO:0003184,1,0.924901102962582,0,11,pulmonary valve morphogenesis,BP,
1460,GO:0003185,1,0.99202642772236,0,1,sinoatrial valve morphogenesis,BP,
1461,GO:0003186,1,0.963418074591952,0,5,tricuspid valve morphogenesis,BP,
1462,GO:0003188,1,0.919264267365457,0,12,heart valve formation,BP,
1463,GO:0003190,1,0.947967741239283,0,7,atrioventricular valve formation,BP,
1464,GO:0003192,1,0.974020234187911,0,3,mitral valve formation,BP,
1465,GO:0003193,1,0.99446213715747,0,1,pulmonary valve formation,BP,
1466,GO:0003195,1,0.987562157286628,0,2,tricuspid valve formation,BP,
1467,GO:0003197,1,0.766250423187137,0,39,endocardial cushion development,BP,
1468,GO:0003198,1,0.898806287797188,0,16,epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
1469,GO:0003199,1,0.975769403516457,0,4,endocardial cushion to mesenchymal transition involved in heart valve formation,BP,
1470,GO:0003203,1,0.823123026869069,0,29,endocardial cushion morphogenesis,BP,
1475,GO:0003209,1,0.82122615276842,0,28,cardiac atrium morphogenesis,BP,
1476,GO:0003210,1,0.994690774858455,0,1,cardiac atrium formation,BP,
1478,GO:0003213,1,0.982802850133218,0,2,cardiac right atrium morphogenesis,BP,
1480,GO:0003215,1,0.8838224037949,0,18,cardiac right ventricle morphogenesis,BP,
1481,GO:0003218,1,0.993407349400836,0,1,cardiac left ventricle formation,BP,
1482,GO:0003219,1,0.979084228628686,0,3,cardiac right ventricle formation,BP,
1483,GO:0003220,1,0.977726745684408,0,2,left ventricular cardiac muscle tissue morphogenesis,BP,
1484,GO:0003221,1,0.977312494057747,0,3,right ventricular cardiac muscle tissue morphogenesis,BP,
1485,GO:0003222,1,0.889880568781465,0,16,ventricular trabecula myocardium morphogenesis,BP,
1486,GO:0003223,1,0.934687246029741,0,8,ventricular compact myocardium morphogenesis,BP,
1487,GO:0003226,1,0.989871255449879,0,1,right ventricular compact myocardium morphogenesis,BP,
1488,GO:0003228,1,0.962418875485187,0,6,atrial cardiac muscle tissue development,BP,
1489,GO:0003229,1,0.698889353553321,0,50,ventricular cardiac muscle tissue development,BP,
1490,GO:0003230,1,0.796367221955038,0,32,cardiac atrium development,BP,
1492,GO:0003235,1,0.994690774858455,0,1,sinus venosus development,BP,
1493,GO:0003236,1,0.994690774858455,0,1,sinus venosus morphogenesis,BP,
1494,GO:0003241,1,0.973567688003548,0,4,growth involved in heart morphogenesis,BP,
1495,GO:0003245,1,0.988192833783106,0,2,cardiac muscle tissue growth involved in heart morphogenesis,BP,
1496,GO:0003247,1,0.994442240407395,0,1,post-embryonic cardiac muscle cell growth involved in heart morphogenesis,BP,
1497,GO:0003249,1,0.979900004592323,0,2,cell proliferation involved in heart valve morphogenesis,BP,
1498,GO:0003250,1,0.979900004592323,0,2,regulation of cell proliferation involved in heart valve morphogenesis,BP,
1499,GO:0003251,1,0.990742296431914,0,1,positive regulation of cell proliferation involved in heart valve morphogenesis,BP,
1500,GO:0003252,1,0.989057415659924,0,1,negative regulation of cell proliferation involved in heart valve morphogenesis,BP,
1501,GO:0003253,1,0.958321518717647,0,7,cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
1502,GO:0003254,1,0.767093104090913,0,39,regulation of membrane depolarization,BP,
1503,GO:0003256,1,0.956842269280996,0,6,regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,
1504,GO:0003257,1,0.978140063572021,0,3,positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,
1505,GO:0003259,1,0.994690774858455,0,1,cardioblast anterior-lateral migration,BP,
1506,GO:0003260,1,0.994690774858455,0,1,cardioblast migration,BP,
1507,GO:0003263,1,0.946646625253222,0,9,cardioblast proliferation,BP,
1508,GO:0003264,1,0.937611550106052,0,10,regulation of cardioblast proliferation,BP,
1509,GO:0003266,1,0.943379023618753,0,9,regulation of secondary heart field cardioblast proliferation,BP,
1510,GO:0003270,1,0.990460959468017,0,1,Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation,BP,
1511,GO:0003272,1,0.867727928987098,0,21,endocardial cushion formation,BP,
1512,GO:0003273,1,0.968428934800791,0,4,cell migration involved in endocardial cushion formation,BP,
1513,GO:0003274,1,0.979387913562881,0,3,endocardial cushion fusion,BP,
1514,GO:0003275,1,0.980664437569727,0,3,apoptotic process involved in outflow tract morphogenesis,BP,
1515,GO:0003278,1,0.963566792871282,0,6,apoptotic process involved in heart morphogenesis,BP,
1518,GO:0003283,1,0.878998235128852,0,18,atrial septum development,BP,
1519,GO:0003284,1,0.972944738319928,0,4,septum primum development,BP,
1520,GO:0003285,1,0.98786274593125,0,2,septum secundum development,BP,
1521,GO:0003289,1,0.972944738319928,0,4,atrial septum primum morphogenesis,BP,
1522,GO:0003290,1,0.993530246327082,0,1,atrial septum secundum morphogenesis,BP,
1523,GO:0003292,1,0.986668936954503,0,2,cardiac septum cell differentiation,BP,
1524,GO:0003294,1,0.993675570705843,0,1,atrial ventricular junction remodeling,BP,
1525,GO:0003298,1,0.891834810449302,0,17,physiological muscle hypertrophy,BP,
1526,GO:0003299,1,0.856121550266493,0,22,muscle hypertrophy in response to stress,BP,
1527,GO:0003300,1,0.596528819062066,0,68,cardiac muscle hypertrophy,BP,
1528,GO:0003301,1,0.891834810449302,0,17,physiological cardiac muscle hypertrophy,BP,
1529,GO:0003306,1,0.950277161181944,0,8,Wnt signaling pathway involved in heart development,BP,
1530,GO:0003307,1,0.971192555929409,0,5,regulation of Wnt signaling pathway involved in heart development,BP,
1531,GO:0003308,1,0.976987459821742,0,4,negative regulation of Wnt signaling pathway involved in heart development,BP,
1532,GO:0003309,1,0.856598341328446,0,23,type B pancreatic cell differentiation,BP,
1533,GO:0003310,1,0.962318359438628,0,6,pancreatic A cell differentiation,BP,
1534,GO:0003312,1,0.988184285710559,0,2,pancreatic PP cell differentiation,BP,
1535,GO:0003318,1,0.994690774858455,0,1,cell migration to the midline involved in heart development,BP,
1536,GO:0003321,1,0.956343331593574,0,7,positive regulation of blood pressure by epinephrine-norepinephrine,BP,
1537,GO:0003322,1,0.991715869214418,0,1,pancreatic A cell development,BP,
1538,GO:0003323,1,0.880139378837589,0,19,type B pancreatic cell development,BP,
1539,GO:0003326,1,0.988184285710559,0,2,pancreatic A cell fate commitment,BP,
1540,GO:0003327,1,0.994217412712474,0,1,type B pancreatic cell fate commitment,BP,
1541,GO:0003329,1,0.988184285710559,0,2,pancreatic PP cell fate commitment,BP,
1542,GO:0003330,1,0.987843763519331,0,2,regulation of extracellular matrix constituent secretion,BP,
1543,GO:0003331,1,0.987843763519331,0,2,positive regulation of extracellular matrix constituent secretion,BP,
1544,GO:0003333,1,0.6236234079365,0,71,amino acid transmembrane transport,BP,
1545,GO:0003334,1,0.936826426180439,0,9,keratinocyte development,BP,
1546,GO:0003335,1,0.99460294546376,0,1,corneocyte development,BP,
1547,GO:0003337,1,0.921612662935556,0,13,mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
1548,GO:0003338,1,0.807897463822786,0,31,metanephros morphogenesis,BP,
1549,GO:0003339,1,0.952015740287404,0,8,regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
1550,GO:0003340,1,0.981893589570265,0,3,negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
1552,GO:0003342,1,0.988061730714718,0,2,proepicardium development,BP,
1553,GO:0003343,1,0.988061730714718,0,2,septum transversum development,BP,
1554,GO:0003344,1,0.934401803311967,0,9,pericardium morphogenesis,BP,
1555,GO:0003345,1,0.993293146809258,0,1,proepicardium cell migration involved in pericardium morphogenesis,BP,
1556,GO:0003348,1,0.958238641158551,0,6,cardiac endothelial cell differentiation,BP,
1557,GO:0003350,1,0.981157339973831,0,3,pulmonary myocardium development,BP,
1558,GO:0003351,1,0.88768200368804,0,19,epithelial cilium movement,BP,
1559,GO:0003352,1,0.916383890213186,0,13,regulation of cilium movement,BP,
1560,GO:0003353,1,0.993737789473264,0,1,positive regulation of cilium movement,BP,
1561,GO:0003356,1,0.933149748381752,0,10,regulation of cilium beat frequency,BP,
1563,GO:0003358,1,0.987878385586013,0,2,noradrenergic neuron development,BP,
1564,GO:0003359,1,0.994010428273367,0,1,noradrenergic neuron fate commitment,BP,
1565,GO:0003360,1,0.956747462323239,0,6,brainstem development,BP,
1566,GO:0003365,1,0.975339260864916,0,3,establishment of cell polarity involved in ameboidal cell migration,BP,
1567,GO:0003366,1,0.98603311360567,0,2,cell-matrix adhesion involved in ameboidal cell migration,BP,
1568,GO:0003373,1,0.951690376495185,0,7,dynamin family protein polymerization involved in membrane fission,BP,
1569,GO:0003374,1,0.951690376495185,0,7,dynamin family protein polymerization involved in mitochondrial fission,BP,
1571,GO:0003382,1,0.832434696423292,0,26,epithelial cell morphogenesis,BP,
1572,GO:0003383,1,0.976644797930857,0,3,apical constriction,BP,
1573,GO:0003400,1,0.994168334678561,0,1,regulation of COPII vesicle coating,BP,
1576,GO:0003404,1,0.987611435037526,0,2,optic vesicle morphogenesis,BP,
1577,GO:0003406,1,0.966151436974542,0,5,retinal pigment epithelium development,BP,
1579,GO:0003408,1,0.977185628106823,0,3,optic cup formation involved in camera-type eye development,BP,
1580,GO:0003409,1,0.993586018595652,0,1,optic cup structural organization,BP,
1581,GO:0003413,1,0.935196950393846,0,10,chondrocyte differentiation involved in endochondral bone morphogenesis,BP,
1582,GO:0003414,1,0.99331447503303,0,1,chondrocyte morphogenesis involved in endochondral bone morphogenesis,BP,
1583,GO:0003415,1,0.973397352120041,0,4,chondrocyte hypertrophy,BP,
1585,GO:0003417,1,0.915696215226418,0,14,growth plate cartilage development,BP,
1586,GO:0003418,1,0.962239040430072,0,6,growth plate cartilage chondrocyte differentiation,BP,
1587,GO:0003419,1,0.977692086509456,0,4,growth plate cartilage chondrocyte proliferation,BP,
1588,GO:0003420,1,0.987780920687782,0,2,regulation of growth plate cartilage chondrocyte proliferation,BP,
1589,GO:0003421,1,0.993291347376045,0,1,growth plate cartilage axis specification,BP,
1590,GO:0003422,1,0.986650223351078,0,2,growth plate cartilage morphogenesis,BP,
1591,GO:0003429,1,0.99331447503303,0,1,growth plate cartilage chondrocyte morphogenesis,BP,
1592,GO:0003430,1,0.986750774429285,0,2,growth plate cartilage chondrocyte growth,BP,
1593,GO:0003431,1,0.973495568870229,0,4,growth plate cartilage chondrocyte development,BP,
1594,GO:0003433,1,0.961327451012752,0,6,chondrocyte development involved in endochondral bone morphogenesis,BP,
1598,GO:0003678,1,0.731834974249229,0,45,DNA helicase activity,MF,
1599,GO:0003680,1,0.939831796999538,0,10,AT DNA binding,MF,
1601,GO:0003684,1,0.646645921385549,0,66,damaged DNA binding,MF,
1603,GO:0003689,1,0.952778066961539,0,8,DNA clamp loader activity,MF,
1605,GO:0003691,1,0.945067050719909,0,9,double-stranded telomeric DNA binding,MF,
1606,GO:0003692,1,0.994159812604404,0,1,left-handed Z-DNA binding,MF,
1607,GO:0003696,1,0.955363334735421,0,7,satellite DNA binding,MF,
1610,GO:0003705,1,0.547989062501958,0,91,transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding,MF,
1612,GO:0003708,1,0.955476707975666,0,7,retinoic acid receptor activity,MF,
1615,GO:0003714,1,0.24887393169433,0,209,transcription corepressor activity,MF,
1616,GO:0003720,1,0.948060551212165,0,8,telomerase activity,MF,
1617,GO:0003721,1,0.993224430037506,0,1,telomerase RNA reverse transcriptase activity,MF,
1619,GO:0003724,1,0.651763184094903,0,65,RNA helicase activity,MF,
1620,GO:0003725,1,0.649240125948927,0,65,double-stranded RNA binding,MF,
1621,GO:0003726,1,0.978942166005807,0,3,double-stranded RNA adenosine deaminase activity,MF,
1622,GO:0003727,1,0.608669213769478,0,77,single-stranded RNA binding,MF,
1623,GO:0003729,1,0.291521265852663,0,189,mRNA binding,MF,
1624,GO:0003730,1,0.661238430311813,0,62,mRNA 3'-UTR binding,MF,
1625,GO:0003735,1,0.441159178253354,0,153,structural constituent of ribosome,MF,
1626,GO:0003743,1,0.732425472912007,0,50,translation initiation factor activity,MF,
1627,GO:0003746,1,0.893578893176715,0,18,translation elongation factor activity,MF,
1628,GO:0003747,1,0.96135526352572,0,6,translation release factor activity,MF,
1629,GO:0003755,1,0.829692701894083,0,31,peptidyl-prolyl cis-trans isomerase activity,MF,
1630,GO:0003756,1,0.897116426065811,0,17,protein disulfide isomerase activity,MF,
1634,GO:0003785,1,0.853442630564675,0,25,actin monomer binding,MF,
1635,GO:0003796,1,0.984277986679574,0,3,lysozyme activity,MF,
1636,GO:0003810,1,0.963318207250005,0,6,protein-glutamine gamma-glutamyltransferase activity,MF,
1637,GO:0003823,1,0.762136007416997,0,45,antigen binding,MF,
1639,GO:0003826,1,0.988331749948927,0,2,alpha-ketoacid dehydrogenase activity,MF,
1640,GO:0003827,1,0.987634387842398,0,2,alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity,MF,
1641,GO:0003828,1,0.955203849061342,0,6,alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity,MF,
1642,GO:0003829,1,0.985965030411306,0,2,beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity,MF,
1643,GO:0003830,1,0.992695474714202,0,1,beta-1,4-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity,MF,
1644,GO:0003831,1,0.94976902395841,0,8,beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity,MF,
1645,GO:0003834,1,0.993850639026861,0,1,beta-carotene 15,15'-monooxygenase activity,MF,
1646,GO:0003835,1,0.984911771979741,0,2,beta-galactoside alpha-2,6-sialyltransferase activity,MF,
1647,GO:0003836,1,0.962147667791509,0,6,beta-galactoside (CMP) alpha-2,3-sialyltransferase activity,MF,
1648,GO:0003837,1,0.994218446119203,0,1,beta-ureidopropionase activity,MF,
1649,GO:0003839,1,0.977871798375563,0,4,gamma-glutamylcyclotransferase activity,MF,
1650,GO:0003841,1,0.889636648789596,0,17,1-acylglycerol-3-phosphate O-acyltransferase activity,MF,
1651,GO:0003842,1,0.993611601194332,0,1,1-pyrroline-5-carboxylate dehydrogenase activity,MF,
1652,GO:0003844,1,0.993683761241314,0,1,1,4-alpha-glucan branching enzyme activity,MF,
1653,GO:0003845,1,0.988907565741305,0,2,11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity,MF,
1654,GO:0003846,1,0.98743244818747,0,2,2-acylglycerol O-acyltransferase activity,MF,
1655,GO:0003847,1,0.971853361657195,0,5,1-alkyl-2-acetylglycerophosphocholine esterase activity,MF,
1656,GO:0003854,1,0.982572146025819,0,3,3-beta-hydroxy-delta5-steroid dehydrogenase activity,MF,
1657,GO:0003857,1,0.948599803432755,0,9,3-hydroxyacyl-CoA dehydrogenase activity,MF,
1658,GO:0003858,1,0.987356766896613,0,2,3-hydroxybutyrate dehydrogenase activity,MF,
1659,GO:0003860,1,0.994291573170334,0,1,3-hydroxyisobutyryl-CoA hydrolase activity,MF,
1660,GO:0003863,1,0.988331749948927,0,2,3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity,MF,
1661,GO:0003865,1,0.988069860211868,0,2,3-oxo-5-alpha-steroid 4-dehydrogenase activity,MF,
1662,GO:0003867,1,0.992750414346676,0,1,4-aminobutyrate transaminase activity,MF,
1663,GO:0003868,1,0.988817913993765,0,2,4-hydroxyphenylpyruvate dioxygenase activity,MF,
1664,GO:0003870,1,0.988354470473356,0,2,5-aminolevulinate synthase activity,MF,
1665,GO:0003872,1,0.981327072388371,0,3,6-phosphofructokinase activity,MF,
1666,GO:0003873,1,0.973706266796493,0,4,6-phosphofructo-2-kinase activity,MF,
1667,GO:0003874,1,0.994806490833661,0,1,6-pyruvoyltetrahydropterin synthase activity,MF,
1668,GO:0003875,1,0.987916032622485,0,2,ADP-ribosylarginine hydrolase activity,MF,
1669,GO:0003876,1,0.986453925378152,0,2,AMP deaminase activity,MF,
1670,GO:0003877,1,0.994198037646091,0,1,ATP adenylyltransferase activity,MF,
1671,GO:0003878,1,0.993041552202719,0,1,ATP citrate synthase activity,MF,
1672,GO:0003880,1,0.98132671467407,0,3,protein C-terminal carboxyl O-methyltransferase activity,MF,
1673,GO:0003881,1,0.994320260174074,0,1,CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity,MF,
1674,GO:0003882,1,0.994022284729709,0,1,CDP-diacylglycerol-serine O-phosphatidyltransferase activity,MF,
1675,GO:0003883,1,0.987146010218211,0,2,CTP synthase activity,MF,
1676,GO:0003884,1,0.988943840682995,0,2,D-amino-acid oxidase activity,MF,
1677,GO:0003886,1,0.978970586396379,0,3,DNA (cytosine-5-)-methyltransferase activity,MF,
1678,GO:0003887,1,0.837737195372232,0,26,DNA-directed DNA polymerase activity,MF,
1679,GO:0003896,1,0.982588511769808,0,3,DNA primase activity,MF,
1680,GO:0003899,1,0.779842324559024,0,41,DNA-directed 5'-3' RNA polymerase activity,MF,
1681,GO:0003905,1,0.994727453981438,0,1,alkylbase DNA N-glycosylase activity,MF,
1682,GO:0003906,1,0.927705227415257,0,13,DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,
1683,GO:0003908,1,0.99463497845893,0,1,methylated-DNA-[protein]-cysteine S-methyltransferase activity,MF,
1684,GO:0003909,1,0.957036878416137,0,7,DNA ligase activity,MF,
1685,GO:0003910,1,0.962625882824204,0,6,DNA ligase (ATP) activity,MF,
1687,GO:0003917,1,0.974736358884786,0,4,DNA topoisomerase type I activity,MF,
1689,GO:0003919,1,0.994269348506945,0,1,FMN adenylyltransferase activity,MF,
1690,GO:0003920,1,0.988851815798577,0,2,GMP reductase activity,MF,
1691,GO:0003921,1,0.994015067472639,0,1,GMP synthase activity,MF,
1692,GO:0003922,1,0.994015067472639,0,1,GMP synthase (glutamine-hydrolyzing) activity,MF,
1693,GO:0003923,1,0.969761043453569,0,5,GPI-anchor transamidase activity,MF,
1695,GO:0003933,1,0.99427916852304,0,1,GTP cyclohydrolase activity,MF,
1696,GO:0003934,1,0.99427916852304,0,1,GTP cyclohydrolase I activity,MF,
1697,GO:0003937,1,0.994204495715103,0,1,IMP cyclohydrolase activity,MF,
1698,GO:0003938,1,0.98843635079554,0,2,IMP dehydrogenase activity,MF,
1699,GO:0003939,1,0.993982085865433,0,1,L-iditol 2-dehydrogenase activity,MF,
1700,GO:0003940,1,0.994154906260876,0,1,L-iduronidase activity,MF,
1701,GO:0003941,1,0.983126092734599,0,3,L-serine ammonia-lyase activity,MF,
1702,GO:0003943,1,0.98726776758776,0,2,N-acetylgalactosamine-4-sulfatase activity,MF,
1703,GO:0003944,1,0.99414819269229,0,1,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase activity,MF,
1704,GO:0003945,1,0.975924573960727,0,4,N-acetyllactosamine synthase activity,MF,
1705,GO:0003947,1,0.99373189799152,0,1,(N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity,MF,
1706,GO:0003948,1,0.99420914570589,0,1,N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity,MF,
1707,GO:0003950,1,0.880950416990539,0,19,NAD+ ADP-ribosyltransferase activity,MF,
1708,GO:0003951,1,0.895793811304731,0,16,NAD+ kinase activity,MF,
1709,GO:0003952,1,0.994025893683851,0,1,NAD+ synthase (glutamine-hydrolyzing) activity,MF,
1710,GO:0003953,1,0.989068729430147,0,2,NAD+ nucleosidase activity,MF,
1711,GO:0003954,1,0.808431054760791,0,40,NADH dehydrogenase activity,MF,
1712,GO:0003955,1,0.982314367934832,0,3,NAD(P)H dehydrogenase (quinone) activity,MF,
1713,GO:0003956,1,0.983603819278697,0,3,NAD(P)+-protein-arginine ADP-ribosyltransferase activity,MF,
1714,GO:0003957,1,0.992876305256662,0,1,NAD(P)+ transhydrogenase (B-specific) activity,MF,
1715,GO:0003958,1,0.95976138761759,0,6,NADPH-hemoprotein reductase activity,MF,
1716,GO:0003960,1,0.977546383421566,0,4,NADPH:quinone reductase activity,MF,
1717,GO:0003962,1,0.994387197314057,0,1,cystathionine gamma-synthase activity,MF,
1718,GO:0003963,1,0.9880519076691,0,2,RNA-3'-phosphate cyclase activity,MF,
1719,GO:0003964,1,0.948060551212165,0,8,RNA-directed DNA polymerase activity,MF,
1720,GO:0003968,1,0.985146994671852,0,2,RNA-directed 5'-3' RNA polymerase activity,MF,
1721,GO:0003972,1,0.993850639026861,0,1,RNA ligase (ATP) activity,MF,
1722,GO:0003973,1,0.986560880956857,0,2,(S)-2-hydroxy-acid oxidase activity,MF,
1723,GO:0003974,1,0.994455160459599,0,1,UDP-N-acetylglucosamine 4-epimerase activity,MF,
1724,GO:0003975,1,0.994180215002525,0,1,UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity,MF,
1725,GO:0003976,1,0.981315276205494,0,3,UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity,MF,
1726,GO:0003977,1,0.987673681805924,0,2,UDP-N-acetylglucosamine diphosphorylase activity,MF,
1727,GO:0003978,1,0.994455160459599,0,1,UDP-glucose 4-epimerase activity,MF,
1728,GO:0003979,1,0.993639744460834,0,1,UDP-glucose 6-dehydrogenase activity,MF,
1729,GO:0003980,1,0.982462357247343,0,2,UDP-glucose:glycoprotein glucosyltransferase activity,MF,
1730,GO:0003983,1,0.994180731565421,0,1,UTP:glucose-1-phosphate uridylyltransferase activity,MF,
1731,GO:0003985,1,0.982485515270185,0,3,acetyl-CoA C-acetyltransferase activity,MF,
1732,GO:0003986,1,0.978288082756615,0,4,acetyl-CoA hydrolase activity,MF,
1733,GO:0003987,1,0.980565955998763,0,3,acetate-CoA ligase activity,MF,
1734,GO:0003988,1,0.965665529972331,0,6,acetyl-CoA C-acyltransferase activity,MF,
1735,GO:0003989,1,0.990475853341656,0,1,acetyl-CoA carboxylase activity,MF,
1736,GO:0003990,1,0.988017713626917,0,2,acetylcholinesterase activity,MF,
1737,GO:0003991,1,0.994217412712474,0,1,acetylglutamate kinase activity,MF,
1738,GO:0003993,1,0.966125004962349,0,6,acid phosphatase activity,MF,
1739,GO:0003994,1,0.987359013165532,0,2,aconitate hydratase activity,MF,
1740,GO:0003995,1,0.90867856391409,0,15,acyl-CoA dehydrogenase activity,MF,
1741,GO:0003996,1,0.970812533796963,0,5,acyl-CoA ligase activity,MF,
1742,GO:0003997,1,0.968052483157377,0,5,acyl-CoA oxidase activity,MF,
1743,GO:0003998,1,0.98964170182335,0,2,acylphosphatase activity,MF,
1744,GO:0003999,1,0.994907218248437,0,1,adenine phosphoribosyltransferase activity,MF,
1745,GO:0004000,1,0.942259218477114,0,9,adenosine deaminase activity,MF,
1746,GO:0004001,1,0.99422671360834,0,1,adenosine kinase activity,MF,
1747,GO:0004003,1,0.804092561713378,0,32,ATP-dependent DNA helicase activity,MF,
1748,GO:0004004,1,0.655903421670291,0,64,ATP-dependent RNA helicase activity,MF,
1749,GO:0004008,1,0.982957627857301,0,2,copper-exporting ATPase activity,MF,
1750,GO:0004012,1,0.851422885293571,0,20,phospholipid-translocating ATPase activity,MF,
1751,GO:0004013,1,0.980120946056949,0,3,adenosylhomocysteinase activity,MF,
1752,GO:0004014,1,0.993604693773063,0,1,adenosylmethionine decarboxylase activity,MF,
1753,GO:0004016,1,0.906464361055561,0,13,adenylate cyclase activity,MF,
1755,GO:0004018,1,0.994523890066322,0,1,N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity,MF,
1756,GO:0004019,1,0.988259359793595,0,2,adenylosuccinate synthase activity,MF,
1757,GO:0004020,1,0.987313897203346,0,2,adenylylsulfate kinase activity,MF,
1758,GO:0004021,1,0.987617072909415,0,2,L-alanine:2-oxoglutarate aminotransferase activity,MF,
1759,GO:0004022,1,0.971073662536076,0,5,alcohol dehydrogenase (NAD) activity,MF,
1760,GO:0004024,1,0.988201359992044,0,2,alcohol dehydrogenase activity, zinc-dependent,MF,
1761,GO:0004027,1,0.994654610940781,0,1,alcohol sulfotransferase activity,MF,
1764,GO:0004030,1,0.963891911934096,0,6,aldehyde dehydrogenase [NAD(P)+] activity,MF,
1765,GO:0004031,1,0.992727920890101,0,1,aldehyde oxidase activity,MF,
1766,GO:0004032,1,0.941329975860951,0,11,alditol:NADP+ 1-oxidoreductase activity,MF,
1767,GO:0004033,1,0.867752718554191,0,25,aldo-keto reductase (NADP) activity,MF,
1768,GO:0004034,1,0.994005274042763,0,1,aldose 1-epimerase activity,MF,
1769,GO:0004035,1,0.987797575298557,0,2,alkaline phosphatase activity,MF,
1770,GO:0004037,1,0.994539908597864,0,1,allantoicase activity,MF,
1771,GO:0004040,1,0.982053500947932,0,3,amidase activity,MF,
1772,GO:0004042,1,0.994217412712474,0,1,acetyl-CoA:L-glutamate N-acetyltransferase activity,MF,
1773,GO:0004043,1,0.993451411434909,0,1,L-aminoadipate-semialdehyde dehydrogenase activity,MF,
1774,GO:0004044,1,0.993356577904322,0,1,amidophosphoribosyltransferase activity,MF,
1775,GO:0004045,1,0.978226843348498,0,4,aminoacyl-tRNA hydrolase activity,MF,
1776,GO:0004046,1,0.972231718629631,0,5,aminoacylase activity,MF,
1777,GO:0004047,1,0.98876006297353,0,2,aminomethyltransferase activity,MF,
1778,GO:0004051,1,0.993966632638298,0,1,arachidonate 5-lipoxygenase activity,MF,
1779,GO:0004052,1,0.982065428536393,0,3,arachidonate 12-lipoxygenase activity,MF,
1780,GO:0004053,1,0.988835349277219,0,2,arginase activity,MF,
1781,GO:0004055,1,0.994344812759299,0,1,argininosuccinate synthase activity,MF,
1782,GO:0004056,1,0.994258753615127,0,1,argininosuccinate lyase activity,MF,
1783,GO:0004057,1,0.994144061487143,0,1,arginyltransferase activity,MF,
1784,GO:0004058,1,0.994244541695516,0,1,aromatic-L-amino-acid decarboxylase activity,MF,
1785,GO:0004059,1,0.99452957410871,0,1,aralkylamine N-acetyltransferase activity,MF,
1786,GO:0004060,1,0.983476473688096,0,3,arylamine N-acetyltransferase activity,MF,
1787,GO:0004061,1,0.994411747803641,0,1,arylformamidase activity,MF,
1788,GO:0004062,1,0.955945167641138,0,8,aryl sulfotransferase activity,MF,
1789,GO:0004063,1,0.989084092677539,0,2,aryldialkylphosphatase activity,MF,
1790,GO:0004064,1,0.966869368645549,0,6,arylesterase activity,MF,
1791,GO:0004065,1,0.930899681735541,0,11,arylsulfatase activity,MF,
1792,GO:0004066,1,0.988132762097574,0,2,asparagine synthase (glutamine-hydrolyzing) activity,MF,
1793,GO:0004067,1,0.988422071166121,0,2,asparaginase activity,MF,
1794,GO:0004069,1,0.988244129426485,0,2,L-aspartate:2-oxoglutarate aminotransferase activity,MF,
1795,GO:0004070,1,0.983962208169502,0,2,aspartate carbamoyltransferase activity,MF,
1796,GO:0004074,1,0.989604217404202,0,2,biliverdin reductase activity,MF,
1797,GO:0004075,1,0.984505495632059,0,2,biotin carboxylase activity,MF,
1798,GO:0004077,1,0.99217517082661,0,1,biotin-[acetyl-CoA-carboxylase] ligase activity,MF,
1799,GO:0004078,1,0.99217517082661,0,1,biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity,MF,
1800,GO:0004079,1,0.99217517082661,0,1,biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity,MF,
1801,GO:0004080,1,0.99217517082661,0,1,biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity,MF,
1802,GO:0004081,1,0.988673540355775,0,2,bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity,MF,
1803,GO:0004082,1,0.978137090065443,0,4,bisphosphoglycerate mutase activity,MF,
1804,GO:0004084,1,0.98550402034736,0,2,branched-chain-amino-acid transaminase activity,MF,
1805,GO:0004085,1,0.994295966577254,0,1,butyryl-CoA dehydrogenase activity,MF,
1806,GO:0004087,1,0.983962208169502,0,2,carbamoyl-phosphate synthase (ammonia) activity,MF,
1807,GO:0004088,1,0.983962208169502,0,2,carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity,MF,
1808,GO:0004089,1,0.926212353541225,0,13,carbonate dehydratase activity,MF,
1809,GO:0004090,1,0.973549517656455,0,5,carbonyl reductase (NADPH) activity,MF,
1810,GO:0004092,1,0.993830867614831,0,1,carnitine O-acetyltransferase activity,MF,
1811,GO:0004095,1,0.974930412685939,0,4,carnitine O-palmitoyltransferase activity,MF,
1812,GO:0004096,1,0.976981144107592,0,4,catalase activity,MF,
1813,GO:0004098,1,0.994304753513272,0,1,cerebroside-sulfatase activity,MF,
1814,GO:0004102,1,0.994013521032001,0,1,choline O-acetyltransferase activity,MF,
1815,GO:0004103,1,0.988374256802279,0,2,choline kinase activity,MF,
1816,GO:0004104,1,0.981987007040944,0,3,cholinesterase activity,MF,
1817,GO:0004105,1,0.986960655559545,0,2,choline-phosphate cytidylyltransferase activity,MF,
1818,GO:0004108,1,0.993749318054857,0,1,citrate (Si)-synthase activity,MF,
1819,GO:0004109,1,0.987921245218751,0,2,coproporphyrinogen oxidase activity,MF,
1820,GO:0004111,1,0.969747354985921,0,5,creatine kinase activity,MF,
1821,GO:0004112,1,0.850704292407265,0,23,cyclic-nucleotide phosphodiesterase activity,MF,
1822,GO:0004113,1,0.992591768950649,0,1,2',3'-cyclic-nucleotide 3'-phosphodiesterase activity,MF,
1823,GO:0004114,1,0.857063473638225,0,22,3',5'-cyclic-nucleotide phosphodiesterase activity,MF,
1824,GO:0004115,1,0.896334225888966,0,15,3',5'-cyclic-AMP phosphodiesterase activity,MF,
1825,GO:0004117,1,0.98172083613237,0,3,calmodulin-dependent cyclic-nucleotide phosphodiesterase activity,MF,
1826,GO:0004118,1,0.975439531269397,0,3,cGMP-stimulated cyclic-nucleotide phosphodiesterase activity,MF,
1827,GO:0004119,1,0.98534289775017,0,2,cGMP-inhibited cyclic-nucleotide phosphodiesterase activity,MF,
1828,GO:0004122,1,0.993944491212098,0,1,cystathionine beta-synthase activity,MF,
1829,GO:0004123,1,0.994387197314057,0,1,cystathionine gamma-lyase activity,MF,
1830,GO:0004126,1,0.944318839882427,0,10,cytidine deaminase activity,MF,
1831,GO:0004127,1,0.975550554886678,0,4,cytidylate kinase activity,MF,
1832,GO:0004128,1,0.959088252809719,0,7,cytochrome-b5 reductase activity, acting on NAD(P)H,MF,
1833,GO:0004129,1,0.889814219008984,0,22,cytochrome-c oxidase activity,MF,
1834,GO:0004132,1,0.994239373961228,0,1,dCMP deaminase activity,MF,
1835,GO:0004133,1,0.99155253960703,0,1,glycogen debranching enzyme activity,MF,
1836,GO:0004134,1,0.99155253960703,0,1,4-alpha-glucanotransferase activity,MF,
1837,GO:0004135,1,0.99155253960703,0,1,amylo-alpha-1,6-glucosidase activity,MF,
1838,GO:0004137,1,0.98666687088075,0,2,deoxycytidine kinase activity,MF,
1839,GO:0004138,1,0.994766198164714,0,1,deoxyguanosine kinase activity,MF,
1840,GO:0004139,1,0.994396242376035,0,1,deoxyribose-phosphate aldolase activity,MF,
1841,GO:0004140,1,0.988367802585733,0,2,dephospho-CoA kinase activity,MF,
1842,GO:0004142,1,0.981667099584765,0,3,diacylglycerol cholinephosphotransferase activity,MF,
1843,GO:0004143,1,0.930436913096886,0,10,diacylglycerol kinase activity,MF,
1844,GO:0004144,1,0.98743244818747,0,2,diacylglycerol O-acyltransferase activity,MF,
1845,GO:0004145,1,0.983765898150188,0,3,diamine N-acetyltransferase activity,MF,
1846,GO:0004146,1,0.988039512861925,0,2,dihydrofolate reductase activity,MF,
1847,GO:0004148,1,0.993439630676661,0,1,dihydrolipoyl dehydrogenase activity,MF,
1848,GO:0004149,1,0.99381598176533,0,1,dihydrolipoyllysine-residue succinyltransferase activity,MF,
1849,GO:0004151,1,0.983962208169502,0,2,dihydroorotase activity,MF,
1850,GO:0004152,1,0.994219479532597,0,1,dihydroorotate dehydrogenase activity,MF,
1851,GO:0004155,1,0.9944355218544,0,1,6,7-dihydropteridine reductase activity,MF,
1852,GO:0004157,1,0.987173125952582,0,2,dihydropyrimidinase activity,MF,
1853,GO:0004161,1,0.988390733946499,0,2,dimethylallyltranstransferase activity,MF,
1854,GO:0004163,1,0.994358510469944,0,1,diphosphomevalonate decarboxylase activity,MF,
1855,GO:0004164,1,0.994362645593927,0,1,diphthine synthase activity,MF,
1856,GO:0004165,1,0.981093458041831,0,3,dodecenoyl-CoA delta-isomerase activity,MF,
1857,GO:0004167,1,0.984114338774977,0,3,dopachrome isomerase activity,MF,
1858,GO:0004168,1,0.99415232406711,0,1,dolichol kinase activity,MF,
1859,GO:0004169,1,0.971110400997344,0,5,dolichyl-phosphate-mannose-protein mannosyltransferase activity,MF,
1860,GO:0004170,1,0.994320777067634,0,1,dUTP diphosphatase activity,MF,
1861,GO:0004174,1,0.987724962689833,0,2,electron-transferring-flavoprotein dehydrogenase activity,MF,
1863,GO:0004176,1,0.974292255018525,0,4,ATP-dependent peptidase activity,MF,
1864,GO:0004177,1,0.760703383290381,0,43,aminopeptidase activity,MF,
1866,GO:0004181,1,0.865398686657799,0,23,metallocarboxypeptidase activity,MF,
1867,GO:0004185,1,0.942757497030544,0,9,serine-type carboxypeptidase activity,MF,
1868,GO:0004190,1,0.895135076664688,0,18,aspartic-type endopeptidase activity,MF,
1870,GO:0004198,1,0.889326324109053,0,19,calcium-dependent cysteine-type endopeptidase activity,MF,
1871,GO:0004222,1,0.531759037855296,0,94,metalloendopeptidase activity,MF,
1873,GO:0004298,1,0.908684931117976,0,18,threonine-type endopeptidase activity,MF,
1874,GO:0004300,1,0.953880266973339,0,8,enoyl-CoA hydratase activity,MF,
1875,GO:0004301,1,0.960250053610382,0,7,epoxide hydrolase activity,MF,
1876,GO:0004303,1,0.950953342635285,0,9,estradiol 17-beta-dehydrogenase activity,MF,
1877,GO:0004304,1,0.994367814467123,0,1,estrone sulfotransferase activity,MF,
1878,GO:0004305,1,0.975726715282328,0,4,ethanolamine kinase activity,MF,
1879,GO:0004306,1,0.994328530495534,0,1,ethanolamine-phosphate cytidylyltransferase activity,MF,
1880,GO:0004307,1,0.988893861706022,0,2,ethanolaminephosphotransferase activity,MF,
1881,GO:0004308,1,0.97063079144652,0,5,exo-alpha-sialidase activity,MF,
1882,GO:0004309,1,0.969904345318855,0,4,exopolyphosphatase activity,MF,
1883,GO:0004310,1,0.994199329235923,0,1,farnesyl-diphosphate farnesyltransferase activity,MF,
1884,GO:0004311,1,0.981885765510655,0,3,farnesyltranstransferase activity,MF,
1885,GO:0004312,1,0.938026359102886,0,10,fatty acid synthase activity,MF,
1886,GO:0004313,1,0.9908871583736,0,1,[acyl-carrier-protein] S-acetyltransferase activity,MF,
1887,GO:0004314,1,0.985220498432862,0,2,[acyl-carrier-protein] S-malonyltransferase activity,MF,
1888,GO:0004315,1,0.985564905366476,0,2,3-oxoacyl-[acyl-carrier-protein] synthase activity,MF,
1889,GO:0004316,1,0.9908871583736,0,1,3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity,MF,
1890,GO:0004317,1,0.9908871583736,0,1,3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity,MF,
1891,GO:0004319,1,0.9908871583736,0,1,enoyl-[acyl-carrier-protein] reductase (NADPH, B-specific) activity,MF,
1892,GO:0004320,1,0.985318076843781,0,2,oleoyl-[acyl-carrier-protein] hydrolase activity,MF,
1893,GO:0004321,1,0.976550171594026,0,4,fatty-acyl-CoA synthase activity,MF,
1894,GO:0004322,1,0.964801228421745,0,5,ferroxidase activity,MF,
1895,GO:0004324,1,0.994307854818459,0,1,ferredoxin-NADP+ reductase activity,MF,
1896,GO:0004325,1,0.991519285270531,0,1,ferrochelatase activity,MF,
1897,GO:0004326,1,0.994001666357671,0,1,tetrahydrofolylpolyglutamate synthase activity,MF,
1898,GO:0004329,1,0.986964081799522,0,2,formate-tetrahydrofolate ligase activity,MF,
1899,GO:0004331,1,0.973706266796493,0,4,fructose-2,6-bisphosphate 2-phosphatase activity,MF,
1900,GO:0004332,1,0.983057076702503,0,3,fructose-bisphosphate aldolase activity,MF,
1901,GO:0004333,1,0.994362645593927,0,1,fumarate hydratase activity,MF,
1902,GO:0004334,1,0.994536291546065,0,1,fumarylacetoacetase activity,MF,
1903,GO:0004335,1,0.988271677160826,0,2,galactokinase activity,MF,
1904,GO:0004336,1,0.993786227088729,0,1,galactosylceramidase activity,MF,
1905,GO:0004337,1,0.988390733946499,0,2,geranyltranstransferase activity,MF,
1906,GO:0004339,1,0.991908703178358,0,1,glucan 1,4-alpha-glucosidase activity,MF,
1907,GO:0004340,1,0.966422993637629,0,5,glucokinase activity,MF,
1908,GO:0004341,1,0.994292606909101,0,1,gluconolactonase activity,MF,
1909,GO:0004342,1,0.988433053863031,0,2,glucosamine-6-phosphate deaminase activity,MF,
1910,GO:0004343,1,0.993264600000506,0,1,glucosamine 6-phosphate N-acetyltransferase activity,MF,
1911,GO:0004344,1,0.99056886626227,0,1,glucose dehydrogenase activity,MF,
1912,GO:0004345,1,0.984703424318349,0,2,glucose-6-phosphate dehydrogenase activity,MF,
1913,GO:0004346,1,0.981970927154767,0,3,glucose-6-phosphatase activity,MF,
1914,GO:0004347,1,0.994209662380629,0,1,glucose-6-phosphate isomerase activity,MF,
1915,GO:0004348,1,0.981994233030205,0,3,glucosylceramidase activity,MF,
1916,GO:0004349,1,0.993498515347074,0,1,glutamate 5-kinase activity,MF,
1917,GO:0004350,1,0.993498515347074,0,1,glutamate-5-semialdehyde dehydrogenase activity,MF,
1918,GO:0004351,1,0.981149472716234,0,3,glutamate decarboxylase activity,MF,
1919,GO:0004352,1,0.987615689994506,0,2,glutamate dehydrogenase (NAD+) activity,MF,
1920,GO:0004353,1,0.987615689994506,0,2,glutamate dehydrogenase [NAD(P)+] activity,MF,
1921,GO:0004356,1,0.985576883599738,0,2,glutamate-ammonia ligase activity,MF,
1922,GO:0004357,1,0.987110389848593,0,2,glutamate-cysteine ligase activity,MF,
1923,GO:0004359,1,0.981117964364319,0,3,glutaminase activity,MF,
1924,GO:0004360,1,0.984589036486935,0,2,glutamine-fructose-6-phosphate transaminase (isomerizing) activity,MF,
1925,GO:0004361,1,0.994403995151308,0,1,glutaryl-CoA dehydrogenase activity,MF,
1926,GO:0004362,1,0.994115664340597,0,1,glutathione-disulfide reductase activity,MF,
1927,GO:0004363,1,0.994303202866797,0,1,glutathione synthase activity,MF,
1928,GO:0004364,1,0.876958870876934,0,24,glutathione transferase activity,MF,
1929,GO:0004365,1,0.994609662171885,0,1,glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity,MF,
1930,GO:0004366,1,0.979836577754502,0,3,glycerol-3-phosphate O-acyltransferase activity,MF,
1931,GO:0004367,1,0.987116743932734,0,2,glycerol-3-phosphate dehydrogenase [NAD+] activity,MF,
1932,GO:0004368,1,0.986072623023957,0,2,glycerol-3-phosphate dehydrogenase activity,MF,
1933,GO:0004370,1,0.983386796320084,0,2,glycerol kinase activity,MF,
1934,GO:0004372,1,0.988183553597633,0,2,glycine hydroxymethyltransferase activity,MF,
1935,GO:0004373,1,0.98722089564515,0,2,glycogen (starch) synthase activity,MF,
1936,GO:0004375,1,0.99331653001693,0,1,glycine dehydrogenase (decarboxylating) activity,MF,
1937,GO:0004376,1,0.976198421090345,0,4,glycolipid mannosyltransferase activity,MF,
1938,GO:0004377,1,0.99397899485547,0,1,GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
1939,GO:0004378,1,0.993788278451954,0,1,GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity,MF,
1940,GO:0004379,1,0.985519604840952,0,2,glycylpeptide N-tetradecanoyltransferase activity,MF,
1941,GO:0004380,1,0.994471697671762,0,1,glycoprotein-fucosylgalactoside alpha-N-acetylgalactosaminyltransferase activity,MF,
1942,GO:0004381,1,0.994471697671762,0,1,fucosylgalactoside 3-alpha-galactosyltransferase activity,MF,
1943,GO:0004382,1,0.987757797520516,0,2,guanosine-diphosphatase activity,MF,
1944,GO:0004383,1,0.913235518784041,0,12,guanylate cyclase activity,MF,
1945,GO:0004385,1,0.911094273808776,0,13,guanylate kinase activity,MF,
1946,GO:0004386,1,0.366321696512531,0,143,helicase activity,MF,
1947,GO:0004392,1,0.988906828290117,0,2,heme oxygenase (decyclizing) activity,MF,
1948,GO:0004394,1,0.99314078775418,0,1,heparan sulfate 2-O-sulfotransferase activity,MF,
1949,GO:0004395,1,0.994634461808247,0,1,hexaprenyldihydroxybenzoate methyltransferase activity,MF,
1950,GO:0004396,1,0.966422993637629,0,5,hexokinase activity,MF,
1951,GO:0004397,1,0.993660727089185,0,1,histidine ammonia-lyase activity,MF,
1952,GO:0004398,1,0.994042910162818,0,1,histidine decarboxylase activity,MF,
1953,GO:0004402,1,0.709597520248283,0,50,histone acetyltransferase activity,MF,
1954,GO:0004407,1,0.747306340561594,0,43,histone deacetylase activity,MF,
1955,GO:0004408,1,0.994106372711102,0,1,holocytochrome-c synthase activity,MF,
1956,GO:0004411,1,0.994292348474168,0,1,homogentisate 1,2-dioxygenase activity,MF,
1957,GO:0004415,1,0.96955652133521,0,5,hyalurononglucosaminidase activity,MF,
1958,GO:0004416,1,0.988259621271998,0,2,hydroxyacylglutathione hydrolase activity,MF,
1959,GO:0004418,1,0.99452957410871,0,1,hydroxymethylbilane synthase activity,MF,
1960,GO:0004419,1,0.988531908742048,0,2,hydroxymethylglutaryl-CoA lyase activity,MF,
1961,GO:0004420,1,0.99296072014961,0,1,hydroxymethylglutaryl-CoA reductase (NADPH) activity,MF,
1962,GO:0004421,1,0.987575457228875,0,2,hydroxymethylglutaryl-CoA synthase activity,MF,
1963,GO:0004422,1,0.988878521246645,0,2,hypoxanthine phosphoribosyltransferase activity,MF,
1964,GO:0004423,1,0.992281976159359,0,1,iduronate-2-sulfatase activity,MF,
1965,GO:0004427,1,0.983610199428614,0,3,inorganic diphosphatase activity,MF,
1966,GO:0004430,1,0.973081911531868,0,4,1-phosphatidylinositol 4-kinase activity,MF,
1967,GO:0004435,1,0.852823340216048,0,23,phosphatidylinositol phospholipase C activity,MF,
1968,GO:0004438,1,0.895962046994116,0,15,phosphatidylinositol-3-phosphatase activity,MF,
1969,GO:0004439,1,0.945588037474685,0,8,phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity,MF,
1970,GO:0004441,1,0.994207854026948,0,1,inositol-1,4-bisphosphate 1-phosphatase activity,MF,
1971,GO:0004445,1,0.96826273195437,0,5,inositol-polyphosphate 5-phosphatase activity,MF,
1972,GO:0004446,1,0.99381854786764,0,1,inositol-hexakisphosphate phosphatase activity,MF,
1973,GO:0004447,1,0.993761105399496,0,1,iodide peroxidase activity,MF,
1974,GO:0004448,1,0.971669145560631,0,5,isocitrate dehydrogenase activity,MF,
1975,GO:0004449,1,0.98296725433988,0,3,isocitrate dehydrogenase (NAD+) activity,MF,
1976,GO:0004450,1,0.988508103394858,0,2,isocitrate dehydrogenase (NADP+) activity,MF,
1977,GO:0004452,1,0.994185897313966,0,1,isopentenyl-diphosphate delta-isomerase activity,MF,
1978,GO:0004454,1,0.994039300222596,0,1,ketohexokinase activity,MF,
1979,GO:0004457,1,0.971900195705243,0,5,lactate dehydrogenase activity,MF,
1980,GO:0004458,1,0.988220433370795,0,2,D-lactate dehydrogenase (cytochrome) activity,MF,
1981,GO:0004459,1,0.983487187358529,0,3,L-lactate dehydrogenase activity,MF,
1982,GO:0004461,1,0.982342648438889,0,3,lactose synthase activity,MF,
1983,GO:0004462,1,0.994231880992772,0,1,lactoylglutathione lyase activity,MF,
1984,GO:0004463,1,0.994216896011637,0,1,leukotriene-A4 hydrolase activity,MF,
1985,GO:0004464,1,0.979759513002708,0,4,leukotriene-C4 synthase activity,MF,
1986,GO:0004465,1,0.963835308475196,0,6,lipoprotein lipase activity,MF,
1987,GO:0004466,1,0.97055086337084,0,5,long-chain-acyl-CoA dehydrogenase activity,MF,
1988,GO:0004467,1,0.925975818794864,0,12,long-chain fatty acid-CoA ligase activity,MF,
1989,GO:0004468,1,0.971245612694476,0,4,lysine N-acetyltransferase activity, acting on acetyl phosphate as donor,MF,
1990,GO:0004470,1,0.975482851944238,0,4,malic enzyme activity,MF,
1991,GO:0004471,1,0.980749171143864,0,3,malate dehydrogenase (decarboxylating) (NAD+) activity,MF,
1992,GO:0004473,1,0.980749171143864,0,3,malate dehydrogenase (decarboxylating) (NADP+) activity,MF,
1993,GO:0004474,1,0.992302408598171,0,1,malate synthase activity,MF,
1994,GO:0004475,1,0.994459294809995,0,1,mannose-1-phosphate guanylyltransferase activity,MF,
1995,GO:0004476,1,0.994371949535733,0,1,mannose-6-phosphate isomerase activity,MF,
1996,GO:0004477,1,0.975352014608035,0,4,methenyltetrahydrofolate cyclohydrolase activity,MF,
1997,GO:0004478,1,0.987403172085295,0,2,methionine adenosyltransferase activity,MF,
1998,GO:0004479,1,0.99386887877746,0,1,methionyl-tRNA formyltransferase activity,MF,
1999,GO:0004482,1,0.992073716894608,0,1,mRNA (guanine-N7-)-methyltransferase activity,MF,
2000,GO:0004483,1,0.987738712940129,0,2,mRNA (nucleoside-2'-O-)-methyltransferase activity,MF,
2001,GO:0004484,1,0.992982052709926,0,1,mRNA guanylyltransferase activity,MF,
2002,GO:0004485,1,0.987402682592774,0,2,methylcrotonoyl-CoA carboxylase activity,MF,
2003,GO:0004486,1,0.99349800348613,0,1,methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity,MF,
2004,GO:0004487,1,0.981809836496756,0,3,methylenetetrahydrofolate dehydrogenase (NAD+) activity,MF,
2005,GO:0004488,1,0.975352014608035,0,4,methylenetetrahydrofolate dehydrogenase (NADP+) activity,MF,
2006,GO:0004489,1,0.991580087513554,0,1,methylenetetrahydrofolate reductase (NAD(P)H) activity,MF,
2007,GO:0004490,1,0.994466529846979,0,1,methylglutaconyl-CoA hydratase activity,MF,
2008,GO:0004491,1,0.994159554370149,0,1,methylmalonate-semialdehyde dehydrogenase (acylating) activity,MF,
2009,GO:0004492,1,0.994195196191595,0,1,methylmalonyl-CoA decarboxylase activity,MF,
2010,GO:0004493,1,0.994840067219187,0,1,methylmalonyl-CoA epimerase activity,MF,
2011,GO:0004494,1,0.993759055231672,0,1,methylmalonyl-CoA mutase activity,MF,
2012,GO:0004496,1,0.994217154361847,0,1,mevalonate kinase activity,MF,
2013,GO:0004497,1,0.624289060460361,0,75,monooxygenase activity,MF,
2014,GO:0004498,1,0.994001666357671,0,1,calcidiol 1-monooxygenase activity,MF,
2015,GO:0004499,1,0.969563089574271,0,5,N,N-dimethylaniline monooxygenase activity,MF,
2016,GO:0004500,1,0.987614354836533,0,2,dopamine beta-monooxygenase activity,MF,
2017,GO:0004502,1,0.992694951264887,0,1,kynurenine 3-monooxygenase activity,MF,
2018,GO:0004504,1,0.993366583143387,0,1,peptidylglycine monooxygenase activity,MF,
2019,GO:0004505,1,0.982828008534855,0,3,phenylalanine 4-monooxygenase activity,MF,
2020,GO:0004506,1,0.993743681559409,0,1,squalene monooxygenase activity,MF,
2021,GO:0004509,1,0.994240665882189,0,1,steroid 21-monooxygenase activity,MF,
2022,GO:0004510,1,0.994348172586718,0,1,tryptophan 5-monooxygenase activity,MF,
2023,GO:0004511,1,0.99430371974848,0,1,tyrosine 3-monooxygenase activity,MF,
2024,GO:0004512,1,0.994119278026145,0,1,inositol-3-phosphate synthase activity,MF,
2025,GO:0004513,1,0.994095017703156,0,1,neolactotetraosylceramide alpha-2,3-sialyltransferase activity,MF,
2026,GO:0004514,1,0.981378654988864,0,3,nicotinate-nucleotide diphosphorylase (carboxylating) activity,MF,
2027,GO:0004515,1,0.972740136350404,0,4,nicotinate-nucleotide adenylyltransferase activity,MF,
2028,GO:0004516,1,0.993850639026861,0,1,nicotinate phosphoribosyltransferase activity,MF,
2029,GO:0004517,1,0.978856802771168,0,3,nitric-oxide synthase activity,MF,
2031,GO:0004519,1,0.479129990318494,0,118,endonuclease activity,MF,
2032,GO:0004520,1,0.746035345013058,0,47,endodeoxyribonuclease activity,MF,
2033,GO:0004521,1,0.734134061485581,0,51,endoribonuclease activity,MF,
2034,GO:0004522,1,0.984303016598635,0,3,ribonuclease A activity,MF,
2035,GO:0004523,1,0.966375777714547,0,6,RNA-DNA hybrid ribonuclease activity,MF,
2036,GO:0004525,1,0.971508917925213,0,4,ribonuclease III activity,MF,
2037,GO:0004526,1,0.937875244848831,0,11,ribonuclease P activity,MF,
2040,GO:0004529,1,0.887948310080088,0,19,exodeoxyribonuclease activity,MF,
2041,GO:0004530,1,0.983726160573187,0,2,deoxyribonuclease I activity,MF,
2042,GO:0004531,1,0.988983292588261,0,2,deoxyribonuclease II activity,MF,
2043,GO:0004532,1,0.798625702391938,0,34,exoribonuclease activity,MF,
2044,GO:0004534,1,0.974431012463392,0,3,5'-3' exoribonuclease activity,MF,
2045,GO:0004535,1,0.919592403571865,0,12,poly(A)-specific ribonuclease activity,MF,
2046,GO:0004536,1,0.66708205492154,0,65,deoxyribonuclease activity,MF,
2047,GO:0004540,1,0.555630662041423,0,94,ribonuclease activity,MF,
2048,GO:0004549,1,0.910223863821985,0,16,tRNA-specific ribonuclease activity,MF,
2051,GO:0004553,1,0.620450331194616,0,75,hydrolase activity, hydrolyzing O-glycosyl compounds,MF,
2052,GO:0004556,1,0.988638552446721,0,2,alpha-amylase activity,MF,
2053,GO:0004557,1,0.987957488402557,0,2,alpha-galactosidase activity,MF,
2054,GO:0004558,1,0.978408579250214,0,3,alpha-1,4-glucosidase activity,MF,
2055,GO:0004559,1,0.912981993117067,0,13,alpha-mannosidase activity,MF,
2056,GO:0004560,1,0.988432995636335,0,2,alpha-L-fucosidase activity,MF,
2057,GO:0004561,1,0.993852436935443,0,1,alpha-N-acetylglucosaminidase activity,MF,
2058,GO:0004563,1,0.968934951073339,0,5,beta-N-acetylhexosaminidase activity,MF,
2059,GO:0004565,1,0.964184140702177,0,6,beta-galactosidase activity,MF,
2060,GO:0004566,1,0.981295976078861,0,3,beta-glucuronidase activity,MF,
2061,GO:0004567,1,0.993575274048212,0,1,beta-mannosidase activity,MF,
2062,GO:0004568,1,0.964825097401833,0,6,chitinase activity,MF,
2063,GO:0004569,1,0.992929998766978,0,1,glycoprotein endo-alpha-1,2-mannosidase activity,MF,
2064,GO:0004571,1,0.952400441476239,0,7,mannosyl-oligosaccharide 1,2-alpha-mannosidase activity,MF,
2065,GO:0004572,1,0.984724218964519,0,2,mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity,MF,
2066,GO:0004573,1,0.993878387298871,0,1,mannosyl-oligosaccharide glucosidase activity,MF,
2067,GO:0004574,1,0.993430409369638,0,1,oligo-1,6-glucosidase activity,MF,
2068,GO:0004576,1,0.943611431448448,0,10,oligosaccharyl transferase activity,MF,
2069,GO:0004577,1,0.988491164909683,0,2,N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity,MF,
2070,GO:0004578,1,0.993258423954284,0,1,chitobiosyldiphosphodolichol beta-mannosyltransferase activity,MF,
2071,GO:0004579,1,0.948657364607535,0,9,dolichyl-diphosphooligosaccharide-protein glycotransferase activity,MF,
2072,GO:0004581,1,0.994683800502034,0,1,dolichyl-phosphate beta-glucosyltransferase activity,MF,
2073,GO:0004582,1,0.9843753188457,0,3,dolichyl-phosphate beta-D-mannosyltransferase activity,MF,
2074,GO:0004583,1,0.971993685399598,0,4,dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity,MF,
2075,GO:0004584,1,0.994067669352465,0,1,dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase activity,MF,
2076,GO:0004585,1,0.9944355218544,0,1,ornithine carbamoyltransferase activity,MF,
2077,GO:0004586,1,0.981268787824922,0,3,ornithine decarboxylase activity,MF,
2078,GO:0004587,1,0.994264180212969,0,1,ornithine-oxo-acid transaminase activity,MF,
2079,GO:0004588,1,0.993916185692466,0,1,orotate phosphoribosyltransferase activity,MF,
2080,GO:0004590,1,0.993916185692466,0,1,orotidine-5'-phosphate decarboxylase activity,MF,
2081,GO:0004591,1,0.973955337872753,0,4,oxoglutarate dehydrogenase (succinyl-transferring) activity,MF,
2082,GO:0004594,1,0.975958585782113,0,4,pantothenate kinase activity,MF,
2083,GO:0004595,1,0.994101211145077,0,1,pantetheine-phosphate adenylyltransferase activity,MF,
2084,GO:0004596,1,0.932958379795202,0,11,peptide alpha-N-acetyltransferase activity,MF,
2085,GO:0004597,1,0.993416318359671,0,1,peptide-aspartate beta-dioxygenase activity,MF,
2086,GO:0004598,1,0.993366583143387,0,1,peptidylamidoglycolate lyase activity,MF,
2087,GO:0004601,1,0.798514055055118,0,38,peroxidase activity,MF,
2088,GO:0004602,1,0.916823115591173,0,16,glutathione peroxidase activity,MF,
2089,GO:0004603,1,0.994691808092006,0,1,phenylethanolamine N-methyltransferase activity,MF,
2090,GO:0004605,1,0.980807240649783,0,3,phosphatidate cytidylyltransferase activity,MF,
2091,GO:0004607,1,0.994588478497205,0,1,phosphatidylcholine-sterol O-acyltransferase activity,MF,
2092,GO:0004608,1,0.99477549658101,0,1,phosphatidylethanolamine N-methyltransferase activity,MF,
2093,GO:0004609,1,0.988125855772005,0,2,phosphatidylserine decarboxylase activity,MF,
2094,GO:0004610,1,0.99425513595037,0,1,phosphoacetylglucosamine mutase activity,MF,
2095,GO:0004611,1,0.988208806513195,0,2,phosphoenolpyruvate carboxykinase activity,MF,
2096,GO:0004613,1,0.988208806513195,0,2,phosphoenolpyruvate carboxykinase (GTP) activity,MF,
2097,GO:0004614,1,0.966764692283788,0,5,phosphoglucomutase activity,MF,
2098,GO:0004615,1,0.988742871783852,0,2,phosphomannomutase activity,MF,
2099,GO:0004616,1,0.982017734312111,0,3,phosphogluconate dehydrogenase (decarboxylating) activity,MF,
2100,GO:0004617,1,0.994244283305648,0,1,phosphoglycerate dehydrogenase activity,MF,
2101,GO:0004618,1,0.99403465917182,0,1,phosphoglycerate kinase activity,MF,
2102,GO:0004619,1,0.978137090065443,0,4,phosphoglycerate mutase activity,MF,
2104,GO:0004621,1,0.994105598455397,0,1,glycosylphosphatidylinositol phospholipase D activity,MF,
2106,GO:0004623,1,0.854458313303088,0,26,phospholipase A2 activity,MF,
2107,GO:0004629,1,0.837261845744586,0,26,phospholipase C activity,MF,
2108,GO:0004630,1,0.963448095662413,0,6,phospholipase D activity,MF,
2109,GO:0004631,1,0.994617928806513,0,1,phosphomevalonate kinase activity,MF,
2110,GO:0004632,1,0.994635753434326,0,1,phosphopantothenate--cysteine ligase activity,MF,
2111,GO:0004633,1,0.994141995949336,0,1,phosphopantothenoylcysteine decarboxylase activity,MF,
2112,GO:0004634,1,0.976942291739695,0,4,phosphopyruvate hydratase activity,MF,
2113,GO:0004637,1,0.993511566977563,0,1,phosphoribosylamine-glycine ligase activity,MF,
2114,GO:0004638,1,0.993564017723362,0,1,phosphoribosylaminoimidazole carboxylase activity,MF,
2115,GO:0004639,1,0.993564017723362,0,1,phosphoribosylaminoimidazolesuccinocarboxamide synthase activity,MF,
2116,GO:0004641,1,0.993511566977563,0,1,phosphoribosylformylglycinamidine cyclo-ligase activity,MF,
2117,GO:0004642,1,0.992494270918822,0,1,phosphoribosylformylglycinamidine synthase activity,MF,
2118,GO:0004643,1,0.994204495715103,0,1,phosphoribosylaminoimidazolecarboxamide formyltransferase activity,MF,
2119,GO:0004644,1,0.993511566977563,0,1,phosphoribosylglycinamide formyltransferase activity,MF,
2120,GO:0004645,1,0.96211129822612,0,6,phosphorylase activity,MF,
2121,GO:0004647,1,0.982983841214476,0,3,phosphoserine phosphatase activity,MF,
2122,GO:0004648,1,0.994192871409988,0,1,O-phospho-L-serine:2-oxoglutarate aminotransferase activity,MF,
2123,GO:0004649,1,0.987544135057742,0,2,poly(ADP-ribose) glycohydrolase activity,MF,
2124,GO:0004651,1,0.987460852684589,0,2,polynucleotide 5'-phosphatase activity,MF,
2125,GO:0004652,1,0.939162995597379,0,9,polynucleotide adenylyltransferase activity,MF,
2126,GO:0004653,1,0.883798795614559,0,19,polypeptide N-acetylgalactosaminyltransferase activity,MF,
2127,GO:0004654,1,0.992915409932579,0,1,polyribonucleotide nucleotidyltransferase activity,MF,
2128,GO:0004655,1,0.99364332663567,0,1,porphobilinogen synthase activity,MF,
2129,GO:0004656,1,0.976223145691775,0,4,procollagen-proline 4-dioxygenase activity,MF,
2130,GO:0004657,1,0.994141995949336,0,1,proline dehydrogenase activity,MF,
2131,GO:0004658,1,0.98839185135006,0,2,propionyl-CoA carboxylase activity,MF,
2132,GO:0004659,1,0.908754735767884,0,15,prenyltransferase activity,MF,
2133,GO:0004660,1,0.988324006377566,0,2,protein farnesyltransferase activity,MF,
2134,GO:0004661,1,0.970566799607665,0,5,protein geranylgeranyltransferase activity,MF,
2135,GO:0004662,1,0.988372542225911,0,2,CAAX-protein geranylgeranyltransferase activity,MF,
2136,GO:0004663,1,0.976546014628731,0,4,Rab geranylgeranyltransferase activity,MF,
2137,GO:0004666,1,0.985705740798015,0,2,prostaglandin-endoperoxide synthase activity,MF,
2139,GO:0004668,1,0.980907620431613,0,3,protein-arginine deiminase activity,MF,
2140,GO:0004671,1,0.992805302927398,0,1,protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity,MF,
2142,GO:0004673,1,0.953512668537238,0,7,protein histidine kinase activity,MF,
2144,GO:0004675,1,0.891225751700363,0,15,transmembrane receptor protein serine/threonine kinase activity,MF,
2145,GO:0004676,1,0.991634688083401,0,1,3-phosphoinositide-dependent protein kinase activity,MF,
2146,GO:0004677,1,0.97195260183414,0,3,DNA-dependent protein kinase activity,MF,
2147,GO:0004679,1,0.952685258777369,0,7,AMP-activated protein kinase activity,MF,
2148,GO:0004683,1,0.829592154497964,0,28,calmodulin-dependent protein kinase activity,MF,
2149,GO:0004686,1,0.991441392775275,0,1,elongation factor-2 kinase activity,MF,
2150,GO:0004687,1,0.969010837400301,0,4,myosin light chain kinase activity,MF,
2151,GO:0004689,1,0.965329559553525,0,5,phosphorylase kinase activity,MF,
2152,GO:0004690,1,0.942886859620584,0,8,cyclic nucleotide-dependent protein kinase activity,MF,
2153,GO:0004691,1,0.955381595961,0,6,cAMP-dependent protein kinase activity,MF,
2154,GO:0004692,1,0.986927718228593,0,2,cGMP-dependent protein kinase activity,MF,
2156,GO:0004694,1,0.972466363555407,0,4,eukaryotic translation initiation factor 2alpha kinase activity,MF,
2157,GO:0004697,1,0.900696942928286,0,15,protein kinase C activity,MF,
2158,GO:0004698,1,0.977092669043254,0,3,calcium-dependent protein kinase C activity,MF,
2159,GO:0004699,1,0.979890309623107,0,3,calcium-independent protein kinase C activity,MF,
2161,GO:0004703,1,0.976276226283329,0,4,G-protein coupled receptor kinase activity,MF,
2162,GO:0004704,1,0.967837626599699,0,5,NF-kappaB-inducing kinase activity,MF,
2163,GO:0004705,1,0.980972705996286,0,3,JUN kinase activity,MF,
2164,GO:0004706,1,0.979489597389888,0,3,JUN kinase kinase kinase activity,MF,
2165,GO:0004707,1,0.915353885914742,0,14,MAP kinase activity,MF,
2166,GO:0004708,1,0.907117320358281,0,15,MAP kinase kinase activity,MF,
2168,GO:0004711,1,0.949925181262709,0,7,ribosomal protein S6 kinase activity,MF,
2169,GO:0004712,1,0.762032192557798,0,41,protein serine/threonine/tyrosine kinase activity,MF,
2172,GO:0004715,1,0.726217724123977,0,49,non-membrane spanning protein tyrosine kinase activity,MF,
2173,GO:0004716,1,0.932990408953187,0,9,signal transducer, downstream of receptor, with protein tyrosine kinase activity,MF,
2174,GO:0004719,1,0.9809374465674,0,3,protein-L-isoaspartate (D-aspartate) O-methyltransferase activity,MF,
2175,GO:0004720,1,0.962190355768366,0,6,protein-lysine 6-oxidase activity,MF,
2176,GO:0004721,1,0.325989406250544,0,166,phosphoprotein phosphatase activity,MF,
2177,GO:0004722,1,0.649383345580949,0,66,protein serine/threonine phosphatase activity,MF,
2178,GO:0004723,1,0.952528954123702,0,7,calcium-dependent protein serine/threonine phosphatase activity,MF,
2179,GO:0004725,1,0.525246103962581,0,94,protein tyrosine phosphatase activity,MF,
2180,GO:0004726,1,0.949944655099365,0,8,non-membrane spanning protein tyrosine phosphatase activity,MF,
2181,GO:0004727,1,0.988877457047156,0,2,prenylated protein tyrosine phosphatase activity,MF,
2182,GO:0004728,1,0.993950154352162,0,1,signal transducer, downstream of receptor, with protein tyrosine phosphatase activity,MF,
2183,GO:0004729,1,0.9943866804482,0,1,oxygen-dependent protoporphyrinogen oxidase activity,MF,
2184,GO:0004730,1,0.994427252745907,0,1,pseudouridylate synthase activity,MF,
2185,GO:0004731,1,0.98683246185258,0,2,purine-nucleoside phosphorylase activity,MF,
2186,GO:0004733,1,0.993501586459489,0,1,pyridoxamine-phosphate oxidase activity,MF,
2187,GO:0004735,1,0.988756745969677,0,2,pyrroline-5-carboxylate reductase activity,MF,
2188,GO:0004736,1,0.993216697803711,0,1,pyruvate carboxylase activity,MF,
2189,GO:0004738,1,0.968828422360119,0,5,pyruvate dehydrogenase activity,MF,
2190,GO:0004739,1,0.98807498407868,0,2,pyruvate dehydrogenase (acetyl-transferring) activity,MF,
2191,GO:0004740,1,0.972208335078993,0,4,pyruvate dehydrogenase (acetyl-transferring) kinase activity,MF,
2192,GO:0004741,1,0.977725724076293,0,3,[pyruvate dehydrogenase (lipoamide)] phosphatase activity,MF,
2193,GO:0004742,1,0.993044926389318,0,1,dihydrolipoyllysine-residue acetyltransferase activity,MF,
2194,GO:0004743,1,0.987609494346041,0,2,pyruvate kinase activity,MF,
2195,GO:0004744,1,0.993936769823406,0,1,retinal isomerase activity,MF,
2196,GO:0004745,1,0.932420535144097,0,12,retinol dehydrogenase activity,MF,
2197,GO:0004747,1,0.994669076685369,0,1,ribokinase activity,MF,
2199,GO:0004749,1,0.976730973393992,0,4,ribose phosphate diphosphokinase activity,MF,
2200,GO:0004750,1,0.994100695006548,0,1,ribulose-phosphate 3-epimerase activity,MF,
2201,GO:0004751,1,0.994339385337794,0,1,ribose-5-phosphate isomerase activity,MF,
2202,GO:0004753,1,0.992242171349954,0,1,saccharopine dehydrogenase activity,MF,
2203,GO:0004756,1,0.988100047207082,0,2,selenide, water dikinase activity,MF,
2204,GO:0004757,1,0.994535774822685,0,1,sepiapterin reductase activity,MF,
2205,GO:0004758,1,0.96728964051189,0,5,serine C-palmitoyltransferase activity,MF,
2206,GO:0004760,1,0.994460328392633,0,1,serine-pyruvate transaminase activity,MF,
2207,GO:0004766,1,0.994629295282871,0,1,spermidine synthase activity,MF,
2208,GO:0004767,1,0.968696016647049,0,5,sphingomyelin phosphodiesterase activity,MF,
2209,GO:0004768,1,0.980203054126795,0,3,stearoyl-CoA 9-desaturase activity,MF,
2210,GO:0004769,1,0.994691808092006,0,1,steroid delta-isomerase activity,MF,
2211,GO:0004771,1,0.950643254887536,0,8,sterol esterase activity,MF,
2212,GO:0004772,1,0.993533828399082,0,1,sterol O-acyltransferase activity,MF,
2213,GO:0004773,1,0.991984906615182,0,1,steryl-sulfatase activity,MF,
2214,GO:0004774,1,0.982870495711753,0,3,succinate-CoA ligase activity,MF,
2215,GO:0004775,1,0.988733085993195,0,2,succinate-CoA ligase (ADP-forming) activity,MF,
2216,GO:0004776,1,0.98863707106701,0,2,succinate-CoA ligase (GDP-forming) activity,MF,
2217,GO:0004777,1,0.992626349998796,0,1,succinate-semialdehyde dehydrogenase (NAD+) activity,MF,
2218,GO:0004778,1,0.994447408466218,0,1,succinyl-CoA hydrolase activity,MF,
2219,GO:0004779,1,0.987313897203346,0,2,sulfate adenylyltransferase activity,MF,
2220,GO:0004781,1,0.987313897203346,0,2,sulfate adenylyltransferase (ATP) activity,MF,
2221,GO:0004782,1,0.993890983044866,0,1,sulfinoalanine decarboxylase activity,MF,
2222,GO:0004784,1,0.973100148343786,0,5,superoxide dismutase activity,MF,
2223,GO:0004788,1,0.994069217099096,0,1,thiamine diphosphokinase activity,MF,
2224,GO:0004790,1,0.993967662710193,0,1,thioether S-methyltransferase activity,MF,
2225,GO:0004791,1,0.954658195525713,0,8,thioredoxin-disulfide reductase activity,MF,
2226,GO:0004792,1,0.983347010921655,0,3,thiosulfate sulfurtransferase activity,MF,
2227,GO:0004793,1,0.988183553597633,0,2,threonine aldolase activity,MF,
2228,GO:0004794,1,0.989053817812553,0,2,L-threonine ammonia-lyase activity,MF,
2229,GO:0004795,1,0.99419571281523,0,1,threonine synthase activity,MF,
2230,GO:0004796,1,0.994197004383004,0,1,thromboxane-A synthase activity,MF,
2231,GO:0004797,1,0.987183581247239,0,2,thymidine kinase activity,MF,
2232,GO:0004798,1,0.988480665307055,0,2,thymidylate kinase activity,MF,
2233,GO:0004799,1,0.994469630547694,0,1,thymidylate synthase activity,MF,
2234,GO:0004800,1,0.986233311339442,0,2,thyroxine 5'-deiodinase activity,MF,
2235,GO:0004801,1,0.994645311402824,0,1,sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity,MF,
2236,GO:0004802,1,0.988157608782538,0,2,transketolase activity,MF,
2237,GO:0004803,1,0.993207931629791,0,1,transposase activity,MF,
2238,GO:0004806,1,0.894116695904346,0,18,triglyceride lipase activity,MF,
2239,GO:0004807,1,0.994534224649968,0,1,triose-phosphate isomerase activity,MF,
2240,GO:0004809,1,0.982389300420735,0,3,tRNA (guanine-N2-)-methyltransferase activity,MF,
2241,GO:0004810,1,0.994112567016873,0,1,tRNA adenylyltransferase activity,MF,
2242,GO:0004812,1,0.761712277817398,0,44,aminoacyl-tRNA ligase activity,MF,
2243,GO:0004813,1,0.98079845812021,0,3,alanine-tRNA ligase activity,MF,
2244,GO:0004814,1,0.982741706072032,0,3,arginine-tRNA ligase activity,MF,
2245,GO:0004815,1,0.987676725744408,0,2,aspartate-tRNA ligase activity,MF,
2246,GO:0004816,1,0.987952598466086,0,2,asparagine-tRNA ligase activity,MF,
2247,GO:0004817,1,0.988274750368456,0,2,cysteine-tRNA ligase activity,MF,
2248,GO:0004818,1,0.986003498118143,0,2,glutamate-tRNA ligase activity,MF,
2249,GO:0004819,1,0.986838967933285,0,2,glutamine-tRNA ligase activity,MF,
2250,GO:0004820,1,0.988361828813511,0,2,glycine-tRNA ligase activity,MF,
2251,GO:0004821,1,0.988302739878687,0,2,histidine-tRNA ligase activity,MF,
2252,GO:0004822,1,0.986474276544419,0,2,isoleucine-tRNA ligase activity,MF,
2253,GO:0004823,1,0.98593552586905,0,2,leucine-tRNA ligase activity,MF,
2254,GO:0004824,1,0.994198037646091,0,1,lysine-tRNA ligase activity,MF,
2255,GO:0004825,1,0.987604115609127,0,2,methionine-tRNA ligase activity,MF,
2256,GO:0004826,1,0.970777300741337,0,5,phenylalanine-tRNA ligase activity,MF,
2257,GO:0004827,1,0.981580795700484,0,3,proline-tRNA ligase activity,MF,
2258,GO:0004828,1,0.988556053337997,0,2,serine-tRNA ligase activity,MF,
2259,GO:0004829,1,0.981563891569853,0,3,threonine-tRNA ligase activity,MF,
2260,GO:0004830,1,0.987768356487674,0,2,tryptophan-tRNA ligase activity,MF,
2261,GO:0004831,1,0.987885545397964,0,2,tyrosine-tRNA ligase activity,MF,
2262,GO:0004832,1,0.979396215427501,0,3,valine-tRNA ligase activity,MF,
2263,GO:0004833,1,0.988917111597875,0,2,tryptophan 2,3-dioxygenase activity,MF,
2264,GO:0004835,1,0.992623206713884,0,1,tubulin-tyrosine ligase activity,MF,
2265,GO:0004838,1,0.993861170812666,0,1,L-tyrosine:2-oxoglutarate aminotransferase activity,MF,
2266,GO:0004839,1,0.966145736068116,0,5,ubiquitin activating enzyme activity,MF,
2268,GO:0004843,1,0.610975936265375,0,70,thiol-dependent ubiquitin-specific protease activity,MF,
2269,GO:0004844,1,0.971710565481844,0,5,uracil DNA N-glycosylase activity,MF,
2270,GO:0004849,1,0.97129200608692,0,5,uridine kinase activity,MF,
2271,GO:0004850,1,0.98842826819611,0,2,uridine phosphorylase activity,MF,
2272,GO:0004852,1,0.994586928447688,0,1,uroporphyrinogen-III synthase activity,MF,
2273,GO:0004853,1,0.994571427762706,0,1,uroporphyrinogen decarboxylase activity,MF,
2274,GO:0004854,1,0.98509875160187,0,2,xanthine dehydrogenase activity,MF,
2275,GO:0004855,1,0.992315508269107,0,1,xanthine oxidase activity,MF,
2276,GO:0004856,1,0.993383253115219,0,1,xylulokinase activity,MF,
2278,GO:0004859,1,0.95641790579393,0,8,phospholipase inhibitor activity,MF,
2280,GO:0004861,1,0.930643541577409,0,12,cyclin-dependent protein serine/threonine kinase inhibitor activity,MF,
2285,GO:0004867,1,0.687386327988799,0,60,serine-type endopeptidase inhibitor activity,MF,
2288,GO:0004873,1,0.989093910874574,0,2,asialoglycoprotein receptor activity,MF,
2289,GO:0004874,1,0.984922493619707,0,2,aryl hydrocarbon receptor activity,MF,
2290,GO:0004875,1,0.956370762099166,0,7,complement receptor activity,MF,
2291,GO:0004876,1,0.994279943800713,0,1,complement component C3a receptor activity,MF,
2292,GO:0004877,1,0.990458391802756,0,1,complement component C3b receptor activity,MF,
2293,GO:0004878,1,0.987967242366608,0,2,complement component C5a receptor activity,MF,
2294,GO:0004879,1,0.736753392628785,0,45,nuclear receptor activity,MF,
2295,GO:0004882,1,0.987356431985732,0,2,androgen receptor activity,MF,
2296,GO:0004883,1,0.991861238675255,0,1,glucocorticoid receptor activity,MF,
2297,GO:0004886,1,0.981004079570258,0,3,9-cis retinoic acid receptor activity,MF,
2298,GO:0004887,1,0.960800321705678,0,6,thyroid hormone receptor activity,MF,
2300,GO:0004890,1,0.896426743673519,0,16,GABA-A receptor activity,MF,
2301,GO:0004896,1,0.593537428200963,0,82,cytokine receptor activity,MF,
2302,GO:0004897,1,0.971380880578924,0,4,ciliary neurotrophic factor receptor activity,MF,
2303,GO:0004900,1,0.994332148773286,0,1,erythropoietin receptor activity,MF,
2304,GO:0004904,1,0.969245241848074,0,5,interferon receptor activity,MF,
2305,GO:0004905,1,0.986732654593659,0,2,type I interferon receptor activity,MF,
2306,GO:0004906,1,0.988366233040505,0,2,interferon-gamma receptor activity,MF,
2307,GO:0004908,1,0.957026159417939,0,7,interleukin-1 receptor activity,MF,
2308,GO:0004909,1,0.987065293711644,0,2,interleukin-1, Type I, activating receptor activity,MF,
2309,GO:0004910,1,0.988327155968196,0,2,interleukin-1, Type II, blocking receptor activity,MF,
2310,GO:0004911,1,0.981439606113969,0,3,interleukin-2 receptor activity,MF,
2311,GO:0004912,1,0.992784399618236,0,1,interleukin-3 receptor activity,MF,
2312,GO:0004913,1,0.98858109815253,0,2,interleukin-4 receptor activity,MF,
2313,GO:0004914,1,0.987069283964201,0,2,interleukin-5 receptor activity,MF,
2314,GO:0004915,1,0.986840937734787,0,2,interleukin-6 receptor activity,MF,
2315,GO:0004917,1,0.988881122898615,0,2,interleukin-7 receptor activity,MF,
2316,GO:0004918,1,0.987904668026335,0,2,interleukin-8 receptor activity,MF,
2317,GO:0004920,1,0.968561732768944,0,5,interleukin-10 receptor activity,MF,
2318,GO:0004921,1,0.993639232728281,0,1,interleukin-11 receptor activity,MF,
2319,GO:0004923,1,0.9837194003714,0,2,leukemia inhibitory factor receptor activity,MF,
2320,GO:0004924,1,0.977235028162721,0,3,oncostatin-M receptor activity,MF,
2321,GO:0004925,1,0.989201170485872,0,1,prolactin receptor activity,MF,
2323,GO:0004931,1,0.959510851601509,0,7,extracellularly ATP-gated cation channel activity,MF,
2324,GO:0004935,1,0.941737681481574,0,10,adrenergic receptor activity,MF,
2325,GO:0004936,1,0.97013464278465,0,5,alpha-adrenergic receptor activity,MF,
2326,GO:0004937,1,0.982303756431887,0,3,alpha1-adrenergic receptor activity,MF,
2327,GO:0004938,1,0.987613880410145,0,2,alpha2-adrenergic receptor activity,MF,
2328,GO:0004939,1,0.982081324541278,0,3,beta-adrenergic receptor activity,MF,
2329,GO:0004940,1,0.993813929007734,0,1,beta1-adrenergic receptor activity,MF,
2330,GO:0004941,1,0.99423601500725,0,1,beta2-adrenergic receptor activity,MF,
2331,GO:0004945,1,0.9835602541253,0,3,angiotensin type II receptor activity,MF,
2332,GO:0004947,1,0.987788039074515,0,2,bradykinin receptor activity,MF,
2333,GO:0004948,1,0.986176658124544,0,2,calcitonin receptor activity,MF,
2334,GO:0004949,1,0.980104010988605,0,3,cannabinoid receptor activity,MF,
2335,GO:0004950,1,0.865940592427586,0,24,chemokine receptor activity,MF,
2336,GO:0004951,1,0.988645223297408,0,2,cholecystokinin receptor activity,MF,
2337,GO:0004952,1,0.960004472512473,0,7,dopamine neurotransmitter receptor activity,MF,
2338,GO:0004953,1,0.902746520947085,0,17,icosanoid receptor activity,MF,
2339,GO:0004954,1,0.934980055780595,0,11,prostanoid receptor activity,MF,
2340,GO:0004955,1,0.940517554723539,0,10,prostaglandin receptor activity,MF,
2341,GO:0004956,1,0.987660423643538,0,2,prostaglandin D receptor activity,MF,
2342,GO:0004957,1,0.964518309579609,0,6,prostaglandin E receptor activity,MF,
2343,GO:0004958,1,0.986397897725783,0,2,prostaglandin F receptor activity,MF,
2344,GO:0004960,1,0.99411592245597,0,1,thromboxane receptor activity,MF,
2345,GO:0004961,1,0.99411592245597,0,1,thromboxane A2 receptor activity,MF,
2346,GO:0004962,1,0.986444046651459,0,2,endothelin receptor activity,MF,
2347,GO:0004965,1,0.978607422409606,0,3,G-protein coupled GABA receptor activity,MF,
2348,GO:0004966,1,0.944785021549438,0,10,galanin receptor activity,MF,
2349,GO:0004967,1,0.988134136806225,0,2,glucagon receptor activity,MF,
2350,GO:0004968,1,0.993100412628746,0,1,gonadotropin-releasing hormone receptor activity,MF,
2351,GO:0004969,1,0.969191969771134,0,5,histamine receptor activity,MF,
2352,GO:0004970,1,0.866266472008553,0,19,ionotropic glutamate receptor activity,MF,
2353,GO:0004971,1,0.970566070590581,0,4,AMPA glutamate receptor activity,MF,
2354,GO:0004972,1,0.944546243006877,0,7,NMDA glutamate receptor activity,MF,
2355,GO:0004974,1,0.965547907791118,0,6,leukotriene receptor activity,MF,
2356,GO:0004977,1,0.977540275739841,0,4,melanocortin receptor activity,MF,
2357,GO:0004979,1,0.994324912224097,0,1,beta-endorphin receptor activity,MF,
2358,GO:0004980,1,0.988273659901915,0,2,melanocyte-stimulating hormone receptor activity,MF,
2359,GO:0004982,1,0.982973823289316,0,3,N-formyl peptide receptor activity,MF,
2360,GO:0004983,1,0.952596020842229,0,8,neuropeptide Y receptor activity,MF,
2361,GO:0004984,1,0.91108520348435,0,17,olfactory receptor activity,MF,
2362,GO:0004985,1,0.954016977892055,0,8,opioid receptor activity,MF,
2363,GO:0004990,1,0.993042850013084,0,1,oxytocin receptor activity,MF,
2364,GO:0004991,1,0.98810692542047,0,2,parathyroid hormone receptor activity,MF,
2365,GO:0004992,1,0.980121540737571,0,3,platelet activating factor receptor activity,MF,
2366,GO:0004993,1,0.925520427488083,0,13,G-protein coupled serotonin receptor activity,MF,
2367,GO:0004994,1,0.976012207550872,0,4,somatostatin receptor activity,MF,
2368,GO:0004995,1,0.982139366807935,0,3,tachykinin receptor activity,MF,
2369,GO:0004996,1,0.987974264394164,0,2,thyroid-stimulating hormone receptor activity,MF,
2370,GO:0004998,1,0.986456530043594,0,2,transferrin receptor activity,MF,
2371,GO:0004999,1,0.98164243452937,0,3,vasoactive intestinal polypeptide receptor activity,MF,
2372,GO:0005000,1,0.968572188965201,0,5,vasopressin receptor activity,MF,
2373,GO:0005001,1,0.884408240424484,0,16,transmembrane receptor protein tyrosine phosphatase activity,MF,
2374,GO:0005003,1,0.878664642804338,0,19,ephrin receptor activity,MF,
2375,GO:0005004,1,0.950480807378019,0,7,GPI-linked ephrin receptor activity,MF,
2376,GO:0005005,1,0.889563207979447,0,17,transmembrane-ephrin receptor activity,MF,
2377,GO:0005006,1,0.987880813656304,0,2,epidermal growth factor-activated receptor activity,MF,
2379,GO:0005008,1,0.991836733701099,0,1,hepatocyte growth factor-activated receptor activity,MF,
2380,GO:0005009,1,0.990597405678448,0,1,insulin-activated receptor activity,MF,
2381,GO:0005010,1,0.966004742560603,0,4,insulin-like growth factor-activated receptor activity,MF,
2382,GO:0005011,1,0.986093551922264,0,2,macrophage colony-stimulating factor receptor activity,MF,
2385,GO:0005019,1,0.986878122745589,0,2,platelet-derived growth factor beta-receptor activity,MF,
2386,GO:0005020,1,0.992611156593489,0,1,stem cell factor receptor activity,MF,
2388,GO:0005024,1,0.942885936331252,0,8,transforming growth factor beta-activated receptor activity,MF,
2389,GO:0005025,1,0.971599093222072,0,4,transforming growth factor beta receptor activity, type I,MF,
2390,GO:0005026,1,0.992882043020951,0,1,transforming growth factor beta receptor activity, type II,MF,
2391,GO:0005030,1,0.971278853392056,0,4,neurotrophin receptor activity,MF,
2392,GO:0005031,1,0.866234864187251,0,24,tumor necrosis factor-activated receptor activity,MF,
2393,GO:0005034,1,0.993659447561876,0,1,osmosensor activity,MF,
2394,GO:0005035,1,0.866234864187251,0,24,death receptor activity,MF,
2395,GO:0005041,1,0.899489918420192,0,13,low-density lipoprotein particle receptor activity,MF,
2396,GO:0005042,1,0.955544255717299,0,6,netrin receptor activity,MF,
2398,GO:0005046,1,0.988395147577064,0,2,KDEL sequence binding,MF,
2400,GO:0005048,1,0.772102113857469,0,39,signal sequence binding,MF,
2401,GO:0005049,1,0.942354705811476,0,8,nuclear export signal receptor activity,MF,
2402,GO:0005052,1,0.987128308335157,0,2,peroxisome matrix targeting signal-1 binding,MF,
2403,GO:0005053,1,0.994520789657335,0,1,peroxisome matrix targeting signal-2 binding,MF,
2404,GO:0005055,1,0.988768607776855,0,2,laminin receptor activity,MF,
2406,GO:0005068,1,0.92532406533555,0,11,transmembrane receptor protein tyrosine kinase adaptor activity,MF,
2407,GO:0005070,1,0.689692279868918,0,57,SH3/SH2 adaptor activity,MF,
2408,GO:0005072,1,0.928300906830515,0,10,transforming growth factor beta receptor, cytoplasmic mediator activity,MF,
2409,GO:0005078,1,0.945913454862386,0,7,MAP-kinase scaffold activity,MF,
2412,GO:0005086,1,0.8621045897057,0,20,ARF guanyl-nucleotide exchange factor activity,MF,
2413,GO:0005087,1,0.977216685946911,0,4,Ran guanyl-nucleotide exchange factor activity,MF,
2415,GO:0005089,1,0.563134311954211,0,76,Rho guanyl-nucleotide exchange factor activity,MF,
2416,GO:0005090,1,0.994168334678561,0,1,Sar guanyl-nucleotide exchange factor activity,MF,
2417,GO:0005092,1,0.91712535149697,0,14,GDP-dissociation inhibitor activity,MF,
2418,GO:0005093,1,0.988114816674851,0,2,Rab GDP-dissociation inhibitor activity,MF,
2419,GO:0005094,1,0.983874086769884,0,3,Rho GDP-dissociation inhibitor activity,MF,
2420,GO:0005095,1,0.911261966851588,0,14,GTPase inhibitor activity,MF,
2424,GO:0005105,1,0.983368894794878,0,3,type 1 fibroblast growth factor receptor binding,MF,
2425,GO:0005109,1,0.809697924236851,0,33,frizzled binding,MF,
2426,GO:0005111,1,0.98421304368714,0,3,type 2 fibroblast growth factor receptor binding,MF,
2427,GO:0005112,1,0.855672661309511,0,21,Notch binding,MF,
2428,GO:0005113,1,0.955863033177669,0,7,patched binding,MF,
2429,GO:0005114,1,0.953371748196995,0,7,type II transforming growth factor beta receptor binding,MF,
2430,GO:0005115,1,0.992268880590988,0,1,receptor tyrosine kinase-like orphan receptor binding,MF,
2431,GO:0005119,1,0.978131774031967,0,3,smoothened binding,MF,
2432,GO:0005123,1,0.904821488038851,0,16,death receptor binding,MF,
2433,GO:0005124,1,0.977324658761311,0,4,scavenger receptor binding,MF,
2437,GO:0005128,1,0.988238495758664,0,2,erythropoietin receptor binding,MF,
2438,GO:0005130,1,0.994504770623119,0,1,granulocyte colony-stimulating factor receptor binding,MF,
2439,GO:0005131,1,0.972734407924902,0,4,growth hormone receptor binding,MF,
2440,GO:0005134,1,0.982045536900563,0,3,interleukin-2 receptor binding,MF,
2441,GO:0005135,1,0.993601879672073,0,1,interleukin-3 receptor binding,MF,
2442,GO:0005136,1,0.988090965920187,0,2,interleukin-4 receptor binding,MF,
2443,GO:0005137,1,0.994168851188967,0,1,interleukin-5 receptor binding,MF,
2444,GO:0005138,1,0.957381081592351,0,7,interleukin-6 receptor binding,MF,
2445,GO:0005139,1,0.988240600921169,0,2,interleukin-7 receptor binding,MF,
2446,GO:0005141,1,0.994446891662628,0,1,interleukin-10 receptor binding,MF,
2447,GO:0005142,1,0.994072312693583,0,1,interleukin-11 receptor binding,MF,
2448,GO:0005143,1,0.981469293962289,0,3,interleukin-12 receptor binding,MF,
2449,GO:0005144,1,0.99462671200744,0,1,interleukin-13 receptor binding,MF,
2450,GO:0005146,1,0.98773848974652,0,2,leukemia inhibitory factor receptor binding,MF,
2451,GO:0005147,1,0.994327496702936,0,1,oncostatin-M receptor binding,MF,
2452,GO:0005149,1,0.932619048370918,0,11,interleukin-1 receptor binding,MF,
2453,GO:0005150,1,0.987835362829205,0,2,interleukin-1, Type I receptor binding,MF,
2454,GO:0005151,1,0.986934954578378,0,2,interleukin-1, Type II receptor binding,MF,
2455,GO:0005152,1,0.986159906248676,0,2,interleukin-1 receptor antagonist activity,MF,
2456,GO:0005153,1,0.987565219207443,0,2,interleukin-8 receptor binding,MF,
2457,GO:0005154,1,0.819629569773398,0,29,epidermal growth factor receptor binding,MF,
2458,GO:0005157,1,0.983004950759239,0,3,macrophage colony-stimulating factor receptor binding,MF,
2459,GO:0005158,1,0.851058943177588,0,21,insulin receptor binding,MF,
2460,GO:0005159,1,0.914030144650399,0,13,insulin-like growth factor receptor binding,MF,
2461,GO:0005160,1,0.74938993851284,0,45,transforming growth factor beta receptor binding,MF,
2463,GO:0005163,1,0.99474760112013,0,1,nerve growth factor receptor binding,MF,
2464,GO:0005164,1,0.843566459478049,0,29,tumor necrosis factor receptor binding,MF,
2465,GO:0005165,1,0.929935853113602,0,11,neurotrophin receptor binding,MF,
2466,GO:0005166,1,0.983431798112075,0,3,neurotrophin p75 receptor binding,MF,
2467,GO:0005167,1,0.945637760641088,0,8,neurotrophin TRK receptor binding,MF,
2468,GO:0005168,1,0.95710043068056,0,6,neurotrophin TRKA receptor binding,MF,
2469,GO:0005169,1,0.980649858043183,0,3,neurotrophin TRKB receptor binding,MF,
2470,GO:0005170,1,0.992532541703704,0,1,neurotrophin TRKC receptor binding,MF,
2471,GO:0005171,1,0.988514939342923,0,2,hepatocyte growth factor receptor binding,MF,
2472,GO:0005172,1,0.937784740866338,0,10,vascular endothelial growth factor receptor binding,MF,
2473,GO:0005173,1,0.977291482839287,0,3,stem cell factor receptor binding,MF,
2474,GO:0005174,1,0.988484433452412,0,2,CD40 receptor binding,MF,
2475,GO:0005175,1,0.994941826221461,0,1,CD27 receptor binding,MF,
2476,GO:0005176,1,0.981873519912003,0,3,ErbB-2 class receptor binding,MF,
2479,GO:0005183,1,0.989512533448496,0,2,gonadotropin hormone-releasing hormone activity,MF,
2482,GO:0005199,1,0.993551226077652,0,1,structural constituent of cell wall,MF,
2485,GO:0005212,1,0.932277824389104,0,13,structural constituent of eye lens,MF,
2488,GO:0005217,1,0.792712631548388,0,30,intracellular ligand-gated ion channel activity,MF,
2489,GO:0005219,1,0.956949630610336,0,4,ryanodine-sensitive calcium-release channel activity,MF,
2490,GO:0005220,1,0.969715767677729,0,3,inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,MF,
2491,GO:0005221,1,0.9475416711266,0,8,intracellular cyclic nucleotide activated cation channel activity,MF,
2492,GO:0005222,1,0.953391802790616,0,7,intracellular cAMP activated cation channel activity,MF,
2493,GO:0005223,1,0.969110697894625,0,5,intracellular cGMP activated cation channel activity,MF,
2494,GO:0005225,1,0.93290273432364,0,10,volume-sensitive anion channel activity,MF,
2495,GO:0005227,1,0.851207499058568,0,25,calcium activated cation channel activity,MF,
2496,GO:0005228,1,0.985090225396369,0,2,intracellular sodium activated potassium channel activity,MF,
2497,GO:0005229,1,0.886965397711632,0,18,intracellular calcium activated chloride channel activity,MF,
2498,GO:0005230,1,0.638418574447651,0,67,extracellular ligand-gated ion channel activity,MF,
2499,GO:0005231,1,0.734374512811004,0,46,excitatory extracellular ligand-gated ion channel activity,MF,
2500,GO:0005234,1,0.866880420834834,0,19,extracellularly glutamate-gated ion channel activity,MF,
2501,GO:0005237,1,0.902780004713904,0,15,inhibitory extracellular ligand-gated ion channel activity,MF,
2502,GO:0005242,1,0.880306299647133,0,20,inward rectifier potassium channel activity,MF,
2503,GO:0005243,1,0.938658815344622,0,10,gap junction channel activity,MF,
2504,GO:0005244,1,0.289938294804779,0,179,voltage-gated ion channel activity,MF,
2505,GO:0005245,1,0.740116438179573,0,41,voltage-gated calcium channel activity,MF,
2506,GO:0005246,1,0.823700917821746,0,30,calcium channel regulator activity,MF,
2507,GO:0005247,1,0.938369020376719,0,9,voltage-gated chloride channel activity,MF,
2508,GO:0005248,1,0.831097782861353,0,23,voltage-gated sodium channel activity,MF,
2509,GO:0005249,1,0.57618378954305,0,84,voltage-gated potassium channel activity,MF,
2510,GO:0005250,1,0.97359868878774,0,4,A-type (transient outward) potassium channel activity,MF,
2511,GO:0005251,1,0.843372064043487,0,26,delayed rectifier potassium channel activity,MF,
2512,GO:0005252,1,0.993240402415367,0,1,open rectifier potassium channel activity,MF,
2515,GO:0005260,1,0.992104559503058,0,1,intracellularly ATP-gated chloride channel activity,MF,
2516,GO:0005261,1,0.137572880060614,0,285,cation channel activity,MF,
2517,GO:0005262,1,0.435548704979983,0,112,calcium channel activity,MF,
2518,GO:0005267,1,0.472337664106007,0,116,potassium channel activity,MF,
2519,GO:0005272,1,0.725283668000977,0,43,sodium channel activity,MF,
2520,GO:0005275,1,0.988033492997947,0,2,amine transmembrane transporter activity,MF,
2521,GO:0005277,1,0.988065605081576,0,2,acetylcholine transmembrane transporter activity,MF,
2522,GO:0005280,1,0.974573537128445,0,4,amino acid:proton symporter activity,MF,
2523,GO:0005283,1,0.891386586730548,0,17,amino acid:sodium symporter activity,MF,
2524,GO:0005287,1,0.98548197293903,0,2,high-affinity basic amino acid transmembrane transporter activity,MF,
2525,GO:0005289,1,0.98548197293903,0,2,high-affinity arginine transmembrane transporter activity,MF,
2526,GO:0005290,1,0.981825924705847,0,3,L-histidine transmembrane transporter activity,MF,
2527,GO:0005292,1,0.98548197293903,0,2,high-affinity lysine transmembrane transporter activity,MF,
2528,GO:0005294,1,0.990290622045223,0,1,neutral L-amino acid secondary active transmembrane transporter activity,MF,
2529,GO:0005295,1,0.987472259341646,0,2,neutral amino acid:sodium symporter activity,MF,
2530,GO:0005298,1,0.986446202867231,0,2,proline:sodium symporter activity,MF,
2531,GO:0005302,1,0.993660727089185,0,1,L-tyrosine transmembrane transporter activity,MF,
2532,GO:0005308,1,0.986411518865172,0,2,creatine transmembrane transporter activity,MF,
2533,GO:0005309,1,0.993462165942772,0,1,creatine:sodium symporter activity,MF,
2534,GO:0005310,1,0.791079480926437,0,35,dicarboxylic acid transmembrane transporter activity,MF,
2535,GO:0005313,1,0.907676475141056,0,14,L-glutamate transmembrane transporter activity,MF,
2536,GO:0005314,1,0.95318289035299,0,7,high-affinity glutamate transmembrane transporter activity,MF,
2537,GO:0005315,1,0.972068915375017,0,4,inorganic phosphate transmembrane transporter activity,MF,
2538,GO:0005316,1,0.993592669983264,0,1,high-affinity inorganic phosphate:sodium symporter activity,MF,
2540,GO:0005324,1,0.970139345638639,0,5,long-chain fatty acid transporter activity,MF,
2541,GO:0005326,1,0.737476211741447,0,46,neurotransmitter transporter activity,MF,
2542,GO:0005328,1,0.855369338466259,0,23,neurotransmitter:sodium symporter activity,MF,
2543,GO:0005329,1,0.966577191044258,0,5,dopamine transmembrane transporter activity,MF,
2544,GO:0005330,1,0.979894183390007,0,3,dopamine:sodium symporter activity,MF,
2545,GO:0005332,1,0.975211842496867,0,4,gamma-aminobutyric acid:sodium symporter activity,MF,
2546,GO:0005333,1,0.987583475091327,0,2,norepinephrine transmembrane transporter activity,MF,
2547,GO:0005334,1,0.993555831129054,0,1,norepinephrine:sodium symporter activity,MF,
2548,GO:0005335,1,0.992947185223779,0,1,serotonin:sodium symporter activity,MF,
2549,GO:0005337,1,0.964896913984721,0,6,nucleoside transmembrane transporter activity,MF,
2550,GO:0005338,1,0.927480695601216,0,12,nucleotide-sugar transmembrane transporter activity,MF,
2552,GO:0005343,1,0.839311466958328,0,26,organic acid:sodium symporter activity,MF,
2553,GO:0005344,1,0.93201778702772,0,13,oxygen carrier activity,MF,
2554,GO:0005345,1,0.970065752420002,0,5,purine nucleobase transmembrane transporter activity,MF,
2555,GO:0005346,1,0.934925837413143,0,11,purine ribonucleotide transmembrane transporter activity,MF,
2556,GO:0005347,1,0.951557845655311,0,8,ATP transmembrane transporter activity,MF,
2557,GO:0005350,1,0.982207358423274,0,3,pyrimidine nucleobase transmembrane transporter activity,MF,
2558,GO:0005351,1,0.936373258649742,0,10,carbohydrate:proton symporter activity,MF,
2559,GO:0005353,1,0.994089340810551,0,1,fructose transmembrane transporter activity,MF,
2561,GO:0005362,1,0.9877603546274,0,2,low-affinity glucose:sodium symporter activity,MF,
2562,GO:0005365,1,0.981060061896536,0,2,myo-inositol transmembrane transporter activity,MF,
2563,GO:0005366,1,0.991658618612257,0,1,myo-inositol:proton symporter activity,MF,
2564,GO:0005367,1,0.989313190688979,0,1,myo-inositol:sodium symporter activity,MF,
2565,GO:0005368,1,0.991916007600299,0,1,taurine transmembrane transporter activity,MF,
2566,GO:0005369,1,0.991916007600299,0,1,taurine:sodium symporter activity,MF,
2568,GO:0005375,1,0.958964274714814,0,6,copper ion transmembrane transporter activity,MF,
2570,GO:0005384,1,0.961193552508305,0,6,manganese ion transmembrane transporter activity,MF,
2571,GO:0005385,1,0.886344791379163,0,19,zinc ion transmembrane transporter activity,MF,
2572,GO:0005388,1,0.89882484089513,0,14,calcium-transporting ATPase activity,MF,
2573,GO:0005391,1,0.932391960522637,0,11,sodium:potassium-exchanging ATPase activity,MF,
2574,GO:0005395,1,0.991470464879919,0,1,eye pigment precursor transporter activity,MF,
2577,GO:0005415,1,0.98840655770369,0,2,nucleoside:sodium symporter activity,MF,
2578,GO:0005416,1,0.879165650090872,0,19,amino acid:cation symporter activity,MF,
2579,GO:0005427,1,0.993375816556392,0,1,proton-dependent oligopeptide secondary active transmembrane transporter activity,MF,
2580,GO:0005432,1,0.960200864851379,0,6,calcium:sodium antiporter activity,MF,
2581,GO:0005436,1,0.968478329219781,0,5,sodium:phosphate symporter activity,MF,
2582,GO:0005451,1,0.916737219129578,0,13,monovalent cation:proton antiporter activity,MF,
2583,GO:0005452,1,0.851702558873279,0,24,inorganic anion exchanger activity,MF,
2584,GO:0005456,1,0.994351273960453,0,1,CMP-N-acetylneuraminate transmembrane transporter activity,MF,
2585,GO:0005457,1,0.985440005982839,0,2,GDP-fucose transmembrane transporter activity,MF,
2586,GO:0005459,1,0.989101058051263,0,2,UDP-galactose transmembrane transporter activity,MF,
2587,GO:0005461,1,0.991939490058702,0,1,UDP-glucuronic acid transmembrane transporter activity,MF,
2588,GO:0005462,1,0.985980092052505,0,2,UDP-N-acetylglucosamine transmembrane transporter activity,MF,
2589,GO:0005464,1,0.991755965992013,0,1,UDP-xylose transmembrane transporter activity,MF,
2590,GO:0005471,1,0.987640677891161,0,2,ATP:ADP antiporter activity,MF,
2591,GO:0005476,1,0.982202073793714,0,3,carnitine:acyl carnitine antiporter activity,MF,
2592,GO:0005477,1,0.99346370216652,0,1,pyruvate secondary active transmembrane transporter activity,MF,
2593,GO:0005483,1,0.981116108481533,0,3,soluble NSF attachment protein activity,MF,
2598,GO:0005499,1,0.974016778589173,0,4,vitamin D binding,MF,
2600,GO:0005502,1,0.975392102647202,0,4,11-cis retinal binding,MF,
2601,GO:0005503,1,0.987175999351485,0,2,all-trans retinal binding,MF,
2604,GO:0005507,1,0.739347844604034,0,49,copper ion binding,MF,
2606,GO:0005513,1,0.922831256292632,0,12,detection of calcium ion,BP,
2609,GO:0005518,1,0.672446188617227,0,58,collagen binding,MF,
2610,GO:0005519,1,0.993238857138244,0,1,cytoskeletal regulatory protein binding,MF,
2611,GO:0005520,1,0.825472033272572,0,29,insulin-like growth factor binding,MF,
2612,GO:0005521,1,0.900162189413806,0,15,lamin binding,MF,
2613,GO:0005522,1,0.925805129210606,0,10,profilin binding,MF,
2614,GO:0005523,1,0.920938582928646,0,13,tropomyosin binding,MF,
2617,GO:0005527,1,0.925810260639314,0,13,macrolide binding,MF,
2618,GO:0005528,1,0.925810260639314,0,13,FK506 binding,MF,
2619,GO:0005534,1,0.970355774364816,0,5,galactose binding,MF,
2620,GO:0005536,1,0.931253233868414,0,11,glucose binding,MF,
2621,GO:0005537,1,0.916289186507464,0,14,mannose binding,MF,
2624,GO:0005542,1,0.943165643756818,0,10,folic acid binding,MF,
2626,GO:0005544,1,0.732560481533805,0,47,calcium-dependent phospholipid binding,MF,
2627,GO:0005545,1,0.899385979476298,0,15,1-phosphatidylinositol binding,MF,
2628,GO:0005546,1,0.675957467808991,0,60,phosphatidylinositol-4,5-bisphosphate binding,MF,
2629,GO:0005547,1,0.793665471202571,0,33,phosphatidylinositol-3,4,5-trisphosphate binding,MF,
2630,GO:0005548,1,0.692059275333556,0,52,phospholipid transporter activity,MF,
2631,GO:0005549,1,0.989640196649392,0,2,odorant binding,MF,
2634,GO:0005577,1,0.954282074206388,0,7,fibrinogen complex,CC,
2636,GO:0005579,1,0.973236548047644,0,4,membrane attack complex,CC,
2637,GO:0005581,1,0.581953940210453,0,78,collagen trimer,CC,
2638,GO:0005582,1,0.99254512263172,0,1,collagen type XV trimer,CC,
2639,GO:0005583,1,0.911975229387134,0,12,fibrillar collagen trimer,CC,
2640,GO:0005584,1,0.984724426216674,0,2,collagen type I trimer,CC,
2641,GO:0005585,1,0.992691287014895,0,1,collagen type II trimer,CC,
2642,GO:0005586,1,0.99242663583062,0,1,collagen type III trimer,CC,
2643,GO:0005587,1,0.949895138479942,0,6,collagen type IV trimer,CC,
2644,GO:0005588,1,0.974831081000248,0,3,collagen type V trimer,CC,
2645,GO:0005589,1,0.978494942416028,0,3,collagen type VI trimer,CC,
2646,GO:0005590,1,0.990482017030119,0,1,collagen type VII trimer,CC,
2647,GO:0005591,1,0.993931880262085,0,1,collagen type VIII trimer,CC,
2648,GO:0005592,1,0.983674638136312,0,2,collagen type XI trimer,CC,
2649,GO:0005593,1,0.956574608277194,0,6,FACIT collagen trimer,CC,
2650,GO:0005594,1,0.981431493508911,0,3,collagen type IX trimer,CC,
2651,GO:0005595,1,0.990172545965464,0,1,collagen type XII trimer,CC,
2652,GO:0005596,1,0.99192487804131,0,1,collagen type XIV trimer,CC,
2653,GO:0005597,1,0.992366871022755,0,1,collagen type XVI trimer,CC,
2654,GO:0005598,1,0.993931880262085,0,1,short-chain collagen trimer,CC,
2655,GO:0005600,1,0.993709361833947,0,1,collagen type XIII trimer,CC,
2656,GO:0005602,1,0.989500928061561,0,2,complement component C1 complex,CC,
2658,GO:0005605,1,0.851495208164816,0,20,basal lamina,CC,
2659,GO:0005606,1,0.973997596017228,0,3,laminin-1 complex,CC,
2660,GO:0005607,1,0.984967772781691,0,2,laminin-2 complex,CC,
2661,GO:0005608,1,0.982678619726856,0,2,laminin-3 complex,CC,
2662,GO:0005610,1,0.973892028761278,0,3,laminin-5 complex,CC,
2663,GO:0005614,1,0.919538705212102,0,12,interstitial matrix,CC,
2669,GO:0005637,1,0.719065093307845,0,50,nuclear inner membrane,CC,
2670,GO:0005638,1,0.975008226445763,0,4,lamin filament,CC,
2671,GO:0005639,1,0.915851641253617,0,14,integral component of nuclear inner membrane,CC,
2672,GO:0005640,1,0.866314887150079,0,20,nuclear outer membrane,CC,
2673,GO:0005641,1,0.945137368878787,0,8,nuclear envelope lumen,CC,
2674,GO:0005642,1,0.963180044797273,0,5,annulate lamellae,CC,
2675,GO:0005643,1,0.592787766080579,0,76,nuclear pore,CC,
2676,GO:0005652,1,0.942008827606378,0,9,nuclear lamina,CC,
2678,GO:0005655,1,0.955384522710465,0,8,nucleolar ribonuclease P complex,CC,
2679,GO:0005656,1,0.982729455714152,0,3,nuclear pre-replicative complex,CC,
2681,GO:0005658,1,0.96290664071466,0,6,alpha DNA polymerase:primase complex,CC,
2682,GO:0005662,1,0.91538759883323,0,14,DNA replication factor A complex,CC,
2683,GO:0005663,1,0.965294637768061,0,6,DNA replication factor C complex,CC,
2684,GO:0005664,1,0.945810949375612,0,9,nuclear origin of replication recognition complex,CC,
2685,GO:0005665,1,0.894847108851343,0,18,DNA-directed RNA polymerase II, core complex,CC,
2686,GO:0005666,1,0.904039496682196,0,17,DNA-directed RNA polymerase III complex,CC,
2687,GO:0005667,1,0.122448762326728,0,318,transcription factor complex,CC,
2688,GO:0005668,1,0.988759816305257,0,2,RNA polymerase transcription factor SL1 complex,CC,
2689,GO:0005669,1,0.79914149852257,0,36,transcription factor TFIID complex,CC,
2690,GO:0005671,1,0.917603125277888,0,13,Ada2/Gcn5/Ada3 transcription activator complex,CC,
2691,GO:0005672,1,0.972653542079771,0,5,transcription factor TFIIA complex,CC,
2692,GO:0005673,1,0.988251831438372,0,2,transcription factor TFIIE complex,CC,
2693,GO:0005674,1,0.988536584677359,0,2,transcription factor TFIIF complex,CC,
2694,GO:0005675,1,0.931372843848888,0,12,holo TFIIH complex,CC,
2695,GO:0005677,1,0.944002827405386,0,8,chromatin silencing complex,CC,
2699,GO:0005683,1,0.963074260151567,0,7,U7 snRNP,CC,
2700,GO:0005684,1,0.704445648737356,0,57,U2-type spliceosomal complex,CC,
2701,GO:0005685,1,0.885594294556749,0,20,U1 snRNP,CC,
2702,GO:0005686,1,0.887496131560673,0,20,U2 snRNP,CC,
2703,GO:0005687,1,0.936185443772681,0,11,U4 snRNP,CC,
2704,GO:0005688,1,0.956981534408081,0,8,U6 snRNP,CC,
2705,GO:0005689,1,0.860228033498863,0,26,U12-type spliceosomal complex,CC,
2706,GO:0005690,1,0.994155939156337,0,1,U4atac snRNP,CC,
2707,GO:0005691,1,0.99302883062763,0,1,U6atac snRNP,CC,
2709,GO:0005697,1,0.866618798249223,0,22,telomerase holoenzyme complex,CC,
2710,GO:0005712,1,0.985276572919814,0,2,chiasma,CC,
2711,GO:0005713,1,0.994013005560847,0,1,recombination nodule,CC,
2712,GO:0005715,1,0.994013005560847,0,1,late recombination nodule,CC,
2713,GO:0005719,1,0.867425063288075,0,23,nuclear euchromatin,CC,
2714,GO:0005720,1,0.814348298195136,0,31,nuclear heterochromatin,CC,
2715,GO:0005721,1,0.875760364122974,0,19,pericentric heterochromatin,CC,
2716,GO:0005724,1,0.994442240407395,0,1,nuclear telomeric heterochromatin,CC,
2717,GO:0005726,1,0.971795866004086,0,4,perichromatin fibrils,CC,
2719,GO:0005731,1,0.994400894056033,0,1,nucleolus organizer region,CC,
2720,GO:0005732,1,0.893395665460186,0,20,small nucleolar ribonucleoprotein complex,CC,
2721,GO:0005736,1,0.929398544212512,0,12,DNA-directed RNA polymerase I complex,CC,
2725,GO:0005741,1,0.348410752300162,0,163,mitochondrial outer membrane,CC,
2726,GO:0005742,1,0.955831463983804,0,8,mitochondrial outer membrane translocase complex,CC,
2728,GO:0005744,1,0.937563891926475,0,11,mitochondrial inner membrane presequence translocase complex,CC,
2729,GO:0005745,1,0.987684990331966,0,2,m-AAA complex,CC,
2730,GO:0005746,1,0.661393641239776,0,76,mitochondrial respiratory chain,CC,
2731,GO:0005747,1,0.795106879647932,0,43,mitochondrial respiratory chain complex I,CC,
2732,GO:0005749,1,0.977407007262679,0,4,mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone),CC,
2733,GO:0005750,1,0.938841865780658,0,11,mitochondrial respiratory chain complex III,CC,
2734,GO:0005751,1,0.935379641051751,0,13,mitochondrial respiratory chain complex IV,CC,
2735,GO:0005753,1,0.994153873375641,0,1,mitochondrial proton-transporting ATP synthase complex,CC,
2736,GO:0005757,1,0.977462376566598,0,4,mitochondrial permeability transition pore complex,CC,
2737,GO:0005758,1,0.672823639428142,0,68,mitochondrial intermembrane space,CC,
2739,GO:0005760,1,0.986042813195425,0,2,gamma DNA polymerase complex,CC,
2740,GO:0005761,1,0.638047902671466,0,82,mitochondrial ribosome,CC,
2741,GO:0005762,1,0.759689357589286,0,50,mitochondrial large ribosomal subunit,CC,
2742,GO:0005763,1,0.863660848347316,0,27,mitochondrial small ribosomal subunit,CC,
2745,GO:0005766,1,0.415574597208915,0,140,primary lysosome,CC,
2746,GO:0005767,1,0.923392887001593,0,13,secondary lysosome,CC,
2750,GO:0005771,1,0.806369554087729,0,35,multivesicular body,CC,
2753,GO:0005775,1,0.374152011777141,0,154,vacuolar lumen,CC,
2754,GO:0005776,1,0.569188894967961,0,86,autophagosome,CC,
2755,GO:0005777,1,0.464398694546774,0,122,peroxisome,CC,
2756,GO:0005778,1,0.692767826581348,0,57,peroxisomal membrane,CC,
2757,GO:0005779,1,0.902912854492719,0,17,integral component of peroxisomal membrane,CC,
2760,GO:0005784,1,0.978743894752576,0,4,Sec61 translocon complex,CC,
2762,GO:0005786,1,0.965910329182426,0,6,signal recognition particle, endoplasmic reticulum targeting,CC,
2763,GO:0005787,1,0.971328474247913,0,5,signal peptidase complex,CC,
2766,GO:0005790,1,0.798870765211416,0,31,smooth endoplasmic reticulum,CC,
2768,GO:0005793,1,0.478878438019911,0,113,endoplasmic reticulum-Golgi intermediate compartment,CC,
2770,GO:0005795,1,0.424280980172614,0,129,Golgi stack,CC,
2771,GO:0005796,1,0.616561859351093,0,72,Golgi lumen,CC,
2772,GO:0005797,1,0.951902696136201,0,8,Golgi medial cisterna,CC,
2774,GO:0005801,1,0.700516384439361,0,53,cis-Golgi network,CC,
2776,GO:0005811,1,0.632873991566319,0,71,lipid droplet,CC,
2780,GO:0005816,1,0.961109003428237,0,6,spindle pole body,CC,
2781,GO:0005818,1,0.945533815213159,0,8,aster,CC,
2783,GO:0005826,1,0.964882026218705,0,5,actomyosin contractile ring,CC,
2784,GO:0005827,1,0.966705531147867,0,5,polar microtubule,CC,
2785,GO:0005828,1,0.94767471083104,0,7,kinetochore microtubule,CC,
2787,GO:0005832,1,0.93361764183407,0,11,chaperonin-containing T-complex,CC,
2788,GO:0005833,1,0.94495378714258,0,11,hemoglobin complex,CC,
2789,GO:0005834,1,0.816044539327527,0,33,heterotrimeric G-protein complex,CC,
2790,GO:0005838,1,0.887505369131476,0,21,proteasome regulatory particle,CC,
2791,GO:0005839,1,0.899554230005379,0,19,proteasome core complex,CC,
2792,GO:0005840,1,0.275260743747604,0,228,ribosome,CC,
2793,GO:0005844,1,0.655427468885563,0,69,polysome,CC,
2794,GO:0005845,1,0.931087372290442,0,11,mRNA cap binding complex,CC,
2795,GO:0005846,1,0.986751922739245,0,2,nuclear cap binding complex,CC,
2798,GO:0005850,1,0.974127256266287,0,4,eukaryotic translation initiation factor 2 complex,CC,
2799,GO:0005851,1,0.964998677318194,0,6,eukaryotic translation initiation factor 2B complex,CC,
2800,GO:0005852,1,0.903431326300874,0,17,eukaryotic translation initiation factor 3 complex,CC,
2801,GO:0005853,1,0.977388194632922,0,4,eukaryotic translation elongation factor 1 complex,CC,
2802,GO:0005854,1,0.98759013551305,0,2,nascent polypeptide-associated complex,CC,
2806,GO:0005861,1,0.964320320358772,0,7,troponin complex,CC,
2807,GO:0005862,1,0.976124302923303,0,4,muscle thin filament tropomyosin,CC,
2808,GO:0005863,1,0.978945498309945,0,3,striated muscle myosin thick filament,CC,
2810,GO:0005868,1,0.862396043802952,0,22,cytoplasmic dynein complex,CC,
2811,GO:0005869,1,0.953243845948715,0,8,dynactin complex,CC,
2813,GO:0005873,1,0.984964575023522,0,2,plus-end kinesin complex,CC,
2817,GO:0005879,1,0.971482247858953,0,4,axonemal microtubule,CC,
2818,GO:0005880,1,0.99453499973681,0,1,nuclear microtubule,CC,
2819,GO:0005881,1,0.695030634830662,0,54,cytoplasmic microtubule,CC,
2821,GO:0005883,1,0.950006793907581,0,7,neurofilament,CC,
2822,GO:0005884,1,0.518801575489596,0,97,actin filament,CC,
2823,GO:0005885,1,0.939564938944631,0,11,Arp2/3 protein complex,CC,
2826,GO:0005889,1,0.986927974932107,0,2,potassium:proton exchanging ATPase complex,CC,
2829,GO:0005892,1,0.903958112491397,0,16,acetylcholine-gated channel complex,CC,
2830,GO:0005895,1,0.994168851188967,0,1,interleukin-5 receptor complex,CC,
2831,GO:0005896,1,0.981588130106271,0,3,interleukin-6 receptor complex,CC,
2832,GO:0005898,1,0.993221852896307,0,1,interleukin-13 receptor complex,CC,
2833,GO:0005899,1,0.973784691000507,0,3,insulin receptor complex,CC,
2834,GO:0005900,1,0.987090132875128,0,2,oncostatin-M receptor complex,CC,
2841,GO:0005913,1,0.489363416021057,0,105,cell-cell adherens junction,CC,
2842,GO:0005914,1,0.993564529379673,0,1,spot adherens junction,CC,
2843,GO:0005915,1,0.952516351389225,0,7,zonula adherens,CC,
2844,GO:0005916,1,0.93265265444886,0,10,fascia adherens,CC,
2845,GO:0005921,1,0.867105154650711,0,23,gap junction,CC,
2846,GO:0005922,1,0.917920337309062,0,14,connexin complex,CC,
2850,GO:0005927,1,0.981878079140936,0,3,muscle tendon junction,CC,
2855,GO:0005942,1,0.878679023133162,0,18,phosphatidylinositol 3-kinase complex,CC,
2856,GO:0005943,1,0.985703592918354,0,2,phosphatidylinositol 3-kinase complex, class IA,CC,
2857,GO:0005944,1,0.98554305268155,0,2,phosphatidylinositol 3-kinase complex, class IB,CC,
2858,GO:0005945,1,0.987321824532426,0,2,6-phosphofructokinase complex,CC,
2859,GO:0005947,1,0.967209484502016,0,5,mitochondrial alpha-ketoglutarate dehydrogenase complex,CC,
2860,GO:0005952,1,0.962384463760092,0,6,cAMP-dependent protein kinase complex,CC,
2861,GO:0005953,1,0.988372542225911,0,2,CAAX-protein geranylgeranyltransferase complex,CC,
2862,GO:0005954,1,0.994008881955777,0,1,calcium- and calmodulin-dependent protein kinase complex,CC,
2863,GO:0005955,1,0.970641233184808,0,4,calcineurin complex,CC,
2864,GO:0005956,1,0.988616990216401,0,2,protein kinase CK2 complex,CC,
2865,GO:0005958,1,0.976131033497129,0,3,DNA-dependent protein kinase-DNA ligase 4 complex,CC,
2866,GO:0005960,1,0.987863562211271,0,2,glycine cleavage complex,CC,
2867,GO:0005964,1,0.965329559553525,0,5,phosphorylase kinase complex,CC,
2868,GO:0005965,1,0.988324006377566,0,2,protein farnesyltransferase complex,CC,
2869,GO:0005967,1,0.98020487588427,0,3,mitochondrial pyruvate dehydrogenase complex,CC,
2870,GO:0005968,1,0.973766681416815,0,4,Rab-protein geranylgeranyltransferase complex,CC,
2871,GO:0005969,1,0.991129449627916,0,1,serine-pyruvate aminotransferase complex,CC,
2874,GO:0005976,1,0.512013672984111,0,99,polysaccharide metabolic process,BP,
2875,GO:0005977,1,0.628278989215273,0,68,glycogen metabolic process,BP,
2876,GO:0005978,1,0.736510918194276,0,44,glycogen biosynthetic process,BP,
2877,GO:0005979,1,0.842844342673758,0,23,regulation of glycogen biosynthetic process,BP,
2878,GO:0005980,1,0.854521111364398,0,23,glycogen catabolic process,BP,
2879,GO:0005981,1,0.973970312152041,0,4,regulation of glycogen catabolic process,BP,
2880,GO:0005982,1,0.991908703178358,0,1,starch metabolic process,BP,
2881,GO:0005983,1,0.991908703178358,0,1,starch catabolic process,BP,
2882,GO:0005984,1,0.943546249705415,0,9,disaccharide metabolic process,BP,
2883,GO:0005985,1,0.987959110673742,0,2,sucrose metabolic process,BP,
2884,GO:0005986,1,0.994492885251886,0,1,sucrose biosynthetic process,BP,
2885,GO:0005988,1,0.981544804143128,0,3,lactose metabolic process,BP,
2886,GO:0005989,1,0.981544804143128,0,3,lactose biosynthetic process,BP,
2887,GO:0005991,1,0.993762130514927,0,1,trehalose metabolic process,BP,
2889,GO:0005997,1,0.977279599880987,0,4,xylulose metabolic process,BP,
2890,GO:0005998,1,0.993383253115219,0,1,xylulose catabolic process,BP,
2891,GO:0005999,1,0.988874361304906,0,2,xylulose biosynthetic process,BP,
2894,GO:0006002,1,0.950349566080154,0,8,fructose 6-phosphate metabolic process,BP,
2895,GO:0006003,1,0.973706266796493,0,4,fructose 2,6-bisphosphate metabolic process,BP,
2896,GO:0006004,1,0.909988547046992,0,14,fucose metabolic process,BP,
2897,GO:0006006,1,0.324806305777135,0,171,glucose metabolic process,BP,
2898,GO:0006007,1,0.840398474680642,0,28,glucose catabolic process,BP,
2899,GO:0006011,1,0.959645509124956,0,6,UDP-glucose metabolic process,BP,
2900,GO:0006012,1,0.914337511141047,0,14,galactose metabolic process,BP,
2901,GO:0006013,1,0.949212517001294,0,8,mannose metabolic process,BP,
2902,GO:0006014,1,0.983760661898126,0,3,D-ribose metabolic process,BP,
2903,GO:0006015,1,0.982096831784345,0,3,5-phosphoribose 1-diphosphate biosynthetic process,BP,
2904,GO:0006020,1,0.923872869720089,0,11,inositol metabolic process,BP,
2905,GO:0006021,1,0.973964812891797,0,4,inositol biosynthetic process,BP,
2906,GO:0006022,1,0.352722334732581,0,157,aminoglycan metabolic process,BP,
2907,GO:0006023,1,0.485441371547704,0,107,aminoglycan biosynthetic process,BP,
2908,GO:0006024,1,0.497455252318934,0,103,glycosaminoglycan biosynthetic process,BP,
2909,GO:0006026,1,0.676041102703083,0,59,aminoglycan catabolic process,BP,
2910,GO:0006027,1,0.700778037062457,0,53,glycosaminoglycan catabolic process,BP,
2912,GO:0006030,1,0.964825097401833,0,6,chitin metabolic process,BP,
2913,GO:0006032,1,0.964825097401833,0,6,chitin catabolic process,BP,
2914,GO:0006040,1,0.795701914890602,0,36,amino sugar metabolic process,BP,
2915,GO:0006041,1,0.976133573658721,0,4,glucosamine metabolic process,BP,
2916,GO:0006043,1,0.988433053863031,0,2,glucosamine catabolic process,BP,
2917,GO:0006044,1,0.9073922051772,0,15,N-acetylglucosamine metabolic process,BP,
2918,GO:0006045,1,0.985932487875949,0,2,N-acetylglucosamine biosynthetic process,BP,
2919,GO:0006046,1,0.982838025446528,0,3,N-acetylglucosamine catabolic process,BP,
2920,GO:0006047,1,0.910074364984575,0,15,UDP-N-acetylglucosamine metabolic process,BP,
2921,GO:0006048,1,0.933499576195441,0,11,UDP-N-acetylglucosamine biosynthetic process,BP,
2922,GO:0006049,1,0.993780586333007,0,1,UDP-N-acetylglucosamine catabolic process,BP,
2923,GO:0006050,1,0.989029668402506,0,2,mannosamine metabolic process,BP,
2924,GO:0006051,1,0.989029668402506,0,2,N-acetylmannosamine metabolic process,BP,
2925,GO:0006054,1,0.933384419958514,0,11,N-acetylneuraminate metabolic process,BP,
2926,GO:0006055,1,0.994647894618283,0,1,CMP-N-acetylneuraminate biosynthetic process,BP,
2927,GO:0006056,1,0.994371949535733,0,1,mannoprotein metabolic process,BP,
2928,GO:0006057,1,0.994371949535733,0,1,mannoprotein biosynthetic process,BP,
2929,GO:0006059,1,0.983223731228227,0,3,hexitol metabolic process,BP,
2930,GO:0006060,1,0.988578149626122,0,2,sorbitol metabolic process,BP,
2931,GO:0006061,1,0.994563677288245,0,1,sorbitol biosynthetic process,BP,
2932,GO:0006062,1,0.993982085865433,0,1,sorbitol catabolic process,BP,
2933,GO:0006063,1,0.952826362283582,0,8,uronic acid metabolic process,BP,
2934,GO:0006064,1,0.971588777423278,0,5,glucuronate catabolic process,BP,
2935,GO:0006065,1,0.979893505892713,0,3,UDP-glucuronate biosynthetic process,BP,
2938,GO:0006068,1,0.949977123117698,0,9,ethanol catabolic process,BP,
2940,GO:0006071,1,0.925373081484542,0,12,glycerol metabolic process,BP,
2941,GO:0006072,1,0.943734779493221,0,8,glycerol-3-phosphate metabolic process,BP,
2942,GO:0006073,1,0.623171591802797,0,69,cellular glucan metabolic process,BP,
2945,GO:0006083,1,0.97948904757066,0,3,acetate metabolic process,BP,
2946,GO:0006084,1,0.800127095630561,0,34,acetyl-CoA metabolic process,BP,
2947,GO:0006085,1,0.880924159023049,0,19,acetyl-CoA biosynthetic process,BP,
2948,GO:0006086,1,0.909601224616218,0,14,acetyl-CoA biosynthetic process from pyruvate,BP,
2949,GO:0006089,1,0.933763967741898,0,11,lactate metabolic process,BP,
2950,GO:0006090,1,0.434373320198227,0,126,pyruvate metabolic process,BP,
2952,GO:0006094,1,0.659614850693383,0,67,gluconeogenesis,BP,
2953,GO:0006096,1,0.539654099935673,0,92,glycolytic process,BP,
2954,GO:0006097,1,0.988508103394858,0,2,glyoxylate cycle,BP,
2955,GO:0006098,1,0.904020738940844,0,17,pentose-phosphate shunt,BP,
2956,GO:0006099,1,0.838941716414814,0,29,tricarboxylic acid cycle,BP,
2958,GO:0006102,1,0.971627416279515,0,5,isocitrate metabolic process,BP,
2959,GO:0006103,1,0.892283072745747,0,18,2-oxoglutarate metabolic process,BP,
2960,GO:0006104,1,0.96463163118034,0,6,succinyl-CoA metabolic process,BP,
2961,GO:0006105,1,0.933001881469231,0,11,succinate metabolic process,BP,
2962,GO:0006106,1,0.982672382888192,0,3,fumarate metabolic process,BP,
2963,GO:0006107,1,0.9285616445858,0,12,oxaloacetate metabolic process,BP,
2964,GO:0006108,1,0.959043828588326,0,7,malate metabolic process,BP,
2965,GO:0006109,1,0.34716760301525,0,155,regulation of carbohydrate metabolic process,BP,
2966,GO:0006110,1,0.654820149441564,0,61,regulation of glycolytic process,BP,
2967,GO:0006111,1,0.841440092417548,0,26,regulation of gluconeogenesis,BP,
2968,GO:0006112,1,0.581768014375612,0,80,energy reserve metabolic process,BP,
2969,GO:0006114,1,0.969921359082899,0,5,glycerol biosynthetic process,BP,
2970,GO:0006116,1,0.974572292221274,0,4,NADH oxidation,BP,
2971,GO:0006117,1,0.993956590534699,0,1,acetaldehyde metabolic process,BP,
2973,GO:0006120,1,0.789918018875348,0,44,mitochondrial electron transport, NADH to ubiquinone,BP,
2974,GO:0006121,1,0.977376543310681,0,4,mitochondrial electron transport, succinate to ubiquinone,BP,
2975,GO:0006122,1,0.92458124390171,0,13,mitochondrial electron transport, ubiquinol to cytochrome c,BP,
2976,GO:0006123,1,0.915885802947478,0,16,mitochondrial electron transport, cytochrome c to oxygen,BP,
2977,GO:0006127,1,0.986072623023957,0,2,glycerophosphate shuttle,BP,
2980,GO:0006144,1,0.872636208760263,0,22,purine nucleobase metabolic process,BP,
2981,GO:0006145,1,0.971503016206726,0,4,purine nucleobase catabolic process,BP,
2982,GO:0006147,1,0.992478017779405,0,1,guanine catabolic process,BP,
2983,GO:0006148,1,0.994041363020688,0,1,inosine catabolic process,BP,
2984,GO:0006152,1,0.964561339893684,0,6,purine nucleoside catabolic process,BP,
2985,GO:0006154,1,0.988487803586386,0,2,adenosine catabolic process,BP,
2986,GO:0006157,1,0.994493918772112,0,1,deoxyadenosine catabolic process,BP,
2990,GO:0006166,1,0.971065992698799,0,5,purine ribonucleoside salvage,BP,
2991,GO:0006167,1,0.966337469667689,0,6,AMP biosynthetic process,BP,
2992,GO:0006168,1,0.98384181048197,0,3,adenine salvage,BP,
2993,GO:0006169,1,0.99422671360834,0,1,adenosine salvage,BP,
2994,GO:0006171,1,0.701632597359588,0,54,cAMP biosynthetic process,BP,
2997,GO:0006174,1,0.993850639026861,0,1,dADP phosphorylation,BP,
2998,GO:0006175,1,0.99422671360834,0,1,dATP biosynthetic process,BP,
2999,GO:0006177,1,0.971590920571978,0,5,GMP biosynthetic process,BP,
3000,GO:0006178,1,0.988878521246645,0,2,guanine salvage,BP,
3001,GO:0006182,1,0.814611247769054,0,31,cGMP biosynthetic process,BP,
3002,GO:0006183,1,0.946621239184787,0,10,GTP biosynthetic process,BP,
3003,GO:0006185,1,0.994777046310465,0,1,dGDP biosynthetic process,BP,
3004,GO:0006186,1,0.993850639026861,0,1,dGDP phosphorylation,BP,
3005,GO:0006188,1,0.938653045622912,0,10,IMP biosynthetic process,BP,
3006,GO:0006189,1,0.96225506482444,0,6,'de novo' IMP biosynthetic process,BP,
3007,GO:0006193,1,0.994719963282845,0,1,ITP catabolic process,BP,
3008,GO:0006195,1,0.748555457486213,0,44,purine nucleotide catabolic process,BP,
3009,GO:0006196,1,0.986293504790736,0,2,AMP catabolic process,BP,
3010,GO:0006198,1,0.884236793804728,0,17,cAMP catabolic process,BP,
3011,GO:0006203,1,0.982899633753087,0,3,dGTP catabolic process,BP,
3012,GO:0006206,1,0.892290762749833,0,18,pyrimidine nucleobase metabolic process,BP,
3013,GO:0006207,1,0.957354640224796,0,6,'de novo' pyrimidine nucleobase biosynthetic process,BP,
3014,GO:0006208,1,0.982130970518913,0,3,pyrimidine nucleobase catabolic process,BP,
3015,GO:0006210,1,0.982130970518913,0,3,thymine catabolic process,BP,
3016,GO:0006211,1,0.970621967320022,0,3,5-methylcytosine catabolic process,BP,
3017,GO:0006212,1,0.987901463071453,0,2,uracil catabolic process,BP,
3018,GO:0006213,1,0.776962155795889,0,43,pyrimidine nucleoside metabolic process,BP,
3019,GO:0006214,1,0.993675570705843,0,1,thymidine catabolic process,BP,
3020,GO:0006216,1,0.955289552073125,0,8,cytidine catabolic process,BP,
3021,GO:0006218,1,0.994352824644852,0,1,uridine catabolic process,BP,
3024,GO:0006222,1,0.940700939427565,0,10,UMP biosynthetic process,BP,
3025,GO:0006226,1,0.983108784050275,0,3,dUMP biosynthetic process,BP,
3026,GO:0006227,1,0.988480665307055,0,2,dUDP biosynthetic process,BP,
3027,GO:0006228,1,0.949638783388139,0,9,UTP biosynthetic process,BP,
3028,GO:0006231,1,0.98282538036942,0,3,dTMP biosynthetic process,BP,
3029,GO:0006233,1,0.988480665307055,0,2,dTDP biosynthetic process,BP,
3030,GO:0006235,1,0.97771113382292,0,4,dTTP biosynthetic process,BP,
3031,GO:0006238,1,0.994644794758761,0,1,CMP salvage,BP,
3032,GO:0006241,1,0.929553911619179,0,13,CTP biosynthetic process,BP,
3033,GO:0006244,1,0.928397390747688,0,13,pyrimidine nucleotide catabolic process,BP,
3034,GO:0006253,1,0.994711955924432,0,1,dCTP catabolic process,BP,
3035,GO:0006256,1,0.993774946284491,0,1,UDP catabolic process,BP,
3036,GO:0006258,1,0.988788053559521,0,2,UDP-glucose catabolic process,BP,
3040,GO:0006264,1,0.936977998622561,0,10,mitochondrial DNA replication,BP,
3043,GO:0006267,1,0.982729455714152,0,3,pre-replicative complex assembly involved in nuclear cell cycle DNA replication,BP,
3044,GO:0006268,1,0.957298983857233,0,7,DNA unwinding involved in DNA replication,BP,
3045,GO:0006269,1,0.968887414762159,0,5,DNA replication, synthesis of RNA primer,BP,
3047,GO:0006271,1,0.882544843655542,0,20,DNA strand elongation involved in DNA replication,BP,
3048,GO:0006272,1,0.978414888864741,0,3,leading strand elongation,BP,
3049,GO:0006273,1,0.932887667766017,0,11,lagging strand elongation,BP,
3051,GO:0006278,1,0.639162661268876,0,67,RNA-dependent DNA biosynthetic process,BP,
3054,GO:0006283,1,0.639732588211378,0,73,transcription-coupled nucleotide-excision repair,BP,
3055,GO:0006284,1,0.768784160963722,0,41,base-excision repair,BP,
3056,GO:0006285,1,0.944355838518778,0,10,base-excision repair, AP site formation,BP,
3057,GO:0006286,1,0.989180757002742,0,2,base-excision repair, base-free sugar-phosphate removal,BP,
3058,GO:0006287,1,0.966718033310149,0,5,base-excision repair, gap-filling,BP,
3059,GO:0006288,1,0.982470182543241,0,3,base-excision repair, DNA ligation,BP,
3060,GO:0006289,1,0.498232144443411,0,112,nucleotide-excision repair,BP,
3061,GO:0006290,1,0.953966509955245,0,7,pyrimidine dimer repair,BP,
3062,GO:0006293,1,0.874409916155252,0,21,nucleotide-excision repair, preincision complex stabilization,BP,
3063,GO:0006294,1,0.837555366855489,0,29,nucleotide-excision repair, preincision complex assembly,BP,
3064,GO:0006295,1,0.874409916155252,0,21,nucleotide-excision repair, DNA incision, 3'-to lesion,BP,
3065,GO:0006296,1,0.795779725124837,0,37,nucleotide-excision repair, DNA incision, 5'-to lesion,BP,
3066,GO:0006297,1,0.868207744262343,0,23,nucleotide-excision repair, DNA gap filling,BP,
3067,GO:0006298,1,0.824388223783487,0,30,mismatch repair,BP,
3070,GO:0006303,1,0.675164218182524,0,58,double-strand break repair via nonhomologous end joining,BP,
3071,GO:0006304,1,0.546342529266665,0,92,DNA modification,BP,
3072,GO:0006305,1,0.694523395843451,0,54,DNA alkylation,BP,
3073,GO:0006306,1,0.694523395843451,0,54,DNA methylation,BP,
3074,GO:0006307,1,0.94126044470453,0,10,DNA dealkylation involved in DNA repair,BP,
3075,GO:0006308,1,0.799188169550014,0,35,DNA catabolic process,BP,
3076,GO:0006309,1,0.879683848621035,0,20,apoptotic DNA fragmentation,BP,
3078,GO:0006311,1,0.974916370674265,0,4,meiotic gene conversion,BP,
3079,GO:0006312,1,0.855681478438308,0,23,mitotic recombination,BP,
3080,GO:0006313,1,0.993207931629791,0,1,transposition, DNA-mediated,BP,
3083,GO:0006333,1,0.431701465816415,0,133,chromatin assembly or disassembly,BP,
3084,GO:0006334,1,0.576207913430454,0,91,nucleosome assembly,BP,
3085,GO:0006335,1,0.921915570277505,0,14,DNA replication-dependent nucleosome assembly,BP,
3086,GO:0006336,1,0.781744139474422,0,40,DNA replication-independent nucleosome assembly,BP,
3087,GO:0006337,1,0.891199289810985,0,17,nucleosome disassembly,BP,
3088,GO:0006338,1,0.351805579172531,0,158,chromatin remodeling,BP,
3089,GO:0006342,1,0.615301748412193,0,75,chromatin silencing,BP,
3090,GO:0006343,1,0.993308052375291,0,1,establishment of chromatin silencing,BP,
3091,GO:0006344,1,0.97040915009199,0,4,maintenance of chromatin silencing,BP,
3092,GO:0006346,1,0.9101375625881,0,14,methylation-dependent chromatin silencing,BP,
3093,GO:0006348,1,0.95013144530855,0,8,chromatin silencing at telomere,BP,
3094,GO:0006349,1,0.894513099470064,0,16,regulation of gene expression by genetic imprinting,BP,
3098,GO:0006354,1,0.45969795034138,0,122,DNA-templated transcription, elongation,BP,
3100,GO:0006356,1,0.815575922217389,0,30,regulation of transcription by RNA polymerase I,BP,
3102,GO:0006359,1,0.833509266502271,0,27,regulation of transcription by RNA polymerase III,BP,
3103,GO:0006360,1,0.679621583897714,0,59,transcription by RNA polymerase I,BP,
3104,GO:0006361,1,0.80520124739045,0,35,transcription initiation from RNA polymerase I promoter,BP,
3105,GO:0006362,1,0.831393074515981,0,30,transcription elongation from RNA polymerase I promoter,BP,
3106,GO:0006363,1,0.833012422604926,0,30,termination of RNA polymerase I transcription,BP,
3107,GO:0006364,1,0.227494348135163,0,249,rRNA processing,BP,
3110,GO:0006368,1,0.53787037316659,0,97,transcription elongation from RNA polymerase II promoter,BP,
3112,GO:0006370,1,0.82780598190856,0,31,7-methylguanosine mRNA capping,BP,
3113,GO:0006376,1,0.838622545461701,0,27,mRNA splice site selection,BP,
3116,GO:0006382,1,0.963664354662602,0,5,adenosine to inosine editing,BP,
3117,GO:0006383,1,0.712781178526344,0,53,transcription by RNA polymerase III,BP,
3118,GO:0006384,1,0.950715365333398,0,7,transcription initiation from RNA polymerase III promoter,BP,
3119,GO:0006386,1,0.994878291890563,0,1,termination of RNA polymerase III transcription,BP,
3120,GO:0006388,1,0.922567465787529,0,14,tRNA splicing, via endonucleolytic cleavage and ligation,BP,
3121,GO:0006390,1,0.917762650051784,0,13,mitochondrial transcription,BP,
3122,GO:0006391,1,0.982083307158155,0,3,transcription initiation from mitochondrial promoter,BP,
3123,GO:0006393,1,0.987738712940129,0,2,termination of mitochondrial transcription,BP,
3126,GO:0006398,1,0.968503747169169,0,5,mRNA 3'-end processing by stem-loop binding and cleavage,BP,
3127,GO:0006399,1,0.331505459332254,0,181,tRNA metabolic process,BP,
3128,GO:0006400,1,0.640503874213587,0,73,tRNA modification,BP,
3129,GO:0006401,1,0.104113457723708,0,361,RNA catabolic process,BP,
3130,GO:0006402,1,0.12503885550643,0,332,mRNA catabolic process,BP,
3132,GO:0006404,1,0.979521052226888,0,3,RNA import into nucleus,BP,
3135,GO:0006407,1,0.980235156516639,0,3,rRNA export from nucleus,BP,
3136,GO:0006408,1,0.988624921935914,0,2,snRNA export from nucleus,BP,
3137,GO:0006409,1,0.808006837136149,0,31,tRNA export from nucleus,BP,
3139,GO:0006413,1,0.322900103086967,0,191,translational initiation,BP,
3140,GO:0006414,1,0.47935441806181,0,126,translational elongation,BP,
3141,GO:0006415,1,0.569896744043641,0,99,translational termination,BP,
3142,GO:0006417,1,0.0773230316932612,0,386,regulation of translation,BP,
3143,GO:0006418,1,0.740968851911575,0,49,tRNA aminoacylation for protein translation,BP,
3144,GO:0006419,1,0.98079845812021,0,3,alanyl-tRNA aminoacylation,BP,
3145,GO:0006420,1,0.982741706072032,0,3,arginyl-tRNA aminoacylation,BP,
3146,GO:0006421,1,0.981585287913954,0,3,asparaginyl-tRNA aminoacylation,BP,
3147,GO:0006422,1,0.994083148316594,0,1,aspartyl-tRNA aminoacylation,BP,
3148,GO:0006423,1,0.988274750368456,0,2,cysteinyl-tRNA aminoacylation,BP,
3149,GO:0006424,1,0.986003498118143,0,2,glutamyl-tRNA aminoacylation,BP,
3150,GO:0006425,1,0.986838967933285,0,2,glutaminyl-tRNA aminoacylation,BP,
3151,GO:0006426,1,0.988361828813511,0,2,glycyl-tRNA aminoacylation,BP,
3152,GO:0006427,1,0.988302739878687,0,2,histidyl-tRNA aminoacylation,BP,
3153,GO:0006428,1,0.986474276544419,0,2,isoleucyl-tRNA aminoacylation,BP,
3154,GO:0006429,1,0.98593552586905,0,2,leucyl-tRNA aminoacylation,BP,
3155,GO:0006430,1,0.994198037646091,0,1,lysyl-tRNA aminoacylation,BP,
3156,GO:0006431,1,0.987604115609127,0,2,methionyl-tRNA aminoacylation,BP,
3157,GO:0006432,1,0.970777300741337,0,5,phenylalanyl-tRNA aminoacylation,BP,
3158,GO:0006433,1,0.981580795700484,0,3,prolyl-tRNA aminoacylation,BP,
3159,GO:0006434,1,0.988556053337997,0,2,seryl-tRNA aminoacylation,BP,
3160,GO:0006435,1,0.981563891569853,0,3,threonyl-tRNA aminoacylation,BP,
3161,GO:0006436,1,0.987768356487674,0,2,tryptophanyl-tRNA aminoacylation,BP,
3162,GO:0006437,1,0.987885545397964,0,2,tyrosyl-tRNA aminoacylation,BP,
3163,GO:0006438,1,0.979396215427501,0,3,valyl-tRNA aminoacylation,BP,
3164,GO:0006446,1,0.621618229327652,0,74,regulation of translational initiation,BP,
3165,GO:0006447,1,0.979975221205257,0,3,regulation of translational initiation by iron,BP,
3166,GO:0006448,1,0.889889290216249,0,18,regulation of translational elongation,BP,
3167,GO:0006449,1,0.949139611400991,0,8,regulation of translational termination,BP,
3168,GO:0006450,1,0.896955424282935,0,18,regulation of translational fidelity,BP,
3169,GO:0006451,1,0.948043040273952,0,8,translational readthrough,BP,
3170,GO:0006452,1,0.980478756500573,0,3,translational frameshifting,BP,
3173,GO:0006463,1,0.993359143591691,0,1,steroid hormone receptor complex assembly,BP,
3175,GO:0006465,1,0.887775420036129,0,20,signal peptide processing,BP,
3179,GO:0006471,1,0.845738414108212,0,26,protein ADP-ribosylation,BP,
3180,GO:0006473,1,0.316699373348468,0,174,protein acetylation,BP,
3181,GO:0006474,1,0.896978764899183,0,16,N-terminal protein amino acid acetylation,BP,
3182,GO:0006475,1,0.377781983512175,0,146,internal protein amino acid acetylation,BP,
3183,GO:0006476,1,0.522292522378198,0,95,protein deacetylation,BP,
3184,GO:0006477,1,0.960791466077032,0,6,protein sulfation,BP,
3185,GO:0006478,1,0.988543459837748,0,2,peptidyl-tyrosine sulfation,BP,
3186,GO:0006479,1,0.332817082717748,0,163,protein methylation,BP,
3187,GO:0006480,1,0.988686691864006,0,2,N-terminal protein amino acid methylation,BP,
3188,GO:0006481,1,0.98132671467407,0,3,C-terminal protein methylation,BP,
3189,GO:0006482,1,0.807615432897914,0,29,protein demethylation,BP,
3190,GO:0006486,1,0.211951276248148,0,234,protein glycosylation,BP,
3191,GO:0006487,1,0.571769399760673,0,89,protein N-linked glycosylation,BP,
3192,GO:0006488,1,0.881027289697472,0,20,dolichol-linked oligosaccharide biosynthetic process,BP,
3193,GO:0006489,1,0.957967397916738,0,7,dolichyl diphosphate biosynthetic process,BP,
3194,GO:0006490,1,0.875715846745071,0,21,oligosaccharide-lipid intermediate biosynthetic process,BP,
3195,GO:0006491,1,0.879784444199352,0,18,N-glycan processing,BP,
3196,GO:0006493,1,0.513410157502233,0,99,protein O-linked glycosylation,BP,
3199,GO:0006499,1,0.970828604360132,0,4,N-terminal protein myristoylation,BP,
3201,GO:0006501,1,0.704699505054786,0,55,C-terminal protein lipidation,BP,
3202,GO:0006505,1,0.818527347268096,0,33,GPI anchor metabolic process,BP,
3203,GO:0006506,1,0.827890941841473,0,31,GPI anchor biosynthetic process,BP,
3204,GO:0006507,1,0.994105598455397,0,1,GPI anchor release,BP,
3206,GO:0006509,1,0.769173606227112,0,40,membrane protein ectodomain proteolysis,BP,
3209,GO:0006515,1,0.847259590473092,0,25,protein quality control for misfolded or incompletely synthesized proteins,BP,
3211,GO:0006517,1,0.795743518825097,0,34,protein deglycosylation,BP,
3214,GO:0006521,1,0.72876870966064,0,55,regulation of cellular amino acid metabolic process,BP,
3215,GO:0006522,1,0.9767045760509,0,4,alanine metabolic process,BP,
3216,GO:0006524,1,0.9767045760509,0,4,alanine catabolic process,BP,
3217,GO:0006525,1,0.880271340773142,0,20,arginine metabolic process,BP,
3218,GO:0006526,1,0.961768112948101,0,6,arginine biosynthetic process,BP,
3219,GO:0006527,1,0.931186316632666,0,11,arginine catabolic process,BP,
3220,GO:0006528,1,0.971444597601995,0,5,asparagine metabolic process,BP,
3221,GO:0006529,1,0.988132762097574,0,2,asparagine biosynthetic process,BP,
3222,GO:0006530,1,0.988422071166121,0,2,asparagine catabolic process,BP,
3223,GO:0006531,1,0.941475001636123,0,10,aspartate metabolic process,BP,
3224,GO:0006532,1,0.988244129426485,0,2,aspartate biosynthetic process,BP,
3225,GO:0006533,1,0.9828802671243,0,3,aspartate catabolic process,BP,
3226,GO:0006534,1,0.922847150990856,0,13,cysteine metabolic process,BP,
3227,GO:0006535,1,0.993944491212098,0,1,cysteine biosynthetic process from serine,BP,
3228,GO:0006536,1,0.824900832179767,0,31,glutamate metabolic process,BP,
3229,GO:0006537,1,0.968359565703769,0,5,glutamate biosynthetic process,BP,
3230,GO:0006538,1,0.94512186794241,0,9,glutamate catabolic process,BP,
3231,GO:0006539,1,0.994305787279892,0,1,glutamate catabolic process via 2-oxoglutarate,BP,
3232,GO:0006540,1,0.980742013335037,0,3,glutamate decarboxylation to succinate,BP,
3233,GO:0006541,1,0.857059233846847,0,23,glutamine metabolic process,BP,
3234,GO:0006542,1,0.985576883599738,0,2,glutamine biosynthetic process,BP,
3235,GO:0006543,1,0.980457253074232,0,3,glutamine catabolic process,BP,
3236,GO:0006544,1,0.941469595911505,0,10,glycine metabolic process,BP,
3237,GO:0006545,1,0.982708685184627,0,3,glycine biosynthetic process,BP,
3238,GO:0006546,1,0.98215096245085,0,3,glycine catabolic process,BP,
3241,GO:0006549,1,0.967808168815812,0,5,isoleucine metabolic process,BP,
3242,GO:0006550,1,0.98866654956938,0,2,isoleucine catabolic process,BP,
3243,GO:0006551,1,0.949807745780451,0,8,leucine metabolic process,BP,
3244,GO:0006552,1,0.963783905721444,0,6,leucine catabolic process,BP,
3245,GO:0006553,1,0.921468204756238,0,13,lysine metabolic process,BP,
3246,GO:0006554,1,0.92721122389677,0,12,lysine catabolic process,BP,
3247,GO:0006555,1,0.879526356073653,0,20,methionine metabolic process,BP,
3248,GO:0006556,1,0.981686319580757,0,3,S-adenosylmethionine biosynthetic process,BP,
3249,GO:0006557,1,0.993604693773063,0,1,S-adenosylmethioninamine biosynthetic process,BP,
3250,GO:0006558,1,0.944523442989561,0,10,L-phenylalanine metabolic process,BP,
3251,GO:0006559,1,0.944523442989561,0,10,L-phenylalanine catabolic process,BP,
3252,GO:0006560,1,0.95941913887983,0,7,proline metabolic process,BP,
3253,GO:0006561,1,0.976692160065072,0,4,proline biosynthetic process,BP,
3254,GO:0006562,1,0.982318952217578,0,3,proline catabolic process,BP,
3255,GO:0006563,1,0.938010646715906,0,11,L-serine metabolic process,BP,
3256,GO:0006564,1,0.965711970531402,0,6,L-serine biosynthetic process,BP,
3257,GO:0006565,1,0.977182386289919,0,4,L-serine catabolic process,BP,
3258,GO:0006566,1,0.977873932767835,0,4,threonine metabolic process,BP,
3259,GO:0006567,1,0.983583888831878,0,3,threonine catabolic process,BP,
3260,GO:0006568,1,0.945889386853745,0,9,tryptophan metabolic process,BP,
3261,GO:0006569,1,0.959971691740149,0,7,tryptophan catabolic process,BP,
3262,GO:0006570,1,0.95534058625508,0,8,tyrosine metabolic process,BP,
3263,GO:0006572,1,0.966544965243994,0,6,tyrosine catabolic process,BP,
3264,GO:0006573,1,0.942577376908455,0,9,valine metabolic process,BP,
3265,GO:0006574,1,0.977064255164343,0,4,valine catabolic process,BP,
3267,GO:0006576,1,0.757007432544156,0,46,cellular biogenic amine metabolic process,BP,
3268,GO:0006577,1,0.89990524961885,0,17,amino-acid betaine metabolic process,BP,
3269,GO:0006578,1,0.957715253955186,0,7,amino-acid betaine biosynthetic process,BP,
3270,GO:0006579,1,0.981798977946397,0,3,amino-acid betaine catabolic process,BP,
3271,GO:0006580,1,0.993896896634834,0,1,ethanolamine metabolic process,BP,
3272,GO:0006581,1,0.987725477089946,0,2,acetylcholine catabolic process,BP,
3273,GO:0006582,1,0.895872559674859,0,16,melanin metabolic process,BP,
3274,GO:0006583,1,0.994074634477245,0,1,melanin biosynthetic process from tyrosine,BP,
3275,GO:0006584,1,0.741113675586591,0,47,catecholamine metabolic process,BP,
3276,GO:0006585,1,0.99430371974848,0,1,dopamine biosynthetic process from tyrosine,BP,
3277,GO:0006586,1,0.930004813151423,0,12,indolalkylamine metabolic process,BP,
3278,GO:0006589,1,0.987614354836533,0,2,octopamine biosynthetic process,BP,
3280,GO:0006591,1,0.947902652828911,0,9,ornithine metabolic process,BP,
3281,GO:0006592,1,0.993498515347074,0,1,ornithine biosynthetic process,BP,
3282,GO:0006593,1,0.9944355218544,0,1,ornithine catabolic process,BP,
3283,GO:0006595,1,0.9125322045393,0,16,polyamine metabolic process,BP,
3284,GO:0006596,1,0.927635374805283,0,13,polyamine biosynthetic process,BP,
3285,GO:0006597,1,0.988053875388748,0,2,spermine biosynthetic process,BP,
3286,GO:0006598,1,0.967428710411537,0,6,polyamine catabolic process,BP,
3287,GO:0006600,1,0.940384835784308,0,10,creatine metabolic process,BP,
3288,GO:0006601,1,0.988751801900015,0,2,creatine biosynthetic process,BP,
3291,GO:0006607,1,0.861792632657148,0,20,NLS-bearing protein import into nucleus,BP,
3292,GO:0006610,1,0.945067037243087,0,8,ribosomal protein import into nucleus,BP,
3294,GO:0006612,1,0.354718229821349,0,177,protein targeting to membrane,BP,
3295,GO:0006613,1,0.598705818589781,0,95,cotranslational protein targeting to membrane,BP,
3296,GO:0006614,1,0.620471845378454,0,90,SRP-dependent cotranslational protein targeting to membrane,BP,
3297,GO:0006616,1,0.96681457734227,0,6,SRP-dependent cotranslational protein targeting to membrane, translocation,BP,
3298,GO:0006617,1,0.988990669846271,0,2,SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition,BP,
3299,GO:0006620,1,0.954991109751275,0,7,posttranslational protein targeting to endoplasmic reticulum membrane,BP,
3300,GO:0006621,1,0.940306174399687,0,10,protein retention in ER lumen,BP,
3301,GO:0006622,1,0.8764973402534,0,19,protein targeting to lysosome,BP,
3302,GO:0006623,1,0.797539024685382,0,31,protein targeting to vacuole,BP,
3303,GO:0006624,1,0.989118083957656,0,2,vacuolar protein processing,BP,
3304,GO:0006625,1,0.89756495751057,0,17,protein targeting to peroxisome,BP,
3306,GO:0006627,1,0.951532933812266,0,8,protein processing involved in protein targeting to mitochondrion,BP,
3310,GO:0006635,1,0.641742140209803,0,70,fatty acid beta-oxidation,BP,
3312,GO:0006637,1,0.562632431540015,0,91,acyl-CoA metabolic process,BP,
3313,GO:0006638,1,0.560856631487195,0,89,neutral lipid metabolic process,BP,
3314,GO:0006639,1,0.564459481980609,0,88,acylglycerol metabolic process,BP,
3315,GO:0006641,1,0.621712908645235,0,74,triglyceride metabolic process,BP,
3316,GO:0006642,1,0.968273758153556,0,4,triglyceride mobilization,BP,
3317,GO:0006643,1,0.27618995719697,0,204,membrane lipid metabolic process,BP,
3320,GO:0006649,1,0.985190811335395,0,2,phospholipid transfer to membrane,BP,
3322,GO:0006651,1,0.986360020588227,0,2,diacylglycerol biosynthetic process,BP,
3323,GO:0006654,1,0.800587083032774,0,33,phosphatidic acid biosynthetic process,BP,
3324,GO:0006655,1,0.939513155184956,0,10,phosphatidylglycerol biosynthetic process,BP,
3325,GO:0006656,1,0.815364738717343,0,33,phosphatidylcholine biosynthetic process,BP,
3326,GO:0006657,1,0.957597077810138,0,7,CDP-choline pathway,BP,
3327,GO:0006658,1,0.862093240341083,0,24,phosphatidylserine metabolic process,BP,
3328,GO:0006659,1,0.975834492186728,0,4,phosphatidylserine biosynthetic process,BP,
3329,GO:0006660,1,0.994367814467123,0,1,phosphatidylserine catabolic process,BP,
3331,GO:0006662,1,0.929473150532526,0,12,glycerol ether metabolic process,BP,
3332,GO:0006663,1,0.975291044666314,0,4,platelet activating factor biosynthetic process,BP,
3333,GO:0006664,1,0.47655584695135,0,118,glycolipid metabolic process,BP,
3334,GO:0006665,1,0.383951002060964,0,150,sphingolipid metabolic process,BP,
3335,GO:0006666,1,0.992601725158807,0,1,3-keto-sphinganine metabolic process,BP,
3336,GO:0006667,1,0.980542042870607,0,3,sphinganine metabolic process,BP,
3337,GO:0006668,1,0.987382666560003,0,2,sphinganine-1-phosphate metabolic process,BP,
3338,GO:0006669,1,0.993758542702764,0,1,sphinganine-1-phosphate biosynthetic process,BP,
3339,GO:0006670,1,0.934133832159143,0,11,sphingosine metabolic process,BP,
3340,GO:0006671,1,0.993024156028235,0,1,phytosphingosine metabolic process,BP,
3341,GO:0006672,1,0.58694086101083,0,84,ceramide metabolic process,BP,
3342,GO:0006677,1,0.895235234882583,0,18,glycosylceramide metabolic process,BP,
3343,GO:0006678,1,0.956176653775555,0,7,glucosylceramide metabolic process,BP,
3344,GO:0006679,1,0.98713464614932,0,2,glucosylceramide biosynthetic process,BP,
3345,GO:0006680,1,0.981430640093549,0,3,glucosylceramide catabolic process,BP,
3346,GO:0006681,1,0.951817747704851,0,8,galactosylceramide metabolic process,BP,
3347,GO:0006682,1,0.970417715864051,0,5,galactosylceramide biosynthetic process,BP,
3348,GO:0006683,1,0.993786227088729,0,1,galactosylceramide catabolic process,BP,
3349,GO:0006684,1,0.920122155303261,0,13,sphingomyelin metabolic process,BP,
3350,GO:0006685,1,0.968139727964631,0,5,sphingomyelin catabolic process,BP,
3351,GO:0006686,1,0.961231938464727,0,6,sphingomyelin biosynthetic process,BP,
3352,GO:0006687,1,0.645146174092793,0,68,glycosphingolipid metabolic process,BP,
3353,GO:0006688,1,0.866417337424868,0,22,glycosphingolipid biosynthetic process,BP,
3354,GO:0006689,1,0.970266861675455,0,5,ganglioside catabolic process,BP,
3356,GO:0006691,1,0.887434988662906,0,20,leukotriene metabolic process,BP,
3361,GO:0006696,1,0.988416045237148,0,2,ergosterol biosynthetic process,BP,
3362,GO:0006699,1,0.819301848131501,0,32,bile acid biosynthetic process,BP,
3363,GO:0006700,1,0.882050572737564,0,20,C21-steroid hormone biosynthetic process,BP,
3364,GO:0006701,1,0.967363275643054,0,5,progesterone biosynthetic process,BP,
3365,GO:0006702,1,0.95631011110567,0,7,androgen biosynthetic process,BP,
3366,GO:0006703,1,0.943712967320707,0,10,estrogen biosynthetic process,BP,
3367,GO:0006704,1,0.920744650851853,0,13,glucocorticoid biosynthetic process,BP,
3368,GO:0006705,1,0.94857435786151,0,8,mineralocorticoid biosynthetic process,BP,
3369,GO:0006706,1,0.885567234836394,0,20,steroid catabolic process,BP,
3370,GO:0006707,1,0.946363357052111,0,9,cholesterol catabolic process,BP,
3371,GO:0006710,1,0.976492212688661,0,4,androgen catabolic process,BP,
3372,GO:0006711,1,0.994367814467123,0,1,estrogen catabolic process,BP,
3373,GO:0006713,1,0.994364196259866,0,1,glucocorticoid catabolic process,BP,
3374,GO:0006714,1,0.989146309159339,0,2,sesquiterpenoid metabolic process,BP,
3377,GO:0006722,1,0.99404523094554,0,1,triterpenoid metabolic process,BP,
3379,GO:0006726,1,0.980989305034428,0,3,eye pigment biosynthetic process,BP,
3380,GO:0006729,1,0.960823436498209,0,7,tetrahydrobiopterin biosynthetic process,BP,
3381,GO:0006730,1,0.815018502254609,0,33,one-carbon metabolic process,BP,
3382,GO:0006732,1,0.108398706787941,0,348,coenzyme metabolic process,BP,
3383,GO:0006733,1,0.329444694308648,0,172,oxidoreduction coenzyme metabolic process,BP,
3384,GO:0006734,1,0.805376474315117,0,35,NADH metabolic process,BP,
3385,GO:0006735,1,0.862797377831677,0,24,NADH regeneration,BP,
3386,GO:0006738,1,0.994041363020688,0,1,nicotinamide riboside catabolic process,BP,
3387,GO:0006739,1,0.819391132019835,0,33,NADP metabolic process,BP,
3388,GO:0006740,1,0.98115665079321,0,3,NADPH regeneration,BP,
3389,GO:0006741,1,0.975639062520863,0,4,NADP biosynthetic process,BP,
3390,GO:0006742,1,0.983107932298327,0,3,NADP catabolic process,BP,
3391,GO:0006743,1,0.916337401538434,0,15,ubiquinone metabolic process,BP,
3392,GO:0006744,1,0.922838775462358,0,14,ubiquinone biosynthetic process,BP,
3393,GO:0006747,1,0.994269348506945,0,1,FAD biosynthetic process,BP,
3394,GO:0006749,1,0.767001669989187,0,46,glutathione metabolic process,BP,
3395,GO:0006750,1,0.919475172227121,0,14,glutathione biosynthetic process,BP,
3396,GO:0006751,1,0.971460671427442,0,5,glutathione catabolic process,BP,
3398,GO:0006754,1,0.469791627869064,0,115,ATP biosynthetic process,BP,
3399,GO:0006756,1,0.993850639026861,0,1,AMP phosphorylation,BP,
3400,GO:0006757,1,0.53631489395478,0,93,ATP generation from ADP,BP,
3401,GO:0006760,1,0.839203858478822,0,28,folic acid-containing compound metabolic process,BP,
3402,GO:0006766,1,0.458370344951738,0,122,vitamin metabolic process,BP,
3403,GO:0006767,1,0.584103168493265,0,83,water-soluble vitamin metabolic process,BP,
3404,GO:0006768,1,0.935938470746719,0,10,biotin metabolic process,BP,
3405,GO:0006771,1,0.956430710579298,0,7,riboflavin metabolic process,BP,
3406,GO:0006772,1,0.976544588173207,0,4,thiamine metabolic process,BP,
3407,GO:0006775,1,0.791540899720621,0,37,fat-soluble vitamin metabolic process,BP,
3408,GO:0006776,1,0.957617998069099,0,7,vitamin A metabolic process,BP,
3409,GO:0006777,1,0.963307640244118,0,6,Mo-molybdopterin cofactor biosynthetic process,BP,
3410,GO:0006778,1,0.823819969905872,0,31,porphyrin-containing compound metabolic process,BP,
3411,GO:0006779,1,0.863128013145896,0,23,porphyrin-containing compound biosynthetic process,BP,
3412,GO:0006780,1,0.988785999224601,0,2,uroporphyrinogen III biosynthetic process,BP,
3413,GO:0006781,1,0.994167818170529,0,1,succinyl-CoA pathway,BP,
3414,GO:0006782,1,0.954836703138435,0,8,protoporphyrinogen IX biosynthetic process,BP,
3415,GO:0006783,1,0.886847303811851,0,19,heme biosynthetic process,BP,
3416,GO:0006784,1,0.985416544648268,0,2,heme a biosynthetic process,BP,
3417,GO:0006787,1,0.978625213976315,0,4,porphyrin-containing compound catabolic process,BP,
3418,GO:0006788,1,0.988906828290117,0,2,heme oxidation,BP,
3419,GO:0006790,1,0.122322050197081,0,331,sulfur compound metabolic process,BP,
3422,GO:0006797,1,0.963907083514324,0,5,polyphosphate metabolic process,BP,
3423,GO:0006798,1,0.969904345318855,0,4,polyphosphate catabolic process,BP,
3424,GO:0006801,1,0.709565594518734,0,55,superoxide metabolic process,BP,
3425,GO:0006805,1,0.57131553005181,0,92,xenobiotic metabolic process,BP,
3427,GO:0006808,1,0.982456627906017,0,3,regulation of nitrogen utilization,BP,
3428,GO:0006809,1,0.682549186373038,0,58,nitric oxide biosynthetic process,BP,
3435,GO:0006817,1,0.89014848499041,0,17,phosphate ion transport,BP,
3438,GO:0006824,1,0.976277474236563,0,4,cobalt ion transport,BP,
3439,GO:0006825,1,0.877448602189733,0,20,copper ion transport,BP,
3441,GO:0006828,1,0.934931486082171,0,10,manganese ion transport,BP,
3442,GO:0006829,1,0.862901336338399,0,23,zinc ion transport,BP,
3444,GO:0006835,1,0.569761127067824,0,83,dicarboxylic acid transport,BP,
3446,GO:0006837,1,0.911614996087778,0,15,serotonin transport,BP,
3448,GO:0006842,1,0.974675800592598,0,4,tricarboxylic acid transport,BP,
3449,GO:0006843,1,0.994460328392633,0,1,mitochondrial citrate transmembrane transport,BP,
3450,GO:0006844,1,0.988420774562126,0,2,acyl carnitine transport,BP,
3451,GO:0006848,1,0.975743796764925,0,4,pyruvate transport,BP,
3452,GO:0006850,1,0.987738712940129,0,2,mitochondrial pyruvate transmembrane transport,BP,
3453,GO:0006851,1,0.871729186238928,0,22,mitochondrial calcium ion transmembrane transport,BP,
3454,GO:0006853,1,0.938223500403396,0,9,carnitine shuttle,BP,
3455,GO:0006855,1,0.615079892849109,0,72,drug transmembrane transport,BP,
3456,GO:0006857,1,0.948871040198418,0,8,oligopeptide transport,BP,
3457,GO:0006858,1,0.982453052491204,0,3,extracellular transport,BP,
3458,GO:0006862,1,0.883810254810937,0,20,nucleotide transport,BP,
3459,GO:0006863,1,0.964774751989896,0,6,purine nucleobase transport,BP,
3460,GO:0006864,1,0.987456090352582,0,2,pyrimidine nucleotide transport,BP,
3461,GO:0006865,1,0.43232717654591,0,126,amino acid transport,BP,
3462,GO:0006867,1,0.987905462970031,0,2,asparagine transport,BP,
3463,GO:0006868,1,0.962122471315589,0,6,glutamine transport,BP,
3468,GO:0006876,1,0.993299058488618,0,1,cellular cadmium ion homeostasis,BP,
3469,GO:0006878,1,0.920653215602893,0,13,cellular copper ion homeostasis,BP,
3471,GO:0006880,1,0.983834663787886,0,3,intracellular sequestering of iron ion,BP,
3472,GO:0006882,1,0.825676004895011,0,32,cellular zinc ion homeostasis,BP,
3473,GO:0006883,1,0.897815304040659,0,16,cellular sodium ion homeostasis,BP,
3474,GO:0006884,1,0.859716340827148,0,22,cell volume homeostasis,BP,
3475,GO:0006885,1,0.535418666369813,0,96,regulation of pH,BP,
3478,GO:0006888,1,0.289964663637116,0,186,ER to Golgi vesicle-mediated transport,BP,
3479,GO:0006890,1,0.595838480136844,0,79,retrograde vesicle-mediated transport, Golgi to ER,BP,
3480,GO:0006891,1,0.808955919935488,0,33,intra-Golgi vesicle-mediated transport,BP,
3481,GO:0006892,1,0.526109801351003,0,92,post-Golgi vesicle-mediated transport,BP,
3482,GO:0006893,1,0.725986127640627,0,47,Golgi to plasma membrane transport,BP,
3483,GO:0006895,1,0.865028062919298,0,19,Golgi to endosome transport,BP,
3484,GO:0006896,1,0.912217045491565,0,14,Golgi to vacuole transport,BP,
3487,GO:0006900,1,0.53922116165981,0,93,vesicle budding from membrane,BP,
3488,GO:0006901,1,0.647234429166765,0,66,vesicle coating,BP,
3489,GO:0006903,1,0.569595339642783,0,85,vesicle targeting,BP,
3490,GO:0006904,1,0.735417955502434,0,48,vesicle docking involved in exocytosis,BP,
3491,GO:0006906,1,0.377155852093301,0,148,vesicle fusion,BP,
3492,GO:0006907,1,0.891693852114009,0,18,pinocytosis,BP,
3493,GO:0006909,1,0.243907236992837,0,218,phagocytosis,BP,
3494,GO:0006910,1,0.915412614381352,0,14,phagocytosis, recognition,BP,
3495,GO:0006911,1,0.752794018626793,0,44,phagocytosis, engulfment,BP,
3499,GO:0006919,1,0.584840419436929,0,86,activation of cysteine-type endopeptidase activity involved in apoptotic process,BP,
3501,GO:0006924,1,0.946466726656017,0,9,activation-induced cell death of T cells,BP,
3502,GO:0006925,1,0.897770507735472,0,17,inflammatory cell apoptotic process,BP,
3504,GO:0006929,1,0.840195397497637,0,25,substrate-dependent cell migration,BP,
3505,GO:0006930,1,0.947903625632347,0,8,substrate-dependent cell migration, cell extension,BP,
3506,GO:0006931,1,0.971988376394292,0,4,substrate-dependent cell migration, cell attachment to substrate,BP,
3507,GO:0006933,1,0.981340521958015,0,3,negative regulation of cell adhesion involved in substrate-bound cell migration,BP,
3514,GO:0006942,1,0.580306190765309,0,79,regulation of striated muscle contraction,BP,
3515,GO:0006948,1,0.993684785110246,0,1,induction by virus of host cell-cell fusion,BP,
3516,GO:0006949,1,0.769256199670116,0,38,syncytium formation,BP,
3519,GO:0006953,1,0.803113817474599,0,36,acute-phase response,BP,
3522,GO:0006956,1,0.743330297715245,0,48,complement activation,BP,
3523,GO:0006957,1,0.9357605153541,0,10,complement activation, alternative pathway,BP,
3524,GO:0006958,1,0.848624177509431,0,26,complement activation, classical pathway,BP,
3525,GO:0006959,1,0.402226353923189,0,154,humoral immune response,BP,
3526,GO:0006968,1,0.743356850492067,0,49,cellular defense response,BP,
3527,GO:0006970,1,0.649365615649336,0,66,response to osmotic stress,BP,
3528,GO:0006971,1,0.936372599194312,0,9,hypotonic response,BP,
3529,GO:0006972,1,0.880042229803833,0,20,hyperosmotic response,BP,
3531,GO:0006975,1,0.947973899644266,0,8,DNA damage induced protein phosphorylation,BP,
3535,GO:0006982,1,0.989223821169711,0,2,response to lipid hydroperoxide,BP,
3536,GO:0006983,1,0.935034358614027,0,10,ER overload response,BP,
3537,GO:0006984,1,0.763844916843522,0,42,ER-nucleus signaling pathway,BP,
3539,GO:0006987,1,0.950506486173731,0,8,activation of signaling protein activity involved in unfolded protein response,BP,
3540,GO:0006990,1,0.979558039815108,0,3,positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response,BP,
3541,GO:0006991,1,0.936809536087206,0,10,response to sterol depletion,BP,
3542,GO:0006995,1,0.938498517797901,0,11,cellular response to nitrogen starvation,BP,
3546,GO:0006999,1,0.899909331959323,0,15,nuclear pore organization,BP,
3547,GO:0007000,1,0.955518664043168,0,7,nucleolus organization,BP,
3548,GO:0007004,1,0.649662591494077,0,65,telomere maintenance via telomerase,BP,
3550,GO:0007006,1,0.532381656873221,0,103,mitochondrial membrane organization,BP,
3551,GO:0007007,1,0.878147897110599,0,22,inner mitochondrial membrane organization,BP,
3552,GO:0007008,1,0.993544062500637,0,1,outer mitochondrial membrane organization,BP,
3555,GO:0007014,1,0.993374277796434,0,1,actin ubiquitination,BP,
3557,GO:0007016,1,0.920412628614437,0,10,cytoskeletal anchoring at plasma membrane,BP,
3560,GO:0007019,1,0.764837797247256,0,38,microtubule depolymerization,BP,
3561,GO:0007020,1,0.83905922964921,0,25,microtubule nucleation,BP,
3562,GO:0007021,1,0.961220636993733,0,7,tubulin complex assembly,BP,
3563,GO:0007023,1,0.976847291491415,0,4,post-chaperonin tubulin folding pathway,BP,
3564,GO:0007026,1,0.855851552549441,0,22,negative regulation of microtubule depolymerization,BP,
3565,GO:0007028,1,0.934411564399047,0,9,cytoplasm organization,BP,
3566,GO:0007029,1,0.738437688813544,0,46,endoplasmic reticulum organization,BP,
3568,GO:0007031,1,0.820274119430873,0,31,peroxisome organization,BP,
3569,GO:0007032,1,0.638461375127279,0,69,endosome organization,BP,
3570,GO:0007033,1,0.364811960700906,0,152,vacuole organization,BP,
3571,GO:0007034,1,0.431238653499332,0,123,vacuolar transport,BP,
3572,GO:0007035,1,0.868250575888857,0,22,vacuolar acidification,BP,
3573,GO:0007039,1,0.905757359037656,0,14,protein catabolic process in the vacuole,BP,
3574,GO:0007040,1,0.682022893821638,0,58,lysosome organization,BP,
3575,GO:0007041,1,0.5267199740446,0,93,lysosomal transport,BP,
3576,GO:0007042,1,0.955684778804871,0,8,lysosomal lumen acidification,BP,
3577,GO:0007043,1,0.479322482266003,0,108,cell-cell junction assembly,BP,
3578,GO:0007044,1,0.528561778027825,0,87,cell-substrate junction assembly,BP,
3579,GO:0007045,1,0.600568032793583,0,71,cell-substrate adherens junction assembly,BP,
3584,GO:0007056,1,0.988333881372545,0,2,spindle assembly involved in female meiosis,BP,
3585,GO:0007057,1,0.988333881372545,0,2,spindle assembly involved in female meiosis I,BP,
3587,GO:0007060,1,0.975625076347372,0,4,male meiosis chromosome segregation,BP,
3590,GO:0007064,1,0.870535158154164,0,19,mitotic sister chromatid cohesion,BP,
3591,GO:0007066,1,0.994804941137137,0,1,female meiosis sister chromatid cohesion,BP,
3592,GO:0007072,1,0.994400894056033,0,1,positive regulation of transcription involved in exit from mitosis,BP,
3595,GO:0007079,1,0.977795382376699,0,3,mitotic chromosome movement towards spindle pole,BP,
3597,GO:0007084,1,0.942459546012309,0,10,mitotic nuclear envelope reassembly,BP,
3599,GO:0007089,1,0.973531712960609,0,4,traversing start control point of mitotic cell cycle,BP,
3605,GO:0007097,1,0.863002920513679,0,19,nuclear migration,BP,
3607,GO:0007099,1,0.822189304829421,0,29,centriole replication,BP,
3608,GO:0007100,1,0.904042234815683,0,15,mitotic centrosome separation,BP,
3609,GO:0007113,1,0.983141920452669,0,3,endomitotic cell cycle,BP,
3611,GO:0007129,1,0.806930212170425,0,34,synapsis,BP,
3612,GO:0007130,1,0.901499365403599,0,16,synaptonemal complex assembly,BP,
3617,GO:0007143,1,0.858544344146449,0,23,female meiotic nuclear division,BP,
3618,GO:0007144,1,0.956662765441178,0,7,female meiosis I,BP,
3619,GO:0007146,1,0.993850639026861,0,1,meiotic recombination nodule assembly,BP,
3620,GO:0007147,1,0.993417599512362,0,1,female meiosis II,BP,
3623,GO:0007156,1,0.493639017827065,0,93,homophilic cell adhesion via plasma membrane adhesion molecules,BP,
3625,GO:0007158,1,0.891814355856299,0,16,neuron cell-cell adhesion,BP,
3626,GO:0007159,1,0.158498929487784,0,290,leukocyte cell-cell adhesion,BP,
3627,GO:0007160,1,0.253288782554529,0,194,cell-matrix adhesion,BP,
3628,GO:0007161,1,0.966466545633347,0,4,calcium-independent cell-matrix adhesion,BP,
3635,GO:0007168,1,0.971031506955217,0,5,receptor guanylyl cyclase signaling pathway,BP,
3637,GO:0007171,1,0.914495644229835,0,13,activation of transmembrane receptor protein tyrosine kinase activity,BP,
3638,GO:0007172,1,0.950183902040056,0,8,signal complex assembly,BP,
3639,GO:0007173,1,0.449764313016923,0,119,epidermal growth factor receptor signaling pathway,BP,
3640,GO:0007174,1,0.994134766915014,0,1,epidermal growth factor catabolic process,BP,
3641,GO:0007175,1,0.910835897796468,0,14,negative regulation of epidermal growth factor-activated receptor activity,BP,
3642,GO:0007176,1,0.837590456191577,0,27,regulation of epidermal growth factor-activated receptor activity,BP,
3645,GO:0007181,1,0.980407393346581,0,3,transforming growth factor beta receptor complex assembly,BP,
3646,GO:0007182,1,0.956146962532345,0,6,common-partner SMAD protein phosphorylation,BP,
3647,GO:0007183,1,0.906474723277128,0,14,SMAD protein complex assembly,BP,
3648,GO:0007185,1,0.951842738703596,0,6,transmembrane receptor protein tyrosine phosphatase signaling pathway,BP,
3652,GO:0007189,1,0.585472613525687,0,82,adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,
3653,GO:0007190,1,0.814816758246195,0,31,activation of adenylate cyclase activity,BP,
3654,GO:0007191,1,0.945451662575736,0,9,adenylate cyclase-activating dopamine receptor signaling pathway,BP,
3656,GO:0007194,1,0.878198825408721,0,20,negative regulation of adenylate cyclase activity,BP,
3657,GO:0007195,1,0.961238559814925,0,6,adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
3658,GO:0007196,1,0.934345901006456,0,9,adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway,BP,
3659,GO:0007197,1,0.9635536939771,0,6,adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway,BP,
3660,GO:0007198,1,0.977178378424088,0,4,adenylate cyclase-inhibiting serotonin receptor signaling pathway,BP,
3661,GO:0007199,1,0.993956333071298,0,1,G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger,BP,
3665,GO:0007205,1,0.842966035796063,0,25,protein kinase C-activating G-protein coupled receptor signaling pathway,BP,
3666,GO:0007206,1,0.984373182440933,0,2,phospholipase C-activating G-protein coupled glutamate receptor signaling pathway,BP,
3667,GO:0007207,1,0.964666665795739,0,6,phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway,BP,
3668,GO:0007208,1,0.98652378671143,0,2,phospholipase C-activating serotonin receptor signaling pathway,BP,
3669,GO:0007210,1,0.925520427488083,0,13,serotonin receptor signaling pathway,BP,
3670,GO:0007212,1,0.785078193828178,0,38,dopamine receptor signaling pathway,BP,
3671,GO:0007213,1,0.904404286607763,0,16,G-protein coupled acetylcholine receptor signaling pathway,BP,
3672,GO:0007214,1,0.858767096789834,0,22,gamma-aminobutyric acid signaling pathway,BP,
3673,GO:0007215,1,0.546699468504406,0,85,glutamate receptor signaling pathway,BP,
3674,GO:0007216,1,0.898071348876723,0,15,G-protein coupled glutamate receptor signaling pathway,BP,
3675,GO:0007217,1,0.961183753495829,0,7,tachykinin receptor signaling pathway,BP,
3677,GO:0007219,1,0.323784763200996,0,170,Notch signaling pathway,BP,
3678,GO:0007220,1,0.89175255514153,0,17,Notch receptor processing,BP,
3679,GO:0007221,1,0.869408742105615,0,18,positive regulation of transcription of Notch receptor target,BP,
3680,GO:0007223,1,0.76563663173567,0,38,Wnt signaling pathway, calcium modulating pathway,BP,
3681,GO:0007224,1,0.434655054111397,0,123,smoothened signaling pathway,BP,
3682,GO:0007225,1,0.992840296006764,0,1,patched ligand maturation,BP,
3683,GO:0007227,1,0.97407855356248,0,4,signal transduction downstream of smoothened,BP,
3684,GO:0007228,1,0.980696339204107,0,3,positive regulation of hh target transcription factor activity,BP,
3686,GO:0007231,1,0.982508471992154,0,3,osmosensory signaling pathway,BP,
3688,GO:0007250,1,0.892684556904758,0,18,activation of NF-kappaB-inducing kinase activity,BP,
3689,GO:0007252,1,0.910850789713627,0,14,I-kappaB phosphorylation,BP,
3690,GO:0007253,1,0.959988285810323,0,7,cytoplasmic sequestering of NF-kappaB,BP,
3692,GO:0007256,1,0.955304205909926,0,6,activation of JNKK activity,BP,
3693,GO:0007257,1,0.805061403904045,0,32,activation of JUN kinase activity,BP,
3694,GO:0007258,1,0.974802577531624,0,4,JUN phosphorylation,BP,
3697,GO:0007263,1,0.874896078091624,0,21,nitric oxide mediated signal transduction,BP,
3703,GO:0007269,1,0.38973592681921,0,138,neurotransmitter secretion,BP,
3704,GO:0007270,1,0.939144587081288,0,8,neuron-neuron synaptic transmission,BP,
3705,GO:0007271,1,0.822525307536369,0,31,synaptic transmission, cholinergic,BP,
3707,GO:0007274,1,0.849146599747037,0,25,neuromuscular synaptic transmission,BP,
3712,GO:0007284,1,0.986173154020322,0,2,spermatogonial cell division,BP,
3714,GO:0007288,1,0.935587374451971,0,10,sperm axoneme assembly,BP,
3715,GO:0007289,1,0.90652893636977,0,14,spermatid nucleus differentiation,BP,
3716,GO:0007290,1,0.992824891804413,0,1,spermatid nucleus elongation,BP,
3717,GO:0007291,1,0.994782728636117,0,1,sperm individualization,BP,
3719,GO:0007296,1,0.96930759372372,0,4,vitellogenesis,BP,
3720,GO:0007308,1,0.98746883095911,0,2,oocyte construction,BP,
3721,GO:0007309,1,0.98746883095911,0,2,oocyte axis specification,BP,
3722,GO:0007314,1,0.98746883095911,0,2,oocyte anterior/posterior axis specification,BP,
3723,GO:0007315,1,0.98746883095911,0,2,pole plasm assembly,BP,
3724,GO:0007320,1,0.938840944051838,0,10,insemination,BP,
3726,GO:0007339,1,0.862212387707935,0,25,binding of sperm to zona pellucida,BP,
3727,GO:0007340,1,0.847927688221101,0,26,acrosome reaction,BP,
3728,GO:0007341,1,0.966420861066768,0,6,penetration of zona pellucida,BP,
3729,GO:0007342,1,0.950982340021901,0,9,fusion of sperm to egg plasma membrane involved in single fertilization,BP,
3730,GO:0007343,1,0.985911893638313,0,2,egg activation,BP,
3733,GO:0007349,1,0.994782728636117,0,1,cellularization,BP,
3734,GO:0007350,1,0.905311721265945,0,15,blastoderm segmentation,BP,
3735,GO:0007351,1,0.923834183307372,0,12,tripartite regional subdivision,BP,
3736,GO:0007352,1,0.978737857879854,0,3,zygotic specification of dorsal/ventral axis,BP,
3737,GO:0007354,1,0.976529424297309,0,4,zygotic determination of anterior/posterior axis, embryo,BP,
3738,GO:0007356,1,0.982835417764084,0,3,thorax and anterior abdomen determination,BP,
3741,GO:0007371,1,0.993360169819569,0,1,ventral midline determination,BP,
3742,GO:0007379,1,0.911625129979593,0,15,segment specification,BP,
3743,GO:0007386,1,0.966683870957759,0,5,compartment pattern specification,BP,
3744,GO:0007387,1,0.993888155097882,0,1,anterior compartment pattern formation,BP,
3745,GO:0007388,1,0.993888155097882,0,1,posterior compartment specification,BP,
3747,GO:0007398,1,0.886734355374009,0,18,ectoderm development,BP,
3749,GO:0007400,1,0.994010428273367,0,1,neuroblast fate determination,BP,
3750,GO:0007402,1,0.988917999636741,0,2,ganglion mother cell fate determination,BP,
3751,GO:0007403,1,0.993522058428007,0,1,glial cell fate determination,BP,
3753,GO:0007406,1,0.964229342369676,0,5,negative regulation of neuroblast proliferation,BP,
3756,GO:0007412,1,0.988011033182753,0,2,axon target recognition,BP,
3758,GO:0007416,1,0.413440605768622,0,122,synapse assembly,BP,
3760,GO:0007418,1,0.973372229865013,0,4,ventral midline development,BP,
3764,GO:0007431,1,0.772234653536067,0,38,salivary gland development,BP,
3765,GO:0007435,1,0.793207236087181,0,34,salivary gland morphogenesis,BP,
3766,GO:0007439,1,0.987762456553011,0,2,ectodermal digestive tract development,BP,
3767,GO:0007440,1,0.925996496557615,0,10,foregut morphogenesis,BP,
3768,GO:0007442,1,0.951800154499034,0,7,hindgut morphogenesis,BP,
3769,GO:0007468,1,0.988241286058736,0,2,regulation of rhodopsin gene expression,BP,
3770,GO:0007492,1,0.592470128336519,0,76,endoderm development,BP,
3771,GO:0007493,1,0.987600867570565,0,2,endodermal cell fate determination,BP,
3772,GO:0007494,1,0.929670827306969,0,11,midgut development,BP,
3773,GO:0007495,1,0.993645373630996,0,1,visceral mesoderm-endoderm interaction involved in midgut development,BP,
3774,GO:0007497,1,0.985889367965976,0,2,posterior midgut development,BP,
3776,GO:0007499,1,0.992896383857593,0,1,ectoderm and mesoderm interaction,BP,
3777,GO:0007500,1,0.988177465284423,0,2,mesodermal cell fate determination,BP,
3779,GO:0007506,1,0.987264242994507,0,2,gonadal mesoderm development,BP,
3781,GO:0007509,1,0.991891487924362,0,1,mesoderm migration involved in gastrulation,BP,
3784,GO:0007518,1,0.988454434475653,0,2,myoblast fate determination,BP,
3786,GO:0007520,1,0.822503424100356,0,29,myoblast fusion,BP,
3787,GO:0007521,1,0.985622974130079,0,2,muscle cell fate determination,BP,
3788,GO:0007522,1,0.992196626573702,0,1,visceral muscle development,BP,
3789,GO:0007525,1,0.976145341540145,0,2,somatic muscle development,BP,
3790,GO:0007528,1,0.7206206825997,0,44,neuromuscular junction development,BP,
3791,GO:0007529,1,0.986461982336491,0,2,establishment of synaptic specificity at neuromuscular junction,BP,
3792,GO:0007530,1,0.873813577002196,0,21,sex determination,BP,
3793,GO:0007538,1,0.985799243394206,0,2,primary sex determination,BP,
3794,GO:0007542,1,0.985799243394206,0,2,primary sex determination, germ-line,BP,
3796,GO:0007549,1,0.914369342583849,0,12,dosage compensation,BP,
3797,GO:0007565,1,0.354529262824644,0,157,female pregnancy,BP,
3798,GO:0007566,1,0.761635208321344,0,42,embryo implantation,BP,
3799,GO:0007567,1,0.901806336245133,0,16,parturition,BP,
3802,GO:0007571,1,0.994759999181943,0,1,age-dependent general metabolic decline,BP,
3803,GO:0007576,1,0.993973328474335,0,1,nucleolar fragmentation,BP,
3805,GO:0007585,1,0.679223447587643,0,59,respiratory gaseous exchange,BP,
3806,GO:0007586,1,0.568180419085422,0,90,digestion,BP,
3808,GO:0007589,1,0.600272385666047,0,77,body fluid secretion,BP,
3809,GO:0007595,1,0.765799218029298,0,38,lactation,BP,
3811,GO:0007597,1,0.911632609934373,0,15,blood coagulation, intrinsic pathway,BP,
3812,GO:0007598,1,0.976447858166782,0,4,blood coagulation, extrinsic pathway,BP,
3815,GO:0007601,1,0.339042027704983,0,164,visual perception,BP,
3816,GO:0007602,1,0.775689994729382,0,41,phototransduction,BP,
3817,GO:0007603,1,0.848150423248491,0,26,phototransduction, visible light,BP,
3819,GO:0007606,1,0.614348278284406,0,81,sensory perception of chemical stimulus,BP,
3820,GO:0007608,1,0.806996267678093,0,35,sensory perception of smell,BP,
3824,GO:0007613,1,0.480755797683958,0,104,memory,BP,
3825,GO:0007614,1,0.945029656079799,0,9,short-term memory,BP,
3826,GO:0007616,1,0.785323594453713,0,34,long-term memory,BP,
3829,GO:0007619,1,0.979891134805628,0,3,courtship behavior,BP,
3830,GO:0007620,1,0.903055935191458,0,16,copulation,BP,
3834,GO:0007624,1,0.993152163886985,0,1,ultradian rhythm,BP,
3835,GO:0007625,1,0.909279835686383,0,15,grooming behavior,BP,
3838,GO:0007631,1,0.594559346513377,0,82,feeding behavior,BP,
3840,GO:0007634,1,0.994027440444057,0,1,optokinetic behavior,BP,
3841,GO:0007635,1,0.911949505651329,0,13,chemosensory behavior,BP,
3842,GO:0007638,1,0.90332434578874,0,13,mechanosensory behavior,BP,
3843,GO:0008009,1,0.839175630309572,0,32,chemokine activity,MF,
3844,GO:0008013,1,0.566282128798795,0,79,beta-catenin binding,MF,
3848,GO:0008020,1,0.954786242318123,0,8,G-protein coupled photoreceptor activity,MF,
3851,GO:0008023,1,0.719002833406279,0,48,transcription elongation factor complex,CC,
3852,GO:0008024,1,0.946037872521765,0,8,cyclin/CDK positive transcription elongation factor complex,CC,
3853,GO:0008026,1,0.545307134130264,0,91,ATP-dependent helicase activity,MF,
3855,GO:0008033,1,0.488810040276891,0,118,tRNA processing,BP,
3856,GO:0008035,1,0.959351888607786,0,7,high-density lipoprotein particle binding,MF,
3859,GO:0008043,1,0.989521982629051,0,2,intracellular ferritin complex,CC,
3860,GO:0008045,1,0.860807536685904,0,21,motor neuron axon guidance,BP,
3861,GO:0008046,1,0.949662156902442,0,7,axon guidance receptor activity,MF,
3863,GO:0008048,1,0.98319841741706,0,3,calcium sensitive guanylate cyclase activator activity,MF,
3864,GO:0008049,1,0.994302685985606,0,1,male courtship behavior,BP,
3865,GO:0008050,1,0.985506701706344,0,2,female courtship behavior,BP,
3866,GO:0008052,1,0.994774980004103,0,1,sensory organ boundary specification,BP,
3867,GO:0008053,1,0.880463478164298,0,21,mitochondrial fusion,BP,
3868,GO:0008057,1,0.99142789815293,0,1,eye pigment granule organization,BP,
3869,GO:0008061,1,0.958689560023122,0,7,chitin binding,MF,
3870,GO:0008063,1,0.961926466318772,0,6,Toll signaling pathway,BP,
3871,GO:0008064,1,0.333910300343627,0,166,regulation of actin polymerization or depolymerization,BP,
3873,GO:0008066,1,0.817083717937461,0,27,glutamate receptor activity,MF,
3874,GO:0008068,1,0.993749318054857,0,1,extracellularly glutamate-gated chloride channel activity,MF,
3875,GO:0008073,1,0.983921327527985,0,3,ornithine decarboxylase inhibitor activity,MF,
3876,GO:0008074,1,0.913235518784041,0,12,guanylate cyclase complex, soluble,CC,
3878,GO:0008078,1,0.981443304209657,0,3,mesodermal cell migration,BP,
3879,GO:0008079,1,0.96135526352572,0,6,translation termination factor activity,MF,
3880,GO:0008080,1,0.600614304294666,0,77,N-acetyltransferase activity,MF,
3883,GO:0008088,1,0.690406350349664,0,54,axo-dendritic transport,BP,
3884,GO:0008089,1,0.783768454926296,0,37,anterograde axonal transport,BP,
3885,GO:0008090,1,0.94407525474097,0,8,retrograde axonal transport,BP,
3886,GO:0008091,1,0.931902423169391,0,8,spectrin,CC,
3888,GO:0008093,1,0.921479593573269,0,12,cytoskeletal adaptor activity,MF,
3890,GO:0008097,1,0.944180378883129,0,10,5S rRNA binding,MF,
3892,GO:0008106,1,0.898652100962798,0,19,alcohol dehydrogenase (NADP+) activity,MF,
3893,GO:0008107,1,0.993101966687149,0,1,galactoside 2-alpha-L-fucosyltransferase activity,MF,
3894,GO:0008108,1,0.994597262047273,0,1,UDP-glucose:hexose-1-phosphate uridylyltransferase activity,MF,
3895,GO:0008109,1,0.986522794491311,0,2,N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity,MF,
3896,GO:0008111,1,0.994268314840275,0,1,alpha-methylacyl-CoA racemase activity,MF,
3897,GO:0008112,1,0.994474281565947,0,1,nicotinamide N-methyltransferase activity,MF,
3898,GO:0008113,1,0.989150440222995,0,2,peptide-methionine (S)-S-oxide reductase activity,MF,
3899,GO:0008115,1,0.994040847314931,0,1,sarcosine oxidase activity,MF,
3900,GO:0008116,1,0.99238993666383,0,1,prostaglandin-I synthase activity,MF,
3901,GO:0008117,1,0.992300312786906,0,1,sphinganine-1-phosphate aldolase activity,MF,
3902,GO:0008118,1,0.994139155906473,0,1,N-acetyllactosaminide alpha-2,3-sialyltransferase activity,MF,
3903,GO:0008119,1,0.993612112860566,0,1,thiopurine S-methyltransferase activity,MF,
3904,GO:0008120,1,0.994444824443174,0,1,ceramide glucosyltransferase activity,MF,
3905,GO:0008121,1,0.961649174919156,0,7,ubiquinol-cytochrome-c reductase activity,MF,
3906,GO:0008124,1,0.988861013455512,0,2,4-alpha-hydroxytetrahydrobiopterin dehydratase activity,MF,
3907,GO:0008126,1,0.99382060087495,0,1,acetylesterase activity,MF,
3908,GO:0008127,1,0.994617412144507,0,1,quercetin 2,3-dioxygenase activity,MF,
3909,GO:0008131,1,0.968438842885601,0,5,primary amine oxidase activity,MF,
3912,GO:0008137,1,0.817730163914159,0,38,NADH dehydrogenase (ubiquinone) activity,MF,
3913,GO:0008138,1,0.775734733928419,0,40,protein tyrosine/serine/threonine phosphatase activity,MF,
3914,GO:0008139,1,0.856162910798034,0,22,nuclear localization sequence binding,MF,
3915,GO:0008140,1,0.949699368718673,0,8,cAMP response element binding protein binding,MF,
3916,GO:0008142,1,0.964283107354706,0,5,oxysterol binding,MF,
3917,GO:0008143,1,0.899209176412192,0,16,poly(A) binding,MF,
3920,GO:0008147,1,0.989985558335165,0,2,structural constituent of bone,MF,
3923,GO:0008154,1,0.290367753490328,0,187,actin polymerization or depolymerization,BP,
3924,GO:0008156,1,0.805247190234806,0,32,negative regulation of DNA replication,BP,
3925,GO:0008157,1,0.886430253137966,0,18,protein phosphatase 1 binding,MF,
3926,GO:0008158,1,0.979376344758778,0,3,hedgehog receptor activity,MF,
3927,GO:0008160,1,0.993937284543643,0,1,protein tyrosine phosphatase activator activity,MF,
3928,GO:0008168,1,0.313002997931093,0,181,methyltransferase activity,MF,
3929,GO:0008169,1,0.981638463994305,0,3,C-methyltransferase activity,MF,
3930,GO:0008170,1,0.588795112190275,0,81,N-methyltransferase activity,MF,
3931,GO:0008171,1,0.894271062202704,0,18,O-methyltransferase activity,MF,
3932,GO:0008172,1,0.960921519710845,0,6,S-methyltransferase activity,MF,
3933,GO:0008173,1,0.727061145525696,0,51,RNA methyltransferase activity,MF,
3934,GO:0008174,1,0.945267594932547,0,9,mRNA methyltransferase activity,MF,
3935,GO:0008175,1,0.842271186458267,0,27,tRNA methyltransferase activity,MF,
3936,GO:0008176,1,0.989035770444843,0,2,tRNA (guanine-N7-)-methyltransferase activity,MF,
3937,GO:0008177,1,0.977407007262679,0,4,succinate dehydrogenase (ubiquinone) activity,MF,
3938,GO:0008179,1,0.913306980346872,0,13,adenylate cyclase binding,MF,
3939,GO:0008180,1,0.809400471761746,0,33,COP9 signalosome,CC,
3940,GO:0008184,1,0.980602106576976,0,3,glycogen phosphorylase activity,MF,
3941,GO:0008186,1,0.651461432633114,0,65,RNA-dependent ATPase activity,MF,
3942,GO:0008187,1,0.860836826217019,0,23,poly-pyrimidine tract binding,MF,
3944,GO:0008190,1,0.935621646177005,0,10,eukaryotic initiation factor 4E binding,MF,
3945,GO:0008191,1,0.909917194279326,0,15,metalloendopeptidase inhibitor activity,MF,
3946,GO:0008192,1,0.980886115435028,0,3,RNA guanylyltransferase activity,MF,
3947,GO:0008193,1,0.987819435330829,0,2,tRNA guanylyltransferase activity,MF,
3948,GO:0008194,1,0.468739549520561,0,118,UDP-glycosyltransferase activity,MF,
3949,GO:0008195,1,0.97776802332449,0,3,phosphatidate phosphatase activity,MF,
3952,GO:0008200,1,0.815742987014073,0,31,ion channel inhibitor activity,MF,
3956,GO:0008204,1,0.988416045237148,0,2,ergosterol metabolic process,BP,
3957,GO:0008206,1,0.767600911873957,0,42,bile acid metabolic process,BP,
3958,GO:0008207,1,0.837316424168546,0,29,C21-steroid hormone metabolic process,BP,
3959,GO:0008209,1,0.874975639763861,0,21,androgen metabolic process,BP,
3960,GO:0008210,1,0.896272031153965,0,18,estrogen metabolic process,BP,
3961,GO:0008211,1,0.888636536170636,0,19,glucocorticoid metabolic process,BP,
3962,GO:0008212,1,0.94857435786151,0,8,mineralocorticoid metabolic process,BP,
3963,GO:0008213,1,0.332817082717748,0,163,protein alkylation,BP,
3964,GO:0008214,1,0.807615432897914,0,29,protein dealkylation,BP,
3965,GO:0008215,1,0.960986884003605,0,7,spermine metabolic process,BP,
3966,GO:0008216,1,0.956013179372152,0,8,spermidine metabolic process,BP,
3968,GO:0008218,1,0.993491860949334,0,1,bioluminescence,BP,
3970,GO:0008227,1,0.824284828285341,0,32,G-protein coupled amine receptor activity,MF,
3971,GO:0008228,1,0.954372497187096,0,7,opsonization,BP,
3974,GO:0008235,1,0.708116705167024,0,54,metalloexopeptidase activity,MF,
3978,GO:0008239,1,0.935401988633405,0,11,dipeptidyl-peptidase activity,MF,
3979,GO:0008240,1,0.97999818242129,0,3,tripeptidyl-peptidase activity,MF,
3980,GO:0008241,1,0.993554040284568,0,1,peptidyl-dipeptidase activity,MF,
3981,GO:0008242,1,0.944465926047568,0,9,omega peptidase activity,MF,
3982,GO:0008250,1,0.933453700748297,0,12,oligosaccharyltransferase complex,CC,
3983,GO:0008251,1,0.985976528631063,0,2,tRNA-specific adenosine deaminase activity,MF,
3984,GO:0008252,1,0.913914883781923,0,14,nucleotidase activity,MF,
3985,GO:0008253,1,0.927267018815832,0,12,5'-nucleotidase activity,MF,
3986,GO:0008254,1,0.9915452641873,0,1,3'-nucleotidase activity,MF,
3987,GO:0008260,1,0.987833677253228,0,2,3-oxoacid CoA-transferase activity,MF,
3988,GO:0008263,1,0.987661947093228,0,2,pyrimidine-specific mismatch base pair DNA N-glycosylase activity,MF,
3989,GO:0008265,1,0.993875560209196,0,1,Mo-molybdopterin cofactor sulfurase activity,MF,
3990,GO:0008266,1,0.884660594384112,0,19,poly(U) RNA binding,MF,
3991,GO:0008267,1,0.991129966925533,0,1,poly-glutamine tract binding,MF,
3992,GO:0008269,1,0.988490050239295,0,2,JAK pathway signal transduction adaptor activity,MF,
3994,GO:0008271,1,0.934633461498059,0,10,secondary active sulfate transmembrane transporter activity,MF,
3995,GO:0008272,1,0.923335310272242,0,12,sulfate transport,BP,
3996,GO:0008273,1,0.973000365951802,0,4,calcium, potassium:sodium antiporter activity,MF,
3997,GO:0008274,1,0.952116697527692,0,7,gamma-tubulin ring complex,CC,
3998,GO:0008275,1,0.973631489530647,0,4,gamma-tubulin small complex,CC,
3999,GO:0008276,1,0.601242813828827,0,77,protein methyltransferase activity,MF,
4001,GO:0008278,1,0.932204466171389,0,10,cohesin complex,CC,
4002,GO:0008281,1,0.985616063347811,0,2,sulfonylurea receptor activity,MF,
4003,GO:0008282,1,0.973586960992808,0,4,inward rectifying potassium channel,CC,
4007,GO:0008286,1,0.451526092268621,0,118,insulin receptor signaling pathway,BP,
4008,GO:0008287,1,0.750154739427445,0,44,protein serine/threonine phosphatase complex,CC,
4010,GO:0008290,1,0.957524139566248,0,7,F-actin capping protein complex,CC,
4011,GO:0008291,1,0.981720673652404,0,3,acetylcholine metabolic process,BP,
4012,GO:0008292,1,0.993921330858198,0,1,acetylcholine biosynthetic process,BP,
4013,GO:0008294,1,0.982082863917519,0,2,calcium- and calmodulin-responsive adenylate cyclase activity,MF,
4014,GO:0008295,1,0.976997370545201,0,4,spermidine biosynthetic process,BP,
4015,GO:0008296,1,0.94052122109864,0,10,3'-5'-exodeoxyribonuclease activity,MF,
4016,GO:0008297,1,0.955859039346648,0,7,single-stranded DNA exodeoxyribonuclease activity,MF,
4017,GO:0008298,1,0.930247872717435,0,12,intracellular mRNA localization,BP,
4018,GO:0008299,1,0.847929000682934,0,27,isoprenoid biosynthetic process,BP,
4019,GO:0008300,1,0.959558647634506,0,7,isoprenoid catabolic process,BP,
4021,GO:0008305,1,0.79721146146387,0,32,integrin complex,CC,
4024,GO:0008308,1,0.912246434901089,0,14,voltage-gated anion channel activity,MF,
4025,GO:0008309,1,0.976755142178392,0,4,double-stranded DNA exodeoxyribonuclease activity,MF,
4026,GO:0008310,1,0.967936488414141,0,5,single-stranded DNA 3'-5' exodeoxyribonuclease activity,MF,
4027,GO:0008311,1,0.988816339751582,0,2,double-stranded DNA 3'-5' exodeoxyribonuclease activity,MF,
4028,GO:0008312,1,0.960260522743012,0,7,7S RNA binding,MF,
4029,GO:0008318,1,0.955010978160611,0,7,protein prenyltransferase activity,MF,
4030,GO:0008320,1,0.929192615893578,0,13,protein transmembrane transporter activity,MF,
4031,GO:0008321,1,0.978754855971685,0,3,Ral guanyl-nucleotide exchange factor activity,MF,
4033,GO:0008327,1,0.906077717060778,0,15,methyl-CpG binding,MF,
4034,GO:0008328,1,0.709447140126594,0,49,ionotropic glutamate receptor complex,CC,
4035,GO:0008329,1,0.916320894771822,0,14,signaling pattern recognition receptor activity,MF,
4036,GO:0008330,1,0.9767675180941,0,4,protein tyrosine/threonine phosphatase activity,MF,
4037,GO:0008331,1,0.905734179561054,0,12,high voltage-gated calcium channel activity,MF,
4038,GO:0008332,1,0.967263486245572,0,4,low voltage-gated calcium channel activity,MF,
4039,GO:0008333,1,0.704923489432777,0,52,endosome to lysosome transport,BP,
4040,GO:0008334,1,0.852524335185002,0,24,histone mRNA metabolic process,BP,
4041,GO:0008336,1,0.994311989915189,0,1,gamma-butyrobetaine dioxygenase activity,MF,
4042,GO:0008340,1,0.919755012899701,0,11,determination of adult lifespan,BP,
4043,GO:0008343,1,0.958920901124683,0,7,adult feeding behavior,BP,
4045,GO:0008347,1,0.774566944230892,0,38,glial cell migration,BP,
4046,GO:0008348,1,0.993398635151442,0,1,negative regulation of antimicrobial humoral response,BP,
4047,GO:0008349,1,0.925145719641694,0,11,MAP kinase kinase kinase kinase activity,MF,
4048,GO:0008352,1,0.99391412779098,0,1,katanin complex,CC,
4050,GO:0008354,1,0.954667442815132,0,7,germ cell migration,BP,
4051,GO:0008355,1,0.986146977449927,0,2,olfactory learning,BP,
4053,GO:0008358,1,0.98746883095911,0,2,maternal determination of anterior/posterior axis, embryo,BP,
4057,GO:0008373,1,0.873938390084009,0,20,sialyltransferase activity,MF,
4058,GO:0008374,1,0.782887993627715,0,37,O-acyltransferase activity,MF,
4059,GO:0008375,1,0.711506426931295,0,53,acetylglucosaminyltransferase activity,MF,
4060,GO:0008376,1,0.754562138091736,0,44,acetylgalactosaminyltransferase activity,MF,
4061,GO:0008378,1,0.825439166272795,0,31,galactosyltransferase activity,MF,
4062,GO:0008379,1,0.97397468210293,0,5,thioredoxin peroxidase activity,MF,
4064,GO:0008381,1,0.945188252469905,0,9,mechanosensitive ion channel activity,MF,
4065,GO:0008384,1,0.986769837179347,0,2,IkappaB kinase activity,MF,
4066,GO:0008385,1,0.94343971462036,0,9,IkappaB kinase complex,CC,
4067,GO:0008386,1,0.994269865341732,0,1,cholesterol monooxygenase (side-chain-cleaving) activity,MF,
4068,GO:0008387,1,0.994111018397422,0,1,steroid 7-alpha-hydroxylase activity,MF,
4069,GO:0008389,1,0.988791189499727,0,2,coumarin 7-hydroxylase activity,MF,
4070,GO:0008391,1,0.95517513079558,0,8,arachidonic acid monooxygenase activity,MF,
4071,GO:0008392,1,0.95517513079558,0,8,arachidonic acid epoxygenase activity,MF,
4072,GO:0008395,1,0.877374075127538,0,22,steroid hydroxylase activity,MF,
4073,GO:0008396,1,0.988196348439196,0,2,oxysterol 7-alpha-hydroxylase activity,MF,
4074,GO:0008397,1,0.993255850191144,0,1,sterol 12-alpha-hydroxylase activity,MF,
4075,GO:0008398,1,0.993701680765667,0,1,sterol 14-demethylase activity,MF,
4076,GO:0008401,1,0.981164562059283,0,3,retinoic acid 4-hydroxylase activity,MF,
4077,GO:0008403,1,0.993651258907726,0,1,25-hydroxycholecalciferol-24-hydroxylase activity,MF,
4078,GO:0008404,1,0.994327496702936,0,1,arachidonic acid 14,15-epoxygenase activity,MF,
4079,GO:0008405,1,0.994327496702936,0,1,arachidonic acid 11,12-epoxygenase activity,MF,
4081,GO:0008408,1,0.733271638526313,0,48,3'-5' exonuclease activity,MF,
4082,GO:0008409,1,0.895339250290876,0,16,5'-3' exonuclease activity,MF,
4083,GO:0008410,1,0.976206085877401,0,4,CoA-transferase activity,MF,
4084,GO:0008413,1,0.989193873363768,0,2,8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity,MF,
4085,GO:0008417,1,0.921574596943605,0,12,fucosyltransferase activity,MF,
4086,GO:0008418,1,0.994712989135503,0,1,protein-N-terminal asparagine amidohydrolase activity,MF,
4087,GO:0008419,1,0.993918758202041,0,1,RNA lariat debranching enzyme activity,MF,
4088,GO:0008420,1,0.951005177366331,0,8,CTD phosphatase activity,MF,
4089,GO:0008422,1,0.974966389264157,0,4,beta-glucosidase activity,MF,
4090,GO:0008424,1,0.993591646691022,0,1,glycoprotein 6-alpha-L-fucosyltransferase activity,MF,
4091,GO:0008425,1,0.994634461808247,0,1,2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity,MF,
4092,GO:0008426,1,0.982893847545628,0,3,protein kinase C inhibitor activity,MF,
4093,GO:0008427,1,0.98353674006912,0,3,calcium-dependent protein kinase inhibitor activity,MF,
4094,GO:0008428,1,0.981249349070999,0,3,ribonuclease inhibitor activity,MF,
4095,GO:0008429,1,0.943622649356414,0,9,phosphatidylethanolamine binding,MF,
4096,GO:0008430,1,0.973936666314093,0,4,selenium binding,MF,
4097,GO:0008431,1,0.987680544993058,0,2,vitamin E binding,MF,
4098,GO:0008432,1,0.947165353184187,0,8,JUN kinase binding,MF,
4099,GO:0008434,1,0.992855173037058,0,1,calcitriol receptor activity,MF,
4100,GO:0008437,1,0.994252551938634,0,1,thyrotropin-releasing hormone activity,MF,
4101,GO:0008440,1,0.967891278764221,0,5,inositol-1,4,5-trisphosphate 3-kinase activity,MF,
4102,GO:0008441,1,0.985611447835075,0,2,3'(2'),5'-bisphosphate nucleotidase activity,MF,
4103,GO:0008442,1,0.994265989104534,0,1,3-hydroxyisobutyrate dehydrogenase activity,MF,
4104,GO:0008443,1,0.955519471443799,0,7,phosphofructokinase activity,MF,
4105,GO:0008444,1,0.994154906260876,0,1,CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity,MF,
4106,GO:0008445,1,0.994452059675825,0,1,D-aspartate oxidase activity,MF,
4107,GO:0008446,1,0.994422084484959,0,1,GDP-mannose 4,6-dehydratase activity,MF,
4108,GO:0008448,1,0.994340160684075,0,1,N-acetylglucosamine-6-phosphate deacetylase activity,MF,
4109,GO:0008449,1,0.978263085851975,0,3,N-acetylglucosamine-6-sulfatase activity,MF,
4110,GO:0008452,1,0.993850639026861,0,1,RNA ligase activity,MF,
4112,GO:0008454,1,0.980469447675993,0,3,alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity,MF,
4113,GO:0008455,1,0.993890983044866,0,1,alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity,MF,
4114,GO:0008456,1,0.99336683965506,0,1,alpha-N-acetylgalactosaminidase activity,MF,
4115,GO:0008457,1,0.993166118223734,0,1,beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity,MF,
4116,GO:0008458,1,0.993611089528904,0,1,carnitine O-octanoyltransferase activity,MF,
4117,GO:0008459,1,0.985822556876704,0,2,chondroitin 6-sulfotransferase activity,MF,
4118,GO:0008460,1,0.994302685985606,0,1,dTDP-glucose 4,6-dehydratase activity,MF,
4119,GO:0008465,1,0.994648411260397,0,1,glycerate dehydrogenase activity,MF,
4120,GO:0008466,1,0.987949279993071,0,2,glycogenin glucosyltransferase activity,MF,
4122,GO:0008469,1,0.947581569462127,0,9,histone-arginine N-methyltransferase activity,MF,
4123,GO:0008470,1,0.992902640044226,0,1,isovaleryl-CoA dehydrogenase activity,MF,
4124,GO:0008474,1,0.941237790983376,0,10,palmitoyl-(protein) hydrolase activity,MF,
4125,GO:0008475,1,0.980805261471511,0,3,procollagen-lysine 5-dioxygenase activity,MF,
4126,GO:0008476,1,0.988543459837748,0,2,protein-tyrosine sulfotransferase activity,MF,
4127,GO:0008478,1,0.991461119267008,0,1,pyridoxal kinase activity,MF,
4128,GO:0008479,1,0.977885145045641,0,4,queuine tRNA-ribosyltransferase activity,MF,
4129,GO:0008480,1,0.993580646328245,0,1,sarcosine dehydrogenase activity,MF,
4130,GO:0008481,1,0.988118519881087,0,2,sphinganine kinase activity,MF,
4131,GO:0008482,1,0.994082632298406,0,1,sulfite oxidase activity,MF,
4133,GO:0008484,1,0.898584470833724,0,16,sulfuric ester hydrolase activity,MF,
4134,GO:0008486,1,0.975932507390272,0,4,diphosphoinositol-polyphosphate diphosphatase activity,MF,
4135,GO:0008488,1,0.993652538349751,0,1,gamma-glutamyl carboxylase activity,MF,
4136,GO:0008489,1,0.993790073474442,0,1,UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity,MF,
4137,GO:0008493,1,0.994325687567316,0,1,tetracycline transmembrane transporter activity,MF,
4138,GO:0008494,1,0.933043978380173,0,11,translation activator activity,MF,
4139,GO:0008495,1,0.993740094998934,0,1,protoheme IX farnesyltransferase activity,MF,
4140,GO:0008496,1,0.993095231774431,0,1,mannan endo-1,6-alpha-mannosidase activity,MF,
4141,GO:0008499,1,0.928505275418672,0,12,UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity,MF,
4142,GO:0008502,1,0.977024466116783,0,4,melatonin receptor activity,MF,
4143,GO:0008503,1,0.93411167775068,0,10,benzodiazepine receptor activity,MF,
4144,GO:0008504,1,0.949194675650995,0,8,monoamine transmembrane transporter activity,MF,
4145,GO:0008506,1,0.981339629418741,0,3,sucrose:proton symporter activity,MF,
4146,GO:0008507,1,0.993440655178386,0,1,sodium:iodide symporter activity,MF,
4147,GO:0008508,1,0.977815436232817,0,4,bile acid:sodium symporter activity,MF,
4149,GO:0008510,1,0.935117217433077,0,9,sodium:bicarbonate symporter activity,MF,
4150,GO:0008511,1,0.984631439458243,0,2,sodium:potassium:chloride symporter activity,MF,
4151,GO:0008513,1,0.98817847192601,0,2,secondary active organic cation transmembrane transporter activity,MF,
4153,GO:0008515,1,0.981339629418741,0,3,sucrose transmembrane transporter activity,MF,
4154,GO:0008517,1,0.962928318380273,0,6,folic acid transmembrane transporter activity,MF,
4155,GO:0008518,1,0.993822653994821,0,1,reduced folate carrier activity,MF,
4156,GO:0008519,1,0.844447361530219,0,27,ammonium transmembrane transporter activity,MF,
4157,GO:0008520,1,0.991679953279934,0,1,L-ascorbate:sodium symporter activity,MF,
4158,GO:0008521,1,0.993914642257477,0,1,acetyl-CoA transmembrane transporter activity,MF,
4159,GO:0008523,1,0.993584227840159,0,1,sodium-dependent multivitamin transmembrane transporter activity,MF,
4160,GO:0008525,1,0.944753572354247,0,8,phosphatidylcholine transporter activity,MF,
4161,GO:0008526,1,0.946854578177326,0,8,phosphatidylinositol transporter activity,MF,
4162,GO:0008527,1,0.92528861182672,0,14,taste receptor activity,MF,
4164,GO:0008531,1,0.993890983044866,0,1,riboflavin kinase activity,MF,
4165,GO:0008532,1,0.952466533059621,0,8,N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity,MF,
4166,GO:0008534,1,0.978401886213583,0,4,oxidized purine nucleobase lesion DNA N-glycosylase activity,MF,
4167,GO:0008535,1,0.865285266960345,0,24,respiratory chain complex IV assembly,BP,
4169,GO:0008537,1,0.983316313424143,0,3,proteasome activator complex,CC,
4170,GO:0008540,1,0.933288438638242,0,12,proteasome regulatory particle, base subcomplex,CC,
4171,GO:0008541,1,0.961490241366986,0,7,proteasome regulatory particle, lid subcomplex,CC,
4175,GO:0008545,1,0.986946659362823,0,2,JUN kinase kinase activity,MF,
4176,GO:0008553,1,0.919711761066796,0,13,proton-exporting ATPase activity, phosphorylative mechanism,MF,
4177,GO:0008554,1,0.992813139429852,0,1,sodium-exporting ATPase activity, phosphorylative mechanism,MF,
4178,GO:0008555,1,0.992509999211576,0,1,chloride-transporting ATPase activity,MF,
4179,GO:0008556,1,0.932391960522637,0,11,potassium-transporting ATPase activity,MF,
4180,GO:0008559,1,0.957504867151906,0,6,xenobiotic transmembrane transporting ATPase activity,MF,
4181,GO:0008565,1,0.60468723541666,0,77,protein transporter activity,MF,
4182,GO:0008568,1,0.935998477554135,0,10,microtubule-severing ATPase activity,MF,
4184,GO:0008574,1,0.810112146745929,0,30,ATP-dependent microtubule motor activity, plus-end-directed,MF,
4185,GO:0008579,1,0.992558226903533,0,1,JUN kinase phosphatase activity,MF,
4186,GO:0008582,1,0.971491302932323,0,4,regulation of synaptic growth at neuromuscular junction,BP,
4189,GO:0008589,1,0.608345416204256,0,72,regulation of smoothened signaling pathway,BP,
4190,GO:0008591,1,0.994356959793459,0,1,regulation of Wnt signaling pathway, calcium modulating pathway,BP,
4191,GO:0008592,1,0.993617741246891,0,1,regulation of Toll signaling pathway,BP,
4192,GO:0008593,1,0.549517419005472,0,90,regulation of Notch signaling pathway,BP,
4193,GO:0008594,1,0.986455890432889,0,2,photoreceptor cell morphogenesis,BP,
4194,GO:0008595,1,0.923834183307372,0,12,anterior/posterior axis specification, embryo,BP,
4195,GO:0008597,1,0.982142716382215,0,3,calcium-dependent protein serine/threonine phosphatase regulator activity,MF,
4196,GO:0008603,1,0.958355112390762,0,7,cAMP-dependent protein kinase regulator activity,MF,
4197,GO:0008607,1,0.981875351614416,0,3,phosphorylase kinase regulator activity,MF,
4198,GO:0008608,1,0.824470652238573,0,30,attachment of spindle microtubules to kinetochore,BP,
4199,GO:0008609,1,0.991308609257935,0,1,alkylglycerone-phosphate synthase activity,MF,
4201,GO:0008611,1,0.967295113675667,0,5,ether lipid biosynthetic process,BP,
4202,GO:0008612,1,0.976237773896743,0,4,peptidyl-lysine modification to peptidyl-hypusine,BP,
4203,GO:0008614,1,0.987731816011715,0,2,pyridoxine metabolic process,BP,
4204,GO:0008615,1,0.987731816011715,0,2,pyridoxine biosynthetic process,BP,
4205,GO:0008616,1,0.983198014075447,0,3,queuosine biosynthetic process,BP,
4206,GO:0008617,1,0.994766198164714,0,1,guanosine metabolic process,BP,
4207,GO:0008622,1,0.969042018428576,0,5,epsilon DNA polymerase complex,CC,
4208,GO:0008623,1,0.986270865391994,0,2,CHRAC,CC,
4210,GO:0008626,1,0.965566820770783,0,6,granzyme-mediated apoptotic signaling pathway,BP,
4211,GO:0008627,1,0.948265060736251,0,8,intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
4212,GO:0008628,1,0.983534446264989,0,3,hormone-mediated apoptotic signaling pathway,BP,
4214,GO:0008631,1,0.7698928293177,0,42,intrinsic apoptotic signaling pathway in response to oxidative stress,BP,
4215,GO:0008635,1,0.944849377931483,0,9,activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c,BP,
4216,GO:0008637,1,0.495403435077696,0,114,apoptotic mitochondrial changes,BP,
4217,GO:0008641,1,0.937717428503873,0,10,ubiquitin-like modifier activating enzyme activity,MF,
4220,GO:0008649,1,0.913497367061903,0,15,rRNA methyltransferase activity,MF,
4221,GO:0008650,1,0.993446801833041,0,1,rRNA (uridine-2'-O-)-methyltransferase activity,MF,
4222,GO:0008652,1,0.620240082698419,0,75,cellular amino acid biosynthetic process,BP,
4224,GO:0008655,1,0.932467244853405,0,12,pyrimidine-containing compound salvage,BP,
4225,GO:0008656,1,0.913335105518438,0,14,cysteine-type endopeptidase activator activity involved in apoptotic process,MF,
4226,GO:0008670,1,0.989138091467623,0,2,2,4-dienoyl-CoA reductase (NADPH) activity,MF,
4227,GO:0008689,1,0.994634461808247,0,1,3-demethylubiquinone-9 3-O-methyltransferase activity,MF,
4228,GO:0008700,1,0.993850639026861,0,1,4-hydroxy-2-oxoglutarate aldolase activity,MF,
4229,GO:0008705,1,0.989815143901705,0,1,methionine synthase activity,MF,
4230,GO:0008709,1,0.994797450914192,0,1,cholate 7-alpha-dehydrogenase activity,MF,
4231,GO:0008721,1,0.994007335679593,0,1,D-serine ammonia-lyase activity,MF,
4232,GO:0008725,1,0.994727453981438,0,1,DNA-3-methyladenine glycosylase activity,MF,
4233,GO:0008732,1,0.988183553597633,0,2,L-allo-threonine aldolase activity,MF,
4234,GO:0008745,1,0.994797709198386,0,1,N-acetylmuramoyl-L-alanine amidase activity,MF,
4235,GO:0008746,1,0.987642480893837,0,2,NAD(P)+ transhydrogenase activity,MF,
4236,GO:0008747,1,0.994483066716391,0,1,N-acetylneuraminate lyase activity,MF,
4237,GO:0008750,1,0.992876305256662,0,1,NAD(P)+ transhydrogenase (AB-specific) activity,MF,
4238,GO:0008753,1,0.993508240235619,0,1,NADPH dehydrogenase (quinone) activity,MF,
4239,GO:0008757,1,0.426556420740717,0,132,S-adenosylmethionine-dependent methyltransferase activity,MF,
4240,GO:0008761,1,0.992549840277366,0,1,UDP-N-acetylglucosamine 2-epimerase activity,MF,
4241,GO:0008768,1,0.994842133436599,0,1,UDP-sugar diphosphatase activity,MF,
4242,GO:0008775,1,0.994345588104529,0,1,acetate CoA-transferase activity,MF,
4243,GO:0008781,1,0.989065601305351,0,2,N-acylneuraminate cytidylyltransferase activity,MF,
4244,GO:0008783,1,0.994152840500699,0,1,agmatinase activity,MF,
4245,GO:0008785,1,0.994479966090823,0,1,alkyl hydroperoxide reductase activity,MF,
4246,GO:0008792,1,0.993850639026861,0,1,arginine decarboxylase activity,MF,
4247,GO:0008794,1,0.994818371788008,0,1,arsenate reductase (glutaredoxin) activity,MF,
4248,GO:0008796,1,0.988673540355775,0,2,bis(5'-nucleosyl)-tetraphosphatase activity,MF,
4249,GO:0008798,1,0.986427422872394,0,2,beta-aspartyl-peptidase activity,MF,
4250,GO:0008802,1,0.993451411434909,0,1,betaine-aldehyde dehydrogenase activity,MF,
4251,GO:0008803,1,0.994778079462415,0,1,bis(5'-nucleosyl)-tetraphosphatase (symmetrical) activity,MF,
4252,GO:0008808,1,0.993329627581151,0,1,cardiolipin synthase activity,MF,
4253,GO:0008812,1,0.99340991212181,0,1,choline dehydrogenase activity,MF,
4254,GO:0008817,1,0.993155265548963,0,1,cob(I)yrinic acid a,c-diamide adenosyltransferase activity,MF,
4255,GO:0008821,1,0.952211568268615,0,8,crossover junction endodeoxyribonuclease activity,MF,
4256,GO:0008823,1,0.966975860033133,0,5,cupric reductase activity,MF,
4257,GO:0008829,1,0.994347655690543,0,1,dCTP deaminase activity,MF,
4258,GO:0008832,1,0.993637697540363,0,1,dGTPase activity,MF,
4259,GO:0008841,1,0.994001666357671,0,1,dihydrofolate synthase activity,MF,
4260,GO:0008843,1,0.994093469418573,0,1,endochitinase activity,MF,
4261,GO:0008852,1,0.993825733887827,0,1,exodeoxyribonuclease I activity,MF,
4262,GO:0008853,1,0.9763910324267,0,4,exodeoxyribonuclease III activity,MF,
4263,GO:0008859,1,0.994795126354332,0,1,exoribonuclease II activity,MF,
4264,GO:0008865,1,0.966422993637629,0,5,fructokinase activity,MF,
4265,GO:0008887,1,0.993618252924019,0,1,glycerate kinase activity,MF,
4266,GO:0008889,1,0.967690034371299,0,5,glycerophosphodiester phosphodiesterase activity,MF,
4267,GO:0008890,1,0.994470147329437,0,1,glycine C-acetyltransferase activity,MF,
4268,GO:0008891,1,0.994384871413264,0,1,glycolate oxidase activity,MF,
4269,GO:0008892,1,0.992478017779405,0,1,guanine deaminase activity,MF,
4270,GO:0008893,1,0.994750184060493,0,1,guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity,MF,
4271,GO:0008894,1,0.993875046213888,0,1,guanosine-5'-triphosphate,3'-diphosphate diphosphatase activity,MF,
4272,GO:0008897,1,0.993810850076158,0,1,holo-[acyl-carrier-protein] synthase activity,MF,
4273,GO:0008900,1,0.9869300104978,0,2,potassium:proton exchanging ATPase activity,MF,
4274,GO:0008903,1,0.994715572158587,0,1,hydroxypyruvate isomerase activity,MF,
4275,GO:0008905,1,0.994459294809995,0,1,mannose-phosphate guanylyltransferase activity,MF,
4276,GO:0008934,1,0.973519979811034,0,4,inositol monophosphate 1-phosphatase activity,MF,
4277,GO:0008940,1,0.980911616204748,0,3,nitrate reductase activity,MF,
4278,GO:0008941,1,0.988307380428046,0,2,nitric oxide dioxygenase activity,MF,
4279,GO:0008948,1,0.975276042403211,0,4,oxaloacetate decarboxylase activity,MF,
4280,GO:0008955,1,0.993250701930044,0,1,peptidoglycan glycosyltransferase activity,MF,
4281,GO:0008962,1,0.988240972952475,0,2,phosphatidylglycerophosphatase activity,MF,
4282,GO:0008963,1,0.994180215002525,0,1,phospho-N-acetylmuramoyl-pentapeptide-transferase activity,MF,
4283,GO:0008967,1,0.987952327262056,0,2,phosphoglycolate phosphatase activity,MF,
4284,GO:0008970,1,0.947261967699441,0,9,phosphatidylcholine 1-acylhydrolase activity,MF,
4285,GO:0008973,1,0.99361364786428,0,1,phosphopentomutase activity,MF,
4286,GO:0008988,1,0.987738712940129,0,2,rRNA (adenine-N6-)-methyltransferase activity,MF,
4287,GO:0008995,1,0.993950154352162,0,1,ribonuclease E activity,MF,
4288,GO:0009000,1,0.994014551987904,0,1,selenocysteine lyase activity,MF,
4289,GO:0009007,1,0.99339350837991,0,1,site-specific DNA-methyltransferase (adenine-specific) activity,MF,
4290,GO:0009008,1,0.967282683180874,0,5,DNA-methyltransferase activity,MF,
4291,GO:0009013,1,0.992626349998796,0,1,succinate-semialdehyde dehydrogenase [NAD(P)+] activity,MF,
4292,GO:0009019,1,0.974360402939422,0,4,tRNA (guanine-N1-)-methyltransferase activity,MF,
4293,GO:0009020,1,0.9942763258542,0,1,tRNA (guanosine-2'-O-)-methyltransferase activity,MF,
4294,GO:0009032,1,0.994430353677249,0,1,thymidine phosphorylase activity,MF,
4295,GO:0009041,1,0.982365139905497,0,3,uridylate kinase activity,MF,
4296,GO:0009048,1,0.925025155364475,0,10,dosage compensation by inactivation of X chromosome,BP,
4297,GO:0009051,1,0.983212453314679,0,3,pentose-phosphate shunt, oxidative branch,BP,
4298,GO:0009052,1,0.970933510944001,0,5,pentose-phosphate shunt, non-oxidative branch,BP,
4299,GO:0009055,1,0.558548493768106,0,101,electron transfer activity,MF,
4304,GO:0009060,1,0.644886114880675,0,74,aerobic respiration,BP,
4305,GO:0009061,1,0.994050130647061,0,1,anaerobic respiration,BP,
4306,GO:0009062,1,0.518198411192147,0,104,fatty acid catabolic process,BP,
4308,GO:0009064,1,0.64674778859247,0,69,glutamine family amino acid metabolic process,BP,
4309,GO:0009065,1,0.837720728982433,0,28,glutamine family amino acid catabolic process,BP,
4310,GO:0009066,1,0.710605337466329,0,55,aspartate family amino acid metabolic process,BP,
4311,GO:0009067,1,0.869398710170966,0,22,aspartate family amino acid biosynthetic process,BP,
4312,GO:0009068,1,0.880224340541061,0,21,aspartate family amino acid catabolic process,BP,
4313,GO:0009069,1,0.804149739075811,0,36,serine family amino acid metabolic process,BP,
4314,GO:0009070,1,0.915179413183575,0,15,serine family amino acid biosynthetic process,BP,
4315,GO:0009071,1,0.938382399624291,0,11,serine family amino acid catabolic process,BP,
4316,GO:0009072,1,0.873066519588142,0,23,aromatic amino acid family metabolic process,BP,
4317,GO:0009074,1,0.901576102562943,0,18,aromatic amino acid family catabolic process,BP,
4318,GO:0009078,1,0.9767045760509,0,4,pyruvate family amino acid metabolic process,BP,
4319,GO:0009080,1,0.9767045760509,0,4,pyruvate family amino acid catabolic process,BP,
4320,GO:0009081,1,0.855431193074734,0,24,branched-chain amino acid metabolic process,BP,
4321,GO:0009082,1,0.98550402034736,0,2,branched-chain amino acid biosynthetic process,BP,
4322,GO:0009083,1,0.873890841159551,0,21,branched-chain amino acid catabolic process,BP,
4323,GO:0009084,1,0.896471164584429,0,17,glutamine family amino acid biosynthetic process,BP,
4324,GO:0009085,1,0.98610055434743,0,2,lysine biosynthetic process,BP,
4325,GO:0009086,1,0.925958655639965,0,12,methionine biosynthetic process,BP,
4326,GO:0009087,1,0.993531781510195,0,1,methionine catabolic process,BP,
4327,GO:0009088,1,0.99419571281523,0,1,threonine biosynthetic process,BP,
4328,GO:0009092,1,0.976562831245307,0,4,homoserine metabolic process,BP,
4329,GO:0009093,1,0.982957165976133,0,3,cysteine catabolic process,BP,
4330,GO:0009098,1,0.98550402034736,0,2,leucine biosynthetic process,BP,
4331,GO:0009099,1,0.98550402034736,0,2,valine biosynthetic process,BP,
4334,GO:0009106,1,0.987898710988989,0,2,lipoate metabolic process,BP,
4335,GO:0009107,1,0.994422859727469,0,1,lipoate biosynthetic process,BP,
4336,GO:0009108,1,0.239925070874019,0,221,coenzyme biosynthetic process,BP,
4337,GO:0009109,1,0.918340931603329,0,14,coenzyme catabolic process,BP,
4338,GO:0009110,1,0.876491543333759,0,21,vitamin biosynthetic process,BP,
4339,GO:0009111,1,0.941539908087787,0,10,vitamin catabolic process,BP,
4340,GO:0009112,1,0.783490264752274,0,39,nucleobase metabolic process,BP,
4341,GO:0009113,1,0.924506224681729,0,13,purine nucleobase biosynthetic process,BP,
4342,GO:0009115,1,0.98509875160187,0,2,xanthine catabolic process,BP,
4343,GO:0009116,1,0.494961326696538,0,113,nucleoside metabolic process,BP,
4345,GO:0009119,1,0.554469128651616,0,94,ribonucleoside metabolic process,BP,
4346,GO:0009120,1,0.964990472840312,0,6,deoxyribonucleoside metabolic process,BP,
4349,GO:0009125,1,0.93597087684387,0,11,nucleoside monophosphate catabolic process,BP,
4352,GO:0009128,1,0.947006295065865,0,9,purine nucleoside monophosphate catabolic process,BP,
4353,GO:0009129,1,0.909116266950092,0,16,pyrimidine nucleoside monophosphate metabolic process,BP,
4354,GO:0009130,1,0.914177052109251,0,15,pyrimidine nucleoside monophosphate biosynthetic process,BP,
4355,GO:0009131,1,0.994469113765464,0,1,pyrimidine nucleoside monophosphate catabolic process,BP,
4358,GO:0009134,1,0.963720352701923,0,6,nucleoside diphosphate catabolic process,BP,
4361,GO:0009137,1,0.981002844558494,0,3,purine nucleoside diphosphate catabolic process,BP,
4362,GO:0009138,1,0.982326601767891,0,3,pyrimidine nucleoside diphosphate metabolic process,BP,
4363,GO:0009139,1,0.988480665307055,0,2,pyrimidine nucleoside diphosphate biosynthetic process,BP,
4364,GO:0009140,1,0.993774946284491,0,1,pyrimidine nucleoside diphosphate catabolic process,BP,
4367,GO:0009143,1,0.928696044860102,0,12,nucleoside triphosphate catabolic process,BP,
4369,GO:0009145,1,0.441940312354829,0,126,purine nucleoside triphosphate biosynthetic process,BP,
4370,GO:0009146,1,0.964708142395701,0,6,purine nucleoside triphosphate catabolic process,BP,
4371,GO:0009147,1,0.885876972728942,0,21,pyrimidine nucleoside triphosphate metabolic process,BP,
4372,GO:0009148,1,0.901165727056724,0,18,pyrimidine nucleoside triphosphate biosynthetic process,BP,
4373,GO:0009149,1,0.989062462928108,0,2,pyrimidine nucleoside triphosphate catabolic process,BP,
4378,GO:0009154,1,0.810739364588153,0,31,purine ribonucleotide catabolic process,BP,
4379,GO:0009155,1,0.969830464873024,0,5,purine deoxyribonucleotide catabolic process,BP,
4381,GO:0009157,1,0.9485560294359,0,9,deoxyribonucleoside monophosphate biosynthetic process,BP,
4382,GO:0009158,1,0.952039279751233,0,8,ribonucleoside monophosphate catabolic process,BP,
4383,GO:0009159,1,0.988353422414914,0,2,deoxyribonucleoside monophosphate catabolic process,BP,
4385,GO:0009162,1,0.932603011760725,0,12,deoxyribonucleoside monophosphate metabolic process,BP,
4386,GO:0009163,1,0.785590873147089,0,41,nucleoside biosynthetic process,BP,
4387,GO:0009164,1,0.853818110144695,0,27,nucleoside catabolic process,BP,
4389,GO:0009166,1,0.358109133064165,0,156,nucleotide catabolic process,BP,
4392,GO:0009169,1,0.952039279751233,0,8,purine ribonucleoside monophosphate catabolic process,BP,
4393,GO:0009170,1,0.994777046310465,0,1,purine deoxyribonucleoside monophosphate metabolic process,BP,
4394,GO:0009173,1,0.940700939427565,0,10,pyrimidine ribonucleoside monophosphate metabolic process,BP,
4395,GO:0009174,1,0.940700939427565,0,10,pyrimidine ribonucleoside monophosphate biosynthetic process,BP,
4396,GO:0009176,1,0.96644471141746,0,6,pyrimidine deoxyribonucleoside monophosphate metabolic process,BP,
4397,GO:0009177,1,0.97182129373887,0,5,pyrimidine deoxyribonucleoside monophosphate biosynthetic process,BP,
4398,GO:0009178,1,0.994469113765464,0,1,pyrimidine deoxyribonucleoside monophosphate catabolic process,BP,
4401,GO:0009181,1,0.981002844558494,0,3,purine ribonucleoside diphosphate catabolic process,BP,
4406,GO:0009187,1,0.466736270220468,0,115,cyclic nucleotide metabolic process,BP,
4409,GO:0009190,1,0.612680090504188,0,76,cyclic nucleotide biosynthetic process,BP,
4410,GO:0009191,1,0.969691913189464,0,5,ribonucleoside diphosphate catabolic process,BP,
4411,GO:0009193,1,0.993774946284491,0,1,pyrimidine ribonucleoside diphosphate metabolic process,BP,
4412,GO:0009195,1,0.993774946284491,0,1,pyrimidine ribonucleoside diphosphate catabolic process,BP,
4413,GO:0009196,1,0.988480665307055,0,2,pyrimidine deoxyribonucleoside diphosphate metabolic process,BP,
4414,GO:0009197,1,0.988480665307055,0,2,pyrimidine deoxyribonucleoside diphosphate biosynthetic process,BP,
4416,GO:0009200,1,0.910349608799,0,16,deoxyribonucleoside triphosphate metabolic process,BP,
4417,GO:0009201,1,0.427702581640346,0,131,ribonucleoside triphosphate biosynthetic process,BP,
4418,GO:0009202,1,0.966085957877959,0,6,deoxyribonucleoside triphosphate biosynthetic process,BP,
4419,GO:0009203,1,0.994719963282845,0,1,ribonucleoside triphosphate catabolic process,BP,
4420,GO:0009204,1,0.959219640814143,0,7,deoxyribonucleoside triphosphate catabolic process,BP,
4422,GO:0009206,1,0.444527748518568,0,125,purine ribonucleoside triphosphate biosynthetic process,BP,
4423,GO:0009207,1,0.994719963282845,0,1,purine ribonucleoside triphosphate catabolic process,BP,
4424,GO:0009208,1,0.916121615273978,0,15,pyrimidine ribonucleoside triphosphate metabolic process,BP,
4425,GO:0009209,1,0.921726716968054,0,14,pyrimidine ribonucleoside triphosphate biosynthetic process,BP,
4426,GO:0009211,1,0.967014957697141,0,6,pyrimidine deoxyribonucleoside triphosphate metabolic process,BP,
4427,GO:0009212,1,0.97771113382292,0,4,pyrimidine deoxyribonucleoside triphosphate biosynthetic process,BP,
4428,GO:0009213,1,0.989062462928108,0,2,pyrimidine deoxyribonucleoside triphosphate catabolic process,BP,
4429,GO:0009214,1,0.865501284024513,0,20,cyclic nucleotide catabolic process,BP,
4430,GO:0009215,1,0.948299015622615,0,9,purine deoxyribonucleoside triphosphate metabolic process,BP,
4431,GO:0009216,1,0.98811249798307,0,2,purine deoxyribonucleoside triphosphate biosynthetic process,BP,
4432,GO:0009217,1,0.969830464873024,0,5,purine deoxyribonucleoside triphosphate catabolic process,BP,
4434,GO:0009219,1,0.89766443860638,0,19,pyrimidine deoxyribonucleotide metabolic process,BP,
4436,GO:0009221,1,0.955440677258216,0,8,pyrimidine deoxyribonucleotide biosynthetic process,BP,
4437,GO:0009222,1,0.993774946284491,0,1,pyrimidine ribonucleotide catabolic process,BP,
4438,GO:0009223,1,0.934216929809953,0,12,pyrimidine deoxyribonucleotide catabolic process,BP,
4439,GO:0009224,1,0.994644794758761,0,1,CMP biosynthetic process,BP,
4440,GO:0009225,1,0.797098132898516,0,36,nucleotide-sugar metabolic process,BP,
4441,GO:0009226,1,0.868770229092619,0,23,nucleotide-sugar biosynthetic process,BP,
4442,GO:0009227,1,0.982637672945242,0,3,nucleotide-sugar catabolic process,BP,
4443,GO:0009229,1,0.994069217099096,0,1,thiamine diphosphate biosynthetic process,BP,
4444,GO:0009231,1,0.993890983044866,0,1,riboflavin biosynthetic process,BP,
4445,GO:0009233,1,0.987090891777939,0,2,menaquinone metabolic process,BP,
4446,GO:0009234,1,0.993407349400836,0,1,menaquinone biosynthetic process,BP,
4447,GO:0009235,1,0.886119366353867,0,18,cobalamin metabolic process,BP,
4448,GO:0009236,1,0.979328652238338,0,3,cobalamin biosynthetic process,BP,
4449,GO:0009237,1,0.993779048068667,0,1,siderophore metabolic process,BP,
4450,GO:0009240,1,0.977568686957687,0,4,isopentenyl diphosphate biosynthetic process,BP,
4451,GO:0009245,1,0.989925940293056,0,2,lipid A biosynthetic process,BP,
4452,GO:0009247,1,0.671887353973688,0,64,glycolipid biosynthetic process,BP,
4453,GO:0009249,1,0.958246665564838,0,8,protein lipoylation,BP,
4454,GO:0009250,1,0.736510918194276,0,44,glucan biosynthetic process,BP,
4455,GO:0009251,1,0.847595992083509,0,24,glucan catabolic process,BP,
4456,GO:0009253,1,0.989601139464883,0,2,peptidoglycan catabolic process,BP,
4457,GO:0009256,1,0.966495128050643,0,5,10-formyltetrahydrofolate metabolic process,BP,
4458,GO:0009257,1,0.986964081799522,0,2,10-formyltetrahydrofolate biosynthetic process,BP,
4459,GO:0009258,1,0.985106746845851,0,2,10-formyltetrahydrofolate catabolic process,BP,
4462,GO:0009261,1,0.805681794848936,0,32,ribonucleotide catabolic process,BP,
4465,GO:0009264,1,0.900930809437265,0,18,deoxyribonucleotide catabolic process,BP,
4468,GO:0009267,1,0.427799316860279,0,130,cellular response to starvation,BP,
4469,GO:0009268,1,0.79964792242154,0,36,response to pH,BP,
4470,GO:0009295,1,0.770301575623013,0,41,nucleoid,CC,
4471,GO:0009298,1,0.977729112962748,0,4,GDP-mannose biosynthetic process,BP,
4472,GO:0009299,1,0.847687766035616,0,25,mRNA transcription,BP,
4473,GO:0009301,1,0.660357916129165,0,66,snRNA transcription,BP,
4474,GO:0009303,1,0.841872905437157,0,27,rRNA transcription,BP,
4475,GO:0009304,1,0.955063553084137,0,7,tRNA transcription,BP,
4476,GO:0009305,1,0.99217517082661,0,1,protein biotinylation,BP,
4478,GO:0009308,1,0.487356347465071,0,120,amine metabolic process,BP,
4479,GO:0009309,1,0.890602339956776,0,20,amine biosynthetic process,BP,
4480,GO:0009310,1,0.880198982037137,0,21,amine catabolic process,BP,
4481,GO:0009311,1,0.627679500701357,0,73,oligosaccharide metabolic process,BP,
4482,GO:0009312,1,0.788635311914774,0,38,oligosaccharide biosynthetic process,BP,
4483,GO:0009313,1,0.933951879239398,0,11,oligosaccharide catabolic process,BP,
4485,GO:0009328,1,0.976308169512202,0,4,phenylalanine-tRNA ligase complex,CC,
4487,GO:0009331,1,0.979437703723124,0,3,glycerol-3-phosphate dehydrogenase complex,CC,
4488,GO:0009346,1,0.993041552202719,0,1,citrate lyase complex,CC,
4489,GO:0009353,1,0.994603462135798,0,1,mitochondrial oxoglutarate dehydrogenase complex,CC,
4490,GO:0009360,1,0.993894068293655,0,1,DNA polymerase III complex,CC,
4491,GO:0009368,1,0.988794244355979,0,2,endopeptidase Clp complex,CC,
4492,GO:0009372,1,0.993596251514619,0,1,quorum sensing,BP,
4493,GO:0009374,1,0.964362256961318,0,5,biotin binding,MF,
4494,GO:0009378,1,0.965802860783276,0,5,four-way junction helicase activity,MF,
4495,GO:0009383,1,0.986934601339041,0,2,rRNA (cytosine-C5-)-methyltransferase activity,MF,
4496,GO:0009384,1,0.992549840277366,0,1,N-acylmannosamine kinase activity,MF,
4497,GO:0009386,1,0.988596975750676,0,2,translational attenuation,BP,
4500,GO:0009396,1,0.947031555363751,0,9,folic acid-containing compound biosynthetic process,BP,
4501,GO:0009397,1,0.973016651280665,0,4,folic acid-containing compound catabolic process,BP,
4502,GO:0009398,1,0.993890983044866,0,1,FMN biosynthetic process,BP,
4503,GO:0009400,1,0.993819061108973,0,1,signal transducer, downstream of receptor, with serine/threonine phosphatase activity,MF,
4504,GO:0009403,1,0.974438670273607,0,4,toxin biosynthetic process,BP,
4505,GO:0009404,1,0.884860096908063,0,20,toxin metabolic process,BP,
4506,GO:0009405,1,0.984753295951413,0,2,pathogenesis,BP,
4507,GO:0009407,1,0.97259447730051,0,5,toxin catabolic process,BP,
4512,GO:0009414,1,0.958479428760001,0,7,response to water deprivation,BP,
4513,GO:0009415,1,0.924338831710027,0,12,response to water,BP,
4515,GO:0009435,1,0.746669032100548,0,47,NAD biosynthetic process,BP,
4516,GO:0009436,1,0.988344690527124,0,2,glyoxylate catabolic process,BP,
4517,GO:0009437,1,0.923198441861445,0,13,carnitine metabolic process,BP,
4518,GO:0009438,1,0.971793617259107,0,5,methylglyoxal metabolic process,BP,
4519,GO:0009439,1,0.989262715469697,0,2,cyanate metabolic process,BP,
4520,GO:0009440,1,0.989262715469697,0,2,cyanate catabolic process,BP,
4521,GO:0009441,1,0.980836446779467,0,3,glycolate metabolic process,BP,
4522,GO:0009443,1,0.991461119267008,0,1,pyridoxal 5'-phosphate salvage,BP,
4523,GO:0009444,1,0.992544860536912,0,1,pyruvate oxidation,BP,
4524,GO:0009445,1,0.959915844049173,0,7,putrescine metabolic process,BP,
4525,GO:0009446,1,0.970077190011983,0,5,putrescine biosynthetic process,BP,
4526,GO:0009447,1,0.983998097800744,0,3,putrescine catabolic process,BP,
4527,GO:0009448,1,0.973117489804906,0,4,gamma-aminobutyric acid metabolic process,BP,
4528,GO:0009449,1,0.980347673830745,0,3,gamma-aminobutyric acid biosynthetic process,BP,
4529,GO:0009450,1,0.985429684614361,0,2,gamma-aminobutyric acid catabolic process,BP,
4530,GO:0009451,1,0.450360648585709,0,130,RNA modification,BP,
4531,GO:0009452,1,0.822317741719431,0,32,7-methylguanosine RNA capping,BP,
4533,GO:0009581,1,0.488172751819767,0,103,detection of external stimulus,BP,
4534,GO:0009582,1,0.478983107845556,0,106,detection of abiotic stimulus,BP,
4535,GO:0009583,1,0.714853521356561,0,53,detection of light stimulus,BP,
4536,GO:0009584,1,0.760181581288118,0,43,detection of visible light,BP,
4537,GO:0009593,1,0.637796937759471,0,75,detection of chemical stimulus,BP,
4538,GO:0009595,1,0.881667702123952,0,19,detection of biotic stimulus,BP,
4539,GO:0009597,1,0.968912933291814,0,5,detection of virus,BP,
4541,GO:0009607,1,0.0100946103788498,0,717,response to biotic stimulus,BP,
4542,GO:0009608,1,0.98794230321674,0,2,response to symbiont,BP,
4543,GO:0009609,1,0.98794230321674,0,2,response to symbiotic bacterium,BP,
4546,GO:0009615,1,0.183652404664421,0,264,response to virus,BP,
4547,GO:0009617,1,0.0686484678516467,0,424,response to bacterium,BP,
4548,GO:0009620,1,0.826166782428785,0,33,response to fungus,BP,
4549,GO:0009624,1,0.993940887741803,0,1,response to nematode,BP,
4551,GO:0009629,1,0.947946713147917,0,9,response to gravity,BP,
4552,GO:0009631,1,0.992649397692802,0,1,cold acclimation,BP,
4553,GO:0009635,1,0.936904508204129,0,11,response to herbicide,BP,
4555,GO:0009637,1,0.986802783390129,0,2,response to blue light,BP,
4556,GO:0009642,1,0.931051953231669,0,11,response to light intensity,BP,
4557,GO:0009644,1,0.986818868934982,0,2,response to high light intensity,BP,
4558,GO:0009645,1,0.993491860949334,0,1,response to low light intensity stimulus,BP,
4559,GO:0009646,1,0.993590111754218,0,1,response to absence of light,BP,
4560,GO:0009648,1,0.856398222722975,0,24,photoperiodism,BP,
4561,GO:0009649,1,0.845916095639056,0,26,entrainment of circadian clock,BP,
4562,GO:0009650,1,0.923026932716321,0,13,UV protection,BP,
4563,GO:0009651,1,0.881369272136286,0,20,response to salt stress,BP,
4565,GO:0009669,1,0.981339629418741,0,3,sucrose:cation symporter activity,MF,
4566,GO:0009673,1,0.993399660438837,0,1,low-affinity phosphate transmembrane transporter activity,MF,
4567,GO:0009674,1,0.984631439458243,0,2,potassium:sodium symporter activity,MF,
4568,GO:0009692,1,0.993940887741803,0,1,ethylene metabolic process,BP,
4569,GO:0009698,1,0.966464215559919,0,6,phenylpropanoid metabolic process,BP,
4570,GO:0009712,1,0.741113675586591,0,47,catechol-containing compound metabolic process,BP,
4571,GO:0009713,1,0.890318279928411,0,19,catechol-containing compound biosynthetic process,BP,
4573,GO:0009720,1,0.993747524560961,0,1,detection of hormone stimulus,BP,
4575,GO:0009726,1,0.977192031757286,0,3,detection of endogenous stimulus,BP,
4576,GO:0009730,1,0.976880816680695,0,4,detection of carbohydrate stimulus,BP,
4577,GO:0009732,1,0.976880816680695,0,4,detection of hexose stimulus,BP,
4578,GO:0009737,1,0.993043888219735,0,1,response to abscisic acid,BP,
4579,GO:0009738,1,0.993043888219735,0,1,abscisic acid-activated signaling pathway,BP,
4580,GO:0009743,1,0.281391859337916,0,192,response to carbohydrate,BP,
4581,GO:0009744,1,0.973553686881561,0,4,response to sucrose,BP,
4582,GO:0009746,1,0.33406832270399,0,166,response to hexose,BP,
4583,GO:0009749,1,0.342601958019083,0,162,response to glucose,BP,
4584,GO:0009750,1,0.950530102404763,0,8,response to fructose,BP,
4585,GO:0009753,1,0.978589249945565,0,4,response to jasmonic acid,BP,
4587,GO:0009756,1,0.958248095788192,0,7,carbohydrate mediated signaling,BP,
4588,GO:0009757,1,0.970142746730354,0,5,hexose mediated signaling,BP,
4589,GO:0009758,1,0.990741781317258,0,1,carbohydrate utilization,BP,
4590,GO:0009785,1,0.986802783390129,0,2,blue light signaling pathway,BP,
4592,GO:0009787,1,0.993043888219735,0,1,regulation of abscisic acid-activated signaling pathway,BP,
4593,GO:0009789,1,0.993043888219735,0,1,positive regulation of abscisic acid-activated signaling pathway,BP,
4595,GO:0009791,1,0.542299193658174,0,84,post-embryonic development,BP,
4597,GO:0009794,1,0.975513379080319,0,4,regulation of mitotic cell cycle, embryonic,BP,
4598,GO:0009798,1,0.586373862423574,0,80,axis specification,BP,
4600,GO:0009804,1,0.966464215559919,0,6,coumarin metabolic process,BP,
4601,GO:0009810,1,0.994147676282294,0,1,stilbene metabolic process,BP,
4602,GO:0009812,1,0.964245048441898,0,6,flavonoid metabolic process,BP,
4603,GO:0009814,1,0.994151291207698,0,1,defense response, incompatible interaction,BP,
4604,GO:0009817,1,0.994151291207698,0,1,defense response to fungus, incompatible interaction,BP,
4605,GO:0009820,1,0.971767725788604,0,5,alkaloid metabolic process,BP,
4606,GO:0009822,1,0.988903234439928,0,2,alkaloid catabolic process,BP,
4607,GO:0009826,1,0.986270159083606,0,2,unidimensional cell growth,BP,
4608,GO:0009838,1,0.971436480649391,0,5,abscission,BP,
4609,GO:0009841,1,0.994069733022162,0,1,mitochondrial endopeptidase Clp complex,CC,
4610,GO:0009850,1,0.989047587288195,0,2,auxin metabolic process,BP,
4611,GO:0009852,1,0.989047587288195,0,2,auxin catabolic process,BP,
4613,GO:0009880,1,0.682660924961498,0,56,embryonic pattern specification,BP,
4614,GO:0009881,1,0.942179868204106,0,10,photoreceptor activity,MF,
4615,GO:0009882,1,0.986802783390129,0,2,blue light photoreceptor activity,MF,
4616,GO:0009886,1,0.923828208611523,0,11,post-embryonic animal morphogenesis,BP,
4628,GO:0009898,1,0.323012560257756,0,170,cytoplasmic side of plasma membrane,CC,
4629,GO:0009912,1,0.966810394628738,0,5,auditory receptor cell fate commitment,BP,
4632,GO:0009918,1,0.99391695742989,0,1,sterol delta7 reductase activity,MF,
4633,GO:0009922,1,0.962660297739722,0,6,fatty acid elongase activity,MF,
4635,GO:0009931,1,0.935365120645938,0,10,calcium-dependent protein serine/threonine kinase activity,MF,
4636,GO:0009946,1,0.983257651347637,0,3,proximal/distal axis specification,BP,
4637,GO:0009948,1,0.756568827089596,0,43,anterior/posterior axis specification,BP,
4638,GO:0009949,1,0.994475315120246,0,1,polarity specification of anterior/posterior axis,BP,
4639,GO:0009950,1,0.891849187968954,0,16,dorsal/ventral axis specification,BP,
4642,GO:0009954,1,0.813712708731686,0,32,proximal/distal pattern formation,BP,
4643,GO:0009955,1,0.994149741938164,0,1,adaxial/abaxial pattern specification,BP,
4644,GO:0009956,1,0.99327308983272,0,1,radial pattern formation,BP,
4645,GO:0009957,1,0.978649121475179,0,3,epidermal cell fate specification,BP,
4649,GO:0009972,1,0.955289552073125,0,8,cytidine deamination,BP,
4650,GO:0009975,1,0.890711787611962,0,16,cyclase activity,MF,
4651,GO:0009982,1,0.925413800648766,0,13,pseudouridine synthase activity,MF,
4654,GO:0009988,1,0.734432723509114,0,51,cell-cell recognition,BP,
4656,GO:0009992,1,0.994162394981062,0,1,cellular water homeostasis,BP,
4657,GO:0009994,1,0.757477003249609,0,43,oocyte differentiation,BP,
4660,GO:0010002,1,0.896972475058883,0,16,cardioblast differentiation,BP,
4662,GO:0010009,1,0.969952112656805,0,5,cytoplasmic side of endosome membrane,CC,
4663,GO:0010015,1,0.994886556596673,0,1,root morphogenesis,BP,
4664,GO:0010021,1,0.993661238904075,0,1,amylopectin biosynthetic process,BP,
4665,GO:0010025,1,0.986806485843434,0,2,wax biosynthetic process,BP,
4666,GO:0010032,1,0.963451936176202,0,5,meiotic chromosome condensation,BP,
4668,GO:0010034,1,0.993464214233885,0,1,response to acetate,BP,
4670,GO:0010037,1,0.993691696544535,0,1,response to carbon dioxide,BP,
4673,GO:0010040,1,0.976294388698368,0,4,response to iron(II) ion,BP,
4674,GO:0010041,1,0.968291013746703,0,5,response to iron(III) ion,BP,
4675,GO:0010042,1,0.898615278353326,0,16,response to manganese ion,BP,
4676,GO:0010043,1,0.745609373026383,0,49,response to zinc ion,BP,
4677,GO:0010044,1,0.970234024429639,0,5,response to aluminum ion,BP,
4678,GO:0010045,1,0.991362010708615,0,1,response to nickel cation,BP,
4679,GO:0010046,1,0.963624740203188,0,6,response to mycotoxin,BP,
4680,GO:0010053,1,0.994886556596673,0,1,root epidermal cell differentiation,BP,
4681,GO:0010054,1,0.994886556596673,0,1,trichoblast differentiation,BP,
4682,GO:0010070,1,0.994040847314931,0,1,zygote asymmetric cell division,BP,
4683,GO:0010085,1,0.99421172909739,0,1,polarity specification of proximal/distal axis,BP,
4685,GO:0010106,1,0.994283044929331,0,1,cellular response to iron ion starvation,BP,
4686,GO:0010107,1,0.770138600540784,0,39,potassium ion import,BP,
4687,GO:0010121,1,0.994264180212969,0,1,arginine catabolic process to proline via ornithine,BP,
4688,GO:0010124,1,0.989047587288195,0,2,phenylacetate catabolic process,BP,
4689,GO:0010133,1,0.987790644560856,0,2,proline catabolic process to glutamate,BP,
4690,GO:0010138,1,0.971883833614895,0,5,pyrimidine ribonucleotide salvage,BP,
4691,GO:0010139,1,0.994453610069964,0,1,pyrimidine deoxyribonucleotide salvage,BP,
4692,GO:0010142,1,0.987575457228875,0,2,farnesyl diphosphate biosynthetic process, mevalonate pathway,BP,
4693,GO:0010155,1,0.915441650442341,0,15,regulation of proton transport,BP,
4694,GO:0010157,1,0.991228824388814,0,1,response to chlorate,BP,
4695,GO:0010159,1,0.980933354380782,0,3,specification of animal organ position,BP,
4696,GO:0010160,1,0.994774980004103,0,1,formation of animal organ boundary,BP,
4697,GO:0010164,1,0.994453610069964,0,1,response to cesium ion,BP,
4699,GO:0010166,1,0.986806485843434,0,2,wax metabolic process,BP,
4700,GO:0010171,1,0.722345046910514,0,47,body morphogenesis,BP,
4701,GO:0010172,1,0.92182501862845,0,11,embryonic body morphogenesis,BP,
4702,GO:0010181,1,0.931411664805024,0,11,FMN binding,MF,
4703,GO:0010182,1,0.970142746730354,0,5,sugar mediated signaling pathway,BP,
4704,GO:0010189,1,0.99442182607053,0,1,vitamin E biosynthetic process,BP,
4705,GO:0010193,1,0.976543469803953,0,4,response to ozone,BP,
4707,GO:0010216,1,0.9658734124171,0,5,maintenance of DNA methylation,BP,
4708,GO:0010224,1,0.900424209820609,0,17,response to UV-B,BP,
4709,GO:0010225,1,0.912557914693986,0,13,response to UV-C,BP,
4710,GO:0010226,1,0.8731422958083,0,21,response to lithium ion,BP,
4711,GO:0010232,1,0.993675570705843,0,1,vascular transport,BP,
4713,GO:0010248,1,0.928846727133178,0,12,establishment or maintenance of transmembrane electrochemical gradient,BP,
4714,GO:0010255,1,0.970142746730354,0,5,glucose mediated signaling pathway,BP,
4716,GO:0010257,1,0.740728962567311,0,55,NADH dehydrogenase complex assembly,BP,
4717,GO:0010259,1,0.836938107041599,0,25,multicellular organism aging,BP,
4718,GO:0010265,1,0.961511127260757,0,6,SCF complex assembly,BP,
4719,GO:0010266,1,0.980138776615666,0,3,response to vitamin B1,BP,
4720,GO:0010269,1,0.965365511152848,0,5,response to selenium ion,BP,
4721,GO:0010273,1,0.942764328089036,0,11,detoxification of copper ion,BP,
4722,GO:0010286,1,0.97180226242337,0,5,heat acclimation,BP,
4723,GO:0010288,1,0.873307739962972,0,21,response to lead ion,BP,
4724,GO:0010309,1,0.994423634968794,0,1,acireductone dioxygenase [iron(II)-requiring] activity,MF,
4725,GO:0010310,1,0.919691162520791,0,14,regulation of hydrogen peroxide metabolic process,BP,
4726,GO:0010314,1,0.932520091343305,0,10,phosphatidylinositol-5-phosphate binding,MF,
4727,GO:0010324,1,0.674768147350893,0,61,membrane invagination,BP,
4728,GO:0010332,1,0.701902353249946,0,52,response to gamma radiation,BP,
4729,GO:0010335,1,0.992970087343192,0,1,response to non-ionic osmotic stress,BP,
4730,GO:0010340,1,0.962616593060473,0,6,carboxyl-O-methyltransferase activity,MF,
4731,GO:0010348,1,0.993850639026861,0,1,lithium:proton antiporter activity,MF,
4732,GO:0010359,1,0.939201123054081,0,9,regulation of anion channel activity,BP,
4733,GO:0010360,1,0.980690044590729,0,3,negative regulation of anion channel activity,BP,
4734,GO:0010369,1,0.909617056319804,0,14,chromocenter,CC,
4735,GO:0010370,1,0.987598657501376,0,2,perinucleolar chromocenter,CC,
4736,GO:0010385,1,0.968007190838708,0,5,double-stranded methylated DNA binding,MF,
4737,GO:0010387,1,0.987990837623154,0,2,COP9 signalosome assembly,BP,
4739,GO:0010390,1,0.833580752071423,0,27,histone monoubiquitination,BP,
4740,GO:0010412,1,0.993575274048212,0,1,mannan metabolic process,BP,
4741,GO:0010420,1,0.994634461808247,0,1,polyprenyldihydroxybenzoate methyltransferase activity,MF,
4742,GO:0010421,1,0.927245920307558,0,12,hydrogen peroxide-mediated programmed cell death,BP,
4743,GO:0010428,1,0.992234840769555,0,1,methyl-CpNpG binding,MF,
4744,GO:0010430,1,0.992859609066904,0,1,fatty acid omega-oxidation,BP,
4745,GO:0010446,1,0.98753453012402,0,2,response to alkaline pH,BP,
4746,GO:0010447,1,0.888403122069982,0,19,response to acidic pH,BP,
4747,GO:0010452,1,0.932807757749732,0,9,histone H3-K36 methylation,BP,
4751,GO:0010457,1,0.921302690474787,0,11,centriole-centriole cohesion,BP,
4754,GO:0010460,1,0.864577888481811,0,22,positive regulation of heart rate,BP,
4755,GO:0010463,1,0.731842652537974,0,46,mesenchymal cell proliferation,BP,
4756,GO:0010464,1,0.792809630176321,0,35,regulation of mesenchymal cell proliferation,BP,
4757,GO:0010465,1,0.985615673045078,0,2,nerve growth factor receptor activity,MF,
4763,GO:0010477,1,0.993613136195534,0,1,response to sulfur dioxide,BP,
4764,GO:0010481,1,0.987545491512959,0,2,epidermal cell division,BP,
4765,GO:0010482,1,0.987545491512959,0,2,regulation of epidermal cell division,BP,
4766,GO:0010484,1,0.969883652876687,0,4,H3 histone acetyltransferase activity,MF,
4767,GO:0010485,1,0.88422057767094,0,18,H4 histone acetyltransferase activity,MF,
4768,GO:0010494,1,0.757451542414907,0,40,cytoplasmic stress granule,CC,
4769,GO:0010496,1,0.994254102342162,0,1,intercellular transport,BP,
4771,GO:0010499,1,0.887555978404997,0,21,proteasomal ubiquitin-independent protein catabolic process,BP,
4772,GO:0010501,1,0.754654433502343,0,44,RNA secondary structure unwinding,BP,
4774,GO:0010507,1,0.637487247859906,0,67,negative regulation of autophagy,BP,
4775,GO:0010508,1,0.512226347552765,0,97,positive regulation of autophagy,BP,
4776,GO:0010509,1,0.99242663583062,0,1,polyamine homeostasis,BP,
4777,GO:0010510,1,0.920902013087745,0,12,regulation of acetyl-CoA biosynthetic process from pyruvate,BP,
4778,GO:0010511,1,0.957893584691007,0,7,regulation of phosphatidylinositol biosynthetic process,BP,
4779,GO:0010512,1,0.987697134027785,0,2,negative regulation of phosphatidylinositol biosynthetic process,BP,
4780,GO:0010513,1,0.969828931444026,0,5,positive regulation of phosphatidylinositol biosynthetic process,BP,
4783,GO:0010519,1,0.968135072559659,0,5,negative regulation of phospholipase activity,BP,
4784,GO:0010520,1,0.981093188654209,0,3,regulation of reciprocal meiotic recombination,BP,
4785,GO:0010521,1,0.981945698928208,0,3,telomerase inhibitor activity,MF,
4787,GO:0010523,1,0.899339559931583,0,17,negative regulation of calcium ion transport into cytosol,BP,
4789,GO:0010528,1,0.898286938747341,0,17,regulation of transposition,BP,
4790,GO:0010529,1,0.898286938747341,0,17,negative regulation of transposition,BP,
4791,GO:0010533,1,0.977865943058867,0,4,regulation of activation of Janus kinase activity,BP,
4792,GO:0010536,1,0.988738953271916,0,2,positive regulation of activation of Janus kinase activity,BP,
4799,GO:0010560,1,0.880932897418642,0,19,positive regulation of glycoprotein biosynthetic process,BP,
4800,GO:0010561,1,0.939656230706012,0,10,negative regulation of glycoprotein biosynthetic process,BP,
4804,GO:0010565,1,0.393102059437363,0,147,regulation of cellular ketone metabolic process,BP,
4805,GO:0010566,1,0.921325343416384,0,13,regulation of ketone biosynthetic process,BP,
4806,GO:0010569,1,0.831711182834211,0,27,regulation of double-strand break repair via homologous recombination,BP,
4807,GO:0010571,1,0.955386140807378,0,6,positive regulation of nuclear cell cycle DNA replication,BP,
4808,GO:0010572,1,0.967977874572699,0,5,positive regulation of platelet activation,BP,
4809,GO:0010573,1,0.81344476975355,0,31,vascular endothelial growth factor production,BP,
4810,GO:0010574,1,0.819795816097735,0,30,regulation of vascular endothelial growth factor production,BP,
4811,GO:0010575,1,0.843156102815194,0,25,positive regulation of vascular endothelial growth factor production,BP,
4812,GO:0010578,1,0.993964572556877,0,1,regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway,BP,
4813,GO:0010585,1,0.994292865344197,0,1,glutamine secretion,BP,
4814,GO:0010586,1,0.864774388496045,0,22,miRNA metabolic process,BP,
4815,GO:0010587,1,0.965463047541497,0,5,miRNA catabolic process,BP,
4816,GO:0010591,1,0.8326751750072,0,27,regulation of lamellipodium assembly,BP,
4817,GO:0010592,1,0.901702936286727,0,15,positive regulation of lamellipodium assembly,BP,
4818,GO:0010593,1,0.984787886180262,0,2,negative regulation of lamellipodium assembly,BP,
4822,GO:0010603,1,0.942509039217826,0,8,regulation of cytoplasmic mRNA processing body assembly,BP,
4825,GO:0010606,1,0.961180407344452,0,5,positive regulation of cytoplasmic mRNA processing body assembly,BP,
4826,GO:0010607,1,0.994275292162827,0,1,negative regulation of cytoplasmic mRNA processing body assembly,BP,
4827,GO:0010608,1,0.0357239604625623,0,508,posttranscriptional regulation of gene expression,BP,
4828,GO:0010609,1,0.987982818802571,0,2,mRNA localization resulting in posttranscriptional regulation of gene expression,BP,
4829,GO:0010611,1,0.737413999747412,0,44,regulation of cardiac muscle hypertrophy,BP,
4830,GO:0010612,1,0.944252060238905,0,8,regulation of cardiac muscle adaptation,BP,
4831,GO:0010613,1,0.835972048776854,0,26,positive regulation of cardiac muscle hypertrophy,BP,
4832,GO:0010614,1,0.897682712978979,0,16,negative regulation of cardiac muscle hypertrophy,BP,
4833,GO:0010615,1,0.986446057618503,0,2,positive regulation of cardiac muscle adaptation,BP,
4834,GO:0010616,1,0.957232015703291,0,6,negative regulation of cardiac muscle adaptation,BP,
4835,GO:0010621,1,0.983105876945341,0,3,negative regulation of transcription by transcription factor localization,BP,
4836,GO:0010623,1,0.923019041473043,0,12,programmed cell death involved in cell development,BP,
4839,GO:0010626,1,0.963799427711768,0,5,negative regulation of Schwann cell proliferation,BP,
4844,GO:0010633,1,0.681215256358204,0,57,negative regulation of epithelial cell migration,BP,
4846,GO:0010635,1,0.950545937886902,0,8,regulation of mitochondrial fusion,BP,
4847,GO:0010636,1,0.985992770559356,0,2,positive regulation of mitochondrial fusion,BP,
4848,GO:0010637,1,0.969986103350603,0,5,negative regulation of mitochondrial fusion,BP,
4852,GO:0010641,1,0.965923913869161,0,5,positive regulation of platelet-derived growth factor receptor signaling pathway,BP,
4854,GO:0010643,1,0.987450021924312,0,2,cell communication by chemical coupling,BP,
4855,GO:0010644,1,0.822530889387444,0,27,cell communication by electrical coupling,BP,
4856,GO:0010645,1,0.993675570705843,0,1,regulation of cell communication by chemical coupling,BP,
4860,GO:0010649,1,0.920461934828908,0,12,regulation of cell communication by electrical coupling,BP,
4861,GO:0010650,1,0.983172046594445,0,2,positive regulation of cell communication by electrical coupling,BP,
4862,GO:0010652,1,0.993675570705843,0,1,positive regulation of cell communication by chemical coupling,BP,
4868,GO:0010661,1,0.882885194280493,0,19,positive regulation of muscle cell apoptotic process,BP,
4870,GO:0010663,1,0.941522061073419,0,9,positive regulation of striated muscle cell apoptotic process,BP,
4873,GO:0010666,1,0.941522061073419,0,9,positive regulation of cardiac muscle cell apoptotic process,BP,
4875,GO:0010668,1,0.95982815429626,0,6,ectodermal cell differentiation,BP,
4876,GO:0010669,1,0.886018815005204,0,19,epithelial structure maintenance,BP,
4877,GO:0010675,1,0.493572330035048,0,104,regulation of cellular carbohydrate metabolic process,BP,
4878,GO:0010676,1,0.736157358196755,0,44,positive regulation of cellular carbohydrate metabolic process,BP,
4879,GO:0010677,1,0.824467199161074,0,29,negative regulation of cellular carbohydrate metabolic process,BP,
4880,GO:0010692,1,0.934278641249028,0,9,regulation of alkaline phosphatase activity,BP,
4881,GO:0010693,1,0.980116523181749,0,3,negative regulation of alkaline phosphatase activity,BP,
4882,GO:0010694,1,0.9532414687428,0,6,positive regulation of alkaline phosphatase activity,BP,
4883,GO:0010698,1,0.988462607118876,0,2,acetyltransferase activator activity,MF,
4884,GO:0010700,1,0.970758091396072,0,5,negative regulation of norepinephrine secretion,BP,
4885,GO:0010701,1,0.98072083604993,0,3,positive regulation of norepinephrine secretion,BP,
4886,GO:0010705,1,0.986826452548921,0,2,meiotic DNA double-strand break processing involved in reciprocal meiotic recombination,BP,
4887,GO:0010710,1,0.982185332581278,0,3,regulation of collagen catabolic process,BP,
4888,GO:0010711,1,0.994889139311718,0,1,negative regulation of collagen catabolic process,BP,
4889,GO:0010712,1,0.824436719687933,0,31,regulation of collagen metabolic process,BP,
4890,GO:0010713,1,0.953498501054825,0,8,negative regulation of collagen metabolic process,BP,
4891,GO:0010714,1,0.880884602381164,0,20,positive regulation of collagen metabolic process,BP,
4892,GO:0010715,1,0.911268982904388,0,13,regulation of extracellular matrix disassembly,BP,
4893,GO:0010716,1,0.976361974059925,0,4,negative regulation of extracellular matrix disassembly,BP,
4899,GO:0010722,1,0.991574369340807,0,1,regulation of ferrochelatase activity,BP,
4900,GO:0010724,1,0.975068136732604,0,4,regulation of definitive erythrocyte differentiation,BP,
4901,GO:0010725,1,0.98810804896972,0,2,regulation of primitive erythrocyte differentiation,BP,
4902,GO:0010726,1,0.987931693387446,0,2,positive regulation of hydrogen peroxide metabolic process,BP,
4903,GO:0010727,1,0.957803061149261,0,7,negative regulation of hydrogen peroxide metabolic process,BP,
4904,GO:0010728,1,0.974428651455772,0,4,regulation of hydrogen peroxide biosynthetic process,BP,
4905,GO:0010729,1,0.994241699425067,0,1,positive regulation of hydrogen peroxide biosynthetic process,BP,
4906,GO:0010730,1,0.980073352945094,0,3,negative regulation of hydrogen peroxide biosynthetic process,BP,
4910,GO:0010735,1,0.973849910459502,0,4,positive regulation of transcription via serum response element binding,BP,
4911,GO:0010736,1,0.987397710167582,0,2,serum response element binding,MF,
4912,GO:0010737,1,0.803284755281425,0,26,protein kinase A signaling,BP,
4913,GO:0010738,1,0.876316163338515,0,18,regulation of protein kinase A signaling,BP,
4914,GO:0010739,1,0.962507683751067,0,6,positive regulation of protein kinase A signaling,BP,
4915,GO:0010742,1,0.819627295014774,0,29,macrophage derived foam cell differentiation,BP,
4916,GO:0010743,1,0.843141427345682,0,25,regulation of macrophage derived foam cell differentiation,BP,
4917,GO:0010744,1,0.912960654088687,0,14,positive regulation of macrophage derived foam cell differentiation,BP,
4918,GO:0010745,1,0.923591943040588,0,11,negative regulation of macrophage derived foam cell differentiation,BP,
4919,GO:0010746,1,0.970649519216536,0,4,regulation of plasma membrane long-chain fatty acid transport,BP,
4920,GO:0010748,1,0.970649519216536,0,4,negative regulation of plasma membrane long-chain fatty acid transport,BP,
4921,GO:0010749,1,0.965485426039528,0,5,regulation of nitric oxide mediated signal transduction,BP,
4922,GO:0010750,1,0.986991653010614,0,2,positive regulation of nitric oxide mediated signal transduction,BP,
4923,GO:0010751,1,0.978213174563566,0,3,negative regulation of nitric oxide mediated signal transduction,BP,
4924,GO:0010752,1,0.985384710952216,0,2,regulation of cGMP-mediated signaling,BP,
4925,GO:0010754,1,0.992285119353974,0,1,negative regulation of cGMP-mediated signaling,BP,
4926,GO:0010755,1,0.941747379266283,0,10,regulation of plasminogen activation,BP,
4927,GO:0010756,1,0.971807266256402,0,5,positive regulation of plasminogen activation,BP,
4928,GO:0010757,1,0.969076857135894,0,5,negative regulation of plasminogen activation,BP,
4929,GO:0010758,1,0.893301312054046,0,18,regulation of macrophage chemotaxis,BP,
4930,GO:0010759,1,0.939064892330911,0,10,positive regulation of macrophage chemotaxis,BP,
4931,GO:0010760,1,0.970249111003784,0,5,negative regulation of macrophage chemotaxis,BP,
4932,GO:0010761,1,0.771129995773823,0,38,fibroblast migration,BP,
4933,GO:0010762,1,0.832708526900376,0,28,regulation of fibroblast migration,BP,
4934,GO:0010763,1,0.928920823086656,0,11,positive regulation of fibroblast migration,BP,
4935,GO:0010764,1,0.950897866208657,0,8,negative regulation of fibroblast migration,BP,
4937,GO:0010766,1,0.906388647512072,0,14,negative regulation of sodium ion transport,BP,
4938,GO:0010767,1,0.977348546152817,0,3,regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,BP,
4939,GO:0010768,1,0.983346219078028,0,2,negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,BP,
4941,GO:0010770,1,0.389962529839701,0,133,positive regulation of cell morphogenesis involved in differentiation,BP,
4943,GO:0010789,1,0.993850639026861,0,1,meiotic sister chromatid cohesion involved in meiosis I,BP,
4944,GO:0010792,1,0.969217945541097,0,5,DNA double-strand break processing involved in repair via single-strand annealing,BP,
4945,GO:0010793,1,0.965152888702799,0,5,regulation of mRNA export from nucleus,BP,
4946,GO:0010795,1,0.994634461808247,0,1,regulation of ubiquinone biosynthetic process,BP,
4947,GO:0010796,1,0.983170923515845,0,3,regulation of multivesicular body size,BP,
4948,GO:0010797,1,0.994661327209651,0,1,regulation of multivesicular body size involved in endosome transport,BP,
4949,GO:0010799,1,0.776602119923339,0,38,regulation of peptidyl-threonine phosphorylation,BP,
4950,GO:0010800,1,0.835486162069703,0,27,positive regulation of peptidyl-threonine phosphorylation,BP,
4951,GO:0010801,1,0.912849065958023,0,14,negative regulation of peptidyl-threonine phosphorylation,BP,
4952,GO:0010803,1,0.716568433744851,0,54,regulation of tumor necrosis factor-mediated signaling pathway,BP,
4953,GO:0010804,1,0.906196633331486,0,17,negative regulation of tumor necrosis factor-mediated signaling pathway,BP,
4954,GO:0010807,1,0.960662407497286,0,6,regulation of synaptic vesicle priming,BP,
4955,GO:0010808,1,0.991972897741676,0,1,positive regulation of synaptic vesicle priming,BP,
4956,GO:0010810,1,0.298901912772488,0,174,regulation of cell-substrate adhesion,BP,
4957,GO:0010811,1,0.503030710200379,0,101,positive regulation of cell-substrate adhesion,BP,
4958,GO:0010812,1,0.701296591263186,0,51,negative regulation of cell-substrate adhesion,BP,
4959,GO:0010813,1,0.987206059927336,0,2,neuropeptide catabolic process,BP,
4960,GO:0010814,1,0.992639445960796,0,1,substance P catabolic process,BP,
4961,GO:0010815,1,0.974026545775374,0,4,bradykinin catabolic process,BP,
4962,GO:0010816,1,0.992639445960796,0,1,calcitonin catabolic process,BP,
4964,GO:0010818,1,0.896951053864488,0,18,T cell chemotaxis,BP,
4965,GO:0010819,1,0.941648827322494,0,10,regulation of T cell chemotaxis,BP,
4966,GO:0010820,1,0.946685109334052,0,9,positive regulation of T cell chemotaxis,BP,
4969,GO:0010823,1,0.750580058510587,0,45,negative regulation of mitochondrion organization,BP,
4970,GO:0010824,1,0.769544636130937,0,39,regulation of centrosome duplication,BP,
4971,GO:0010825,1,0.960094799517084,0,6,positive regulation of centrosome duplication,BP,
4972,GO:0010826,1,0.922637774358308,0,12,negative regulation of centrosome duplication,BP,
4973,GO:0010827,1,0.636831270964228,0,66,regulation of glucose transmembrane transport,BP,
4974,GO:0010828,1,0.758445098411879,0,39,positive regulation of glucose transmembrane transport,BP,
4975,GO:0010829,1,0.903932172310336,0,16,negative regulation of glucose transmembrane transport,BP,
4976,GO:0010830,1,0.74298152838669,0,46,regulation of myotube differentiation,BP,
4977,GO:0010831,1,0.85281037417234,0,25,positive regulation of myotube differentiation,BP,
4978,GO:0010832,1,0.911001905381167,0,14,negative regulation of myotube differentiation,BP,
4979,GO:0010833,1,0.608321265769467,0,75,telomere maintenance via telomere lengthening,BP,
4980,GO:0010835,1,0.963012121113725,0,6,regulation of protein ADP-ribosylation,BP,
4981,GO:0010836,1,0.982937344803972,0,3,negative regulation of protein ADP-ribosylation,BP,
4982,GO:0010837,1,0.840398750064189,0,25,regulation of keratinocyte proliferation,BP,
4983,GO:0010838,1,0.954698990468937,0,7,positive regulation of keratinocyte proliferation,BP,
4984,GO:0010839,1,0.922243503802815,0,11,negative regulation of keratinocyte proliferation,BP,
4985,GO:0010840,1,0.982170042551208,0,3,regulation of circadian sleep/wake cycle, wakefulness,BP,
4986,GO:0010841,1,0.982170042551208,0,3,positive regulation of circadian sleep/wake cycle, wakefulness,BP,
4987,GO:0010842,1,0.867499121266717,0,19,retina layer formation,BP,
4988,GO:0010845,1,0.987353600235634,0,2,positive regulation of reciprocal meiotic recombination,BP,
4989,GO:0010847,1,0.970796620400103,0,4,regulation of chromatin assembly,BP,
4990,GO:0010848,1,0.986676476471892,0,2,regulation of chromatin disassembly,BP,
4991,GO:0010849,1,0.994153873375641,0,1,regulation of proton-transporting ATPase activity, rotational mechanism,BP,
4992,GO:0010851,1,0.970896090037585,0,5,cyclase regulator activity,MF,
4993,GO:0010853,1,0.977618743451576,0,4,cyclase activator activity,MF,
4994,GO:0010854,1,0.993125007660252,0,1,adenylate cyclase regulator activity,MF,
4995,GO:0010855,1,0.993125007660252,0,1,adenylate cyclase inhibitor activity,MF,
4996,GO:0010856,1,0.993594204923514,0,1,adenylate cyclase activator activity,MF,
4997,GO:0010857,1,0.929668294464223,0,11,calcium-dependent protein kinase activity,MF,
4998,GO:0010858,1,0.98353674006912,0,3,calcium-dependent protein kinase regulator activity,MF,
4999,GO:0010859,1,0.993031946621236,0,1,calcium-dependent cysteine-type endopeptidase inhibitor activity,MF,
5000,GO:0010862,1,0.752380469185964,0,44,positive regulation of pathway-restricted SMAD protein phosphorylation,BP,
5002,GO:0010866,1,0.909686298776833,0,15,regulation of triglyceride biosynthetic process,BP,
5003,GO:0010867,1,0.934076742716119,0,11,positive regulation of triglyceride biosynthetic process,BP,
5004,GO:0010868,1,0.98626617806651,0,2,negative regulation of triglyceride biosynthetic process,BP,
5005,GO:0010869,1,0.884204311736054,0,18,regulation of receptor biosynthetic process,BP,
5006,GO:0010870,1,0.93896056502311,0,10,positive regulation of receptor biosynthetic process,BP,
5007,GO:0010871,1,0.963284080903752,0,5,negative regulation of receptor biosynthetic process,BP,
5008,GO:0010872,1,0.955208895870167,0,8,regulation of cholesterol esterification,BP,
5009,GO:0010873,1,0.967170787000424,0,6,positive regulation of cholesterol esterification,BP,
5010,GO:0010874,1,0.880712762068251,0,18,regulation of cholesterol efflux,BP,
5011,GO:0010875,1,0.908976576702745,0,13,positive regulation of cholesterol efflux,BP,
5013,GO:0010877,1,0.988829148108003,0,2,lipid transport involved in lipid storage,BP,
5014,GO:0010878,1,0.898948975551217,0,15,cholesterol storage,BP,
5015,GO:0010879,1,0.994118245529178,0,1,cholesterol transport involved in cholesterol storage,BP,
5016,GO:0010880,1,0.832870318834729,0,25,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,
5017,GO:0010881,1,0.879171753568031,0,18,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,BP,
5018,GO:0010882,1,0.847704257835249,0,23,regulation of cardiac muscle contraction by calcium ion signaling,BP,
5019,GO:0010883,1,0.765314263041054,0,40,regulation of lipid storage,BP,
5020,GO:0010884,1,0.876327329600118,0,20,positive regulation of lipid storage,BP,
5021,GO:0010885,1,0.910163935278484,0,13,regulation of cholesterol storage,BP,
5022,GO:0010886,1,0.950564505925114,0,7,positive regulation of cholesterol storage,BP,
5023,GO:0010887,1,0.957519620016502,0,6,negative regulation of cholesterol storage,BP,
5024,GO:0010888,1,0.896334589813068,0,16,negative regulation of lipid storage,BP,
5025,GO:0010889,1,0.924896889130897,0,12,regulation of sequestering of triglyceride,BP,
5026,GO:0010890,1,0.960194092083397,0,7,positive regulation of sequestering of triglyceride,BP,
5027,GO:0010891,1,0.963254313407569,0,5,negative regulation of sequestering of triglyceride,BP,
5029,GO:0010894,1,0.874393014971963,0,22,negative regulation of steroid biosynthetic process,BP,
5030,GO:0010896,1,0.957891979138141,0,7,regulation of triglyceride catabolic process,BP,
5031,GO:0010897,1,0.980764598230284,0,3,negative regulation of triglyceride catabolic process,BP,
5032,GO:0010898,1,0.976683311091627,0,4,positive regulation of triglyceride catabolic process,BP,
5033,GO:0010899,1,0.981627563072727,0,3,regulation of phosphatidylcholine catabolic process,BP,
5034,GO:0010900,1,0.995050814576977,0,1,negative regulation of phosphatidylcholine catabolic process,BP,
5035,GO:0010901,1,0.989768672648446,0,2,regulation of very-low-density lipoprotein particle remodeling,BP,
5036,GO:0010902,1,0.994917032482871,0,1,positive regulation of very-low-density lipoprotein particle remodeling,BP,
5037,GO:0010903,1,0.994825603629511,0,1,negative regulation of very-low-density lipoprotein particle remodeling,BP,
5038,GO:0010904,1,0.994159554370149,0,1,regulation of UDP-glucose catabolic process,BP,
5039,GO:0010905,1,0.994159554370149,0,1,negative regulation of UDP-glucose catabolic process,BP,
5040,GO:0010906,1,0.571487206779117,0,81,regulation of glucose metabolic process,BP,
5041,GO:0010907,1,0.817491577921037,0,28,positive regulation of glucose metabolic process,BP,
5042,GO:0010908,1,0.980732194579498,0,3,regulation of heparan sulfate proteoglycan biosynthetic process,BP,
5043,GO:0010909,1,0.980732194579498,0,3,positive regulation of heparan sulfate proteoglycan biosynthetic process,BP,
5044,GO:0010911,1,0.952717003931127,0,7,regulation of isomerase activity,BP,
5045,GO:0010912,1,0.952717003931127,0,7,positive regulation of isomerase activity,BP,
5046,GO:0010915,1,0.984523309030325,0,3,regulation of very-low-density lipoprotein particle clearance,BP,
5047,GO:0010916,1,0.984523309030325,0,3,negative regulation of very-low-density lipoprotein particle clearance,BP,
5048,GO:0010917,1,0.952817026358018,0,8,negative regulation of mitochondrial membrane potential,BP,
5049,GO:0010918,1,0.9518758920903,0,8,positive regulation of mitochondrial membrane potential,BP,
5050,GO:0010919,1,0.927239947942224,0,12,regulation of inositol phosphate biosynthetic process,BP,
5051,GO:0010920,1,0.993814442186848,0,1,negative regulation of inositol phosphate biosynthetic process,BP,
5053,GO:0010922,1,0.817835129681413,0,28,positive regulation of phosphatase activity,BP,
5055,GO:0010924,1,0.993814442186848,0,1,regulation of inositol-polyphosphate 5-phosphatase activity,BP,
5056,GO:0010925,1,0.993814442186848,0,1,positive regulation of inositol-polyphosphate 5-phosphatase activity,BP,
5058,GO:0010931,1,0.991014165157806,0,1,macrophage tolerance induction,BP,
5059,GO:0010932,1,0.991014165157806,0,1,regulation of macrophage tolerance induction,BP,
5060,GO:0010933,1,0.991014165157806,0,1,positive regulation of macrophage tolerance induction,BP,
5061,GO:0010934,1,0.912323884572927,0,14,macrophage cytokine production,BP,
5062,GO:0010935,1,0.924030217649469,0,12,regulation of macrophage cytokine production,BP,
5063,GO:0010936,1,0.966531899337394,0,5,negative regulation of macrophage cytokine production,BP,
5064,GO:0010938,1,0.993403761369442,0,1,cytoplasmic microtubule depolymerization,BP,
5065,GO:0010939,1,0.852785117334774,0,27,regulation of necrotic cell death,BP,
5066,GO:0010940,1,0.967054235580629,0,6,positive regulation of necrotic cell death,BP,
5069,GO:0010944,1,0.950167056843486,0,8,negative regulation of transcription by competitive promoter binding,BP,
5071,GO:0010949,1,0.993908469052429,0,1,negative regulation of intestinal phytosterol absorption,BP,
5077,GO:0010956,1,0.981187673170056,0,3,negative regulation of calcidiol 1-monooxygenase activity,BP,
5078,GO:0010957,1,0.970052950973229,0,5,negative regulation of vitamin D biosynthetic process,BP,
5079,GO:0010958,1,0.960875137447139,0,6,regulation of amino acid import across plasma membrane,BP,
5081,GO:0010960,1,0.927018096069234,0,10,magnesium ion homeostasis,BP,
5082,GO:0010961,1,0.971238935244018,0,4,cellular magnesium ion homeostasis,BP,
5083,GO:0010962,1,0.842844342673758,0,23,regulation of glucan biosynthetic process,BP,
5084,GO:0010963,1,0.988528395330711,0,2,regulation of L-arginine import,BP,
5086,GO:0010966,1,0.971045803452316,0,4,regulation of phosphate transport,BP,
5087,GO:0010967,1,0.994411747803641,0,1,regulation of polyamine biosynthetic process,BP,
5088,GO:0010968,1,0.962854492725441,0,6,regulation of microtubule nucleation,BP,
5089,GO:0010970,1,0.389819400487187,0,137,transport along microtubule,BP,
5095,GO:0010979,1,0.986899266404019,0,2,regulation of vitamin D 24-hydroxylase activity,BP,
5096,GO:0010980,1,0.986899266404019,0,2,positive regulation of vitamin D 24-hydroxylase activity,BP,
5097,GO:0010982,1,0.987298748950471,0,2,regulation of high-density lipoprotein particle clearance,BP,
5098,GO:0010983,1,0.987298748950471,0,2,positive regulation of high-density lipoprotein particle clearance,BP,
5099,GO:0010984,1,0.918362205462067,0,14,regulation of lipoprotein particle clearance,BP,
5100,GO:0010985,1,0.958992653056435,0,7,negative regulation of lipoprotein particle clearance,BP,
5101,GO:0010986,1,0.974508509937291,0,4,positive regulation of lipoprotein particle clearance,BP,
5102,GO:0010988,1,0.951898604667962,0,8,regulation of low-density lipoprotein particle clearance,BP,
5103,GO:0010989,1,0.97407203786542,0,4,negative regulation of low-density lipoprotein particle clearance,BP,
5104,GO:0010990,1,0.960067056920974,0,6,regulation of SMAD protein complex assembly,BP,
5105,GO:0010991,1,0.966616680809316,0,5,negative regulation of SMAD protein complex assembly,BP,
5108,GO:0010996,1,0.861712611632162,0,21,response to auditory stimulus,BP,
5109,GO:0010997,1,0.967949289851969,0,5,anaphase-promoting complex binding,MF,
5110,GO:0010998,1,0.935414423641336,0,10,regulation of translational initiation by eIF2 alpha phosphorylation,BP,
5111,GO:0010999,1,0.992983353030873,0,1,regulation of eIF2 alpha phosphorylation by heme,BP,
5115,GO:0012507,1,0.696054444270323,0,57,ER to Golgi transport vesicle membrane,CC,
5116,GO:0012510,1,0.913412198688555,0,14,trans-Golgi network transport vesicle membrane,CC,
5119,GO:0014004,1,0.980787013060923,0,3,microglia differentiation,BP,
5120,GO:0014005,1,0.980787013060923,0,3,microglia development,BP,
5123,GO:0014011,1,0.993850639026861,0,1,Schwann cell proliferation involved in axon regeneration,BP,
5124,GO:0014012,1,0.969976011597921,0,5,peripheral nervous system axon regeneration,BP,
5128,GO:0014016,1,0.982129986171185,0,3,neuroblast differentiation,BP,
5129,GO:0014017,1,0.994010428273367,0,1,neuroblast fate commitment,BP,
5131,GO:0014022,1,0.9801572795578,0,3,neural plate elongation,BP,
5133,GO:0014029,1,0.929354417613582,0,11,neural crest formation,BP,
5137,GO:0014034,1,0.981048144720152,0,3,neural crest cell fate commitment,BP,
5138,GO:0014036,1,0.987977940778164,0,2,neural crest cell fate specification,BP,
5141,GO:0014040,1,0.983991720221099,0,2,positive regulation of Schwann cell differentiation,BP,
5142,GO:0014041,1,0.936546044788653,0,9,regulation of neuron maturation,BP,
5143,GO:0014042,1,0.96915066966706,0,4,positive regulation of neuron maturation,BP,
5144,GO:0014043,1,0.980808676875284,0,3,negative regulation of neuron maturation,BP,
5145,GO:0014044,1,0.80709083775942,0,28,Schwann cell development,BP,
5146,GO:0014045,1,0.975102231224152,0,4,establishment of endothelial blood-brain barrier,BP,
5147,GO:0014046,1,0.869260943765492,0,22,dopamine secretion,BP,
5149,GO:0014048,1,0.914489686502273,0,14,regulation of glutamate secretion,BP,
5150,GO:0014049,1,0.949000430399921,0,8,positive regulation of glutamate secretion,BP,
5151,GO:0014050,1,0.969810004721267,0,5,negative regulation of glutamate secretion,BP,
5152,GO:0014051,1,0.936118009798247,0,9,gamma-aminobutyric acid secretion,BP,
5153,GO:0014052,1,0.960467660958453,0,6,regulation of gamma-aminobutyric acid secretion,BP,
5154,GO:0014053,1,0.992750414346676,0,1,negative regulation of gamma-aminobutyric acid secretion,BP,
5155,GO:0014054,1,0.974294819109126,0,4,positive regulation of gamma-aminobutyric acid secretion,BP,
5156,GO:0014055,1,0.982020340573773,0,3,acetylcholine secretion, neurotransmission,BP,
5157,GO:0014056,1,0.982020340573773,0,3,regulation of acetylcholine secretion, neurotransmission,BP,
5158,GO:0014057,1,0.988040511979686,0,2,positive regulation of acetylcholine secretion, neurotransmission,BP,
5159,GO:0014059,1,0.869260943765492,0,22,regulation of dopamine secretion,BP,
5160,GO:0014060,1,0.977216632238396,0,4,regulation of epinephrine secretion,BP,
5161,GO:0014061,1,0.92961705573779,0,12,regulation of norepinephrine secretion,BP,
5162,GO:0014062,1,0.959275815975655,0,7,regulation of serotonin secretion,BP,
5163,GO:0014063,1,0.976549960834571,0,4,negative regulation of serotonin secretion,BP,
5164,GO:0014064,1,0.992947185223779,0,1,positive regulation of serotonin secretion,BP,
5167,GO:0014067,1,0.936445790456342,0,10,negative regulation of phosphatidylinositol 3-kinase signaling,BP,
5169,GO:0014069,1,0.20389733960219,0,221,postsynaptic density,CC,
5172,GO:0014074,1,0.38753217043348,0,139,response to purine-containing compound,BP,
5174,GO:0014701,1,0.926215019584083,0,9,junctional sarcoplasmic reticulum membrane,CC,
5176,GO:0014705,1,0.993100930658391,0,1,C zone,CC,
5178,GO:0014707,1,0.988319568048589,0,2,branchiomeric skeletal muscle development,BP,
5179,GO:0014717,1,0.988218873595316,0,2,regulation of satellite cell activation involved in skeletal muscle regeneration,BP,
5180,GO:0014718,1,0.988218873595316,0,2,positive regulation of satellite cell activation involved in skeletal muscle regeneration,BP,
5181,GO:0014719,1,0.967188163122146,0,5,skeletal muscle satellite cell activation,BP,
5182,GO:0014721,1,0.9672308495559,0,5,twitch skeletal muscle contraction,BP,
5183,GO:0014722,1,0.963473685878033,0,6,regulation of skeletal muscle contraction by calcium ion signaling,BP,
5184,GO:0014724,1,0.985668366345659,0,2,regulation of twitch skeletal muscle contraction,BP,
5185,GO:0014728,1,0.992150058315214,0,1,regulation of the force of skeletal muscle contraction,BP,
5186,GO:0014731,1,0.941252386905987,0,7,spectrin-associated cytoskeleton,CC,
5187,GO:0014732,1,0.956647125445162,0,7,skeletal muscle atrophy,BP,
5188,GO:0014733,1,0.930906972228473,0,10,regulation of skeletal muscle adaptation,BP,
5189,GO:0014734,1,0.977205876839964,0,3,skeletal muscle hypertrophy,BP,
5190,GO:0014735,1,0.979837350724033,0,3,regulation of muscle atrophy,BP,
5191,GO:0014736,1,0.985366547913717,0,2,negative regulation of muscle atrophy,BP,
5192,GO:0014737,1,0.994389523203463,0,1,positive regulation of muscle atrophy,BP,
5193,GO:0014738,1,0.982847026014447,0,3,regulation of muscle hyperplasia,BP,
5194,GO:0014739,1,0.994958871840741,0,1,positive regulation of muscle hyperplasia,BP,
5195,GO:0014740,1,0.987827405763859,0,2,negative regulation of muscle hyperplasia,BP,
5196,GO:0014741,1,0.88504990436084,0,18,negative regulation of muscle hypertrophy,BP,
5197,GO:0014742,1,0.835972048776854,0,26,positive regulation of muscle hypertrophy,BP,
5198,GO:0014743,1,0.727016122720654,0,46,regulation of muscle hypertrophy,BP,
5199,GO:0014744,1,0.96692709897485,0,5,positive regulation of muscle adaptation,BP,
5200,GO:0014745,1,0.924326553194144,0,11,negative regulation of muscle adaptation,BP,
5201,GO:0014802,1,0.970784515054645,0,4,terminal cisterna,CC,
5202,GO:0014804,1,0.994274775318442,0,1,terminal cisterna lumen,CC,
5203,GO:0014805,1,0.978129031967301,0,4,smooth muscle adaptation,BP,
5204,GO:0014806,1,0.988535444133379,0,2,smooth muscle hyperplasia,BP,
5205,GO:0014807,1,0.955507564293539,0,7,regulation of somitogenesis,BP,
5206,GO:0014808,1,0.812491545206017,0,28,release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,
5207,GO:0014809,1,0.969478544489275,0,5,regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,BP,
5208,GO:0014810,1,0.994884490422735,0,1,positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,BP,
5210,GO:0014813,1,0.994119794279228,0,1,skeletal muscle satellite cell commitment,BP,
5211,GO:0014816,1,0.950228881193664,0,7,skeletal muscle satellite cell differentiation,BP,
5212,GO:0014819,1,0.930865765093332,0,11,regulation of skeletal muscle contraction,BP,
5213,GO:0014820,1,0.945140771546174,0,9,tonic smooth muscle contraction,BP,
5214,GO:0014821,1,0.897433310231026,0,18,phasic smooth muscle contraction,BP,
5215,GO:0014822,1,0.993967147671658,0,1,detection of wounding,BP,
5217,GO:0014824,1,0.958300659452941,0,7,artery smooth muscle contraction,BP,
5218,GO:0014825,1,0.99486796096715,0,1,stomach fundus smooth muscle contraction,BP,
5219,GO:0014826,1,0.976094654941117,0,4,vein smooth muscle contraction,BP,
5220,GO:0014827,1,0.964327030248748,0,6,intestine smooth muscle contraction,BP,
5221,GO:0014828,1,0.992611156593489,0,1,distal stomach smooth muscle contraction,BP,
5222,GO:0014829,1,0.880330779873546,0,19,vascular smooth muscle contraction,BP,
5224,GO:0014832,1,0.955953160676914,0,7,urinary bladder smooth muscle contraction,BP,
5225,GO:0014834,1,0.973427652128245,0,4,skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration,BP,
5226,GO:0014835,1,0.987218646289464,0,2,myoblast differentiation involved in skeletal muscle regeneration,BP,
5227,GO:0014839,1,0.988925301506258,0,2,myoblast migration involved in skeletal muscle regeneration,BP,
5228,GO:0014841,1,0.915056759363341,0,13,skeletal muscle satellite cell proliferation,BP,
5229,GO:0014842,1,0.923097706904674,0,12,regulation of skeletal muscle satellite cell proliferation,BP,
5230,GO:0014843,1,0.991780449301438,0,1,growth factor dependent regulation of skeletal muscle satellite cell proliferation,BP,
5231,GO:0014846,1,0.985520709849484,0,2,esophagus smooth muscle contraction,BP,
5232,GO:0014847,1,0.99486796096715,0,1,proximal stomach smooth muscle contraction,BP,
5233,GO:0014848,1,0.955953160676914,0,7,urinary tract smooth muscle contraction,BP,
5234,GO:0014850,1,0.865900414945507,0,21,response to muscle activity,BP,
5235,GO:0014852,1,0.993808027935622,0,1,regulation of skeletal muscle contraction by neural stimulation via neuromuscular junction,BP,
5236,GO:0014853,1,0.993808027935622,0,1,regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction,BP,
5237,GO:0014854,1,0.912827489801672,0,13,response to inactivity,BP,
5239,GO:0014856,1,0.909996834933692,0,14,skeletal muscle cell proliferation,BP,
5240,GO:0014857,1,0.917993768717929,0,13,regulation of skeletal muscle cell proliferation,BP,
5241,GO:0014858,1,0.979882288803372,0,3,positive regulation of skeletal muscle cell proliferation,BP,
5242,GO:0014859,1,0.980407134936336,0,3,negative regulation of skeletal muscle cell proliferation,BP,
5243,GO:0014861,1,0.992507902145364,0,1,regulation of skeletal muscle contraction via regulation of action potential,BP,
5244,GO:0014862,1,0.992150058315214,0,1,regulation of skeletal muscle contraction by chemo-mechanical energy conversion,BP,
5245,GO:0014866,1,0.889306096050675,0,12,skeletal myofibril assembly,BP,
5246,GO:0014870,1,0.929041072389398,0,10,response to muscle inactivity,BP,
5247,GO:0014873,1,0.988379423368806,0,2,response to muscle activity involved in regulation of muscle adaptation,BP,
5248,GO:0014874,1,0.904739203890891,0,14,response to stimulus involved in regulation of muscle adaptation,BP,
5249,GO:0014876,1,0.994575044620396,0,1,response to injury involved in regulation of muscle adaptation,BP,
5250,GO:0014877,1,0.934793357707951,0,9,response to muscle inactivity involved in regulation of muscle adaptation,BP,
5251,GO:0014878,1,0.973575908952081,0,4,response to electrical stimulus involved in regulation of muscle adaptation,BP,
5252,GO:0014883,1,0.96620709934522,0,5,transition between fast and slow fiber,BP,
5253,GO:0014886,1,0.993604949601281,0,1,transition between slow and fast fiber,BP,
5254,GO:0014887,1,0.856121550266493,0,22,cardiac muscle adaptation,BP,
5255,GO:0014888,1,0.762989337738689,0,40,striated muscle adaptation,BP,
5256,GO:0014889,1,0.925867913005075,0,12,muscle atrophy,BP,
5257,GO:0014891,1,0.950785827530476,0,8,striated muscle atrophy,BP,
5258,GO:0014894,1,0.934793357707951,0,9,response to denervation involved in regulation of muscle adaptation,BP,
5259,GO:0014895,1,0.994933045122769,0,1,smooth muscle hypertrophy,BP,
5260,GO:0014896,1,0.581711741294972,0,72,muscle hypertrophy,BP,
5261,GO:0014897,1,0.588337248748424,0,70,striated muscle hypertrophy,BP,
5262,GO:0014898,1,0.856121550266493,0,22,cardiac muscle hypertrophy in response to stress,BP,
5263,GO:0014900,1,0.977428350476605,0,4,muscle hyperplasia,BP,
5264,GO:0014901,1,0.988218873595316,0,2,satellite cell activation involved in skeletal muscle regeneration,BP,
5265,GO:0014902,1,0.550370939606641,0,88,myotube differentiation,BP,
5266,GO:0014904,1,0.817792263426629,0,30,myotube cell development,BP,
5267,GO:0014908,1,0.986439100820348,0,2,myotube differentiation involved in skeletal muscle regeneration,BP,
5271,GO:0014912,1,0.865639995023108,0,21,negative regulation of smooth muscle cell migration,BP,
5272,GO:0014916,1,0.975757679821793,0,3,regulation of lung blood pressure,BP,
5273,GO:0015002,1,0.889814219008984,0,22,heme-copper terminal oxidase activity,MF,
5274,GO:0015012,1,0.839856153791355,0,25,heparan sulfate proteoglycan biosynthetic process,BP,
5275,GO:0015014,1,0.957411240943374,0,6,heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
5276,GO:0015015,1,0.959416085983937,0,6,heparan sulfate proteoglycan biosynthetic process, enzymatic modification,BP,
5277,GO:0015016,1,0.970445393252789,0,4,[heparan sulfate]-glucosamine N-sulfotransferase activity,MF,
5278,GO:0015018,1,0.982380439823909,0,3,galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity,MF,
5279,GO:0015019,1,0.992589148765386,0,1,heparan-alpha-glucosaminide N-acetyltransferase activity,MF,
5280,GO:0015020,1,0.915325363456044,0,14,glucuronosyltransferase activity,MF,
5281,GO:0015026,1,0.789283072454137,0,36,coreceptor activity,MF,
5282,GO:0015030,1,0.717979279645602,0,53,Cajal body,CC,
5284,GO:0015035,1,0.889922115500188,0,20,protein disulfide oxidoreductase activity,MF,
5285,GO:0015036,1,0.810037844971681,0,36,disulfide oxidoreductase activity,MF,
5286,GO:0015037,1,0.929078049578378,0,13,peptide disulfide oxidoreductase activity,MF,
5287,GO:0015038,1,0.973209211817638,0,5,glutathione disulfide oxidoreductase activity,MF,
5288,GO:0015039,1,0.994307854818459,0,1,NADPH-adrenodoxin reductase activity,MF,
5289,GO:0015052,1,0.993924418237861,0,1,beta3-adrenergic receptor activity,MF,
5290,GO:0015054,1,0.994193646332661,0,1,gastrin receptor activity,MF,
5291,GO:0015056,1,0.988408167636957,0,2,corticotrophin-releasing factor receptor activity,MF,
5292,GO:0015057,1,0.968930351114869,0,5,thrombin-activated receptor activity,MF,
5293,GO:0015065,1,0.982876662334862,0,3,uridine nucleotide receptor activity,MF,
5294,GO:0015067,1,0.993951698959211,0,1,amidinotransferase activity,MF,
5295,GO:0015068,1,0.993951698959211,0,1,glycine amidinotransferase activity,MF,
5296,GO:0015074,1,0.934955972243377,0,10,DNA integration,BP,
5299,GO:0015078,1,0.549794604509485,0,97,proton transmembrane transporter activity,MF,
5300,GO:0015079,1,0.376387397391333,0,149,potassium ion transmembrane transporter activity,MF,
5302,GO:0015085,1,0.372560339659719,0,133,calcium ion transmembrane transporter activity,MF,
5303,GO:0015086,1,0.993138201536524,0,1,cadmium ion transmembrane transporter activity,MF,
5304,GO:0015087,1,0.993138201536524,0,1,cobalt ion transmembrane transporter activity,MF,
5306,GO:0015093,1,0.979700910268242,0,3,ferrous iron transmembrane transporter activity,MF,
5307,GO:0015094,1,0.993138201536524,0,1,lead ion transmembrane transporter activity,MF,
5308,GO:0015095,1,0.8992424811011,0,16,magnesium ion transmembrane transporter activity,MF,
5309,GO:0015098,1,0.994307596375763,0,1,molybdate ion transmembrane transporter activity,MF,
5310,GO:0015101,1,0.86296935084036,0,24,organic cation transmembrane transporter activity,MF,
5312,GO:0015105,1,0.994625678694867,0,1,arsenite transmembrane transporter activity,MF,
5313,GO:0015106,1,0.861616069419197,0,21,bicarbonate transmembrane transporter activity,MF,
5315,GO:0015111,1,0.97943396584692,0,3,iodide transmembrane transporter activity,MF,
5316,GO:0015112,1,0.993918243688359,0,1,nitrate transmembrane transporter activity,MF,
5317,GO:0015114,1,0.926972471975758,0,11,phosphate ion transmembrane transporter activity,MF,
5318,GO:0015116,1,0.92931363483345,0,11,sulfate transmembrane transporter activity,MF,
5319,GO:0015117,1,0.994311989915189,0,1,thiosulfate transmembrane transporter activity,MF,
5320,GO:0015119,1,0.981137065471432,0,3,hexose phosphate transmembrane transporter activity,MF,
5322,GO:0015126,1,0.992813139429852,0,1,canalicular bile acid transmembrane transporter activity,MF,
5323,GO:0015127,1,0.992666679637346,0,1,bilirubin transmembrane transporter activity,MF,
5324,GO:0015129,1,0.967632523830849,0,5,lactate transmembrane transporter activity,MF,
5325,GO:0015130,1,0.993154490170671,0,1,mevalonate transmembrane transporter activity,MF,
5326,GO:0015131,1,0.994311989915189,0,1,oxaloacetate transmembrane transporter activity,MF,
5327,GO:0015132,1,0.993108699877276,0,1,prostaglandin transmembrane transporter activity,MF,
5328,GO:0015136,1,0.993576808987684,0,1,sialic acid transmembrane transporter activity,MF,
5329,GO:0015137,1,0.974675800592598,0,4,citrate transmembrane transporter activity,MF,
5330,GO:0015139,1,0.993809823819756,0,1,alpha-ketoglutarate transmembrane transporter activity,MF,
5331,GO:0015140,1,0.988712546194228,0,2,malate transmembrane transporter activity,MF,
5332,GO:0015141,1,0.981252132597294,0,3,succinate transmembrane transporter activity,MF,
5333,GO:0015142,1,0.974675800592598,0,4,tricarboxylic acid transmembrane transporter activity,MF,
5334,GO:0015143,1,0.982713379445425,0,3,urate transmembrane transporter activity,MF,
5338,GO:0015152,1,0.994199845875246,0,1,glucose-6-phosphate transmembrane transporter activity,MF,
5339,GO:0015154,1,0.981339629418741,0,3,disaccharide transmembrane transporter activity,MF,
5340,GO:0015157,1,0.981339629418741,0,3,oligosaccharide transmembrane transporter activity,MF,
5341,GO:0015165,1,0.939208010362091,0,10,pyrimidine nucleotide-sugar transmembrane transporter activity,MF,
5343,GO:0015168,1,0.971277165989673,0,5,glycerol transmembrane transporter activity,MF,
5344,GO:0015171,1,0.62376295777295,0,72,amino acid transmembrane transporter activity,MF,
5345,GO:0015172,1,0.907676475141056,0,14,acidic amino acid transmembrane transporter activity,MF,
5346,GO:0015173,1,0.981583259523463,0,3,aromatic amino acid transmembrane transporter activity,MF,
5347,GO:0015174,1,0.931544611647259,0,11,basic amino acid transmembrane transporter activity,MF,
5348,GO:0015175,1,0.828286206916886,0,29,neutral amino acid transmembrane transporter activity,MF,
5349,GO:0015179,1,0.705237956175522,0,53,L-amino acid transmembrane transporter activity,MF,
5350,GO:0015180,1,0.967672785908479,0,5,L-alanine transmembrane transporter activity,MF,
5351,GO:0015181,1,0.96008806774595,0,6,arginine transmembrane transporter activity,MF,
5352,GO:0015182,1,0.987905462970031,0,2,L-asparagine transmembrane transporter activity,MF,
5353,GO:0015183,1,0.975340009091617,0,4,L-aspartate transmembrane transporter activity,MF,
5354,GO:0015184,1,0.980686975395652,0,3,L-cystine transmembrane transporter activity,MF,
5355,GO:0015185,1,0.969320012581435,0,5,gamma-aminobutyric acid transmembrane transporter activity,MF,
5356,GO:0015186,1,0.968397224863528,0,5,L-glutamine transmembrane transporter activity,MF,
5357,GO:0015187,1,0.962723275633415,0,6,glycine transmembrane transporter activity,MF,
5358,GO:0015189,1,0.96008806774595,0,6,L-lysine transmembrane transporter activity,MF,
5359,GO:0015190,1,0.993852950638919,0,1,L-leucine transmembrane transporter activity,MF,
5360,GO:0015191,1,0.993852950638919,0,1,L-methionine transmembrane transporter activity,MF,
5361,GO:0015193,1,0.965722460130975,0,5,L-proline transmembrane transporter activity,MF,
5362,GO:0015194,1,0.947639869234527,0,9,L-serine transmembrane transporter activity,MF,
5363,GO:0015195,1,0.993070090473458,0,1,L-threonine transmembrane transporter activity,MF,
5364,GO:0015196,1,0.994013005560847,0,1,L-tryptophan transmembrane transporter activity,MF,
5365,GO:0015203,1,0.988721860816571,0,2,polyamine transmembrane transporter activity,MF,
5367,GO:0015205,1,0.961992293519891,0,6,nucleobase transmembrane transporter activity,MF,
5368,GO:0015207,1,0.987640677891161,0,2,adenine transmembrane transporter activity,MF,
5369,GO:0015215,1,0.905820086162099,0,16,nucleotide transmembrane transporter activity,MF,
5370,GO:0015216,1,0.928298271579898,0,12,purine nucleotide transmembrane transporter activity,MF,
5371,GO:0015217,1,0.945820249630609,0,9,ADP transmembrane transporter activity,MF,
5372,GO:0015218,1,0.987456090352582,0,2,pyrimidine nucleotide transmembrane transporter activity,MF,
5373,GO:0015220,1,0.962654951512103,0,6,choline transmembrane transporter activity,MF,
5374,GO:0015222,1,0.981184976486871,0,3,serotonin transmembrane transporter activity,MF,
5375,GO:0015226,1,0.96464311036738,0,6,carnitine transmembrane transporter activity,MF,
5376,GO:0015227,1,0.988420774562126,0,2,acyl carnitine transmembrane transporter activity,MF,
5377,GO:0015228,1,0.981872023432743,0,3,coenzyme A transmembrane transporter activity,MF,
5378,GO:0015229,1,0.991679953279934,0,1,L-ascorbic acid transmembrane transporter activity,MF,
5379,GO:0015230,1,0.987882057183487,0,2,FAD transmembrane transporter activity,MF,
5380,GO:0015232,1,0.948979463987935,0,8,heme transporter activity,MF,
5381,GO:0015234,1,0.981317521600299,0,3,thiamine transmembrane transporter activity,MF,
5382,GO:0015238,1,0.553833989621891,0,91,drug transmembrane transporter activity,MF,
5383,GO:0015245,1,0.951657658925073,0,8,fatty acid transmembrane transporter activity,MF,
5384,GO:0015247,1,0.978399300699614,0,3,aminophospholipid transmembrane transporter activity,MF,
5385,GO:0015248,1,0.847830867620309,0,25,sterol transporter activity,MF,
5387,GO:0015252,1,0.982132071726511,0,3,proton channel activity,MF,
5388,GO:0015254,1,0.977272338630507,0,4,glycerol channel activity,MF,
5391,GO:0015269,1,0.904434707780622,0,16,calcium-activated potassium channel activity,MF,
5392,GO:0015271,1,0.90927639962831,0,14,outward rectifier potassium channel activity,MF,
5393,GO:0015272,1,0.967837417865907,0,5,ATP-activated inward rectifier potassium channel activity,MF,
5394,GO:0015275,1,0.980310152499559,0,3,stretch-activated, cation-selective, calcium channel activity,MF,
5395,GO:0015276,1,0.40465467141028,0,131,ligand-gated ion channel activity,MF,
5396,GO:0015277,1,0.964693647121235,0,5,kainate selective glutamate receptor activity,MF,
5397,GO:0015278,1,0.843350493207745,0,21,calcium-release channel activity,MF,
5398,GO:0015279,1,0.937713988661705,0,9,store-operated calcium channel activity,MF,
5399,GO:0015280,1,0.949074082478655,0,8,ligand-gated sodium channel activity,MF,
5400,GO:0015288,1,0.965940341205372,0,6,porin activity,MF,
5402,GO:0015292,1,0.993850639026861,0,1,uniporter activity,MF,
5405,GO:0015295,1,0.873582773987478,0,21,solute:proton symporter activity,MF,
5406,GO:0015296,1,0.93010020927383,0,10,anion:cation symporter activity,MF,
5407,GO:0015297,1,0.602070502555404,0,76,antiporter activity,MF,
5408,GO:0015298,1,0.813279731842972,0,31,solute:cation antiporter activity,MF,
5409,GO:0015299,1,0.88777874168213,0,18,solute:proton antiporter activity,MF,
5410,GO:0015301,1,0.828644143589415,0,28,anion:anion antiporter activity,MF,
5411,GO:0015307,1,0.982279604591821,0,3,drug:proton antiporter activity,MF,
5412,GO:0015315,1,0.981137065471432,0,3,organophosphate:inorganic phosphate antiporter activity,MF,
5413,GO:0015317,1,0.994418983502989,0,1,phosphate:proton symporter activity,MF,
5415,GO:0015319,1,0.980866279955814,0,3,sodium:inorganic phosphate symporter activity,MF,
5416,GO:0015321,1,0.968478329219781,0,5,sodium-dependent phosphate transmembrane transporter activity,MF,
5417,GO:0015322,1,0.993375816556392,0,1,secondary active oligopeptide transmembrane transporter activity,MF,
5418,GO:0015327,1,0.990290622045223,0,1,cystine:glutamate antiporter activity,MF,
5419,GO:0015328,1,0.990290622045223,0,1,cystine secondary active transmembrane transporter activity,MF,
5420,GO:0015333,1,0.980657444720879,0,3,peptide:proton symporter activity,MF,
5421,GO:0015343,1,0.993850639026861,0,1,siderophore transmembrane transporter activity,MF,
5423,GO:0015349,1,0.974517036122288,0,4,thyroid hormone transmembrane transporter activity,MF,
5424,GO:0015350,1,0.985800545250709,0,2,methotrexate transmembrane transporter activity,MF,
5425,GO:0015355,1,0.934116775555672,0,11,secondary active monocarboxylate transmembrane transporter activity,MF,
5426,GO:0015362,1,0.993194518260331,0,1,high-affinity sodium:dicarboxylate symporter activity,MF,
5427,GO:0015367,1,0.994368848236939,0,1,oxoglutarate:malate antiporter activity,MF,
5428,GO:0015368,1,0.927217772744172,0,11,calcium:cation antiporter activity,MF,
5429,GO:0015369,1,0.992461764302843,0,1,calcium:proton antiporter activity,MF,
5431,GO:0015373,1,0.972097926670919,0,4,anion:sodium symporter activity,MF,
5432,GO:0015375,1,0.987472259341646,0,2,glycine:sodium symporter activity,MF,
5433,GO:0015377,1,0.942097617445987,0,8,cation:chloride symporter activity,MF,
5434,GO:0015378,1,0.984631439458243,0,2,sodium:chloride symporter activity,MF,
5435,GO:0015379,1,0.942097617445987,0,8,potassium:chloride symporter activity,MF,
5436,GO:0015382,1,0.993791868572001,0,1,sodium:sulfate symporter activity,MF,
5437,GO:0015385,1,0.922655185944431,0,12,sodium:proton antiporter activity,MF,
5438,GO:0015386,1,0.934116495804397,0,10,potassium:proton antiporter activity,MF,
5439,GO:0015389,1,0.98840655770369,0,2,pyrimidine- and adenine-specific:sodium symporter activity,MF,
5440,GO:0015390,1,0.994139930455338,0,1,purine-specific nucleoside:sodium symporter activity,MF,
5441,GO:0015391,1,0.98840655770369,0,2,nucleobase:cation symporter activity,MF,
5442,GO:0015399,1,0.491089211811058,0,102,primary active transmembrane transporter activity,MF,
5443,GO:0015405,1,0.491089211811058,0,102,P-P-bond-hydrolysis-driven transmembrane transporter activity,MF,
5444,GO:0015410,1,0.980431942994703,0,3,manganese-transporting ATPase activity,MF,
5445,GO:0015420,1,0.991969765251917,0,1,cobalamin-transporting ATPase activity,MF,
5446,GO:0015421,1,0.993465750414541,0,1,oligopeptide-transporting ATPase activity,MF,
5447,GO:0015431,1,0.991969765251917,0,1,glutathione S-conjugate-exporting ATPase activity,MF,
5448,GO:0015432,1,0.986323091749268,0,2,bile acid-exporting ATPase activity,MF,
5449,GO:0015433,1,0.986739015412594,0,2,peptide antigen-transporting ATPase activity,MF,
5450,GO:0015439,1,0.993747268352421,0,1,heme-transporting ATPase activity,MF,
5451,GO:0015440,1,0.974174399472833,0,4,peptide-transporting ATPase activity,MF,
5452,GO:0015450,1,0.967088692693815,0,6,P-P-bond-hydrolysis-driven protein transmembrane transporter activity,MF,
5453,GO:0015459,1,0.741745402945704,0,46,potassium channel regulator activity,MF,
5454,GO:0015464,1,0.888148311387809,0,19,acetylcholine receptor activity,MF,
5455,GO:0015467,1,0.936588720055395,0,10,G-protein activated inward rectifier potassium channel activity,MF,
5456,GO:0015485,1,0.784781137827233,0,37,cholesterol binding,MF,
5457,GO:0015489,1,0.988721860816571,0,2,putrescine transmembrane transporter activity,MF,
5458,GO:0015491,1,0.827894602997222,0,28,cation:cation antiporter activity,MF,
5459,GO:0015495,1,0.993959937679864,0,1,gamma-aminobutyric acid:proton symporter activity,MF,
5460,GO:0015499,1,0.99391695742989,0,1,formate transmembrane transporter activity,MF,
5461,GO:0015501,1,0.95318289035299,0,7,glutamate:sodium symporter activity,MF,
5462,GO:0015526,1,0.981137065471432,0,3,hexose-phosphate:inorganic phosphate antiporter activity,MF,
5463,GO:0015538,1,0.993576808987684,0,1,sialic acid:proton symporter activity,MF,
5464,GO:0015556,1,0.951658215551709,0,8,C4-dicarboxylate transmembrane transporter activity,MF,
5465,GO:0015562,1,0.978745359585151,0,3,efflux transmembrane transporter activity,MF,
5466,GO:0015578,1,0.994020222567129,0,1,mannose transmembrane transporter activity,MF,
5467,GO:0015605,1,0.864204360831556,0,23,organophosphate ester transmembrane transporter activity,MF,
5468,GO:0015616,1,0.968114972988121,0,4,DNA translocase activity,MF,
5472,GO:0015633,1,0.994206045695518,0,1,zinc-transporting ATPase activity,MF,
5473,GO:0015636,1,0.994094501604895,0,1,short-chain fatty acid transmembrane transporter activity,MF,
5474,GO:0015643,1,0.946298894096625,0,9,toxic substance binding,MF,
5475,GO:0015645,1,0.898910003783579,0,17,fatty acid ligase activity,MF,
5476,GO:0015651,1,0.945881729869891,0,9,quaternary ammonium group transmembrane transporter activity,MF,
5477,GO:0015658,1,0.993852950638919,0,1,branched-chain amino acid transmembrane transporter activity,MF,
5478,GO:0015660,1,0.99391695742989,0,1,formate efflux transmembrane transporter activity,MF,
5479,GO:0015662,1,0.773985674566317,0,37,ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism,MF,
5480,GO:0015665,1,0.988658362406913,0,2,alcohol transmembrane transporter activity,MF,
5481,GO:0015669,1,0.91048274116526,0,17,gas transport,BP,
5482,GO:0015670,1,0.982740880375408,0,3,carbon dioxide transport,BP,
5483,GO:0015671,1,0.926485305263767,0,14,oxygen transport,BP,
5485,GO:0015677,1,0.943666656121801,0,8,copper ion import,BP,
5486,GO:0015679,1,0.983770882664162,0,2,plasma membrane copper ion transport,BP,
5487,GO:0015680,1,0.981901016984892,0,3,intracellular copper ion transport,BP,
5489,GO:0015684,1,0.979700910268242,0,3,ferrous iron transport,BP,
5490,GO:0015688,1,0.98297316924415,0,3,iron chelate transport,BP,
5491,GO:0015689,1,0.994307596375763,0,1,molybdate ion transport,BP,
5492,GO:0015691,1,0.974548416806674,0,4,cadmium ion transport,BP,
5493,GO:0015692,1,0.993138201536524,0,1,lead ion transport,BP,
5494,GO:0015693,1,0.892498067957762,0,17,magnesium ion transport,BP,
5495,GO:0015694,1,0.992666679637346,0,1,mercury ion transport,BP,
5496,GO:0015695,1,0.787623232121422,0,38,organic cation transport,BP,
5497,GO:0015696,1,0.586772722689368,0,85,ammonium transport,BP,
5498,GO:0015697,1,0.926580792126721,0,12,quaternary ammonium group transport,BP,
5500,GO:0015700,1,0.994625678694867,0,1,arsenite transport,BP,
5501,GO:0015701,1,0.76750859731678,0,41,bicarbonate transport,BP,
5502,GO:0015705,1,0.961519312784109,0,5,iodide transport,BP,
5503,GO:0015706,1,0.993918243688359,0,1,nitrate transport,BP,
5504,GO:0015707,1,0.993299058488618,0,1,nitrite transport,BP,
5505,GO:0015709,1,0.994311989915189,0,1,thiosulfate transport,BP,
5507,GO:0015712,1,0.969526418085892,0,5,hexose phosphate transport,BP,
5510,GO:0015722,1,0.972947720629149,0,4,canalicular bile acid transport,BP,
5511,GO:0015723,1,0.992666679637346,0,1,bilirubin transport,BP,
5512,GO:0015724,1,0.99391695742989,0,1,formate transport,BP,
5513,GO:0015727,1,0.960921434129927,0,6,lactate transport,BP,
5514,GO:0015728,1,0.993154490170671,0,1,mevalonate transport,BP,
5515,GO:0015729,1,0.994311989915189,0,1,oxaloacetate transport,BP,
5516,GO:0015732,1,0.921229268506958,0,13,prostaglandin transport,BP,
5517,GO:0015734,1,0.991916007600299,0,1,taurine transport,BP,
5518,GO:0015739,1,0.993576808987684,0,1,sialic acid transport,BP,
5519,GO:0015740,1,0.92099270731263,0,12,C4-dicarboxylate transport,BP,
5520,GO:0015742,1,0.982476876376694,0,3,alpha-ketoglutarate transport,BP,
5521,GO:0015743,1,0.994311989915189,0,1,malate transport,BP,
5522,GO:0015744,1,0.981252132597294,0,3,succinate transport,BP,
5523,GO:0015746,1,0.974675800592598,0,4,citrate transport,BP,
5524,GO:0015747,1,0.976780229510185,0,4,urate transport,BP,
5525,GO:0015748,1,0.573174196885819,0,83,organophosphate ester transport,BP,
5527,GO:0015755,1,0.994089340810551,0,1,fructose transmembrane transport,BP,
5528,GO:0015760,1,0.969526418085892,0,5,glucose-6-phosphate transport,BP,
5529,GO:0015761,1,0.994020222567129,0,1,mannose transmembrane transport,BP,
5530,GO:0015766,1,0.981339629418741,0,3,disaccharide transport,BP,
5531,GO:0015770,1,0.981339629418741,0,3,sucrose transport,BP,
5532,GO:0015772,1,0.981339629418741,0,3,oligosaccharide transport,BP,
5533,GO:0015780,1,0.922018946602205,0,13,nucleotide-sugar transmembrane transport,BP,
5534,GO:0015782,1,0.994351273960453,0,1,CMP-N-acetylneuraminate transmembrane transport,BP,
5535,GO:0015783,1,0.985440005982839,0,2,GDP-fucose transmembrane transport,BP,
5536,GO:0015786,1,0.994115664340597,0,1,UDP-glucose transmembrane transport,BP,
5537,GO:0015787,1,0.991939490058702,0,1,UDP-glucuronic acid transmembrane transport,BP,
5538,GO:0015790,1,0.991755965992013,0,1,UDP-xylose transmembrane transport,BP,
5540,GO:0015793,1,0.971277165989673,0,5,glycerol transport,BP,
5541,GO:0015797,1,0.99391695742989,0,1,mannitol transport,BP,
5543,GO:0015800,1,0.668895535050599,0,59,acidic amino acid transport,BP,
5544,GO:0015801,1,0.969438995988701,0,5,aromatic amino acid transport,BP,
5545,GO:0015802,1,0.926774158308018,0,12,basic amino acid transport,BP,
5546,GO:0015803,1,0.973253737960936,0,4,branched-chain amino acid transport,BP,
5547,GO:0015804,1,0.807981335651659,0,33,neutral amino acid transport,BP,
5548,GO:0015805,1,0.994137348650146,0,1,S-adenosyl-L-methionine transport,BP,
5549,GO:0015807,1,0.67180203570441,0,60,L-amino acid transport,BP,
5550,GO:0015808,1,0.967672785908479,0,5,L-alanine transport,BP,
5551,GO:0015809,1,0.949298731504585,0,8,arginine transport,BP,
5552,GO:0015810,1,0.981373704288448,0,3,aspartate transmembrane transport,BP,
5553,GO:0015811,1,0.980686975395652,0,3,L-cystine transport,BP,
5554,GO:0015812,1,0.91381224272397,0,13,gamma-aminobutyric acid transport,BP,
5555,GO:0015813,1,0.853898335347346,0,23,L-glutamate transmembrane transport,BP,
5556,GO:0015816,1,0.947832236833196,0,8,glycine transport,BP,
5557,GO:0015817,1,0.987899335495093,0,2,histidine transport,BP,
5558,GO:0015819,1,0.99431302369311,0,1,lysine transport,BP,
5559,GO:0015820,1,0.979274657195491,0,3,leucine transport,BP,
5560,GO:0015821,1,0.993852950638919,0,1,methionine transport,BP,
5561,GO:0015822,1,0.959505556273605,0,6,ornithine transport,BP,
5562,GO:0015824,1,0.951298179838373,0,7,proline transport,BP,
5563,GO:0015825,1,0.947639869234527,0,9,L-serine transport,BP,
5564,GO:0015826,1,0.993070090473458,0,1,threonine transport,BP,
5565,GO:0015827,1,0.981716513507647,0,3,tryptophan transport,BP,
5566,GO:0015828,1,0.993660727089185,0,1,tyrosine transport,BP,
5568,GO:0015837,1,0.64183223524063,0,71,amine transport,BP,
5569,GO:0015838,1,0.94496320636231,0,9,amino-acid betaine transport,BP,
5571,GO:0015842,1,0.976869712815694,0,4,aminergic neurotransmitter loading into synaptic vesicle,BP,
5572,GO:0015844,1,0.676701078000657,0,62,monoamine transport,BP,
5573,GO:0015846,1,0.958834617572722,0,7,polyamine transport,BP,
5574,GO:0015847,1,0.988721860816571,0,2,putrescine transport,BP,
5577,GO:0015851,1,0.956744886216935,0,7,nucleobase transport,BP,
5578,GO:0015853,1,0.982254794140454,0,3,adenine transport,BP,
5579,GO:0015855,1,0.982207358423274,0,3,pyrimidine nucleobase transport,BP,
5580,GO:0015858,1,0.958933770332915,0,7,nucleoside transport,BP,
5581,GO:0015860,1,0.994139930455338,0,1,purine nucleoside transmembrane transport,BP,
5582,GO:0015862,1,0.994084180363645,0,1,uridine transport,BP,
5583,GO:0015864,1,0.988258429594149,0,2,pyrimidine nucleoside transport,BP,
5584,GO:0015865,1,0.911525980020179,0,15,purine nucleotide transport,BP,
5585,GO:0015866,1,0.945820249630609,0,9,ADP transport,BP,
5586,GO:0015867,1,0.939588780969957,0,10,ATP transport,BP,
5587,GO:0015868,1,0.918035003220325,0,14,purine ribonucleotide transport,BP,
5588,GO:0015870,1,0.976049872608377,0,4,acetylcholine transport,BP,
5589,GO:0015871,1,0.953597715966392,0,7,choline transport,BP,
5591,GO:0015874,1,0.905454662254122,0,16,norepinephrine transport,BP,
5592,GO:0015876,1,0.993914642257477,0,1,acetyl-CoA transport,BP,
5593,GO:0015878,1,0.993584227840159,0,1,biotin transport,BP,
5594,GO:0015879,1,0.95904350877233,0,7,carnitine transport,BP,
5595,GO:0015880,1,0.981872023432743,0,3,coenzyme A transport,BP,
5596,GO:0015881,1,0.986411518865172,0,2,creatine transmembrane transport,BP,
5597,GO:0015882,1,0.991679953279934,0,1,L-ascorbic acid transmembrane transport,BP,
5598,GO:0015884,1,0.945691592799743,0,8,folic acid transport,BP,
5599,GO:0015886,1,0.948979463987935,0,8,heme transport,BP,
5600,GO:0015887,1,0.993584227840159,0,1,pantothenate transmembrane transport,BP,
5601,GO:0015888,1,0.980681237020859,0,3,thiamine transport,BP,
5602,GO:0015889,1,0.959641332047525,0,6,cobalamin transport,BP,
5603,GO:0015891,1,0.98297316924415,0,3,siderophore transport,BP,
5604,GO:0015893,1,0.325520426947333,0,175,drug transport,BP,
5605,GO:0015904,1,0.994325687567316,0,1,tetracycline transport,BP,
5608,GO:0015910,1,0.987535581387204,0,2,peroxisomal long-chain fatty acid import,BP,
5609,GO:0015911,1,0.964886071406709,0,5,plasma membrane long-chain fatty acid transport,BP,
5610,GO:0015912,1,0.994094501604895,0,1,short-chain fatty acid transport,BP,
5611,GO:0015913,1,0.994094501604895,0,1,short-chain fatty acid import,BP,
5612,GO:0015914,1,0.669184566660969,0,58,phospholipid transport,BP,
5613,GO:0015916,1,0.993914642257477,0,1,fatty-acyl-CoA transport,BP,
5614,GO:0015917,1,0.97006488234878,0,4,aminophospholipid transport,BP,
5615,GO:0015918,1,0.60968176564485,0,74,sterol transport,BP,
5616,GO:0015919,1,0.902926621566208,0,16,peroxisomal membrane transport,BP,
5617,GO:0015920,1,0.988277907068856,0,2,lipopolysaccharide transport,BP,
5618,GO:0015922,1,0.994452059675825,0,1,aspartate oxidase activity,MF,
5619,GO:0015923,1,0.907110956050281,0,14,mannosidase activity,MF,
5620,GO:0015924,1,0.937844671909928,0,9,mannosyl-oligosaccharide mannosidase activity,MF,
5621,GO:0015925,1,0.952568687351153,0,8,galactosidase activity,MF,
5622,GO:0015926,1,0.933729905880269,0,10,glucosidase activity,MF,
5623,GO:0015928,1,0.988432995636335,0,2,fucosidase activity,MF,
5624,GO:0015929,1,0.928863885011134,0,12,hexosaminidase activity,MF,
5626,GO:0015932,1,0.799159043403015,0,36,nucleobase-containing compound transmembrane transporter activity,MF,
5627,GO:0015934,1,0.540463130719539,0,113,large ribosomal subunit,CC,
5628,GO:0015935,1,0.685701924179671,0,69,small ribosomal subunit,CC,
5629,GO:0015936,1,0.913006448992771,0,15,coenzyme A metabolic process,BP,
5630,GO:0015937,1,0.943033434714577,0,10,coenzyme A biosynthetic process,BP,
5631,GO:0015938,1,0.994766198164714,0,1,coenzyme A catabolic process,BP,
5632,GO:0015939,1,0.950363808893957,0,8,pantothenate metabolic process,BP,
5633,GO:0015942,1,0.964489335386952,0,6,formate metabolic process,BP,
5635,GO:0015950,1,0.988851815798577,0,2,purine nucleotide interconversion,BP,
5636,GO:0015951,1,0.988851815798577,0,2,purine ribonucleotide interconversion,BP,
5637,GO:0015959,1,0.957924767935339,0,7,diadenosine polyphosphate metabolic process,BP,
5638,GO:0015960,1,0.981552671092752,0,3,diadenosine polyphosphate biosynthetic process,BP,
5639,GO:0015961,1,0.975932507390272,0,4,diadenosine polyphosphate catabolic process,BP,
5640,GO:0015965,1,0.981552671092752,0,3,diadenosine tetraphosphate metabolic process,BP,
5641,GO:0015966,1,0.981552671092752,0,3,diadenosine tetraphosphate biosynthetic process,BP,
5643,GO:0015985,1,0.946709264513337,0,9,energy coupled proton transport, down electrochemical gradient,BP,
5644,GO:0015986,1,0.946709264513337,0,9,ATP synthesis coupled proton transport,BP,
5645,GO:0015988,1,0.841855963698226,0,28,energy coupled proton transmembrane transport, against electrochemical gradient,BP,
5646,GO:0015990,1,0.994881391158626,0,1,electron transport coupled proton transport,BP,
5647,GO:0015991,1,0.846194604204189,0,27,ATP hydrolysis coupled proton transport,BP,
5648,GO:0016004,1,0.944981309929493,0,9,phospholipase activator activity,MF,
5649,GO:0016005,1,0.986721619898143,0,2,phospholipase A2 activator activity,MF,
5651,GO:0016011,1,0.954215801198295,0,7,dystroglycan complex,CC,
5652,GO:0016012,1,0.961583797420248,0,6,sarcoglycan complex,CC,
5654,GO:0016015,1,0.965643583043157,0,6,morphogen activity,MF,
5655,GO:0016018,1,0.940399571506812,0,10,cyclosporin A binding,MF,
5656,GO:0016019,1,0.989293764411297,0,2,peptidoglycan receptor activity,MF,
5659,GO:0016024,1,0.926064477233138,0,11,CDP-diacylglycerol biosynthetic process,BP,
5660,GO:0016028,1,0.993412474712787,0,1,rhabdomere,CC,
5661,GO:0016031,1,0.993544062500637,0,1,tRNA import into mitochondrion,BP,
5663,GO:0016034,1,0.994597262047273,0,1,maleylacetoacetate isomerase activity,MF,
5664,GO:0016035,1,0.984496907052248,0,2,zeta DNA polymerase complex,CC,
5665,GO:0016036,1,0.99411592245597,0,1,cellular response to phosphate starvation,BP,
5666,GO:0016037,1,0.99385962939908,0,1,light absorption,BP,
5667,GO:0016038,1,0.99385962939908,0,1,absorption of visible light,BP,
5670,GO:0016045,1,0.933341012014612,0,10,detection of bacterium,BP,
5671,GO:0016046,1,0.992368443602378,0,1,detection of fungus,BP,
5672,GO:0016048,1,0.890005683000323,0,18,detection of temperature stimulus,BP,
5674,GO:0016050,1,0.0830151412250961,0,370,vesicle organization,BP,
5675,GO:0016051,1,0.270522497671425,0,203,carbohydrate biosynthetic process,BP,
5680,GO:0016056,1,0.86528009142925,0,23,rhodopsin mediated signaling pathway,BP,
5681,GO:0016062,1,0.99396302755062,0,1,adaptation of rhodopsin mediated signaling,BP,
5682,GO:0016064,1,0.568643457928431,0,90,immunoglobulin mediated immune response,BP,
5683,GO:0016068,1,0.98346560635127,0,3,type I hypersensitivity,BP,
5686,GO:0016072,1,0.186137124463519,0,279,rRNA metabolic process,BP,
5687,GO:0016073,1,0.595959668707758,0,84,snRNA metabolic process,BP,
5688,GO:0016074,1,0.934419998259704,0,12,snoRNA metabolic process,BP,
5689,GO:0016075,1,0.905350099742422,0,16,rRNA catabolic process,BP,
5690,GO:0016077,1,0.992169153657553,0,1,snoRNA catabolic process,BP,
5691,GO:0016078,1,0.965909986097611,0,6,tRNA catabolic process,BP,
5692,GO:0016079,1,0.55724440967491,0,85,synaptic vesicle exocytosis,BP,
5693,GO:0016080,1,0.971261470396849,0,4,synaptic vesicle targeting,BP,
5694,GO:0016081,1,0.936733938159371,0,9,synaptic vesicle docking,BP,
5695,GO:0016082,1,0.898147367175122,0,15,synaptic vesicle priming,BP,
5696,GO:0016093,1,0.953794587883655,0,8,polyprenol metabolic process,BP,
5697,GO:0016094,1,0.980438243161177,0,3,polyprenol biosynthetic process,BP,
5698,GO:0016095,1,0.983126337939855,0,3,polyprenol catabolic process,BP,
5699,GO:0016098,1,0.988925336753727,0,2,monoterpenoid metabolic process,BP,
5701,GO:0016102,1,0.947438276417096,0,9,diterpenoid biosynthetic process,BP,
5702,GO:0016103,1,0.982109396361004,0,3,diterpenoid catabolic process,BP,
5703,GO:0016107,1,0.989146309159339,0,2,sesquiterpenoid catabolic process,BP,
5704,GO:0016108,1,0.981711799929198,0,3,tetraterpenoid metabolic process,BP,
5705,GO:0016109,1,0.993936769823406,0,1,tetraterpenoid biosynthetic process,BP,
5706,GO:0016114,1,0.919179174661575,0,14,terpenoid biosynthetic process,BP,
5707,GO:0016115,1,0.971447949564841,0,5,terpenoid catabolic process,BP,
5708,GO:0016116,1,0.981711799929198,0,3,carotenoid metabolic process,BP,
5709,GO:0016117,1,0.993936769823406,0,1,carotenoid biosynthetic process,BP,
5710,GO:0016119,1,0.987701206322352,0,2,carotene metabolic process,BP,
5711,GO:0016121,1,0.993812902670023,0,1,carotene catabolic process,BP,
5712,GO:0016122,1,0.987786809536619,0,2,xanthophyll metabolic process,BP,
5713,GO:0016123,1,0.993936769823406,0,1,xanthophyll biosynthetic process,BP,
5716,GO:0016127,1,0.946363357052111,0,9,sterol catabolic process,BP,
5717,GO:0016128,1,0.982402762437504,0,3,phytosteroid metabolic process,BP,
5718,GO:0016129,1,0.982402762437504,0,3,phytosteroid biosynthetic process,BP,
5719,GO:0016131,1,0.99391695742989,0,1,brassinosteroid metabolic process,BP,
5720,GO:0016132,1,0.99391695742989,0,1,brassinosteroid biosynthetic process,BP,
5721,GO:0016137,1,0.90632144574606,0,17,glycoside metabolic process,BP,
5722,GO:0016139,1,0.953111982724889,0,8,glycoside catabolic process,BP,
5723,GO:0016149,1,0.993386329940779,0,1,translation release factor activity, codon specific,MF,
5724,GO:0016150,1,0.994452059675825,0,1,translation release factor activity, codon nonspecific,MF,
5725,GO:0016151,1,0.988554807949116,0,2,nickel cation binding,MF,
5726,GO:0016153,1,0.993550458561575,0,1,urocanate hydratase activity,MF,
5727,GO:0016154,1,0.994430353677249,0,1,pyrimidine-nucleoside phosphorylase activity,MF,
5728,GO:0016155,1,0.985106746845851,0,2,formyltetrahydrofolate dehydrogenase activity,MF,
5729,GO:0016160,1,0.980638265063283,0,3,amylase activity,MF,
5730,GO:0016165,1,0.988033391847534,0,2,linoleate 13S-lipoxygenase activity,MF,
5731,GO:0016167,1,0.984303106442702,0,2,glial cell-derived neurotrophic factor receptor activity,MF,
5732,GO:0016174,1,0.959073437164059,0,6,NAD(P)H oxidase activity,MF,
5733,GO:0016175,1,0.957566162289843,0,7,superoxide-generating NADPH oxidase activity,MF,
5734,GO:0016176,1,0.948010246805634,0,8,superoxide-generating NADPH oxidase activator activity,MF,
5735,GO:0016180,1,0.866330140264999,0,23,snRNA processing,BP,
5736,GO:0016182,1,0.992797987742345,0,1,synaptic vesicle budding from endosome,BP,
5737,GO:0016185,1,0.978498954703678,0,3,synaptic vesicle budding from presynaptic endocytic zone membrane,BP,
5738,GO:0016188,1,0.924960660970227,0,11,synaptic vesicle maturation,BP,
5739,GO:0016189,1,0.991129449627916,0,1,synaptic vesicle to endosome fusion,BP,
5740,GO:0016191,1,0.965250122097396,0,5,synaptic vesicle uncoating,BP,
5742,GO:0016197,1,0.291796116017017,0,183,endosomal transport,BP,
5743,GO:0016198,1,0.95874483530431,0,6,axon choice point recognition,BP,
5744,GO:0016199,1,0.970423112080424,0,4,axon midline choice point recognition,BP,
5746,GO:0016206,1,0.987864472745575,0,2,catechol O-methyltransferase activity,MF,
5747,GO:0016208,1,0.942178727459396,0,10,AMP binding,MF,
5748,GO:0016209,1,0.658625562459886,0,71,antioxidant activity,MF,
5749,GO:0016211,1,0.985576883599738,0,2,ammonia ligase activity,MF,
5750,GO:0016212,1,0.988195610530937,0,2,kynurenine-oxoglutarate transaminase activity,MF,
5751,GO:0016213,1,0.993660215276567,0,1,linoleoyl-CoA desaturase activity,MF,
5752,GO:0016215,1,0.980203054126795,0,3,acyl-CoA desaturase activity,MF,
5753,GO:0016222,1,0.987805734577763,0,2,procollagen-proline 4-dioxygenase complex,CC,
5754,GO:0016226,1,0.889632414459992,0,20,iron-sulfur cluster assembly,BP,
5755,GO:0016229,1,0.868474257551205,0,25,steroid dehydrogenase activity,MF,
5756,GO:0016230,1,0.988057000900914,0,2,sphingomyelin phosphodiesterase activator activity,MF,
5757,GO:0016231,1,0.992637874538034,0,1,beta-N-acetylglucosaminidase activity,MF,
5758,GO:0016232,1,0.993834461646515,0,1,HNK-1 sulfotransferase activity,MF,
5759,GO:0016233,1,0.756314489713942,0,42,telomere capping,BP,
5760,GO:0016234,1,0.58736506016671,0,77,inclusion body,CC,
5761,GO:0016235,1,0.758120655805732,0,41,aggresome,CC,
5762,GO:0016236,1,0.163174352141833,0,278,macroautophagy,BP,
5763,GO:0016237,1,0.992720072441794,0,1,lysosomal microautophagy,BP,
5764,GO:0016239,1,0.671516369971406,0,57,positive regulation of macroautophagy,BP,
5765,GO:0016240,1,0.973815358097364,0,4,autophagosome membrane docking,BP,
5766,GO:0016241,1,0.358475153324581,0,155,regulation of macroautophagy,BP,
5767,GO:0016242,1,0.832334661656568,0,27,negative regulation of macroautophagy,BP,
5768,GO:0016243,1,0.993224945433582,0,1,regulation of autophagosome size,BP,
5769,GO:0016246,1,0.904506390530448,0,15,RNA interference,BP,
5771,GO:0016248,1,0.810271615604245,0,32,channel inhibitor activity,MF,
5772,GO:0016250,1,0.993858601823483,0,1,N-sulfoglucosamine sulfohydrolase activity,MF,
5773,GO:0016254,1,0.90912994613035,0,16,preassembly of GPI anchor in ER membrane,BP,
5774,GO:0016255,1,0.954373178016268,0,7,attachment of GPI anchor to protein,BP,
5775,GO:0016256,1,0.987060509972945,0,2,N-glycan processing to lysosome,BP,
5776,GO:0016259,1,0.974972746605182,0,4,selenocysteine metabolic process,BP,
5777,GO:0016260,1,0.988100047207082,0,2,selenocysteine biosynthetic process,BP,
5778,GO:0016262,1,0.980749016868198,0,3,protein N-acetylglucosaminyltransferase activity,MF,
5779,GO:0016263,1,0.988674768288738,0,2,glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity,MF,
5780,GO:0016264,1,0.936834907433817,0,10,gap junction assembly,BP,
5781,GO:0016266,1,0.722412499396126,0,48,O-glycan processing,BP,
5782,GO:0016267,1,0.988674768288738,0,2,O-glycan processing, core 1,BP,
5783,GO:0016272,1,0.963707168805484,0,7,prefoldin complex,CC,
5784,GO:0016273,1,0.930476426259381,0,12,arginine N-methyltransferase activity,MF,
5785,GO:0016274,1,0.930476426259381,0,12,protein-arginine N-methyltransferase activity,MF,
5786,GO:0016277,1,0.994046520305129,0,1,[myelin basic protein]-arginine N-methyltransferase activity,MF,
5787,GO:0016278,1,0.705084072851872,0,51,lysine N-methyltransferase activity,MF,
5788,GO:0016279,1,0.709461915934761,0,50,protein-lysine N-methyltransferase activity,MF,
5789,GO:0016281,1,0.943014580546006,0,9,eukaryotic translation initiation factor 4F complex,CC,
5790,GO:0016282,1,0.992971648288315,0,1,eukaryotic 43S preinitiation complex,CC,
5791,GO:0016286,1,0.976505943726633,0,4,small conductance calcium-activated potassium channel activity,MF,
5792,GO:0016287,1,0.99389921087106,0,1,glycerone-phosphate O-acyltransferase activity,MF,
5793,GO:0016289,1,0.905848796324728,0,17,CoA hydrolase activity,MF,
5794,GO:0016290,1,0.949285870137141,0,9,palmitoyl-CoA hydrolase activity,MF,
5795,GO:0016295,1,0.985318076843781,0,2,myristoyl-[acyl-carrier-protein] hydrolase activity,MF,
5796,GO:0016296,1,0.985318076843781,0,2,palmitoyl-[acyl-carrier-protein] hydrolase activity,MF,
5797,GO:0016297,1,0.985318076843781,0,2,acyl-[acyl-carrier-protein] hydrolase activity,MF,
5799,GO:0016300,1,0.980819979280897,0,3,tRNA (uracil) methyltransferase activity,MF,
5802,GO:0016307,1,0.900283392426956,0,15,phosphatidylinositol phosphate kinase activity,MF,
5803,GO:0016308,1,0.96070624898867,0,6,1-phosphatidylinositol-4-phosphate 5-kinase activity,MF,
5804,GO:0016309,1,0.987030111388393,0,2,1-phosphatidylinositol-5-phosphate 4-kinase activity,MF,
5807,GO:0016312,1,0.973101282891659,0,4,inositol bisphosphate phosphatase activity,MF,
5808,GO:0016314,1,0.979682149075944,0,3,phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity,MF,
5809,GO:0016316,1,0.985049915296123,0,2,phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity,MF,
5810,GO:0016320,1,0.985733632028488,0,2,endoplasmic reticulum membrane fusion,BP,
5811,GO:0016321,1,0.975970178610012,0,4,female meiosis chromosome segregation,BP,
5812,GO:0016322,1,0.937371355761432,0,10,neuron remodeling,BP,
5815,GO:0016327,1,0.904801271157883,0,16,apicolateral plasma membrane,CC,
5818,GO:0016332,1,0.993273347060655,0,1,establishment or maintenance of polarity of embryonic epithelium,BP,
5819,GO:0016333,1,0.993770588536703,0,1,morphogenesis of follicular epithelium,BP,
5820,GO:0016334,1,0.993770588536703,0,1,establishment or maintenance of polarity of follicular epithelium,BP,
5822,GO:0016339,1,0.802103621960659,0,33,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,BP,
5823,GO:0016340,1,0.983921161911844,0,2,calcium-dependent cell-matrix adhesion,BP,
5824,GO:0016342,1,0.826663745970938,0,28,catenin complex,CC,
5825,GO:0016344,1,0.979246861268832,0,3,meiotic chromosome movement towards spindle pole,BP,
5827,GO:0016361,1,0.972318244137047,0,4,activin receptor activity, type I,MF,
5828,GO:0016362,1,0.978584264159095,0,2,activin receptor activity, type II,MF,
5830,GO:0016401,1,0.974077539917438,0,4,palmitoyl-CoA oxidase activity,MF,
5831,GO:0016402,1,0.987943300874709,0,2,pristanoyl-CoA oxidase activity,MF,
5832,GO:0016403,1,0.987862804465444,0,2,dimethylargininase activity,MF,
5833,GO:0016404,1,0.986888683006908,0,2,15-hydroxyprostaglandin dehydrogenase (NAD+) activity,MF,
5834,GO:0016405,1,0.870594924222524,0,22,CoA-ligase activity,MF,
5835,GO:0016406,1,0.962722123489511,0,6,carnitine O-acyltransferase activity,MF,
5836,GO:0016407,1,0.537187427699927,0,94,acetyltransferase activity,MF,
5837,GO:0016408,1,0.902155342768466,0,17,C-acyltransferase activity,MF,
5838,GO:0016409,1,0.782839915872124,0,38,palmitoyltransferase activity,MF,
5839,GO:0016410,1,0.546943686057917,0,92,N-acyltransferase activity,MF,
5840,GO:0016411,1,0.867966380863196,0,21,acylglycerol O-acyltransferase activity,MF,
5841,GO:0016413,1,0.955924249109992,0,7,O-acetyltransferase activity,MF,
5842,GO:0016414,1,0.993611089528904,0,1,O-octanoyltransferase activity,MF,
5843,GO:0016415,1,0.988438621826114,0,2,octanoyltransferase activity,MF,
5844,GO:0016416,1,0.967877083822233,0,5,O-palmitoyltransferase activity,MF,
5845,GO:0016417,1,0.818452382140376,0,31,S-acyltransferase activity,MF,
5846,GO:0016418,1,0.983994830883591,0,2,S-acetyltransferase activity,MF,
5847,GO:0016419,1,0.985220498432862,0,2,S-malonyltransferase activity,MF,
5848,GO:0016420,1,0.985220498432862,0,2,malonyltransferase activity,MF,
5849,GO:0016421,1,0.966642042250212,0,5,CoA carboxylase activity,MF,
5850,GO:0016422,1,0.982427076395434,0,3,mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity,MF,
5851,GO:0016423,1,0.922582028251141,0,13,tRNA (guanine) methyltransferase activity,MF,
5852,GO:0016426,1,0.981914069549653,0,3,tRNA (adenine) methyltransferase activity,MF,
5853,GO:0016427,1,0.948508882739414,0,8,tRNA (cytosine) methyltransferase activity,MF,
5854,GO:0016428,1,0.974085974034265,0,4,tRNA (cytosine-5-)-methyltransferase activity,MF,
5855,GO:0016429,1,0.981914069549653,0,3,tRNA (adenine-N1-)-methyltransferase activity,MF,
5856,GO:0016433,1,0.965383741802327,0,6,rRNA (adenine) methyltransferase activity,MF,
5857,GO:0016434,1,0.98086478031938,0,3,rRNA (cytosine) methyltransferase activity,MF,
5858,GO:0016435,1,0.981180718896759,0,3,rRNA (guanine) methyltransferase activity,MF,
5859,GO:0016436,1,0.987209185431979,0,2,rRNA (uridine) methyltransferase activity,MF,
5860,GO:0016441,1,0.443136960883365,0,121,posttranscriptional gene silencing,BP,
5861,GO:0016442,1,0.923714267784696,0,11,RISC complex,CC,
5862,GO:0016444,1,0.709537125962842,0,51,somatic cell DNA recombination,BP,
5863,GO:0016445,1,0.727854109381256,0,48,somatic diversification of immunoglobulins,BP,
5864,GO:0016446,1,0.931696118909198,0,11,somatic hypermutation of immunoglobulin genes,BP,
5865,GO:0016447,1,0.752634551517672,0,43,somatic recombination of immunoglobulin gene segments,BP,
5866,GO:0016453,1,0.977051547194742,0,4,C-acetyltransferase activity,MF,
5867,GO:0016454,1,0.96728964051189,0,5,C-palmitoyltransferase activity,MF,
5868,GO:0016458,1,0.241131387328067,0,212,gene silencing,BP,
5871,GO:0016461,1,0.925787239363556,0,10,unconventional myosin complex,CC,
5874,GO:0016471,1,0.912278133891167,0,15,vacuolar proton-transporting V-type ATPase complex,CC,
5875,GO:0016476,1,0.980304293347053,0,3,regulation of embryonic cell shape,BP,
5877,GO:0016479,1,0.972918842588879,0,4,negative regulation of transcription by RNA polymerase I,BP,
5878,GO:0016480,1,0.983251456260715,0,3,negative regulation of transcription by RNA polymerase III,BP,
5879,GO:0016482,1,0.389696082604649,0,136,cytosolic transport,BP,
5881,GO:0016486,1,0.845797486797442,0,26,peptide hormone processing,BP,
5882,GO:0016487,1,0.989146309159339,0,2,farnesol metabolic process,BP,
5883,GO:0016488,1,0.989146309159339,0,2,farnesol catabolic process,BP,
5886,GO:0016493,1,0.942150371923857,0,10,C-C chemokine receptor activity,MF,
5887,GO:0016494,1,0.953848227334934,0,8,C-X-C chemokine receptor activity,MF,
5888,GO:0016495,1,0.993647932416095,0,1,C-X3-C chemokine receptor activity,MF,
5889,GO:0016496,1,0.993610066200417,0,1,substance P receptor activity,MF,
5890,GO:0016497,1,0.99404033161332,0,1,substance K receptor activity,MF,
5891,GO:0016499,1,0.994252551938634,0,1,orexin receptor activity,MF,
5892,GO:0016500,1,0.934990682037903,0,10,protein-hormone receptor activity,MF,
5893,GO:0016501,1,0.988019800738066,0,2,prostacyclin receptor activity,MF,
5894,GO:0016502,1,0.893798544530123,0,19,nucleotide receptor activity,MF,
5895,GO:0016503,1,0.994612245504974,0,1,pheromone receptor activity,MF,
5898,GO:0016507,1,0.993713970873707,0,1,mitochondrial fatty acid beta-oxidation multienzyme complex,CC,
5899,GO:0016508,1,0.981005967025223,0,3,long-chain-enoyl-CoA hydratase activity,MF,
5900,GO:0016509,1,0.981950735202364,0,3,long-chain-3-hydroxyacyl-CoA dehydrogenase activity,MF,
5901,GO:0016514,1,0.902969705326376,0,15,SWI/SNF complex,CC,
5902,GO:0016517,1,0.994262112923769,0,1,interleukin-12 receptor activity,MF,
5903,GO:0016519,1,0.994238082048865,0,1,gastric inhibitory peptide receptor activity,MF,
5904,GO:0016520,1,0.987536224462605,0,2,growth hormone-releasing hormone receptor activity,MF,
5905,GO:0016521,1,0.993652794239666,0,1,pituitary adenylate cyclase activating polypeptide activity,MF,
5906,GO:0016525,1,0.559675029408048,0,85,negative regulation of angiogenesis,BP,
5910,GO:0016531,1,0.97088569495644,0,5,copper chaperone activity,MF,
5911,GO:0016532,1,0.980563765276924,0,3,superoxide dismutase copper chaperone activity,MF,
5912,GO:0016533,1,0.982115394736588,0,3,cyclin-dependent protein kinase 5 holoenzyme complex,CC,
5913,GO:0016534,1,0.987354327668317,0,2,cyclin-dependent protein kinase 5 activator activity,MF,
5914,GO:0016538,1,0.840794964562183,0,29,cyclin-dependent protein serine/threonine kinase regulator activity,MF,
5915,GO:0016539,1,0.994475315120246,0,1,intein-mediated protein splicing,BP,
5917,GO:0016553,1,0.914081503922312,0,14,base conversion or substitution editing,BP,
5918,GO:0016554,1,0.948566325424054,0,9,cytidine to uridine editing,BP,
5919,GO:0016556,1,0.914318010624291,0,15,mRNA modification,BP,
5920,GO:0016557,1,0.982977128415942,0,3,peroxisome membrane biogenesis,BP,
5921,GO:0016558,1,0.927325009532216,0,12,protein import into peroxisome matrix,BP,
5922,GO:0016559,1,0.948509441526223,0,9,peroxisome fission,BP,
5923,GO:0016560,1,0.974584104601949,0,4,protein import into peroxisome matrix, docking,BP,
5924,GO:0016561,1,0.987809274732963,0,2,protein import into peroxisome matrix, translocation,BP,
5928,GO:0016571,1,0.43046662310858,0,122,histone methylation,BP,
5930,GO:0016573,1,0.39936985937849,0,137,histone acetylation,BP,
5931,GO:0016574,1,0.743158365835043,0,43,histone ubiquitination,BP,
5932,GO:0016575,1,0.568902561832117,0,83,histone deacetylation,BP,
5933,GO:0016576,1,0.961254995962661,0,6,histone dephosphorylation,BP,
5934,GO:0016577,1,0.817214648476947,0,27,histone demethylation,BP,
5935,GO:0016578,1,0.862032025216343,0,22,histone deubiquitination,BP,
5937,GO:0016580,1,0.918998992586105,0,12,Sin3 complex,CC,
5938,GO:0016581,1,0.882692584228944,0,17,NuRD complex,CC,
5939,GO:0016584,1,0.95886639071628,0,7,nucleosome positioning,BP,
5940,GO:0016586,1,0.984408187788764,0,2,RSC-type complex,CC,
5941,GO:0016589,1,0.950678408214407,0,7,NURF complex,CC,
5942,GO:0016590,1,0.992190084652495,0,1,ACF complex,CC,
5943,GO:0016591,1,0.499984471371906,0,107,DNA-directed RNA polymerase II, holoenzyme,CC,
5944,GO:0016592,1,0.785866940162382,0,36,mediator complex,CC,
5945,GO:0016593,1,0.947027140441709,0,8,Cdc73/Paf1 complex,CC,
5946,GO:0016594,1,0.908199893957912,0,15,glycine binding,MF,
5947,GO:0016595,1,0.934613046252792,0,10,glutamate binding,MF,
5948,GO:0016596,1,0.993850639026861,0,1,thienylcyclohexylpiperidine binding,MF,
5949,GO:0016597,1,0.695700001206653,0,57,amino acid binding,MF,
5950,GO:0016598,1,0.988517803565363,0,2,protein arginylation,BP,
5951,GO:0016600,1,0.936941746760641,0,9,flotillin complex,CC,
5952,GO:0016601,1,0.778984212491551,0,37,Rac protein signal transduction,BP,
5953,GO:0016602,1,0.974741315256653,0,4,CCAAT-binding factor complex,CC,
5954,GO:0016603,1,0.988611058158123,0,2,glutaminyl-peptide cyclotransferase activity,MF,
5956,GO:0016605,1,0.528947061214694,0,94,PML body,CC,
5958,GO:0016608,1,0.990000973708804,0,2,growth hormone-releasing hormone activity,MF,
5959,GO:0016614,1,0.493331451393391,0,117,oxidoreductase activity, acting on CH-OH group of donors,MF,
5960,GO:0016615,1,0.958929628831974,0,7,malate dehydrogenase activity,MF,
5961,GO:0016616,1,0.54227471640325,0,103,oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,
5962,GO:0016618,1,0.982317843195232,0,3,hydroxypyruvate reductase activity,MF,
5964,GO:0016623,1,0.987153216092024,0,2,oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor,MF,
5965,GO:0016624,1,0.951104696614036,0,8,oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor,MF,
5966,GO:0016627,1,0.722500340887059,0,53,oxidoreductase activity, acting on the CH-CH group of donors,MF,
5967,GO:0016628,1,0.865988591283937,0,24,oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor,MF,
5968,GO:0016634,1,0.950985055797619,0,8,oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor,MF,
5969,GO:0016635,1,0.971755784455753,0,5,oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor,MF,
5970,GO:0016638,1,0.878232040962449,0,21,oxidoreductase activity, acting on the CH-NH2 group of donors,MF,
5971,GO:0016639,1,0.982261073494603,0,3,oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor,MF,
5972,GO:0016641,1,0.904842908734918,0,16,oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor,MF,
5973,GO:0016642,1,0.99331653001693,0,1,oxidoreductase activity, acting on the CH-NH2 group of donors, disulfide as acceptor,MF,
5974,GO:0016645,1,0.860177013604367,0,24,oxidoreductase activity, acting on the CH-NH group of donors,MF,
5975,GO:0016646,1,0.902864484804608,0,16,oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor,MF,
5976,GO:0016647,1,0.982768634936227,0,3,oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor,MF,
5977,GO:0016649,1,0.987724962689833,0,2,oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor,MF,
5978,GO:0016651,1,0.571091714408009,0,97,oxidoreductase activity, acting on NAD(P)H,MF,
5979,GO:0016652,1,0.987642480893837,0,2,oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor,MF,
5980,GO:0016653,1,0.918285490992191,0,13,oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor,MF,
5981,GO:0016655,1,0.756153032451823,0,52,oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor,MF,
5982,GO:0016657,1,0.988851815798577,0,2,oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor,MF,
5983,GO:0016661,1,0.969800943895116,0,5,oxidoreductase activity, acting on other nitrogenous compounds as donors,MF,
5984,GO:0016662,1,0.993944491212098,0,1,oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor,MF,
5985,GO:0016667,1,0.728664362210964,0,53,oxidoreductase activity, acting on a sulfur group of donors,MF,
5986,GO:0016668,1,0.926611323008239,0,13,oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor,MF,
5987,GO:0016670,1,0.949693412050702,0,8,oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor,MF,
5988,GO:0016671,1,0.937974758837682,0,11,oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor,MF,
5989,GO:0016672,1,0.989428399915997,0,2,oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor,MF,
5990,GO:0016675,1,0.884462268239612,0,23,oxidoreductase activity, acting on a heme group of donors,MF,
5991,GO:0016676,1,0.889814219008984,0,22,oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor,MF,
5992,GO:0016679,1,0.955820137877568,0,8,oxidoreductase activity, acting on diphenols and related substances as donors,MF,
5993,GO:0016681,1,0.961649174919156,0,7,oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor,MF,
5994,GO:0016684,1,0.779805160425784,0,42,oxidoreductase activity, acting on peroxide as acceptor,MF,
5995,GO:0016701,1,0.862060387771981,0,25,oxidoreductase activity, acting on single donors with incorporation of molecular oxygen,MF,
5996,GO:0016702,1,0.862060387771981,0,25,oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen,MF,
5997,GO:0016705,1,0.435477502841291,0,129,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,MF,
5998,GO:0016706,1,0.758686116105496,0,41,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors,MF,
5999,GO:0016708,1,0.988307380428046,0,2,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor,MF,
6000,GO:0016709,1,0.797267452251621,0,36,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen,MF,
6001,GO:0016711,1,0.993940887741803,0,1,flavonoid 3'-monooxygenase activity,MF,
6002,GO:0016712,1,0.892123810713041,0,19,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen,MF,
6003,GO:0016713,1,0.988694811643758,0,2,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen,MF,
6004,GO:0016714,1,0.965727069218356,0,6,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen,MF,
6005,GO:0016715,1,0.974396032196429,0,4,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen,MF,
6006,GO:0016717,1,0.967362565096202,0,5,oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water,MF,
6007,GO:0016721,1,0.973100148343786,0,5,oxidoreductase activity, acting on superoxide radicals as acceptor,MF,
6008,GO:0016722,1,0.898206592280784,0,16,oxidoreductase activity, oxidizing metal ions,MF,
6009,GO:0016723,1,0.936555167012728,0,10,oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor,MF,
6010,GO:0016724,1,0.964801228421745,0,5,oxidoreductase activity, oxidizing metal ions, oxygen as acceptor,MF,
6012,GO:0016726,1,0.98509875160187,0,2,oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor,MF,
6013,GO:0016727,1,0.992315508269107,0,1,oxidoreductase activity, acting on CH or CH2 groups, oxygen as acceptor,MF,
6015,GO:0016730,1,0.994307854818459,0,1,oxidoreductase activity, acting on iron-sulfur proteins as donors,MF,
6016,GO:0016731,1,0.994307854818459,0,1,oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor,MF,
6018,GO:0016741,1,0.288982595495894,0,193,transferase activity, transferring one-carbon groups,MF,
6020,GO:0016743,1,0.97848608031785,0,3,carboxyl- or carbamoyltransferase activity,MF,
6021,GO:0016744,1,0.982865696851601,0,3,transferase activity, transferring aldehyde or ketonic groups,MF,
6022,GO:0016746,1,0.240757406085149,0,220,transferase activity, transferring acyl groups,MF,
6023,GO:0016747,1,0.285086987504786,0,193,transferase activity, transferring acyl groups other than amino-acyl groups,MF,
6024,GO:0016748,1,0.982241747065676,0,3,succinyltransferase activity,MF,
6025,GO:0016749,1,0.988354470473356,0,2,N-succinyltransferase activity,MF,
6026,GO:0016751,1,0.99381598176533,0,1,S-succinyltransferase activity,MF,
6027,GO:0016755,1,0.929798052330027,0,12,transferase activity, transferring amino-acyl groups,MF,
6028,GO:0016757,1,0.213002185694623,0,240,transferase activity, transferring glycosyl groups,MF,
6029,GO:0016758,1,0.32474620913214,0,175,transferase activity, transferring hexosyl groups,MF,
6030,GO:0016763,1,0.754275103286738,0,44,transferase activity, transferring pentosyl groups,MF,
6031,GO:0016765,1,0.727525419854757,0,54,transferase activity, transferring alkyl or aryl (other than methyl) groups,MF,
6032,GO:0016768,1,0.994413815157045,0,1,spermine synthase activity,MF,
6036,GO:0016774,1,0.981860130142898,0,3,phosphotransferase activity, carboxyl group as acceptor,MF,
6037,GO:0016775,1,0.924652724568549,0,12,phosphotransferase activity, nitrogenous group as acceptor,MF,
6039,GO:0016778,1,0.97093681949371,0,5,diphosphotransferase activity,MF,
6040,GO:0016779,1,0.431152391114249,0,131,nucleotidyltransferase activity,MF,
6041,GO:0016780,1,0.892861137058551,0,18,phosphotransferase activity, for other substituted phosphate groups,MF,
6042,GO:0016781,1,0.988100047207082,0,2,phosphotransferase activity, paired acceptors,MF,
6044,GO:0016783,1,0.93477225811048,0,12,sulfurtransferase activity,MF,
6045,GO:0016784,1,0.99452673209409,0,1,3-mercaptopyruvate sulfurtransferase activity,MF,
6046,GO:0016785,1,0.992366871022755,0,1,transferase activity, transferring selenium-containing groups,MF,
6049,GO:0016790,1,0.825708828364741,0,32,thiolester hydrolase activity,MF,
6050,GO:0016791,1,0.206342347855028,0,236,phosphatase activity,MF,
6051,GO:0016793,1,0.993637697540363,0,1,triphosphoric monoester hydrolase activity,MF,
6052,GO:0016794,1,0.994750184060493,0,1,diphosphoric monoester hydrolase activity,MF,
6053,GO:0016796,1,0.721028349680715,0,50,exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters,MF,
6054,GO:0016798,1,0.536706806197154,0,100,hydrolase activity, acting on glycosyl bonds,MF,
6055,GO:0016799,1,0.878501488040117,0,22,hydrolase activity, hydrolyzing N-glycosyl compounds,MF,
6056,GO:0016801,1,0.918563748368071,0,14,hydrolase activity, acting on ether bonds,MF,
6057,GO:0016802,1,0.980120946056949,0,3,trialkylsulfonium hydrolase activity,MF,
6058,GO:0016803,1,0.937206619040457,0,11,ether hydrolase activity,MF,
6060,GO:0016807,1,0.993850639026861,0,1,cysteine-type carboxypeptidase activity,MF,
6061,GO:0016810,1,0.423143145433701,0,135,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds,MF,
6062,GO:0016811,1,0.584559703111551,0,84,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides,MF,
6063,GO:0016812,1,0.952851356168598,0,7,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides,MF,
6064,GO:0016813,1,0.947369163911174,0,9,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines,MF,
6065,GO:0016814,1,0.834966223539115,0,29,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines,MF,
6066,GO:0016815,1,0.994583828338402,0,1,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in nitriles,MF,
6069,GO:0016822,1,0.983567274982415,0,3,hydrolase activity, acting on acid carbon-carbon bonds,MF,
6070,GO:0016823,1,0.983567274982415,0,3,hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances,MF,
6071,GO:0016826,1,0.993858601823483,0,1,hydrolase activity, acting on acid sulfur-nitrogen bonds,MF,
6073,GO:0016830,1,0.750733063090385,0,47,carbon-carbon lyase activity,MF,
6074,GO:0016831,1,0.822027394560655,0,32,carboxy-lyase activity,MF,
6075,GO:0016832,1,0.952656101473374,0,8,aldehyde-lyase activity,MF,
6076,GO:0016833,1,0.963269519194301,0,6,oxo-acid-lyase activity,MF,
6078,GO:0016836,1,0.750329555375108,0,48,hydro-lyase activity,MF,
6080,GO:0016840,1,0.927224527154625,0,13,carbon-nitrogen lyase activity,MF,
6081,GO:0016841,1,0.971330288757668,0,5,ammonia-lyase activity,MF,
6082,GO:0016842,1,0.960514408730817,0,7,amidine-lyase activity,MF,
6083,GO:0016843,1,0.993850639026861,0,1,amine-lyase activity,MF,
6084,GO:0016844,1,0.993850639026861,0,1,strictosidine synthase activity,MF,
6085,GO:0016846,1,0.952074688031836,0,9,carbon-sulfur lyase activity,MF,
6086,GO:0016849,1,0.890391271003404,0,16,phosphorus-oxygen lyase activity,MF,
6088,GO:0016854,1,0.905787352844759,0,16,racemase and epimerase activity,MF,
6089,GO:0016855,1,0.994007335679593,0,1,racemase and epimerase activity, acting on amino acids and derivatives,MF,
6090,GO:0016857,1,0.931380370539545,0,11,racemase and epimerase activity, acting on carbohydrates and derivatives,MF,
6091,GO:0016859,1,0.820188561686226,0,33,cis-trans isomerase activity,MF,
6093,GO:0016861,1,0.955151975509912,0,8,intramolecular oxidoreductase activity, interconverting aldoses and ketoses,MF,
6094,GO:0016862,1,0.989980933293215,0,2,intramolecular oxidoreductase activity, interconverting keto- and enol-groups,MF,
6095,GO:0016863,1,0.944711097665757,0,10,intramolecular oxidoreductase activity, transposing C=C bonds,MF,
6096,GO:0016864,1,0.897116426065811,0,17,intramolecular oxidoreductase activity, transposing S-S bonds,MF,
6097,GO:0016866,1,0.848882722914222,0,27,intramolecular transferase activity,MF,
6098,GO:0016868,1,0.934970297913133,0,11,intramolecular transferase activity, phosphotransferases,MF,
6099,GO:0016872,1,0.994119278026145,0,1,intramolecular lyase activity,MF,
6101,GO:0016875,1,0.761712277817398,0,44,ligase activity, forming carbon-oxygen bonds,MF,
6102,GO:0016877,1,0.797019641071822,0,36,ligase activity, forming carbon-sulfur bonds,MF,
6103,GO:0016878,1,0.85004697363438,0,26,acid-thiol ligase activity,MF,
6105,GO:0016880,1,0.979515329007047,0,3,acid-ammonia (or amide) ligase activity,MF,
6107,GO:0016882,1,0.988377592261479,0,2,cyclo-ligase activity,MF,
6108,GO:0016884,1,0.936490667731557,0,10,carbon-nitrogen ligase activity, with glutamine as amido-N-donor,MF,
6109,GO:0016885,1,0.95449598617903,0,7,ligase activity, forming carbon-carbon bonds,MF,
6110,GO:0016886,1,0.939778973535938,0,10,ligase activity, forming phosphoric ester bonds,MF,
6112,GO:0016888,1,0.935621956371817,0,10,endodeoxyribonuclease activity, producing 5'-phosphomonoesters,MF,
6113,GO:0016889,1,0.888878067912843,0,20,endodeoxyribonuclease activity, producing 3'-phosphomonoesters,MF,
6114,GO:0016890,1,0.987560580173127,0,2,site-specific endodeoxyribonuclease activity, specific for altered base,MF,
6115,GO:0016891,1,0.84781584301256,0,27,endoribonuclease activity, producing 5'-phosphomonoesters,MF,
6116,GO:0016892,1,0.956568743207786,0,8,endoribonuclease activity, producing 3'-phosphomonoesters,MF,
6117,GO:0016893,1,0.810935505234241,0,34,endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters,MF,
6118,GO:0016894,1,0.850227981019679,0,28,endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters,MF,
6119,GO:0016895,1,0.887948310080088,0,19,exodeoxyribonuclease activity, producing 5'-phosphomonoesters,MF,
6120,GO:0016896,1,0.807982851862088,0,32,exoribonuclease activity, producing 5'-phosphomonoesters,MF,
6121,GO:0016898,1,0.988220433370795,0,2,oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor,MF,
6122,GO:0016899,1,0.979996479758605,0,3,oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor,MF,
6123,GO:0016900,1,0.989528417099102,0,2,oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor,MF,
6124,GO:0016901,1,0.986072623023957,0,2,oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor,MF,
6126,GO:0016907,1,0.9635536939771,0,6,G-protein coupled acetylcholine receptor activity,MF,
6127,GO:0016909,1,0.980972705996286,0,3,SAP kinase activity,MF,
6128,GO:0016917,1,0.877228910608409,0,19,GABA receptor activity,MF,
6129,GO:0016918,1,0.928372511124604,0,13,retinal binding,MF,
6130,GO:0016920,1,0.991618044453962,0,1,pyroglutamyl-peptidase activity,MF,
6131,GO:0016922,1,0.858571333852005,0,21,ligand-dependent nuclear receptor binding,MF,
6133,GO:0016926,1,0.953008414219245,0,7,protein desumoylation,BP,
6134,GO:0016929,1,0.958355838011695,0,6,SUMO-specific protease activity,MF,
6135,GO:0016933,1,0.96981659933639,0,5,extracellularly glycine-gated ion channel activity,MF,
6136,GO:0016934,1,0.96981659933639,0,5,extracellularly glycine-gated chloride channel activity,MF,
6137,GO:0016935,1,0.98718067792203,0,2,glycine-gated chloride channel complex,CC,
6138,GO:0016936,1,0.978364370992089,0,4,galactoside binding,MF,
6139,GO:0016938,1,0.993764437102289,0,1,kinesin I complex,CC,
6140,GO:0016939,1,0.978068845088947,0,3,kinesin II complex,CC,
6141,GO:0016941,1,0.98068220963974,0,3,natriuretic peptide receptor activity,MF,
6142,GO:0016942,1,0.966962763748725,0,5,insulin-like growth factor binding protein complex,CC,
6143,GO:0016964,1,0.987605570906056,0,1,alpha-2 macroglobulin receptor activity,MF,
6144,GO:0016971,1,0.980881570224355,0,3,flavin-linked sulfhydryl oxidase activity,MF,
6145,GO:0016972,1,0.973853286502068,0,4,thiol oxidase activity,MF,
6146,GO:0016973,1,0.927885400992645,0,12,poly(A)+ mRNA export from nucleus,BP,
6147,GO:0016979,1,0.994558510255316,0,1,lipoate-protein ligase activity,MF,
6148,GO:0016990,1,0.994112567016873,0,1,arginine deiminase activity,MF,
6149,GO:0016992,1,0.994422859727469,0,1,lipoate synthase activity,MF,
6150,GO:0016997,1,0.97063079144652,0,5,alpha-sialidase activity,MF,
6151,GO:0016998,1,0.977953260539006,0,4,cell wall macromolecule catabolic process,BP,
6153,GO:0017000,1,0.90640912031265,0,15,antibiotic biosynthetic process,BP,
6154,GO:0017001,1,0.782506868290281,0,42,antibiotic catabolic process,BP,
6155,GO:0017002,1,0.944423152895574,0,7,activin-activated receptor activity,MF,
6156,GO:0017003,1,0.994106372711102,0,1,protein-heme linkage,BP,
6157,GO:0017004,1,0.813724866773719,0,34,cytochrome complex assembly,BP,
6158,GO:0017005,1,0.99340991212181,0,1,3'-tyrosyl-DNA phosphodiesterase activity,MF,
6159,GO:0017006,1,0.994106372711102,0,1,protein-tetrapyrrole linkage,BP,
6163,GO:0017017,1,0.93463756137786,0,11,MAP kinase tyrosine/serine/threonine phosphatase activity,MF,
6164,GO:0017018,1,0.977292314410514,0,3,myosin phosphatase activity,MF,
6165,GO:0017020,1,0.993808027935622,0,1,myosin phosphatase regulator activity,MF,
6167,GO:0017024,1,0.994826636747117,0,1,myosin I binding,MF,
6168,GO:0017025,1,0.853333874459559,0,25,TBP-class protein binding,MF,
6169,GO:0017034,1,0.962769012055484,0,5,Rap guanyl-nucleotide exchange factor activity,MF,
6171,GO:0017040,1,0.970185584483249,0,5,N-acylsphingosine amidohydrolase activity,MF,
6172,GO:0017042,1,0.994418208254504,0,1,glycosylceramidase activity,MF,
6173,GO:0017045,1,0.994629295282871,0,1,corticotropin-releasing hormone activity,MF,
6174,GO:0017046,1,0.794390175310906,0,35,peptide hormone binding,MF,
6176,GO:0017049,1,0.87699472291027,0,20,GTP-Rho binding,MF,
6177,GO:0017050,1,0.988118519881087,0,2,D-erythro-sphingosine kinase activity,MF,
6178,GO:0017053,1,0.559677436474805,0,82,transcriptional repressor complex,CC,
6179,GO:0017055,1,0.987599320519256,0,2,negative regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,
6180,GO:0017056,1,0.85320717014403,0,23,structural constituent of nuclear pore,MF,
6181,GO:0017057,1,0.985373183331601,0,2,6-phosphogluconolactonase activity,MF,
6182,GO:0017059,1,0.9509222080327,0,8,serine C-palmitoyltransferase complex,CC,
6183,GO:0017060,1,0.982217775971796,0,3,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity,MF,
6184,GO:0017061,1,0.99274832228324,0,1,S-methyl-5-thioadenosine phosphorylase activity,MF,
6185,GO:0017062,1,0.945646548926414,0,9,respiratory chain complex III assembly,BP,
6186,GO:0017064,1,0.988480774171472,0,2,fatty acid amide hydrolase activity,MF,
6187,GO:0017065,1,0.994477898997577,0,1,single-strand selective uracil DNA N-glycosylase activity,MF,
6188,GO:0017069,1,0.792959217969402,0,38,snRNA binding,MF,
6189,GO:0017070,1,0.935159894440881,0,11,U6 snRNA binding,MF,
6190,GO:0017071,1,0.993404017666075,0,1,intracellular cyclic nucleotide activated cation channel complex,CC,
6191,GO:0017075,1,0.856221342860515,0,22,syntaxin-1 binding,MF,
6193,GO:0017077,1,0.988553060771623,0,2,oxidative phosphorylation uncoupler activity,MF,
6195,GO:0017081,1,0.905415951940997,0,15,chloride channel regulator activity,MF,
6196,GO:0017082,1,0.993850639026861,0,1,mineralocorticoid receptor activity,MF,
6197,GO:0017084,1,0.993498515347074,0,1,delta1-pyrroline-5-carboxylate synthetase activity,MF,
6198,GO:0017085,1,0.90308339252893,0,16,response to insecticide,BP,
6199,GO:0017087,1,0.993265629207653,0,1,mitochondrial processing peptidase complex,CC,
6200,GO:0017089,1,0.988369895256131,0,2,glycolipid transporter activity,MF,
6201,GO:0017090,1,0.993771870185204,0,1,meprin A complex,CC,
6202,GO:0017091,1,0.857975954834642,0,24,AU-rich element binding,MF,
6203,GO:0017095,1,0.977633667720734,0,3,heparan sulfate 6-O-sulfotransferase activity,MF,
6204,GO:0017098,1,0.988069210885638,0,2,sulfonylurea receptor binding,MF,
6205,GO:0017099,1,0.976410618945017,0,4,very-long-chain-acyl-CoA dehydrogenase activity,MF,
6206,GO:0017101,1,0.928336279754235,0,12,aminoacyl-tRNA synthetase multienzyme complex,CC,
6207,GO:0017102,1,0.987667693078417,0,2,methionyl glutamyl tRNA synthetase complex,CC,
6208,GO:0017108,1,0.96907149165862,0,5,5'-flap endonuclease activity,MF,
6209,GO:0017109,1,0.987110389848593,0,2,glutamate-cysteine ligase complex,CC,
6210,GO:0017110,1,0.918806719022901,0,13,nucleoside-diphosphatase activity,MF,
6212,GO:0017112,1,0.706184835578663,0,51,Rab guanyl-nucleotide exchange factor activity,MF,
6213,GO:0017113,1,0.993675570705843,0,1,dihydropyrimidine dehydrogenase (NADP+) activity,MF,
6214,GO:0017116,1,0.980490856074682,0,3,single-stranded DNA-dependent ATP-dependent DNA helicase activity,MF,
6215,GO:0017119,1,0.920103939174873,0,13,Golgi transport complex,CC,
6216,GO:0017121,1,0.937691891279499,0,10,phospholipid scrambling,BP,
6217,GO:0017124,1,0.433274822487052,0,121,SH3 domain binding,MF,
6218,GO:0017125,1,0.992838468660549,0,1,deoxycytidyl transferase activity,MF,
6219,GO:0017126,1,0.992532279593257,0,1,nucleologenesis,BP,
6220,GO:0017127,1,0.9062948923133,0,15,cholesterol transporter activity,MF,
6221,GO:0017128,1,0.949204241440815,0,8,phospholipid scramblase activity,MF,
6222,GO:0017129,1,0.987788140420696,0,2,triglyceride binding,MF,
6223,GO:0017130,1,0.99175205968801,0,1,poly(C) RNA binding,MF,
6224,GO:0017133,1,0.994072312693583,0,1,mitochondrial electron transfer flavoprotein complex,CC,
6226,GO:0017136,1,0.900070963157017,0,16,NAD-dependent histone deacetylase activity,MF,
6228,GO:0017143,1,0.987886662319618,0,2,insecticide metabolic process,BP,
6231,GO:0017146,1,0.917776915499467,0,11,NMDA selective glutamate receptor complex,CC,
6233,GO:0017148,1,0.248657926040751,0,205,negative regulation of translation,BP,
6234,GO:0017150,1,0.976880984589888,0,4,tRNA dihydrouridine synthase activity,MF,
6235,GO:0017151,1,0.948221123687597,0,8,DEAD/H-box RNA helicase binding,MF,
6236,GO:0017153,1,0.940657939241046,0,9,sodium:dicarboxylate symporter activity,MF,
6237,GO:0017154,1,0.915019397277733,0,11,semaphorin receptor activity,MF,
6238,GO:0017156,1,0.474050212278779,0,109,calcium ion regulated exocytosis,BP,
6240,GO:0017158,1,0.612621906306008,0,72,regulation of calcium ion-dependent exocytosis,BP,
6241,GO:0017159,1,0.982071382045312,0,3,pantetheine hydrolase activity,MF,
6242,GO:0017160,1,0.895310667049696,0,16,Ral GTPase binding,MF,
6243,GO:0017161,1,0.985049915296123,0,2,inositol-1,3,4-trisphosphate 4-phosphatase activity,MF,
6244,GO:0017162,1,0.939855346460695,0,9,aryl hydrocarbon receptor binding,MF,
6245,GO:0017166,1,0.925676480280546,0,10,vinculin binding,MF,
6246,GO:0017168,1,0.993210510248544,0,1,5-oxoprolinase (ATP-hydrolyzing) activity,MF,
6247,GO:0017169,1,0.959496122842087,0,7,CDP-alcohol phosphatidyltransferase activity,MF,
6249,GO:0017172,1,0.99445567725514,0,1,cysteine dioxygenase activity,MF,
6250,GO:0017174,1,0.994736752706523,0,1,glycine N-methyltransferase activity,MF,
6251,GO:0017176,1,0.961203616631979,0,7,phosphatidylinositol N-acetylglucosaminyltransferase activity,MF,
6252,GO:0017177,1,0.993275919213088,0,1,glucosidase II complex,CC,
6253,GO:0017178,1,0.993850639026861,0,1,diphthine-ammonia ligase activity,MF,
6254,GO:0017182,1,0.952026410177373,0,8,peptidyl-diphthamide metabolic process,BP,
6255,GO:0017183,1,0.952026410177373,0,8,peptidyl-diphthamide biosynthetic process from peptidyl-histidine,BP,
6256,GO:0017185,1,0.950659445837878,0,8,peptidyl-lysine hydroxylation,BP,
6257,GO:0017186,1,0.988611058158123,0,2,peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase,BP,
6258,GO:0017187,1,0.955057610240162,0,8,peptidyl-glutamic acid carboxylation,BP,
6259,GO:0017188,1,0.992252644630104,0,1,aspartate N-acetyltransferase activity,MF,
6260,GO:0017196,1,0.961223252209147,0,6,N-terminal peptidyl-methionine acetylation,BP,
6261,GO:0017198,1,0.989366744417119,0,2,N-terminal peptidyl-serine acetylation,BP,
6262,GO:0018002,1,0.989366744417119,0,2,N-terminal peptidyl-glutamic acid acetylation,BP,
6263,GO:0018008,1,0.985519604840952,0,2,N-terminal peptidyl-glycine N-myristoylation,BP,
6264,GO:0018009,1,0.99418486414704,0,1,N-terminal peptidyl-L-cysteine N-palmitoylation,BP,
6265,GO:0018011,1,0.993850639026861,0,1,N-terminal peptidyl-alanine methylation,BP,
6266,GO:0018012,1,0.993850639026861,0,1,N-terminal peptidyl-alanine trimethylation,BP,
6267,GO:0018013,1,0.993850639026861,0,1,N-terminal peptidyl-glycine methylation,BP,
6268,GO:0018016,1,0.993850639026861,0,1,N-terminal peptidyl-proline dimethylation,BP,
6269,GO:0018022,1,0.484583489837072,0,104,peptidyl-lysine methylation,BP,
6270,GO:0018023,1,0.786757543042463,0,35,peptidyl-lysine trimethylation,BP,
6271,GO:0018024,1,0.750861992496588,0,41,histone-lysine N-methyltransferase activity,MF,
6272,GO:0018025,1,0.993850639026861,0,1,calmodulin-lysine N-methyltransferase activity,MF,
6273,GO:0018026,1,0.947493850034267,0,8,peptidyl-lysine monomethylation,BP,
6274,GO:0018027,1,0.903014432811831,0,15,peptidyl-lysine dimethylation,BP,
6275,GO:0018032,1,0.993366583143387,0,1,protein amidation,BP,
6276,GO:0018057,1,0.974488592636839,0,4,peptidyl-lysine oxidation,BP,
6277,GO:0018063,1,0.994106372711102,0,1,cytochrome c-heme linkage,BP,
6278,GO:0018065,1,0.936994246246591,0,12,protein-cofactor linkage,BP,
6279,GO:0018076,1,0.966751752507924,0,4,N-terminal peptidyl-lysine acetylation,BP,
6280,GO:0018094,1,0.993530758056386,0,1,protein polyglycylation,BP,
6281,GO:0018095,1,0.943919194630295,0,9,protein polyglutamylation,BP,
6282,GO:0018101,1,0.980907620431613,0,3,protein citrullination,BP,
6283,GO:0018103,1,0.965713028281407,0,5,protein C-linked glycosylation,BP,
6285,GO:0018106,1,0.994911350561277,0,1,peptidyl-histidine phosphorylation,BP,
6288,GO:0018114,1,0.994007335679593,0,1,threonine racemase activity,MF,
6289,GO:0018117,1,0.994436555483609,0,1,protein adenylylation,BP,
6291,GO:0018125,1,0.982443228418193,0,3,peptidyl-cysteine methylation,BP,
6292,GO:0018126,1,0.867182882140171,0,22,protein hydroxylation,BP,
6294,GO:0018146,1,0.843591557979804,0,26,keratan sulfate biosynthetic process,BP,
6295,GO:0018149,1,0.840588503315963,0,27,peptide cross-linking,BP,
6296,GO:0018153,1,0.988012233649394,0,2,isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine,BP,
6297,GO:0018158,1,0.930445079054644,0,12,protein oxidation,BP,
6298,GO:0018160,1,0.99452957410871,0,1,peptidyl-pyrromethane cofactor linkage,BP,
6299,GO:0018166,1,0.992623206713884,0,1,C-terminal protein-tyrosinylation,BP,
6300,GO:0018171,1,0.976828453255656,0,4,peptidyl-cysteine oxidation,BP,
6301,GO:0018175,1,0.994436555483609,0,1,protein nucleotidylation,BP,
6302,GO:0018192,1,0.994020738101129,0,1,enzyme active site formation via cysteine modification to L-cysteine persulfide,BP,
6304,GO:0018194,1,0.993850639026861,0,1,peptidyl-alanine modification,BP,
6305,GO:0018195,1,0.881022611481079,0,21,peptidyl-arginine modification,BP,
6306,GO:0018196,1,0.763854034785367,0,43,peptidyl-asparagine modification,BP,
6307,GO:0018197,1,0.978501241548576,0,3,peptidyl-aspartic acid modification,BP,
6309,GO:0018199,1,0.976758455818322,0,4,peptidyl-glutamine modification,BP,
6310,GO:0018200,1,0.847589579805617,0,27,peptidyl-glutamic acid modification,BP,
6311,GO:0018201,1,0.979458398990907,0,3,peptidyl-glycine modification,BP,
6312,GO:0018202,1,0.93931975707396,0,10,peptidyl-histidine modification,BP,
6314,GO:0018206,1,0.933376130525498,0,11,peptidyl-methionine modification,BP,
6315,GO:0018208,1,0.75871543231991,0,45,peptidyl-proline modification,BP,
6318,GO:0018211,1,0.965713028281407,0,5,peptidyl-tryptophan modification,BP,
6320,GO:0018214,1,0.955057610240162,0,8,protein carboxylation,BP,
6321,GO:0018216,1,0.913039087524261,0,15,peptidyl-arginine methylation,BP,
6322,GO:0018217,1,0.993224945433582,0,1,peptidyl-aspartic acid phosphorylation,BP,
6323,GO:0018230,1,0.869289683626347,0,22,peptidyl-L-cysteine S-palmitoylation,BP,
6324,GO:0018231,1,0.869289683626347,0,22,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine,BP,
6325,GO:0018242,1,0.878357232195373,0,20,protein O-linked glycosylation via serine,BP,
6326,GO:0018243,1,0.883798795614559,0,19,protein O-linked glycosylation via threonine,BP,
6327,GO:0018262,1,0.988012233649394,0,2,isopeptide cross-linking,BP,
6328,GO:0018271,1,0.99217517082661,0,1,biotin-protein ligase activity,MF,
6329,GO:0018272,1,0.994387197314057,0,1,protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine,BP,
6330,GO:0018277,1,0.994067669352465,0,1,protein deamination,BP,
6331,GO:0018279,1,0.770258964741828,0,42,protein N-linked glycosylation via asparagine,BP,
6332,GO:0018282,1,0.985683336050745,0,2,metal incorporation into metallo-sulfur cluster,BP,
6333,GO:0018283,1,0.985683336050745,0,2,iron incorporation into metallo-sulfur cluster,BP,
6334,GO:0018293,1,0.994665460271981,0,1,protein-FAD linkage,BP,
6335,GO:0018298,1,0.953311856708479,0,8,protein-chromophore linkage,BP,
6336,GO:0018307,1,0.988857970035426,0,2,enzyme active site formation,BP,
6337,GO:0018312,1,0.98758304019277,0,2,peptidyl-serine ADP-ribosylation,BP,
6338,GO:0018315,1,0.993089013418687,0,1,molybdenum incorporation into molybdenum-molybdopterin complex,BP,
6339,GO:0018317,1,0.965713028281407,0,5,protein C-linked glycosylation via tryptophan,BP,
6340,GO:0018322,1,0.992623206713884,0,1,protein tyrosinylation,BP,
6341,GO:0018323,1,0.994806490833661,0,1,enzyme active site formation via L-cysteine sulfinic acid,BP,
6342,GO:0018335,1,0.974250215027553,0,4,protein succinylation,BP,
6343,GO:0018342,1,0.947014340478489,0,8,protein prenylation,BP,
6344,GO:0018343,1,0.988324006377566,0,2,protein farnesylation,BP,
6345,GO:0018344,1,0.962441226564108,0,6,protein geranylgeranylation,BP,
6347,GO:0018350,1,0.994053741186128,0,1,protein esterification,BP,
6348,GO:0018352,1,0.988484237799303,0,2,protein-pyridoxal-5-phosphate linkage,BP,
6349,GO:0018364,1,0.989701830035232,0,2,peptidyl-glutamine methylation,BP,
6350,GO:0018377,1,0.970828604360132,0,4,protein myristoylation,BP,
6351,GO:0018393,1,0.39203586234813,0,140,internal peptidyl-lysine acetylation,BP,
6352,GO:0018394,1,0.374838266141311,0,147,peptidyl-lysine acetylation,BP,
6353,GO:0018395,1,0.993421186575349,0,1,peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine,BP,
6354,GO:0018400,1,0.991842989665113,0,1,peptidyl-proline hydroxylation to 3-hydroxy-L-proline,BP,
6355,GO:0018401,1,0.967872938675759,0,5,peptidyl-proline hydroxylation to 4-hydroxy-L-proline,BP,
6356,GO:0018406,1,0.965713028281407,0,5,protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan,BP,
6357,GO:0018410,1,0.66927639026336,0,63,C-terminal protein amino acid modification,BP,
6358,GO:0018423,1,0.988439066716024,0,2,protein C-terminal leucine carboxyl O-methyltransferase activity,MF,
6359,GO:0018444,1,0.978933243915491,0,3,translation release factor complex,CC,
6360,GO:0018455,1,0.994627745318633,0,1,alcohol dehydrogenase [NAD(P)+] activity,MF,
6361,GO:0018467,1,0.993922359961523,0,1,formaldehyde dehydrogenase activity,MF,
6362,GO:0018478,1,0.994159554370149,0,1,malonate-semialdehyde dehydrogenase (acetylating) activity,MF,
6364,GO:0018549,1,0.994404511998592,0,1,methanethiol oxidase activity,MF,
6365,GO:0018585,1,0.994171175514886,0,1,fluorene oxygenase activity,MF,
6366,GO:0018636,1,0.983833327231967,0,3,phenanthrene 9,10-monooxygenase activity,MF,
6367,GO:0018685,1,0.994393141231139,0,1,alkane 1-monooxygenase activity,MF,
6368,GO:0018733,1,0.9946721764564,0,1,3,4-dihydrocoumarin hydrolase activity,MF,
6369,GO:0018738,1,0.994670626572246,0,1,S-formylglutathione hydrolase activity,MF,
6370,GO:0018773,1,0.994420533996374,0,1,acetylpyruvate hydrolase activity,MF,
6371,GO:0018812,1,0.97562626446412,0,4,3-hydroxyacyl-CoA dehydratase activity,MF,
6372,GO:0018872,1,0.994012490094232,0,1,arsonoacetate metabolic process,BP,
6373,GO:0018874,1,0.994224646697629,0,1,benzoate metabolic process,BP,
6374,GO:0018879,1,0.988115561464556,0,2,biphenyl metabolic process,BP,
6375,GO:0018885,1,0.994425185447864,0,1,carbon tetrachloride metabolic process,BP,
6376,GO:0018894,1,0.987886662319618,0,2,dibenzo-p-dioxin metabolic process,BP,
6377,GO:0018904,1,0.908226214016321,0,16,ether metabolic process,BP,
6378,GO:0018910,1,0.994425185447864,0,1,benzene metabolic process,BP,
6379,GO:0018916,1,0.977251252364119,0,4,nitrobenzene metabolic process,BP,
6380,GO:0018917,1,0.994171175514886,0,1,fluorene metabolic process,BP,
6381,GO:0018931,1,0.994563677288245,0,1,naphthalene metabolic process,BP,
6382,GO:0018958,1,0.579119924105658,0,83,phenol-containing compound metabolic process,BP,
6383,GO:0018963,1,0.988247306461997,0,2,phthalate metabolic process,BP,
6384,GO:0018964,1,0.993083830356423,0,1,propylene metabolic process,BP,
6385,GO:0018969,1,0.993792894375982,0,1,thiocyanate metabolic process,BP,
6386,GO:0018992,1,0.985799243394206,0,2,germ-line sex determination,BP,
6387,GO:0018993,1,0.987542172962939,0,2,somatic sex determination,BP,
6390,GO:0019002,1,0.987008216229333,0,2,GMP binding,MF,
6391,GO:0019003,1,0.698274368778564,0,58,GDP binding,MF,
6393,GO:0019008,1,0.98773265991683,0,2,molybdopterin synthase complex,CC,
6394,GO:0019034,1,0.985837033113979,0,2,viral replication complex,CC,
6396,GO:0019042,1,0.931300184176472,0,11,viral latency,BP,
6397,GO:0019043,1,0.947481318154429,0,9,establishment of viral latency,BP,
6398,GO:0019045,1,0.982931169006893,0,2,latent virus replication,BP,
6399,GO:0019046,1,0.982931169006893,0,2,release from viral latency,BP,
6400,GO:0019048,1,0.802156561134746,0,32,modulation by virus of host morphology or physiology,BP,
6401,GO:0019049,1,0.973139911908542,0,4,evasion or tolerance of host defenses by virus,BP,
6402,GO:0019050,1,0.98270263562849,0,3,suppression by virus of host apoptotic process,BP,
6403,GO:0019054,1,0.870637214731218,0,21,modulation by virus of host process,BP,
6404,GO:0019056,1,0.99380469293822,0,1,modulation by virus of host transcription,BP,
6406,GO:0019060,1,0.989287971048749,0,2,intracellular transport of viral protein in host cell,BP,
6407,GO:0019061,1,0.994113083229661,0,1,uncoating of virus,BP,
6408,GO:0019062,1,0.955762623393809,0,7,virion attachment to host cell,BP,
6409,GO:0019064,1,0.964310865453964,0,6,fusion of virus membrane with host plasma membrane,BP,
6410,GO:0019065,1,0.980483721158434,0,3,receptor-mediated endocytosis of virus by host cell,BP,
6411,GO:0019068,1,0.797908201583236,0,37,virion assembly,BP,
6412,GO:0019072,1,0.985330664334911,0,2,viral genome packaging,BP,
6413,GO:0019074,1,0.985330664334911,0,2,viral RNA genome packaging,BP,
6414,GO:0019075,1,0.987738712940129,0,2,virus maturation,BP,
6415,GO:0019076,1,0.808197586404181,0,33,viral release from host cell,BP,
6417,GO:0019080,1,0.332204836749083,0,184,viral gene expression,BP,
6418,GO:0019081,1,0.912715412335823,0,14,viral translation,BP,
6419,GO:0019082,1,0.993128888930999,0,1,viral protein processing,BP,
6420,GO:0019083,1,0.364231625516495,0,170,viral transcription,BP,
6421,GO:0019085,1,0.986570836428007,0,2,early viral transcription,BP,
6422,GO:0019086,1,0.975570633324007,0,4,late viral transcription,BP,
6423,GO:0019087,1,0.97935215752666,0,3,transformation of host cell by virus,BP,
6424,GO:0019088,1,0.994469630547694,0,1,immortalization of host cell by virus,BP,
6425,GO:0019089,1,0.991974986127913,0,1,transmission of virus,BP,
6427,GO:0019100,1,0.985799243394206,0,2,male germ-line sex determination,BP,
6428,GO:0019101,1,0.99378520144327,0,1,female somatic sex determination,BP,
6429,GO:0019102,1,0.99371832414261,0,1,male somatic sex determination,BP,
6430,GO:0019103,1,0.964888889916885,0,6,pyrimidine nucleotide binding,MF,
6431,GO:0019104,1,0.918713504354208,0,15,DNA N-glycosylase activity,MF,
6432,GO:0019107,1,0.985519604840952,0,2,myristoyltransferase activity,MF,
6433,GO:0019115,1,0.994264955450685,0,1,benzaldehyde dehydrogenase activity,MF,
6434,GO:0019118,1,0.994583828338402,0,1,phenanthrene-epoxide hydrolase activity,MF,
6435,GO:0019119,1,0.994583828338402,0,1,phenanthrene-9,10-epoxide hydrolase activity,MF,
6436,GO:0019135,1,0.994313799027465,0,1,deoxyhypusine monooxygenase activity,MF,
6437,GO:0019136,1,0.976066974147056,0,4,deoxynucleoside kinase activity,MF,
6438,GO:0019144,1,0.989189227470131,0,2,ADP-sugar diphosphatase activity,MF,
6439,GO:0019145,1,0.993993936382896,0,1,aminobutyraldehyde dehydrogenase activity,MF,
6440,GO:0019150,1,0.994224388335562,0,1,D-ribulokinase activity,MF,
6441,GO:0019153,1,0.994462912340561,0,1,protein-disulfide reductase (glutathione) activity,MF,
6442,GO:0019158,1,0.966422993637629,0,5,mannokinase activity,MF,
6443,GO:0019166,1,0.982945887045838,0,3,trans-2-enoyl-CoA reductase (NADPH) activity,MF,
6444,GO:0019171,1,0.9908871583736,0,1,3-hydroxyacyl-[acyl-carrier-protein] dehydratase activity,MF,
6445,GO:0019184,1,0.907758767467334,0,16,nonribosomal peptide biosynthetic process,BP,
6446,GO:0019185,1,0.98683904753847,0,2,snRNA-activating protein complex,CC,
6447,GO:0019187,1,0.993258423954284,0,1,beta-1,4-mannosyltransferase activity,MF,
6448,GO:0019198,1,0.884408240424484,0,16,transmembrane receptor protein phosphatase activity,MF,
6450,GO:0019200,1,0.869127897880393,0,22,carbohydrate kinase activity,MF,
6452,GO:0019202,1,0.98738873299389,0,2,amino acid kinase activity,MF,
6453,GO:0019203,1,0.950878572598705,0,8,carbohydrate phosphatase activity,MF,
6458,GO:0019209,1,0.617691710836568,0,74,kinase activator activity,MF,
6460,GO:0019211,1,0.937616477281144,0,10,phosphatase activator activity,MF,
6462,GO:0019213,1,0.692387799730822,0,55,deacetylase activity,MF,
6463,GO:0019215,1,0.921002724726015,0,12,intermediate filament binding,MF,
6465,GO:0019217,1,0.611232632892234,0,73,regulation of fatty acid metabolic process,BP,
6471,GO:0019226,1,0.62047083900515,0,67,transmission of nerve impulse,BP,
6472,GO:0019227,1,0.959291476251666,0,6,neuronal action potential propagation,BP,
6473,GO:0019228,1,0.776183748416131,0,34,neuronal action potential,BP,
6474,GO:0019229,1,0.713877008710638,0,52,regulation of vasoconstriction,BP,
6475,GO:0019230,1,0.971713031030688,0,4,proprioception,BP,
6477,GO:0019236,1,0.977611138812074,0,4,response to pheromone,BP,
6478,GO:0019237,1,0.960784062208678,0,6,centromeric DNA binding,MF,
6479,GO:0019238,1,0.964148737053563,0,6,cyclohydrolase activity,MF,
6480,GO:0019239,1,0.832054374539957,0,30,deaminase activity,MF,
6481,GO:0019240,1,0.963092596432825,0,5,citrulline biosynthetic process,BP,
6482,GO:0019242,1,0.994209662380629,0,1,methylglyoxal biosynthetic process,BP,
6483,GO:0019243,1,0.988259621271998,0,2,methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione,BP,
6484,GO:0019244,1,0.99463807835601,0,1,lactate biosynthetic process from pyruvate,BP,
6485,GO:0019249,1,0.981551431725513,0,3,lactate biosynthetic process,BP,
6486,GO:0019254,1,0.981878750357188,0,3,carnitine metabolic process, CoA-linked,BP,
6487,GO:0019255,1,0.988468962425528,0,2,glucose 1-phosphate metabolic process,BP,
6488,GO:0019262,1,0.966689798999861,0,6,N-acetylneuraminate catabolic process,BP,
6489,GO:0019264,1,0.988183553597633,0,2,glycine biosynthetic process from serine,BP,
6490,GO:0019265,1,0.994460328392633,0,1,glycine biosynthetic process, by transamination of glyoxylate,BP,
6491,GO:0019276,1,0.987099337411709,0,2,UDP-N-acetylgalactosamine metabolic process,BP,
6492,GO:0019285,1,0.986904046305534,0,2,glycine betaine biosynthetic process from choline,BP,
6493,GO:0019287,1,0.983286587522931,0,3,isopentenyl diphosphate biosynthetic process, mevalonate pathway,BP,
6494,GO:0019290,1,0.993779048068667,0,1,siderophore biosynthetic process,BP,
6495,GO:0019303,1,0.989361661053984,0,2,D-ribose catabolic process,BP,
6496,GO:0019317,1,0.944397385550446,0,8,fucose catabolic process,BP,
6498,GO:0019319,1,0.64738320250798,0,70,hexose biosynthetic process,BP,
6500,GO:0019321,1,0.92276199811639,0,14,pentose metabolic process,BP,
6501,GO:0019322,1,0.977399022489283,0,4,pentose biosynthetic process,BP,
6502,GO:0019323,1,0.971864610223054,0,5,pentose catabolic process,BP,
6503,GO:0019336,1,0.945839187913839,0,9,phenol-containing compound catabolic process,BP,
6504,GO:0019341,1,0.993940887741803,0,1,dibenzo-p-dioxin catabolic process,BP,
6505,GO:0019343,1,0.988365335339112,0,2,cysteine biosynthetic process via cystathionine,BP,
6506,GO:0019344,1,0.98250005893638,0,3,cysteine biosynthetic process,BP,
6507,GO:0019346,1,0.976562831245307,0,4,transsulfuration,BP,
6508,GO:0019348,1,0.970490082316633,0,5,dolichol metabolic process,BP,
6509,GO:0019353,1,0.993889440504794,0,1,protoporphyrinogen IX biosynthetic process from glutamate,BP,
6510,GO:0019355,1,0.980217341223609,0,3,nicotinamide nucleotide biosynthetic process from aspartate,BP,
6511,GO:0019357,1,0.993850639026861,0,1,nicotinate nucleotide biosynthetic process,BP,
6512,GO:0019358,1,0.993850639026861,0,1,nicotinate nucleotide salvage,BP,
6513,GO:0019359,1,0.455242425757607,0,119,nicotinamide nucleotide biosynthetic process,BP,
6514,GO:0019362,1,0.359849730768684,0,157,pyridine nucleotide metabolic process,BP,
6515,GO:0019363,1,0.455242425757607,0,119,pyridine nucleotide biosynthetic process,BP,
6516,GO:0019364,1,0.983107932298327,0,3,pyridine nucleotide catabolic process,BP,
6517,GO:0019365,1,0.993850639026861,0,1,pyridine nucleotide salvage,BP,
6518,GO:0019367,1,0.962660297739722,0,6,fatty acid elongation, saturated fatty acid,BP,
6519,GO:0019368,1,0.962660297739722,0,6,fatty acid elongation, unsaturated fatty acid,BP,
6521,GO:0019370,1,0.938539479551721,0,11,leukotriene biosynthetic process,BP,
6523,GO:0019372,1,0.910957331090033,0,16,lipoxygenase pathway,BP,
6524,GO:0019373,1,0.936864411422978,0,11,epoxygenase P450 pathway,BP,
6525,GO:0019374,1,0.951817747704851,0,8,galactolipid metabolic process,BP,
6526,GO:0019375,1,0.970417715864051,0,5,galactolipid biosynthetic process,BP,
6527,GO:0019376,1,0.993786227088729,0,1,galactolipid catabolic process,BP,
6528,GO:0019377,1,0.924298066925734,0,13,glycolipid catabolic process,BP,
6529,GO:0019388,1,0.945070283164707,0,9,galactose catabolic process,BP,
6530,GO:0019389,1,0.993923903660075,0,1,glucuronoside metabolic process,BP,
6531,GO:0019391,1,0.993923903660075,0,1,glucuronoside catabolic process,BP,
6532,GO:0019395,1,0.545826453189854,0,95,fatty acid oxidation,BP,
6533,GO:0019400,1,0.909836703264827,0,15,alditol metabolic process,BP,
6534,GO:0019401,1,0.964646929853286,0,6,alditol biosynthetic process,BP,
6535,GO:0019402,1,0.994584345024232,0,1,galactitol metabolic process,BP,
6536,GO:0019405,1,0.964560443162821,0,5,alditol catabolic process,BP,
6537,GO:0019406,1,0.994563677288245,0,1,hexitol biosynthetic process,BP,
6538,GO:0019407,1,0.993982085865433,0,1,hexitol catabolic process,BP,
6539,GO:0019408,1,0.986767442662405,0,2,dolichol biosynthetic process,BP,
6540,GO:0019413,1,0.986766090475425,0,2,acetate biosynthetic process,BP,
6541,GO:0019417,1,0.986776722421614,0,2,sulfur oxidation,BP,
6542,GO:0019418,1,0.978348364168436,0,4,sulfide oxidation,BP,
6543,GO:0019427,1,0.986766090475425,0,2,acetyl-CoA biosynthetic process from acetate,BP,
6544,GO:0019430,1,0.876707909196145,0,22,removal of superoxide radicals,BP,
6545,GO:0019432,1,0.833797524087572,0,28,triglyceride biosynthetic process,BP,
6546,GO:0019433,1,0.85525900674583,0,25,triglyceride catabolic process,BP,
6549,GO:0019441,1,0.96516313766579,0,6,tryptophan catabolic process to kynurenine,BP,
6550,GO:0019442,1,0.988961049709776,0,2,tryptophan catabolic process to acetyl-CoA,BP,
6551,GO:0019448,1,0.982957165976133,0,3,L-cysteine catabolic process,BP,
6552,GO:0019464,1,0.98215096245085,0,3,glycine decarboxylation via glycine cleavage system,BP,
6553,GO:0019470,1,0.975845597811657,0,4,4-hydroxyproline catabolic process,BP,
6554,GO:0019471,1,0.939584268501301,0,10,4-hydroxyproline metabolic process,BP,
6555,GO:0019474,1,0.97448234233936,0,4,L-lysine catabolic process to acetyl-CoA,BP,
6556,GO:0019477,1,0.97448234233936,0,4,L-lysine catabolic process,BP,
6557,GO:0019478,1,0.988943840682995,0,2,D-amino acid catabolic process,BP,
6558,GO:0019482,1,0.975753524356275,0,4,beta-alanine metabolic process,BP,
6559,GO:0019483,1,0.987930214569538,0,2,beta-alanine biosynthetic process,BP,
6560,GO:0019493,1,0.994264180212969,0,1,arginine catabolic process to proline,BP,
6561,GO:0019509,1,0.970102227723327,0,5,L-methionine salvage from methylthioadenosine,BP,
6562,GO:0019510,1,0.994104308045454,0,1,S-adenosylhomocysteine catabolic process,BP,
6563,GO:0019511,1,0.920271566974265,0,13,peptidyl-proline hydroxylation,BP,
6564,GO:0019516,1,0.988620345417105,0,2,lactate oxidation,BP,
6565,GO:0019518,1,0.994470147329437,0,1,L-threonine catabolic process to glycine,BP,
6566,GO:0019519,1,0.993982085865433,0,1,pentitol metabolic process,BP,
6567,GO:0019520,1,0.988169513782767,0,2,aldonic acid metabolic process,BP,
6568,GO:0019521,1,0.988169513782767,0,2,D-gluconate metabolic process,BP,
6569,GO:0019527,1,0.993982085865433,0,1,pentitol catabolic process,BP,
6570,GO:0019530,1,0.961258366626836,0,6,taurine metabolic process,BP,
6571,GO:0019531,1,0.940475667147564,0,9,oxalate transmembrane transporter activity,MF,
6572,GO:0019532,1,0.935262517938534,0,10,oxalate transport,BP,
6573,GO:0019534,1,0.969921732998326,0,4,toxin transmembrane transporter activity,MF,
6575,GO:0019541,1,0.975129383632042,0,4,propionate metabolic process,BP,
6576,GO:0019542,1,0.986766090475425,0,2,propionate biosynthetic process,BP,
6577,GO:0019543,1,0.988208806513195,0,2,propionate catabolic process,BP,
6578,GO:0019544,1,0.994264180212969,0,1,arginine catabolic process to glutamate,BP,
6579,GO:0019546,1,0.994112567016873,0,1,arginine deiminase pathway,BP,
6580,GO:0019547,1,0.988835349277219,0,2,arginine catabolic process to ornithine,BP,
6581,GO:0019550,1,0.988244129426485,0,2,glutamate catabolic process to aspartate,BP,
6582,GO:0019551,1,0.988244129426485,0,2,glutamate catabolic process to 2-oxoglutarate,BP,
6583,GO:0019556,1,0.975919939108296,0,4,histidine catabolic process to glutamate and formamide,BP,
6584,GO:0019557,1,0.975919939108296,0,4,histidine catabolic process to glutamate and formate,BP,
6585,GO:0019563,1,0.970402005975115,0,4,glycerol catabolic process,BP,
6586,GO:0019566,1,0.987738712940129,0,2,arabinose metabolic process,BP,
6587,GO:0019585,1,0.952826362283582,0,8,glucuronate metabolic process,BP,
6588,GO:0019605,1,0.988553224961065,0,2,butyrate metabolic process,BP,
6589,GO:0019614,1,0.95135554432182,0,8,catechol-containing compound catabolic process,BP,
6590,GO:0019626,1,0.952639451776748,0,8,short-chain fatty acid catabolic process,BP,
6591,GO:0019627,1,0.923274283432971,0,13,urea metabolic process,BP,
6593,GO:0019640,1,0.971588777423278,0,5,glucuronate catabolic process to xylulose 5-phosphate,BP,
6594,GO:0019646,1,0.915885802947478,0,16,aerobic electron transport chain,BP,
6595,GO:0019673,1,0.961954345929573,0,7,GDP-mannose metabolic process,BP,
6596,GO:0019674,1,0.672760519368339,0,64,NAD metabolic process,BP,
6597,GO:0019676,1,0.987256966442603,0,2,ammonia assimilation cycle,BP,
6598,GO:0019677,1,0.988247654776075,0,2,NAD catabolic process,BP,
6602,GO:0019694,1,0.961258366626836,0,6,alkanesulfonate metabolic process,BP,
6603,GO:0019695,1,0.943700963924356,0,9,choline metabolic process,BP,
6604,GO:0019706,1,0.841797016703002,0,27,protein-cysteine S-palmitoyltransferase activity,MF,
6605,GO:0019707,1,0.841797016703002,0,27,protein-cysteine S-acyltransferase activity,MF,
6606,GO:0019720,1,0.963307640244118,0,6,Mo-molybdopterin cofactor metabolic process,BP,
6607,GO:0019722,1,0.350284465643455,0,153,calcium-mediated signaling,BP,
6608,GO:0019724,1,0.565218986683898,0,91,B cell mediated immunity,BP,
6610,GO:0019730,1,0.724729266253142,0,58,antimicrobial humoral response,BP,
6611,GO:0019731,1,0.884597826140935,0,22,antibacterial humoral response,BP,
6612,GO:0019732,1,0.977937663891753,0,4,antifungal humoral response,BP,
6613,GO:0019740,1,0.968284026373318,0,5,nitrogen utilization,BP,
6614,GO:0019742,1,0.99404523094554,0,1,pentacyclic triterpenoid metabolic process,BP,
6615,GO:0019747,1,0.989508109393996,0,2,regulation of isoprenoid metabolic process,BP,
6616,GO:0019748,1,0.705522912992471,0,56,secondary metabolic process,BP,
6617,GO:0019751,1,0.514649307438493,0,101,polyol metabolic process,BP,
6620,GO:0019763,1,0.971999221383317,0,5,immunoglobulin receptor activity,MF,
6621,GO:0019767,1,0.994983148865882,0,1,IgE receptor activity,MF,
6622,GO:0019770,1,0.988867768709045,0,2,IgG receptor activity,MF,
6623,GO:0019772,1,0.994459036414026,0,1,low-affinity IgG receptor activity,MF,
6624,GO:0019773,1,0.963584737851222,0,7,proteasome core complex, alpha-subunit complex,CC,
6625,GO:0019774,1,0.953835807992849,0,9,proteasome core complex, beta-subunit complex,CC,
6626,GO:0019776,1,0.981371104417395,0,3,Atg8 ligase activity,MF,
6627,GO:0019777,1,0.988745965453582,0,2,Atg12 transferase activity,MF,
6628,GO:0019778,1,0.992720072441794,0,1,Atg12 activating enzyme activity,MF,
6629,GO:0019779,1,0.992720072441794,0,1,Atg8 activating enzyme activity,MF,
6630,GO:0019780,1,0.991935836835067,0,1,FAT10 activating enzyme activity,MF,
6631,GO:0019781,1,0.988575588559181,0,2,NEDD8 activating enzyme activity,MF,
6632,GO:0019782,1,0.993570669213338,0,1,ISG15 activating enzyme activity,MF,
6633,GO:0019783,1,0.501957177457109,0,98,ubiquitin-like protein-specific protease activity,MF,
6634,GO:0019784,1,0.960308636965131,0,7,NEDD8-specific protease activity,MF,
6635,GO:0019785,1,0.987462181511242,0,2,ISG15-specific protease activity,MF,
6637,GO:0019788,1,0.964765478239156,0,6,NEDD8 transferase activity,MF,
6638,GO:0019789,1,0.900480216428827,0,16,SUMO transferase activity,MF,
6639,GO:0019797,1,0.981663996163023,0,3,procollagen-proline 3-dioxygenase activity,MF,
6640,GO:0019798,1,0.958318800910352,0,7,procollagen-proline dioxygenase activity,MF,
6641,GO:0019799,1,0.993850639026861,0,1,tubulin N-acetyltransferase activity,MF,
6642,GO:0019800,1,0.963690833326108,0,6,peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan,BP,
6643,GO:0019805,1,0.981946045546714,0,3,quinolinate biosynthetic process,BP,
6644,GO:0019807,1,0.994572977846928,0,1,aspartoacylase activity,MF,
6645,GO:0019808,1,0.977473376409862,0,4,polyamine binding,MF,
6646,GO:0019809,1,0.983765898150188,0,3,spermidine binding,MF,
6647,GO:0019810,1,0.993604693773063,0,1,putrescine binding,MF,
6648,GO:0019811,1,0.992947185223779,0,1,cocaine binding,MF,
6649,GO:0019814,1,0.971037409954665,0,5,immunoglobulin complex,CC,
6650,GO:0019815,1,0.982100048460819,0,3,B cell receptor complex,CC,
6651,GO:0019825,1,0.824429889232474,0,33,oxygen binding,MF,
6652,GO:0019826,1,0.97907311031697,0,3,oxygen sensor activity,MF,
6655,GO:0019829,1,0.709710697530689,0,51,cation-transporting ATPase activity,MF,
6656,GO:0019834,1,0.983544272508307,0,3,phospholipase A2 inhibitor activity,MF,
6657,GO:0019835,1,0.840087506012757,0,30,cytolysis,BP,
6658,GO:0019836,1,0.988054531763341,0,2,hemolysis by symbiont of host erythrocytes,BP,
6661,GO:0019841,1,0.938916969744507,0,11,retinol binding,MF,
6663,GO:0019843,1,0.72792544360368,0,55,rRNA binding,MF,
6664,GO:0019852,1,0.94018391701861,0,10,L-ascorbic acid metabolic process,BP,
6665,GO:0019853,1,0.988850262999494,0,2,L-ascorbic acid biosynthetic process,BP,
6666,GO:0019855,1,0.946149733120649,0,9,calcium channel inhibitor activity,MF,
6667,GO:0019856,1,0.957354640224796,0,6,pyrimidine nucleobase biosynthetic process,BP,
6668,GO:0019857,1,0.970621967320022,0,3,5-methylcytosine metabolic process,BP,
6669,GO:0019858,1,0.988206347210528,0,2,cytosine metabolic process,BP,
6670,GO:0019859,1,0.982130970518913,0,3,thymine metabolic process,BP,
6671,GO:0019860,1,0.982437332568572,0,3,uracil metabolic process,BP,
6672,GO:0019862,1,0.994478415771611,0,1,IgA binding,MF,
6673,GO:0019863,1,0.978850972032625,0,4,IgE binding,MF,
6674,GO:0019864,1,0.95068326110761,0,9,IgG binding,MF,
6675,GO:0019865,1,0.910467397597542,0,16,immunoglobulin binding,MF,
6677,GO:0019867,1,0.300015246799263,0,183,outer membrane,CC,
6678,GO:0019869,1,0.939718189322314,0,9,chloride channel inhibitor activity,MF,
6679,GO:0019870,1,0.957204029895561,0,6,potassium channel inhibitor activity,MF,
6680,GO:0019871,1,0.959132392749923,0,6,sodium channel inhibitor activity,MF,
6681,GO:0019878,1,0.98610055434743,0,2,lysine biosynthetic process via aminoadipic acid,BP,
6682,GO:0019882,1,0.279819239094616,0,206,antigen processing and presentation,BP,
6683,GO:0019883,1,0.93261931401265,0,11,antigen processing and presentation of endogenous antigen,BP,
6684,GO:0019884,1,0.357226555956556,0,167,antigen processing and presentation of exogenous antigen,BP,
6685,GO:0019885,1,0.955369646479858,0,7,antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
6686,GO:0019886,1,0.551276077951514,0,93,antigen processing and presentation of exogenous peptide antigen via MHC class II,BP,
6689,GO:0019894,1,0.773122209589493,0,37,kinesin binding,MF,
6690,GO:0019896,1,0.927392123753476,0,11,axonal transport of mitochondrion,BP,
6696,GO:0019902,1,0.325693411542541,0,164,phosphatase binding,MF,
6697,GO:0019903,1,0.457085835601619,0,116,protein phosphatase binding,MF,
6699,GO:0019905,1,0.555112813136901,0,87,syntaxin binding,MF,
6700,GO:0019907,1,0.956424305011962,0,7,cyclin-dependent protein kinase activating kinase holoenzyme complex,CC,
6701,GO:0019908,1,0.899847197265334,0,16,nuclear cyclin-dependent protein kinase holoenzyme complex,CC,
6703,GO:0019912,1,0.988269466748948,0,2,cyclin-dependent protein kinase activating kinase activity,MF,
6704,GO:0019915,1,0.676201796385225,0,59,lipid storage,BP,
6705,GO:0019918,1,0.975992974803101,0,4,peptidyl-arginine methylation, to symmetrical-dimethyl arginine,BP,
6706,GO:0019919,1,0.953277081731788,0,8,peptidyl-arginine methylation, to asymmetrical-dimethyl arginine,BP,
6709,GO:0019934,1,0.936681088952965,0,10,cGMP-mediated signaling,BP,
6712,GO:0019948,1,0.987958094744384,0,2,SUMO activating enzyme activity,MF,
6715,GO:0019956,1,0.853979850411604,0,25,chemokine binding,MF,
6716,GO:0019957,1,0.941513768430607,0,10,C-C chemokine binding,MF,
6717,GO:0019958,1,0.962973559563308,0,6,C-X-C chemokine binding,MF,
6718,GO:0019959,1,0.980862666791038,0,3,interleukin-8 binding,MF,
6719,GO:0019960,1,0.964097500912561,0,5,C-X3-C chemokine binding,MF,
6720,GO:0019961,1,0.985682952624547,0,2,interferon binding,MF,
6721,GO:0019962,1,0.99213227446864,0,1,type I interferon binding,MF,
6722,GO:0019964,1,0.993500050914606,0,1,interferon-gamma binding,MF,
6723,GO:0019966,1,0.955651032687821,0,7,interleukin-1 binding,MF,
6724,GO:0019969,1,0.993370687136735,0,1,interleukin-10 binding,MF,
6725,GO:0019970,1,0.993639232728281,0,1,interleukin-11 binding,MF,
6726,GO:0019972,1,0.99454559249468,0,1,interleukin-12 binding,MF,
6727,GO:0019975,1,0.99454559249468,0,1,interleukin-17 binding,MF,
6728,GO:0019976,1,0.981439606113969,0,3,interleukin-2 binding,MF,
6729,GO:0019981,1,0.986840937734787,0,2,interleukin-6 binding,MF,
6731,GO:0019988,1,0.99386887877746,0,1,charged-tRNA amino acid modification,BP,
6732,GO:0019992,1,0.916914108068207,0,12,diacylglycerol binding,MF,
6733,GO:0020003,1,0.982858465489183,0,3,symbiont-containing vacuole,CC,
6734,GO:0020005,1,0.988940499153409,0,2,symbiont-containing vacuole membrane,CC,
6735,GO:0020012,1,0.986531221880676,0,2,evasion or tolerance of host immune response,BP,
6736,GO:0020016,1,0.980009095084817,0,3,ciliary pocket,CC,
6737,GO:0020018,1,0.980009095084817,0,3,ciliary pocket membrane,CC,
6738,GO:0020021,1,0.994469630547694,0,1,immortalization of host cell,BP,
6739,GO:0020027,1,0.920128827324187,0,14,hemoglobin metabolic process,BP,
6740,GO:0020037,1,0.539046478746992,0,99,heme binding,MF,
6741,GO:0021501,1,0.994210695735449,0,1,prechordal plate formation,BP,
6742,GO:0021502,1,0.98072635845089,0,3,neural fold elevation formation,BP,
6743,GO:0021503,1,0.990908571980159,0,1,neural fold bending,BP,
6744,GO:0021508,1,0.99177836536002,0,1,floor plate formation,BP,
6745,GO:0021509,1,0.994259787243675,0,1,roof plate formation,BP,
6748,GO:0021512,1,0.993094713633398,0,1,spinal cord anterior/posterior patterning,BP,
6754,GO:0021519,1,0.99462671200744,0,1,spinal cord association neuron specification,BP,
6758,GO:0021523,1,0.974591844945451,0,4,somatic motor neuron differentiation,BP,
6759,GO:0021524,1,0.982807441720343,0,3,visceral motor neuron differentiation,BP,
6760,GO:0021526,1,0.98841231067148,0,2,medial motor column neuron differentiation,BP,
6761,GO:0021527,1,0.93279015078678,0,11,spinal cord association neuron differentiation,BP,
6762,GO:0021528,1,0.993850639026861,0,1,commissural neuron differentiation in spinal cord,BP,
6763,GO:0021529,1,0.982336553252745,0,3,spinal cord oligodendrocyte cell differentiation,BP,
6764,GO:0021530,1,0.982336553252745,0,3,spinal cord oligodendrocyte cell fate specification,BP,
6765,GO:0021532,1,0.791927694854435,0,35,neural tube patterning,BP,
6766,GO:0021533,1,0.883676158247977,0,17,cell differentiation in hindbrain,BP,
6767,GO:0021534,1,0.92929633257016,0,11,cell proliferation in hindbrain,BP,
6768,GO:0021535,1,0.910295310362878,0,13,cell migration in hindbrain,BP,
6769,GO:0021536,1,0.631801562214206,0,70,diencephalon development,BP,
6771,GO:0021538,1,0.97866056095732,0,3,epithalamus development,BP,
6772,GO:0021539,1,0.988636508838993,0,2,subthalamus development,BP,
6773,GO:0021540,1,0.966128979054101,0,5,corpus callosum morphogenesis,BP,
6774,GO:0021541,1,0.993111030192293,0,1,ammon gyrus development,BP,
6777,GO:0021544,1,0.855320802323046,0,23,subpallium development,BP,
6779,GO:0021546,1,0.970216657011129,0,5,rhombomere development,BP,
6780,GO:0021547,1,0.994210695735449,0,1,midbrain-hindbrain boundary initiation,BP,
6781,GO:0021548,1,0.948861821310329,0,8,pons development,BP,
6783,GO:0021550,1,0.994010428273367,0,1,medulla oblongata development,BP,
6784,GO:0021551,1,0.989136098846001,0,1,central nervous system morphogenesis,BP,
6785,GO:0021553,1,0.976576117120913,0,3,olfactory nerve development,BP,
6787,GO:0021555,1,0.981808018714549,0,3,midbrain-hindbrain boundary morphogenesis,BP,
6788,GO:0021557,1,0.988159055926555,0,2,oculomotor nerve development,BP,
6789,GO:0021558,1,0.994538358435351,0,1,trochlear nerve development,BP,
6790,GO:0021559,1,0.937271072182717,0,10,trigeminal nerve development,BP,
6791,GO:0021560,1,0.987624425123465,0,2,abducens nerve development,BP,
6792,GO:0021561,1,0.941613580655555,0,9,facial nerve development,BP,
6793,GO:0021562,1,0.960211283935036,0,6,vestibulocochlear nerve development,BP,
6794,GO:0021563,1,0.964835012645603,0,5,glossopharyngeal nerve development,BP,
6795,GO:0021564,1,0.977856507031436,0,3,vagus nerve development,BP,
6796,GO:0021566,1,0.992736291507055,0,1,hypoglossal nerve development,BP,
6797,GO:0021568,1,0.994600362098142,0,1,rhombomere 2 development,BP,
6798,GO:0021569,1,0.988309477356808,0,2,rhombomere 3 development,BP,
6799,GO:0021570,1,0.994463429128669,0,1,rhombomere 4 development,BP,
6800,GO:0021571,1,0.987410490596376,0,2,rhombomere 5 development,BP,
6801,GO:0021572,1,0.993558901124192,0,1,rhombomere 6 development,BP,
6802,GO:0021575,1,0.769603949363596,0,37,hindbrain morphogenesis,BP,
6803,GO:0021577,1,0.987234113092914,0,2,hindbrain structural organization,BP,
6804,GO:0021578,1,0.959930165237938,0,6,hindbrain maturation,BP,
6805,GO:0021586,1,0.980524742925907,0,3,pons maturation,BP,
6806,GO:0021587,1,0.784116082545401,0,34,cerebellum morphogenesis,BP,
6807,GO:0021589,1,0.987234113092914,0,2,cerebellum structural organization,BP,
6808,GO:0021590,1,0.979000498410344,0,3,cerebellum maturation,BP,
6810,GO:0021592,1,0.992560323497004,0,1,fourth ventricle development,BP,
6811,GO:0021593,1,0.993812132934618,0,1,rhombomere morphogenesis,BP,
6812,GO:0021594,1,0.993812132934618,0,1,rhombomere formation,BP,
6813,GO:0021598,1,0.987624425123465,0,2,abducens nerve morphogenesis,BP,
6814,GO:0021599,1,0.987624425123465,0,2,abducens nerve formation,BP,
6815,GO:0021602,1,0.851685915319817,0,24,cranial nerve morphogenesis,BP,
6816,GO:0021603,1,0.961857211994284,0,6,cranial nerve formation,BP,
6817,GO:0021604,1,0.942299745675852,0,9,cranial nerve structural organization,BP,
6818,GO:0021610,1,0.941613580655555,0,9,facial nerve morphogenesis,BP,
6819,GO:0021612,1,0.954328384279776,0,7,facial nerve structural organization,BP,
6820,GO:0021615,1,0.974905451843387,0,4,glossopharyngeal nerve morphogenesis,BP,
6821,GO:0021618,1,0.992736291507055,0,1,hypoglossal nerve morphogenesis,BP,
6822,GO:0021622,1,0.993586018595652,0,1,oculomotor nerve morphogenesis,BP,
6823,GO:0021623,1,0.993586018595652,0,1,oculomotor nerve formation,BP,
6824,GO:0021626,1,0.959930165237938,0,6,central nervous system maturation,BP,
6825,GO:0021631,1,0.957141774154011,0,6,optic nerve morphogenesis,BP,
6826,GO:0021633,1,0.987401615558996,0,2,optic nerve structural organization,BP,
6827,GO:0021634,1,0.993169734686661,0,1,optic nerve formation,BP,
6828,GO:0021636,1,0.965620964920751,0,5,trigeminal nerve morphogenesis,BP,
6829,GO:0021637,1,0.965620964920751,0,5,trigeminal nerve structural organization,BP,
6830,GO:0021644,1,0.988061470470821,0,2,vagus nerve morphogenesis,BP,
6831,GO:0021648,1,0.974323677652195,0,4,vestibulocochlear nerve morphogenesis,BP,
6832,GO:0021649,1,0.994004758645168,0,1,vestibulocochlear nerve structural organization,BP,
6833,GO:0021650,1,0.980201405422351,0,3,vestibulocochlear nerve formation,BP,
6834,GO:0021658,1,0.993812132934618,0,1,rhombomere 3 morphogenesis,BP,
6835,GO:0021660,1,0.993812132934618,0,1,rhombomere 3 formation,BP,
6836,GO:0021664,1,0.993812132934618,0,1,rhombomere 5 morphogenesis,BP,
6837,GO:0021666,1,0.993812132934618,0,1,rhombomere 5 formation,BP,
6838,GO:0021670,1,0.933371536042594,0,10,lateral ventricle development,BP,
6840,GO:0021678,1,0.982545150526422,0,3,third ventricle development,BP,
6841,GO:0021679,1,0.98733024002969,0,2,cerebellar molecular layer development,BP,
6842,GO:0021680,1,0.857059828339648,0,21,cerebellar Purkinje cell layer development,BP,
6843,GO:0021681,1,0.915905498179143,0,13,cerebellar granular layer development,BP,
6844,GO:0021682,1,0.99234066337832,0,1,nerve maturation,BP,
6845,GO:0021683,1,0.939658440411023,0,9,cerebellar granular layer morphogenesis,BP,
6846,GO:0021684,1,0.953322045369708,0,7,cerebellar granular layer formation,BP,
6847,GO:0021685,1,0.99150474030068,0,1,cerebellar granular layer structural organization,BP,
6848,GO:0021686,1,0.994439656358838,0,1,cerebellar granular layer maturation,BP,
6849,GO:0021687,1,0.98733024002969,0,2,cerebellar molecular layer morphogenesis,BP,
6850,GO:0021688,1,0.99357936721576,0,1,cerebellar molecular layer formation,BP,
6851,GO:0021691,1,0.984475382620755,0,2,cerebellar Purkinje cell layer maturation,BP,
6852,GO:0021692,1,0.916242032614319,0,11,cerebellar Purkinje cell layer morphogenesis,BP,
6853,GO:0021693,1,0.985138105989946,0,2,cerebellar Purkinje cell layer structural organization,BP,
6854,GO:0021694,1,0.938341477416775,0,8,cerebellar Purkinje cell layer formation,BP,
6855,GO:0021695,1,0.736796167054131,0,44,cerebellar cortex development,BP,
6856,GO:0021696,1,0.818178611130562,0,28,cerebellar cortex morphogenesis,BP,
6857,GO:0021697,1,0.871676605230225,0,19,cerebellar cortex formation,BP,
6858,GO:0021698,1,0.985138105989946,0,2,cerebellar cortex structural organization,BP,
6859,GO:0021699,1,0.979000498410344,0,3,cerebellar cortex maturation,BP,
6861,GO:0021702,1,0.938341477416775,0,8,cerebellar Purkinje cell differentiation,BP,
6862,GO:0021707,1,0.953322045369708,0,7,cerebellar granule cell differentiation,BP,
6863,GO:0021718,1,0.987354327668317,0,2,superior olivary nucleus development,BP,
6864,GO:0021722,1,0.987354327668317,0,2,superior olivary nucleus maturation,BP,
6865,GO:0021730,1,0.984770636043619,0,2,trigeminal sensory nucleus development,BP,
6866,GO:0021740,1,0.984770636043619,0,2,principal sensory nucleus of trigeminal nerve development,BP,
6867,GO:0021747,1,0.978961368877488,0,3,cochlear nucleus development,BP,
6868,GO:0021750,1,0.994010428273367,0,1,vestibular nucleus development,BP,
6869,GO:0021756,1,0.888012785253325,0,17,striatum development,BP,
6870,GO:0021757,1,0.99340991212181,0,1,caudate nucleus development,BP,
6871,GO:0021758,1,0.99340991212181,0,1,putamen development,BP,
6872,GO:0021759,1,0.97446723186804,0,4,globus pallidus development,BP,
6875,GO:0021763,1,0.994133734240773,0,1,subthalamic nucleus development,BP,
6876,GO:0021764,1,0.968443419488744,0,4,amygdala development,BP,
6878,GO:0021767,1,0.990536994876242,0,1,mammillary body development,BP,
6879,GO:0021768,1,0.99348367027734,0,1,nucleus accumbens development,BP,
6880,GO:0021769,1,0.973983756843752,0,4,orbitofrontal cortex development,BP,
6881,GO:0021771,1,0.992331753754925,0,1,lateral geniculate nucleus development,BP,
6882,GO:0021772,1,0.80829985001401,0,30,olfactory bulb development,BP,
6883,GO:0021773,1,0.977210481200098,0,3,striatal medium spiny neuron differentiation,BP,
6884,GO:0021775,1,0.975759484175166,0,3,smoothened signaling pathway involved in ventral spinal cord interneuron specification,BP,
6885,GO:0021776,1,0.975759484175166,0,3,smoothened signaling pathway involved in spinal cord motor neuron cell fate specification,BP,
6886,GO:0021778,1,0.965090048246868,0,5,oligodendrocyte cell fate specification,BP,
6887,GO:0021779,1,0.965090048246868,0,5,oligodendrocyte cell fate commitment,BP,
6888,GO:0021780,1,0.965090048246868,0,5,glial cell fate specification,BP,
6889,GO:0021781,1,0.923288141911145,0,12,glial cell fate commitment,BP,
6891,GO:0021783,1,0.915767474745961,0,13,preganglionic parasympathetic fiber development,BP,
6892,GO:0021784,1,0.988502403639887,0,2,postganglionic parasympathetic fiber development,BP,
6893,GO:0021785,1,0.946345066097204,0,7,branchiomotor neuron axon guidance,BP,
6894,GO:0021793,1,0.993531781510195,0,1,chemorepulsion of branchiomotor axon,BP,
6895,GO:0021794,1,0.916047333285057,0,13,thalamus development,BP,
6896,GO:0021795,1,0.768963555354432,0,38,cerebral cortex cell migration,BP,
6898,GO:0021797,1,0.981872667529033,0,3,forebrain anterior/posterior pattern specification,BP,
6899,GO:0021798,1,0.953937881575479,0,7,forebrain dorsal/ventral pattern formation,BP,
6900,GO:0021799,1,0.844977030485224,0,24,cerebral cortex radially oriented cell migration,BP,
6901,GO:0021800,1,0.941067923022087,0,8,cerebral cortex tangential migration,BP,
6902,GO:0021801,1,0.885414498795863,0,17,cerebral cortex radial glia guided migration,BP,
6903,GO:0021812,1,0.986245044506197,0,2,neuronal-glial interaction involved in cerebral cortex radial glia guided migration,BP,
6904,GO:0021813,1,0.993949639493987,0,1,cell-cell adhesion involved in neuronal-glial interactions involved in cerebral cortex radial glia guided migration,BP,
6905,GO:0021814,1,0.963272943313345,0,5,cell motility involved in cerebral cortex radial glia guided migration,BP,
6906,GO:0021815,1,0.975766747316193,0,3,modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration,BP,
6907,GO:0021817,1,0.975766747316193,0,3,nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration,BP,
6908,GO:0021819,1,0.925625695935865,0,11,layer formation in cerebral cortex,BP,
6909,GO:0021822,1,0.994182539552809,0,1,negative regulation of cell motility involved in cerebral cortex radial glia guided migration,BP,
6910,GO:0021823,1,0.984214108548198,0,2,cerebral cortex tangential migration using cell-cell interactions,BP,
6911,GO:0021824,1,0.986409117076351,0,2,cerebral cortex tangential migration using cell-axon interactions,BP,
6912,GO:0021825,1,0.970835635931443,0,4,substrate-dependent cerebral cortex tangential migration,BP,
6914,GO:0021827,1,0.984214108548198,0,2,postnatal olfactory bulb interneuron migration,BP,
6915,GO:0021828,1,0.986409117076351,0,2,gonadotrophin-releasing hormone neuronal migration to the hypothalamus,BP,
6917,GO:0021831,1,0.993805719061549,0,1,embryonic olfactory bulb interneuron precursor migration,BP,
6918,GO:0021836,1,0.984214108548198,0,2,chemorepulsion involved in postnatal olfactory bulb interneuron migration,BP,
6919,GO:0021840,1,0.98748259534052,0,2,directional guidance of interneurons involved in migration from the subpallium to the cortex,BP,
6920,GO:0021842,1,0.98748259534052,0,2,chemorepulsion involved in interneuron migration from the subpallium to the cortex,BP,
6923,GO:0021847,1,0.979758670561237,0,3,ventricular zone neuroblast division,BP,
6924,GO:0021849,1,0.9869470574927,0,2,neuroblast division in subventricular zone,BP,
6926,GO:0021854,1,0.895282896097074,0,18,hypothalamus development,BP,
6927,GO:0021855,1,0.980621781380327,0,3,hypothalamus cell migration,BP,
6928,GO:0021856,1,0.986409117076351,0,2,hypothalamic tangential migration using cell-axon interactions,BP,
6929,GO:0021859,1,0.942199731324039,0,8,pyramidal neuron differentiation,BP,
6930,GO:0021860,1,0.950276218498323,0,7,pyramidal neuron development,BP,
6931,GO:0021861,1,0.957227515640706,0,7,forebrain radial glial cell differentiation,BP,
6932,GO:0021869,1,0.960340248279839,0,6,forebrain ventricular zone progenitor cell division,BP,
6933,GO:0021870,1,0.992136458591208,0,1,Cajal-Retzius cell differentiation,BP,
6937,GO:0021877,1,0.93460182023052,0,10,forebrain neuron fate commitment,BP,
6939,GO:0021881,1,0.993535619407016,0,1,Wnt-activated signaling pathway involved in forebrain neuron fate commitment,BP,
6940,GO:0021882,1,0.98824584876093,0,2,regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment,BP,
6943,GO:0021886,1,0.9812681585395,0,3,hypothalamus gonadotrophin-releasing hormone neuron differentiation,BP,
6944,GO:0021888,1,0.9812681585395,0,3,hypothalamus gonadotrophin-releasing hormone neuron development,BP,
6945,GO:0021889,1,0.92315165336287,0,11,olfactory bulb interneuron differentiation,BP,
6946,GO:0021891,1,0.95048075432127,0,7,olfactory bulb interneuron development,BP,
6948,GO:0021893,1,0.98824584876093,0,2,cerebral cortex GABAergic interneuron fate commitment,BP,
6951,GO:0021896,1,0.981489100019353,0,2,forebrain astrocyte differentiation,BP,
6952,GO:0021897,1,0.981489100019353,0,2,forebrain astrocyte development,BP,
6953,GO:0021898,1,0.981856690681531,0,3,commitment of multipotent stem cells to neuronal lineage in forebrain,BP,
6954,GO:0021902,1,0.957509470175543,0,6,commitment of neuronal cell to specific neuron type in forebrain,BP,
6955,GO:0021903,1,0.936379662632721,0,10,rostrocaudal neural tube patterning,BP,
6956,GO:0021904,1,0.869414170789488,0,21,dorsal/ventral neural tube patterning,BP,
6957,GO:0021905,1,0.991715869214418,0,1,forebrain-midbrain boundary formation,BP,
6958,GO:0021910,1,0.945415135649357,0,8,smoothened signaling pathway involved in ventral spinal cord patterning,BP,
6961,GO:0021914,1,0.969009908129082,0,5,negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning,BP,
6963,GO:0021917,1,0.991715869214418,0,1,somatic motor neuron fate commitment,BP,
6964,GO:0021918,1,0.991715869214418,0,1,regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment,BP,
6965,GO:0021919,1,0.99346319009556,0,1,BMP signaling pathway involved in spinal cord dorsal/ventral patterning,BP,
6966,GO:0021920,1,0.99462671200744,0,1,regulation of transcription from RNA polymerase II promoter involved in spinal cord association neuron specification,BP,
6967,GO:0021924,1,0.93483377468708,0,10,cell proliferation in external granule layer,BP,
6968,GO:0021930,1,0.93483377468708,0,10,cerebellar granule cell precursor proliferation,BP,
6969,GO:0021932,1,0.939552171201513,0,9,hindbrain radial glia guided cell migration,BP,
6970,GO:0021933,1,0.994439656358838,0,1,radial glia guided migration of cerebellar granule cell,BP,
6971,GO:0021934,1,0.981820964303119,0,2,hindbrain tangential cell migration,BP,
6972,GO:0021935,1,0.981820964303119,0,2,cerebellar granule cell precursor tangential migration,BP,
6973,GO:0021936,1,0.942969093944853,0,9,regulation of cerebellar granule cell precursor proliferation,BP,
6974,GO:0021937,1,0.967736555625876,0,5,cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation,BP,
6975,GO:0021938,1,0.973372229865013,0,4,smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation,BP,
6976,GO:0021940,1,0.954982923685226,0,7,positive regulation of cerebellar granule cell precursor proliferation,BP,
6977,GO:0021941,1,0.987425663919637,0,2,negative regulation of cerebellar granule cell precursor proliferation,BP,
6978,GO:0021942,1,0.972476515507684,0,4,radial glia guided migration of Purkinje cell,BP,
6979,GO:0021943,1,0.971556954127035,0,4,formation of radial glial scaffolds,BP,
6980,GO:0021952,1,0.844281056534543,0,23,central nervous system projection neuron axonogenesis,BP,
6983,GO:0021955,1,0.817198719311562,0,28,central nervous system neuron axonogenesis,BP,
6984,GO:0021956,1,0.994256169563211,0,1,central nervous system interneuron axonogenesis,BP,
6985,GO:0021957,1,0.956408807968202,0,6,corticospinal tract morphogenesis,BP,
6986,GO:0021960,1,0.964909111126685,0,5,anterior commissure morphogenesis,BP,
6987,GO:0021965,1,0.974720901876617,0,3,spinal cord ventral commissure morphogenesis,BP,
6988,GO:0021966,1,0.987383411766084,0,2,corticospinal neuron axon guidance,BP,
6989,GO:0021972,1,0.992716932799276,0,1,corticospinal neuron axon guidance through spinal cord,BP,
6991,GO:0021979,1,0.962133706458556,0,6,hypothalamus cell differentiation,BP,
6992,GO:0021983,1,0.770371111535626,0,41,pituitary gland development,BP,
6993,GO:0021984,1,0.930313153380191,0,12,adenohypophysis development,BP,
6994,GO:0021985,1,0.987133259577198,0,2,neurohypophysis development,BP,
6995,GO:0021986,1,0.97866056095732,0,3,habenula development,BP,
6997,GO:0021988,1,0.803087733522413,0,31,olfactory lobe development,BP,
6998,GO:0021993,1,0.992560323497004,0,1,initiation of neural tube closure,BP,
6999,GO:0021997,1,0.983320606291363,0,2,neural plate axis specification,BP,
7000,GO:0021998,1,0.993421186575349,0,1,neural plate mediolateral regionalization,BP,
7001,GO:0021999,1,0.960165543301119,0,6,neural plate anterior/posterior regionalization,BP,
7002,GO:0022007,1,0.9801572795578,0,3,convergent extension involved in neural plate elongation,BP,
7004,GO:0022009,1,0.975102231224152,0,4,central nervous system vasculogenesis,BP,
7006,GO:0022011,1,0.824631001562487,0,25,myelination in peripheral nervous system,BP,
7007,GO:0022012,1,0.991028115651163,0,1,subpallium cell proliferation in forebrain,BP,
7008,GO:0022018,1,0.991028115651163,0,1,lateral ganglionic eminence cell proliferation,BP,
7009,GO:0022027,1,0.94923514184049,0,6,interkinetic nuclear migration,BP,
7010,GO:0022028,1,0.955417668077562,0,6,tangential migration from the subventricular zone to the olfactory bulb,BP,
7012,GO:0022030,1,0.885414498795863,0,17,telencephalon glial cell migration,BP,
7015,GO:0022400,1,0.881342933588759,0,20,regulation of rhodopsin mediated signaling pathway,BP,
7018,GO:0022404,1,0.570571831790437,0,83,molting cycle process,BP,
7019,GO:0022405,1,0.570571831790437,0,83,hair cycle process,BP,
7023,GO:0022409,1,0.24178719344733,0,224,positive regulation of cell-cell adhesion,BP,
7028,GO:0022417,1,0.96173879369745,0,7,protein maturation by protein folding,BP,
7029,GO:0022600,1,0.625730908421895,0,74,digestive system process,BP,
7033,GO:0022605,1,0.963506401951947,0,6,mammalian oogenesis stage,BP,
7036,GO:0022612,1,0.46843686843894,0,110,gland morphogenesis,BP,
7037,GO:0022613,1,0.0637074853122093,0,442,ribonucleoprotein complex biogenesis,BP,
7038,GO:0022614,1,0.966560996164397,0,5,membrane to membrane docking,BP,
7039,GO:0022615,1,0.977216116929791,0,4,protein to membrane docking,BP,
7040,GO:0022616,1,0.845146092668358,0,26,DNA strand elongation,BP,
7041,GO:0022617,1,0.584375278551428,0,78,extracellular matrix disassembly,BP,
7042,GO:0022618,1,0.288329048014496,0,195,ribonucleoprotein complex assembly,BP,
7043,GO:0022622,1,0.994886556596673,0,1,root system development,BP,
7044,GO:0022624,1,0.872680779965451,0,24,proteasome accessory complex,CC,
7045,GO:0022625,1,0.716075702938884,0,62,cytosolic large ribosomal subunit,CC,
7046,GO:0022626,1,0.535032404054518,0,114,cytosolic ribosome,CC,
7047,GO:0022627,1,0.781360778090208,0,45,cytosolic small ribosomal subunit,CC,
7050,GO:0022821,1,0.908878563943148,0,14,potassium ion antiporter activity,MF,
7051,GO:0022824,1,0.70557438113749,0,51,transmitter-gated ion channel activity,MF,
7052,GO:0022829,1,0.901211809886854,0,17,wide pore channel activity,MF,
7053,GO:0022832,1,0.289938294804779,0,179,voltage-gated channel activity,MF,
7054,GO:0022834,1,0.40465467141028,0,131,ligand-gated channel activity,MF,
7055,GO:0022835,1,0.70557438113749,0,51,transmitter-gated channel activity,MF,
7056,GO:0022836,1,0.120423871379326,0,308,gated channel activity,MF,
7058,GO:0022839,1,0.12266375274314,0,305,ion gated channel activity,MF,
7059,GO:0022840,1,0.905125658962109,0,16,leak channel activity,MF,
7060,GO:0022841,1,0.918368614735574,0,14,potassium ion leak channel activity,MF,
7061,GO:0022842,1,0.905125658962109,0,16,narrow pore channel activity,MF,
7062,GO:0022843,1,0.402623510875627,0,132,voltage-gated cation channel activity,MF,
7063,GO:0022848,1,0.916944152617093,0,14,acetylcholine-gated cation-selective channel activity,MF,
7064,GO:0022849,1,0.959553576036354,0,5,glutamate-gated calcium ion channel activity,MF,
7065,GO:0022850,1,0.977109999132269,0,4,serotonin-gated cation-selective channel activity,MF,
7066,GO:0022851,1,0.926216883434952,0,11,GABA-gated chloride ion channel activity,MF,
7067,GO:0022852,1,0.987042627555048,0,2,glycine-gated chloride ion channel activity,MF,
7068,GO:0022853,1,0.704712956314637,0,52,active ion transmembrane transporter activity,MF,
7070,GO:0022858,1,0.967672785908479,0,5,alanine transmembrane transporter activity,MF,
7071,GO:0022884,1,0.916177761305844,0,15,macromolecule transmembrane transporter activity,MF,
7072,GO:0022889,1,0.947639869234527,0,9,serine transmembrane transporter activity,MF,
7074,GO:0022894,1,0.994130119971222,0,1,Intermediate conductance calcium-activated potassium channel activity,MF,
7079,GO:0023016,1,0.978002516446137,0,3,signal transduction by trans-phosphorylation,BP,
7080,GO:0023019,1,0.892030635155644,0,18,signal transduction involved in regulation of gene expression,BP,
7081,GO:0023021,1,0.982087754429576,0,3,termination of signal transduction,BP,
7082,GO:0023023,1,0.890486345523164,0,20,MHC protein complex binding,MF,
7083,GO:0023024,1,0.982917219118203,0,3,MHC class I protein complex binding,MF,
7084,GO:0023025,1,0.987826321823129,0,2,MHC class Ib protein complex binding,MF,
7085,GO:0023026,1,0.911314716746413,0,16,MHC class II protein complex binding,MF,
7086,GO:0023029,1,0.968929199704304,0,5,MHC class Ib protein binding,MF,
7087,GO:0023030,1,0.987826321823129,0,2,MHC class Ib protein binding, via antigen binding groove,MF,
7088,GO:0023035,1,0.951252241931944,0,8,CD40 signaling pathway,BP,
7089,GO:0023041,1,0.961167275402392,0,6,neuronal signal transduction,BP,
7097,GO:0030002,1,0.932223027560791,0,10,cellular anion homeostasis,BP,
7099,GO:0030004,1,0.497131274622555,0,106,cellular monovalent inorganic cation homeostasis,BP,
7100,GO:0030007,1,0.916264722198926,0,13,cellular potassium ion homeostasis,BP,
7101,GO:0030008,1,0.919558574123175,0,14,TRAPP complex,CC,
7102,GO:0030010,1,0.43303845697613,0,119,establishment of cell polarity,BP,
7104,GO:0030014,1,0.90263766462398,0,15,CCR4-NOT complex,CC,
7105,GO:0030015,1,0.967718846219941,0,5,CCR4-NOT core complex,CC,
7109,GO:0030020,1,0.957055286450164,0,6,extracellular matrix structural constituent conferring tensile strength,MF,
7110,GO:0030021,1,0.993699120586828,0,1,extracellular matrix structural constituent conferring compression resistance,MF,
7111,GO:0030023,1,0.958009563954253,0,5,extracellular matrix constituent conferring elasticity,MF,
7112,GO:0030027,1,0.289461289055375,0,176,lamellipodium,CC,
7116,GO:0030032,1,0.696140981485532,0,53,lamellipodium assembly,BP,
7117,GO:0030033,1,0.894622875147325,0,16,microvillus assembly,BP,
7118,GO:0030035,1,0.972164946908442,0,4,microspike assembly,BP,
7120,GO:0030037,1,0.992720595701055,0,1,actin filament reorganization involved in cell cycle,BP,
7122,GO:0030041,1,0.347393365440594,0,161,actin filament polymerization,BP,
7123,GO:0030042,1,0.719680370846376,0,47,actin filament depolymerization,BP,
7124,GO:0030043,1,0.976713392527637,0,4,actin filament fragmentation,BP,
7126,GO:0030047,1,0.980062509270224,0,3,actin modification,BP,
7132,GO:0030056,1,0.95186571644059,0,5,hemidesmosome,CC,
7133,GO:0030057,1,0.864512913689672,0,20,desmosome,CC,
7134,GO:0030060,1,0.977756489955986,0,4,L-malate dehydrogenase activity,MF,
7135,GO:0030061,1,0.973711112829029,0,4,mitochondrial crista,CC,
7136,GO:0030062,1,0.961473244949452,0,6,mitochondrial tricarboxylic acid cycle enzyme complex,CC,
7137,GO:0030070,1,0.972411990971337,0,4,insulin processing,BP,
7139,GO:0030072,1,0.232747222063997,0,219,peptide hormone secretion,BP,
7140,GO:0030073,1,0.291927738559317,0,183,insulin secretion,BP,
7141,GO:0030091,1,0.960701905274096,0,7,protein repair,BP,
7143,GO:0030098,1,0.15180023724502,0,286,lymphocyte differentiation,BP,
7144,GO:0030099,1,0.102479743307472,0,344,myeloid cell differentiation,BP,
7146,GO:0030101,1,0.737366752241874,0,49,natural killer cell activation,BP,
7147,GO:0030103,1,0.988674599517289,0,2,vasopressin secretion,BP,
7149,GO:0030107,1,0.993809823819756,0,1,HLA-A specific inhibitory MHC class I receptor activity,MF,
7150,GO:0030108,1,0.99452673209409,0,1,HLA-A specific activating MHC class I receptor activity,MF,
7151,GO:0030109,1,0.98814947770791,0,2,HLA-B specific inhibitory MHC class I receptor activity,MF,
7153,GO:0030117,1,0.531823112138813,0,96,membrane coat,CC,
7154,GO:0030118,1,0.722301039404697,0,48,clathrin coat,CC,
7155,GO:0030119,1,0.74133211858085,0,45,AP-type membrane coat adaptor complex,CC,
7156,GO:0030120,1,0.702047388269289,0,54,vesicle coat,CC,
7157,GO:0030121,1,0.961798009209766,0,6,AP-1 adaptor complex,CC,
7158,GO:0030122,1,0.909009129395918,0,14,AP-2 adaptor complex,CC,
7159,GO:0030123,1,0.934865059649198,0,10,AP-3 adaptor complex,CC,
7160,GO:0030124,1,0.974890460113663,0,4,AP-4 adaptor complex,CC,
7161,GO:0030125,1,0.839260536000939,0,26,clathrin vesicle coat,CC,
7162,GO:0030126,1,0.911481256656416,0,15,COPI vesicle coat,CC,
7163,GO:0030127,1,0.911856107763832,0,14,COPII vesicle coat,CC,
7164,GO:0030128,1,0.902531679321592,0,15,clathrin coat of endocytic vesicle,CC,
7165,GO:0030130,1,0.923530654806882,0,12,clathrin coat of trans-Golgi network vesicle,CC,
7166,GO:0030131,1,0.823477169681897,0,29,clathrin adaptor complex,CC,
7167,GO:0030132,1,0.8781914427292,0,19,clathrin coat of coated pit,CC,
7169,GO:0030134,1,0.587051504522424,0,83,COPII-coated ER to Golgi transport vesicle,CC,
7174,GO:0030140,1,0.816186211208504,0,30,trans-Golgi network transport vesicle,CC,
7176,GO:0030144,1,0.981305511884215,0,3,alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity,MF,
7177,GO:0030145,1,0.729153580101452,0,48,manganese ion binding,MF,
7178,GO:0030148,1,0.554431973044393,0,92,sphingolipid biosynthetic process,BP,
7180,GO:0030150,1,0.905721596328109,0,17,protein import into mitochondrial matrix,BP,
7181,GO:0030151,1,0.975878520511731,0,4,molybdenum ion binding,MF,
7184,GO:0030156,1,0.994907734787848,0,1,benzodiazepine receptor binding,MF,
7185,GO:0030157,1,0.918411832425725,0,13,pancreatic juice secretion,BP,
7186,GO:0030158,1,0.977909254878269,0,3,protein xylosyltransferase activity,MF,
7187,GO:0030159,1,0.845078963100475,0,24,receptor signaling complex scaffold activity,MF,
7188,GO:0030160,1,0.968391014505537,0,4,GKAP/Homer scaffold activity,MF,
7192,GO:0030166,1,0.657595151529659,0,60,proteoglycan biosynthetic process,BP,
7193,GO:0030167,1,0.974586807435975,0,4,proteoglycan catabolic process,BP,
7195,GO:0030169,1,0.913709121053848,0,13,low-density lipoprotein particle binding,MF,
7197,GO:0030171,1,0.994396500803866,0,1,voltage-gated proton channel activity,MF,
7198,GO:0030172,1,0.984306426961406,0,3,troponin C binding,MF,
7199,GO:0030173,1,0.770924893693565,0,41,integral component of Golgi membrane,CC,
7200,GO:0030174,1,0.963760552297651,0,6,regulation of DNA-dependent DNA replication initiation,BP,
7202,GO:0030176,1,0.42639606137449,0,137,integral component of endoplasmic reticulum membrane,CC,
7206,GO:0030183,1,0.524970343958552,0,96,B cell differentiation,BP,
7207,GO:0030184,1,0.993866823174771,0,1,nitric oxide transmembrane transporter activity,MF,
7208,GO:0030185,1,0.983132135672939,0,3,nitric oxide transport,BP,
7209,GO:0030186,1,0.99452957410871,0,1,melatonin metabolic process,BP,
7210,GO:0030187,1,0.99452957410871,0,1,melatonin biosynthetic process,BP,
7212,GO:0030194,1,0.865859338666858,0,23,positive regulation of blood coagulation,BP,
7214,GO:0030197,1,0.986904868376869,0,2,extracellular matrix constituent, lubricant activity,MF,
7217,GO:0030200,1,0.981733541036358,0,3,heparan sulfate proteoglycan catabolic process,BP,
7219,GO:0030202,1,0.943958732771403,0,8,heparin metabolic process,BP,
7220,GO:0030203,1,0.377239093472366,0,146,glycosaminoglycan metabolic process,BP,
7221,GO:0030204,1,0.760889338141195,0,40,chondroitin sulfate metabolic process,BP,
7222,GO:0030205,1,0.913199586567966,0,13,dermatan sulfate metabolic process,BP,
7223,GO:0030206,1,0.840463430466952,0,25,chondroitin sulfate biosynthetic process,BP,
7224,GO:0030207,1,0.915905361896693,0,13,chondroitin sulfate catabolic process,BP,
7225,GO:0030208,1,0.918573328875573,0,12,dermatan sulfate biosynthetic process,BP,
7226,GO:0030209,1,0.994154906260876,0,1,dermatan sulfate catabolic process,BP,
7227,GO:0030210,1,0.943958732771403,0,8,heparin biosynthetic process,BP,
7228,GO:0030212,1,0.804241220273277,0,34,hyaluronan metabolic process,BP,
7229,GO:0030213,1,0.918980899075282,0,13,hyaluronan biosynthetic process,BP,
7230,GO:0030214,1,0.915532668304568,0,14,hyaluronan catabolic process,BP,
7231,GO:0030215,1,0.866246410177914,0,20,semaphorin receptor binding,MF,
7232,GO:0030216,1,0.436841976994591,0,126,keratinocyte differentiation,BP,
7233,GO:0030217,1,0.262271921221712,0,204,T cell differentiation,BP,
7234,GO:0030218,1,0.514893178346188,0,101,erythrocyte differentiation,BP,
7235,GO:0030219,1,0.631583390727699,0,70,megakaryocyte differentiation,BP,
7236,GO:0030220,1,0.884681771540609,0,18,platelet formation,BP,
7237,GO:0030221,1,0.987271442097659,0,2,basophil differentiation,BP,
7238,GO:0030222,1,0.981604155310916,0,3,eosinophil differentiation,BP,
7239,GO:0030223,1,0.963447464775933,0,6,neutrophil differentiation,BP,
7240,GO:0030224,1,0.820101031438079,0,30,monocyte differentiation,BP,
7241,GO:0030225,1,0.797029089543917,0,36,macrophage differentiation,BP,
7242,GO:0030226,1,0.969530043479856,0,3,apolipoprotein receptor activity,MF,
7243,GO:0030228,1,0.88308226500934,0,16,lipoprotein particle receptor activity,MF,
7244,GO:0030229,1,0.973224187842833,0,4,very-low-density lipoprotein particle receptor activity,MF,
7245,GO:0030233,1,0.994439139547591,0,1,deoxynucleotide transmembrane transporter activity,MF,
7247,GO:0030235,1,0.953722395608864,0,7,nitric-oxide synthase regulator activity,MF,
7248,GO:0030237,1,0.987104023754516,0,2,female sex determination,BP,
7249,GO:0030238,1,0.911683750960209,0,14,male sex determination,BP,
7251,GO:0030240,1,0.901935211743565,0,10,skeletal muscle thin filament assembly,BP,
7252,GO:0030241,1,0.917368434859552,0,7,skeletal muscle myosin thick filament assembly,BP,
7253,GO:0030242,1,0.965821929620139,0,5,autophagy of peroxisome,BP,
7256,GO:0030249,1,0.977618743451576,0,4,guanylate cyclase regulator activity,MF,
7257,GO:0030250,1,0.977618743451576,0,4,guanylate cyclase activator activity,MF,
7258,GO:0030252,1,0.91134201513391,0,14,growth hormone secretion,BP,
7260,GO:0030259,1,0.958418507640973,0,7,lipid glycosylation,BP,
7265,GO:0030264,1,0.993850639026861,0,1,nuclear fragmentation involved in apoptotic nuclear change,BP,
7266,GO:0030267,1,0.982317843195232,0,3,glyoxylate reductase (NADP) activity,MF,
7267,GO:0030272,1,0.994832835439462,0,1,5-formyltetrahydrofolate cyclo-ligase activity,MF,
7268,GO:0030273,1,0.994038784533493,0,1,melanin-concentrating hormone receptor activity,MF,
7269,GO:0030274,1,0.960484658502979,0,6,LIM domain binding,MF,
7270,GO:0030275,1,0.905503087817688,0,15,LRR domain binding,MF,
7271,GO:0030276,1,0.628858991302967,0,68,clathrin binding,MF,
7272,GO:0030277,1,0.921380731206862,0,13,maintenance of gastrointestinal epithelium,BP,
7274,GO:0030279,1,0.67409783621683,0,59,negative regulation of ossification,BP,
7275,GO:0030280,1,0.970694221377714,0,5,structural constituent of epidermis,MF,
7277,GO:0030283,1,0.994797450914192,0,1,testosterone dehydrogenase [NAD(P)] activity,MF,
7278,GO:0030284,1,0.967382353998162,0,5,estrogen receptor activity,MF,
7279,GO:0030285,1,0.895895249729475,0,17,integral component of synaptic vesicle membrane,CC,
7281,GO:0030289,1,0.982485633018758,0,3,protein phosphatase 4 complex,CC,
7282,GO:0030290,1,0.993443216357972,0,1,sphingolipid activator protein activity,MF,
7284,GO:0030292,1,0.980883533936982,0,3,protein tyrosine kinase inhibitor activity,MF,
7285,GO:0030294,1,0.994147418078294,0,1,receptor signaling protein tyrosine kinase inhibitor activity,MF,
7286,GO:0030295,1,0.642962289122224,0,68,protein kinase activator activity,MF,
7287,GO:0030296,1,0.901955379595784,0,15,protein tyrosine kinase activator activity,MF,
7288,GO:0030297,1,0.954004860598741,0,7,transmembrane receptor protein tyrosine kinase activator activity,MF,
7289,GO:0030299,1,0.951415309030808,0,8,intestinal cholesterol absorption,BP,
7290,GO:0030300,1,0.982359889147466,0,3,regulation of intestinal cholesterol absorption,BP,
7291,GO:0030301,1,0.6400857750448,0,67,cholesterol transport,BP,
7292,GO:0030302,1,0.994439139547591,0,1,deoxynucleotide transport,BP,
7293,GO:0030305,1,0.987504345569334,0,2,heparanase activity,MF,
7294,GO:0030306,1,0.943100879311346,0,8,ADP-ribosylation factor binding,MF,
7297,GO:0030309,1,0.952204974035804,0,8,poly-N-acetyllactosamine metabolic process,BP,
7298,GO:0030311,1,0.958362374657088,0,7,poly-N-acetyllactosamine biosynthetic process,BP,
7299,GO:0030312,1,0.994127538437076,0,1,external encapsulating structure,CC,
7300,GO:0030314,1,0.948121296425385,0,7,junctional membrane complex,CC,
7302,GO:0030316,1,0.596229956638278,0,76,osteoclast differentiation,BP,
7303,GO:0030317,1,0.68361553343423,0,58,flagellated sperm motility,BP,
7304,GO:0030318,1,0.852502887972758,0,22,melanocyte differentiation,BP,
7305,GO:0030320,1,0.932223027560791,0,10,cellular monovalent inorganic anion homeostasis,BP,
7306,GO:0030321,1,0.968718706157605,0,5,transepithelial chloride transport,BP,
7307,GO:0030322,1,0.918146045447002,0,14,stabilization of membrane potential,BP,
7310,GO:0030325,1,0.881293196501432,0,19,adrenal gland development,BP,
7312,GO:0030327,1,0.980268726978125,0,3,prenylated protein catabolic process,BP,
7313,GO:0030328,1,0.986524947083108,0,2,prenylcysteine catabolic process,BP,
7314,GO:0030329,1,0.986524947083108,0,2,prenylcysteine metabolic process,BP,
7316,GO:0030331,1,0.775437394175141,0,37,estrogen receptor binding,MF,
7321,GO:0030337,1,0.988481047300413,0,2,DNA polymerase processivity factor activity,MF,
7322,GO:0030342,1,0.993651258907726,0,1,1-alpha,25-dihydroxyvitamin D3 24-hydroxylase activity,MF,
7323,GO:0030343,1,0.994453610069964,0,1,vitamin D3 25-hydroxylase activity,MF,
7324,GO:0030345,1,0.993699120586828,0,1,structural constituent of tooth enamel,MF,
7325,GO:0030346,1,0.953630646534927,0,7,protein phosphatase 2B binding,MF,
7326,GO:0030348,1,0.980418702359726,0,3,syntaxin-3 binding,MF,
7327,GO:0030350,1,0.985487220715515,0,2,iron-responsive element binding,MF,
7328,GO:0030351,1,0.99381854786764,0,1,inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity,MF,
7329,GO:0030366,1,0.989018611189182,0,2,molybdopterin synthase activity,MF,
7330,GO:0030368,1,0.948283264496162,0,8,interleukin-17 receptor activity,MF,
7331,GO:0030369,1,0.986464345480296,0,2,ICAM-3 receptor activity,MF,
7332,GO:0030371,1,0.848652401472148,0,24,translation repressor activity,MF,
7333,GO:0030372,1,0.992811572229613,0,1,high molecular weight B cell growth factor receptor binding,MF,
7334,GO:0030374,1,0.628550218324075,0,67,ligand-dependent nuclear receptor transcription coactivator activity,MF,
7335,GO:0030375,1,0.970205575285334,0,4,thyroid hormone receptor coactivator activity,MF,
7336,GO:0030377,1,0.99454507577888,0,1,urokinase plasminogen activator receptor activity,MF,
7337,GO:0030378,1,0.994007335679593,0,1,serine racemase activity,MF,
7338,GO:0030379,1,0.991644571672678,0,1,neurotensin receptor activity, non-G-protein coupled,MF,
7340,GO:0030387,1,0.9945476593537,0,1,fructosamine-3-kinase activity,MF,
7341,GO:0030388,1,0.971433623145417,0,5,fructose 1,6-bisphosphate metabolic process,BP,
7342,GO:0030389,1,0.989511135718769,0,2,fructosamine metabolic process,BP,
7343,GO:0030393,1,0.9945476593537,0,1,fructoselysine metabolic process,BP,
7344,GO:0030395,1,0.989419027645724,0,2,lactose binding,MF,
7346,GO:0030407,1,0.994307337933181,0,1,formimidoyltransferase activity,MF,
7347,GO:0030409,1,0.994307337933181,0,1,glutamate formimidoyltransferase activity,MF,
7348,GO:0030412,1,0.994307337933181,0,1,formimidoyltetrahydrofolate cyclodeaminase activity,MF,
7350,GO:0030421,1,0.994825603629511,0,1,defecation,BP,
7351,GO:0030422,1,0.943094793657411,0,9,production of siRNA involved in RNA interference,BP,
7352,GO:0030423,1,0.97209108643948,0,4,targeting of mRNA for destruction involved in RNA interference,BP,
7355,GO:0030426,1,0.361966305079558,0,145,growth cone,CC,
7356,GO:0030427,1,0.346385679475708,0,150,site of polarized growth,CC,
7357,GO:0030429,1,0.994520531289197,0,1,kynureninase activity,MF,
7358,GO:0030430,1,0.963994947929986,0,6,host cell cytoplasm,CC,
7360,GO:0030432,1,0.953459908985888,0,8,peristalsis,BP,
7362,GO:0030449,1,0.796875056275719,0,36,regulation of complement activation,BP,
7363,GO:0030450,1,0.984644470299082,0,2,regulation of complement activation, classical pathway,BP,
7364,GO:0030451,1,0.990458391802756,0,1,regulation of complement activation, alternative pathway,BP,
7365,GO:0030473,1,0.962066884540464,0,5,nuclear migration along microtubule,BP,
7366,GO:0030474,1,0.993850639026861,0,1,spindle pole body duplication,BP,
7367,GO:0030478,1,0.973396099977285,0,4,actin cap,CC,
7368,GO:0030479,1,0.951807343874327,0,7,actin cortical patch,CC,
7369,GO:0030485,1,0.987436717371692,0,2,smooth muscle contractile fiber,CC,
7370,GO:0030488,1,0.824608218947531,0,31,tRNA methylation,BP,
7371,GO:0030490,1,0.731831597132755,0,51,maturation of SSU-rRNA,BP,
7372,GO:0030492,1,0.97939491831909,0,4,hemoglobin binding,MF,
7374,GO:0030497,1,0.934191931189887,0,11,fatty acid elongation,BP,
7375,GO:0030500,1,0.67069886234157,0,60,regulation of bone mineralization,BP,
7376,GO:0030501,1,0.793126191594774,0,34,positive regulation of bone mineralization,BP,
7377,GO:0030502,1,0.931883124971618,0,11,negative regulation of bone mineralization,BP,
7378,GO:0030504,1,0.991032766287627,0,1,inorganic diphosphate transmembrane transporter activity,MF,
7379,GO:0030505,1,0.982531620456261,0,2,inorganic diphosphate transport,BP,
7380,GO:0030506,1,0.866246898937706,0,17,ankyrin binding,MF,
7384,GO:0030511,1,0.843465527964113,0,25,positive regulation of transforming growth factor beta receptor signaling pathway,BP,
7385,GO:0030512,1,0.632982483416961,0,66,negative regulation of transforming growth factor beta receptor signaling pathway,BP,
7388,GO:0030515,1,0.837550567329404,0,29,snoRNA binding,MF,
7391,GO:0030518,1,0.429682959200167,0,125,intracellular steroid hormone receptor signaling pathway,BP,
7392,GO:0030520,1,0.709765832858498,0,51,intracellular estrogen receptor signaling pathway,BP,
7393,GO:0030521,1,0.660508366398797,0,61,androgen receptor signaling pathway,BP,
7395,GO:0030523,1,0.993044926389318,0,1,dihydrolipoamide S-acyltransferase activity,MF,
7396,GO:0030526,1,0.992784399618236,0,1,granulocyte macrophage colony-stimulating factor receptor complex,CC,
7399,GO:0030538,1,0.982072035094691,0,3,embryonic genitalia morphogenesis,BP,
7400,GO:0030539,1,0.88327202876878,0,19,male genitalia development,BP,
7401,GO:0030540,1,0.892076050899647,0,16,female genitalia development,BP,
7404,GO:0030546,1,0.926886989582813,0,11,receptor activator activity,MF,
7405,GO:0030547,1,0.890476394613319,0,19,receptor inhibitor activity,MF,
7406,GO:0030548,1,0.959525102820203,0,7,acetylcholine receptor regulator activity,MF,
7407,GO:0030549,1,0.994694649478445,0,1,acetylcholine receptor activator activity,MF,
7408,GO:0030550,1,0.975410673759786,0,4,acetylcholine receptor inhibitor activity,MF,
7409,GO:0030551,1,0.791922681091198,0,34,cyclic nucleotide binding,MF,
7410,GO:0030552,1,0.85167420850306,0,23,cAMP binding,MF,
7411,GO:0030553,1,0.920686387266041,0,12,cGMP binding,MF,
7413,GO:0030572,1,0.993329627581151,0,1,phosphatidyltransferase activity,MF,
7414,GO:0030573,1,0.994111018397422,0,1,bile acid catabolic process,BP,
7416,GO:0030575,1,0.920644797480551,0,11,nuclear body organization,BP,
7417,GO:0030576,1,0.981446637737254,0,3,Cajal body organization,BP,
7418,GO:0030578,1,0.968792328755907,0,4,PML body organization,BP,
7419,GO:0030579,1,0.967290615764107,0,5,ubiquitin-dependent SMAD protein catabolic process,BP,
7420,GO:0030580,1,0.994634461808247,0,1,quinone cofactor methyltransferase activity,MF,
7421,GO:0030581,1,0.989287971048749,0,2,symbiont intracellular protein transport in host,BP,
7422,GO:0030586,1,0.993590111754218,0,1,[methionine synthase] reductase activity,MF,
7423,GO:0030593,1,0.662176720179864,0,69,neutrophil chemotaxis,BP,
7424,GO:0030594,1,0.556975228886031,0,89,neurotransmitter receptor activity,MF,
7425,GO:0030595,1,0.3546036464515,0,169,leukocyte chemotaxis,BP,
7426,GO:0030611,1,0.994818371788008,0,1,arsenate reductase activity,MF,
7427,GO:0030613,1,0.984301000006673,0,3,oxidoreductase activity, acting on phosphorus or arsenic in donors,MF,
7428,GO:0030614,1,0.984301000006673,0,3,oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor,MF,
7429,GO:0030616,1,0.990742296431914,0,1,transforming growth factor beta receptor, common-partner cytoplasmic mediator activity,MF,
7430,GO:0030617,1,0.987539403228232,0,2,transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity,MF,
7431,GO:0030618,1,0.960581294990647,0,5,transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity,MF,
7432,GO:0030619,1,0.9567257916784,0,7,U1 snRNA binding,MF,
7433,GO:0030620,1,0.964905912286402,0,6,U2 snRNA binding,MF,
7434,GO:0030621,1,0.967809096922866,0,5,U4 snRNA binding,MF,
7435,GO:0030622,1,0.986683208752978,0,2,U4atac snRNA binding,MF,
7436,GO:0030623,1,0.991489158971363,0,1,U5 snRNA binding,MF,
7437,GO:0030624,1,0.99302883062763,0,1,U6atac snRNA binding,MF,
7438,GO:0030626,1,0.987663080868326,0,2,U12 snRNA binding,MF,
7439,GO:0030627,1,0.98850800786446,0,2,pre-mRNA 5'-splice site binding,MF,
7440,GO:0030628,1,0.965608898403912,0,6,pre-mRNA 3'-splice site binding,MF,
7441,GO:0030629,1,0.993850639026861,0,1,U6 snRNA 3'-end binding,MF,
7442,GO:0030638,1,0.956381120694804,0,8,polyketide metabolic process,BP,
7443,GO:0030641,1,0.559336123769429,0,89,regulation of cellular pH,BP,
7444,GO:0030643,1,0.957173963499339,0,6,cellular phosphate ion homeostasis,BP,
7445,GO:0030644,1,0.973944072688985,0,4,cellular chloride ion homeostasis,BP,
7446,GO:0030647,1,0.956381120694804,0,8,aminoglycoside antibiotic metabolic process,BP,
7447,GO:0030653,1,0.992666679637346,0,1,beta-lactam antibiotic metabolic process,BP,
7448,GO:0030656,1,0.935094988904264,0,11,regulation of vitamin metabolic process,BP,
7449,GO:0030658,1,0.301888719339636,0,184,transport vesicle membrane,CC,
7451,GO:0030660,1,0.510365869857519,0,105,Golgi-associated vesicle membrane,CC,
7453,GO:0030663,1,0.89625531703964,0,18,COPI-coated vesicle membrane,CC,
7455,GO:0030666,1,0.37404777643295,0,151,endocytic vesicle membrane,CC,
7456,GO:0030667,1,0.160731762288801,0,276,secretory granule membrane,CC,
7457,GO:0030669,1,0.764546862419735,0,41,clathrin-coated endocytic vesicle membrane,CC,
7458,GO:0030670,1,0.654699207525712,0,67,phagocytic vesicle membrane,CC,
7459,GO:0030672,1,0.556196825110908,0,90,synaptic vesicle membrane,CC,
7460,GO:0030673,1,0.884481212529741,0,16,axolemma,CC,
7461,GO:0030674,1,0.334246745197973,0,163,protein binding, bridging,MF,
7462,GO:0030676,1,0.891887104070554,0,16,Rac guanyl-nucleotide exchange factor activity,MF,
7463,GO:0030677,1,0.927251425460674,0,13,ribonuclease P complex,CC,
7464,GO:0030678,1,0.982687533729882,0,3,mitochondrial ribonuclease P complex,CC,
7465,GO:0030681,1,0.943596922122369,0,10,multimeric ribonuclease P complex,CC,
7466,GO:0030682,1,0.986531221880676,0,2,evasion or tolerance of host defense response,BP,
7467,GO:0030683,1,0.986531221880676,0,2,evasion or tolerance by virus of host immune response,BP,
7468,GO:0030684,1,0.633098566447295,0,72,preribosome,CC,
7469,GO:0030686,1,0.8241144659571,0,30,90S preribosome,CC,
7470,GO:0030687,1,0.858241553551499,0,24,preribosome, large subunit precursor,CC,
7471,GO:0030688,1,0.925326708343653,0,12,preribosome, small subunit precursor,CC,
7472,GO:0030689,1,0.98215759606268,0,3,Noc complex,CC,
7473,GO:0030690,1,0.993836002051663,0,1,Noc1p-Noc2p complex,CC,
7474,GO:0030691,1,0.993836002051663,0,1,Noc2p-Noc3p complex,CC,
7475,GO:0030692,1,0.988249891783721,0,2,Noc4p-Nop14p complex,CC,
7477,GO:0030696,1,0.993656888548923,0,1,tRNA (m5U54) methyltransferase activity,MF,
7478,GO:0030697,1,0.993656888548923,0,1,S-adenosylmethionine-dependent tRNA (m5U54) methyltransferase activity,MF,
7479,GO:0030702,1,0.993210510248544,0,1,chromatin silencing at centromere,BP,
7481,GO:0030718,1,0.987832779833483,0,2,germ-line stem cell population maintenance,BP,
7482,GO:0030719,1,0.98746883095911,0,2,P granule organization,BP,
7483,GO:0030728,1,0.879036306190511,0,19,ovulation,BP,
7484,GO:0030729,1,0.993568622610004,0,1,acetoacetate-CoA ligase activity,MF,
7485,GO:0030730,1,0.906836152755813,0,15,sequestering of triglyceride,BP,
7486,GO:0030731,1,0.994768781065011,0,1,guanidinoacetate N-methyltransferase activity,MF,
7487,GO:0030742,1,0.86206076897759,0,23,GTP-dependent protein binding,MF,
7488,GO:0030748,1,0.993967662710193,0,1,amine N-methyltransferase activity,MF,
7489,GO:0030760,1,0.994474281565947,0,1,pyridine N-methyltransferase activity,MF,
7490,GO:0030791,1,0.994012490094232,0,1,arsenite methyltransferase activity,MF,
7491,GO:0030792,1,0.994012490094232,0,1,methylarsonite methyltransferase activity,MF,
7492,GO:0030799,1,0.600923097124769,0,80,regulation of cyclic nucleotide metabolic process,BP,
7493,GO:0030800,1,0.84588020546233,0,26,negative regulation of cyclic nucleotide metabolic process,BP,
7494,GO:0030801,1,0.770513620838276,0,43,positive regulation of cyclic nucleotide metabolic process,BP,
7495,GO:0030802,1,0.696429200109978,0,58,regulation of cyclic nucleotide biosynthetic process,BP,
7496,GO:0030803,1,0.868026405470654,0,22,negative regulation of cyclic nucleotide biosynthetic process,BP,
7497,GO:0030804,1,0.823608581617581,0,32,positive regulation of cyclic nucleotide biosynthetic process,BP,
7498,GO:0030805,1,0.977750776841414,0,3,regulation of cyclic nucleotide catabolic process,BP,
7499,GO:0030806,1,0.985456234692573,0,2,negative regulation of cyclic nucleotide catabolic process,BP,
7500,GO:0030807,1,0.992181973321879,0,1,positive regulation of cyclic nucleotide catabolic process,BP,
7501,GO:0030808,1,0.433685880391491,0,127,regulation of nucleotide biosynthetic process,BP,
7502,GO:0030809,1,0.794301087364118,0,35,negative regulation of nucleotide biosynthetic process,BP,
7503,GO:0030810,1,0.698910548984307,0,56,positive regulation of nucleotide biosynthetic process,BP,
7504,GO:0030811,1,0.640189204509002,0,64,regulation of nucleotide catabolic process,BP,
7505,GO:0030812,1,0.919232192177732,0,12,negative regulation of nucleotide catabolic process,BP,
7506,GO:0030813,1,0.886080233866447,0,17,positive regulation of nucleotide catabolic process,BP,
7507,GO:0030814,1,0.683789076305364,0,60,regulation of cAMP metabolic process,BP,
7508,GO:0030815,1,0.850511854823445,0,25,negative regulation of cAMP metabolic process,BP,
7509,GO:0030816,1,0.855121665605537,0,26,positive regulation of cAMP metabolic process,BP,
7510,GO:0030817,1,0.767937290908305,0,42,regulation of cAMP biosynthetic process,BP,
7511,GO:0030818,1,0.872778072493857,0,21,negative regulation of cAMP biosynthetic process,BP,
7512,GO:0030819,1,0.901704910080736,0,17,positive regulation of cAMP biosynthetic process,BP,
7513,GO:0030820,1,0.977750776841414,0,3,regulation of cAMP catabolic process,BP,
7514,GO:0030821,1,0.985456234692573,0,2,negative regulation of cAMP catabolic process,BP,
7515,GO:0030822,1,0.992181973321879,0,1,positive regulation of cAMP catabolic process,BP,
7516,GO:0030823,1,0.87016582331164,0,22,regulation of cGMP metabolic process,BP,
7517,GO:0030824,1,0.994563160586758,0,1,negative regulation of cGMP metabolic process,BP,
7518,GO:0030825,1,0.901205750515834,0,17,positive regulation of cGMP metabolic process,BP,
7519,GO:0030826,1,0.902182509347202,0,17,regulation of cGMP biosynthetic process,BP,
7520,GO:0030827,1,0.994563160586758,0,1,negative regulation of cGMP biosynthetic process,BP,
7521,GO:0030828,1,0.913476885570559,0,15,positive regulation of cGMP biosynthetic process,BP,
7522,GO:0030832,1,0.327863371475391,0,167,regulation of actin filament length,BP,
7523,GO:0030833,1,0.381114749905533,0,147,regulation of actin filament polymerization,BP,
7524,GO:0030834,1,0.735928465442045,0,44,regulation of actin filament depolymerization,BP,
7525,GO:0030835,1,0.786094814771491,0,34,negative regulation of actin filament depolymerization,BP,
7526,GO:0030836,1,0.936253707010447,0,10,positive regulation of actin filament depolymerization,BP,
7527,GO:0030837,1,0.709121421512525,0,51,negative regulation of actin filament polymerization,BP,
7528,GO:0030838,1,0.571311068366362,0,88,positive regulation of actin filament polymerization,BP,
7529,GO:0030842,1,0.992416674289449,0,1,regulation of intermediate filament depolymerization,BP,
7530,GO:0030844,1,0.992416674289449,0,1,positive regulation of intermediate filament depolymerization,BP,
7531,GO:0030845,1,0.993814442186848,0,1,phospholipase C-inhibiting G-protein coupled receptor signaling pathway,BP,
7532,GO:0030846,1,0.989585442732175,0,1,termination of RNA polymerase II transcription, poly(A)-coupled,BP,
7533,GO:0030849,1,0.98706358429256,0,2,autosome,CC,
7534,GO:0030850,1,0.728611499740043,0,46,prostate gland development,BP,
7535,GO:0030851,1,0.853825307601107,0,25,granulocyte differentiation,BP,
7536,GO:0030852,1,0.920993832216943,0,13,regulation of granulocyte differentiation,BP,
7537,GO:0030853,1,0.955212071173071,0,7,negative regulation of granulocyte differentiation,BP,
7538,GO:0030854,1,0.957845569349543,0,7,positive regulation of granulocyte differentiation,BP,
7540,GO:0030856,1,0.446143955287649,0,120,regulation of epithelial cell differentiation,BP,
7541,GO:0030857,1,0.803671582804945,0,33,negative regulation of epithelial cell differentiation,BP,
7542,GO:0030858,1,0.718478227555894,0,50,positive regulation of epithelial cell differentiation,BP,
7543,GO:0030859,1,0.884595716246339,0,18,polarized epithelial cell differentiation,BP,
7544,GO:0030860,1,0.986461605727578,0,2,regulation of polarized epithelial cell differentiation,BP,
7545,GO:0030862,1,0.992417985007152,0,1,positive regulation of polarized epithelial cell differentiation,BP,
7548,GO:0030865,1,0.717890037124635,0,49,cortical cytoskeleton organization,BP,
7549,GO:0030866,1,0.766220999854653,0,39,cortical actin cytoskeleton organization,BP,
7551,GO:0030868,1,0.969509301557652,0,5,smooth endoplasmic reticulum membrane,CC,
7552,GO:0030870,1,0.966526811072303,0,5,Mre11 complex,CC,
7553,GO:0030874,1,0.994400894056033,0,1,nucleolar chromatin,CC,
7554,GO:0030877,1,0.91756140775976,0,12,beta-catenin destruction complex,CC,
7555,GO:0030878,1,0.852069165431632,0,25,thyroid gland development,BP,
7556,GO:0030879,1,0.423157584799676,0,124,mammary gland development,BP,
7557,GO:0030880,1,0.420725417078314,0,134,RNA polymerase complex,CC,
7558,GO:0030881,1,0.965363010460574,0,6,beta-2-microglobulin binding,MF,
7559,GO:0030882,1,0.987328662258086,0,2,lipid antigen binding,MF,
7560,GO:0030883,1,0.987328662258086,0,2,endogenous lipid antigen binding,MF,
7561,GO:0030884,1,0.987328662258086,0,2,exogenous lipid antigen binding,MF,
7562,GO:0030885,1,0.972661300862476,0,5,regulation of myeloid dendritic cell activation,BP,
7563,GO:0030886,1,0.983204651603894,0,3,negative regulation of myeloid dendritic cell activation,BP,
7564,GO:0030887,1,0.994498052834499,0,1,positive regulation of myeloid dendritic cell activation,BP,
7565,GO:0030888,1,0.701842307062049,0,55,regulation of B cell proliferation,BP,
7566,GO:0030889,1,0.899244688866365,0,16,negative regulation of B cell proliferation,BP,
7567,GO:0030890,1,0.796546240613397,0,36,positive regulation of B cell proliferation,BP,
7568,GO:0030891,1,0.975881452601936,0,4,VCB complex,CC,
7569,GO:0030893,1,0.958765604398824,0,6,meiotic cohesin complex,CC,
7570,GO:0030894,1,0.851208441066464,0,26,replisome,CC,
7571,GO:0030895,1,0.988252374598752,0,2,apolipoprotein B mRNA editing enzyme complex,CC,
7572,GO:0030896,1,0.969944104698781,0,5,checkpoint clamp complex,CC,
7573,GO:0030897,1,0.905062241507457,0,14,HOPS complex,CC,
7574,GO:0030898,1,0.90896053326934,0,12,actin-dependent ATPase activity,MF,
7575,GO:0030899,1,0.984221577251121,0,3,calcium-dependent ATPase activity,MF,
7580,GO:0030904,1,0.869432565073534,0,21,retromer complex,CC,
7581,GO:0030905,1,0.973496021498277,0,4,retromer, tubulation complex,CC,
7582,GO:0030906,1,0.975859264561564,0,4,retromer, cargo-selective complex,CC,
7583,GO:0030908,1,0.994475315120246,0,1,protein splicing,BP,
7584,GO:0030910,1,0.973479480795556,0,4,olfactory placode formation,BP,
7585,GO:0030911,1,0.946965399726884,0,8,TPR domain binding,MF,
7586,GO:0030913,1,0.950039155086071,0,7,paranodal junction assembly,BP,
7587,GO:0030914,1,0.930599417552117,0,11,STAGA complex,CC,
7588,GO:0030915,1,0.963836288469551,0,6,Smc5-Smc6 complex,CC,
7589,GO:0030916,1,0.951525428863738,0,8,otic vesicle formation,BP,
7590,GO:0030917,1,0.955345053510482,0,7,midbrain-hindbrain boundary development,BP,
7591,GO:0030920,1,0.989366744417119,0,2,peptidyl-serine acetylation,BP,
7592,GO:0030934,1,0.972825967353297,0,3,anchoring collagen complex,CC,
7593,GO:0030935,1,0.993931880262085,0,1,sheet-forming collagen trimer,CC,
7594,GO:0030936,1,0.993709361833947,0,1,transmembrane collagen trimer,CC,
7595,GO:0030942,1,0.982916838482745,0,3,endoplasmic reticulum signal peptide binding,MF,
7596,GO:0030943,1,0.981981619079564,0,3,mitochondrion targeting sequence binding,MF,
7597,GO:0030947,1,0.831629315202459,0,28,regulation of vascular endothelial growth factor receptor signaling pathway,BP,
7598,GO:0030948,1,0.942225042876707,0,9,negative regulation of vascular endothelial growth factor receptor signaling pathway,BP,
7599,GO:0030949,1,0.907683119830709,0,15,positive regulation of vascular endothelial growth factor receptor signaling pathway,BP,
7600,GO:0030950,1,0.914055482993018,0,14,establishment or maintenance of actin cytoskeleton polarity,BP,
7601,GO:0030951,1,0.973423742462355,0,4,establishment or maintenance of microtubule cytoskeleton polarity,BP,
7602,GO:0030952,1,0.889741544069883,0,18,establishment or maintenance of cytoskeleton polarity,BP,
7603,GO:0030953,1,0.950212708538872,0,7,astral microtubule organization,BP,
7604,GO:0030955,1,0.907350315615326,0,14,potassium ion binding,MF,
7605,GO:0030956,1,0.982197055458679,0,3,glutamyl-tRNA(Gln) amidotransferase complex,CC,
7606,GO:0030957,1,0.939289229815952,0,10,Tat protein binding,MF,
7607,GO:0030961,1,0.993850639026861,0,1,peptidyl-arginine hydroxylation,BP,
7608,GO:0030964,1,0.795106879647932,0,43,NADH dehydrogenase complex,CC,
7609,GO:0030968,1,0.450905282775152,0,123,endoplasmic reticulum unfolded protein response,BP,
7610,GO:0030969,1,0.981074370298454,0,3,mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response,BP,
7611,GO:0030970,1,0.846994315600245,0,26,retrograde protein transport, ER to cytosol,BP,
7612,GO:0030971,1,0.688211349231812,0,55,receptor tyrosine kinase binding,MF,
7613,GO:0030974,1,0.988393933328105,0,2,thiamine pyrophosphate transmembrane transport,BP,
7614,GO:0030975,1,0.994069217099096,0,1,thiamine binding,MF,
7615,GO:0030976,1,0.967845330761004,0,5,thiamine pyrophosphate binding,MF,
7616,GO:0030977,1,0.994352307750253,0,1,taurine binding,MF,
7617,GO:0030981,1,0.976836274740614,0,3,cortical microtubule cytoskeleton,CC,
7618,GO:0030983,1,0.919462010756846,0,13,mismatched DNA binding,MF,
7619,GO:0030984,1,0.988570139734225,0,2,kininogen binding,MF,
7620,GO:0030990,1,0.818137745725179,0,31,intraciliary transport particle,CC,
7621,GO:0030991,1,0.945457643100652,0,8,intraciliary transport particle A,CC,
7622,GO:0030992,1,0.882589981044259,0,20,intraciliary transport particle B,CC,
7623,GO:0030997,1,0.97881587055661,0,3,regulation of centriole-centriole cohesion,BP,
7624,GO:0031000,1,0.869350455923668,0,18,response to caffeine,BP,
7625,GO:0031001,1,0.993850639026861,0,1,response to brefeldin A,BP,
7626,GO:0031005,1,0.927929364308169,0,11,filamin binding,MF,
7627,GO:0031010,1,0.923598191986535,0,11,ISWI-type complex,CC,
7628,GO:0031011,1,0.91434204926638,0,15,Ino80 complex,CC,
7630,GO:0031013,1,0.972671989192213,0,5,troponin I binding,MF,
7631,GO:0031014,1,0.979616044325166,0,4,troponin T binding,MF,
7633,GO:0031017,1,0.968240003791624,0,5,exocrine pancreas development,BP,
7635,GO:0031021,1,0.982231002966744,0,3,interphase microtubule organizing center,CC,
7636,GO:0031022,1,0.982283563234215,0,2,nuclear migration along microfilament,BP,
7641,GO:0031038,1,0.994199329235923,0,1,myosin II filament organization,BP,
7643,GO:0031047,1,0.391539985441645,0,140,gene silencing by RNA,BP,
7644,GO:0031048,1,0.986854211915319,0,2,chromatin silencing by small RNA,BP,
7645,GO:0031049,1,0.993828043976683,0,1,programmed DNA elimination,BP,
7646,GO:0031050,1,0.744982261531595,0,43,dsRNA fragmentation,BP,
7647,GO:0031052,1,0.993828043976683,0,1,chromosome breakage,BP,
7648,GO:0031053,1,0.933075852460676,0,10,primary miRNA processing,BP,
7649,GO:0031054,1,0.916106532550421,0,13,pre-miRNA processing,BP,
7650,GO:0031055,1,0.828001005765183,0,32,chromatin remodeling at centromere,BP,
7651,GO:0031056,1,0.406888931865695,0,132,regulation of histone modification,BP,
7652,GO:0031057,1,0.776357011755136,0,37,negative regulation of histone modification,BP,
7653,GO:0031058,1,0.581757303361379,0,81,positive regulation of histone modification,BP,
7654,GO:0031060,1,0.671862500166619,0,57,regulation of histone methylation,BP,
7655,GO:0031061,1,0.888421837690837,0,17,negative regulation of histone methylation,BP,
7656,GO:0031062,1,0.797542357283252,0,33,positive regulation of histone methylation,BP,
7657,GO:0031063,1,0.844659670946597,0,25,regulation of histone deacetylation,BP,
7658,GO:0031064,1,0.971343765795903,0,4,negative regulation of histone deacetylation,BP,
7659,GO:0031065,1,0.890438786245738,0,17,positive regulation of histone deacetylation,BP,
7660,GO:0031069,1,0.854568038291561,0,24,hair follicle morphogenesis,BP,
7661,GO:0031071,1,0.994059415282712,0,1,cysteine desulfurase activity,MF,
7663,GO:0031074,1,0.980407937052435,0,3,nucleocytoplasmic transport complex,CC,
7665,GO:0031077,1,0.954958995541337,0,7,post-embryonic camera-type eye development,BP,
7666,GO:0031078,1,0.927347368695936,0,11,histone deacetylase activity (H3-K14 specific),MF,
7667,GO:0031080,1,0.935105033270173,0,10,nuclear pore outer ring,CC,
7668,GO:0031081,1,0.987021871183852,0,2,nuclear pore distribution,BP,
7669,GO:0031082,1,0.890453318141791,0,19,BLOC complex,CC,
7670,GO:0031083,1,0.920711111063737,0,14,BLOC-1 complex,CC,
7671,GO:0031084,1,0.979889717591714,0,3,BLOC-2 complex,CC,
7672,GO:0031085,1,0.987015210779892,0,2,BLOC-3 complex,CC,
7673,GO:0031086,1,0.957482818420982,0,7,nuclear-transcribed mRNA catabolic process, deadenylation-independent decay,BP,
7674,GO:0031087,1,0.963526039800447,0,6,deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
7675,GO:0031088,1,0.95989163885434,0,6,platelet dense granule membrane,CC,
7676,GO:0031089,1,0.937437576238914,0,11,platelet dense granule lumen,CC,
7678,GO:0031091,1,0.582292590354884,0,84,platelet alpha granule,CC,
7679,GO:0031092,1,0.895680554264875,0,16,platelet alpha granule membrane,CC,
7680,GO:0031093,1,0.671736637110579,0,63,platelet alpha granule lumen,CC,
7681,GO:0031094,1,0.916862336739041,0,11,platelet dense tubular network,CC,
7682,GO:0031095,1,0.928514761809268,0,9,platelet dense tubular network membrane,CC,
7687,GO:0031103,1,0.765443803791673,0,40,axon regeneration,BP,
7688,GO:0031104,1,0.99318032256854,0,1,dendrite regeneration,BP,
7691,GO:0031109,1,0.516410576515375,0,97,microtubule polymerization or depolymerization,BP,
7692,GO:0031110,1,0.634476044441187,0,66,regulation of microtubule polymerization or depolymerization,BP,
7693,GO:0031111,1,0.803047404450102,0,32,negative regulation of microtubule polymerization or depolymerization,BP,
7694,GO:0031112,1,0.829541503567219,0,27,positive regulation of microtubule polymerization or depolymerization,BP,
7695,GO:0031113,1,0.755940223621786,0,41,regulation of microtubule polymerization,BP,
7696,GO:0031114,1,0.827348062019552,0,26,regulation of microtubule depolymerization,BP,
7697,GO:0031115,1,0.933629512120151,0,11,negative regulation of microtubule polymerization,BP,
7698,GO:0031116,1,0.844258404390679,0,24,positive regulation of microtubule polymerization,BP,
7699,GO:0031117,1,0.982597778577139,0,3,positive regulation of microtubule depolymerization,BP,
7700,GO:0031118,1,0.956898898593832,0,8,rRNA pseudouridine synthesis,BP,
7701,GO:0031119,1,0.960322599356451,0,7,tRNA pseudouridine synthesis,BP,
7702,GO:0031120,1,0.978601798327012,0,4,snRNA pseudouridine synthesis,BP,
7703,GO:0031122,1,0.691602256728174,0,52,cytoplasmic microtubule organization,BP,
7706,GO:0031125,1,0.935253820182044,0,12,rRNA 3'-end processing,BP,
7707,GO:0031126,1,0.962130869943378,0,7,snoRNA 3'-end processing,BP,
7708,GO:0031127,1,0.993101966687149,0,1,alpha-(1,2)-fucosyltransferase activity,MF,
7710,GO:0031129,1,0.992604869055274,0,1,inductive cell-cell signaling,BP,
7712,GO:0031134,1,0.981126033422347,0,3,sister chromatid biorientation,BP,
7713,GO:0031143,1,0.913679439159028,0,14,pseudopodium,CC,
7716,GO:0031151,1,0.991423746361938,0,1,histone methyltransferase activity (H3-K79 specific),MF,
7717,GO:0031161,1,0.993665333506847,0,1,phosphatidylinositol catabolic process,BP,
7718,GO:0031163,1,0.889632414459992,0,20,metallo-sulfur cluster assembly,BP,
7719,GO:0031166,1,0.980316844267116,0,3,integral component of vacuolar membrane,CC,
7720,GO:0031167,1,0.897549856011702,0,18,rRNA methylation,BP,
7722,GO:0031177,1,0.980903983539443,0,3,phosphopantetheine binding,MF,
7723,GO:0031179,1,0.993366583143387,0,1,peptide modification,BP,
7724,GO:0031201,1,0.738736016630806,0,49,SNARE complex,CC,
7725,GO:0031204,1,0.97998214634131,0,3,posttranslational protein targeting to membrane, translocation,BP,
7726,GO:0031205,1,0.979639445187033,0,3,endoplasmic reticulum Sec complex,CC,
7727,GO:0031208,1,0.985780179413715,0,2,POZ domain binding,MF,
7728,GO:0031209,1,0.945344190066602,0,8,SCAR complex,CC,
7729,GO:0031210,1,0.896276059080489,0,17,phosphatidylcholine binding,MF,
7730,GO:0031211,1,0.9509222080327,0,8,endoplasmic reticulum palmitoyltransferase complex,CC,
7731,GO:0031213,1,0.985975965385522,0,2,RSF complex,CC,
7733,GO:0031223,1,0.917965595252877,0,11,auditory behavior,BP,
7737,GO:0031227,1,0.415115084510589,0,141,intrinsic component of endoplasmic reticulum membrane,CC,
7738,GO:0031228,1,0.75209835474892,0,45,intrinsic component of Golgi membrane,CC,
7739,GO:0031229,1,0.915851641253617,0,14,intrinsic component of nuclear inner membrane,CC,
7740,GO:0031231,1,0.902912854492719,0,17,intrinsic component of peroxisomal membrane,CC,
7742,GO:0031233,1,0.892774941523225,0,18,intrinsic component of external side of plasma membrane,CC,
7743,GO:0031234,1,0.505492174886771,0,105,extrinsic component of cytoplasmic side of plasma membrane,CC,
7744,GO:0031235,1,0.898668807337926,0,14,intrinsic component of the cytoplasmic side of the plasma membrane,CC,
7745,GO:0031247,1,0.988135378810095,0,2,actin rod assembly,BP,
7746,GO:0031248,1,0.571835887718348,0,85,protein acetyltransferase complex,CC,
7747,GO:0031249,1,0.99403672181897,0,1,denatured protein binding,MF,
7748,GO:0031251,1,0.984965726920484,0,2,PAN complex,CC,
7751,GO:0031254,1,0.919334732682793,0,13,cell trailing edge,CC,
7753,GO:0031257,1,0.993850639026861,0,1,cell trailing edge membrane,CC,
7754,GO:0031258,1,0.855354092322822,0,22,lamellipodium membrane,CC,
7755,GO:0031259,1,0.993850639026861,0,1,uropod membrane,CC,
7756,GO:0031261,1,0.970085157501619,0,5,DNA replication preinitiation complex,CC,
7757,GO:0031262,1,0.978176592085667,0,4,Ndc80 complex,CC,
7758,GO:0031264,1,0.945778693699313,0,9,death-inducing signaling complex,CC,
7759,GO:0031265,1,0.96324052439693,0,6,CD95 death-inducing signaling complex,CC,
7761,GO:0031268,1,0.920372768705889,0,13,pseudopodium organization,BP,
7762,GO:0031269,1,0.920372768705889,0,13,pseudopodium assembly,BP,
7763,GO:0031271,1,0.993850639026861,0,1,lateral pseudopodium assembly,BP,
7764,GO:0031272,1,0.920372768705889,0,13,regulation of pseudopodium assembly,BP,
7765,GO:0031274,1,0.92607192623103,0,12,positive regulation of pseudopodium assembly,BP,
7766,GO:0031275,1,0.993850639026861,0,1,regulation of lateral pseudopodium assembly,BP,
7767,GO:0031279,1,0.768180197129839,0,41,regulation of cyclase activity,BP,
7768,GO:0031280,1,0.873417944601088,0,21,negative regulation of cyclase activity,BP,
7769,GO:0031281,1,0.90263554588974,0,16,positive regulation of cyclase activity,BP,
7770,GO:0031282,1,0.946326757071263,0,9,regulation of guanylate cyclase activity,BP,
7771,GO:0031283,1,0.994563160586758,0,1,negative regulation of guanylate cyclase activity,BP,
7772,GO:0031284,1,0.951502516668322,0,8,positive regulation of guanylate cyclase activity,BP,
7773,GO:0031289,1,0.993716019435524,0,1,actin phosphorylation,BP,
7774,GO:0031290,1,0.872851906749978,0,19,retinal ganglion cell axon guidance,BP,
7775,GO:0031291,1,0.981803807877286,0,3,Ran protein signal transduction,BP,
7776,GO:0031293,1,0.853042711557095,0,24,membrane protein intracellular domain proteolysis,BP,
7777,GO:0031294,1,0.660826484197821,0,68,lymphocyte costimulation,BP,
7778,GO:0031295,1,0.664378906350246,0,67,T cell costimulation,BP,
7779,GO:0031296,1,0.984246109904917,0,3,B cell costimulation,BP,
7780,GO:0031297,1,0.833626169001849,0,27,replication fork processing,BP,
7782,GO:0031300,1,0.323113067331981,0,181,intrinsic component of organelle membrane,CC,
7783,GO:0031301,1,0.354552617204948,0,166,integral component of organelle membrane,CC,
7784,GO:0031302,1,0.992639445960796,0,1,intrinsic component of endosome membrane,CC,
7785,GO:0031304,1,0.811984310947783,0,35,intrinsic component of mitochondrial inner membrane,CC,
7786,GO:0031305,1,0.811984310947783,0,35,integral component of mitochondrial inner membrane,CC,
7787,GO:0031306,1,0.867119360711451,0,23,intrinsic component of mitochondrial outer membrane,CC,
7788,GO:0031307,1,0.873321764156128,0,22,integral component of mitochondrial outer membrane,CC,
7789,GO:0031308,1,0.993850639026861,0,1,intrinsic component of nuclear outer membrane,CC,
7790,GO:0031309,1,0.993850639026861,0,1,integral component of nuclear outer membrane,CC,
7791,GO:0031310,1,0.980316844267116,0,3,intrinsic component of vacuolar membrane,CC,
7792,GO:0031312,1,0.813884239281085,0,32,extrinsic component of organelle membrane,CC,
7793,GO:0031313,1,0.949313969764935,0,8,extrinsic component of endosome membrane,CC,
7794,GO:0031314,1,0.967804588224296,0,5,extrinsic component of mitochondrial inner membrane,CC,
7795,GO:0031315,1,0.985522120462361,0,2,extrinsic component of mitochondrial outer membrane,CC,
7796,GO:0031320,1,0.993982085865433,0,1,hexitol dehydrogenase activity,MF,
7805,GO:0031331,1,0.118391023187202,0,312,positive regulation of cellular catabolic process,BP,
7806,GO:0031332,1,0.923714267784696,0,11,RNAi effector complex,CC,
7807,GO:0031333,1,0.456983310722635,0,118,negative regulation of protein complex assembly,BP,
7808,GO:0031334,1,0.216031594256379,0,232,positive regulation of protein complex assembly,BP,
7809,GO:0031335,1,0.988146893139276,0,2,regulation of sulfur amino acid metabolic process,BP,
7810,GO:0031337,1,0.99411592245597,0,1,positive regulation of sulfur amino acid metabolic process,BP,
7811,GO:0031338,1,0.682145540385143,0,57,regulation of vesicle fusion,BP,
7812,GO:0031339,1,0.960123437651636,0,6,negative regulation of vesicle fusion,BP,
7813,GO:0031340,1,0.956029836355784,0,7,positive regulation of vesicle fusion,BP,
7814,GO:0031341,1,0.695943404477638,0,60,regulation of cell killing,BP,
7815,GO:0031342,1,0.908445848183808,0,16,negative regulation of cell killing,BP,
7816,GO:0031343,1,0.794092524649718,0,38,positive regulation of cell killing,BP,
7823,GO:0031362,1,0.914040083204208,0,14,anchored component of external side of plasma membrane,CC,
7825,GO:0031369,1,0.832951763051985,0,29,translation initiation factor binding,MF,
7826,GO:0031370,1,0.992837685489592,0,1,eukaryotic initiation factor 4G binding,MF,
7827,GO:0031371,1,0.952667386533373,0,8,ubiquitin conjugating enzyme complex,CC,
7828,GO:0031372,1,0.988507292637424,0,2,UBC13-MMS2 complex,CC,
7829,GO:0031379,1,0.986857536672415,0,2,RNA-directed RNA polymerase complex,CC,
7830,GO:0031380,1,0.993590111754218,0,1,nuclear RNA-directed RNA polymerase complex,CC,
7831,GO:0031386,1,0.914265718864881,0,16,protein tag,MF,
7832,GO:0031389,1,0.993792381470899,0,1,Rad17 RFC-like complex,CC,
7833,GO:0031390,1,0.953261725794639,0,8,Ctf18 RFC-like complex,CC,
7834,GO:0031392,1,0.968076534906467,0,5,regulation of prostaglandin biosynthetic process,BP,
7835,GO:0031393,1,0.987026538105805,0,2,negative regulation of prostaglandin biosynthetic process,BP,
7836,GO:0031394,1,0.980803426182787,0,3,positive regulation of prostaglandin biosynthetic process,BP,
7838,GO:0031397,1,0.673500798229879,0,61,negative regulation of protein ubiquitination,BP,
7843,GO:0031402,1,0.918123085516377,0,12,sodium ion binding,MF,
7844,GO:0031403,1,0.985051130579767,0,2,lithium ion binding,MF,
7845,GO:0031404,1,0.950035725973219,0,8,chloride ion binding,MF,
7846,GO:0031405,1,0.989695383480043,0,1,lipoic acid binding,MF,
7848,GO:0031407,1,0.994066121639822,0,1,oxylipin metabolic process,BP,
7850,GO:0031414,1,0.934260836520592,0,10,N-terminal protein acetyltransferase complex,CC,
7851,GO:0031415,1,0.969899161609797,0,5,NatA complex,CC,
7852,GO:0031416,1,0.987047453562503,0,2,NatB complex,CC,
7853,GO:0031417,1,0.97591038537394,0,3,NatC complex,CC,
7854,GO:0031418,1,0.883019074867707,0,20,L-ascorbic acid binding,MF,
7855,GO:0031419,1,0.938847202976092,0,9,cobalamin binding,MF,
7856,GO:0031420,1,0.875235731733308,0,19,alkali metal ion binding,MF,
7857,GO:0031424,1,0.673868790359468,0,63,keratinization,BP,
7858,GO:0031427,1,0.974463086171814,0,4,response to methotrexate,BP,
7859,GO:0031428,1,0.977862660173882,0,4,box C/D snoRNP complex,CC,
7860,GO:0031429,1,0.973414907809869,0,5,box H/ACA snoRNP complex,CC,
7862,GO:0031431,1,0.987149627151753,0,2,Dbf4-dependent protein kinase complex,CC,
7864,GO:0031433,1,0.934730550666883,0,5,telethonin binding,MF,
7866,GO:0031435,1,0.904835252828595,0,15,mitogen-activated protein kinase kinase kinase binding,MF,
7867,GO:0031436,1,0.985590286863037,0,2,BRCA1-BARD1 complex,CC,
7868,GO:0031437,1,0.980876969770082,0,3,regulation of mRNA cleavage,BP,
7869,GO:0031438,1,0.993702192811864,0,1,negative regulation of mRNA cleavage,BP,
7870,GO:0031439,1,0.987094312641488,0,2,positive regulation of mRNA cleavage,BP,
7871,GO:0031440,1,0.866336885954013,0,22,regulation of mRNA 3'-end processing,BP,
7872,GO:0031441,1,0.943259606021157,0,9,negative regulation of mRNA 3'-end processing,BP,
7873,GO:0031442,1,0.942449853801975,0,9,positive regulation of mRNA 3'-end processing,BP,
7874,GO:0031443,1,0.985242933970132,0,2,fast-twitch skeletal muscle fiber contraction,BP,
7875,GO:0031444,1,0.981720848335942,0,3,slow-twitch skeletal muscle fiber contraction,BP,
7876,GO:0031445,1,0.984737868954136,0,2,regulation of heterochromatin assembly,BP,
7877,GO:0031446,1,0.993467542585081,0,1,regulation of fast-twitch skeletal muscle fiber contraction,BP,
7878,GO:0031448,1,0.993467542585081,0,1,positive regulation of fast-twitch skeletal muscle fiber contraction,BP,
7879,GO:0031449,1,0.992150058315214,0,1,regulation of slow-twitch skeletal muscle fiber contraction,BP,
7880,GO:0031453,1,0.984737868954136,0,2,positive regulation of heterochromatin assembly,BP,
7881,GO:0031455,1,0.986904046305534,0,2,glycine betaine metabolic process,BP,
7882,GO:0031456,1,0.986904046305534,0,2,glycine betaine biosynthetic process,BP,
7883,GO:0031460,1,0.992762965153064,0,1,glycine betaine transport,BP,
7885,GO:0031462,1,0.912161456545494,0,14,Cul2-RING ubiquitin ligase complex,CC,
7886,GO:0031463,1,0.641637166704683,0,66,Cul3-RING ubiquitin ligase complex,CC,
7889,GO:0031466,1,0.963655683153081,0,6,Cul5-RING ubiquitin ligase complex,CC,
7890,GO:0031467,1,0.969203491392207,0,5,Cul7-RING ubiquitin ligase complex,CC,
7891,GO:0031468,1,0.896317680796793,0,18,nuclear envelope reassembly,BP,
7892,GO:0031475,1,0.994503220371054,0,1,myosin V complex,CC,
7893,GO:0031477,1,0.991462676802844,0,1,myosin VII complex,CC,
7894,GO:0031489,1,0.904829738097806,0,16,myosin V binding,MF,
7895,GO:0031490,1,0.548644973326915,0,90,chromatin DNA binding,MF,
7896,GO:0031491,1,0.701349885824841,0,55,nucleosome binding,MF,
7897,GO:0031492,1,0.819157647277465,0,32,nucleosomal DNA binding,MF,
7898,GO:0031493,1,0.988289727641627,0,2,nucleosomal histone binding,MF,
7899,GO:0031497,1,0.514249501114623,0,108,chromatin assembly,BP,
7900,GO:0031498,1,0.87931164699607,0,19,chromatin disassembly,BP,
7901,GO:0031501,1,0.978534751780253,0,4,mannosyltransferase complex,CC,
7903,GO:0031506,1,0.994371949535733,0,1,cell wall glycoprotein biosynthetic process,BP,
7904,GO:0031507,1,0.940226723854831,0,9,heterochromatin assembly,BP,
7905,GO:0031508,1,0.988402106919122,0,2,pericentric heterochromatin assembly,BP,
7906,GO:0031509,1,0.994442240407395,0,1,telomeric heterochromatin assembly,BP,
7907,GO:0031510,1,0.982562073229394,0,3,SUMO activating enzyme complex,CC,
7909,GO:0031515,1,0.982151972858876,0,3,tRNA (m1A) methyltransferase complex,CC,
7910,GO:0031519,1,0.732279707450808,0,46,PcG protein complex,CC,
7912,GO:0031526,1,0.752840979008903,0,41,brush border membrane,CC,
7913,GO:0031527,1,0.881274519305073,0,17,filopodium membrane,CC,
7914,GO:0031528,1,0.86995738380137,0,21,microvillus membrane,CC,
7915,GO:0031529,1,0.757395908150874,0,44,ruffle organization,BP,
7916,GO:0031530,1,0.989512533448496,0,2,gonadotropin-releasing hormone receptor binding,MF,
7917,GO:0031531,1,0.994603462135798,0,1,thyrotropin-releasing hormone receptor binding,MF,
7919,GO:0031533,1,0.992073716894608,0,1,mRNA cap methyltransferase complex,CC,
7921,GO:0031543,1,0.927845715067199,0,12,peptidyl-proline dioxygenase activity,MF,
7922,GO:0031544,1,0.975504146582818,0,4,peptidyl-proline 3-dioxygenase activity,MF,
7923,GO:0031545,1,0.95115675849861,0,8,peptidyl-proline 4-dioxygenase activity,MF,
7924,GO:0031547,1,0.962505857688279,0,5,brain-derived neurotrophic factor receptor signaling pathway,BP,
7925,GO:0031548,1,0.985770709543503,0,2,regulation of brain-derived neurotrophic factor receptor signaling pathway,BP,
7926,GO:0031549,1,0.992501610870141,0,1,negative regulation of brain-derived neurotrophic factor receptor signaling pathway,BP,
7927,GO:0031550,1,0.993218759971047,0,1,positive regulation of brain-derived neurotrophic factor receptor signaling pathway,BP,
7928,GO:0031554,1,0.989585442732175,0,1,regulation of DNA-templated transcription, termination,BP,
7929,GO:0031559,1,0.99309393640295,0,1,oxidosqualene cyclase activity,MF,
7933,GO:0031573,1,0.918171526246558,0,14,intra-S DNA damage checkpoint,BP,
7937,GO:0031581,1,0.919003471692271,0,11,hemidesmosome assembly,BP,
7938,GO:0031583,1,0.994204754044007,0,1,phospholipase D-activating G-protein coupled receptor signaling pathway,BP,
7939,GO:0031584,1,0.969190907102808,0,5,activation of phospholipase D activity,BP,
7940,GO:0031585,1,0.963754840697245,0,4,regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,BP,
7941,GO:0031587,1,0.974491532172098,0,3,positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,BP,
7942,GO:0031588,1,0.940268040709702,0,9,nucleotide-activated protein kinase complex,CC,
7943,GO:0031589,1,0.12829083437513,0,295,cell-substrate adhesion,BP,
7944,GO:0031590,1,0.987673673740812,0,2,wybutosine metabolic process,BP,
7945,GO:0031591,1,0.987673673740812,0,2,wybutosine biosynthetic process,BP,
7946,GO:0031592,1,0.991170325144447,0,1,centrosomal corona,CC,
7947,GO:0031593,1,0.793169148010718,0,35,polyubiquitin modification-dependent protein binding,MF,
7949,GO:0031595,1,0.95578750607056,0,8,nuclear proteasome complex,CC,
7950,GO:0031597,1,0.931556401999267,0,12,cytosolic proteasome complex,CC,
7951,GO:0031616,1,0.941345555020875,0,10,spindle pole centrosome,CC,
7952,GO:0031618,1,0.935356578672585,0,9,nuclear pericentric heterochromatin,CC,
7953,GO:0031620,1,0.956043737330717,0,7,regulation of fever generation,BP,
7954,GO:0031622,1,0.962708031482704,0,6,positive regulation of fever generation,BP,
7956,GO:0031624,1,0.793039767647395,0,33,ubiquitin conjugating enzyme binding,MF,
7958,GO:0031626,1,0.992601201167981,0,1,beta-endorphin binding,MF,
7959,GO:0031627,1,0.981093066895442,0,3,telomeric loop formation,BP,
7960,GO:0031628,1,0.950623648851173,0,8,opioid receptor binding,MF,
7961,GO:0031629,1,0.906004764823348,0,16,synaptic vesicle fusion to presynaptic active zone membrane,BP,
7962,GO:0031630,1,0.981360597683509,0,3,regulation of synaptic vesicle fusion to presynaptic active zone membrane,BP,
7963,GO:0031635,1,0.987095249339031,0,2,adenylate cyclase-inhibiting opioid receptor signaling pathway,BP,
7964,GO:0031638,1,0.779369417318524,0,40,zymogen activation,BP,
7965,GO:0031639,1,0.891614397982366,0,19,plasminogen activation,BP,
7966,GO:0031640,1,0.828190606283197,0,34,killing of cells of other organism,BP,
7968,GO:0031642,1,0.95965726230371,0,6,negative regulation of myelination,BP,
7971,GO:0031645,1,0.925266552566412,0,12,negative regulation of neurological system process,BP,
7974,GO:0031648,1,0.756118507657823,0,41,protein destabilization,BP,
7975,GO:0031649,1,0.892166115653118,0,18,heat generation,BP,
7976,GO:0031650,1,0.925676581758227,0,12,regulation of heat generation,BP,
7977,GO:0031651,1,0.993142856533742,0,1,negative regulation of heat generation,BP,
7978,GO:0031652,1,0.938571332938577,0,10,positive regulation of heat generation,BP,
7979,GO:0031657,1,0.90806327513446,0,14,regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,
7980,GO:0031658,1,0.954151257741066,0,7,negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,
7981,GO:0031659,1,0.951719732659523,0,7,positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,
7982,GO:0031663,1,0.734051510783004,0,49,lipopolysaccharide-mediated signaling pathway,BP,
7983,GO:0031664,1,0.874594305038025,0,21,regulation of lipopolysaccharide-mediated signaling pathway,BP,
7984,GO:0031665,1,0.939635002805861,0,10,negative regulation of lipopolysaccharide-mediated signaling pathway,BP,
7985,GO:0031666,1,0.94952719750011,0,8,positive regulation of lipopolysaccharide-mediated signaling pathway,BP,
7988,GO:0031669,1,0.276831191672225,0,195,cellular response to nutrient levels,BP,
7989,GO:0031670,1,0.683733300333101,0,58,cellular response to nutrient,BP,
7991,GO:0031673,1,0.986242610056039,0,1,H zone,CC,
7993,GO:0031681,1,0.946221463042726,0,9,G-protein beta-subunit binding,MF,
7994,GO:0031682,1,0.99372037283893,0,1,G-protein gamma-subunit binding,MF,
7995,GO:0031683,1,0.892225661841867,0,18,G-protein beta/gamma-subunit complex binding,MF,
7996,GO:0031685,1,0.981451325144048,0,3,adenosine receptor binding,MF,
7997,GO:0031686,1,0.993687856789293,0,1,A1 adenosine receptor binding,MF,
7998,GO:0031687,1,0.99445567725514,0,1,A2A adenosine receptor binding,MF,
7999,GO:0031690,1,0.888913012988584,0,18,adrenergic receptor binding,MF,
8000,GO:0031691,1,0.988487735612465,0,2,alpha-1A adrenergic receptor binding,MF,
8001,GO:0031692,1,0.981860115673758,0,3,alpha-1B adrenergic receptor binding,MF,
8002,GO:0031694,1,0.977016577570899,0,4,alpha-2A adrenergic receptor binding,MF,
8003,GO:0031695,1,0.994017902719211,0,1,alpha-2B adrenergic receptor binding,MF,
8004,GO:0031696,1,0.987353578534501,0,2,alpha-2C adrenergic receptor binding,MF,
8005,GO:0031697,1,0.971080900908309,0,4,beta-1 adrenergic receptor binding,MF,
8006,GO:0031698,1,0.971908251466588,0,4,beta-2 adrenergic receptor binding,MF,
8007,GO:0031699,1,0.987108517784853,0,2,beta-3 adrenergic receptor binding,MF,
8008,GO:0031700,1,0.994540425317856,0,1,adrenomedullin receptor binding,MF,
8009,GO:0031701,1,0.929811052666433,0,11,angiotensin receptor binding,MF,
8010,GO:0031702,1,0.935285679257814,0,10,type 1 angiotensin receptor binding,MF,
8011,GO:0031703,1,0.993956333071298,0,1,type 2 angiotensin receptor binding,MF,
8012,GO:0031704,1,0.993627463299271,0,1,apelin receptor binding,MF,
8013,GO:0031705,1,0.982897287377257,0,3,bombesin receptor binding,MF,
8014,GO:0031707,1,0.994204754044007,0,1,endothelin A receptor binding,MF,
8015,GO:0031708,1,0.982897287377257,0,3,endothelin B receptor binding,MF,
8016,GO:0031711,1,0.987678534565035,0,2,bradykinin receptor binding,MF,
8017,GO:0031714,1,0.99263630308952,0,1,C5a anaphylatoxin chemotactic receptor binding,MF,
8018,GO:0031715,1,0.99263630308952,0,1,C5L2 anaphylatoxin chemotactic receptor binding,MF,
8019,GO:0031717,1,0.994439656358838,0,1,cannabinoid receptor binding,MF,
8020,GO:0031718,1,0.994439656358838,0,1,type 1 cannabinoid receptor binding,MF,
8021,GO:0031720,1,0.98501026194217,0,3,haptoglobin binding,MF,
8022,GO:0031724,1,0.994668043425921,0,1,CXCR5 chemokine receptor binding,MF,
8023,GO:0031726,1,0.994874159526814,0,1,CCR1 chemokine receptor binding,MF,
8024,GO:0031727,1,0.983862266926621,0,3,CCR2 chemokine receptor binding,MF,
8025,GO:0031728,1,0.990082186390784,0,2,CCR3 chemokine receptor binding,MF,
8026,GO:0031730,1,0.974061947048075,0,4,CCR5 chemokine receptor binding,MF,
8027,GO:0031731,1,0.994854788968432,0,1,CCR6 chemokine receptor binding,MF,
8028,GO:0031732,1,0.989798993814721,0,2,CCR7 chemokine receptor binding,MF,
8029,GO:0031735,1,0.984513213755012,0,3,CCR10 chemokine receptor binding,MF,
8030,GO:0031737,1,0.993602391325548,0,1,CX3C chemokine receptor binding,MF,
8031,GO:0031739,1,0.994193646332661,0,1,cholecystokinin receptor binding,MF,
8032,GO:0031741,1,0.994193646332661,0,1,type B gastrin/cholecystokinin receptor binding,MF,
8038,GO:0031753,1,0.993846786647362,0,1,endothelial differentiation G-protein coupled receptor binding,MF,
8039,GO:0031755,1,0.993846786647362,0,1,Edg-2 lysophosphatidic acid receptor binding,MF,
8040,GO:0031762,1,0.988487735612465,0,2,follicle-stimulating hormone receptor binding,MF,
8041,GO:0031763,1,0.994886556596673,0,1,galanin receptor binding,MF,
8042,GO:0031764,1,0.994886556596673,0,1,type 1 galanin receptor binding,MF,
8043,GO:0031765,1,0.994886556596673,0,1,type 2 galanin receptor binding,MF,
8044,GO:0031766,1,0.994886556596673,0,1,type 3 galanin receptor binding,MF,
8045,GO:0031768,1,0.994920131708846,0,1,ghrelin receptor binding,MF,
8046,GO:0031770,1,0.995055979916928,0,1,growth hormone-releasing hormone receptor binding,MF,
8047,GO:0031773,1,0.994921164783572,0,1,kisspeptin receptor binding,MF,
8048,GO:0031775,1,0.99101623176355,0,1,lutropin-choriogonadotropic hormone receptor binding,MF,
8049,GO:0031779,1,0.97880625421759,0,4,melanocortin receptor binding,MF,
8050,GO:0031780,1,0.989046396184039,0,2,corticotropin hormone receptor binding,MF,
8051,GO:0031781,1,0.97880625421759,0,4,type 3 melanocortin receptor binding,MF,
8052,GO:0031782,1,0.97880625421759,0,4,type 4 melanocortin receptor binding,MF,
8053,GO:0031783,1,0.989046396184039,0,2,type 5 melanocortin receptor binding,MF,
8054,GO:0031798,1,0.99132286387763,0,1,type 1 metabotropic glutamate receptor binding,MF,
8055,GO:0031802,1,0.968240496236128,0,5,type 5 metabotropic glutamate receptor binding,MF,
8056,GO:0031811,1,0.993280291346679,0,1,G-protein coupled nucleotide receptor binding,MF,
8057,GO:0031812,1,0.993280291346679,0,1,P2Y1 nucleotide receptor binding,MF,
8058,GO:0031821,1,0.956639037138789,0,7,G-protein coupled serotonin receptor binding,MF,
8059,GO:0031826,1,0.98303392768341,0,3,type 2A serotonin receptor binding,MF,
8060,GO:0031834,1,0.994700848837669,0,1,neurokinin receptor binding,MF,
8061,GO:0031835,1,0.994700848837669,0,1,substance P receptor binding,MF,
8062,GO:0031838,1,0.979683881052351,0,4,haptoglobin-hemoglobin complex,CC,
8063,GO:0031839,1,0.99486796096715,0,1,type 1 neuromedin U receptor binding,MF,
8064,GO:0031840,1,0.99486796096715,0,1,type 2 neuromedin U receptor binding,MF,
8065,GO:0031841,1,0.994999677880221,0,1,neuropeptide Y receptor binding,MF,
8066,GO:0031848,1,0.937140066290534,0,10,protection from non-homologous end joining at telomere,BP,
8067,GO:0031849,1,0.976327401542002,0,4,olfactory receptor binding,MF,
8068,GO:0031852,1,0.972322389997082,0,4,mu-type opioid receptor binding,MF,
8069,GO:0031858,1,0.993652794239666,0,1,pituitary adenylate cyclase-activating polypeptide receptor binding,MF,
8070,GO:0031859,1,0.994304236630648,0,1,platelet activating factor receptor binding,MF,
8071,GO:0031860,1,0.97872082678615,0,3,telomeric 3' overhang formation,BP,
8072,GO:0031862,1,0.985505645137398,0,2,prostanoid receptor binding,MF,
8073,GO:0031867,1,0.993310878501268,0,1,EP4 subtype prostaglandin E2 receptor binding,MF,
8074,GO:0031870,1,0.992142735134942,0,1,thromboxane A2 receptor binding,MF,
8075,GO:0031871,1,0.980368612778973,0,3,proteinase activated receptor binding,MF,
8076,GO:0031877,1,0.991838297651918,0,1,somatostatin receptor binding,MF,
8077,GO:0031883,1,0.994202945751452,0,1,taste receptor binding,MF,
8078,GO:0031893,1,0.98733976459283,0,2,vasopressin receptor binding,MF,
8079,GO:0031894,1,0.993149578866293,0,1,V1A vasopressin receptor binding,MF,
8080,GO:0031896,1,0.994150516569983,0,1,V2 vasopressin receptor binding,MF,
8081,GO:0031901,1,0.429620013492653,0,127,early endosome membrane,CC,
8082,GO:0031902,1,0.492137563536792,0,114,late endosome membrane,CC,
8083,GO:0031903,1,0.692767826581348,0,57,microbody membrane,CC,
8084,GO:0031904,1,0.840305296445459,0,26,endosome lumen,CC,
8085,GO:0031905,1,0.982051127063689,0,3,early endosome lumen,CC,
8086,GO:0031906,1,0.968003605310105,0,6,late endosome lumen,CC,
8088,GO:0031914,1,0.972056263481472,0,4,negative regulation of synaptic plasticity,BP,
8089,GO:0031915,1,0.940674397781744,0,9,positive regulation of synaptic plasticity,BP,
8090,GO:0031929,1,0.510803577529512,0,99,TOR signaling,BP,
8091,GO:0031930,1,0.994533191199364,0,1,mitochondria-nucleus signaling pathway,BP,
8092,GO:0031931,1,0.951577481652075,0,7,TORC1 complex,CC,
8093,GO:0031932,1,0.917816255271404,0,13,TORC2 complex,CC,
8094,GO:0031933,1,0.978266809644234,0,3,telomeric heterochromatin,CC,
8095,GO:0031935,1,0.87429805660659,0,19,regulation of chromatin silencing,BP,
8096,GO:0031936,1,0.942100725757965,0,8,negative regulation of chromatin silencing,BP,
8097,GO:0031937,1,0.946016081861553,0,8,positive regulation of chromatin silencing,BP,
8098,GO:0031938,1,0.988768561846599,0,2,regulation of chromatin silencing at telomere,BP,
8099,GO:0031940,1,0.994442240407395,0,1,positive regulation of chromatin silencing at telomere,BP,
8100,GO:0031941,1,0.784782343305143,0,36,filamentous actin,CC,
8101,GO:0031943,1,0.945329171956378,0,9,regulation of glucocorticoid metabolic process,BP,
8102,GO:0031944,1,0.968847071968972,0,5,negative regulation of glucocorticoid metabolic process,BP,
8103,GO:0031945,1,0.993277462394299,0,1,positive regulation of glucocorticoid metabolic process,BP,
8104,GO:0031946,1,0.955485928808312,0,7,regulation of glucocorticoid biosynthetic process,BP,
8105,GO:0031947,1,0.968847071968972,0,5,negative regulation of glucocorticoid biosynthetic process,BP,
8106,GO:0031948,1,0.993277462394299,0,1,positive regulation of glucocorticoid biosynthetic process,BP,
8107,GO:0031952,1,0.767946127119443,0,39,regulation of protein autophosphorylation,BP,
8108,GO:0031953,1,0.936743798684265,0,10,negative regulation of protein autophosphorylation,BP,
8109,GO:0031954,1,0.844155678192287,0,25,positive regulation of protein autophosphorylation,BP,
8110,GO:0031956,1,0.955046732658453,0,7,medium-chain fatty acid-CoA ligase activity,MF,
8111,GO:0031957,1,0.945198775654117,0,9,very long-chain fatty acid-CoA ligase activity,MF,
8112,GO:0031958,1,0.888042631317409,0,17,corticosteroid receptor signaling pathway,BP,
8113,GO:0031959,1,0.986444270546525,0,2,mineralocorticoid receptor signaling pathway,BP,
8114,GO:0031960,1,0.393944931712629,0,146,response to corticosteroid,BP,
8115,GO:0031962,1,0.992231437486126,0,1,mineralocorticoid receptor binding,MF,
8119,GO:0031968,1,0.305139864522495,0,181,organelle outer membrane,CC,
8120,GO:0031970,1,0.635766815427209,0,76,organelle envelope lumen,CC,
8127,GO:0031985,1,0.525050159958881,0,98,Golgi cisterna,CC,
8128,GO:0031987,1,0.944046738948016,0,8,locomotion involved in locomotory behavior,BP,
8129,GO:0031990,1,0.984387356556588,0,2,mRNA export from nucleus in response to heat stress,BP,
8130,GO:0031994,1,0.910100656251884,0,13,insulin-like growth factor I binding,MF,
8131,GO:0031995,1,0.946345417185125,0,8,insulin-like growth factor II binding,MF,
8132,GO:0031996,1,0.933305056077898,0,11,thioesterase binding,MF,
8133,GO:0031997,1,0.981946694285533,0,3,N-terminal myristoylation domain binding,MF,
8134,GO:0031998,1,0.888498378046799,0,16,regulation of fatty acid beta-oxidation,BP,
8135,GO:0031999,1,0.970909075662441,0,4,negative regulation of fatty acid beta-oxidation,BP,
8136,GO:0032000,1,0.93622756346506,0,9,positive regulation of fatty acid beta-oxidation,BP,
8137,GO:0032002,1,0.988173109784633,0,2,interleukin-28 receptor complex,CC,
8138,GO:0032006,1,0.573885906457667,0,82,regulation of TOR signaling,BP,
8139,GO:0032007,1,0.773057054106375,0,38,negative regulation of TOR signaling,BP,
8140,GO:0032008,1,0.804235800269473,0,33,positive regulation of TOR signaling,BP,
8141,GO:0032009,1,0.946146509625669,0,8,early phagosome,CC,
8142,GO:0032010,1,0.971120371587229,0,5,phagolysosome,CC,
8143,GO:0032011,1,0.730877925935273,0,44,ARF protein signal transduction,BP,
8144,GO:0032012,1,0.730877925935273,0,44,regulation of ARF protein signal transduction,BP,
8145,GO:0032020,1,0.966037586159515,0,6,ISG15-protein conjugation,BP,
8146,GO:0032021,1,0.97562626446412,0,4,NELF complex,CC,
8147,GO:0032023,1,0.994111018397422,0,1,trypsinogen activation,BP,
8148,GO:0032024,1,0.690658396080618,0,59,positive regulation of insulin secretion,BP,
8149,GO:0032025,1,0.945051321446946,0,9,response to cobalt ion,BP,
8150,GO:0032026,1,0.889221423313648,0,16,response to magnesium ion,BP,
8151,GO:0032027,1,0.975355246306065,0,4,myosin light chain binding,MF,
8152,GO:0032028,1,0.994199845875246,0,1,myosin head/neck binding,MF,
8153,GO:0032029,1,0.98920522315132,0,1,myosin tail binding,MF,
8154,GO:0032036,1,0.943998006547106,0,9,myosin heavy chain binding,MF,
8155,GO:0032038,1,0.98966640583679,0,2,myosin II heavy chain binding,MF,
8156,GO:0032039,1,0.898441854695835,0,15,integrator complex,CC,
8157,GO:0032040,1,0.817348528526151,0,32,small-subunit processome,CC,
8158,GO:0032041,1,0.927347368695936,0,11,NAD-dependent histone deacetylase activity (H3-K14 specific),MF,
8159,GO:0032042,1,0.900590426523436,0,16,mitochondrial DNA metabolic process,BP,
8160,GO:0032044,1,0.987922323797003,0,2,DSIF complex,CC,
8161,GO:0032045,1,0.913431701509451,0,13,guanyl-nucleotide exchange factor complex,CC,
8162,GO:0032048,1,0.915642158258312,0,14,cardiolipin metabolic process,BP,
8163,GO:0032049,1,0.9520128644228,0,8,cardiolipin biosynthetic process,BP,
8164,GO:0032050,1,0.949489050760552,0,7,clathrin heavy chain binding,MF,
8165,GO:0032051,1,0.963120412299238,0,5,clathrin light chain binding,MF,
8166,GO:0032052,1,0.94526287481581,0,10,bile acid binding,MF,
8167,GO:0032053,1,0.985724633923149,0,2,ciliary basal body organization,BP,
8168,GO:0032055,1,0.961407027388265,0,6,negative regulation of translation in response to stress,BP,
8169,GO:0032056,1,0.961262483495677,0,6,positive regulation of translation in response to stress,BP,
8170,GO:0032057,1,0.973121451734956,0,4,negative regulation of translational initiation in response to stress,BP,
8171,GO:0032058,1,0.972514148163661,0,4,positive regulation of translational initiation in response to stress,BP,
8172,GO:0032059,1,0.948472458413806,0,8,bleb,CC,
8174,GO:0032069,1,0.83068738142115,0,30,regulation of nuclease activity,BP,
8175,GO:0032070,1,0.942043825963278,0,10,regulation of deoxyribonuclease activity,BP,
8176,GO:0032071,1,0.952992252058819,0,8,regulation of endodeoxyribonuclease activity,BP,
8177,GO:0032072,1,0.993523081940165,0,1,regulation of restriction endodeoxyribonuclease activity,BP,
8178,GO:0032074,1,0.958173116081631,0,7,negative regulation of nuclease activity,BP,
8179,GO:0032075,1,0.90652764396547,0,16,positive regulation of nuclease activity,BP,
8180,GO:0032076,1,0.988744300522121,0,2,negative regulation of deoxyribonuclease activity,BP,
8181,GO:0032077,1,0.970710213286843,0,5,positive regulation of deoxyribonuclease activity,BP,
8182,GO:0032078,1,0.994826120188389,0,1,negative regulation of endodeoxyribonuclease activity,BP,
8183,GO:0032079,1,0.975984240681193,0,4,positive regulation of endodeoxyribonuclease activity,BP,
8184,GO:0032088,1,0.600960314652944,0,79,negative regulation of NF-kappaB transcription factor activity,BP,
8185,GO:0032089,1,0.986418288694664,0,2,NACHT domain binding,MF,
8186,GO:0032090,1,0.988327889184387,0,2,Pyrin domain binding,MF,
8187,GO:0032091,1,0.554754871508951,0,91,negative regulation of protein binding,BP,
8188,GO:0032092,1,0.564038411813615,0,84,positive regulation of protein binding,BP,
8189,GO:0032093,1,0.993850639026861,0,1,SAM domain binding,MF,
8193,GO:0032097,1,0.984326357647868,0,3,positive regulation of response to food,BP,
8196,GO:0032100,1,0.984326357647868,0,3,positive regulation of appetite,BP,
8202,GO:0032106,1,0.972732218548034,0,5,positive regulation of response to extracellular stimulus,BP,
8205,GO:0032109,1,0.972732218548034,0,5,positive regulation of response to nutrient levels,BP,
8206,GO:0032116,1,0.983945735432404,0,2,SMC loading complex,CC,
8207,GO:0032119,1,0.933645676752466,0,11,sequestering of zinc ion,BP,
8208,GO:0032127,1,0.98688561978863,0,2,dense core granule membrane,CC,
8209,GO:0032129,1,0.987787111474519,0,2,histone deacetylase activity (H3-K9 specific),MF,
8211,GO:0032135,1,0.96206515225524,0,6,DNA insertion or deletion binding,MF,
8212,GO:0032137,1,0.980854693244402,0,3,guanine/thymine mispair binding,MF,
8213,GO:0032138,1,0.973697682154012,0,4,single base insertion or deletion binding,MF,
8214,GO:0032139,1,0.981270622954296,0,3,dinucleotide insertion or deletion binding,MF,
8215,GO:0032142,1,0.979752962418095,0,3,single guanine insertion binding,MF,
8216,GO:0032143,1,0.98676323220283,0,2,single thymine insertion binding,MF,
8217,GO:0032144,1,0.992750414346676,0,1,4-aminobutyrate transaminase complex,CC,
8218,GO:0032145,1,0.992750414346676,0,1,succinate-semialdehyde dehydrogenase binding,MF,
8222,GO:0032154,1,0.707260845318606,0,51,cleavage furrow,CC,
8223,GO:0032155,1,0.665534227841003,0,60,cell division site part,CC,
8226,GO:0032173,1,0.993739838824806,0,1,septin collar,CC,
8227,GO:0032181,1,0.98660144182806,0,2,dinucleotide repeat insertion binding,MF,
8229,GO:0032183,1,0.903566554173685,0,14,SUMO binding,MF,
8230,GO:0032184,1,0.964417908775878,0,5,SUMO polymer binding,MF,
8232,GO:0032190,1,0.983302244514068,0,3,acrosin binding,MF,
8233,GO:0032194,1,0.993407349400836,0,1,ubiquinone biosynthetic process via 3,4-dihydroxy-5-polyprenylbenzoate,BP,
8234,GO:0032196,1,0.886383394384516,0,19,transposition,BP,
8235,GO:0032200,1,0.373240080563154,0,149,telomere organization,BP,
8236,GO:0032201,1,0.845460009991833,0,27,telomere maintenance via semi-conservative replication,BP,
8237,GO:0032202,1,0.97619073436912,0,4,telomere assembly,BP,
8238,GO:0032203,1,0.99432878894376,0,1,telomere formation via telomerase,BP,
8239,GO:0032204,1,0.596498443064136,0,76,regulation of telomere maintenance,BP,
8240,GO:0032205,1,0.785259878307852,0,34,negative regulation of telomere maintenance,BP,
8242,GO:0032207,1,0.993791868572001,0,1,regulation of telomere maintenance via recombination,BP,
8243,GO:0032208,1,0.993791868572001,0,1,negative regulation of telomere maintenance via recombination,BP,
8244,GO:0032210,1,0.705898391224235,0,52,regulation of telomere maintenance via telomerase,BP,
8245,GO:0032211,1,0.876875397171214,0,19,negative regulation of telomere maintenance via telomerase,BP,
8246,GO:0032212,1,0.802594915485772,0,34,positive regulation of telomere maintenance via telomerase,BP,
8247,GO:0032213,1,0.987603798904906,0,2,regulation of telomere maintenance via semi-conservative replication,BP,
8248,GO:0032214,1,0.987603798904906,0,2,negative regulation of telomere maintenance via semi-conservative replication,BP,
8249,GO:0032217,1,0.976436184741949,0,4,riboflavin transmembrane transporter activity,MF,
8250,GO:0032218,1,0.981663996163023,0,3,riboflavin transport,BP,
8251,GO:0032222,1,0.955290592875532,0,7,regulation of synaptic transmission, cholinergic,BP,
8252,GO:0032223,1,0.993956075609241,0,1,negative regulation of synaptic transmission, cholinergic,BP,
8253,GO:0032224,1,0.966994958308322,0,5,positive regulation of synaptic transmission, cholinergic,BP,
8254,GO:0032225,1,0.910703536779209,0,15,regulation of synaptic transmission, dopaminergic,BP,
8255,GO:0032226,1,0.95862493318314,0,7,positive regulation of synaptic transmission, dopaminergic,BP,
8256,GO:0032227,1,0.979708343751014,0,3,negative regulation of synaptic transmission, dopaminergic,BP,
8257,GO:0032228,1,0.813407532763719,0,30,regulation of synaptic transmission, GABAergic,BP,
8258,GO:0032229,1,0.963999420205914,0,6,negative regulation of synaptic transmission, GABAergic,BP,
8259,GO:0032230,1,0.924647347461266,0,12,positive regulation of synaptic transmission, GABAergic,BP,
8261,GO:0032232,1,0.855989499002216,0,22,negative regulation of actin filament bundle assembly,BP,
8263,GO:0032237,1,0.973028061091255,0,4,activation of store-operated calcium channel activity,BP,
8264,GO:0032239,1,0.885618789900733,0,17,regulation of nucleobase-containing compound transport,BP,
8265,GO:0032240,1,0.982654519158608,0,2,negative regulation of nucleobase-containing compound transport,BP,
8266,GO:0032241,1,0.946953086330301,0,8,positive regulation of nucleobase-containing compound transport,BP,
8267,GO:0032242,1,0.993822140704241,0,1,regulation of nucleoside transport,BP,
8268,GO:0032244,1,0.993822140704241,0,1,positive regulation of nucleoside transport,BP,
8269,GO:0032252,1,0.968431881506868,0,4,secretory granule localization,BP,
8270,GO:0032253,1,0.993850639026861,0,1,dense core granule localization,BP,
8271,GO:0032258,1,0.9880637154025,0,2,protein localization by the Cvt pathway,BP,
8272,GO:0032259,1,0.135448954293566,0,305,methylation,BP,
8273,GO:0032261,1,0.959592925989768,0,7,purine nucleotide salvage,BP,
8274,GO:0032262,1,0.966491836672735,0,6,pyrimidine nucleotide salvage,BP,
8275,GO:0032263,1,0.988878521246645,0,2,GMP salvage,BP,
8276,GO:0032264,1,0.975481595375238,0,4,IMP salvage,BP,
8277,GO:0032266,1,0.79723405998964,0,33,phosphatidylinositol-3-phosphate binding,MF,
8281,GO:0032271,1,0.278041428013161,0,193,regulation of protein polymerization,BP,
8282,GO:0032272,1,0.658249852825195,0,63,negative regulation of protein polymerization,BP,
8283,GO:0032273,1,0.468998645338467,0,116,positive regulation of protein polymerization,BP,
8284,GO:0032274,1,0.912429484956712,0,14,gonadotropin secretion,BP,
8285,GO:0032275,1,0.935000276221428,0,10,luteinizing hormone secretion,BP,
8286,GO:0032276,1,0.93847768499539,0,10,regulation of gonadotropin secretion,BP,
8287,GO:0032277,1,0.964294815099929,0,6,negative regulation of gonadotropin secretion,BP,
8288,GO:0032278,1,0.956163038178859,0,7,positive regulation of gonadotropin secretion,BP,
8289,GO:0032279,1,0.196719843535243,0,226,asymmetric synapse,CC,
8290,GO:0032280,1,0.944851482217312,0,8,symmetric synapse,CC,
8291,GO:0032281,1,0.841032741668911,0,27,AMPA glutamate receptor complex,CC,
8293,GO:0032287,1,0.924423279083093,0,9,peripheral nervous system myelin maintenance,BP,
8294,GO:0032288,1,0.861722044443651,0,20,myelin assembly,BP,
8295,GO:0032289,1,0.98166985014866,0,3,central nervous system myelin formation,BP,
8296,GO:0032290,1,0.962894596416789,0,4,peripheral nervous system myelin formation,BP,
8298,GO:0032292,1,0.824631001562487,0,25,peripheral nervous system axon ensheathment,BP,
8299,GO:0032296,1,0.971508917925213,0,4,double-stranded RNA-specific ribonuclease activity,MF,
8300,GO:0032298,1,0.994129861814522,0,1,positive regulation of DNA-dependent DNA replication initiation,BP,
8301,GO:0032299,1,0.983118430301001,0,3,ribonuclease H2 complex,CC,
8302,GO:0032300,1,0.94006674341169,0,9,mismatch repair complex,CC,
8303,GO:0032301,1,0.98676323220283,0,2,MutSalpha complex,CC,
8304,GO:0032302,1,0.98660144182806,0,2,MutSbeta complex,CC,
8305,GO:0032303,1,0.933869404764308,0,11,regulation of icosanoid secretion,BP,
8306,GO:0032304,1,0.992686052058233,0,1,negative regulation of icosanoid secretion,BP,
8307,GO:0032305,1,0.940751035707146,0,10,positive regulation of icosanoid secretion,BP,
8308,GO:0032306,1,0.960304994508208,0,7,regulation of prostaglandin secretion,BP,
8309,GO:0032308,1,0.960304994508208,0,7,positive regulation of prostaglandin secretion,BP,
8310,GO:0032309,1,0.840451028187097,0,28,icosanoid secretion,BP,
8311,GO:0032310,1,0.940852744163038,0,10,prostaglandin secretion,BP,
8312,GO:0032311,1,0.989121523759817,0,2,angiogenin-PRI complex,CC,
8313,GO:0032324,1,0.95794556484966,0,7,molybdopterin cofactor biosynthetic process,BP,
8314,GO:0032328,1,0.947497314990083,0,8,alanine transport,BP,
8315,GO:0032329,1,0.941908080619219,0,10,serine transport,BP,
8316,GO:0032330,1,0.752105578134071,0,42,regulation of chondrocyte differentiation,BP,
8317,GO:0032331,1,0.895667258677626,0,17,negative regulation of chondrocyte differentiation,BP,
8318,GO:0032332,1,0.878393708500491,0,19,positive regulation of chondrocyte differentiation,BP,
8319,GO:0032341,1,0.954071779399052,0,7,aldosterone metabolic process,BP,
8320,GO:0032342,1,0.954071779399052,0,7,aldosterone biosynthetic process,BP,
8321,GO:0032344,1,0.962654915972655,0,6,regulation of aldosterone metabolic process,BP,
8322,GO:0032345,1,0.975332250559992,0,4,negative regulation of aldosterone metabolic process,BP,
8323,GO:0032346,1,0.987005292809429,0,2,positive regulation of aldosterone metabolic process,BP,
8324,GO:0032347,1,0.962654915972655,0,6,regulation of aldosterone biosynthetic process,BP,
8325,GO:0032348,1,0.975332250559992,0,4,negative regulation of aldosterone biosynthetic process,BP,
8326,GO:0032349,1,0.987005292809429,0,2,positive regulation of aldosterone biosynthetic process,BP,
8328,GO:0032351,1,0.934244275703273,0,11,negative regulation of hormone metabolic process,BP,
8329,GO:0032352,1,0.925477930890631,0,12,positive regulation of hormone metabolic process,BP,
8330,GO:0032353,1,0.939267713982304,0,10,negative regulation of hormone biosynthetic process,BP,
8331,GO:0032354,1,0.905310514785374,0,14,response to follicle-stimulating hormone,BP,
8332,GO:0032355,1,0.485212356619803,0,114,response to estradiol,BP,
8333,GO:0032356,1,0.937929045955733,0,10,oxidized DNA binding,MF,
8334,GO:0032357,1,0.943407581849055,0,9,oxidized purine DNA binding,MF,
8335,GO:0032358,1,0.994854530693101,0,1,oxidized pyrimidine DNA binding,MF,
8336,GO:0032361,1,0.994254102342162,0,1,pyridoxal phosphate catabolic process,BP,
8337,GO:0032364,1,0.961925319055113,0,6,oxygen homeostasis,BP,
8338,GO:0032365,1,0.819239113709299,0,29,intracellular lipid transport,BP,
8339,GO:0032366,1,0.884951983672876,0,18,intracellular sterol transport,BP,
8340,GO:0032367,1,0.884951983672876,0,18,intracellular cholesterol transport,BP,
8341,GO:0032368,1,0.581312325695438,0,82,regulation of lipid transport,BP,
8342,GO:0032369,1,0.87988959683314,0,19,negative regulation of lipid transport,BP,
8343,GO:0032370,1,0.735923876164676,0,47,positive regulation of lipid transport,BP,
8344,GO:0032371,1,0.792982637790094,0,35,regulation of sterol transport,BP,
8345,GO:0032372,1,0.951798059672987,0,8,negative regulation of sterol transport,BP,
8346,GO:0032373,1,0.881252639525243,0,18,positive regulation of sterol transport,BP,
8347,GO:0032374,1,0.792982637790094,0,35,regulation of cholesterol transport,BP,
8348,GO:0032375,1,0.951798059672987,0,8,negative regulation of cholesterol transport,BP,
8349,GO:0032376,1,0.881252639525243,0,18,positive regulation of cholesterol transport,BP,
8350,GO:0032377,1,0.955437337413294,0,7,regulation of intracellular lipid transport,BP,
8351,GO:0032378,1,0.993410937173695,0,1,negative regulation of intracellular lipid transport,BP,
8352,GO:0032379,1,0.982866869797113,0,3,positive regulation of intracellular lipid transport,BP,
8353,GO:0032380,1,0.955437337413294,0,7,regulation of intracellular sterol transport,BP,
8354,GO:0032381,1,0.993410937173695,0,1,negative regulation of intracellular sterol transport,BP,
8355,GO:0032382,1,0.982866869797113,0,3,positive regulation of intracellular sterol transport,BP,
8356,GO:0032383,1,0.955437337413294,0,7,regulation of intracellular cholesterol transport,BP,
8357,GO:0032384,1,0.993410937173695,0,1,negative regulation of intracellular cholesterol transport,BP,
8358,GO:0032385,1,0.982866869797113,0,3,positive regulation of intracellular cholesterol transport,BP,
8360,GO:0032387,1,0.70247719219714,0,56,negative regulation of intracellular transport,BP,
8362,GO:0032389,1,0.973920952425614,0,4,MutLalpha complex,CC,
8365,GO:0032393,1,0.960848479061871,0,7,MHC class I receptor activity,MF,
8366,GO:0032394,1,0.99447324800972,0,1,MHC class Ib receptor activity,MF,
8367,GO:0032395,1,0.951223637738685,0,9,MHC class II receptor activity,MF,
8368,GO:0032396,1,0.981997708717555,0,3,inhibitory MHC class I receptor activity,MF,
8369,GO:0032397,1,0.99452673209409,0,1,activating MHC class I receptor activity,MF,
8370,GO:0032398,1,0.994421050826427,0,1,MHC class Ib protein complex,CC,
8371,GO:0032400,1,0.847955433598247,0,26,melanosome localization,BP,
8372,GO:0032401,1,0.858363101068051,0,24,establishment of melanosome localization,BP,
8373,GO:0032402,1,0.865795546133955,0,23,melanosome transport,BP,
8374,GO:0032404,1,0.950026008431898,0,8,mismatch repair complex binding,MF,
8375,GO:0032405,1,0.967175382425031,0,5,MutLalpha complex binding,MF,
8376,GO:0032407,1,0.968006236414869,0,5,MutSalpha complex binding,MF,
8378,GO:0032410,1,0.647503218585513,0,67,negative regulation of transporter activity,BP,
8381,GO:0032413,1,0.678074883066528,0,60,negative regulation of ion transmembrane transporter activity,BP,
8383,GO:0032415,1,0.971062747905828,0,5,regulation of sodium:proton antiporter activity,BP,
8384,GO:0032416,1,0.994253068738624,0,1,negative regulation of sodium:proton antiporter activity,BP,
8385,GO:0032417,1,0.976676978614518,0,4,positive regulation of sodium:proton antiporter activity,BP,
8386,GO:0032418,1,0.673447822304817,0,62,lysosome localization,BP,
8387,GO:0032419,1,0.994134766915014,0,1,extrinsic component of lysosome membrane,CC,
8390,GO:0032422,1,0.973070628466351,0,4,purine-rich negative regulatory element binding,MF,
8391,GO:0032423,1,0.980424318363476,0,3,regulation of mismatch repair,BP,
8392,GO:0032425,1,0.987231575537121,0,2,positive regulation of mismatch repair,BP,
8394,GO:0032427,1,0.987156754400816,0,2,GBD domain binding,MF,
8395,GO:0032428,1,0.993443216357972,0,1,beta-N-acetylgalactosaminidase activity,MF,
8396,GO:0032429,1,0.945930086240561,0,8,regulation of phospholipase A2 activity,BP,
8397,GO:0032430,1,0.970143839065396,0,5,positive regulation of phospholipase A2 activity,BP,
8398,GO:0032431,1,0.983066764984461,0,3,activation of phospholipase A2 activity,BP,
8399,GO:0032432,1,0.676951097248063,0,56,actin filament bundle,CC,
8400,GO:0032433,1,0.889032761079163,0,16,filopodium tip,CC,
8403,GO:0032436,1,0.602771777688599,0,78,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,
8404,GO:0032437,1,0.963310540979588,0,5,cuticular plate,CC,
8405,GO:0032438,1,0.8433815032273,0,26,melanosome organization,BP,
8406,GO:0032440,1,0.994641694887482,0,1,2-alkenal reductase [NAD(P)] activity,MF,
8407,GO:0032444,1,0.974994111770554,0,3,activin responsive factor complex,CC,
8408,GO:0032445,1,0.994089340810551,0,1,fructose import,BP,
8410,GO:0032447,1,0.994020738101129,0,1,protein urmylation,BP,
8411,GO:0032448,1,0.994471697671762,0,1,DNA hairpin binding,MF,
8412,GO:0032449,1,0.967775257604473,0,5,CBM complex,CC,
8413,GO:0032450,1,0.978408579250214,0,3,maltose alpha-glucosidase activity,MF,
8414,GO:0032451,1,0.783129432745244,0,34,demethylase activity,MF,
8415,GO:0032452,1,0.827220436252357,0,25,histone demethylase activity,MF,
8416,GO:0032453,1,0.953867571803099,0,6,histone demethylase activity (H3-K4 specific),MF,
8417,GO:0032454,1,0.91570419421905,0,12,histone demethylase activity (H3-K9 specific),MF,
8418,GO:0032455,1,0.975244352318478,0,4,nerve growth factor processing,BP,
8419,GO:0032456,1,0.793661027056456,0,34,endocytic recycling,BP,
8420,GO:0032458,1,0.993291861510697,0,1,slow endocytic recycling,BP,
8421,GO:0032459,1,0.795243994054738,0,36,regulation of protein oligomerization,BP,
8422,GO:0032460,1,0.910779339953215,0,14,negative regulation of protein oligomerization,BP,
8423,GO:0032461,1,0.878710457073063,0,21,positive regulation of protein oligomerization,BP,
8424,GO:0032462,1,0.901914436693994,0,17,regulation of protein homooligomerization,BP,
8425,GO:0032463,1,0.9407964484407,0,10,negative regulation of protein homooligomerization,BP,
8426,GO:0032464,1,0.957866096991651,0,7,positive regulation of protein homooligomerization,BP,
8427,GO:0032465,1,0.604656412006412,0,73,regulation of cytokinesis,BP,
8428,GO:0032466,1,0.956528120041624,0,7,negative regulation of cytokinesis,BP,
8429,GO:0032467,1,0.822429232530031,0,29,positive regulation of cytokinesis,BP,
8430,GO:0032468,1,0.993484182216223,0,1,Golgi calcium ion homeostasis,BP,
8431,GO:0032469,1,0.86976396804518,0,21,endoplasmic reticulum calcium ion homeostasis,BP,
8432,GO:0032470,1,0.984541872760131,0,2,positive regulation of endoplasmic reticulum calcium ion concentration,BP,
8433,GO:0032471,1,0.952143466896839,0,8,negative regulation of endoplasmic reticulum calcium ion concentration,BP,
8434,GO:0032472,1,0.987793833358751,0,2,Golgi calcium ion transport,BP,
8435,GO:0032473,1,0.990489208522649,0,1,cytoplasmic side of mitochondrial outer membrane,CC,
8436,GO:0032474,1,0.980179398363746,0,3,otolith morphogenesis,BP,
8437,GO:0032475,1,0.993921330858198,0,1,otolith formation,BP,
8438,GO:0032479,1,0.472199210513209,0,115,regulation of type I interferon production,BP,
8439,GO:0032480,1,0.745845094444358,0,45,negative regulation of type I interferon production,BP,
8440,GO:0032481,1,0.635510540384958,0,69,positive regulation of type I interferon production,BP,
8441,GO:0032482,1,0.662687822010361,0,67,Rab protein signal transduction,BP,
8442,GO:0032483,1,0.972062517145403,0,4,regulation of Rab protein signal transduction,BP,
8443,GO:0032484,1,0.978028927598938,0,3,Ral protein signal transduction,BP,
8444,GO:0032485,1,0.978028927598938,0,3,regulation of Ral protein signal transduction,BP,
8445,GO:0032486,1,0.912131033886275,0,13,Rap protein signal transduction,BP,
8446,GO:0032487,1,0.978041739527872,0,3,regulation of Rap protein signal transduction,BP,
8447,GO:0032488,1,0.91209113485479,0,14,Cdc42 protein signal transduction,BP,
8448,GO:0032489,1,0.961118653961989,0,6,regulation of Cdc42 protein signal transduction,BP,
8449,GO:0032490,1,0.922304923842053,0,12,detection of molecule of bacterial origin,BP,
8450,GO:0032493,1,0.947912314019225,0,8,response to bacterial lipoprotein,BP,
8451,GO:0032494,1,0.938326661387432,0,10,response to peptidoglycan,BP,
8452,GO:0032495,1,0.908517266843596,0,14,response to muramyl dipeptide,BP,
8453,GO:0032496,1,0.155147622384521,0,295,response to lipopolysaccharide,BP,
8454,GO:0032497,1,0.976210881829922,0,4,detection of lipopolysaccharide,BP,
8455,GO:0032498,1,0.992972688877791,0,1,detection of muramyl dipeptide,BP,
8456,GO:0032499,1,0.987754777526748,0,2,detection of peptidoglycan,BP,
8457,GO:0032500,1,0.992972688877791,0,1,muramyl dipeptide binding,MF,
8461,GO:0032506,1,0.857195904027305,0,23,cytokinetic process,BP,
8462,GO:0032507,1,0.607368138840482,0,72,maintenance of protein location in cell,BP,
8464,GO:0032509,1,0.873416939283376,0,21,endosome transport via multivesicular body sorting pathway,BP,
8465,GO:0032510,1,0.958005340566217,0,6,endosome to lysosome transport via multivesicular body sorting pathway,BP,
8466,GO:0032511,1,0.953578536076514,0,8,late endosome to vacuole transport via multivesicular body sorting pathway,BP,
8468,GO:0032516,1,0.891779748862351,0,16,positive regulation of phosphoprotein phosphatase activity,BP,
8469,GO:0032525,1,0.943196461690009,0,9,somite rostral/caudal axis specification,BP,
8470,GO:0032526,1,0.535969916473976,0,96,response to retinoic acid,BP,
8471,GO:0032527,1,0.77311758711074,0,39,protein exit from endoplasmic reticulum,BP,
8475,GO:0032534,1,0.958602767903156,0,6,regulation of microvillus assembly,BP,
8478,GO:0032541,1,0.969692984591074,0,5,cortical endoplasmic reticulum,CC,
8479,GO:0032542,1,0.987494818270033,0,2,sulfiredoxin activity,MF,
8480,GO:0032543,1,0.483537794693901,0,127,mitochondrial translation,BP,
8481,GO:0032545,1,0.987829341732332,0,2,CURI complex,CC,
8484,GO:0032551,1,0.986400320868373,0,2,pyrimidine ribonucleoside binding,MF,
8485,GO:0032552,1,0.965663983350306,0,6,deoxyribonucleotide binding,MF,
8487,GO:0032554,1,0.97634536757564,0,4,purine deoxyribonucleotide binding,MF,
8489,GO:0032556,1,0.989062462928108,0,2,pyrimidine deoxyribonucleotide binding,MF,
8490,GO:0032557,1,0.980659400791752,0,3,pyrimidine ribonucleotide binding,MF,
8491,GO:0032558,1,0.982598059192537,0,3,adenyl deoxyribonucleotide binding,MF,
8493,GO:0032560,1,0.993637697540363,0,1,guanyl deoxyribonucleotide binding,MF,
8495,GO:0032564,1,0.982598059192537,0,3,dATP binding,MF,
8496,GO:0032567,1,0.993637697540363,0,1,dGTP binding,MF,
8497,GO:0032570,1,0.777613294033431,0,40,response to progesterone,BP,
8498,GO:0032571,1,0.976528826740323,0,4,response to vitamin K,BP,
8499,GO:0032574,1,0.993246067646976,0,1,5'-3' RNA helicase activity,MF,
8500,GO:0032575,1,0.993246067646976,0,1,ATP-dependent 5'-3' RNA helicase activity,MF,
8501,GO:0032580,1,0.604004561638726,0,77,Golgi cisterna membrane,CC,
8502,GO:0032581,1,0.994334991708616,0,1,ER-dependent peroxisome organization,BP,
8503,GO:0032584,1,0.96298290333531,0,6,growth cone membrane,CC,
8504,GO:0032585,1,0.946967062222513,0,9,multivesicular body membrane,CC,
8507,GO:0032589,1,0.685714066397678,0,53,neuron projection membrane,CC,
8508,GO:0032590,1,0.779745292348202,0,37,dendrite membrane,CC,
8509,GO:0032591,1,0.912200514175651,0,13,dendritic spine membrane,CC,
8510,GO:0032592,1,0.674807207274047,0,65,integral component of mitochondrial membrane,CC,
8511,GO:0032593,1,0.952327832920941,0,7,insulin-responsive compartment,CC,
8512,GO:0032594,1,0.850153236313826,0,26,protein transport within lipid bilayer,BP,
8513,GO:0032596,1,0.968598318377722,0,5,protein transport into membrane raft,BP,
8514,GO:0032601,1,0.99462671200744,0,1,connective tissue growth factor production,BP,
8516,GO:0032603,1,0.994817338665145,0,1,fractalkine production,BP,
8517,GO:0032604,1,0.92803286211489,0,12,granulocyte macrophage colony-stimulating factor production,BP,
8518,GO:0032605,1,0.993637697540363,0,1,hepatocyte growth factor production,BP,
8519,GO:0032606,1,0.469601878261754,0,116,type I interferon production,BP,
8520,GO:0032607,1,0.838888576731494,0,26,interferon-alpha production,BP,
8521,GO:0032608,1,0.736229794462383,0,47,interferon-beta production,BP,
8522,GO:0032609,1,0.571333378705523,0,91,interferon-gamma production,BP,
8523,GO:0032610,1,0.961183082544073,0,7,interleukin-1 alpha production,BP,
8524,GO:0032611,1,0.690354464559581,0,59,interleukin-1 beta production,BP,
8525,GO:0032612,1,0.639273959990459,0,72,interleukin-1 production,BP,
8526,GO:0032613,1,0.774091326048276,0,42,interleukin-10 production,BP,
8527,GO:0032615,1,0.734479083458781,0,49,interleukin-12 production,BP,
8528,GO:0032616,1,0.899334347968811,0,17,interleukin-13 production,BP,
8529,GO:0032618,1,0.988818429031921,0,2,interleukin-15 production,BP,
8530,GO:0032620,1,0.886089863638095,0,20,interleukin-17 production,BP,
8531,GO:0032621,1,0.948879163577342,0,8,interleukin-18 production,BP,
8532,GO:0032623,1,0.69786818399273,0,56,interleukin-2 production,BP,
8533,GO:0032625,1,0.993451155354443,0,1,interleukin-21 production,BP,
8534,GO:0032627,1,0.968399820987612,0,5,interleukin-23 production,BP,
8535,GO:0032632,1,0.980207546618797,0,3,interleukin-3 production,BP,
8536,GO:0032633,1,0.824163770783511,0,31,interleukin-4 production,BP,
8537,GO:0032634,1,0.908100501000917,0,15,interleukin-5 production,BP,
8539,GO:0032637,1,0.68253460550932,0,61,interleukin-8 production,BP,
8540,GO:0032639,1,0.988182217919473,0,2,TRAIL production,BP,
8541,GO:0032640,1,0.498175392114173,0,110,tumor necrosis factor production,BP,
8542,GO:0032641,1,0.987612668489746,0,2,lymphotoxin A production,BP,
8544,GO:0032643,1,0.99462671200744,0,1,regulation of connective tissue growth factor production,BP,
8545,GO:0032644,1,0.994817338665145,0,1,regulation of fractalkine production,BP,
8546,GO:0032645,1,0.933267758079564,0,11,regulation of granulocyte macrophage colony-stimulating factor production,BP,
8547,GO:0032646,1,0.993637697540363,0,1,regulation of hepatocyte growth factor production,BP,
8548,GO:0032647,1,0.843501203408456,0,25,regulation of interferon-alpha production,BP,
8549,GO:0032648,1,0.745256224917925,0,45,regulation of interferon-beta production,BP,
8550,GO:0032649,1,0.613253717225978,0,80,regulation of interferon-gamma production,BP,
8551,GO:0032650,1,0.966038732205166,0,6,regulation of interleukin-1 alpha production,BP,
8552,GO:0032651,1,0.72887664929796,0,51,regulation of interleukin-1 beta production,BP,
8553,GO:0032652,1,0.678396325284138,0,63,regulation of interleukin-1 production,BP,
8554,GO:0032653,1,0.783765126934259,0,40,regulation of interleukin-10 production,BP,
8555,GO:0032655,1,0.743872614383954,0,47,regulation of interleukin-12 production,BP,
8556,GO:0032656,1,0.904134337312332,0,16,regulation of interleukin-13 production,BP,
8557,GO:0032658,1,0.994366780695613,0,1,regulation of interleukin-15 production,BP,
8558,GO:0032660,1,0.901750783496654,0,17,regulation of interleukin-17 production,BP,
8559,GO:0032661,1,0.962013516863384,0,6,regulation of interleukin-18 production,BP,
8560,GO:0032663,1,0.729286775119918,0,49,regulation of interleukin-2 production,BP,
8561,GO:0032667,1,0.968399820987612,0,5,regulation of interleukin-23 production,BP,
8562,GO:0032672,1,0.986821059881452,0,2,regulation of interleukin-3 production,BP,
8563,GO:0032673,1,0.858156061634649,0,25,regulation of interleukin-4 production,BP,
8564,GO:0032674,1,0.908100501000917,0,15,regulation of interleukin-5 production,BP,
8566,GO:0032677,1,0.708930397294105,0,55,regulation of interleukin-8 production,BP,
8567,GO:0032679,1,0.988182217919473,0,2,regulation of TRAIL production,BP,
8568,GO:0032680,1,0.507540909832148,0,107,regulation of tumor necrosis factor production,BP,
8569,GO:0032681,1,0.993886098528668,0,1,regulation of lymphotoxin A production,BP,
8570,GO:0032682,1,0.910229906535432,0,16,negative regulation of chemokine production,BP,
8571,GO:0032685,1,0.993603926289274,0,1,negative regulation of granulocyte macrophage colony-stimulating factor production,BP,
8572,GO:0032686,1,0.993637697540363,0,1,negative regulation of hepatocyte growth factor production,BP,
8573,GO:0032687,1,0.961884731279261,0,6,negative regulation of interferon-alpha production,BP,
8574,GO:0032688,1,0.915633300064304,0,14,negative regulation of interferon-beta production,BP,
8575,GO:0032689,1,0.854140708623625,0,26,negative regulation of interferon-gamma production,BP,
8576,GO:0032690,1,0.994548692780716,0,1,negative regulation of interleukin-1 alpha production,BP,
8577,GO:0032691,1,0.914208416671455,0,15,negative regulation of interleukin-1 beta production,BP,
8578,GO:0032692,1,0.882003807841959,0,21,negative regulation of interleukin-1 production,BP,
8579,GO:0032693,1,0.919864713114961,0,14,negative regulation of interleukin-10 production,BP,
8580,GO:0032695,1,0.900678019071872,0,16,negative regulation of interleukin-12 production,BP,
8581,GO:0032696,1,0.981279780141592,0,3,negative regulation of interleukin-13 production,BP,
8582,GO:0032700,1,0.945806058075792,0,9,negative regulation of interleukin-17 production,BP,
8583,GO:0032701,1,0.988085979206935,0,2,negative regulation of interleukin-18 production,BP,
8584,GO:0032703,1,0.887890500106573,0,19,negative regulation of interleukin-2 production,BP,
8585,GO:0032707,1,0.986477347752676,0,2,negative regulation of interleukin-23 production,BP,
8586,GO:0032712,1,0.994088824750106,0,1,negative regulation of interleukin-3 production,BP,
8587,GO:0032713,1,0.969011373426381,0,5,negative regulation of interleukin-4 production,BP,
8588,GO:0032714,1,0.981099304984431,0,3,negative regulation of interleukin-5 production,BP,
8589,GO:0032715,1,0.81118298110404,0,33,negative regulation of interleukin-6 production,BP,
8590,GO:0032717,1,0.905432008482274,0,16,negative regulation of interleukin-8 production,BP,
8591,GO:0032720,1,0.769654944019414,0,43,negative regulation of tumor necrosis factor production,BP,
8593,GO:0032723,1,0.99462671200744,0,1,positive regulation of connective tissue growth factor production,BP,
8594,GO:0032724,1,0.994817338665145,0,1,positive regulation of fractalkine production,BP,
8595,GO:0032725,1,0.939279248364671,0,10,positive regulation of granulocyte macrophage colony-stimulating factor production,BP,
8596,GO:0032727,1,0.876970672969898,0,19,positive regulation of interferon-alpha production,BP,
8597,GO:0032728,1,0.825405688961426,0,29,positive regulation of interferon-beta production,BP,
8598,GO:0032729,1,0.711844867848257,0,55,positive regulation of interferon-gamma production,BP,
8599,GO:0032730,1,0.971335332527333,0,5,positive regulation of interleukin-1 alpha production,BP,
8600,GO:0032731,1,0.816090334235827,0,32,positive regulation of interleukin-1 beta production,BP,
8601,GO:0032732,1,0.786662101691704,0,38,positive regulation of interleukin-1 production,BP,
8602,GO:0032733,1,0.843003049587214,0,28,positive regulation of interleukin-10 production,BP,
8603,GO:0032735,1,0.837983154651774,0,29,positive regulation of interleukin-12 production,BP,
8604,GO:0032736,1,0.921397234348584,0,13,positive regulation of interleukin-13 production,BP,
8605,GO:0032738,1,0.994366780695613,0,1,positive regulation of interleukin-15 production,BP,
8606,GO:0032740,1,0.947866889957499,0,9,positive regulation of interleukin-17 production,BP,
8607,GO:0032741,1,0.9798713902214,0,3,positive regulation of interleukin-18 production,BP,
8608,GO:0032743,1,0.82631053748494,0,29,positive regulation of interleukin-2 production,BP,
8609,GO:0032747,1,0.987453224227653,0,2,positive regulation of interleukin-23 production,BP,
8610,GO:0032752,1,0.992689454821734,0,1,positive regulation of interleukin-3 production,BP,
8611,GO:0032753,1,0.880386317408165,0,21,positive regulation of interleukin-4 production,BP,
8612,GO:0032754,1,0.930971438923355,0,11,positive regulation of interleukin-5 production,BP,
8614,GO:0032757,1,0.778659147849454,0,40,positive regulation of interleukin-8 production,BP,
8615,GO:0032759,1,0.988182217919473,0,2,positive regulation of TRAIL production,BP,
8616,GO:0032760,1,0.662291237102919,0,64,positive regulation of tumor necrosis factor production,BP,
8617,GO:0032761,1,0.993886098528668,0,1,positive regulation of lymphotoxin A production,BP,
8618,GO:0032762,1,0.956824439455363,0,7,mast cell cytokine production,BP,
8619,GO:0032763,1,0.969543226336678,0,5,regulation of mast cell cytokine production,BP,
8620,GO:0032764,1,0.987990143348434,0,2,negative regulation of mast cell cytokine production,BP,
8621,GO:0032765,1,0.981331103210864,0,3,positive regulation of mast cell cytokine production,BP,
8622,GO:0032767,1,0.979415092623695,0,3,copper-dependent protein binding,MF,
8624,GO:0032769,1,0.937103938809151,0,10,negative regulation of monooxygenase activity,BP,
8626,GO:0032771,1,0.993079164753351,0,1,regulation of monophenol monooxygenase activity,BP,
8627,GO:0032773,1,0.993079164753351,0,1,positive regulation of monophenol monooxygenase activity,BP,
8629,GO:0032775,1,0.99339350837991,0,1,DNA methylation on adenine,BP,
8630,GO:0032776,1,0.978970586396379,0,3,DNA methylation on cytosine,BP,
8631,GO:0032777,1,0.975948851608432,0,4,Piccolo NuA4 histone acetyltransferase complex,CC,
8632,GO:0032780,1,0.925064731169663,0,13,negative regulation of ATPase activity,BP,
8634,GO:0032782,1,0.975817048657757,0,4,bile acid secretion,BP,
8635,GO:0032783,1,0.948934621092367,0,6,ELL-EAF complex,CC,
8636,GO:0032784,1,0.769696810380575,0,41,regulation of DNA-templated transcription, elongation,BP,
8637,GO:0032785,1,0.920166121374874,0,13,negative regulation of DNA-templated transcription, elongation,BP,
8638,GO:0032786,1,0.863086912701804,0,23,positive regulation of DNA-templated transcription, elongation,BP,
8640,GO:0032788,1,0.994447408466218,0,1,saturated monocarboxylic acid metabolic process,BP,
8641,GO:0032789,1,0.994447408466218,0,1,unsaturated monocarboxylic acid metabolic process,BP,
8642,GO:0032790,1,0.949456411964359,0,8,ribosome disassembly,BP,
8643,GO:0032792,1,0.968723478784378,0,5,negative regulation of CREB transcription factor activity,BP,
8644,GO:0032793,1,0.907164225386423,0,14,positive regulation of CREB transcription factor activity,BP,
8645,GO:0032794,1,0.903779792861936,0,14,GTPase activating protein binding,MF,
8646,GO:0032795,1,0.981957675977271,0,3,heterotrimeric G-protein binding,MF,
8647,GO:0032796,1,0.985877523814316,0,2,uropod organization,BP,
8648,GO:0032797,1,0.928797670861323,0,12,SMN complex,CC,
8649,GO:0032798,1,0.987738712940129,0,2,Swi5-Sfr1 complex,CC,
8650,GO:0032799,1,0.876251298805735,0,20,low-density lipoprotein receptor particle metabolic process,BP,
8651,GO:0032800,1,0.863410140102539,0,22,receptor biosynthetic process,BP,
8652,GO:0032801,1,0.803888700962857,0,32,receptor catabolic process,BP,
8653,GO:0032802,1,0.919296079741616,0,13,low-density lipoprotein particle receptor catabolic process,BP,
8654,GO:0032803,1,0.969734501786088,0,5,regulation of low-density lipoprotein particle receptor catabolic process,BP,
8655,GO:0032804,1,0.987609190488099,0,2,negative regulation of low-density lipoprotein particle receptor catabolic process,BP,
8656,GO:0032805,1,0.988125565106649,0,2,positive regulation of low-density lipoprotein particle receptor catabolic process,BP,
8657,GO:0032806,1,0.856935812384228,0,24,carboxy-terminal domain protein kinase complex,CC,
8658,GO:0032807,1,0.975596220218197,0,4,DNA ligase IV complex,CC,
8659,GO:0032808,1,0.952955094329561,0,7,lacrimal gland development,BP,
8660,GO:0032809,1,0.85920634422255,0,23,neuronal cell body membrane,CC,
8661,GO:0032810,1,0.987246288713058,0,2,sterol response element binding,MF,
8662,GO:0032811,1,0.982309031356053,0,3,negative regulation of epinephrine secretion,BP,
8663,GO:0032812,1,0.994816822103454,0,1,positive regulation of epinephrine secretion,BP,
8664,GO:0032813,1,0.772705488085492,0,43,tumor necrosis factor receptor superfamily binding,MF,
8665,GO:0032814,1,0.872545648489288,0,22,regulation of natural killer cell activation,BP,
8666,GO:0032815,1,0.971852102030457,0,5,negative regulation of natural killer cell activation,BP,
8667,GO:0032816,1,0.921184635010675,0,13,positive regulation of natural killer cell activation,BP,
8668,GO:0032817,1,0.964299297185334,0,6,regulation of natural killer cell proliferation,BP,
8669,GO:0032819,1,0.976707405167817,0,4,positive regulation of natural killer cell proliferation,BP,
8670,GO:0032823,1,0.938345192081333,0,10,regulation of natural killer cell differentiation,BP,
8671,GO:0032824,1,0.994797709198386,0,1,negative regulation of natural killer cell differentiation,BP,
8672,GO:0032825,1,0.955466995325544,0,7,positive regulation of natural killer cell differentiation,BP,
8673,GO:0032826,1,0.989261116642694,0,2,regulation of natural killer cell differentiation involved in immune response,BP,
8674,GO:0032827,1,0.994797709198386,0,1,negative regulation of natural killer cell differentiation involved in immune response,BP,
8675,GO:0032829,1,0.988539447433462,0,2,regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation,BP,
8676,GO:0032831,1,0.988539447433462,0,2,positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation,BP,
8677,GO:0032832,1,0.994424668622026,0,1,regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response,BP,
8678,GO:0032834,1,0.994424668622026,0,1,positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response,BP,
8680,GO:0032836,1,0.92761121440426,0,10,glomerular basement membrane development,BP,
8682,GO:0032839,1,0.833821553196391,0,27,dendrite cytoplasm,CC,
8683,GO:0032841,1,0.99342374861696,0,1,calcitonin binding,MF,
8684,GO:0032847,1,0.97555555048373,0,4,regulation of cellular pH reduction,BP,
8685,GO:0032848,1,0.993306510747315,0,1,negative regulation of cellular pH reduction,BP,
8686,GO:0032849,1,0.982130624844681,0,3,positive regulation of cellular pH reduction,BP,
8687,GO:0032868,1,0.203525474449013,0,238,response to insulin,BP,
8688,GO:0032869,1,0.282988673443717,0,187,cellular response to insulin stimulus,BP,
8692,GO:0032874,1,0.403484477189436,0,136,positive regulation of stress-activated MAPK cascade,BP,
8693,GO:0032875,1,0.949313359827224,0,7,regulation of DNA endoreduplication,BP,
8694,GO:0032876,1,0.969225133792768,0,4,negative regulation of DNA endoreduplication,BP,
8695,GO:0032877,1,0.985736882225884,0,2,positive regulation of DNA endoreduplication,BP,
8696,GO:0032878,1,0.859971528229915,0,21,regulation of establishment or maintenance of cell polarity,BP,
8699,GO:0032881,1,0.789147918969692,0,33,regulation of polysaccharide metabolic process,BP,
8700,GO:0032885,1,0.802983832727061,0,30,regulation of polysaccharide biosynthetic process,BP,
8702,GO:0032887,1,0.991555657821302,0,1,regulation of spindle elongation,BP,
8703,GO:0032888,1,0.991555657821302,0,1,regulation of mitotic spindle elongation,BP,
8704,GO:0032889,1,0.993983631437683,0,1,regulation of vacuole fusion, non-autophagic,BP,
8705,GO:0032890,1,0.759630061527318,0,42,regulation of organic acid transport,BP,
8706,GO:0032891,1,0.905238070538692,0,15,negative regulation of organic acid transport,BP,
8707,GO:0032892,1,0.87081038942612,0,22,positive regulation of organic acid transport,BP,
8708,GO:0032897,1,0.879728126306089,0,20,negative regulation of viral transcription,BP,
8709,GO:0032898,1,0.974074395485327,0,4,neurotrophin production,BP,
8710,GO:0032899,1,0.987148384662692,0,2,regulation of neurotrophin production,BP,
8711,GO:0032900,1,0.993822140704241,0,1,negative regulation of neurotrophin production,BP,
8712,GO:0032901,1,0.99328517707573,0,1,positive regulation of neurotrophin production,BP,
8713,GO:0032902,1,0.986757520226629,0,2,nerve growth factor production,BP,
8714,GO:0032905,1,0.937637575652563,0,10,transforming growth factor beta1 production,BP,
8715,GO:0032906,1,0.945197950285846,0,8,transforming growth factor beta2 production,BP,
8716,GO:0032907,1,0.982543595227905,0,2,transforming growth factor beta3 production,BP,
8717,GO:0032908,1,0.937637575652563,0,10,regulation of transforming growth factor beta1 production,BP,
8718,GO:0032909,1,0.945197950285846,0,8,regulation of transforming growth factor beta2 production,BP,
8719,GO:0032910,1,0.982543595227905,0,2,regulation of transforming growth factor beta3 production,BP,
8720,GO:0032911,1,0.97349834787402,0,4,negative regulation of transforming growth factor beta1 production,BP,
8721,GO:0032912,1,0.986610023211248,0,2,negative regulation of transforming growth factor beta2 production,BP,
8722,GO:0032914,1,0.963172794147866,0,6,positive regulation of transforming growth factor beta1 production,BP,
8723,GO:0032915,1,0.988520343849744,0,2,positive regulation of transforming growth factor beta2 production,BP,
8724,GO:0032916,1,0.982543595227905,0,2,positive regulation of transforming growth factor beta3 production,BP,
8725,GO:0032917,1,0.983765898150188,0,3,polyamine acetylation,BP,
8726,GO:0032918,1,0.983765898150188,0,3,spermidine acetylation,BP,
8727,GO:0032919,1,0.994790477223093,0,1,spermine acetylation,BP,
8728,GO:0032920,1,0.994790477223093,0,1,putrescine acetylation,BP,
8729,GO:0032922,1,0.700508022175998,0,50,circadian regulation of gene expression,BP,
8730,GO:0032924,1,0.784591778164216,0,36,activin receptor signaling pathway,BP,
8731,GO:0032925,1,0.85980476381337,0,23,regulation of activin receptor signaling pathway,BP,
8732,GO:0032926,1,0.9435502198658,0,9,negative regulation of activin receptor signaling pathway,BP,
8733,GO:0032927,1,0.943143039287269,0,8,positive regulation of activin receptor signaling pathway,BP,
8734,GO:0032928,1,0.907533600037162,0,16,regulation of superoxide anion generation,BP,
8735,GO:0032929,1,0.989172517625548,0,2,negative regulation of superoxide anion generation,BP,
8736,GO:0032930,1,0.924238207085663,0,13,positive regulation of superoxide anion generation,BP,
8737,GO:0032933,1,0.949684812443075,0,8,SREBP signaling pathway,BP,
8738,GO:0032934,1,0.761738594088918,0,41,sterol binding,MF,
8739,GO:0032937,1,0.981024068300805,0,3,SREBP-SCAP-Insig complex,CC,
8741,GO:0032941,1,0.812594060543732,0,33,secretion by tissue,BP,
8745,GO:0032946,1,0.483858120319574,0,118,positive regulation of mononuclear cell proliferation,BP,
8747,GO:0032954,1,0.985634729738397,0,2,regulation of cytokinetic process,BP,
8749,GO:0032957,1,0.946839473387128,0,8,inositol trisphosphate metabolic process,BP,
8750,GO:0032958,1,0.854533996874213,0,24,inositol phosphate biosynthetic process,BP,
8751,GO:0032959,1,0.960525959369796,0,6,inositol trisphosphate biosynthetic process,BP,
8752,GO:0032960,1,0.973881083948657,0,4,regulation of inositol trisphosphate biosynthetic process,BP,
8753,GO:0032962,1,0.980701747113705,0,3,positive regulation of inositol trisphosphate biosynthetic process,BP,
8755,GO:0032964,1,0.797463626904016,0,35,collagen biosynthetic process,BP,
8756,GO:0032965,1,0.844192777446105,0,27,regulation of collagen biosynthetic process,BP,
8757,GO:0032966,1,0.958398843673871,0,7,negative regulation of collagen biosynthetic process,BP,
8758,GO:0032967,1,0.880884602381164,0,20,positive regulation of collagen biosynthetic process,BP,
8759,GO:0032968,1,0.912839984892093,0,14,positive regulation of transcription elongation from RNA polymerase II promoter,BP,
8761,GO:0032971,1,0.976775045145635,0,4,regulation of muscle filament sliding,BP,
8762,GO:0032972,1,0.989656620674914,0,2,regulation of muscle filament sliding speed,BP,
8763,GO:0032976,1,0.99487002715562,0,1,release of matrix enzymes from mitochondria,BP,
8764,GO:0032977,1,0.992956035583836,0,1,membrane insertase activity,MF,
8765,GO:0032978,1,0.992956035583836,0,1,protein insertion into membrane from inner side,BP,
8766,GO:0032979,1,0.992956035583836,0,1,protein insertion into mitochondrial membrane from inner side,BP,
8767,GO:0032981,1,0.740728962567311,0,55,mitochondrial respiratory chain complex I assembly,BP,
8769,GO:0032983,1,0.964693647121235,0,5,kainate selective glutamate receptor complex,CC,
8770,GO:0032984,1,0.149355294281966,0,294,protein-containing complex disassembly,BP,
8771,GO:0032986,1,0.881463243131687,0,19,protein-DNA complex disassembly,BP,
8772,GO:0032988,1,0.920202902557476,0,13,ribonucleoprotein complex disassembly,BP,
8776,GO:0032993,1,0.430234525083286,0,137,protein-DNA complex,CC,
8777,GO:0032994,1,0.805763321870649,0,34,protein-lipid complex,CC,
8778,GO:0032996,1,0.994323878433758,0,1,Bcl3-Bcl10 complex,CC,
8779,GO:0032997,1,0.989415964419858,0,2,Fc receptor complex,CC,
8780,GO:0032998,1,0.989415964419858,0,2,Fc-epsilon receptor I complex,CC,
8782,GO:0033003,1,0.805207948089917,0,35,regulation of mast cell activation,BP,
8783,GO:0033004,1,0.935938872266644,0,11,negative regulation of mast cell activation,BP,
8784,GO:0033005,1,0.911664220401817,0,15,positive regulation of mast cell activation,BP,
8785,GO:0033006,1,0.847140711879114,0,27,regulation of mast cell activation involved in immune response,BP,
8786,GO:0033007,1,0.959832600216311,0,7,negative regulation of mast cell activation involved in immune response,BP,
8787,GO:0033008,1,0.929725463540212,0,12,positive regulation of mast cell activation involved in immune response,BP,
8788,GO:0033010,1,0.950217845499317,0,7,paranodal junction,CC,
8789,GO:0033011,1,0.988413540569103,0,2,perinuclear theca,CC,
8790,GO:0033013,1,0.72982979859458,0,49,tetrapyrrole metabolic process,BP,
8791,GO:0033014,1,0.845259725887504,0,26,tetrapyrrole biosynthetic process,BP,
8792,GO:0033015,1,0.978625213976315,0,4,tetrapyrrole catabolic process,BP,
8793,GO:0033017,1,0.767261557642535,0,36,sarcoplasmic reticulum membrane,CC,
8794,GO:0033018,1,0.956940513119987,0,7,sarcoplasmic reticulum lumen,CC,
8795,GO:0033023,1,0.981053024054331,0,3,mast cell homeostasis,BP,
8796,GO:0033024,1,0.981053024054331,0,3,mast cell apoptotic process,BP,
8797,GO:0033025,1,0.981053024054331,0,3,regulation of mast cell apoptotic process,BP,
8798,GO:0033026,1,0.987521217727885,0,2,negative regulation of mast cell apoptotic process,BP,
8799,GO:0033028,1,0.838122801558381,0,28,myeloid cell apoptotic process,BP,
8800,GO:0033029,1,0.961114241786218,0,6,regulation of neutrophil apoptotic process,BP,
8801,GO:0033030,1,0.986007212589047,0,2,negative regulation of neutrophil apoptotic process,BP,
8802,GO:0033031,1,0.974757311163416,0,4,positive regulation of neutrophil apoptotic process,BP,
8803,GO:0033032,1,0.858367152110774,0,24,regulation of myeloid cell apoptotic process,BP,
8804,GO:0033033,1,0.922289479742304,0,13,negative regulation of myeloid cell apoptotic process,BP,
8805,GO:0033034,1,0.955408193693123,0,7,positive regulation of myeloid cell apoptotic process,BP,
8807,GO:0033037,1,0.992314722248821,0,1,polysaccharide localization,BP,
8808,GO:0033038,1,0.948130102446035,0,10,bitter taste receptor activity,MF,
8809,GO:0033040,1,0.993708337644235,0,1,sour taste receptor activity,MF,
8810,GO:0033041,1,0.993966632638298,0,1,sweet taste receptor activity,MF,
8817,GO:0033058,1,0.974999485462739,0,3,directional locomotion,BP,
8818,GO:0033059,1,0.71081120845951,0,52,cellular pigmentation,BP,
8819,GO:0033061,1,0.947359674493561,0,9,DNA recombinase mediator complex,CC,
8820,GO:0033063,1,0.959124708300046,0,7,Rad51B-Rad51C-Rad51D-XRCC2 complex,CC,
8821,GO:0033065,1,0.988778526204715,0,2,Rad51C-XRCC3 complex,CC,
8822,GO:0033076,1,0.983112866874746,0,3,isoquinoline alkaloid metabolic process,BP,
8823,GO:0033077,1,0.672577566306833,0,60,T cell differentiation in thymus,BP,
8824,GO:0033078,1,0.981701141720272,0,3,extrathymic T cell differentiation,BP,
8825,GO:0033079,1,0.958160224210078,0,7,immature T cell proliferation,BP,
8826,GO:0033080,1,0.969420477038056,0,5,immature T cell proliferation in thymus,BP,
8827,GO:0033081,1,0.880494124933588,0,20,regulation of T cell differentiation in thymus,BP,
8828,GO:0033082,1,0.987224841690705,0,2,regulation of extrathymic T cell differentiation,BP,
8829,GO:0033083,1,0.964647453465593,0,6,regulation of immature T cell proliferation,BP,
8830,GO:0033084,1,0.975983166613418,0,4,regulation of immature T cell proliferation in thymus,BP,
8831,GO:0033085,1,0.964859140996217,0,6,negative regulation of T cell differentiation in thymus,BP,
8832,GO:0033087,1,0.981723967719278,0,3,negative regulation of immature T cell proliferation,BP,
8833,GO:0033088,1,0.987249334320209,0,2,negative regulation of immature T cell proliferation in thymus,BP,
8834,GO:0033089,1,0.944142735197769,0,9,positive regulation of T cell differentiation in thymus,BP,
8835,GO:0033091,1,0.982608798911456,0,3,positive regulation of immature T cell proliferation,BP,
8836,GO:0033092,1,0.988589797204751,0,2,positive regulation of immature T cell proliferation in thymus,BP,
8837,GO:0033093,1,0.964881624965101,0,5,Weibel-Palade body,CC,
8838,GO:0033106,1,0.982535678618198,0,3,cis-Golgi network membrane,CC,
8839,GO:0033108,1,0.611603679115613,0,87,mitochondrial respiratory chain complex assembly,BP,
8840,GO:0033116,1,0.672161278429431,0,62,endoplasmic reticulum-Golgi intermediate compartment membrane,CC,
8841,GO:0033119,1,0.862781519627806,0,24,negative regulation of RNA splicing,BP,
8842,GO:0033120,1,0.824754176591388,0,29,positive regulation of RNA splicing,BP,
8843,GO:0033121,1,0.977750776841414,0,3,regulation of purine nucleotide catabolic process,BP,
8844,GO:0033122,1,0.985456234692573,0,2,negative regulation of purine nucleotide catabolic process,BP,
8845,GO:0033123,1,0.992181973321879,0,1,positive regulation of purine nucleotide catabolic process,BP,
8846,GO:0033127,1,0.920351396087868,0,13,regulation of histone phosphorylation,BP,
8847,GO:0033128,1,0.982754385055463,0,3,negative regulation of histone phosphorylation,BP,
8848,GO:0033129,1,0.948185533107038,0,8,positive regulation of histone phosphorylation,BP,
8849,GO:0033130,1,0.940059022223128,0,9,acetylcholine receptor binding,MF,
8850,GO:0033131,1,0.943229747845346,0,9,regulation of glucokinase activity,BP,
8851,GO:0033132,1,0.97644894792023,0,4,negative regulation of glucokinase activity,BP,
8852,GO:0033133,1,0.965987633247948,0,5,positive regulation of glucokinase activity,BP,
8854,GO:0033137,1,0.862172036976899,0,23,negative regulation of peptidyl-serine phosphorylation,BP,
8856,GO:0033139,1,0.97433422639017,0,4,regulation of peptidyl-serine phosphorylation of STAT protein,BP,
8857,GO:0033140,1,0.994325946015146,0,1,negative regulation of peptidyl-serine phosphorylation of STAT protein,BP,
8858,GO:0033141,1,0.979895343309249,0,3,positive regulation of peptidyl-serine phosphorylation of STAT protein,BP,
8859,GO:0033142,1,0.994156455607876,0,1,progesterone receptor binding,MF,
8860,GO:0033143,1,0.635390938872001,0,69,regulation of intracellular steroid hormone receptor signaling pathway,BP,
8861,GO:0033144,1,0.821387763030016,0,30,negative regulation of intracellular steroid hormone receptor signaling pathway,BP,
8862,GO:0033145,1,0.913523938724241,0,14,positive regulation of intracellular steroid hormone receptor signaling pathway,BP,
8863,GO:0033146,1,0.797348294230669,0,34,regulation of intracellular estrogen receptor signaling pathway,BP,
8864,GO:0033147,1,0.922828341505894,0,12,negative regulation of intracellular estrogen receptor signaling pathway,BP,
8865,GO:0033148,1,0.947907279619978,0,8,positive regulation of intracellular estrogen receptor signaling pathway,BP,
8866,GO:0033149,1,0.985149051443367,0,2,FFAT motif binding,MF,
8867,GO:0033150,1,0.994287696673407,0,1,cytoskeletal calyx,CC,
8868,GO:0033151,1,0.914194787922149,0,12,V(D)J recombination,BP,
8869,GO:0033152,1,0.969577080562662,0,4,immunoglobulin V(D)J recombination,BP,
8870,GO:0033153,1,0.960733738130492,0,5,T cell receptor V(D)J recombination,BP,
8873,GO:0033159,1,0.980711373981527,0,3,negative regulation of protein import into nucleus, translocation,BP,
8875,GO:0033162,1,0.93793907505258,0,11,melanosome membrane,CC,
8876,GO:0033165,1,0.987697683002669,0,2,interphotoreceptor matrix,CC,
8877,GO:0033167,1,0.989975151946925,0,1,ARC complex,CC,
8878,GO:0033168,1,0.989975151946925,0,1,conversion of ds siRNA to ss siRNA involved in RNA interference,BP,
8879,GO:0033169,1,0.910169793329138,0,13,histone H3-K9 demethylation,BP,
8880,GO:0033170,1,0.952778066961539,0,8,protein-DNA loading ATPase activity,MF,
8881,GO:0033173,1,0.846621021762959,0,24,calcineurin-NFAT signaling cascade,BP,
8882,GO:0033176,1,0.866243167244418,0,24,proton-transporting V-type ATPase complex,CC,
8883,GO:0033177,1,0.935913354835997,0,11,proton-transporting two-sector ATPase complex, proton-transporting domain,CC,
8884,GO:0033178,1,0.935940873192626,0,11,proton-transporting two-sector ATPase complex, catalytic domain,CC,
8885,GO:0033179,1,0.941027843000954,0,10,proton-transporting V-type ATPase, V0 domain,CC,
8886,GO:0033180,1,0.946457636437822,0,9,proton-transporting V-type ATPase, V1 domain,CC,
8887,GO:0033181,1,0.988519436022416,0,2,plasma membrane proton-transporting V-type ATPase complex,CC,
8888,GO:0033182,1,0.933698262573037,0,10,regulation of histone ubiquitination,BP,
8889,GO:0033183,1,0.976566914684873,0,3,negative regulation of histone ubiquitination,BP,
8890,GO:0033184,1,0.967540618725087,0,5,positive regulation of histone ubiquitination,BP,
8891,GO:0033185,1,0.9843753188457,0,3,dolichol-phosphate-mannose synthase complex,CC,
8892,GO:0033186,1,0.978983213821304,0,3,CAF-1 complex,CC,
8893,GO:0033188,1,0.980101803823174,0,3,sphingomyelin synthase activity,MF,
8894,GO:0033189,1,0.912659767762659,0,15,response to vitamin A,BP,
8895,GO:0033192,1,0.964932694159371,0,5,calmodulin-dependent protein phosphatase activity,MF,
8896,GO:0033193,1,0.99270698963186,0,1,Lsd1/2 complex,CC,
8897,GO:0033194,1,0.905177927956254,0,16,response to hydroperoxide,BP,
8898,GO:0033197,1,0.928628131687726,0,12,response to vitamin E,BP,
8899,GO:0033198,1,0.828337349083022,0,29,response to ATP,BP,
8900,GO:0033202,1,0.91434204926638,0,15,DNA helicase complex,CC,
8901,GO:0033204,1,0.994005531743305,0,1,ribonuclease P RNA binding,MF,
8902,GO:0033206,1,0.965680668728512,0,5,meiotic cytokinesis,BP,
8903,GO:0033209,1,0.382387901248911,0,161,tumor necrosis factor-mediated signaling pathway,BP,
8904,GO:0033210,1,0.944972667889506,0,9,leptin-mediated signaling pathway,BP,
8905,GO:0033211,1,0.969291652071407,0,5,adiponectin-activated signaling pathway,BP,
8906,GO:0033212,1,0.994063026317346,0,1,iron assimilation,BP,
8907,GO:0033214,1,0.994063026317346,0,1,iron assimilation by chelation and transport,BP,
8908,GO:0033216,1,0.960852751523291,0,6,ferric iron import,BP,
8910,GO:0033220,1,0.974174399472833,0,4,amide-transporting ATPase activity,MF,
8911,GO:0033227,1,0.968122037860309,0,5,dsRNA transport,BP,
8912,GO:0033229,1,0.99336683965506,0,1,cysteine transmembrane transporter activity,MF,
8913,GO:0033231,1,0.993232675100923,0,1,carbohydrate export,BP,
8914,GO:0033233,1,0.87572205187478,0,21,regulation of protein sumoylation,BP,
8915,GO:0033234,1,0.939122775602395,0,10,negative regulation of protein sumoylation,BP,
8916,GO:0033235,1,0.932637576932079,0,11,positive regulation of protein sumoylation,BP,
8917,GO:0033238,1,0.654353757967022,0,72,regulation of cellular amine metabolic process,BP,
8918,GO:0033239,1,0.964504397783272,0,5,negative regulation of cellular amine metabolic process,BP,
8919,GO:0033240,1,0.947374634283693,0,9,positive regulation of cellular amine metabolic process,BP,
8920,GO:0033241,1,0.990713196986705,0,1,regulation of cellular amine catabolic process,BP,
8921,GO:0033242,1,0.990713196986705,0,1,negative regulation of cellular amine catabolic process,BP,
8922,GO:0033256,1,0.958453115857256,0,7,I-kappaB/NF-kappaB complex,CC,
8923,GO:0033257,1,0.988065532720912,0,2,Bcl3/NF-kappaB2 complex,CC,
8924,GO:0033260,1,0.731929928462848,0,49,nuclear DNA replication,BP,
8925,GO:0033262,1,0.921377669564195,0,12,regulation of nuclear cell cycle DNA replication,BP,
8926,GO:0033263,1,0.972750317248785,0,4,CORVET complex,CC,
8927,GO:0033265,1,0.987958884665418,0,2,choline binding,MF,
8932,GO:0033273,1,0.590087511303267,0,83,response to vitamin,BP,
8933,GO:0033274,1,0.991580087513554,0,1,response to vitamin B2,BP,
8935,GO:0033276,1,0.918174318990572,0,13,transcription factor TFTC complex,CC,
8936,GO:0033277,1,0.98619909424038,0,2,abortive mitotic cell cycle,BP,
8937,GO:0033278,1,0.966903515629308,0,5,cell proliferation in midbrain,BP,
8938,GO:0033280,1,0.811181337532411,0,32,response to vitamin D,BP,
8939,GO:0033283,1,0.986323091749268,0,2,organic acid-transporting ATPase activity,MF,
8940,GO:0033284,1,0.986323091749268,0,2,carboxylic acid-transporting ATPase activity,MF,
8941,GO:0033285,1,0.986323091749268,0,2,monocarboxylic acid-transporting ATPase activity,MF,
8942,GO:0033290,1,0.993141304965301,0,1,eukaryotic 48S preinitiation complex,CC,
8943,GO:0033291,1,0.99509601150734,0,1,eukaryotic 80S initiation complex,CC,
8944,GO:0033292,1,0.982175370560108,0,2,T-tubule organization,BP,
8946,GO:0033299,1,0.969617648710336,0,5,secretion of lysosomal enzymes,BP,
8947,GO:0033300,1,0.980293802789189,0,3,dehydroascorbic acid transmembrane transporter activity,MF,
8948,GO:0033301,1,0.99337094362272,0,1,cell cycle comprising mitosis without cytokinesis,BP,
8949,GO:0033306,1,0.987703210438038,0,2,phytol metabolic process,BP,
8950,GO:0033313,1,0.968898560567603,0,5,meiotic cell cycle checkpoint,BP,
8951,GO:0033314,1,0.951186594546663,0,8,mitotic DNA replication checkpoint,BP,
8952,GO:0033316,1,0.993723958214045,0,1,meiotic spindle assembly checkpoint,BP,
8953,GO:0033319,1,0.994207079025024,0,1,UDP-D-xylose metabolic process,BP,
8954,GO:0033320,1,0.994207079025024,0,1,UDP-D-xylose biosynthetic process,BP,
8955,GO:0033326,1,0.986659435020192,0,2,cerebrospinal fluid secretion,BP,
8956,GO:0033327,1,0.937446238826676,0,10,Leydig cell differentiation,BP,
8957,GO:0033328,1,0.993424517206004,0,1,peroxisome membrane targeting sequence binding,MF,
8958,GO:0033341,1,0.985234841808247,0,2,regulation of collagen binding,BP,
8959,GO:0033342,1,0.993984146638361,0,1,negative regulation of collagen binding,BP,
8960,GO:0033343,1,0.991198275872789,0,1,positive regulation of collagen binding,BP,
8961,GO:0033344,1,0.8025007271922,0,32,cholesterol efflux,BP,
8962,GO:0033345,1,0.994058641514321,0,1,asparagine catabolic process via L-aspartate,BP,
8963,GO:0033353,1,0.973837210154204,0,4,S-adenosylmethionine cycle,BP,
8964,GO:0033363,1,0.839819748859944,0,25,secretory granule organization,BP,
8965,GO:0033364,1,0.983033043690087,0,2,mast cell secretory granule organization,BP,
8967,GO:0033366,1,0.994642728179214,0,1,protein localization to secretory granule,BP,
8968,GO:0033367,1,0.994642728179214,0,1,protein localization to mast cell secretory granule,BP,
8969,GO:0033368,1,0.994642728179214,0,1,protease localization to mast cell secretory granule,BP,
8970,GO:0033370,1,0.994642728179214,0,1,maintenance of protein location in mast cell secretory granule,BP,
8971,GO:0033371,1,0.994642728179214,0,1,T cell secretory granule organization,BP,
8972,GO:0033373,1,0.994642728179214,0,1,maintenance of protease location in mast cell secretory granule,BP,
8973,GO:0033374,1,0.994642728179214,0,1,protein localization to T cell secretory granule,BP,
8974,GO:0033375,1,0.994642728179214,0,1,protease localization to T cell secretory granule,BP,
8975,GO:0033377,1,0.994642728179214,0,1,maintenance of protein location in T cell secretory granule,BP,
8976,GO:0033379,1,0.994642728179214,0,1,maintenance of protease location in T cell secretory granule,BP,
8977,GO:0033380,1,0.994642728179214,0,1,granzyme B localization to T cell secretory granule,BP,
8978,GO:0033382,1,0.994642728179214,0,1,maintenance of granzyme B location in T cell secretory granule,BP,
8979,GO:0033383,1,0.988390733946499,0,2,geranyl diphosphate metabolic process,BP,
8980,GO:0033384,1,0.988390733946499,0,2,geranyl diphosphate biosynthetic process,BP,
8981,GO:0033385,1,0.993837029023573,0,1,geranylgeranyl diphosphate metabolic process,BP,
8982,GO:0033386,1,0.993837029023573,0,1,geranylgeranyl diphosphate biosynthetic process,BP,
8983,GO:0033387,1,0.981268787824922,0,3,putrescine biosynthetic process from ornithine,BP,
8984,GO:0033388,1,0.994152840500699,0,1,putrescine biosynthetic process from arginine,BP,
8985,GO:0033391,1,0.927605814426424,0,11,chromatoid body,CC,
8986,GO:0033396,1,0.994218446119203,0,1,beta-alanine biosynthetic process via 3-ureidopropionate,BP,
8987,GO:0033477,1,0.994258236802506,0,1,S-methylmethionine metabolic process,BP,
8988,GO:0033483,1,0.944330411398613,0,9,gas homeostasis,BP,
8989,GO:0033484,1,0.981715761771114,0,3,nitric oxide homeostasis,BP,
8990,GO:0033488,1,0.993701680765667,0,1,cholesterol biosynthetic process via 24,25-dihydrolanosterol,BP,
8991,GO:0033489,1,0.975757649744046,0,4,cholesterol biosynthetic process via desmosterol,BP,
8992,GO:0033490,1,0.975757649744046,0,4,cholesterol biosynthetic process via lathosterol,BP,
8993,GO:0033499,1,0.988634598442344,0,2,galactose catabolic process via UDP-galactose,BP,
8994,GO:0033500,1,0.278527885829691,0,194,carbohydrate homeostasis,BP,
8995,GO:0033503,1,0.974880009190672,0,4,HULC complex,CC,
8996,GO:0033504,1,0.965175535023805,0,5,floor plate development,BP,
8997,GO:0033505,1,0.986037206304031,0,2,floor plate morphogenesis,BP,
8998,GO:0033512,1,0.980325420615992,0,3,L-lysine catabolic process to acetyl-CoA via saccharopine,BP,
8999,GO:0033514,1,0.994040847314931,0,1,L-lysine catabolic process to acetyl-CoA via L-pipecolate,BP,
9000,GO:0033522,1,0.847330132531537,0,24,histone H2A ubiquitination,BP,
9001,GO:0033523,1,0.923751670704008,0,12,histone H2B ubiquitination,BP,
9002,GO:0033526,1,0.993889440504794,0,1,tetrapyrrole biosynthetic process from glutamate,BP,
9003,GO:0033539,1,0.916395142676615,0,14,fatty acid beta-oxidation using acyl-CoA dehydrogenase,BP,
9004,GO:0033540,1,0.916841366819865,0,14,fatty acid beta-oxidation using acyl-CoA oxidase,BP,
9005,GO:0033549,1,0.928246011046768,0,12,MAP kinase phosphatase activity,MF,
9006,GO:0033552,1,0.993951184084783,0,1,response to vitamin B3,BP,
9007,GO:0033553,1,0.972540225095481,0,4,rDNA heterochromatin,CC,
9009,GO:0033555,1,0.646174819305026,0,66,multicellular organismal response to stress,BP,
9010,GO:0033557,1,0.987738712940129,0,2,Slx1-Slx4 complex,CC,
9011,GO:0033558,1,0.742556582506247,0,44,protein deacetylase activity,MF,
9013,GO:0033560,1,0.993269745658162,0,1,folate reductase activity,MF,
9014,GO:0033561,1,0.8901303720327,0,18,regulation of water loss via skin,BP,
9015,GO:0033563,1,0.976090302258927,0,3,dorsal/ventral axon guidance,BP,
9016,GO:0033564,1,0.956564066871876,0,6,anterior/posterior axon guidance,BP,
9017,GO:0033565,1,0.980000175361456,0,3,ESCRT-0 complex,CC,
9018,GO:0033566,1,0.987925713017584,0,2,gamma-tubulin complex localization,BP,
9019,GO:0033567,1,0.970314437247014,0,5,DNA replication, Okazaki fragment processing,BP,
9020,GO:0033570,1,0.986456530043594,0,2,transferrin transmembrane transporter activity,MF,
9022,GO:0033574,1,0.772490166872651,0,41,response to testosterone,BP,
9023,GO:0033577,1,0.987804298490207,0,2,protein glycosylation in endoplasmic reticulum,BP,
9024,GO:0033578,1,0.96771103954111,0,5,protein glycosylation in Golgi,BP,
9025,GO:0033588,1,0.970152869341321,0,5,Elongator holoenzyme complex,CC,
9026,GO:0033590,1,0.98249155714292,0,3,response to cobalamin,BP,
9027,GO:0033591,1,0.967699062321122,0,5,response to L-ascorbic acid,BP,
9028,GO:0033592,1,0.967022427363389,0,5,RNA strand annealing activity,MF,
9029,GO:0033593,1,0.989396406575162,0,1,BRCA2-MAGE-D1 complex,CC,
9030,GO:0033594,1,0.976978289987803,0,4,response to hydroxyisoflavone,BP,
9031,GO:0033595,1,0.987837952388777,0,2,response to genistein,BP,
9032,GO:0033596,1,0.983280295274493,0,2,TSC1-TSC2 complex,CC,
9033,GO:0033597,1,0.994175824307592,0,1,mitotic checkpoint complex,CC,
9034,GO:0033598,1,0.836340803796789,0,26,mammary gland epithelial cell proliferation,BP,
9035,GO:0033599,1,0.888449719584279,0,17,regulation of mammary gland epithelial cell proliferation,BP,
9036,GO:0033600,1,0.969430889526289,0,4,negative regulation of mammary gland epithelial cell proliferation,BP,
9037,GO:0033601,1,0.942839782179811,0,8,positive regulation of mammary gland epithelial cell proliferation,BP,
9038,GO:0033602,1,0.979093267767555,0,3,negative regulation of dopamine secretion,BP,
9039,GO:0033603,1,0.96222663357519,0,6,positive regulation of dopamine secretion,BP,
9040,GO:0033604,1,0.938523217220497,0,10,negative regulation of catecholamine secretion,BP,
9041,GO:0033605,1,0.938774498878691,0,10,positive regulation of catecholamine secretion,BP,
9042,GO:0033608,1,0.993850639026861,0,1,formyl-CoA transferase activity,MF,
9043,GO:0033609,1,0.993850639026861,0,1,oxalate metabolic process,BP,
9044,GO:0033612,1,0.890862281981795,0,18,receptor serine/threonine kinase binding,MF,
9045,GO:0033613,1,0.61866498308552,0,70,activating transcription factor binding,MF,
9046,GO:0033615,1,0.981927966026789,0,3,mitochondrial proton-transporting ATP synthase complex assembly,BP,
9047,GO:0033617,1,0.888249651558647,0,20,mitochondrial respiratory chain complex IV assembly,BP,
9048,GO:0033619,1,0.669796482661443,0,61,membrane protein proteolysis,BP,
9049,GO:0033622,1,0.879808305198513,0,19,integrin activation,BP,
9050,GO:0033623,1,0.936527426238494,0,10,regulation of integrin activation,BP,
9051,GO:0033624,1,0.985088383386715,0,2,negative regulation of integrin activation,BP,
9052,GO:0033625,1,0.969287696352423,0,5,positive regulation of integrin activation,BP,
9053,GO:0033626,1,0.993375816556392,0,1,positive regulation of integrin activation by cell surface receptor linked signal transduction,BP,
9056,GO:0033629,1,0.947272759992299,0,8,negative regulation of cell adhesion mediated by integrin,BP,
9058,GO:0033631,1,0.930137189943345,0,11,cell-cell adhesion mediated by integrin,BP,
9059,GO:0033632,1,0.956089638763431,0,7,regulation of cell-cell adhesion mediated by integrin,BP,
9060,GO:0033633,1,0.992784922303895,0,1,negative regulation of cell-cell adhesion mediated by integrin,BP,
9061,GO:0033634,1,0.980855619723572,0,3,positive regulation of cell-cell adhesion mediated by integrin,BP,
9062,GO:0033643,1,0.925932641003969,0,12,host cell part,CC,
9063,GO:0033644,1,0.993129923835772,0,1,host cell membrane,CC,
9064,GO:0033646,1,0.944729410213095,0,9,host intracellular part,CC,
9065,GO:0033647,1,0.968194395943694,0,5,host intracellular organelle,CC,
9066,GO:0033648,1,0.968194395943694,0,5,host intracellular membrane-bounded organelle,CC,
9067,GO:0033650,1,0.99438280393633,0,1,host cell mitochondrion,CC,
9068,GO:0033655,1,0.963994947929986,0,6,host cell cytoplasm part,CC,
9069,GO:0033668,1,0.975972574832035,0,4,negative regulation by symbiont of host apoptotic process,BP,
9072,GO:0033676,1,0.994561610479903,0,1,double-stranded DNA-dependent ATPase activity,MF,
9073,GO:0033677,1,0.980818568790285,0,3,DNA/RNA helicase activity,MF,
9074,GO:0033678,1,0.993912584427091,0,1,5'-3' DNA/RNA helicase activity,MF,
9075,GO:0033679,1,0.992902900696797,0,1,3'-5' DNA/RNA helicase activity,MF,
9076,GO:0033680,1,0.986858254621079,0,2,ATP-dependent DNA/RNA helicase activity,MF,
9077,GO:0033681,1,0.992902900696797,0,1,ATP-dependent 3'-5' DNA/RNA helicase activity,MF,
9078,GO:0033682,1,0.993912584427091,0,1,ATP-dependent 5'-3' DNA/RNA helicase activity,MF,
9079,GO:0033683,1,0.78635572229007,0,39,nucleotide-excision repair, DNA incision,BP,
9080,GO:0033684,1,0.955238672803404,0,7,regulation of luteinizing hormone secretion,BP,
9081,GO:0033685,1,0.981512128218206,0,3,negative regulation of luteinizing hormone secretion,BP,
9082,GO:0033686,1,0.973236632466395,0,4,positive regulation of luteinizing hormone secretion,BP,
9083,GO:0033687,1,0.843542384029505,0,26,osteoblast proliferation,BP,
9084,GO:0033688,1,0.858788949344817,0,23,regulation of osteoblast proliferation,BP,
9085,GO:0033689,1,0.938991939620879,0,9,negative regulation of osteoblast proliferation,BP,
9086,GO:0033690,1,0.931880652905933,0,11,positive regulation of osteoblast proliferation,BP,
9088,GO:0033692,1,0.658844885956118,0,61,cellular polysaccharide biosynthetic process,BP,
9089,GO:0033693,1,0.987210943014818,0,2,neurofilament bundle assembly,BP,
9090,GO:0033695,1,0.994292865344197,0,1,oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor,MF,
9091,GO:0033699,1,0.994244283305648,0,1,DNA 5'-adenosine monophosphate hydrolase activity,MF,
9092,GO:0033700,1,0.946900635252131,0,8,phospholipid efflux,BP,
9093,GO:0033735,1,0.994799775470274,0,1,aspartate dehydrogenase activity,MF,
9094,GO:0033737,1,0.993993936382896,0,1,1-pyrroline dehydrogenase activity,MF,
9095,GO:0033743,1,0.9760984249944,0,4,peptide-methionine (R)-S-oxide reductase activity,MF,
9096,GO:0033745,1,0.981400155048039,0,3,L-methionine-(R)-S-oxide reductase activity,MF,
9097,GO:0033746,1,0.993421186575349,0,1,histone demethylase activity (H3-R2 specific),MF,
9098,GO:0033749,1,0.993421186575349,0,1,histone demethylase activity (H4-R3 specific),MF,
9099,GO:0033750,1,0.92661279222441,0,13,ribosome localization,BP,
9100,GO:0033754,1,0.994476348672616,0,1,indoleamine 2,3-dioxygenase activity,MF,
9101,GO:0033762,1,0.737006967331499,0,46,response to glucagon,BP,
9102,GO:0033764,1,0.884216755649091,0,22,steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,
9103,GO:0033765,1,0.988069860211868,0,2,steroid dehydrogenase activity, acting on the CH-CH group of donors,MF,
9104,GO:0033768,1,0.993767256412252,0,1,SUMO-targeted ubiquitin ligase complex,CC,
9105,GO:0033778,1,0.993255850191144,0,1,7alpha-hydroxycholest-4-en-3-one 12alpha-hydroxylase activity,MF,
9106,GO:0033781,1,0.994210695735449,0,1,cholesterol 24-hydroxylase activity,MF,
9107,GO:0033787,1,0.99381854786764,0,1,cyanocobalamin reductase (cyanide-eliminating) activity,MF,
9108,GO:0033791,1,0.994090889012699,0,1,3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity,MF,
9109,GO:0033798,1,0.994204495715103,0,1,thyroxine 5-deiodinase activity,MF,
9110,GO:0033814,1,0.994554376599818,0,1,propanoyl-CoA C-acyltransferase activity,MF,
9111,GO:0033819,1,0.994794609784953,0,1,lipoyl(octanoyl) transferase activity,MF,
9112,GO:0033823,1,0.993745218727644,0,1,procollagen glucosyltransferase activity,MF,
9113,GO:0033829,1,0.98282341439338,0,3,O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity,MF,
9114,GO:0033842,1,0.987050572362189,0,2,N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity,MF,
9115,GO:0033857,1,0.984975611485702,0,2,diphosphoinositol-pentakisphosphate kinase activity,MF,
9116,GO:0033858,1,0.993653306021037,0,1,N-acetylgalactosamine kinase activity,MF,
9117,GO:0033860,1,0.961023714704641,0,7,regulation of NAD(P)H oxidase activity,BP,
9118,GO:0033861,1,0.988721831809153,0,2,negative regulation of NAD(P)H oxidase activity,BP,
9119,GO:0033862,1,0.993746755938986,0,1,UMP kinase activity,MF,
9120,GO:0033864,1,0.971989102769503,0,5,positive regulation of NAD(P)H oxidase activity,BP,
9121,GO:0033865,1,0.796311641181485,0,37,nucleoside bisphosphate metabolic process,BP,
9122,GO:0033866,1,0.906243493440755,0,16,nucleoside bisphosphate biosynthetic process,BP,
9123,GO:0033867,1,0.994438622735821,0,1,Fas-activated serine/threonine kinase activity,MF,
9124,GO:0033869,1,0.994766198164714,0,1,nucleoside bisphosphate catabolic process,BP,
9125,GO:0033871,1,0.99428252807261,0,1,[heparan sulfate]-glucosamine 3-sulfotransferase 2 activity,MF,
9126,GO:0033872,1,0.988259110264468,0,2,[heparan sulfate]-glucosamine 3-sulfotransferase 3 activity,MF,
9127,GO:0033875,1,0.796311641181485,0,37,ribonucleoside bisphosphate metabolic process,BP,
9128,GO:0033878,1,0.993325262286932,0,1,hormone-sensitive lipase activity,MF,
9129,GO:0033882,1,0.994690258241244,0,1,choloyl-CoA hydrolase activity,MF,
9130,GO:0033883,1,0.988993055251144,0,2,pyridoxal phosphatase activity,MF,
9131,GO:0033885,1,0.994147676282294,0,1,10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activity,MF,
9132,GO:0033897,1,0.994642728179214,0,1,ribonuclease T2 activity,MF,
9133,GO:0033906,1,0.988466155000364,0,2,hyaluronoglucuronidase activity,MF,
9134,GO:0033919,1,0.993275919213088,0,1,glucan 1,3-alpha-glucosidase activity,MF,
9135,GO:0033925,1,0.992970087343192,0,1,mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity,MF,
9136,GO:0033961,1,0.994385129847255,0,1,cis-stilbene-oxide hydrolase activity,MF,
9137,GO:0033962,1,0.87418403298046,0,18,cytoplasmic mRNA processing body assembly,BP,
9138,GO:0033967,1,0.994685092053482,0,1,box C/D snoRNA metabolic process,BP,
9139,GO:0033979,1,0.993956590534699,0,1,box H/ACA snoRNA metabolic process,BP,
9140,GO:0033981,1,0.994956289174288,0,1,D-dopachrome decarboxylase activity,MF,
9141,GO:0033989,1,0.993898696585579,0,1,3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity,MF,
9143,GO:0034014,1,0.994105598455397,0,1,response to triglyceride,BP,
9144,GO:0034030,1,0.906243493440755,0,16,ribonucleoside bisphosphate biosynthetic process,BP,
9145,GO:0034031,1,0.994766198164714,0,1,ribonucleoside bisphosphate catabolic process,BP,
9146,GO:0034032,1,0.796311641181485,0,37,purine nucleoside bisphosphate metabolic process,BP,
9147,GO:0034033,1,0.906243493440755,0,16,purine nucleoside bisphosphate biosynthetic process,BP,
9148,GO:0034034,1,0.994766198164714,0,1,purine nucleoside bisphosphate catabolic process,BP,
9149,GO:0034035,1,0.872295936790623,0,22,purine ribonucleoside bisphosphate metabolic process,BP,
9150,GO:0034036,1,0.96101031974321,0,6,purine ribonucleoside bisphosphate biosynthetic process,BP,
9151,GO:0034038,1,0.994675276216597,0,1,deoxyhypusine synthase activity,MF,
9152,GO:0034039,1,0.988667315657268,0,2,8-oxo-7,8-dihydroguanine DNA N-glycosylase activity,MF,
9153,GO:0034040,1,0.958827088751062,0,6,lipid-transporting ATPase activity,MF,
9154,GO:0034041,1,0.981140337222114,0,3,sterol-transporting ATPase activity,MF,
9155,GO:0034045,1,0.895225593426094,0,16,phagophore assembly site membrane,CC,
9156,GO:0034046,1,0.950200662507259,0,7,poly(G) binding,MF,
9157,GO:0034056,1,0.973213689887313,0,4,estrogen response element binding,MF,
9158,GO:0034057,1,0.987236879076018,0,2,RNA strand-exchange activity,MF,
9159,GO:0034058,1,0.931844929675168,0,10,endosomal vesicle fusion,BP,
9160,GO:0034059,1,0.978712815426927,0,3,response to anoxia,BP,
9161,GO:0034061,1,0.79414976332929,0,34,DNA polymerase activity,MF,
9162,GO:0034062,1,0.769973366584344,0,43,5'-3' RNA polymerase activity,MF,
9163,GO:0034063,1,0.910561468783586,0,13,stress granule assembly,BP,
9164,GO:0034066,1,0.988500304442471,0,2,RIC1-RGP1 guanyl-nucleotide exchange factor complex,CC,
9165,GO:0034067,1,0.852970820615321,0,21,protein localization to Golgi apparatus,BP,
9166,GO:0034080,1,0.837734260800233,0,30,CENP-A containing nucleosome assembly,BP,
9167,GO:0034085,1,0.959121100663772,0,6,establishment of sister chromatid cohesion,BP,
9168,GO:0034086,1,0.928964473981058,0,10,maintenance of sister chromatid cohesion,BP,
9169,GO:0034087,1,0.983544361240663,0,2,establishment of mitotic sister chromatid cohesion,BP,
9170,GO:0034088,1,0.928964473981058,0,10,maintenance of mitotic sister chromatid cohesion,BP,
9171,GO:0034091,1,0.956597899233852,0,6,regulation of maintenance of sister chromatid cohesion,BP,
9172,GO:0034092,1,0.974868717876864,0,3,negative regulation of maintenance of sister chromatid cohesion,BP,
9173,GO:0034093,1,0.981262944869749,0,3,positive regulation of maintenance of sister chromatid cohesion,BP,
9175,GO:0034098,1,0.942044920811712,0,9,VCP-NPL4-UFD1 AAA ATPase complex,CC,
9176,GO:0034101,1,0.491352721975095,0,109,erythrocyte homeostasis,BP,
9177,GO:0034103,1,0.680682381504853,0,58,regulation of tissue remodeling,BP,
9178,GO:0034104,1,0.901896686641307,0,16,negative regulation of tissue remodeling,BP,
9179,GO:0034105,1,0.864631500964593,0,22,positive regulation of tissue remodeling,BP,
9181,GO:0034110,1,0.857568833774706,0,23,regulation of homotypic cell-cell adhesion,BP,
9182,GO:0034111,1,0.913127827277464,0,14,negative regulation of homotypic cell-cell adhesion,BP,
9183,GO:0034112,1,0.973142027211155,0,4,positive regulation of homotypic cell-cell adhesion,BP,
9187,GO:0034116,1,0.940596503102535,0,10,positive regulation of heterotypic cell-cell adhesion,BP,
9188,GO:0034117,1,0.995001744006589,0,1,erythrocyte aggregation,BP,
9189,GO:0034118,1,0.995001744006589,0,1,regulation of erythrocyte aggregation,BP,
9190,GO:0034120,1,0.995001744006589,0,1,positive regulation of erythrocyte aggregation,BP,
9191,GO:0034121,1,0.689771482620469,0,57,regulation of toll-like receptor signaling pathway,BP,
9192,GO:0034122,1,0.801923011658558,0,33,negative regulation of toll-like receptor signaling pathway,BP,
9193,GO:0034123,1,0.883556874834192,0,20,positive regulation of toll-like receptor signaling pathway,BP,
9194,GO:0034124,1,0.976618154099581,0,4,regulation of MyD88-dependent toll-like receptor signaling pathway,BP,
9195,GO:0034125,1,0.988723339586609,0,2,negative regulation of MyD88-dependent toll-like receptor signaling pathway,BP,
9196,GO:0034127,1,0.950212123190877,0,8,regulation of MyD88-independent toll-like receptor signaling pathway,BP,
9197,GO:0034128,1,0.955693595263075,0,7,negative regulation of MyD88-independent toll-like receptor signaling pathway,BP,
9198,GO:0034130,1,0.993818034633296,0,1,toll-like receptor 1 signaling pathway,BP,
9199,GO:0034134,1,0.926563450254172,0,12,toll-like receptor 2 signaling pathway,BP,
9200,GO:0034135,1,0.956694637546776,0,7,regulation of toll-like receptor 2 signaling pathway,BP,
9201,GO:0034136,1,0.979104635320284,0,3,negative regulation of toll-like receptor 2 signaling pathway,BP,
9202,GO:0034137,1,0.977116570128042,0,4,positive regulation of toll-like receptor 2 signaling pathway,BP,
9203,GO:0034138,1,0.887956700686627,0,19,toll-like receptor 3 signaling pathway,BP,
9204,GO:0034139,1,0.944003684674098,0,9,regulation of toll-like receptor 3 signaling pathway,BP,
9205,GO:0034140,1,0.980098172041667,0,3,negative regulation of toll-like receptor 3 signaling pathway,BP,
9206,GO:0034141,1,0.957207996632996,0,7,positive regulation of toll-like receptor 3 signaling pathway,BP,
9207,GO:0034142,1,0.838969571928189,0,28,toll-like receptor 4 signaling pathway,BP,
9208,GO:0034143,1,0.910512189758979,0,15,regulation of toll-like receptor 4 signaling pathway,BP,
9209,GO:0034144,1,0.962387433533737,0,6,negative regulation of toll-like receptor 4 signaling pathway,BP,
9210,GO:0034145,1,0.946117645780394,0,9,positive regulation of toll-like receptor 4 signaling pathway,BP,
9211,GO:0034146,1,0.986140769768078,0,2,toll-like receptor 5 signaling pathway,BP,
9212,GO:0034147,1,0.993003891125131,0,1,regulation of toll-like receptor 5 signaling pathway,BP,
9213,GO:0034148,1,0.993003891125131,0,1,negative regulation of toll-like receptor 5 signaling pathway,BP,
9214,GO:0034150,1,0.992248455173689,0,1,toll-like receptor 6 signaling pathway,BP,
9215,GO:0034154,1,0.956613277803442,0,7,toll-like receptor 7 signaling pathway,BP,
9216,GO:0034155,1,0.982206787844564,0,3,regulation of toll-like receptor 7 signaling pathway,BP,
9217,GO:0034156,1,0.994405028845343,0,1,negative regulation of toll-like receptor 7 signaling pathway,BP,
9218,GO:0034157,1,0.987733817580344,0,2,positive regulation of toll-like receptor 7 signaling pathway,BP,
9219,GO:0034158,1,0.993118537557403,0,1,toll-like receptor 8 signaling pathway,BP,
9220,GO:0034162,1,0.877610427062985,0,20,toll-like receptor 9 signaling pathway,BP,
9221,GO:0034163,1,0.960915611624151,0,6,regulation of toll-like receptor 9 signaling pathway,BP,
9222,GO:0034164,1,0.986293717445457,0,2,negative regulation of toll-like receptor 9 signaling pathway,BP,
9223,GO:0034165,1,0.987042430286969,0,2,positive regulation of toll-like receptor 9 signaling pathway,BP,
9224,GO:0034166,1,0.993581413795375,0,1,toll-like receptor 10 signaling pathway,BP,
9225,GO:0034182,1,0.956597899233852,0,6,regulation of maintenance of mitotic sister chromatid cohesion,BP,
9226,GO:0034183,1,0.974868717876864,0,3,negative regulation of maintenance of mitotic sister chromatid cohesion,BP,
9227,GO:0034184,1,0.981262944869749,0,3,positive regulation of maintenance of mitotic sister chromatid cohesion,BP,
9228,GO:0034185,1,0.886483195932842,0,16,apolipoprotein binding,MF,
9229,GO:0034186,1,0.972737432187352,0,4,apolipoprotein A-I binding,MF,
9230,GO:0034188,1,0.981699903930729,0,2,apolipoprotein A-I receptor activity,MF,
9231,GO:0034189,1,0.986882927153511,0,2,very-low-density lipoprotein particle binding,MF,
9232,GO:0034190,1,0.967850376327234,0,5,apolipoprotein receptor binding,MF,
9233,GO:0034191,1,0.974271597786168,0,4,apolipoprotein A-I receptor binding,MF,
9234,GO:0034196,1,0.976659430479665,0,4,acylglycerol transport,BP,
9235,GO:0034197,1,0.976659430479665,0,4,triglyceride transport,BP,
9236,GO:0034198,1,0.765894570483878,0,42,cellular response to amino acid starvation,BP,
9237,GO:0034199,1,0.891817258670086,0,16,activation of protein kinase A activity,BP,
9238,GO:0034201,1,0.968346706187751,0,5,response to oleic acid,BP,
9239,GO:0034203,1,0.992653063846595,0,1,glycolipid translocation,BP,
9240,GO:0034204,1,0.828980428572111,0,24,lipid translocation,BP,
9241,GO:0034205,1,0.854671407624704,0,23,amyloid-beta formation,BP,
9242,GO:0034211,1,0.990489208522649,0,1,GTP-dependent protein kinase activity,MF,
9243,GO:0034212,1,0.66584500591141,0,60,peptide N-acetyltransferase activity,MF,
9244,GO:0034213,1,0.994488751152327,0,1,quinolinate catabolic process,BP,
9245,GO:0034214,1,0.948495801910395,0,8,protein hexamerization,BP,
9248,GO:0034224,1,0.994126763991112,0,1,cellular response to zinc ion starvation,BP,
9249,GO:0034227,1,0.971714181046921,0,5,tRNA thio-modification,BP,
9250,GO:0034230,1,0.992838729714531,0,1,enkephalin processing,BP,
9251,GO:0034231,1,0.992838729714531,0,1,islet amyloid polypeptide processing,BP,
9252,GO:0034235,1,0.964295841902927,0,6,GPI anchor binding,MF,
9253,GO:0034236,1,0.907875068660282,0,14,protein kinase A catalytic subunit binding,MF,
9254,GO:0034237,1,0.876920757697512,0,17,protein kinase A regulatory subunit binding,MF,
9255,GO:0034238,1,0.993233705544346,0,1,macrophage fusion,BP,
9256,GO:0034239,1,0.993233705544346,0,1,regulation of macrophage fusion,BP,
9257,GO:0034241,1,0.993233705544346,0,1,positive regulation of macrophage fusion,BP,
9258,GO:0034242,1,0.981256160374572,0,3,negative regulation of syncytium formation by plasma membrane fusion,BP,
9259,GO:0034243,1,0.849902793436376,0,25,regulation of transcription elongation from RNA polymerase II promoter,BP,
9260,GO:0034244,1,0.932543397147818,0,11,negative regulation of transcription elongation from RNA polymerase II promoter,BP,
9261,GO:0034245,1,0.99332218056773,0,1,mitochondrial DNA-directed RNA polymerase complex,CC,
9262,GO:0034247,1,0.994621545430803,0,1,snoRNA splicing,BP,
9264,GO:0034249,1,0.223406634608757,0,221,negative regulation of cellular amide metabolic process,BP,
9265,GO:0034250,1,0.4316015977975,0,131,positive regulation of cellular amide metabolic process,BP,
9266,GO:0034255,1,0.994178148773045,0,1,regulation of urea metabolic process,BP,
9267,GO:0034260,1,0.74270393570315,0,44,negative regulation of GTPase activity,BP,
9268,GO:0034271,1,0.980677907239974,0,3,phosphatidylinositol 3-kinase complex, class III, type I,CC,
9269,GO:0034272,1,0.980677907239974,0,3,phosphatidylinositol 3-kinase complex, class III, type II,CC,
9270,GO:0034274,1,0.979637291593961,0,3,Atg12-Atg5-Atg16 complex,CC,
9271,GO:0034275,1,0.994476348672616,0,1,kynurenic acid metabolic process,BP,
9272,GO:0034276,1,0.994476348672616,0,1,kynurenic acid biosynthetic process,BP,
9273,GO:0034284,1,0.323159409280201,0,171,response to monosaccharide,BP,
9274,GO:0034285,1,0.973553686881561,0,4,response to disaccharide,BP,
9275,GO:0034287,1,0.976880816680695,0,4,detection of monosaccharide stimulus,BP,
9277,GO:0034309,1,0.994806490833661,0,1,primary alcohol biosynthetic process,BP,
9278,GO:0034310,1,0.934381413154238,0,12,primary alcohol catabolic process,BP,
9279,GO:0034311,1,0.892628472801896,0,19,diol metabolic process,BP,
9280,GO:0034312,1,0.908160166776795,0,16,diol biosynthetic process,BP,
9281,GO:0034314,1,0.822731074747434,0,31,Arp2/3 complex-mediated actin nucleation,BP,
9282,GO:0034315,1,0.909108873048345,0,15,regulation of Arp2/3 complex-mediated actin nucleation,BP,
9283,GO:0034316,1,0.969937398633032,0,5,negative regulation of Arp2/3 complex-mediated actin nucleation,BP,
9284,GO:0034329,1,0.220457067923947,0,215,cell junction assembly,BP,
9285,GO:0034330,1,0.164306169846618,0,256,cell junction organization,BP,
9286,GO:0034331,1,0.931530984090161,0,11,cell junction maintenance,BP,
9287,GO:0034332,1,0.425766998033289,0,121,adherens junction organization,BP,
9288,GO:0034333,1,0.560229820008284,0,81,adherens junction assembly,BP,
9289,GO:0034334,1,0.972881556531022,0,4,adherens junction maintenance,BP,
9290,GO:0034338,1,0.973497859471491,0,4,short-chain carboxylesterase activity,MF,
9291,GO:0034340,1,0.622948654134744,0,75,response to type I interferon,BP,
9293,GO:0034342,1,0.988076037769447,0,2,response to type III interferon,BP,
9294,GO:0034343,1,0.980199019455129,0,3,type III interferon production,BP,
9295,GO:0034344,1,0.980199019455129,0,3,regulation of type III interferon production,BP,
9296,GO:0034346,1,0.993720116748368,0,1,positive regulation of type III interferon production,BP,
9297,GO:0034349,1,0.911367647133965,0,14,glial cell apoptotic process,BP,
9298,GO:0034350,1,0.948590334697422,0,8,regulation of glial cell apoptotic process,BP,
9299,GO:0034351,1,0.948590334697422,0,8,negative regulation of glial cell apoptotic process,BP,
9300,GO:0034353,1,0.993850639026861,0,1,RNA pyrophosphohydrolase activity,MF,
9301,GO:0034354,1,0.994623095407419,0,1,'de novo' NAD biosynthetic process from tryptophan,BP,
9302,GO:0034355,1,0.993850639026861,0,1,NAD salvage,BP,
9303,GO:0034356,1,0.925887318902498,0,12,NAD biosynthesis via nicotinamide riboside salvage pathway,BP,
9304,GO:0034358,1,0.815586938005474,0,32,plasma lipoprotein particle,CC,
9305,GO:0034359,1,0.988017795476345,0,1,mature chylomicron,CC,
9306,GO:0034360,1,0.988017795476345,0,1,chylomicron remnant,CC,
9307,GO:0034361,1,0.911657982500558,0,15,very-low-density lipoprotein particle,CC,
9308,GO:0034362,1,0.922870927463241,0,12,low-density lipoprotein particle,CC,
9309,GO:0034363,1,0.972704124571008,0,4,intermediate-density lipoprotein particle,CC,
9310,GO:0034364,1,0.886403412932996,0,21,high-density lipoprotein particle,CC,
9311,GO:0034365,1,0.984481013669519,0,3,discoidal high-density lipoprotein particle,CC,
9312,GO:0034366,1,0.967919224835112,0,6,spherical high-density lipoprotein particle,CC,
9313,GO:0034367,1,0.865168423418193,0,23,protein-containing complex remodeling,BP,
9314,GO:0034368,1,0.870640451109881,0,22,protein-lipid complex remodeling,BP,
9315,GO:0034369,1,0.870640451109881,0,22,plasma lipoprotein particle remodeling,BP,
9316,GO:0034370,1,0.950322468597031,0,8,triglyceride-rich lipoprotein particle remodeling,BP,
9317,GO:0034371,1,0.966239241707168,0,5,chylomicron remodeling,BP,
9318,GO:0034372,1,0.961852074379015,0,7,very-low-density lipoprotein particle remodeling,BP,
9319,GO:0034373,1,0.99445826122538,0,1,intermediate-density lipoprotein particle remodeling,BP,
9320,GO:0034374,1,0.930305719524229,0,11,low-density lipoprotein particle remodeling,BP,
9321,GO:0034375,1,0.920936289805647,0,14,high-density lipoprotein particle remodeling,BP,
9322,GO:0034377,1,0.865059187254015,0,22,plasma lipoprotein particle assembly,BP,
9323,GO:0034378,1,0.952885399757183,0,7,chylomicron assembly,BP,
9324,GO:0034379,1,0.940980137570009,0,9,very-low-density lipoprotein particle assembly,BP,
9325,GO:0034380,1,0.931180289676682,0,11,high-density lipoprotein particle assembly,BP,
9326,GO:0034381,1,0.744131858488053,0,46,plasma lipoprotein particle clearance,BP,
9327,GO:0034382,1,0.954511596257904,0,7,chylomicron remnant clearance,BP,
9328,GO:0034383,1,0.826410119370666,0,29,low-density lipoprotein particle clearance,BP,
9329,GO:0034384,1,0.937779124391591,0,10,high-density lipoprotein particle clearance,BP,
9330,GO:0034385,1,0.911657982500558,0,15,triglyceride-rich plasma lipoprotein particle,CC,
9331,GO:0034386,1,0.992750414346676,0,1,4-aminobutyrate:2-oxoglutarate transaminase activity,MF,
9332,GO:0034388,1,0.961822848206607,0,6,Pwp2p-containing subcomplex of 90S preribosome,CC,
9333,GO:0034389,1,0.899561679715799,0,17,lipid particle organization,BP,
9334,GO:0034390,1,0.89381003153525,0,17,smooth muscle cell apoptotic process,BP,
9335,GO:0034391,1,0.89381003153525,0,17,regulation of smooth muscle cell apoptotic process,BP,
9336,GO:0034392,1,0.965245221883245,0,5,negative regulation of smooth muscle cell apoptotic process,BP,
9337,GO:0034393,1,0.937757896211618,0,10,positive regulation of smooth muscle cell apoptotic process,BP,
9338,GO:0034394,1,0.707830303281767,0,51,protein localization to cell surface,BP,
9339,GO:0034395,1,0.988080749452562,0,2,regulation of transcription from RNA polymerase II promoter in response to iron,BP,
9340,GO:0034397,1,0.927595588435386,0,11,telomere localization,BP,
9341,GO:0034398,1,0.96128664328054,0,6,telomere tethering at nuclear periphery,BP,
9343,GO:0034402,1,0.986344132773742,0,2,recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex,BP,
9344,GO:0034404,1,0.278148878996904,0,198,nucleobase-containing small molecule biosynthetic process,BP,
9345,GO:0034405,1,0.800974068867798,0,33,response to fluid shear stress,BP,
9346,GO:0034414,1,0.987495215043761,0,2,tRNA 3'-trailer cleavage, endonucleolytic,BP,
9347,GO:0034416,1,0.99381854786764,0,1,bisphosphoglycerate phosphatase activity,MF,
9348,GO:0034417,1,0.99381854786764,0,1,bisphosphoglycerate 3-phosphatase activity,MF,
9349,GO:0034418,1,0.988249745546934,0,2,urate biosynthetic process,BP,
9350,GO:0034421,1,0.980758006480112,0,3,post-translational protein acetylation,BP,
9351,GO:0034423,1,0.99392802044389,0,1,autophagosome lumen,CC,
9352,GO:0034427,1,0.944590008142929,0,10,nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5',BP,
9353,GO:0034431,1,0.975932507390272,0,4,bis(5'-adenosyl)-hexaphosphatase activity,MF,
9354,GO:0034432,1,0.975932507390272,0,4,bis(5'-adenosyl)-pentaphosphatase activity,MF,
9355,GO:0034433,1,0.94389109613726,0,10,steroid esterification,BP,
9356,GO:0034434,1,0.94389109613726,0,10,sterol esterification,BP,
9357,GO:0034435,1,0.94389109613726,0,10,cholesterol esterification,BP,
9358,GO:0034436,1,0.982060465688171,0,3,glycoprotein transport,BP,
9359,GO:0034437,1,0.987217324921146,0,2,glycoprotein transporter activity,MF,
9360,GO:0034439,1,0.988261248710465,0,2,lipoprotein lipid oxidation,BP,
9361,GO:0034440,1,0.539836815126137,0,97,lipid oxidation,BP,
9362,GO:0034441,1,0.989282613612548,0,2,plasma lipoprotein particle oxidation,BP,
9363,GO:0034442,1,0.988261248710465,0,2,regulation of lipoprotein oxidation,BP,
9364,GO:0034443,1,0.994704723417011,0,1,negative regulation of lipoprotein oxidation,BP,
9365,GO:0034444,1,0.994895337817464,0,1,regulation of plasma lipoprotein oxidation,BP,
9366,GO:0034445,1,0.994895337817464,0,1,negative regulation of plasma lipoprotein oxidation,BP,
9367,GO:0034446,1,0.587594522146744,0,79,substrate adhesion-dependent cell spreading,BP,
9368,GO:0034447,1,0.950470933494776,0,8,very-low-density lipoprotein particle clearance,BP,
9369,GO:0034448,1,0.970597159186513,0,5,EGO complex,CC,
9370,GO:0034450,1,0.915359337431762,0,13,ubiquitin-ubiquitin ligase activity,MF,
9371,GO:0034451,1,0.827308446849458,0,27,centriolar satellite,CC,
9372,GO:0034452,1,0.924347804397773,0,10,dynactin binding,MF,
9373,GO:0034453,1,0.847580332262725,0,22,microtubule anchoring,BP,
9374,GO:0034454,1,0.932003703970344,0,9,microtubule anchoring at centrosome,BP,
9375,GO:0034455,1,0.985812643290871,0,2,t-UTP complex,CC,
9376,GO:0034456,1,0.987829341732332,0,2,UTP-C complex,CC,
9377,GO:0034457,1,0.983488306565998,0,3,Mpp10 complex,CC,
9378,GO:0034458,1,0.986950292967864,0,2,3'-5' RNA helicase activity,MF,
9379,GO:0034459,1,0.992902900696797,0,1,ATP-dependent 3'-5' RNA helicase activity,MF,
9380,GO:0034462,1,0.994125989551806,0,1,small-subunit processome assembly,BP,
9381,GO:0034463,1,0.99509601150734,0,1,90S preribosome assembly,BP,
9382,GO:0034464,1,0.945847836445852,0,9,BBSome,CC,
9383,GO:0034465,1,0.974924209327968,0,4,response to carbon monoxide,BP,
9384,GO:0034466,1,0.993859115607931,0,1,chromaffin granule lumen,CC,
9385,GO:0034470,1,0.0932534199768899,0,389,ncRNA processing,BP,
9386,GO:0034471,1,0.891378792240034,0,19,ncRNA 5'-end processing,BP,
9387,GO:0034472,1,0.911033727702672,0,15,snRNA 3'-end processing,BP,
9388,GO:0034473,1,0.983791641589117,0,3,U1 snRNA 3'-end processing,BP,
9389,GO:0034474,1,0.991652895524377,0,1,U2 snRNA 3'-end processing,BP,
9390,GO:0034475,1,0.957378787934591,0,8,U4 snRNA 3'-end processing,BP,
9391,GO:0034476,1,0.983791641589117,0,3,U5 snRNA 3'-end processing,BP,
9392,GO:0034477,1,0.993850639026861,0,1,U6 snRNA 3'-end processing,BP,
9393,GO:0034481,1,0.961455059340499,0,6,chondroitin sulfotransferase activity,MF,
9395,GO:0034485,1,0.973649432191538,0,4,phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,MF,
9396,GO:0034497,1,0.916700527565772,0,13,protein localization to phagophore assembly site,BP,
9397,GO:0034498,1,0.947736189502995,0,8,early endosome to Golgi transport,BP,
9398,GO:0034499,1,0.984550196756919,0,2,late endosome to Golgi transport,BP,
9402,GO:0034505,1,0.90069043540094,0,15,tooth mineralization,BP,
9403,GO:0034506,1,0.993213088589486,0,1,chromosome, centromeric core domain,CC,
9405,GO:0034511,1,0.967435793992412,0,5,U3 snoRNA binding,MF,
9406,GO:0034513,1,0.973414907809869,0,5,box H/ACA snoRNA binding,MF,
9407,GO:0034515,1,0.987424893767889,0,2,proteasome storage granule,CC,
9408,GO:0034516,1,0.994520531289197,0,1,response to vitamin B6,BP,
9409,GO:0034518,1,0.931087372290442,0,11,RNA cap binding complex,CC,
9410,GO:0034545,1,0.994420533996374,0,1,fumarylpyruvate hydrolase activity,MF,
9411,GO:0034551,1,0.945646548926414,0,9,mitochondrial respiratory chain complex III assembly,BP,
9412,GO:0034552,1,0.989399175099942,0,2,respiratory chain complex II assembly,BP,
9413,GO:0034553,1,0.989399175099942,0,2,mitochondrial respiratory chain complex II assembly,BP,
9414,GO:0034584,1,0.986985885897732,0,2,piRNA binding,MF,
9415,GO:0034587,1,0.914252622640042,0,14,piRNA metabolic process,BP,
9416,GO:0034589,1,0.993070090473458,0,1,hydroxyproline transport,BP,
9417,GO:0034590,1,0.993070090473458,0,1,L-hydroxyproline transmembrane transporter activity,MF,
9418,GO:0034593,1,0.837112476961174,0,25,phosphatidylinositol bisphosphate phosphatase activity,MF,
9419,GO:0034594,1,0.96079644643582,0,6,phosphatidylinositol trisphosphate phosphatase activity,MF,
9420,GO:0034595,1,0.913078864242978,0,13,phosphatidylinositol phosphate 5-phosphatase activity,MF,
9421,GO:0034596,1,0.943178748704026,0,8,phosphatidylinositol phosphate 4-phosphatase activity,MF,
9422,GO:0034597,1,0.985049915296123,0,2,phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity,MF,
9424,GO:0034602,1,0.993068793904575,0,1,oxoglutarate dehydrogenase (NAD+) activity,MF,
9425,GO:0034603,1,0.968828422360119,0,5,pyruvate dehydrogenase [NAD(P)+] activity,MF,
9426,GO:0034604,1,0.968828422360119,0,5,pyruvate dehydrogenase (NAD+) activity,MF,
9428,GO:0034612,1,0.191616206783141,0,268,response to tumor necrosis factor,BP,
9431,GO:0034616,1,0.912150565805264,0,14,response to laminar fluid shear stress,BP,
9432,GO:0034617,1,0.973279759634627,0,4,tetrahydrobiopterin binding,MF,
9433,GO:0034618,1,0.961831259759061,0,6,arginine binding,MF,
9436,GO:0034625,1,0.962660297739722,0,6,fatty acid elongation, monounsaturated fatty acid,BP,
9437,GO:0034626,1,0.962660297739722,0,6,fatty acid elongation, polyunsaturated fatty acid,BP,
9438,GO:0034627,1,0.974945744519808,0,4,'de novo' NAD biosynthetic process,BP,
9439,GO:0034628,1,0.980217341223609,0,3,'de novo' NAD biosynthetic process from aspartate,BP,
9440,GO:0034629,1,0.864161225009303,0,23,cellular protein-containing complex localization,BP,
9441,GO:0034632,1,0.988658362406913,0,2,retinol transmembrane transporter activity,MF,
9442,GO:0034633,1,0.988658362406913,0,2,retinol transport,BP,
9443,GO:0034634,1,0.991969765251917,0,1,glutathione transmembrane transporter activity,MF,
9444,GO:0034635,1,0.986268520340479,0,2,glutathione transport,BP,
9445,GO:0034637,1,0.603999505450781,0,75,cellular carbohydrate biosynthetic process,BP,
9447,GO:0034640,1,0.993623881442226,0,1,establishment of mitochondrion localization by microtubule attachment,BP,
9449,GO:0034643,1,0.875291060037325,0,19,establishment of mitochondrion localization, microtubule-mediated,BP,
9452,GO:0034647,1,0.981705708895195,0,2,histone demethylase activity (H3-trimethyl-K4 specific),MF,
9453,GO:0034648,1,0.968963883725782,0,4,histone demethylase activity (H3-dimethyl-K4 specific),MF,
9454,GO:0034649,1,0.99328517707573,0,1,histone demethylase activity (H3-monomethyl-K4 specific),MF,
9455,GO:0034650,1,0.947841047027198,0,8,cortisol metabolic process,BP,
9456,GO:0034651,1,0.953306252482312,0,7,cortisol biosynthetic process,BP,
9457,GO:0034653,1,0.982109396361004,0,3,retinoic acid catabolic process,BP,
9459,GO:0034655,1,0.0246972501331621,0,577,nucleobase-containing compound catabolic process,BP,
9460,GO:0034656,1,0.769708129808423,0,43,nucleobase-containing small molecule catabolic process,BP,
9461,GO:0034657,1,0.974494447842375,0,4,GID complex,CC,
9462,GO:0034660,1,0.033938848743785,0,546,ncRNA metabolic process,BP,
9463,GO:0034661,1,0.853344042511504,0,24,ncRNA catabolic process,BP,
9464,GO:0034663,1,0.945957015568703,0,9,endoplasmic reticulum chaperone complex,CC,
9465,GO:0034665,1,0.986197931793351,0,2,integrin alpha1-beta1 complex,CC,
9466,GO:0034666,1,0.978407574136288,0,3,integrin alpha2-beta1 complex,CC,
9467,GO:0034667,1,0.986116636793103,0,2,integrin alpha3-beta1 complex,CC,
9468,GO:0034668,1,0.993262026815901,0,1,integrin alpha4-beta1 complex,CC,
9469,GO:0034669,1,0.98603311360567,0,2,integrin alpha4-beta7 complex,CC,
9470,GO:0034670,1,0.990237072028201,0,1,chemotaxis to arachidonic acid,BP,
9471,GO:0034673,1,0.979233956451083,0,3,inhibin-betaglycan-ActRII complex,CC,
9472,GO:0034676,1,0.992306338347545,0,1,integrin alpha6-beta4 complex,CC,
9473,GO:0034677,1,0.993348366555419,0,1,integrin alpha7-beta1 complex,CC,
9474,GO:0034678,1,0.979997116497262,0,3,integrin alpha8-beta1 complex,CC,
9475,GO:0034679,1,0.993236281470676,0,1,integrin alpha9-beta1 complex,CC,
9476,GO:0034680,1,0.986002973202639,0,2,integrin alpha10-beta1 complex,CC,
9477,GO:0034681,1,0.986090381125678,0,2,integrin alpha11-beta1 complex,CC,
9478,GO:0034683,1,0.984507678153825,0,2,integrin alphav-beta3 complex,CC,
9479,GO:0034684,1,0.985288031529326,0,2,integrin alphav-beta5 complex,CC,
9480,GO:0034685,1,0.985783805949214,0,2,integrin alphav-beta6 complex,CC,
9481,GO:0034686,1,0.982505236932284,0,2,integrin alphav-beta8 complex,CC,
9482,GO:0034687,1,0.986464345480296,0,2,integrin alphaL-beta2 complex,CC,
9483,GO:0034688,1,0.986641345821685,0,2,integrin alphaM-beta2 complex,CC,
9484,GO:0034693,1,0.994016098455656,0,1,U11/U12 snRNP,CC,
9485,GO:0034694,1,0.823601187912378,0,29,response to prostaglandin,BP,
9486,GO:0034695,1,0.866783697694346,0,22,response to prostaglandin E,BP,
9487,GO:0034696,1,0.988189104570408,0,2,response to prostaglandin F,BP,
9488,GO:0034698,1,0.844372184654041,0,25,response to gonadotropin,BP,
9489,GO:0034699,1,0.97984608773682,0,3,response to luteinizing hormone,BP,
9494,GO:0034706,1,0.837736777650999,0,23,sodium channel complex,CC,
9495,GO:0034707,1,0.75864498481439,0,42,chloride channel complex,CC,
9496,GO:0034708,1,0.559085638503813,0,88,methyltransferase complex,CC,
9497,GO:0034709,1,0.936954194602682,0,12,methylosome,CC,
9498,GO:0034711,1,0.968984661853445,0,5,inhibin binding,MF,
9499,GO:0034713,1,0.941552101502044,0,9,type I transforming growth factor beta receptor binding,MF,
9500,GO:0034714,1,0.980526623844809,0,3,type III transforming growth factor beta receptor binding,MF,
9501,GO:0034715,1,0.968279392967063,0,6,pICln-Sm protein complex,CC,
9502,GO:0034718,1,0.992483785073678,0,1,SMN-Gemin2 complex,CC,
9503,GO:0034719,1,0.906807958157585,0,17,SMN-Sm protein complex,CC,
9504,GO:0034720,1,0.953867571803099,0,6,histone H3-K4 demethylation,BP,
9505,GO:0034721,1,0.981705708895195,0,2,histone H3-K4 demethylation, trimethyl-H3-K4-specific,BP,
9506,GO:0034722,1,0.99451768923251,0,1,gamma-glutamyl-peptidase activity,MF,
9507,GO:0034723,1,0.921915570277505,0,14,DNA replication-dependent nucleosome organization,BP,
9508,GO:0034724,1,0.776149967574811,0,41,DNA replication-independent nucleosome organization,BP,
9509,GO:0034727,1,0.992720072441794,0,1,piecemeal microautophagy of the nucleus,BP,
9510,GO:0034728,1,0.480934154680486,0,117,nucleosome organization,BP,
9511,GO:0034729,1,0.979292773579335,0,3,histone H3-K79 methylation,BP,
9512,GO:0034736,1,0.993533828399082,0,1,cholesterol O-acyltransferase activity,MF,
9513,GO:0034739,1,0.988715113026727,0,2,histone deacetylase activity (H4-K16 specific),MF,
9514,GO:0034750,1,0.98616602221437,0,2,Scrib-APC-beta-catenin complex,CC,
9515,GO:0034751,1,0.980797765258061,0,3,aryl hydrocarbon receptor complex,CC,
9516,GO:0034752,1,0.992051244950117,0,1,cytosolic aryl hydrocarbon receptor complex,CC,
9517,GO:0034753,1,0.992051244950117,0,1,nuclear aryl hydrocarbon receptor complex,CC,
9519,GO:0034755,1,0.900362125761665,0,16,iron ion transmembrane transport,BP,
9521,GO:0034757,1,0.985996938943484,0,2,negative regulation of iron ion transport,BP,
9522,GO:0034759,1,0.985996938943484,0,2,regulation of iron ion transmembrane transport,BP,
9523,GO:0034760,1,0.985996938943484,0,2,negative regulation of iron ion transmembrane transport,BP,
9525,GO:0034763,1,0.522280063545623,0,100,negative regulation of transmembrane transport,BP,
9528,GO:0034766,1,0.592231895355352,0,80,negative regulation of ion transmembrane transport,BP,
9530,GO:0034769,1,0.987428048117633,0,2,basement membrane disassembly,BP,
9531,GO:0034770,1,0.952101557421776,0,6,histone H4-K20 methylation,BP,
9532,GO:0034773,1,0.971065314747637,0,4,histone H4-K20 trimethylation,BP,
9534,GO:0034775,1,0.991969765251917,0,1,glutathione transmembrane transport,BP,
9535,GO:0034776,1,0.939769603605934,0,9,response to histamine,BP,
9536,GO:0034777,1,0.994133476073996,0,1,recycling endosome lumen,CC,
9537,GO:0034875,1,0.994292865344197,0,1,caffeine oxidase activity,MF,
9538,GO:0034899,1,0.994213537497698,0,1,trimethylamine monooxygenase activity,MF,
9539,GO:0034959,1,0.992639445960796,0,1,endothelin maturation,BP,
9540,GO:0034963,1,0.994685092053482,0,1,box C/D snoRNA processing,BP,
9541,GO:0034964,1,0.993956590534699,0,1,box H/ACA snoRNA processing,BP,
9542,GO:0034968,1,0.509754755529948,0,96,histone lysine methylation,BP,
9543,GO:0034969,1,0.929826914110702,0,12,histone arginine methylation,BP,
9544,GO:0034970,1,0.987715414539559,0,2,histone H3-R2 methylation,BP,
9545,GO:0034971,1,0.987965529792195,0,2,histone H3-R17 methylation,BP,
9546,GO:0034975,1,0.921426564373406,0,13,protein folding in endoplasmic reticulum,BP,
9548,GO:0034979,1,0.894360960403378,0,17,NAD-dependent protein deacetylase activity,MF,
9549,GO:0034982,1,0.92882441811216,0,12,mitochondrial protein processing,BP,
9550,GO:0034983,1,0.953918142473691,0,7,peptidyl-lysine deacetylation,BP,
9552,GO:0034987,1,0.962467896027705,0,6,immunoglobulin receptor binding,MF,
9553,GO:0034988,1,0.984941571092321,0,2,Fc-gamma receptor I complex binding,MF,
9554,GO:0034991,1,0.974935387587277,0,4,nuclear meiotic cohesin complex,CC,
9555,GO:0034992,1,0.944631736623841,0,7,microtubule organizing center attachment site,CC,
9556,GO:0034993,1,0.944631736623841,0,7,meiotic nuclear membrane microtubule tethering complex,CC,
9557,GO:0034998,1,0.993850639026861,0,1,oligosaccharyltransferase I complex,CC,
9559,GO:0035005,1,0.948245714774349,0,7,1-phosphatidylinositol-4-phosphate 3-kinase activity,MF,
9560,GO:0035014,1,0.946592838631909,0,8,phosphatidylinositol 3-kinase regulator activity,MF,
9561,GO:0035019,1,0.643112665040949,0,67,somatic stem cell population maintenance,BP,
9562,GO:0035020,1,0.892547689694171,0,16,regulation of Rac protein signal transduction,BP,
9563,GO:0035021,1,0.969754780161574,0,4,negative regulation of Rac protein signal transduction,BP,
9564,GO:0035022,1,0.972689626590182,0,4,positive regulation of Rac protein signal transduction,BP,
9566,GO:0035024,1,0.882148738170939,0,18,negative regulation of Rho protein signal transduction,BP,
9568,GO:0035026,1,0.986535187022468,0,2,leading edge cell differentiation,BP,
9569,GO:0035032,1,0.962976928909522,0,6,phosphatidylinositol 3-kinase complex, class III,CC,
9570,GO:0035033,1,0.98197027095723,0,3,histone deacetylase regulator activity,MF,
9571,GO:0035034,1,0.987896045897414,0,2,histone acetyltransferase regulator activity,MF,
9572,GO:0035035,1,0.819631227744418,0,29,histone acetyltransferase binding,MF,
9573,GO:0035036,1,0.813869211296525,0,35,sperm-egg recognition,BP,
9574,GO:0035037,1,0.992957597176944,0,1,sperm entry,BP,
9575,GO:0035038,1,0.987834515463672,0,2,female pronucleus assembly,BP,
9576,GO:0035039,1,0.994092437245931,0,1,male pronucleus assembly,BP,
9577,GO:0035050,1,0.626230226994804,0,69,embryonic heart tube development,BP,
9579,GO:0035054,1,0.981471555281389,0,3,embryonic heart tube anterior/posterior pattern specification,BP,
9580,GO:0035061,1,0.970805824499361,0,4,interchromatin granule,CC,
9581,GO:0035063,1,0.981725117116635,0,2,nuclear speck organization,BP,
9582,GO:0035064,1,0.679817434255681,0,56,methylated histone binding,MF,
9583,GO:0035065,1,0.713047809142936,0,52,regulation of histone acetylation,BP,
9584,GO:0035066,1,0.834491224285794,0,28,positive regulation of histone acetylation,BP,
9585,GO:0035067,1,0.895776175477067,0,17,negative regulation of histone acetylation,BP,
9586,GO:0035068,1,0.937990369119934,0,9,micro-ribonucleoprotein complex,CC,
9587,GO:0035082,1,0.703133554007935,0,51,axoneme assembly,BP,
9588,GO:0035087,1,0.973019157597942,0,4,siRNA loading onto RISC involved in RNA interference,BP,
9590,GO:0035089,1,0.892717888215723,0,17,establishment of apical/basal cell polarity,BP,
9592,GO:0035091,1,0.214317497982467,0,224,phosphatidylinositol binding,MF,
9593,GO:0035092,1,0.957346610325847,0,6,sperm chromatin condensation,BP,
9594,GO:0035093,1,0.96935161843579,0,4,spermatogenesis, exchange of chromosomal proteins,BP,
9596,GO:0035095,1,0.951890293430698,0,7,behavioral response to nicotine,BP,
9597,GO:0035097,1,0.62652087294893,0,68,histone methyltransferase complex,CC,
9598,GO:0035098,1,0.89742753871152,0,16,ESC/E(Z) complex,CC,
9599,GO:0035101,1,0.980687058734917,0,3,FACT complex,CC,
9600,GO:0035102,1,0.92846119126337,0,11,PRC1 complex,CC,
9601,GO:0035106,1,0.9813179254005,0,3,operant conditioning,BP,
9606,GO:0035115,1,0.811179415831848,0,32,embryonic forelimb morphogenesis,BP,
9607,GO:0035116,1,0.831984633544224,0,28,embryonic hindlimb morphogenesis,BP,
9608,GO:0035120,1,0.989525691929859,0,1,post-embryonic appendage morphogenesis,BP,
9609,GO:0035127,1,0.989525691929859,0,1,post-embryonic limb morphogenesis,BP,
9610,GO:0035128,1,0.989525691929859,0,1,post-embryonic forelimb morphogenesis,BP,
9611,GO:0035136,1,0.762591827611882,0,40,forelimb morphogenesis,BP,
9612,GO:0035137,1,0.784375375279199,0,36,hindlimb morphogenesis,BP,
9613,GO:0035145,1,0.886399531346177,0,19,exon-exon junction complex,CC,
9615,GO:0035150,1,0.464276672709336,0,121,regulation of tube size,BP,
9616,GO:0035162,1,0.871012443365161,0,20,embryonic hemopoiesis,BP,
9617,GO:0035166,1,0.980328676360757,0,3,post-embryonic hemopoiesis,BP,
9619,GO:0035174,1,0.955858079579563,0,7,histone serine kinase activity,MF,
9620,GO:0035175,1,0.994405028845343,0,1,histone kinase activity (H3-S10 specific),MF,
9621,GO:0035176,1,0.704656666309256,0,49,social behavior,BP,
9622,GO:0035184,1,0.965753190633426,0,5,histone threonine kinase activity,MF,
9623,GO:0035188,1,0.993611601194332,0,1,hatching,BP,
9624,GO:0035189,1,0.980986343548554,0,3,Rb-E2F complex,CC,
9625,GO:0035194,1,0.447106675711429,0,120,posttranscriptional gene silencing by RNA,BP,
9626,GO:0035195,1,0.464727316261743,0,114,gene silencing by miRNA,BP,
9627,GO:0035196,1,0.759606596189812,0,40,production of miRNAs involved in gene silencing by miRNA,BP,
9628,GO:0035197,1,0.931897134649943,0,10,siRNA binding,MF,
9629,GO:0035198,1,0.866841373580894,0,22,miRNA binding,MF,
9630,GO:0035226,1,0.993701168722969,0,1,glutamate-cysteine ligase catalytic subunit binding,MF,
9631,GO:0035227,1,0.993701168722969,0,1,regulation of glutamate-cysteine ligase activity,BP,
9632,GO:0035229,1,0.993701168722969,0,1,positive regulation of glutamate-cysteine ligase activity,BP,
9633,GO:0035234,1,0.95085062501929,0,7,ectopic germ cell programmed cell death,BP,
9634,GO:0035235,1,0.825355213819853,0,26,ionotropic glutamate receptor signaling pathway,BP,
9635,GO:0035238,1,0.993850639026861,0,1,vitamin A biosynthetic process,BP,
9637,GO:0035240,1,0.952986778698978,0,8,dopamine binding,MF,
9638,GO:0035241,1,0.976115333897769,0,4,protein-arginine omega-N monomethyltransferase activity,MF,
9639,GO:0035242,1,0.953277081731788,0,8,protein-arginine omega-N asymmetric methyltransferase activity,MF,
9640,GO:0035243,1,0.975992974803101,0,4,protein-arginine omega-N symmetric methyltransferase activity,MF,
9641,GO:0035246,1,0.930476426259381,0,12,peptidyl-arginine N-methylation,BP,
9642,GO:0035247,1,0.941751386776973,0,10,peptidyl-arginine omega-N-methylation,BP,
9643,GO:0035248,1,0.993807258296005,0,1,alpha-1,4-N-acetylgalactosaminyltransferase activity,MF,
9644,GO:0035249,1,0.537015095592996,0,88,synaptic transmission, glutamatergic,BP,
9645,GO:0035250,1,0.846110324914148,0,27,UDP-galactosyltransferase activity,MF,
9646,GO:0035251,1,0.941988324001405,0,9,UDP-glucosyltransferase activity,MF,
9647,GO:0035252,1,0.958254418227475,0,6,UDP-xylosyltransferase activity,MF,
9648,GO:0035253,1,0.925588866782359,0,11,ciliary rootlet,CC,
9649,GO:0035254,1,0.754204830984563,0,40,glutamate receptor binding,MF,
9650,GO:0035255,1,0.830345851847989,0,26,ionotropic glutamate receptor binding,MF,
9651,GO:0035256,1,0.950814790545186,0,8,G-protein coupled glutamate receptor binding,MF,
9652,GO:0035257,1,0.3802072036368,0,143,nuclear hormone receptor binding,MF,
9653,GO:0035258,1,0.565698075088124,0,84,steroid hormone receptor binding,MF,
9654,GO:0035259,1,0.908955115890327,0,14,glucocorticoid receptor binding,MF,
9655,GO:0035261,1,0.980195777888357,0,2,external genitalia morphogenesis,BP,
9656,GO:0035262,1,0.984898081133356,0,2,gonad morphogenesis,BP,
9657,GO:0035264,1,0.402759052400171,0,131,multicellular organism growth,BP,
9659,GO:0035267,1,0.890389244626158,0,18,NuA4 histone acetyltransferase complex,CC,
9660,GO:0035268,1,0.894051541107438,0,17,protein mannosylation,BP,
9661,GO:0035269,1,0.927917936478906,0,12,protein O-linked mannosylation,BP,
9663,GO:0035272,1,0.727033002763872,0,47,exocrine system development,BP,
9664,GO:0035276,1,0.986738238316494,0,2,ethanol binding,MF,
9665,GO:0035278,1,0.909196757233206,0,13,miRNA mediated inhibition of translation,BP,
9666,GO:0035279,1,0.987326897335999,0,2,mRNA cleavage involved in gene silencing by miRNA,BP,
9667,GO:0035280,1,0.952783487976539,0,7,miRNA loading onto RISC involved in gene silencing by miRNA,BP,
9668,GO:0035281,1,0.98727745957757,0,2,pre-miRNA export from nucleus,BP,
9670,GO:0035283,1,0.987410490596376,0,2,central nervous system segmentation,BP,
9671,GO:0035284,1,0.987410490596376,0,2,brain segmentation,BP,
9672,GO:0035290,1,0.97996632189811,0,3,trunk segmentation,BP,
9674,GO:0035296,1,0.489153889718376,0,112,regulation of tube diameter,BP,
9675,GO:0035299,1,0.993015843841938,0,1,inositol pentakisphosphate 2-kinase activity,MF,
9679,GO:0035306,1,0.720460372956878,0,48,positive regulation of dephosphorylation,BP,
9680,GO:0035307,1,0.785687921657022,0,36,positive regulation of protein dephosphorylation,BP,
9682,GO:0035312,1,0.962086122193888,0,6,5'-3' exodeoxyribonuclease activity,MF,
9683,GO:0035313,1,0.900741775021899,0,14,wound healing, spreading of epidermal cells,BP,
9685,GO:0035325,1,0.940124751022218,0,10,Toll-like receptor binding,MF,
9687,GO:0035327,1,0.873228472971737,0,21,transcriptionally active chromatin,CC,
9690,GO:0035331,1,0.940943169631658,0,8,negative regulation of hippo signaling,BP,
9692,GO:0035333,1,0.916535844868586,0,13,Notch receptor processing, ligand-dependent,BP,
9693,GO:0035335,1,0.528463829865908,0,93,peptidyl-tyrosine dephosphorylation,BP,
9694,GO:0035336,1,0.870375886990867,0,22,long-chain fatty-acyl-CoA metabolic process,BP,
9695,GO:0035337,1,0.801343249670092,0,35,fatty-acyl-CoA metabolic process,BP,
9696,GO:0035338,1,0.903506563323539,0,16,long-chain fatty-acyl-CoA biosynthetic process,BP,
9697,GO:0035339,1,0.977497294382899,0,4,SPOTS complex,CC,
9698,GO:0035349,1,0.981872023432743,0,3,coenzyme A transmembrane transport,BP,
9699,GO:0035350,1,0.987882057183487,0,2,FAD transmembrane transport,BP,
9700,GO:0035352,1,0.994118245529178,0,1,NAD transmembrane transport,BP,
9701,GO:0035354,1,0.987393978306325,0,2,Toll-like receptor 1-Toll-like receptor 2 protein complex,CC,
9702,GO:0035355,1,0.992248455173689,0,1,Toll-like receptor 2-Toll-like receptor 6 protein complex,CC,
9703,GO:0035356,1,0.958564445241724,0,7,cellular triglyceride homeostasis,BP,
9704,GO:0035357,1,0.874839123899571,0,20,peroxisome proliferator activated receptor signaling pathway,BP,
9705,GO:0035358,1,0.925017075765755,0,12,regulation of peroxisome proliferator activated receptor signaling pathway,BP,
9706,GO:0035359,1,0.981766356779017,0,3,negative regulation of peroxisome proliferator activated receptor signaling pathway,BP,
9707,GO:0035360,1,0.954381518318966,0,7,positive regulation of peroxisome proliferator activated receptor signaling pathway,BP,
9708,GO:0035363,1,0.975593967159547,0,4,histone locus body,CC,
9709,GO:0035368,1,0.974049770175994,0,4,selenocysteine insertion sequence binding,MF,
9710,GO:0035370,1,0.988097935753501,0,2,UBC13-UEV1A complex,CC,
9711,GO:0035371,1,0.869984410223167,0,18,microtubule plus-end,CC,
9712,GO:0035372,1,0.91308913105459,0,13,protein localization to microtubule,BP,
9713,GO:0035373,1,0.975148166726432,0,3,chondroitin sulfate proteoglycan binding,MF,
9714,GO:0035374,1,0.959150393873018,0,6,chondroitin sulfate binding,MF,
9715,GO:0035375,1,0.991296688917182,0,1,zymogen binding,MF,
9716,GO:0035376,1,0.958826327407336,0,7,sterol import,BP,
9717,GO:0035377,1,0.986019321286001,0,2,transepithelial water transport,BP,
9718,GO:0035378,1,0.993866823174771,0,1,carbon dioxide transmembrane transport,BP,
9719,GO:0035379,1,0.993866823174771,0,1,carbon dioxide transmembrane transporter activity,MF,
9720,GO:0035381,1,0.951931940605378,0,8,ATP-gated ion channel activity,MF,
9721,GO:0035383,1,0.562632431540015,0,91,thioester metabolic process,BP,
9722,GO:0035384,1,0.739484216612051,0,46,thioester biosynthetic process,BP,
9723,GO:0035385,1,0.948583144021147,0,7,Roundabout signaling pathway,BP,
9724,GO:0035397,1,0.993684785110246,0,1,helper T cell enhancement of adaptive immune response,BP,
9725,GO:0035400,1,0.992548267741827,0,1,histone tyrosine kinase activity,MF,
9726,GO:0035401,1,0.992548267741827,0,1,histone kinase activity (H3-Y41 specific),MF,
9727,GO:0035402,1,0.987664647194134,0,2,histone kinase activity (H3-T11 specific),MF,
9728,GO:0035403,1,0.983320212071064,0,2,histone kinase activity (H3-T6 specific),MF,
9730,GO:0035405,1,0.965753190633426,0,5,histone-threonine phosphorylation,BP,
9731,GO:0035406,1,0.992548267741827,0,1,histone-tyrosine phosphorylation,BP,
9732,GO:0035407,1,0.987664647194134,0,2,histone H3-T11 phosphorylation,BP,
9733,GO:0035408,1,0.983320212071064,0,2,histone H3-T6 phosphorylation,BP,
9734,GO:0035409,1,0.992548267741827,0,1,histone H3-Y41 phosphorylation,BP,
9735,GO:0035410,1,0.994655127578734,0,1,dihydrotestosterone 17-beta-dehydrogenase activity,MF,
9736,GO:0035418,1,0.771562072006234,0,35,protein localization to synapse,BP,
9737,GO:0035425,1,0.986942032529624,0,2,autocrine signaling,BP,
9738,GO:0035426,1,0.965999226852865,0,5,extracellular matrix-cell signaling,BP,
9739,GO:0035434,1,0.958964274714814,0,6,copper ion transmembrane transport,BP,
9740,GO:0035435,1,0.939366676803318,0,9,phosphate ion transmembrane transport,BP,
9741,GO:0035437,1,0.921657565760528,0,13,maintenance of protein localization in endoplasmic reticulum,BP,
9742,GO:0035438,1,0.994415365666449,0,1,cyclic-di-GMP binding,MF,
9743,GO:0035441,1,0.976821714791825,0,3,cell migration involved in vasculogenesis,BP,
9744,GO:0035442,1,0.988377255050008,0,2,dipeptide transmembrane transport,BP,
9745,GO:0035443,1,0.991969765251917,0,1,tripeptide transmembrane transport,BP,
9746,GO:0035445,1,0.993680689705067,0,1,borate transmembrane transport,BP,
9747,GO:0035455,1,0.879898911675774,0,20,response to interferon-alpha,BP,
9748,GO:0035456,1,0.888294796055926,0,20,response to interferon-beta,BP,
9749,GO:0035457,1,0.933829573323869,0,10,cellular response to interferon-alpha,BP,
9750,GO:0035458,1,0.923089429800921,0,13,cellular response to interferon-beta,BP,
9751,GO:0035459,1,0.875057884410379,0,20,cargo loading into vesicle,BP,
9752,GO:0035461,1,0.923594325536333,0,11,vitamin transmembrane transport,BP,
9753,GO:0035469,1,0.966432877708191,0,5,determination of pancreatic left/right asymmetry,BP,
9754,GO:0035470,1,0.98880943294889,0,2,positive regulation of vascular wound healing,BP,
9755,GO:0035473,1,0.969809855571653,0,4,lipase binding,MF,
9756,GO:0035480,1,0.994690774858455,0,1,regulation of Notch signaling pathway involved in heart induction,BP,
9757,GO:0035481,1,0.994690774858455,0,1,positive regulation of Notch signaling pathway involved in heart induction,BP,
9758,GO:0035482,1,0.979350861702947,0,4,gastric motility,BP,
9759,GO:0035483,1,0.984836900356346,0,3,gastric emptying,BP,
9760,GO:0035485,1,0.994336025503631,0,1,adenine/guanine mispair binding,MF,
9761,GO:0035490,1,0.993657144447763,0,1,regulation of leukotriene production involved in inflammatory response,BP,
9762,GO:0035491,1,0.993657144447763,0,1,positive regulation of leukotriene production involved in inflammatory response,BP,
9763,GO:0035493,1,0.908732486130743,0,15,SNARE complex assembly,BP,
9764,GO:0035494,1,0.981585126527744,0,3,SNARE complex disassembly,BP,
9765,GO:0035497,1,0.917817595972075,0,13,cAMP response element binding,MF,
9768,GO:0035500,1,0.987216031786025,0,2,MH2 domain binding,MF,
9769,GO:0035501,1,0.993828043976683,0,1,MH1 domain binding,MF,
9770,GO:0035502,1,0.969067702680636,0,5,metanephric part of ureteric bud development,BP,
9771,GO:0035504,1,0.994513555307944,0,1,regulation of myosin light chain kinase activity,BP,
9772,GO:0035505,1,0.994513555307944,0,1,positive regulation of myosin light chain kinase activity,BP,
9773,GO:0035507,1,0.949988397055219,0,7,regulation of myosin-light-chain-phosphatase activity,BP,
9774,GO:0035508,1,0.992392033649782,0,1,positive regulation of myosin-light-chain-phosphatase activity,BP,
9775,GO:0035509,1,0.96523679400306,0,5,negative regulation of myosin-light-chain-phosphatase activity,BP,
9776,GO:0035510,1,0.828863912310098,0,28,DNA dealkylation,BP,
9777,GO:0035511,1,0.970272850240504,0,5,oxidative DNA demethylation,BP,
9778,GO:0035513,1,0.97525319667501,0,4,oxidative RNA demethylation,BP,
9779,GO:0035514,1,0.982453409581655,0,3,DNA demethylase activity,MF,
9780,GO:0035515,1,0.97525319667501,0,4,oxidative RNA demethylase activity,MF,
9781,GO:0035516,1,0.993075016881986,0,1,oxidative DNA demethylase activity,MF,
9782,GO:0035517,1,0.969868272701074,0,4,PR-DUB complex,CC,
9783,GO:0035518,1,0.898230193340206,0,16,histone H2A monoubiquitination,BP,
9784,GO:0035519,1,0.976242525758985,0,4,protein K29-linked ubiquitination,BP,
9785,GO:0035520,1,0.937999754053463,0,9,monoubiquitinated protein deubiquitination,BP,
9786,GO:0035521,1,0.974569955232679,0,4,monoubiquitinated histone deubiquitination,BP,
9787,GO:0035522,1,0.974569955232679,0,4,monoubiquitinated histone H2A deubiquitination,BP,
9788,GO:0035523,1,0.976142875314699,0,3,protein K29-linked deubiquitination,BP,
9789,GO:0035524,1,0.965722460130975,0,5,proline transmembrane transport,BP,
9790,GO:0035525,1,0.993956590534699,0,1,NF-kappaB p50/p65 complex,CC,
9791,GO:0035526,1,0.985944576230296,0,2,retrograde transport, plasma membrane to Golgi,BP,
9792,GO:0035529,1,0.957735995984157,0,7,NADH pyrophosphatase activity,MF,
9793,GO:0035538,1,0.993607763722277,0,1,carbohydrate response element binding,MF,
9794,GO:0035539,1,0.989193873363768,0,2,8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity,MF,
9795,GO:0035542,1,0.942550322467964,0,9,regulation of SNARE complex assembly,BP,
9796,GO:0035544,1,0.979972602107771,0,3,negative regulation of SNARE complex assembly,BP,
9797,GO:0035545,1,0.993260997475039,0,1,determination of left/right asymmetry in nervous system,BP,
9798,GO:0035546,1,0.962831045907855,0,5,interferon-beta secretion,BP,
9799,GO:0035547,1,0.962831045907855,0,5,regulation of interferon-beta secretion,BP,
9800,GO:0035548,1,0.993809823819756,0,1,negative regulation of interferon-beta secretion,BP,
9801,GO:0035549,1,0.968830187253986,0,4,positive regulation of interferon-beta secretion,BP,
9802,GO:0035552,1,0.981615240920632,0,3,oxidative single-stranded DNA demethylation,BP,
9803,GO:0035553,1,0.98118784096185,0,3,oxidative single-stranded RNA demethylation,BP,
9805,GO:0035561,1,0.871631108340203,0,21,regulation of chromatin binding,BP,
9806,GO:0035562,1,0.952194035725381,0,7,negative regulation of chromatin binding,BP,
9807,GO:0035563,1,0.921406101192051,0,13,positive regulation of chromatin binding,BP,
9808,GO:0035564,1,0.983723254368747,0,2,regulation of kidney size,BP,
9809,GO:0035566,1,0.993169734686661,0,1,regulation of metanephros size,BP,
9811,GO:0035568,1,0.993850639026861,0,1,N-terminal peptidyl-proline methylation,BP,
9812,GO:0035570,1,0.993850639026861,0,1,N-terminal peptidyl-serine methylation,BP,
9813,GO:0035572,1,0.993850639026861,0,1,N-terminal peptidyl-serine dimethylation,BP,
9814,GO:0035573,1,0.993850639026861,0,1,N-terminal peptidyl-serine trimethylation,BP,
9815,GO:0035574,1,0.986043286399825,0,2,histone H4-K20 demethylation,BP,
9816,GO:0035575,1,0.986043286399825,0,2,histone demethylase activity (H4-K20 specific),MF,
9817,GO:0035577,1,0.708337607835768,0,53,azurophil granule membrane,CC,
9818,GO:0035578,1,0.609822876861349,0,81,azurophil granule lumen,CC,
9819,GO:0035579,1,0.566333688039732,0,86,specific granule membrane,CC,
9820,GO:0035580,1,0.704033881372401,0,58,specific granule lumen,CC,
9821,GO:0035581,1,0.943036740493573,0,8,sequestering of extracellular ligand from receptor,BP,
9822,GO:0035582,1,0.97278952439109,0,4,sequestering of BMP in extracellular matrix,BP,
9823,GO:0035583,1,0.971806824350956,0,3,sequestering of TGFbeta in extracellular matrix,BP,
9824,GO:0035584,1,0.892390038632786,0,17,calcium-mediated signaling using intracellular calcium source,BP,
9825,GO:0035585,1,0.982225670741047,0,2,calcium-mediated signaling using extracellular calcium source,BP,
9826,GO:0035586,1,0.877878423508417,0,22,purinergic receptor activity,MF,
9829,GO:0035589,1,0.931542395744587,0,12,G-protein coupled purinergic nucleotide receptor signaling pathway,BP,
9830,GO:0035590,1,0.887373285087921,0,20,purinergic nucleotide receptor signaling pathway,BP,
9831,GO:0035591,1,0.58278265064665,0,80,signaling adaptor activity,MF,
9833,GO:0035596,1,0.987875477502635,0,2,methylthiotransferase activity,MF,
9834,GO:0035597,1,0.994242216198529,0,1,N6-isopentenyladenosine methylthiotransferase activity,MF,
9835,GO:0035598,1,0.993596763163241,0,1,N6-threonylcarbomyladenosine methylthiotransferase activity,MF,
9836,GO:0035600,1,0.987875477502635,0,2,tRNA methylthiolation,BP,
9837,GO:0035601,1,0.491286127376671,0,105,protein deacylation,BP,
9838,GO:0035602,1,0.993176965952509,0,1,fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow,BP,
9839,GO:0035603,1,0.993176965952509,0,1,fibroblast growth factor receptor signaling pathway involved in hemopoiesis,BP,
9840,GO:0035604,1,0.993176965952509,0,1,fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow,BP,
9841,GO:0035605,1,0.994609662171885,0,1,peptidyl-cysteine S-nitrosylase activity,MF,
9842,GO:0035606,1,0.989628315575864,0,2,peptidyl-cysteine S-trans-nitrosylation,BP,
9843,GO:0035607,1,0.985599561369849,0,2,fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development,BP,
9844,GO:0035608,1,0.956590251387403,0,7,protein deglutamylation,BP,
9845,GO:0035609,1,0.975182881211665,0,4,C-terminal protein deglutamylation,BP,
9846,GO:0035610,1,0.97399418692202,0,4,protein side chain deglutamylation,BP,
9847,GO:0035611,1,0.9938203442429,0,1,protein branching point deglutamylation,BP,
9848,GO:0035612,1,0.938024319557367,0,8,AP-2 adaptor complex binding,MF,
9849,GO:0035613,1,0.902688733572071,0,15,RNA stem-loop binding,MF,
9850,GO:0035614,1,0.98294981843303,0,3,snRNA stem-loop binding,MF,
9851,GO:0035615,1,0.928885563309414,0,11,clathrin adaptor activity,MF,
9852,GO:0035616,1,0.979173795913537,0,3,histone H2B conserved C-terminal lysine deubiquitination,BP,
9853,GO:0035617,1,0.980488614481483,0,3,stress granule disassembly,BP,
9854,GO:0035620,1,0.973786462315204,0,4,ceramide transporter activity,MF,
9855,GO:0035621,1,0.986801327148663,0,2,ER to Golgi ceramide transport,BP,
9856,GO:0035622,1,0.993266658376875,0,1,intrahepatic bile duct development,BP,
9857,GO:0035623,1,0.993616717895591,0,1,renal glucose absorption,BP,
9858,GO:0035624,1,0.972450531364779,0,4,receptor transactivation,BP,
9859,GO:0035625,1,0.981145085893809,0,3,epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway,BP,
9860,GO:0035627,1,0.953376708996157,0,7,ceramide transport,BP,
9861,GO:0035630,1,0.953881006785019,0,7,bone mineralization involved in bone maturation,BP,
9862,GO:0035631,1,0.933614798014875,0,11,CD40 receptor complex,CC,
9864,GO:0035634,1,0.981038392900735,0,3,response to stilbenoid,BP,
9865,GO:0035635,1,0.883569797503589,0,18,entry of bacterium into host cell,BP,
9867,GO:0035638,1,0.992840296006764,0,1,signal maturation,BP,
9869,GO:0035640,1,0.854768416395892,0,23,exploration behavior,BP,
9870,GO:0035641,1,0.913971423181013,0,13,locomotory exploration behavior,BP,
9871,GO:0035642,1,0.993751367835902,0,1,histone methyltransferase activity (H3-R17 specific),MF,
9872,GO:0035643,1,0.994410714123709,0,1,L-DOPA receptor activity,MF,
9873,GO:0035644,1,0.993736252507657,0,1,phosphoanandamide dephosphorylation,BP,
9874,GO:0035645,1,0.993080201623054,0,1,enteric smooth muscle cell differentiation,BP,
9875,GO:0035646,1,0.93893809705422,0,10,endosome to melanosome transport,BP,
9876,GO:0035650,1,0.976507021592426,0,4,AP-1 adaptor complex binding,MF,
9877,GO:0035651,1,0.982461850439049,0,3,AP-3 adaptor complex binding,MF,
9878,GO:0035655,1,0.952945193123534,0,8,interleukin-18-mediated signaling pathway,BP,
9879,GO:0035658,1,0.981803903380927,0,3,Mon1-Ccz1 complex,CC,
9880,GO:0035659,1,0.994403478303465,0,1,Wnt signaling pathway involved in wound healing, spreading of epidermal cells,BP,
9881,GO:0035662,1,0.984517563954108,0,3,Toll-like receptor 4 binding,MF,
9882,GO:0035663,1,0.980558150411917,0,3,Toll-like receptor 2 binding,MF,
9883,GO:0035664,1,0.994366780695613,0,1,TIRAP-dependent toll-like receptor signaling pathway,BP,
9884,GO:0035665,1,0.994366780695613,0,1,TIRAP-dependent toll-like receptor 4 signaling pathway,BP,
9885,GO:0035666,1,0.847425439166823,0,27,TRIF-dependent toll-like receptor signaling pathway,BP,
9886,GO:0035668,1,0.986224430896061,0,2,TRAM-dependent toll-like receptor signaling pathway,BP,
9887,GO:0035669,1,0.986224430896061,0,2,TRAM-dependent toll-like receptor 4 signaling pathway,BP,
9888,GO:0035671,1,0.982788113715549,0,3,enone reductase activity,MF,
9889,GO:0035672,1,0.960269408891313,0,6,oligopeptide transmembrane transport,BP,
9890,GO:0035673,1,0.971564932177066,0,4,oligopeptide transmembrane transporter activity,MF,
9891,GO:0035674,1,0.98812401101046,0,2,tricarboxylic acid transmembrane transport,BP,
9892,GO:0035675,1,0.993921330858198,0,1,neuromast hair cell development,BP,
9893,GO:0035684,1,0.994904635550139,0,1,helper T cell extravasation,BP,
9894,GO:0035686,1,0.976523587564877,0,4,sperm fibrous sheath,CC,
9896,GO:0035691,1,0.987698410350019,0,2,macrophage migration inhibitory factor signaling pathway,BP,
9897,GO:0035692,1,0.987362328392014,0,2,macrophage migration inhibitory factor receptor complex,CC,
9898,GO:0035693,1,0.994610178839212,0,1,NOS2-CD74 complex,CC,
9899,GO:0035694,1,0.97454274191911,0,4,mitochondrial protein catabolic process,BP,
9900,GO:0035695,1,0.993068793904575,0,1,mitophagy by induced vacuole formation,BP,
9901,GO:0035696,1,0.979147497085999,0,3,monocyte extravasation,BP,
9902,GO:0035697,1,0.982723006297383,0,3,CD8-positive, alpha-beta T cell extravasation,BP,
9903,GO:0035698,1,0.988658578052625,0,2,CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
9904,GO:0035700,1,0.988398826594949,0,2,astrocyte chemotaxis,BP,
9905,GO:0035701,1,0.959382778223836,0,6,hematopoietic stem cell migration,BP,
9906,GO:0035704,1,0.993997028244295,0,1,helper T cell chemotaxis,BP,
9907,GO:0035705,1,0.993997028244295,0,1,T-helper 17 cell chemotaxis,BP,
9908,GO:0035708,1,0.993489301443189,0,1,interleukin-4-dependent isotype switching to IgE isotypes,BP,
9909,GO:0035709,1,0.987676750153661,0,2,memory T cell activation,BP,
9910,GO:0035710,1,0.654951121244329,0,66,CD4-positive, alpha-beta T cell activation,BP,
9911,GO:0035711,1,0.988215559910112,0,2,T-helper 1 cell activation,BP,
9912,GO:0035712,1,0.987130894210922,0,2,T-helper 2 cell activation,BP,
9913,GO:0035713,1,0.993489301443189,0,1,response to nitrogen dioxide,BP,
9914,GO:0035715,1,0.993997028244295,0,1,chemokine (C-C motif) ligand 2 binding,MF,
9915,GO:0035716,1,0.993997028244295,0,1,chemokine (C-C motif) ligand 12 binding,MF,
9916,GO:0035717,1,0.987941185940643,0,2,chemokine (C-C motif) ligand 7 binding,MF,
9917,GO:0035718,1,0.989158661473575,0,2,macrophage migration inhibitory factor binding,MF,
9918,GO:0035720,1,0.979888990019556,0,3,intraciliary anterograde transport,BP,
9919,GO:0035721,1,0.918058548922754,0,12,intraciliary retrograde transport,BP,
9920,GO:0035722,1,0.765838222221086,0,44,interleukin-12-mediated signaling pathway,BP,
9921,GO:0035723,1,0.916118730846728,0,13,interleukin-15-mediated signaling pathway,BP,
9922,GO:0035724,1,0.991771332408741,0,1,CD24 biosynthetic process,BP,
9924,GO:0035726,1,0.961317048484563,0,6,common myeloid progenitor cell proliferation,BP,
9926,GO:0035728,1,0.903642496930281,0,15,response to hepatocyte growth factor,BP,
9927,GO:0035729,1,0.917082192244912,0,13,cellular response to hepatocyte growth factor stimulus,BP,
9928,GO:0035730,1,0.99479306007569,0,1,S-nitrosoglutathione binding,MF,
9929,GO:0035731,1,0.99479306007569,0,1,dinitrosyl-iron complex binding,MF,
9930,GO:0035732,1,0.99479306007569,0,1,nitric oxide storage,BP,
9931,GO:0035733,1,0.955296000687527,0,7,hepatic stellate cell activation,BP,
9932,GO:0035735,1,0.76366105589984,0,40,intraciliary transport involved in cilium assembly,BP,
9933,GO:0035739,1,0.963943193581628,0,6,CD4-positive, alpha-beta T cell proliferation,BP,
9934,GO:0035740,1,0.982633332083647,0,3,CD8-positive, alpha-beta T cell proliferation,BP,
9935,GO:0035743,1,0.920353237682909,0,14,CD4-positive, alpha-beta T cell cytokine production,BP,
9936,GO:0035744,1,0.977990698270538,0,4,T-helper 1 cell cytokine production,BP,
9937,GO:0035745,1,0.941879445138661,0,10,T-helper 2 cell cytokine production,BP,
9938,GO:0035746,1,0.994658227399849,0,1,granzyme A production,BP,
9939,GO:0035747,1,0.958904883933466,0,7,natural killer cell chemotaxis,BP,
9940,GO:0035748,1,0.959892761718406,0,6,myelin sheath abaxonal region,CC,
9942,GO:0035750,1,0.992515766071741,0,1,protein localization to myelin sheath abaxonal region,BP,
9943,GO:0035751,1,0.930191464454948,0,12,regulation of lysosomal lumen pH,BP,
9944,GO:0035752,1,0.9943044950719,0,1,lysosomal lumen pH elevation,BP,
9945,GO:0035754,1,0.952636732871691,0,8,B cell chemotaxis,BP,
9946,GO:0035755,1,0.993959937679864,0,1,cardiolipin hydrolase activity,MF,
9947,GO:0035757,1,0.994167818170529,0,1,chemokine (C-C motif) ligand 19 binding,MF,
9948,GO:0035758,1,0.994167818170529,0,1,chemokine (C-C motif) ligand 21 binding,MF,
9949,GO:0035759,1,0.98875329038436,0,2,mesangial cell-matrix adhesion,BP,
9953,GO:0035770,1,0.290518159621671,0,187,ribonucleoprotein granule,CC,
9954,GO:0035771,1,0.955198636080348,0,7,interleukin-4-mediated signaling pathway,BP,
9955,GO:0035772,1,0.994379185829871,0,1,interleukin-13-mediated signaling pathway,BP,
9956,GO:0035773,1,0.700557215363781,0,55,insulin secretion involved in cellular response to glucose stimulus,BP,
9957,GO:0035774,1,0.858276048105431,0,25,positive regulation of insulin secretion involved in cellular response to glucose stimulus,BP,
9958,GO:0035782,1,0.994658227399849,0,1,mature natural killer cell chemotaxis,BP,
9959,GO:0035783,1,0.993489301443189,0,1,CD4-positive, alpha-beta T cell costimulation,BP,
9960,GO:0035787,1,0.972787396882268,0,4,cell migration involved in kidney development,BP,
9961,GO:0035788,1,0.980115038480902,0,3,cell migration involved in metanephros development,BP,
9962,GO:0035789,1,0.980115038480902,0,3,metanephric mesenchymal cell migration,BP,
9965,GO:0035793,1,0.980115038480902,0,3,positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,
9966,GO:0035794,1,0.698166133872626,0,59,positive regulation of mitochondrial membrane permeability,BP,
9967,GO:0035795,1,0.970250562379733,0,5,negative regulation of mitochondrial membrane permeability,BP,
9968,GO:0035799,1,0.973498666974674,0,4,ureter maturation,BP,
9969,GO:0035800,1,0.987904977337756,0,2,deubiquitinase activator activity,MF,
9970,GO:0035801,1,0.9881374332112,0,2,adrenal cortex development,BP,
9971,GO:0035802,1,0.9881374332112,0,2,adrenal cortex formation,BP,
9972,GO:0035803,1,0.989145304298173,0,2,egg coat formation,BP,
9973,GO:0035805,1,0.994127538437076,0,1,egg coat,CC,
9974,GO:0035809,1,0.89402639434919,0,18,regulation of urine volume,BP,
9975,GO:0035810,1,0.926651441877241,0,12,positive regulation of urine volume,BP,
9976,GO:0035811,1,0.981311109674588,0,3,negative regulation of urine volume,BP,
9980,GO:0035815,1,0.945079631236531,0,9,positive regulation of renal sodium excretion,BP,
9981,GO:0035821,1,0.485359789658723,0,115,modification of morphology or physiology of other organism,BP,
9982,GO:0035822,1,0.96706214757058,0,5,gene conversion,BP,
9984,GO:0035838,1,0.977881432130801,0,3,growing cell tip,CC,
9985,GO:0035841,1,0.984647085505499,0,2,new growing cell tip,CC,
9986,GO:0035844,1,0.974223994277556,0,4,cloaca development,BP,
9987,GO:0035845,1,0.939506245886467,0,9,photoreceptor cell outer segment organization,BP,
9988,GO:0035850,1,0.753503265164817,0,41,epithelial cell differentiation involved in kidney development,BP,
9989,GO:0035851,1,0.99375495514484,0,1,Krueppel-associated box domain binding,MF,
9990,GO:0035853,1,0.992976330684101,0,1,chromosome passenger complex localization to spindle midzone,BP,
9991,GO:0035854,1,0.98810804896972,0,2,eosinophil fate commitment,BP,
9992,GO:0035855,1,0.899644335866185,0,15,megakaryocyte development,BP,
9993,GO:0035859,1,0.922264479356742,0,13,Seh1-associated complex,CC,
9994,GO:0035860,1,0.96394101588153,0,5,glial cell-derived neurotrophic factor receptor signaling pathway,BP,
9995,GO:0035861,1,0.817235509457404,0,30,site of double-strand break,CC,
9996,GO:0035862,1,0.992169153657553,0,1,dITP metabolic process,BP,
9997,GO:0035863,1,0.992169153657553,0,1,dITP catabolic process,BP,
9998,GO:0035864,1,0.9359759611767,0,10,response to potassium ion,BP,
9999,GO:0035865,1,0.96089466020143,0,6,cellular response to potassium ion,BP,
10000,GO:0035866,1,0.975388925910076,0,3,alphav-beta3 integrin-PKCalpha complex,CC,
10001,GO:0035867,1,0.965884965190236,0,4,alphav-beta3 integrin-IGF-1-IGF1R complex,CC,
10002,GO:0035868,1,0.978130100647968,0,3,alphav-beta3 integrin-HMGB1 complex,CC,
10004,GO:0035870,1,0.9869300491055,0,2,dITP diphosphatase activity,MF,
10005,GO:0035871,1,0.941060729120954,0,8,protein K11-linked deubiquitination,BP,
10006,GO:0035872,1,0.800127886644666,0,34,nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway,BP,
10007,GO:0035873,1,0.960921434129927,0,6,lactate transmembrane transport,BP,
10008,GO:0035877,1,0.975297430152822,0,4,death effector domain binding,MF,
10009,GO:0035878,1,0.949584944520161,0,8,nail development,BP,
10010,GO:0035879,1,0.980584097569153,0,3,plasma membrane lactate transport,BP,
10011,GO:0035880,1,0.981895839928682,0,3,embryonic nail plate morphogenesis,BP,
10012,GO:0035881,1,0.956863772604725,0,7,amacrine cell differentiation,BP,
10013,GO:0035883,1,0.846734965027483,0,25,enteroendocrine cell differentiation,BP,
10014,GO:0035886,1,0.8843227209566,0,19,vascular smooth muscle cell differentiation,BP,
10015,GO:0035887,1,0.994387197314057,0,1,aortic smooth muscle cell differentiation,BP,
10016,GO:0035890,1,0.808197586404181,0,33,exit from host,BP,
10017,GO:0035891,1,0.808197586404181,0,33,exit from host cell,BP,
10018,GO:0035897,1,0.964265342519664,0,6,proteolysis in other organism,BP,
10019,GO:0035898,1,0.980512976388821,0,3,parathyroid hormone secretion,BP,
10020,GO:0035900,1,0.963539320807511,0,6,response to isolation stress,BP,
10021,GO:0035902,1,0.885083616769754,0,19,response to immobilization stress,BP,
10022,GO:0035904,1,0.712270962748104,0,47,aorta development,BP,
10023,GO:0035905,1,0.97407788152648,0,4,ascending aorta development,BP,
10024,GO:0035907,1,0.943931869104841,0,9,dorsal aorta development,BP,
10025,GO:0035909,1,0.806911435830489,0,30,aorta morphogenesis,BP,
10026,GO:0035910,1,0.97407788152648,0,4,ascending aorta morphogenesis,BP,
10027,GO:0035912,1,0.950016733914109,0,8,dorsal aorta morphogenesis,BP,
10029,GO:0035915,1,0.994232656113384,0,1,pore formation in membrane of other organism,BP,
10030,GO:0035921,1,0.994205529033535,0,1,desmosome disassembly,BP,
10031,GO:0035922,1,0.99446213715747,0,1,foramen ovale closure,BP,
10033,GO:0035925,1,0.923278855376258,0,12,mRNA 3'-UTR AU-rich region binding,MF,
10035,GO:0035927,1,0.976164202915898,0,4,RNA import into mitochondrion,BP,
10036,GO:0035928,1,0.982508342815002,0,3,rRNA import into mitochondrion,BP,
10037,GO:0035929,1,0.896696726876542,0,18,steroid hormone secretion,BP,
10038,GO:0035930,1,0.925497516076566,0,13,corticosteroid hormone secretion,BP,
10039,GO:0035931,1,0.975835585506386,0,4,mineralocorticoid secretion,BP,
10040,GO:0035932,1,0.975835585506386,0,4,aldosterone secretion,BP,
10041,GO:0035933,1,0.948427838481917,0,9,glucocorticoid secretion,BP,
10042,GO:0035934,1,0.978107913987809,0,4,corticosterone secretion,BP,
10043,GO:0035935,1,0.993598298111347,0,1,androgen secretion,BP,
10044,GO:0035936,1,0.9853482156489,0,2,testosterone secretion,BP,
10045,GO:0035938,1,0.979568051879514,0,3,estradiol secretion,BP,
10046,GO:0035939,1,0.981295820962846,0,3,microsatellite binding,MF,
10047,GO:0035945,1,0.994005274042763,0,1,mitochondrial ncRNA surveillance,BP,
10048,GO:0035946,1,0.994005274042763,0,1,mitochondrial mRNA surveillance,BP,
10049,GO:0035947,1,0.966775070570464,0,5,regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter,BP,
10050,GO:0035948,1,0.980278037069418,0,3,positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter,BP,
10051,GO:0035962,1,0.981701635952588,0,3,response to interleukin-13,BP,
10052,GO:0035963,1,0.981701635952588,0,3,cellular response to interleukin-13,BP,
10053,GO:0035964,1,0.962198940067893,0,6,COPI-coated vesicle budding,BP,
10054,GO:0035965,1,0.969081336528634,0,5,cardiolipin acyl-chain remodeling,BP,
10057,GO:0035970,1,0.902338428957757,0,16,peptidyl-threonine dephosphorylation,BP,
10058,GO:0035971,1,0.994658227399849,0,1,peptidyl-histidine dephosphorylation,BP,
10059,GO:0035973,1,0.950932839935926,0,7,aggrephagy,BP,
10060,GO:0035976,1,0.971574091952282,0,5,transcription factor AP-1 complex,CC,
10061,GO:0035977,1,0.972403089111753,0,4,protein deglycosylation involved in glycoprotein catabolic process,BP,
10062,GO:0035978,1,0.993828043976683,0,1,histone H2A-S139 phosphorylation,BP,
10063,GO:0035981,1,0.987486274093285,0,2,tongue muscle cell differentiation,BP,
10064,GO:0035983,1,0.973792584920325,0,4,response to trichostatin A,BP,
10065,GO:0035984,1,0.973792584920325,0,4,cellular response to trichostatin A,BP,
10066,GO:0035985,1,0.977322377243699,0,4,senescence-associated heterochromatin focus,CC,
10067,GO:0035986,1,0.982883513532781,0,3,senescence-associated heterochromatin focus assembly,BP,
10068,GO:0035987,1,0.732458141727773,0,45,endodermal cell differentiation,BP,
10070,GO:0035989,1,0.966073656927477,0,5,tendon development,BP,
10071,GO:0035990,1,0.983311903524215,0,3,tendon cell differentiation,BP,
10072,GO:0035992,1,0.983311903524215,0,3,tendon formation,BP,
10073,GO:0035993,1,0.988533742629659,0,2,deltoid tuberosity development,BP,
10074,GO:0035994,1,0.859324972650975,0,17,response to muscle stretch,BP,
10075,GO:0035995,1,0.953046944028405,0,2,detection of muscle stretch,BP,
10076,GO:0035998,1,0.99427916852304,0,1,7,8-dihydroneopterin 3'-triphosphate biosynthetic process,BP,
10077,GO:0035999,1,0.945670730731217,0,9,tetrahydrofolate interconversion,BP,
10078,GO:0036002,1,0.797405952007562,0,35,pre-mRNA binding,MF,
10079,GO:0036003,1,0.853530238851997,0,25,positive regulation of transcription from RNA polymerase II promoter in response to stress,BP,
10080,GO:0036004,1,0.994651511106357,0,1,GAF domain binding,MF,
10081,GO:0036005,1,0.950540358371664,0,8,response to macrophage colony-stimulating factor,BP,
10082,GO:0036006,1,0.950540358371664,0,8,cellular response to macrophage colony-stimulating factor stimulus,BP,
10083,GO:0036009,1,0.994685092053482,0,1,protein-glutamine N-methyltransferase activity,MF,
10084,GO:0036010,1,0.88153907300295,0,18,protein localization to endosome,BP,
10085,GO:0036015,1,0.973879379902148,0,4,response to interleukin-3,BP,
10086,GO:0036016,1,0.973879379902148,0,4,cellular response to interleukin-3,BP,
10087,GO:0036017,1,0.961868308079341,0,7,response to erythropoietin,BP,
10088,GO:0036018,1,0.966635022575243,0,6,cellular response to erythropoietin,BP,
10089,GO:0036019,1,0.880140492526542,0,19,endolysosome,CC,
10090,GO:0036020,1,0.908028555495991,0,14,endolysosome membrane,CC,
10091,GO:0036021,1,0.969316694851816,0,5,endolysosome lumen,CC,
10092,GO:0036022,1,0.98228247881734,0,3,limb joint morphogenesis,BP,
10093,GO:0036023,1,0.98228247881734,0,3,embryonic skeletal limb joint morphogenesis,BP,
10094,GO:0036024,1,0.994093469418573,0,1,protein C inhibitor-TMPRSS7 complex,CC,
10095,GO:0036025,1,0.994093469418573,0,1,protein C inhibitor-TMPRSS11E complex,CC,
10096,GO:0036026,1,0.994093469418573,0,1,protein C inhibitor-PLAT complex,CC,
10097,GO:0036027,1,0.994093469418573,0,1,protein C inhibitor-PLAU complex,CC,
10098,GO:0036028,1,0.994093469418573,0,1,protein C inhibitor-thrombin complex,CC,
10099,GO:0036029,1,0.994093469418573,0,1,protein C inhibitor-KLK3 complex,CC,
10100,GO:0036030,1,0.994093469418573,0,1,protein C inhibitor-plasma kallikrein complex,CC,
10101,GO:0036033,1,0.964961722603282,0,4,mediator complex binding,MF,
10102,GO:0036034,1,0.98801705095952,0,2,mediator complex assembly,BP,
10103,GO:0036035,1,0.893936299558341,0,16,osteoclast development,BP,
10104,GO:0036037,1,0.922816853154689,0,13,CD8-positive, alpha-beta T cell activation,BP,
10105,GO:0036038,1,0.922450230472195,0,13,MKS complex,CC,
10106,GO:0036041,1,0.951218059850624,0,9,long-chain fatty acid binding,MF,
10107,GO:0036042,1,0.977979996981338,0,4,long-chain fatty acyl-CoA binding,MF,
10108,GO:0036046,1,0.993662774362528,0,1,protein demalonylation,BP,
10109,GO:0036047,1,0.993662774362528,0,1,peptidyl-lysine demalonylation,BP,
10110,GO:0036048,1,0.993662774362528,0,1,protein desuccinylation,BP,
10111,GO:0036049,1,0.993662774362528,0,1,peptidyl-lysine desuccinylation,BP,
10112,GO:0036053,1,0.993885584402155,0,1,glomerular endothelium fenestra,CC,
10113,GO:0036054,1,0.993662774362528,0,1,protein-malonyllysine demalonylase activity,MF,
10114,GO:0036055,1,0.993662774362528,0,1,protein-succinyllysine desuccinylase activity,MF,
10115,GO:0036056,1,0.948870831203835,0,7,filtration diaphragm,CC,
10116,GO:0036057,1,0.948870831203835,0,7,slit diaphragm,CC,
10117,GO:0036058,1,0.993211799453621,0,1,filtration diaphragm assembly,BP,
10118,GO:0036060,1,0.993211799453621,0,1,slit diaphragm assembly,BP,
10120,GO:0036065,1,0.844313469375585,0,25,fucosylation,BP,
10121,GO:0036066,1,0.910180774567922,0,14,protein O-linked fucosylation,BP,
10122,GO:0036071,1,0.993591646691022,0,1,N-glycan fucosylation,BP,
10123,GO:0036072,1,0.959778930397291,0,6,direct ossification,BP,
10125,GO:0036080,1,0.985440005982839,0,2,purine nucleotide-sugar transmembrane transporter activity,MF,
10126,GO:0036085,1,0.993632068637027,0,1,GDP-fucose import into Golgi lumen,BP,
10127,GO:0036088,1,0.994461361973286,0,1,D-serine catabolic process,BP,
10128,GO:0036089,1,0.955254549197902,0,7,cleavage furrow formation,BP,
10129,GO:0036090,1,0.988525474144753,0,2,cleavage furrow ingression,BP,
10130,GO:0036091,1,0.967082845874315,0,5,positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,
10132,GO:0036093,1,0.966462931483902,0,6,germ cell proliferation,BP,
10134,GO:0036100,1,0.988170529572986,0,2,leukotriene catabolic process,BP,
10135,GO:0036101,1,0.988170529572986,0,2,leukotriene B4 catabolic process,BP,
10136,GO:0036102,1,0.988170529572986,0,2,leukotriene B4 metabolic process,BP,
10137,GO:0036105,1,0.993424517206004,0,1,peroxisome membrane class-1 targeting sequence binding,MF,
10138,GO:0036109,1,0.926314544717565,0,12,alpha-linolenic acid metabolic process,BP,
10139,GO:0036111,1,0.993898696585579,0,1,very long-chain fatty-acyl-CoA metabolic process,BP,
10140,GO:0036112,1,0.982255705944413,0,3,medium-chain fatty-acyl-CoA metabolic process,BP,
10141,GO:0036114,1,0.994497794456455,0,1,medium-chain fatty-acyl-CoA catabolic process,BP,
10142,GO:0036115,1,0.994497794456455,0,1,fatty-acyl-CoA catabolic process,BP,
10143,GO:0036116,1,0.994497794456455,0,1,long-chain fatty-acyl-CoA catabolic process,BP,
10144,GO:0036117,1,0.988197767537004,0,2,hyaluranon cable,CC,
10145,GO:0036118,1,0.981487606881003,0,3,hyaluranon cable assembly,BP,
10146,GO:0036119,1,0.862846378515904,0,21,response to platelet-derived growth factor,BP,
10147,GO:0036120,1,0.868273830384033,0,20,cellular response to platelet-derived growth factor stimulus,BP,
10148,GO:0036122,1,0.942597222058484,0,9,BMP binding,MF,
10149,GO:0036123,1,0.964009467080652,0,6,histone H3-K9 dimethylation,BP,
10150,GO:0036124,1,0.905415251608915,0,14,histone H3-K9 trimethylation,BP,
10151,GO:0036125,1,0.993713970873707,0,1,fatty acid beta-oxidation multienzyme complex,CC,
10154,GO:0036130,1,0.994655127578734,0,1,prostaglandin H2 endoperoxidase reductase activity,MF,
10155,GO:0036131,1,0.994655127578734,0,1,prostaglandin D2 11-ketoreductase activity,MF,
10156,GO:0036132,1,0.981177499348756,0,3,13-prostaglandin reductase activity,MF,
10157,GO:0036134,1,0.994197004383004,0,1,12-hydroxyheptadecatrienoic acid synthase activity,MF,
10158,GO:0036135,1,0.985448406373991,0,2,Schwann cell migration,BP,
10159,GO:0036137,1,0.988195610530937,0,2,kynurenine aminotransferase activity,MF,
10160,GO:0036138,1,0.991706498478991,0,1,peptidyl-histidine hydroxylation,BP,
10161,GO:0036139,1,0.991706498478991,0,1,peptidyl-histidine dioxygenase activity,MF,
10162,GO:0036140,1,0.991706498478991,0,1,peptidyl-asparagine 3-dioxygenase activity,MF,
10163,GO:0036143,1,0.994849881731338,0,1,kringle domain binding,MF,
10164,GO:0036145,1,0.994368331352244,0,1,dendritic cell homeostasis,BP,
10165,GO:0036146,1,0.969291620665848,0,5,cellular response to mycotoxin,BP,
10166,GO:0036148,1,0.919181272323781,0,13,phosphatidylglycerol acyl-chain remodeling,BP,
10167,GO:0036149,1,0.941372385431848,0,10,phosphatidylinositol acyl-chain remodeling,BP,
10168,GO:0036150,1,0.909799512215903,0,15,phosphatidylserine acyl-chain remodeling,BP,
10169,GO:0036151,1,0.877739253479111,0,21,phosphatidylcholine acyl-chain remodeling,BP,
10170,GO:0036152,1,0.886372407561304,0,20,phosphatidylethanolamine acyl-chain remodeling,BP,
10171,GO:0036153,1,0.993838056023524,0,1,triglyceride acyl-chain remodeling,BP,
10172,GO:0036155,1,0.968857221348455,0,5,acylglycerol acyl-chain remodeling,BP,
10173,GO:0036156,1,0.957539639941448,0,4,inner dynein arm,CC,
10174,GO:0036157,1,0.934356605482483,0,9,outer dynein arm,CC,
10175,GO:0036158,1,0.895343124675815,0,16,outer dynein arm assembly,BP,
10176,GO:0036159,1,0.901412052079706,0,14,inner dynein arm assembly,BP,
10177,GO:0036164,1,0.994720738185183,0,1,cell-abiotic substrate adhesion,BP,
10178,GO:0036166,1,0.971528052622826,0,4,phenotypic switching,BP,
10179,GO:0036179,1,0.993865281541942,0,1,osteoclast maturation,BP,
10180,GO:0036194,1,0.983559100715053,0,3,muscle cell projection,CC,
10181,GO:0036195,1,0.983559100715053,0,3,muscle cell projection membrane,CC,
10183,GO:0036213,1,0.994161620261592,0,1,contractile ring contraction,BP,
10184,GO:0036215,1,0.986414845130923,0,2,response to stem cell factor,BP,
10185,GO:0036216,1,0.986414845130923,0,2,cellular response to stem cell factor stimulus,BP,
10186,GO:0036219,1,0.994920131708846,0,1,GTP diphosphatase activity,MF,
10187,GO:0036220,1,0.994719963282845,0,1,ITP diphosphatase activity,MF,
10188,GO:0036222,1,0.994719963282845,0,1,XTP diphosphatase activity,MF,
10189,GO:0036228,1,0.987178448082562,0,2,protein localization to nuclear inner membrane,BP,
10190,GO:0036230,1,0.0500331855026653,0,470,granulocyte activation,BP,
10191,GO:0036245,1,0.98735077856763,0,2,cellular response to menadione,BP,
10192,GO:0036250,1,0.994292348474168,0,1,peroxisome transport along microtubule,BP,
10193,GO:0036255,1,0.99331653001693,0,1,response to methylamine,BP,
10194,GO:0036257,1,0.828092965607987,0,31,multivesicular body organization,BP,
10195,GO:0036258,1,0.833233964995643,0,30,multivesicular body assembly,BP,
10196,GO:0036260,1,0.822317741719431,0,32,RNA capping,BP,
10197,GO:0036261,1,0.993382740290077,0,1,7-methylguanosine cap hypermethylation,BP,
10198,GO:0036265,1,0.976279165726559,0,4,RNA (guanine-N7)-methylation,BP,
10199,GO:0036266,1,0.993971010586614,0,1,Cdc48p-Npl4p-Vms1p AAA ATPase complex,CC,
10200,GO:0036269,1,0.986576256234835,0,2,swimming behavior,BP,
10201,GO:0036270,1,0.869350455923668,0,18,response to diuretic,BP,
10202,GO:0036284,1,0.985882011529478,0,2,tubulobulbar complex,CC,
10203,GO:0036289,1,0.951548351709543,0,7,peptidyl-serine autophosphorylation,BP,
10204,GO:0036290,1,0.993216182234582,0,1,protein trans-autophosphorylation,BP,
10205,GO:0036292,1,0.987974365385026,0,2,DNA rewinding,BP,
10206,GO:0036293,1,0.113498732045789,0,331,response to decreased oxygen levels,BP,
10207,GO:0036294,1,0.293978429433439,0,189,cellular response to decreased oxygen levels,BP,
10208,GO:0036295,1,0.920268813763488,0,13,cellular response to increased oxygen levels,BP,
10209,GO:0036296,1,0.842230209863755,0,27,response to increased oxygen levels,BP,
10210,GO:0036297,1,0.752623912594395,0,44,interstrand cross-link repair,BP,
10211,GO:0036301,1,0.969675561641522,0,5,macrophage colony-stimulating factor production,BP,
10212,GO:0036302,1,0.948568332551864,0,7,atrioventricular canal development,BP,
10213,GO:0036303,1,0.876730105903625,0,18,lymph vessel morphogenesis,BP,
10214,GO:0036304,1,0.988045763276731,0,2,umbilical cord morphogenesis,BP,
10215,GO:0036306,1,0.99446213715747,0,1,embryonic heart tube elongation,BP,
10216,GO:0036309,1,0.975243284572177,0,2,protein localization to M-band,BP,
10217,GO:0036310,1,0.949369899175816,0,8,annealing helicase activity,MF,
10218,GO:0036312,1,0.939214477914278,0,8,phosphatidylinositol 3-kinase regulatory subunit binding,MF,
10219,GO:0036313,1,0.994031565328439,0,1,phosphatidylinositol 3-kinase catalytic subunit binding,MF,
10220,GO:0036314,1,0.84386868094767,0,23,response to sterol,BP,
10221,GO:0036315,1,0.894772872696842,0,15,cellular response to sterol,BP,
10222,GO:0036316,1,0.993886869730289,0,1,SREBP-SCAP complex retention in endoplasmic reticulum,BP,
10223,GO:0036317,1,0.993850639026861,0,1,tyrosyl-RNA phosphodiesterase activity,MF,
10224,GO:0036323,1,0.992842123278886,0,1,vascular endothelial growth factor receptor-1 signaling pathway,BP,
10225,GO:0036324,1,0.98771453596703,0,2,vascular endothelial growth factor receptor-2 signaling pathway,BP,
10226,GO:0036326,1,0.992842123278886,0,1,VEGF-A-activated receptor activity,MF,
10227,GO:0036327,1,0.992842123278886,0,1,VEGF-B-activated receptor activity,MF,
10228,GO:0036328,1,0.992600415177484,0,1,VEGF-C-activated receptor activity,MF,
10229,GO:0036332,1,0.992842123278886,0,1,placental growth factor-activated receptor activity,MF,
10230,GO:0036333,1,0.993928277755103,0,1,hepatocyte homeostasis,BP,
10231,GO:0036335,1,0.992572378383314,0,1,intestinal stem cell homeostasis,BP,
10232,GO:0036336,1,0.848629177427461,0,26,dendritic cell migration,BP,
10233,GO:0036337,1,0.973027719501592,0,4,Fas signaling pathway,BP,
10235,GO:0036343,1,0.977240755365563,0,4,psychomotor behavior,BP,
10236,GO:0036344,1,0.879680791570589,0,19,platelet morphogenesis,BP,
10237,GO:0036345,1,0.988238153178859,0,2,platelet maturation,BP,
10238,GO:0036351,1,0.99409192116475,0,1,histone H2A-K13 ubiquitination,BP,
10239,GO:0036352,1,0.99409192116475,0,1,histone H2A-K15 ubiquitination,BP,
10240,GO:0036353,1,0.953976221227014,0,7,histone H2A-K119 monoubiquitination,BP,
10241,GO:0036361,1,0.994007335679593,0,1,racemase activity, acting on amino acids and derivatives,MF,
10242,GO:0036363,1,0.98694187695716,0,2,transforming growth factor beta activation,BP,
10243,GO:0036367,1,0.99396302755062,0,1,light adaption,BP,
10244,GO:0036369,1,0.982845527741141,0,2,transcription factor catabolic process,BP,
10245,GO:0036371,1,0.991079802654305,0,1,protein localization to T-tubule,BP,
10246,GO:0036372,1,0.994784794930311,0,1,opsin transport,BP,
10247,GO:0036374,1,0.982090602941592,0,3,glutathione hydrolase activity,MF,
10249,GO:0036378,1,0.988488211144106,0,2,calcitriol biosynthetic process from calciol,BP,
10251,GO:0036387,1,0.982729455714152,0,3,pre-replicative complex,CC,
10252,GO:0036388,1,0.982729455714152,0,3,pre-replicative complex assembly,BP,
10253,GO:0036392,1,0.993374277796434,0,1,chemokine (C-C motif) ligand 20 production,BP,
10254,GO:0036393,1,0.993792894375982,0,1,thiocyanate peroxidase activity,MF,
10255,GO:0036396,1,0.982966982244679,0,3,RNA N6-methyladenosine methyltransferase complex,CC,
10256,GO:0036398,1,0.987663091654951,0,2,TCR signalosome,CC,
10257,GO:0036399,1,0.993596251514619,0,1,TCR signalosome assembly,BP,
10258,GO:0036402,1,0.967510258001386,0,6,proteasome-activating ATPase activity,MF,
10259,GO:0036403,1,0.993931622930891,0,1,arachidonate 8(S)-lipoxygenase activity,MF,
10260,GO:0036404,1,0.989975151946925,0,1,conversion of ds siRNA to ss siRNA,BP,
10261,GO:0036413,1,0.987187707095063,0,2,histone H3-R26 citrullination,BP,
10262,GO:0036414,1,0.980907620431613,0,3,histone citrullination,BP,
10263,GO:0036435,1,0.987951169422062,0,2,K48-linked polyubiquitin modification-dependent protein binding,MF,
10264,GO:0036438,1,0.974742552122322,0,4,maintenance of lens transparency,BP,
10265,GO:0036440,1,0.993749318054857,0,1,citrate synthase activity,MF,
10266,GO:0036442,1,0.84515260969444,0,27,proton-exporting ATPase activity,MF,
10267,GO:0036444,1,0.949626336615687,0,8,calcium import into the mitochondrion,BP,
10269,GO:0036446,1,0.979170570163523,0,3,myofibroblast differentiation,BP,
10271,GO:0036451,1,0.987738712940129,0,2,cap mRNA methylation,BP,
10272,GO:0036452,1,0.843520422484341,0,28,ESCRT complex,CC,
10273,GO:0036454,1,0.966962763748725,0,5,growth factor complex,CC,
10274,GO:0036455,1,0.994708081373426,0,1,iron-sulfur transferase activity,MF,
10275,GO:0036458,1,0.994154906260876,0,1,hepatocyte growth factor binding,MF,
10276,GO:0036459,1,0.535869569890285,0,88,thiol-dependent ubiquitinyl hydrolase activity,MF,
10277,GO:0036461,1,0.989258873433225,0,2,BLOC-2 complex binding,MF,
10278,GO:0036462,1,0.957281178666905,0,7,TRAIL-activated apoptotic signaling pathway,BP,
10279,GO:0036464,1,0.308582577388131,0,178,cytoplasmic ribonucleoprotein granule,CC,
10281,GO:0036466,1,0.985791839357746,0,2,synaptic vesicle recycling via endosome,BP,
10282,GO:0036468,1,0.994244541695516,0,1,L-dopa decarboxylase activity,MF,
10283,GO:0036470,1,0.994806490833661,0,1,tyrosine 3-monooxygenase activator activity,MF,
10284,GO:0036471,1,0.994806490833661,0,1,cellular response to glyoxal,BP,
10285,GO:0036473,1,0.625296240151279,0,73,cell death in response to oxidative stress,BP,
10286,GO:0036474,1,0.84757780762238,0,26,cell death in response to hydrogen peroxide,BP,
10287,GO:0036475,1,0.868777803213263,0,21,neuron death in response to oxidative stress,BP,
10288,GO:0036476,1,0.975928539262051,0,4,neuron death in response to hydrogen peroxide,BP,
10290,GO:0036478,1,0.994806490833661,0,1,L-dopa decarboxylase activator activity,MF,
10291,GO:0036479,1,0.990489208522649,0,1,peroxidase inhibitor activity,MF,
10292,GO:0036480,1,0.956355606209587,0,7,neuron intrinsic apoptotic signaling pathway in response to oxidative stress,BP,
10293,GO:0036481,1,0.96551143002768,0,6,intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
10294,GO:0036482,1,0.988751396060123,0,2,neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
10295,GO:0036483,1,0.992936770176133,0,1,neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,
10296,GO:0036484,1,0.97996632189811,0,3,trunk neural crest cell migration,BP,
10297,GO:0036486,1,0.97996632189811,0,3,ventral trunk neural crest cell migration,BP,
10298,GO:0036487,1,0.990713196986705,0,1,nitric-oxide synthase inhibitor activity,MF,
10299,GO:0036488,1,0.989189877602012,0,2,CHOP-C/EBP complex,CC,
10300,GO:0036490,1,0.947456623798509,0,8,regulation of translation in response to endoplasmic reticulum stress,BP,
10301,GO:0036491,1,0.953668147051145,0,7,regulation of translation initiation in response to endoplasmic reticulum stress,BP,
10302,GO:0036492,1,0.959370243768048,0,6,eiF2alpha phosphorylation in response to endoplasmic reticulum stress,BP,
10303,GO:0036493,1,0.980920495651845,0,3,positive regulation of translation in response to endoplasmic reticulum stress,BP,
10304,GO:0036494,1,0.992399897484993,0,1,positive regulation of translation initiation in response to endoplasmic reticulum stress,BP,
10305,GO:0036496,1,0.988619106121224,0,2,regulation of translational initiation by eIF2 alpha dephosphorylation,BP,
10306,GO:0036497,1,0.994058899436136,0,1,eIF2alpha dephosphorylation in response to endoplasmic reticulum stress,BP,
10307,GO:0036498,1,0.646625096210067,0,67,IRE1-mediated unfolded protein response,BP,
10308,GO:0036499,1,0.883220703801931,0,20,PERK-mediated unfolded protein response,BP,
10309,GO:0036500,1,0.939590226568056,0,10,ATF6-mediated unfolded protein response,BP,
10310,GO:0036501,1,0.993025194891002,0,1,UFD1-NPL4 complex,CC,
10311,GO:0036502,1,0.993671475702717,0,1,Derlin-1-VIMP complex,CC,
10313,GO:0036505,1,0.987821317680433,0,2,prosaposin receptor activity,MF,
10314,GO:0036506,1,0.979367901789858,0,3,maintenance of unfolded protein,BP,
10315,GO:0036507,1,0.850693294970125,0,24,protein demannosylation,BP,
10316,GO:0036508,1,0.850693294970125,0,24,protein alpha-1,2-demannosylation,BP,
10317,GO:0036509,1,0.988205604012407,0,2,trimming of terminal mannose on B branch,BP,
10318,GO:0036510,1,0.980398220486858,0,3,trimming of terminal mannose on C branch,BP,
10319,GO:0036511,1,0.988205604012407,0,2,trimming of first mannose on A branch,BP,
10320,GO:0036512,1,0.988205604012407,0,2,trimming of second mannose on A branch,BP,
10321,GO:0036513,1,0.931510296382302,0,11,Derlin-1 retrotranslocation complex,CC,
10322,GO:0036514,1,0.961531057713835,0,5,dopaminergic neuron axon guidance,BP,
10323,GO:0036515,1,0.967562886465183,0,4,serotonergic neuron axon guidance,BP,
10324,GO:0036517,1,0.992268880590988,0,1,chemoattraction of serotonergic neuron axon,BP,
10325,GO:0036518,1,0.986084602979642,0,2,chemorepulsion of dopaminergic neuron axon,BP,
10326,GO:0036524,1,0.994806490833661,0,1,protein deglycase activity,MF,
10327,GO:0036525,1,0.994806490833661,0,1,protein deglycation,BP,
10328,GO:0036526,1,0.994806490833661,0,1,peptidyl-cysteine deglycation,BP,
10329,GO:0036527,1,0.994806490833661,0,1,peptidyl-arginine deglycation,BP,
10330,GO:0036528,1,0.994806490833661,0,1,peptidyl-lysine deglycation,BP,
10331,GO:0036529,1,0.994806490833661,0,1,protein deglycation, glyoxal removal,BP,
10332,GO:0036530,1,0.994806490833661,0,1,protein deglycation, methylglyoxal removal,BP,
10333,GO:0036531,1,0.994806490833661,0,1,glutathione deglycation,BP,
10334,GO:0038001,1,0.97643597998903,0,3,paracrine signaling,BP,
10335,GO:0038002,1,0.992519173708898,0,1,endocrine signaling,BP,
10336,GO:0038003,1,0.941867960230052,0,10,opioid receptor signaling pathway,BP,
10337,GO:0038007,1,0.948835477115475,0,7,netrin-activated signaling pathway,BP,
10338,GO:0038016,1,0.987626927713513,0,2,insulin receptor internalization,BP,
10339,GO:0038018,1,0.984892725387559,0,2,Wnt receptor catabolic process,BP,
10340,GO:0038021,1,0.993091604575837,0,1,leptin receptor activity,MF,
10343,GO:0038025,1,0.986584971179042,0,2,reelin receptor activity,MF,
10344,GO:0038026,1,0.969156204015469,0,4,reelin-mediated signaling pathway,BP,
10345,GO:0038027,1,0.960974507148612,0,5,apolipoprotein A-I-mediated signaling pathway,BP,
10346,GO:0038028,1,0.973870748550202,0,4,insulin receptor signaling pathway via phosphatidylinositol 3-kinase,BP,
10347,GO:0038030,1,0.954232812578985,0,7,non-canonical Wnt signaling pathway via MAPK cascade,BP,
10348,GO:0038031,1,0.960693719319123,0,6,non-canonical Wnt signaling pathway via JNK cascade,BP,
10349,GO:0038033,1,0.967849351217391,0,5,positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway,BP,
10350,GO:0038034,1,0.65226895522914,0,67,signal transduction in absence of ligand,BP,
10352,GO:0038037,1,0.948643986017816,0,8,G-protein coupled receptor dimeric complex,CC,
10353,GO:0038038,1,0.991713266135945,0,1,G-protein coupled receptor homodimeric complex,CC,
10354,GO:0038039,1,0.985379074835398,0,2,G-protein coupled receptor heterodimeric complex,CC,
10355,GO:0038042,1,0.957467197769814,0,7,dimeric G-protein coupled receptor signaling pathway,BP,
10356,GO:0038043,1,0.987069283964201,0,2,interleukin-5-mediated signaling pathway,BP,
10357,GO:0038044,1,0.9636377694796,0,5,transforming growth factor-beta secretion,BP,
10358,GO:0038046,1,0.994372983298238,0,1,enkephalin receptor activity,MF,
10359,GO:0038047,1,0.994324912224097,0,1,morphine receptor activity,MF,
10360,GO:0038048,1,0.992729490465192,0,1,dynorphin receptor activity,MF,
10361,GO:0038049,1,0.981320929806194,0,2,transcription factor activity, ligand-activated RNA polymerase II transcription factor binding,MF,
10362,GO:0038051,1,0.991861238675255,0,1,glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity,MF,
10363,GO:0038052,1,0.986069731112128,0,2,RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding,MF,
10364,GO:0038060,1,0.993564017723362,0,1,nitric oxide-cGMP-mediated signaling pathway,BP,
10365,GO:0038061,1,0.488896407749119,0,117,NIK/NF-kappaB signaling,BP,
10366,GO:0038062,1,0.986987915840521,0,2,protein tyrosine kinase collagen receptor activity,MF,
10367,GO:0038063,1,0.932696153955555,0,9,collagen-activated tyrosine kinase receptor signaling pathway,BP,
10368,GO:0038064,1,0.971150449681993,0,4,collagen receptor activity,MF,
10369,GO:0038065,1,0.917721391201169,0,11,collagen-activated signaling pathway,BP,
10370,GO:0038066,1,0.786818619256548,0,37,p38MAPK cascade,BP,
10371,GO:0038083,1,0.699621277609239,0,52,peptidyl-tyrosine autophosphorylation,BP,
10375,GO:0038089,1,0.952460616761351,0,7,positive regulation of cell migration by vascular endothelial growth factor signaling pathway,BP,
10377,GO:0038092,1,0.912937886624133,0,14,nodal signaling pathway,BP,
10378,GO:0038093,1,0.324120855916738,0,178,Fc receptor signaling pathway,BP,
10379,GO:0038094,1,0.619793379386031,0,74,Fc-gamma receptor signaling pathway,BP,
10380,GO:0038095,1,0.477947050825608,0,118,Fc-epsilon receptor signaling pathway,BP,
10381,GO:0038096,1,0.633797111526142,0,70,Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
10382,GO:0038097,1,0.992544860536912,0,1,positive regulation of mast cell activation by Fc-epsilon receptor signaling pathway,BP,
10383,GO:0038098,1,0.987411055662645,0,2,sequestering of BMP from receptor via BMP binding,BP,
10384,GO:0038100,1,0.985105405275463,0,2,nodal binding,MF,
10385,GO:0038101,1,0.99439520866328,0,1,sequestering of nodal from receptor via nodal binding,BP,
10386,GO:0038107,1,0.956961320762967,0,7,nodal signaling pathway involved in determination of left/right asymmetry,BP,
10387,GO:0038108,1,0.975519549340456,0,4,negative regulation of appetite by leptin-mediated signaling pathway,BP,
10388,GO:0038109,1,0.986414845130923,0,2,Kit signaling pathway,BP,
10389,GO:0038110,1,0.928318471387135,0,11,interleukin-2-mediated signaling pathway,BP,
10390,GO:0038111,1,0.885809132103596,0,18,interleukin-7-mediated signaling pathway,BP,
10391,GO:0038112,1,0.987904668026335,0,2,interleukin-8-mediated signaling pathway,BP,
10392,GO:0038113,1,0.979770267631625,0,3,interleukin-9-mediated signaling pathway,BP,
10393,GO:0038114,1,0.954178537450029,0,7,interleukin-21-mediated signaling pathway,BP,
10394,GO:0038115,1,0.994167818170529,0,1,chemokine (C-C motif) ligand 19 signaling pathway,BP,
10395,GO:0038116,1,0.994167818170529,0,1,chemokine (C-C motif) ligand 21 signaling pathway,BP,
10396,GO:0038117,1,0.994167818170529,0,1,C-C motif chemokine 19 receptor activity,MF,
10397,GO:0038118,1,0.994745534763665,0,1,C-C chemokine receptor CCR7 signaling pathway,BP,
10398,GO:0038121,1,0.994167818170529,0,1,C-C motif chemokine 21 receptor activity,MF,
10399,GO:0038123,1,0.981930585200786,0,3,toll-like receptor TLR1:TLR2 signaling pathway,BP,
10400,GO:0038124,1,0.974709836488574,0,4,toll-like receptor TLR6:TLR2 signaling pathway,BP,
10401,GO:0038127,1,0.383400774433771,0,141,ERBB signaling pathway,BP,
10402,GO:0038128,1,0.77552559382806,0,38,ERBB2 signaling pathway,BP,
10403,GO:0038129,1,0.982421691846115,0,3,ERBB3 signaling pathway,BP,
10404,GO:0038131,1,0.987927394737587,0,2,neuregulin receptor activity,MF,
10405,GO:0038132,1,0.963211738689881,0,5,neuregulin binding,MF,
10406,GO:0038133,1,0.994233947988402,0,1,ERBB2-ERBB3 signaling pathway,BP,
10407,GO:0038145,1,0.969369786776105,0,5,macrophage colony-stimulating factor signaling pathway,BP,
10408,GO:0038154,1,0.993639232728281,0,1,interleukin-11-mediated signaling pathway,BP,
10409,GO:0038155,1,0.956023992525105,0,7,interleukin-23-mediated signaling pathway,BP,
10410,GO:0038156,1,0.992784399618236,0,1,interleukin-3-mediated signaling pathway,BP,
10411,GO:0038158,1,0.987968315136118,0,2,granulocyte colony-stimulating factor signaling pathway,BP,
10412,GO:0038161,1,0.983117551039665,0,2,prolactin signaling pathway,BP,
10413,GO:0038162,1,0.98165673986615,0,3,erythropoietin-mediated signaling pathway,BP,
10414,GO:0038163,1,0.982645344308719,0,3,thrombopoietin-mediated signaling pathway,BP,
10415,GO:0038164,1,0.993406836840875,0,1,thrombopoietin receptor activity,MF,
10416,GO:0038165,1,0.97169037338947,0,4,oncostatin-M-mediated signaling pathway,BP,
10417,GO:0038166,1,0.94528218760201,0,9,angiotensin-activated signaling pathway,BP,
10418,GO:0038167,1,0.992518649459711,0,1,epidermal growth factor receptor signaling pathway via positive regulation of NF-kappaB transcription factor activity,BP,
10419,GO:0038168,1,0.992518649459711,0,1,epidermal growth factor receptor signaling pathway via I-kappaB kinase/NF-kappaB cascade,BP,
10420,GO:0038169,1,0.976012207550872,0,4,somatostatin receptor signaling pathway,BP,
10421,GO:0038170,1,0.976012207550872,0,4,somatostatin signaling pathway,BP,
10422,GO:0038171,1,0.954146931614478,0,7,cannabinoid signaling pathway,BP,
10423,GO:0038172,1,0.981469090388133,0,3,interleukin-33-mediated signaling pathway,BP,
10424,GO:0038178,1,0.987967242366608,0,2,complement component C5a signaling pathway,BP,
10425,GO:0038179,1,0.791509236518041,0,35,neurotrophin signaling pathway,BP,
10426,GO:0038180,1,0.921676911955395,0,12,nerve growth factor signaling pathway,BP,
10427,GO:0038181,1,0.981662341672058,0,3,bile acid receptor activity,MF,
10428,GO:0038182,1,0.99451768923251,0,1,G-protein coupled bile acid receptor activity,MF,
10429,GO:0038183,1,0.981662341672058,0,3,bile acid signaling pathway,BP,
10430,GO:0038184,1,0.99451768923251,0,1,cell surface bile acid receptor signaling pathway,BP,
10431,GO:0038185,1,0.994178148773045,0,1,intracellular bile acid receptor signaling pathway,BP,
10432,GO:0038186,1,0.992855173037058,0,1,lithocholic acid receptor activity,MF,
10433,GO:0038187,1,0.916320894771822,0,14,pattern recognition receptor activity,MF,
10434,GO:0038188,1,0.988645223297408,0,2,cholecystokinin signaling pathway,BP,
10435,GO:0038189,1,0.974268744734081,0,4,neuropilin signaling pathway,BP,
10436,GO:0038190,1,0.987517179471662,0,2,VEGF-activated neuropilin signaling pathway,BP,
10437,GO:0038191,1,0.871126167412628,0,19,neuropilin binding,MF,
10438,GO:0038192,1,0.994238082048865,0,1,gastric inhibitory peptide signaling pathway,BP,
10439,GO:0038193,1,0.99411592245597,0,1,thromboxane A2 signaling pathway,BP,
10440,GO:0038194,1,0.987974264394164,0,2,thyroid-stimulating hormone signaling pathway,BP,
10441,GO:0038195,1,0.99454507577888,0,1,urokinase plasminogen activator signaling pathway,BP,
10442,GO:0038201,1,0.897716813221743,0,16,TOR complex,CC,
10443,GO:0038202,1,0.807487553002302,0,32,TORC1 signaling,BP,
10444,GO:0038203,1,0.957333279415204,0,7,TORC2 signaling,BP,
10445,GO:0039003,1,0.986508997543432,0,2,pronephric field specification,BP,
10446,GO:0039007,1,0.992417985007152,0,1,pronephric nephron morphogenesis,BP,
10447,GO:0039008,1,0.992417985007152,0,1,pronephric nephron tubule morphogenesis,BP,
10448,GO:0039017,1,0.986508997543432,0,2,pattern specification involved in pronephros development,BP,
10449,GO:0039019,1,0.985878888415282,0,2,pronephric nephron development,BP,
10450,GO:0039020,1,0.992417985007152,0,1,pronephric nephron tubule development,BP,
10451,GO:0039022,1,0.992417985007152,0,1,pronephric duct development,BP,
10452,GO:0039023,1,0.992417985007152,0,1,pronephric duct morphogenesis,BP,
10453,GO:0039502,1,0.992596485148829,0,1,suppression by virus of host type I interferon-mediated signaling pathway,BP,
10454,GO:0039503,1,0.992596485148829,0,1,suppression by virus of host innate immune response,BP,
10455,GO:0039506,1,0.986504179167762,0,2,modulation by virus of host molecular function,BP,
10456,GO:0039507,1,0.986504179167762,0,2,suppression by virus of host molecular function,BP,
10457,GO:0039513,1,0.993862712286301,0,1,suppression by virus of host catalytic activity,BP,
10458,GO:0039514,1,0.992596485148829,0,1,suppression by virus of host JAK-STAT cascade,BP,
10459,GO:0039516,1,0.993862712286301,0,1,modulation by virus of host catalytic activity,BP,
10460,GO:0039519,1,0.985196084324965,0,2,modulation by virus of host autophagy,BP,
10461,GO:0039520,1,0.992421392890153,0,1,induction by virus of host autophagy,BP,
10462,GO:0039521,1,0.992720072441794,0,1,suppression by virus of host autophagy,BP,
10463,GO:0039526,1,0.98270263562849,0,3,modulation by virus of host apoptotic process,BP,
10464,GO:0039528,1,0.872245155221257,0,20,cytoplasmic pattern recognition receptor signaling pathway in response to virus,BP,
10465,GO:0039529,1,0.899226038074433,0,15,RIG-I signaling pathway,BP,
10466,GO:0039530,1,0.948012322798099,0,8,MDA-5 signaling pathway,BP,
10467,GO:0039531,1,0.900349633973043,0,15,regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,BP,
10468,GO:0039532,1,0.94296392279895,0,9,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,BP,
10469,GO:0039533,1,0.965057669958946,0,5,regulation of MDA-5 signaling pathway,BP,
10470,GO:0039534,1,0.981934941264583,0,3,negative regulation of MDA-5 signaling pathway,BP,
10471,GO:0039535,1,0.911790227950637,0,13,regulation of RIG-I signaling pathway,BP,
10472,GO:0039536,1,0.954940381177205,0,7,negative regulation of RIG-I signaling pathway,BP,
10473,GO:0039552,1,0.992444986426735,0,1,RIG-I binding,MF,
10474,GO:0039562,1,0.992596485148829,0,1,suppression by virus of host STAT activity,BP,
10475,GO:0039563,1,0.992596485148829,0,1,suppression by virus of host STAT1 activity,BP,
10476,GO:0039564,1,0.992596485148829,0,1,suppression by virus of host STAT2 activity,BP,
10477,GO:0039650,1,0.993862712286301,0,1,suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process,BP,
10478,GO:0039656,1,0.981977421691131,0,3,modulation by virus of host gene expression,BP,
10479,GO:0039663,1,0.964310865453964,0,6,membrane fusion involved in viral entry into host cell,BP,
10480,GO:0039689,1,0.981445370669152,0,3,negative stranded viral RNA replication,BP,
10483,GO:0039695,1,0.992902900696797,0,1,DNA-templated viral transcription,BP,
10484,GO:0039702,1,0.881801557013655,0,21,viral budding via host ESCRT complex,BP,
10485,GO:0039706,1,0.93135584726221,0,11,co-receptor binding,MF,
10486,GO:0039713,1,0.993514637734672,0,1,viral factory,CC,
10487,GO:0039714,1,0.993514637734672,0,1,cytoplasmic viral factory,CC,
10491,GO:0040009,1,0.961743491669698,0,5,regulation of growth rate,BP,
10492,GO:0040010,1,0.994920131708846,0,1,positive regulation of growth rate,BP,
10496,GO:0040014,1,0.66541969861433,0,60,regulation of multicellular organism growth,BP,
10497,GO:0040015,1,0.927831520711063,0,11,negative regulation of multicellular organism growth,BP,
10500,GO:0040018,1,0.822073269707532,0,29,positive regulation of multicellular organism growth,BP,
10501,GO:0040019,1,0.82113726077871,0,29,positive regulation of embryonic development,BP,
10502,GO:0040020,1,0.848086756683847,0,26,regulation of meiotic nuclear division,BP,
10503,GO:0040029,1,0.165686754722031,0,266,regulation of gene expression, epigenetic,BP,
10504,GO:0040030,1,0.988354865553031,0,2,regulation of molecular function, epigenetic,BP,
10505,GO:0040031,1,0.966620017312681,0,6,snRNA modification,BP,
10506,GO:0040032,1,0.994310697694815,0,1,post-embryonic body morphogenesis,BP,
10507,GO:0040033,1,0.909196757233206,0,13,negative regulation of translation, ncRNA-mediated,BP,
10508,GO:0040034,1,0.924257351603196,0,12,regulation of development, heterochronic,BP,
10509,GO:0040036,1,0.841740745301285,0,26,regulation of fibroblast growth factor receptor signaling pathway,BP,
10510,GO:0040037,1,0.916574465185978,0,13,negative regulation of fibroblast growth factor receptor signaling pathway,BP,
10511,GO:0040038,1,0.978215190868673,0,3,polar body extrusion after meiotic divisions,BP,
10512,GO:0040040,1,0.992146396651589,0,1,thermosensory behavior,BP,
10513,GO:0042000,1,0.994040589463601,0,1,translocation of peptides or proteins into host,BP,
10514,GO:0042007,1,0.994555410016131,0,1,interleukin-18 binding,MF,
10515,GO:0042008,1,0.993471894822818,0,1,interleukin-18 receptor activity,MF,
10516,GO:0042011,1,0.993684785110246,0,1,interleukin-16 binding,MF,
10517,GO:0042012,1,0.993684785110246,0,1,interleukin-16 receptor activity,MF,
10518,GO:0042015,1,0.981579483902664,0,3,interleukin-20 binding,MF,
10519,GO:0042019,1,0.994262112923769,0,1,interleukin-23 binding,MF,
10520,GO:0042020,1,0.994262112923769,0,1,interleukin-23 receptor activity,MF,
10521,GO:0042022,1,0.994262112923769,0,1,interleukin-12 receptor complex,CC,
10522,GO:0042023,1,0.943472631456917,0,8,DNA endoreduplication,BP,
10523,GO:0042025,1,0.980022225397132,0,3,host cell nucleus,CC,
10525,GO:0042030,1,0.978723428855716,0,3,ATPase inhibitor activity,MF,
10526,GO:0042033,1,0.932564923440907,0,12,chemokine biosynthetic process,BP,
10527,GO:0042035,1,0.578518422148809,0,87,regulation of cytokine biosynthetic process,BP,
10528,GO:0042036,1,0.843673842704358,0,28,negative regulation of cytokine biosynthetic process,BP,
10529,GO:0042040,1,0.993089013418687,0,1,metal incorporation into metallo-molybdopterin complex,BP,
10530,GO:0042043,1,0.913809287659851,0,13,neurexin family protein binding,MF,
10532,GO:0042045,1,0.951445922846529,0,7,epithelial fluid transport,BP,
10533,GO:0042048,1,0.947286097925602,0,7,olfactory behavior,BP,
10534,GO:0042053,1,0.89326247948289,0,18,regulation of dopamine metabolic process,BP,
10535,GO:0042054,1,0.69874034206934,0,53,histone methyltransferase activity,MF,
10536,GO:0042056,1,0.877921252579255,0,22,chemoattractant activity,MF,
10537,GO:0042058,1,0.606641762732689,0,77,regulation of epidermal growth factor receptor signaling pathway,BP,
10538,GO:0042059,1,0.765254831250737,0,41,negative regulation of epidermal growth factor receptor signaling pathway,BP,
10541,GO:0042069,1,0.89326247948289,0,18,regulation of catecholamine metabolic process,BP,
10542,GO:0042073,1,0.71565724144694,0,50,intraciliary transport,BP,
10544,GO:0042078,1,0.982077747473234,0,3,germ-line stem cell division,BP,
10545,GO:0042083,1,0.994469630547694,0,1,5,10-methylenetetrahydrofolate-dependent methyltransferase activity,MF,
10546,GO:0042084,1,0.989815143901705,0,1,5-methyltetrahydrofolate-dependent methyltransferase activity,MF,
10547,GO:0042088,1,0.801017365891557,0,36,T-helper 1 type immune response,BP,
10548,GO:0042089,1,0.557371950323766,0,93,cytokine biosynthetic process,BP,
10549,GO:0042090,1,0.954966026132682,0,7,interleukin-12 biosynthetic process,BP,
10550,GO:0042091,1,0.980415978363259,0,3,interleukin-10 biosynthetic process,BP,
10551,GO:0042092,1,0.818881610146188,0,33,type 2 immune response,BP,
10552,GO:0042093,1,0.732157922976142,0,48,T-helper cell differentiation,BP,
10553,GO:0042094,1,0.884334929366427,0,20,interleukin-2 biosynthetic process,BP,
10554,GO:0042095,1,0.912818382728587,0,15,interferon-gamma biosynthetic process,BP,
10555,GO:0042097,1,0.980172878963254,0,3,interleukin-4 biosynthetic process,BP,
10556,GO:0042098,1,0.37238305835166,0,158,T cell proliferation,BP,
10557,GO:0042100,1,0.647918773997686,0,68,B cell proliferation,BP,
10558,GO:0042101,1,0.891766229938082,0,19,T cell receptor complex,CC,
10559,GO:0042102,1,0.598823352993092,0,84,positive regulation of T cell proliferation,BP,
10560,GO:0042104,1,0.89010852705813,0,19,positive regulation of activated T cell proliferation,BP,
10561,GO:0042105,1,0.972893189901164,0,5,alpha-beta T cell receptor complex,CC,
10562,GO:0042107,1,0.554153905276232,0,94,cytokine metabolic process,BP,
10563,GO:0042108,1,0.718998432527225,0,52,positive regulation of cytokine biosynthetic process,BP,
10564,GO:0042109,1,0.987612668489746,0,2,lymphotoxin A biosynthetic process,BP,
10565,GO:0042110,1,0.0736135670626955,0,403,T cell activation,BP,
10566,GO:0042113,1,0.274034604673522,0,197,B cell activation,BP,
10567,GO:0042116,1,0.671266730489646,0,60,macrophage activation,BP,
10568,GO:0042117,1,0.958766162342722,0,7,monocyte activation,BP,
10569,GO:0042118,1,0.941334745078624,0,9,endothelial cell activation,BP,
10570,GO:0042119,1,0.0516052668725953,0,465,neutrophil activation,BP,
10571,GO:0042126,1,0.975993256377585,0,4,nitrate metabolic process,BP,
10573,GO:0042128,1,0.994082632298406,0,1,nitrate assimilation,BP,
10574,GO:0042129,1,0.43814548430955,0,133,regulation of T cell proliferation,BP,
10575,GO:0042130,1,0.72463866694018,0,51,negative regulation of T cell proliferation,BP,
10576,GO:0042131,1,0.993982858645972,0,1,thiamine phosphate phosphatase activity,MF,
10577,GO:0042132,1,0.994492885251886,0,1,fructose 1,6-bisphosphate 1-phosphatase activity,MF,
10578,GO:0042133,1,0.451068483457159,0,122,neurotransmitter metabolic process,BP,
10579,GO:0042134,1,0.989040836837571,0,2,rRNA primary transcript binding,MF,
10580,GO:0042135,1,0.87501578207507,0,21,neurotransmitter catabolic process,BP,
10581,GO:0042136,1,0.584037304644663,0,83,neurotransmitter biosynthetic process,BP,
10582,GO:0042137,1,0.988088799414394,0,2,sequestering of neurotransmitter,BP,
10583,GO:0042138,1,0.981859940307668,0,3,meiotic DNA double-strand break formation,BP,
10584,GO:0042140,1,0.993850639026861,0,1,late meiotic recombination nodule assembly,BP,
10585,GO:0042144,1,0.986797496531828,0,2,vacuole fusion, non-autophagic,BP,
10586,GO:0042147,1,0.613032683778789,0,72,retrograde transport, endosome to Golgi,BP,
10587,GO:0042148,1,0.95173765239538,0,8,strand invasion,BP,
10588,GO:0042149,1,0.786351578756657,0,37,cellular response to glucose starvation,BP,
10591,GO:0042159,1,0.908295155215545,0,14,lipoprotein catabolic process,BP,
10592,GO:0042160,1,0.988261248710465,0,2,lipoprotein modification,BP,
10593,GO:0042161,1,0.988261248710465,0,2,lipoprotein oxidation,BP,
10594,GO:0042162,1,0.785373691954916,0,36,telomeric DNA binding,MF,
10595,GO:0042163,1,0.99454559249468,0,1,interleukin-12 beta subunit binding,MF,
10596,GO:0042165,1,0.736440140609122,0,49,neurotransmitter binding,MF,
10597,GO:0042166,1,0.905144103298291,0,16,acetylcholine binding,MF,
10598,GO:0042167,1,0.978625213976315,0,4,heme catabolic process,BP,
10599,GO:0042168,1,0.857665630419722,0,25,heme metabolic process,BP,
10600,GO:0042169,1,0.802457410348357,0,32,SH2 domain binding,MF,
10601,GO:0042171,1,0.884148298522331,0,18,lysophosphatidic acid acyltransferase activity,MF,
10605,GO:0042178,1,0.943821175626221,0,10,xenobiotic catabolic process,BP,
10606,GO:0042180,1,0.286403091042714,0,199,cellular ketone metabolic process,BP,
10607,GO:0042181,1,0.817180255643269,0,33,ketone biosynthetic process,BP,
10608,GO:0042182,1,0.965066549940501,0,6,ketone catabolic process,BP,
10609,GO:0042197,1,0.994425185447864,0,1,halogenated hydrocarbon metabolic process,BP,
10610,GO:0042214,1,0.982074281717605,0,3,terpene metabolic process,BP,
10611,GO:0042219,1,0.883050060603947,0,20,cellular modified amino acid catabolic process,BP,
10614,GO:0042222,1,0.983435046960842,0,3,interleukin-1 biosynthetic process,BP,
10615,GO:0042223,1,0.992689454821734,0,1,interleukin-3 biosynthetic process,BP,
10616,GO:0042226,1,0.915960266814115,0,14,interleukin-6 biosynthetic process,BP,
10617,GO:0042228,1,0.938038491964215,0,10,interleukin-8 biosynthetic process,BP,
10618,GO:0042231,1,0.98727707048506,0,2,interleukin-13 biosynthetic process,BP,
10619,GO:0042241,1,0.993617741246891,0,1,interleukin-18 biosynthetic process,BP,
10620,GO:0042245,1,0.987069202580218,0,2,RNA repair,BP,
10622,GO:0042247,1,0.993770588536703,0,1,establishment of planar polarity of follicular epithelium,BP,
10624,GO:0042253,1,0.981365445193788,0,3,granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
10625,GO:0042254,1,0.155757364123346,0,309,ribosome biogenesis,BP,
10626,GO:0042255,1,0.73533522530192,0,53,ribosome assembly,BP,
10627,GO:0042256,1,0.969737143714144,0,5,mature ribosome assembly,BP,
10628,GO:0042262,1,0.97293424988704,0,5,DNA protection,BP,
10629,GO:0042264,1,0.98517687157408,0,2,peptidyl-aspartic acid hydroxylation,BP,
10630,GO:0042265,1,0.991706498478991,0,1,peptidyl-asparagine hydroxylation,BP,
10631,GO:0042267,1,0.743039892290029,0,48,natural killer cell mediated cytotoxicity,BP,
10632,GO:0042268,1,0.944155129077246,0,10,regulation of cytolysis,BP,
10633,GO:0042269,1,0.826174769729294,0,31,regulation of natural killer cell mediated cytotoxicity,BP,
10634,GO:0042270,1,0.987611548921716,0,2,protection from natural killer cell mediated cytotoxicity,BP,
10635,GO:0042271,1,0.980272607649898,0,3,susceptibility to natural killer cell mediated cytotoxicity,BP,
10636,GO:0042272,1,0.976781315872136,0,3,nuclear RNA export factor complex,CC,
10637,GO:0042273,1,0.676734063316548,0,66,ribosomal large subunit biogenesis,BP,
10638,GO:0042274,1,0.670729391861884,0,67,ribosomal small subunit biogenesis,BP,
10639,GO:0042275,1,0.994502703619459,0,1,error-free postreplication DNA repair,BP,
10640,GO:0042276,1,0.887405397211137,0,19,error-prone translesion synthesis,BP,
10642,GO:0042278,1,0.628263103006726,0,73,purine nucleoside metabolic process,BP,
10643,GO:0042281,1,0.987984321667192,0,2,dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity,MF,
10644,GO:0042282,1,0.99296072014961,0,1,hydroxymethylglutaryl-CoA reductase activity,MF,
10645,GO:0042284,1,0.988925300258575,0,2,sphingolipid delta-4 desaturase activity,MF,
10646,GO:0042285,1,0.958254418227475,0,6,xylosyltransferase activity,MF,
10647,GO:0042287,1,0.847824444397813,0,27,MHC protein binding,MF,
10648,GO:0042288,1,0.908200530928513,0,16,MHC class I protein binding,MF,
10649,GO:0042289,1,0.964530426372677,0,6,MHC class II protein binding,MF,
10650,GO:0042292,1,0.994020738101129,0,1,URM1 activating enzyme activity,MF,
10651,GO:0042296,1,0.977228615720299,0,4,ISG15 transferase activity,MF,
10652,GO:0042297,1,0.94120982221864,0,7,vocal learning,BP,
10653,GO:0042301,1,0.933782175716544,0,11,phosphate ion binding,MF,
10654,GO:0042303,1,0.516853843579602,0,98,molting cycle,BP,
10655,GO:0042304,1,0.804112115261892,0,34,regulation of fatty acid biosynthetic process,BP,
10658,GO:0042308,1,0.93988656405533,0,10,negative regulation of protein import into nucleus,BP,
10659,GO:0042309,1,0.993859115607931,0,1,homoiothermy,BP,
10660,GO:0042310,1,0.647154927065893,0,67,vasoconstriction,BP,
10661,GO:0042311,1,0.845683810540106,0,27,vasodilation,BP,
10662,GO:0042313,1,0.994204754044007,0,1,protein kinase C deactivation,BP,
10663,GO:0042316,1,0.992666679637346,0,1,penicillin metabolic process,BP,
10664,GO:0042320,1,0.971938402628924,0,5,regulation of circadian sleep/wake cycle, REM sleep,BP,
10665,GO:0042321,1,0.972094807239391,0,5,negative regulation of circadian sleep/wake cycle, sleep,BP,
10666,GO:0042322,1,0.989576434900639,0,2,negative regulation of circadian sleep/wake cycle, REM sleep,BP,
10667,GO:0042323,1,0.988349733434263,0,2,negative regulation of circadian sleep/wake cycle, non-REM sleep,BP,
10671,GO:0042328,1,0.9705788329957,0,4,heparan sulfate N-acetylglucosaminyltransferase activity,MF,
10673,GO:0042335,1,0.978671052378675,0,3,cuticle development,BP,
10674,GO:0042339,1,0.817731148194353,0,31,keratan sulfate metabolic process,BP,
10675,GO:0042340,1,0.930079491094986,0,11,keratan sulfate catabolic process,BP,
10676,GO:0042350,1,0.982375055415679,0,3,GDP-L-fucose biosynthetic process,BP,
10677,GO:0042351,1,0.98903581993825,0,2,'de novo' GDP-L-fucose biosynthetic process,BP,
10678,GO:0042352,1,0.993266143796993,0,1,GDP-L-fucose salvage,BP,
10679,GO:0042354,1,0.944397385550446,0,8,L-fucose metabolic process,BP,
10680,GO:0042355,1,0.944397385550446,0,8,L-fucose catabolic process,BP,
10681,GO:0042356,1,0.994583828338402,0,1,GDP-4-dehydro-D-rhamnose reductase activity,MF,
10682,GO:0042357,1,0.988463419027332,0,2,thiamine diphosphate metabolic process,BP,
10683,GO:0042359,1,0.881580916973189,0,19,vitamin D metabolic process,BP,
10684,GO:0042360,1,0.9828420157505,0,3,vitamin E metabolic process,BP,
10685,GO:0042361,1,0.993642047277922,0,1,menaquinone catabolic process,BP,
10686,GO:0042362,1,0.92995082179613,0,12,fat-soluble vitamin biosynthetic process,BP,
10687,GO:0042363,1,0.963848831254306,0,6,fat-soluble vitamin catabolic process,BP,
10688,GO:0042364,1,0.942554803923354,0,9,water-soluble vitamin biosynthetic process,BP,
10689,GO:0042365,1,0.982052873703879,0,3,water-soluble vitamin catabolic process,BP,
10690,GO:0042368,1,0.947208776629971,0,9,vitamin D biosynthetic process,BP,
10691,GO:0042369,1,0.987690624712277,0,2,vitamin D catabolic process,BP,
10692,GO:0042371,1,0.993407349400836,0,1,vitamin K biosynthetic process,BP,
10693,GO:0042373,1,0.9715226970337,0,5,vitamin K metabolic process,BP,
10694,GO:0042374,1,0.988391393262865,0,2,phylloquinone metabolic process,BP,
10695,GO:0042376,1,0.988391393262865,0,2,phylloquinone catabolic process,BP,
10696,GO:0042377,1,0.993642047277922,0,1,vitamin K catabolic process,BP,
10697,GO:0042379,1,0.792155422714647,0,41,chemokine receptor binding,MF,
10698,GO:0042382,1,0.96123727215695,0,6,paraspeckles,CC,
10701,GO:0042392,1,0.988287417289671,0,2,sphingosine-1-phosphate phosphatase activity,MF,
10702,GO:0042393,1,0.312838555602361,0,170,histone binding,MF,
10704,GO:0042401,1,0.895375980715203,0,19,cellular biogenic amine biosynthetic process,BP,
10705,GO:0042402,1,0.888459742914759,0,20,cellular biogenic amine catabolic process,BP,
10706,GO:0042403,1,0.891233919868476,0,17,thyroid hormone metabolic process,BP,
10707,GO:0042404,1,0.994204495715103,0,1,thyroid hormone catabolic process,BP,
10708,GO:0042405,1,0.916302807837914,0,11,nuclear inclusion body,CC,
10709,GO:0042406,1,0.976509882699955,0,4,extrinsic component of endoplasmic reticulum membrane,CC,
10710,GO:0042407,1,0.914921628039601,0,15,cristae formation,BP,
10711,GO:0042412,1,0.988380190276772,0,2,taurine biosynthetic process,BP,
10712,GO:0042413,1,0.994000120277301,0,1,carnitine catabolic process,BP,
10713,GO:0042414,1,0.980006525461854,0,3,epinephrine metabolic process,BP,
10714,GO:0042415,1,0.937017907199559,0,10,norepinephrine metabolic process,BP,
10715,GO:0042416,1,0.934446523475619,0,11,dopamine biosynthetic process,BP,
10716,GO:0042417,1,0.801917624996337,0,34,dopamine metabolic process,BP,
10717,GO:0042418,1,0.989025460696067,0,2,epinephrine biosynthetic process,BP,
10718,GO:0042420,1,0.957378254577171,0,7,dopamine catabolic process,BP,
10719,GO:0042421,1,0.964028963525391,0,6,norepinephrine biosynthetic process,BP,
10720,GO:0042423,1,0.890318279928411,0,19,catecholamine biosynthetic process,BP,
10721,GO:0042424,1,0.95135554432182,0,8,catecholamine catabolic process,BP,
10722,GO:0042426,1,0.961692913278613,0,6,choline catabolic process,BP,
10723,GO:0042427,1,0.988624916151297,0,2,serotonin biosynthetic process,BP,
10724,GO:0042428,1,0.935953988189501,0,9,serotonin metabolic process,BP,
10725,GO:0042430,1,0.888538536272669,0,18,indole-containing compound metabolic process,BP,
10726,GO:0042435,1,0.983216092899753,0,3,indole-containing compound biosynthetic process,BP,
10727,GO:0042436,1,0.959971691740149,0,7,indole-containing compound catabolic process,BP,
10728,GO:0042438,1,0.901915798898282,0,15,melanin biosynthetic process,BP,
10729,GO:0042439,1,0.962792132416158,0,6,ethanolamine-containing compound metabolic process,BP,
10730,GO:0042440,1,0.691146820917398,0,58,pigment metabolic process,BP,
10731,GO:0042441,1,0.980989305034428,0,3,eye pigment metabolic process,BP,
10733,GO:0042446,1,0.656783347605021,0,67,hormone biosynthetic process,BP,
10734,GO:0042447,1,0.917982986846589,0,14,hormone catabolic process,BP,
10735,GO:0042448,1,0.923505463679531,0,13,progesterone metabolic process,BP,
10736,GO:0042450,1,0.988725901332704,0,2,arginine biosynthetic process via ornithine,BP,
10737,GO:0042451,1,0.886628030318484,0,21,purine nucleoside biosynthetic process,BP,
10738,GO:0042454,1,0.910503777227418,0,16,ribonucleoside catabolic process,BP,
10739,GO:0042455,1,0.809390876631856,0,36,ribonucleoside biosynthetic process,BP,
10742,GO:0042470,1,0.525555290619962,0,101,melanosome,CC,
10745,GO:0042473,1,0.944626208181842,0,9,outer ear morphogenesis,BP,
10746,GO:0042474,1,0.891490159024388,0,19,middle ear morphogenesis,BP,
10747,GO:0042475,1,0.618800020161688,0,70,odontogenesis of dentin-containing tooth,BP,
10748,GO:0042476,1,0.494512402958234,0,104,odontogenesis,BP,
10749,GO:0042481,1,0.884056565680113,0,20,regulation of odontogenesis,BP,
10750,GO:0042482,1,0.958679398035787,0,7,positive regulation of odontogenesis,BP,
10751,GO:0042483,1,0.973995013900597,0,4,negative regulation of odontogenesis,BP,
10752,GO:0042487,1,0.94649633447405,0,9,regulation of odontogenesis of dentin-containing tooth,BP,
10753,GO:0042488,1,0.994033627873654,0,1,positive regulation of odontogenesis of dentin-containing tooth,BP,
10754,GO:0042489,1,0.987777907039729,0,2,negative regulation of odontogenesis of dentin-containing tooth,BP,
10757,GO:0042492,1,0.959652760887481,0,6,gamma-delta T cell differentiation,BP,
10759,GO:0042494,1,0.964167502215115,0,5,detection of bacterial lipoprotein,BP,
10760,GO:0042495,1,0.987393978306325,0,2,detection of triacyl bacterial lipopeptide,BP,
10761,GO:0042496,1,0.985834442887232,0,2,detection of diacyl bacterial lipopeptide,BP,
10762,GO:0042497,1,0.993536386976335,0,1,triacyl lipopeptide binding,MF,
10763,GO:0042500,1,0.962317933923481,0,6,aspartic endopeptidase activity, intramembrane cleaving,MF,
10764,GO:0042501,1,0.956377097329945,0,7,serine phosphorylation of STAT protein,BP,
10767,GO:0042532,1,0.937487525997443,0,10,negative regulation of tyrosine phosphorylation of STAT protein,BP,
10768,GO:0042533,1,0.892796845817093,0,18,tumor necrosis factor biosynthetic process,BP,
10769,GO:0042534,1,0.892796845817093,0,18,regulation of tumor necrosis factor biosynthetic process,BP,
10770,GO:0042535,1,0.930785418985725,0,11,positive regulation of tumor necrosis factor biosynthetic process,BP,
10771,GO:0042536,1,0.971502430492429,0,5,negative regulation of tumor necrosis factor biosynthetic process,BP,
10772,GO:0042537,1,0.900708555231814,0,18,benzene-containing compound metabolic process,BP,
10773,GO:0042538,1,0.957833641719253,0,7,hyperosmotic salinity response,BP,
10774,GO:0042539,1,0.985116401468499,0,2,hypotonic salinity response,BP,
10775,GO:0042541,1,0.947502671511759,0,9,hemoglobin biosynthetic process,BP,
10777,GO:0042543,1,0.995006392790976,0,1,protein N-linked glycosylation via arginine,BP,
10778,GO:0042546,1,0.994371949535733,0,1,cell wall biogenesis,BP,
10781,GO:0042554,1,0.862508765448653,0,24,superoxide anion generation,BP,
10782,GO:0042555,1,0.932872015258629,0,11,MCM complex,CC,
10783,GO:0042558,1,0.808092382409368,0,34,pteridine-containing compound metabolic process,BP,
10784,GO:0042559,1,0.921356280221031,0,14,pteridine-containing compound biosynthetic process,BP,
10785,GO:0042560,1,0.973016651280665,0,4,pteridine-containing compound catabolic process,BP,
10787,GO:0042564,1,0.993042850013084,0,1,NLS-dependent protein nuclear import complex,CC,
10788,GO:0042565,1,0.98727745957757,0,2,RNA nuclear export complex,CC,
10789,GO:0042567,1,0.972028518981818,0,4,insulin-like growth factor ternary complex,CC,
10790,GO:0042568,1,0.994789960651998,0,1,insulin-like growth factor binary complex,CC,
10791,GO:0042571,1,0.988737776457168,0,2,immunoglobulin complex, circulating,CC,
10793,GO:0042573,1,0.901501350458665,0,17,retinoic acid metabolic process,BP,
10794,GO:0042574,1,0.921540745336625,0,13,retinal metabolic process,BP,
10795,GO:0042575,1,0.899536925818616,0,16,DNA polymerase complex,CC,
10796,GO:0042577,1,0.987812059168791,0,2,lipid phosphatase activity,MF,
10798,GO:0042579,1,0.464398694546774,0,122,microbody,CC,
10799,GO:0042581,1,0.381451719875593,0,151,specific granule,CC,
10800,GO:0042582,1,0.415574597208915,0,140,azurophil granule,CC,
10801,GO:0042583,1,0.946739595857079,0,8,chromaffin granule,CC,
10802,GO:0042584,1,0.958159286812749,0,6,chromaffin granule membrane,CC,
10803,GO:0042585,1,0.994133217907939,0,1,germinal vesicle,CC,
10804,GO:0042586,1,0.994691808092006,0,1,peptide deformylase activity,MF,
10805,GO:0042587,1,0.966267523685925,0,5,glycogen granule,CC,
10806,GO:0042588,1,0.925163756529912,0,12,zymogen granule,CC,
10807,GO:0042589,1,0.937162574403539,0,10,zymogen granule membrane,CC,
10808,GO:0042590,1,0.660540570068866,0,72,antigen processing and presentation of exogenous peptide antigen via MHC class I,BP,
10810,GO:0042593,1,0.278527885829691,0,194,glucose homeostasis,BP,
10811,GO:0042594,1,0.345766290770486,0,162,response to starvation,BP,
10812,GO:0042595,1,0.988158698367701,0,2,behavioral response to starvation,BP,
10813,GO:0042596,1,0.786978969610069,0,37,fear response,BP,
10814,GO:0042599,1,0.910919292673759,0,15,lamellar body,CC,
10815,GO:0042602,1,0.994846265864434,0,1,riboflavin reductase (NADPH) activity,MF,
10816,GO:0042605,1,0.882863022109168,0,21,peptide antigen binding,MF,
10817,GO:0042608,1,0.958837955360709,0,7,T cell receptor binding,MF,
10818,GO:0042609,1,0.957030311155179,0,7,CD4 receptor binding,MF,
10819,GO:0042610,1,0.988444040252249,0,2,CD8 receptor binding,MF,
10820,GO:0042611,1,0.886457338447691,0,22,MHC protein complex,CC,
10821,GO:0042612,1,0.957215328614059,0,8,MHC class I protein complex,CC,
10822,GO:0042613,1,0.926110792694315,0,14,MHC class II protein complex,CC,
10823,GO:0042622,1,0.917166540260915,0,13,photoreceptor outer segment membrane,CC,
10825,GO:0042624,1,0.994933045122769,0,1,ATPase activity, uncoupled,MF,
10826,GO:0042625,1,0.704712956314637,0,52,ATPase coupled ion transmembrane transporter activity,MF,
10827,GO:0042626,1,0.507918371270399,0,96,ATPase activity, coupled to transmembrane movement of substances,MF,
10828,GO:0042627,1,0.944870071434164,0,9,chylomicron,CC,
10829,GO:0042628,1,0.994120052406903,0,1,mating plug formation,BP,
10830,GO:0042629,1,0.87333748410662,0,21,mast cell granule,CC,
10831,GO:0042631,1,0.986639041978689,0,2,cellular response to water deprivation,BP,
10832,GO:0042632,1,0.716346584187186,0,52,cholesterol homeostasis,BP,
10833,GO:0042633,1,0.516853843579602,0,98,hair cycle,BP,
10834,GO:0042634,1,0.845153305273484,0,25,regulation of hair cycle,BP,
10835,GO:0042635,1,0.927734866841057,0,12,positive regulation of hair cycle,BP,
10836,GO:0042636,1,0.972859155269207,0,4,negative regulation of hair cycle,BP,
10837,GO:0042637,1,0.974954263595242,0,4,catagen,BP,
10838,GO:0042640,1,0.966384529545876,0,5,anagen,BP,
10839,GO:0042641,1,0.631468574779101,0,64,actomyosin,CC,
10840,GO:0042643,1,0.987195665689862,0,2,actomyosin, actin portion,CC,
10841,GO:0042645,1,0.770301575623013,0,41,mitochondrial nucleoid,CC,
10842,GO:0042658,1,0.994610178839212,0,1,MHC class II protein binding, via antigen binding groove,MF,
10844,GO:0042660,1,0.991780449301438,0,1,positive regulation of cell fate specification,BP,
10847,GO:0042663,1,0.983090164528901,0,3,regulation of endodermal cell fate specification,BP,
10848,GO:0042664,1,0.994690774858455,0,1,negative regulation of endodermal cell fate specification,BP,
10849,GO:0042665,1,0.993306253802084,0,1,regulation of ectodermal cell fate specification,BP,
10850,GO:0042666,1,0.993306253802084,0,1,negative regulation of ectodermal cell fate specification,BP,
10851,GO:0042668,1,0.989182817161195,0,2,auditory receptor cell fate determination,BP,
10854,GO:0042693,1,0.929213199078251,0,12,muscle cell fate commitment,BP,
10855,GO:0042695,1,0.967111597500277,0,5,thelarche,BP,
10857,GO:0042699,1,0.988487735612465,0,2,follicle-stimulating hormone signaling pathway,BP,
10858,GO:0042700,1,0.992901858075983,0,1,luteinizing hormone signaling pathway,BP,
10859,GO:0042701,1,0.975148901445304,0,4,progesterone secretion,BP,
10860,GO:0042704,1,0.986295983686873,0,2,uterine wall breakdown,BP,
10861,GO:0042709,1,0.994071280813827,0,1,succinate-CoA ligase complex,CC,
10862,GO:0042710,1,0.994063026317346,0,1,biofilm formation,BP,
10863,GO:0042711,1,0.923980648998014,0,12,maternal behavior,BP,
10864,GO:0042713,1,0.965799352408465,0,5,sperm ejaculation,BP,
10865,GO:0042719,1,0.972885849773155,0,5,mitochondrial intermembrane space protein transporter complex,CC,
10866,GO:0042720,1,0.989407840694278,0,2,mitochondrial inner membrane peptidase complex,CC,
10867,GO:0042721,1,0.972036495530147,0,5,mitochondrial inner membrane protein insertion complex,CC,
10868,GO:0042723,1,0.958295979587524,0,7,thiamine-containing compound metabolic process,BP,
10869,GO:0042726,1,0.95001393089866,0,8,flavin-containing compound metabolic process,BP,
10870,GO:0042727,1,0.988194988449865,0,2,flavin-containing compound biosynthetic process,BP,
10871,GO:0042728,1,0.993293917962388,0,1,flavin-containing compound catabolic process,BP,
10872,GO:0042730,1,0.886197501431627,0,20,fibrinolysis,BP,
10873,GO:0042731,1,0.974206953533434,0,4,PH domain binding,MF,
10874,GO:0042732,1,0.983066287225489,0,3,D-xylose metabolic process,BP,
10876,GO:0042734,1,0.574140364912875,0,77,presynaptic membrane,CC,
10877,GO:0042737,1,0.508182858294709,0,113,drug catabolic process,BP,
10878,GO:0042738,1,0.91870026079888,0,14,exogenous drug catabolic process,BP,
10879,GO:0042742,1,0.40948243019389,0,147,defense response to bacterium,BP,
10880,GO:0042743,1,0.787335872040409,0,40,hydrogen peroxide metabolic process,BP,
10881,GO:0042744,1,0.88193207595794,0,21,hydrogen peroxide catabolic process,BP,
10883,GO:0042746,1,0.982170042551208,0,3,circadian sleep/wake cycle, wakefulness,BP,
10884,GO:0042747,1,0.955424363862498,0,8,circadian sleep/wake cycle, REM sleep,BP,
10885,GO:0042748,1,0.949675337515742,0,8,circadian sleep/wake cycle, non-REM sleep,BP,
10888,GO:0042753,1,0.902415550248656,0,16,positive regulation of circadian rhythm,BP,
10889,GO:0042754,1,0.920526847860445,0,13,negative regulation of circadian rhythm,BP,
10890,GO:0042755,1,0.854491789467481,0,25,eating behavior,BP,
10891,GO:0042756,1,0.953107708854396,0,8,drinking behavior,BP,
10892,GO:0042758,1,0.952851164989288,0,8,long-chain fatty acid catabolic process,BP,
10894,GO:0042760,1,0.956761473963607,0,7,very long-chain fatty acid catabolic process,BP,
10895,GO:0042761,1,0.934191931189887,0,11,very long-chain fatty acid biosynthetic process,BP,
10896,GO:0042762,1,0.890859294271214,0,17,regulation of sulfur metabolic process,BP,
10897,GO:0042765,1,0.969761043453569,0,5,GPI-anchor transamidase complex,CC,
10898,GO:0042766,1,0.991000991641604,0,1,nucleosome mobilization,BP,
10901,GO:0042771,1,0.764332513703909,0,42,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
10904,GO:0042774,1,0.993850639026861,0,1,plasma membrane ATP synthesis coupled electron transport,BP,
10906,GO:0042776,1,0.979052897693233,0,4,mitochondrial ATP synthesis coupled proton transport,BP,
10907,GO:0042779,1,0.987495215043761,0,2,tRNA 3'-trailer cleavage,BP,
10908,GO:0042780,1,0.959085339105716,0,7,tRNA 3'-end processing,BP,
10909,GO:0042781,1,0.987495215043761,0,2,3'-tRNA processing endoribonuclease activity,MF,
10910,GO:0042788,1,0.843658075957631,0,30,polysomal ribosome,CC,
10911,GO:0042789,1,0.881828300334856,0,19,mRNA transcription by RNA polymerase II,BP,
10912,GO:0042790,1,0.925518014981257,0,12,nucleolar large rRNA transcription by RNA polymerase I,BP,
10913,GO:0042791,1,0.961392111921014,0,6,5S class rRNA transcription by RNA polymerase III,BP,
10914,GO:0042795,1,0.660357916129165,0,66,snRNA transcription by RNA polymerase II,BP,
10915,GO:0042796,1,0.96275103710576,0,6,snRNA transcription by RNA polymerase III,BP,
10916,GO:0042797,1,0.961392111921014,0,6,tRNA transcription by RNA polymerase III,BP,
10917,GO:0042799,1,0.988789231366654,0,1,histone methyltransferase activity (H4-K20 specific),MF,
10918,GO:0042800,1,0.89810950440396,0,16,histone methyltransferase activity (H3-K4 specific),MF,
10922,GO:0042806,1,0.976539771695487,0,4,fucose binding,MF,
10923,GO:0042809,1,0.900083218598992,0,15,vitamin D receptor binding,MF,
10925,GO:0042816,1,0.966586025484126,0,5,vitamin B6 metabolic process,BP,
10926,GO:0042819,1,0.979296645270429,0,3,vitamin B6 biosynthetic process,BP,
10927,GO:0042820,1,0.994254102342162,0,1,vitamin B6 catabolic process,BP,
10928,GO:0042822,1,0.979356967929787,0,3,pyridoxal phosphate metabolic process,BP,
10929,GO:0042823,1,0.985017639037194,0,2,pyridoxal phosphate biosynthetic process,BP,
10930,GO:0042824,1,0.974991696749757,0,4,MHC class I peptide loading complex,CC,
10931,GO:0042825,1,0.98058303873722,0,3,TAP complex,CC,
10933,GO:0042827,1,0.893569139174336,0,18,platelet dense granule,CC,
10934,GO:0042832,1,0.899547664368031,0,17,defense response to protozoan,BP,
10935,GO:0042834,1,0.9510004875829,0,8,peptidoglycan binding,MF,
10936,GO:0042835,1,0.986105564263923,0,2,BRE binding,MF,
10937,GO:0042839,1,0.99452673209409,0,1,D-glucuronate metabolic process,BP,
10938,GO:0042840,1,0.99452673209409,0,1,D-glucuronate catabolic process,BP,
10939,GO:0042843,1,0.994729003774522,0,1,D-xylose catabolic process,BP,
10940,GO:0042851,1,0.982145311468022,0,3,L-alanine metabolic process,BP,
10941,GO:0042853,1,0.982145311468022,0,3,L-alanine catabolic process,BP,
10942,GO:0042866,1,0.527152535562852,0,96,pyruvate biosynthetic process,BP,
10943,GO:0042883,1,0.99336683965506,0,1,cysteine transport,BP,
10946,GO:0042891,1,0.950065947632596,0,8,antibiotic transport,BP,
10947,GO:0042895,1,0.963246551507295,0,6,antibiotic transmembrane transporter activity,MF,
10948,GO:0042903,1,0.987485271420918,0,2,tubulin deacetylase activity,MF,
10949,GO:0042904,1,0.976113445947404,0,4,9-cis-retinoic acid biosynthetic process,BP,
10950,GO:0042905,1,0.976113445947404,0,4,9-cis-retinoic acid metabolic process,BP,
10951,GO:0042908,1,0.943484156757441,0,8,xenobiotic transport,BP,
10952,GO:0042910,1,0.943484156757441,0,8,xenobiotic transmembrane transporter activity,MF,
10953,GO:0042921,1,0.900259167318192,0,15,glucocorticoid receptor signaling pathway,BP,
10954,GO:0042922,1,0.99486796096715,0,1,neuromedin U receptor binding,MF,
10955,GO:0042923,1,0.893411207335424,0,19,neuropeptide binding,MF,
10956,GO:0042924,1,0.987860544115187,0,2,neuromedin U binding,MF,
10957,GO:0042930,1,0.993850639026861,0,1,enterobactin transport,BP,
10958,GO:0042931,1,0.993850639026861,0,1,enterobactin transmembrane transporter activity,MF,
10959,GO:0042937,1,0.991969765251917,0,1,tripeptide transmembrane transporter activity,MF,
10960,GO:0042938,1,0.988377255050008,0,2,dipeptide transport,BP,
10961,GO:0042939,1,0.986268520340479,0,2,tripeptide transport,BP,
10962,GO:0042940,1,0.957995493301071,0,6,D-amino acid transport,BP,
10963,GO:0042941,1,0.994279943800713,0,1,D-alanine transport,BP,
10964,GO:0042942,1,0.988268963610955,0,2,D-serine transport,BP,
10965,GO:0042946,1,0.993850639026861,0,1,glucoside transport,BP,
10966,GO:0042947,1,0.993850639026861,0,1,glucoside transmembrane transporter activity,MF,
10967,GO:0042953,1,0.897614441177063,0,13,lipoprotein transport,BP,
10968,GO:0042954,1,0.950484909979975,0,6,lipoprotein transporter activity,MF,
10969,GO:0042974,1,0.853930616221165,0,23,retinoic acid receptor binding,MF,
10970,GO:0042975,1,0.928319144103138,0,10,peroxisome proliferator activated receptor binding,MF,
10971,GO:0042976,1,0.940784665205904,0,9,activation of Janus kinase activity,BP,
10972,GO:0042978,1,0.976315194964196,0,3,ornithine decarboxylase activator activity,MF,
10973,GO:0042979,1,0.960613571877337,0,6,ornithine decarboxylase regulator activity,MF,
10978,GO:0042985,1,0.968902406520786,0,5,negative regulation of amyloid precursor protein biosynthetic process,BP,
10979,GO:0042986,1,0.987850901114564,0,2,positive regulation of amyloid precursor protein biosynthetic process,BP,
10980,GO:0042987,1,0.806305159545797,0,32,amyloid precursor protein catabolic process,BP,
10981,GO:0042988,1,0.992608274847914,0,1,X11-like protein binding,MF,
10982,GO:0042989,1,0.946364866301021,0,10,sequestering of actin monomers,BP,
10983,GO:0042994,1,0.891305261936282,0,18,cytoplasmic sequestering of transcription factor,BP,
10985,GO:0042996,1,0.961837046865851,0,6,regulation of Golgi to plasma membrane protein transport,BP,
10986,GO:0042997,1,0.975109868519862,0,4,negative regulation of Golgi to plasma membrane protein transport,BP,
10987,GO:0042998,1,0.986391824662977,0,2,positive regulation of Golgi to plasma membrane protein transport,BP,
10988,GO:0042999,1,0.992920360360367,0,1,regulation of Golgi to plasma membrane CFTR protein transport,BP,
10989,GO:0043000,1,0.987500332135369,0,2,Golgi to plasma membrane CFTR protein transport,BP,
10991,GO:0043002,1,0.992920360360367,0,1,negative regulation of Golgi to plasma membrane CFTR protein transport,BP,
10992,GO:0043004,1,0.992920360360367,0,1,cytoplasmic sequestering of CFTR protein,BP,
10994,GO:0043006,1,0.988222183279365,0,2,activation of phospholipase A2 activity by calcium-mediated signaling,BP,
10995,GO:0043008,1,0.952069116775526,0,8,ATP-dependent protein binding,MF,
10998,GO:0043011,1,0.91346773854112,0,15,myeloid dendritic cell differentiation,BP,
10999,GO:0043012,1,0.993948609793923,0,1,regulation of fusion of sperm to egg plasma membrane,BP,
11000,GO:0043014,1,0.836295313140223,0,27,alpha-tubulin binding,MF,
11001,GO:0043015,1,0.842205792604715,0,26,gamma-tubulin binding,MF,
11002,GO:0043016,1,0.993886098528668,0,1,regulation of lymphotoxin A biosynthetic process,BP,
11003,GO:0043017,1,0.993886098528668,0,1,positive regulation of lymphotoxin A biosynthetic process,BP,
11004,GO:0043020,1,0.954233263823662,0,8,NADPH oxidase complex,CC,
11006,GO:0043022,1,0.735544728723725,0,47,ribosome binding,MF,
11007,GO:0043023,1,0.933552074324256,0,11,ribosomal large subunit binding,MF,
11008,GO:0043024,1,0.914035356369221,0,14,ribosomal small subunit binding,MF,
11010,GO:0043027,1,0.86310604198255,0,23,cysteine-type endopeptidase inhibitor activity involved in apoptotic process,MF,
11011,GO:0043028,1,0.783288405915938,0,38,cysteine-type endopeptidase regulator activity involved in apoptotic process,MF,
11012,GO:0043029,1,0.790811497028228,0,37,T cell homeostasis,BP,
11013,GO:0043030,1,0.785745904905039,0,36,regulation of macrophage activation,BP,
11014,GO:0043031,1,0.953575506168352,0,8,negative regulation of macrophage activation,BP,
11015,GO:0043032,1,0.872030460185722,0,21,positive regulation of macrophage activation,BP,
11016,GO:0043033,1,0.99155253960703,0,1,isoamylase complex,CC,
11017,GO:0043034,1,0.857923822446153,0,19,costamere,CC,
11018,GO:0043035,1,0.993333992327336,0,1,chromatin insulator sequence binding,MF,
11019,GO:0043038,1,0.722954955137676,0,53,amino acid activation,BP,
11020,GO:0043039,1,0.727737755473161,0,52,tRNA aminoacylation,BP,
11021,GO:0043041,1,0.993448850585345,0,1,amino acid activation for nonribosomal peptide biosynthetic process,BP,
11023,GO:0043044,1,0.67019703141239,0,62,ATP-dependent chromatin remodeling,BP,
11024,GO:0043045,1,0.958353336891374,0,6,DNA methylation involved in embryo development,BP,
11025,GO:0043046,1,0.896965323059948,0,17,DNA methylation involved in gamete generation,BP,
11026,GO:0043047,1,0.932221913558879,0,11,single-stranded telomeric DNA binding,MF,
11027,GO:0043048,1,0.99415232406711,0,1,dolichyl monophosphate biosynthetic process,BP,
11028,GO:0043049,1,0.993704753095749,0,1,otic placode formation,BP,
11029,GO:0043060,1,0.994013005560847,0,1,meiotic metaphase I plate congression,BP,
11031,GO:0043063,1,0.992762703705893,0,1,intercellular bridge organization,BP,
11038,GO:0043083,1,0.937348671185989,0,9,synaptic cleft,CC,
11039,GO:0043084,1,0.953265586143674,0,7,penile erection,BP,
11043,GO:0043090,1,0.860820862196314,0,22,amino acid import,BP,
11044,GO:0043094,1,0.815900334263379,0,34,cellular metabolic compound salvage,BP,
11045,GO:0043095,1,0.994921164783572,0,1,regulation of GTP cyclohydrolase I activity,BP,
11046,GO:0043096,1,0.972513775333678,0,5,purine nucleobase salvage,BP,
11047,GO:0043097,1,0.937671310979502,0,11,pyrimidine nucleoside salvage,BP,
11048,GO:0043101,1,0.920243896567623,0,14,purine-containing compound salvage,BP,
11049,GO:0043102,1,0.958737275671588,0,7,amino acid salvage,BP,
11050,GO:0043103,1,0.983106286027324,0,3,hypoxanthine salvage,BP,
11051,GO:0043105,1,0.994921164783572,0,1,negative regulation of GTP cyclohydrolase I activity,BP,
11052,GO:0043111,1,0.987287611545119,0,2,replication fork arrest,BP,
11054,GO:0043113,1,0.719309528402772,0,47,receptor clustering,BP,
11055,GO:0043114,1,0.820914658827056,0,30,regulation of vascular permeability,BP,
11056,GO:0043116,1,0.930703700455362,0,11,negative regulation of vascular permeability,BP,
11057,GO:0043117,1,0.940782009056261,0,10,positive regulation of vascular permeability,BP,
11058,GO:0043120,1,0.970574927275367,0,5,tumor necrosis factor binding,MF,
11059,GO:0043121,1,0.932826603838209,0,10,neurotrophin binding,MF,
11062,GO:0043124,1,0.766416469947836,0,39,negative regulation of I-kappaB kinase/NF-kappaB signaling,BP,
11063,GO:0043125,1,0.974128631554225,0,4,ErbB-3 class receptor binding,MF,
11064,GO:0043126,1,0.994513555307944,0,1,regulation of 1-phosphatidylinositol 4-kinase activity,BP,
11065,GO:0043128,1,0.994513555307944,0,1,positive regulation of 1-phosphatidylinositol 4-kinase activity,BP,
11066,GO:0043129,1,0.949175426075637,0,8,surfactant homeostasis,BP,
11068,GO:0043131,1,0.992626349998796,0,1,erythrocyte enucleation,BP,
11069,GO:0043132,1,0.987821990353806,0,2,NAD transport,BP,
11070,GO:0043136,1,0.993671987568872,0,1,glycerol-3-phosphatase activity,MF,
11071,GO:0043137,1,0.976481606879331,0,4,DNA replication, removal of RNA primer,BP,
11072,GO:0043138,1,0.923202991046992,0,12,3'-5' DNA helicase activity,MF,
11073,GO:0043139,1,0.957553695755577,0,7,5'-3' DNA helicase activity,MF,
11074,GO:0043140,1,0.951674516594016,0,7,ATP-dependent 3'-5' DNA helicase activity,MF,
11075,GO:0043141,1,0.969957727202316,0,5,ATP-dependent 5'-3' DNA helicase activity,MF,
11076,GO:0043142,1,0.918938279588989,0,13,single-stranded DNA-dependent ATPase activity,MF,
11077,GO:0043144,1,0.956954077496745,0,8,snoRNA processing,BP,
11079,GO:0043152,1,0.975415095157232,0,4,induction of bacterial agglutination,BP,
11080,GO:0043153,1,0.872309545966295,0,21,entrainment of circadian clock by photoperiod,BP,
11082,GO:0043159,1,0.988056067470083,0,2,acrosomal matrix,CC,
11084,GO:0043162,1,0.892437836905987,0,18,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,BP,
11085,GO:0043163,1,0.98778980084707,0,2,cell envelope organization,BP,
11090,GO:0043171,1,0.849798602276826,0,25,peptide catabolic process,BP,
11091,GO:0043173,1,0.915506325997958,0,15,nucleotide salvage,BP,
11092,GO:0043174,1,0.910523324162334,0,16,nucleoside salvage,BP,
11093,GO:0043175,1,0.795128801021787,0,35,RNA polymerase core enzyme binding,MF,
11094,GO:0043176,1,0.935400288587359,0,11,amine binding,MF,
11096,GO:0043178,1,0.629188256792989,0,69,alcohol binding,MF,
11097,GO:0043179,1,0.994204754044007,0,1,rhythmic excitation,BP,
11098,GO:0043181,1,0.993430409369638,0,1,vacuolar sequestering,BP,
11099,GO:0043183,1,0.988218267613579,0,2,vascular endothelial growth factor receptor 1 binding,MF,
11100,GO:0043184,1,0.955749473398299,0,7,vascular endothelial growth factor receptor 2 binding,MF,
11101,GO:0043185,1,0.994213279153493,0,1,vascular endothelial growth factor receptor 3 binding,MF,
11102,GO:0043186,1,0.913746007738874,0,14,P granule,CC,
11103,GO:0043189,1,0.890389244626158,0,18,H4/H2A histone acetyltransferase complex,CC,
11104,GO:0043190,1,0.951785568879498,0,7,ATP-binding cassette (ABC) transporter complex,CC,
11105,GO:0043194,1,0.909877872646038,0,12,axon initial segment,CC,
11106,GO:0043195,1,0.636026301911163,0,67,terminal bouton,CC,
11107,GO:0043196,1,0.958467049923746,0,7,varicosity,CC,
11110,GO:0043199,1,0.973399562363474,0,4,sulfate binding,MF,
11111,GO:0043200,1,0.501106168999041,0,104,response to amino acid,BP,
11112,GO:0043201,1,0.91520980432577,0,12,response to leucine,BP,
11113,GO:0043202,1,0.565006751216877,0,87,lysosomal lumen,CC,
11116,GO:0043207,1,0.0128521430736102,0,681,response to external biotic stimulus,BP,
11119,GO:0043210,1,0.994352307750253,0,1,alkanesulfonate binding,MF,
11120,GO:0043215,1,0.993232675100923,0,1,daunorubicin transport,BP,
11123,GO:0043219,1,0.974311699076477,0,4,lateral loop,CC,
11125,GO:0043221,1,0.993296488332598,0,1,SMC family protein binding,MF,
11126,GO:0043224,1,0.989513375156004,0,2,nuclear SCF ubiquitin ligase complex,CC,
11127,GO:0043225,1,0.917162951459337,0,12,ATPase-coupled anion transmembrane transporter activity,MF,
11137,GO:0043236,1,0.83737570752143,0,26,laminin binding,MF,
11138,GO:0043237,1,0.965673507958267,0,5,laminin-1 binding,MF,
11139,GO:0043240,1,0.943823604150578,0,9,Fanconi anaemia nuclear complex,CC,
11140,GO:0043242,1,0.645815079139345,0,62,negative regulation of protein complex disassembly,BP,
11141,GO:0043243,1,0.81075936528787,0,30,positive regulation of protein complex disassembly,BP,
11142,GO:0043244,1,0.500979544411588,0,97,regulation of protein complex disassembly,BP,
11143,GO:0043247,1,0.917002964424906,0,13,telomere maintenance in response to DNA damage,BP,
11144,GO:0043248,1,0.935516909589246,0,12,proteasome assembly,BP,
11145,GO:0043249,1,0.92299490548829,0,13,erythrocyte maturation,BP,
11146,GO:0043250,1,0.99451200507888,0,1,sodium-dependent organic anion transmembrane transporter activity,MF,
11147,GO:0043251,1,0.99451200507888,0,1,sodium-dependent organic anion transport,BP,
11150,GO:0043255,1,0.629893302496965,0,67,regulation of carbohydrate biosynthetic process,BP,
11151,GO:0043256,1,0.934315519310774,0,8,laminin complex,CC,
11152,GO:0043257,1,0.992248978845208,0,1,laminin-8 complex,CC,
11153,GO:0043259,1,0.973029686081977,0,3,laminin-10 complex,CC,
11154,GO:0043260,1,0.973050747422758,0,3,laminin-11 complex,CC,
11155,GO:0043262,1,0.981772093942724,0,3,adenosine-diphosphatase activity,MF,
11156,GO:0043265,1,0.993667892711435,0,1,ectoplasm,CC,
11157,GO:0043266,1,0.570491121132022,0,83,regulation of potassium ion transport,BP,
11158,GO:0043267,1,0.84664014460825,0,25,negative regulation of potassium ion transport,BP,
11159,GO:0043268,1,0.762649057702058,0,39,positive regulation of potassium ion transport,BP,
11162,GO:0043271,1,0.460889303214052,0,119,negative regulation of ion transport,BP,
11163,GO:0043273,1,0.992494795205258,0,1,CTPase activity,MF,
11164,GO:0043274,1,0.916308497255103,0,13,phospholipase binding,MF,
11165,GO:0043276,1,0.82159153496479,0,29,anoikis,BP,
11166,GO:0043277,1,0.761543968097779,0,41,apoptotic cell clearance,BP,
11169,GO:0043280,1,0.464383202185405,0,122,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,
11171,GO:0043291,1,0.979392795887882,0,2,RAVE complex,CC,
11173,GO:0043293,1,0.986045958353557,0,2,apoptosome,CC,
11174,GO:0043295,1,0.938359939240623,0,11,glutathione binding,MF,
11176,GO:0043297,1,0.686437639471097,0,56,apical junction assembly,BP,
11177,GO:0043299,1,0.0416258185755672,0,497,leukocyte degranulation,BP,
11178,GO:0043300,1,0.772536512196297,0,41,regulation of leukocyte degranulation,BP,
11179,GO:0043301,1,0.933682007448745,0,11,negative regulation of leukocyte degranulation,BP,
11180,GO:0043302,1,0.88232789080152,0,20,positive regulation of leukocyte degranulation,BP,
11181,GO:0043303,1,0.765258182020599,0,42,mast cell degranulation,BP,
11182,GO:0043304,1,0.847140711879114,0,27,regulation of mast cell degranulation,BP,
11183,GO:0043305,1,0.965863601627744,0,6,negative regulation of mast cell degranulation,BP,
11184,GO:0043306,1,0.929725463540212,0,12,positive regulation of mast cell degranulation,BP,
11185,GO:0043307,1,0.97119082760631,0,5,eosinophil activation,BP,
11186,GO:0043308,1,0.976747389335865,0,4,eosinophil degranulation,BP,
11187,GO:0043309,1,0.982471255827862,0,3,regulation of eosinophil degranulation,BP,
11188,GO:0043310,1,0.993997028244295,0,1,negative regulation of eosinophil degranulation,BP,
11189,GO:0043311,1,0.988405322386981,0,2,positive regulation of eosinophil degranulation,BP,
11190,GO:0043312,1,0.0552785530685762,0,454,neutrophil degranulation,BP,
11191,GO:0043313,1,0.946259946871435,0,8,regulation of neutrophil degranulation,BP,
11192,GO:0043314,1,0.984353525995414,0,2,negative regulation of neutrophil degranulation,BP,
11193,GO:0043315,1,0.974070146359063,0,4,positive regulation of neutrophil degranulation,BP,
11194,GO:0043316,1,0.981907306973665,0,3,cytotoxic T cell degranulation,BP,
11195,GO:0043317,1,0.987992705307767,0,2,regulation of cytotoxic T cell degranulation,BP,
11196,GO:0043318,1,0.987992705307767,0,2,negative regulation of cytotoxic T cell degranulation,BP,
11197,GO:0043320,1,0.967437473575457,0,5,natural killer cell degranulation,BP,
11198,GO:0043321,1,0.985758277234711,0,2,regulation of natural killer cell degranulation,BP,
11199,GO:0043323,1,0.985758277234711,0,2,positive regulation of natural killer cell degranulation,BP,
11200,GO:0043324,1,0.980989305034428,0,3,pigment metabolic process involved in developmental pigmentation,BP,
11201,GO:0043325,1,0.87392586149571,0,20,phosphatidylinositol-3,4-bisphosphate binding,MF,
11202,GO:0043328,1,0.977345929041376,0,4,protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,BP,
11203,GO:0043330,1,0.835969280675967,0,28,response to exogenous dsRNA,BP,
11204,GO:0043331,1,0.595141395983536,0,78,response to dsRNA,BP,
11205,GO:0043335,1,0.988018751058868,0,2,protein unfolding,BP,
11206,GO:0043337,1,0.993329627581151,0,1,CDP-diacylglycerol-phosphatidylglycerol phosphatidyltransferase activity,MF,
11207,GO:0043353,1,0.946608343043534,0,8,enucleate erythrocyte differentiation,BP,
11208,GO:0043354,1,0.992626349998796,0,1,enucleate erythrocyte maturation,BP,
11209,GO:0043363,1,0.993850639026861,0,1,nucleate erythrocyte differentiation,BP,
11210,GO:0043366,1,0.981385723792207,0,3,beta selection,BP,
11211,GO:0043367,1,0.687530424907432,0,58,CD4-positive, alpha-beta T cell differentiation,BP,
11212,GO:0043368,1,0.833201031769451,0,28,positive T cell selection,BP,
11213,GO:0043369,1,0.890603807372648,0,18,CD4-positive or CD8-positive, alpha-beta T cell lineage commitment,BP,
11214,GO:0043370,1,0.816787521742596,0,32,regulation of CD4-positive, alpha-beta T cell differentiation,BP,
11215,GO:0043371,1,0.910961152787583,0,14,negative regulation of CD4-positive, alpha-beta T cell differentiation,BP,
11216,GO:0043372,1,0.880910758557322,0,21,positive regulation of CD4-positive, alpha-beta T cell differentiation,BP,
11217,GO:0043373,1,0.915666286725242,0,14,CD4-positive, alpha-beta T cell lineage commitment,BP,
11218,GO:0043374,1,0.944201407552739,0,9,CD8-positive, alpha-beta T cell differentiation,BP,
11219,GO:0043375,1,0.993306510747315,0,1,CD8-positive, alpha-beta T cell lineage commitment,BP,
11220,GO:0043376,1,0.986739345978497,0,2,regulation of CD8-positive, alpha-beta T cell differentiation,BP,
11221,GO:0043378,1,0.993269745658162,0,1,positive regulation of CD8-positive, alpha-beta T cell differentiation,BP,
11222,GO:0043379,1,0.961038854980688,0,6,memory T cell differentiation,BP,
11223,GO:0043380,1,0.969948605879741,0,5,regulation of memory T cell differentiation,BP,
11224,GO:0043382,1,0.976328720537282,0,4,positive regulation of memory T cell differentiation,BP,
11225,GO:0043383,1,0.931797355520154,0,11,negative T cell selection,BP,
11226,GO:0043385,1,0.993874018242704,0,1,mycotoxin metabolic process,BP,
11227,GO:0043387,1,0.993874018242704,0,1,mycotoxin catabolic process,BP,
11228,GO:0043388,1,0.719646086679005,0,51,positive regulation of DNA binding,BP,
11230,GO:0043393,1,0.271529220965113,0,196,regulation of protein binding,BP,
11231,GO:0043394,1,0.784048778974134,0,34,proteoglycan binding,MF,
11232,GO:0043395,1,0.87759806241267,0,18,heparan sulfate proteoglycan binding,MF,
11233,GO:0043396,1,0.986509814265463,0,2,corticotropin-releasing hormone secretion,BP,
11234,GO:0043397,1,0.986509814265463,0,2,regulation of corticotropin-releasing hormone secretion,BP,
11235,GO:0043398,1,0.980771861130976,0,3,HLH domain binding,MF,
11236,GO:0043400,1,0.970662716323984,0,5,cortisol secretion,BP,
11238,GO:0043402,1,0.974354365658572,0,3,glucocorticoid mediated signaling pathway,BP,
11239,GO:0043403,1,0.843415226552113,0,27,skeletal muscle tissue regeneration,BP,
11247,GO:0043413,1,0.211951276248148,0,234,macromolecule glycosylation,BP,
11248,GO:0043414,1,0.187270064887352,0,253,macromolecule methylation,BP,
11249,GO:0043415,1,0.96927931063483,0,5,positive regulation of skeletal muscle tissue regeneration,BP,
11250,GO:0043416,1,0.96927931063483,0,5,regulation of skeletal muscle tissue regeneration,BP,
11251,GO:0043418,1,0.981682604364523,0,3,homocysteine catabolic process,BP,
11252,GO:0043420,1,0.994520531289197,0,1,anthranilate metabolic process,BP,
11253,GO:0043422,1,0.923711785510153,0,12,protein kinase B binding,MF,
11254,GO:0043423,1,0.993046483574022,0,1,3-phosphoinositide-dependent protein kinase binding,MF,
11255,GO:0043425,1,0.849995950041159,0,24,bHLH transcription factor binding,MF,
11256,GO:0043426,1,0.965551428675495,0,5,MRF binding,MF,
11257,GO:0043433,1,0.376271438694324,0,149,negative regulation of DNA binding transcription factor activity,BP,
11258,GO:0043434,1,0.0772712874104838,0,382,response to peptide hormone,BP,
11259,GO:0043435,1,0.968728865253777,0,5,response to corticotropin-releasing hormone,BP,
11261,GO:0043438,1,0.993802640770212,0,1,acetoacetic acid metabolic process,BP,
11262,GO:0043449,1,0.987066203383813,0,2,cellular alkene metabolic process,BP,
11263,GO:0043455,1,0.928140113366291,0,11,regulation of secondary metabolic process,BP,
11264,GO:0043456,1,0.978137090065443,0,4,regulation of pentose-phosphate shunt,BP,
11266,GO:0043461,1,0.976511769007529,0,4,proton-transporting ATP synthase complex assembly,BP,
11269,GO:0043470,1,0.623546348332135,0,69,regulation of carbohydrate catabolic process,BP,
11270,GO:0043471,1,0.947104130848363,0,9,regulation of cellular carbohydrate catabolic process,BP,
11271,GO:0043473,1,0.535801655185467,0,93,pigmentation,BP,
11272,GO:0043474,1,0.980989305034428,0,3,pigment metabolic process involved in pigmentation,BP,
11273,GO:0043476,1,0.9211887668047,0,12,pigment accumulation,BP,
11274,GO:0043482,1,0.9211887668047,0,12,cellular pigment accumulation,BP,
11275,GO:0043484,1,0.476766548465407,0,111,regulation of RNA splicing,BP,
11276,GO:0043485,1,0.93893809705422,0,10,endosome to pigment granule transport,BP,
11277,GO:0043486,1,0.783382611516098,0,40,histone exchange,BP,
11278,GO:0043487,1,0.366190010393238,0,156,regulation of RNA stability,BP,
11279,GO:0043488,1,0.386677787744255,0,148,regulation of mRNA stability,BP,
11280,GO:0043489,1,0.793309225659303,0,35,RNA stabilization,BP,
11281,GO:0043490,1,0.986902762336591,0,2,malate-aspartate shuttle,BP,
11283,GO:0043492,1,0.458077555107634,0,109,ATPase activity, coupled to movement of substances,MF,
11284,GO:0043495,1,0.938719270408958,0,9,protein membrane anchor,MF,
11285,GO:0043496,1,0.87404040812972,0,21,regulation of protein homodimerization activity,BP,
11286,GO:0043497,1,0.9390732606513,0,10,regulation of protein heterodimerization activity,BP,
11287,GO:0043500,1,0.57453813253082,0,83,muscle adaptation,BP,
11288,GO:0043501,1,0.8755450607209,0,20,skeletal muscle adaptation,BP,
11289,GO:0043502,1,0.627494359637791,0,67,regulation of muscle adaptation,BP,
11290,GO:0043503,1,0.98890527483992,0,2,skeletal muscle fiber adaptation,BP,
11291,GO:0043504,1,0.98021198978092,0,3,mitochondrial DNA repair,BP,
11293,GO:0043507,1,0.642414095005694,0,64,positive regulation of JUN kinase activity,BP,
11295,GO:0043509,1,0.994166785161602,0,1,activin A complex,CC,
11296,GO:0043511,1,0.988753121613354,0,2,inhibin complex,CC,
11297,GO:0043512,1,0.988753121613354,0,2,inhibin A complex,CC,
11298,GO:0043513,1,0.994554893308177,0,1,inhibin B complex,CC,
11299,GO:0043514,1,0.99454559249468,0,1,interleukin-12 complex,CC,
11300,GO:0043515,1,0.964776680548934,0,5,kinetochore binding,MF,
11301,GO:0043516,1,0.828716069490915,0,29,regulation of DNA damage response, signal transduction by p53 class mediator,BP,
11302,GO:0043517,1,0.909849242022785,0,14,positive regulation of DNA damage response, signal transduction by p53 class mediator,BP,
11303,GO:0043518,1,0.916030247963027,0,14,negative regulation of DNA damage response, signal transduction by p53 class mediator,BP,
11304,GO:0043519,1,0.994199329235923,0,1,regulation of myosin II filament organization,BP,
11305,GO:0043522,1,0.945232189935605,0,9,leucine zipper domain binding,MF,
11309,GO:0043527,1,0.971381483203417,0,5,tRNA methyltransferase complex,CC,
11310,GO:0043531,1,0.799329419519286,0,33,ADP binding,MF,
11311,GO:0043532,1,0.991799728013938,0,1,angiostatin binding,MF,
11312,GO:0043533,1,0.963301161041995,0,5,inositol 1,3,4,5 tetrakisphosphate binding,MF,
11313,GO:0043534,1,0.51682304404569,0,98,blood vessel endothelial cell migration,BP,
11314,GO:0043535,1,0.591283635993338,0,78,regulation of blood vessel endothelial cell migration,BP,
11315,GO:0043536,1,0.725106968601192,0,48,positive regulation of blood vessel endothelial cell migration,BP,
11316,GO:0043537,1,0.822316801907423,0,29,negative regulation of blood vessel endothelial cell migration,BP,
11317,GO:0043538,1,0.993716019435524,0,1,regulation of actin phosphorylation,BP,
11318,GO:0043539,1,0.822235358704174,0,31,protein serine/threonine kinase activator activity,MF,
11319,GO:0043540,1,0.994388489476242,0,1,6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex,CC,
11320,GO:0043541,1,0.987128457715624,0,2,UDP-N-acetylglucosamine transferase complex,CC,
11323,GO:0043544,1,0.993439630676661,0,1,lipoamide binding,MF,
11324,GO:0043545,1,0.95794556484966,0,7,molybdopterin cofactor metabolic process,BP,
11325,GO:0043546,1,0.960572104911209,0,6,molybdopterin cofactor binding,MF,
11327,GO:0043548,1,0.821754643119498,0,27,phosphatidylinositol 3-kinase binding,MF,
11332,GO:0043553,1,0.987049137038442,0,2,negative regulation of phosphatidylinositol 3-kinase activity,BP,
11333,GO:0043555,1,0.888710824530524,0,18,regulation of translation in response to stress,BP,
11334,GO:0043558,1,0.913267305385511,0,14,regulation of translational initiation in response to stress,BP,
11335,GO:0043559,1,0.95918544490369,0,5,insulin binding,MF,
11336,GO:0043560,1,0.921623875631758,0,11,insulin receptor substrate binding,MF,
11337,GO:0043562,1,0.938498517797901,0,11,cellular response to nitrogen levels,BP,
11338,GO:0043564,1,0.987732489157038,0,2,Ku70:Ku80 complex,CC,
11340,GO:0043567,1,0.887449662859468,0,18,regulation of insulin-like growth factor receptor signaling pathway,BP,
11341,GO:0043568,1,0.938882430825539,0,9,positive regulation of insulin-like growth factor receptor signaling pathway,BP,
11342,GO:0043569,1,0.953128835186481,0,7,negative regulation of insulin-like growth factor receptor signaling pathway,BP,
11343,GO:0043570,1,0.966413364877218,0,5,maintenance of DNA repeat elements,BP,
11344,GO:0043574,1,0.891632432341865,0,18,peroxisomal transport,BP,
11345,GO:0043576,1,0.86675193248436,0,21,regulation of respiratory gaseous exchange,BP,
11346,GO:0043578,1,0.972376696815217,0,3,nuclear matrix organization,BP,
11348,GO:0043584,1,0.894136069486799,0,16,nose development,BP,
11349,GO:0043585,1,0.977352085824464,0,3,nose morphogenesis,BP,
11350,GO:0043586,1,0.877109021533145,0,19,tongue development,BP,
11351,GO:0043587,1,0.948239209873874,0,8,tongue morphogenesis,BP,
11352,GO:0043588,1,0.204464197137518,0,234,skin development,BP,
11353,GO:0043589,1,0.943130950442091,0,8,skin morphogenesis,BP,
11355,GO:0043601,1,0.860869918973516,0,24,nuclear replisome,CC,
11356,GO:0043602,1,0.99399239051705,0,1,nitrate catabolic process,BP,
11359,GO:0043605,1,0.983202057040464,0,3,cellular amide catabolic process,BP,
11360,GO:0043606,1,0.975919939108296,0,4,formamide metabolic process,BP,
11361,GO:0043610,1,0.990741781317258,0,1,regulation of carbohydrate utilization,BP,
11362,GO:0043614,1,0.985731318830488,0,2,multi-eIF complex,CC,
11363,GO:0043615,1,0.958351188853298,0,7,astrocyte cell migration,BP,
11364,GO:0043616,1,0.795322407690232,0,33,keratinocyte proliferation,BP,
11365,GO:0043618,1,0.513222248203296,0,108,regulation of transcription from RNA polymerase II promoter in response to stress,BP,
11366,GO:0043619,1,0.928573790290502,0,11,regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,
11367,GO:0043620,1,0.495153723746388,0,113,regulation of DNA-templated transcription in response to stress,BP,
11369,GO:0043622,1,0.972688475164849,0,4,cortical microtubule organization,BP,
11370,GO:0043624,1,0.28310424778433,0,199,cellular protein complex disassembly,BP,
11371,GO:0043625,1,0.976436601277388,0,4,delta DNA polymerase complex,CC,
11372,GO:0043626,1,0.994597520385358,0,1,PCNA complex,CC,
11373,GO:0043627,1,0.649165459252586,0,68,response to estrogen,BP,
11374,GO:0043628,1,0.8438317759631,0,28,ncRNA 3'-end processing,BP,
11375,GO:0043629,1,0.991118328435804,0,1,ncRNA polyadenylation,BP,
11376,GO:0043630,1,0.991118328435804,0,1,ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process,BP,
11379,GO:0043633,1,0.951483818814146,0,8,polyadenylation-dependent RNA catabolic process,BP,
11380,GO:0043634,1,0.958275722221922,0,7,polyadenylation-dependent ncRNA catabolic process,BP,
11381,GO:0043647,1,0.659472641086908,0,62,inositol phosphate metabolic process,BP,
11382,GO:0043648,1,0.544235282520971,0,98,dicarboxylic acid metabolic process,BP,
11383,GO:0043649,1,0.894393386859397,0,18,dicarboxylic acid catabolic process,BP,
11384,GO:0043650,1,0.927429903570507,0,12,dicarboxylic acid biosynthetic process,BP,
11385,GO:0043651,1,0.911438784212001,0,15,linoleic acid metabolic process,BP,
11386,GO:0043652,1,0.931941904317635,0,11,engulfment of apoptotic cell,BP,
11387,GO:0043653,1,0.94409594058614,0,9,mitochondrial fragmentation involved in apoptotic process,BP,
11388,GO:0043654,1,0.961402766787368,0,6,recognition of apoptotic cell,BP,
11389,GO:0043656,1,0.944729410213095,0,9,intracellular region of host,CC,
11393,GO:0043682,1,0.982957627857301,0,2,copper-transporting ATPase activity,MF,
11394,GO:0043686,1,0.98262878577432,0,3,co-translational protein modification,BP,
11396,GO:0043691,1,0.921009351512963,0,13,reverse cholesterol transport,BP,
11397,GO:0043696,1,0.951689093598938,0,7,dedifferentiation,BP,
11398,GO:0043697,1,0.951689093598938,0,7,cell dedifferentiation,BP,
11399,GO:0043733,1,0.994727453981438,0,1,DNA-3-methylbase glycosylase activity,MF,
11400,GO:0043734,1,0.976511187501089,0,4,DNA-N1-methyladenine dioxygenase activity,MF,
11401,GO:0043739,1,0.993613136195534,0,1,G/U mismatch-specific uracil-DNA glycosylase activity,MF,
11402,GO:0043754,1,0.989695383480043,0,1,dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity,MF,
11403,GO:0043783,1,0.994072312693583,0,1,oxidoreductase activity, oxidizing metal ions with flavin as acceptor,MF,
11404,GO:0043795,1,0.994563677288245,0,1,glyceraldehyde oxidoreductase activity,MF,
11405,GO:0043812,1,0.978809083196606,0,3,phosphatidylinositol-4-phosphate phosphatase activity,MF,
11406,GO:0043813,1,0.962460243247394,0,5,phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity,MF,
11407,GO:0043843,1,0.993966632638298,0,1,ADP-specific glucokinase activity,MF,
11408,GO:0043849,1,0.993781868260109,0,1,Ras palmitoyltransferase activity,MF,
11409,GO:0043855,1,0.9475416711266,0,8,cyclic nucleotide-gated ion channel activity,MF,
11410,GO:0043865,1,0.993852950638919,0,1,methionine transmembrane transporter activity,MF,
11411,GO:0043874,1,0.994247900793154,0,1,acireductone synthase activity,MF,
11412,GO:0043890,1,0.994063542194857,0,1,N-acetylgalactosamine-6-sulfatase activity,MF,
11413,GO:0043891,1,0.994609662171885,0,1,glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity,MF,
11415,GO:0043901,1,0.406804246111921,0,143,negative regulation of multi-organism process,BP,
11418,GO:0043914,1,0.993265629207653,0,1,NADPH:sulfur oxidoreductase activity,MF,
11419,GO:0043916,1,0.994727453981438,0,1,DNA-7-methylguanine glycosylase activity,MF,
11420,GO:0043921,1,0.852951890842657,0,24,modulation by host of viral transcription,BP,
11421,GO:0043922,1,0.944809952894254,0,9,negative regulation by host of viral transcription,BP,
11422,GO:0043923,1,0.89113929595038,0,17,positive regulation by host of viral transcription,BP,
11423,GO:0043924,1,0.98686405211305,0,1,suramin binding,MF,
11424,GO:0043928,1,0.820274453026585,0,32,exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay,BP,
11425,GO:0043931,1,0.894904173332209,0,14,ossification involved in bone maturation,BP,
11426,GO:0043932,1,0.976719047676579,0,4,ossification involved in bone remodeling,BP,
11428,GO:0043946,1,0.994386163581782,0,1,positive regulation of catalytic activity in other organism involved in symbiotic interaction,BP,
11429,GO:0043947,1,0.994386163581782,0,1,positive regulation by host of symbiont catalytic activity,BP,
11433,GO:0043954,1,0.78787482352754,0,35,cellular component maintenance,BP,
11434,GO:0043966,1,0.695673816587132,0,56,histone H3 acetylation,BP,
11435,GO:0043967,1,0.660487645031449,0,62,histone H4 acetylation,BP,
11436,GO:0043968,1,0.906459285361832,0,15,histone H2A acetylation,BP,
11437,GO:0043969,1,0.990737145415483,0,1,histone H2B acetylation,BP,
11438,GO:0043970,1,0.917128055698942,0,13,histone H3-K9 acetylation,BP,
11439,GO:0043972,1,0.992850736553354,0,1,histone H3-K23 acetylation,BP,
11440,GO:0043973,1,0.99414948372887,0,1,histone H3-K4 acetylation,BP,
11441,GO:0043974,1,0.979086401508582,0,3,histone H3-K27 acetylation,BP,
11442,GO:0043981,1,0.907350731776397,0,15,histone H4-K5 acetylation,BP,
11443,GO:0043982,1,0.907350731776397,0,15,histone H4-K8 acetylation,BP,
11444,GO:0043983,1,0.958548956630791,0,7,histone H4-K12 acetylation,BP,
11445,GO:0043984,1,0.885352795056081,0,18,histone H4-K16 acetylation,BP,
11446,GO:0043985,1,0.964075478902804,0,6,histone H4-R3 methylation,BP,
11448,GO:0043988,1,0.982115062326116,0,3,histone H3-S28 phosphorylation,BP,
11449,GO:0043990,1,0.993691440555327,0,1,histone H2A-S1 phosphorylation,BP,
11450,GO:0043994,1,0.992850736553354,0,1,histone acetyltransferase activity (H3-K23 specific),MF,
11451,GO:0043995,1,0.934832632033567,0,10,histone acetyltransferase activity (H4-K5 specific),MF,
11452,GO:0043996,1,0.934832632033567,0,10,histone acetyltransferase activity (H4-K8 specific),MF,
11453,GO:0043997,1,0.993676082593291,0,1,histone acetyltransferase activity (H4-K12 specific),MF,
11454,GO:0043998,1,0.993567599305559,0,1,H2A histone acetyltransferase activity,MF,
11455,GO:0044003,1,0.77135546702217,0,38,modification by symbiont of host morphology or physiology,BP,
11456,GO:0044004,1,0.970452333081335,0,5,disruption by symbiont of host cell,BP,
11457,GO:0044007,1,0.991974986127913,0,1,dissemination or transmission of symbiont from host,BP,
11458,GO:0044010,1,0.994063026317346,0,1,single-species biofilm formation,BP,
11459,GO:0044020,1,0.976756450501117,0,4,histone methyltransferase activity (H4-R3 specific),MF,
11460,GO:0044026,1,0.987934301059012,0,2,DNA hypermethylation,BP,
11461,GO:0044027,1,0.994561868831304,0,1,hypermethylation of CpG island,BP,
11462,GO:0044028,1,0.986712192282693,0,2,DNA hypomethylation,BP,
11463,GO:0044029,1,0.986712192282693,0,2,hypomethylation of CpG island,BP,
11464,GO:0044030,1,0.904466058032192,0,15,regulation of DNA methylation,BP,
11465,GO:0044033,1,0.958904470657595,0,7,multi-organism metabolic process,BP,
11466,GO:0044035,1,0.994442498811555,0,1,multi-organism catabolic process,BP,
11467,GO:0044036,1,0.972448052943462,0,5,cell wall macromolecule metabolic process,BP,
11468,GO:0044038,1,0.994371949535733,0,1,cell wall macromolecule biosynthetic process,BP,
11469,GO:0044042,1,0.623171591802797,0,69,glucan metabolic process,BP,
11470,GO:0044053,1,0.994040589463601,0,1,translocation of peptides or proteins into host cell cytoplasm,BP,
11472,GO:0044058,1,0.820334556448744,0,32,regulation of digestive system process,BP,
11473,GO:0044060,1,0.778790839470217,0,40,regulation of endocrine process,BP,
11475,GO:0044065,1,0.90630727919659,0,15,regulation of respiratory system process,BP,
11476,GO:0044068,1,0.847372832842481,0,25,modulation by symbiont of host cellular process,BP,
11477,GO:0044070,1,0.614840506663111,0,73,regulation of anion transport,BP,
11480,GO:0044088,1,0.771875536801247,0,39,regulation of vacuole organization,BP,
11482,GO:0044090,1,0.926369234899363,0,11,positive regulation of vacuole organization,BP,
11483,GO:0044091,1,0.799805230545858,0,32,membrane biogenesis,BP,
11486,GO:0044094,1,0.980022225397132,0,3,host cell nuclear part,CC,
11487,GO:0044105,1,0.994859179643979,0,1,L-xylulose reductase (NAD+) activity,MF,
11488,GO:0044106,1,0.511584324975344,0,112,cellular amine metabolic process,BP,
11489,GO:0044107,1,0.977036275892183,0,4,cellular alcohol metabolic process,BP,
11490,GO:0044108,1,0.977036275892183,0,4,cellular alcohol biosynthetic process,BP,
11491,GO:0044110,1,0.927397501985796,0,13,growth involved in symbiotic interaction,BP,
11492,GO:0044111,1,0.986461636555288,0,2,development involved in symbiotic interaction,BP,
11493,GO:0044115,1,0.994442498811555,0,1,development of symbiont involved in interaction with host,BP,
11494,GO:0044116,1,0.927397501985796,0,13,growth of symbiont involved in interaction with host,BP,
11495,GO:0044117,1,0.932135988033334,0,12,growth of symbiont in host,BP,
11496,GO:0044126,1,0.937013805823001,0,11,regulation of growth of symbiont in host,BP,
11497,GO:0044128,1,0.9926593483268,0,1,positive regulation of growth of symbiont in host,BP,
11498,GO:0044130,1,0.943947015975935,0,10,negative regulation of growth of symbiont in host,BP,
11499,GO:0044133,1,0.994920131708846,0,1,growth of symbiont on or near host,BP,
11500,GO:0044139,1,0.994920131708846,0,1,modulation of growth of symbiont on or near host,BP,
11501,GO:0044140,1,0.994920131708846,0,1,negative regulation of growth of symbiont on or near host surface,BP,
11502,GO:0044144,1,0.932250774418666,0,12,modulation of growth of symbiont involved in interaction with host,BP,
11503,GO:0044145,1,0.994442498811555,0,1,modulation of development of symbiont involved in interaction with host,BP,
11504,GO:0044146,1,0.939149098211187,0,11,negative regulation of growth of symbiont involved in interaction with host,BP,
11505,GO:0044147,1,0.994442498811555,0,1,negative regulation of development of symbiont involved in interaction with host,BP,
11506,GO:0044148,1,0.9926593483268,0,1,positive regulation of growth of symbiont involved in interaction with host,BP,
11507,GO:0044154,1,0.951353844614873,0,8,histone H3-K14 acetylation,BP,
11508,GO:0044179,1,0.988054531763341,0,2,hemolysis in other organism,BP,
11510,GO:0044190,1,0.99438280393633,0,1,host cell mitochondrial envelope,CC,
11511,GO:0044194,1,0.97139545934521,0,5,cytolytic granule,CC,
11512,GO:0044205,1,0.979854826574411,0,3,'de novo' UMP biosynthetic process,BP,
11513,GO:0044206,1,0.971883833614895,0,5,UMP salvage,BP,
11514,GO:0044207,1,0.993141304965301,0,1,translation initiation ternary complex,CC,
11515,GO:0044208,1,0.982846898458595,0,3,'de novo' AMP biosynthetic process,BP,
11516,GO:0044209,1,0.989163038192769,0,2,AMP salvage,BP,
11517,GO:0044210,1,0.987146010218211,0,2,'de novo' CTP biosynthetic process,BP,
11518,GO:0044211,1,0.983263829304062,0,3,CTP salvage,BP,
11520,GO:0044213,1,0.923341243839522,0,12,intronic transcription regulatory region DNA binding,MF,
11521,GO:0044214,1,0.962606888480276,0,5,spanning component of plasma membrane,CC,
11525,GO:0044218,1,0.969533495471185,0,5,other organism cell membrane,CC,
11526,GO:0044220,1,0.99279119412585,0,1,host cell perinuclear region of cytoplasm,CC,
11527,GO:0044221,1,0.993129923835772,0,1,host cell synapse,CC,
11529,GO:0044228,1,0.992844994555994,0,1,host cell surface,CC,
11530,GO:0044231,1,0.993129923835772,0,1,host cell presynaptic membrane,CC,
11531,GO:0044232,1,0.88265709487331,0,19,organelle membrane contact site,CC,
11532,GO:0044233,1,0.919525217799003,0,13,ER-mitochondrion membrane contact site,CC,
11535,GO:0044241,1,0.94551901815693,0,9,lipid digestion,BP,
11537,GO:0044245,1,0.980572560446926,0,3,polysaccharide digestion,BP,
11538,GO:0044247,1,0.842141348031718,0,25,cellular polysaccharide catabolic process,BP,
11543,GO:0044258,1,0.994053741186128,0,1,intestinal lipid catabolic process,BP,
11545,GO:0044262,1,0.218176192523807,0,227,cellular carbohydrate metabolic process,BP,
11546,GO:0044264,1,0.550172888307305,0,88,cellular polysaccharide metabolic process,BP,
11551,GO:0044272,1,0.337934562542186,0,167,sulfur compound biosynthetic process,BP,
11552,GO:0044273,1,0.764773842416499,0,42,sulfur compound catabolic process,BP,
11553,GO:0044275,1,0.771372093693717,0,39,cellular carbohydrate catabolic process,BP,
11554,GO:0044279,1,0.969533495471185,0,5,other organism membrane,CC,
11558,GO:0044284,1,0.994824053951884,0,1,mitochondrial crista junction,CC,
11560,GO:0044292,1,0.936507679420418,0,10,dendrite terminus,CC,
11561,GO:0044294,1,0.958567850469121,0,6,dendritic growth cone,CC,
11562,GO:0044295,1,0.863979755138634,0,21,axonal growth cone,CC,
11564,GO:0044298,1,0.85920634422255,0,23,cell body membrane,CC,
11565,GO:0044299,1,0.991911311833391,0,1,C-fiber,CC,
11566,GO:0044300,1,0.965313041020266,0,5,cerebellar mossy fiber,CC,
11567,GO:0044301,1,0.987529827912603,0,2,climbing fiber,CC,
11568,GO:0044302,1,0.969330142971698,0,4,dentate gyrus mossy fiber,CC,
11570,GO:0044305,1,0.967150117733274,0,4,calyx of Held,CC,
11572,GO:0044307,1,0.988846237687762,0,1,dendritic branch,CC,
11573,GO:0044308,1,0.976503509071382,0,3,axonal spine,CC,
11575,GO:0044313,1,0.97662488706175,0,3,protein K6-linked deubiquitination,BP,
11576,GO:0044314,1,0.977776388843479,0,4,protein K27-linked ubiquitination,BP,
11577,GO:0044316,1,0.987371029162016,0,2,cone cell pedicle,CC,
11578,GO:0044317,1,0.994579694837941,0,1,rod spherule,CC,
11579,GO:0044319,1,0.830182750896211,0,27,wound healing, spreading of cells,BP,
11580,GO:0044320,1,0.908040322353159,0,15,cellular response to leptin stimulus,BP,
11581,GO:0044321,1,0.885572890879915,0,19,response to leptin,BP,
11582,GO:0044322,1,0.830103520159639,0,28,endoplasmic reticulum quality control compartment,CC,
11584,GO:0044324,1,0.994819404910203,0,1,regulation of transcription involved in anterior/posterior axis specification,BP,
11586,GO:0044326,1,0.971109392262022,0,4,dendritic spine neck,CC,
11587,GO:0044327,1,0.948689344676727,0,8,dendritic spine head,CC,
11588,GO:0044331,1,0.813942107165868,0,32,cell-cell adhesion mediated by cadherin,BP,
11589,GO:0044332,1,0.952431890539327,0,6,Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
11590,GO:0044333,1,0.994317675710056,0,1,Wnt signaling pathway involved in digestive tract morphogenesis,BP,
11591,GO:0044334,1,0.986801203414648,0,2,canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition,BP,
11592,GO:0044335,1,0.99006331330171,0,1,canonical Wnt signaling pathway involved in neural crest cell differentiation,BP,
11593,GO:0044336,1,0.980391838697604,0,3,canonical Wnt signaling pathway involved in negative regulation of apoptotic process,BP,
11594,GO:0044338,1,0.987602439630474,0,2,canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation,BP,
11595,GO:0044339,1,0.973371236140318,0,4,canonical Wnt signaling pathway involved in osteoblast differentiation,BP,
11596,GO:0044340,1,0.965295691665337,0,5,canonical Wnt signaling pathway involved in regulation of cell proliferation,BP,
11597,GO:0044341,1,0.955836847202973,0,7,sodium-dependent phosphate transport,BP,
11598,GO:0044342,1,0.903804740285773,0,16,type B pancreatic cell proliferation,BP,
11599,GO:0044343,1,0.992986733621958,0,1,canonical Wnt signaling pathway involved in regulation of type B pancreatic cell proliferation,BP,
11601,GO:0044345,1,0.992986733621958,0,1,stromal-epithelial cell signaling involved in prostate gland development,BP,
11602,GO:0044346,1,0.885370830011492,0,18,fibroblast apoptotic process,BP,
11603,GO:0044349,1,0.994396242376035,0,1,DNA excision,BP,
11604,GO:0044351,1,0.955348660576521,0,7,macropinocytosis,BP,
11605,GO:0044352,1,0.973175126440548,0,4,pinosome,CC,
11606,GO:0044354,1,0.973175126440548,0,4,macropinosome,CC,
11607,GO:0044355,1,0.994542492193625,0,1,clearance of foreign intracellular DNA,BP,
11608,GO:0044356,1,0.994542492193625,0,1,clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine,BP,
11609,GO:0044359,1,0.951908594232782,0,8,modulation of molecular function in other organism,BP,
11610,GO:0044362,1,0.959640982701995,0,7,negative regulation of molecular function in other organism,BP,
11611,GO:0044364,1,0.828190606283197,0,34,disruption of cells of other organism,BP,
11612,GO:0044375,1,0.983973856342936,0,3,regulation of peroxisome size,BP,
11613,GO:0044378,1,0.986672717049876,0,2,non-sequence-specific DNA binding, bending,MF,
11614,GO:0044380,1,0.702975175482692,0,49,protein localization to cytoskeleton,BP,
11615,GO:0044381,1,0.864184045490767,0,21,glucose import in response to insulin stimulus,BP,
11616,GO:0044387,1,0.949198534681566,0,8,negative regulation of protein kinase activity by regulation of protein phosphorylation,BP,
11617,GO:0044388,1,0.972245259261414,0,5,small protein activating enzyme binding,MF,
11619,GO:0044390,1,0.76624277570905,0,39,ubiquitin-like protein conjugating enzyme binding,MF,
11620,GO:0044391,1,0.371885203952067,0,181,ribosomal subunit,CC,
11621,GO:0044393,1,0.980954410587259,0,3,microspike,CC,
11622,GO:0044396,1,0.966747208102071,0,5,actin cortical patch organization,BP,
11624,GO:0044406,1,0.933231713582789,0,11,adhesion of symbiont to host,BP,
11625,GO:0044407,1,0.994063026317346,0,1,single-species biofilm formation in or on host organism,BP,
11627,GO:0044413,1,0.973139911908542,0,4,avoidance of host defenses,BP,
11628,GO:0044414,1,0.992596485148829,0,1,suppression of host defenses,BP,
11629,GO:0044415,1,0.973139911908542,0,4,evasion or tolerance of host defenses,BP,
11630,GO:0044416,1,0.994151291207698,0,1,induction by symbiont of host defense response,BP,
11631,GO:0044417,1,0.947223181388145,0,9,translocation of molecules into host,BP,
11646,GO:0044438,1,0.57383566118401,0,89,microbody part,CC,
11647,GO:0044439,1,0.57383566118401,0,89,peroxisomal part,CC,
11658,GO:0044452,1,0.338239963811001,0,169,nucleolar part,CC,
11659,GO:0044453,1,0.91021475024922,0,15,nuclear membrane part,CC,
11661,GO:0044455,1,0.371486072872155,0,170,mitochondrial membrane part,CC,
11663,GO:0044458,1,0.890993779393314,0,19,motile cilium assembly,BP,
11667,GO:0044467,1,0.987838595453272,0,2,glial cell-derived neurotrophic factor secretion,BP,
11668,GO:0044495,1,0.99486796096715,0,1,modulation of blood pressure in other organism,BP,
11669,GO:0044497,1,0.99486796096715,0,1,positive regulation of blood pressure in other organism,BP,
11670,GO:0044501,1,0.986240687281154,0,2,modulation of signal transduction in other organism,BP,
11671,GO:0044508,1,0.993673523183041,0,1,glucagon-like peptide 1 receptor activity,MF,
11672,GO:0044524,1,0.994387197314057,0,1,protein sulfhydration,BP,
11673,GO:0044528,1,0.97553522250212,0,4,regulation of mitochondrial mRNA stability,BP,
11674,GO:0044530,1,0.978784975173679,0,3,supraspliceosomal complex,CC,
11675,GO:0044531,1,0.963670600658522,0,6,modulation of programmed cell death in other organism,BP,
11676,GO:0044532,1,0.963670600658522,0,6,modulation of apoptotic process in other organism,BP,
11677,GO:0044533,1,0.98218713697563,0,3,positive regulation of apoptotic process in other organism,BP,
11678,GO:0044537,1,0.994367297581572,0,1,regulation of circulating fibrinogen levels,BP,
11680,GO:0044540,1,0.994387197314057,0,1,L-cystine L-cysteine-lyase (deaminating),MF,
11681,GO:0044545,1,0.970093923509058,0,5,NSL complex,CC,
11682,GO:0044546,1,0.922521862253227,0,12,NLRP3 inflammasome complex assembly,BP,
11683,GO:0044547,1,0.968426028477593,0,5,DNA topoisomerase binding,MF,
11685,GO:0044549,1,0.994921164783572,0,1,GTP cyclohydrolase binding,MF,
11686,GO:0044550,1,0.861999876499209,0,22,secondary metabolite biosynthetic process,BP,
11687,GO:0044557,1,0.956527152758578,0,7,relaxation of smooth muscle,BP,
11688,GO:0044558,1,0.992701755809941,0,1,uterine smooth muscle relaxation,BP,
11689,GO:0044565,1,0.988315885981752,0,2,dendritic cell proliferation,BP,
11690,GO:0044571,1,0.978411644290917,0,4,[2Fe-2S] cluster assembly,BP,
11691,GO:0044594,1,0.993898696585579,0,1,17-beta-hydroxysteroid dehydrogenase (NAD+) activity,MF,
11692,GO:0044595,1,0.994634461808247,0,1,decaprenyldihydroxybenzoate methyltransferase activity,MF,
11693,GO:0044596,1,0.994634461808247,0,1,3-demethylubiquinone-10 3-O-methyltransferase activity,MF,
11694,GO:0044597,1,0.956381120694804,0,8,daunorubicin metabolic process,BP,
11695,GO:0044598,1,0.956381120694804,0,8,doxorubicin metabolic process,BP,
11696,GO:0044599,1,0.993850639026861,0,1,AP-5 adaptor complex,CC,
11697,GO:0044601,1,0.994436555483609,0,1,protein denucleotidylation,BP,
11698,GO:0044602,1,0.994436555483609,0,1,protein deadenylylation,BP,
11699,GO:0044603,1,0.994436555483609,0,1,protein adenylylhydrolase activity,MF,
11700,GO:0044609,1,0.988070903300464,0,2,DBIRD complex,CC,
11701,GO:0044610,1,0.994118245529178,0,1,FMN transmembrane transporter activity,MF,
11702,GO:0044611,1,0.977592352127835,0,3,nuclear pore inner ring,CC,
11703,GO:0044613,1,0.932283064814334,0,11,nuclear pore central transport channel,CC,
11704,GO:0044614,1,0.969715058753218,0,4,nuclear pore cytoplasmic filaments,CC,
11705,GO:0044615,1,0.938419310664451,0,8,nuclear pore nuclear basket,CC,
11706,GO:0044620,1,0.989925940293056,0,2,ACP phosphopantetheine attachment site binding,MF,
11707,GO:0044648,1,0.993850639026861,0,1,histone H3-K4 dimethylation,BP,
11708,GO:0044650,1,0.944571973321617,0,9,adhesion of symbiont to host cell,BP,
11709,GO:0044651,1,0.994625162038072,0,1,adhesion of symbiont to host epithelial cell,BP,
11710,GO:0044665,1,0.829914465004281,0,28,MLL1/2 complex,CC,
11711,GO:0044666,1,0.935695817107252,0,10,MLL3/4 complex,CC,
11712,GO:0044691,1,0.97590699775098,0,3,tooth eruption,BP,
11714,GO:0044706,1,0.297866257014551,0,184,multi-multicellular organism process,BP,
11715,GO:0044713,1,0.994920131708846,0,1,2-hydroxy-adenosine triphosphate pyrophosphatase activity,MF,
11716,GO:0044714,1,0.994920131708846,0,1,2-hydroxy-(deoxy)adenosine-triphosphate pyrophosphatase activity,MF,
11717,GO:0044715,1,0.994664427008244,0,1,8-oxo-dGDP phosphatase activity,MF,
11718,GO:0044721,1,0.994292348474168,0,1,protein import into peroxisome matrix, substrate release,BP,
11719,GO:0044722,1,0.993291347376045,0,1,renal phosphate excretion,BP,
11720,GO:0044725,1,0.989611897985762,0,1,chromatin reprogramming in the zygote,BP,
11721,GO:0044727,1,0.989611897985762,0,1,DNA demethylation of male pronucleus,BP,
11722,GO:0044728,1,0.607028285311569,0,74,DNA methylation or demethylation,BP,
11723,GO:0044729,1,0.987449515670909,0,2,hemi-methylated DNA-binding,MF,
11724,GO:0044730,1,0.994442498811555,0,1,bone sialoprotein binding,MF,
11725,GO:0044732,1,0.993850639026861,0,1,mitotic spindle pole body,CC,
11726,GO:0044736,1,0.981663996163023,0,3,acid-sensing ion channel activity,MF,
11727,GO:0044743,1,0.803317895218025,0,37,protein transmembrane import into intracellular organelle,BP,
11728,GO:0044752,1,0.981272097363052,0,3,response to human chorionic gonadotropin,BP,
11729,GO:0044753,1,0.984337497901299,0,2,amphisome,CC,
11730,GO:0044754,1,0.950519128809728,0,8,autolysosome,CC,
11731,GO:0044764,1,0.806539397572402,0,33,multi-organism cellular process,BP,
11732,GO:0044766,1,0.638807916978419,0,69,multi-organism transport,BP,
11733,GO:0044769,1,0.885781207707815,0,20,ATPase activity, coupled to transmembrane movement of ions, rotational mechanism,MF,
11735,GO:0044771,1,0.987508038083345,0,2,meiotic cell cycle phase transition,BP,
11739,GO:0044778,1,0.9881985073577,0,2,meiotic DNA integrity checkpoint,BP,
11740,GO:0044779,1,0.993723958214045,0,1,meiotic spindle checkpoint,BP,
11744,GO:0044785,1,0.993723958214045,0,1,metaphase/anaphase transition of meiotic cell cycle,BP,
11745,GO:0044786,1,0.690429006180428,0,57,cell cycle DNA replication,BP,
11746,GO:0044788,1,0.877668051646277,0,20,modulation by host of viral process,BP,
11747,GO:0044789,1,0.965810217858982,0,5,modulation by host of viral release from host cell,BP,
11748,GO:0044791,1,0.965810217858982,0,5,positive regulation by host of viral release from host cell,BP,
11749,GO:0044793,1,0.961109222154714,0,6,negative regulation by host of viral process,BP,
11750,GO:0044794,1,0.9176929761916,0,13,positive regulation by host of viral process,BP,
11751,GO:0044795,1,0.994691291475363,0,1,trans-Golgi network to recycling endosome transport,BP,
11752,GO:0044796,1,0.994597520385358,0,1,DNA polymerase processivity factor complex,CC,
11753,GO:0044798,1,0.313960464924426,0,175,nuclear transcription factor complex,CC,
11754,GO:0044800,1,0.964310865453964,0,6,multi-organism membrane fusion,BP,
11755,GO:0044803,1,0.957320481191757,0,7,multi-organism membrane organization,BP,
11756,GO:0044804,1,0.882752076583707,0,19,autophagy of nucleus,BP,
11757,GO:0044805,1,0.979144778080646,0,3,late nucleophagy,BP,
11758,GO:0044806,1,0.952688424883715,0,7,G-quadruplex DNA unwinding,BP,
11762,GO:0044821,1,0.968473531471934,0,5,meiotic telomere tethering at nuclear periphery,BP,
11763,GO:0044827,1,0.921642822270565,0,12,modulation by host of viral genome replication,BP,
11764,GO:0044828,1,0.97240658443911,0,4,negative regulation by host of viral genome replication,BP,
11765,GO:0044829,1,0.952455275250065,0,7,positive regulation by host of viral genome replication,BP,
11766,GO:0044830,1,0.986865131993503,0,2,modulation by host of viral RNA genome replication,BP,
11767,GO:0044837,1,0.953377459834116,0,7,actomyosin contractile ring organization,BP,
11770,GO:0044848,1,0.942172461723882,0,9,biological phase,BP,
11771,GO:0044849,1,0.916830005724417,0,14,estrous cycle,BP,
11772,GO:0044851,1,0.942172461723882,0,9,hair cycle phase,BP,
11774,GO:0044854,1,0.976292693176564,0,4,plasma membrane raft assembly,BP,
11775,GO:0044855,1,0.993875817209287,0,1,plasma membrane raft distribution,BP,
11776,GO:0044856,1,0.993875817209287,0,1,plasma membrane raft localization,BP,
11777,GO:0044857,1,0.976292693176564,0,4,plasma membrane raft organization,BP,
11778,GO:0044858,1,0.993875817209287,0,1,plasma membrane raft polarization,BP,
11779,GO:0044860,1,0.974657009757205,0,4,protein localization to plasma membrane raft,BP,
11780,GO:0044861,1,0.986624581557561,0,2,protein transport into plasma membrane raft,BP,
11781,GO:0044866,1,0.994288730402198,0,1,modulation by host of viral exo-alpha-sialidase activity,BP,
11782,GO:0044867,1,0.994288730402198,0,1,modulation by host of viral catalytic activity,BP,
11783,GO:0044868,1,0.986280022075889,0,2,modulation by host of viral molecular function,BP,
11784,GO:0044869,1,0.994288730402198,0,1,negative regulation by host of viral exo-alpha-sialidase activity,BP,
11785,GO:0044870,1,0.994288730402198,0,1,modulation by host of viral glycoprotein metabolic process,BP,
11786,GO:0044871,1,0.994288730402198,0,1,negative regulation by host of viral glycoprotein metabolic process,BP,
11787,GO:0044872,1,0.897614441177063,0,13,lipoprotein localization,BP,
11789,GO:0044878,1,0.977448546183786,0,4,mitotic cytokinesis checkpoint,BP,
11790,GO:0045002,1,0.963691009069951,0,6,double-strand break repair via single-strand annealing,BP,
11791,GO:0045003,1,0.941581758366975,0,10,double-strand break repair via synthesis-dependent strand annealing,BP,
11792,GO:0045004,1,0.984760101243385,0,2,DNA replication proofreading,BP,
11793,GO:0045005,1,0.801210485095571,0,33,DNA-dependent DNA replication maintenance of fidelity,BP,
11794,GO:0045006,1,0.934353680888159,0,12,DNA deamination,BP,
11795,GO:0045007,1,0.98345392247045,0,3,depurination,BP,
11796,GO:0045008,1,0.954774369266507,0,8,depyrimidination,BP,
11797,GO:0045009,1,0.93793907505258,0,11,chitosome,CC,
11798,GO:0045010,1,0.747404522163947,0,45,actin nucleation,BP,
11799,GO:0045016,1,0.993562482750717,0,1,mitochondrial magnesium ion transmembrane transport,BP,
11801,GO:0045019,1,0.925384225197067,0,12,negative regulation of nitric oxide biosynthetic process,BP,
11802,GO:0045022,1,0.778744636289858,0,37,early endosome to late endosome transport,BP,
11804,GO:0045025,1,0.98696272796186,0,2,mitochondrial degradosome,CC,
11805,GO:0045026,1,0.844588773727782,0,28,plasma membrane fusion,BP,
11806,GO:0045027,1,0.994202945751452,0,1,DNA end binding,MF,
11807,GO:0045028,1,0.931542395744587,0,12,G-protein coupled purinergic nucleotide receptor activity,MF,
11808,GO:0045029,1,0.988368894408722,0,2,UDP-activated nucleotide receptor activity,MF,
11809,GO:0045030,1,0.994443790830389,0,1,UTP-activated nucleotide receptor activity,MF,
11810,GO:0045031,1,0.987993785028433,0,2,ATP-activated adenosine receptor activity,MF,
11811,GO:0045032,1,0.993687856789293,0,1,ADP-activated adenosine receptor activity,MF,
11812,GO:0045039,1,0.967600040496956,0,6,protein import into mitochondrial inner membrane,BP,
11813,GO:0045040,1,0.966300475273319,0,6,protein import into mitochondrial outer membrane,BP,
11814,GO:0045041,1,0.98862908853697,0,2,protein import into mitochondrial intermembrane space,BP,
11815,GO:0045046,1,0.962561766814856,0,6,protein import into peroxisome membrane,BP,
11816,GO:0045047,1,0.583511189377313,0,100,protein targeting to ER,BP,
11817,GO:0045048,1,0.968685202382207,0,5,protein insertion into ER membrane,BP,
11818,GO:0045053,1,0.950147277471169,0,5,protein retention in Golgi apparatus,BP,
11819,GO:0045054,1,0.976313656331695,0,4,constitutive secretory pathway,BP,
11821,GO:0045056,1,0.902351856775019,0,15,transcytosis,BP,
11822,GO:0045058,1,0.760087985385761,0,42,T cell selection,BP,
11823,GO:0045059,1,0.94496013694743,0,9,positive thymic T cell selection,BP,
11824,GO:0045060,1,0.938089899073871,0,10,negative thymic T cell selection,BP,
11825,GO:0045061,1,0.88993231391883,0,18,thymic T cell selection,BP,
11826,GO:0045062,1,0.994405545691548,0,1,extrathymic T cell selection,BP,
11827,GO:0045063,1,0.897574493387506,0,17,T-helper 1 cell differentiation,BP,
11828,GO:0045064,1,0.91818615809879,0,14,T-helper 2 cell differentiation,BP,
11829,GO:0045065,1,0.981778950516799,0,3,cytotoxic T cell differentiation,BP,
11830,GO:0045066,1,0.847678049992525,0,26,regulatory T cell differentiation,BP,
11833,GO:0045071,1,0.735864225822007,0,49,negative regulation of viral genome replication,BP,
11834,GO:0045072,1,0.91768960554959,0,14,regulation of interferon-gamma biosynthetic process,BP,
11835,GO:0045073,1,0.937540443995808,0,11,regulation of chemokine biosynthetic process,BP,
11836,GO:0045074,1,0.980415978363259,0,3,regulation of interleukin-10 biosynthetic process,BP,
11837,GO:0045075,1,0.954966026132682,0,7,regulation of interleukin-12 biosynthetic process,BP,
11838,GO:0045076,1,0.900190376477429,0,17,regulation of interleukin-2 biosynthetic process,BP,
11839,GO:0045077,1,0.976815740051813,0,4,negative regulation of interferon-gamma biosynthetic process,BP,
11840,GO:0045078,1,0.939484442419843,0,10,positive regulation of interferon-gamma biosynthetic process,BP,
11841,GO:0045079,1,0.983998356922688,0,3,negative regulation of chemokine biosynthetic process,BP,
11842,GO:0045080,1,0.952794111166233,0,8,positive regulation of chemokine biosynthetic process,BP,
11843,GO:0045081,1,0.993423492418206,0,1,negative regulation of interleukin-10 biosynthetic process,BP,
11844,GO:0045082,1,0.986907242477235,0,2,positive regulation of interleukin-10 biosynthetic process,BP,
11845,GO:0045083,1,0.993175158344425,0,1,negative regulation of interleukin-12 biosynthetic process,BP,
11846,GO:0045084,1,0.968987065347261,0,5,positive regulation of interleukin-12 biosynthetic process,BP,
11847,GO:0045085,1,0.977544114920141,0,4,negative regulation of interleukin-2 biosynthetic process,BP,
11848,GO:0045086,1,0.926200492061394,0,12,positive regulation of interleukin-2 biosynthetic process,BP,
11853,GO:0045092,1,0.993430921702662,0,1,interleukin-18 receptor complex,CC,
11854,GO:0045095,1,0.886668567229694,0,20,keratin filament,CC,
11855,GO:0045098,1,0.982907607368869,0,3,type III intermediate filament,CC,
11858,GO:0045105,1,0.992416674289449,0,1,intermediate filament polymerization or depolymerization,BP,
11859,GO:0045106,1,0.992416674289449,0,1,intermediate filament depolymerization,BP,
11860,GO:0045108,1,0.992416674289449,0,1,regulation of intermediate filament polymerization or depolymerization,BP,
11862,GO:0045110,1,0.967556116915589,0,5,intermediate filament bundle assembly,BP,
11864,GO:0045112,1,0.966987798398591,0,5,integrin biosynthetic process,BP,
11865,GO:0045113,1,0.975884064099495,0,4,regulation of integrin biosynthetic process,BP,
11866,GO:0045116,1,0.918093809434945,0,14,protein neddylation,BP,
11867,GO:0045117,1,0.890942173321156,0,19,azole transport,BP,
11870,GO:0045123,1,0.735450751880962,0,48,cellular extravasation,BP,
11871,GO:0045124,1,0.816017969489241,0,30,regulation of bone resorption,BP,
11873,GO:0045127,1,0.994473764788083,0,1,N-acetylglucosamine kinase activity,MF,
11874,GO:0045128,1,0.993660215276567,0,1,negative regulation of reciprocal meiotic recombination,BP,
11875,GO:0045130,1,0.993885327341274,0,1,keratan sulfotransferase activity,MF,
11876,GO:0045131,1,0.993748805621917,0,1,pre-mRNA branch point binding,MF,
11878,GO:0045134,1,0.975594760077477,0,4,uridine-diphosphatase activity,MF,
11879,GO:0045136,1,0.942669839388535,0,9,development of secondary sexual characteristics,BP,
11881,GO:0045141,1,0.934533098504885,0,10,meiotic telomere clustering,BP,
11882,GO:0045142,1,0.986206645996726,0,2,triplex DNA binding,MF,
11885,GO:0045145,1,0.987526559232549,0,2,single-stranded DNA 5'-3' exodeoxyribonuclease activity,MF,
11886,GO:0045153,1,0.994662877110345,0,1,electron transporter, transferring electrons within CoQH2-cytochrome c reductase complex activity,MF,
11887,GO:0045155,1,0.987146216194345,0,2,electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity,MF,
11888,GO:0045159,1,0.964974818602851,0,6,myosin II binding,MF,
11890,GO:0045162,1,0.947784131374024,0,7,clustering of voltage-gated sodium channels,BP,
11893,GO:0045167,1,0.994403478303465,0,1,asymmetric protein localization involved in cell fate determination,BP,
11894,GO:0045168,1,0.988152440511452,0,2,cell-cell signaling involved in cell fate commitment,BP,
11896,GO:0045174,1,0.989428399915997,0,2,glutathione dehydrogenase (ascorbate) activity,MF,
11900,GO:0045179,1,0.956426583492859,0,7,apical cortex,CC,
11901,GO:0045180,1,0.960627679059503,0,5,basal cortex,CC,
11902,GO:0045182,1,0.724796221128271,0,49,translation regulator activity,MF,
11903,GO:0045183,1,0.993850639026861,0,1,translation factor activity, non-nucleic acid binding,MF,
11905,GO:0045185,1,0.494232608609126,0,102,maintenance of protein location,BP,
11906,GO:0045186,1,0.99139987721998,0,1,zonula adherens assembly,BP,
11908,GO:0045188,1,0.958510229526059,0,7,regulation of circadian sleep/wake cycle, non-REM sleep,BP,
11909,GO:0045190,1,0.776548863429577,0,39,isotype switching,BP,
11910,GO:0045191,1,0.838822648958514,0,27,regulation of isotype switching,BP,
11911,GO:0045196,1,0.979230372337802,0,3,establishment or maintenance of neuroblast polarity,BP,
11913,GO:0045198,1,0.917129225470081,0,13,establishment of epithelial cell apical/basal polarity,BP,
11915,GO:0045200,1,0.979230372337802,0,3,establishment of neuroblast polarity,BP,
11917,GO:0045204,1,0.979218353158043,0,3,MAPK export from nucleus,BP,
11918,GO:0045208,1,0.993449362763273,0,1,MAPK phosphatase export from nucleus,BP,
11919,GO:0045209,1,0.993449362763273,0,1,MAPK phosphatase export from nucleus, leptomycin B sensitive,BP,
11920,GO:0045210,1,0.984760281705287,0,2,FasL biosynthetic process,BP,
11921,GO:0045211,1,0.199716518848339,0,229,postsynaptic membrane,CC,
11922,GO:0045212,1,0.993956075609241,0,1,neurotransmitter receptor biosynthetic process,BP,
11923,GO:0045213,1,0.98257587316548,0,3,neurotransmitter receptor metabolic process,BP,
11925,GO:0045216,1,0.208739547189559,0,224,cell-cell junction organization,BP,
11926,GO:0045217,1,0.93866330979234,0,10,cell-cell junction maintenance,BP,
11927,GO:0045218,1,0.98032720706693,0,3,zonula adherens maintenance,BP,
11928,GO:0045219,1,0.992471201832294,0,1,regulation of FasL biosynthetic process,BP,
11929,GO:0045221,1,0.992471201832294,0,1,negative regulation of FasL biosynthetic process,BP,
11930,GO:0045222,1,0.994690258241244,0,1,CD4 biosynthetic process,BP,
11931,GO:0045223,1,0.994690258241244,0,1,regulation of CD4 biosynthetic process,BP,
11932,GO:0045225,1,0.994690258241244,0,1,negative regulation of CD4 biosynthetic process,BP,
11933,GO:0045226,1,0.981821087338591,0,3,extracellular polysaccharide biosynthetic process,BP,
11934,GO:0045229,1,0.98778980084707,0,2,external encapsulating structure organization,BP,
11935,GO:0045234,1,0.99436574692248,0,1,protein palmitoleylation,BP,
11936,GO:0045236,1,0.912795314198639,0,16,CXCR chemokine receptor binding,MF,
11937,GO:0045239,1,0.91844402008581,0,13,tricarboxylic acid cycle enzyme complex,CC,
11938,GO:0045240,1,0.929168014463363,0,11,dihydrolipoyl dehydrogenase complex,CC,
11939,GO:0045244,1,0.994071280813827,0,1,succinate-CoA ligase complex (GDP-forming),CC,
11940,GO:0045251,1,0.994072312693583,0,1,electron transfer flavoprotein complex,CC,
11941,GO:0045252,1,0.95549536815096,0,7,oxoglutarate dehydrogenase complex,CC,
11942,GO:0045254,1,0.956298386125478,0,7,pyruvate dehydrogenase complex,CC,
11943,GO:0045257,1,0.977407007262679,0,4,succinate dehydrogenase complex (ubiquinone),CC,
11944,GO:0045259,1,0.98875363595262,0,2,proton-transporting ATP synthase complex,CC,
11945,GO:0045263,1,0.994568327583638,0,1,proton-transporting ATP synthase complex, coupling factor F(o),CC,
11946,GO:0045271,1,0.795106879647932,0,43,respiratory chain complex I,CC,
11947,GO:0045272,1,0.983300703693943,0,3,plasma membrane respiratory chain complex I,CC,
11948,GO:0045273,1,0.977407007262679,0,4,respiratory chain complex II,CC,
11949,GO:0045274,1,0.994050130647061,0,1,plasma membrane respiratory chain complex II,CC,
11950,GO:0045275,1,0.938841865780658,0,11,respiratory chain complex III,CC,
11951,GO:0045277,1,0.930750051904885,0,14,respiratory chain complex IV,CC,
11952,GO:0045281,1,0.977407007262679,0,4,succinate dehydrogenase complex,CC,
11953,GO:0045282,1,0.994050130647061,0,1,plasma membrane succinate dehydrogenase complex,CC,
11954,GO:0045283,1,0.977407007262679,0,4,fumarate reductase complex,CC,
11955,GO:0045292,1,0.89954189989907,0,17,mRNA cis splicing, via spliceosome,BP,
11956,GO:0045293,1,0.982966982244679,0,3,mRNA editing complex,CC,
11957,GO:0045294,1,0.925337050797746,0,11,alpha-catenin binding,MF,
11958,GO:0045295,1,0.914803773919914,0,11,gamma-catenin binding,MF,
11959,GO:0045296,1,0.12569669309051,0,309,cadherin binding,MF,
11960,GO:0045297,1,0.994120052406903,0,1,post-mating behavior,BP,
11961,GO:0045298,1,0.966037426991871,0,5,tubulin complex,CC,
11962,GO:0045309,1,0.738349153474102,0,44,protein phosphorylated amino acid binding,MF,
11964,GO:0045322,1,0.981024128087014,0,3,unmethylated CpG binding,MF,
11965,GO:0045323,1,0.981419398430058,0,3,interleukin-1 receptor complex,CC,
11966,GO:0045324,1,0.934985136027057,0,11,late endosome to vacuole transport,BP,
11967,GO:0045329,1,0.970427760607825,0,5,carnitine biosynthetic process,BP,
11968,GO:0045332,1,0.835127179651029,0,23,phospholipid translocation,BP,
11971,GO:0045335,1,0.468787683748983,0,118,phagocytic vesicle,CC,
11972,GO:0045337,1,0.976108990739148,0,4,farnesyl diphosphate biosynthetic process,BP,
11973,GO:0045338,1,0.970445523896407,0,5,farnesyl diphosphate metabolic process,BP,
11974,GO:0045340,1,0.994806490833661,0,1,mercury ion binding,MF,
11975,GO:0045341,1,0.965868753581949,0,5,MHC class I biosynthetic process,BP,
11976,GO:0045342,1,0.932515670412704,0,11,MHC class II biosynthetic process,BP,
11977,GO:0045343,1,0.965868753581949,0,5,regulation of MHC class I biosynthetic process,BP,
11978,GO:0045345,1,0.965868753581949,0,5,positive regulation of MHC class I biosynthetic process,BP,
11979,GO:0045346,1,0.938810585264646,0,10,regulation of MHC class II biosynthetic process,BP,
11980,GO:0045347,1,0.969717432589021,0,5,negative regulation of MHC class II biosynthetic process,BP,
11981,GO:0045348,1,0.962759799791987,0,6,positive regulation of MHC class II biosynthetic process,BP,
11982,GO:0045349,1,0.962413727087735,0,6,interferon-alpha biosynthetic process,BP,
11983,GO:0045350,1,0.943294529508871,0,9,interferon-beta biosynthetic process,BP,
11984,GO:0045351,1,0.932671925749376,0,11,type I interferon biosynthetic process,BP,
11985,GO:0045352,1,0.994367814467123,0,1,interleukin-1 Type I receptor antagonist activity,MF,
11986,GO:0045353,1,0.994367814467123,0,1,interleukin-1 Type II receptor antagonist activity,MF,
11987,GO:0045354,1,0.962413727087735,0,6,regulation of interferon-alpha biosynthetic process,BP,
11988,GO:0045355,1,0.988999857558202,0,2,negative regulation of interferon-alpha biosynthetic process,BP,
11989,GO:0045356,1,0.973121129591605,0,4,positive regulation of interferon-alpha biosynthetic process,BP,
11990,GO:0045357,1,0.943294529508871,0,9,regulation of interferon-beta biosynthetic process,BP,
11991,GO:0045358,1,0.989006539535526,0,2,negative regulation of interferon-beta biosynthetic process,BP,
11992,GO:0045359,1,0.953784913536971,0,7,positive regulation of interferon-beta biosynthetic process,BP,
11993,GO:0045360,1,0.983435046960842,0,3,regulation of interleukin-1 biosynthetic process,BP,
11994,GO:0045362,1,0.983435046960842,0,3,positive regulation of interleukin-1 biosynthetic process,BP,
11995,GO:0045366,1,0.992541453272855,0,1,regulation of interleukin-13 biosynthetic process,BP,
11996,GO:0045368,1,0.992541453272855,0,1,positive regulation of interleukin-13 biosynthetic process,BP,
11997,GO:0045381,1,0.993617741246891,0,1,regulation of interleukin-18 biosynthetic process,BP,
11998,GO:0045399,1,0.992689454821734,0,1,regulation of interleukin-3 biosynthetic process,BP,
11999,GO:0045401,1,0.992689454821734,0,1,positive regulation of interleukin-3 biosynthetic process,BP,
12000,GO:0045402,1,0.980172878963254,0,3,regulation of interleukin-4 biosynthetic process,BP,
12001,GO:0045403,1,0.993614671204414,0,1,negative regulation of interleukin-4 biosynthetic process,BP,
12002,GO:0045404,1,0.986472695225791,0,2,positive regulation of interleukin-4 biosynthetic process,BP,
12003,GO:0045408,1,0.921782995252439,0,13,regulation of interleukin-6 biosynthetic process,BP,
12004,GO:0045409,1,0.975475392563315,0,4,negative regulation of interleukin-6 biosynthetic process,BP,
12005,GO:0045410,1,0.955833524102085,0,7,positive regulation of interleukin-6 biosynthetic process,BP,
12006,GO:0045414,1,0.944686804731921,0,9,regulation of interleukin-8 biosynthetic process,BP,
12007,GO:0045415,1,0.977174133425835,0,4,negative regulation of interleukin-8 biosynthetic process,BP,
12008,GO:0045416,1,0.961744323623142,0,6,positive regulation of interleukin-8 biosynthetic process,BP,
12009,GO:0045423,1,0.986598624460497,0,2,regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
12010,GO:0045425,1,0.986598624460497,0,2,positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
12011,GO:0045428,1,0.736575246855386,0,47,regulation of nitric oxide biosynthetic process,BP,
12012,GO:0045429,1,0.79610933013121,0,35,positive regulation of nitric oxide biosynthetic process,BP,
12014,GO:0045445,1,0.609955094516073,0,76,myoblast differentiation,BP,
12016,GO:0045448,1,0.975513379080319,0,4,mitotic cell cycle, embryonic,BP,
12017,GO:0045453,1,0.72901577490812,0,48,bone resorption,BP,
12018,GO:0045454,1,0.683588369757805,0,63,cell redox homeostasis,BP,
12020,GO:0045472,1,0.93464704681109,0,10,response to ether,BP,
12021,GO:0045475,1,0.930418097075644,0,10,locomotor rhythm,BP,
12022,GO:0045485,1,0.993009608217916,0,1,omega-6 fatty acid desaturase activity,MF,
12024,GO:0045495,1,0.913746007738874,0,14,pole plasm,CC,
12025,GO:0045499,1,0.863245831472313,0,21,chemorepellent activity,MF,
12027,GO:0045504,1,0.914530173838841,0,14,dynein heavy chain binding,MF,
12029,GO:0045509,1,0.987283434576561,0,2,interleukin-27 receptor activity,MF,
12030,GO:0045513,1,0.99454559249468,0,1,interleukin-27 binding,MF,
12031,GO:0045519,1,0.994751217235029,0,1,interleukin-23 receptor binding,MF,
12032,GO:0045523,1,0.989481913095858,0,2,interleukin-27 receptor binding,MF,
12034,GO:0045541,1,0.970856864514834,0,5,negative regulation of cholesterol biosynthetic process,BP,
12036,GO:0045545,1,0.957165702826683,0,6,syndecan binding,MF,
12037,GO:0045550,1,0.989146309159339,0,2,geranylgeranyl reductase activity,MF,
12038,GO:0045553,1,0.993726519320699,0,1,TRAIL biosynthetic process,BP,
12039,GO:0045554,1,0.993726519320699,0,1,regulation of TRAIL biosynthetic process,BP,
12040,GO:0045556,1,0.993726519320699,0,1,positive regulation of TRAIL biosynthetic process,BP,
12041,GO:0045569,1,0.975831678389434,0,4,TRAIL binding,MF,
12042,GO:0045575,1,0.987367421246343,0,2,basophil activation,BP,
12043,GO:0045576,1,0.720448444505017,0,52,mast cell activation,BP,
12044,GO:0045577,1,0.838393769981409,0,27,regulation of B cell differentiation,BP,
12045,GO:0045578,1,0.970110059623754,0,5,negative regulation of B cell differentiation,BP,
12046,GO:0045579,1,0.919242077026505,0,13,positive regulation of B cell differentiation,BP,
12047,GO:0045580,1,0.485988911769223,0,112,regulation of T cell differentiation,BP,
12048,GO:0045581,1,0.832674393917855,0,28,negative regulation of T cell differentiation,BP,
12049,GO:0045582,1,0.66701441891288,0,64,positive regulation of T cell differentiation,BP,
12050,GO:0045583,1,0.987890863558977,0,2,regulation of cytotoxic T cell differentiation,BP,
12051,GO:0045585,1,0.987890863558977,0,2,positive regulation of cytotoxic T cell differentiation,BP,
12052,GO:0045586,1,0.97209073073963,0,4,regulation of gamma-delta T cell differentiation,BP,
12053,GO:0045588,1,0.978761195744555,0,3,positive regulation of gamma-delta T cell differentiation,BP,
12054,GO:0045589,1,0.857977688353852,0,24,regulation of regulatory T cell differentiation,BP,
12055,GO:0045590,1,0.981355179026101,0,3,negative regulation of regulatory T cell differentiation,BP,
12056,GO:0045591,1,0.942515807182085,0,10,positive regulation of regulatory T cell differentiation,BP,
12061,GO:0045599,1,0.750212190858404,0,43,negative regulation of fat cell differentiation,BP,
12063,GO:0045601,1,0.814453857516742,0,30,regulation of endothelial cell differentiation,BP,
12064,GO:0045602,1,0.943325866740135,0,8,negative regulation of endothelial cell differentiation,BP,
12065,GO:0045603,1,0.904858035450792,0,15,positive regulation of endothelial cell differentiation,BP,
12066,GO:0045604,1,0.729438762786254,0,48,regulation of epidermal cell differentiation,BP,
12067,GO:0045605,1,0.943748610583687,0,9,negative regulation of epidermal cell differentiation,BP,
12068,GO:0045606,1,0.873624976409476,0,20,positive regulation of epidermal cell differentiation,BP,
12069,GO:0045607,1,0.955746383736951,0,7,regulation of inner ear auditory receptor cell differentiation,BP,
12070,GO:0045608,1,0.978725285739796,0,3,negative regulation of inner ear auditory receptor cell differentiation,BP,
12071,GO:0045616,1,0.810251142076433,0,31,regulation of keratinocyte differentiation,BP,
12072,GO:0045617,1,0.975374550277962,0,4,negative regulation of keratinocyte differentiation,BP,
12073,GO:0045618,1,0.907782728811268,0,14,positive regulation of keratinocyte differentiation,BP,
12074,GO:0045619,1,0.414752061275678,0,137,regulation of lymphocyte differentiation,BP,
12075,GO:0045620,1,0.798920174698349,0,35,negative regulation of lymphocyte differentiation,BP,
12076,GO:0045621,1,0.621462411318881,0,75,positive regulation of lymphocyte differentiation,BP,
12077,GO:0045622,1,0.84787416504945,0,26,regulation of T-helper cell differentiation,BP,
12078,GO:0045623,1,0.916905060609226,0,13,negative regulation of T-helper cell differentiation,BP,
12079,GO:0045624,1,0.90813946105559,0,16,positive regulation of T-helper cell differentiation,BP,
12080,GO:0045625,1,0.940798959748395,0,10,regulation of T-helper 1 cell differentiation,BP,
12081,GO:0045626,1,0.98014564131537,0,3,negative regulation of T-helper 1 cell differentiation,BP,
12082,GO:0045627,1,0.964932299430385,0,6,positive regulation of T-helper 1 cell differentiation,BP,
12083,GO:0045628,1,0.934139400258373,0,11,regulation of T-helper 2 cell differentiation,BP,
12084,GO:0045629,1,0.975357742631772,0,4,negative regulation of T-helper 2 cell differentiation,BP,
12085,GO:0045630,1,0.957750709013223,0,7,positive regulation of T-helper 2 cell differentiation,BP,
12086,GO:0045631,1,0.955746383736951,0,7,regulation of mechanoreceptor differentiation,BP,
12087,GO:0045632,1,0.973454046052139,0,4,negative regulation of mechanoreceptor differentiation,BP,
12088,GO:0045634,1,0.949861366534705,0,7,regulation of melanocyte differentiation,BP,
12089,GO:0045636,1,0.960755154638783,0,5,positive regulation of melanocyte differentiation,BP,
12090,GO:0045637,1,0.266223778781949,0,200,regulation of myeloid cell differentiation,BP,
12091,GO:0045638,1,0.624264490406889,0,73,negative regulation of myeloid cell differentiation,BP,
12092,GO:0045639,1,0.617092910227529,0,74,positive regulation of myeloid cell differentiation,BP,
12093,GO:0045643,1,0.993418624412123,0,1,regulation of eosinophil differentiation,BP,
12094,GO:0045645,1,0.993418624412123,0,1,positive regulation of eosinophil differentiation,BP,
12095,GO:0045646,1,0.757657635547319,0,42,regulation of erythrocyte differentiation,BP,
12096,GO:0045647,1,0.949784314707226,0,8,negative regulation of erythrocyte differentiation,BP,
12097,GO:0045648,1,0.835471090319984,0,27,positive regulation of erythrocyte differentiation,BP,
12098,GO:0045649,1,0.887919774144988,0,19,regulation of macrophage differentiation,BP,
12099,GO:0045650,1,0.964909613244689,0,6,negative regulation of macrophage differentiation,BP,
12100,GO:0045651,1,0.920237934359368,0,13,positive regulation of macrophage differentiation,BP,
12101,GO:0045652,1,0.705847440927118,0,54,regulation of megakaryocyte differentiation,BP,
12102,GO:0045653,1,0.958138937130959,0,8,negative regulation of megakaryocyte differentiation,BP,
12103,GO:0045654,1,0.965442981476631,0,6,positive regulation of megakaryocyte differentiation,BP,
12104,GO:0045655,1,0.900420119697808,0,16,regulation of monocyte differentiation,BP,
12105,GO:0045656,1,0.957978537513395,0,6,negative regulation of monocyte differentiation,BP,
12106,GO:0045657,1,0.951599870227161,0,8,positive regulation of monocyte differentiation,BP,
12107,GO:0045658,1,0.980588226387126,0,3,regulation of neutrophil differentiation,BP,
12108,GO:0045659,1,0.98625081531702,0,2,negative regulation of neutrophil differentiation,BP,
12109,GO:0045660,1,0.994259270428858,0,1,positive regulation of neutrophil differentiation,BP,
12110,GO:0045661,1,0.741270255881012,0,46,regulation of myoblast differentiation,BP,
12111,GO:0045662,1,0.865499866100168,0,23,negative regulation of myoblast differentiation,BP,
12112,GO:0045663,1,0.890783712370184,0,17,positive regulation of myoblast differentiation,BP,
12117,GO:0045668,1,0.773717892843077,0,38,negative regulation of osteoblast differentiation,BP,
12119,GO:0045670,1,0.703242118668275,0,52,regulation of osteoclast differentiation,BP,
12120,GO:0045671,1,0.846981613390978,0,24,negative regulation of osteoclast differentiation,BP,
12121,GO:0045672,1,0.895005957480507,0,17,positive regulation of osteoclast differentiation,BP,
12122,GO:0045682,1,0.640883252331801,0,68,regulation of epidermis development,BP,
12123,GO:0045683,1,0.924114127182415,0,12,negative regulation of epidermis development,BP,
12124,GO:0045684,1,0.812735987905733,0,32,positive regulation of epidermis development,BP,
12128,GO:0045703,1,0.994655127578734,0,1,ketoreductase activity,MF,
12129,GO:0045713,1,0.946662400739169,0,8,low-density lipoprotein particle receptor biosynthetic process,BP,
12130,GO:0045714,1,0.952064431771139,0,7,regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
12131,GO:0045715,1,0.984507678153825,0,2,negative regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
12132,GO:0045716,1,0.981625414335213,0,3,positive regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
12133,GO:0045717,1,0.92088258543608,0,13,negative regulation of fatty acid biosynthetic process,BP,
12134,GO:0045719,1,0.964277469426321,0,5,negative regulation of glycogen biosynthetic process,BP,
12135,GO:0045720,1,0.988105752440507,0,2,negative regulation of integrin biosynthetic process,BP,
12136,GO:0045721,1,0.944678158677048,0,9,negative regulation of gluconeogenesis,BP,
12137,GO:0045722,1,0.937431926202741,0,9,positive regulation of gluconeogenesis,BP,
12138,GO:0045723,1,0.92270096539561,0,13,positive regulation of fatty acid biosynthetic process,BP,
12139,GO:0045724,1,0.882332937117898,0,18,positive regulation of cilium assembly,BP,
12140,GO:0045725,1,0.90542883656684,0,13,positive regulation of glycogen biosynthetic process,BP,
12141,GO:0045726,1,0.986368400038796,0,2,positive regulation of integrin biosynthetic process,BP,
12142,GO:0045727,1,0.488362886481124,0,112,positive regulation of translation,BP,
12143,GO:0045728,1,0.99417298335658,0,1,respiratory burst after phagocytosis,BP,
12144,GO:0045730,1,0.867238855015933,0,23,respiratory burst,BP,
12146,GO:0045736,1,0.818156396196566,0,30,negative regulation of cyclin-dependent protein serine/threonine kinase activity,BP,
12147,GO:0045737,1,0.817321073365648,0,32,positive regulation of cyclin-dependent protein serine/threonine kinase activity,BP,
12148,GO:0045738,1,0.85971052506523,0,22,negative regulation of DNA repair,BP,
12151,GO:0045741,1,0.937209283902499,0,10,positive regulation of epidermal growth factor-activated receptor activity,BP,
12152,GO:0045742,1,0.811797738634999,0,32,positive regulation of epidermal growth factor receptor signaling pathway,BP,
12153,GO:0045743,1,0.966866220944251,0,5,positive regulation of fibroblast growth factor receptor signaling pathway,BP,
12156,GO:0045746,1,0.782104518797842,0,39,negative regulation of Notch signaling pathway,BP,
12157,GO:0045747,1,0.737749781418393,0,44,positive regulation of Notch signaling pathway,BP,
12158,GO:0045751,1,0.993617741246891,0,1,negative regulation of Toll signaling pathway,BP,
12159,GO:0045759,1,0.962155715352971,0,6,negative regulation of action potential,BP,
12160,GO:0045760,1,0.932028925287798,0,10,positive regulation of action potential,BP,
12161,GO:0045761,1,0.827917570741519,0,29,regulation of adenylate cyclase activity,BP,
12162,GO:0045762,1,0.966021010322184,0,5,positive regulation of adenylate cyclase activity,BP,
12163,GO:0045763,1,0.983465974014394,0,2,negative regulation of cellular amino acid metabolic process,BP,
12164,GO:0045764,1,0.983194484923952,0,3,positive regulation of cellular amino acid metabolic process,BP,
12168,GO:0045773,1,0.761332006920643,0,37,positive regulation of axon extension,BP,
12169,GO:0045776,1,0.794701344095123,0,36,negative regulation of blood pressure,BP,
12172,GO:0045779,1,0.944647519656185,0,9,negative regulation of bone resorption,BP,
12173,GO:0045780,1,0.914309763869758,0,13,positive regulation of bone resorption,BP,
12177,GO:0045792,1,0.93977385376008,0,9,negative regulation of cell size,BP,
12178,GO:0045793,1,0.935546448108643,0,10,positive regulation of cell size,BP,
12179,GO:0045794,1,0.963848265830228,0,5,negative regulation of cell volume,BP,
12180,GO:0045795,1,0.991723678894873,0,1,positive regulation of cell volume,BP,
12181,GO:0045796,1,0.993908469052429,0,1,negative regulation of intestinal cholesterol absorption,BP,
12182,GO:0045799,1,0.97755505471359,0,3,positive regulation of chromatin assembly or disassembly,BP,
12185,GO:0045813,1,0.994356959793459,0,1,positive regulation of Wnt signaling pathway, calcium modulating pathway,BP,
12186,GO:0045814,1,0.555713651427691,0,90,negative regulation of gene expression, epigenetic,BP,
12187,GO:0045815,1,0.692671571796763,0,57,positive regulation of gene expression, epigenetic,BP,
12188,GO:0045819,1,0.993261512150274,0,1,positive regulation of glycogen catabolic process,BP,
12189,GO:0045820,1,0.932808195879601,0,10,negative regulation of glycolytic process,BP,
12190,GO:0045821,1,0.893070223347657,0,16,positive regulation of glycolytic process,BP,
12192,GO:0045823,1,0.80230139738693,0,34,positive regulation of heart contraction,BP,
12193,GO:0045824,1,0.776505185758581,0,39,negative regulation of innate immune response,BP,
12194,GO:0045827,1,0.994655127578734,0,1,negative regulation of isoprenoid metabolic process,BP,
12195,GO:0045829,1,0.975396524668305,0,4,negative regulation of isotype switching,BP,
12196,GO:0045830,1,0.883143417896472,0,19,positive regulation of isotype switching,BP,
12197,GO:0045833,1,0.659875939238063,0,66,negative regulation of lipid metabolic process,BP,
12199,GO:0045835,1,0.944779102500423,0,9,negative regulation of meiotic nuclear division,BP,
12200,GO:0045836,1,0.931716290914498,0,11,positive regulation of meiotic nuclear division,BP,
12201,GO:0045837,1,0.947564733245352,0,9,negative regulation of membrane potential,BP,
12202,GO:0045838,1,0.931551563312207,0,11,positive regulation of membrane potential,BP,
12207,GO:0045843,1,0.759708997307508,0,42,negative regulation of striated muscle tissue development,BP,
12209,GO:0045848,1,0.994178148773045,0,1,positive regulation of nitrogen utilization,BP,
12210,GO:0045851,1,0.743113656974057,0,48,pH reduction,BP,
12211,GO:0045852,1,0.973888158807963,0,4,pH elevation,BP,
12216,GO:0045869,1,0.947965650452345,0,9,negative regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,
12218,GO:0045872,1,0.994270123759474,0,1,positive regulation of rhodopsin gene expression,BP,
12220,GO:0045876,1,0.946877609202999,0,8,positive regulation of sister chromatid cohesion,BP,
12221,GO:0045879,1,0.819184063580402,0,29,negative regulation of smoothened signaling pathway,BP,
12222,GO:0045880,1,0.821704957316085,0,29,positive regulation of smoothened signaling pathway,BP,
12223,GO:0045887,1,0.991479811447965,0,1,positive regulation of synaptic growth at neuromuscular junction,BP,
12226,GO:0045898,1,0.913658651014186,0,14,regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,
12227,GO:0045899,1,0.931779006682942,0,11,positive regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,
12228,GO:0045900,1,0.973796383712485,0,4,negative regulation of translational elongation,BP,
12229,GO:0045901,1,0.974347873772184,0,4,positive regulation of translational elongation,BP,
12230,GO:0045903,1,0.983900043305639,0,3,positive regulation of translational fidelity,BP,
12231,GO:0045905,1,0.980478756500573,0,3,positive regulation of translational termination,BP,
12232,GO:0045906,1,0.948064054478665,0,7,negative regulation of vasoconstriction,BP,
12233,GO:0045907,1,0.850529899756978,0,26,positive regulation of vasoconstriction,BP,
12234,GO:0045910,1,0.855340368678727,0,23,negative regulation of DNA recombination,BP,
12235,GO:0045911,1,0.859499534093461,0,23,positive regulation of DNA recombination,BP,
12236,GO:0045912,1,0.806810928642715,0,32,negative regulation of carbohydrate metabolic process,BP,
12237,GO:0045913,1,0.664246869867517,0,59,positive regulation of carbohydrate metabolic process,BP,
12238,GO:0045914,1,0.980722854954309,0,3,negative regulation of catecholamine metabolic process,BP,
12239,GO:0045915,1,0.963956638293547,0,6,positive regulation of catecholamine metabolic process,BP,
12240,GO:0045916,1,0.957652554662054,0,6,negative regulation of complement activation,BP,
12241,GO:0045917,1,0.980515398026189,0,3,positive regulation of complement activation,BP,
12242,GO:0045918,1,0.983031293030819,0,3,negative regulation of cytolysis,BP,
12243,GO:0045919,1,0.960459476535681,0,7,positive regulation of cytolysis,BP,
12244,GO:0045920,1,0.840827482912708,0,27,negative regulation of exocytosis,BP,
12245,GO:0045921,1,0.607393905905869,0,76,positive regulation of exocytosis,BP,
12246,GO:0045922,1,0.883989358928513,0,19,negative regulation of fatty acid metabolic process,BP,
12247,GO:0045923,1,0.827207215044355,0,28,positive regulation of fatty acid metabolic process,BP,
12249,GO:0045925,1,0.994038011007675,0,1,positive regulation of female receptivity,BP,
12254,GO:0045932,1,0.881618365752428,0,19,negative regulation of muscle contraction,BP,
12260,GO:0045938,1,0.967084802640425,0,6,positive regulation of circadian sleep/wake cycle, sleep,BP,
12261,GO:0045939,1,0.874393014971963,0,22,negative regulation of steroid metabolic process,BP,
12263,GO:0045943,1,0.866270824990465,0,21,positive regulation of transcription by RNA polymerase I,BP,
12265,GO:0045945,1,0.925695014901535,0,11,positive regulation of transcription by RNA polymerase III,BP,
12266,GO:0045947,1,0.882387454922636,0,19,negative regulation of translational initiation,BP,
12267,GO:0045948,1,0.843199103088534,0,26,positive regulation of translational initiation,BP,
12268,GO:0045950,1,0.982040911715378,0,3,negative regulation of mitotic recombination,BP,
12269,GO:0045953,1,0.942100936802448,0,10,negative regulation of natural killer cell mediated cytotoxicity,BP,
12270,GO:0045954,1,0.887436324920879,0,19,positive regulation of natural killer cell mediated cytotoxicity,BP,
12271,GO:0045955,1,0.939990288019615,0,9,negative regulation of calcium ion-dependent exocytosis,BP,
12272,GO:0045956,1,0.861227725514089,0,22,positive regulation of calcium ion-dependent exocytosis,BP,
12273,GO:0045957,1,0.990458391802756,0,1,negative regulation of complement activation, alternative pathway,BP,
12274,GO:0045959,1,0.984644470299082,0,2,negative regulation of complement activation, classical pathway,BP,
12275,GO:0045963,1,0.980722854954309,0,3,negative regulation of dopamine metabolic process,BP,
12276,GO:0045964,1,0.963956638293547,0,6,positive regulation of dopamine metabolic process,BP,
12277,GO:0045967,1,0.979935382338211,0,2,negative regulation of growth rate,BP,
12278,GO:0045974,1,0.909196757233206,0,13,regulation of translation, ncRNA-mediated,BP,
12279,GO:0045976,1,0.986837520823288,0,2,negative regulation of mitotic cell cycle, embryonic,BP,
12280,GO:0045977,1,0.994538358435351,0,1,positive regulation of mitotic cell cycle, embryonic,BP,
12281,GO:0045980,1,0.742477651010573,0,46,negative regulation of nucleotide metabolic process,BP,
12283,GO:0045986,1,0.92392914846088,0,12,negative regulation of smooth muscle contraction,BP,
12285,GO:0045988,1,0.953333870894364,0,7,negative regulation of striated muscle contraction,BP,
12286,GO:0045989,1,0.918375639778938,0,14,positive regulation of striated muscle contraction,BP,
12287,GO:0045990,1,0.968044297413397,0,5,carbon catabolite regulation of transcription,BP,
12288,GO:0045991,1,0.968044297413397,0,5,carbon catabolite activation of transcription,BP,
12290,GO:0045993,1,0.992983353030873,0,1,negative regulation of translational initiation by iron,BP,
12291,GO:0045994,1,0.986900875083888,0,2,positive regulation of translational initiation by iron,BP,
12293,GO:0046005,1,0.989768626745187,0,2,positive regulation of circadian sleep/wake cycle, REM sleep,BP,
12294,GO:0046006,1,0.819958979838248,0,32,regulation of activated T cell proliferation,BP,
12295,GO:0046007,1,0.931263167756814,0,11,negative regulation of activated T cell proliferation,BP,
12296,GO:0046010,1,0.983018004257781,0,3,positive regulation of circadian sleep/wake cycle, non-REM sleep,BP,
12297,GO:0046013,1,0.988292688829644,0,2,regulation of T cell homeostatic proliferation,BP,
12298,GO:0046015,1,0.970694190862396,0,5,regulation of transcription by glucose,BP,
12299,GO:0046016,1,0.976138822561081,0,4,positive regulation of transcription by glucose,BP,
12300,GO:0046030,1,0.926804178574354,0,11,inositol trisphosphate phosphatase activity,MF,
12302,GO:0046032,1,0.994495727428049,0,1,ADP catabolic process,BP,
12303,GO:0046033,1,0.935672599373902,0,11,AMP metabolic process,BP,
12305,GO:0046035,1,0.994644794758761,0,1,CMP metabolic process,BP,
12306,GO:0046036,1,0.929553911619179,0,13,CTP metabolic process,BP,
12307,GO:0046037,1,0.86775762142677,0,21,GMP metabolic process,BP,
12308,GO:0046038,1,0.994556443430817,0,1,GMP catabolic process,BP,
12309,GO:0046039,1,0.830695402843228,0,30,GTP metabolic process,BP,
12310,GO:0046040,1,0.92069754013598,0,13,IMP metabolic process,BP,
12311,GO:0046041,1,0.988675626428488,0,2,ITP metabolic process,BP,
12312,GO:0046048,1,0.993774946284491,0,1,UDP metabolic process,BP,
12313,GO:0046049,1,0.940700939427565,0,10,UMP metabolic process,BP,
12314,GO:0046051,1,0.943865681438921,0,10,UTP metabolic process,BP,
12315,GO:0046054,1,0.994777046310465,0,1,dGMP metabolic process,BP,
12317,GO:0046058,1,0.569050032168781,0,85,cAMP metabolic process,BP,
12318,GO:0046060,1,0.972362533703123,0,5,dATP metabolic process,BP,
12319,GO:0046061,1,0.983145938261268,0,3,dATP catabolic process,BP,
12320,GO:0046065,1,0.994711955924432,0,1,dCTP metabolic process,BP,
12321,GO:0046066,1,0.988659480280542,0,2,dGDP metabolic process,BP,
12322,GO:0046068,1,0.751520056096726,0,42,cGMP metabolic process,BP,
12323,GO:0046069,1,0.958660554277232,0,6,cGMP catabolic process,BP,
12324,GO:0046070,1,0.977754436817297,0,4,dGTP metabolic process,BP,
12325,GO:0046072,1,0.988480665307055,0,2,dTDP metabolic process,BP,
12326,GO:0046073,1,0.98282538036942,0,3,dTMP metabolic process,BP,
12327,GO:0046075,1,0.97771113382292,0,4,dTTP metabolic process,BP,
12328,GO:0046077,1,0.988480665307055,0,2,dUDP metabolic process,BP,
12329,GO:0046078,1,0.972262277373678,0,5,dUMP metabolic process,BP,
12330,GO:0046079,1,0.994469113765464,0,1,dUMP catabolic process,BP,
12331,GO:0046080,1,0.994320777067634,0,1,dUTP metabolic process,BP,
12332,GO:0046081,1,0.994320777067634,0,1,dUTP catabolic process,BP,
12333,GO:0046083,1,0.98384181048197,0,3,adenine metabolic process,BP,
12334,GO:0046084,1,0.98384181048197,0,3,adenine biosynthetic process,BP,
12335,GO:0046085,1,0.946060492412696,0,9,adenosine metabolic process,BP,
12336,GO:0046086,1,0.987462692737054,0,2,adenosine biosynthetic process,BP,
12337,GO:0046087,1,0.955289552073125,0,8,cytidine metabolic process,BP,
12338,GO:0046090,1,0.994493918772112,0,1,deoxyadenosine metabolic process,BP,
12339,GO:0046092,1,0.992680031411337,0,1,deoxycytidine metabolic process,BP,
12340,GO:0046098,1,0.975251243746087,0,4,guanine metabolic process,BP,
12341,GO:0046099,1,0.988878521246645,0,2,guanine biosynthetic process,BP,
12342,GO:0046100,1,0.971796912155789,0,5,hypoxanthine metabolic process,BP,
12343,GO:0046101,1,0.977377741229495,0,4,hypoxanthine biosynthetic process,BP,
12344,GO:0046102,1,0.982597076276047,0,3,inosine metabolic process,BP,
12345,GO:0046103,1,0.988487803586386,0,2,inosine biosynthetic process,BP,
12346,GO:0046104,1,0.980939397452076,0,3,thymidine metabolic process,BP,
12347,GO:0046108,1,0.98842826819611,0,2,uridine metabolic process,BP,
12348,GO:0046110,1,0.979673897405512,0,3,xanthine metabolic process,BP,
12349,GO:0046111,1,0.994493918772112,0,1,xanthine biosynthetic process,BP,
12350,GO:0046112,1,0.885049725794384,0,19,nucleobase biosynthetic process,BP,
12351,GO:0046113,1,0.960213460543791,0,6,nucleobase catabolic process,BP,
12352,GO:0046116,1,0.983198014075447,0,3,queuosine metabolic process,BP,
12353,GO:0046121,1,0.982665644473359,0,3,deoxyribonucleoside catabolic process,BP,
12354,GO:0046122,1,0.989288644764335,0,2,purine deoxyribonucleoside metabolic process,BP,
12355,GO:0046124,1,0.994493918772112,0,1,purine deoxyribonucleoside catabolic process,BP,
12356,GO:0046125,1,0.980939397452076,0,3,pyrimidine deoxyribonucleoside metabolic process,BP,
12357,GO:0046127,1,0.993675570705843,0,1,pyrimidine deoxyribonucleoside catabolic process,BP,
12358,GO:0046128,1,0.640165434171776,0,70,purine ribonucleoside metabolic process,BP,
12359,GO:0046129,1,0.886628030318484,0,21,purine ribonucleoside biosynthetic process,BP,
12360,GO:0046130,1,0.964561339893684,0,6,purine ribonucleoside catabolic process,BP,
12361,GO:0046131,1,0.839051850006561,0,30,pyrimidine ribonucleoside metabolic process,BP,
12362,GO:0046132,1,0.889293629012002,0,20,pyrimidine ribonucleoside biosynthetic process,BP,
12363,GO:0046133,1,0.943976181782237,0,10,pyrimidine ribonucleoside catabolic process,BP,
12364,GO:0046134,1,0.863168603319554,0,25,pyrimidine nucleoside biosynthetic process,BP,
12365,GO:0046135,1,0.890221811717953,0,20,pyrimidine nucleoside catabolic process,BP,
12366,GO:0046136,1,0.988971589173323,0,2,positive regulation of vitamin metabolic process,BP,
12367,GO:0046137,1,0.964866551983537,0,6,negative regulation of vitamin metabolic process,BP,
12368,GO:0046144,1,0.994461361973286,0,1,D-alanine family amino acid metabolic process,BP,
12369,GO:0046146,1,0.960823436498209,0,7,tetrahydrobiopterin metabolic process,BP,
12370,GO:0046148,1,0.725358965134448,0,50,pigment biosynthetic process,BP,
12371,GO:0046149,1,0.978625213976315,0,4,pigment catabolic process,BP,
12372,GO:0046160,1,0.985416544648268,0,2,heme a metabolic process,BP,
12373,GO:0046164,1,0.77794612510789,0,40,alcohol catabolic process,BP,
12375,GO:0046166,1,0.988763912606554,0,2,glyceraldehyde-3-phosphate biosynthetic process,BP,
12376,GO:0046167,1,0.983386796320084,0,2,glycerol-3-phosphate biosynthetic process,BP,
12377,GO:0046168,1,0.987116743932734,0,2,glycerol-3-phosphate catabolic process,BP,
12378,GO:0046173,1,0.720474477486802,0,52,polyol biosynthetic process,BP,
12379,GO:0046174,1,0.890446758499956,0,17,polyol catabolic process,BP,
12380,GO:0046176,1,0.993850639026861,0,1,aldonic acid catabolic process,BP,
12381,GO:0046177,1,0.993850639026861,0,1,D-gluconate catabolic process,BP,
12382,GO:0046184,1,0.917186667240729,0,13,aldehyde biosynthetic process,BP,
12383,GO:0046185,1,0.943431302455858,0,10,aldehyde catabolic process,BP,
12384,GO:0046189,1,0.798346870949268,0,35,phenol-containing compound biosynthetic process,BP,
12385,GO:0046203,1,0.989116480633424,0,2,spermidine catabolic process,BP,
12386,GO:0046204,1,0.994790477223093,0,1,nor-spermidine metabolic process,BP,
12387,GO:0046208,1,0.977703563453752,0,4,spermine catabolic process,BP,
12388,GO:0046209,1,0.668828303797066,0,61,nitric oxide metabolic process,BP,
12389,GO:0046210,1,0.99399239051705,0,1,nitric oxide catabolic process,BP,
12390,GO:0046218,1,0.959971691740149,0,7,indolalkylamine catabolic process,BP,
12391,GO:0046219,1,0.983216092899753,0,3,indolalkylamine biosynthetic process,BP,
12392,GO:0046222,1,0.993874018242704,0,1,aflatoxin metabolic process,BP,
12393,GO:0046223,1,0.993874018242704,0,1,aflatoxin catabolic process,BP,
12394,GO:0046226,1,0.989077408749512,0,2,coumarin catabolic process,BP,
12395,GO:0046247,1,0.993812902670023,0,1,terpene catabolic process,BP,
12396,GO:0046271,1,0.989077408749512,0,2,phenylpropanoid catabolic process,BP,
12397,GO:0046272,1,0.994147676282294,0,1,stilbene catabolic process,BP,
12398,GO:0046292,1,0.981530742339589,0,3,formaldehyde metabolic process,BP,
12399,GO:0046293,1,0.992824891804413,0,1,formaldehyde biosynthetic process,BP,
12400,GO:0046294,1,0.988625050944774,0,2,formaldehyde catabolic process,BP,
12401,GO:0046295,1,0.994806490833661,0,1,glycolate biosynthetic process,BP,
12402,GO:0046296,1,0.994384871413264,0,1,glycolate catabolic process,BP,
12403,GO:0046305,1,0.988380190276772,0,2,alkanesulfonate biosynthetic process,BP,
12404,GO:0046316,1,0.993850639026861,0,1,gluconokinase activity,MF,
12405,GO:0046317,1,0.992649397692802,0,1,regulation of glucosylceramide biosynthetic process,BP,
12406,GO:0046318,1,0.992649397692802,0,1,negative regulation of glucosylceramide biosynthetic process,BP,
12407,GO:0046320,1,0.820989288660238,0,28,regulation of fatty acid oxidation,BP,
12408,GO:0046321,1,0.896585874630563,0,15,positive regulation of fatty acid oxidation,BP,
12409,GO:0046322,1,0.948590903537959,0,8,negative regulation of fatty acid oxidation,BP,
12410,GO:0046323,1,0.62922186229064,0,67,glucose import,BP,
12411,GO:0046324,1,0.684221571794471,0,55,regulation of glucose import,BP,
12412,GO:0046325,1,0.926921775747073,0,12,negative regulation of glucose import,BP,
12413,GO:0046326,1,0.77972253104567,0,35,positive regulation of glucose import,BP,
12414,GO:0046327,1,0.988208806513195,0,2,glycerol biosynthetic process from pyruvate,BP,
12417,GO:0046330,1,0.460105761744602,0,116,positive regulation of JNK cascade,BP,
12418,GO:0046331,1,0.988152440511452,0,2,lateral inhibition,BP,
12419,GO:0046332,1,0.589319077988672,0,74,SMAD binding,MF,
12420,GO:0046333,1,0.987614354836533,0,2,octopamine metabolic process,BP,
12422,GO:0046338,1,0.987387568599962,0,2,phosphatidylethanolamine catabolic process,BP,
12423,GO:0046339,1,0.922457600972662,0,12,diacylglycerol metabolic process,BP,
12424,GO:0046340,1,0.979650378688664,0,3,diacylglycerol catabolic process,BP,
12425,GO:0046341,1,0.920800600152145,0,12,CDP-diacylglycerol metabolic process,BP,
12426,GO:0046348,1,0.926870371413263,0,13,amino sugar catabolic process,BP,
12427,GO:0046349,1,0.920358493891976,0,13,amino sugar biosynthetic process,BP,
12428,GO:0046351,1,0.97613830919574,0,4,disaccharide biosynthetic process,BP,
12429,GO:0046355,1,0.993575274048212,0,1,mannan catabolic process,BP,
12430,GO:0046356,1,0.988979649800935,0,2,acetyl-CoA catabolic process,BP,
12431,GO:0046359,1,0.994295966577254,0,1,butyrate catabolic process,BP,
12432,GO:0046360,1,0.99419571281523,0,1,2-oxobutyrate biosynthetic process,BP,
12433,GO:0046361,1,0.99419571281523,0,1,2-oxobutyrate metabolic process,BP,
12434,GO:0046364,1,0.625601160674442,0,76,monosaccharide biosynthetic process,BP,
12436,GO:0046368,1,0.976078521368054,0,4,GDP-L-fucose metabolic process,BP,
12437,GO:0046370,1,0.988578149626122,0,2,fructose biosynthetic process,BP,
12438,GO:0046373,1,0.987738712940129,0,2,L-arabinose metabolic process,BP,
12439,GO:0046379,1,0.981821087338591,0,3,extracellular polysaccharide metabolic process,BP,
12440,GO:0046380,1,0.993333478855918,0,1,N-acetylneuraminate biosynthetic process,BP,
12441,GO:0046381,1,0.994647894618283,0,1,CMP-N-acetylneuraminate metabolic process,BP,
12443,GO:0046386,1,0.895171098451549,0,19,deoxyribose phosphate catabolic process,BP,
12445,GO:0046391,1,0.982096831784345,0,3,5-phosphoribose 1-diphosphate metabolic process,BP,
12448,GO:0046398,1,0.973278560466144,0,4,UDP-glucuronate metabolic process,BP,
12449,GO:0046403,1,0.994396242376035,0,1,polynucleotide 3'-phosphatase activity,MF,
12450,GO:0046404,1,0.980657983087179,0,3,ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity,MF,
12451,GO:0046415,1,0.957404210539881,0,7,urate metabolic process,BP,
12452,GO:0046416,1,0.983016768116062,0,3,D-amino acid metabolic process,BP,
12454,GO:0046426,1,0.747714993580699,0,45,negative regulation of JAK-STAT cascade,BP,
12457,GO:0046436,1,0.994461361973286,0,1,D-alanine metabolic process,BP,
12458,GO:0046437,1,0.994007335679593,0,1,D-amino acid biosynthetic process,BP,
12459,GO:0046439,1,0.957235855424341,0,7,L-cysteine metabolic process,BP,
12460,GO:0046440,1,0.97448234233936,0,4,L-lysine metabolic process,BP,
12461,GO:0046443,1,0.994269348506945,0,1,FAD metabolic process,BP,
12462,GO:0046444,1,0.993890983044866,0,1,FMN metabolic process,BP,
12463,GO:0046448,1,0.994025893683851,0,1,tropane alkaloid metabolic process,BP,
12464,GO:0046449,1,0.971419915092034,0,4,creatinine metabolic process,BP,
12465,GO:0046452,1,0.982312631211706,0,3,dihydrofolate metabolic process,BP,
12468,GO:0046459,1,0.906594648051635,0,16,short-chain fatty acid metabolic process,BP,
12469,GO:0046460,1,0.822403789187332,0,30,neutral lipid biosynthetic process,BP,
12470,GO:0046461,1,0.820817917364558,0,31,neutral lipid catabolic process,BP,
12471,GO:0046462,1,0.98825273982339,0,2,monoacylglycerol metabolic process,BP,
12472,GO:0046463,1,0.822403789187332,0,30,acylglycerol biosynthetic process,BP,
12473,GO:0046464,1,0.820817917364558,0,31,acylglycerol catabolic process,BP,
12474,GO:0046465,1,0.957967397916738,0,7,dolichyl diphosphate metabolic process,BP,
12475,GO:0046466,1,0.857687741927904,0,25,membrane lipid catabolic process,BP,
12476,GO:0046467,1,0.429455060657916,0,134,membrane lipid biosynthetic process,BP,
12477,GO:0046469,1,0.962398779186027,0,6,platelet activating factor metabolic process,BP,
12479,GO:0046471,1,0.841348686003192,0,27,phosphatidylglycerol metabolic process,BP,
12480,GO:0046473,1,0.79506719031797,0,34,phosphatidic acid metabolic process,BP,
12483,GO:0046476,1,0.957929184461867,0,7,glycosylceramide biosynthetic process,BP,
12484,GO:0046477,1,0.958202188855986,0,7,glycosylceramide catabolic process,BP,
12485,GO:0046478,1,0.992803212983447,0,1,lactosylceramide metabolic process,BP,
12486,GO:0046479,1,0.929699718508131,0,12,glycosphingolipid catabolic process,BP,
12488,GO:0046485,1,0.944587751432018,0,9,ether lipid metabolic process,BP,
12490,GO:0046487,1,0.959771693602465,0,7,glyoxylate metabolic process,BP,
12492,GO:0046490,1,0.977568686957687,0,4,isopentenyl diphosphate metabolic process,BP,
12493,GO:0046491,1,0.994840067219187,0,1,L-methylmalonyl-CoA metabolic process,BP,
12494,GO:0046493,1,0.989925940293056,0,2,lipid A metabolic process,BP,
12495,GO:0046495,1,0.994041363020688,0,1,nicotinamide riboside metabolic process,BP,
12496,GO:0046496,1,0.359849730768684,0,157,nicotinamide nucleotide metabolic process,BP,
12497,GO:0046497,1,0.993850639026861,0,1,nicotinate nucleotide metabolic process,BP,
12498,GO:0046498,1,0.963678678618473,0,6,S-adenosylhomocysteine metabolic process,BP,
12499,GO:0046499,1,0.993604693773063,0,1,S-adenosylmethioninamine metabolic process,BP,
12500,GO:0046500,1,0.927751908140842,0,12,S-adenosylmethionine metabolic process,BP,
12501,GO:0046501,1,0.940088674094825,0,10,protoporphyrinogen IX metabolic process,BP,
12502,GO:0046502,1,0.988785999224601,0,2,uroporphyrinogen III metabolic process,BP,
12504,GO:0046504,1,0.967295113675667,0,5,glycerol ether biosynthetic process,BP,
12505,GO:0046511,1,0.985902493849194,0,2,sphinganine biosynthetic process,BP,
12506,GO:0046512,1,0.945210962522864,0,9,sphingosine biosynthetic process,BP,
12507,GO:0046513,1,0.710113126317284,0,54,ceramide biosynthetic process,BP,
12508,GO:0046514,1,0.91951394213616,0,14,ceramide catabolic process,BP,
12509,GO:0046519,1,0.915993411281585,0,14,sphingoid metabolic process,BP,
12510,GO:0046520,1,0.938877940002967,0,10,sphingoid biosynthetic process,BP,
12511,GO:0046521,1,0.994324912224097,0,1,sphingoid catabolic process,BP,
12512,GO:0046523,1,0.993685553019784,0,1,S-methyl-5-thioribose-1-phosphate isomerase activity,MF,
12513,GO:0046525,1,0.994396759231569,0,1,xylosylprotein 4-beta-galactosyltransferase activity,MF,
12514,GO:0046526,1,0.993982085865433,0,1,D-xylulose reductase activity,MF,
12515,GO:0046527,1,0.898295449730521,0,16,glucosyltransferase activity,MF,
12517,GO:0046532,1,0.960618813458658,0,6,regulation of photoreceptor cell differentiation,BP,
12518,GO:0046533,1,0.960618813458658,0,6,negative regulation of photoreceptor cell differentiation,BP,
12519,GO:0046538,1,0.978137090065443,0,4,2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity,MF,
12520,GO:0046539,1,0.994821471152595,0,1,histamine N-methyltransferase activity,MF,
12521,GO:0046540,1,0.866833095248266,0,23,U4/U6 x U5 tri-snRNP complex,CC,
12522,GO:0046541,1,0.942230688272026,0,10,saliva secretion,BP,
12523,GO:0046543,1,0.954096551459106,0,7,development of secondary female sexual characteristics,BP,
12524,GO:0046544,1,0.992651492656258,0,1,development of secondary male sexual characteristics,BP,
12527,GO:0046548,1,0.953713671426957,0,7,retinal rod cell development,BP,
12529,GO:0046554,1,0.994613278835708,0,1,malate dehydrogenase (NADP+) activity,MF,
12530,GO:0046556,1,0.987738712940129,0,2,alpha-L-arabinofuranosidase activity,MF,
12531,GO:0046570,1,0.994637561707332,0,1,methylthioribulose 1-phosphate dehydratase activity,MF,
12532,GO:0046573,1,0.983585881393274,0,3,lactonohydrolase activity,MF,
12533,GO:0046577,1,0.993347083371187,0,1,long-chain-alcohol oxidase activity,MF,
12536,GO:0046580,1,0.72535055890891,0,46,negative regulation of Ras protein signal transduction,BP,
12537,GO:0046581,1,0.958288838158507,0,6,intercellular canaliculus,CC,
12538,GO:0046586,1,0.988587533664359,0,2,regulation of calcium-dependent cell-cell adhesion,BP,
12539,GO:0046587,1,0.993734971734107,0,1,positive regulation of calcium-dependent cell-cell adhesion,BP,
12540,GO:0046588,1,0.994820438031726,0,1,negative regulation of calcium-dependent cell-cell adhesion,BP,
12541,GO:0046592,1,0.988660893303247,0,2,polyamine oxidase activity,MF,
12542,GO:0046596,1,0.853988008523684,0,26,regulation of viral entry into host cell,BP,
12543,GO:0046597,1,0.906689401093451,0,16,negative regulation of viral entry into host cell,BP,
12544,GO:0046598,1,0.948302798915182,0,9,positive regulation of viral entry into host cell,BP,
12545,GO:0046599,1,0.892246388876473,0,17,regulation of centriole replication,BP,
12546,GO:0046600,1,0.945914644596134,0,8,negative regulation of centriole replication,BP,
12547,GO:0046601,1,0.980566184043597,0,3,positive regulation of centriole replication,BP,
12548,GO:0046602,1,0.934182837271114,0,10,regulation of mitotic centrosome separation,BP,
12549,GO:0046603,1,0.994546884282342,0,1,negative regulation of mitotic centrosome separation,BP,
12550,GO:0046604,1,0.97184137304487,0,4,positive regulation of mitotic centrosome separation,BP,
12551,GO:0046605,1,0.694681855683943,0,54,regulation of centrosome cycle,BP,
12552,GO:0046606,1,0.912263255075141,0,14,negative regulation of centrosome cycle,BP,
12553,GO:0046607,1,0.933048886809104,0,10,positive regulation of centrosome cycle,BP,
12554,GO:0046618,1,0.975631002640845,0,4,drug export,BP,
12555,GO:0046619,1,0.985488549202545,0,2,optic placode formation involved in camera-type eye formation,BP,
12557,GO:0046621,1,0.847749382482417,0,24,negative regulation of organ growth,BP,
12559,GO:0046623,1,0.991969765251917,0,1,sphingolipid-translocating ATPase activity,MF,
12560,GO:0046624,1,0.943054229048285,0,9,sphingolipid transporter activity,MF,
12562,GO:0046626,1,0.726302251231612,0,48,regulation of insulin receptor signaling pathway,BP,
12563,GO:0046627,1,0.816734309905654,0,31,negative regulation of insulin receptor signaling pathway,BP,
12564,GO:0046628,1,0.923740207643579,0,11,positive regulation of insulin receptor signaling pathway,BP,
12565,GO:0046629,1,0.930611729417748,0,11,gamma-delta T cell activation,BP,
12566,GO:0046631,1,0.505639877224795,0,106,alpha-beta T cell activation,BP,
12567,GO:0046632,1,0.582729507464219,0,83,alpha-beta T cell differentiation,BP,
12568,GO:0046633,1,0.866185291926706,0,23,alpha-beta T cell proliferation,BP,
12569,GO:0046634,1,0.654980544058769,0,67,regulation of alpha-beta T cell activation,BP,
12570,GO:0046635,1,0.757171014622562,0,45,positive regulation of alpha-beta T cell activation,BP,
12571,GO:0046636,1,0.849574017370598,0,25,negative regulation of alpha-beta T cell activation,BP,
12572,GO:0046637,1,0.740154251440248,0,47,regulation of alpha-beta T cell differentiation,BP,
12573,GO:0046638,1,0.808674289668121,0,34,positive regulation of alpha-beta T cell differentiation,BP,
12574,GO:0046639,1,0.897787733768542,0,16,negative regulation of alpha-beta T cell differentiation,BP,
12575,GO:0046640,1,0.884061039837036,0,20,regulation of alpha-beta T cell proliferation,BP,
12576,GO:0046641,1,0.908323262387657,0,16,positive regulation of alpha-beta T cell proliferation,BP,
12577,GO:0046642,1,0.969060128094175,0,5,negative regulation of alpha-beta T cell proliferation,BP,
12578,GO:0046643,1,0.959280358876158,0,6,regulation of gamma-delta T cell activation,BP,
12579,GO:0046645,1,0.965863804261015,0,5,positive regulation of gamma-delta T cell activation,BP,
12582,GO:0046653,1,0.89327079806036,0,18,tetrahydrofolate metabolic process,BP,
12583,GO:0046654,1,0.957700001912721,0,7,tetrahydrofolate biosynthetic process,BP,
12584,GO:0046655,1,0.879528378878497,0,20,folic acid metabolic process,BP,
12585,GO:0046657,1,0.987728969495263,0,2,folic acid catabolic process,BP,
12586,GO:0046658,1,0.792930101832746,0,37,anchored component of plasma membrane,CC,
12589,GO:0046666,1,0.977017229003809,0,4,retinal cell programmed cell death,BP,
12590,GO:0046668,1,0.987657217895439,0,2,regulation of retinal cell programmed cell death,BP,
12591,GO:0046671,1,0.993306510747315,0,1,negative regulation of retinal cell programmed cell death,BP,
12592,GO:0046676,1,0.793968346525407,0,35,negative regulation of insulin secretion,BP,
12594,GO:0046680,1,0.994208112361827,0,1,response to DDT,BP,
12596,GO:0046684,1,0.976138146049102,0,4,response to pyrethroid,BP,
12597,GO:0046685,1,0.836000864415002,0,29,response to arsenic-containing substance,BP,
12599,GO:0046687,1,0.994723062888751,0,1,response to chromate,BP,
12601,GO:0046689,1,0.952842578418406,0,8,response to mercury ion,BP,
12602,GO:0046690,1,0.993491860949334,0,1,response to tellurium ion,BP,
12603,GO:0046691,1,0.993811876359536,0,1,intracellular canaliculus,CC,
12604,GO:0046695,1,0.982928170872812,0,3,SLIK (SAGA-like) complex,CC,
12605,GO:0046696,1,0.969961833234466,0,5,lipopolysaccharide receptor complex,CC,
12606,GO:0046697,1,0.882277008744933,0,19,decidualization,BP,
12608,GO:0046703,1,0.961651735537307,0,7,natural killer cell lectin-like receptor binding,MF,
12609,GO:0046707,1,0.986707551700227,0,2,IDP metabolic process,BP,
12610,GO:0046709,1,0.986707551700227,0,2,IDP catabolic process,BP,
12611,GO:0046710,1,0.911094273808776,0,13,GDP metabolic process,BP,
12612,GO:0046711,1,0.994777046310465,0,1,GDP biosynthetic process,BP,
12613,GO:0046713,1,0.993680689705067,0,1,borate transport,BP,
12614,GO:0046715,1,0.993680689705067,0,1,active borate transmembrane transporter activity,MF,
12615,GO:0046716,1,0.907866820769597,0,15,muscle cell cellular homeostasis,BP,
12616,GO:0046717,1,0.526907622362801,0,99,acid secretion,BP,
12618,GO:0046719,1,0.956870864447604,0,7,regulation by virus of viral protein levels in host cell,BP,
12619,GO:0046724,1,0.988410645216338,0,2,oxalic acid secretion,BP,
12620,GO:0046725,1,0.993447314027227,0,1,negative regulation by virus of viral protein levels in host cell,BP,
12621,GO:0046726,1,0.973616911564053,0,4,positive regulation by virus of viral protein levels in host cell,BP,
12622,GO:0046730,1,0.994151291207698,0,1,induction of host immune response by virus,BP,
12623,GO:0046732,1,0.994151291207698,0,1,active induction of host immune response by virus,BP,
12624,GO:0046745,1,0.993850639026861,0,1,viral capsid secondary envelopment,BP,
12625,GO:0046755,1,0.86581757768437,0,24,viral budding,BP,
12627,GO:0046778,1,0.988099741301014,0,2,modification by virus of host mRNA processing,BP,
12628,GO:0046782,1,0.682244344082959,0,60,regulation of viral transcription,BP,
12629,GO:0046784,1,0.952904692606472,0,8,viral mRNA export from host cell nucleus,BP,
12630,GO:0046785,1,0.639223517677831,0,66,microtubule polymerization,BP,
12631,GO:0046786,1,0.992753552302774,0,1,viral replication complex formation and maintenance,BP,
12632,GO:0046789,1,0.993637697540363,0,1,host cell surface receptor binding,MF,
12633,GO:0046790,1,0.964008878919752,0,5,virion binding,MF,
12634,GO:0046794,1,0.69056026885797,0,56,transport of virus,BP,
12635,GO:0046811,1,0.987346915258876,0,2,histone deacetylase inhibitor activity,MF,
12636,GO:0046812,1,0.993637697540363,0,1,host cell surface binding,MF,
12637,GO:0046813,1,0.968231200809982,0,5,receptor-mediated virion attachment to host cell,BP,
12639,GO:0046823,1,0.885343961666141,0,19,negative regulation of nucleocytoplasmic transport,BP,
12641,GO:0046825,1,0.76834625712946,0,39,regulation of protein export from nucleus,BP,
12642,GO:0046826,1,0.958639309263062,0,7,negative regulation of protein export from nucleus,BP,
12643,GO:0046827,1,0.871604135476598,0,20,positive regulation of protein export from nucleus,BP,
12644,GO:0046831,1,0.897151560292143,0,15,regulation of RNA export from nucleus,BP,
12645,GO:0046832,1,0.982654519158608,0,2,negative regulation of RNA export from nucleus,BP,
12646,GO:0046833,1,0.952842477031552,0,7,positive regulation of RNA export from nucleus,BP,
12648,GO:0046835,1,0.846017233782892,0,26,carbohydrate phosphorylation,BP,
12649,GO:0046836,1,0.970000689017872,0,5,glycolipid transport,BP,
12650,GO:0046838,1,0.928710235014981,0,11,phosphorylated carbohydrate dephosphorylation,BP,
12651,GO:0046839,1,0.843624165876837,0,24,phospholipid dephosphorylation,BP,
12652,GO:0046847,1,0.686727656408295,0,54,filopodium assembly,BP,
12653,GO:0046848,1,0.995013107702519,0,1,hydroxyapatite binding,MF,
12654,GO:0046849,1,0.620098634870513,0,72,bone remodeling,BP,
12655,GO:0046850,1,0.772783289682645,0,38,regulation of bone remodeling,BP,
12656,GO:0046851,1,0.931598398580572,0,11,negative regulation of bone remodeling,BP,
12657,GO:0046852,1,0.914309763869758,0,13,positive regulation of bone remodeling,BP,
12659,GO:0046855,1,0.934610777423219,0,10,inositol phosphate dephosphorylation,BP,
12660,GO:0046856,1,0.848598658395199,0,23,phosphatidylinositol dephosphorylation,BP,
12661,GO:0046864,1,0.988658362406913,0,2,isoprenoid transport,BP,
12662,GO:0046865,1,0.988658362406913,0,2,terpenoid transport,BP,
12663,GO:0046870,1,0.968267841818243,0,5,cadmium ion binding,MF,
12666,GO:0046874,1,0.976533302507147,0,4,quinolinate metabolic process,BP,
12667,GO:0046875,1,0.834225762326522,0,27,ephrin receptor binding,MF,
12668,GO:0046877,1,0.965020165467676,0,6,regulation of saliva secretion,BP,
12669,GO:0046878,1,0.982282028720055,0,3,positive regulation of saliva secretion,BP,
12671,GO:0046880,1,0.96104598832566,0,6,regulation of follicle-stimulating hormone secretion,BP,
12672,GO:0046881,1,0.96104598832566,0,6,positive regulation of follicle-stimulating hormone secretion,BP,
12673,GO:0046882,1,0.982461658361945,0,3,negative regulation of follicle-stimulating hormone secretion,BP,
12675,GO:0046884,1,0.954157663533211,0,7,follicle-stimulating hormone secretion,BP,
12676,GO:0046885,1,0.855543833232797,0,24,regulation of hormone biosynthetic process,BP,
12677,GO:0046886,1,0.943097309977146,0,9,positive regulation of hormone biosynthetic process,BP,
12679,GO:0046888,1,0.696689939061108,0,56,negative regulation of hormone secretion,BP,
12682,GO:0046898,1,0.972568414658297,0,4,response to cycloheximide,BP,
12683,GO:0046899,1,0.987811531538253,0,2,nucleoside triphosphate adenylate kinase activity,MF,
12684,GO:0046900,1,0.988551909776765,0,2,tetrahydrofolylpolyglutamate metabolic process,BP,
12685,GO:0046901,1,0.994001666357671,0,1,tetrahydrofolylpolyglutamate biosynthetic process,BP,
12686,GO:0046902,1,0.649729456125645,0,70,regulation of mitochondrial membrane permeability,BP,
12688,GO:0046906,1,0.505882319355279,0,108,tetrapyrrole binding,MF,
12690,GO:0046911,1,0.994679925836776,0,1,metal chelating activity,MF,
12691,GO:0046912,1,0.967067541546396,0,5,transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer,MF,
12695,GO:0046920,1,0.945996386048102,0,8,alpha-(1->3)-fucosyltransferase activity,MF,
12696,GO:0046921,1,0.993591646691022,0,1,alpha-(1->6)-fucosyltransferase activity,MF,
12697,GO:0046922,1,0.987294131395426,0,2,peptide-O-fucosyltransferase activity,MF,
12698,GO:0046923,1,0.971195625572743,0,5,ER retention sequence binding,MF,
12699,GO:0046928,1,0.698837317690292,0,52,regulation of neurotransmitter secretion,BP,
12700,GO:0046929,1,0.929945896604631,0,10,negative regulation of neurotransmitter secretion,BP,
12701,GO:0046930,1,0.912685765798425,0,15,pore complex,CC,
12702,GO:0046931,1,0.898274584917471,0,16,pore complex assembly,BP,
12703,GO:0046933,1,0.983910758357605,0,3,proton-transporting ATP synthase activity, rotational mechanism,MF,
12705,GO:0046935,1,0.965669565782789,0,5,1-phosphatidylinositol-3-kinase regulator activity,MF,
12707,GO:0046940,1,0.970419384552956,0,5,nucleoside monophosphate phosphorylation,BP,
12710,GO:0046946,1,0.980805261471511,0,3,hydroxylysine metabolic process,BP,
12711,GO:0046947,1,0.980805261471511,0,3,hydroxylysine biosynthetic process,BP,
12712,GO:0046949,1,0.842257513388575,0,27,fatty-acyl-CoA biosynthetic process,BP,
12713,GO:0046950,1,0.935164415865829,0,11,cellular ketone body metabolic process,BP,
12714,GO:0046951,1,0.946688472665151,0,9,ketone body biosynthetic process,BP,
12715,GO:0046952,1,0.975739572150262,0,4,ketone body catabolic process,BP,
12716,GO:0046958,1,0.958686097498903,0,6,nonassociative learning,BP,
12717,GO:0046959,1,0.97062492860138,0,4,habituation,BP,
12718,GO:0046960,1,0.987652666720779,0,2,sensitization,BP,
12719,GO:0046961,1,0.885781207707815,0,20,proton-transporting ATPase activity, rotational mechanism,MF,
12720,GO:0046963,1,0.988487964696343,0,2,3'-phosphoadenosine 5'-phosphosulfate transport,BP,
12721,GO:0046964,1,0.988487964696343,0,2,3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity,MF,
12722,GO:0046965,1,0.907727126172754,0,14,retinoid X receptor binding,MF,
12723,GO:0046966,1,0.831147219221734,0,26,thyroid hormone receptor binding,MF,
12724,GO:0046967,1,0.987017130121453,0,2,cytosol to ER transport,BP,
12725,GO:0046968,1,0.986370919052552,0,2,peptide antigen transport,BP,
12726,GO:0046969,1,0.987787111474519,0,2,NAD-dependent histone deacetylase activity (H3-K9 specific),MF,
12727,GO:0046970,1,0.99428252807261,0,1,NAD-dependent histone deacetylase activity (H4-K16 specific),MF,
12728,GO:0046972,1,0.934832632033567,0,10,histone acetyltransferase activity (H4-K16 specific),MF,
12729,GO:0046974,1,0.966800686888331,0,5,histone methyltransferase activity (H3-K9 specific),MF,
12730,GO:0046975,1,0.952597797965046,0,6,histone methyltransferase activity (H3-K36 specific),MF,
12731,GO:0046976,1,0.968018845607272,0,5,histone methyltransferase activity (H3-K27 specific),MF,
12732,GO:0046977,1,0.97531101525872,0,4,TAP binding,MF,
12733,GO:0046978,1,0.97531101525872,0,4,TAP1 binding,MF,
12734,GO:0046979,1,0.981976825394431,0,3,TAP2 binding,MF,
12735,GO:0046980,1,0.993213088589486,0,1,tapasin binding,MF,
12738,GO:0046984,1,0.975682353031432,0,4,regulation of hemoglobin biosynthetic process,BP,
12739,GO:0046985,1,0.982577975701867,0,3,positive regulation of hemoglobin biosynthetic process,BP,
12740,GO:0046986,1,0.992983353030873,0,1,negative regulation of hemoglobin biosynthetic process,BP,
12741,GO:0046996,1,0.993850639026861,0,1,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, with NAD(P)H as one donor, and the other dehydrogenated,MF,
12742,GO:0046997,1,0.987313194700175,0,2,oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor,MF,
12743,GO:0047006,1,0.989151985198063,0,2,17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity,MF,
12744,GO:0047012,1,0.99446187876287,0,1,sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity,MF,
12745,GO:0047015,1,0.994797450914192,0,1,3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity,MF,
12746,GO:0047016,1,0.994158521439347,0,1,cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity,MF,
12747,GO:0047017,1,0.988538303783819,0,2,prostaglandin-F synthase activity,MF,
12748,GO:0047020,1,0.994655127578734,0,1,15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity,MF,
12749,GO:0047021,1,0.994646344689977,0,1,15-hydroxyprostaglandin dehydrogenase (NADP+) activity,MF,
12750,GO:0047023,1,0.978589249945565,0,4,androsterone dehydrogenase activity,MF,
12751,GO:0047025,1,0.988317312192949,0,2,3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity,MF,
12752,GO:0047035,1,0.967959243548959,0,6,testosterone dehydrogenase (NAD+) activity,MF,
12753,GO:0047042,1,0.994574527927613,0,1,androsterone dehydrogenase (B-specific) activity,MF,
12754,GO:0047045,1,0.984086367996252,0,3,testosterone 17-beta-dehydrogenase (NADP+) activity,MF,
12755,GO:0047057,1,0.989528417099102,0,2,vitamin-K-epoxide reductase (warfarin-sensitive) activity,MF,
12756,GO:0047066,1,0.994802874872577,0,1,phospholipid-hydroperoxide glutathione peroxidase activity,MF,
12757,GO:0047086,1,0.978589249945565,0,4,ketosteroid monooxygenase activity,MF,
12758,GO:0047105,1,0.993993936382896,0,1,4-trimethylammoniobutyraldehyde dehydrogenase activity,MF,
12759,GO:0047115,1,0.978646692764707,0,4,trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity,MF,
12760,GO:0047117,1,0.9908871583736,0,1,enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity,MF,
12761,GO:0047127,1,0.994578919803861,0,1,thiomorpholine-carboxylate dehydrogenase activity,MF,
12762,GO:0047130,1,0.992242171349954,0,1,saccharopine dehydrogenase (NADP+, L-lysine-forming) activity,MF,
12763,GO:0047131,1,0.992242171349954,0,1,saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity,MF,
12764,GO:0047134,1,0.966365632676666,0,6,protein-disulfide reductase activity,MF,
12765,GO:0047144,1,0.941256860190228,0,9,2-acylglycerol-3-phosphate O-acyltransferase activity,MF,
12766,GO:0047150,1,0.988288361560146,0,2,betaine-homocysteine S-methyltransferase activity,MF,
12767,GO:0047159,1,0.993251731661176,0,1,1-alkenylglycerophosphocholine O-acyltransferase activity,MF,
12768,GO:0047166,1,0.994298550954258,0,1,1-alkenylglycerophosphoethanolamine O-acyltransferase activity,MF,
12769,GO:0047173,1,0.992767148142801,0,1,phosphatidylcholine-retinol O-acyltransferase activity,MF,
12770,GO:0047179,1,0.98943309163781,0,2,platelet-activating factor acetyltransferase activity,MF,
12771,GO:0047184,1,0.96886376901022,0,5,1-acylglycerophosphocholine O-acyltransferase activity,MF,
12772,GO:0047186,1,0.9932841485684,0,1,N-acetylneuraminate 7-O(or 9-O)-acetyltransferase activity,MF,
12773,GO:0047191,1,0.993251731661176,0,1,1-alkylglycerophosphocholine O-acyltransferase activity,MF,
12774,GO:0047192,1,0.980180565287563,0,3,1-alkylglycerophosphocholine O-acetyltransferase activity,MF,
12775,GO:0047220,1,0.993849868520174,0,1,galactosylxylosylprotein 3-beta-galactosyltransferase activity,MF,
12776,GO:0047223,1,0.99381572516462,0,1,beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity,MF,
12777,GO:0047237,1,0.980553425594703,0,3,glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,MF,
12778,GO:0047238,1,0.967233191188883,0,5,glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,MF,
12779,GO:0047256,1,0.993166118223734,0,1,lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity,MF,
12780,GO:0047263,1,0.993790073474442,0,1,N-acylsphingosine galactosyltransferase activity,MF,
12781,GO:0047273,1,0.993578343925094,0,1,galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity,MF,
12782,GO:0047275,1,0.987669274598514,0,2,glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity,MF,
12783,GO:0047277,1,0.994281494361482,0,1,globoside alpha-N-acetylgalactosaminyltransferase activity,MF,
12784,GO:0047280,1,0.992924268127064,0,1,nicotinamide phosphoribosyltransferase activity,MF,
12785,GO:0047288,1,0.987418339156101,0,2,monosialoganglioside sialyltransferase activity,MF,
12786,GO:0047290,1,0.994437589110749,0,1,(alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3)-N-acetyl-galactosaminide 6-alpha-sialyltransferase activity,MF,
12787,GO:0047291,1,0.994095017703156,0,1,lactosylceramide alpha-2,3-sialyltransferase activity,MF,
12788,GO:0047293,1,0.994440689979797,0,1,4-hydroxybenzoate nonaprenyltransferase activity,MF,
12789,GO:0047298,1,0.992750414346676,0,1,(S)-3-amino-2-methylpropionate transaminase activity,MF,
12790,GO:0047322,1,0.983163461296199,0,2,[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity,MF,
12791,GO:0047323,1,0.994186930489377,0,1,[3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity,MF,
12792,GO:0047325,1,0.993609042874978,0,1,inositol tetrakisphosphate 1-kinase activity,MF,
12793,GO:0047326,1,0.994361611814873,0,1,inositol tetrakisphosphate 5-kinase activity,MF,
12794,GO:0047341,1,0.993522570185009,0,1,fucose-1-phosphate guanylyltransferase activity,MF,
12795,GO:0047349,1,0.992469891067957,0,1,D-ribitol-5-phosphate cytidylyltransferase activity,MF,
12796,GO:0047369,1,0.993850639026861,0,1,succinate-hydroxymethylglutarate CoA-transferase activity,MF,
12797,GO:0047372,1,0.931358631702109,0,11,acylglycerol lipase activity,MF,
12798,GO:0047374,1,0.982290721615984,0,3,methylumbelliferyl-acetate deacetylase activity,MF,
12799,GO:0047389,1,0.986152476232978,0,2,glycerophosphocholine phosphodiesterase activity,MF,
12800,GO:0047390,1,0.99325945339157,0,1,glycerophosphocholine cholinephosphodiesterase activity,MF,
12802,GO:0047394,1,0.994131927088367,0,1,glycerophosphoinositol inositolphosphodiesterase activity,MF,
12803,GO:0047395,1,0.993772895529134,0,1,glycerophosphoinositol glycerophosphodiesterase activity,MF,
12804,GO:0047408,1,0.987865048665944,0,2,alkenylglycerophosphocholine hydrolase activity,MF,
12805,GO:0047409,1,0.987865048665944,0,2,alkenylglycerophosphoethanolamine hydrolase activity,MF,
12806,GO:0047429,1,0.944458534431197,0,9,nucleoside-triphosphate diphosphatase activity,MF,
12807,GO:0047444,1,0.994647894618283,0,1,N-acylneuraminate-9-phosphate synthase activity,MF,
12808,GO:0047451,1,0.9908871583736,0,1,3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity,MF,
12809,GO:0047464,1,0.992685005023224,0,1,heparosan-N-sulfate-glucuronate 5-epimerase activity,MF,
12810,GO:0047484,1,0.943606788755851,0,9,regulation of response to osmotic stress,BP,
12811,GO:0047485,1,0.499195658711257,0,106,protein N-terminus binding,MF,
12812,GO:0047493,1,0.980101803823174,0,3,ceramide cholinephosphotransferase activity,MF,
12814,GO:0047497,1,0.875291060037325,0,19,mitochondrion transport along microtubule,BP,
12815,GO:0047498,1,0.957516088946394,0,7,calcium-dependent phospholipase A2 activity,MF,
12816,GO:0047499,1,0.964309698135526,0,6,calcium-independent phospholipase A2 activity,MF,
12817,GO:0047522,1,0.981177499348756,0,3,15-oxoprostaglandin 13-oxidase activity,MF,
12818,GO:0047536,1,0.994139155906473,0,1,2-aminoadipate transaminase activity,MF,
12819,GO:0047545,1,0.99213227446864,0,1,2-hydroxyglutarate dehydrogenase activity,MF,
12820,GO:0047555,1,0.918240969606583,0,12,3',5'-cyclic-GMP phosphodiesterase activity,MF,
12821,GO:0047560,1,0.992601725158807,0,1,3-dehydrosphinganine reductase activity,MF,
12822,GO:0047578,1,0.994021769182433,0,1,4-hydroxyglutamate transaminase activity,MF,
12823,GO:0047598,1,0.99391695742989,0,1,7-dehydrocholesterol reductase activity,MF,
12824,GO:0047617,1,0.915852008446409,0,15,acyl-CoA hydrolase activity,MF,
12825,GO:0047620,1,0.993772895529134,0,1,acylglycerol kinase activity,MF,
12826,GO:0047621,1,0.994420533996374,0,1,acylpyruvate hydrolase activity,MF,
12827,GO:0047623,1,0.986453925378152,0,2,adenosine-phosphate deaminase activity,MF,
12828,GO:0047631,1,0.972864066014253,0,5,ADP-ribose diphosphatase activity,MF,
12829,GO:0047635,1,0.987617072909415,0,2,alanine-oxo-acid transaminase activity,MF,
12830,GO:0047658,1,0.994411747803641,0,1,alpha-amino-acid esterase activity,MF,
12831,GO:0047661,1,0.994007335679593,0,1,amino-acid racemase activity,MF,
12832,GO:0047676,1,0.992607750886338,0,1,arachidonate-CoA ligase activity,MF,
12833,GO:0047685,1,0.994510196473227,0,1,amine sulfotransferase activity,MF,
12834,GO:0047693,1,0.994920131708846,0,1,ATP diphosphatase activity,MF,
12835,GO:0047696,1,0.987760395117524,0,2,beta-adrenergic receptor kinase activity,MF,
12836,GO:0047708,1,0.988937555872445,0,2,biotinidase activity,MF,
12837,GO:0047710,1,0.987639653667137,0,2,bis(5'-adenosyl)-triphosphatase activity,MF,
12838,GO:0047718,1,0.983779132771276,0,3,indanol dehydrogenase activity,MF,
12839,GO:0047726,1,0.99399239051705,0,1,iron-cytochrome-c reductase activity,MF,
12841,GO:0047734,1,0.993850639026861,0,1,CDP-glycerol diphosphatase activity,MF,
12842,GO:0047743,1,0.994670626572246,0,1,chlordecone reductase activity,MF,
12843,GO:0047747,1,0.994064058076202,0,1,cholate-CoA ligase activity,MF,
12844,GO:0047750,1,0.989503493902303,0,2,cholestenol delta-isomerase activity,MF,
12845,GO:0047751,1,0.988069860211868,0,2,cholestenone 5-alpha-reductase activity,MF,
12846,GO:0047756,1,0.97528558551767,0,4,chondroitin 4-sulfotransferase activity,MF,
12847,GO:0047757,1,0.983764672931081,0,2,chondroitin-glucuronate 5-epimerase activity,MF,
12848,GO:0047760,1,0.970268107714129,0,5,butyrate-CoA ligase activity,MF,
12849,GO:0047777,1,0.992302408598171,0,1,(3S)-citramalyl-CoA lyase activity,MF,
12850,GO:0047787,1,0.994655127578734,0,1,delta4-3-oxosteroid 5beta-reductase activity,MF,
12851,GO:0047800,1,0.993371969550735,0,1,cysteamine dioxygenase activity,MF,
12852,GO:0047801,1,0.99418796367324,0,1,L-cysteine:2-oxoglutarate aminotransferase activity,MF,
12853,GO:0047837,1,0.994729003774522,0,1,D-xylose 1-dehydrogenase (NADP+) activity,MF,
12854,GO:0047840,1,0.994711955924432,0,1,dCTP diphosphatase activity,MF,
12855,GO:0047844,1,0.960490295446505,0,7,deoxycytidine deaminase activity,MF,
12856,GO:0047856,1,0.9946721764564,0,1,dihydrocoumarin hydrolase activity,MF,
12857,GO:0047860,1,0.994631361897078,0,1,diiodophenylpyruvate reductase activity,MF,
12858,GO:0047865,1,0.993692464516946,0,1,dimethylglycine dehydrogenase activity,MF,
12859,GO:0047874,1,0.994196746068461,0,1,dolichyldiphosphatase activity,MF,
12860,GO:0047888,1,0.994280977507103,0,1,fatty acid peroxidase activity,MF,
12861,GO:0047894,1,0.983769627043103,0,3,flavonol 3-sulfotransferase activity,MF,
12862,GO:0047915,1,0.994419500334649,0,1,ganglioside galactosyltransferase activity,MF,
12863,GO:0047933,1,0.990879419746098,0,1,glucose-1,6-bisphosphate synthase activity,MF,
12864,GO:0047936,1,0.99056886626227,0,1,glucose 1-dehydrogenase [NAD(P)] activity,MF,
12865,GO:0047939,1,0.99452673209409,0,1,L-glucuronate reductase activity,MF,
12866,GO:0047946,1,0.994218962825068,0,1,glutamine N-acyltransferase activity,MF,
12867,GO:0047961,1,0.988827108920931,0,2,glycine N-acyltransferase activity,MF,
12868,GO:0047963,1,0.993522314306743,0,1,glycine N-choloyltransferase activity,MF,
12869,GO:0047969,1,0.994384871413264,0,1,glyoxylate oxidase activity,MF,
12870,GO:0047977,1,0.988003215315166,0,2,hepoxilin-epoxide hydrolase activity,MF,
12871,GO:0047982,1,0.994387197314057,0,1,homocysteine desulfhydrase activity,MF,
12872,GO:0047988,1,0.994305787279892,0,1,hydroxyacid-oxoacid transhydrogenase activity,MF,
12873,GO:0047992,1,0.993850639026861,0,1,hydroxylysine kinase activity,MF,
12874,GO:0048002,1,0.34006816223084,0,175,antigen processing and presentation of peptide antigen,BP,
12875,GO:0048003,1,0.973573626764893,0,4,antigen processing and presentation of lipid antigen via MHC class Ib,BP,
12876,GO:0048006,1,0.993339126633875,0,1,antigen processing and presentation, endogenous lipid antigen via MHC class Ib,BP,
12877,GO:0048007,1,0.973573626764893,0,4,antigen processing and presentation, exogenous lipid antigen via MHC class Ib,BP,
12879,GO:0048009,1,0.798829637087413,0,31,insulin-like growth factor receptor signaling pathway,BP,
12880,GO:0048010,1,0.547327974152621,0,91,vascular endothelial growth factor receptor signaling pathway,BP,
12881,GO:0048011,1,0.854499042274452,0,24,neurotrophin TRK receptor signaling pathway,BP,
12882,GO:0048012,1,0.902760348360476,0,16,hepatocyte growth factor receptor signaling pathway,BP,
12883,GO:0048013,1,0.564863340740449,0,87,ephrin receptor signaling pathway,BP,
12884,GO:0048014,1,0.978596888605286,0,3,Tie signaling pathway,BP,
12889,GO:0048019,1,0.92967813845232,0,12,receptor antagonist activity,MF,
12890,GO:0048020,1,0.893614959469088,0,20,CCR chemokine receptor binding,MF,
12891,GO:0048021,1,0.957192067457818,0,6,regulation of melanin biosynthetic process,BP,
12892,GO:0048022,1,0.98407864119253,0,2,negative regulation of melanin biosynthetic process,BP,
12893,GO:0048023,1,0.972682794548269,0,4,positive regulation of melanin biosynthetic process,BP,
12894,GO:0048024,1,0.618653389890611,0,74,regulation of mRNA splicing, via spliceosome,BP,
12895,GO:0048025,1,0.888282440638674,0,19,negative regulation of mRNA splicing, via spliceosome,BP,
12896,GO:0048026,1,0.90996947722545,0,15,positive regulation of mRNA splicing, via spliceosome,BP,
12897,GO:0048027,1,0.872635953218083,0,22,mRNA 5'-UTR binding,MF,
12898,GO:0048029,1,0.672390462736602,0,64,monosaccharide binding,MF,
12899,GO:0048030,1,0.983902096884862,0,3,disaccharide binding,MF,
12900,GO:0048033,1,0.993740094998934,0,1,heme o metabolic process,BP,
12901,GO:0048034,1,0.993740094998934,0,1,heme O biosynthetic process,BP,
12903,GO:0048038,1,0.923014188671967,0,14,quinone binding,MF,
12904,GO:0048039,1,0.966803026481677,0,6,ubiquinone binding,MF,
12905,GO:0048040,1,0.994207079025024,0,1,UDP-glucuronate decarboxylase activity,MF,
12906,GO:0048041,1,0.600568032793583,0,71,focal adhesion assembly,BP,
12908,GO:0048050,1,0.962062288877331,0,6,post-embryonic eye morphogenesis,BP,
12909,GO:0048066,1,0.752585469464682,0,42,developmental pigmentation,BP,
12910,GO:0048069,1,0.95555765439057,0,7,eye pigmentation,BP,
12911,GO:0048070,1,0.901525024643056,0,15,regulation of developmental pigmentation,BP,
12912,GO:0048073,1,0.986157321502616,0,2,regulation of eye pigmentation,BP,
12913,GO:0048075,1,0.993066719268796,0,1,positive regulation of eye pigmentation,BP,
12914,GO:0048087,1,0.937550066998005,0,9,positive regulation of developmental pigmentation,BP,
12915,GO:0048096,1,0.940497419011831,0,9,chromatin-mediated maintenance of transcription,BP,
12916,GO:0048101,1,0.987755802002252,0,2,calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity,MF,
12917,GO:0048102,1,0.956193756946226,0,7,autophagic cell death,BP,
12919,GO:0048104,1,0.96850832712136,0,4,establishment of body hair or bristle planar orientation,BP,
12920,GO:0048105,1,0.96850832712136,0,4,establishment of body hair planar orientation,BP,
12921,GO:0048133,1,0.982077747473234,0,3,male germ-line stem cell asymmetric division,BP,
12922,GO:0048143,1,0.917419970087333,0,12,astrocyte activation,BP,
12926,GO:0048147,1,0.840996256598285,0,27,negative regulation of fibroblast proliferation,BP,
12928,GO:0048149,1,0.936796964235197,0,10,behavioral response to ethanol,BP,
12929,GO:0048156,1,0.934294039213625,0,11,tau protein binding,MF,
12930,GO:0048160,1,0.992901858075983,0,1,primary follicle stage,BP,
12931,GO:0048162,1,0.982868438038362,0,3,multi-layer follicle stage,BP,
12932,GO:0048165,1,0.985369738147513,0,2,fused antrum stage,BP,
12935,GO:0048169,1,0.836585245639298,0,26,regulation of long-term neuronal synaptic plasticity,BP,
12936,GO:0048170,1,0.965404530019655,0,5,positive regulation of long-term neuronal synaptic plasticity,BP,
12937,GO:0048172,1,0.89847117344561,0,15,regulation of short-term neuronal synaptic plasticity,BP,
12938,GO:0048174,1,0.993179548007666,0,1,negative regulation of short-term neuronal synaptic plasticity,BP,
12939,GO:0048175,1,0.993637697540363,0,1,hepatocyte growth factor biosynthetic process,BP,
12940,GO:0048176,1,0.993637697540363,0,1,regulation of hepatocyte growth factor biosynthetic process,BP,
12941,GO:0048178,1,0.993637697540363,0,1,negative regulation of hepatocyte growth factor biosynthetic process,BP,
12942,GO:0048179,1,0.97905038870677,0,3,activin receptor complex,CC,
12943,GO:0048180,1,0.994166785161602,0,1,activin complex,CC,
12944,GO:0048185,1,0.921140452767652,0,12,activin binding,MF,
12945,GO:0048188,1,0.918139967682165,0,12,Set1C/COMPASS complex,CC,
12946,GO:0048193,1,0.10197536655897,0,335,Golgi vesicle transport,BP,
12947,GO:0048194,1,0.592798222663181,0,78,Golgi vesicle budding,BP,
12948,GO:0048199,1,0.630843375134877,0,70,vesicle targeting, to, from or within Golgi,BP,
12949,GO:0048200,1,0.962198940067893,0,6,Golgi transport vesicle coating,BP,
12950,GO:0048203,1,0.988137138281886,0,2,vesicle targeting, trans-Golgi to endosome,BP,
12951,GO:0048205,1,0.962198940067893,0,6,COPI coating of Golgi vesicle,BP,
12952,GO:0048207,1,0.664246148440108,0,62,vesicle targeting, rough ER to cis-Golgi,BP,
12953,GO:0048208,1,0.664246148440108,0,62,COPII vesicle coating,BP,
12954,GO:0048209,1,0.986804435474066,0,2,regulation of vesicle targeting, to, from or within Golgi,BP,
12955,GO:0048210,1,0.97619603105626,0,4,Golgi vesicle fusion to target membrane,BP,
12956,GO:0048211,1,0.987194836075724,0,2,Golgi vesicle docking,BP,
12957,GO:0048213,1,0.988240052458385,0,2,Golgi vesicle prefusion complex stabilization,BP,
12958,GO:0048227,1,0.950158433317163,0,8,plasma membrane to endosome transport,BP,
12960,GO:0048237,1,0.983196182147195,0,3,rough endoplasmic reticulum lumen,CC,
12961,GO:0048239,1,0.988023766633378,0,2,negative regulation of DNA recombination at telomere,BP,
12963,GO:0048241,1,0.977216632238396,0,4,epinephrine transport,BP,
12964,GO:0048242,1,0.977216632238396,0,4,epinephrine secretion,BP,
12965,GO:0048243,1,0.922709090098789,0,13,norepinephrine secretion,BP,
12966,GO:0048244,1,0.994428286391786,0,1,phytanoyl-CoA dioxygenase activity,MF,
12967,GO:0048245,1,0.939910103756432,0,11,eosinophil chemotaxis,BP,
12968,GO:0048246,1,0.83931514587159,0,29,macrophage chemotaxis,BP,
12969,GO:0048247,1,0.795370546993883,0,39,lymphocyte chemotaxis,BP,
12970,GO:0048248,1,0.973181521068655,0,5,CXCR3 chemokine receptor binding,MF,
12971,GO:0048250,1,0.988843084762659,0,2,iron import into the mitochondrion,BP,
12972,GO:0048251,1,0.938390829824527,0,9,elastic fiber assembly,BP,
12973,GO:0048254,1,0.975921684826173,0,4,snoRNA localization,BP,
12974,GO:0048255,1,0.813114137516972,0,31,mRNA stabilization,BP,
12975,GO:0048256,1,0.957166224544503,0,7,flap endonuclease activity,MF,
12976,GO:0048257,1,0.987930838699389,0,2,3'-flap endonuclease activity,MF,
12979,GO:0048261,1,0.898395359264854,0,17,negative regulation of receptor-mediated endocytosis,BP,
12980,GO:0048262,1,0.946656989847808,0,9,determination of dorsal/ventral asymmetry,BP,
12981,GO:0048263,1,0.952627658980931,0,8,determination of dorsal identity,BP,
12982,GO:0048264,1,0.993735484040148,0,1,determination of ventral identity,BP,
12983,GO:0048265,1,0.840586813624808,0,26,response to pain,BP,
12984,GO:0048266,1,0.922195165643404,0,12,behavioral response to pain,BP,
12985,GO:0048268,1,0.894577123185553,0,16,clathrin coat assembly,BP,
12986,GO:0048269,1,0.988078197242578,0,2,methionine adenosyltransferase complex,CC,
12987,GO:0048270,1,0.994210954075274,0,1,methionine adenosyltransferase regulator activity,MF,
12988,GO:0048273,1,0.960413293768218,0,6,mitogen-activated protein kinase p38 binding,MF,
12989,GO:0048278,1,0.640050906175892,0,69,vesicle docking,BP,
12990,GO:0048280,1,0.952232334409569,0,8,vesicle fusion with Golgi apparatus,BP,
12993,GO:0048286,1,0.779835348674079,0,35,lung alveolus development,BP,
12994,GO:0048289,1,0.962651920211052,0,6,isotype switching to IgE isotypes,BP,
12995,GO:0048290,1,0.964250742863606,0,6,isotype switching to IgA isotypes,BP,
12996,GO:0048291,1,0.932214559711004,0,11,isotype switching to IgG isotypes,BP,
12997,GO:0048293,1,0.962651920211052,0,6,regulation of isotype switching to IgE isotypes,BP,
12998,GO:0048294,1,0.981101848229687,0,3,negative regulation of isotype switching to IgE isotypes,BP,
12999,GO:0048295,1,0.981198276551362,0,3,positive regulation of isotype switching to IgE isotypes,BP,
13000,GO:0048296,1,0.970498489632545,0,5,regulation of isotype switching to IgA isotypes,BP,
13001,GO:0048297,1,0.994185897313966,0,1,negative regulation of isotype switching to IgA isotypes,BP,
13002,GO:0048298,1,0.976175453302229,0,4,positive regulation of isotype switching to IgA isotypes,BP,
13003,GO:0048302,1,0.937758498915277,0,10,regulation of isotype switching to IgG isotypes,BP,
13004,GO:0048304,1,0.955698099093624,0,7,positive regulation of isotype switching to IgG isotypes,BP,
13005,GO:0048305,1,0.900707580243259,0,18,immunoglobulin secretion,BP,
13008,GO:0048311,1,0.891113600519698,0,16,mitochondrion distribution,BP,
13009,GO:0048312,1,0.943246901218049,0,8,intracellular distribution of mitochondria,BP,
13011,GO:0048318,1,0.957832765562412,0,7,axial mesoderm development,BP,
13012,GO:0048319,1,0.979773938699914,0,3,axial mesoderm morphogenesis,BP,
13013,GO:0048320,1,0.987784390298139,0,2,axial mesoderm formation,BP,
13014,GO:0048321,1,0.99421172909739,0,1,axial mesodermal cell differentiation,BP,
13015,GO:0048322,1,0.99421172909739,0,1,axial mesodermal cell fate commitment,BP,
13016,GO:0048327,1,0.99421172909739,0,1,axial mesodermal cell fate specification,BP,
13019,GO:0048338,1,0.993421186575349,0,1,mesoderm structural organization,BP,
13020,GO:0048339,1,0.890117850661629,0,17,paraxial mesoderm development,BP,
13021,GO:0048340,1,0.939002149725939,0,9,paraxial mesoderm morphogenesis,BP,
13022,GO:0048341,1,0.962366346707071,0,6,paraxial mesoderm formation,BP,
13023,GO:0048342,1,0.994423118141374,0,1,paraxial mesodermal cell differentiation,BP,
13024,GO:0048343,1,0.994423118141374,0,1,paraxial mesodermal cell fate commitment,BP,
13025,GO:0048352,1,0.993421186575349,0,1,paraxial mesoderm structural organization,BP,
13026,GO:0048364,1,0.994886556596673,0,1,root development,BP,
13027,GO:0048365,1,0.658341802466956,0,60,Rac GTPase binding,MF,
13028,GO:0048368,1,0.909192739395382,0,15,lateral mesoderm development,BP,
13029,GO:0048369,1,0.97446601712285,0,4,lateral mesoderm morphogenesis,BP,
13030,GO:0048370,1,0.97446601712285,0,4,lateral mesoderm formation,BP,
13031,GO:0048371,1,0.979893644524322,0,3,lateral mesodermal cell differentiation,BP,
13032,GO:0048372,1,0.985841937403818,0,2,lateral mesodermal cell fate commitment,BP,
13033,GO:0048377,1,0.985841937403818,0,2,lateral mesodermal cell fate specification,BP,
13034,GO:0048378,1,0.985841937403818,0,2,regulation of lateral mesodermal cell fate specification,BP,
13035,GO:0048382,1,0.976322685962102,0,4,mesendoderm development,BP,
13038,GO:0048386,1,0.974929417734692,0,4,positive regulation of retinoic acid receptor signaling pathway,BP,
13040,GO:0048388,1,0.98219569810604,0,3,endosomal lumen acidification,BP,
13041,GO:0048389,1,0.988710490264874,0,2,intermediate mesoderm development,BP,
13042,GO:0048390,1,0.994367297581572,0,1,intermediate mesoderm morphogenesis,BP,
13043,GO:0048391,1,0.994367297581572,0,1,intermediate mesoderm formation,BP,
13044,GO:0048392,1,0.994367297581572,0,1,intermediate mesodermal cell differentiation,BP,
13045,GO:0048403,1,0.977554264953277,0,3,brain-derived neurotrophic factor binding,MF,
13046,GO:0048406,1,0.960206794362902,0,6,nerve growth factor binding,MF,
13048,GO:0048408,1,0.98263535175932,0,3,epidermal growth factor binding,MF,
13052,GO:0048475,1,0.531823112138813,0,96,coated membrane,CC,
13053,GO:0048476,1,0.971699879242362,0,5,Holliday junction resolvase complex,CC,
13055,GO:0048478,1,0.952543529341712,0,7,replication fork protection,BP,
13057,GO:0048484,1,0.935883103526821,0,10,enteric nervous system development,BP,
13059,GO:0048486,1,0.911127938032764,0,14,parasympathetic nervous system development,BP,
13060,GO:0048487,1,0.794666061896932,0,36,beta-tubulin binding,MF,
13062,GO:0048489,1,0.457458621174218,0,115,synaptic vesicle transport,BP,
13063,GO:0048490,1,0.899556300700012,0,17,anterograde synaptic vesicle transport,BP,
13064,GO:0048495,1,0.962612084345154,0,5,Roundabout binding,MF,
13065,GO:0048496,1,0.968715569141744,0,4,maintenance of animal organ identity,BP,
13066,GO:0048499,1,0.976056002108766,0,4,synaptic vesicle membrane organization,BP,
13067,GO:0048500,1,0.948684783713849,0,9,signal recognition particle,CC,
13068,GO:0048505,1,0.929262890775115,0,11,regulation of timing of cell differentiation,BP,
13076,GO:0048520,1,0.892514151958737,0,18,positive regulation of behavior,BP,
13077,GO:0048521,1,0.9271643587639,0,13,negative regulation of behavior,BP,
13081,GO:0048525,1,0.603095263596545,0,80,negative regulation of viral process,BP,
13082,GO:0048531,1,0.917981895830394,0,14,beta-1,3-galactosyltransferase activity,MF,
13083,GO:0048532,1,0.904548708417448,0,15,anatomical structure arrangement,BP,
13085,GO:0048535,1,0.910781836876387,0,15,lymph node development,BP,
13086,GO:0048536,1,0.805694595544048,0,33,spleen development,BP,
13087,GO:0048537,1,0.963071916408811,0,6,mucosal-associated lymphoid tissue development,BP,
13088,GO:0048538,1,0.746047645635554,0,43,thymus development,BP,
13089,GO:0048539,1,0.956038913068659,0,7,bone marrow development,BP,
13090,GO:0048541,1,0.963071916408811,0,6,Peyer's patch development,BP,
13093,GO:0048548,1,0.943258923284984,0,9,regulation of pinocytosis,BP,
13094,GO:0048549,1,0.973199324161963,0,4,positive regulation of pinocytosis,BP,
13095,GO:0048550,1,0.969243389165514,0,5,negative regulation of pinocytosis,BP,
13097,GO:0048560,1,0.988336446991774,0,2,establishment of anatomical structure orientation,BP,
13098,GO:0048561,1,0.994140963196833,0,1,establishment of animal organ orientation,BP,
13100,GO:0048563,1,0.94692688616979,0,8,post-embryonic animal organ morphogenesis,BP,
13103,GO:0048567,1,0.993967147671658,0,1,ectodermal digestive tract morphogenesis,BP,
13105,GO:0048569,1,0.901517059374975,0,15,post-embryonic animal organ development,BP,
13115,GO:0048597,1,0.983730863747204,0,3,post-embryonic camera-type eye morphogenesis,BP,
13117,GO:0048599,1,0.779946612179714,0,38,oocyte development,BP,
13120,GO:0048611,1,0.987762456553011,0,2,embryonic ectodermal digestive tract development,BP,
13121,GO:0048613,1,0.993967147671658,0,1,embryonic ectodermal digestive tract morphogenesis,BP,
13122,GO:0048617,1,0.93492077011562,0,9,embryonic foregut morphogenesis,BP,
13123,GO:0048619,1,0.981354303868932,0,3,embryonic hindgut morphogenesis,BP,
13124,GO:0048625,1,0.968724446291111,0,5,myoblast fate commitment,BP,
13125,GO:0048627,1,0.988217601297432,0,2,myoblast development,BP,
13126,GO:0048630,1,0.954765055714291,0,7,skeletal muscle tissue growth,BP,
13127,GO:0048631,1,0.965719037946283,0,5,regulation of skeletal muscle tissue growth,BP,
13128,GO:0048632,1,0.985666634378905,0,2,negative regulation of skeletal muscle tissue growth,BP,
13129,GO:0048633,1,0.979765249441949,0,3,positive regulation of skeletal muscle tissue growth,BP,
13131,GO:0048635,1,0.754694434386797,0,43,negative regulation of muscle organ development,BP,
13136,GO:0048641,1,0.735345849742966,0,46,regulation of skeletal muscle tissue development,BP,
13137,GO:0048642,1,0.917960930939888,0,13,negative regulation of skeletal muscle tissue development,BP,
13138,GO:0048643,1,0.870314223630045,0,21,positive regulation of skeletal muscle tissue development,BP,
13139,GO:0048644,1,0.559341430810237,0,78,muscle organ morphogenesis,BP,
13142,GO:0048659,1,0.463611186428091,0,117,smooth muscle cell proliferation,BP,
13143,GO:0048660,1,0.473103274985146,0,114,regulation of smooth muscle cell proliferation,BP,
13144,GO:0048661,1,0.619244145009178,0,72,positive regulation of smooth muscle cell proliferation,BP,
13145,GO:0048662,1,0.783073587115336,0,39,negative regulation of smooth muscle cell proliferation,BP,
13147,GO:0048664,1,0.965866480581367,0,6,neuron fate determination,BP,
13151,GO:0048668,1,0.842703638971801,0,25,collateral sprouting,BP,
13152,GO:0048669,1,0.980677110304447,0,3,collateral sprouting in absence of injury,BP,
13153,GO:0048670,1,0.880913897072866,0,19,regulation of collateral sprouting,BP,
13154,GO:0048671,1,0.942246908146324,0,8,negative regulation of collateral sprouting,BP,
13155,GO:0048672,1,0.934945512703843,0,11,positive regulation of collateral sprouting,BP,
13156,GO:0048673,1,0.994470664110692,0,1,collateral sprouting of intact axon in response to injury,BP,
13157,GO:0048674,1,0.994026409266231,0,1,collateral sprouting of injured axon,BP,
13159,GO:0048677,1,0.978822819756052,0,3,axon extension involved in regeneration,BP,
13161,GO:0048679,1,0.865289218236053,0,22,regulation of axon regeneration,BP,
13162,GO:0048680,1,0.95900878061596,0,7,positive regulation of axon regeneration,BP,
13163,GO:0048681,1,0.922575636989709,0,12,negative regulation of axon regeneration,BP,
13164,GO:0048682,1,0.972974472316634,0,4,sprouting of injured axon,BP,
13165,GO:0048683,1,0.994470664110692,0,1,regulation of collateral sprouting of intact axon in response to injury,BP,
13166,GO:0048685,1,0.994470664110692,0,1,negative regulation of collateral sprouting of intact axon in response to injury,BP,
13167,GO:0048686,1,0.980555217810163,0,3,regulation of sprouting of injured axon,BP,
13168,GO:0048687,1,0.98786773872627,0,2,positive regulation of sprouting of injured axon,BP,
13169,GO:0048688,1,0.986668759929057,0,2,negative regulation of sprouting of injured axon,BP,
13170,GO:0048689,1,0.994026409266231,0,1,formation of growth cone in injured axon,BP,
13171,GO:0048690,1,0.986448668260751,0,2,regulation of axon extension involved in regeneration,BP,
13172,GO:0048691,1,0.99380469293822,0,1,positive regulation of axon extension involved in regeneration,BP,
13173,GO:0048692,1,0.992598581179802,0,1,negative regulation of axon extension involved in regeneration,BP,
13174,GO:0048693,1,0.994026409266231,0,1,regulation of collateral sprouting of injured axon,BP,
13175,GO:0048694,1,0.994026409266231,0,1,positive regulation of collateral sprouting of injured axon,BP,
13176,GO:0048696,1,0.994515622273784,0,1,regulation of collateral sprouting in absence of injury,BP,
13177,GO:0048697,1,0.994515622273784,0,1,positive regulation of collateral sprouting in absence of injury,BP,
13180,GO:0048702,1,0.952330316134993,0,7,embryonic neurocranium morphogenesis,BP,
13181,GO:0048703,1,0.936637302302274,0,9,embryonic viscerocranium morphogenesis,BP,
13189,GO:0048712,1,0.929096194408094,0,11,negative regulation of astrocyte differentiation,BP,
13191,GO:0048714,1,0.89812237899988,0,17,positive regulation of oligodendrocyte differentiation,BP,
13194,GO:0048730,1,0.839441134687931,0,27,epidermis morphogenesis,BP,
13196,GO:0048732,1,0.0676655158373817,0,396,gland development,BP,
13197,GO:0048733,1,0.95653507333777,0,6,sebaceous gland development,BP,
13200,GO:0048739,1,0.881188834355962,0,13,cardiac muscle fiber development,BP,
13201,GO:0048741,1,0.834685630608622,0,27,skeletal muscle fiber development,BP,
13202,GO:0048742,1,0.941565724100052,0,9,regulation of skeletal muscle fiber development,BP,
13203,GO:0048743,1,0.962776115707212,0,6,positive regulation of skeletal muscle fiber development,BP,
13204,GO:0048745,1,0.875994566932879,0,19,smooth muscle tissue development,BP,
13205,GO:0048747,1,0.682146361544766,0,51,muscle fiber development,BP,
13206,GO:0048749,1,0.993213862037877,0,1,compound eye development,BP,
13207,GO:0048752,1,0.952339495594695,0,7,semicircular canal morphogenesis,BP,
13208,GO:0048753,1,0.837726650895124,0,27,pigment granule organization,BP,
13210,GO:0048755,1,0.937383048154372,0,9,branching morphogenesis of a nerve,BP,
13211,GO:0048757,1,0.93893809705422,0,10,pigment granule maturation,BP,
13213,GO:0048763,1,0.95491559952306,0,4,calcium-induced calcium release activity,MF,
13214,GO:0048764,1,0.994886556596673,0,1,trichoblast maturation,BP,
13215,GO:0048765,1,0.994886556596673,0,1,root hair cell differentiation,BP,
13216,GO:0048767,1,0.994886556596673,0,1,root hair elongation,BP,
13217,GO:0048769,1,0.938779646266345,0,4,sarcomerogenesis,BP,
13218,GO:0048770,1,0.525555290619962,0,101,pigment granule,CC,
13219,GO:0048771,1,0.405611752188814,0,135,tissue remodeling,BP,
13220,GO:0048786,1,0.774789341204968,0,34,presynaptic active zone,CC,
13221,GO:0048787,1,0.966475336987581,0,5,presynaptic active zone membrane,CC,
13222,GO:0048788,1,0.943439868448962,0,6,cytoskeleton of presynaptic active zone,CC,
13223,GO:0048789,1,0.992749368324187,0,1,cytoskeletal matrix organization at active zone,BP,
13224,GO:0048790,1,0.994513038565373,0,1,maintenance of presynaptic active zone structure,BP,
13225,GO:0048791,1,0.782304902587299,0,36,calcium ion-regulated exocytosis of neurotransmitter,BP,
13226,GO:0048792,1,0.993517964303733,0,1,spontaneous exocytosis of neurotransmitter,BP,
13227,GO:0048793,1,0.95847284217888,0,6,pronephros development,BP,
13229,GO:0048806,1,0.753204352021039,0,40,genitalia development,BP,
13230,GO:0048807,1,0.982768131259642,0,3,female genitalia morphogenesis,BP,
13231,GO:0048808,1,0.981235793893309,0,3,male genitalia morphogenesis,BP,
13233,GO:0048813,1,0.3985833374711,0,128,dendrite morphogenesis,BP,
13234,GO:0048814,1,0.577016657574621,0,77,regulation of dendrite morphogenesis,BP,
13235,GO:0048817,1,0.985753433617822,0,2,negative regulation of hair follicle maturation,BP,
13236,GO:0048818,1,0.968424832176329,0,5,positive regulation of hair follicle maturation,BP,
13237,GO:0048819,1,0.942172461723882,0,9,regulation of hair follicle maturation,BP,
13238,GO:0048820,1,0.892056757548484,0,16,hair follicle maturation,BP,
13239,GO:0048821,1,0.835202368033437,0,28,erythrocyte development,BP,
13240,GO:0048822,1,0.978034244022318,0,3,enucleate erythrocyte development,BP,
13241,GO:0048823,1,0.993850639026861,0,1,nucleate erythrocyte development,BP,
13243,GO:0048840,1,0.973919368962508,0,4,otolith development,BP,
13244,GO:0048841,1,0.814067204190069,0,27,regulation of axon extension involved in axon guidance,BP,
13245,GO:0048842,1,0.942636495362244,0,7,positive regulation of axon extension involved in axon guidance,BP,
13246,GO:0048843,1,0.872162593653126,0,19,negative regulation of axon extension involved in axon guidance,BP,
13247,GO:0048844,1,0.655761497736072,0,58,artery morphogenesis,BP,
13248,GO:0048845,1,0.932036558182857,0,10,venous blood vessel morphogenesis,BP,
13249,GO:0048846,1,0.783308931477774,0,32,axon extension involved in axon guidance,BP,
13250,GO:0048850,1,0.984318241568374,0,2,hypophysis morphogenesis,BP,
13251,GO:0048852,1,0.978578638835765,0,3,diencephalon morphogenesis,BP,
13252,GO:0048853,1,0.914883516865922,0,13,forebrain morphogenesis,BP,
13253,GO:0048854,1,0.779304844802231,0,35,brain morphogenesis,BP,
13254,GO:0048855,1,0.991988039624665,0,1,adenohypophysis morphogenesis,BP,
13258,GO:0048859,1,0.969238461274459,0,5,formation of anatomical boundary,BP,
13259,GO:0048861,1,0.971655528025881,0,4,leukemia inhibitory factor signaling pathway,BP,
13262,GO:0048865,1,0.953285907734645,0,8,stem cell fate commitment,BP,
13263,GO:0048866,1,0.976633998669601,0,4,stem cell fate specification,BP,
13264,GO:0048867,1,0.982994139051719,0,3,stem cell fate determination,BP,
13268,GO:0048872,1,0.22958466738462,0,225,homeostasis of number of cells,BP,
13269,GO:0048873,1,0.840069131737633,0,27,homeostasis of number of cells within a tissue,BP,
13270,GO:0048874,1,0.993596251514619,0,1,homeostasis of number of cells in a free-living population,BP,
13271,GO:0048875,1,0.937274845841035,0,10,chemical homeostasis within a tissue,BP,
13273,GO:0048880,1,0.973752925211743,0,4,sensory system development,BP,
13274,GO:0048882,1,0.993921330858198,0,1,lateral line development,BP,
13275,GO:0048884,1,0.993921330858198,0,1,neuromast development,BP,
13276,GO:0048886,1,0.993921330858198,0,1,neuromast hair cell differentiation,BP,
13277,GO:0048925,1,0.993921330858198,0,1,lateral line system development,BP,
13278,GO:0048934,1,0.911663703901553,0,13,peripheral nervous system neuron differentiation,BP,
13279,GO:0048935,1,0.911663703901553,0,13,peripheral nervous system neuron development,BP,
13280,GO:0048936,1,0.981656416397506,0,3,peripheral nervous system neuron axonogenesis,BP,
13282,GO:0050011,1,0.994466529846979,0,1,itaconyl-CoA hydratase activity,MF,
13283,GO:0050023,1,0.994326462910923,0,1,L-fuconate dehydratase activity,MF,
13284,GO:0050031,1,0.994040847314931,0,1,L-pipecolate oxidase activity,MF,
13285,GO:0050038,1,0.994859179643979,0,1,L-xylulose reductase (NADP+) activity,MF,
13286,GO:0050046,1,0.993850639026861,0,1,lathosterol oxidase activity,MF,
13287,GO:0050051,1,0.988170529572986,0,2,leukotriene-B4 20-monooxygenase activity,MF,
13288,GO:0050072,1,0.953978883330214,0,7,m7G(5')pppN diphosphatase activity,MF,
13289,GO:0050080,1,0.994155422707334,0,1,malonyl-CoA decarboxylase activity,MF,
13290,GO:0050104,1,0.994513038565373,0,1,L-gulonate 3-dehydrogenase activity,MF,
13291,GO:0050115,1,0.992767148142801,0,1,myosin-light-chain-phosphatase activity,MF,
13292,GO:0050119,1,0.98440670143528,0,2,N-acetylglucosamine deacetylase activity,MF,
13293,GO:0050121,1,0.994525956996914,0,1,N-acylglucosamine 2-epimerase activity,MF,
13294,GO:0050124,1,0.993333478855918,0,1,N-acylneuraminate-9-phosphatase activity,MF,
13295,GO:0050129,1,0.993637185814252,0,1,N-formylglutamate deformylase activity,MF,
13296,GO:0050135,1,0.989068729430147,0,2,NAD(P)+ nucleosidase activity,MF,
13297,GO:0050136,1,0.817730163914159,0,38,NADH dehydrogenase (quinone) activity,MF,
13298,GO:0050144,1,0.993850639026861,0,1,nucleoside deoxyribosyltransferase activity,MF,
13299,GO:0050145,1,0.970419384552956,0,5,nucleoside phosphate kinase activity,MF,
13300,GO:0050146,1,0.992536997534387,0,1,nucleoside phosphotransferase activity,MF,
13301,GO:0050152,1,0.99462981193693,0,1,omega-amidase activity,MF,
13302,GO:0050178,1,0.989980933293215,0,2,phenylpyruvate tautomerase activity,MF,
13303,GO:0050185,1,0.984165827612869,0,2,phosphatidylinositol deacylase activity,MF,
13304,GO:0050197,1,0.994092437245931,0,1,phytanate-CoA ligase activity,MF,
13305,GO:0050201,1,0.993266143796993,0,1,fucokinase activity,MF,
13306,GO:0050211,1,0.981559855594877,0,3,procollagen galactosyltransferase activity,MF,
13307,GO:0050220,1,0.978128470975596,0,4,prostaglandin-E synthase activity,MF,
13308,GO:0050221,1,0.994646344689977,0,1,prostaglandin-E2 9-reductase activity,MF,
13309,GO:0050252,1,0.98743244818747,0,2,retinol O-fatty-acyltransferase activity,MF,
13310,GO:0050253,1,0.98652389444348,0,2,retinyl-palmitate esterase activity,MF,
13311,GO:0050254,1,0.988374966279198,0,2,rhodopsin kinase activity,MF,
13312,GO:0050262,1,0.987738712940129,0,2,ribosylnicotinamide kinase activity,MF,
13313,GO:0050265,1,0.978597927343698,0,3,RNA uridylyltransferase activity,MF,
13314,GO:0050277,1,0.993309850847727,0,1,sedoheptulokinase activity,MF,
13315,GO:0050290,1,0.992839251817979,0,1,sphingomyelin phosphodiesterase D activity,MF,
13316,GO:0050291,1,0.958163556152373,0,7,sphingosine N-acyltransferase activity,MF,
13317,GO:0050294,1,0.983749952584384,0,3,steroid sulfotransferase activity,MF,
13318,GO:0050308,1,0.950878572598705,0,8,sugar-phosphatase activity,MF,
13319,GO:0050309,1,0.981970927154767,0,3,sugar-terminal-phosphatase activity,MF,
13320,GO:0050313,1,0.994790477223093,0,1,sulfur dioxygenase activity,MF,
13321,GO:0050321,1,0.916337429770805,0,13,tau-protein kinase activity,MF,
13322,GO:0050333,1,0.994361094924849,0,1,thiamin-triphosphatase activity,MF,
13323,GO:0050337,1,0.99498728112046,0,1,thiosulfate-thiol sulfurtransferase activity,MF,
13324,GO:0050346,1,0.993850639026861,0,1,trans-L-3-hydroxyproline dehydratase activity,MF,
13325,GO:0050347,1,0.987941967495655,0,2,trans-octaprenyltranstransferase activity,MF,
13326,GO:0050353,1,0.993812902670023,0,1,trimethyllysine dioxygenase activity,MF,
13327,GO:0050355,1,0.992982052709926,0,1,triphosphatase activity,MF,
13328,GO:0050379,1,0.992685005023224,0,1,UDP-glucuronate 5'-epimerase activity,MF,
13329,GO:0050405,1,0.983163461296199,0,2,[acetyl-CoA carboxylase] kinase activity,MF,
13330,GO:0050421,1,0.993944491212098,0,1,nitrite reductase (NO-forming) activity,MF,
13331,GO:0050427,1,0.872295936790623,0,22,3'-phosphoadenosine 5'-phosphosulfate metabolic process,BP,
13332,GO:0050428,1,0.96101031974321,0,6,3'-phosphoadenosine 5'-phosphosulfate biosynthetic process,BP,
13333,GO:0050429,1,0.991941577680705,0,1,calcium-dependent phospholipase C activity,MF,
13334,GO:0050431,1,0.874823614067343,0,19,transforming growth factor beta binding,MF,
13335,GO:0050432,1,0.78109188021694,0,39,catecholamine secretion,BP,
13336,GO:0050433,1,0.799153016068151,0,36,regulation of catecholamine secretion,BP,
13337,GO:0050434,1,0.769927653174817,0,41,positive regulation of viral transcription,BP,
13338,GO:0050435,1,0.802180728145165,0,32,amyloid-beta metabolic process,BP,
13339,GO:0050436,1,0.985932136414648,0,2,microfibril binding,MF,
13340,GO:0050444,1,0.993590111754218,0,1,aquacobalamin reductase (NADPH) activity,MF,
13342,GO:0050462,1,0.994647894618283,0,1,N-acetylneuraminate synthase activity,MF,
13343,GO:0050473,1,0.980924039062734,0,3,arachidonate 15-lipoxygenase activity,MF,
13344,GO:0050479,1,0.993850639026861,0,1,glyceryl-ether monooxygenase activity,MF,
13345,GO:0050480,1,0.994183314412697,0,1,imidazolonepropionase activity,MF,
13346,GO:0050482,1,0.88887647387832,0,19,arachidonic acid secretion,BP,
13347,GO:0050497,1,0.987875477502635,0,2,transferase activity, transferring alkylthio groups,MF,
13348,GO:0050501,1,0.97618646710444,0,4,hyaluronan synthase activity,MF,
13349,GO:0050508,1,0.980271013496166,0,3,glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,MF,
13350,GO:0050509,1,0.9869652545495,0,2,N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity,MF,
13351,GO:0050510,1,0.973684006847426,0,4,N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity,MF,
13352,GO:0050512,1,0.99420914570589,0,1,lactosylceramide 4-alpha-galactosyltransferase activity,MF,
13353,GO:0050528,1,0.994052709583558,0,1,acyloxyacyl hydrolase activity,MF,
13354,GO:0050542,1,0.967821465782601,0,6,icosanoid binding,MF,
13355,GO:0050543,1,0.968153985397988,0,6,icosatetraenoic acid binding,MF,
13356,GO:0050544,1,0.973292144020456,0,5,arachidonic acid binding,MF,
13357,GO:0050560,1,0.993555831129054,0,1,aspartate-tRNA(Asn) ligase activity,MF,
13358,GO:0050561,1,0.993269231134763,0,1,glutamate-tRNA(Gln) ligase activity,MF,
13359,GO:0050567,1,0.982197055458679,0,3,glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity,MF,
13360,GO:0050571,1,0.994456710844738,0,1,1,5-anhydro-D-fructose reductase activity,MF,
13361,GO:0050577,1,0.994583828338402,0,1,GDP-L-fucose synthase activity,MF,
13362,GO:0050610,1,0.989428399915997,0,2,methylarsonate reductase activity,MF,
13363,GO:0050613,1,0.987838317187344,0,2,delta14-sterol reductase activity,MF,
13364,GO:0050614,1,0.993077609375079,0,1,delta24-sterol reductase activity,MF,
13365,GO:0050632,1,0.994554376599818,0,1,propionyl-CoA C2-trimethyltridecanoyltransferase activity,MF,
13366,GO:0050646,1,0.994380736450329,0,1,5-oxo-6E,8Z,11Z,14Z-icosatetraenoic acid binding,MF,
13367,GO:0050647,1,0.994380736450329,0,1,5-hydroxy-6E,8Z,11Z,14Z-icosatetraenoic acid binding,MF,
13368,GO:0050648,1,0.994380736450329,0,1,5(S)-hydroxyperoxy-6E,8Z,11Z,14Z-icosatetraenoic acid binding,MF,
13369,GO:0050650,1,0.816244964301595,0,30,chondroitin sulfate proteoglycan biosynthetic process,BP,
13370,GO:0050651,1,0.90136346102031,0,15,dermatan sulfate proteoglycan biosynthetic process,BP,
13371,GO:0050652,1,0.993369404682948,0,1,dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
13372,GO:0050653,1,0.986664409541341,0,2,chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
13373,GO:0050654,1,0.752233993233508,0,42,chondroitin sulfate proteoglycan metabolic process,BP,
13374,GO:0050655,1,0.896089393136667,0,16,dermatan sulfate proteoglycan metabolic process,BP,
13375,GO:0050656,1,0.960601627576977,0,6,3'-phosphoadenosine 5'-phosphosulfate binding,MF,
13378,GO:0050659,1,0.985243673506058,0,2,N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity,MF,
13380,GO:0050661,1,0.757102642637481,0,44,NADP binding,MF,
13383,GO:0050664,1,0.924812999958459,0,12,oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor,MF,
13384,GO:0050665,1,0.931433439362391,0,11,hydrogen peroxide biosynthetic process,BP,
13385,GO:0050666,1,0.988146893139276,0,2,regulation of homocysteine metabolic process,BP,
13386,GO:0050667,1,0.914813992167511,0,14,homocysteine metabolic process,BP,
13387,GO:0050668,1,0.99411592245597,0,1,positive regulation of homocysteine metabolic process,BP,
13389,GO:0050671,1,0.486783595789451,0,117,positive regulation of lymphocyte proliferation,BP,
13392,GO:0050674,1,0.994965586769087,0,1,urothelial cell proliferation,BP,
13393,GO:0050675,1,0.994965586769087,0,1,regulation of urothelial cell proliferation,BP,
13394,GO:0050677,1,0.994965586769087,0,1,positive regulation of urothelial cell proliferation,BP,
13398,GO:0050681,1,0.758172020015175,0,41,androgen receptor binding,MF,
13399,GO:0050682,1,0.976684169276031,0,3,AF-2 domain binding,MF,
13400,GO:0050683,1,0.993169218082853,0,1,AF-1 domain binding,MF,
13401,GO:0050684,1,0.486265837534297,0,111,regulation of mRNA processing,BP,
13402,GO:0050685,1,0.858881822848344,0,24,positive regulation of mRNA processing,BP,
13403,GO:0050686,1,0.832536466865662,0,29,negative regulation of mRNA processing,BP,
13404,GO:0050687,1,0.875237710494564,0,21,negative regulation of defense response to virus,BP,
13405,GO:0050688,1,0.684792882801629,0,58,regulation of defense response to virus,BP,
13406,GO:0050689,1,0.971674223340157,0,5,negative regulation of defense response to virus by host,BP,
13407,GO:0050690,1,0.832152812888529,0,29,regulation of defense response to virus by virus,BP,
13408,GO:0050691,1,0.815398208468313,0,32,regulation of defense response to virus by host,BP,
13409,GO:0050692,1,0.980589638821969,0,3,DBD domain binding,MF,
13410,GO:0050693,1,0.961332320830715,0,6,LBD domain binding,MF,
13411,GO:0050694,1,0.976664049410022,0,4,galactose 3-O-sulfotransferase activity,MF,
13412,GO:0050698,1,0.987593571161184,0,2,proteoglycan sulfotransferase activity,MF,
13413,GO:0050699,1,0.825414691472548,0,30,WW domain binding,MF,
13414,GO:0050700,1,0.929417047111481,0,11,CARD domain binding,MF,
13415,GO:0050701,1,0.759313975430933,0,44,interleukin-1 secretion,BP,
13416,GO:0050702,1,0.780996491085492,0,39,interleukin-1 beta secretion,BP,
13417,GO:0050703,1,0.972099148842,0,5,interleukin-1 alpha secretion,BP,
13418,GO:0050704,1,0.796961371710202,0,37,regulation of interleukin-1 secretion,BP,
13419,GO:0050705,1,0.977009381357915,0,4,regulation of interleukin-1 alpha secretion,BP,
13420,GO:0050706,1,0.815580674568185,0,33,regulation of interleukin-1 beta secretion,BP,
13423,GO:0050709,1,0.523469192725801,0,101,negative regulation of protein secretion,BP,
13424,GO:0050710,1,0.735318268151845,0,49,negative regulation of cytokine secretion,BP,
13425,GO:0050711,1,0.936039140786399,0,11,negative regulation of interleukin-1 secretion,BP,
13426,GO:0050712,1,0.994548692780716,0,1,negative regulation of interleukin-1 alpha secretion,BP,
13427,GO:0050713,1,0.952948355832424,0,8,negative regulation of interleukin-1 beta secretion,BP,
13430,GO:0050716,1,0.849278276785517,0,26,positive regulation of interleukin-1 secretion,BP,
13431,GO:0050717,1,0.982365518321833,0,3,positive regulation of interleukin-1 alpha secretion,BP,
13432,GO:0050718,1,0.859162993537276,0,24,positive regulation of interleukin-1 beta secretion,BP,
13433,GO:0050719,1,0.994854788968432,0,1,interleukin-1 alpha biosynthetic process,BP,
13434,GO:0050720,1,0.988521792521612,0,2,interleukin-1 beta biosynthetic process,BP,
13435,GO:0050721,1,0.994854788968432,0,1,regulation of interleukin-1 alpha biosynthetic process,BP,
13436,GO:0050722,1,0.988521792521612,0,2,regulation of interleukin-1 beta biosynthetic process,BP,
13437,GO:0050725,1,0.988521792521612,0,2,positive regulation of interleukin-1 beta biosynthetic process,BP,
13438,GO:0050726,1,0.994854788968432,0,1,positive regulation of interleukin-1 alpha biosynthetic process,BP,
13441,GO:0050729,1,0.541723731725107,0,99,positive regulation of inflammatory response,BP,
13445,GO:0050733,1,0.967513239181643,0,5,RS domain binding,MF,
13447,GO:0050747,1,0.968015047888539,0,5,positive regulation of lipoprotein metabolic process,BP,
13449,GO:0050750,1,0.881953758563404,0,18,low-density lipoprotein particle receptor binding,MF,
13450,GO:0050751,1,0.994817338665145,0,1,fractalkine biosynthetic process,BP,
13451,GO:0050752,1,0.994817338665145,0,1,regulation of fractalkine biosynthetic process,BP,
13452,GO:0050754,1,0.994817338665145,0,1,positive regulation of fractalkine biosynthetic process,BP,
13453,GO:0050755,1,0.932564923440907,0,12,chemokine metabolic process,BP,
13454,GO:0050756,1,0.994817338665145,0,1,fractalkine metabolic process,BP,
13455,GO:0050757,1,0.988666379460419,0,2,thymidylate synthase biosynthetic process,BP,
13456,GO:0050758,1,0.988666379460419,0,2,regulation of thymidylate synthase biosynthetic process,BP,
13457,GO:0050760,1,0.993925190115375,0,1,negative regulation of thymidylate synthase biosynthetic process,BP,
13458,GO:0050764,1,0.647972664289154,0,68,regulation of phagocytosis,BP,
13459,GO:0050765,1,0.923739718536775,0,13,negative regulation of phagocytosis,BP,
13460,GO:0050766,1,0.730054544561059,0,49,positive regulation of phagocytosis,BP,
13466,GO:0050772,1,0.574925875972712,0,77,positive regulation of axonogenesis,BP,
13468,GO:0050774,1,0.902230817972837,0,15,negative regulation of dendrite morphogenesis,BP,
13469,GO:0050775,1,0.795087986287435,0,32,positive regulation of dendrite morphogenesis,BP,
13471,GO:0050777,1,0.472172995663883,0,118,negative regulation of immune response,BP,
13473,GO:0050779,1,0.842932307915248,0,24,RNA destabilization,BP,
13475,GO:0050783,1,0.994025893683851,0,1,cocaine metabolic process,BP,
13476,GO:0050785,1,0.994595712016855,0,1,advanced glycation end-product receptor activity,MF,
13477,GO:0050786,1,0.948711087039989,0,10,RAGE receptor binding,MF,
13478,GO:0050787,1,0.987510873676576,0,2,detoxification of mercury ion,BP,
13485,GO:0050796,1,0.353266377783922,0,156,regulation of insulin secretion,BP,
13486,GO:0050798,1,0.797923684607547,0,36,activated T cell proliferation,BP,
13489,GO:0050803,1,0.333977077939065,0,158,regulation of synapse structure or activity,BP,
13491,GO:0050805,1,0.636434042291217,0,66,negative regulation of synaptic transmission,BP,
13493,GO:0050807,1,0.357152496034058,0,148,regulation of synapse organization,BP,
13496,GO:0050811,1,0.910091316656894,0,14,GABA receptor binding,MF,
13497,GO:0050812,1,0.915052950751422,0,13,regulation of acyl-CoA biosynthetic process,BP,
13498,GO:0050815,1,0.962260893213389,0,6,phosphoserine residue binding,MF,
13499,GO:0050816,1,0.980238465924692,0,3,phosphothreonine residue binding,MF,
13503,GO:0050820,1,0.859040748302058,0,24,positive regulation of coagulation,BP,
13504,GO:0050821,1,0.387407229687142,0,145,protein stabilization,BP,
13505,GO:0050822,1,0.993482134442596,0,1,peptide stabilization,BP,
13506,GO:0050823,1,0.993482134442596,0,1,peptide antigen stabilization,BP,
13507,GO:0050829,1,0.783144233552062,0,42,defense response to Gram-negative bacterium,BP,
13508,GO:0050830,1,0.753846244777306,0,49,defense response to Gram-positive bacterium,BP,
13509,GO:0050832,1,0.881223522795686,0,23,defense response to fungus,BP,
13510,GO:0050833,1,0.975743796764925,0,4,pyruvate transmembrane transporter activity,MF,
13512,GO:0050840,1,0.72013180866292,0,48,extracellular matrix binding,MF,
13513,GO:0050847,1,0.939891860940395,0,8,progesterone receptor signaling pathway,BP,
13514,GO:0050848,1,0.62207286016515,0,71,regulation of calcium-mediated signaling,BP,
13515,GO:0050849,1,0.89553419372485,0,17,negative regulation of calcium-mediated signaling,BP,
13516,GO:0050850,1,0.808974361938165,0,33,positive regulation of calcium-mediated signaling,BP,
13519,GO:0050853,1,0.715889203280649,0,52,B cell receptor signaling pathway,BP,
13520,GO:0050854,1,0.715964672033582,0,52,regulation of antigen receptor-mediated signaling pathway,BP,
13521,GO:0050855,1,0.878444364574384,0,20,regulation of B cell receptor signaling pathway,BP,
13522,GO:0050856,1,0.801366758420554,0,35,regulation of T cell receptor signaling pathway,BP,
13523,GO:0050857,1,0.879688861699651,0,20,positive regulation of antigen receptor-mediated signaling pathway,BP,
13524,GO:0050858,1,0.874487602688275,0,22,negative regulation of antigen receptor-mediated signaling pathway,BP,
13525,GO:0050859,1,0.970036689308232,0,5,negative regulation of B cell receptor signaling pathway,BP,
13526,GO:0050860,1,0.896223878173552,0,18,negative regulation of T cell receptor signaling pathway,BP,
13527,GO:0050861,1,0.954263142669562,0,7,positive regulation of B cell receptor signaling pathway,BP,
13528,GO:0050862,1,0.928685071459374,0,12,positive regulation of T cell receptor signaling pathway,BP,
13529,GO:0050863,1,0.166533613809548,0,283,regulation of T cell activation,BP,
13530,GO:0050864,1,0.505768336461508,0,106,regulation of B cell activation,BP,
13533,GO:0050867,1,0.164391421707926,0,285,positive regulation of cell activation,BP,
13534,GO:0050868,1,0.574116248869603,0,87,negative regulation of T cell activation,BP,
13535,GO:0050869,1,0.82002695636989,0,31,negative regulation of B cell activation,BP,
13536,GO:0050870,1,0.310465865863768,0,187,positive regulation of T cell activation,BP,
13537,GO:0050871,1,0.648850461175897,0,68,positive regulation of B cell activation,BP,
13538,GO:0050872,1,0.924151931247439,0,12,white fat cell differentiation,BP,
13539,GO:0050873,1,0.809576571128255,0,33,brown fat cell differentiation,BP,
13542,GO:0050879,1,0.742612443558034,0,45,multicellular organismal movement,BP,
13543,GO:0050880,1,0.466848760793645,0,120,regulation of blood vessel size,BP,
13544,GO:0050881,1,0.742612443558034,0,45,musculoskeletal movement,BP,
13545,GO:0050882,1,0.950125308553923,0,6,voluntary musculoskeletal movement,BP,
13546,GO:0050883,1,0.994010428273367,0,1,musculoskeletal movement, spinal reflex action,BP,
13547,GO:0050884,1,0.9088552825797,0,14,neuromuscular process controlling posture,BP,
13549,GO:0050886,1,0.637046288551322,0,71,endocrine process,BP,
13552,GO:0050892,1,0.846253001595124,0,26,intestinal absorption,BP,
13553,GO:0050893,1,0.974413152204881,0,4,sensory processing,BP,
13554,GO:0050894,1,0.991838297651918,0,1,determination of affect,BP,
13556,GO:0050897,1,0.992169153657553,0,1,cobalt ion binding,MF,
13558,GO:0050901,1,0.85912950727615,0,24,leukocyte tethering or rolling,BP,
13559,GO:0050902,1,0.987622078938061,0,2,leukocyte adhesive activation,BP,
13560,GO:0050904,1,0.985939442167588,0,2,diapedesis,BP,
13562,GO:0050906,1,0.590469956320662,0,86,detection of stimulus involved in sensory perception,BP,
13563,GO:0050907,1,0.790415687878097,0,42,detection of chemical stimulus involved in sensory perception,BP,
13564,GO:0050908,1,0.910722345828615,0,14,detection of light stimulus involved in visual perception,BP,
13565,GO:0050909,1,0.780210354970218,0,42,sensory perception of taste,BP,
13566,GO:0050910,1,0.931216998817585,0,11,detection of mechanical stimulus involved in sensory perception of sound,BP,
13567,GO:0050911,1,0.91108520348435,0,17,detection of chemical stimulus involved in sensory perception of smell,BP,
13568,GO:0050912,1,0.879069877317487,0,23,detection of chemical stimulus involved in sensory perception of taste,BP,
13569,GO:0050913,1,0.864770974177113,0,25,sensory perception of bitter taste,BP,
13570,GO:0050915,1,0.975486546445724,0,4,sensory perception of sour taste,BP,
13571,GO:0050916,1,0.972745773151751,0,4,sensory perception of sweet taste,BP,
13572,GO:0050917,1,0.966612471152702,0,5,sensory perception of umami taste,BP,
13573,GO:0050918,1,0.724511327324088,0,50,positive chemotaxis,BP,
13574,GO:0050919,1,0.769736299026789,0,36,negative chemotaxis,BP,
13577,GO:0050922,1,0.738706422936558,0,45,negative regulation of chemotaxis,BP,
13578,GO:0050923,1,0.970250849443994,0,4,regulation of negative chemotaxis,BP,
13579,GO:0050924,1,0.992716932799276,0,1,positive regulation of negative chemotaxis,BP,
13580,GO:0050925,1,0.983734806508311,0,2,negative regulation of negative chemotaxis,BP,
13581,GO:0050926,1,0.858819642140057,0,24,regulation of positive chemotaxis,BP,
13582,GO:0050927,1,0.865259459413016,0,23,positive regulation of positive chemotaxis,BP,
13583,GO:0050928,1,0.992568185484181,0,1,negative regulation of positive chemotaxis,BP,
13584,GO:0050929,1,0.992716932799276,0,1,induction of negative chemotaxis,BP,
13585,GO:0050930,1,0.926051718649541,0,13,induction of positive chemotaxis,BP,
13586,GO:0050931,1,0.800366080832133,0,32,pigment cell differentiation,BP,
13587,GO:0050932,1,0.938208829003064,0,9,regulation of pigment cell differentiation,BP,
13588,GO:0050942,1,0.948970326304997,0,7,positive regulation of pigment cell differentiation,BP,
13589,GO:0050951,1,0.88180126453379,0,19,sensory perception of temperature stimulus,BP,
13592,GO:0050955,1,0.985579828001539,0,2,thermoception,BP,
13594,GO:0050960,1,0.993156557790908,0,1,detection of temperature stimulus involved in thermoception,BP,
13595,GO:0050961,1,0.915709489840016,0,14,detection of temperature stimulus involved in sensory perception,BP,
13596,GO:0050962,1,0.910722345828615,0,14,detection of light stimulus involved in sensory perception,BP,
13597,GO:0050965,1,0.915709489840016,0,14,detection of temperature stimulus involved in sensory perception of pain,BP,
13598,GO:0050966,1,0.944716418679948,0,8,detection of mechanical stimulus involved in sensory perception of pain,BP,
13599,GO:0050968,1,0.987048857287086,0,2,detection of chemical stimulus involved in sensory perception of pain,BP,
13600,GO:0050974,1,0.858898357420869,0,23,detection of mechanical stimulus involved in sensory perception,BP,
13601,GO:0050975,1,0.980148056830643,0,3,sensory perception of touch,BP,
13602,GO:0050976,1,0.985556560423888,0,2,detection of mechanical stimulus involved in sensory perception of touch,BP,
13603,GO:0050982,1,0.744025904193935,0,37,detection of mechanical stimulus,BP,
13604,GO:0050992,1,0.994185897313966,0,1,dimethylallyl diphosphate biosynthetic process,BP,
13605,GO:0050993,1,0.994185897313966,0,1,dimethylallyl diphosphate metabolic process,BP,
13606,GO:0050994,1,0.755810373052404,0,42,regulation of lipid catabolic process,BP,
13607,GO:0050995,1,0.894098359765796,0,17,negative regulation of lipid catabolic process,BP,
13608,GO:0050996,1,0.896913907694924,0,16,positive regulation of lipid catabolic process,BP,
13609,GO:0050997,1,0.896276059080489,0,17,quaternary ammonium group binding,MF,
13613,GO:0051001,1,0.96118173771707,0,6,negative regulation of nitric-oxide synthase activity,BP,
13614,GO:0051004,1,0.912431041788874,0,15,regulation of lipoprotein lipase activity,BP,
13615,GO:0051005,1,0.981144681988449,0,3,negative regulation of lipoprotein lipase activity,BP,
13616,GO:0051006,1,0.960257496454453,0,7,positive regulation of lipoprotein lipase activity,BP,
13617,GO:0051010,1,0.898517238431283,0,13,microtubule plus-end binding,MF,
13618,GO:0051011,1,0.931303911895151,0,9,microtubule minus-end binding,MF,
13619,GO:0051012,1,0.987066536796749,0,2,microtubule sliding,BP,
13620,GO:0051013,1,0.954805349073646,0,7,microtubule severing,BP,
13621,GO:0051014,1,0.949771531981125,0,8,actin filament severing,BP,
13623,GO:0051016,1,0.91513325335163,0,14,barbed-end actin filament capping,BP,
13625,GO:0051018,1,0.712002785991722,0,46,protein kinase A binding,MF,
13626,GO:0051019,1,0.838794498232398,0,26,mitogen-activated protein kinase binding,MF,
13628,GO:0051021,1,0.969430659448568,0,5,GDP-dissociation inhibitor binding,MF,
13629,GO:0051022,1,0.97478062033706,0,4,Rho GDP-dissociation inhibitor binding,MF,
13630,GO:0051023,1,0.917537504462888,0,15,regulation of immunoglobulin secretion,BP,
13631,GO:0051024,1,0.950310189225505,0,9,positive regulation of immunoglobulin secretion,BP,
13632,GO:0051025,1,0.987661932876797,0,2,negative regulation of immunoglobulin secretion,BP,
13633,GO:0051026,1,0.963472429970539,0,6,chiasma assembly,BP,
13635,GO:0051029,1,0.963085790833771,0,6,rRNA transport,BP,
13636,GO:0051030,1,0.977921364423648,0,4,snRNA transport,BP,
13637,GO:0051031,1,0.802779188732934,0,32,tRNA transport,BP,
13638,GO:0051032,1,0.986003688885712,0,2,nucleic acid transmembrane transporter activity,MF,
13639,GO:0051033,1,0.986003688885712,0,2,RNA transmembrane transporter activity,MF,
13640,GO:0051036,1,0.970168212548177,0,5,regulation of endosome size,BP,
13641,GO:0051040,1,0.987306827559265,0,2,regulation of calcium-independent cell-cell adhesion,BP,
13642,GO:0051041,1,0.993602391325548,0,1,positive regulation of calcium-independent cell-cell adhesion,BP,
13643,GO:0051042,1,0.993664309842,0,1,negative regulation of calcium-independent cell-cell adhesion,BP,
13644,GO:0051043,1,0.872994545851313,0,21,regulation of membrane protein ectodomain proteolysis,BP,
13645,GO:0051044,1,0.921111689835767,0,13,positive regulation of membrane protein ectodomain proteolysis,BP,
13646,GO:0051045,1,0.947804078924801,0,8,negative regulation of membrane protein ectodomain proteolysis,BP,
13654,GO:0051053,1,0.449578889628681,0,117,negative regulation of DNA metabolic process,BP,
13656,GO:0051055,1,0.759906998951593,0,44,negative regulation of lipid biosynthetic process,BP,
13659,GO:0051058,1,0.695036063514266,0,52,negative regulation of small GTPase mediated signal transduction,BP,
13660,GO:0051059,1,0.838728012729279,0,28,NF-kappaB binding,MF,
13661,GO:0051066,1,0.988746203777005,0,2,dihydrobiopterin metabolic process,BP,
13662,GO:0051068,1,0.993439630676661,0,1,dihydrolipoamide metabolic process,BP,
13665,GO:0051083,1,0.988565831002245,0,2,'de novo' cotranslational protein folding,BP,
13668,GO:0051086,1,0.994273224790602,0,1,chaperone mediated protein folding independent of cofactor,BP,
13670,GO:0051088,1,0.980076489710785,0,3,PMA-inducible membrane protein ectodomain proteolysis,BP,
13671,GO:0051089,1,0.99325945339157,0,1,constitutive protein ectodomain proteolysis,BP,
13672,GO:0051090,1,0.0834279747996354,0,376,regulation of DNA binding transcription factor activity,BP,
13673,GO:0051091,1,0.226159014872163,0,226,positive regulation of DNA binding transcription factor activity,BP,
13674,GO:0051092,1,0.422813574410307,0,135,positive regulation of NF-kappaB transcription factor activity,BP,
13677,GO:0051095,1,0.944595407488131,0,9,regulation of helicase activity,BP,
13678,GO:0051096,1,0.96220998705207,0,6,positive regulation of helicase activity,BP,
13679,GO:0051097,1,0.981700680461779,0,3,negative regulation of helicase activity,BP,
13681,GO:0051099,1,0.340725106622463,0,163,positive regulation of binding,BP,
13684,GO:0051102,1,0.993199162222386,0,1,DNA ligation involved in DNA recombination,BP,
13685,GO:0051103,1,0.935314352144826,0,11,DNA ligation involved in DNA repair,BP,
13686,GO:0051105,1,0.963573615524835,0,6,regulation of DNA ligation,BP,
13687,GO:0051106,1,0.969594359695329,0,5,positive regulation of DNA ligation,BP,
13688,GO:0051107,1,0.993792381470899,0,1,negative regulation of DNA ligation,BP,
13691,GO:0051120,1,0.981653277089972,0,3,hepoxilin A3 synthase activity,MF,
13692,GO:0051121,1,0.969830566381791,0,5,hepoxilin metabolic process,BP,
13693,GO:0051122,1,0.969830566381791,0,5,hepoxilin biosynthetic process,BP,
13694,GO:0051123,1,0.820645286513564,0,31,RNA polymerase II transcriptional preinitiation complex assembly,BP,
13695,GO:0051124,1,0.931663451164288,0,9,synaptic growth at neuromuscular junction,BP,
13696,GO:0051125,1,0.836872043091123,0,27,regulation of actin nucleation,BP,
13697,GO:0051126,1,0.958618046512116,0,7,negative regulation of actin nucleation,BP,
13698,GO:0051127,1,0.900073875508569,0,15,positive regulation of actin nucleation,BP,
13702,GO:0051131,1,0.896823970740084,0,18,chaperone-mediated protein complex assembly,BP,
13703,GO:0051132,1,0.953795268911471,0,8,NK T cell activation,BP,
13704,GO:0051133,1,0.965776321778369,0,6,regulation of NK T cell activation,BP,
13705,GO:0051134,1,0.994312506803972,0,1,negative regulation of NK T cell activation,BP,
13706,GO:0051135,1,0.971302218226125,0,5,positive regulation of NK T cell activation,BP,
13707,GO:0051136,1,0.960822145251846,0,6,regulation of NK T cell differentiation,BP,
13708,GO:0051138,1,0.973259066438701,0,4,positive regulation of NK T cell differentiation,BP,
13709,GO:0051139,1,0.98581082973129,0,2,metal ion:proton antiporter activity,MF,
13710,GO:0051140,1,0.983127066895709,0,3,regulation of NK T cell proliferation,BP,
13711,GO:0051142,1,0.983127066895709,0,3,positive regulation of NK T cell proliferation,BP,
13712,GO:0051145,1,0.715939988319078,0,51,smooth muscle cell differentiation,BP,
13714,GO:0051147,1,0.429952999643872,0,127,regulation of muscle cell differentiation,BP,
13715,GO:0051148,1,0.765613672905529,0,40,negative regulation of muscle cell differentiation,BP,
13716,GO:0051149,1,0.621842538628733,0,73,positive regulation of muscle cell differentiation,BP,
13717,GO:0051150,1,0.843822427091303,0,26,regulation of smooth muscle cell differentiation,BP,
13718,GO:0051151,1,0.929853413116577,0,11,negative regulation of smooth muscle cell differentiation,BP,
13719,GO:0051152,1,0.9331577663375,0,11,positive regulation of smooth muscle cell differentiation,BP,
13720,GO:0051153,1,0.582357773626694,0,82,regulation of striated muscle cell differentiation,BP,
13721,GO:0051154,1,0.828788305408624,0,28,negative regulation of striated muscle cell differentiation,BP,
13722,GO:0051155,1,0.737634059018497,0,47,positive regulation of striated muscle cell differentiation,BP,
13723,GO:0051156,1,0.852888822098348,0,26,glucose 6-phosphate metabolic process,BP,
13724,GO:0051160,1,0.993982085865433,0,1,L-xylitol catabolic process,BP,
13725,GO:0051164,1,0.993982085865433,0,1,L-xylitol metabolic process,BP,
13726,GO:0051167,1,0.971588777423278,0,5,xylulose 5-phosphate metabolic process,BP,
13734,GO:0051176,1,0.979465697324013,0,3,positive regulation of sulfur metabolic process,BP,
13737,GO:0051180,1,0.819935624129025,0,30,vitamin transport,BP,
13738,GO:0051181,1,0.768815017242897,0,41,cofactor transport,BP,
13739,GO:0051182,1,0.949867044043401,0,8,coenzyme transport,BP,
13740,GO:0051184,1,0.876792593818073,0,20,cofactor transmembrane transporter activity,MF,
13741,GO:0051185,1,0.962098791800216,0,6,coenzyme transmembrane transporter activity,MF,
13742,GO:0051186,1,0.0392481244281104,0,512,cofactor metabolic process,BP,
13743,GO:0051187,1,0.765260334543707,0,45,cofactor catabolic process,BP,
13744,GO:0051188,1,0.171002033636363,0,274,cofactor biosynthetic process,BP,
13745,GO:0051189,1,0.95794556484966,0,7,prosthetic group metabolic process,BP,
13746,GO:0051192,1,0.989925940293056,0,2,prosthetic group binding,MF,
13747,GO:0051193,1,0.531239886275676,0,94,regulation of cofactor metabolic process,BP,
13748,GO:0051194,1,0.876868481277278,0,19,positive regulation of cofactor metabolic process,BP,
13749,GO:0051195,1,0.899973921866772,0,16,negative regulation of cofactor metabolic process,BP,
13750,GO:0051196,1,0.578015889589808,0,80,regulation of coenzyme metabolic process,BP,
13751,GO:0051197,1,0.893070223347657,0,16,positive regulation of coenzyme metabolic process,BP,
13752,GO:0051198,1,0.932808195879601,0,10,negative regulation of coenzyme metabolic process,BP,
13753,GO:0051204,1,0.812672921802423,0,34,protein insertion into mitochondrial membrane,BP,
13754,GO:0051205,1,0.754683247641683,0,46,protein insertion into membrane,BP,
13757,GO:0051213,1,0.568427023193462,0,85,dioxygenase activity,MF,
13759,GO:0051219,1,0.601102429642282,0,74,phosphoprotein binding,MF,
13760,GO:0051220,1,0.852702817222367,0,24,cytoplasmic sequestering of protein,BP,
13763,GO:0051224,1,0.401521671484838,0,143,negative regulation of protein transport,BP,
13765,GO:0051228,1,0.992615610054587,0,1,mitotic spindle disassembly,BP,
13766,GO:0051230,1,0.992615610054587,0,1,spindle disassembly,BP,
13767,GO:0051231,1,0.931206442336172,0,11,spindle elongation,BP,
13768,GO:0051232,1,0.994061478707865,0,1,meiotic spindle elongation,BP,
13773,GO:0051238,1,0.918542586649982,0,14,sequestering of metal ion,BP,
13782,GO:0051251,1,0.216140316435195,0,243,positive regulation of lymphocyte activation,BP,
13786,GO:0051255,1,0.93893734417643,0,10,spindle midzone assembly,BP,
13787,GO:0051256,1,0.950746211457282,0,8,mitotic spindle midzone assembly,BP,
13788,GO:0051257,1,0.994013005560847,0,1,meiotic spindle midzone assembly,BP,
13792,GO:0051261,1,0.511102280849047,0,96,protein depolymerization,BP,
13793,GO:0051262,1,0.444912733636969,0,125,protein tetramerization,BP,
13794,GO:0051264,1,0.993838056023524,0,1,mono-olein transacylation activity,MF,
13795,GO:0051265,1,0.993838056023524,0,1,diolein transacylation activity,MF,
13796,GO:0051267,1,0.993614671204414,0,1,CP2 mannose-ethanolamine phosphotransferase activity,MF,
13802,GO:0051280,1,0.923880475325876,0,13,negative regulation of release of sequestered calcium ion into cytosol,BP,
13806,GO:0051284,1,0.911734797525807,0,14,positive regulation of sequestering of calcium ion,BP,
13807,GO:0051286,1,0.952091591953672,0,7,cell tip,CC,
13809,GO:0051289,1,0.61740953882715,0,75,protein homotetramerization,BP,
13810,GO:0051290,1,0.839760301171161,0,28,protein heterotetramerization,BP,
13811,GO:0051291,1,0.525210307085014,0,100,protein heterooligomerization,BP,
13812,GO:0051292,1,0.931379589579995,0,10,nuclear pore complex assembly,BP,
13814,GO:0051294,1,0.837557541466494,0,26,establishment of spindle orientation,BP,
13815,GO:0051295,1,0.969782285420162,0,4,establishment of meiotic spindle localization,BP,
13816,GO:0051298,1,0.653632204624997,0,62,centrosome duplication,BP,
13817,GO:0051299,1,0.898029270388984,0,16,centrosome separation,BP,
13818,GO:0051300,1,0.993850639026861,0,1,spindle pole body organization,BP,
13823,GO:0051305,1,0.957498506717941,0,6,chromosome movement towards spindle pole,BP,
13826,GO:0051308,1,0.993850639026861,0,1,male meiosis chromosome separation,BP,
13828,GO:0051311,1,0.994013005560847,0,1,meiotic metaphase plate congression,BP,
13829,GO:0051315,1,0.919802391846522,0,13,attachment of mitotic spindle microtubules to kinetochore,BP,
13830,GO:0051316,1,0.988010334566473,0,2,attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation,BP,
13834,GO:0051339,1,0.767844197317944,0,41,regulation of lyase activity,BP,
13835,GO:0051340,1,0.949005672651195,0,9,regulation of ligase activity,BP,
13837,GO:0051342,1,0.950979255664286,0,8,regulation of cyclic-nucleotide phosphodiesterase activity,BP,
13838,GO:0051343,1,0.975780561110776,0,4,positive regulation of cyclic-nucleotide phosphodiesterase activity,BP,
13839,GO:0051344,1,0.968468930940691,0,5,negative regulation of cyclic-nucleotide phosphodiesterase activity,BP,
13844,GO:0051349,1,0.906666615519628,0,15,positive regulation of lyase activity,BP,
13845,GO:0051350,1,0.863169514845844,0,23,negative regulation of lyase activity,BP,
13846,GO:0051351,1,0.960420034085593,0,7,positive regulation of ligase activity,BP,
13847,GO:0051352,1,0.988120061750547,0,2,negative regulation of ligase activity,BP,
13849,GO:0051354,1,0.881528743289186,0,20,negative regulation of oxidoreductase activity,BP,
13850,GO:0051355,1,0.99332577587971,0,1,proprioception involved in equilibrioception,BP,
13851,GO:0051365,1,0.981608427145416,0,3,cellular response to potassium ion starvation,BP,
13853,GO:0051373,1,0.969948994289181,0,5,FATZ binding,MF,
13854,GO:0051377,1,0.980134111154691,0,3,mannose-ethanolamine phosphotransferase activity,MF,
13855,GO:0051378,1,0.935400288587359,0,11,serotonin binding,MF,
13856,GO:0051379,1,0.958969699064972,0,7,epinephrine binding,MF,
13857,GO:0051380,1,0.970213971506914,0,5,norepinephrine binding,MF,
13860,GO:0051384,1,0.438943951590684,0,129,response to glucocorticoid,BP,
13861,GO:0051385,1,0.839666299126387,0,28,response to mineralocorticoid,BP,
13862,GO:0051386,1,0.943616300684809,0,9,regulation of neurotrophin TRK receptor signaling pathway,BP,
13863,GO:0051387,1,0.98230369089278,0,3,negative regulation of neurotrophin TRK receptor signaling pathway,BP,
13864,GO:0051388,1,0.973031262664503,0,4,positive regulation of neurotrophin TRK receptor signaling pathway,BP,
13865,GO:0051389,1,0.982320016736802,0,2,inactivation of MAPKK activity,BP,
13866,GO:0051391,1,0.993250444491064,0,1,tRNA acetylation,BP,
13867,GO:0051392,1,0.993250444491064,0,1,tRNA N-acetyltransferase activity,MF,
13869,GO:0051400,1,0.951054971672134,0,8,BH domain binding,MF,
13872,GO:0051409,1,0.937694437073822,0,10,response to nitrosative stress,BP,
13873,GO:0051410,1,0.970529783466077,0,5,detoxification of nitrogen compound,BP,
13874,GO:0051412,1,0.903167320257507,0,16,response to corticosterone,BP,
13875,GO:0051413,1,0.993991359963957,0,1,response to cortisone,BP,
13876,GO:0051414,1,0.964616588822373,0,5,response to cortisol,BP,
13877,GO:0051415,1,0.96705779729755,0,5,microtubule nucleation by interphase microtubule organizing center,BP,
13878,GO:0051417,1,0.993850639026861,0,1,microtubule nucleation by spindle pole body,BP,
13879,GO:0051418,1,0.950650647592976,0,7,microtubule nucleation by microtubule organizing center,BP,
13880,GO:0051424,1,0.994338351542684,0,1,corticotropin-releasing hormone binding,MF,
13881,GO:0051425,1,0.970775764695439,0,4,PTB domain binding,MF,
13882,GO:0051427,1,0.336653502871458,0,163,hormone receptor binding,MF,
13883,GO:0051428,1,0.904570336755516,0,17,peptide hormone receptor binding,MF,
13884,GO:0051429,1,0.971584695006789,0,5,corticotropin-releasing hormone receptor binding,MF,
13885,GO:0051430,1,0.976936776825626,0,4,corticotropin-releasing hormone receptor 1 binding,MF,
13886,GO:0051431,1,0.984207421173956,0,3,corticotropin-releasing hormone receptor 2 binding,MF,
13887,GO:0051433,1,0.992943540305731,0,1,BH2 domain binding,MF,
13888,GO:0051434,1,0.975709441298855,0,4,BH3 domain binding,MF,
13891,GO:0051444,1,0.91739393410648,0,14,negative regulation of ubiquitin-protein transferase activity,BP,
13893,GO:0051446,1,0.911819652332631,0,14,positive regulation of meiotic cell cycle,BP,
13894,GO:0051447,1,0.91635687978011,0,14,negative regulation of meiotic cell cycle,BP,
13895,GO:0051450,1,0.891233044314302,0,18,myoblast proliferation,BP,
13896,GO:0051451,1,0.929658745092435,0,11,myoblast migration,BP,
13897,GO:0051452,1,0.747460616746469,0,47,intracellular pH reduction,BP,
13898,GO:0051453,1,0.573944250444577,0,85,regulation of intracellular pH,BP,
13899,GO:0051454,1,0.973888158807963,0,4,intracellular pH elevation,BP,
13900,GO:0051455,1,0.993850639026861,0,1,attachment of spindle microtubules to kinetochore involved in homologous chromosome segregation,BP,
13901,GO:0051456,1,0.994123924412939,0,1,attachment of spindle microtubules to kinetochore involved in meiotic sister chromatid segregation,BP,
13902,GO:0051457,1,0.862909955308818,0,22,maintenance of protein location in nucleus,BP,
13903,GO:0051458,1,0.959921422625329,0,7,corticotropin secretion,BP,
13904,GO:0051459,1,0.965752197038938,0,6,regulation of corticotropin secretion,BP,
13905,GO:0051460,1,0.994338351542684,0,1,negative regulation of corticotropin secretion,BP,
13906,GO:0051461,1,0.971252705523737,0,5,positive regulation of corticotropin secretion,BP,
13907,GO:0051462,1,0.970662716323984,0,5,regulation of cortisol secretion,BP,
13908,GO:0051463,1,0.992030345783312,0,1,negative regulation of cortisol secretion,BP,
13909,GO:0051464,1,0.978462431942977,0,4,positive regulation of cortisol secretion,BP,
13910,GO:0051466,1,0.993627463299271,0,1,positive regulation of corticotropin-releasing hormone secretion,BP,
13912,GO:0051481,1,0.934979475232244,0,9,negative regulation of cytosolic calcium ion concentration,BP,
13914,GO:0051489,1,0.764633969264817,0,39,regulation of filopodium assembly,BP,
13915,GO:0051490,1,0.988284607980593,0,2,negative regulation of filopodium assembly,BP,
13916,GO:0051491,1,0.827309803798599,0,28,positive regulation of filopodium assembly,BP,
13919,GO:0051494,1,0.423872498205157,0,126,negative regulation of cytoskeleton organization,BP,
13922,GO:0051497,1,0.870385358778185,0,20,negative regulation of stress fiber assembly,BP,
13923,GO:0051499,1,0.988466411528369,0,2,D-aminoacyl-tRNA deacylase activity,MF,
13924,GO:0051500,1,0.988466411528369,0,2,D-tyrosyl-tRNA(Tyr) deacylase activity,MF,
13925,GO:0051503,1,0.923163894111938,0,13,adenine nucleotide transport,BP,
13926,GO:0051525,1,0.965811780722944,0,5,NFAT protein binding,MF,
13929,GO:0051538,1,0.982121841143534,0,3,3 iron, 4 sulfur cluster binding,MF,
13930,GO:0051539,1,0.777340921928075,0,40,4 iron, 4 sulfur cluster binding,MF,
13932,GO:0051541,1,0.973330072445197,0,4,elastin metabolic process,BP,
13933,GO:0051542,1,0.985005773935837,0,2,elastin biosynthetic process,BP,
13934,GO:0051543,1,0.994070248948975,0,1,regulation of elastin biosynthetic process,BP,
13935,GO:0051545,1,0.994070248948975,0,1,negative regulation of elastin biosynthetic process,BP,
13936,GO:0051546,1,0.917525052280342,0,13,keratinocyte migration,BP,
13937,GO:0051547,1,0.940831073267525,0,9,regulation of keratinocyte migration,BP,
13938,GO:0051548,1,0.99241929572855,0,1,negative regulation of keratinocyte migration,BP,
13939,GO:0051549,1,0.948021603741507,0,8,positive regulation of keratinocyte migration,BP,
13940,GO:0051552,1,0.992013629895481,0,1,flavone metabolic process,BP,
13941,GO:0051560,1,0.876519527162674,0,21,mitochondrial calcium ion homeostasis,BP,
13942,GO:0051561,1,0.941525650780716,0,10,positive regulation of mitochondrial calcium ion concentration,BP,
13943,GO:0051562,1,0.98245032498165,0,3,negative regulation of mitochondrial calcium ion concentration,BP,
13944,GO:0051563,1,0.985683554689172,0,2,smooth endoplasmic reticulum calcium ion homeostasis,BP,
13945,GO:0051567,1,0.813519302390104,0,29,histone H3-K9 methylation,BP,
13946,GO:0051568,1,0.717854768190283,0,48,histone H3-K4 methylation,BP,
13947,GO:0051569,1,0.850934634398439,0,24,regulation of histone H3-K4 methylation,BP,
13948,GO:0051570,1,0.866898229242693,0,20,regulation of histone H3-K9 methylation,BP,
13949,GO:0051571,1,0.901523500077723,0,15,positive regulation of histone H3-K4 methylation,BP,
13950,GO:0051572,1,0.978037660823726,0,3,negative regulation of histone H3-K4 methylation,BP,
13951,GO:0051573,1,0.933856813911048,0,10,negative regulation of histone H3-K9 methylation,BP,
13952,GO:0051574,1,0.937590699524114,0,9,positive regulation of histone H3-K9 methylation,BP,
13953,GO:0051575,1,0.966643623286619,0,5,5'-deoxyribose-5-phosphate lyase activity,MF,
13955,GO:0051581,1,0.974078468713799,0,4,negative regulation of neurotransmitter uptake,BP,
13956,GO:0051582,1,0.97730374498766,0,4,positive regulation of neurotransmitter uptake,BP,
13957,GO:0051583,1,0.935831451720363,0,11,dopamine uptake involved in synaptic transmission,BP,
13958,GO:0051584,1,0.960030168973915,0,7,regulation of dopamine uptake involved in synaptic transmission,BP,
13959,GO:0051585,1,0.993653817804457,0,1,negative regulation of dopamine uptake involved in synaptic transmission,BP,
13960,GO:0051586,1,0.983087015631762,0,3,positive regulation of dopamine uptake involved in synaptic transmission,BP,
13962,GO:0051589,1,0.878139641731439,0,19,negative regulation of neurotransmitter transport,BP,
13963,GO:0051590,1,0.845203060925346,0,26,positive regulation of neurotransmitter transport,BP,
13964,GO:0051591,1,0.544353246846203,0,90,response to cAMP,BP,
13966,GO:0051593,1,0.935904920080268,0,11,response to folic acid,BP,
13967,GO:0051594,1,0.976880816680695,0,4,detection of glucose,BP,
13968,GO:0051595,1,0.981304541615387,0,3,response to methylglyoxal,BP,
13969,GO:0051596,1,0.988259621271998,0,2,methylglyoxal catabolic process,BP,
13970,GO:0051597,1,0.95347790641455,0,7,response to methylmercury,BP,
13971,GO:0051598,1,0.992915149365599,0,1,meiotic recombination checkpoint,BP,
13972,GO:0051599,1,0.96439543968503,0,5,response to hydrostatic pressure,BP,
13973,GO:0051601,1,0.950368417000194,0,8,exocyst localization,BP,
13974,GO:0051602,1,0.779557844559135,0,39,response to electrical stimulus,BP,
13978,GO:0051607,1,0.303184741912622,0,186,defense response to virus,BP,
13979,GO:0051608,1,0.941805991639634,0,10,histamine transport,BP,
13980,GO:0051610,1,0.972859503835249,0,4,serotonin uptake,BP,
13981,GO:0051611,1,0.979771068674135,0,3,regulation of serotonin uptake,BP,
13982,GO:0051612,1,0.979771068674135,0,3,negative regulation of serotonin uptake,BP,
13983,GO:0051615,1,0.992377879330887,0,1,histamine uptake,BP,
13984,GO:0051620,1,0.993653817804457,0,1,norepinephrine uptake,BP,
13985,GO:0051621,1,0.993653817804457,0,1,regulation of norepinephrine uptake,BP,
13986,GO:0051622,1,0.993653817804457,0,1,negative regulation of norepinephrine uptake,BP,
13987,GO:0051639,1,0.947156189511374,0,8,actin filament network formation,BP,
13991,GO:0051643,1,0.961732178417188,0,5,endoplasmic reticulum localization,BP,
13992,GO:0051645,1,0.914954862891959,0,13,Golgi localization,BP,
13993,GO:0051646,1,0.764140693494235,0,39,mitochondrion localization,BP,
13994,GO:0051647,1,0.848238215297593,0,22,nucleus localization,BP,
14000,GO:0051654,1,0.875291060037325,0,19,establishment of mitochondrion localization,BP,
14003,GO:0051659,1,0.987628953826061,0,2,maintenance of mitochondrion location,BP,
14004,GO:0051660,1,0.972331589859639,0,4,establishment of centrosome localization,BP,
14006,GO:0051664,1,0.987021871183852,0,2,nuclear pore localization,BP,
14008,GO:0051666,1,0.966747208102071,0,5,actin cortical patch localization,BP,
14010,GO:0051673,1,0.973149981168682,0,5,membrane disruption in other organism,BP,
14012,GO:0051683,1,0.957167909843405,0,7,establishment of Golgi localization,BP,
14013,GO:0051684,1,0.978135033865514,0,3,maintenance of Golgi location,BP,
14014,GO:0051685,1,0.993850639026861,0,1,maintenance of ER location,BP,
14015,GO:0051686,1,0.988985116420387,0,1,establishment of ER localization,BP,
14016,GO:0051691,1,0.994418208254504,0,1,cellular oligosaccharide metabolic process,BP,
14017,GO:0051692,1,0.994418208254504,0,1,cellular oligosaccharide catabolic process,BP,
14018,GO:0051693,1,0.803834250623032,0,31,actin filament capping,BP,
14019,GO:0051694,1,0.960034501264195,0,6,pointed-end actin filament capping,BP,
14020,GO:0051695,1,0.992945623162288,0,1,actin filament uncapping,BP,
14021,GO:0051697,1,0.976829237257306,0,4,protein delipidation,BP,
14023,GO:0051702,1,0.679502127687642,0,61,interaction with symbiont,BP,
14024,GO:0051703,1,0.704656666309256,0,49,intraspecies interaction between organisms,BP,
14026,GO:0051705,1,0.643843508299862,0,63,multi-organism behavior,BP,
14027,GO:0051707,1,0.0130042992230944,0,679,response to other organism,BP,
14028,GO:0051708,1,0.989287971048749,0,2,intracellular protein transport in other organism involved in symbiotic interaction,BP,
14029,GO:0051709,1,0.941991674965249,0,10,regulation of killing of cells of other organism,BP,
14030,GO:0051710,1,0.994797709198386,0,1,regulation of cytolysis in other organism,BP,
14031,GO:0051712,1,0.947998705257357,0,9,positive regulation of killing of cells of other organism,BP,
14032,GO:0051714,1,0.994797709198386,0,1,positive regulation of cytolysis in other organism,BP,
14033,GO:0051715,1,0.978049308912232,0,4,cytolysis in other organism,BP,
14035,GO:0051717,1,0.986284233416277,0,2,inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity,MF,
14036,GO:0051721,1,0.833165306353236,0,27,protein phosphatase 2A binding,MF,
14037,GO:0051722,1,0.994017129456668,0,1,protein C-terminal methylesterase activity,MF,
14038,GO:0051723,1,0.994017129456668,0,1,protein methylesterase activity,MF,
14039,GO:0051724,1,0.994118245529178,0,1,NAD transmembrane transporter activity,MF,
14040,GO:0051725,1,0.975628697278183,0,4,protein de-ADP-ribosylation,BP,
14042,GO:0051728,1,0.993745218727644,0,1,cell cycle switching, mitotic to meiotic cell cycle,BP,
14043,GO:0051729,1,0.993745218727644,0,1,germline cell cycle switching, mitotic to meiotic cell cycle,BP,
14044,GO:0051731,1,0.972623942469897,0,4,polynucleotide 5'-hydroxyl-kinase activity,MF,
14045,GO:0051732,1,0.994385905148363,0,1,polyribonucleotide kinase activity,MF,
14046,GO:0051733,1,0.980657983087179,0,3,polydeoxyribonucleotide kinase activity,MF,
14047,GO:0051734,1,0.980657983087179,0,3,ATP-dependent polynucleotide kinase activity,MF,
14048,GO:0051736,1,0.994385905148363,0,1,ATP-dependent polyribonucleotide 5'-hydroxyl-kinase activity,MF,
14049,GO:0051747,1,0.989305072388557,0,2,cytosine C-5 DNA demethylase activity,MF,
14050,GO:0051748,1,0.994180731565421,0,1,UTP-monosaccharide-1-phosphate uridylyltransferase activity,MF,
14051,GO:0051750,1,0.994634461808247,0,1,delta3,5-delta2,4-dienoyl-CoA isomerase activity,MF,
14053,GO:0051758,1,0.991955670378217,0,1,homologous chromosome movement towards spindle pole involved in homologous chromosome segregation,BP,
14054,GO:0051764,1,0.928621794411972,0,11,actin crosslink formation,BP,
14055,GO:0051765,1,0.988006327395489,0,2,inositol tetrakisphosphate kinase activity,MF,
14056,GO:0051766,1,0.961703494105541,0,6,inositol trisphosphate kinase activity,MF,
14057,GO:0051767,1,0.894093932563865,0,17,nitric-oxide synthase biosynthetic process,BP,
14058,GO:0051769,1,0.894093932563865,0,17,regulation of nitric-oxide synthase biosynthetic process,BP,
14059,GO:0051770,1,0.909596502270291,0,14,positive regulation of nitric-oxide synthase biosynthetic process,BP,
14060,GO:0051771,1,0.982972822719512,0,3,negative regulation of nitric-oxide synthase biosynthetic process,BP,
14061,GO:0051775,1,0.929304178049764,0,11,response to redox state,BP,
14062,GO:0051780,1,0.993154490170671,0,1,behavioral response to nutrient,BP,
14068,GO:0051786,1,0.993578343925094,0,1,all-trans-retinol 13,14-reductase activity,MF,
14070,GO:0051788,1,0.858514191863437,0,23,response to misfolded protein,BP,
14071,GO:0051790,1,0.97576796639646,0,4,short-chain fatty acid biosynthetic process,BP,
14072,GO:0051791,1,0.940502381382566,0,10,medium-chain fatty acid metabolic process,BP,
14073,GO:0051792,1,0.968928029373766,0,5,medium-chain fatty acid biosynthetic process,BP,
14074,GO:0051793,1,0.96833197037976,0,5,medium-chain fatty acid catabolic process,BP,
14075,GO:0051794,1,0.974954263595242,0,4,regulation of timing of catagen,BP,
14076,GO:0051795,1,0.981750053769441,0,3,positive regulation of timing of catagen,BP,
14077,GO:0051796,1,0.993079164753351,0,1,negative regulation of timing of catagen,BP,
14078,GO:0051797,1,0.888910077090595,0,18,regulation of hair follicle development,BP,
14079,GO:0051798,1,0.934068057288813,0,11,positive regulation of hair follicle development,BP,
14080,GO:0051799,1,0.97920725300373,0,3,negative regulation of hair follicle development,BP,
14081,GO:0051800,1,0.986802700978389,0,2,phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity,MF,
14082,GO:0051801,1,0.988054531763341,0,2,cytolysis in other organism involved in symbiotic interaction,BP,
14083,GO:0051805,1,0.986531221880676,0,2,evasion or tolerance of immune response of other organism involved in symbiotic interaction,BP,
14085,GO:0051807,1,0.986531221880676,0,2,evasion or tolerance of defense response of other organism involved in symbiotic interaction,BP,
14086,GO:0051808,1,0.994040589463601,0,1,translocation of peptides or proteins into other organism involved in symbiotic interaction,BP,
14087,GO:0051817,1,0.556557860603784,0,90,modification of morphology or physiology of other organism involved in symbiotic interaction,BP,
14088,GO:0051818,1,0.934487096066845,0,12,disruption of cells of other organism involved in symbiotic interaction,BP,
14089,GO:0051821,1,0.991974986127913,0,1,dissemination or transmission of organism from other organism involved in symbiotic interaction,BP,
14090,GO:0051823,1,0.937172153730886,0,9,regulation of synapse structural plasticity,BP,
14092,GO:0051832,1,0.973139911908542,0,4,avoidance of defenses of other organism involved in symbiotic interaction,BP,
14093,GO:0051833,1,0.992596485148829,0,1,suppression of defenses of other organism involved in symbiotic interaction,BP,
14094,GO:0051834,1,0.973139911908542,0,4,evasion or tolerance of defenses of other organism involved in symbiotic interaction,BP,
14095,GO:0051835,1,0.971466980497939,0,4,positive regulation of synapse structural plasticity,BP,
14096,GO:0051836,1,0.947223181388145,0,9,translocation of molecules into other organism involved in symbiotic interaction,BP,
14097,GO:0051851,1,0.698360535613941,0,57,modification by host of symbiont morphology or physiology,BP,
14098,GO:0051852,1,0.957758138575828,0,8,disruption by host of symbiont cells,BP,
14100,GO:0051864,1,0.943844480683544,0,8,histone demethylase activity (H3-K36 specific),MF,
14101,GO:0051865,1,0.693131409499399,0,54,protein autoubiquitination,BP,
14102,GO:0051866,1,0.988136187074127,0,2,general adaptation syndrome,BP,
14103,GO:0051867,1,0.994633686831591,0,1,general adaptation syndrome, behavioral process,BP,
14104,GO:0051870,1,0.982824801929979,0,3,methotrexate binding,MF,
14105,GO:0051873,1,0.957758138575828,0,8,killing by host of symbiont cells,BP,
14106,GO:0051875,1,0.840704153800231,0,27,pigment granule localization,BP,
14107,GO:0051877,1,0.987639413375277,0,2,pigment granule aggregation in cell center,BP,
14108,GO:0051879,1,0.812630831034901,0,32,Hsp90 protein binding,MF,
14109,GO:0051880,1,0.94906249620942,0,7,G-quadruplex DNA binding,MF,
14110,GO:0051881,1,0.699154735444898,0,59,regulation of mitochondrial membrane potential,BP,
14111,GO:0051882,1,0.881207549366558,0,20,mitochondrial depolarization,BP,
14112,GO:0051883,1,0.934487096066845,0,12,killing of cells in other organism involved in symbiotic interaction,BP,
14113,GO:0051884,1,0.966384529545876,0,5,regulation of timing of anagen,BP,
14114,GO:0051885,1,0.986429581118485,0,2,positive regulation of timing of anagen,BP,
14115,GO:0051886,1,0.992623730601324,0,1,negative regulation of timing of anagen,BP,
14116,GO:0051890,1,0.961059285653442,0,6,regulation of cardioblast differentiation,BP,
14117,GO:0051891,1,0.967743283201975,0,5,positive regulation of cardioblast differentiation,BP,
14118,GO:0051892,1,0.993095490841172,0,1,negative regulation of cardioblast differentiation,BP,
14119,GO:0051893,1,0.684639304561353,0,53,regulation of focal adhesion assembly,BP,
14120,GO:0051894,1,0.84776699946239,0,23,positive regulation of focal adhesion assembly,BP,
14121,GO:0051895,1,0.901325347140512,0,15,negative regulation of focal adhesion assembly,BP,
14124,GO:0051898,1,0.768754460011354,0,39,negative regulation of protein kinase B signaling,BP,
14125,GO:0051899,1,0.526454455187586,0,89,membrane depolarization,BP,
14126,GO:0051900,1,0.892693185425378,0,18,regulation of mitochondrial depolarization,BP,
14127,GO:0051901,1,0.952570917341881,0,8,positive regulation of mitochondrial depolarization,BP,
14128,GO:0051902,1,0.963995878955237,0,6,negative regulation of mitochondrial depolarization,BP,
14129,GO:0051903,1,0.993922359961523,0,1,S-(hydroxymethyl)glutathione dehydrogenase activity,MF,
14130,GO:0051904,1,0.858393255621604,0,24,pigment granule transport,BP,
14131,GO:0051905,1,0.851023720303296,0,25,establishment of pigment granule localization,BP,
14132,GO:0051908,1,0.993637185814252,0,1,double-stranded DNA 5'-3' exodeoxyribonuclease activity,MF,
14133,GO:0051916,1,0.993756748892356,0,1,granulocyte colony-stimulating factor binding,MF,
14134,GO:0051917,1,0.94021184087864,0,10,regulation of fibrinolysis,BP,
14135,GO:0051918,1,0.957165746459761,0,7,negative regulation of fibrinolysis,BP,
14136,GO:0051919,1,0.982512456642199,0,3,positive regulation of fibrinolysis,BP,
14137,GO:0051920,1,0.957596185693746,0,8,peroxiredoxin activity,MF,
14138,GO:0051923,1,0.9174578060428,0,14,sulfation,BP,
14140,GO:0051926,1,0.729393082811683,0,50,negative regulation of calcium ion transport,BP,
14144,GO:0051932,1,0.743181301321773,0,43,synaptic transmission, GABAergic,BP,
14145,GO:0051933,1,0.9776238726636,0,3,amino acid neurotransmitter reuptake,BP,
14146,GO:0051934,1,0.935831451720363,0,11,catecholamine uptake involved in synaptic transmission,BP,
14147,GO:0051935,1,0.9776238726636,0,3,glutamate reuptake,BP,
14148,GO:0051937,1,0.724900077633569,0,51,catecholamine transport,BP,
14149,GO:0051938,1,0.919532273921346,0,12,L-glutamate import,BP,
14150,GO:0051939,1,0.992966444854854,0,1,gamma-aminobutyric acid import,BP,
14151,GO:0051940,1,0.960030168973915,0,7,regulation of catecholamine uptake involved in synaptic transmission,BP,
14152,GO:0051941,1,0.984515289193681,0,2,regulation of amino acid uptake involved in synaptic transmission,BP,
14153,GO:0051944,1,0.983087015631762,0,3,positive regulation of catecholamine uptake involved in synaptic transmission,BP,
14154,GO:0051945,1,0.993653817804457,0,1,negative regulation of catecholamine uptake involved in synaptic transmission,BP,
14155,GO:0051946,1,0.984515289193681,0,2,regulation of glutamate uptake involved in transmission of nerve impulse,BP,
14156,GO:0051952,1,0.668925043719107,0,64,regulation of amine transport,BP,
14157,GO:0051953,1,0.882516250819412,0,20,negative regulation of amine transport,BP,
14158,GO:0051954,1,0.837994788345655,0,28,positive regulation of amine transport,BP,
14159,GO:0051955,1,0.834543555549277,0,28,regulation of amino acid transport,BP,
14160,GO:0051956,1,0.939506030977208,0,10,negative regulation of amino acid transport,BP,
14161,GO:0051957,1,0.913534916689272,0,14,positive regulation of amino acid transport,BP,
14162,GO:0051958,1,0.985800545250709,0,2,methotrexate transport,BP,
14167,GO:0051963,1,0.581657732250255,0,77,regulation of synapse assembly,BP,
14168,GO:0051964,1,0.954887634242765,0,6,negative regulation of synapse assembly,BP,
14169,GO:0051965,1,0.664680564580125,0,59,positive regulation of synapse assembly,BP,
14170,GO:0051966,1,0.640343333573985,0,63,regulation of synaptic transmission, glutamatergic,BP,
14171,GO:0051967,1,0.936052632981507,0,10,negative regulation of synaptic transmission, glutamatergic,BP,
14172,GO:0051968,1,0.821132287562537,0,28,positive regulation of synaptic transmission, glutamatergic,BP,
14173,GO:0051969,1,0.921405516129069,0,13,regulation of transmission of nerve impulse,BP,
14174,GO:0051970,1,0.981932038652217,0,3,negative regulation of transmission of nerve impulse,BP,
14175,GO:0051971,1,0.967116173596138,0,5,positive regulation of transmission of nerve impulse,BP,
14176,GO:0051972,1,0.752249010047631,0,45,regulation of telomerase activity,BP,
14177,GO:0051973,1,0.802129389165644,0,35,positive regulation of telomerase activity,BP,
14178,GO:0051974,1,0.946118611491212,0,9,negative regulation of telomerase activity,BP,
14179,GO:0051977,1,0.994157230289949,0,1,lysophospholipid transport,BP,
14180,GO:0051978,1,0.994157230289949,0,1,lysophospholipid transporter activity,MF,
14184,GO:0051987,1,0.968043343485206,0,5,positive regulation of attachment of spindle microtubules to kinetochore,BP,
14185,GO:0051988,1,0.922528112529671,0,12,regulation of attachment of spindle microtubules to kinetochore,BP,
14186,GO:0051990,1,0.988068739099344,0,2,(R)-2-hydroxyglutarate dehydrogenase activity,MF,
14187,GO:0051996,1,0.994199329235923,0,1,squalene synthase activity,MF,
14188,GO:0051998,1,0.962616593060473,0,6,protein carboxyl O-methyltransferase activity,MF,
14189,GO:0052026,1,0.99380469293822,0,1,modulation by symbiont of host transcription,BP,
14190,GO:0052027,1,0.986240687281154,0,2,modulation by symbiont of host signal transduction pathway,BP,
14191,GO:0052029,1,0.992596485148829,0,1,negative regulation by symbiont of host signal transduction pathway,BP,
14192,GO:0052031,1,0.986790642886837,0,2,modulation by symbiont of host defense response,BP,
14193,GO:0052037,1,0.992596485148829,0,1,negative regulation by symbiont of host defense response,BP,
14194,GO:0052040,1,0.963670600658522,0,6,modulation by symbiont of host programmed cell death,BP,
14195,GO:0052041,1,0.975972574832035,0,4,negative regulation by symbiont of host programmed cell death,BP,
14196,GO:0052042,1,0.98218713697563,0,3,positive regulation by symbiont of host programmed cell death,BP,
14197,GO:0052047,1,0.985053511929674,0,2,interaction with other organism via secreted substance involved in symbiotic interaction,BP,
14198,GO:0052053,1,0.993862712286301,0,1,negative regulation by symbiont of host catalytic activity,BP,
14199,GO:0052055,1,0.986504179167762,0,2,modulation by symbiont of host molecular function,BP,
14200,GO:0052056,1,0.986504179167762,0,2,negative regulation by symbiont of host molecular function,BP,
14201,GO:0052066,1,0.991689841766479,0,1,entry of symbiont into host cell by promotion of host phagocytosis,BP,
14202,GO:0052097,1,0.993596251514619,0,1,interspecies quorum sensing,BP,
14203,GO:0052106,1,0.993596251514619,0,1,quorum sensing involved in interaction with host,BP,
14204,GO:0052126,1,0.808197586404181,0,33,movement in host environment,BP,
14205,GO:0052148,1,0.993862712286301,0,1,modulation by symbiont of host catalytic activity,BP,
14206,GO:0052150,1,0.968894935630403,0,5,modulation by symbiont of host apoptotic process,BP,
14207,GO:0052151,1,0.987510828410428,0,2,positive regulation by symbiont of host apoptotic process,BP,
14208,GO:0052167,1,0.992596485148829,0,1,modulation by symbiont of host innate immune response,BP,
14209,GO:0052170,1,0.992596485148829,0,1,negative regulation by symbiont of host innate immune response,BP,
14210,GO:0052173,1,0.967708821016237,0,5,response to defenses of other organism involved in symbiotic interaction,BP,
14211,GO:0052182,1,0.994062510443658,0,1,modification by host of symbiont morphology or physiology via secreted substance,BP,
14212,GO:0052190,1,0.991689841766479,0,1,modulation by symbiont of host phagocytosis,BP,
14213,GO:0052191,1,0.991689841766479,0,1,positive regulation by symbiont of host phagocytosis,BP,
14214,GO:0052192,1,0.808197586404181,0,33,movement in environment of other organism involved in symbiotic interaction,BP,
14215,GO:0052199,1,0.988186142214265,0,2,negative regulation of catalytic activity in other organism involved in symbiotic interaction,BP,
14216,GO:0052200,1,0.967708821016237,0,5,response to host defenses,BP,
14217,GO:0052203,1,0.982637962241313,0,3,modulation of catalytic activity in other organism involved in symbiotic interaction,BP,
14218,GO:0052204,1,0.959640982701995,0,7,negative regulation of molecular function in other organism involved in symbiotic interaction,BP,
14219,GO:0052205,1,0.951908594232782,0,8,modulation of molecular function in other organism involved in symbiotic interaction,BP,
14220,GO:0052212,1,0.994062510443658,0,1,modification of morphology or physiology of other organism via secreted substance involved in symbiotic interaction,BP,
14221,GO:0052213,1,0.994062510443658,0,1,interaction with symbiont via secreted substance involved in symbiotic interaction,BP,
14222,GO:0052214,1,0.994442498811555,0,1,metabolism of substance in other organism involved in symbiotic interaction,BP,
14223,GO:0052227,1,0.994442498811555,0,1,catabolism of substance in other organism involved in symbiotic interaction,BP,
14224,GO:0052229,1,0.994442498811555,0,1,metabolism of macromolecule in other organism involved in symbiotic interaction,BP,
14225,GO:0052231,1,0.991689841766479,0,1,modulation of phagocytosis in other organism involved in symbiotic interaction,BP,
14226,GO:0052248,1,0.963670600658522,0,6,modulation of programmed cell death in other organism involved in symbiotic interaction,BP,
14227,GO:0052250,1,0.986240687281154,0,2,modulation of signal transduction in other organism involved in symbiotic interaction,BP,
14228,GO:0052251,1,0.994151291207698,0,1,induction by organism of defense response of other organism involved in symbiotic interaction,BP,
14229,GO:0052255,1,0.986790642886837,0,2,modulation by organism of defense response of other organism involved in symbiotic interaction,BP,
14230,GO:0052261,1,0.992596485148829,0,1,suppression of defense response of other organism involved in symbiotic interaction,BP,
14231,GO:0052306,1,0.992596485148829,0,1,modulation by organism of innate immune response in other organism involved in symbiotic interaction,BP,
14232,GO:0052309,1,0.992596485148829,0,1,negative regulation by organism of innate immune response in other organism involved in symbiotic interaction,BP,
14233,GO:0052312,1,0.847659121207716,0,25,modulation of transcription in other organism involved in symbiotic interaction,BP,
14234,GO:0052314,1,0.988580716604364,0,2,phytoalexin metabolic process,BP,
14235,GO:0052330,1,0.98218713697563,0,3,positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction,BP,
14236,GO:0052331,1,0.988054531763341,0,2,hemolysis in other organism involved in symbiotic interaction,BP,
14237,GO:0052360,1,0.994442498811555,0,1,catabolism by host of symbiont macromolecule,BP,
14238,GO:0052361,1,0.994442498811555,0,1,catabolism by organism of macromolecule in other organism involved in symbiotic interaction,BP,
14239,GO:0052362,1,0.994442498811555,0,1,catabolism by host of symbiont protein,BP,
14240,GO:0052363,1,0.994442498811555,0,1,catabolism by organism of protein in other organism involved in symbiotic interaction,BP,
14241,GO:0052364,1,0.994442498811555,0,1,catabolism by host of substance in symbiont,BP,
14242,GO:0052370,1,0.991689841766479,0,1,entry of organism into cell of other organism by promotion of phagocytosis in other organism involved in symbiotic interaction,BP,
14243,GO:0052381,1,0.994186930489377,0,1,tRNA dimethylallyltransferase activity,MF,
14244,GO:0052403,1,0.994288730402198,0,1,negative regulation by host of symbiont catalytic activity,BP,
14245,GO:0052405,1,0.972772990666734,0,5,negative regulation by host of symbiont molecular function,BP,
14246,GO:0052416,1,0.994442498811555,0,1,metabolism by host of symbiont macromolecule,BP,
14247,GO:0052417,1,0.994442498811555,0,1,metabolism by host of symbiont protein,BP,
14248,GO:0052418,1,0.994442498811555,0,1,metabolism by organism of protein in other organism involved in symbiotic interaction,BP,
14249,GO:0052419,1,0.994442498811555,0,1,metabolism by host of substance in symbiont,BP,
14250,GO:0052422,1,0.988706633790834,0,2,modulation by host of symbiont catalytic activity,BP,
14251,GO:0052428,1,0.964935860789643,0,6,modulation by host of symbiont molecular function,BP,
14252,GO:0052433,1,0.963670600658522,0,6,modulation by organism of apoptotic process in other organism involved in symbiotic interaction,BP,
14253,GO:0052472,1,0.852951890842657,0,24,modulation by host of symbiont transcription,BP,
14254,GO:0052490,1,0.975972574832035,0,4,negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction,BP,
14255,GO:0052493,1,0.992596485148829,0,1,negative regulation by organism of signal transduction in other organism involved in symbiotic interaction,BP,
14256,GO:0052501,1,0.98218713697563,0,3,positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction,BP,
14257,GO:0052509,1,0.994151291207698,0,1,positive regulation by symbiont of host defense response,BP,
14258,GO:0052510,1,0.994151291207698,0,1,positive regulation by organism of defense response of other organism involved in symbiotic interaction,BP,
14259,GO:0052522,1,0.991689841766479,0,1,positive regulation by organism of phagocytosis in other organism involved in symbiotic interaction,BP,
14262,GO:0052550,1,0.994420533996374,0,1,response to defense-related reactive oxygen species production by other organism involved in symbiotic interaction,BP,
14263,GO:0052552,1,0.986790642886837,0,2,modulation by organism of immune response of other organism involved in symbiotic interaction,BP,
14264,GO:0052553,1,0.986790642886837,0,2,modulation by symbiont of host immune response,BP,
14265,GO:0052561,1,0.992596485148829,0,1,negative regulation by organism of immune response of other organism involved in symbiotic interaction,BP,
14266,GO:0052562,1,0.992596485148829,0,1,negative regulation by symbiont of host immune response,BP,
14267,GO:0052564,1,0.975287308502616,0,4,response to immune response of other organism involved in symbiotic interaction,BP,
14268,GO:0052567,1,0.994420533996374,0,1,response to defense-related host reactive oxygen species production,BP,
14269,GO:0052572,1,0.975287308502616,0,4,response to host immune response,BP,
14270,GO:0052590,1,0.992221751913041,0,1,sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity,MF,
14271,GO:0052591,1,0.992221751913041,0,1,sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity,MF,
14272,GO:0052593,1,0.987191370446509,0,2,tryptamine:oxygen oxidoreductase (deaminating) activity,MF,
14273,GO:0052594,1,0.987191370446509,0,2,aminoacetone:oxygen oxidoreductase(deaminating) activity,MF,
14274,GO:0052595,1,0.987191370446509,0,2,aliphatic-amine oxidase activity,MF,
14275,GO:0052596,1,0.987191370446509,0,2,phenethylamine:oxygen oxidoreductase (deaminating) activity,MF,
14276,GO:0052629,1,0.914632407752965,0,12,phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity,MF,
14277,GO:0052642,1,0.988368294034287,0,2,lysophosphatidic acid phosphatase activity,MF,
14278,GO:0052646,1,0.938401257556308,0,9,alditol phosphate metabolic process,BP,
14279,GO:0052650,1,0.954965189036337,0,8,NADP-retinol dehydrogenase activity,MF,
14280,GO:0052651,1,0.98825273982339,0,2,monoacylglycerol catabolic process,BP,
14281,GO:0052652,1,0.612680090504188,0,76,cyclic purine nucleotide metabolic process,BP,
14282,GO:0052654,1,0.98550402034736,0,2,L-leucine transaminase activity,MF,
14283,GO:0052655,1,0.98550402034736,0,2,L-valine transaminase activity,MF,
14284,GO:0052656,1,0.98550402034736,0,2,L-isoleucine transaminase activity,MF,
14285,GO:0052657,1,0.994556443430817,0,1,guanine phosphoribosyltransferase activity,MF,
14286,GO:0052658,1,0.95943801513313,0,6,inositol-1,4,5-trisphosphate 5-phosphatase activity,MF,
14287,GO:0052659,1,0.939647594263093,0,9,inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity,MF,
14288,GO:0052666,1,0.9942763258542,0,1,tRNA (cytosine-2'-O-)-methyltransferase activity,MF,
14290,GO:0052692,1,0.994554893308177,0,1,raffinose alpha-galactosidase activity,MF,
14291,GO:0052695,1,0.980694503197748,0,3,cellular glucuronidation,BP,
14292,GO:0052717,1,0.992051244950117,0,1,tRNA-specific adenosine-34 deaminase activity,MF,
14293,GO:0052718,1,0.992051244950117,0,1,tRNA-specific adenosine-34 deaminase complex,CC,
14294,GO:0052723,1,0.966899096663535,0,5,inositol hexakisphosphate 1-kinase activity,MF,
14295,GO:0052724,1,0.966899096663535,0,5,inositol hexakisphosphate 3-kinase activity,MF,
14296,GO:0052725,1,0.993609042874978,0,1,inositol-1,3,4-trisphosphate 6-kinase activity,MF,
14297,GO:0052726,1,0.993609042874978,0,1,inositol-1,3,4-trisphosphate 5-kinase activity,MF,
14298,GO:0052731,1,0.994199587555346,0,1,phosphocholine phosphatase activity,MF,
14299,GO:0052732,1,0.994199587555346,0,1,phosphoethanolamine phosphatase activity,MF,
14300,GO:0052735,1,0.979356033875412,0,3,tRNA (cytosine-3-)-methyltransferase activity,MF,
14301,GO:0052739,1,0.983339731022535,0,3,phosphatidylserine 1-acylhydrolase activity,MF,
14302,GO:0052740,1,0.988897230764079,0,2,1-acyl-2-lysophosphatidylserine acylhydrolase activity,MF,
14304,GO:0052743,1,0.926751559455666,0,11,inositol tetrakisphosphate phosphatase activity,MF,
14305,GO:0052744,1,0.895962046994116,0,15,phosphatidylinositol monophosphate phosphatase activity,MF,
14306,GO:0052745,1,0.877828770934488,0,19,inositol phosphate phosphatase activity,MF,
14307,GO:0052746,1,0.986669074384287,0,2,inositol phosphorylation,BP,
14308,GO:0052794,1,0.982269519575496,0,3,exo-alpha-(2->3)-sialidase activity,MF,
14309,GO:0052795,1,0.982269519575496,0,3,exo-alpha-(2->6)-sialidase activity,MF,
14310,GO:0052796,1,0.982269519575496,0,3,exo-alpha-(2->8)-sialidase activity,MF,
14311,GO:0052798,1,0.994204495715103,0,1,beta-galactoside alpha-2,3-sialyltransferase activity,MF,
14314,GO:0052810,1,0.987315827883781,0,2,1-phosphatidylinositol-5-kinase activity,MF,
14315,GO:0052811,1,0.973527177163302,0,4,1-phosphatidylinositol-3-phosphate 4-kinase activity,MF,
14316,GO:0052812,1,0.98008390135343,0,3,phosphatidylinositol-3,4-bisphosphate 5-kinase activity,MF,
14318,GO:0052815,1,0.988246621763279,0,2,medium-chain acyl-CoA hydrolase activity,MF,
14319,GO:0052816,1,0.993522314306743,0,1,long-chain acyl-CoA hydrolase activity,MF,
14320,GO:0052817,1,0.993522314306743,0,1,very long chain acyl-CoA hydrolase activity,MF,
14321,GO:0052821,1,0.994727453981438,0,1,DNA-7-methyladenine glycosylase activity,MF,
14322,GO:0052822,1,0.994727453981438,0,1,DNA-3-methylguanine glycosylase activity,MF,
14323,GO:0052825,1,0.993609042874978,0,1,inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity,MF,
14324,GO:0052826,1,0.99381854786764,0,1,inositol hexakisphosphate 2-phosphatase activity,MF,
14325,GO:0052827,1,0.987466699516045,0,2,inositol pentakisphosphate phosphatase activity,MF,
14326,GO:0052828,1,0.985049915296123,0,2,inositol-3,4-bisphosphate 4-phosphatase activity,MF,
14327,GO:0052829,1,0.994207854026948,0,1,inositol-1,3,4-trisphosphate 1-phosphatase activity,MF,
14328,GO:0052830,1,0.993609042874978,0,1,inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity,MF,
14329,GO:0052831,1,0.993609042874978,0,1,inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity,MF,
14330,GO:0052832,1,0.973519979811034,0,4,inositol monophosphate 3-phosphatase activity,MF,
14331,GO:0052833,1,0.973519979811034,0,4,inositol monophosphate 4-phosphatase activity,MF,
14332,GO:0052834,1,0.973519979811034,0,4,inositol monophosphate phosphatase activity,MF,
14333,GO:0052835,1,0.993609042874978,0,1,inositol-3,4,6-trisphosphate 1-kinase activity,MF,
14334,GO:0052836,1,0.981650533454439,0,3,inositol 5-diphosphate pentakisphosphate 5-kinase activity,MF,
14335,GO:0052839,1,0.981650533454439,0,3,inositol diphosphate tetrakisphosphate kinase activity,MF,
14336,GO:0052840,1,0.975932507390272,0,4,inositol diphosphate tetrakisphosphate diphosphatase activity,MF,
14337,GO:0052841,1,0.975932507390272,0,4,inositol bisdiphosphate tetrakisphosphate diphosphatase activity,MF,
14338,GO:0052842,1,0.975932507390272,0,4,inositol diphosphate pentakisphosphate diphosphatase activity,MF,
14339,GO:0052843,1,0.975932507390272,0,4,inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity,MF,
14340,GO:0052844,1,0.975932507390272,0,4,inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity,MF,
14341,GO:0052845,1,0.975932507390272,0,4,inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity,MF,
14342,GO:0052846,1,0.975932507390272,0,4,inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity,MF,
14343,GO:0052847,1,0.975932507390272,0,4,inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity,MF,
14344,GO:0052848,1,0.975932507390272,0,4,inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity,MF,
14345,GO:0052851,1,0.966975860033133,0,5,ferric-chelate reductase (NADPH) activity,MF,
14346,GO:0052852,1,0.994384871413264,0,1,very-long-chain-(S)-2-hydroxy-acid oxidase activity,MF,
14347,GO:0052853,1,0.994384871413264,0,1,long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity,MF,
14348,GO:0052854,1,0.994384871413264,0,1,medium-chain-(S)-2-hydroxy-acid oxidase activity,MF,
14349,GO:0052856,1,0.994780145763862,0,1,NADHX epimerase activity,MF,
14350,GO:0052857,1,0.994780145763862,0,1,NADPHX epimerase activity,MF,
14351,GO:0052858,1,0.993445265225789,0,1,peptidyl-lysine acetyltransferase activity,MF,
14352,GO:0052866,1,0.819868264821371,0,28,phosphatidylinositol phosphate phosphatase activity,MF,
14353,GO:0052870,1,0.993742656804343,0,1,tocopherol omega-hydroxylase activity,MF,
14354,GO:0052871,1,0.993742656804343,0,1,alpha-tocopherol omega-hydroxylase activity,MF,
14355,GO:0052884,1,0.993936769823406,0,1,all-trans-retinyl-palmitate hydrolase, 11-cis retinol forming activity,MF,
14356,GO:0052885,1,0.993936769823406,0,1,all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity,MF,
14357,GO:0052890,1,0.994295966577254,0,1,oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor,MF,
14358,GO:0052894,1,0.994217154361847,0,1,norspermine:oxygen oxidoreductase activity,MF,
14359,GO:0052895,1,0.994217154361847,0,1,N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity,MF,
14360,GO:0052899,1,0.994411747803641,0,1,N(1),N(12)-diacetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
14361,GO:0052901,1,0.988660893303247,0,2,spermine:oxygen oxidoreductase (spermidine-forming) activity,MF,
14362,GO:0052902,1,0.994411747803641,0,1,spermidine:oxygen oxidoreductase (3-aminopropanal-forming) activity,MF,
14363,GO:0052903,1,0.994411747803641,0,1,N1-acetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
14364,GO:0052904,1,0.994411747803641,0,1,N1-acetylspermidine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
14365,GO:0052905,1,0.981663996163023,0,3,tRNA (guanine(9)-N(1))-methyltransferase activity,MF,
14366,GO:0052906,1,0.992561371783925,0,1,tRNA (guanine(37)-N(1))-methyltransferase activity,MF,
14367,GO:0052907,1,0.993850639026861,0,1,23S rRNA (adenine(1618)-N(6))-methyltransferase activity,MF,
14368,GO:0052909,1,0.993850639026861,0,1,18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity,MF,
14369,GO:0052917,1,0.994060962845764,0,1,dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase activity,MF,
14370,GO:0052918,1,0.992029039744305,0,1,dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
14371,GO:0052925,1,0.994503995497604,0,1,dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity,MF,
14372,GO:0052926,1,0.992029039744305,0,1,dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
14373,GO:0052927,1,0.994112567016873,0,1,CTP:tRNA cytidylyltransferase activity,MF,
14374,GO:0052928,1,0.994112567016873,0,1,CTP:3'-cytidine-tRNA cytidylyltransferase activity,MF,
14375,GO:0052929,1,0.994112567016873,0,1,ATP:3'-cytidine-cytidine-tRNA adenylyltransferase activity,MF,
14379,GO:0055005,1,0.980587315031881,0,3,ventricular cardiac myofibril assembly,BP,
14382,GO:0055008,1,0.618331181561868,0,63,cardiac muscle tissue morphogenesis,BP,
14383,GO:0055009,1,0.962418875485187,0,6,atrial cardiac muscle tissue morphogenesis,BP,
14384,GO:0055010,1,0.728826442877678,0,44,ventricular cardiac muscle tissue morphogenesis,BP,
14385,GO:0055011,1,0.988738241652496,0,2,atrial cardiac muscle cell differentiation,BP,
14388,GO:0055014,1,0.988738241652496,0,2,atrial cardiac muscle cell development,BP,
14391,GO:0055018,1,0.994367297581572,0,1,regulation of cardiac muscle fiber development,BP,
14392,GO:0055020,1,0.994367297581572,0,1,positive regulation of cardiac muscle fiber development,BP,
14394,GO:0055022,1,0.902463456515694,0,16,negative regulation of cardiac muscle tissue growth,BP,
14398,GO:0055026,1,0.847329798268129,0,25,negative regulation of cardiac muscle tissue development,BP,
14399,GO:0055028,1,0.991555657821302,0,1,cortical microtubule,CC,
14400,GO:0055029,1,0.429268282649062,0,131,nuclear DNA-directed RNA polymerase complex,CC,
14402,GO:0055038,1,0.650745678426108,0,67,recycling endosome membrane,CC,
14403,GO:0055048,1,0.991555657821302,0,1,anastral spindle assembly,BP,
14404,GO:0055056,1,0.94316435453483,0,9,D-glucose transmembrane transporter activity,MF,
14406,GO:0055059,1,0.959700339767039,0,6,asymmetric neuroblast division,BP,
14407,GO:0055062,1,0.937938793857064,0,9,phosphate ion homeostasis,BP,
14408,GO:0055064,1,0.918554048410223,0,12,chloride ion homeostasis,BP,
14411,GO:0055069,1,0.819889196866545,0,33,zinc ion homeostasis,BP,
14412,GO:0055070,1,0.902733657808534,0,16,copper ion homeostasis,BP,
14414,GO:0055073,1,0.988321644376404,0,2,cadmium ion homeostasis,BP,
14416,GO:0055075,1,0.835513645289791,0,26,potassium ion homeostasis,BP,
14418,GO:0055077,1,0.987629630831171,0,2,gap junction hemi-channel activity,MF,
14421,GO:0055081,1,0.740625395202597,0,44,anion homeostasis,BP,
14423,GO:0055083,1,0.861500100634705,0,21,monovalent inorganic anion homeostasis,BP,
14426,GO:0055087,1,0.980532276987984,0,3,Ski complex,CC,
14427,GO:0055088,1,0.539117603024001,0,95,lipid homeostasis,BP,
14428,GO:0055089,1,0.923099799210142,0,12,fatty acid homeostasis,BP,
14429,GO:0055090,1,0.856640737475532,0,25,acylglycerol homeostasis,BP,
14430,GO:0055091,1,0.948407238316302,0,8,phospholipid homeostasis,BP,
14431,GO:0055092,1,0.716346584187186,0,52,sterol homeostasis,BP,
14432,GO:0055093,1,0.87950457565405,0,20,response to hyperoxia,BP,
14433,GO:0055094,1,0.869761034553793,0,21,response to lipoprotein particle,BP,
14434,GO:0055095,1,0.98100696882434,0,3,lipoprotein particle mediated signaling,BP,
14435,GO:0055096,1,0.98100696882434,0,3,low-density lipoprotein particle mediated signaling,BP,
14436,GO:0055100,1,0.980866463734763,0,3,adiponectin binding,MF,
14437,GO:0055102,1,0.939958366236887,0,11,lipase inhibitor activity,MF,
14438,GO:0055103,1,0.993614671204414,0,1,ligase regulator activity,MF,
14439,GO:0055105,1,0.968448931798828,0,6,ubiquitin-protein transferase inhibitor activity,MF,
14440,GO:0055106,1,0.911204403029326,0,16,ubiquitin-protein transferase regulator activity,MF,
14441,GO:0055108,1,0.994266505932956,0,1,Golgi to transport vesicle transport,BP,
14443,GO:0055113,1,0.989603248318874,0,1,epiboly involved in gastrulation with mouth forming second,BP,
14445,GO:0055117,1,0.617610487539631,0,69,regulation of cardiac muscle contraction,BP,
14446,GO:0055118,1,0.96057989343007,0,6,negative regulation of cardiac muscle contraction,BP,
14447,GO:0055119,1,0.890392629413312,0,17,relaxation of cardiac muscle,BP,
14448,GO:0055120,1,0.994748117708665,0,1,striated muscle dense body,CC,
14450,GO:0055129,1,0.976692160065072,0,4,L-proline biosynthetic process,BP,
14451,GO:0055130,1,0.994461361973286,0,1,D-alanine catabolic process,BP,
14452,GO:0055131,1,0.964830459656112,0,6,C3HC4-type RING finger domain binding,MF,
14453,GO:0060001,1,0.990785576390639,0,1,minus-end directed microfilament motor activity,MF,
14454,GO:0060002,1,0.981729657144778,0,2,plus-end directed microfilament motor activity,MF,
14455,GO:0060003,1,0.982957627857301,0,2,copper ion export,BP,
14456,GO:0060004,1,0.885353913395783,0,18,reflex,BP,
14457,GO:0060005,1,0.973223790948091,0,4,vestibular reflex,BP,
14458,GO:0060007,1,0.993135615049628,0,1,linear vestibuloocular reflex,BP,
14459,GO:0060008,1,0.893158586705637,0,17,Sertoli cell differentiation,BP,
14460,GO:0060009,1,0.915431640994237,0,13,Sertoli cell development,BP,
14461,GO:0060010,1,0.993576553164592,0,1,Sertoli cell fate commitment,BP,
14462,GO:0060011,1,0.98101888489299,0,3,Sertoli cell proliferation,BP,
14463,GO:0060012,1,0.957663249141906,0,7,synaptic transmission, glycinergic,BP,
14464,GO:0060013,1,0.945245345407515,0,8,righting reflex,BP,
14465,GO:0060014,1,0.99378520144327,0,1,granulosa cell differentiation,BP,
14466,GO:0060017,1,0.960813647350774,0,6,parathyroid gland development,BP,
14467,GO:0060018,1,0.979825744191173,0,3,astrocyte fate commitment,BP,
14468,GO:0060019,1,0.928438019635711,0,12,radial glial cell differentiation,BP,
14473,GO:0060024,1,0.972682761934963,0,4,rhythmic synaptic transmission,BP,
14474,GO:0060025,1,0.978966957634781,0,3,regulation of synaptic activity,BP,
14476,GO:0060027,1,0.947266886136617,0,8,convergent extension involved in gastrulation,BP,
14478,GO:0060029,1,0.961835440915039,0,6,convergent extension involved in organogenesis,BP,
14479,GO:0060031,1,0.986605938728695,0,2,mediolateral intercalation,BP,
14480,GO:0060032,1,0.985324213154364,0,2,notochord regression,BP,
14481,GO:0060033,1,0.935777620164125,0,10,anatomical structure regression,BP,
14482,GO:0060037,1,0.849188954003707,0,24,pharyngeal system development,BP,
14484,GO:0060039,1,0.866501739970198,0,19,pericardium development,BP,
14485,GO:0060040,1,0.976686882132134,0,4,retinal bipolar neuron differentiation,BP,
14489,GO:0060044,1,0.925276401197578,0,12,negative regulation of cardiac muscle cell proliferation,BP,
14491,GO:0060046,1,0.92890267336194,0,12,regulation of acrosome reaction,BP,
14494,GO:0060049,1,0.916126335779181,0,13,regulation of protein glycosylation,BP,
14495,GO:0060050,1,0.939731346174814,0,9,positive regulation of protein glycosylation,BP,
14496,GO:0060051,1,0.988261429813006,0,2,negative regulation of protein glycosylation,BP,
14497,GO:0060052,1,0.962359756736444,0,6,neurofilament cytoskeleton organization,BP,
14498,GO:0060053,1,0.985825863008774,0,2,neurofilament cytoskeleton,CC,
14499,GO:0060054,1,0.976014968147323,0,4,positive regulation of epithelial cell proliferation involved in wound healing,BP,
14500,GO:0060055,1,0.884855591495205,0,19,angiogenesis involved in wound healing,BP,
14501,GO:0060056,1,0.949851855165708,0,8,mammary gland involution,BP,
14502,GO:0060057,1,0.980969023431266,0,3,apoptotic process involved in mammary gland involution,BP,
14503,GO:0060058,1,0.980969023431266,0,3,positive regulation of apoptotic process involved in mammary gland involution,BP,
14504,GO:0060059,1,0.943063829365009,0,7,embryonic retina morphogenesis in camera-type eye,BP,
14505,GO:0060060,1,0.991590485107797,0,1,post-embryonic retina morphogenesis in camera-type eye,BP,
14506,GO:0060061,1,0.986451134217854,0,2,Spemann organizer formation,BP,
14507,GO:0060064,1,0.994515622273784,0,1,Spemann organizer formation at the anterior end of the primitive streak,BP,
14508,GO:0060065,1,0.87234564582116,0,19,uterus development,BP,
14509,GO:0060066,1,0.98796142649209,0,2,oviduct development,BP,
14510,GO:0060067,1,0.992268880590988,0,1,cervix development,BP,
14511,GO:0060068,1,0.936619275447234,0,9,vagina development,BP,
14514,GO:0060072,1,0.992040533529167,0,1,large conductance calcium-activated potassium channel activity,MF,
14515,GO:0060073,1,0.954146698743703,0,7,micturition,BP,
14516,GO:0060074,1,0.883310602297348,0,17,synapse maturation,BP,
14517,GO:0060075,1,0.951881274928753,0,7,regulation of resting membrane potential,BP,
14518,GO:0060076,1,0.811956205938952,0,29,excitatory synapse,CC,
14519,GO:0060077,1,0.904305181829336,0,15,inhibitory synapse,CC,
14520,GO:0060078,1,0.421697865942835,0,125,regulation of postsynaptic membrane potential,BP,
14521,GO:0060079,1,0.487380980169259,0,105,excitatory postsynaptic potential,BP,
14522,GO:0060080,1,0.899664161820671,0,15,inhibitory postsynaptic potential,BP,
14523,GO:0060081,1,0.930464226534875,0,11,membrane hyperpolarization,BP,
14524,GO:0060083,1,0.978954385349368,0,3,smooth muscle contraction involved in micturition,BP,
14525,GO:0060084,1,0.980390161960064,0,3,synaptic transmission involved in micturition,BP,
14526,GO:0060086,1,0.987571097066061,0,2,circadian temperature homeostasis,BP,
14527,GO:0060087,1,0.971174530310498,0,5,relaxation of vascular smooth muscle,BP,
14528,GO:0060088,1,0.933987370833822,0,10,auditory receptor cell stereocilium organization,BP,
14530,GO:0060090,1,0.292196381742312,0,182,molecular adaptor activity,MF,
14531,GO:0060091,1,0.956838619131678,0,7,kinocilium,CC,
14532,GO:0060092,1,0.993627463299271,0,1,regulation of synaptic transmission, glycinergic,BP,
14533,GO:0060099,1,0.929944722208818,0,11,regulation of phagocytosis, engulfment,BP,
14534,GO:0060100,1,0.941010122155989,0,9,positive regulation of phagocytosis, engulfment,BP,
14535,GO:0060101,1,0.994312506803972,0,1,negative regulation of phagocytosis, engulfment,BP,
14536,GO:0060112,1,0.989287467327199,0,2,generation of ovulation cycle rhythm,BP,
14538,GO:0060117,1,0.888537417139568,0,17,auditory receptor cell development,BP,
14540,GO:0060120,1,0.966810394628738,0,5,inner ear receptor cell fate commitment,BP,
14542,GO:0060123,1,0.929534714745053,0,11,regulation of growth hormone secretion,BP,
14543,GO:0060124,1,0.954139287591599,0,8,positive regulation of growth hormone secretion,BP,
14544,GO:0060125,1,0.984195124524455,0,2,negative regulation of growth hormone secretion,BP,
14545,GO:0060126,1,0.982097784103461,0,3,somatotropin secreting cell differentiation,BP,
14546,GO:0060127,1,0.994133734240773,0,1,prolactin secreting cell differentiation,BP,
14547,GO:0060128,1,0.988446137437159,0,2,corticotropin hormone secreting cell differentiation,BP,
14548,GO:0060129,1,0.981800493482353,0,3,thyroid-stimulating hormone-secreting cell differentiation,BP,
14549,GO:0060133,1,0.994580211526846,0,1,somatotropin secreting cell development,BP,
14550,GO:0060134,1,0.920319849252941,0,12,prepulse inhibition,BP,
14551,GO:0060135,1,0.687173153440721,0,55,maternal process involved in female pregnancy,BP,
14552,GO:0060136,1,0.962210855019827,0,6,embryonic process involved in female pregnancy,BP,
14553,GO:0060137,1,0.950184992314551,0,8,maternal process involved in parturition,BP,
14554,GO:0060139,1,0.987510828410428,0,2,positive regulation of apoptotic process by virus,BP,
14555,GO:0060142,1,0.896733540414638,0,18,regulation of syncytium formation by plasma membrane fusion,BP,
14556,GO:0060143,1,0.90672738057062,0,16,positive regulation of syncytium formation by plasma membrane fusion,BP,
14557,GO:0060147,1,0.569069669539504,0,86,regulation of posttranscriptional gene silencing,BP,
14558,GO:0060148,1,0.87086898144862,0,21,positive regulation of posttranscriptional gene silencing,BP,
14559,GO:0060149,1,0.907510416167861,0,14,negative regulation of posttranscriptional gene silencing,BP,
14560,GO:0060151,1,0.986030911560592,0,2,peroxisome localization,BP,
14561,GO:0060152,1,0.986030911560592,0,2,microtubule-based peroxisome localization,BP,
14562,GO:0060154,1,0.981602185433292,0,3,cellular process regulating host cell cycle in response to virus,BP,
14563,GO:0060155,1,0.95048295345257,0,8,platelet dense granule organization,BP,
14564,GO:0060156,1,0.993675570705843,0,1,milk ejection reflex,BP,
14565,GO:0060157,1,0.967010304108979,0,5,urinary bladder development,BP,
14566,GO:0060158,1,0.947759277469241,0,9,phospholipase C-activating dopamine receptor signaling pathway,BP,
14567,GO:0060159,1,0.942449960340486,0,9,regulation of dopamine receptor signaling pathway,BP,
14568,GO:0060160,1,0.987790077329612,0,2,negative regulation of dopamine receptor signaling pathway,BP,
14569,GO:0060161,1,0.972033527998999,0,4,positive regulation of dopamine receptor signaling pathway,BP,
14570,GO:0060163,1,0.988705978224812,0,2,subpallium neuron fate commitment,BP,
14571,GO:0060164,1,0.982259930573428,0,3,regulation of timing of neuron differentiation,BP,
14572,GO:0060165,1,0.994010428273367,0,1,regulation of timing of subpallium neuron differentiation,BP,
14573,GO:0060166,1,0.982154835496717,0,3,olfactory pit development,BP,
14576,GO:0060169,1,0.994493918772112,0,1,negative regulation of adenosine receptor signaling pathway,BP,
14577,GO:0060170,1,0.618306081708779,0,71,ciliary membrane,CC,
14578,GO:0060171,1,0.981685223549035,0,2,stereocilium membrane,CC,
14581,GO:0060175,1,0.991599843953944,0,1,brain-derived neurotrophic factor-activated receptor activity,MF,
14582,GO:0060177,1,0.993554040284568,0,1,regulation of angiotensin metabolic process,BP,
14583,GO:0060178,1,0.994121859321931,0,1,regulation of exocyst localization,BP,
14584,GO:0060179,1,0.974157050256312,0,4,male mating behavior,BP,
14586,GO:0060183,1,0.993627463299271,0,1,apelin receptor signaling pathway,BP,
14587,GO:0060184,1,0.993745218727644,0,1,cell cycle switching,BP,
14588,GO:0060187,1,0.985453186767815,0,2,cell pole,CC,
14590,GO:0060192,1,0.93366299885172,0,11,negative regulation of lipase activity,BP,
14592,GO:0060197,1,0.981668404268908,0,3,cloacal septation,BP,
14593,GO:0060198,1,0.929566111043173,0,12,clathrin-sculpted vesicle,CC,
14594,GO:0060199,1,0.97546749935953,0,4,clathrin-sculpted glutamate transport vesicle,CC,
14595,GO:0060200,1,0.981471821177563,0,3,clathrin-sculpted acetylcholine transport vesicle,CC,
14596,GO:0060201,1,0.981471821177563,0,3,clathrin-sculpted acetylcholine transport vesicle membrane,CC,
14597,GO:0060203,1,0.97546749935953,0,4,clathrin-sculpted glutamate transport vesicle membrane,CC,
14599,GO:0060211,1,0.92248720447674,0,11,regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
14600,GO:0060212,1,0.994347655690543,0,1,negative regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
14601,GO:0060213,1,0.92248720447674,0,11,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
14602,GO:0060214,1,0.976878021236591,0,4,endocardium formation,BP,
14603,GO:0060215,1,0.948835230762258,0,8,primitive hemopoiesis,BP,
14604,GO:0060216,1,0.867095472876035,0,21,definitive hemopoiesis,BP,
14605,GO:0060217,1,0.99270698963186,0,1,hemangioblast cell differentiation,BP,
14606,GO:0060218,1,0.589692782714448,0,89,hematopoietic stem cell differentiation,BP,
14608,GO:0060221,1,0.981586147651533,0,3,retinal rod cell differentiation,BP,
14609,GO:0060228,1,0.984634879250675,0,3,phosphatidylcholine-sterol O-acyltransferase activator activity,MF,
14610,GO:0060229,1,0.939938858138934,0,10,lipase activator activity,MF,
14611,GO:0060230,1,0.989610877248879,0,2,lipoprotein lipase activator activity,MF,
14612,GO:0060231,1,0.882519039294944,0,20,mesenchymal to epithelial transition,BP,
14613,GO:0060232,1,0.981873996553184,0,3,delamination,BP,
14614,GO:0060235,1,0.967933590541212,0,4,lens induction in camera-type eye,BP,
14616,GO:0060242,1,0.949196587551448,0,8,contact inhibition,BP,
14617,GO:0060243,1,0.993105074528504,0,1,negative regulation of cell growth involved in contact inhibition,BP,
14618,GO:0060244,1,0.981806202086057,0,3,negative regulation of cell proliferation involved in contact inhibition,BP,
14619,GO:0060245,1,0.993360169819569,0,1,detection of cell density,BP,
14620,GO:0060246,1,0.993360169819569,0,1,detection of cell density by contact stimulus,BP,
14621,GO:0060248,1,0.993360169819569,0,1,detection of cell density by contact stimulus involved in contact inhibition,BP,
14628,GO:0060259,1,0.895016162271697,0,17,regulation of feeding behavior,BP,
14629,GO:0060260,1,0.840054586601026,0,27,regulation of transcription initiation from RNA polymerase II promoter,BP,
14630,GO:0060261,1,0.879067579898236,0,20,positive regulation of transcription initiation from RNA polymerase II promoter,BP,
14632,GO:0060263,1,0.93933331738705,0,10,regulation of respiratory burst,BP,
14633,GO:0060264,1,0.983413456099217,0,3,regulation of respiratory burst involved in inflammatory response,BP,
14634,GO:0060265,1,0.989220697350131,0,2,positive regulation of respiratory burst involved in inflammatory response,BP,
14635,GO:0060266,1,0.989010441798578,0,2,negative regulation of respiratory burst involved in inflammatory response,BP,
14636,GO:0060267,1,0.974295645769412,0,4,positive regulation of respiratory burst,BP,
14637,GO:0060268,1,0.980825966539733,0,3,negative regulation of respiratory burst,BP,
14639,GO:0060272,1,0.928789147643101,0,12,embryonic skeletal joint morphogenesis,BP,
14640,GO:0060278,1,0.982001710073495,0,3,regulation of ovulation,BP,
14641,GO:0060279,1,0.987841222629528,0,2,positive regulation of ovulation,BP,
14642,GO:0060280,1,0.994089340810551,0,1,negative regulation of ovulation,BP,
14643,GO:0060281,1,0.936891180501744,0,10,regulation of oocyte development,BP,
14644,GO:0060282,1,0.973582824921223,0,4,positive regulation of oocyte development,BP,
14645,GO:0060283,1,0.974085922117244,0,4,negative regulation of oocyte development,BP,
14648,GO:0060287,1,0.944169698573765,0,9,epithelial cilium movement involved in determination of left/right asymmetry,BP,
14649,GO:0060290,1,0.967138366082484,0,5,transdifferentiation,BP,
14651,GO:0060292,1,0.824344505911996,0,28,long term synaptic depression,BP,
14652,GO:0060293,1,0.913746007738874,0,14,germ plasm,CC,
14653,GO:0060294,1,0.910705456787594,0,16,cilium movement involved in cell motility,BP,
14654,GO:0060295,1,0.969839451253232,0,5,regulation of cilium movement involved in cell motility,BP,
14655,GO:0060296,1,0.969839451253232,0,5,regulation of cilium beat frequency involved in ciliary motility,BP,
14656,GO:0060297,1,0.960140540573976,0,5,regulation of sarcomere organization,BP,
14657,GO:0060298,1,0.97919217898205,0,3,positive regulation of sarcomere organization,BP,
14658,GO:0060300,1,0.976114542365227,0,4,regulation of cytokine activity,BP,
14659,GO:0060301,1,0.994004758645168,0,1,positive regulation of cytokine activity,BP,
14660,GO:0060302,1,0.988791178236797,0,2,negative regulation of cytokine activity,BP,
14661,GO:0060304,1,0.955651530622441,0,6,regulation of phosphatidylinositol dephosphorylation,BP,
14662,GO:0060305,1,0.993814442186848,0,1,regulation of cell diameter,BP,
14665,GO:0060309,1,0.994889139311718,0,1,elastin catabolic process,BP,
14666,GO:0060310,1,0.994889139311718,0,1,regulation of elastin catabolic process,BP,
14667,GO:0060311,1,0.994889139311718,0,1,negative regulation of elastin catabolic process,BP,
14668,GO:0060312,1,0.947447856577017,0,8,regulation of blood vessel remodeling,BP,
14669,GO:0060313,1,0.979321832625093,0,3,negative regulation of blood vessel remodeling,BP,
14670,GO:0060314,1,0.847709636854707,0,25,regulation of ryanodine-sensitive calcium-release channel activity,BP,
14671,GO:0060315,1,0.935724040565894,0,11,negative regulation of ryanodine-sensitive calcium-release channel activity,BP,
14672,GO:0060316,1,0.948792944165421,0,8,positive regulation of ryanodine-sensitive calcium-release channel activity,BP,
14673,GO:0060317,1,0.817759042355821,0,31,cardiac epithelial to mesenchymal transition,BP,
14674,GO:0060318,1,0.967226448645044,0,5,definitive erythrocyte differentiation,BP,
14675,GO:0060319,1,0.975389188053351,0,4,primitive erythrocyte differentiation,BP,
14677,GO:0060323,1,0.792942889175147,0,34,head morphogenesis,BP,
14678,GO:0060324,1,0.728931615458832,0,46,face development,BP,
14679,GO:0060325,1,0.817020480125012,0,29,face morphogenesis,BP,
14681,GO:0060327,1,0.993867850962962,0,1,cytoplasmic actin-based contraction involved in cell motility,BP,
14682,GO:0060330,1,0.869298786604838,0,22,regulation of response to interferon-gamma,BP,
14683,GO:0060331,1,0.963813955377807,0,6,negative regulation of response to interferon-gamma,BP,
14684,GO:0060332,1,0.965124332778687,0,5,positive regulation of response to interferon-gamma,BP,
14685,GO:0060333,1,0.59724840285933,0,83,interferon-gamma-mediated signaling pathway,BP,
14686,GO:0060334,1,0.869298786604838,0,22,regulation of interferon-gamma-mediated signaling pathway,BP,
14687,GO:0060335,1,0.965124332778687,0,5,positive regulation of interferon-gamma-mediated signaling pathway,BP,
14688,GO:0060336,1,0.963813955377807,0,6,negative regulation of interferon-gamma-mediated signaling pathway,BP,
14689,GO:0060337,1,0.640329395392436,0,71,type I interferon signaling pathway,BP,
14690,GO:0060338,1,0.816653839830936,0,30,regulation of type I interferon-mediated signaling pathway,BP,
14691,GO:0060339,1,0.953547571332803,0,7,negative regulation of type I interferon-mediated signaling pathway,BP,
14692,GO:0060340,1,0.932146478599835,0,10,positive regulation of type I interferon-mediated signaling pathway,BP,
14694,GO:0060342,1,0.988210818606435,0,2,photoreceptor inner segment membrane,CC,
14695,GO:0060343,1,0.855233315122939,0,23,trabecula formation,BP,
14696,GO:0060345,1,0.993557877795695,0,1,spleen trabecula formation,BP,
14697,GO:0060346,1,0.930006641212846,0,10,bone trabecula formation,BP,
14698,GO:0060347,1,0.925623250023562,0,12,heart trabecula formation,BP,
14702,GO:0060351,1,0.860175671892093,0,23,cartilage development involved in endochondral bone morphogenesis,BP,
14703,GO:0060352,1,0.958315716511516,0,7,cell adhesion molecule production,BP,
14704,GO:0060353,1,0.971582095949821,0,5,regulation of cell adhesion molecule production,BP,
14705,GO:0060354,1,0.994825603629511,0,1,negative regulation of cell adhesion molecule production,BP,
14706,GO:0060355,1,0.976636806984013,0,4,positive regulation of cell adhesion molecule production,BP,
14708,GO:0060363,1,0.950695310180975,0,8,cranial suture morphogenesis,BP,
14709,GO:0060364,1,0.973241188880439,0,4,frontal suture morphogenesis,BP,
14710,GO:0060366,1,0.991028115651163,0,1,lambdoid suture morphogenesis,BP,
14711,GO:0060367,1,0.991028115651163,0,1,sagittal suture morphogenesis,BP,
14712,GO:0060368,1,0.962796954015647,0,6,regulation of Fc receptor mediated stimulatory signaling pathway,BP,
14713,GO:0060369,1,0.974313867032698,0,4,positive regulation of Fc receptor mediated stimulatory signaling pathway,BP,
14714,GO:0060370,1,0.987095559408488,0,2,susceptibility to T cell mediated cytotoxicity,BP,
14715,GO:0060371,1,0.948929168926586,0,7,regulation of atrial cardiac muscle cell membrane depolarization,BP,
14716,GO:0060372,1,0.950276568049298,0,7,regulation of atrial cardiac muscle cell membrane repolarization,BP,
14717,GO:0060373,1,0.964296165283748,0,5,regulation of ventricular cardiac muscle cell membrane depolarization,BP,
14718,GO:0060374,1,0.965598862297151,0,5,mast cell differentiation,BP,
14719,GO:0060375,1,0.986367762068167,0,2,regulation of mast cell differentiation,BP,
14720,GO:0060377,1,0.993614671204414,0,1,negative regulation of mast cell differentiation,BP,
14721,GO:0060378,1,0.985669762126535,0,2,regulation of brood size,BP,
14722,GO:0060379,1,0.932608819589074,0,10,cardiac muscle cell myoblast differentiation,BP,
14723,GO:0060380,1,0.994222579812237,0,1,regulation of single-stranded telomeric DNA binding,BP,
14724,GO:0060381,1,0.994222579812237,0,1,positive regulation of single-stranded telomeric DNA binding,BP,
14725,GO:0060382,1,0.985178659783472,0,2,regulation of DNA strand elongation,BP,
14726,GO:0060383,1,0.99317851521984,0,1,positive regulation of DNA strand elongation,BP,
14727,GO:0060384,1,0.83551009951169,0,25,innervation,BP,
14728,GO:0060385,1,0.967109977655561,0,5,axonogenesis involved in innervation,BP,
14729,GO:0060386,1,0.992325464944775,0,1,synapse assembly involved in innervation,BP,
14730,GO:0060389,1,0.683361464095072,0,59,pathway-restricted SMAD protein phosphorylation,BP,
14731,GO:0060390,1,0.893363174601601,0,17,regulation of SMAD protein signal transduction,BP,
14732,GO:0060391,1,0.915632434362015,0,13,positive regulation of SMAD protein signal transduction,BP,
14733,GO:0060392,1,0.982886112910171,0,3,negative regulation of SMAD protein signal transduction,BP,
14734,GO:0060393,1,0.698856617627046,0,56,regulation of pathway-restricted SMAD protein phosphorylation,BP,
14735,GO:0060394,1,0.940026255580438,0,10,negative regulation of pathway-restricted SMAD protein phosphorylation,BP,
14736,GO:0060395,1,0.669371305619558,0,60,SMAD protein signal transduction,BP,
14737,GO:0060396,1,0.880631536902493,0,18,growth hormone receptor signaling pathway,BP,
14738,GO:0060397,1,0.923444837009056,0,11,JAK-STAT cascade involved in growth hormone signaling pathway,BP,
14739,GO:0060398,1,0.972811052530774,0,4,regulation of growth hormone receptor signaling pathway,BP,
14740,GO:0060399,1,0.979773697129851,0,3,positive regulation of growth hormone receptor signaling pathway,BP,
14741,GO:0060400,1,0.992895080359243,0,1,negative regulation of growth hormone receptor signaling pathway,BP,
14744,GO:0060404,1,0.993403761369442,0,1,axonemal microtubule depolymerization,BP,
14745,GO:0060405,1,0.967024181465226,0,5,regulation of penile erection,BP,
14746,GO:0060406,1,0.979944987443526,0,3,positive regulation of penile erection,BP,
14747,GO:0060407,1,0.994493918772112,0,1,negative regulation of penile erection,BP,
14750,GO:0060413,1,0.906408782874626,0,14,atrial septum morphogenesis,BP,
14751,GO:0060414,1,0.977658284178282,0,3,aorta smooth muscle tissue morphogenesis,BP,
14752,GO:0060415,1,0.581223465407909,0,72,muscle tissue morphogenesis,BP,
14753,GO:0060416,1,0.816964828059983,0,29,response to growth hormone,BP,
14757,GO:0060422,1,0.994102759580476,0,1,peptidyl-dipeptidase inhibitor activity,MF,
14758,GO:0060423,1,0.981570774761569,0,3,foregut regionalization,BP,
14759,GO:0060424,1,0.981570774761569,0,3,lung field specification,BP,
14761,GO:0060426,1,0.969818025284571,0,5,lung vasculature development,BP,
14762,GO:0060428,1,0.8047541797395,0,33,lung epithelium development,BP,
14764,GO:0060430,1,0.960482972163614,0,6,lung saccule development,BP,
14765,GO:0060431,1,0.969678201811976,0,5,primary lung bud formation,BP,
14766,GO:0060432,1,0.994965586769087,0,1,lung pattern specification process,BP,
14767,GO:0060433,1,0.939332959872669,0,10,bronchus development,BP,
14768,GO:0060434,1,0.986890678583833,0,2,bronchus morphogenesis,BP,
14769,GO:0060435,1,0.989594401591382,0,2,bronchiole development,BP,
14770,GO:0060436,1,0.994965586769087,0,1,bronchiole morphogenesis,BP,
14771,GO:0060437,1,0.968806851718512,0,5,lung growth,BP,
14772,GO:0060438,1,0.881707302313591,0,19,trachea development,BP,
14773,GO:0060439,1,0.93074437075558,0,11,trachea morphogenesis,BP,
14774,GO:0060440,1,0.962993910020019,0,6,trachea formation,BP,
14775,GO:0060441,1,0.831586184939956,0,28,epithelial tube branching involved in lung morphogenesis,BP,
14776,GO:0060442,1,0.9226172911386,0,12,branching involved in prostate gland morphogenesis,BP,
14777,GO:0060443,1,0.739281950174191,0,43,mammary gland morphogenesis,BP,
14778,GO:0060444,1,0.852935652619082,0,22,branching involved in mammary gland duct morphogenesis,BP,
14779,GO:0060445,1,0.859043369013042,0,22,branching involved in salivary gland morphogenesis,BP,
14780,GO:0060447,1,0.980897929554667,0,3,bud outgrowth involved in lung branching,BP,
14781,GO:0060448,1,0.976618831480189,0,3,dichotomous subdivision of terminal units involved in lung branching,BP,
14782,GO:0060449,1,0.957557039730679,0,7,bud elongation involved in lung branching,BP,
14783,GO:0060452,1,0.935398147834176,0,11,positive regulation of cardiac muscle contraction,BP,
14784,GO:0060453,1,0.941127735234858,0,10,regulation of gastric acid secretion,BP,
14785,GO:0060454,1,0.986797717851889,0,2,positive regulation of gastric acid secretion,BP,
14786,GO:0060455,1,0.97246653963019,0,5,negative regulation of gastric acid secretion,BP,
14787,GO:0060456,1,0.942828485395168,0,10,positive regulation of digestive system process,BP,
14788,GO:0060457,1,0.921206923998124,0,13,negative regulation of digestive system process,BP,
14789,GO:0060458,1,0.988475457414763,0,2,right lung development,BP,
14790,GO:0060459,1,0.982917951143326,0,3,left lung development,BP,
14791,GO:0060460,1,0.988379077638714,0,2,left lung morphogenesis,BP,
14792,GO:0060461,1,0.993967147671658,0,1,right lung morphogenesis,BP,
14793,GO:0060462,1,0.961313683915264,0,6,lung lobe development,BP,
14794,GO:0060463,1,0.961313683915264,0,6,lung lobe morphogenesis,BP,
14795,GO:0060465,1,0.98709887747622,0,2,pharynx development,BP,
14796,GO:0060466,1,0.991771332408741,0,1,activation of meiosis involved in egg activation,BP,
14797,GO:0060467,1,0.988728983707334,0,2,negative regulation of fertilization,BP,
14798,GO:0060474,1,0.993564273551594,0,1,positive regulation of flagellated sperm motility involved in capacitation,BP,
14799,GO:0060478,1,0.975958153710146,0,4,acrosomal vesicle exocytosis,BP,
14800,GO:0060479,1,0.87831989821297,0,20,lung cell differentiation,BP,
14801,GO:0060480,1,0.983627262322676,0,3,lung goblet cell differentiation,BP,
14802,GO:0060481,1,0.977010149042966,0,4,lobar bronchus epithelium development,BP,
14803,GO:0060482,1,0.970436601517065,0,5,lobar bronchus development,BP,
14804,GO:0060484,1,0.949690279247889,0,8,lung-associated mesenchyme development,BP,
14806,GO:0060486,1,0.973010861706756,0,4,Clara cell differentiation,BP,
14807,GO:0060487,1,0.884053857623477,0,19,lung epithelial cell differentiation,BP,
14808,GO:0060488,1,0.981994534134445,0,2,orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis,BP,
14809,GO:0060489,1,0.981994534134445,0,2,planar dichotomous subdivision of terminal units involved in lung branching morphogenesis,BP,
14810,GO:0060490,1,0.981994534134445,0,2,lateral sprouting involved in lung morphogenesis,BP,
14811,GO:0060491,1,0.380484862627591,0,143,regulation of cell projection assembly,BP,
14812,GO:0060492,1,0.981570774761569,0,3,lung induction,BP,
14813,GO:0060495,1,0.994965586769087,0,1,cell-cell signaling involved in lung development,BP,
14814,GO:0060496,1,0.994965586769087,0,1,mesenchymal-epithelial cell signaling involved in lung development,BP,
14815,GO:0060501,1,0.962273604001134,0,6,positive regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
14816,GO:0060502,1,0.936202022518239,0,10,epithelial cell proliferation involved in lung morphogenesis,BP,
14817,GO:0060503,1,0.994367297581572,0,1,bud dilation involved in lung branching,BP,
14818,GO:0060509,1,0.961775934361398,0,5,Type I pneumocyte differentiation,BP,
14819,GO:0060510,1,0.968685509198939,0,5,Type II pneumocyte differentiation,BP,
14820,GO:0060512,1,0.838088891749133,0,26,prostate gland morphogenesis,BP,
14821,GO:0060513,1,0.936242591864743,0,10,prostatic bud formation,BP,
14822,GO:0060514,1,0.99371832414261,0,1,prostate induction,BP,
14823,GO:0060515,1,0.99371832414261,0,1,prostate field specification,BP,
14824,GO:0060516,1,0.98777879946997,0,2,primary prostatic bud elongation,BP,
14825,GO:0060517,1,0.993266658376875,0,1,epithelial cell proliferation involved in prostatic bud elongation,BP,
14826,GO:0060520,1,0.99371832414261,0,1,activation of prostate induction by androgen receptor signaling pathway,BP,
14827,GO:0060523,1,0.979790757667651,0,3,prostate epithelial cord elongation,BP,
14828,GO:0060525,1,0.929832452435715,0,10,prostate glandular acinus development,BP,
14829,GO:0060526,1,0.958440498590575,0,6,prostate glandular acinus morphogenesis,BP,
14830,GO:0060527,1,0.958440498590575,0,6,prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis,BP,
14831,GO:0060528,1,0.97710666611279,0,3,secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,BP,
14832,GO:0060529,1,0.986121332057173,0,2,squamous basal epithelial stem cell differentiation involved in prostate gland acinus development,BP,
14833,GO:0060532,1,0.986375471530452,0,2,bronchus cartilage development,BP,
14834,GO:0060534,1,0.946604527786888,0,8,trachea cartilage development,BP,
14835,GO:0060535,1,0.971894662831875,0,4,trachea cartilage morphogenesis,BP,
14836,GO:0060536,1,0.929543480493133,0,11,cartilage morphogenesis,BP,
14839,GO:0060539,1,0.956799007619675,0,7,diaphragm development,BP,
14841,GO:0060542,1,0.992301360687703,0,1,regulation of strand invasion,BP,
14842,GO:0060544,1,0.885320806700345,0,20,regulation of necroptotic process,BP,
14843,GO:0060545,1,0.987627743072361,0,2,positive regulation of necroptotic process,BP,
14844,GO:0060546,1,0.938518205739536,0,10,negative regulation of necroptotic process,BP,
14845,GO:0060547,1,0.924070292658765,0,13,negative regulation of necrotic cell death,BP,
14847,GO:0060556,1,0.952494273841088,0,8,regulation of vitamin D biosynthetic process,BP,
14848,GO:0060557,1,0.988971589173323,0,2,positive regulation of vitamin D biosynthetic process,BP,
14849,GO:0060558,1,0.963429479463773,0,6,regulation of calcidiol 1-monooxygenase activity,BP,
14850,GO:0060559,1,0.988971589173323,0,2,positive regulation of calcidiol 1-monooxygenase activity,BP,
14852,GO:0060561,1,0.857556887672975,0,23,apoptotic process involved in morphogenesis,BP,
14855,GO:0060566,1,0.989585442732175,0,1,positive regulation of DNA-templated transcription, termination,BP,
14856,GO:0060571,1,0.84742979546449,0,26,morphogenesis of an epithelial fold,BP,
14857,GO:0060572,1,0.896513462822768,0,17,morphogenesis of an epithelial bud,BP,
14859,GO:0060574,1,0.976651586302219,0,4,intestinal epithelial cell maturation,BP,
14860,GO:0060575,1,0.904747814974629,0,16,intestinal epithelial cell differentiation,BP,
14861,GO:0060576,1,0.941729351774204,0,10,intestinal epithelial cell development,BP,
14862,GO:0060577,1,0.988628031407564,0,2,pulmonary vein morphogenesis,BP,
14863,GO:0060578,1,0.994133734240773,0,1,superior vena cava morphogenesis,BP,
14865,GO:0060580,1,0.994217412712474,0,1,ventral spinal cord interneuron fate determination,BP,
14867,GO:0060582,1,0.994217412712474,0,1,cell fate determination involved in pattern specification,BP,
14868,GO:0060584,1,0.981933380379167,0,3,regulation of prostaglandin-endoperoxide synthase activity,BP,
14869,GO:0060585,1,0.981933380379167,0,3,positive regulation of prostaglandin-endoperoxide synthase activity,BP,
14870,GO:0060586,1,0.94912090386714,0,8,multicellular organismal iron ion homeostasis,BP,
14871,GO:0060587,1,0.988261248710465,0,2,regulation of lipoprotein lipid oxidation,BP,
14872,GO:0060588,1,0.994704723417011,0,1,negative regulation of lipoprotein lipid oxidation,BP,
14874,GO:0060590,1,0.781146308265098,0,40,ATPase regulator activity,MF,
14875,GO:0060591,1,0.973778144413687,0,4,chondroblast differentiation,BP,
14876,GO:0060592,1,0.954214825454993,0,7,mammary gland formation,BP,
14877,GO:0060594,1,0.979309691933394,0,3,mammary gland specification,BP,
14878,GO:0060595,1,0.98817655751685,0,2,fibroblast growth factor receptor signaling pathway involved in mammary gland specification,BP,
14879,GO:0060596,1,0.979900903215568,0,3,mammary placode formation,BP,
14880,GO:0060598,1,0.994649961184821,0,1,dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis,BP,
14881,GO:0060599,1,0.986035282196747,0,2,lateral sprouting involved in mammary gland duct morphogenesis,BP,
14882,GO:0060600,1,0.928776641848091,0,10,dichotomous subdivision of an epithelial terminal unit,BP,
14883,GO:0060601,1,0.913095769279146,0,13,lateral sprouting from an epithelium,BP,
14885,GO:0060603,1,0.805832919120176,0,30,mammary gland duct morphogenesis,BP,
14886,GO:0060605,1,0.967537327319209,0,5,tube lumen cavitation,BP,
14888,GO:0060611,1,0.994033627873654,0,1,mammary gland fat development,BP,
14889,GO:0060612,1,0.794972257222451,0,35,adipose tissue development,BP,
14890,GO:0060613,1,0.959909875520981,0,6,fat pad development,BP,
14891,GO:0060615,1,0.98817655751685,0,2,mammary gland bud formation,BP,
14892,GO:0060620,1,0.993850639026861,0,1,regulation of cholesterol import,BP,
14893,GO:0060623,1,0.987663453551892,0,2,regulation of chromosome condensation,BP,
14895,GO:0060628,1,0.923703648721904,0,12,regulation of ER to Golgi vesicle-mediated transport,BP,
14896,GO:0060629,1,0.993817521405908,0,1,regulation of homologous chromosome segregation,BP,
14897,GO:0060631,1,0.95676556130448,0,7,regulation of meiosis I,BP,
14898,GO:0060632,1,0.861435073965347,0,23,regulation of microtubule-based movement,BP,
14899,GO:0060633,1,0.968241704227809,0,5,negative regulation of transcription initiation from RNA polymerase II promoter,BP,
14900,GO:0060638,1,0.94837536564023,0,8,mesenchymal-epithelial cell signaling,BP,
14901,GO:0060644,1,0.89505677354635,0,16,mammary gland epithelial cell differentiation,BP,
14902,GO:0060648,1,0.982568407295517,0,3,mammary gland bud morphogenesis,BP,
14903,GO:0060661,1,0.989162985139108,0,2,submandibular salivary gland formation,BP,
14904,GO:0060662,1,0.967537327319209,0,5,salivary gland cavitation,BP,
14905,GO:0060664,1,0.970982205218091,0,5,epithelial cell proliferation involved in salivary gland morphogenesis,BP,
14906,GO:0060665,1,0.975080636523498,0,4,regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling,BP,
14907,GO:0060666,1,0.961799333419462,0,5,dichotomous subdivision of terminal units involved in salivary gland branching,BP,
14908,GO:0060667,1,0.98817655751685,0,2,branch elongation involved in salivary gland morphogenesis,BP,
14909,GO:0060668,1,0.993423236218272,0,1,regulation of branching involved in salivary gland morphogenesis by extracellular matrix-epithelial cell signaling,BP,
14910,GO:0060669,1,0.861385248446646,0,23,embryonic placenta morphogenesis,BP,
14911,GO:0060670,1,0.939443518974822,0,10,branching involved in labyrinthine layer morphogenesis,BP,
14912,GO:0060671,1,0.988016872305077,0,2,epithelial cell differentiation involved in embryonic placenta development,BP,
14913,GO:0060672,1,0.988016872305077,0,2,epithelial cell morphogenesis involved in placental branching,BP,
14914,GO:0060674,1,0.822274997986124,0,29,placenta blood vessel development,BP,
14916,GO:0060676,1,0.96267715813017,0,6,ureteric bud formation,BP,
14918,GO:0060678,1,0.994119794279228,0,1,dichotomous subdivision of terminal units involved in ureteric bud branching,BP,
14920,GO:0060683,1,0.993857060510416,0,1,regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling,BP,
14921,GO:0060684,1,0.965150260828991,0,6,epithelial-mesenchymal cell signaling,BP,
14922,GO:0060685,1,0.961046306678939,0,6,regulation of prostatic bud formation,BP,
14923,GO:0060686,1,0.972497762001072,0,4,negative regulation of prostatic bud formation,BP,
14924,GO:0060687,1,0.953218434249733,0,7,regulation of branching involved in prostate gland morphogenesis,BP,
14925,GO:0060688,1,0.718410963852455,0,51,regulation of morphogenesis of a branching structure,BP,
14926,GO:0060689,1,0.979199797977279,0,3,cell differentiation involved in salivary gland development,BP,
14927,GO:0060690,1,0.994355150667844,0,1,epithelial cell differentiation involved in salivary gland development,BP,
14928,GO:0060691,1,0.994355150667844,0,1,epithelial cell maturation involved in salivary gland development,BP,
14929,GO:0060693,1,0.944599328198083,0,9,regulation of branching involved in salivary gland morphogenesis,BP,
14930,GO:0060694,1,0.99432878894376,0,1,regulation of cholesterol transporter activity,BP,
14931,GO:0060696,1,0.964882132785801,0,6,regulation of phospholipid catabolic process,BP,
14932,GO:0060697,1,0.988795547799812,0,2,positive regulation of phospholipid catabolic process,BP,
14933,GO:0060698,1,0.986866977329492,0,2,endoribonuclease inhibitor activity,MF,
14934,GO:0060699,1,0.975666026113725,0,4,regulation of endoribonuclease activity,BP,
14935,GO:0060700,1,0.944896912079928,0,9,regulation of ribonuclease activity,BP,
14936,GO:0060701,1,0.986866977329492,0,2,negative regulation of ribonuclease activity,BP,
14937,GO:0060702,1,0.986866977329492,0,2,negative regulation of endoribonuclease activity,BP,
14938,GO:0060703,1,0.993886869730289,0,1,deoxyribonuclease inhibitor activity,MF,
14939,GO:0060706,1,0.868617094227103,0,22,cell differentiation involved in embryonic placenta development,BP,
14940,GO:0060707,1,0.931514265561744,0,11,trophoblast giant cell differentiation,BP,
14941,GO:0060708,1,0.98188505450887,0,3,spongiotrophoblast differentiation,BP,
14942,GO:0060709,1,0.993809310701639,0,1,glycogen cell differentiation involved in embryonic placenta development,BP,
14943,GO:0060710,1,0.957018158915535,0,7,chorio-allantoic fusion,BP,
14944,GO:0060711,1,0.756064220078651,0,43,labyrinthine layer development,BP,
14945,GO:0060712,1,0.90947856754368,0,14,spongiotrophoblast layer development,BP,
14946,GO:0060713,1,0.886782879133231,0,19,labyrinthine layer morphogenesis,BP,
14947,GO:0060715,1,0.980128897646053,0,3,syncytiotrophoblast cell differentiation involved in labyrinthine layer development,BP,
14948,GO:0060716,1,0.886244491116441,0,19,labyrinthine layer blood vessel development,BP,
14949,GO:0060717,1,0.952833556188679,0,7,chorion development,BP,
14950,GO:0060718,1,0.964752351564764,0,5,chorionic trophoblast cell differentiation,BP,
14951,GO:0060720,1,0.985961953775961,0,2,spongiotrophoblast cell proliferation,BP,
14952,GO:0060721,1,0.985961953775961,0,2,regulation of spongiotrophoblast cell proliferation,BP,
14953,GO:0060722,1,0.985961953775961,0,2,cell proliferation involved in embryonic placenta development,BP,
14954,GO:0060723,1,0.985961953775961,0,2,regulation of cell proliferation involved in embryonic placenta development,BP,
14955,GO:0060729,1,0.968010929118992,0,5,intestinal epithelial structure maintenance,BP,
14956,GO:0060730,1,0.987566856019478,0,2,regulation of intestinal epithelial structure maintenance,BP,
14957,GO:0060731,1,0.993596251514619,0,1,positive regulation of intestinal epithelial structure maintenance,BP,
14958,GO:0060732,1,0.939552494063323,0,10,positive regulation of inositol phosphate biosynthetic process,BP,
14959,GO:0060733,1,0.98582119246313,0,2,regulation of eIF2 alpha phosphorylation by amino acid starvation,BP,
14960,GO:0060734,1,0.992886215431389,0,1,regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,BP,
14961,GO:0060735,1,0.994582794965587,0,1,regulation of eIF2 alpha phosphorylation by dsRNA,BP,
14962,GO:0060736,1,0.922411826891536,0,11,prostate gland growth,BP,
14963,GO:0060737,1,0.973192136073287,0,4,prostate gland morphogenetic growth,BP,
14964,GO:0060738,1,0.994475315120246,0,1,epithelial-mesenchymal signaling involved in prostate gland development,BP,
14965,GO:0060739,1,0.991339194625388,0,1,mesenchymal-epithelial cell signaling involved in prostate gland development,BP,
14966,GO:0060740,1,0.84227208304525,0,25,prostate gland epithelium morphogenesis,BP,
14967,GO:0060741,1,0.989150114507228,0,2,prostate gland stromal morphogenesis,BP,
14968,GO:0060742,1,0.933798206231931,0,10,epithelial cell differentiation involved in prostate gland development,BP,
14969,GO:0060743,1,0.987730378195424,0,2,epithelial cell maturation involved in prostate gland development,BP,
14970,GO:0060744,1,0.967111597500277,0,5,mammary gland branching involved in thelarche,BP,
14971,GO:0060745,1,0.952439483712236,0,6,mammary gland branching involved in pregnancy,BP,
14972,GO:0060746,1,0.917238138462733,0,13,parental behavior,BP,
14973,GO:0060748,1,0.975755872522738,0,3,tertiary branching involved in mammary gland duct morphogenesis,BP,
14974,GO:0060749,1,0.890433198251482,0,17,mammary gland alveolus development,BP,
14975,GO:0060750,1,0.970313177084021,0,4,epithelial cell proliferation involved in mammary gland duct elongation,BP,
14976,GO:0060751,1,0.964636375311631,0,5,branch elongation involved in mammary gland duct branching,BP,
14977,GO:0060752,1,0.993908469052429,0,1,intestinal phytosterol absorption,BP,
14978,GO:0060753,1,0.96463301729512,0,6,regulation of mast cell chemotaxis,BP,
14979,GO:0060754,1,0.969940134405929,0,5,positive regulation of mast cell chemotaxis,BP,
14980,GO:0060759,1,0.38211625071515,0,149,regulation of response to cytokine stimulus,BP,
14981,GO:0060760,1,0.742066393293852,0,46,positive regulation of response to cytokine stimulus,BP,
14982,GO:0060761,1,0.737176575593092,0,48,negative regulation of response to cytokine stimulus,BP,
14983,GO:0060762,1,0.974386077426087,0,4,regulation of branching involved in mammary gland duct morphogenesis,BP,
14984,GO:0060763,1,0.986053419060569,0,2,mammary duct terminal end bud growth,BP,
14985,GO:0060764,1,0.987274439852779,0,2,cell-cell signaling involved in mammary gland development,BP,
14986,GO:0060765,1,0.849524847792701,0,25,regulation of androgen receptor signaling pathway,BP,
14987,GO:0060766,1,0.931653364695603,0,11,negative regulation of androgen receptor signaling pathway,BP,
14988,GO:0060767,1,0.932134991319438,0,11,epithelial cell proliferation involved in prostate gland development,BP,
14989,GO:0060768,1,0.938457991141359,0,10,regulation of epithelial cell proliferation involved in prostate gland development,BP,
14990,GO:0060769,1,0.981825548094617,0,3,positive regulation of epithelial cell proliferation involved in prostate gland development,BP,
14991,GO:0060770,1,0.965046583319313,0,6,negative regulation of epithelial cell proliferation involved in prostate gland development,BP,
14992,GO:0060775,1,0.986605938728695,0,2,planar cell polarity pathway involved in gastrula mediolateral intercalation,BP,
14993,GO:0060781,1,0.994475315120246,0,1,mesenchymal cell proliferation involved in prostate gland development,BP,
14994,GO:0060782,1,0.994475315120246,0,1,regulation of mesenchymal cell proliferation involved in prostate gland development,BP,
14995,GO:0060783,1,0.994475315120246,0,1,mesenchymal smoothened signaling pathway involved in prostate gland development,BP,
14996,GO:0060784,1,0.993266658376875,0,1,regulation of cell proliferation involved in tissue homeostasis,BP,
14997,GO:0060788,1,0.911270424506882,0,14,ectodermal placode formation,BP,
14998,GO:0060789,1,0.963290085204416,0,6,hair follicle placode formation,BP,
15000,GO:0060796,1,0.98862781906279,0,2,regulation of transcription involved in primary germ layer cell fate commitment,BP,
15001,GO:0060800,1,0.980378951933273,0,3,regulation of cell differentiation involved in embryonic placenta development,BP,
15002,GO:0060802,1,0.99421172909739,0,1,epiblast cell-extraembryonic ectoderm cell signaling involved in anterior/posterior axis specification,BP,
15003,GO:0060803,1,0.994519239446906,0,1,BMP signaling pathway involved in mesodermal cell fate specification,BP,
15004,GO:0060804,1,0.993664309842,0,1,positive regulation of Wnt signaling pathway by BMP signaling pathway,BP,
15005,GO:0060806,1,0.994416399336703,0,1,negative regulation of cell differentiation involved in embryonic placenta development,BP,
15006,GO:0060807,1,0.994076440360544,0,1,regulation of transcription from RNA polymerase II promoter involved in definitive endodermal cell fate specification,BP,
15007,GO:0060809,1,0.98619182483099,0,2,mesodermal to mesenchymal transition involved in gastrulation,BP,
15008,GO:0060816,1,0.983428098544736,0,2,random inactivation of X chromosome,BP,
15009,GO:0060819,1,0.98401412405973,0,2,inactivation of X chromosome by genetic imprinting,BP,
15010,GO:0060821,1,0.990774239189823,0,1,inactivation of X chromosome by DNA methylation,BP,
15011,GO:0060823,1,0.986769074344937,0,2,canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
15012,GO:0060825,1,0.988773705540957,0,2,fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
15013,GO:0060827,1,0.993189873360537,0,1,regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
15015,GO:0060829,1,0.993189873360537,0,1,negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
15016,GO:0060830,1,0.981116563858279,0,3,ciliary receptor clustering involved in smoothened signaling pathway,BP,
15017,GO:0060831,1,0.912563959336204,0,13,smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
15018,GO:0060836,1,0.942695294869363,0,8,lymphatic endothelial cell differentiation,BP,
15019,GO:0060837,1,0.942667690410966,0,9,blood vessel endothelial cell differentiation,BP,
15020,GO:0060838,1,0.98098214600346,0,3,lymphatic endothelial cell fate commitment,BP,
15021,GO:0060839,1,0.957078752084863,0,7,endothelial cell fate commitment,BP,
15022,GO:0060840,1,0.574750419401531,0,76,artery development,BP,
15023,GO:0060841,1,0.888552882671475,0,16,venous blood vessel development,BP,
15024,GO:0060842,1,0.961012607335866,0,6,arterial endothelial cell differentiation,BP,
15025,GO:0060843,1,0.990460959468017,0,1,venous endothelial cell differentiation,BP,
15026,GO:0060844,1,0.987687050265079,0,2,arterial endothelial cell fate commitment,BP,
15027,GO:0060846,1,0.981764888859211,0,3,blood vessel endothelial cell fate commitment,BP,
15028,GO:0060847,1,0.981764888859211,0,3,endothelial cell fate specification,BP,
15029,GO:0060849,1,0.987019765521719,0,2,regulation of transcription involved in lymphatic endothelial cell fate commitment,BP,
15031,GO:0060853,1,0.99357936721576,0,1,Notch signaling pathway involved in arterial endothelial cell fate commitment,BP,
15032,GO:0060856,1,0.939302518322678,0,10,establishment of blood-brain barrier,BP,
15033,GO:0060857,1,0.994112050807224,0,1,establishment of glial blood-brain barrier,BP,
15034,GO:0060872,1,0.937698284599225,0,9,semicircular canal development,BP,
15035,GO:0060873,1,0.991028115651163,0,1,anterior semicircular canal development,BP,
15036,GO:0060875,1,0.991028115651163,0,1,lateral semicircular canal development,BP,
15037,GO:0060876,1,0.989022793135799,0,2,semicircular canal formation,BP,
15038,GO:0060879,1,0.994965586769087,0,1,semicircular canal fusion,BP,
15039,GO:0060896,1,0.937929105942634,0,9,neural plate pattern specification,BP,
15040,GO:0060897,1,0.953846208162793,0,7,neural plate regionalization,BP,
15042,GO:0060901,1,0.993079164753351,0,1,regulation of hair cycle by canonical Wnt signaling pathway,BP,
15043,GO:0060903,1,0.975003132393829,0,4,positive regulation of meiosis I,BP,
15044,GO:0060904,1,0.993244007704684,0,1,regulation of protein folding in endoplasmic reticulum,BP,
15045,GO:0060907,1,0.956041394104762,0,7,positive regulation of macrophage cytokine production,BP,
15046,GO:0060911,1,0.941163361669749,0,10,cardiac cell fate commitment,BP,
15047,GO:0060912,1,0.987963139596358,0,2,cardiac cell fate specification,BP,
15048,GO:0060913,1,0.98275402610333,0,3,cardiac cell fate determination,BP,
15049,GO:0060914,1,0.868776777305299,0,22,heart formation,BP,
15050,GO:0060915,1,0.98817655751685,0,2,mesenchymal cell differentiation involved in lung development,BP,
15051,GO:0060916,1,0.966004744442657,0,5,mesenchymal cell proliferation involved in lung development,BP,
15052,GO:0060920,1,0.967048156938232,0,5,cardiac pacemaker cell differentiation,BP,
15053,GO:0060921,1,0.980116788344118,0,3,sinoatrial node cell differentiation,BP,
15054,GO:0060922,1,0.986668936954503,0,2,atrioventricular node cell differentiation,BP,
15055,GO:0060923,1,0.963614585292174,0,6,cardiac muscle cell fate commitment,BP,
15056,GO:0060926,1,0.972211311993744,0,4,cardiac pacemaker cell development,BP,
15057,GO:0060927,1,0.994295966577254,0,1,cardiac pacemaker cell fate commitment,BP,
15058,GO:0060928,1,0.986668936954503,0,2,atrioventricular node cell development,BP,
15059,GO:0060929,1,0.994295966577254,0,1,atrioventricular node cell fate commitment,BP,
15060,GO:0060931,1,0.985349006213298,0,2,sinoatrial node cell development,BP,
15061,GO:0060932,1,0.987171759748557,0,2,His-Purkinje system cell differentiation,BP,
15062,GO:0060935,1,0.979563221100214,0,3,cardiac fibroblast cell differentiation,BP,
15063,GO:0060936,1,0.979563221100214,0,3,cardiac fibroblast cell development,BP,
15064,GO:0060938,1,0.979563221100214,0,3,epicardium-derived cardiac fibroblast cell differentiation,BP,
15065,GO:0060939,1,0.979563221100214,0,3,epicardium-derived cardiac fibroblast cell development,BP,
15066,GO:0060940,1,0.98750390816496,0,2,epithelial to mesenchymal transition involved in cardiac fibroblast development,BP,
15067,GO:0060947,1,0.945993388005501,0,8,cardiac vascular smooth muscle cell differentiation,BP,
15068,GO:0060948,1,0.978001766915701,0,3,cardiac vascular smooth muscle cell development,BP,
15069,GO:0060956,1,0.958238641158551,0,6,endocardial cell differentiation,BP,
15070,GO:0060957,1,0.993760336576739,0,1,endocardial cell fate commitment,BP,
15071,GO:0060964,1,0.582066665740247,0,83,regulation of gene silencing by miRNA,BP,
15072,GO:0060965,1,0.921175240055336,0,12,negative regulation of gene silencing by miRNA,BP,
15073,GO:0060966,1,0.569069669539504,0,86,regulation of gene silencing by RNA,BP,
15074,GO:0060967,1,0.907510416167861,0,14,negative regulation of gene silencing by RNA,BP,
15075,GO:0060968,1,0.494215844947481,0,106,regulation of gene silencing,BP,
15076,GO:0060969,1,0.854916227196873,0,22,negative regulation of gene silencing,BP,
15077,GO:0060971,1,0.971809104744884,0,4,embryonic heart tube left/right pattern formation,BP,
15078,GO:0060972,1,0.865491882181107,0,21,left/right pattern formation,BP,
15079,GO:0060973,1,0.89124910899986,0,17,cell migration involved in heart development,BP,
15080,GO:0060974,1,0.989466495421338,0,2,cell migration involved in heart formation,BP,
15081,GO:0060975,1,0.994690774858455,0,1,cardioblast migration to the midline involved in heart field formation,BP,
15083,GO:0060977,1,0.889573049460943,0,15,coronary vasculature morphogenesis,BP,
15084,GO:0060978,1,0.97847805784287,0,3,angiogenesis involved in coronary vascular morphogenesis,BP,
15085,GO:0060979,1,0.967748104438841,0,4,vasculogenesis involved in coronary vascular morphogenesis,BP,
15086,GO:0060980,1,0.993407349400836,0,1,cell migration involved in coronary vasculogenesis,BP,
15087,GO:0060981,1,0.992324416837963,0,1,cell migration involved in coronary angiogenesis,BP,
15088,GO:0060982,1,0.93161774306597,0,9,coronary artery morphogenesis,BP,
15089,GO:0060986,1,0.760324906997543,0,43,endocrine hormone secretion,BP,
15090,GO:0060987,1,0.994089340810551,0,1,lipid tube,CC,
15091,GO:0060988,1,0.987247114759297,0,2,lipid tube assembly,BP,
15092,GO:0060992,1,0.926924373897419,0,11,response to fungicide,BP,
15094,GO:0060994,1,0.987782856636545,0,2,regulation of transcription from RNA polymerase II promoter involved in kidney development,BP,
15095,GO:0060995,1,0.986324183710921,0,2,cell-cell signaling involved in kidney development,BP,
15097,GO:0060997,1,0.704268540788645,0,48,dendritic spine morphogenesis,BP,
15100,GO:0061000,1,0.922977867429827,0,11,negative regulation of dendritic spine development,BP,
15101,GO:0061001,1,0.778644994932337,0,34,regulation of dendritic spine morphogenesis,BP,
15102,GO:0061002,1,0.958710336553818,0,6,negative regulation of dendritic spine morphogenesis,BP,
15103,GO:0061003,1,0.881258858840429,0,17,positive regulation of dendritic spine morphogenesis,BP,
15104,GO:0061004,1,0.94746422016629,0,9,pattern specification involved in kidney development,BP,
15105,GO:0061005,1,0.708527711647176,0,50,cell differentiation involved in kidney development,BP,
15106,GO:0061008,1,0.408684097072208,0,134,hepaticobiliary system development,BP,
15107,GO:0061009,1,0.97065505591073,0,5,common bile duct development,BP,
15108,GO:0061010,1,0.978638622091584,0,3,gall bladder development,BP,
15109,GO:0061011,1,0.994381253322679,0,1,hepatic duct development,BP,
15110,GO:0061013,1,0.332547474600856,0,169,regulation of mRNA catabolic process,BP,
15111,GO:0061014,1,0.757304346469299,0,39,positive regulation of mRNA catabolic process,BP,
15112,GO:0061015,1,0.989174533363125,0,2,snRNA import into nucleus,BP,
15113,GO:0061017,1,0.994381253322679,0,1,hepatoblast differentiation,BP,
15115,GO:0061025,1,0.246309443936592,0,215,membrane fusion,BP,
15116,GO:0061026,1,0.989136098846001,0,1,cardiac muscle tissue regeneration,BP,
15117,GO:0061027,1,0.988045763276731,0,2,umbilical cord development,BP,
15118,GO:0061028,1,0.772430541160483,0,38,establishment of endothelial barrier,BP,
15120,GO:0061030,1,0.98188688274703,0,3,epithelial cell differentiation involved in mammary gland alveolus development,BP,
15121,GO:0061031,1,0.982893476820754,0,3,endodermal digestive tract morphogenesis,BP,
15122,GO:0061032,1,0.987841719118466,0,2,visceral serous pericardium development,BP,
15123,GO:0061033,1,0.988260682324021,0,2,secretion by lung epithelial cell involved in lung growth,BP,
15124,GO:0061034,1,0.985724406390771,0,2,olfactory bulb mitral cell layer development,BP,
15125,GO:0061035,1,0.685094094227597,0,56,regulation of cartilage development,BP,
15126,GO:0061036,1,0.830169340946069,0,27,positive regulation of cartilage development,BP,
15127,GO:0061037,1,0.869034426359036,0,22,negative regulation of cartilage development,BP,
15128,GO:0061038,1,0.954813496675333,0,6,uterus morphogenesis,BP,
15129,GO:0061040,1,0.990742296431914,0,1,female gonad morphogenesis,BP,
15131,GO:0061042,1,0.94570365479579,0,9,vascular wound healing,BP,
15132,GO:0061043,1,0.975661692500455,0,4,regulation of vascular wound healing,BP,
15133,GO:0061044,1,0.993657144447763,0,1,negative regulation of vascular wound healing,BP,
15135,GO:0061046,1,0.964063437387386,0,6,regulation of branching involved in lung morphogenesis,BP,
15136,GO:0061047,1,0.97604084204947,0,4,positive regulation of branching involved in lung morphogenesis,BP,
15137,GO:0061048,1,0.994427769569109,0,1,negative regulation of branching involved in lung morphogenesis,BP,
15138,GO:0061049,1,0.891834810449302,0,17,cell growth involved in cardiac muscle cell development,BP,
15139,GO:0061050,1,0.927668470324587,0,11,regulation of cell growth involved in cardiac muscle cell development,BP,
15140,GO:0061051,1,0.95111195128309,0,7,positive regulation of cell growth involved in cardiac muscle cell development,BP,
15141,GO:0061052,1,0.975363822560133,0,4,negative regulation of cell growth involved in cardiac muscle cell development,BP,
15144,GO:0061055,1,0.973313241396817,0,4,myotome development,BP,
15147,GO:0061072,1,0.936933096716457,0,9,iris morphogenesis,BP,
15148,GO:0061073,1,0.980463960876515,0,3,ciliary body morphogenesis,BP,
15149,GO:0061074,1,0.969777827595693,0,5,regulation of neural retina development,BP,
15150,GO:0061075,1,0.98824584876093,0,2,positive regulation of neural retina development,BP,
15151,GO:0061076,1,0.993669940119772,0,1,negative regulation of neural retina development,BP,
15153,GO:0061078,1,0.994999677880221,0,1,positive regulation of prostaglandin secretion involved in immune response,BP,
15154,GO:0061081,1,0.933490876312264,0,11,positive regulation of myeloid leukocyte cytokine production involved in immune response,BP,
15155,GO:0061082,1,0.868527295249942,0,22,myeloid leukocyte cytokine production,BP,
15156,GO:0061083,1,0.974830717927661,0,4,regulation of protein refolding,BP,
15157,GO:0061084,1,0.974830717927661,0,4,negative regulation of protein refolding,BP,
15158,GO:0061085,1,0.942601961990468,0,9,regulation of histone H3-K27 methylation,BP,
15159,GO:0061086,1,0.974104461612641,0,4,negative regulation of histone H3-K27 methylation,BP,
15160,GO:0061087,1,0.961492884964142,0,6,positive regulation of histone H3-K27 methylation,BP,
15161,GO:0061088,1,0.942991001769305,0,9,regulation of sequestering of zinc ion,BP,
15162,GO:0061090,1,0.99404755181113,0,1,positive regulation of sequestering of zinc ion,BP,
15163,GO:0061091,1,0.977094523519692,0,3,regulation of phospholipid translocation,BP,
15164,GO:0061092,1,0.977094523519692,0,3,positive regulation of phospholipid translocation,BP,
15165,GO:0061097,1,0.642139489964903,0,67,regulation of protein tyrosine kinase activity,BP,
15166,GO:0061098,1,0.776007113997915,0,38,positive regulation of protein tyrosine kinase activity,BP,
15167,GO:0061099,1,0.856248855170445,0,24,negative regulation of protein tyrosine kinase activity,BP,
15168,GO:0061100,1,0.994010428273367,0,1,lung neuroendocrine cell differentiation,BP,
15169,GO:0061101,1,0.953854384904652,0,8,neuroendocrine cell differentiation,BP,
15170,GO:0061102,1,0.988581170776143,0,2,stomach neuroendocrine cell differentiation,BP,
15171,GO:0061103,1,0.994010428273367,0,1,carotid body glomus cell differentiation,BP,
15172,GO:0061104,1,0.987878385586013,0,2,adrenal chromaffin cell differentiation,BP,
15173,GO:0061105,1,0.994538358435351,0,1,regulation of stomach neuroendocrine cell differentiation,BP,
15174,GO:0061106,1,0.994538358435351,0,1,negative regulation of stomach neuroendocrine cell differentiation,BP,
15175,GO:0061107,1,0.982395810034821,0,3,seminal vesicle development,BP,
15176,GO:0061108,1,0.994120052406903,0,1,seminal vesicle epithelium development,BP,
15177,GO:0061110,1,0.978524017773669,0,3,dense core granule biogenesis,BP,
15178,GO:0061113,1,0.979919560406268,0,3,pancreas morphogenesis,BP,
15179,GO:0061114,1,0.993704753095749,0,1,branching involved in pancreas morphogenesis,BP,
15180,GO:0061115,1,0.994965586769087,0,1,lung proximal/distal axis specification,BP,
15181,GO:0061117,1,0.902463456515694,0,16,negative regulation of heart growth,BP,
15187,GO:0061140,1,0.947110650374946,0,9,lung secretory cell differentiation,BP,
15188,GO:0061141,1,0.979746162753391,0,3,lung ciliated cell differentiation,BP,
15189,GO:0061143,1,0.993818034633296,0,1,alveolar primary septum development,BP,
15190,GO:0061145,1,0.986375471530452,0,2,lung smooth muscle development,BP,
15191,GO:0061146,1,0.980888243260382,0,3,Peyer's patch morphogenesis,BP,
15192,GO:0061149,1,0.994367297581572,0,1,BMP signaling pathway involved in ureter morphogenesis,BP,
15193,GO:0061150,1,0.994367297581572,0,1,renal system segmentation,BP,
15194,GO:0061151,1,0.994367297581572,0,1,BMP signaling pathway involved in renal system segmentation,BP,
15195,GO:0061152,1,0.988194073535833,0,2,trachea submucosa development,BP,
15196,GO:0061153,1,0.988194073535833,0,2,trachea gland development,BP,
15198,GO:0061155,1,0.994367297581572,0,1,pulmonary artery endothelial tube morphogenesis,BP,
15199,GO:0061156,1,0.955206678364083,0,6,pulmonary artery morphogenesis,BP,
15200,GO:0061157,1,0.85380711013547,0,22,mRNA destabilization,BP,
15201,GO:0061158,1,0.915116808673388,0,12,3'-UTR-mediated mRNA destabilization,BP,
15202,GO:0061162,1,0.875881627395361,0,19,establishment of monopolar cell polarity,BP,
15203,GO:0061178,1,0.729734344743619,0,49,regulation of insulin secretion involved in cellular response to glucose stimulus,BP,
15204,GO:0061179,1,0.946751548709071,0,9,negative regulation of insulin secretion involved in cellular response to glucose stimulus,BP,
15205,GO:0061180,1,0.638780308333393,0,64,mammary gland epithelium development,BP,
15206,GO:0061181,1,0.993105592466267,0,1,regulation of chondrocyte development,BP,
15208,GO:0061184,1,0.993277462394299,0,1,positive regulation of dermatome development,BP,
15210,GO:0061187,1,0.984719835064582,0,2,regulation of chromatin silencing at rDNA,BP,
15211,GO:0061188,1,0.984719835064582,0,2,negative regulation of chromatin silencing at rDNA,BP,
15212,GO:0061189,1,0.994475315120246,0,1,positive regulation of sclerotome development,BP,
15213,GO:0061190,1,0.994475315120246,0,1,regulation of sclerotome development,BP,
15214,GO:0061193,1,0.994774980004103,0,1,taste bud development,BP,
15215,GO:0061196,1,0.960321374941955,0,6,fungiform papilla development,BP,
15216,GO:0061197,1,0.966007668735648,0,5,fungiform papilla morphogenesis,BP,
15217,GO:0061198,1,0.979703990250689,0,3,fungiform papilla formation,BP,
15218,GO:0061200,1,0.95231381729691,0,8,clathrin-sculpted gamma-aminobutyric acid transport vesicle,CC,
15219,GO:0061202,1,0.95231381729691,0,8,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,CC,
15220,GO:0061205,1,0.987136638423202,0,2,paramesonephric duct development,BP,
15221,GO:0061209,1,0.976055561792013,0,4,cell proliferation involved in mesonephros development,BP,
15222,GO:0061213,1,0.880964000316292,0,20,positive regulation of mesonephros development,BP,
15223,GO:0061216,1,0.994367297581572,0,1,regulation of transcription from RNA polymerase II promoter involved in mesonephros development,BP,
15224,GO:0061217,1,0.865848420737603,0,23,regulation of mesonephros development,BP,
15225,GO:0061218,1,0.969725746962774,0,5,negative regulation of mesonephros development,BP,
15226,GO:0061227,1,0.988710490264874,0,2,pattern specification involved in mesonephros development,BP,
15228,GO:0061289,1,0.986324183710921,0,2,Wnt signaling pathway involved in kidney development,BP,
15229,GO:0061290,1,0.986324183710921,0,2,canonical Wnt signaling pathway involved in metanephric kidney development,BP,
15231,GO:0061299,1,0.939009533329818,0,9,retina vasculature morphogenesis in camera-type eye,BP,
15232,GO:0061300,1,0.986014419801684,0,2,cerebellum vasculature development,BP,
15233,GO:0061301,1,0.991464753558551,0,1,cerebellum vasculature morphogenesis,BP,
15234,GO:0061302,1,0.970432304388252,0,5,smooth muscle cell-matrix adhesion,BP,
15236,GO:0061304,1,0.96897142376094,0,4,retinal blood vessel morphogenesis,BP,
15237,GO:0061307,1,0.934020952953663,0,11,cardiac neural crest cell differentiation involved in heart development,BP,
15238,GO:0061308,1,0.934020952953663,0,11,cardiac neural crest cell development involved in heart development,BP,
15239,GO:0061309,1,0.945627920137691,0,9,cardiac neural crest cell development involved in outflow tract morphogenesis,BP,
15240,GO:0061311,1,0.854622791638064,0,24,cell surface receptor signaling pathway involved in heart development,BP,
15241,GO:0061312,1,0.964823099548944,0,6,BMP signaling pathway involved in heart development,BP,
15242,GO:0061314,1,0.937695656751406,0,9,Notch signaling involved in heart development,BP,
15243,GO:0061316,1,0.982056142494806,0,3,canonical Wnt signaling pathway involved in heart development,BP,
15244,GO:0061317,1,0.988460077738153,0,2,canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
15245,GO:0061318,1,0.901452357939619,0,15,renal filtration cell differentiation,BP,
15246,GO:0061323,1,0.905378704199593,0,15,cell proliferation involved in heart morphogenesis,BP,
15247,GO:0061324,1,0.993522058428007,0,1,canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation,BP,
15248,GO:0061325,1,0.976300946669495,0,4,cell proliferation involved in outflow tract morphogenesis,BP,
15252,GO:0061339,1,0.875881627395361,0,19,establishment or maintenance of monopolar cell polarity,BP,
15253,GO:0061341,1,0.984851292884506,0,2,non-canonical Wnt signaling pathway involved in heart development,BP,
15254,GO:0061343,1,0.971130661072324,0,4,cell adhesion involved in heart morphogenesis,BP,
15255,GO:0061346,1,0.984851292884506,0,2,planar cell polarity pathway involved in heart morphogenesis,BP,
15256,GO:0061347,1,0.992268880590988,0,1,planar cell polarity pathway involved in outflow tract morphogenesis,BP,
15257,GO:0061348,1,0.992268880590988,0,1,planar cell polarity pathway involved in ventricular septum morphogenesis,BP,
15258,GO:0061349,1,0.992268880590988,0,1,planar cell polarity pathway involved in cardiac right atrium morphogenesis,BP,
15259,GO:0061350,1,0.992268880590988,0,1,planar cell polarity pathway involved in cardiac muscle tissue morphogenesis,BP,
15261,GO:0061354,1,0.992268880590988,0,1,planar cell polarity pathway involved in pericardium morphogenesis,BP,
15262,GO:0061355,1,0.974749576473661,0,4,Wnt protein secretion,BP,
15263,GO:0061356,1,0.974749576473661,0,4,regulation of Wnt protein secretion,BP,
15264,GO:0061357,1,0.98031405946414,0,3,positive regulation of Wnt protein secretion,BP,
15265,GO:0061358,1,0.994324912224097,0,1,negative regulation of Wnt protein secretion,BP,
15266,GO:0061360,1,0.993169734686661,0,1,optic chiasma development,BP,
15267,GO:0061364,1,0.977610597549196,0,3,apoptotic process involved in luteolysis,BP,
15268,GO:0061365,1,0.960257496454453,0,7,positive regulation of triglyceride lipase activity,BP,
15269,GO:0061366,1,0.980733915836126,0,3,behavioral response to chemical pain,BP,
15270,GO:0061368,1,0.980733915836126,0,3,behavioral response to formalin induced pain,BP,
15271,GO:0061369,1,0.993277462394299,0,1,negative regulation of testicular blood vessel morphogenesis,BP,
15272,GO:0061370,1,0.964806128525905,0,6,testosterone biosynthetic process,BP,
15273,GO:0061371,1,0.678476906430248,0,58,determination of heart left/right asymmetry,BP,
15274,GO:0061373,1,0.990536994876242,0,1,mammillary axonal complex development,BP,
15275,GO:0061377,1,0.890433198251482,0,17,mammary gland lobule development,BP,
15276,GO:0061383,1,0.723395684796132,0,46,trabecula morphogenesis,BP,
15277,GO:0061384,1,0.805733784049077,0,31,heart trabecula morphogenesis,BP,
15280,GO:0061394,1,0.988665003642431,0,2,regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance,BP,
15281,GO:0061395,1,0.994401152481387,0,1,positive regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance,BP,
15282,GO:0061400,1,0.993850639026861,0,1,positive regulation of transcription from RNA polymerase II promoter in response to calcium ion,BP,
15283,GO:0061402,1,0.987954516708625,0,2,positive regulation of transcription from RNA polymerase II promoter in response to acidic pH,BP,
15284,GO:0061408,1,0.982146317325851,0,3,positive regulation of transcription from RNA polymerase II promoter in response to heat stress,BP,
15285,GO:0061418,1,0.636658159438067,0,74,regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
15286,GO:0061419,1,0.965578345681039,0,5,positive regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
15287,GO:0061428,1,0.974396470254784,0,4,negative regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
15288,GO:0061430,1,0.909038616974267,0,13,bone trabecula morphogenesis,BP,
15289,GO:0061433,1,0.99428252807261,0,1,cellular response to caloric restriction,BP,
15290,GO:0061436,1,0.901729654488185,0,16,establishment of skin barrier,BP,
15295,GO:0061441,1,0.986721728877588,0,2,renal artery morphogenesis,BP,
15296,GO:0061443,1,0.985988002423481,0,2,endocardial cushion cell differentiation,BP,
15297,GO:0061444,1,0.992179356917506,0,1,endocardial cushion cell development,BP,
15298,GO:0061445,1,0.993760336576739,0,1,endocardial cushion cell fate commitment,BP,
15300,GO:0061450,1,0.940217134273138,0,10,trophoblast cell migration,BP,
15302,GO:0061459,1,0.991365641064658,0,1,L-arginine transmembrane transporter activity,MF,
15303,GO:0061462,1,0.793861643971251,0,35,protein localization to lysosome,BP,
15304,GO:0061469,1,0.949601285052037,0,8,regulation of type B pancreatic cell proliferation,BP,
15305,GO:0061470,1,0.97106317988928,0,4,T follicular helper cell differentiation,BP,
15306,GO:0061474,1,0.99397435867985,0,1,phagolysosome membrane,CC,
15307,GO:0061476,1,0.966779517250541,0,5,response to anticoagulant,BP,
15308,GO:0061478,1,0.915107192586726,0,12,response to platelet aggregation inhibitor,BP,
15309,GO:0061481,1,0.994854530693101,0,1,response to TNF agonist,BP,
15310,GO:0061484,1,0.973401965765064,0,4,hematopoietic stem cell homeostasis,BP,
15311,GO:0061485,1,0.991404546779438,0,1,memory T cell proliferation,BP,
15312,GO:0061495,1,0.993850639026861,0,1,gamma-tubulin small complex, mitotic spindle pole body,CC,
15313,GO:0061502,1,0.968395978854587,0,4,early endosome to recycling endosome transport,BP,
15315,GO:0061507,1,0.994415365666449,0,1,cyclic-GMP-AMP binding,MF,
15316,GO:0061508,1,0.993850639026861,0,1,CDP phosphorylation,BP,
15317,GO:0061511,1,0.97326748957798,0,4,centriole elongation,BP,
15318,GO:0061512,1,0.804305771599111,0,33,protein localization to cilium,BP,
15319,GO:0061513,1,0.981137065471432,0,3,glucose 6-phosphate:inorganic phosphate antiporter activity,MF,
15320,GO:0061515,1,0.66212374434413,0,62,myeloid cell development,BP,
15321,GO:0061517,1,0.987778097918091,0,2,macrophage proliferation,BP,
15322,GO:0061518,1,0.987778097918091,0,2,microglial cell proliferation,BP,
15323,GO:0061519,1,0.993436044783864,0,1,macrophage homeostasis,BP,
15324,GO:0061523,1,0.993403761369442,0,1,cilium disassembly,BP,
15325,GO:0061525,1,0.944655146903347,0,8,hindgut development,BP,
15326,GO:0061526,1,0.976049872608377,0,4,acetylcholine secretion,BP,
15327,GO:0061528,1,0.992750414346676,0,1,aspartate secretion,BP,
15328,GO:0061534,1,0.988887627046022,0,1,gamma-aminobutyric acid secretion, neurotransmission,BP,
15329,GO:0061535,1,0.975095232994221,0,3,glutamate secretion, neurotransmission,BP,
15330,GO:0061536,1,0.993627463299271,0,1,glycine secretion,BP,
15331,GO:0061537,1,0.993627463299271,0,1,glycine secretion, neurotransmission,BP,
15332,GO:0061542,1,0.994634461808247,0,1,3-demethylubiquinone-n 3-O-methyltransferase activity,MF,
15333,GO:0061547,1,0.98722089564515,0,2,glycogen synthase activity, transferring glucose-1-phosphate,MF,
15334,GO:0061548,1,0.923387141466465,0,12,ganglion development,BP,
15335,GO:0061549,1,0.948178807755425,0,8,sympathetic ganglion development,BP,
15336,GO:0061550,1,0.966317664015395,0,5,cranial ganglion development,BP,
15337,GO:0061551,1,0.972620000517936,0,4,trigeminal ganglion development,BP,
15338,GO:0061552,1,0.994004758645168,0,1,ganglion morphogenesis,BP,
15340,GO:0061565,1,0.993850639026861,0,1,dAMP phosphorylation,BP,
15341,GO:0061566,1,0.993850639026861,0,1,CMP phosphorylation,BP,
15342,GO:0061567,1,0.993850639026861,0,1,dCMP phosphorylation,BP,
15343,GO:0061568,1,0.993850639026861,0,1,GDP phosphorylation,BP,
15344,GO:0061569,1,0.993850639026861,0,1,UDP phosphorylation,BP,
15345,GO:0061570,1,0.993850639026861,0,1,dCDP phosphorylation,BP,
15346,GO:0061571,1,0.993850639026861,0,1,TDP phosphorylation,BP,
15348,GO:0061574,1,0.981280603216251,0,3,ASAP complex,CC,
15349,GO:0061575,1,0.978770436687876,0,4,cyclin-dependent protein serine/threonine kinase activator activity,MF,
15350,GO:0061577,1,0.922327739267629,0,11,calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
15351,GO:0061578,1,0.931962203587589,0,10,Lys63-specific deubiquitinase activity,MF,
15352,GO:0061580,1,0.993164051426579,0,1,colon epithelial cell migration,BP,
15353,GO:0061582,1,0.985248331524838,0,2,intestinal epithelial cell migration,BP,
15354,GO:0061588,1,0.966416337036167,0,5,calcium activated phospholipid scrambling,BP,
15355,GO:0061589,1,0.974009732893179,0,4,calcium activated phosphatidylserine scrambling,BP,
15356,GO:0061590,1,0.966416337036167,0,5,calcium activated phosphatidylcholine scrambling,BP,
15357,GO:0061591,1,0.966416337036167,0,5,calcium activated galactosylceramide scrambling,BP,
15358,GO:0061598,1,0.993089013418687,0,1,molybdopterin adenylyltransferase activity,MF,
15359,GO:0061599,1,0.993089013418687,0,1,molybdopterin molybdotransferase activity,MF,
15360,GO:0061604,1,0.994020738101129,0,1,molybdopterin-synthase sulfurtransferase activity,MF,
15361,GO:0061605,1,0.994020738101129,0,1,molybdopterin-synthase adenylyltransferase activity,MF,
15362,GO:0061608,1,0.942911382855495,0,9,nuclear import signal receptor activity,MF,
15363,GO:0061609,1,0.994033112230947,0,1,fructose-1-phosphate aldolase activity,MF,
15364,GO:0061611,1,0.994371949535733,0,1,mannose to fructose-6-phosphate metabolic process,BP,
15365,GO:0061614,1,0.774716474743428,0,37,pri-miRNA transcription by RNA polymerase II,BP,
15366,GO:0061615,1,0.858117807840375,0,25,glycolytic process through fructose-6-phosphate,BP,
15367,GO:0061617,1,0.954604156006944,0,8,MICOS complex,CC,
15368,GO:0061618,1,0.989363669441096,0,1,sublamina densa,CC,
15369,GO:0061620,1,0.858117807840375,0,25,glycolytic process through glucose-6-phosphate,BP,
15370,GO:0061621,1,0.862797377831677,0,24,canonical glycolysis,BP,
15371,GO:0061622,1,0.988249535712048,0,2,glycolytic process through glucose-1-phosphate,BP,
15372,GO:0061623,1,0.994584345024232,0,1,glycolytic process from galactose,BP,
15374,GO:0061626,1,0.953962895252922,0,7,pharyngeal arch artery morphogenesis,BP,
15375,GO:0061627,1,0.994258236802506,0,1,S-methylmethionine-homocysteine S-methyltransferase activity,MF,
15376,GO:0061628,1,0.975874489963366,0,3,H3K27me3 modified histone binding,MF,
15377,GO:0061629,1,0.968782510885302,0,5,RNA polymerase II sequence-specific DNA binding transcription factor binding,MF,
15380,GO:0061635,1,0.958896379708853,0,7,regulation of protein complex stability,BP,
15382,GO:0061641,1,0.837734260800233,0,30,CENP-A containing chromatin organization,BP,
15383,GO:0061642,1,0.992268880590988,0,1,chemoattraction of axon,BP,
15384,GO:0061643,1,0.979705492574031,0,3,chemorepulsion of axon,BP,
15385,GO:0061645,1,0.951807343874327,0,7,endocytic patch,CC,
15386,GO:0061646,1,0.992736291507055,0,1,positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization,BP,
15387,GO:0061647,1,0.756393405385023,0,40,histone H3-K9 modification,BP,
15388,GO:0061649,1,0.979285071822074,0,3,ubiquitin modification-dependent histone binding,MF,
15390,GO:0061656,1,0.994668043425921,0,1,SUMO conjugating enzyme activity,MF,
15392,GO:0061663,1,0.991469945654152,0,1,NEDD8 ligase activity,MF,
15393,GO:0061665,1,0.96946331725789,0,5,SUMO ligase activity,MF,
15394,GO:0061668,1,0.961720552242428,0,6,mitochondrial ribosome assembly,BP,
15395,GO:0061669,1,0.975687809423674,0,3,spontaneous neurotransmitter secretion,BP,
15396,GO:0061670,1,0.994513038565373,0,1,evoked neurotransmitter secretion,BP,
15397,GO:0061673,1,0.96737974574758,0,5,mitotic spindle astral microtubule,CC,
15399,GO:0061682,1,0.994079020271407,0,1,seminal vesicle morphogenesis,BP,
15401,GO:0061685,1,0.993850639026861,0,1,diphthine methylesterase activity,MF,
15402,GO:0061687,1,0.93045946586164,0,13,detoxification of inorganic compound,BP,
15403,GO:0061689,1,0.973629906780871,0,4,tricellular tight junction,CC,
15404,GO:0061690,1,0.994684575433119,0,1,lipoamidase activity,MF,
15406,GO:0061697,1,0.993662774362528,0,1,protein-glutaryllysine deglutarylase activity,MF,
15407,GO:0061698,1,0.993662774362528,0,1,protein deglutarylation,BP,
15408,GO:0061699,1,0.993662774362528,0,1,peptidyl-lysine deglutarylation,BP,
15409,GO:0061700,1,0.94584360008178,0,9,GATOR2 complex,CC,
15410,GO:0061702,1,0.928745300812348,0,12,inflammasome complex,CC,
15411,GO:0061709,1,0.99182813245031,0,1,reticulophagy,BP,
15412,GO:0061711,1,0.988608797908072,0,2,N(6)-L-threonylcarbamoyladenine synthase activity,MF,
15413,GO:0061712,1,0.993596763163241,0,1,tRNA (N(6)-L-threonylcarbamoyladenosine(37)-C(2))-methylthiotransferase,MF,
15414,GO:0061713,1,0.994748117708665,0,1,anterior neural tube closure,BP,
15415,GO:0061714,1,0.989484996756733,0,2,folic acid receptor activity,MF,
15416,GO:0061718,1,0.862797377831677,0,24,glucose catabolic process to pyruvate,BP,
15417,GO:0061723,1,0.985899799287835,0,2,glycophagy,BP,
15418,GO:0061724,1,0.956813925439725,0,6,lipophagy,BP,
15419,GO:0061726,1,0.592469529097879,0,80,mitochondrion disassembly,BP,
15420,GO:0061727,1,0.988259621271998,0,2,methylglyoxal catabolic process to lactate,BP,
15422,GO:0061732,1,0.963650318063745,0,6,mitochondrial acetyl-CoA biosynthetic process from pyruvate,BP,
15423,GO:0061733,1,0.700240456585001,0,52,peptide-lysine-N-acetyltransferase activity,MF,
15424,GO:0061734,1,0.961406931290887,0,5,parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
15425,GO:0061736,1,0.99233463622063,0,1,engulfment of target by autophagosome,BP,
15426,GO:0061737,1,0.971369842087144,0,5,leukotriene signaling pathway,BP,
15427,GO:0061738,1,0.982050990308174,0,3,late endosomal microautophagy,BP,
15428,GO:0061739,1,0.980284948475382,0,3,protein lipidation involved in autophagosome assembly,BP,
15429,GO:0061740,1,0.981360002982544,0,3,protein targeting to lysosome involved in chaperone-mediated autophagy,BP,
15430,GO:0061741,1,0.988091885827697,0,2,chaperone-mediated protein transport involved in chaperone-mediated autophagy,BP,
15431,GO:0061743,1,0.976348556884889,0,4,motor learning,BP,
15432,GO:0061744,1,0.970140718390308,0,5,motor behavior,BP,
15433,GO:0061749,1,0.985301265548137,0,2,forked DNA-dependent helicase activity,MF,
15434,GO:0061750,1,0.994086760543214,0,1,acid sphingomyelin phosphodiesterase activity,MF,
15435,GO:0061752,1,0.988063825004377,0,2,telomeric repeat-containing RNA binding,MF,
15436,GO:0061753,1,0.99233463622063,0,1,substrate localization to autophagosome,BP,
15437,GO:0061756,1,0.84204961158633,0,27,leukocyte adhesion to vascular endothelial cell,BP,
15438,GO:0061757,1,0.988237564619208,0,2,leukocyte adhesion to arterial endothelial cell,BP,
15439,GO:0061760,1,0.988714049066916,0,2,antifungal innate immune response,BP,
15440,GO:0061762,1,0.975809855170119,0,3,CAMKK-AMPK signaling cascade,BP,
15441,GO:0061763,1,0.987818692289296,0,2,multivesicular body-lysosome fusion,BP,
15442,GO:0061767,1,0.992231437486126,0,1,negative regulation of lung blood pressure,BP,
15443,GO:0061768,1,0.992780740674459,0,1,magnesium:sodium antiporter activity,MF,
15444,GO:0061769,1,0.987738712940129,0,2,ribosylnicotinate kinase activity,MF,
15445,GO:0061770,1,0.99417298335658,0,1,translation elongation factor binding,MF,
15446,GO:0061771,1,0.981637071493047,0,3,response to caloric restriction,BP,
15447,GO:0061772,1,0.993526152433194,0,1,drug transport across blood-nerve barrier,BP,
15448,GO:0061778,1,0.886965397711632,0,18,intracellular chloride channel activity,MF,
15449,GO:0061780,1,0.990034427969389,0,1,mitotic cohesin loading,BP,
15450,GO:0061782,1,0.993179548007666,0,1,vesicle fusion with vesicle,BP,
15451,GO:0061783,1,0.979156667570717,0,4,peptidoglycan muralytic activity,MF,
15452,GO:0061789,1,0.973444286931859,0,3,dense core granule priming,BP,
15453,GO:0061792,1,0.978876567367759,0,3,secretory granule maturation,BP,
15454,GO:0061798,1,0.993142856533742,0,1,GTP 3',8'-cyclase activity,MF,
15455,GO:0061799,1,0.993142856533742,0,1,cyclic pyranopterin monophosphate synthase activity,MF,
15456,GO:0061809,1,0.989068729430147,0,2,NAD+ nucleotidase, cyclic ADP-ribose generating,MF,
15457,GO:0061811,1,0.994522339863804,0,1,ADP-ribosyl cyclase activity,MF,
15458,GO:0061812,1,0.994522339863804,0,1,cyclic ADP-ribose hydrolase,MF,
15459,GO:0061817,1,0.978464818655239,0,3,endoplasmic reticulum-plasma membrane tethering,BP,
15460,GO:0061819,1,0.979694683904826,0,3,telomeric DNA-containing double minutes formation,BP,
15461,GO:0061820,1,0.948205902947066,0,8,telomeric D-loop disassembly,BP,
15462,GO:0061821,1,0.972034300435872,0,4,telomeric D-loop binding,MF,
15463,GO:0061825,1,0.993264085382676,0,1,podosome core,CC,
15464,GO:0061827,1,0.970560259949972,0,5,sperm head,CC,
15465,GO:0061828,1,0.99132286387763,0,1,apical tubulobulbar complex,CC,
15466,GO:0061829,1,0.99132286387763,0,1,basal tubulobulbar complex,CC,
15467,GO:0061832,1,0.991229860110368,0,1,basal ectoplasmic specialization,CC,
15468,GO:0061833,1,0.987231913000737,0,2,protein localization to tricellular tight junction,BP,
15470,GO:0061844,1,0.851698425117994,0,30,antimicrobial humoral immune response mediated by antimicrobial peptide,BP,
15471,GO:0061845,1,0.993609042874978,0,1,neuron projection branch point,CC,
15472,GO:0061846,1,0.993609042874978,0,1,dendritic spine cytoplasm,CC,
15473,GO:0061847,1,0.99409604990986,0,1,response to cholecystokinin,BP,
15474,GO:0061849,1,0.985301265548137,0,2,telomeric G-quadruplex DNA binding,MF,
15475,GO:0061850,1,0.994831285768497,0,1,growth cone leading edge,CC,
15476,GO:0061851,1,0.993883785009252,0,1,leading edge of lamellipodium,CC,
15477,GO:0061853,1,0.992701755809941,0,1,regulation of neuroblast migration,BP,
15478,GO:0061855,1,0.992701755809941,0,1,negative regulation of neuroblast migration,BP,
15479,GO:0061857,1,0.987185381204243,0,2,endoplasmic reticulum stress-induced pre-emptive quality control,BP,
15480,GO:0061880,1,0.99440916359976,0,1,regulation of anterograde axonal transport of mitochondrion,BP,
15481,GO:0061881,1,0.99440916359976,0,1,positive regulation of anterograde axonal transport of mitochondrion,BP,
15482,GO:0061884,1,0.99423601500725,0,1,regulation of mini excitatory postsynaptic potential,BP,
15483,GO:0061885,1,0.99423601500725,0,1,positive regulation of mini excitatory postsynaptic potential,BP,
15484,GO:0061888,1,0.972527867843207,0,4,regulation of astrocyte activation,BP,
15485,GO:0061889,1,0.992563468337774,0,1,negative regulation of astrocyte activation,BP,
15486,GO:0061890,1,0.979815793512248,0,3,positive regulation of astrocyte activation,BP,
15487,GO:0061896,1,0.992870566691896,0,1,all-trans retinol 3,4-desaturase activity,MF,
15488,GO:0061897,1,0.992870566691896,0,1,all-trans retinal 3,4-desaturase activity,MF,
15489,GO:0061898,1,0.992870566691896,0,1,all-trans retinoic acid 3,4-desaturase activity,MF,
15490,GO:0061899,1,0.992870566691896,0,1,11-cis-retinal 3,4-desaturase activity,MF,
15492,GO:0061901,1,0.994277359549027,0,1,regulation of 1-phosphatidylinositol-3-kinase activity,BP,
15493,GO:0061903,1,0.994277359549027,0,1,positive regulation of 1-phosphatidylinositol-3-kinase activity,BP,
15494,GO:0061912,1,0.762205918800844,0,40,selective autophagy,BP,
15496,GO:0061920,1,0.990737145415483,0,1,protein propionyltransferase activity,MF,
15497,GO:0061921,1,0.990737145415483,0,1,peptidyl-lysine propionylation,BP,
15498,GO:0061930,1,0.992626349998796,0,1,regulation of erythrocyte enucleation,BP,
15499,GO:0061931,1,0.992626349998796,0,1,positive regulation of erythrocyte enucleation,BP,
15500,GO:0061944,1,0.993053230403247,0,1,negative regulation of protein K48-linked ubiquitination,BP,
15501,GO:0061945,1,0.981056356461812,0,3,regulation of protein K48-linked ubiquitination,BP,
15502,GO:0061951,1,0.771506459875815,0,39,establishment of protein localization to plasma membrane,BP,
15503,GO:0061953,1,0.981914069549653,0,3,mRNA (adenine-N1-)-methyltransferase activity,MF,
15505,GO:0061980,1,0.818446131899976,0,30,regulatory RNA binding,MF,
15506,GO:0061981,1,0.994520531289197,0,1,3-hydroxykynureninase activity,MF,
15509,GO:0061986,1,0.994041878730589,0,1,negative regulation of transcription by glucose,BP,
15510,GO:0061987,1,0.994041878730589,0,1,negative regulation of transcription from RNA polymerase II promoter by glucose,BP,
15514,GO:0062014,1,0.528145240619057,0,99,negative regulation of small molecule metabolic process,BP,
15515,GO:0065001,1,0.973359128518185,0,4,specification of axis polarity,BP,
15516,GO:0065002,1,0.743870240975579,0,49,intracellular protein transmembrane transport,BP,
15519,GO:0065005,1,0.85401112491353,0,24,protein-lipid complex assembly,BP,
15520,GO:0065006,1,0.989370909577331,0,2,protein-carbohydrate complex assembly,BP,
15524,GO:0065010,1,0.971247490657791,0,5,extracellular membrane-bounded organelle,CC,
15525,GO:0070001,1,0.895135076664688,0,18,aspartic-type peptidase activity,MF,
15526,GO:0070003,1,0.908684931117976,0,18,threonine-type peptidase activity,MF,
15527,GO:0070004,1,0.993850639026861,0,1,cysteine-type exopeptidase activity,MF,
15528,GO:0070006,1,0.881688497287478,0,19,metalloaminopeptidase activity,MF,
15529,GO:0070008,1,0.924181117250853,0,12,serine-type exopeptidase activity,MF,
15531,GO:0070012,1,0.987904602363193,0,2,oligopeptidase activity,MF,
15533,GO:0070016,1,0.933135269810873,0,10,armadillo repeat domain binding,MF,
15534,GO:0070022,1,0.971760679178287,0,4,transforming growth factor beta receptor complex,CC,
15535,GO:0070025,1,0.993944491212098,0,1,carbon monoxide binding,MF,
15536,GO:0070026,1,0.988768764938984,0,2,nitric oxide binding,MF,
15537,GO:0070032,1,0.976984236308985,0,4,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex,CC,
15538,GO:0070033,1,0.981354275836051,0,3,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex,CC,
15539,GO:0070034,1,0.859915738351409,0,22,telomerase RNA binding,MF,
15540,GO:0070035,1,0.545307134130264,0,91,purine NTP-dependent helicase activity,MF,
15541,GO:0070037,1,0.994746051353136,0,1,rRNA (pseudouridine) methyltransferase activity,MF,
15542,GO:0070039,1,0.992626873870278,0,1,rRNA (guanosine-2'-O-)-methyltransferase activity,MF,
15543,GO:0070042,1,0.993721653306979,0,1,rRNA (uridine-N3-)-methyltransferase activity,MF,
15544,GO:0070044,1,0.976212601715193,0,4,synaptobrevin 2-SNAP-25-syntaxin-1a complex,CC,
15545,GO:0070050,1,0.942188611808002,0,10,neuron cellular homeostasis,BP,
15546,GO:0070051,1,0.979929143569221,0,3,fibrinogen binding,MF,
15547,GO:0070052,1,0.985987660270089,0,2,collagen V binding,MF,
15548,GO:0070053,1,0.980821105014047,0,3,thrombospondin receptor activity,MF,
15549,GO:0070054,1,0.981074370298454,0,3,mRNA splicing, via endonucleolytic cleavage and ligation,BP,
15550,GO:0070055,1,0.981074370298454,0,3,mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
15551,GO:0070059,1,0.709599863622704,0,54,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,
15552,GO:0070060,1,0.990558583961521,0,1,'de novo' actin filament nucleation,BP,
15553,GO:0070061,1,0.970255117710972,0,5,fructose binding,MF,
15555,GO:0070063,1,0.698748267428747,0,54,RNA polymerase binding,MF,
15556,GO:0070064,1,0.879761298930072,0,18,proline-rich region binding,MF,
15557,GO:0070069,1,0.870522602745509,0,25,cytochrome complex,CC,
15558,GO:0070070,1,0.928960779009306,0,10,proton-transporting V-type ATPase complex assembly,BP,
15559,GO:0070071,1,0.907125078945422,0,14,proton-transporting two-sector ATPase complex assembly,BP,
15560,GO:0070072,1,0.928960779009306,0,10,vacuolar proton-transporting V-type ATPase complex assembly,BP,
15561,GO:0070075,1,0.994965586769087,0,1,tear secretion,BP,
15562,GO:0070076,1,0.829790406768041,0,25,histone lysine demethylation,BP,
15563,GO:0070077,1,0.993421186575349,0,1,histone arginine demethylation,BP,
15564,GO:0070078,1,0.993421186575349,0,1,histone H3-R2 demethylation,BP,
15565,GO:0070079,1,0.993421186575349,0,1,histone H4-R3 demethylation,BP,
15566,GO:0070080,1,0.987775046003848,0,2,titin Z domain binding,MF,
15567,GO:0070081,1,0.969975156756845,0,5,clathrin-sculpted monoamine transport vesicle,CC,
15568,GO:0070083,1,0.969975156756845,0,5,clathrin-sculpted monoamine transport vesicle membrane,CC,
15569,GO:0070085,1,0.202848409729672,0,241,glycosylation,BP,
15570,GO:0070086,1,0.975134252466205,0,4,ubiquitin-dependent endocytosis,BP,
15571,GO:0070087,1,0.954023493665049,0,6,chromo shadow domain binding,MF,
15572,GO:0070091,1,0.95825476922076,0,7,glucagon secretion,BP,
15573,GO:0070092,1,0.963383962932849,0,6,regulation of glucagon secretion,BP,
15574,GO:0070093,1,0.983063744924573,0,3,negative regulation of glucagon secretion,BP,
15575,GO:0070094,1,0.993953758510869,0,1,positive regulation of glucagon secretion,BP,
15576,GO:0070095,1,0.982295359117455,0,3,fructose-6-phosphate binding,MF,
15577,GO:0070096,1,0.993544062500637,0,1,mitochondrial outer membrane translocase complex assembly,BP,
15578,GO:0070097,1,0.955730904165717,0,6,delta-catenin binding,MF,
15579,GO:0070098,1,0.690017332831913,0,63,chemokine-mediated signaling pathway,BP,
15580,GO:0070099,1,0.952823847104973,0,7,regulation of chemokine-mediated signaling pathway,BP,
15581,GO:0070100,1,0.97001850268997,0,4,negative regulation of chemokine-mediated signaling pathway,BP,
15582,GO:0070101,1,0.982279289342164,0,3,positive regulation of chemokine-mediated signaling pathway,BP,
15583,GO:0070102,1,0.887072244063408,0,17,interleukin-6-mediated signaling pathway,BP,
15584,GO:0070103,1,0.982957346459645,0,3,regulation of interleukin-6-mediated signaling pathway,BP,
15585,GO:0070104,1,0.994408129914415,0,1,negative regulation of interleukin-6-mediated signaling pathway,BP,
15586,GO:0070105,1,0.988485474230217,0,2,positive regulation of interleukin-6-mediated signaling pathway,BP,
15588,GO:0070110,1,0.981177545059451,0,3,ciliary neurotrophic factor receptor complex,CC,
15589,GO:0070119,1,0.993158625234134,0,1,ciliary neurotrophic factor binding,MF,
15590,GO:0070120,1,0.965855044493721,0,5,ciliary neurotrophic factor-mediated signaling pathway,BP,
15591,GO:0070121,1,0.992417985007152,0,1,Kupffer's vesicle development,BP,
15592,GO:0070122,1,0.968225438507245,0,5,isopeptidase activity,MF,
15593,GO:0070123,1,0.991959846410181,0,1,transforming growth factor beta receptor activity, type III,MF,
15594,GO:0070124,1,0.988645789776931,0,2,mitochondrial translational initiation,BP,
15595,GO:0070125,1,0.6290648479948,0,84,mitochondrial translational elongation,BP,
15596,GO:0070126,1,0.621544364959145,0,86,mitochondrial translational termination,BP,
15597,GO:0070127,1,0.951095835061,0,8,tRNA aminoacylation for mitochondrial protein translation,BP,
15598,GO:0070129,1,0.896260861480606,0,18,regulation of mitochondrial translation,BP,
15599,GO:0070130,1,0.993850639026861,0,1,negative regulation of mitochondrial translation,BP,
15600,GO:0070131,1,0.93603436980778,0,11,positive regulation of mitochondrial translation,BP,
15601,GO:0070137,1,0.970670023398074,0,4,ubiquitin-like protein-specific endopeptidase activity,MF,
15602,GO:0070138,1,0.979889810569957,0,3,ubiquitin-like protein-specific isopeptidase activity,MF,
15603,GO:0070139,1,0.970670023398074,0,4,SUMO-specific endopeptidase activity,MF,
15604,GO:0070140,1,0.979889810569957,0,3,SUMO-specific isopeptidase activity,MF,
15605,GO:0070141,1,0.962006146416914,0,6,response to UV-A,BP,
15606,GO:0070142,1,0.965878822898474,0,5,synaptic vesicle budding,BP,
15607,GO:0070143,1,0.992812617035379,0,1,mitochondrial alanyl-tRNA aminoacylation,BP,
15608,GO:0070145,1,0.993555831129054,0,1,mitochondrial asparaginyl-tRNA aminoacylation,BP,
15609,GO:0070150,1,0.988361828813511,0,2,mitochondrial glycyl-tRNA aminoacylation,BP,
15610,GO:0070159,1,0.99405683608892,0,1,mitochondrial threonyl-tRNA aminoacylation,BP,
15613,GO:0070162,1,0.960546687476768,0,6,adiponectin secretion,BP,
15614,GO:0070163,1,0.960546687476768,0,6,regulation of adiponectin secretion,BP,
15615,GO:0070164,1,0.972914127506895,0,4,negative regulation of adiponectin secretion,BP,
15616,GO:0070165,1,0.987291753693003,0,2,positive regulation of adiponectin secretion,BP,
15617,GO:0070166,1,0.937465000909469,0,9,enamel mineralization,BP,
15618,GO:0070167,1,0.658926630333554,0,63,regulation of biomineral tissue development,BP,
15619,GO:0070168,1,0.920730837315963,0,13,negative regulation of biomineral tissue development,BP,
15620,GO:0070169,1,0.788682817637191,0,35,positive regulation of biomineral tissue development,BP,
15621,GO:0070170,1,0.97424581592026,0,4,regulation of tooth mineralization,BP,
15622,GO:0070171,1,0.986048287647232,0,2,negative regulation of tooth mineralization,BP,
15623,GO:0070172,1,0.988032222151119,0,2,positive regulation of tooth mineralization,BP,
15624,GO:0070176,1,0.994359027361531,0,1,DRM complex,CC,
15625,GO:0070178,1,0.988501555248422,0,2,D-serine metabolic process,BP,
15626,GO:0070179,1,0.994007335679593,0,1,D-serine biosynthetic process,BP,
15627,GO:0070180,1,0.99499038031084,0,1,large ribosomal subunit rRNA binding,MF,
15628,GO:0070181,1,0.955234324484446,0,8,small ribosomal subunit rRNA binding,MF,
15629,GO:0070182,1,0.901255643158797,0,16,DNA polymerase binding,MF,
15630,GO:0070183,1,0.993832664587356,0,1,mitochondrial tryptophanyl-tRNA aminoacylation,BP,
15631,GO:0070184,1,0.99417298335658,0,1,mitochondrial tyrosyl-tRNA aminoacylation,BP,
15632,GO:0070187,1,0.963958181274651,0,6,shelterin complex,CC,
15633,GO:0070189,1,0.959391107701839,0,7,kynurenine metabolic process,BP,
15634,GO:0070191,1,0.988171825494204,0,2,methionine-R-sulfoxide reductase activity,MF,
15638,GO:0070195,1,0.993039215998748,0,1,growth hormone receptor complex,CC,
15639,GO:0070197,1,0.968473531471934,0,5,meiotic attachment of telomere to nuclear envelope,BP,
15640,GO:0070198,1,0.832980741594097,0,27,protein localization to chromosome, telomeric region,BP,
15641,GO:0070199,1,0.864496087734081,0,23,establishment of protein localization to chromosome,BP,
15642,GO:0070200,1,0.908538607009119,0,15,establishment of protein localization to telomere,BP,
15644,GO:0070202,1,0.936321242323277,0,11,regulation of establishment of protein localization to chromosome,BP,
15645,GO:0070203,1,0.942118147945913,0,10,regulation of establishment of protein localization to telomere,BP,
15646,GO:0070206,1,0.734237129723929,0,48,protein trimerization,BP,
15647,GO:0070207,1,0.835019073701084,0,28,protein homotrimerization,BP,
15648,GO:0070208,1,0.93007227342149,0,11,protein heterotrimerization,BP,
15649,GO:0070209,1,0.993564529379673,0,1,ASTRA complex,CC,
15650,GO:0070212,1,0.971397288412961,0,4,protein poly-ADP-ribosylation,BP,
15651,GO:0070213,1,0.970122957317142,0,4,protein auto-ADP-ribosylation,BP,
15652,GO:0070221,1,0.978348364168436,0,4,sulfide oxidation, using sulfide:quinone oxidoreductase,BP,
15653,GO:0070227,1,0.674695267254967,0,63,lymphocyte apoptotic process,BP,
15654,GO:0070228,1,0.74154019510132,0,48,regulation of lymphocyte apoptotic process,BP,
15655,GO:0070229,1,0.842768470319426,0,27,negative regulation of lymphocyte apoptotic process,BP,
15656,GO:0070230,1,0.918983639138407,0,14,positive regulation of lymphocyte apoptotic process,BP,
15657,GO:0070231,1,0.766235058017298,0,43,T cell apoptotic process,BP,
15658,GO:0070232,1,0.83571661237363,0,29,regulation of T cell apoptotic process,BP,
15659,GO:0070233,1,0.897871136340899,0,17,negative regulation of T cell apoptotic process,BP,
15660,GO:0070234,1,0.942471626786531,0,10,positive regulation of T cell apoptotic process,BP,
15661,GO:0070235,1,0.969328210305607,0,5,regulation of activation-induced cell death of T cells,BP,
15662,GO:0070236,1,0.974892470733641,0,4,negative regulation of activation-induced cell death of T cells,BP,
15663,GO:0070238,1,0.994424668622026,0,1,activated T cell autonomous cell death,BP,
15664,GO:0070239,1,0.994424668622026,0,1,regulation of activated T cell autonomous cell death,BP,
15665,GO:0070241,1,0.994424668622026,0,1,positive regulation of activated T cell autonomous cell death,BP,
15666,GO:0070242,1,0.896390038221584,0,17,thymocyte apoptotic process,BP,
15667,GO:0070243,1,0.926886789634106,0,12,regulation of thymocyte apoptotic process,BP,
15668,GO:0070244,1,0.956490830182396,0,7,negative regulation of thymocyte apoptotic process,BP,
15669,GO:0070245,1,0.969063011970823,0,5,positive regulation of thymocyte apoptotic process,BP,
15670,GO:0070246,1,0.994618962129487,0,1,natural killer cell apoptotic process,BP,
15671,GO:0070247,1,0.994618962129487,0,1,regulation of natural killer cell apoptotic process,BP,
15672,GO:0070251,1,0.994092437245931,0,1,pristanate-CoA ligase activity,MF,
15674,GO:0070253,1,0.978647466275261,0,4,somatostatin secretion,BP,
15675,GO:0070254,1,0.940858405945032,0,10,mucus secretion,BP,
15676,GO:0070255,1,0.945677738725192,0,9,regulation of mucus secretion,BP,
15677,GO:0070256,1,0.988349733434263,0,2,negative regulation of mucus secretion,BP,
15678,GO:0070257,1,0.962701034011157,0,6,positive regulation of mucus secretion,BP,
15679,GO:0070259,1,0.987300669187419,0,2,tyrosyl-DNA phosphodiesterase activity,MF,
15680,GO:0070260,1,0.993850639026861,0,1,5'-tyrosyl-DNA phosphodiesterase activity,MF,
15681,GO:0070262,1,0.905705780554952,0,16,peptidyl-serine dephosphorylation,BP,
15682,GO:0070265,1,0.746637852512053,0,48,necrotic cell death,BP,
15683,GO:0070266,1,0.798376066141636,0,36,necroptotic process,BP,
15684,GO:0070267,1,0.993439118419326,0,1,oncosis,BP,
15685,GO:0070268,1,0.715870488378826,0,53,cornification,BP,
15686,GO:0070269,1,0.948314749401619,0,9,pyroptosis,BP,
15687,GO:0070273,1,0.864199647101837,0,22,phosphatidylinositol-4-phosphate binding,MF,
15688,GO:0070274,1,0.988781394677809,0,2,RES complex,CC,
15689,GO:0070278,1,0.969829619422837,0,5,extracellular matrix constituent secretion,BP,
15691,GO:0070280,1,0.99331653001693,0,1,pyridoxal binding,MF,
15692,GO:0070283,1,0.994422859727469,0,1,radical SAM enzyme activity,MF,
15693,GO:0070286,1,0.810385116021394,0,29,axonemal dynein complex assembly,BP,
15694,GO:0070287,1,0.993417599512362,0,1,ferritin receptor activity,MF,
15695,GO:0070288,1,0.989521982629051,0,2,ferritin complex,CC,
15696,GO:0070290,1,0.967318471645097,0,5,N-acylphosphatidylethanolamine-specific phospholipase D activity,MF,
15697,GO:0070291,1,0.980857044878207,0,3,N-acylethanolamine metabolic process,BP,
15698,GO:0070292,1,0.986339232739228,0,2,N-acylphosphatidylethanolamine metabolic process,BP,
15699,GO:0070293,1,0.912315952060048,0,15,renal absorption,BP,
15700,GO:0070294,1,0.973347571087271,0,4,renal sodium ion absorption,BP,
15701,GO:0070295,1,0.982200343612557,0,3,renal water absorption,BP,
15702,GO:0070296,1,0.796769690095045,0,31,sarcoplasmic reticulum calcium ion transport,BP,
15703,GO:0070300,1,0.88491645959583,0,18,phosphatidic acid binding,MF,
15707,GO:0070304,1,0.400922061394869,0,137,positive regulation of stress-activated protein kinase signaling cascade,BP,
15708,GO:0070305,1,0.956833867876811,0,6,response to cGMP,BP,
15709,GO:0070306,1,0.839227797148784,0,26,lens fiber cell differentiation,BP,
15710,GO:0070307,1,0.931998055683741,0,11,lens fiber cell development,BP,
15711,GO:0070309,1,0.974558042454613,0,4,lens fiber cell morphogenesis,BP,
15712,GO:0070314,1,0.961519360473786,0,6,G1 to G0 transition,BP,
15713,GO:0070315,1,0.987304790640188,0,2,G1 to G0 transition involved in cell differentiation,BP,
15716,GO:0070318,1,0.973815449422708,0,4,positive regulation of G0 to G1 transition,BP,
15717,GO:0070320,1,0.993908726252119,0,1,inward rectifier potassium channel inhibitor activity,MF,
15718,GO:0070324,1,0.957490022718319,0,7,thyroid hormone binding,MF,
15719,GO:0070325,1,0.857198519764242,0,21,lipoprotein particle receptor binding,MF,
15720,GO:0070326,1,0.972136259981746,0,4,very-low-density lipoprotein particle receptor binding,MF,
15721,GO:0070327,1,0.957128035242536,0,7,thyroid hormone transport,BP,
15722,GO:0070328,1,0.856640737475532,0,25,triglyceride homeostasis,BP,
15723,GO:0070329,1,0.988100047207082,0,2,tRNA seleno-modification,BP,
15724,GO:0070330,1,0.907247197098724,0,16,aromatase activity,MF,
15725,GO:0070335,1,0.991585806044034,0,1,aspartate binding,MF,
15726,GO:0070336,1,0.986198866684756,0,2,flap-structured DNA binding,MF,
15727,GO:0070337,1,0.992301360687703,0,1,3'-flap-structured DNA binding,MF,
15728,GO:0070339,1,0.963224107368382,0,6,response to bacterial lipopeptide,BP,
15729,GO:0070340,1,0.979739173021128,0,3,detection of bacterial lipopeptide,BP,
15730,GO:0070341,1,0.944091919760953,0,9,fat cell proliferation,BP,
15731,GO:0070343,1,0.982763219943004,0,3,white fat cell proliferation,BP,
15732,GO:0070344,1,0.944091919760953,0,9,regulation of fat cell proliferation,BP,
15733,GO:0070345,1,0.966567995472725,0,5,negative regulation of fat cell proliferation,BP,
15734,GO:0070346,1,0.983566727292617,0,3,positive regulation of fat cell proliferation,BP,
15735,GO:0070350,1,0.982763219943004,0,3,regulation of white fat cell proliferation,BP,
15736,GO:0070352,1,0.989617021549393,0,2,positive regulation of white fat cell proliferation,BP,
15737,GO:0070358,1,0.96090916378626,0,6,actin polymerization-dependent cell motility,BP,
15738,GO:0070365,1,0.920794706058613,0,13,hepatocyte differentiation,BP,
15739,GO:0070366,1,0.98895759845825,0,2,regulation of hepatocyte differentiation,BP,
15740,GO:0070367,1,0.994236531765539,0,1,negative regulation of hepatocyte differentiation,BP,
15741,GO:0070368,1,0.994690774858455,0,1,positive regulation of hepatocyte differentiation,BP,
15742,GO:0070369,1,0.977885889030808,0,3,beta-catenin-TCF7L2 complex,CC,
15743,GO:0070370,1,0.97180226242337,0,5,cellular heat acclimation,BP,
15746,GO:0070373,1,0.685246129730809,0,58,negative regulation of ERK1 and ERK2 cascade,BP,
15748,GO:0070375,1,0.98044884630152,0,3,ERK5 cascade,BP,
15749,GO:0070376,1,0.993793407287285,0,1,regulation of ERK5 cascade,BP,
15750,GO:0070377,1,0.993793407287285,0,1,negative regulation of ERK5 cascade,BP,
15751,GO:0070381,1,0.986906411983682,0,2,endosome to plasma membrane transport vesicle,CC,
15753,GO:0070383,1,0.954521351148231,0,8,DNA cytosine deamination,BP,
15754,GO:0070384,1,0.975761497363442,0,4,Harderian gland development,BP,
15755,GO:0070390,1,0.994403478303465,0,1,transcription export complex 2,CC,
15756,GO:0070391,1,0.935799638165408,0,11,response to lipoteichoic acid,BP,
15757,GO:0070392,1,0.994745534763665,0,1,detection of lipoteichoic acid,BP,
15758,GO:0070401,1,0.988593859830789,0,2,NADP+ binding,MF,
15759,GO:0070402,1,0.92171489603515,0,13,NADPH binding,MF,
15760,GO:0070403,1,0.919678832522861,0,14,NAD+ binding,MF,
15761,GO:0070404,1,0.983403333868536,0,3,NADH binding,MF,
15762,GO:0070405,1,0.693080790858224,0,59,ammonium ion binding,MF,
15763,GO:0070407,1,0.993677106376401,0,1,oxidation-dependent protein catabolic process,BP,
15764,GO:0070408,1,0.992312364217936,0,1,carbamoyl phosphate metabolic process,BP,
15765,GO:0070409,1,0.992312364217936,0,1,carbamoyl phosphate biosynthetic process,BP,
15766,GO:0070410,1,0.912060196147524,0,12,co-SMAD binding,MF,
15767,GO:0070411,1,0.923492292780724,0,11,I-SMAD binding,MF,
15768,GO:0070412,1,0.845836103392603,0,23,R-SMAD binding,MF,
15769,GO:0070413,1,0.993762130514927,0,1,trehalose metabolism in response to stress,BP,
15770,GO:0070417,1,0.952647472016327,0,7,cellular response to cold,BP,
15771,GO:0070418,1,0.992615872017292,0,1,DNA-dependent protein kinase complex,CC,
15772,GO:0070419,1,0.952190789273751,0,7,nonhomologous end joining complex,CC,
15773,GO:0070423,1,0.804779494353616,0,33,nucleotide-binding oligomerization domain containing signaling pathway,BP,
15774,GO:0070424,1,0.945980038333365,0,8,regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
15775,GO:0070425,1,0.98678352582689,0,2,negative regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
15776,GO:0070426,1,0.98051912923627,0,3,positive regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
15777,GO:0070427,1,0.974054333726546,0,4,nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
15778,GO:0070428,1,0.985425190933601,0,2,regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
15779,GO:0070429,1,0.993003891125131,0,1,negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
15780,GO:0070430,1,0.992368443602378,0,1,positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
15781,GO:0070431,1,0.938116836435667,0,10,nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15782,GO:0070432,1,0.967557565323504,0,5,regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15783,GO:0070433,1,0.98678352582689,0,2,negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15784,GO:0070434,1,0.98051912923627,0,3,positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15785,GO:0070435,1,0.987574676234133,0,2,Shc-EGFR complex,CC,
15786,GO:0070436,1,0.986702246079924,0,2,Grb2-EGFR complex,CC,
15787,GO:0070442,1,0.994575044620396,0,1,integrin alphaIIb-beta3 complex,CC,
15788,GO:0070444,1,0.942659607413273,0,8,oligodendrocyte progenitor proliferation,BP,
15789,GO:0070445,1,0.942659607413273,0,8,regulation of oligodendrocyte progenitor proliferation,BP,
15790,GO:0070446,1,0.99428252807261,0,1,negative regulation of oligodendrocyte progenitor proliferation,BP,
15791,GO:0070447,1,0.975218774187837,0,3,positive regulation of oligodendrocyte progenitor proliferation,BP,
15792,GO:0070458,1,0.982579600820023,0,3,cellular detoxification of nitrogen compound,BP,
15793,GO:0070459,1,0.959008103240449,0,7,prolactin secretion,BP,
15794,GO:0070460,1,0.993293917962388,0,1,thyroid-stimulating hormone secretion,BP,
15795,GO:0070461,1,0.858496307963582,0,23,SAGA-type complex,CC,
15796,GO:0070462,1,0.993403761369442,0,1,plus-end specific microtubule depolymerization,BP,
15797,GO:0070463,1,0.993496979756482,0,1,tubulin-dependent ATPase activity,MF,
15798,GO:0070469,1,0.641519469439073,0,81,respiratory chain,CC,
15799,GO:0070470,1,0.977449199890768,0,4,plasma membrane respiratory chain,CC,
15800,GO:0070471,1,0.95098555979485,0,8,uterine smooth muscle contraction,BP,
15801,GO:0070472,1,0.956770536965702,0,7,regulation of uterine smooth muscle contraction,BP,
15802,GO:0070473,1,0.994279943800713,0,1,negative regulation of uterine smooth muscle contraction,BP,
15803,GO:0070474,1,0.962276948388391,0,6,positive regulation of uterine smooth muscle contraction,BP,
15804,GO:0070475,1,0.959811935995769,0,7,rRNA base methylation,BP,
15805,GO:0070476,1,0.99499038031084,0,1,rRNA (guanine-N7)-methylation,BP,
15806,GO:0070478,1,0.993127853983742,0,1,nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay,BP,
15807,GO:0070481,1,0.993783150223992,0,1,nuclear-transcribed mRNA catabolic process, non-stop decay,BP,
15809,GO:0070483,1,0.993645373630996,0,1,detection of hypoxia,BP,
15810,GO:0070486,1,0.926400988140116,0,12,leukocyte aggregation,BP,
15811,GO:0070487,1,0.967020160060426,0,5,monocyte aggregation,BP,
15812,GO:0070488,1,0.990095549339981,0,2,neutrophil aggregation,BP,
15813,GO:0070489,1,0.987562219480562,0,2,T cell aggregation,BP,
15814,GO:0070491,1,0.665481054062953,0,62,repressing transcription factor binding,MF,
15815,GO:0070492,1,0.947218610181524,0,9,oligosaccharide binding,MF,
15816,GO:0070493,1,0.924085698958828,0,12,thrombin-activated receptor signaling pathway,BP,
15817,GO:0070494,1,0.980073817661306,0,3,regulation of thrombin-activated receptor signaling pathway,BP,
15818,GO:0070495,1,0.980073817661306,0,3,negative regulation of thrombin-activated receptor signaling pathway,BP,
15819,GO:0070498,1,0.556372643229484,0,96,interleukin-1-mediated signaling pathway,BP,
15820,GO:0070506,1,0.987853672986258,0,2,high-density lipoprotein particle receptor activity,MF,
15822,GO:0070508,1,0.958826327407336,0,7,cholesterol import,BP,
15823,GO:0070509,1,0.637856142631752,0,64,calcium ion import,BP,
15824,GO:0070510,1,0.991594384510575,0,1,regulation of histone H4-K20 methylation,BP,
15825,GO:0070512,1,0.991594384510575,0,1,positive regulation of histone H4-K20 methylation,BP,
15826,GO:0070513,1,0.948287026652155,0,9,death domain binding,MF,
15827,GO:0070522,1,0.973668942994373,0,4,ERCC4-ERCC1 complex,CC,
15828,GO:0070524,1,0.994559802017333,0,1,11-beta-hydroxysteroid dehydrogenase (NADP+) activity,MF,
15829,GO:0070525,1,0.925537182621902,0,13,tRNA threonylcarbamoyladenosine metabolic process,BP,
15831,GO:0070528,1,0.839944872115793,0,27,protein kinase C signaling,BP,
15832,GO:0070530,1,0.892156236716204,0,17,K63-linked polyubiquitin modification-dependent protein binding,MF,
15833,GO:0070531,1,0.967552507915096,0,5,BRCA1-A complex,CC,
15834,GO:0070534,1,0.758250127430073,0,42,protein K63-linked ubiquitination,BP,
15835,GO:0070535,1,0.96344457542367,0,5,histone H2A K63-linked ubiquitination,BP,
15836,GO:0070536,1,0.846867473705026,0,24,protein K63-linked deubiquitination,BP,
15837,GO:0070537,1,0.981600052547989,0,3,histone H2A K63-linked deubiquitination,BP,
15838,GO:0070538,1,0.989305115882239,0,2,oleic acid binding,MF,
15839,GO:0070539,1,0.993475990824954,0,1,linoleic acid binding,MF,
15840,GO:0070541,1,0.979882135899083,0,3,response to platinum ion,BP,
15841,GO:0070542,1,0.614489081486624,0,75,response to fatty acid,BP,
15842,GO:0070543,1,0.994217929414997,0,1,response to linoleic acid,BP,
15843,GO:0070544,1,0.943844480683544,0,8,histone H3-K36 demethylation,BP,
15844,GO:0070545,1,0.981243343609709,0,3,PeBoW complex,CC,
15845,GO:0070547,1,0.993861170812666,0,1,L-tyrosine aminotransferase activity,MF,
15846,GO:0070548,1,0.984589036486935,0,2,L-glutamine aminotransferase activity,MF,
15847,GO:0070550,1,0.990034427969389,0,1,rDNA condensation,BP,
15848,GO:0070551,1,0.993850639026861,0,1,endoribonuclease activity, cleaving siRNA-paired mRNA,MF,
15849,GO:0070552,1,0.981891137917145,0,3,BRISC complex,CC,
15850,GO:0070553,1,0.993850639026861,0,1,nicotinic acid receptor activity,MF,
15851,GO:0070554,1,0.987088962994221,0,2,synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex,CC,
15852,GO:0070555,1,0.35546652669627,0,166,response to interleukin-1,BP,
15853,GO:0070557,1,0.988779320942482,0,2,PCNA-p21 complex,CC,
15854,GO:0070560,1,0.987702736466584,0,2,protein secretion by platelet,BP,
15855,GO:0070561,1,0.941328831964719,0,9,vitamin D receptor signaling pathway,BP,
15856,GO:0070562,1,0.960035413841855,0,6,regulation of vitamin D receptor signaling pathway,BP,
15857,GO:0070563,1,0.986910630421799,0,2,negative regulation of vitamin D receptor signaling pathway,BP,
15858,GO:0070564,1,0.988223115225302,0,2,positive regulation of vitamin D receptor signaling pathway,BP,
15859,GO:0070566,1,0.837423203129073,0,27,adenylyltransferase activity,MF,
15860,GO:0070567,1,0.944822963216584,0,9,cytidylyltransferase activity,MF,
15861,GO:0070568,1,0.969130265212742,0,5,guanylyltransferase activity,MF,
15862,GO:0070569,1,0.955712743109921,0,7,uridylyltransferase activity,MF,
15863,GO:0070570,1,0.842201104077351,0,26,regulation of neuron projection regeneration,BP,
15864,GO:0070571,1,0.909353017768392,0,14,negative regulation of neuron projection regeneration,BP,
15865,GO:0070572,1,0.953492618545317,0,8,positive regulation of neuron projection regeneration,BP,
15866,GO:0070573,1,0.981925131470057,0,3,metallodipeptidase activity,MF,
15867,GO:0070574,1,0.974548416806674,0,4,cadmium ion transmembrane transport,BP,
15868,GO:0070576,1,0.987630228114219,0,2,vitamin D 24-hydroxylase activity,MF,
15869,GO:0070577,1,0.87898127978105,0,17,lysine-acetylated histone binding,MF,
15870,GO:0070578,1,0.943026427217905,0,9,RISC-loading complex,CC,
15871,GO:0070579,1,0.964750591727394,0,4,methylcytosine dioxygenase activity,MF,
15872,GO:0070584,1,0.876735878797499,0,21,mitochondrion morphogenesis,BP,
15877,GO:0070589,1,0.994371949535733,0,1,cellular component macromolecule biosynthetic process,BP,
15878,GO:0070593,1,0.984347291468666,0,2,dendrite self-avoidance,BP,
15880,GO:0070602,1,0.975026962004429,0,4,regulation of centromeric sister chromatid cohesion,BP,
15881,GO:0070603,1,0.604580244037479,0,73,SWI/SNF superfamily-type complex,CC,
15882,GO:0070611,1,0.993926476606755,0,1,histone methyltransferase activity (H3-R2 specific),MF,
15883,GO:0070612,1,0.993926476606755,0,1,histone methyltransferase activity (H2A-R3 specific),MF,
15885,GO:0070615,1,0.993183420554318,0,1,nucleosome-dependent ATPase activity,MF,
15886,GO:0070618,1,0.993900239460429,0,1,Grb2-Sos complex,CC,
15887,GO:0070625,1,0.994213279153493,0,1,zymogen granule exocytosis,BP,
15888,GO:0070626,1,0.994523890066322,0,1,(S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity,MF,
15889,GO:0070627,1,0.993138201536524,0,1,ferrous iron import,BP,
15890,GO:0070628,1,0.874969523662873,0,21,proteasome binding,MF,
15891,GO:0070631,1,0.993850639026861,0,1,spindle pole body localization,BP,
15892,GO:0070632,1,0.993850639026861,0,1,establishment of spindle pole body localization,BP,
15893,GO:0070633,1,0.903489722277205,0,15,transepithelial transport,BP,
15894,GO:0070634,1,0.986055102575075,0,2,transepithelial ammonium transport,BP,
15895,GO:0070637,1,0.994041363020688,0,1,pyridine nucleoside metabolic process,BP,
15896,GO:0070638,1,0.994041363020688,0,1,pyridine nucleoside catabolic process,BP,
15897,GO:0070640,1,0.980946219863168,0,3,vitamin D3 metabolic process,BP,
15898,GO:0070643,1,0.994453610069964,0,1,vitamin D 25-hydroxylase activity,MF,
15899,GO:0070644,1,0.978526569453928,0,3,vitamin D response element binding,MF,
15902,GO:0070649,1,0.978215190868673,0,3,formin-nucleated actin cable assembly,BP,
15903,GO:0070651,1,0.993783150223992,0,1,nonfunctional rRNA decay,BP,
15904,GO:0070652,1,0.949855859187625,0,8,HAUS complex,CC,
15905,GO:0070653,1,0.994825603629511,0,1,high-density lipoprotein particle receptor binding,MF,
15907,GO:0070662,1,0.97896630520616,0,3,mast cell proliferation,BP,
15910,GO:0070665,1,0.474635676803976,0,121,positive regulation of leukocyte proliferation,BP,
15911,GO:0070666,1,0.98625460051184,0,2,regulation of mast cell proliferation,BP,
15912,GO:0070667,1,0.993707057427848,0,1,negative regulation of mast cell proliferation,BP,
15913,GO:0070668,1,0.98625460051184,0,2,positive regulation of mast cell proliferation,BP,
15914,GO:0070669,1,0.917711617801815,0,13,response to interleukin-2,BP,
15915,GO:0070670,1,0.828086784701624,0,30,response to interleukin-4,BP,
15916,GO:0070671,1,0.756420309597124,0,46,response to interleukin-12,BP,
15917,GO:0070672,1,0.909340582594397,0,14,response to interleukin-15,BP,
15918,GO:0070673,1,0.935321594427408,0,11,response to interleukin-18,BP,
15919,GO:0070676,1,0.983150186750207,0,3,intralumenal vesicle formation,BP,
15920,GO:0070678,1,0.993903839715766,0,1,preprotein binding,MF,
15921,GO:0070679,1,0.904182548312479,0,13,inositol 1,4,5 trisphosphate binding,MF,
15922,GO:0070681,1,0.982197055458679,0,3,glutaminyl-tRNAGln biosynthesis via transamidation,BP,
15923,GO:0070682,1,0.982234125928382,0,3,proteasome regulatory particle assembly,BP,
15924,GO:0070684,1,0.994702140365824,0,1,seminal clot liquefaction,BP,
15925,GO:0070685,1,0.994197521013564,0,1,macropinocytic cup,CC,
15926,GO:0070694,1,0.993850639026861,0,1,deoxyribonucleoside 5'-monophosphate N-glycosidase activity,MF,
15927,GO:0070695,1,0.962250388324321,0,5,FHF complex,CC,
15928,GO:0070696,1,0.895945529982909,0,17,transmembrane receptor protein serine/threonine kinase binding,MF,
15929,GO:0070697,1,0.968567131161535,0,5,activin receptor binding,MF,
15930,GO:0070698,1,0.988051411790887,0,2,type I activin receptor binding,MF,
15931,GO:0070699,1,0.985930492976277,0,2,type II activin receptor binding,MF,
15932,GO:0070700,1,0.925044876952761,0,12,BMP receptor binding,MF,
15933,GO:0070704,1,0.986902802350349,0,2,sterol desaturase activity,MF,
15934,GO:0070715,1,0.993596251514619,0,1,sodium-dependent organic cation transport,BP,
15935,GO:0070717,1,0.855525963970504,0,23,poly-purine tract binding,MF,
15936,GO:0070722,1,0.993485206085046,0,1,Tle3-Aes complex,CC,
15937,GO:0070723,1,0.863396791814268,0,20,response to cholesterol,BP,
15938,GO:0070724,1,0.993664309842,0,1,BMP receptor complex,CC,
15940,GO:0070728,1,0.953914967095626,0,7,leucine binding,MF,
15941,GO:0070733,1,0.994436555483609,0,1,protein adenylyltransferase activity,MF,
15942,GO:0070734,1,0.881384289650603,0,19,histone H3-K27 methylation,BP,
15943,GO:0070735,1,0.993530758056386,0,1,protein-glycine ligase activity,MF,
15944,GO:0070736,1,0.993530758056386,0,1,protein-glycine ligase activity, initiating,MF,
15945,GO:0070739,1,0.955641934061051,0,7,protein-glutamic acid ligase activity,MF,
15946,GO:0070740,1,0.955641934061051,0,7,tubulin-glutamic acid ligase activity,MF,
15947,GO:0070741,1,0.792559690191523,0,35,response to interleukin-6,BP,
15948,GO:0070742,1,0.909082013263739,0,14,C2H2 zinc finger domain binding,MF,
15949,GO:0070743,1,0.994751217235029,0,1,interleukin-23 complex,CC,
15950,GO:0070757,1,0.929987129338656,0,11,interleukin-35-mediated signaling pathway,BP,
15951,GO:0070761,1,0.969129360471053,0,5,pre-snoRNP complex,CC,
15952,GO:0070762,1,0.993850639026861,0,1,nuclear pore transmembrane ring,CC,
15953,GO:0070765,1,0.962013731829354,0,6,gamma-secretase complex,CC,
15954,GO:0070772,1,0.993684785110246,0,1,PAS complex,CC,
15955,GO:0070773,1,0.99459157858605,0,1,protein-N-terminal glutamine amidohydrolase activity,MF,
15956,GO:0070774,1,0.993024156028235,0,1,phytoceramidase activity,MF,
15957,GO:0070775,1,0.953360617389665,0,7,H3 histone acetyltransferase complex,CC,
15958,GO:0070776,1,0.953360617389665,0,7,MOZ/MORF histone acetyltransferase complex,CC,
15959,GO:0070777,1,0.969370769206955,0,4,D-aspartate transport,BP,
15960,GO:0070778,1,0.962476864408729,0,6,L-aspartate transmembrane transport,BP,
15961,GO:0070779,1,0.969370769206955,0,4,D-aspartate import across plasma membrane,BP,
15962,GO:0070780,1,0.988287417289671,0,2,dihydrosphingosine-1-phosphate phosphatase activity,MF,
15963,GO:0070781,1,0.986653796907749,0,2,response to biotin,BP,
15964,GO:0070782,1,0.994174532957652,0,1,phosphatidylserine exposure on apoptotic cell surface,BP,
15965,GO:0070813,1,0.969360984356644,0,5,hydrogen sulfide metabolic process,BP,
15966,GO:0070814,1,0.974438670273607,0,4,hydrogen sulfide biosynthetic process,BP,
15967,GO:0070815,1,0.97435146751594,0,4,peptidyl-lysine 5-dioxygenase activity,MF,
15968,GO:0070816,1,0.907912986349449,0,15,phosphorylation of RNA polymerase II C-terminal domain,BP,
15969,GO:0070818,1,0.9943866804482,0,1,protoporphyrinogen oxidase activity,MF,
15970,GO:0070820,1,0.380225332027346,0,152,tertiary granule,CC,
15971,GO:0070821,1,0.631610490947347,0,69,tertiary granule membrane,CC,
15972,GO:0070822,1,0.902244217509892,0,15,Sin3-type complex,CC,
15973,GO:0070826,1,0.993138201536524,0,1,paraferritin complex,CC,
15974,GO:0070827,1,0.970993309757743,0,4,chromatin maintenance,BP,
15975,GO:0070828,1,0.900567514061121,0,15,heterochromatin organization,BP,
15976,GO:0070829,1,0.984499733589313,0,2,heterochromatin maintenance,BP,
15978,GO:0070831,1,0.942442567556666,0,8,basement membrane assembly,BP,
15979,GO:0070836,1,0.981851092348671,0,3,caveola assembly,BP,
15980,GO:0070837,1,0.980293802789189,0,3,dehydroascorbic acid transport,BP,
15982,GO:0070839,1,0.986899671418412,0,2,divalent metal ion export,BP,
15985,GO:0070842,1,0.974661743875488,0,4,aggresome assembly,BP,
15986,GO:0070843,1,0.993164051426579,0,1,misfolded protein transport,BP,
15987,GO:0070844,1,0.993164051426579,0,1,polyubiquitinated protein transport,BP,
15988,GO:0070845,1,0.993164051426579,0,1,polyubiquitinated misfolded protein transport,BP,
15989,GO:0070846,1,0.993164051426579,0,1,Hsp90 deacetylation,BP,
15990,GO:0070847,1,0.953194642478019,0,8,core mediator complex,CC,
15992,GO:0070849,1,0.743873310952537,0,43,response to epidermal growth factor,BP,
15994,GO:0070852,1,0.95655565995763,0,6,cell body fiber,CC,
15995,GO:0070853,1,0.982864024366587,0,2,myosin VI binding,MF,
15996,GO:0070856,1,0.992139596809083,0,1,myosin VI light chain binding,MF,
15997,GO:0070857,1,0.9516912586041,0,8,regulation of bile acid biosynthetic process,BP,
15998,GO:0070858,1,0.981843368176696,0,3,negative regulation of bile acid biosynthetic process,BP,
15999,GO:0070859,1,0.981994128478464,0,3,positive regulation of bile acid biosynthetic process,BP,
16000,GO:0070860,1,0.994096566018293,0,1,RNA polymerase I core factor complex,CC,
16001,GO:0070861,1,0.854808747083543,0,23,regulation of protein exit from endoplasmic reticulum,BP,
16002,GO:0070862,1,0.938912627757924,0,10,negative regulation of protein exit from endoplasmic reticulum,BP,
16003,GO:0070863,1,0.924150687632434,0,11,positive regulation of protein exit from endoplasmic reticulum,BP,
16004,GO:0070873,1,0.828328652911434,0,26,regulation of glycogen metabolic process,BP,
16005,GO:0070874,1,0.964277469426321,0,5,negative regulation of glycogen metabolic process,BP,
16006,GO:0070875,1,0.89932151407755,0,14,positive regulation of glycogen metabolic process,BP,
16007,GO:0070876,1,0.974755567386931,0,4,SOSS complex,CC,
16008,GO:0070877,1,0.986888853068321,0,2,microprocessor complex,CC,
16009,GO:0070878,1,0.944437839406058,0,8,primary miRNA binding,MF,
16010,GO:0070883,1,0.96654167360864,0,5,pre-miRNA binding,MF,
16011,GO:0070884,1,0.892959324844547,0,16,regulation of calcineurin-NFAT signaling cascade,BP,
16012,GO:0070885,1,0.978591713774726,0,3,negative regulation of calcineurin-NFAT signaling cascade,BP,
16013,GO:0070886,1,0.940402088548008,0,9,positive regulation of calcineurin-NFAT signaling cascade,BP,
16015,GO:0070888,1,0.816182022982299,0,31,E-box binding,MF,
16016,GO:0070889,1,0.988031892013412,0,2,platelet alpha granule organization,BP,
16017,GO:0070890,1,0.991679953279934,0,1,sodium-dependent L-ascorbate transmembrane transporter activity,MF,
16018,GO:0070891,1,0.97733699695185,0,4,lipoteichoic acid binding,MF,
16019,GO:0070892,1,0.994217929414997,0,1,lipoteichoic acid receptor activity,MF,
16020,GO:0070893,1,0.986393043052851,0,2,transposon integration,BP,
16021,GO:0070894,1,0.986393043052851,0,2,regulation of transposon integration,BP,
16022,GO:0070895,1,0.986393043052851,0,2,negative regulation of transposon integration,BP,
16023,GO:0070897,1,0.759598956003134,0,42,DNA-templated transcriptional preinitiation complex assembly,BP,
16024,GO:0070898,1,0.989548316409782,0,1,RNA polymerase III transcriptional preinitiation complex assembly,BP,
16025,GO:0070899,1,0.993737533309498,0,1,mitochondrial tRNA wobble uridine modification,BP,
16026,GO:0070900,1,0.947655773630944,0,9,mitochondrial tRNA modification,BP,
16027,GO:0070901,1,0.975765497470819,0,4,mitochondrial tRNA methylation,BP,
16028,GO:0070902,1,0.994427252745907,0,1,mitochondrial tRNA pseudouridine synthesis,BP,
16029,GO:0070903,1,0.994271157432806,0,1,mitochondrial tRNA thio-modification,BP,
16030,GO:0070904,1,0.991679953279934,0,1,transepithelial L-ascorbic acid transport,BP,
16031,GO:0070905,1,0.981453236987113,0,3,serine binding,MF,
16032,GO:0070911,1,0.819080704241286,0,32,global genome nucleotide-excision repair,BP,
16033,GO:0070914,1,0.931689163471143,0,11,UV-damage excision repair,BP,
16035,GO:0070918,1,0.744982261531595,0,43,production of small RNA involved in gene silencing by RNA,BP,
16036,GO:0070920,1,0.904393067570825,0,15,regulation of production of small RNA involved in gene silencing by RNA,BP,
16037,GO:0070922,1,0.940704191561494,0,9,small RNA loading onto RISC,BP,
16039,GO:0070926,1,0.993295974275756,0,1,regulation of ATP:ADP antiporter activity,BP,
16040,GO:0070931,1,0.992323630763253,0,1,Golgi-associated vesicle lumen,CC,
16041,GO:0070932,1,0.874315906558902,0,20,histone H3 deacetylation,BP,
16042,GO:0070933,1,0.938658131172256,0,9,histone H4 deacetylation,BP,
16043,GO:0070934,1,0.971230000293086,0,4,CRD-mediated mRNA stabilization,BP,
16044,GO:0070935,1,0.906450893357952,0,15,3'-UTR-mediated mRNA stabilization,BP,
16046,GO:0070937,1,0.96458525739616,0,5,CRD-mediated mRNA stability complex,CC,
16047,GO:0070938,1,0.922584105686762,0,11,contractile ring,CC,
16048,GO:0070939,1,0.979175964658193,0,3,Dsl1/NZR complex,CC,
16049,GO:0070940,1,0.968471925917826,0,5,dephosphorylation of RNA polymerase II C-terminal domain,BP,
16050,GO:0070942,1,0.961261684658377,0,7,neutrophil mediated cytotoxicity,BP,
16051,GO:0070943,1,0.972691424386793,0,5,neutrophil mediated killing of symbiont cell,BP,
16052,GO:0070944,1,0.978033277269002,0,4,neutrophil mediated killing of bacterium,BP,
16053,GO:0070945,1,0.983129378462585,0,3,neutrophil mediated killing of gram-negative bacterium,BP,
16054,GO:0070947,1,0.989379608585703,0,2,neutrophil mediated killing of fungus,BP,
16055,GO:0070948,1,0.976762858881729,0,4,regulation of neutrophil mediated cytotoxicity,BP,
16056,GO:0070949,1,0.988375023649995,0,2,regulation of neutrophil mediated killing of symbiont cell,BP,
16057,GO:0070950,1,0.9938021277445,0,1,regulation of neutrophil mediated killing of bacterium,BP,
16058,GO:0070951,1,0.9938021277445,0,1,regulation of neutrophil mediated killing of gram-negative bacterium,BP,
16059,GO:0070953,1,0.994539391877455,0,1,regulation of neutrophil mediated killing of fungus,BP,
16060,GO:0070960,1,0.988375023649995,0,2,positive regulation of neutrophil mediated cytotoxicity,BP,
16061,GO:0070961,1,0.988375023649995,0,2,positive regulation of neutrophil mediated killing of symbiont cell,BP,
16062,GO:0070962,1,0.9938021277445,0,1,positive regulation of neutrophil mediated killing of bacterium,BP,
16063,GO:0070963,1,0.9938021277445,0,1,positive regulation of neutrophil mediated killing of gram-negative bacterium,BP,
16064,GO:0070965,1,0.994539391877455,0,1,positive regulation of neutrophil mediated killing of fungus,BP,
16065,GO:0070966,1,0.979175967072564,0,3,nuclear-transcribed mRNA catabolic process, no-go decay,BP,
16066,GO:0070970,1,0.932761066364251,0,10,interleukin-2 secretion,BP,
16067,GO:0070971,1,0.887249664663928,0,17,endoplasmic reticulum exit site,CC,
16068,GO:0070972,1,0.476351762752501,0,129,protein localization to endoplasmic reticulum,BP,
16069,GO:0070973,1,0.957365604697473,0,6,protein localization to endoplasmic reticulum exit site,BP,
16070,GO:0070974,1,0.99371832414261,0,1,POU domain binding,MF,
16071,GO:0070975,1,0.991465791954088,0,1,FHA domain binding,MF,
16072,GO:0070976,1,0.993888412176122,0,1,TIR domain binding,MF,
16075,GO:0070981,1,0.994085728460805,0,1,L-asparagine biosynthetic process,BP,
16076,GO:0070982,1,0.994085728460805,0,1,L-asparagine metabolic process,BP,
16077,GO:0070984,1,0.9931397532995,0,1,SET domain binding,MF,
16078,GO:0070985,1,0.989106242921135,0,2,TFIIK complex,CC,
16079,GO:0070986,1,0.912039363348805,0,13,left/right axis specification,BP,
16080,GO:0070987,1,0.894000620211284,0,18,error-free translesion synthesis,BP,
16081,GO:0070988,1,0.661613475488022,0,59,demethylation,BP,
16082,GO:0070989,1,0.919978906698415,0,12,oxidative demethylation,BP,
16083,GO:0070990,1,0.967052352728114,0,6,snRNP binding,MF,
16084,GO:0070991,1,0.981453971522461,0,3,medium-chain-acyl-CoA dehydrogenase activity,MF,
16085,GO:0070992,1,0.988834383523554,0,2,translation initiation complex,CC,
16086,GO:0070993,1,0.986160675225809,0,2,translation preinitiation complex,CC,
16087,GO:0070995,1,0.980582146336223,0,3,NADPH oxidation,BP,
16088,GO:0070996,1,0.983737762793604,0,3,type 1 melanocortin receptor binding,MF,
16090,GO:0071000,1,0.988433218101533,0,2,response to magnetism,BP,
16091,GO:0071001,1,0.98188298873987,0,3,U4/U6 snRNP,CC,
16092,GO:0071004,1,0.897058146029539,0,17,U2-type prespliceosome,CC,
16093,GO:0071005,1,0.994155939156337,0,1,U2-type precatalytic spliceosome,CC,
16094,GO:0071006,1,0.981847593614006,0,3,U2-type catalytic step 1 spliceosome,CC,
16096,GO:0071008,1,0.976252400473497,0,4,U2-type post-mRNA release spliceosomal complex,CC,
16097,GO:0071010,1,0.870987435261404,0,22,prespliceosome,CC,
16099,GO:0071012,1,0.963596659985318,0,6,catalytic step 1 spliceosome,CC,
16101,GO:0071014,1,0.947197789589166,0,9,post-mRNA release spliceosomal complex,CC,
16102,GO:0071020,1,0.988813804692759,0,2,post-spliceosomal complex,CC,
16103,GO:0071021,1,0.994405545691548,0,1,U2-type post-spliceosomal complex,CC,
16104,GO:0071025,1,0.914493180126078,0,15,RNA surveillance,BP,
16105,GO:0071026,1,0.994005274042763,0,1,cytoplasmic RNA surveillance,BP,
16106,GO:0071027,1,0.925772905551417,0,13,nuclear RNA surveillance,BP,
16107,GO:0071028,1,0.925772905551417,0,13,nuclear mRNA surveillance,BP,
16108,GO:0071029,1,0.966866017854231,0,6,nuclear ncRNA surveillance,BP,
16109,GO:0071030,1,0.988288964284506,0,2,nuclear mRNA surveillance of spliceosomal pre-mRNA splicing,BP,
16110,GO:0071031,1,0.988881281021936,0,2,nuclear mRNA surveillance of mRNA 3'-end processing,BP,
16111,GO:0071033,1,0.971828413300506,0,5,nuclear retention of pre-mRNA at the site of transcription,BP,
16112,GO:0071034,1,0.974289105163881,0,4,CUT catabolic process,BP,
16113,GO:0071035,1,0.966866017854231,0,6,nuclear polyadenylation-dependent rRNA catabolic process,BP,
16114,GO:0071038,1,0.972851341130894,0,5,nuclear polyadenylation-dependent tRNA catabolic process,BP,
16115,GO:0071042,1,0.976820734257178,0,4,nuclear polyadenylation-dependent mRNA catabolic process,BP,
16116,GO:0071043,1,0.974289105163881,0,4,CUT metabolic process,BP,
16117,GO:0071044,1,0.920755884715033,0,11,histone mRNA catabolic process,BP,
16118,GO:0071045,1,0.994439139547591,0,1,nuclear histone mRNA catabolic process,BP,
16119,GO:0071046,1,0.966866017854231,0,6,nuclear polyadenylation-dependent ncRNA catabolic process,BP,
16120,GO:0071047,1,0.976820734257178,0,4,polyadenylation-dependent mRNA catabolic process,BP,
16121,GO:0071048,1,0.988288964284506,0,2,nuclear retention of unspliced pre-mRNA at the site of transcription,BP,
16122,GO:0071049,1,0.988881281021936,0,2,nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription,BP,
16123,GO:0071051,1,0.973156361097987,0,5,polyadenylation-dependent snoRNA 3'-end processing,BP,
16124,GO:0071062,1,0.980393713811311,0,3,alphav-beta3 integrin-vitronectin complex,CC,
16125,GO:0071065,1,0.987460218187102,0,2,alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex,CC,
16126,GO:0071071,1,0.922744519227165,0,13,regulation of phospholipid biosynthetic process,BP,
16127,GO:0071072,1,0.974610475656413,0,4,negative regulation of phospholipid biosynthetic process,BP,
16128,GO:0071073,1,0.952434522885852,0,8,positive regulation of phospholipid biosynthetic process,BP,
16129,GO:0071074,1,0.994300618465776,0,1,eukaryotic initiation factor eIF2 binding,MF,
16130,GO:0071077,1,0.981872023432743,0,3,adenosine 3',5'-bisphosphate transmembrane transporter activity,MF,
16132,GO:0071104,1,0.974689632097589,0,4,response to interleukin-9,BP,
16133,GO:0071105,1,0.98767309117172,0,2,response to interleukin-11,BP,
16134,GO:0071106,1,0.981872023432743,0,3,adenosine 3',5'-bisphosphate transmembrane transport,BP,
16135,GO:0071107,1,0.95129374513484,0,7,response to parathyroid hormone,BP,
16136,GO:0071108,1,0.834323852615934,0,24,protein K48-linked deubiquitination,BP,
16137,GO:0071109,1,0.981850426425261,0,2,superior temporal gyrus development,BP,
16138,GO:0071110,1,0.99217517082661,0,1,histone biotinylation,BP,
16139,GO:0071133,1,0.993663286186664,0,1,alpha9-beta1 integrin-ADAM8 complex,CC,
16140,GO:0071139,1,0.98601407965679,0,2,resolution of recombination intermediates,BP,
16141,GO:0071140,1,0.98601407965679,0,2,resolution of mitotic recombination intermediates,BP,
16142,GO:0071141,1,0.939512572921615,0,8,SMAD protein complex,CC,
16143,GO:0071144,1,0.982194264395535,0,2,heteromeric SMAD protein complex,CC,
16144,GO:0071148,1,0.983025149635153,0,2,TEAD-1-YAP complex,CC,
16145,GO:0071149,1,0.986764817005853,0,2,TEAD-2-YAP complex,CC,
16147,GO:0071157,1,0.877492932880494,0,21,negative regulation of cell cycle arrest,BP,
16149,GO:0071159,1,0.988841904726596,0,2,NF-kappaB complex,CC,
16150,GO:0071163,1,0.982957225498625,0,3,DNA replication preinitiation complex assembly,BP,
16151,GO:0071164,1,0.993382740290077,0,1,RNA trimethylguanosine synthase activity,MF,
16153,GO:0071168,1,0.878287686367331,0,20,protein localization to chromatin,BP,
16154,GO:0071169,1,0.957459931185654,0,7,establishment of protein localization to chromatin,BP,
16157,GO:0071203,1,0.965054367525088,0,5,WASH complex,CC,
16158,GO:0071204,1,0.962843380540155,0,6,histone pre-mRNA 3'end processing complex,CC,
16161,GO:0071207,1,0.987342666420864,0,2,histone pre-mRNA stem-loop binding,MF,
16162,GO:0071208,1,0.978719808736686,0,4,histone pre-mRNA DCP binding,MF,
16163,GO:0071209,1,0.983481194165215,0,3,U7 snRNA binding,MF,
16164,GO:0071211,1,0.973836097738074,0,4,protein targeting to vacuole involved in autophagy,BP,
16166,GO:0071215,1,0.993043888219735,0,1,cellular response to abscisic acid stimulus,BP,
16167,GO:0071216,1,0.319440726310156,0,178,cellular response to biotic stimulus,BP,
16168,GO:0071217,1,0.993232675100923,0,1,cellular response to external biotic stimulus,BP,
16169,GO:0071218,1,0.868886328289589,0,21,cellular response to misfolded protein,BP,
16170,GO:0071219,1,0.36391699595681,0,159,cellular response to molecule of bacterial origin,BP,
16171,GO:0071220,1,0.963224107368382,0,6,cellular response to bacterial lipoprotein,BP,
16172,GO:0071221,1,0.963224107368382,0,6,cellular response to bacterial lipopeptide,BP,
16173,GO:0071222,1,0.383301605393078,0,151,cellular response to lipopolysaccharide,BP,
16174,GO:0071223,1,0.935799638165408,0,11,cellular response to lipoteichoic acid,BP,
16175,GO:0071224,1,0.969089069171935,0,5,cellular response to peptidoglycan,BP,
16176,GO:0071225,1,0.967186827976829,0,5,cellular response to muramyl dipeptide,BP,
16177,GO:0071226,1,0.986666017720341,0,2,cellular response to molecule of fungal origin,BP,
16178,GO:0071228,1,0.994724354388498,0,1,cellular response to tumor cell,BP,
16179,GO:0071229,1,0.284951624674607,0,188,cellular response to acid chemical,BP,
16180,GO:0071230,1,0.66042708039109,0,61,cellular response to amino acid stimulus,BP,
16181,GO:0071231,1,0.989484996756733,0,2,cellular response to folic acid,BP,
16182,GO:0071233,1,0.935426638997653,0,9,cellular response to leucine,BP,
16185,GO:0071242,1,0.707339498591069,0,53,cellular response to ammonium ion,BP,
16186,GO:0071243,1,0.909521138396472,0,16,cellular response to arsenic-containing substance,BP,
16187,GO:0071245,1,0.993411193433432,0,1,cellular response to carbon monoxide,BP,
16188,GO:0071247,1,0.994723062888751,0,1,cellular response to chromate,BP,
16190,GO:0071250,1,0.992013629895481,0,1,cellular response to nitrite,BP,
16191,GO:0071253,1,0.974415002453367,0,4,connexin binding,MF,
16192,GO:0071256,1,0.978743894752576,0,4,translocon complex,CC,
16193,GO:0071257,1,0.924999376980524,0,12,cellular response to electrical stimulus,BP,
16194,GO:0071258,1,0.993154490170671,0,1,cellular response to gravity,BP,
16195,GO:0071259,1,0.988433218101533,0,2,cellular response to magnetism,BP,
16197,GO:0071262,1,0.98582119246313,0,2,regulation of translational initiation in response to starvation,BP,
16198,GO:0071264,1,0.98582119246313,0,2,positive regulation of translational initiation in response to starvation,BP,
16199,GO:0071265,1,0.953353786349599,0,8,L-methionine biosynthetic process,BP,
16200,GO:0071266,1,0.994387197314057,0,1,'de novo' L-methionine biosynthetic process,BP,
16201,GO:0071267,1,0.958737275671588,0,7,L-methionine salvage,BP,
16202,GO:0071268,1,0.994104308045454,0,1,homocysteine biosynthetic process,BP,
16203,GO:0071275,1,0.994177632221241,0,1,cellular response to aluminum ion,BP,
16204,GO:0071276,1,0.830788486511578,0,32,cellular response to cadmium ion,BP,
16206,GO:0071279,1,0.979997455135251,0,3,cellular response to cobalt ion,BP,
16207,GO:0071280,1,0.903515016542331,0,18,cellular response to copper ion,BP,
16209,GO:0071283,1,0.989017673269669,0,2,cellular response to iron(III) ion,BP,
16210,GO:0071284,1,0.971329431743325,0,4,cellular response to lead ion,BP,
16211,GO:0071285,1,0.935527670342204,0,11,cellular response to lithium ion,BP,
16212,GO:0071286,1,0.950651541154465,0,6,cellular response to magnesium ion,BP,
16213,GO:0071287,1,0.940898489207945,0,9,cellular response to manganese ion,BP,
16214,GO:0071288,1,0.993866823174771,0,1,cellular response to mercury ion,BP,
16215,GO:0071294,1,0.906982820456557,0,17,cellular response to zinc ion,BP,
16216,GO:0071295,1,0.837160218129315,0,27,cellular response to vitamin,BP,
16217,GO:0071298,1,0.993522570185009,0,1,cellular response to L-ascorbic acid,BP,
16218,GO:0071300,1,0.655987716872092,0,64,cellular response to retinoic acid,BP,
16219,GO:0071301,1,0.991469945654152,0,1,cellular response to vitamin B1,BP,
16220,GO:0071305,1,0.88782501052257,0,18,cellular response to vitamin D,BP,
16221,GO:0071306,1,0.9865713078783,0,2,cellular response to vitamin E,BP,
16222,GO:0071307,1,0.987655216607518,0,2,cellular response to vitamin K,BP,
16224,GO:0071312,1,0.804527047911032,0,31,cellular response to alkaloid,BP,
16225,GO:0071313,1,0.928502559257121,0,8,cellular response to caffeine,BP,
16226,GO:0071314,1,0.982907491422472,0,3,cellular response to cocaine,BP,
16227,GO:0071315,1,0.975430346425392,0,4,cellular response to morphine,BP,
16228,GO:0071316,1,0.95346276591832,0,8,cellular response to nicotine,BP,
16229,GO:0071317,1,0.975430346425392,0,4,cellular response to isoquinoline alkaloid,BP,
16230,GO:0071318,1,0.915723380961103,0,13,cellular response to ATP,BP,
16231,GO:0071320,1,0.714039912719946,0,48,cellular response to cAMP,BP,
16232,GO:0071321,1,0.956833867876811,0,6,cellular response to cGMP,BP,
16233,GO:0071322,1,0.458567004903604,0,119,cellular response to carbohydrate stimulus,BP,
16234,GO:0071324,1,0.992705419526355,0,1,cellular response to disaccharide stimulus,BP,
16235,GO:0071326,1,0.483002345091249,0,111,cellular response to monosaccharide stimulus,BP,
16236,GO:0071329,1,0.992705419526355,0,1,cellular response to sucrose stimulus,BP,
16237,GO:0071331,1,0.486174454741523,0,110,cellular response to hexose stimulus,BP,
16238,GO:0071332,1,0.96867169212198,0,5,cellular response to fructose stimulus,BP,
16239,GO:0071333,1,0.492101106863382,0,108,cellular response to glucose stimulus,BP,
16240,GO:0071335,1,0.989162985139108,0,2,hair follicle cell proliferation,BP,
16241,GO:0071336,1,0.989162985139108,0,2,regulation of hair follicle cell proliferation,BP,
16242,GO:0071338,1,0.989162985139108,0,2,positive regulation of hair follicle cell proliferation,BP,
16243,GO:0071339,1,0.829914465004281,0,28,MLL1 complex,CC,
16244,GO:0071340,1,0.943883285309445,0,9,skeletal muscle acetylcholine-gated channel clustering,BP,
16245,GO:0071344,1,0.989108802309356,0,2,diphosphate metabolic process,BP,
16248,GO:0071347,1,0.406083875236822,0,146,cellular response to interleukin-1,BP,
16249,GO:0071348,1,0.992820713514125,0,1,cellular response to interleukin-11,BP,
16250,GO:0071349,1,0.765838222221086,0,44,cellular response to interleukin-12,BP,
16251,GO:0071350,1,0.916118730846728,0,13,cellular response to interleukin-15,BP,
16252,GO:0071351,1,0.952945193123534,0,8,cellular response to interleukin-18,BP,
16253,GO:0071352,1,0.922498172488551,0,12,cellular response to interleukin-2,BP,
16254,GO:0071353,1,0.838583642602785,0,28,cellular response to interleukin-4,BP,
16255,GO:0071354,1,0.811016222061439,0,31,cellular response to interleukin-6,BP,
16256,GO:0071355,1,0.979770267631625,0,3,cellular response to interleukin-9,BP,
16257,GO:0071356,1,0.21567894414513,0,250,cellular response to tumor necrosis factor,BP,
16258,GO:0071357,1,0.640329395392436,0,71,cellular response to type I interferon,BP,
16259,GO:0071359,1,0.658928023237293,0,62,cellular response to dsRNA,BP,
16260,GO:0071360,1,0.918933240546203,0,13,cellular response to exogenous dsRNA,BP,
16261,GO:0071361,1,0.912620533473578,0,13,cellular response to ethanol,BP,
16262,GO:0071362,1,0.965342456662094,0,5,cellular response to ether,BP,
16264,GO:0071364,1,0.765176407298391,0,39,cellular response to epidermal growth factor stimulus,BP,
16265,GO:0071371,1,0.897976782752954,0,16,cellular response to gonadotropin stimulus,BP,
16266,GO:0071372,1,0.933226649751619,0,10,cellular response to follicle-stimulating hormone stimulus,BP,
16267,GO:0071373,1,0.987789044650138,0,2,cellular response to luteinizing hormone stimulus,BP,
16268,GO:0071374,1,0.964748157240251,0,5,cellular response to parathyroid hormone stimulus,BP,
16269,GO:0071375,1,0.150595475713605,0,281,cellular response to peptide hormone stimulus,BP,
16270,GO:0071376,1,0.968728865253777,0,5,cellular response to corticotropin-releasing hormone stimulus,BP,
16271,GO:0071377,1,0.793346843411238,0,35,cellular response to glucagon stimulus,BP,
16272,GO:0071378,1,0.875260952157755,0,19,cellular response to growth hormone stimulus,BP,
16273,GO:0071379,1,0.863435573859185,0,21,cellular response to prostaglandin stimulus,BP,
16274,GO:0071380,1,0.897941807160717,0,16,cellular response to prostaglandin E stimulus,BP,
16276,GO:0071384,1,0.67561874667783,0,61,cellular response to corticosteroid stimulus,BP,
16277,GO:0071385,1,0.691174989459183,0,57,cellular response to glucocorticoid stimulus,BP,
16278,GO:0071386,1,0.976981703690633,0,3,cellular response to corticosterone stimulus,BP,
16279,GO:0071387,1,0.992601201167981,0,1,cellular response to cortisol stimulus,BP,
16280,GO:0071389,1,0.954636107105451,0,7,cellular response to mineralocorticoid stimulus,BP,
16281,GO:0071391,1,0.922721718859108,0,12,cellular response to estrogen stimulus,BP,
16282,GO:0071392,1,0.808710722820386,0,33,cellular response to estradiol stimulus,BP,
16283,GO:0071393,1,0.987051934580626,0,2,cellular response to progesterone stimulus,BP,
16284,GO:0071394,1,0.944285434097083,0,9,cellular response to testosterone stimulus,BP,
16285,GO:0071395,1,0.978589249945565,0,4,cellular response to jasmonic acid stimulus,BP,
16287,GO:0071397,1,0.915466590687803,0,12,cellular response to cholesterol,BP,
16288,GO:0071398,1,0.71799468356829,0,49,cellular response to fatty acid,BP,
16289,GO:0071400,1,0.986378096058967,0,2,cellular response to oleic acid,BP,
16290,GO:0071401,1,0.994105598455397,0,1,cellular response to triglyceride,BP,
16291,GO:0071402,1,0.858646425767408,0,23,cellular response to lipoprotein particle stimulus,BP,
16292,GO:0071403,1,0.987238960913605,0,2,cellular response to high density lipoprotein particle stimulus,BP,
16293,GO:0071404,1,0.899006037899382,0,16,cellular response to low-density lipoprotein particle stimulus,BP,
16295,GO:0071409,1,0.978423227870361,0,3,cellular response to cycloheximide,BP,
16296,GO:0071412,1,0.994109469806523,0,1,cellular response to genistein,BP,
16297,GO:0071413,1,0.994109469806523,0,1,cellular response to hydroxyisoflavone,BP,
16298,GO:0071415,1,0.921286726963241,0,9,cellular response to purine-containing compound,BP,
16299,GO:0071417,1,0.0327820635343227,0,496,cellular response to organonitrogen compound,BP,
16300,GO:0071418,1,0.994586928447688,0,1,cellular response to amine stimulus,BP,
16301,GO:0071420,1,0.950674433130877,0,7,cellular response to histamine,BP,
16302,GO:0071421,1,0.973799635683181,0,4,manganese ion transmembrane transport,BP,
16303,GO:0071422,1,0.981252132597294,0,3,succinate transmembrane transport,BP,
16304,GO:0071423,1,0.994311989915189,0,1,malate transmembrane transport,BP,
16305,GO:0071424,1,0.993850639026861,0,1,rRNA (cytosine-N4-)-methyltransferase activity,MF,
16309,GO:0071428,1,0.913236182342859,0,15,rRNA-containing ribonucleoprotein complex export from nucleus,BP,
16310,GO:0071431,1,0.808006837136149,0,31,tRNA-containing ribonucleoprotein complex export from nucleus,BP,
16311,GO:0071435,1,0.927949886196831,0,12,potassium ion export,BP,
16312,GO:0071437,1,0.910644870059535,0,14,invadopodium,CC,
16313,GO:0071438,1,0.96813464100637,0,5,invadopodium membrane,CC,
16314,GO:0071439,1,0.940359315678775,0,9,clathrin complex,CC,
16315,GO:0071440,1,0.963020275199384,0,6,regulation of histone H3-K14 acetylation,BP,
16316,GO:0071441,1,0.993308052375291,0,1,negative regulation of histone H3-K14 acetylation,BP,
16317,GO:0071442,1,0.975510474032656,0,4,positive regulation of histone H3-K14 acetylation,BP,
16318,GO:0071444,1,0.995180467225628,0,1,cellular response to pheromone,BP,
16319,GO:0071447,1,0.949892922773516,0,8,cellular response to hydroperoxide,BP,
16320,GO:0071449,1,0.994815788979588,0,1,cellular response to lipid hydroperoxide,BP,
16321,GO:0071450,1,0.867281240446107,0,24,cellular response to oxygen radical,BP,
16322,GO:0071451,1,0.867281240446107,0,24,cellular response to superoxide,BP,
16324,GO:0071454,1,0.991441392775275,0,1,cellular response to anoxia,BP,
16325,GO:0071455,1,0.96095968172663,0,6,cellular response to hyperoxia,BP,
16326,GO:0071456,1,0.31110456786964,0,182,cellular response to hypoxia,BP,
16327,GO:0071458,1,0.968557386993267,0,5,integral component of cytoplasmic side of endoplasmic reticulum membrane,CC,
16329,GO:0071460,1,0.989323328679498,0,2,cellular response to cell-matrix adhesion,BP,
16330,GO:0071461,1,0.988533473603297,0,2,cellular response to redox state,BP,
16331,GO:0071462,1,0.979409439779496,0,3,cellular response to water stimulus,BP,
16332,GO:0071464,1,0.992673486701873,0,1,cellular response to hydrostatic pressure,BP,
16333,GO:0071466,1,0.398629427576229,0,145,cellular response to xenobiotic stimulus,BP,
16334,GO:0071467,1,0.888932598347567,0,19,cellular response to pH,BP,
16335,GO:0071468,1,0.943848399985259,0,9,cellular response to acidic pH,BP,
16336,GO:0071469,1,0.98753453012402,0,2,cellular response to alkaline pH,BP,
16337,GO:0071470,1,0.811386989791837,0,32,cellular response to osmotic stress,BP,
16338,GO:0071471,1,0.992970087343192,0,1,cellular response to non-ionic osmotic stress,BP,
16339,GO:0071472,1,0.943233013356311,0,9,cellular response to salt stress,BP,
16340,GO:0071474,1,0.933808503648209,0,11,cellular hyperosmotic response,BP,
16341,GO:0071475,1,0.975713033059604,0,4,cellular hyperosmotic salinity response,BP,
16342,GO:0071476,1,0.952173955417863,0,7,cellular hypotonic response,BP,
16343,GO:0071477,1,0.985116401468499,0,2,cellular hypotonic salinity response,BP,
16346,GO:0071480,1,0.836071550472688,0,27,cellular response to gamma radiation,BP,
16349,GO:0071483,1,0.986802783390129,0,2,cellular response to blue light,BP,
16350,GO:0071484,1,0.986202852663294,0,2,cellular response to light intensity,BP,
16351,GO:0071485,1,0.993590111754218,0,1,cellular response to absence of light,BP,
16352,GO:0071486,1,0.992565564864568,0,1,cellular response to high light intensity,BP,
16353,GO:0071492,1,0.980668432558191,0,3,cellular response to UV-A,BP,
16354,GO:0071493,1,0.953167981126982,0,8,cellular response to UV-B,BP,
16355,GO:0071494,1,0.970974354890411,0,4,cellular response to UV-C,BP,
16358,GO:0071498,1,0.890032684701198,0,18,cellular response to fluid shear stress,BP,
16359,GO:0071499,1,0.958119598685251,0,7,cellular response to laminar fluid shear stress,BP,
16360,GO:0071500,1,0.961578989236243,0,6,cellular response to nitrosative stress,BP,
16361,GO:0071501,1,0.942745703925456,0,9,cellular response to sterol depletion,BP,
16362,GO:0071502,1,0.968952038603097,0,5,cellular response to temperature stimulus,BP,
16363,GO:0071503,1,0.972918680273476,0,4,response to heparin,BP,
16364,GO:0071504,1,0.972918680273476,0,4,cellular response to heparin,BP,
16365,GO:0071505,1,0.987513196653817,0,2,response to mycophenolic acid,BP,
16366,GO:0071506,1,0.987513196653817,0,2,cellular response to mycophenolic acid,BP,
16367,GO:0071514,1,0.862570543736465,0,22,genetic imprinting,BP,
16368,GO:0071526,1,0.790434020932429,0,32,semaphorin-plexin signaling pathway,BP,
16369,GO:0071527,1,0.994066637540254,0,1,semaphorin-plexin signaling pathway involved in outflow tract morphogenesis,BP,
16370,GO:0071528,1,0.993286719769978,0,1,tRNA re-export from nucleus,BP,
16371,GO:0071529,1,0.993954273412238,0,1,cementum mineralization,BP,
16372,GO:0071532,1,0.964069824890049,0,5,ankyrin repeat binding,MF,
16373,GO:0071535,1,0.975363468495108,0,4,RING-like zinc finger domain binding,MF,
16374,GO:0071538,1,0.99409604990986,0,1,SH2 domain-mediated complex assembly,BP,
16375,GO:0071539,1,0.820330001327356,0,27,protein localization to centrosome,BP,
16376,GO:0071540,1,0.992539356466562,0,1,eukaryotic translation initiation factor 3 complex, eIF3e,CC,
16377,GO:0071541,1,0.95968128089671,0,7,eukaryotic translation initiation factor 3 complex, eIF3m,CC,
16379,GO:0071543,1,0.975932507390272,0,4,diphosphoinositol polyphosphate metabolic process,BP,
16380,GO:0071544,1,0.99459157858605,0,1,diphosphoinositol polyphosphate catabolic process,BP,
16381,GO:0071545,1,0.923190150255615,0,12,inositol phosphate catabolic process,BP,
16382,GO:0071546,1,0.961432132276055,0,6,pi-body,CC,
16383,GO:0071547,1,0.96901452512321,0,5,piP-body,CC,
16384,GO:0071548,1,0.77050169302127,0,41,response to dexamethasone,BP,
16385,GO:0071549,1,0.817044837612866,0,32,cellular response to dexamethasone stimulus,BP,
16386,GO:0071550,1,0.94831380900969,0,9,death-inducing signaling complex assembly,BP,
16387,GO:0071553,1,0.982876662334862,0,3,G-protein coupled pyrimidinergic nucleotide receptor activity,MF,
16388,GO:0071554,1,0.972448052943462,0,5,cell wall organization or biogenesis,BP,
16389,GO:0071556,1,0.865677119771313,0,25,integral component of lumenal side of endoplasmic reticulum membrane,CC,
16390,GO:0071557,1,0.963375152988494,0,5,histone H3-K27 demethylation,BP,
16391,GO:0071558,1,0.963375152988494,0,5,histone demethylase activity (H3-K27 specific),MF,
16394,GO:0071561,1,0.992679769633415,0,1,nucleus-vacuole junction,CC,
16395,GO:0071564,1,0.92220456524967,0,12,npBAF complex,CC,
16396,GO:0071565,1,0.907892507453271,0,14,nBAF complex,CC,
16397,GO:0071566,1,0.993766743798255,0,1,UFM1 activating enzyme activity,MF,
16398,GO:0071567,1,0.988869999555612,0,2,UFM1 hydrolase activity,MF,
16399,GO:0071568,1,0.988591705392176,0,2,UFM1 transferase activity,MF,
16400,GO:0071569,1,0.965718570546757,0,6,protein ufmylation,BP,
16401,GO:0071573,1,0.99377366455181,0,1,shelterin complex assembly,BP,
16402,GO:0071577,1,0.879453361974784,0,20,zinc ion transmembrane transport,BP,
16403,GO:0071578,1,0.956012895577796,0,7,zinc ion import across plasma membrane,BP,
16404,GO:0071579,1,0.98809858265743,0,2,regulation of zinc ion transport,BP,
16405,GO:0071580,1,0.994247384005406,0,1,regulation of zinc ion transmembrane transport,BP,
16406,GO:0071581,1,0.994247384005406,0,1,regulation of zinc ion transmembrane import,BP,
16407,GO:0071582,1,0.994247384005406,0,1,negative regulation of zinc ion transport,BP,
16408,GO:0071583,1,0.994247384005406,0,1,negative regulation of zinc ion transmembrane transport,BP,
16409,GO:0071584,1,0.994247384005406,0,1,negative regulation of zinc ion transmembrane import,BP,
16410,GO:0071585,1,0.994247384005406,0,1,detoxification of cadmium ion,BP,
16411,GO:0071586,1,0.988221563693987,0,2,CAAX-box protein processing,BP,
16412,GO:0071593,1,0.97446430134278,0,4,lymphocyte aggregation,BP,
16413,GO:0071595,1,0.987738712940129,0,2,Nem1-Spo7 phosphatase complex,CC,
16414,GO:0071596,1,0.975158464162096,0,3,ubiquitin-dependent protein catabolic process via the N-end rule pathway,BP,
16415,GO:0071598,1,0.969578767702204,0,5,neuronal ribonucleoprotein granule,CC,
16416,GO:0071599,1,0.907625842364341,0,15,otic vesicle development,BP,
16417,GO:0071600,1,0.93913938800406,0,10,otic vesicle morphogenesis,BP,
16418,GO:0071602,1,0.993024156028235,0,1,phytosphingosine biosynthetic process,BP,
16419,GO:0071603,1,0.973998815057854,0,4,endothelial cell-cell adhesion,BP,
16420,GO:0071604,1,0.830623065032695,0,28,transforming growth factor beta production,BP,
16421,GO:0071605,1,0.931409566109196,0,12,monocyte chemotactic protein-1 production,BP,
16422,GO:0071606,1,0.994264955450685,0,1,chemokine (C-C motif) ligand 4 production,BP,
16423,GO:0071608,1,0.97534869586947,0,4,macrophage inflammatory protein-1 alpha production,BP,
16424,GO:0071609,1,0.935555687206891,0,10,chemokine (C-C motif) ligand 5 production,BP,
16425,GO:0071610,1,0.993991359963957,0,1,chemokine (C-C motif) ligand 1 production,BP,
16426,GO:0071611,1,0.970596741875963,0,5,granulocyte colony-stimulating factor production,BP,
16427,GO:0071612,1,0.989217382212431,0,1,IP-10 production,BP,
16428,GO:0071613,1,0.988680336395279,0,2,granzyme B production,BP,
16429,GO:0071614,1,0.994327496702936,0,1,linoleic acid epoxygenase activity,MF,
16430,GO:0071616,1,0.739484216612051,0,46,acyl-CoA biosynthetic process,BP,
16431,GO:0071617,1,0.884148298522331,0,18,lysophospholipid acyltransferase activity,MF,
16432,GO:0071619,1,0.994113857554735,0,1,phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
16433,GO:0071621,1,0.606531034946246,0,83,granulocyte chemotaxis,BP,
16434,GO:0071622,1,0.777075001705276,0,43,regulation of granulocyte chemotaxis,BP,
16435,GO:0071623,1,0.986611908758098,0,2,negative regulation of granulocyte chemotaxis,BP,
16436,GO:0071624,1,0.844091439992827,0,30,positive regulation of granulocyte chemotaxis,BP,
16437,GO:0071625,1,0.878069279525722,0,17,vocalization behavior,BP,
16438,GO:0071626,1,0.994633428505869,0,1,mastication,BP,
16439,GO:0071629,1,0.994439139547591,0,1,cytoplasm protein quality control by the ubiquitin-proteasome system,BP,
16440,GO:0071630,1,0.977941900527846,0,3,nuclear protein quality control by the ubiquitin-proteasome system,BP,
16441,GO:0071633,1,0.993815468565623,0,1,dihydroceramidase activity,MF,
16442,GO:0071634,1,0.836551608857381,0,27,regulation of transforming growth factor beta production,BP,
16443,GO:0071635,1,0.955765844423908,0,7,negative regulation of transforming growth factor beta production,BP,
16444,GO:0071636,1,0.896180348752718,0,17,positive regulation of transforming growth factor beta production,BP,
16445,GO:0071637,1,0.931409566109196,0,12,regulation of monocyte chemotactic protein-1 production,BP,
16446,GO:0071638,1,0.970416694477845,0,5,negative regulation of monocyte chemotactic protein-1 production,BP,
16447,GO:0071639,1,0.959815685078749,0,7,positive regulation of monocyte chemotactic protein-1 production,BP,
16448,GO:0071640,1,0.97534869586947,0,4,regulation of macrophage inflammatory protein 1 alpha production,BP,
16449,GO:0071641,1,0.987784094722716,0,2,negative regulation of macrophage inflammatory protein 1 alpha production,BP,
16450,GO:0071642,1,0.987412366288561,0,2,positive regulation of macrophage inflammatory protein 1 alpha production,BP,
16451,GO:0071643,1,0.994264955450685,0,1,regulation of chemokine (C-C motif) ligand 4 production,BP,
16452,GO:0071644,1,0.994264955450685,0,1,negative regulation of chemokine (C-C motif) ligand 4 production,BP,
16453,GO:0071649,1,0.940808122499928,0,9,regulation of chemokine (C-C motif) ligand 5 production,BP,
16454,GO:0071650,1,0.982830234357975,0,3,negative regulation of chemokine (C-C motif) ligand 5 production,BP,
16455,GO:0071651,1,0.957251092369739,0,6,positive regulation of chemokine (C-C motif) ligand 5 production,BP,
16456,GO:0071652,1,0.993991359963957,0,1,regulation of chemokine (C-C motif) ligand 1 production,BP,
16457,GO:0071654,1,0.993991359963957,0,1,positive regulation of chemokine (C-C motif) ligand 1 production,BP,
16458,GO:0071655,1,0.976069246783436,0,4,regulation of granulocyte colony-stimulating factor production,BP,
16459,GO:0071656,1,0.994088824750106,0,1,negative regulation of granulocyte colony-stimulating factor production,BP,
16460,GO:0071657,1,0.981874347984227,0,3,positive regulation of granulocyte colony-stimulating factor production,BP,
16461,GO:0071658,1,0.989217382212431,0,1,regulation of IP-10 production,BP,
16462,GO:0071660,1,0.989217382212431,0,1,positive regulation of IP-10 production,BP,
16463,GO:0071661,1,0.988680336395279,0,2,regulation of granzyme B production,BP,
16464,GO:0071663,1,0.988680336395279,0,2,positive regulation of granzyme B production,BP,
16465,GO:0071664,1,0.971578304571612,0,4,catenin-TCF7L2 complex,CC,
16466,GO:0071665,1,0.993551226077652,0,1,gamma-catenin-TCF7L2 complex,CC,
16469,GO:0071672,1,0.976967017893419,0,4,negative regulation of smooth muscle cell chemotaxis,BP,
16471,GO:0071674,1,0.719543575459625,0,55,mononuclear cell migration,BP,
16472,GO:0071675,1,0.810389018265975,0,34,regulation of mononuclear cell migration,BP,
16473,GO:0071676,1,0.960648843308133,0,6,negative regulation of mononuclear cell migration,BP,
16474,GO:0071677,1,0.90414325553666,0,17,positive regulation of mononuclear cell migration,BP,
16475,GO:0071678,1,0.991295652439186,0,1,olfactory bulb axon guidance,BP,
16476,GO:0071679,1,0.943355311360104,0,8,commissural neuron axon guidance,BP,
16477,GO:0071680,1,0.965296114099099,0,5,response to indole-3-methanol,BP,
16478,GO:0071681,1,0.965296114099099,0,5,cellular response to indole-3-methanol,BP,
16479,GO:0071682,1,0.892544553286522,0,19,endocytic vesicle lumen,CC,
16480,GO:0071684,1,0.993611601194332,0,1,organism emergence from protective structure,BP,
16482,GO:0071691,1,0.991692964668783,0,1,cardiac muscle thin filament assembly,BP,
16483,GO:0071692,1,0.955662294442874,0,6,protein localization to extracellular region,BP,
16484,GO:0071694,1,0.955662294442874,0,6,maintenance of protein location in extracellular region,BP,
16486,GO:0071696,1,0.905802022931049,0,15,ectodermal placode development,BP,
16487,GO:0071697,1,0.911270424506882,0,14,ectodermal placode morphogenesis,BP,
16488,GO:0071698,1,0.973479480795556,0,4,olfactory placode development,BP,
16489,GO:0071699,1,0.973479480795556,0,4,olfactory placode morphogenesis,BP,
16490,GO:0071701,1,0.992783354231433,0,1,regulation of MAPK export from nucleus,BP,
16494,GO:0071706,1,0.486109751070248,0,114,tumor necrosis factor superfamily cytokine production,BP,
16495,GO:0071707,1,0.994633428505869,0,1,immunoglobulin heavy chain V-D-J recombination,BP,
16496,GO:0071709,1,0.824198197830262,0,27,membrane assembly,BP,
16497,GO:0071711,1,0.873300773143036,0,19,basement membrane organization,BP,
16498,GO:0071712,1,0.924531263335769,0,12,ER-associated misfolded protein catabolic process,BP,
16499,GO:0071713,1,0.992859609066904,0,1,para-aminobenzoyl-glutamate hydrolase activity,MF,
16500,GO:0071714,1,0.993108699877276,0,1,icosanoid transmembrane transporter activity,MF,
16501,GO:0071715,1,0.822901861246045,0,31,icosanoid transport,BP,
16502,GO:0071723,1,0.956523104910087,0,7,lipopeptide binding,MF,
16503,GO:0071724,1,0.974709836488574,0,4,response to diacyl bacterial lipopeptide,BP,
16504,GO:0071725,1,0.981930585200786,0,3,response to triacyl bacterial lipopeptide,BP,
16505,GO:0071726,1,0.974709836488574,0,4,cellular response to diacyl bacterial lipopeptide,BP,
16506,GO:0071727,1,0.981930585200786,0,3,cellular response to triacyl bacterial lipopeptide,BP,
16507,GO:0071731,1,0.89205706527399,0,18,response to nitric oxide,BP,
16508,GO:0071732,1,0.909504043658156,0,15,cellular response to nitric oxide,BP,
16509,GO:0071733,1,0.972957604315866,0,4,transcriptional activation by promoter-enhancer looping,BP,
16510,GO:0071763,1,0.962503840129901,0,6,nuclear membrane organization,BP,
16511,GO:0071765,1,0.993115431326703,0,1,nuclear inner membrane organization,BP,
16515,GO:0071782,1,0.892453930169598,0,18,endoplasmic reticulum tubular network,CC,
16516,GO:0071786,1,0.90696244631238,0,15,endoplasmic reticulum tubular network organization,BP,
16517,GO:0071787,1,0.976111963286926,0,4,endoplasmic reticulum tubular network formation,BP,
16518,GO:0071789,1,0.993850639026861,0,1,spindle pole body localization to nuclear envelope,BP,
16519,GO:0071790,1,0.993850639026861,0,1,establishment of spindle pole body localization to nuclear envelope,BP,
16520,GO:0071791,1,0.987413875832579,0,2,chemokine (C-C motif) ligand 5 binding,MF,
16521,GO:0071796,1,0.994621545430803,0,1,K6-linked polyubiquitin modification-dependent protein binding,MF,
16522,GO:0071797,1,0.975765255737788,0,4,LUBAC complex,CC,
16523,GO:0071798,1,0.967214618882881,0,5,response to prostaglandin D,BP,
16524,GO:0071799,1,0.967214618882881,0,5,cellular response to prostaglandin D stimulus,BP,
16525,GO:0071800,1,0.874300709259026,0,20,podosome assembly,BP,
16526,GO:0071801,1,0.917964187924021,0,13,regulation of podosome assembly,BP,
16527,GO:0071802,1,0.993126301483339,0,1,negative regulation of podosome assembly,BP,
16528,GO:0071803,1,0.941554232979246,0,9,positive regulation of podosome assembly,BP,
16529,GO:0071804,1,0.294841862037618,0,183,cellular potassium ion transport,BP,
16530,GO:0071805,1,0.294841862037618,0,183,potassium ion transmembrane transport,BP,
16531,GO:0071806,1,0.72250774374431,0,54,protein transmembrane transport,BP,
16532,GO:0071812,1,0.993674035059727,0,1,positive regulation of fever generation by positive regulation of prostaglandin secretion,BP,
16533,GO:0071813,1,0.869771652352282,0,21,lipoprotein particle binding,MF,
16534,GO:0071814,1,0.869771652352282,0,21,protein-lipid complex binding,MF,
16535,GO:0071816,1,0.97686346769893,0,4,tail-anchored membrane protein insertion into ER membrane,BP,
16536,GO:0071817,1,0.970590150457003,0,5,MMXD complex,CC,
16537,GO:0071818,1,0.98226219779945,0,3,BAT3 complex,CC,
16538,GO:0071819,1,0.988455694438395,0,2,DUBm complex,CC,
16539,GO:0071820,1,0.994538358435351,0,1,N-box binding,MF,
16540,GO:0071821,1,0.98643761163094,0,2,FANCM-MHF complex,CC,
16541,GO:0071823,1,0.989370909577331,0,2,protein-carbohydrate complex subunit organization,BP,
16543,GO:0071825,1,0.776264598331727,0,39,protein-lipid complex subunit organization,BP,
16544,GO:0071826,1,0.267646094395002,0,207,ribonucleoprotein complex subunit organization,BP,
16545,GO:0071827,1,0.786316628794631,0,37,plasma lipoprotein particle organization,BP,
16546,GO:0071830,1,0.954511596257904,0,7,triglyceride-rich lipoprotein particle clearance,BP,
16547,GO:0071837,1,0.893595887337166,0,17,HMG box domain binding,MF,
16548,GO:0071838,1,0.961097505521823,0,6,cell proliferation in bone marrow,BP,
16549,GO:0071839,1,0.976309387156933,0,4,apoptotic process in bone marrow,BP,
16551,GO:0071846,1,0.994948541168532,0,1,actin filament debranching,BP,
16552,GO:0071847,1,0.986688147248088,0,2,TNFSF11-mediated signaling pathway,BP,
16553,GO:0071848,1,0.993674035059727,0,1,positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling,BP,
16554,GO:0071850,1,0.915153596259699,0,14,mitotic cell cycle arrest,BP,
16555,GO:0071855,1,0.87795184148977,0,23,neuropeptide receptor binding,MF,
16556,GO:0071863,1,0.960732627151755,0,6,regulation of cell proliferation in bone marrow,BP,
16557,GO:0071864,1,0.960732627151755,0,6,positive regulation of cell proliferation in bone marrow,BP,
16558,GO:0071865,1,0.975483788264757,0,4,regulation of apoptotic process in bone marrow,BP,
16559,GO:0071866,1,0.975483788264757,0,4,negative regulation of apoptotic process in bone marrow,BP,
16560,GO:0071867,1,0.783094525536424,0,35,response to monoamine,BP,
16561,GO:0071868,1,0.798403885487425,0,32,cellular response to monoamine stimulus,BP,
16562,GO:0071869,1,0.783094525536424,0,35,response to catecholamine,BP,
16563,GO:0071870,1,0.798403885487425,0,32,cellular response to catecholamine stimulus,BP,
16564,GO:0071871,1,0.897860082931443,0,15,response to epinephrine,BP,
16565,GO:0071872,1,0.915388629270597,0,12,cellular response to epinephrine stimulus,BP,
16566,GO:0071873,1,0.97966492847378,0,3,response to norepinephrine,BP,
16567,GO:0071874,1,0.987552884738311,0,2,cellular response to norepinephrine stimulus,BP,
16568,GO:0071875,1,0.864938636452092,0,21,adrenergic receptor signaling pathway,BP,
16569,GO:0071877,1,0.99459157858605,0,1,regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway,BP,
16570,GO:0071878,1,0.984070807023563,0,2,negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway,BP,
16571,GO:0071879,1,0.97903125277961,0,3,positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway,BP,
16572,GO:0071880,1,0.880812165911821,0,18,adenylate cyclase-activating adrenergic receptor signaling pathway,BP,
16573,GO:0071881,1,0.987923446834783,0,2,adenylate cyclase-inhibiting adrenergic receptor signaling pathway,BP,
16574,GO:0071882,1,0.993295974275756,0,1,phospholipase C-activating adrenergic receptor signaling pathway,BP,
16575,GO:0071885,1,0.988686691864006,0,2,N-terminal protein N-methyltransferase activity,MF,
16576,GO:0071886,1,0.98652378671143,0,2,1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine binding,MF,
16577,GO:0071887,1,0.557070164527946,0,93,leukocyte apoptotic process,BP,
16578,GO:0071888,1,0.944478946319433,0,9,macrophage apoptotic process,BP,
16579,GO:0071889,1,0.842022568846782,0,25,14-3-3 protein binding,MF,
16580,GO:0071890,1,0.992592292981321,0,1,bicarbonate binding,MF,
16581,GO:0071893,1,0.994367297581572,0,1,BMP signaling pathway involved in nephric duct formation,BP,
16582,GO:0071894,1,0.987746771808999,0,2,histone H2B conserved C-terminal lysine ubiquitination,BP,
16583,GO:0071895,1,0.962932407908738,0,6,odontoblast differentiation,BP,
16584,GO:0071896,1,0.967686341066241,0,4,protein localization to adherens junction,BP,
16586,GO:0071898,1,0.981706769060406,0,3,regulation of estrogen receptor binding,BP,
16587,GO:0071899,1,0.981706769060406,0,3,negative regulation of estrogen receptor binding,BP,
16591,GO:0071907,1,0.951254289261747,0,7,determination of digestive tract left/right asymmetry,BP,
16592,GO:0071908,1,0.992502135147244,0,1,determination of intestine left/right asymmetry,BP,
16593,GO:0071909,1,0.992502135147244,0,1,determination of stomach left/right asymmetry,BP,
16594,GO:0071910,1,0.959349862227736,0,6,determination of liver left/right asymmetry,BP,
16595,GO:0071914,1,0.986618548454213,0,2,prominosome,CC,
16597,GO:0071920,1,0.988158823613678,0,2,cleavage body,CC,
16598,GO:0071921,1,0.965451619800936,0,5,cohesin loading,BP,
16599,GO:0071922,1,0.971427018979749,0,4,regulation of cohesin loading,BP,
16600,GO:0071926,1,0.973521298432953,0,4,endocannabinoid signaling pathway,BP,
16601,GO:0071929,1,0.987565219207443,0,2,alpha-tubulin acetylation,BP,
16602,GO:0071930,1,0.979169540512928,0,3,negative regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
16603,GO:0071931,1,0.982271928375229,0,3,positive regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
16604,GO:0071933,1,0.946917998956962,0,8,Arp2/3 complex binding,MF,
16605,GO:0071934,1,0.981317521600299,0,3,thiamine transmembrane transport,BP,
16606,GO:0071936,1,0.943066283405684,0,8,coreceptor activity involved in Wnt signaling pathway,MF,
16607,GO:0071938,1,0.993818034633296,0,1,vitamin A transport,BP,
16608,GO:0071939,1,0.993818034633296,0,1,vitamin A import,BP,
16609,GO:0071941,1,0.917806533810473,0,14,nitrogen cycle metabolic process,BP,
16610,GO:0071942,1,0.981427993945082,0,3,XPC complex,CC,
16612,GO:0071947,1,0.979594910102531,0,3,protein deubiquitination involved in ubiquitin-dependent protein catabolic process,BP,
16613,GO:0071949,1,0.850677169854762,0,25,FAD binding,MF,
16614,GO:0071951,1,0.99386887877746,0,1,conversion of methionyl-tRNA to N-formyl-methionyl-tRNA,BP,
16615,GO:0071953,1,0.975964503223385,0,4,elastic fiber,CC,
16616,GO:0071954,1,0.993489301443189,0,1,chemokine (C-C motif) ligand 11 production,BP,
16617,GO:0071955,1,0.984509243382711,0,2,recycling endosome to Golgi transport,BP,
16618,GO:0071960,1,0.994831285768497,0,1,maintenance of mitotic sister chromatid cohesion, centromeric,BP,
16619,GO:0071962,1,0.98271651706802,0,3,mitotic sister chromatid cohesion, centromeric,BP,
16620,GO:0071963,1,0.994386422015062,0,1,establishment or maintenance of cell polarity regulating cell shape,BP,
16621,GO:0071971,1,0.957040873373381,0,7,extracellular exosome assembly,BP,
16622,GO:0071976,1,0.993588576818909,0,1,cell gliding,BP,
16623,GO:0071985,1,0.83270471584941,0,28,multivesicular body sorting pathway,BP,
16624,GO:0071986,1,0.963780864802184,0,6,Ragulator complex,CC,
16625,GO:0071987,1,0.972255909837813,0,4,WD40-repeat domain binding,MF,
16626,GO:0071988,1,0.991555657821302,0,1,protein localization to spindle pole body,BP,
16627,GO:0071997,1,0.991969765251917,0,1,glutathione S-conjugate-transporting ATPase activity,MF,
16629,GO:0072003,1,0.98111469337096,0,3,kidney rudiment formation,BP,
16630,GO:0072004,1,0.986508997543432,0,2,kidney field specification,BP,
16632,GO:0072007,1,0.955915229115849,0,7,mesangial cell differentiation,BP,
16633,GO:0072008,1,0.961386271292971,0,6,glomerular mesangial cell differentiation,BP,
16635,GO:0072010,1,0.884704675129257,0,18,glomerular epithelium development,BP,
16636,GO:0072011,1,0.988342459245525,0,2,glomerular endothelium development,BP,
16638,GO:0072014,1,0.963987522883264,0,5,proximal tubule development,BP,
16639,GO:0072015,1,0.935578513040885,0,9,glomerular visceral epithelial cell development,BP,
16640,GO:0072016,1,0.993926991213386,0,1,glomerular parietal epithelial cell development,BP,
16641,GO:0072017,1,0.918592749611805,0,11,distal tubule development,BP,
16642,GO:0072019,1,0.994183314412697,0,1,proximal convoluted tubule development,BP,
16643,GO:0072021,1,0.975380628101961,0,3,ascending thin limb development,BP,
16644,GO:0072023,1,0.994514588791753,0,1,thick ascending limb development,BP,
16645,GO:0072024,1,0.994514588791753,0,1,macula densa development,BP,
16646,GO:0072025,1,0.975187513328424,0,4,distal convoluted tubule development,BP,
16647,GO:0072027,1,0.9939779645589,0,1,connecting tubule development,BP,
16649,GO:0072033,1,0.941685333174826,0,8,renal vesicle formation,BP,
16650,GO:0072034,1,0.980388888638971,0,3,renal vesicle induction,BP,
16651,GO:0072036,1,0.993360169819569,0,1,mesenchymal to epithelial transition involved in renal vesicle formation,BP,
16652,GO:0072038,1,0.968777048356773,0,5,mesenchymal stem cell maintenance involved in nephron morphogenesis,BP,
16653,GO:0072039,1,0.979810189188761,0,3,regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
16654,GO:0072040,1,0.979810189188761,0,3,negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
16655,GO:0072044,1,0.916441355256985,0,12,collecting duct development,BP,
16656,GO:0072046,1,0.994532674473419,0,1,establishment of planar polarity involved in nephron morphogenesis,BP,
16657,GO:0072047,1,0.971583718678356,0,5,proximal/distal pattern formation involved in nephron development,BP,
16658,GO:0072048,1,0.94746422016629,0,9,renal system pattern specification,BP,
16659,GO:0072049,1,0.969512262874165,0,5,comma-shaped body morphogenesis,BP,
16660,GO:0072050,1,0.956378277609931,0,7,S-shaped body morphogenesis,BP,
16661,GO:0072051,1,0.994514588791753,0,1,juxtaglomerular apparatus development,BP,
16662,GO:0072053,1,0.986838543150052,0,2,renal inner medulla development,BP,
16663,GO:0072054,1,0.986838543150052,0,2,renal outer medulla development,BP,
16664,GO:0072055,1,0.992673486701873,0,1,renal cortex development,BP,
16665,GO:0072059,1,0.992673486701873,0,1,cortical collecting duct development,BP,
16666,GO:0072060,1,0.993273347060655,0,1,outer medullary collecting duct development,BP,
16667,GO:0072061,1,0.981719359907624,0,3,inner medullary collecting duct development,BP,
16668,GO:0072069,1,0.981096849256732,0,3,DCT cell differentiation,BP,
16669,GO:0072070,1,0.93322509232148,0,10,loop of Henle development,BP,
16670,GO:0072071,1,0.988880587754606,0,2,kidney interstitial fibroblast differentiation,BP,
16672,GO:0072074,1,0.888547787951963,0,18,kidney mesenchyme development,BP,
16673,GO:0072075,1,0.909747396939893,0,14,metanephric mesenchyme development,BP,
16674,GO:0072076,1,0.978227882970023,0,3,nephrogenic mesenchyme development,BP,
16675,GO:0072077,1,0.885897796921094,0,18,renal vesicle morphogenesis,BP,
16677,GO:0072079,1,0.894811193173088,0,18,nephron tubule formation,BP,
16679,GO:0072081,1,0.971583718678356,0,5,specification of nephron tubule identity,BP,
16680,GO:0072086,1,0.97714352168452,0,4,specification of loop of Henle identity,BP,
16681,GO:0072087,1,0.880852188087771,0,19,renal vesicle development,BP,
16685,GO:0072092,1,0.97325898276154,0,3,ureteric bud invasion,BP,
16686,GO:0072093,1,0.966794946461065,0,4,metanephric renal vesicle formation,BP,
16687,GO:0072095,1,0.980468052140561,0,3,regulation of branch elongation involved in ureteric bud branching,BP,
16688,GO:0072096,1,0.994367297581572,0,1,negative regulation of branch elongation involved in ureteric bud branching,BP,
16689,GO:0072097,1,0.994367297581572,0,1,negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway,BP,
16690,GO:0072098,1,0.988710490264874,0,2,anterior/posterior pattern specification involved in kidney development,BP,
16691,GO:0072099,1,0.994367297581572,0,1,anterior/posterior pattern specification involved in ureteric bud development,BP,
16692,GO:0072100,1,0.994367297581572,0,1,specification of ureteric bud anterior/posterior symmetry,BP,
16693,GO:0072101,1,0.994367297581572,0,1,specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway,BP,
16697,GO:0072106,1,0.974854794319249,0,4,regulation of ureteric bud formation,BP,
16698,GO:0072107,1,0.974854794319249,0,4,positive regulation of ureteric bud formation,BP,
16699,GO:0072108,1,0.974908232556592,0,4,positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
16700,GO:0072109,1,0.913426815193489,0,14,glomerular mesangium development,BP,
16701,GO:0072110,1,0.944242012919946,0,9,glomerular mesangial cell proliferation,BP,
16702,GO:0072111,1,0.891617577868509,0,18,cell proliferation involved in kidney development,BP,
16703,GO:0072112,1,0.901452357939619,0,15,glomerular visceral epithelial cell differentiation,BP,
16704,GO:0072114,1,0.992417985007152,0,1,pronephros morphogenesis,BP,
16705,GO:0072124,1,0.951549358625563,0,8,regulation of glomerular mesangial cell proliferation,BP,
16706,GO:0072125,1,0.981430739510702,0,3,negative regulation of glomerular mesangial cell proliferation,BP,
16707,GO:0072126,1,0.969558923065751,0,5,positive regulation of glomerular mesangial cell proliferation,BP,
16708,GO:0072127,1,0.994119794279228,0,1,renal capsule development,BP,
16709,GO:0072128,1,0.994119794279228,0,1,renal capsule morphogenesis,BP,
16710,GO:0072129,1,0.994119794279228,0,1,renal capsule formation,BP,
16711,GO:0072130,1,0.994119794279228,0,1,renal capsule specification,BP,
16712,GO:0072131,1,0.972611467132445,0,4,kidney mesenchyme morphogenesis,BP,
16713,GO:0072132,1,0.741051605642502,0,45,mesenchyme morphogenesis,BP,
16714,GO:0072133,1,0.972611467132445,0,4,metanephric mesenchyme morphogenesis,BP,
16715,GO:0072134,1,0.984015032629341,0,2,nephrogenic mesenchyme morphogenesis,BP,
16716,GO:0072135,1,0.981249914980954,0,3,kidney mesenchymal cell proliferation,BP,
16717,GO:0072136,1,0.981249914980954,0,3,metanephric mesenchymal cell proliferation involved in metanephros development,BP,
16718,GO:0072137,1,0.964081211540705,0,4,condensed mesenchymal cell proliferation,BP,
16719,GO:0072138,1,0.98223936276134,0,3,mesenchymal cell proliferation involved in ureteric bud development,BP,
16720,GO:0072139,1,0.987231573260046,0,2,glomerular parietal epithelial cell differentiation,BP,
16721,GO:0072141,1,0.988880587754606,0,2,renal interstitial fibroblast development,BP,
16722,GO:0072143,1,0.96179837162108,0,6,mesangial cell development,BP,
16723,GO:0072144,1,0.967302742795901,0,5,glomerular mesangial cell development,BP,
16724,GO:0072148,1,0.908237867966323,0,15,epithelial cell fate commitment,BP,
16725,GO:0072156,1,0.973124943815097,0,3,distal tubule morphogenesis,BP,
16726,GO:0072160,1,0.908987447416126,0,13,nephron tubule epithelial cell differentiation,BP,
16727,GO:0072161,1,0.957391856188023,0,7,mesenchymal cell differentiation involved in kidney development,BP,
16728,GO:0072162,1,0.974451545016709,0,4,metanephric mesenchymal cell differentiation,BP,
16731,GO:0072165,1,0.994311473026755,0,1,anterior mesonephric tubule development,BP,
16732,GO:0072166,1,0.988085036819701,0,2,posterior mesonephric tubule development,BP,
16733,GO:0072167,1,0.994311473026755,0,1,specification of mesonephric tubule identity,BP,
16734,GO:0072168,1,0.994311473026755,0,1,specification of anterior mesonephric tubule identity,BP,
16735,GO:0072169,1,0.994311473026755,0,1,specification of posterior mesonephric tubule identity,BP,
16736,GO:0072170,1,0.857345189925157,0,22,metanephric tubule development,BP,
16738,GO:0072172,1,0.951963217767621,0,8,mesonephric tubule formation,BP,
16739,GO:0072173,1,0.927321028305417,0,11,metanephric tubule morphogenesis,BP,
16740,GO:0072174,1,0.961870274301959,0,6,metanephric tubule formation,BP,
16742,GO:0072176,1,0.912192827599472,0,13,nephric duct development,BP,
16743,GO:0072177,1,0.958623274393303,0,6,mesonephric duct development,BP,
16744,GO:0072178,1,0.935441247426688,0,10,nephric duct morphogenesis,BP,
16745,GO:0072179,1,0.975991643493385,0,4,nephric duct formation,BP,
16746,GO:0072180,1,0.983042644935625,0,3,mesonephric duct morphogenesis,BP,
16747,GO:0072181,1,0.994532674473419,0,1,mesonephric duct formation,BP,
16748,GO:0072182,1,0.923044503321988,0,11,regulation of nephron tubule epithelial cell differentiation,BP,
16749,GO:0072183,1,0.987795687813841,0,2,negative regulation of nephron tubule epithelial cell differentiation,BP,
16750,GO:0072184,1,0.994311473026755,0,1,renal vesicle progenitor cell differentiation,BP,
16751,GO:0072185,1,0.988413062463476,0,2,metanephric cap development,BP,
16752,GO:0072186,1,0.988413062463476,0,2,metanephric cap morphogenesis,BP,
16753,GO:0072189,1,0.91746412151204,0,13,ureter development,BP,
16754,GO:0072190,1,0.982052403557144,0,3,ureter urothelium development,BP,
16755,GO:0072191,1,0.976224417101524,0,4,ureter smooth muscle development,BP,
16756,GO:0072192,1,0.994367297581572,0,1,ureter epithelial cell differentiation,BP,
16757,GO:0072193,1,0.976224417101524,0,4,ureter smooth muscle cell differentiation,BP,
16758,GO:0072194,1,0.98157249197495,0,3,kidney smooth muscle tissue development,BP,
16759,GO:0072195,1,0.994475315120246,0,1,kidney smooth muscle cell differentiation,BP,
16760,GO:0072197,1,0.98146472387934,0,3,ureter morphogenesis,BP,
16761,GO:0072198,1,0.982843390743422,0,3,mesenchymal cell proliferation involved in ureter development,BP,
16762,GO:0072199,1,0.982843390743422,0,3,regulation of mesenchymal cell proliferation involved in ureter development,BP,
16763,GO:0072200,1,0.994367297581572,0,1,negative regulation of mesenchymal cell proliferation involved in ureter development,BP,
16764,GO:0072201,1,0.948392275774963,0,8,negative regulation of mesenchymal cell proliferation,BP,
16765,GO:0072202,1,0.856335338565519,0,23,cell differentiation involved in metanephros development,BP,
16766,GO:0072203,1,0.936449250930462,0,10,cell proliferation involved in metanephros development,BP,
16767,GO:0072204,1,0.986324183710921,0,2,cell-cell signaling involved in metanephros development,BP,
16768,GO:0072205,1,0.948625352716755,0,7,metanephric collecting duct development,BP,
16769,GO:0072206,1,0.994514588791753,0,1,metanephric juxtaglomerular apparatus development,BP,
16770,GO:0072207,1,0.845372480529862,0,24,metanephric epithelium development,BP,
16771,GO:0072208,1,0.987026218516011,0,2,metanephric smooth muscle tissue development,BP,
16772,GO:0072209,1,0.987725482903276,0,2,metanephric mesangial cell differentiation,BP,
16774,GO:0072213,1,0.994119794279228,0,1,metanephric capsule development,BP,
16775,GO:0072214,1,0.992673486701873,0,1,metanephric cortex development,BP,
16776,GO:0072215,1,0.874292312513602,0,20,regulation of metanephros development,BP,
16777,GO:0072216,1,0.925874257976927,0,12,positive regulation of metanephros development,BP,
16778,GO:0072217,1,0.957153131488537,0,7,negative regulation of metanephros development,BP,
16779,GO:0072218,1,0.975380628101961,0,3,metanephric ascending thin limb development,BP,
16780,GO:0072219,1,0.992673486701873,0,1,metanephric cortical collecting duct development,BP,
16781,GO:0072221,1,0.975187513328424,0,4,metanephric distal convoluted tubule development,BP,
16782,GO:0072223,1,0.967839423640584,0,5,metanephric glomerular mesangium development,BP,
16784,GO:0072227,1,0.994514588791753,0,1,metanephric macula densa development,BP,
16785,GO:0072229,1,0.994183314412697,0,1,metanephric proximal convoluted tubule development,BP,
16786,GO:0072233,1,0.994514588791753,0,1,metanephric thick ascending limb development,BP,
16787,GO:0072234,1,0.873276295258192,0,19,metanephric nephron tubule development,BP,
16788,GO:0072235,1,0.956421715971737,0,6,metanephric distal tubule development,BP,
16789,GO:0072236,1,0.968817935809998,0,4,metanephric loop of Henle development,BP,
16790,GO:0072237,1,0.982253452116726,0,2,metanephric proximal tubule development,BP,
16792,GO:0072240,1,0.981096849256732,0,3,metanephric DCT cell differentiation,BP,
16793,GO:0072243,1,0.866517062156256,0,20,metanephric nephron epithelium development,BP,
16794,GO:0072244,1,0.992270451965043,0,1,metanephric glomerular epithelium development,BP,
16795,GO:0072248,1,0.992270451965043,0,1,metanephric glomerular visceral epithelial cell differentiation,BP,
16796,GO:0072249,1,0.992270451965043,0,1,metanephric glomerular visceral epithelial cell development,BP,
16797,GO:0072254,1,0.987725482903276,0,2,metanephric glomerular mesangial cell differentiation,BP,
16798,GO:0072255,1,0.993802384256541,0,1,metanephric glomerular mesangial cell development,BP,
16799,GO:0072257,1,0.946689075584518,0,7,metanephric nephron tubule epithelial cell differentiation,BP,
16800,GO:0072258,1,0.994311473026755,0,1,metanephric interstitial fibroblast differentiation,BP,
16801,GO:0072259,1,0.994311473026755,0,1,metanephric interstitial fibroblast development,BP,
16802,GO:0072262,1,0.979869301921881,0,3,metanephric glomerular mesangial cell proliferation involved in metanephros development,BP,
16803,GO:0072265,1,0.994119794279228,0,1,metanephric capsule morphogenesis,BP,
16804,GO:0072266,1,0.994119794279228,0,1,metanephric capsule formation,BP,
16805,GO:0072267,1,0.994119794279228,0,1,metanephric capsule specification,BP,
16806,GO:0072268,1,0.976867763064076,0,4,pattern specification involved in metanephros development,BP,
16807,GO:0072272,1,0.988269414673668,0,2,proximal/distal pattern formation involved in metanephric nephron development,BP,
16808,GO:0072273,1,0.841161821690478,0,25,metanephric nephron morphogenesis,BP,
16809,GO:0072274,1,0.992270451965043,0,1,metanephric glomerular basement membrane development,BP,
16813,GO:0072278,1,0.980116502805227,0,3,metanephric comma-shaped body morphogenesis,BP,
16814,GO:0072282,1,0.944538644200005,0,8,metanephric nephron tubule morphogenesis,BP,
16815,GO:0072283,1,0.90363709054374,0,15,metanephric renal vesicle morphogenesis,BP,
16816,GO:0072284,1,0.966840311568062,0,5,metanephric S-shaped body morphogenesis,BP,
16817,GO:0072285,1,0.993360169819569,0,1,mesenchymal to epithelial transition involved in metanephric renal vesicle formation,BP,
16818,GO:0072286,1,0.9939779645589,0,1,metanephric connecting tubule development,BP,
16819,GO:0072287,1,0.98800104150365,0,1,metanephric distal tubule morphogenesis,BP,
16820,GO:0072289,1,0.973707371815375,0,4,metanephric nephron tubule formation,BP,
16821,GO:0072298,1,0.973602000721103,0,4,regulation of metanephric glomerulus development,BP,
16822,GO:0072299,1,0.993738301804264,0,1,negative regulation of metanephric glomerulus development,BP,
16823,GO:0072300,1,0.979738089521683,0,3,positive regulation of metanephric glomerulus development,BP,
16824,GO:0072301,1,0.987449515670909,0,2,regulation of metanephric glomerular mesangial cell proliferation,BP,
16825,GO:0072302,1,0.993738301804264,0,1,negative regulation of metanephric glomerular mesangial cell proliferation,BP,
16826,GO:0072303,1,0.993671987568872,0,1,positive regulation of glomerular metanephric mesangial cell proliferation,BP,
16827,GO:0072304,1,0.986508997543432,0,2,regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
16828,GO:0072305,1,0.986508997543432,0,2,negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
16829,GO:0072307,1,0.946689075584518,0,7,regulation of metanephric nephron tubule epithelial cell differentiation,BP,
16830,GO:0072308,1,0.993447314027227,0,1,negative regulation of metanephric nephron tubule epithelial cell differentiation,BP,
16831,GO:0072309,1,0.986508997543432,0,2,mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis,BP,
16832,GO:0072310,1,0.929892925830943,0,10,glomerular epithelial cell development,BP,
16833,GO:0072311,1,0.895972107156451,0,16,glomerular epithelial cell differentiation,BP,
16834,GO:0072312,1,0.992270451965043,0,1,metanephric glomerular epithelial cell differentiation,BP,
16835,GO:0072313,1,0.992270451965043,0,1,metanephric glomerular epithelial cell development,BP,
16836,GO:0072318,1,0.959685949308995,0,6,clathrin coat disassembly,BP,
16837,GO:0072319,1,0.954080615353416,0,7,vesicle uncoating,BP,
16838,GO:0072320,1,0.974077840903241,0,4,volume-sensitive chloride channel activity,MF,
16839,GO:0072321,1,0.944190833089335,0,10,chaperone-mediated protein transport,BP,
16840,GO:0072329,1,0.464696805558308,0,122,monocarboxylic acid catabolic process,BP,
16843,GO:0072332,1,0.602154993243159,0,79,intrinsic apoptotic signaling pathway by p53 class mediator,BP,
16844,GO:0072334,1,0.989101058051263,0,2,UDP-galactose transmembrane transport,BP,
16845,GO:0072337,1,0.889943441260746,0,17,modified amino acid transport,BP,
16846,GO:0072338,1,0.958903411126035,0,6,cellular lactam metabolic process,BP,
16847,GO:0072340,1,0.994411747803641,0,1,cellular lactam catabolic process,BP,
16849,GO:0072343,1,0.988985667549452,0,2,pancreatic stellate cell proliferation,BP,
16850,GO:0072344,1,0.976005554936668,0,4,rescue of stalled ribosome,BP,
16851,GO:0072345,1,0.961532642851424,0,6,NAADP-sensitive calcium-release channel activity,MF,
16853,GO:0072348,1,0.822535686484935,0,30,sulfur compound transport,BP,
16854,GO:0072349,1,0.915020955983234,0,13,modified amino acid transmembrane transporter activity,MF,
16855,GO:0072350,1,0.80128684880594,0,36,tricarboxylic acid metabolic process,BP,
16856,GO:0072354,1,0.994405028845343,0,1,histone kinase activity (H3-T3 specific),MF,
16857,GO:0072355,1,0.994405028845343,0,1,histone H3-T3 phosphorylation,BP,
16858,GO:0072356,1,0.993213088589486,0,1,chromosome passenger complex localization to kinetochore,BP,
16859,GO:0072357,1,0.953611078763892,0,7,PTW/PP1 phosphatase complex,CC,
16862,GO:0072361,1,0.981361268020496,0,2,regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter,BP,
16863,GO:0072362,1,0.991166185021313,0,1,regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter,BP,
16864,GO:0072363,1,0.990108576688462,0,1,regulation of glycolytic process by positive regulation of transcription from RNA polymerase II promoter,BP,
16865,GO:0072364,1,0.981001994284477,0,2,regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter,BP,
16866,GO:0072365,1,0.99080335800469,0,1,regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter,BP,
16867,GO:0072366,1,0.990108576688462,0,1,regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter,BP,
16868,GO:0072367,1,0.968473155145601,0,4,regulation of lipid transport by regulation of transcription from RNA polymerase II promoter,BP,
16869,GO:0072368,1,0.984289939227532,0,2,regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter,BP,
16870,GO:0072369,1,0.983933313626113,0,2,regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter,BP,
16871,GO:0072376,1,0.664967456060529,0,66,protein activation cascade,BP,
16872,GO:0072378,1,0.878731597134774,0,21,blood coagulation, fibrin clot formation,BP,
16873,GO:0072379,1,0.98226219779945,0,3,ER membrane insertion complex,CC,
16874,GO:0072382,1,0.987883348328765,0,1,minus-end-directed vesicle transport along microtubule,BP,
16875,GO:0072383,1,0.947945818801204,0,7,plus-end-directed vesicle transport along microtubule,BP,
16876,GO:0072384,1,0.618703571705114,0,69,organelle transport along microtubule,BP,
16877,GO:0072385,1,0.967747475996954,0,4,minus-end-directed organelle transport along microtubule,BP,
16878,GO:0072386,1,0.940647730281228,0,8,plus-end-directed organelle transport along microtubule,BP,
16879,GO:0072387,1,0.987601310791922,0,2,flavin adenine dinucleotide metabolic process,BP,
16880,GO:0072388,1,0.994269348506945,0,1,flavin adenine dinucleotide biosynthetic process,BP,
16881,GO:0072389,1,0.993293917962388,0,1,flavin adenine dinucleotide catabolic process,BP,
16882,GO:0072393,1,0.918943333627849,0,11,microtubule anchoring at microtubule organizing center,BP,
16884,GO:0072396,1,0.964350753714538,0,5,response to cell cycle checkpoint signaling,BP,
16886,GO:0072402,1,0.964350753714538,0,5,response to DNA integrity checkpoint signaling,BP,
16888,GO:0072414,1,0.991622205077179,0,1,response to mitotic cell cycle checkpoint signaling,BP,
16890,GO:0072423,1,0.964350753714538,0,5,response to DNA damage checkpoint signaling,BP,
16892,GO:0072428,1,0.994323361538874,0,1,signal transduction involved in intra-S DNA damage checkpoint,BP,
16893,GO:0072429,1,0.982081879064938,0,3,response to intra-S DNA damage checkpoint signaling,BP,
16895,GO:0072432,1,0.991622205077179,0,1,response to G1 DNA damage checkpoint signaling,BP,
16896,GO:0072434,1,0.983361293089207,0,2,signal transduction involved in mitotic G2 DNA damage checkpoint,BP,
16897,GO:0072487,1,0.974578820402337,0,4,MSL complex,CC,
16898,GO:0072488,1,0.934730593108671,0,11,ammonium transmembrane transport,BP,
16899,GO:0072492,1,0.99438280393633,0,1,host cell mitochondrial intermembrane space,CC,
16901,GO:0072498,1,0.917852716740712,0,14,embryonic skeletal joint development,BP,
16902,GO:0072501,1,0.957173963499339,0,6,cellular divalent inorganic anion homeostasis,BP,
16903,GO:0072502,1,0.957173963499339,0,6,cellular trivalent inorganic anion homeostasis,BP,
16905,GO:0072505,1,0.937938793857064,0,9,divalent inorganic anion homeostasis,BP,
16906,GO:0072506,1,0.937938793857064,0,9,trivalent inorganic anion homeostasis,BP,
16908,GO:0072509,1,0.86256834641348,0,23,divalent inorganic cation transmembrane transporter activity,MF,
16912,GO:0072513,1,0.975668985711348,0,4,positive regulation of secondary heart field cardioblast proliferation,BP,
16913,GO:0072517,1,0.993514637734672,0,1,host cell viral assembly compartment,CC,
16914,GO:0072518,1,0.991959324395744,0,1,Rho-dependent protein serine/threonine kinase activity,MF,
16915,GO:0072520,1,0.927223446109844,0,11,seminiferous tubule development,BP,
16918,GO:0072523,1,0.724354997739971,0,49,purine-containing compound catabolic process,BP,
16919,GO:0072524,1,0.347703072330997,0,162,pyridine-containing compound metabolic process,BP,
16920,GO:0072525,1,0.445742969172634,0,122,pyridine-containing compound biosynthetic process,BP,
16921,GO:0072526,1,0.966276005647271,0,6,pyridine-containing compound catabolic process,BP,
16924,GO:0072529,1,0.8110907491938,0,34,pyrimidine-containing compound catabolic process,BP,
16925,GO:0072530,1,0.953292487739516,0,8,purine-containing compound transmembrane transport,BP,
16926,GO:0072531,1,0.945970714579133,0,9,pyrimidine-containing compound transmembrane transport,BP,
16927,GO:0072534,1,0.983712956894821,0,2,perineuronal net,CC,
16928,GO:0072535,1,0.987763555586207,0,2,tumor necrosis factor (ligand) superfamily member 11 production,BP,
16929,GO:0072536,1,0.994262112923769,0,1,interleukin-23 receptor complex,CC,
16930,GO:0072537,1,0.943268742484225,0,9,fibroblast activation,BP,
16931,GO:0072538,1,0.896184155454098,0,17,T-helper 17 type immune response,BP,
16932,GO:0072539,1,0.901962404196883,0,16,T-helper 17 cell differentiation,BP,
16933,GO:0072540,1,0.941162750402364,0,10,T-helper 17 cell lineage commitment,BP,
16934,GO:0072542,1,0.957246705447126,0,7,protein phosphatase activator activity,MF,
16935,GO:0072544,1,0.994410714123709,0,1,L-DOPA binding,MF,
16936,GO:0072545,1,0.988615938954529,0,2,tyrosine binding,MF,
16937,GO:0072546,1,0.939746048635147,0,10,ER membrane protein complex,CC,
16938,GO:0072553,1,0.959838789685541,0,6,terminal button organization,BP,
16939,GO:0072554,1,0.987648900668585,0,2,blood vessel lumenization,BP,
16940,GO:0072556,1,0.993129923835772,0,1,other organism presynaptic membrane,CC,
16941,GO:0072557,1,0.977730032397185,0,4,IPAF inflammasome complex,CC,
16942,GO:0072558,1,0.976867871093002,0,4,NLRP1 inflammasome complex,CC,
16943,GO:0072559,1,0.952895407872493,0,8,NLRP3 inflammasome complex,CC,
16944,GO:0072560,1,0.988421151900139,0,2,type B pancreatic cell maturation,BP,
16946,GO:0072563,1,0.988163696504824,0,2,endothelial microparticle,CC,
16947,GO:0072564,1,0.9886775941202,0,2,blood microparticle formation,BP,
16948,GO:0072566,1,0.988061587152251,0,2,chemokine (C-X-C motif) ligand 1 production,BP,
16950,GO:0072570,1,0.993616462058373,0,1,ADP-D-ribose binding,MF,
16951,GO:0072572,1,0.994182797838896,0,1,poly-ADP-D-ribose binding,MF,
16952,GO:0072573,1,0.993003891125131,0,1,tolerance induction to lipopolysaccharide,BP,
16953,GO:0072574,1,0.914309814224201,0,14,hepatocyte proliferation,BP,
16954,GO:0072575,1,0.914309814224201,0,14,epithelial cell proliferation involved in liver morphogenesis,BP,
16955,GO:0072576,1,0.906776861894017,0,15,liver morphogenesis,BP,
16956,GO:0072577,1,0.732552293249705,0,46,endothelial cell apoptotic process,BP,
16957,GO:0072578,1,0.928425297303557,0,10,neurotransmitter-gated ion channel clustering,BP,
16958,GO:0072579,1,0.993089013418687,0,1,glycine receptor clustering,BP,
16959,GO:0072583,1,0.763176639382169,0,38,clathrin-dependent endocytosis,BP,
16960,GO:0072584,1,0.942581029072466,0,9,caveolin-mediated endocytosis,BP,
16961,GO:0072586,1,0.992964363255853,0,1,DNA topoisomerase (ATP-hydrolyzing) regulator activity,MF,
16962,GO:0072587,1,0.992964363255853,0,1,DNA topoisomerase (ATP-hydrolyzing) activator activity,MF,
16963,GO:0072588,1,0.973414907809869,0,5,box H/ACA RNP complex,CC,
16964,GO:0072589,1,0.978716448686309,0,4,box H/ACA scaRNP complex,CC,
16965,GO:0072590,1,0.982172667568632,0,2,N-acetyl-L-aspartate-L-glutamate ligase activity,MF,
16966,GO:0072591,1,0.99227149956228,0,1,citrate-L-glutamate ligase activity,MF,
16967,GO:0072592,1,0.971089309020538,0,5,oxygen metabolic process,BP,
16970,GO:0072595,1,0.769671458598465,0,40,maintenance of protein localization in organelle,BP,
16971,GO:0072599,1,0.562901694262086,0,104,establishment of protein localization to endoplasmic reticulum,BP,
16972,GO:0072602,1,0.961100789766663,0,6,interleukin-4 secretion,BP,
16973,GO:0072603,1,0.963620049691764,0,6,interleukin-5 secretion,BP,
16975,GO:0072606,1,0.851098660751464,0,26,interleukin-8 secretion,BP,
16976,GO:0072608,1,0.954211852542612,0,8,interleukin-10 secretion,BP,
16977,GO:0072610,1,0.946632068583323,0,9,interleukin-12 secretion,BP,
16978,GO:0072611,1,0.958509395212772,0,7,interleukin-13 secretion,BP,
16979,GO:0072615,1,0.988476157226266,0,2,interleukin-17 secretion,BP,
16980,GO:0072616,1,0.993226749235791,0,1,interleukin-18 secretion,BP,
16981,GO:0072619,1,0.993451155354443,0,1,interleukin-21 secretion,BP,
16982,GO:0072641,1,0.95024696891388,0,7,type I interferon secretion,BP,
16983,GO:0072642,1,0.956168491592652,0,6,interferon-alpha secretion,BP,
16984,GO:0072643,1,0.909590627300198,0,15,interferon-gamma secretion,BP,
16986,GO:0072656,1,0.967956672143526,0,5,maintenance of protein location in mitochondrion,BP,
16988,GO:0072658,1,0.990140555769818,0,1,maintenance of protein location in membrane,BP,
16990,GO:0072660,1,0.990140555769818,0,1,maintenance of protein location in plasma membrane,BP,
16991,GO:0072662,1,0.89756495751057,0,17,protein localization to peroxisome,BP,
16992,GO:0072663,1,0.89756495751057,0,17,establishment of protein localization to peroxisome,BP,
16993,GO:0072665,1,0.691943877641601,0,54,protein localization to vacuole,BP,
16994,GO:0072666,1,0.747800877673963,0,42,establishment of protein localization to vacuole,BP,
16995,GO:0072669,1,0.961236571152032,0,7,tRNA-splicing ligase complex,CC,
16996,GO:0072671,1,0.993971010586614,0,1,mitochondria-associated ubiquitin-dependent protein catabolic process,BP,
16997,GO:0072672,1,0.954907629375075,0,7,neutrophil extravasation,BP,
16999,GO:0072674,1,0.967279748989689,0,4,multinuclear osteoclast differentiation,BP,
17000,GO:0072675,1,0.967279748989689,0,4,osteoclast fusion,BP,
17001,GO:0072676,1,0.656405182826961,0,69,lymphocyte migration,BP,
17002,GO:0072677,1,0.922621472794179,0,14,eosinophil migration,BP,
17003,GO:0072678,1,0.772899965824835,0,42,T cell migration,BP,
17004,GO:0072679,1,0.971268478491822,0,5,thymocyte migration,BP,
17005,GO:0072680,1,0.993663286186664,0,1,extracellular matrix-dependent thymocyte migration,BP,
17006,GO:0072681,1,0.993663286186664,0,1,fibronectin-dependent thymocyte migration,BP,
17007,GO:0072682,1,0.993529222863612,0,1,eosinophil extravasation,BP,
17008,GO:0072683,1,0.977714794028495,0,4,T cell extravasation,BP,
17009,GO:0072684,1,0.993320639602953,0,1,mitochondrial tRNA 3'-trailer cleavage, endonucleolytic,BP,
17012,GO:0072695,1,0.988023766633378,0,2,regulation of DNA recombination at telomere,BP,
17013,GO:0072697,1,0.92805392941397,0,11,protein localization to cell cortex,BP,
17014,GO:0072698,1,0.73346659160934,0,43,protein localization to microtubule cytoskeleton,BP,
17015,GO:0072702,1,0.992376568788314,0,1,response to methyl methanesulfonate,BP,
17016,GO:0072703,1,0.992376568788314,0,1,cellular response to methyl methanesulfonate,BP,
17017,GO:0072706,1,0.99396122510297,0,1,response to sodium dodecyl sulfate,BP,
17018,GO:0072707,1,0.99396122510297,0,1,cellular response to sodium dodecyl sulfate,BP,
17019,GO:0072708,1,0.970105879250764,0,5,response to sorbitol,BP,
17020,GO:0072709,1,0.982096892378751,0,3,cellular response to sorbitol,BP,
17021,GO:0072710,1,0.944586719662036,0,8,response to hydroxyurea,BP,
17022,GO:0072711,1,0.950434275278178,0,7,cellular response to hydroxyurea,BP,
17023,GO:0072714,1,0.994389523203463,0,1,response to selenite ion,BP,
17024,GO:0072715,1,0.994389523203463,0,1,cellular response to selenite ion,BP,
17025,GO:0072716,1,0.974503784680783,0,4,response to actinomycin D,BP,
17026,GO:0072717,1,0.980534639962294,0,3,cellular response to actinomycin D,BP,
17027,GO:0072718,1,0.941954634923297,0,9,response to cisplatin,BP,
17028,GO:0072719,1,0.961787689092071,0,6,cellular response to cisplatin,BP,
17029,GO:0072720,1,0.987738712940129,0,2,response to dithiothreitol,BP,
17030,GO:0072721,1,0.993850639026861,0,1,cellular response to dithiothreitol,BP,
17031,GO:0072733,1,0.982483766394354,0,3,response to staurosporine,BP,
17032,GO:0072734,1,0.982483766394354,0,3,cellular response to staurosporine,BP,
17033,GO:0072737,1,0.988162899280564,0,2,response to diamide,BP,
17034,GO:0072738,1,0.988162899280564,0,2,cellular response to diamide,BP,
17035,GO:0072739,1,0.988195200165495,0,2,response to anisomycin,BP,
17036,GO:0072740,1,0.994309922363705,0,1,cellular response to anisomycin,BP,
17037,GO:0072741,1,0.978963743271495,0,3,protein localization to cell division site,BP,
17038,GO:0072749,1,0.99435385843341,0,1,cellular response to cytochalasin B,BP,
17039,GO:0072750,1,0.994624645380928,0,1,cellular response to leptomycin B,BP,
17040,GO:0072752,1,0.99186853930065,0,1,cellular response to rapamycin,BP,
17041,GO:0072755,1,0.993349906318514,0,1,cellular response to benomyl,BP,
17042,GO:0072757,1,0.974553990803333,0,4,cellular response to camptothecin,BP,
17043,GO:0075044,1,0.971129820020914,0,4,autophagy of host cells involved in interaction with symbiont,BP,
17044,GO:0075071,1,0.971129820020914,0,4,autophagy involved in symbiotic interaction,BP,
17045,GO:0075109,1,0.992596485148829,0,1,modulation by symbiont of host receptor-mediated signal transduction,BP,
17046,GO:0075111,1,0.992596485148829,0,1,negative regulation by symbiont of host receptor-mediated signal transduction,BP,
17047,GO:0075112,1,0.992596485148829,0,1,modulation by symbiont of host transmembrane receptor-mediated signal transduction,BP,
17048,GO:0075114,1,0.992596485148829,0,1,negative regulation by symbiont of host transmembrane receptor-mediated signal transduction,BP,
17049,GO:0075136,1,0.967708821016237,0,5,response to host,BP,
17050,GO:0075341,1,0.994102501505852,0,1,host cell PML body,CC,
17051,GO:0075509,1,0.980483721158434,0,3,endocytosis involved in viral entry into host cell,BP,
17052,GO:0075519,1,0.994929429371126,0,1,microtubule-dependent intracellular transport of viral material,BP,
17053,GO:0075521,1,0.994929429371126,0,1,microtubule-dependent intracellular transport of viral material towards nucleus,BP,
17054,GO:0075522,1,0.936568360954125,0,10,IRES-dependent viral translational initiation,BP,
17055,GO:0075525,1,0.969874003510912,0,5,viral translational termination-reinitiation,BP,
17056,GO:0075528,1,0.986790642886837,0,2,modulation by virus of host immune response,BP,
17057,GO:0075606,1,0.994929429371126,0,1,transport of viral material towards nucleus,BP,
17058,GO:0075713,1,0.952947197124759,0,8,establishment of integrated proviral latency,BP,
17059,GO:0075732,1,0.985367653540629,0,2,viral penetration into host nucleus,BP,
17060,GO:0075733,1,0.704354924598204,0,53,intracellular transport of virus,BP,
17062,GO:0080009,1,0.941880782638091,0,10,mRNA methylation,BP,
17063,GO:0080019,1,0.986806485843434,0,2,fatty-acyl-CoA reductase (alcohol-forming) activity,MF,
17064,GO:0080023,1,0.987738712940129,0,2,3R-hydroxyacyl-CoA dehydratase activity,MF,
17065,GO:0080025,1,0.860487163758807,0,22,phosphatidylinositol-3,5-bisphosphate binding,MF,
17066,GO:0080033,1,0.992013629895481,0,1,response to nitrite,BP,
17067,GO:0080048,1,0.993850639026861,0,1,GDP-D-glucose phosphorylase activity,MF,
17068,GO:0080058,1,0.994585895079447,0,1,protein deglutathionylation,BP,
17069,GO:0080084,1,0.963123841425327,0,5,5S rDNA binding,MF,
17071,GO:0080101,1,0.99477549658101,0,1,phosphatidyl-N-dimethylethanolamine N-methyltransferase activity,MF,
17072,GO:0080111,1,0.85994596586941,0,22,DNA demethylation,BP,
17073,GO:0080120,1,0.988221563693987,0,2,CAAX-box protein maturation,BP,
17074,GO:0080121,1,0.987826061326358,0,2,AMP transport,BP,
17075,GO:0080122,1,0.981872023432743,0,3,AMP transmembrane transporter activity,MF,
17076,GO:0080129,1,0.994724354388498,0,1,proteasome core complex assembly,BP,
17077,GO:0080132,1,0.99403465917182,0,1,fatty acid alpha-hydroxylase activity,MF,
17080,GO:0080144,1,0.987429605292907,0,2,amino acid homeostasis,BP,
17081,GO:0080146,1,0.994387197314057,0,1,L-cysteine desulfhydrase activity,MF,
17082,GO:0080147,1,0.994886556596673,0,1,root hair cell development,BP,
17083,GO:0080154,1,0.906529988309104,0,16,regulation of fertilization,BP,
17084,GO:0080163,1,0.994051935892101,0,1,regulation of protein serine/threonine phosphatase activity,BP,
17085,GO:0080171,1,0.682022893821638,0,58,lytic vacuole organization,BP,
17086,GO:0080182,1,0.894881166704191,0,16,histone H3-K4 trimethylation,BP,
17087,GO:0080184,1,0.971209409225304,0,5,response to phenylpropanoid,BP,
17088,GO:0085018,1,0.993866823174771,0,1,maintenance of symbiont-containing vacuole by host,BP,
17089,GO:0085020,1,0.957675103225701,0,7,protein K6-linked ubiquitination,BP,
17091,GO:0085032,1,0.993597274812223,0,1,modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade,BP,
17095,GO:0086004,1,0.777495411143598,0,33,regulation of cardiac muscle cell contraction,BP,
17097,GO:0086006,1,0.964036946636384,0,5,voltage-gated sodium channel activity involved in cardiac muscle cell action potential,MF,
17098,GO:0086007,1,0.958072089471643,0,5,voltage-gated calcium channel activity involved in cardiac muscle cell action potential,MF,
17099,GO:0086008,1,0.928032539059183,0,12,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization,MF,
17101,GO:0086010,1,0.698658557847263,0,45,membrane depolarization during action potential,BP,
17102,GO:0086011,1,0.857113876247826,0,24,membrane repolarization during action potential,BP,
17103,GO:0086012,1,0.856091336094389,0,20,membrane depolarization during cardiac muscle cell action potential,BP,
17104,GO:0086013,1,0.873542228471699,0,21,membrane repolarization during cardiac muscle cell action potential,BP,
17105,GO:0086014,1,0.869703184217988,0,18,atrial cardiac muscle cell action potential,BP,
17106,GO:0086015,1,0.931199887700767,0,8,SA node cell action potential,BP,
17107,GO:0086016,1,0.925521575509353,0,9,AV node cell action potential,BP,
17108,GO:0086017,1,0.978849556483315,0,3,Purkinje myocyte action potential,BP,
17109,GO:0086018,1,0.931199887700767,0,8,SA node cell to atrial cardiac muscle cell signaling,BP,
17110,GO:0086019,1,0.805029865172188,0,29,cell-cell signaling involved in cardiac conduction,BP,
17111,GO:0086020,1,0.991329862412657,0,1,gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling,MF,
17112,GO:0086021,1,0.991329862412657,0,1,SA node cell to atrial cardiac muscle cell communication by electrical coupling,BP,
17113,GO:0086023,1,0.951429811386106,0,6,adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
17114,GO:0086024,1,0.991075666620809,0,1,adenylate cyclase-activating adrenergic receptor signaling pathway involved in positive regulation of heart rate,BP,
17115,GO:0086026,1,0.869703184217988,0,18,atrial cardiac muscle cell to AV node cell signaling,BP,
17116,GO:0086027,1,0.925521575509353,0,9,AV node cell to bundle of His cell signaling,BP,
17117,GO:0086028,1,0.958995442983546,0,6,bundle of His cell to Purkinje myocyte signaling,BP,
17118,GO:0086029,1,0.960086383450274,0,5,Purkinje myocyte to ventricular cardiac muscle cell signaling,BP,
17119,GO:0086030,1,0.994232397739479,0,1,adenylate cyclase-activating adrenergic receptor signaling pathway involved in cardiac muscle relaxation,BP,
17121,GO:0086037,1,0.993449874937186,0,1,sodium:potassium-exchanging ATPase activity involved in regulation of cardiac muscle cell membrane potential,MF,
17122,GO:0086038,1,0.993850639026861,0,1,calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential,MF,
17123,GO:0086039,1,0.99101623176355,0,1,calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential,MF,
17124,GO:0086040,1,0.992927915001839,0,1,sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential,MF,
17125,GO:0086041,1,0.991542146327512,0,1,voltage-gated potassium channel activity involved in SA node cell action potential depolarization,MF,
17126,GO:0086042,1,0.950920339115378,0,7,cardiac muscle cell-cardiac muscle cell adhesion,BP,
17127,GO:0086043,1,0.958995442983546,0,6,bundle of His cell action potential,BP,
17128,GO:0086045,1,0.957590899373205,0,5,membrane depolarization during AV node cell action potential,BP,
17129,GO:0086046,1,0.956897480822261,0,5,membrane depolarization during SA node cell action potential,BP,
17130,GO:0086047,1,0.978849556483315,0,3,membrane depolarization during Purkinje myocyte cell action potential,BP,
17131,GO:0086048,1,0.977544266459976,0,3,membrane depolarization during bundle of His cell action potential,BP,
17132,GO:0086050,1,0.993811876359536,0,1,membrane repolarization during bundle of His cell action potential,BP,
17133,GO:0086052,1,0.993811876359536,0,1,membrane repolarization during SA node cell action potential,BP,
17134,GO:0086053,1,0.991329862412657,0,1,AV node cell to bundle of His cell communication by electrical coupling,BP,
17135,GO:0086056,1,0.973029861831929,0,3,voltage-gated calcium channel activity involved in AV node cell action potential,MF,
17136,GO:0086057,1,0.993301628432331,0,1,voltage-gated calcium channel activity involved in bundle of His cell action potential,MF,
17137,GO:0086059,1,0.982708981263953,0,2,voltage-gated calcium channel activity involved SA node cell action potential,MF,
17138,GO:0086060,1,0.990886126518871,0,1,voltage-gated sodium channel activity involved in AV node cell action potential,MF,
17139,GO:0086061,1,0.990886126518871,0,1,voltage-gated sodium channel activity involved in bundle of His cell action potential,MF,
17140,GO:0086062,1,0.985562343019591,0,2,voltage-gated sodium channel activity involved in Purkinje myocyte action potential,MF,
17141,GO:0086063,1,0.990886126518871,0,1,voltage-gated sodium channel activity involved in SA node cell action potential,MF,
17142,GO:0086064,1,0.853666463097028,0,22,cell communication by electrical coupling involved in cardiac conduction,BP,
17143,GO:0086065,1,0.689308551185658,0,52,cell communication involved in cardiac conduction,BP,
17144,GO:0086066,1,0.869703184217988,0,18,atrial cardiac muscle cell to AV node cell communication,BP,
17145,GO:0086067,1,0.917490937355538,0,10,AV node cell to bundle of His cell communication,BP,
17146,GO:0086068,1,0.960086383450274,0,5,Purkinje myocyte to ventricular cardiac muscle cell communication,BP,
17147,GO:0086069,1,0.91158635317449,0,13,bundle of His cell to Purkinje myocyte communication,BP,
17148,GO:0086070,1,0.923120476237744,0,9,SA node cell to atrial cardiac muscle cell communication,BP,
17149,GO:0086072,1,0.994011459174668,0,1,AV node cell-bundle of His cell adhesion involved in cell communication,BP,
17150,GO:0086073,1,0.956651844759881,0,6,bundle of His cell-Purkinje myocyte adhesion involved in cell communication,BP,
17151,GO:0086075,1,0.985059717450265,0,2,gap junction channel activity involved in cardiac conduction electrical coupling,MF,
17152,GO:0086077,1,0.991329862412657,0,1,gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling,MF,
17153,GO:0086080,1,0.927880963594045,0,10,protein binding involved in heterotypic cell-cell adhesion,MF,
17154,GO:0086082,1,0.994011459174668,0,1,cell adhesive protein binding involved in AV node cell-bundle of His cell communication,MF,
17155,GO:0086083,1,0.962791582766102,0,5,cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication,MF,
17156,GO:0086087,1,0.993811876359536,0,1,voltage-gated potassium channel activity involved in bundle of His cell action potential repolarization,MF,
17157,GO:0086089,1,0.975301711330779,0,4,voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,MF,
17158,GO:0086090,1,0.993811876359536,0,1,voltage-gated potassium channel activity involved in SA node cell action potential repolarization,MF,
17159,GO:0086091,1,0.775953564000216,0,35,regulation of heart rate by cardiac conduction,BP,
17160,GO:0086092,1,0.98737211471041,0,2,regulation of the force of heart contraction by cardiac conduction,BP,
17161,GO:0086096,1,0.99459157858605,0,1,adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,
17162,GO:0086097,1,0.9870736792732,0,2,phospholipase C-activating angiotensin-activated signaling pathway,BP,
17163,GO:0086098,1,0.987148642045952,0,2,angiotensin-activated signaling pathway involved in heart process,BP,
17164,GO:0086100,1,0.986444046651459,0,2,endothelin receptor signaling pathway,BP,
17165,GO:0086103,1,0.929061586703686,0,10,G-protein coupled receptor signaling pathway involved in heart process,BP,
17166,GO:0089700,1,0.972969027662194,0,4,protein kinase D signaling,BP,
17167,GO:0089701,1,0.971978797749055,0,5,U2AF,CC,
17168,GO:0089709,1,0.982042123618733,0,3,L-histidine transmembrane transport,BP,
17169,GO:0089717,1,0.928283574570495,0,10,spanning component of membrane,CC,
17170,GO:0089718,1,0.877492650845797,0,19,amino acid import across plasma membrane,BP,
17171,GO:0089720,1,0.950106454775571,0,9,caspase binding,MF,
17172,GO:0090009,1,0.941809266184305,0,9,primitive streak formation,BP,
17173,GO:0090010,1,0.99421172909739,0,1,transforming growth factor beta receptor signaling pathway involved in primitive streak formation,BP,
17174,GO:0090022,1,0.822299153486429,0,34,regulation of neutrophil chemotaxis,BP,
17175,GO:0090023,1,0.848552251095646,0,29,positive regulation of neutrophil chemotaxis,BP,
17176,GO:0090024,1,0.986611908758098,0,2,negative regulation of neutrophil chemotaxis,BP,
17177,GO:0090025,1,0.896352004036691,0,18,regulation of monocyte chemotaxis,BP,
17178,GO:0090026,1,0.925841024542051,0,13,positive regulation of monocyte chemotaxis,BP,
17179,GO:0090027,1,0.974306190236372,0,4,negative regulation of monocyte chemotaxis,BP,
17180,GO:0090030,1,0.943743134904861,0,9,regulation of steroid hormone biosynthetic process,BP,
17181,GO:0090031,1,0.981074969175632,0,3,positive regulation of steroid hormone biosynthetic process,BP,
17182,GO:0090032,1,0.968847071968972,0,5,negative regulation of steroid hormone biosynthetic process,BP,
17183,GO:0090034,1,0.987661868432871,0,2,regulation of chaperone-mediated protein complex assembly,BP,
17184,GO:0090035,1,0.987661868432871,0,2,positive regulation of chaperone-mediated protein complex assembly,BP,
17185,GO:0090036,1,0.902833091709483,0,15,regulation of protein kinase C signaling,BP,
17186,GO:0090037,1,0.949745561740454,0,8,positive regulation of protein kinase C signaling,BP,
17187,GO:0090038,1,0.986998655120734,0,2,negative regulation of protein kinase C signaling,BP,
17188,GO:0090042,1,0.939121140190314,0,9,tubulin deacetylation,BP,
17189,GO:0090043,1,0.951029009033898,0,7,regulation of tubulin deacetylation,BP,
17190,GO:0090044,1,0.994460328392633,0,1,positive regulation of tubulin deacetylation,BP,
17191,GO:0090045,1,0.946929068992165,0,8,positive regulation of deacetylase activity,BP,
17192,GO:0090049,1,0.79618032706672,0,34,regulation of cell migration involved in sprouting angiogenesis,BP,
17193,GO:0090050,1,0.887585799588693,0,18,positive regulation of cell migration involved in sprouting angiogenesis,BP,
17194,GO:0090051,1,0.902914009854348,0,15,negative regulation of cell migration involved in sprouting angiogenesis,BP,
17195,GO:0090063,1,0.973555319480304,0,4,positive regulation of microtubule nucleation,BP,
17196,GO:0090065,1,0.993224430037506,0,1,regulation of production of siRNA involved in RNA interference,BP,
17198,GO:0090067,1,0.992947185223779,0,1,regulation of thalamus size,BP,
17200,GO:0090069,1,0.91736389134096,0,13,regulation of ribosome biogenesis,BP,
17201,GO:0090070,1,0.950339943808032,0,8,positive regulation of ribosome biogenesis,BP,
17202,GO:0090071,1,0.972538378721389,0,4,negative regulation of ribosome biogenesis,BP,
17203,GO:0090073,1,0.943572452987005,0,9,positive regulation of protein homodimerization activity,BP,
17204,GO:0090074,1,0.96546392386882,0,5,negative regulation of protein homodimerization activity,BP,
17205,GO:0090075,1,0.838237282624719,0,27,relaxation of muscle,BP,
17206,GO:0090076,1,0.986023895856327,0,2,relaxation of skeletal muscle,BP,
17207,GO:0090077,1,0.819627295014774,0,29,foam cell differentiation,BP,
17208,GO:0090079,1,0.852910440208983,0,24,translation regulator activity, nucleic acid binding,MF,
17209,GO:0090080,1,0.985131057105112,0,2,positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway,BP,
17210,GO:0090081,1,0.989077393495349,0,2,regulation of heart induction by regulation of canonical Wnt signaling pathway,BP,
17211,GO:0090082,1,0.989077393495349,0,2,positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway,BP,
17214,GO:0090085,1,0.931291565663417,0,11,regulation of protein deubiquitination,BP,
17215,GO:0090086,1,0.983806081878014,0,3,negative regulation of protein deubiquitination,BP,
17217,GO:0090088,1,0.988377255050008,0,2,regulation of oligopeptide transport,BP,
17218,GO:0090089,1,0.988377255050008,0,2,regulation of dipeptide transport,BP,
17220,GO:0090091,1,0.964558485995184,0,5,positive regulation of extracellular matrix disassembly,BP,
17222,GO:0090094,1,0.988413062463476,0,2,metanephric cap mesenchymal cell proliferation involved in metanephros development,BP,
17223,GO:0090095,1,0.994068185264237,0,1,regulation of metanephric cap mesenchymal cell proliferation,BP,
17224,GO:0090096,1,0.994068185264237,0,1,positive regulation of metanephric cap mesenchymal cell proliferation,BP,
17227,GO:0090102,1,0.74789859236702,0,43,cochlea development,BP,
17228,GO:0090103,1,0.865682869686136,0,22,cochlea morphogenesis,BP,
17229,GO:0090107,1,0.978831174375907,0,3,regulation of high-density lipoprotein particle assembly,BP,
17230,GO:0090108,1,0.994218446119203,0,1,positive regulation of high-density lipoprotein particle assembly,BP,
17231,GO:0090109,1,0.684639304561353,0,53,regulation of cell-substrate junction assembly,BP,
17232,GO:0090110,1,0.914100957355466,0,13,cargo loading into COPII-coated vesicle,BP,
17233,GO:0090113,1,0.994168334678561,0,1,regulation of ER to Golgi vesicle-mediated transport by GTP hydrolysis,BP,
17234,GO:0090114,1,0.631736591747856,0,69,COPII-coated vesicle budding,BP,
17235,GO:0090116,1,0.978970586396379,0,3,C-5 methylation of cytosine,BP,
17236,GO:0090118,1,0.964749492871113,0,5,receptor-mediated endocytosis involved in cholesterol transport,BP,
17237,GO:0090119,1,0.987238362356409,0,2,vesicle-mediated cholesterol transport,BP,
17238,GO:0090122,1,0.994246867218908,0,1,cholesterol ester hydrolysis involved in cholesterol transport,BP,
17239,GO:0090128,1,0.929724478839812,0,10,regulation of synapse maturation,BP,
17240,GO:0090129,1,0.943185664077164,0,8,positive regulation of synapse maturation,BP,
17242,GO:0090131,1,0.97127187350992,0,5,mesenchyme migration,BP,
17244,GO:0090133,1,0.994748892591033,0,1,mesendoderm migration,BP,
17245,GO:0090134,1,0.994748892591033,0,1,cell migration involved in mesendoderm migration,BP,
17246,GO:0090135,1,0.980961583680908,0,3,actin filament branching,BP,
17247,GO:0090136,1,0.903744169935601,0,15,epithelial cell-cell adhesion,BP,
17248,GO:0090138,1,0.993397609841904,0,1,regulation of actin cytoskeleton organization by cell-cell adhesion,BP,
17249,GO:0090140,1,0.862537131824068,0,21,regulation of mitochondrial fission,BP,
17250,GO:0090141,1,0.911159697693691,0,14,positive regulation of mitochondrial fission,BP,
17251,GO:0090148,1,0.920679781864151,0,12,membrane fission,BP,
17252,GO:0090149,1,0.987071096172421,0,2,mitochondrial membrane fission,BP,
17253,GO:0090150,1,0.177811389195071,0,285,establishment of protein localization to membrane,BP,
17254,GO:0090151,1,0.934981701552423,0,12,establishment of protein localization to mitochondrial membrane,BP,
17255,GO:0090153,1,0.923579530422917,0,13,regulation of sphingolipid biosynthetic process,BP,
17256,GO:0090154,1,0.951667190379056,0,8,positive regulation of sphingolipid biosynthetic process,BP,
17257,GO:0090155,1,0.975857209846184,0,4,negative regulation of sphingolipid biosynthetic process,BP,
17258,GO:0090156,1,0.983084715486106,0,3,cellular sphingolipid homeostasis,BP,
17259,GO:0090158,1,0.963552000162083,0,6,endoplasmic reticulum membrane organization,BP,
17260,GO:0090160,1,0.948112952087878,0,8,Golgi to lysosome transport,BP,
17261,GO:0090161,1,0.925185632999397,0,11,Golgi ribbon formation,BP,
17262,GO:0090162,1,0.823178640389254,0,28,establishment of epithelial cell polarity,BP,
17263,GO:0090164,1,0.985310731995711,0,2,asymmetric Golgi ribbon formation,BP,
17265,GO:0090168,1,0.973843463624521,0,4,Golgi reassembly,BP,
17266,GO:0090169,1,0.838459216525719,0,25,regulation of spindle assembly,BP,
17267,GO:0090170,1,0.976252100262029,0,4,regulation of Golgi inheritance,BP,
17268,GO:0090171,1,0.99331447503303,0,1,chondrocyte morphogenesis,BP,
17269,GO:0090174,1,0.364727982556325,0,153,organelle membrane fusion,BP,
17271,GO:0090176,1,0.992383121576144,0,1,microtubule cytoskeleton organization involved in establishment of planar polarity,BP,
17276,GO:0090182,1,0.988732574799183,0,2,regulation of secretion of lysosomal enzymes,BP,
17277,GO:0090183,1,0.731780051455649,0,48,regulation of kidney development,BP,
17278,GO:0090184,1,0.800723382430481,0,35,positive regulation of kidney development,BP,
17279,GO:0090185,1,0.911097506078435,0,15,negative regulation of kidney development,BP,
17280,GO:0090186,1,0.952669412041855,0,7,regulation of pancreatic juice secretion,BP,
17281,GO:0090187,1,0.989270367260516,0,2,positive regulation of pancreatic juice secretion,BP,
17282,GO:0090188,1,0.96300602781239,0,5,negative regulation of pancreatic juice secretion,BP,
17283,GO:0090189,1,0.881813099234154,0,20,regulation of branching involved in ureteric bud morphogenesis,BP,
17284,GO:0090190,1,0.897204515954413,0,17,positive regulation of branching involved in ureteric bud morphogenesis,BP,
17285,GO:0090191,1,0.975869850441556,0,4,negative regulation of branching involved in ureteric bud morphogenesis,BP,
17286,GO:0090192,1,0.932861378836747,0,11,regulation of glomerulus development,BP,
17287,GO:0090193,1,0.950520814770084,0,8,positive regulation of glomerulus development,BP,
17288,GO:0090194,1,0.981430739510702,0,3,negative regulation of glomerulus development,BP,
17292,GO:0090198,1,0.9938021277445,0,1,negative regulation of chemokine secretion,BP,
17293,GO:0090199,1,0.775000611428835,0,42,regulation of release of cytochrome c from mitochondria,BP,
17294,GO:0090200,1,0.846567438599533,0,28,positive regulation of release of cytochrome c from mitochondria,BP,
17295,GO:0090201,1,0.910240930946332,0,15,negative regulation of release of cytochrome c from mitochondria,BP,
17296,GO:0090202,1,0.972957604315866,0,4,gene looping,BP,
17297,GO:0090204,1,0.981025680298151,0,3,protein localization to nuclear pore,BP,
17299,GO:0090206,1,0.970856864514834,0,5,negative regulation of cholesterol metabolic process,BP,
17300,GO:0090207,1,0.859824744140248,0,24,regulation of triglyceride metabolic process,BP,
17301,GO:0090208,1,0.912282325924918,0,15,positive regulation of triglyceride metabolic process,BP,
17302,GO:0090209,1,0.962144535394016,0,6,negative regulation of triglyceride metabolic process,BP,
17303,GO:0090210,1,0.987126736709408,0,2,regulation of establishment of blood-brain barrier,BP,
17304,GO:0090212,1,0.987126736709408,0,2,negative regulation of establishment of blood-brain barrier,BP,
17305,GO:0090214,1,0.985961953775961,0,2,spongiotrophoblast layer developmental growth,BP,
17307,GO:0090219,1,0.980801247304293,0,3,negative regulation of lipid kinase activity,BP,
17308,GO:0090220,1,0.934533098504885,0,10,chromosome localization to nuclear envelope involved in homologous chromosome segregation,BP,
17309,GO:0090222,1,0.983039637283018,0,2,centrosome-templated microtubule nucleation,BP,
17311,GO:0090226,1,0.994860729291905,0,1,regulation of microtubule nucleation by Ran protein signal transduction,BP,
17312,GO:0090230,1,0.972561419859608,0,4,regulation of centromere complex assembly,BP,
17313,GO:0090231,1,0.907574518206173,0,15,regulation of spindle checkpoint,BP,
17314,GO:0090232,1,0.948109972707639,0,8,positive regulation of spindle checkpoint,BP,
17315,GO:0090233,1,0.993904868414913,0,1,negative regulation of spindle checkpoint,BP,
17316,GO:0090234,1,0.97960005782191,0,3,regulation of kinetochore assembly,BP,
17317,GO:0090235,1,0.946440893901404,0,7,regulation of metaphase plate congression,BP,
17318,GO:0090237,1,0.967618684934236,0,5,regulation of arachidonic acid secretion,BP,
17319,GO:0090238,1,0.97474644686141,0,4,positive regulation of arachidonic acid secretion,BP,
17320,GO:0090239,1,0.927416596975258,0,12,regulation of histone H4 acetylation,BP,
17321,GO:0090240,1,0.956462911685425,0,7,positive regulation of histone H4 acetylation,BP,
17322,GO:0090241,1,0.970530446833334,0,5,negative regulation of histone H4 acetylation,BP,
17324,GO:0090245,1,0.969016442159078,0,4,axis elongation involved in somitogenesis,BP,
17325,GO:0090246,1,0.992986733621958,0,1,convergent extension involved in somitogenesis,BP,
17326,GO:0090247,1,0.993950154352162,0,1,cell motility involved in somitogenic axis elongation,BP,
17327,GO:0090249,1,0.993950154352162,0,1,regulation of cell motility involved in somitogenic axis elongation,BP,
17328,GO:0090251,1,0.98939082267812,0,1,protein localization involved in establishment of planar polarity,BP,
17330,GO:0090258,1,0.978387492445983,0,3,negative regulation of mitochondrial fission,BP,
17331,GO:0090259,1,0.967503114736832,0,5,regulation of retinal ganglion cell axon guidance,BP,
17332,GO:0090260,1,0.985977675536682,0,2,negative regulation of retinal ganglion cell axon guidance,BP,
17333,GO:0090261,1,0.977331112300736,0,4,positive regulation of inclusion body assembly,BP,
17335,GO:0090264,1,0.988488992593771,0,2,regulation of immune complex clearance by monocytes and macrophages,BP,
17336,GO:0090265,1,0.993997028244295,0,1,positive regulation of immune complex clearance by monocytes and macrophages,BP,
17337,GO:0090266,1,0.91343369707999,0,14,regulation of mitotic cell cycle spindle assembly checkpoint,BP,
17338,GO:0090267,1,0.954228133138268,0,7,positive regulation of mitotic cell cycle spindle assembly checkpoint,BP,
17339,GO:0090269,1,0.958597535811481,0,6,fibroblast growth factor production,BP,
17340,GO:0090270,1,0.958597535811481,0,6,regulation of fibroblast growth factor production,BP,
17341,GO:0090271,1,0.977527645612892,0,3,positive regulation of fibroblast growth factor production,BP,
17342,GO:0090272,1,0.980639106816711,0,3,negative regulation of fibroblast growth factor production,BP,
17343,GO:0090273,1,0.988707502253075,0,2,regulation of somatostatin secretion,BP,
17344,GO:0090274,1,0.988707502253075,0,2,positive regulation of somatostatin secretion,BP,
17345,GO:0090276,1,0.301920014318392,0,181,regulation of peptide hormone secretion,BP,
17346,GO:0090277,1,0.621386202645707,0,77,positive regulation of peptide hormone secretion,BP,
17347,GO:0090278,1,0.769915858473292,0,40,negative regulation of peptide hormone secretion,BP,
17348,GO:0090279,1,0.842126695353025,0,27,regulation of calcium ion import,BP,
17349,GO:0090280,1,0.91481058186609,0,14,positive regulation of calcium ion import,BP,
17350,GO:0090281,1,0.972685329247981,0,5,negative regulation of calcium ion import,BP,
17351,GO:0090282,1,0.993730873445988,0,1,positive regulation of transcription involved in G2/M transition of mitotic cell cycle,BP,
17352,GO:0090283,1,0.979893649736092,0,3,regulation of protein glycosylation in Golgi,BP,
17353,GO:0090284,1,0.991533832554487,0,1,positive regulation of protein glycosylation in Golgi,BP,
17354,GO:0090285,1,0.988261429813006,0,2,negative regulation of protein glycosylation in Golgi,BP,
17355,GO:0090286,1,0.950479566884637,0,6,cytoskeletal anchoring at nuclear membrane,BP,
17358,GO:0090289,1,0.981034559295064,0,3,regulation of osteoclast proliferation,BP,
17359,GO:0090290,1,0.994751733821945,0,1,positive regulation of osteoclast proliferation,BP,
17360,GO:0090291,1,0.98621118253611,0,2,negative regulation of osteoclast proliferation,BP,
17361,GO:0090292,1,0.972376696815217,0,3,nuclear matrix anchoring at nuclear membrane,BP,
17362,GO:0090293,1,0.994178148773045,0,1,nitrogen catabolite regulation of transcription,BP,
17363,GO:0090294,1,0.994178148773045,0,1,nitrogen catabolite activation of transcription,BP,
17364,GO:0090296,1,0.975007988452432,0,4,regulation of mitochondrial DNA replication,BP,
17365,GO:0090297,1,0.994628261973722,0,1,positive regulation of mitochondrial DNA replication,BP,
17366,GO:0090298,1,0.980274825534255,0,3,negative regulation of mitochondrial DNA replication,BP,
17367,GO:0090299,1,0.994429320035563,0,1,regulation of neural crest formation,BP,
17368,GO:0090301,1,0.994429320035563,0,1,negative regulation of neural crest formation,BP,
17369,GO:0090303,1,0.762187500757353,0,42,positive regulation of wound healing,BP,
17374,GO:0090308,1,0.950889314296805,0,7,regulation of methylation-dependent chromatin silencing,BP,
17375,GO:0090309,1,0.972535177228636,0,4,positive regulation of methylation-dependent chromatin silencing,BP,
17376,GO:0090310,1,0.984228658342067,0,2,negative regulation of methylation-dependent chromatin silencing,BP,
17377,GO:0090311,1,0.780586459800574,0,36,regulation of protein deacetylation,BP,
17379,GO:0090313,1,0.821978561199754,0,31,regulation of protein targeting to membrane,BP,
17380,GO:0090314,1,0.842810424118645,0,27,positive regulation of protein targeting to membrane,BP,
17381,GO:0090315,1,0.969797882184054,0,5,negative regulation of protein targeting to membrane,BP,
17383,GO:0090317,1,0.797980223498255,0,36,negative regulation of intracellular protein transport,BP,
17384,GO:0090322,1,0.849907702475589,0,27,regulation of superoxide metabolic process,BP,
17385,GO:0090323,1,0.994999677880221,0,1,prostaglandin secretion involved in immune response,BP,
17386,GO:0090324,1,0.969324336173166,0,5,negative regulation of oxidative phosphorylation,BP,
17387,GO:0090325,1,0.980771300822769,0,3,regulation of locomotion involved in locomotory behavior,BP,
17388,GO:0090326,1,0.993589088463867,0,1,positive regulation of locomotion involved in locomotory behavior,BP,
17389,GO:0090327,1,0.993142856533742,0,1,negative regulation of locomotion involved in locomotory behavior,BP,
17390,GO:0090329,1,0.742315991136898,0,45,regulation of DNA-dependent DNA replication,BP,
17391,GO:0090330,1,0.887261437641836,0,18,regulation of platelet aggregation,BP,
17392,GO:0090331,1,0.930725433734738,0,11,negative regulation of platelet aggregation,BP,
17393,GO:0090335,1,0.921303267705083,0,12,regulation of brown fat cell differentiation,BP,
17394,GO:0090336,1,0.960567993554458,0,6,positive regulation of brown fat cell differentiation,BP,
17395,GO:0090340,1,0.994218446119203,0,1,positive regulation of secretion of lysosomal enzymes,BP,
17396,GO:0090341,1,0.994482549946646,0,1,negative regulation of secretion of lysosomal enzymes,BP,
17398,GO:0090343,1,0.941874858358805,0,10,positive regulation of cell aging,BP,
17400,GO:0090345,1,0.988494911431172,0,2,cellular organohalogen metabolic process,BP,
17401,GO:0090346,1,0.988494911431172,0,2,cellular organofluorine metabolic process,BP,
17402,GO:0090347,1,0.994469630547694,0,1,regulation of cellular organohalogen metabolic process,BP,
17403,GO:0090348,1,0.994469630547694,0,1,regulation of cellular organofluorine metabolic process,BP,
17404,GO:0090349,1,0.994469630547694,0,1,negative regulation of cellular organohalogen metabolic process,BP,
17405,GO:0090350,1,0.994469630547694,0,1,negative regulation of cellular organofluorine metabolic process,BP,
17406,GO:0090360,1,0.981504754554216,0,3,platelet-derived growth factor production,BP,
17407,GO:0090361,1,0.981504754554216,0,3,regulation of platelet-derived growth factor production,BP,
17408,GO:0090362,1,0.987210555036488,0,2,positive regulation of platelet-derived growth factor production,BP,
17409,GO:0090365,1,0.994161103785021,0,1,regulation of mRNA modification,BP,
17410,GO:0090367,1,0.994161103785021,0,1,negative regulation of mRNA modification,BP,
17411,GO:0090370,1,0.980427802831279,0,3,negative regulation of cholesterol efflux,BP,
17412,GO:0090381,1,0.989077393495349,0,2,regulation of heart induction,BP,
17413,GO:0090382,1,0.778278319173282,0,40,phagosome maturation,BP,
17414,GO:0090383,1,0.85572969177703,0,26,phagosome acidification,BP,
17415,GO:0090385,1,0.956550945864317,0,7,phagosome-lysosome fusion,BP,
17416,GO:0090386,1,0.984421874917429,0,2,phagosome maturation involved in apoptotic cell clearance,BP,
17417,GO:0090387,1,0.984421874917429,0,2,phagolysosome assembly involved in apoptotic cell clearance,BP,
17418,GO:0090389,1,0.991323382269278,0,1,phagosome-lysosome fusion involved in apoptotic cell clearance,BP,
17419,GO:0090394,1,0.932204030769038,0,10,negative regulation of excitatory postsynaptic potential,BP,
17420,GO:0090398,1,0.685051616029336,0,58,cellular senescence,BP,
17421,GO:0090399,1,0.914590091617615,0,13,replicative senescence,BP,
17422,GO:0090400,1,0.950083266457556,0,8,stress-induced premature senescence,BP,
17423,GO:0090402,1,0.988130351765588,0,2,oncogene-induced cell senescence,BP,
17424,GO:0090403,1,0.974464683965846,0,4,oxidative stress-induced premature senescence,BP,
17426,GO:0090409,1,0.994105856539822,0,1,malonyl-CoA synthetase activity,MF,
17427,GO:0090410,1,0.994105856539822,0,1,malonate catabolic process,BP,
17428,GO:0090416,1,0.993963542547474,0,1,nicotinate transmembrane transporter activity,MF,
17429,GO:0090420,1,0.994563677288245,0,1,naphthalene-containing compound metabolic process,BP,
17430,GO:0090422,1,0.988393933328105,0,2,thiamine pyrophosphate transmembrane transporter activity,MF,
17431,GO:0090425,1,0.993704753095749,0,1,acinar cell differentiation,BP,
17432,GO:0090427,1,0.980338325663306,0,3,activation of meiosis,BP,
17433,GO:0090435,1,0.956860296425191,0,7,protein localization to nuclear envelope,BP,
17434,GO:0090461,1,0.993077609375079,0,1,glutamate homeostasis,BP,
17435,GO:0090472,1,0.993128888930999,0,1,dibasic protein processing,BP,
17436,GO:0090480,1,0.979379284772071,0,3,purine nucleotide-sugar transmembrane transport,BP,
17437,GO:0090481,1,0.933677901690564,0,11,pyrimidine nucleotide-sugar transmembrane transport,BP,
17438,GO:0090482,1,0.869120304858375,0,22,vitamin transmembrane transporter activity,MF,
17439,GO:0090493,1,0.935831451720363,0,11,catecholamine uptake,BP,
17440,GO:0090494,1,0.935831451720363,0,11,dopamine uptake,BP,
17441,GO:0090498,1,0.980013507408129,0,3,extrinsic component of Golgi membrane,CC,
17442,GO:0090500,1,0.96952277354138,0,5,endocardial cushion to mesenchymal transition,BP,
17444,GO:0090502,1,0.681500791145972,0,62,RNA phosphodiester bond hydrolysis, endonucleolytic,BP,
17445,GO:0090503,1,0.794269301462932,0,35,RNA phosphodiester bond hydrolysis, exonucleolytic,BP,
17446,GO:0090504,1,0.821535412939147,0,28,epiboly,BP,
17447,GO:0090505,1,0.830182750896211,0,27,epiboly involved in wound healing,BP,
17449,GO:0090521,1,0.973133659146453,0,4,glomerular visceral epithelial cell migration,BP,
17450,GO:0090527,1,0.923374342160647,0,11,actin filament reorganization,BP,
17451,GO:0090529,1,0.994333182567743,0,1,cell septum assembly,BP,
17453,GO:0090534,1,0.994405028845343,0,1,calcium ion-transporting ATPase complex,CC,
17454,GO:0090537,1,0.985602322602754,0,2,CERF complex,CC,
17455,GO:0090541,1,0.986922423926049,0,2,MIT domain binding,MF,
17456,GO:0090543,1,0.84109334136757,0,26,Flemming body,CC,
17457,GO:0090545,1,0.882692584228944,0,17,CHD-type complex,CC,
17458,GO:0090554,1,0.967995867033744,0,4,phosphatidylcholine-translocating ATPase activity,MF,
17459,GO:0090555,1,0.984293503664201,0,2,phosphatidylethanolamine-translocating ATPase activity,MF,
17460,GO:0090556,1,0.981699903930729,0,2,phosphatidylserine-translocating ATPase activity,MF,
17461,GO:0090557,1,0.942849705611152,0,8,establishment of endothelial intestinal barrier,BP,
17462,GO:0090558,1,0.994886556596673,0,1,plant epidermis development,BP,
17463,GO:0090559,1,0.622797292666552,0,76,regulation of membrane permeability,BP,
17464,GO:0090560,1,0.994174274689378,0,1,2-(3-amino-3-carboxypropyl)histidine synthase activity,MF,
17465,GO:0090568,1,0.813124963224856,0,29,nuclear transcriptional repressor complex,CC,
17466,GO:0090571,1,0.975945529523739,0,4,RNA polymerase II transcription repressor complex,CC,
17467,GO:0090575,1,0.383026639318523,0,146,RNA polymerase II transcription factor complex,CC,
17468,GO:0090576,1,0.945076924105997,0,8,RNA polymerase III transcription factor complex,CC,
17469,GO:0090579,1,0.972957604315866,0,4,dsDNA loop formation,BP,
17470,GO:0090594,1,0.958083831852112,0,7,inflammatory response to wounding,BP,
17472,GO:0090598,1,0.981235793893309,0,3,male anatomical structure morphogenesis,BP,
17473,GO:0090599,1,0.963616397703714,0,5,alpha-glucosidase activity,MF,
17474,GO:0090600,1,0.993275919213088,0,1,alpha-1,3-glucosidase activity,MF,
17475,GO:0090601,1,0.992626349998796,0,1,enucleation,BP,
17476,GO:0090611,1,0.969242584893905,0,5,ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway,BP,
17477,GO:0090615,1,0.987251894844541,0,2,mitochondrial mRNA processing,BP,
17478,GO:0090616,1,0.992915409932579,0,1,mitochondrial mRNA 3'-end processing,BP,
17479,GO:0090624,1,0.993850639026861,0,1,endoribonuclease activity, cleaving miRNA-paired mRNA,MF,
17480,GO:0090625,1,0.993850639026861,0,1,mRNA cleavage involved in gene silencing by siRNA,BP,
17481,GO:0090627,1,0.994886556596673,0,1,plant epidermal cell differentiation,BP,
17482,GO:0090630,1,0.579371591239965,0,79,activation of GTPase activity,BP,
17483,GO:0090634,1,0.994505287372902,0,1,microglial cell mediated cytotoxicity,BP,
17484,GO:0090646,1,0.930102523349521,0,12,mitochondrial tRNA processing,BP,
17485,GO:0090647,1,0.953914926757811,0,7,modulation of age-related behavioral decline,BP,
17486,GO:0090648,1,0.992056470489845,0,1,response to environmental enrichment,BP,
17487,GO:0090649,1,0.962304224773525,0,5,response to oxygen-glucose deprivation,BP,
17488,GO:0090650,1,0.962304224773525,0,5,cellular response to oxygen-glucose deprivation,BP,
17489,GO:0090651,1,0.991788785542614,0,1,apical cytoplasm,CC,
17490,GO:0090656,1,0.911480212789203,0,14,t-circle formation,BP,
17491,GO:0090657,1,0.935789632260664,0,10,telomeric loop disassembly,BP,
17493,GO:0090661,1,0.978716448686309,0,4,box H/ACA telomerase RNP complex,CC,
17494,GO:0090662,1,0.836028704903264,0,29,ATP hydrolysis coupled transmembrane transport,BP,
17495,GO:0090663,1,0.98934007424342,0,2,galanin-activated signaling pathway,BP,
17497,GO:0090666,1,0.97692148692681,0,4,scaRNA localization to Cajal body,BP,
17498,GO:0090667,1,0.991210442280677,0,1,cell chemotaxis to vascular endothelial growth factor,BP,
17499,GO:0090668,1,0.991210442280677,0,1,endothelial cell chemotaxis to vascular endothelial growth factor,BP,
17500,GO:0090669,1,0.975693366800125,0,4,telomerase RNA stabilization,BP,
17501,GO:0090670,1,0.89204861005906,0,19,RNA localization to Cajal body,BP,
17502,GO:0090671,1,0.89204861005906,0,19,telomerase RNA localization to Cajal body,BP,
17503,GO:0090672,1,0.89204861005906,0,19,telomerase RNA localization,BP,
17504,GO:0090673,1,0.991482407886399,0,1,endothelial cell-matrix adhesion,BP,
17505,GO:0090675,1,0.993105074528504,0,1,intermicrovillar adhesion,BP,
17506,GO:0090677,1,0.98816417001049,0,2,reversible differentiation,BP,
17507,GO:0090678,1,0.98816417001049,0,2,cell dedifferentiation involved in phenotypic switching,BP,
17508,GO:0090685,1,0.89204861005906,0,19,RNA localization to nucleus,BP,
17509,GO:0090694,1,0.983945735432404,0,2,Scc2-Scc4 cohesin loading complex,CC,
17510,GO:0090713,1,0.961038854980688,0,6,immunological memory process,BP,
17511,GO:0090715,1,0.961038854980688,0,6,immunological memory formation process,BP,
17512,GO:0090722,1,0.973806769482127,0,4,receptor-receptor interaction,MF,
17513,GO:0090723,1,0.912269910927163,0,14,growth cone part,CC,
17514,GO:0090724,1,0.980895309064541,0,3,central region of growth cone,CC,
17515,GO:0090725,1,0.994831285768497,0,1,peripheral region of growth cone,CC,
17516,GO:0090731,1,0.994679925836776,0,1,cellular response to very-low-density lipoprotein particle stimulus,BP,
17517,GO:0090734,1,0.801309128059275,0,33,site of DNA damage,CC,
17518,GO:0090735,1,0.941581758366975,0,10,DNA repair complex assembly,BP,
17519,GO:0090737,1,0.911480212789203,0,14,telomere maintenance via telomere trimming,BP,
17520,GO:0090741,1,0.93793907505258,0,11,pigment granule membrane,CC,
17521,GO:0093001,1,0.993631045219099,0,1,glycolysis from storage polysaccharide through glucose-1-phosphate,BP,
17522,GO:0095500,1,0.874872091570932,0,21,acetylcholine receptor signaling pathway,BP,
17524,GO:0097003,1,0.987470072411902,0,2,adipokinetic hormone receptor activity,MF,
17525,GO:0097006,1,0.622237014314851,0,73,regulation of plasma lipoprotein particle levels,BP,
17526,GO:0097009,1,0.88756976692655,0,18,energy homeostasis,BP,
17527,GO:0097010,1,0.979915528526353,0,3,eukaryotic translation initiation factor 4F complex assembly,BP,
17528,GO:0097011,1,0.951205985837573,0,8,cellular response to granulocyte macrophage colony-stimulating factor stimulus,BP,
17529,GO:0097012,1,0.951205985837573,0,8,response to granulocyte macrophage colony-stimulating factor,BP,
17530,GO:0097013,1,0.983789400229397,0,3,phagocytic vesicle lumen,CC,
17532,GO:0097016,1,0.975263943679904,0,4,L27 domain binding,MF,
17533,GO:0097017,1,0.987905654202797,0,2,renal protein absorption,BP,
17534,GO:0097018,1,0.993993421089467,0,1,renal albumin absorption,BP,
17535,GO:0097020,1,0.993552761103155,0,1,COPII adaptor activity,MF,
17536,GO:0097021,1,0.981404047405972,0,3,lymphocyte migration into lymphoid organs,BP,
17537,GO:0097022,1,0.994167818170529,0,1,lymphocyte migration into lymph node,BP,
17538,GO:0097025,1,0.968037653386935,0,5,MPP7-DLG1-LIN7 complex,CC,
17539,GO:0097026,1,0.975248111025276,0,4,dendritic cell dendrite assembly,BP,
17540,GO:0097027,1,0.959154172067012,0,7,ubiquitin-protein transferase activator activity,MF,
17541,GO:0097028,1,0.80085361311004,0,37,dendritic cell differentiation,BP,
17542,GO:0097029,1,0.97786186172075,0,4,mature conventional dendritic cell differentiation,BP,
17543,GO:0097035,1,0.764893688199304,0,37,regulation of membrane lipid distribution,BP,
17544,GO:0097036,1,0.99454559249468,0,1,regulation of plasma membrane sterol distribution,BP,
17545,GO:0097037,1,0.99351694075314,0,1,heme export,BP,
17546,GO:0097038,1,0.928001699467095,0,11,perinuclear endoplasmic reticulum,CC,
17547,GO:0097039,1,0.965441647935518,0,5,protein linear polyubiquitination,BP,
17548,GO:0097045,1,0.992819407722906,0,1,phosphatidylserine exposure on blood platelet,BP,
17549,GO:0097048,1,0.940399216055471,0,10,dendritic cell apoptotic process,BP,
17551,GO:0097050,1,0.921374379288329,0,12,type B pancreatic cell apoptotic process,BP,
17552,GO:0097051,1,0.97771455927825,0,3,establishment of protein localization to endoplasmic reticulum membrane,BP,
17553,GO:0097052,1,0.982780175304129,0,3,L-kynurenine metabolic process,BP,
17554,GO:0097053,1,0.994520531289197,0,1,L-kynurenine catabolic process,BP,
17555,GO:0097055,1,0.988039074613535,0,2,agmatine biosynthetic process,BP,
17556,GO:0097056,1,0.975522159188675,0,4,selenocysteinyl-tRNA(Sec) biosynthetic process,BP,
17557,GO:0097057,1,0.988932893082028,0,2,TRAF2-GSTP1 complex,CC,
17559,GO:0097059,1,0.988653696140685,0,2,CNTFR-CLCF1 complex,CC,
17560,GO:0097060,1,0.120749094805612,0,299,synaptic membrane,CC,
17561,GO:0097061,1,0.621519650693907,0,66,dendritic spine organization,BP,
17562,GO:0097062,1,0.888170063319068,0,17,dendritic spine maintenance,BP,
17563,GO:0097064,1,0.782972409275917,0,36,ncRNA export from nucleus,BP,
17564,GO:0097065,1,0.961104751361511,0,6,anterior head development,BP,
17565,GO:0097066,1,0.855453179853368,0,24,response to thyroid hormone,BP,
17566,GO:0097067,1,0.898550150533601,0,16,cellular response to thyroid hormone stimulus,BP,
17567,GO:0097068,1,0.967743070327591,0,5,response to thyroxine,BP,
17568,GO:0097069,1,0.987110389848593,0,2,cellular response to thyroxine stimulus,BP,
17569,GO:0097070,1,0.966171335497002,0,5,ductus arteriosus closure,BP,
17570,GO:0097084,1,0.949685097386553,0,8,vascular smooth muscle cell development,BP,
17571,GO:0097086,1,0.993401710947692,0,1,amniotic stem cell differentiation,BP,
17572,GO:0097089,1,0.988553308038461,0,2,methyl-branched fatty acid metabolic process,BP,
17574,GO:0097091,1,0.936546490224196,0,9,synaptic vesicle clustering,BP,
17575,GO:0097094,1,0.901753332253211,0,15,craniofacial suture morphogenesis,BP,
17576,GO:0097100,1,0.970167772242912,0,5,supercoiled DNA binding,MF,
17577,GO:0097101,1,0.981764888859211,0,3,blood vessel endothelial cell fate specification,BP,
17578,GO:0097102,1,0.987622232579283,0,2,endothelial tip cell fate specification,BP,
17579,GO:0097104,1,0.91927859708377,0,11,postsynaptic membrane assembly,BP,
17580,GO:0097105,1,0.928722200471087,0,10,presynaptic membrane assembly,BP,
17581,GO:0097106,1,0.890191935989629,0,15,postsynaptic density organization,BP,
17582,GO:0097107,1,0.942860125266469,0,7,postsynaptic density assembly,BP,
17583,GO:0097108,1,0.9780531524451,0,3,hedgehog family protein binding,MF,
17584,GO:0097109,1,0.963344464887524,0,5,neuroligin family protein binding,MF,
17585,GO:0097110,1,0.667721552058654,0,58,scaffold protein binding,MF,
17586,GO:0097111,1,0.983743226299998,0,2,endoplasmic reticulum-Golgi intermediate compartment organization,BP,
17587,GO:0097112,1,0.986848534261505,0,2,gamma-aminobutyric acid receptor clustering,BP,
17588,GO:0097113,1,0.950999939797093,0,7,AMPA glutamate receptor clustering,BP,
17589,GO:0097114,1,0.968656195773926,0,4,NMDA glutamate receptor clustering,BP,
17590,GO:0097115,1,0.992749368324187,0,1,neurexin clustering involved in presynaptic membrane assembly,BP,
17591,GO:0097116,1,0.975503971309227,0,3,gephyrin clustering involved in postsynaptic density assembly,BP,
17592,GO:0097117,1,0.991576968465899,0,1,guanylate kinase-associated protein clustering,BP,
17593,GO:0097118,1,0.967555669625394,0,4,neuroligin clustering involved in postsynaptic membrane assembly,BP,
17594,GO:0097119,1,0.933026043689697,0,9,postsynaptic density protein 95 clustering,BP,
17595,GO:0097120,1,0.808364762998556,0,32,receptor localization to synapse,BP,
17596,GO:0097123,1,0.988466683448525,0,2,cyclin A1-CDK2 complex,CC,
17597,GO:0097124,1,0.988008320929875,0,2,cyclin A2-CDK2 complex,CC,
17599,GO:0097129,1,0.981202415528796,0,3,cyclin D2-CDK4 complex,CC,
17600,GO:0097134,1,0.988484926363797,0,2,cyclin E1-CDK2 complex,CC,
17601,GO:0097135,1,0.988044078357004,0,2,cyclin E2-CDK2 complex,CC,
17602,GO:0097136,1,0.963112627889181,0,6,Bcl-2 family protein complex,CC,
17603,GO:0097144,1,0.99487002715562,0,1,BAX complex,CC,
17604,GO:0097145,1,0.994155422707334,0,1,BAK complex,CC,
17605,GO:0097149,1,0.98046035133412,0,3,centralspindlin complex,CC,
17607,GO:0097151,1,0.948479075210128,0,7,positive regulation of inhibitory postsynaptic potential,BP,
17608,GO:0097152,1,0.926882748773566,0,12,mesenchymal cell apoptotic process,BP,
17609,GO:0097153,1,0.926762621580834,0,13,cysteine-type endopeptidase activity involved in apoptotic process,MF,
17611,GO:0097155,1,0.974903743590314,0,3,fasciculation of sensory neuron axon,BP,
17612,GO:0097156,1,0.985147616421764,0,2,fasciculation of motor neuron axon,BP,
17613,GO:0097157,1,0.946475006371449,0,8,pre-mRNA intronic binding,MF,
17614,GO:0097158,1,0.994439656358838,0,1,pre-mRNA intronic pyrimidine-rich binding,MF,
17616,GO:0097161,1,0.991995872618971,0,1,DH domain binding,MF,
17617,GO:0097162,1,0.993598298111347,0,1,MADS box domain binding,MF,
17619,GO:0097165,1,0.968039543673633,0,5,nuclear stress granule,CC,
17621,GO:0097167,1,0.973718198903419,0,4,circadian regulation of translation,BP,
17622,GO:0097168,1,0.987144238343582,0,2,mesenchymal stem cell proliferation,BP,
17623,GO:0097169,1,0.973619623892405,0,5,AIM2 inflammasome complex,CC,
17624,GO:0097176,1,0.977157580264413,0,4,epoxide metabolic process,BP,
17625,GO:0097177,1,0.983031069157383,0,3,mitochondrial ribosome binding,MF,
17626,GO:0097178,1,0.807644620556317,0,34,ruffle assembly,BP,
17627,GO:0097179,1,0.978356119070355,0,4,protease inhibitor complex,CC,
17628,GO:0097180,1,0.98856358283847,0,2,serine protease inhibitor complex,CC,
17629,GO:0097181,1,0.994093469418573,0,1,protein C inhibitor-coagulation factor V complex,CC,
17630,GO:0097182,1,0.994093469418573,0,1,protein C inhibitor-coagulation factor Xa complex,CC,
17631,GO:0097183,1,0.994093469418573,0,1,protein C inhibitor-coagulation factor XI complex,CC,
17632,GO:0097186,1,0.894428394689356,0,16,amelogenesis,BP,
17633,GO:0097187,1,0.981823544272646,0,3,dentinogenesis,BP,
17636,GO:0097192,1,0.65226895522914,0,67,extrinsic apoptotic signaling pathway in absence of ligand,BP,
17639,GO:0097195,1,0.981410216502112,0,3,pilomotor reflex,BP,
17640,GO:0097196,1,0.988171311779279,0,2,Shu complex,CC,
17641,GO:0097197,1,0.957232200781376,0,7,tetraspanin-enriched microdomain,CC,
17642,GO:0097198,1,0.984703772574916,0,2,histone H3-K36 trimethylation,BP,
17643,GO:0097199,1,0.964944797149899,0,6,cysteine-type endopeptidase activity involved in apoptotic signaling pathway,MF,
17644,GO:0097200,1,0.936303820467363,0,11,cysteine-type endopeptidase activity involved in execution phase of apoptosis,MF,
17645,GO:0097201,1,0.927794297331084,0,12,negative regulation of transcription from RNA polymerase II promoter in response to stress,BP,
17646,GO:0097202,1,0.917599852875654,0,13,activation of cysteine-type endopeptidase activity,BP,
17647,GO:0097205,1,0.900079801085586,0,16,renal filtration,BP,
17648,GO:0097208,1,0.963182148597099,0,6,alveolar lamellar body,CC,
17649,GO:0097209,1,0.973320998662902,0,4,epidermal lamellar body,CC,
17650,GO:0097210,1,0.968548354312622,0,5,response to gonadotropin-releasing hormone,BP,
17651,GO:0097211,1,0.968548354312622,0,5,cellular response to gonadotropin-releasing hormone,BP,
17652,GO:0097212,1,0.983478214391005,0,3,lysosomal membrane organization,BP,
17653,GO:0097213,1,0.989150124570145,0,2,regulation of lysosomal membrane permeability,BP,
17654,GO:0097214,1,0.994989347247422,0,1,positive regulation of lysosomal membrane permeability,BP,
17655,GO:0097222,1,0.992915409932579,0,1,mitochondrial mRNA polyadenylation,BP,
17657,GO:0097224,1,0.98873618928697,0,2,sperm connecting piece,CC,
17658,GO:0097225,1,0.91426862316716,0,15,sperm midpiece,CC,
17659,GO:0097226,1,0.99410792124435,0,1,sperm mitochondrial sheath,CC,
17661,GO:0097228,1,0.896420042192274,0,17,sperm principal piece,CC,
17662,GO:0097229,1,0.994601395445488,0,1,sperm end piece,CC,
17663,GO:0097231,1,0.994401927756649,0,1,cell motility in response to calcium ion,BP,
17664,GO:0097232,1,0.985461020262676,0,2,lamellar body membrane,CC,
17665,GO:0097233,1,0.985461020262676,0,2,alveolar lamellar body membrane,CC,
17667,GO:0097238,1,0.98939811764195,0,2,cellular response to methylglyoxal,BP,
17668,GO:0097240,1,0.968473531471934,0,5,chromosome attachment to the nuclear envelope,BP,
17669,GO:0097241,1,0.988134069025474,0,2,hematopoietic stem cell migration to bone marrow,BP,
17670,GO:0097242,1,0.866090931924204,0,19,amyloid-beta clearance,BP,
17671,GO:0097252,1,0.981474471719918,0,3,oligodendrocyte apoptotic process,BP,
17672,GO:0097254,1,0.994195971127795,0,1,renal tubular secretion,BP,
17673,GO:0097255,1,0.96625188690107,0,6,R2TP complex,CC,
17674,GO:0097258,1,0.993742656804343,0,1,20-hydroxy-leukotriene B4 omega oxidase activity,MF,
17675,GO:0097259,1,0.993742656804343,0,1,20-aldehyde-leukotriene B4 20-monooxygenase activity,MF,
17676,GO:0097260,1,0.993901268074294,0,1,eoxin A4 synthase activity,MF,
17677,GO:0097264,1,0.96251657472903,0,6,self proteolysis,BP,
17678,GO:0097267,1,0.973955101938266,0,4,omega-hydroxylase P450 pathway,BP,
17679,GO:0097272,1,0.986781375872319,0,2,ammonia homeostasis,BP,
17680,GO:0097273,1,0.992303456518261,0,1,creatinine homeostasis,BP,
17681,GO:0097274,1,0.985855064867128,0,2,urea homeostasis,BP,
17682,GO:0097275,1,0.992303456518261,0,1,cellular ammonia homeostasis,BP,
17683,GO:0097276,1,0.992303456518261,0,1,cellular creatinine homeostasis,BP,
17684,GO:0097277,1,0.992303456518261,0,1,cellular urea homeostasis,BP,
17685,GO:0097278,1,0.982543310196723,0,3,complement-dependent cytotoxicity,BP,
17686,GO:0097283,1,0.970488447814717,0,5,keratinocyte apoptotic process,BP,
17687,GO:0097284,1,0.925531685934635,0,12,hepatocyte apoptotic process,BP,
17689,GO:0097291,1,0.994253068738624,0,1,renal phosphate ion absorption,BP,
17690,GO:0097296,1,0.92286780189715,0,13,activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
17691,GO:0097298,1,0.993264085382676,0,1,regulation of nucleus size,BP,
17692,GO:0097300,1,0.775721906099193,0,41,programmed necrotic cell death,BP,
17694,GO:0097306,1,0.690025971176637,0,53,cellular response to alcohol,BP,
17695,GO:0097309,1,0.987738712940129,0,2,cap1 mRNA methylation,BP,
17696,GO:0097310,1,0.993850639026861,0,1,cap2 mRNA methylation,BP,
17698,GO:0097322,1,0.954889635206625,0,7,7SK snRNA binding,MF,
17699,GO:0097323,1,0.988108387567445,0,2,B cell adhesion,BP,
17700,GO:0097324,1,0.983217372764231,0,2,melanocyte migration,BP,
17701,GO:0097325,1,0.986158684107489,0,2,melanocyte proliferation,BP,
17702,GO:0097326,1,0.992611156593489,0,1,melanocyte adhesion,BP,
17703,GO:0097327,1,0.576808296822079,0,84,response to antineoplastic agent,BP,
17704,GO:0097329,1,0.920451177158402,0,12,response to antimetabolite,BP,
17705,GO:0097332,1,0.98128187825478,0,3,response to antipsychotic drug,BP,
17706,GO:0097338,1,0.986420858866834,0,2,response to clozapine,BP,
17709,GO:0097342,1,0.9625510225836,0,6,ripoptosome,CC,
17710,GO:0097343,1,0.977652890275783,0,3,ripoptosome assembly,BP,
17711,GO:0097344,1,0.98822195951904,0,2,Rix1 complex,CC,
17712,GO:0097345,1,0.72418405857527,0,53,mitochondrial outer membrane permeabilization,BP,
17713,GO:0097346,1,0.863155707738695,0,23,INO80-type complex,CC,
17714,GO:0097350,1,0.968732860704978,0,5,neutrophil clearance,BP,
17715,GO:0097352,1,0.808980739650147,0,33,autophagosome maturation,BP,
17716,GO:0097354,1,0.947014340478489,0,8,prenylation,BP,
17717,GO:0097359,1,0.982462357247343,0,2,UDP-glucosylation,BP,
17718,GO:0097360,1,0.971140581569787,0,4,chorionic trophoblast cell proliferation,BP,
17719,GO:0097361,1,0.97590334430234,0,4,CIA complex,CC,
17720,GO:0097362,1,0.987430893857052,0,2,MCM8-MCM9 complex,CC,
17721,GO:0097363,1,0.986350476994782,0,2,protein O-GlcNAc transferase activity,MF,
17724,GO:0097368,1,0.973160356365342,0,4,establishment of Sertoli cell barrier,BP,
17725,GO:0097371,1,0.952469186678726,0,7,MDM2/MDM4 family protein binding,MF,
17726,GO:0097372,1,0.994400894056033,0,1,NAD-dependent histone deacetylase activity (H3-K18 specific),MF,
17727,GO:0097374,1,0.994004758645168,0,1,sensory neuron axon guidance,BP,
17728,GO:0097376,1,0.988688414447238,0,2,interneuron axon guidance,BP,
17729,GO:0097377,1,0.994101727286906,0,1,spinal cord interneuron axon guidance,BP,
17730,GO:0097378,1,0.994101727286906,0,1,dorsal spinal cord interneuron axon guidance,BP,
17731,GO:0097380,1,0.994101727286906,0,1,dorsal spinal cord interneuron anterior axon guidance,BP,
17732,GO:0097381,1,0.90644265939749,0,15,photoreceptor disc membrane,CC,
17733,GO:0097382,1,0.992169153657553,0,1,deoxynucleoside-diphosphatase activity,MF,
17734,GO:0097383,1,0.992169153657553,0,1,dIDP diphosphatase activity,MF,
17735,GO:0097384,1,0.956086267402973,0,7,cellular lipid biosynthetic process,BP,
17737,GO:0097393,1,0.989525691929859,0,1,telomeric repeat-containing RNA transcription,BP,
17738,GO:0097394,1,0.989525691929859,0,1,telomeric repeat-containing RNA transcription by RNA polymerase II,BP,
17739,GO:0097396,1,0.96942046110811,0,5,response to interleukin-17,BP,
17740,GO:0097398,1,0.96942046110811,0,5,cellular response to interleukin-17,BP,
17741,GO:0097400,1,0.96942046110811,0,5,interleukin-17-mediated signaling pathway,BP,
17742,GO:0097401,1,0.993749318054857,0,1,synaptic vesicle lumen acidification,BP,
17743,GO:0097402,1,0.986732436091443,0,2,neuroblast migration,BP,
17744,GO:0097403,1,0.99373036117976,0,1,cellular response to raffinose,BP,
17745,GO:0097409,1,0.994276584277594,0,1,glial cytoplasmic inclusion,CC,
17746,GO:0097411,1,0.965867473211469,0,5,hypoxia-inducible factor-1alpha signaling pathway,BP,
17747,GO:0097413,1,0.95861377684194,0,7,Lewy body,CC,
17748,GO:0097414,1,0.994276584277594,0,1,classical Lewy body,CC,
17749,GO:0097418,1,0.967062477315504,0,5,neurofibrillary tangle,CC,
17750,GO:0097421,1,0.819272080050388,0,32,liver regeneration,BP,
17751,GO:0097422,1,0.968810435145706,0,5,tubular endosome,CC,
17752,GO:0097425,1,0.969509301557652,0,5,smooth endoplasmic reticulum part,CC,
17753,GO:0097427,1,0.959790048043141,0,6,microtubule bundle,CC,
17754,GO:0097428,1,0.946468029058213,0,10,protein maturation by iron-sulfur cluster transfer,BP,
17756,GO:0097433,1,0.969655442196889,0,5,dense body,CC,
17758,GO:0097440,1,0.896554437225378,0,15,apical dendrite,CC,
17759,GO:0097441,1,0.963712989331622,0,5,basal dendrite,CC,
17760,GO:0097442,1,0.977617540313183,0,3,CA3 pyramidal cell dendrite,CC,
17761,GO:0097443,1,0.959026640817395,0,6,sorting endosome,CC,
17762,GO:0097444,1,0.992636041178951,0,1,spine apparatus,CC,
17766,GO:0097451,1,0.986459047926605,0,2,glial limiting end-foot,CC,
17767,GO:0097452,1,0.974027812648768,0,4,GAIT complex,CC,
17769,GO:0097454,1,0.97846840398132,0,3,Schwann cell microvillus,CC,
17770,GO:0097457,1,0.975465981922826,0,3,hippocampal mossy fiber,CC,
17772,GO:0097462,1,0.994276584277594,0,1,Lewy neurite,CC,
17773,GO:0097466,1,0.972403089111753,0,4,ubiquitin-dependent glycoprotein ERAD pathway,BP,
17774,GO:0097468,1,0.927245920307558,0,12,programmed cell death in response to reactive oxygen species,BP,
17775,GO:0097470,1,0.963499422756478,0,5,ribbon synapse,CC,
17777,GO:0097473,1,0.992565564864568,0,1,retinal rod cell apoptotic process,BP,
17778,GO:0097475,1,0.962797897410057,0,5,motor neuron migration,BP,
17779,GO:0097476,1,0.983299874279384,0,2,spinal cord motor neuron migration,BP,
17780,GO:0097477,1,0.983299874279384,0,2,lateral motor column neuron migration,BP,
17781,GO:0097479,1,0.434147863570874,0,122,synaptic vesicle localization,BP,
17782,GO:0097480,1,0.457458621174218,0,115,establishment of synaptic vesicle localization,BP,
17785,GO:0097486,1,0.973313904458475,0,5,multivesicular body lumen,CC,
17786,GO:0097487,1,0.97360664080547,0,4,multivesicular body, internal vesicle,CC,
17787,GO:0097489,1,0.99396508756942,0,1,multivesicular body, internal vesicle lumen,CC,
17788,GO:0097490,1,0.972623851544956,0,4,sympathetic neuron projection extension,BP,
17789,GO:0097491,1,0.972623851544956,0,4,sympathetic neuron projection guidance,BP,
17791,GO:0097494,1,0.973178752488905,0,4,regulation of vesicle size,BP,
17792,GO:0097497,1,0.993659447561876,0,1,blood vessel endothelial cell delamination,BP,
17793,GO:0097498,1,0.986591822658679,0,2,endothelial tube lumen extension,BP,
17794,GO:0097499,1,0.949676118593061,0,8,protein localization to non-motile cilium,BP,
17795,GO:0097500,1,0.974297010867221,0,4,receptor localization to non-motile cilium,BP,
17796,GO:0097501,1,0.931000967705125,0,13,stress response to metal ion,BP,
17797,GO:0097502,1,0.83149927818822,0,29,mannosylation,BP,
17798,GO:0097503,1,0.873938390084009,0,20,sialylation,BP,
17799,GO:0097504,1,0.927648861104171,0,12,Gemini of coiled bodies,CC,
17800,GO:0097505,1,0.992317080324481,0,1,Rad6-Rad18 complex,CC,
17801,GO:0097506,1,0.971710565481844,0,5,deaminated base DNA N-glycosylase activity,MF,
17802,GO:0097510,1,0.994228522175594,0,1,base-excision repair, AP site formation via deaminated base removal,BP,
17803,GO:0097512,1,0.964145054027752,0,6,cardiac myofibril,CC,
17804,GO:0097513,1,0.974658509483767,0,3,myosin II filament,CC,
17805,GO:0097517,1,0.693693454877216,0,52,contractile actin filament bundle,CC,
17806,GO:0097524,1,0.978348253396597,0,3,sperm plasma membrane,CC,
17808,GO:0097526,1,0.844277651569712,0,28,spliceosomal tri-snRNP complex,CC,
17809,GO:0097527,1,0.96458902360781,0,6,necroptotic signaling pathway,BP,
17810,GO:0097529,1,0.415770389957258,0,143,myeloid leukocyte migration,BP,
17811,GO:0097530,1,0.566280072542484,0,94,granulocyte migration,BP,
17812,GO:0097531,1,0.932300468182626,0,11,mast cell migration,BP,
17813,GO:0097532,1,0.987948240282344,0,2,stress response to acid chemical,BP,
17814,GO:0097533,1,0.987948240282344,0,2,cellular stress response to acid chemical,BP,
17815,GO:0097534,1,0.991295652439186,0,1,lymphoid lineage cell migration,BP,
17816,GO:0097535,1,0.991295652439186,0,1,lymphoid lineage cell migration into thymus,BP,
17817,GO:0097536,1,0.994195971127795,0,1,thymus epithelium morphogenesis,BP,
17819,GO:0097541,1,0.993850639026861,0,1,axonemal basal plate,CC,
17820,GO:0097542,1,0.748506602700182,0,43,ciliary tip,CC,
17821,GO:0097543,1,0.986356887969559,0,2,ciliary inversin compartment,CC,
17822,GO:0097546,1,0.837279195113895,0,27,ciliary base,CC,
17823,GO:0097550,1,0.964106716440955,0,6,transcriptional preinitiation complex,CC,
17825,GO:0097573,1,0.994585895079447,0,1,glutathione oxidoreductase activity,MF,
17826,GO:0097574,1,0.985326748992857,0,2,lateral part of cell,CC,
17827,GO:0097575,1,0.985326748992857,0,2,lateral cell cortex,CC,
17828,GO:0097576,1,0.986797496531828,0,2,vacuole fusion,BP,
17829,GO:0097577,1,0.983834663787886,0,3,sequestering of iron ion,BP,
17831,GO:0097598,1,0.986393207927234,0,2,sperm cytoplasmic droplet,CC,
17832,GO:0097602,1,0.896984915480116,0,17,cullin family protein binding,MF,
17833,GO:0097603,1,0.987547640503301,0,2,temperature-gated ion channel activity,MF,
17834,GO:0097604,1,0.994352824644852,0,1,temperature-gated cation channel activity,MF,
17835,GO:0097617,1,0.918045822753106,0,13,annealing activity,MF,
17836,GO:0097621,1,0.994100695006548,0,1,monoamine oxidase activity,MF,
17837,GO:0097623,1,0.957306053347417,0,7,potassium ion export across plasma membrane,BP,
17838,GO:0097625,1,0.991365641064658,0,1,low-affinity basic amino acid transmembrane transporter activity,MF,
17839,GO:0097626,1,0.991365641064658,0,1,low-affinity L-arginine transmembrane transporter activity,MF,
17840,GO:0097627,1,0.991365641064658,0,1,high-affinity L-ornithine transmembrane transporter activity,MF,
17841,GO:0097629,1,0.968504921073395,0,5,extrinsic component of omegasome membrane,CC,
17842,GO:0097630,1,0.993850639026861,0,1,intrinsic component of omegasome membrane,CC,
17843,GO:0097631,1,0.993850639026861,0,1,integral component of omegasome membrane,CC,
17844,GO:0097632,1,0.986475527019311,0,2,extrinsic component of phagophore assembly site membrane,CC,
17845,GO:0097635,1,0.985518706125522,0,2,extrinsic component of autophagosome membrane,CC,
17846,GO:0097636,1,0.987004735648026,0,2,intrinsic component of autophagosome membrane,CC,
17847,GO:0097637,1,0.987004735648026,0,2,integral component of autophagosome membrane,CC,
17848,GO:0097638,1,0.971241244971313,0,4,L-arginine import across plasma membrane,BP,
17849,GO:0097639,1,0.985373634371549,0,2,L-lysine import across plasma membrane,BP,
17850,GO:0097640,1,0.991365641064658,0,1,L-ornithine import across plasma membrane,BP,
17851,GO:0097642,1,0.964842971537779,0,6,calcitonin family receptor activity,MF,
17852,GO:0097643,1,0.977907239459469,0,4,amylin receptor activity,MF,
17853,GO:0097644,1,0.976048855074523,0,4,calcitonin family binding,MF,
17854,GO:0097646,1,0.965470623384645,0,6,calcitonin family receptor signaling pathway,BP,
17855,GO:0097647,1,0.972567078893528,0,5,amylin receptor signaling pathway,BP,
17856,GO:0097648,1,0.948643986017816,0,8,G-protein coupled receptor complex,CC,
17857,GO:0097651,1,0.971451271470205,0,4,phosphatidylinositol 3-kinase complex, class I,CC,
17858,GO:0097655,1,0.993850639026861,0,1,serpin family protein binding,MF,
17860,GO:0097676,1,0.974498189013367,0,3,histone H3-K36 dimethylation,BP,
17861,GO:0097677,1,0.965711967823011,0,5,STAT family protein binding,MF,
17862,GO:0097679,1,0.989081347967094,0,2,other organism cytoplasm,CC,
17863,GO:0097680,1,0.980128442803701,0,3,double-strand break repair via classical nonhomologous end joining,BP,
17864,GO:0097681,1,0.979154976524488,0,2,double-strand break repair via alternative nonhomologous end joining,BP,
17865,GO:0097682,1,0.994200362516499,0,1,intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity,MF,
17866,GO:0097688,1,0.950999939797093,0,7,glutamate receptor clustering,BP,
17867,GO:0097689,1,0.993557877795695,0,1,iron channel activity,MF,
17868,GO:0097692,1,0.99205176749062,0,1,histone H3-K4 monomethylation,BP,
17869,GO:0097694,1,0.974527525284197,0,3,establishment of RNA localization to telomere,BP,
17870,GO:0097695,1,0.974527525284197,0,3,establishment of protein-containing complex localization to telomere,BP,
17872,GO:0097698,1,0.994518205971086,0,1,telomere maintenance via base-excision repair,BP,
17873,GO:0097699,1,0.992988293775739,0,1,vascular endothelial cell response to fluid shear stress,BP,
17874,GO:0097707,1,0.994802874872577,0,1,ferroptosis,BP,
17876,GO:0097709,1,0.962554907590834,0,6,connective tissue replacement,BP,
17878,GO:0097712,1,0.993850639026861,0,1,vesicle targeting, trans-Golgi to periciliary membrane compartment,BP,
17880,GO:0097720,1,0.835825592445794,0,26,calcineurin-mediated signaling,BP,
17881,GO:0097722,1,0.672415201697863,0,60,sperm motility,BP,
17882,GO:0097724,1,0.994343262068184,0,1,sperm flagellum movement,BP,
17883,GO:0097726,1,0.994709631195631,0,1,LEM domain binding,MF,
17887,GO:0097732,1,0.956838619131678,0,7,9+2 non-motile cilium,CC,
17889,GO:0097734,1,0.895065413815459,0,18,extracellular exosome biogenesis,BP,
17890,GO:0097742,1,0.973227750906086,0,4,de novo centriole assembly,BP,
17891,GO:0097745,1,0.982687533729882,0,3,mitochondrial tRNA 5'-end processing,BP,
17892,GO:0097746,1,0.489153889718376,0,112,regulation of blood vessel diameter,BP,
17893,GO:0097747,1,0.769973366584344,0,43,RNA polymerase activity,MF,
17894,GO:0097749,1,0.985912122279331,0,2,membrane tubulation,BP,
17895,GO:0097752,1,0.981659175782692,0,3,regulation of DNA stability,BP,
17896,GO:0097753,1,0.98724945938942,0,2,membrane bending,BP,
17897,GO:0097755,1,0.727616564194534,0,50,positive regulation of blood vessel diameter,BP,
17898,GO:0097756,1,0.629591251379381,0,71,negative regulation of blood vessel diameter,BP,
17899,GO:0098501,1,0.971301006116187,0,5,polynucleotide dephosphorylation,BP,
17900,GO:0098502,1,0.983637019716719,0,3,DNA dephosphorylation,BP,
17901,GO:0098503,1,0.994396242376035,0,1,DNA 3' dephosphorylation,BP,
17902,GO:0098504,1,0.994396242376035,0,1,DNA 3' dephosphorylation involved in DNA repair,BP,
17903,GO:0098505,1,0.939496481095685,0,10,G-rich strand telomeric DNA binding,MF,
17904,GO:0098506,1,0.994396242376035,0,1,polynucleotide 3' dephosphorylation,BP,
17905,GO:0098507,1,0.987460852684589,0,2,polynucleotide 5' dephosphorylation,BP,
17906,GO:0098508,1,0.988140103660039,0,2,endothelial to hematopoietic transition,BP,
17907,GO:0098518,1,0.981926657636789,0,3,polynucleotide phosphatase activity,MF,
17908,GO:0098519,1,0.968777809714744,0,5,nucleotide phosphatase activity, acting on free nucleotides,MF,
17909,GO:0098528,1,0.967593065347121,0,5,skeletal muscle fiber differentiation,BP,
17910,GO:0098530,1,0.992301360687703,0,1,positive regulation of strand invasion,BP,
17911,GO:0098531,1,0.736753392628785,0,45,transcription factor activity, direct ligand regulated sequence-specific DNA binding,MF,
17912,GO:0098532,1,0.954634438638909,0,7,histone H3-K27 trimethylation,BP,
17914,GO:0098534,1,0.812868164073841,0,31,centriole assembly,BP,
17915,GO:0098535,1,0.973227750906086,0,4,de novo centriole assembly involved in multi-ciliated epithelial cell differentiation,BP,
17916,GO:0098536,1,0.973947305805374,0,4,deuterosome,CC,
17917,GO:0098542,1,0.12116816977538,0,337,defense response to other organism,BP,
17918,GO:0098543,1,0.926213224703936,0,11,detection of other organism,BP,
17919,GO:0098547,1,0.994125989551806,0,1,lumenal side of Golgi membrane,CC,
17921,GO:0098553,1,0.865677119771313,0,25,lumenal side of endoplasmic reticulum membrane,CC,
17922,GO:0098554,1,0.925444015334222,0,13,cytoplasmic side of endoplasmic reticulum membrane,CC,
17923,GO:0098556,1,0.974758391303038,0,5,cytoplasmic side of rough endoplasmic reticulum membrane,CC,
17924,GO:0098559,1,0.98199483046363,0,3,cytoplasmic side of early endosome membrane,CC,
17925,GO:0098560,1,0.987859887517522,0,2,cytoplasmic side of late endosome membrane,CC,
17927,GO:0098563,1,0.849856975252077,0,26,intrinsic component of synaptic vesicle membrane,CC,
17928,GO:0098573,1,0.670002215327086,0,66,intrinsic component of mitochondrial membrane,CC,
17930,GO:0098575,1,0.988398089969164,0,2,lumenal side of lysosomal membrane,CC,
17931,GO:0098576,1,0.976240840079348,0,4,lumenal side of membrane,CC,
17932,GO:0098577,1,0.99175205968801,0,1,inactive sex chromosome,CC,
17933,GO:0098581,1,0.899129079433737,0,16,detection of external biotic stimulus,BP,
17934,GO:0098582,1,0.985672008184927,0,2,innate vocalization behavior,BP,
17935,GO:0098583,1,0.994633428505869,0,1,learned vocalization behavior,BP,
17936,GO:0098586,1,0.772475245464037,0,39,cellular response to virus,BP,
17940,GO:0098592,1,0.980865579781022,0,3,cytoplasmic side of apical plasma membrane,CC,
17941,GO:0098594,1,0.994906701708957,0,1,mucin granule,CC,
17942,GO:0098595,1,0.994127538437076,0,1,perivitelline space,CC,
17943,GO:0098596,1,0.94120982221864,0,7,imitative learning,BP,
17944,GO:0098597,1,0.930744393710302,0,8,observational learning,BP,
17945,GO:0098598,1,0.936155668913127,0,8,learned vocalization behavior or vocal learning,BP,
17946,GO:0098599,1,0.941237790983376,0,10,palmitoyl hydrolase activity,MF,
17947,GO:0098601,1,0.993531781510195,0,1,selenomethionine adenosyltransferase activity,MF,
17949,GO:0098619,1,0.99430630416389,0,1,selenocysteine-tRNA ligase activity,MF,
17950,GO:0098621,1,0.992366871022755,0,1,phosphoseryl-selenocysteinyl-tRNA selenium transferase activity,MF,
17951,GO:0098625,1,0.993329370814404,0,1,methylselenol reductase activity,MF,
17952,GO:0098626,1,0.993329370814404,0,1,methylseleninic acid reductase activity,MF,
17953,GO:0098629,1,0.993850639026861,0,1,trans-Golgi network membrane organization,BP,
17954,GO:0098631,1,0.767857941393039,0,40,cell adhesion mediator activity,MF,
17955,GO:0098632,1,0.816271587464764,0,31,cell-cell adhesion mediator activity,MF,
17956,GO:0098633,1,0.993980025172119,0,1,collagen fibril binding,MF,
17957,GO:0098634,1,0.951499132556991,0,7,cell-matrix adhesion mediator activity,MF,
17958,GO:0098636,1,0.782510613909015,0,35,protein complex involved in cell adhesion,CC,
17959,GO:0098637,1,0.993262026815901,0,1,protein complex involved in cell-matrix adhesion,CC,
17960,GO:0098639,1,0.963195826706259,0,5,collagen binding involved in cell-matrix adhesion,MF,
17961,GO:0098640,1,0.987860939459092,0,2,integrin binding involved in cell-matrix adhesion,MF,
17962,GO:0098641,1,0.892964004043873,0,19,cadherin binding involved in cell-cell adhesion,MF,
17963,GO:0098642,1,0.944128078161144,0,7,network-forming collagen trimer,CC,
17964,GO:0098643,1,0.911975229387134,0,12,banded collagen fibril,CC,
17965,GO:0098644,1,0.852768297452935,0,20,complex of collagen trimers,CC,
17966,GO:0098645,1,0.944128078161144,0,7,collagen network,CC,
17967,GO:0098646,1,0.993931880262085,0,1,collagen sheet,CC,
17968,GO:0098647,1,0.978494942416028,0,3,collagen beaded filament,CC,
17969,GO:0098648,1,0.990482017030119,0,1,collagen anchoring fibril,CC,
17970,GO:0098651,1,0.93708565014785,0,8,basement membrane collagen trimer,CC,
17971,GO:0098652,1,0.990482017030119,0,1,collagen type VII anchoring fibril,CC,
17975,GO:0098659,1,0.724216120482373,0,48,inorganic cation import across plasma membrane,BP,
17979,GO:0098664,1,0.925520427488083,0,13,G-protein coupled serotonin receptor signaling pathway,BP,
17980,GO:0098679,1,0.981361268020496,0,2,regulation of carbohydrate catabolic process by regulation of transcription from RNA polymerase II promoter,BP,
17981,GO:0098680,1,0.993224430037506,0,1,template-free RNA nucleotidyltransferase,MF,
17983,GO:0098693,1,0.742326822839714,0,42,regulation of synaptic vesicle cycle,BP,
17984,GO:0098698,1,0.942860125266469,0,7,postsynaptic specialization assembly,BP,
17985,GO:0098700,1,0.951945354837407,0,8,neurotransmitter loading into synaptic vesicle,BP,
17986,GO:0098703,1,0.915818440787196,0,13,calcium ion import across plasma membrane,BP,
17987,GO:0098704,1,0.994089340810551,0,1,carbohydrate import across plasma membrane,BP,
17988,GO:0098705,1,0.992824108403156,0,1,copper ion import across plasma membrane,BP,
17989,GO:0098706,1,0.971933472896748,0,4,ferric iron import across plasma membrane,BP,
17990,GO:0098711,1,0.959927820806055,0,6,iron ion import across plasma membrane,BP,
17991,GO:0098712,1,0.925320680618525,0,11,L-glutamate import across plasma membrane,BP,
17992,GO:0098713,1,0.994118761776139,0,1,leucine import across plasma membrane,BP,
17993,GO:0098719,1,0.906773735192646,0,14,sodium ion import across plasma membrane,BP,
17994,GO:0098722,1,0.942493263403888,0,9,asymmetric stem cell division,BP,
17995,GO:0098725,1,0.993850639026861,0,1,symmetric cell division,BP,
17997,GO:0098728,1,0.982077747473234,0,3,germline stem cell asymmetric division,BP,
17998,GO:0098732,1,0.488505364275366,0,106,macromolecule deacylation,BP,
17999,GO:0098734,1,0.941237790983376,0,10,macromolecule depalmitoylation,BP,
18000,GO:0098735,1,0.964019273249707,0,4,positive regulation of the force of heart contraction,BP,
18001,GO:0098736,1,0.990713196986705,0,1,negative regulation of the force of heart contraction,BP,
18002,GO:0098739,1,0.622989481168351,0,69,import across plasma membrane,BP,
18004,GO:0098743,1,0.892769445916684,0,17,cell aggregation,BP,
18005,GO:0098745,1,0.994388489476242,0,1,Dcp1-Dcp2 complex,CC,
18006,GO:0098746,1,0.992804257966383,0,1,fast, calcium ion-dependent exocytosis of neurotransmitter,BP,
18007,GO:0098748,1,0.928885563309414,0,11,endocytic adaptor activity,MF,
18008,GO:0098749,1,0.992904464575226,0,1,cerebellar neuron development,BP,
18009,GO:0098751,1,0.804128354350586,0,31,bone cell development,BP,
18010,GO:0098754,1,0.55433282653777,0,100,detoxification,BP,
18011,GO:0098756,1,0.954178537450029,0,7,response to interleukin-21,BP,
18012,GO:0098757,1,0.954178537450029,0,7,cellular response to interleukin-21,BP,
18013,GO:0098758,1,0.981652428746955,0,3,response to interleukin-8,BP,
18014,GO:0098759,1,0.981652428746955,0,3,cellular response to interleukin-8,BP,
18015,GO:0098760,1,0.880428052821324,0,19,response to interleukin-7,BP,
18016,GO:0098761,1,0.880428052821324,0,19,cellular response to interleukin-7,BP,
18017,GO:0098770,1,0.982697526728626,0,2,FBXO family protein binding,MF,
18020,GO:0098773,1,0.574928804686911,0,82,skin epidermis development,BP,
18021,GO:0098779,1,0.945387273824758,0,8,positive regulation of mitophagy in response to mitochondrial depolarization,BP,
18022,GO:0098780,1,0.891972658134016,0,17,response to mitochondrial depolarisation,BP,
18023,GO:0098781,1,0.551355157881069,0,94,ncRNA transcription,BP,
18024,GO:0098782,1,0.994352824644852,0,1,mechanosensitived potassium channel activity,MF,
18028,GO:0098792,1,0.93782307105003,0,10,xenophagy,BP,
18031,GO:0098795,1,0.987326897335999,0,2,mRNA cleavage involved in gene silencing,BP,
18034,GO:0098798,1,0.293606522345566,0,217,mitochondrial protein complex,CC,
18035,GO:0098799,1,0.932524881169784,0,12,outer mitochondrial membrane protein complex,CC,
18036,GO:0098800,1,0.574105696122919,0,100,inner mitochondrial membrane protein complex,CC,
18039,GO:0098803,1,0.689847868274864,0,69,respiratory chain complex,CC,
18041,GO:0098808,1,0.988162321891134,0,2,mRNA cap binding,MF,
18042,GO:0098809,1,0.993944491212098,0,1,nitrite reductase activity,MF,
18043,GO:0098810,1,0.902084573001459,0,16,neurotransmitter reuptake,BP,
18045,GO:0098814,1,0.964100580257172,0,5,spontaneous synaptic transmission,BP,
18046,GO:0098815,1,0.764319067318172,0,38,modulation of excitatory postsynaptic potential,BP,
18047,GO:0098816,1,0.99423601500725,0,1,mini excitatory postsynaptic potential,BP,
18048,GO:0098821,1,0.963051029012439,0,5,BMP receptor activity,MF,
18049,GO:0098822,1,0.994020738101129,0,1,peptidyl-cysteine modification to L-cysteine persulfide,BP,
18050,GO:0098826,1,0.976073339616349,0,4,endoplasmic reticulum tubular network membrane,CC,
18052,GO:0098828,1,0.948479075210128,0,7,modulation of inhibitory postsynaptic potential,BP,
18053,GO:0098829,1,0.991928530826385,0,1,intestinal folate absorption,BP,
18054,GO:0098830,1,0.992797987742345,0,1,presynaptic endosome,CC,
18055,GO:0098831,1,0.918371635497073,0,9,presynaptic active zone cytoplasmic component,CC,
18056,GO:0098833,1,0.99273315265613,0,1,presynaptic endocytic zone,CC,
18057,GO:0098835,1,0.99273315265613,0,1,presynaptic endocytic zone membrane,CC,
18058,GO:0098837,1,0.982154956474077,0,3,postsynaptic recycling endosome,CC,
18059,GO:0098838,1,0.993822653994821,0,1,reduced folate transmembrane transport,BP,
18060,GO:0098839,1,0.79158345633738,0,32,postsynaptic density membrane,CC,
18061,GO:0098840,1,0.971368639458631,0,4,protein transport along microtubule,BP,
18062,GO:0098842,1,0.988212888331131,0,2,postsynaptic early endosome,CC,
18063,GO:0098843,1,0.960683451545294,0,6,postsynaptic endocytic zone,CC,
18064,GO:0098844,1,0.978498954703678,0,3,postsynaptic endocytic zone membrane,CC,
18065,GO:0098845,1,0.963903140624335,0,6,postsynaptic endosome,CC,
18066,GO:0098847,1,0.921580383458218,0,13,sequence-specific single stranded DNA binding,MF,
18067,GO:0098850,1,0.99428252807261,0,1,extrinsic component of synaptic vesicle membrane,CC,
18069,GO:0098855,1,0.97775045705185,0,3,HCN channel complex,CC,
18070,GO:0098856,1,0.951415309030808,0,8,intestinal lipid absorption,BP,
18075,GO:0098869,1,0.612722742463676,0,82,cellular oxidant detoxification,BP,
18076,GO:0098870,1,0.959291476251666,0,6,action potential propagation,BP,
18077,GO:0098871,1,0.994413298319495,0,1,postsynaptic actin cytoskeleton,CC,
18078,GO:0098875,1,0.992842906372749,0,1,epididymosome,CC,
18079,GO:0098876,1,0.633106148202578,0,68,vesicle-mediated transport to the plasma membrane,BP,
18080,GO:0098877,1,0.938658877204088,0,10,neurotransmitter receptor transport to plasma membrane,BP,
18081,GO:0098878,1,0.701269341735364,0,51,neurotransmitter receptor complex,CC,
18082,GO:0098881,1,0.975233644221212,0,4,exocytic insertion of neurotransmitter receptor to plasma membrane,BP,
18083,GO:0098883,1,0.994356959793459,0,1,synapse disassembly,BP,
18084,GO:0098884,1,0.978498954703678,0,3,postsynaptic neurotransmitter receptor internalization,BP,
18085,GO:0098885,1,0.991546303497539,0,1,modification of postsynaptic actin cytoskeleton,BP,
18086,GO:0098886,1,0.986531509611971,0,2,modification of dendritic spine,BP,
18087,GO:0098887,1,0.974407015328974,0,4,neurotransmitter receptor transport, endosome to postsynaptic membrane,BP,
18088,GO:0098888,1,0.991523960930815,0,1,extrinsic component of presynaptic membrane,CC,
18089,GO:0098889,1,0.974756583625263,0,4,intrinsic component of presynaptic membrane,CC,
18090,GO:0098890,1,0.991523960930815,0,1,extrinsic component of postsynaptic membrane,CC,
18091,GO:0098895,1,0.993126818994063,0,1,postsynaptic endosome membrane,CC,
18092,GO:0098900,1,0.722177060720157,0,44,regulation of action potential,BP,
18093,GO:0098901,1,0.82069313312657,0,25,regulation of cardiac muscle cell action potential,BP,
18094,GO:0098902,1,0.970202238897727,0,4,regulation of membrane depolarization during action potential,BP,
18095,GO:0098903,1,0.945900866352167,0,8,regulation of membrane repolarization during action potential,BP,
18096,GO:0098904,1,0.980953390479639,0,2,regulation of AV node cell action potential,BP,
18097,GO:0098905,1,0.994860729291905,0,1,regulation of bundle of His cell action potential,BP,
18098,GO:0098907,1,0.978059862316929,0,2,regulation of SA node cell action potential,BP,
18099,GO:0098908,1,0.97522446348698,0,4,regulation of neuronal action potential,BP,
18100,GO:0098909,1,0.948610387632079,0,7,regulation of cardiac muscle cell action potential involved in regulation of contraction,BP,
18101,GO:0098910,1,0.956010842900201,0,5,regulation of atrial cardiac muscle cell action potential,BP,
18102,GO:0098911,1,0.896047298302157,0,14,regulation of ventricular cardiac muscle cell action potential,BP,
18103,GO:0098912,1,0.97256268995444,0,3,membrane depolarization during atrial cardiac muscle cell action potential,BP,
18104,GO:0098914,1,0.96084162016984,0,6,membrane repolarization during atrial cardiac muscle cell action potential,BP,
18105,GO:0098915,1,0.926554334765134,0,12,membrane repolarization during ventricular cardiac muscle cell action potential,BP,
18107,GO:0098917,1,0.952669776253823,0,7,retrograde trans-synaptic signaling,BP,
18108,GO:0098918,1,0.99435385843341,0,1,structural constituent of synapse,MF,
18109,GO:0098920,1,0.986234151379416,0,2,retrograde trans-synaptic signaling by lipid,BP,
18110,GO:0098921,1,0.986234151379416,0,2,retrograde trans-synaptic signaling by endocannabinoid,BP,
18111,GO:0098923,1,0.991583726537015,0,1,retrograde trans-synaptic signaling by soluble gas,BP,
18112,GO:0098924,1,0.991583726537015,0,1,retrograde trans-synaptic signaling by nitric oxide,BP,
18113,GO:0098926,1,0.991682555409492,0,1,postsynaptic signal transduction,BP,
18114,GO:0098927,1,0.760668604371723,0,40,vesicle-mediated transport between endosomal compartments,BP,
18115,GO:0098928,1,0.973054938014211,0,2,presynaptic signal transduction,BP,
18116,GO:0098930,1,0.736506944491954,0,45,axonal transport,BP,
18117,GO:0098935,1,0.962981694780664,0,5,dendritic transport,BP,
18118,GO:0098936,1,0.92836143361674,0,10,intrinsic component of postsynaptic membrane,CC,
18119,GO:0098937,1,0.962981694780664,0,5,anterograde dendritic transport,BP,
18120,GO:0098939,1,0.991902964399666,0,1,dendritic transport of mitochondrion,BP,
18121,GO:0098942,1,0.992749368324187,0,1,retrograde trans-synaptic signaling by trans-synaptic protein complex,BP,
18122,GO:0098943,1,0.959320301801639,0,7,neurotransmitter receptor transport, postsynaptic endosome to lysosome,BP,
18123,GO:0098945,1,0.993031946621236,0,1,intrinsic component of presynaptic active zone membrane,CC,
18124,GO:0098948,1,0.966015382348471,0,4,intrinsic component of postsynaptic specialization membrane,CC,
18125,GO:0098953,1,0.953150689886614,0,8,receptor diffusion trapping,BP,
18126,GO:0098957,1,0.972651497290337,0,4,anterograde axonal transport of mitochondrion,BP,
18127,GO:0098960,1,0.775590786457544,0,37,postsynaptic neurotransmitter receptor activity,MF,
18128,GO:0098961,1,0.991686718970902,0,1,dendritic transport of ribonucleoprotein complex,BP,
18129,GO:0098963,1,0.991686718970902,0,1,dendritic transport of messenger ribonucleoprotein complex,BP,
18130,GO:0098964,1,0.991686718970902,0,1,anterograde dendritic transport of messenger ribonucleoprotein complex,BP,
18131,GO:0098967,1,0.975233644221212,0,4,exocytic insertion of neurotransmitter receptor to postsynaptic membrane,BP,
18132,GO:0098968,1,0.992596485148829,0,1,neurotransmitter receptor transport postsynaptic membrane to endosome,BP,
18133,GO:0098969,1,0.944718855437561,0,9,neurotransmitter receptor transport to postsynaptic membrane,BP,
18134,GO:0098970,1,0.953150689886614,0,8,postsynaptic neurotransmitter receptor diffusion trapping,BP,
18135,GO:0098971,1,0.970844999158746,0,4,anterograde dendritic transport of neurotransmitter receptor complex,BP,
18136,GO:0098972,1,0.991902964399666,0,1,anterograde dendritic transport of mitochondrion,BP,
18137,GO:0098973,1,0.99435385843341,0,1,structural constituent of postsynaptic actin cytoskeleton,MF,
18138,GO:0098974,1,0.99435385843341,0,1,postsynaptic actin cytoskeleton organization,BP,
18139,GO:0098976,1,0.940133188091081,0,8,excitatory chemical synaptic transmission,BP,
18140,GO:0098978,1,0.955433250704285,0,6,glutamatergic synapse,CC,
18141,GO:0098982,1,0.96529661802211,0,5,GABA-ergic synapse,CC,
18142,GO:0098983,1,0.971402175996725,0,4,symmetric, GABA-ergic, inhibitory synapse,CC,
18143,GO:0098984,1,0.192882820973076,0,229,neuron to neuron synapse,CC,
18144,GO:0098985,1,0.955433250704285,0,6,asymmetric, glutamatergic, excitatory synapse,CC,
18145,GO:0098988,1,0.956955209383906,0,6,G-protein coupled glutamate receptor activity,MF,
18146,GO:0098989,1,0.986102443660057,0,2,NMDA selective glutamate receptor signaling pathway,BP,
18147,GO:0098992,1,0.994011974632174,0,1,neuronal dense core vesicle,CC,
18148,GO:0098993,1,0.948667563793687,0,9,anchored component of synaptic vesicle membrane,CC,
18149,GO:0098999,1,0.993126818994063,0,1,extrinsic component of postsynaptic endosome membrane,CC,
18151,GO:0099004,1,0.970932816319847,0,4,calmodulin dependent kinase signaling pathway,BP,
18152,GO:0099010,1,0.978190535088905,0,3,modification of postsynaptic structure,BP,
18153,GO:0099011,1,0.959640693598817,0,5,neuronal dense core vesicle exocytosis,BP,
18154,GO:0099022,1,0.988305574903627,0,2,vesicle tethering,BP,
18155,GO:0099023,1,0.632494517110866,0,69,tethering complex,CC,
18156,GO:0099024,1,0.710737590844883,0,53,plasma membrane invagination,BP,
18157,GO:0099038,1,0.992761919357174,0,1,ceramide-translocating ATPase activity,MF,
18158,GO:0099039,1,0.98478922600553,0,2,sphingolipid translocation,BP,
18159,GO:0099040,1,0.992761919357174,0,1,ceramide translocation,BP,
18160,GO:0099044,1,0.988305574903627,0,2,vesicle tethering to endoplasmic reticulum,BP,
18161,GO:0099046,1,0.994542492193625,0,1,clearance of foreign intracellular nucleic acids,BP,
18162,GO:0099050,1,0.993878644316695,0,1,vesicle scission,BP,
18163,GO:0099053,1,0.980628440470321,0,3,activating signal cointegrator 1 complex,CC,
18164,GO:0099054,1,0.878327347709509,0,18,presynapse assembly,BP,
18165,GO:0099055,1,0.92836143361674,0,10,integral component of postsynaptic membrane,CC,
18166,GO:0099056,1,0.974756583625263,0,4,integral component of presynaptic membrane,CC,
18167,GO:0099059,1,0.993031946621236,0,1,integral component of presynaptic active zone membrane,CC,
18168,GO:0099060,1,0.966015382348471,0,4,integral component of postsynaptic specialization membrane,CC,
18169,GO:0099061,1,0.972795755054007,0,3,integral component of postsynaptic density membrane,CC,
18170,GO:0099068,1,0.876680603546298,0,17,postsynapse assembly,BP,
18171,GO:0099072,1,0.88105400816138,0,20,regulation of postsynaptic membrane neurotransmitter receptor levels,BP,
18172,GO:0099073,1,0.986577413324282,0,2,mitochondrion-derived vesicle,CC,
18173,GO:0099074,1,0.987541329307922,0,2,mitochondrion to lysosome transport,BP,
18174,GO:0099075,1,0.987541329307922,0,2,mitochondrion-derived vesicle mediated transport,BP,
18175,GO:0099077,1,0.992305290401354,0,1,histone-dependent DNA binding,MF,
18176,GO:0099078,1,0.978039942439311,0,4,BORC complex,CC,
18179,GO:0099082,1,0.981289195904815,0,3,retrograde trans-synaptic signaling by neuropeptide,BP,
18180,GO:0099083,1,0.988028816110881,0,2,retrograde trans-synaptic signaling by neuropeptide, modulating synaptic transmission,BP,
18181,GO:0099084,1,0.890191935989629,0,15,postsynaptic specialization organization,BP,
18183,GO:0099089,1,0.988985116420387,0,1,establishment of endoplasmic reticulum localization to postsynapse,BP,
18184,GO:0099093,1,0.98635829374783,0,2,calcium export from the mitochondrion,BP,
18185,GO:0099094,1,0.509705791276953,0,97,ligand-gated cation channel activity,MF,
18186,GO:0099095,1,0.885562835579264,0,18,ligand-gated anion channel activity,MF,
18187,GO:0099098,1,0.993623881442226,0,1,microtubule polymerization based movement,BP,
18188,GO:0099103,1,0.975945815364577,0,4,channel activator activity,MF,
18189,GO:0099104,1,0.975945815364577,0,4,potassium channel activator activity,MF,
18190,GO:0099106,1,0.570414807988512,0,86,ion channel regulator activity,MF,
18191,GO:0099111,1,0.389819400487187,0,137,microtubule-based transport,BP,
18192,GO:0099116,1,0.910850435395741,0,16,tRNA 5'-end processing,BP,
18193,GO:0099118,1,0.971368639458631,0,4,microtubule-based protein transport,BP,
18194,GO:0099122,1,0.978767935034418,0,3,RNA polymerase II C-terminal domain binding,MF,
18195,GO:0099130,1,0.994139414088738,0,1,estrogen binding,MF,
18196,GO:0099131,1,0.840246285316671,0,28,ATP hydrolysis coupled ion transmembrane transport,BP,
18197,GO:0099132,1,0.73536203870907,0,45,ATP hydrolysis coupled cation transmembrane transport,BP,
18198,GO:0099133,1,0.917162951459337,0,12,ATP hydrolysis coupled anion transmembrane transport,BP,
18199,GO:0099142,1,0.992104559503058,0,1,intracellularly ATP-gated ion channel activity,MF,
18200,GO:0099146,1,0.972795755054007,0,3,intrinsic component of postsynaptic density membrane,CC,
18201,GO:0099159,1,0.991546303497539,0,1,regulation of modification of postsynaptic structure,BP,
18202,GO:0099163,1,0.991583726537015,0,1,synaptic signaling by nitric oxide,BP,
18203,GO:0099170,1,0.980756539592048,0,3,postsynaptic modulation of chemical synaptic transmission,BP,
18204,GO:0099172,1,0.866632983091604,0,20,presynapse organization,BP,
18205,GO:0099173,1,0.509227776279724,0,95,postsynapse organization,BP,
18206,GO:0099174,1,0.966301827018842,0,5,regulation of presynapse organization,BP,
18207,GO:0099175,1,0.690863755345215,0,52,regulation of postsynapse organization,BP,
18209,GO:0099186,1,0.99435385843341,0,1,structural constituent of postsynapse,MF,
18210,GO:0099188,1,0.99435385843341,0,1,postsynaptic cytoskeleton organization,BP,
18211,GO:0099240,1,0.92836143361674,0,10,intrinsic component of synaptic membrane,CC,
18212,GO:0099243,1,0.991523960930815,0,1,extrinsic component of synaptic membrane,CC,
18213,GO:0099400,1,0.990489208522649,0,1,caveola neck,CC,
18214,GO:0099402,1,0.994886556596673,0,1,plant organ development,BP,
18215,GO:0099403,1,0.979934754663598,0,2,maintenance of mitotic sister chromatid cohesion, telomeric,BP,
18216,GO:0099404,1,0.979934754663598,0,2,mitotic sister chromatid cohesion, telomeric,BP,
18217,GO:0099500,1,0.906004764823348,0,16,vesicle fusion to plasma membrane,BP,
18218,GO:0099501,1,0.556196825110908,0,90,exocytic vesicle membrane,CC,
18221,GO:0099509,1,0.983148644389729,0,3,regulation of presynaptic cytosolic calcium ion concentration,BP,
18224,GO:0099514,1,0.899556300700012,0,17,synaptic vesicle cytoskeletal transport,BP,
18226,GO:0099516,1,0.685783645512978,0,56,ion antiporter activity,MF,
18227,GO:0099517,1,0.899556300700012,0,17,synaptic vesicle transport along microtubule,BP,
18229,GO:0099519,1,0.993850639026861,0,1,dense core granule cytoskeletal transport,BP,
18230,GO:0099522,1,0.994237565286352,0,1,region of cytosol,CC,
18231,GO:0099523,1,0.994237565286352,0,1,presynaptic cytosol,CC,
18232,GO:0099524,1,0.994237565286352,0,1,postsynaptic cytosol,CC,
18233,GO:0099525,1,0.959640693598817,0,5,presynaptic dense core vesicle exocytosis,BP,
18234,GO:0099526,1,0.973054938014211,0,2,presynapse to nucleus signaling pathway,BP,
18235,GO:0099527,1,0.991682555409492,0,1,postsynapse to nucleus signaling pathway,BP,
18236,GO:0099528,1,0.851731648350265,0,26,G-protein coupled neurotransmitter receptor activity,MF,
18237,GO:0099529,1,0.789049727925574,0,35,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential,MF,
18238,GO:0099530,1,0.982983236760572,0,2,G-protein coupled receptor activity involved in regulation of postsynaptic membrane potential,MF,
18239,GO:0099531,1,0.36684749475716,0,148,presynaptic process involved in chemical synaptic transmission,BP,
18240,GO:0099532,1,0.983990683788207,0,2,synaptic vesicle endosomal processing,BP,
18243,GO:0099538,1,0.973044648316048,0,4,synaptic signaling via neuropeptide,BP,
18244,GO:0099540,1,0.973044648316048,0,4,trans-synaptic signaling by neuropeptide,BP,
18245,GO:0099541,1,0.963530349011083,0,5,trans-synaptic signaling by lipid,BP,
18246,GO:0099542,1,0.963530349011083,0,5,trans-synaptic signaling by endocannabinoid,BP,
18247,GO:0099543,1,0.991583726537015,0,1,trans-synaptic signaling by soluble gas,BP,
18248,GO:0099545,1,0.985572845842131,0,2,trans-synaptic signaling by trans-synaptic complex,BP,
18249,GO:0099547,1,0.980756539592048,0,3,regulation of translation at synapse, modulating synaptic transmission,BP,
18250,GO:0099548,1,0.991583726537015,0,1,trans-synaptic signaling by nitric oxide,BP,
18251,GO:0099550,1,0.950250812962337,0,7,trans-synaptic signaling, modulating synaptic transmission,BP,
18252,GO:0099551,1,0.979728214893444,0,3,trans-synaptic signaling by neuropeptide, modulating synaptic transmission,BP,
18253,GO:0099552,1,0.976982481747876,0,3,trans-synaptic signaling by lipid, modulating synaptic transmission,BP,
18254,GO:0099553,1,0.976982481747876,0,3,trans-synaptic signaling by endocannabinoid, modulating synaptic transmission,BP,
18255,GO:0099557,1,0.992771592226114,0,1,trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission,BP,
18256,GO:0099558,1,0.989058450758074,0,2,maintenance of synapse structure,BP,
18257,GO:0099560,1,0.977059436119921,0,3,synaptic membrane adhesion,BP,
18258,GO:0099563,1,0.927628278709226,0,11,modification of synaptic structure,BP,
18259,GO:0099565,1,0.437595781472169,0,120,chemical synaptic transmission, postsynaptic,BP,
18260,GO:0099566,1,0.97543232879613,0,3,regulation of postsynaptic cytosolic calcium ion concentration,BP,
18262,GO:0099569,1,0.937257083319761,0,7,presynaptic cytoskeleton,CC,
18263,GO:0099571,1,0.994413298319495,0,1,postsynaptic cytoskeleton,CC,
18264,GO:0099572,1,0.202465483229772,0,222,postsynaptic specialization,CC,
18265,GO:0099578,1,0.980756539592048,0,3,regulation of translation at postsynapse, modulating synaptic transmission,BP,
18266,GO:0099580,1,0.984794960655108,0,2,ion antiporter activity involved in regulation of postsynaptic membrane potential,MF,
18267,GO:0099583,1,0.97543232879613,0,3,neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration,MF,
18268,GO:0099587,1,0.724216120482373,0,48,inorganic ion import across plasma membrane,BP,
18269,GO:0099589,1,0.925520427488083,0,13,serotonin receptor activity,MF,
18270,GO:0099590,1,0.932804584841577,0,11,neurotransmitter receptor internalization,BP,
18271,GO:0099601,1,0.740804550092084,0,44,regulation of neurotransmitter receptor activity,BP,
18272,GO:0099602,1,0.959525102820203,0,7,neurotransmitter receptor regulator activity,MF,
18273,GO:0099604,1,0.804510107070933,0,27,ligand-gated calcium channel activity,MF,
18274,GO:0099606,1,0.990804131196533,0,1,microtubule plus-end directed mitotic chromosome migration,BP,
18275,GO:0099607,1,0.990804131196533,0,1,lateral attachment of mitotic spindle microtubules to kinetochore,BP,
18276,GO:0099609,1,0.984596165971856,0,2,microtubule lateral binding,MF,
18278,GO:0099617,1,0.993537922105355,0,1,matrix side of mitochondrial inner membrane,CC,
18281,GO:0099624,1,0.933126408372521,0,10,atrial cardiac muscle cell membrane repolarization,BP,
18283,GO:0099628,1,0.953150689886614,0,8,neurotransmitter receptor diffusion trapping,BP,
18284,GO:0099631,1,0.989408683121398,0,2,postsynaptic endocytic zone cytoplasmic component,CC,
18285,GO:0099632,1,0.892810280469425,0,18,protein transport within plasma membrane,BP,
18286,GO:0099634,1,0.786054676553322,0,33,postsynaptic specialization membrane,CC,
18287,GO:0099637,1,0.892810280469425,0,18,neurotransmitter receptor transport,BP,
18288,GO:0099638,1,0.968158547212302,0,5,endosome to plasma membrane protein transport,BP,
18289,GO:0099639,1,0.968158547212302,0,5,neurotransmitter receptor transport, endosome to plasma membrane,BP,
18290,GO:0099640,1,0.986555931796112,0,2,axo-dendritic protein transport,BP,
18291,GO:0099641,1,0.994826636747117,0,1,anterograde axonal protein transport,BP,
18292,GO:0099643,1,0.38973592681921,0,138,signal release from synapse,BP,
18293,GO:0099699,1,0.92836143361674,0,10,integral component of synaptic membrane,CC,
18294,GO:0099738,1,0.776419838019839,0,34,cell cortex region,CC,
18295,GO:0100001,1,0.992507902145364,0,1,regulation of skeletal muscle contraction by action potential,BP,
18296,GO:0100002,1,0.993809310701639,0,1,negative regulation of protein kinase activity by protein phosphorylation,BP,
18297,GO:0100012,1,0.989077393495349,0,2,regulation of heart induction by canonical Wnt signaling pathway,BP,
18298,GO:0100057,1,0.991337379953931,0,1,regulation of phenotypic switching by transcription from RNA polymerase II promoter,BP,
18299,GO:0101002,1,0.325965506645741,0,178,ficolin-1-rich granule,CC,
18300,GO:0101003,1,0.69366836876801,0,55,ficolin-1-rich granule membrane,CC,
18301,GO:0101005,1,0.535869569890285,0,88,ubiquitinyl hydrolase activity,MF,
18302,GO:0101006,1,0.983014158758014,0,3,protein histidine phosphatase activity,MF,
18303,GO:0101020,1,0.98273595367857,0,3,estrogen 16-alpha-hydroxylase activity,MF,
18304,GO:0101023,1,0.907135202502598,0,14,vascular endothelial cell proliferation,BP,
18305,GO:0101030,1,0.994597262047273,0,1,tRNA-guanine transglycosylation,BP,
18306,GO:0101031,1,0.9284078434564,0,12,chaperone complex,CC,
18307,GO:0102005,1,0.994508387862055,0,1,2-octaprenyl-6-methoxy-1,4-benzoquinone methylase activity,MF,
18308,GO:0102007,1,0.983585881393274,0,3,acyl-L-homoserine-lactone lactonohydrolase activity,MF,
18309,GO:0102008,1,0.992700185587619,0,1,cytosolic dipeptidase activity,MF,
18310,GO:0102009,1,0.994309405476792,0,1,proline dipeptidase activity,MF,
18311,GO:0102076,1,0.993812902670023,0,1,beta,beta-carotene-9',10'-cleaving oxygenase activity,MF,
18312,GO:0102077,1,0.988480774171472,0,2,oleamide hydrolase activity,MF,
18313,GO:0102084,1,0.987864472745575,0,2,L-dopa O-methyltransferase activity,MF,
18314,GO:0102092,1,0.984975611485702,0,2,5-diphosphoinositol pentakisphosphate 3-kinase activity,MF,
18316,GO:0102113,1,0.991706498478991,0,1,hypoxia-inducible factor-asparagine oxygenase activity,MF,
18317,GO:0102121,1,0.981950093389202,0,3,ceramidase activity,MF,
18318,GO:0102131,1,0.9908871583736,0,1,3-oxo-glutaryl-[acp] methyl ester reductase activity,MF,
18319,GO:0102132,1,0.9908871583736,0,1,3-oxo-pimeloyl-[acp] methyl ester reductase activity,MF,
18320,GO:0102148,1,0.98256665723898,0,3,N-acetyl-beta-D-galactosaminidase activity,MF,
18321,GO:0102158,1,0.97562626446412,0,4,very-long-chain 3-hydroxyacyl-CoA dehydratase activity,MF,
18322,GO:0102166,1,0.992637874538034,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity,MF,
18323,GO:0102167,1,0.992637874538034,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity,MF,
18324,GO:0102200,1,0.992595961135538,0,1,N-acetylphosphatidylethanolamine-hydrolysing phospholipas activity,MF,
18325,GO:0102250,1,0.980602106576976,0,3,linear malto-oligosaccharide phosphorylase activity,MF,
18326,GO:0102279,1,0.992767148142801,0,1,lecithin:11-cis retinol acyltransferase activity,MF,
18327,GO:0102336,1,0.962660297739722,0,6,3-oxo-arachidoyl-CoA synthase activity,MF,
18328,GO:0102337,1,0.962660297739722,0,6,3-oxo-cerotoyl-CoA synthase activity,MF,
18329,GO:0102338,1,0.962660297739722,0,6,3-oxo-lignoceronyl-CoA synthase activity,MF,
18330,GO:0102339,1,0.993975388905689,0,1,3-oxo-arachidoyl-CoA reductase activity,MF,
18331,GO:0102340,1,0.993975388905689,0,1,3-oxo-behenoyl-CoA reductase activity,MF,
18332,GO:0102341,1,0.993975388905689,0,1,3-oxo-lignoceroyl-CoA reductase activity,MF,
18333,GO:0102342,1,0.993975388905689,0,1,3-oxo-cerotoyl-CoA reductase activity,MF,
18334,GO:0102343,1,0.97562626446412,0,4,3-hydroxy-arachidoyl-CoA dehydratase activity,MF,
18335,GO:0102344,1,0.97562626446412,0,4,3-hydroxy-behenoyl-CoA dehydratase activity,MF,
18336,GO:0102345,1,0.97562626446412,0,4,3-hydroxy-lignoceroyl-CoA dehydratase activity,MF,
18337,GO:0102389,1,0.993914642257477,0,1,polyprenol reductase activity,MF,
18338,GO:0102390,1,0.993923903660075,0,1,mycophenolic acid acyl-glucuronide esterase activity,MF,
18339,GO:0102391,1,0.955046732658453,0,7,decanoate-CoA ligase activity,MF,
18340,GO:0102420,1,0.985851915407785,0,2,sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity,MF,
18341,GO:0102483,1,0.994418208254504,0,1,scopolin beta-glucosidase activity,MF,
18342,GO:0102485,1,0.976976429953252,0,3,dATP phosphohydrolase activity,MF,
18343,GO:0102486,1,0.976976429953252,0,3,dCTP phosphohydrolase activity,MF,
18344,GO:0102487,1,0.976976429953252,0,3,dUTP phosphohydrolase activity,MF,
18345,GO:0102488,1,0.976976429953252,0,3,dTTP phosphohydrolase activity,MF,
18346,GO:0102489,1,0.976976429953252,0,3,GTP phosphohydrolase activity,MF,
18347,GO:0102490,1,0.976976429953252,0,3,8-oxo-dGTP phosphohydrolase activity,MF,
18348,GO:0102491,1,0.976976429953252,0,3,dGTP phosphohydrolase activity,MF,
18349,GO:0102499,1,0.980602106576976,0,3,SHG alpha-glucan phosphorylase activity,MF,
18350,GO:0102500,1,0.99155253960703,0,1,beta-maltose 4-alpha-glucanotransferase activity,MF,
18351,GO:0102521,1,0.993566575999109,0,1,tRNA-4-demethylwyosine synthase activity,MF,
18352,GO:0102522,1,0.994145094272314,0,1,tRNA 4-demethylwyosine alpha-amino-alpha-carboxypropyltransferase activity,MF,
18353,GO:0102524,1,0.993850639026861,0,1,tRNAPhe (7-(3-amino-3-carboxypropyl)wyosine37-C2)-hydroxylase activity,MF,
18354,GO:0102555,1,0.994794609784953,0,1,octanoyl transferase activity (acting on glycine-cleavage complex H protein),MF,
18355,GO:0102567,1,0.911451817686808,0,15,phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine),MF,
18356,GO:0102568,1,0.911451817686808,0,15,phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine),MF,
18357,GO:0102571,1,0.992637874538034,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity,MF,
18358,GO:0102704,1,0.993788278451954,0,1,GDP-Man:Man2GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase activity,MF,
18359,GO:0102707,1,0.993967662710193,0,1,S-adenosyl-L-methionine:beta-alanine N-methyltransferase activity,MF,
18360,GO:0102751,1,0.987949279993071,0,2,UDP-alpha-D-glucose:glucosyl-glycogenin alpha-D-glucosyltransferase activity,MF,
18361,GO:0102752,1,0.993683761241314,0,1,1,4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis),MF,
18362,GO:0102756,1,0.962660297739722,0,6,very-long-chain 3-ketoacyl-CoA synthase activity,MF,
18363,GO:0102758,1,0.994684058812469,0,1,very-long-chain enoyl-CoA reductase activity,MF,
18364,GO:0102769,1,0.994444824443174,0,1,dihydroceramide glucosyltransferase activity,MF,
18365,GO:0102773,1,0.992993493741932,0,1,dihydroceramide kinase activity,MF,
18366,GO:0102797,1,0.992727920890101,0,1,geranial:oxygen oxidoreductase activity,MF,
18367,GO:0102798,1,0.992727920890101,0,1,heptaldehyde:oxygen oxidoreductase activity,MF,
18368,GO:0102867,1,0.993875560209196,0,1,molybdenum cofactor sulfurtransferase activity,MF,
18369,GO:0102938,1,0.987864472745575,0,2,orcinol O-methyltransferase activity,MF,
18370,GO:0102953,1,0.982090602941592,0,3,hypoglycin A gamma-glutamyl transpeptidase activity,MF,
18371,GO:0102965,1,0.986806485843434,0,2,alcohol-forming fatty acyl-CoA reductase activity,MF,
18372,GO:0102991,1,0.965942923264942,0,6,myristoyl-CoA hydrolase activity,MF,
18373,GO:0103025,1,0.988638552446721,0,2,alpha-amylase activity (releasing maltohexaose),MF,
18374,GO:0103045,1,0.994217412712474,0,1,methione N-acyltransferase activity,MF,
18375,GO:0103046,1,0.992700185587619,0,1,alanylglutamate dipeptidase activity,MF,
18376,GO:0103053,1,0.988785175601925,0,2,1-ethyladenine demethylase activity,MF,
18377,GO:0103066,1,0.99446187876287,0,1,4alpha-carboxy-4beta-methyl-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-oxidoreductase (decarboxylating) activity,MF,
18378,GO:0103067,1,0.99446187876287,0,1,4alpha-carboxy-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-dehydrogenase (decarboxylating) activity,MF,
18379,GO:0103068,1,0.982090602941592,0,3,leukotriene C4 gamma-glutamyl transferase activity,MF,
18380,GO:0103073,1,0.988480774171472,0,2,anandamide amidohydrolase activity,MF,
18383,GO:0106001,1,0.961866139984668,0,6,intestinal hexose absorption,BP,
18384,GO:0106003,1,0.924749161241182,0,11,amyloid-beta complex,CC,
18385,GO:0106004,1,0.989035770444843,0,2,tRNA (guanine-N7)-methylation,BP,
18386,GO:0106005,1,0.992073716894608,0,1,RNA 5'-cap (guanine-N7)-methylation,BP,
18387,GO:0106014,1,0.988385097505537,0,2,regulation of inflammatory response to wounding,BP,
18388,GO:0106015,1,0.988385097505537,0,2,negative regulation of inflammatory response to wounding,BP,
18389,GO:0106017,1,0.972047952943415,0,4,phosphatidylinositol-3,4-bisphosphate phosphatase activity,MF,
18390,GO:0106018,1,0.895081112411287,0,15,phosphatidylinositol-3,5-bisphosphate phosphatase activity,MF,
18391,GO:0106019,1,0.931443489871321,0,10,phosphatidylinositol-4,5-bisphosphate phosphatase activity,MF,
18392,GO:0106020,1,0.987430513417716,0,2,regulation of vesicle docking,BP,
18393,GO:0106022,1,0.993269488397639,0,1,positive regulation of vesicle docking,BP,
18394,GO:0106027,1,0.608546875621056,0,69,neuron projection organization,BP,
18395,GO:0106028,1,0.992771592226114,0,1,neuron projection retraction,BP,
18397,GO:0106044,1,0.994806490833661,0,1,guanine deglycation,BP,
18398,GO:0106045,1,0.994806490833661,0,1,guanine deglycation, methylglyoxal removal,BP,
18399,GO:0106046,1,0.994806490833661,0,1,guanine deglycation, glyoxal removal,BP,
18400,GO:0106049,1,0.962976277291877,0,6,regulation of cellular response to osmotic stress,BP,
18401,GO:0106050,1,0.9942763258542,0,1,tRNA 2'-O-methyltransferase activity,MF,
18402,GO:0106056,1,0.892959324844547,0,16,regulation of calcineurin-mediated signaling,BP,
18403,GO:0106057,1,0.978591713774726,0,3,negative regulation of calcineurin-mediated signaling,BP,
18404,GO:0106058,1,0.940402088548008,0,9,positive regulation of calcineurin-mediated signaling,BP,
18405,GO:0106064,1,0.992302408598171,0,1,regulation of cobalamin metabolic process,BP,
18406,GO:0106068,1,0.963836288469551,0,6,SUMO ligase complex,CC,
18407,GO:0106070,1,0.93349521762448,0,10,regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,
18408,GO:0106071,1,0.965960914228354,0,5,positive regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,
18409,GO:0106072,1,0.955812592594751,0,7,negative regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,
18410,GO:0106073,1,0.983816848024132,0,2,dolichyl pyrophosphate Glc2Man9GlcNAc2 alpha-1,2-glucosyltransferase activity,MF,
18411,GO:0106074,1,0.931365862577429,0,11,aminoacyl-tRNA metabolism involved in translational fidelity,BP,
18412,GO:0106075,1,0.993676082593291,0,1,peptide N-succinyltransferase activity,MF,
18413,GO:0106077,1,0.974250215027553,0,4,histone succinylation,BP,
18414,GO:0106078,1,0.993676082593291,0,1,histone succinyltransferase activity,MF,
18415,GO:0106083,1,0.944631736623841,0,7,nuclear membrane protein complex,CC,
18416,GO:0106088,1,0.991727844330766,0,1,regulation of cell adhesion involved in sprouting angiogenesis,BP,
18417,GO:0106089,1,0.991727844330766,0,1,negative regulation of cell adhesion involved in sprouting angiogenesis,BP,
18418,GO:0106094,1,0.944631736623841,0,7,nuclear membrane microtubule tethering complex,CC,
18419,GO:0106101,1,0.994334991708616,0,1,ER-dependent peroxisome localization,BP,
18420,GO:0106104,1,0.977829788379347,0,3,regulation of glutamate receptor clustering,BP,
18421,GO:0110008,1,0.993713202678993,0,1,ncRNA deadenylation,BP,
18422,GO:0110009,1,0.978215190868673,0,3,formin-nucleated actin cable organization,BP,
18423,GO:0110011,1,0.960305493702139,0,5,regulation of basement membrane organization,BP,
18424,GO:0110017,1,0.989314290456522,0,2,cap-independent translational initiation of linear mRNA,BP,
18426,GO:0110021,1,0.98123166432342,0,3,cardiac muscle myoblast proliferation,BP,
18427,GO:0110022,1,0.98123166432342,0,3,regulation of cardiac muscle myoblast proliferation,BP,
18428,GO:0110024,1,0.98123166432342,0,3,positive regulation of cardiac muscle myoblast proliferation,BP,
18429,GO:0110025,1,0.99371089814647,0,1,DNA strand resection involved in replication fork processing,BP,
18430,GO:0110026,1,0.99371089814647,0,1,regulation of DNA strand resection involved in replication fork processing,BP,
18431,GO:0110028,1,0.991555657821302,0,1,positive regulation of mitotic spindle organization,BP,
18432,GO:0110029,1,0.993660215276567,0,1,negative regulation of meiosis I,BP,
18434,GO:0110057,1,0.992452326742341,0,1,regulation of blood vessel endothelial cell differentiation,BP,
18435,GO:0110059,1,0.992452326742341,0,1,negative regulation of blood vessel endothelial cell differentiation,BP,
18436,GO:0110075,1,0.994802874872577,0,1,regulation of ferroptosis,BP,
18437,GO:0110076,1,0.994802874872577,0,1,negative regulation of ferroptosis,BP,
18438,GO:0110095,1,0.98349002515644,0,3,cellular detoxification of aldehyde,BP,
18439,GO:0110096,1,0.972415360294585,0,5,cellular response to aldehyde,BP,
18440,GO:0120009,1,0.968997008875523,0,5,intermembrane lipid transfer,BP,
18441,GO:0120012,1,0.992494270918822,0,1,intermembrane sphingolipid transfer,BP,
18442,GO:0120013,1,0.968997008875523,0,5,intermembrane lipid transfer activity,MF,
18443,GO:0120016,1,0.992494270918822,0,1,intermembrane sphingolipid transfer activity,MF,
18444,GO:0120017,1,0.992494270918822,0,1,intermembrane ceramide transfer activity,MF,
18447,GO:0120032,1,0.385744938401768,0,141,regulation of plasma membrane bounded cell projection assembly,BP,
18448,GO:0120033,1,0.881335587766979,0,20,negative regulation of plasma membrane bounded cell projection assembly,BP,
18449,GO:0120034,1,0.577835774358758,0,81,positive regulation of plasma membrane bounded cell projection assembly,BP,
18454,GO:0120043,1,0.992839773915386,0,1,stereocilium shaft,CC,
18455,GO:0120044,1,0.992839773915386,0,1,stereocilium base,CC,
18456,GO:0120048,1,0.993850639026861,0,1,U6 snRNA (adenine-(43)-N(6))-methyltransferase activity,MF,
18457,GO:0120049,1,0.993850639026861,0,1,snRNA (adenine-N6)-methylation,BP,
18458,GO:0120054,1,0.994920131708846,0,1,intestinal motility,BP,
18459,GO:0120055,1,0.994920131708846,0,1,small intestinal transit,BP,
18460,GO:0120057,1,0.994920131708846,0,1,regulation of small intestinal transit,BP,
18461,GO:0120058,1,0.994920131708846,0,1,positive regulation of small intestinal transit,BP,
18462,GO:0120060,1,0.99486796096715,0,1,regulation of gastric emptying,BP,
18463,GO:0120061,1,0.99486796096715,0,1,negative regulation of gastric emptying,BP,
18464,GO:0120063,1,0.987516656586615,0,2,stomach smooth muscle contraction,BP,
18465,GO:0120064,1,0.992611156593489,0,1,stomach pylorus smooth muscle contraction,BP,
18466,GO:0120065,1,0.992611156593489,0,1,pyloric antrum smooth muscle contraction,BP,
18467,GO:0120068,1,0.99486796096715,0,1,regulation of stomach fundus smooth muscle contraction,BP,
18468,GO:0120069,1,0.99486796096715,0,1,positive regulation of stomach fundus smooth muscle contraction,BP,
18469,GO:0120071,1,0.992611156593489,0,1,regulation of pyloric antrum smooth muscle contraction,BP,
18470,GO:0120072,1,0.992611156593489,0,1,positive regulation of pyloric antrum smooth muscle contraction,BP,
18471,GO:0120077,1,0.991727844330766,0,1,angiogenic sprout fusion,BP,
18472,GO:0120078,1,0.991727844330766,0,1,cell adhesion involved in sprouting angiogenesis,BP,
18473,GO:0120092,1,0.993553272776423,0,1,crotonyl-CoA hydratase activity,MF,
18474,GO:0120093,1,0.993553272776423,0,1,regulation of peptidyl-lysine crotonylation,BP,
18475,GO:0120094,1,0.993553272776423,0,1,negative regulation of peptidyl-lysine crotonylation,BP,
18476,GO:0120103,1,0.939799495430581,0,9,centriolar subdistal appendage,CC,
18477,GO:0120108,1,0.994244283305648,0,1,DNA-3'-diphospho-5'-guanosine diphosphatase,MF,
18478,GO:0120111,1,0.636343778369877,0,67,neuron projection cytoplasm,CC,
18480,GO:0140007,1,0.976484133891733,0,4,KICSTOR complex,CC,
18481,GO:0140009,1,0.986814934390918,0,2,L-aspartate import across plasma membrane,BP,
18484,GO:0140029,1,0.613630400999858,0,76,exocytic process,BP,
18485,GO:0140030,1,0.458567940026883,0,113,modification-dependent protein binding,MF,
18486,GO:0140031,1,0.987866049070081,0,2,phosphorylation-dependent protein binding,MF,
18487,GO:0140033,1,0.87898127978105,0,17,acetylation-dependent protein binding,MF,
18488,GO:0140034,1,0.679817434255681,0,56,methylation-dependent protein binding,MF,
18489,GO:0140035,1,0.966058893290434,0,5,ubiquitination-like modification-dependent protein binding,MF,
18490,GO:0140036,1,0.966058893290434,0,5,ubiquitin-dependent protein binding,MF,
18491,GO:0140041,1,0.994806490833661,0,1,cellular detoxification of methylglyoxal,BP,
18492,GO:0140049,1,0.994430353677249,0,1,regulation of endocardial cushion to mesenchymal transition,BP,
18493,GO:0140051,1,0.994430353677249,0,1,positive regulation of endocardial cushion to mesenchymal transition,BP,
18494,GO:0140052,1,0.967054516262036,0,5,cellular response to oxidised low-density lipoprotein particle stimulus,BP,
18495,GO:0140053,1,0.414111134982716,0,151,mitochondrial gene expression,BP,
18497,GO:0140058,1,0.88571265651209,0,16,neuron projection arborization,BP,
18498,GO:0140059,1,0.967495374148016,0,5,dendrite arborization,BP,
18499,GO:0140064,1,0.990737145415483,0,1,peptide crotonyltransferase activity,MF,
18500,GO:0140065,1,0.990737145415483,0,1,peptide butyryltransferase activity,MF,
18501,GO:0140066,1,0.984349535386613,0,2,peptidyl-lysine crotonylation,BP,
18502,GO:0140067,1,0.990737145415483,0,1,peptidyl-lysine butyrylation,BP,
18503,GO:0140068,1,0.990737145415483,0,1,histone crotonyltransferase activity,MF,
18504,GO:0140069,1,0.990737145415483,0,1,histone butyryltransferase activity,MF,
18505,GO:0140074,1,0.992610108694485,0,1,cardiac endothelial to mesenchymal transition,BP,
18506,GO:0140078,1,0.94392477581911,0,10,class I DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,
18507,GO:0140080,1,0.94392477581911,0,10,class III/IV DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,
18510,GO:0140098,1,0.117979272113897,0,338,catalytic activity, acting on RNA,MF,
18511,GO:0140101,1,0.494055808620121,0,115,catalytic activity, acting on a tRNA,MF,
18512,GO:0140102,1,0.913497367061903,0,15,catalytic activity, acting on a rRNA,MF,
18513,GO:0140103,1,0.880831396652186,0,20,catalytic activity, acting on a glycoprotein,MF,
18516,GO:0140112,1,0.884035908768917,0,20,extracellular vesicle biogenesis,BP,
18518,GO:0140131,1,0.929914736514426,0,12,positive regulation of lymphocyte chemotaxis,BP,
18519,GO:0140135,1,0.974773059740642,0,4,mechanosensitive cation channel activity,MF,
18520,GO:0140142,1,0.883842165987055,0,18,nucleocytoplasmic carrier activity,MF,
18521,GO:0140161,1,0.953571764791808,0,8,monocarboxylate:sodium symporter activity,MF,
18522,GO:0140192,1,0.982374302580205,0,2,regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
18523,GO:0140193,1,0.99459157858605,0,1,regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,
18524,GO:0140194,1,0.99459157858605,0,1,negative regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,
18525,GO:0140196,1,0.991583726537015,0,1,positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
18526,GO:0140199,1,0.990713196986705,0,1,negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
18527,GO:0140200,1,0.991075666620809,0,1,adenylate cyclase-activating adrenergic receptor signaling pathway involved in regulation of heart rate,BP,
18528,GO:0150003,1,0.971401168769767,0,4,regulation of spontaneous synaptic transmission,BP,
18529,GO:0150005,1,0.933409154674394,0,11,enzyme activator complex,CC,
18530,GO:0150011,1,0.950910781646778,0,7,regulation of neuron projection arborization,BP,
18531,GO:0150012,1,0.950910781646778,0,7,positive regulation of neuron projection arborization,BP,
18532,GO:0150018,1,0.979328489571363,0,3,basal dendrite development,BP,
18533,GO:0150019,1,0.979328489571363,0,3,basal dendrite morphogenesis,BP,
18534,GO:0150020,1,0.979328489571363,0,3,basal dendrite arborization,BP,
18535,GO:0150024,1,0.994217929414997,0,1,oxidised low-density lipoprotein particle clearance,BP,
18536,GO:0150025,1,0.994217929414997,0,1,oxidised low-density lipoprotein particle receptor activity,MF,
18537,GO:0150031,1,0.991959324395744,0,1,regulation of protein localization to lysosome,BP,
18538,GO:0150033,1,0.991959324395744,0,1,negative regulation of protein localization to lysosome,BP,
18541,GO:1900003,1,0.964539461749295,0,6,regulation of serine-type endopeptidase activity,BP,
18542,GO:1900004,1,0.964539461749295,0,6,negative regulation of serine-type endopeptidase activity,BP,
18543,GO:1900005,1,0.990458391802756,0,1,positive regulation of serine-type endopeptidase activity,BP,
18545,GO:1900010,1,0.994338351542684,0,1,regulation of corticotropin-releasing hormone receptor activity,BP,
18546,GO:1900011,1,0.994338351542684,0,1,negative regulation of corticotropin-releasing hormone receptor activity,BP,
18547,GO:1900015,1,0.841101778474706,0,27,regulation of cytokine production involved in inflammatory response,BP,
18548,GO:1900016,1,0.945309438883137,0,9,negative regulation of cytokine production involved in inflammatory response,BP,
18549,GO:1900017,1,0.920750808437294,0,13,positive regulation of cytokine production involved in inflammatory response,BP,
18550,GO:1900019,1,0.973526458409486,0,4,regulation of protein kinase C activity,BP,
18551,GO:1900020,1,0.973526458409486,0,4,positive regulation of protein kinase C activity,BP,
18552,GO:1900024,1,0.749656310388117,0,44,regulation of substrate adhesion-dependent cell spreading,BP,
18553,GO:1900025,1,0.92514174315282,0,12,negative regulation of substrate adhesion-dependent cell spreading,BP,
18554,GO:1900026,1,0.816161331128333,0,31,positive regulation of substrate adhesion-dependent cell spreading,BP,
18555,GO:1900027,1,0.860436014981701,0,24,regulation of ruffle assembly,BP,
18556,GO:1900028,1,0.970321979083394,0,5,negative regulation of ruffle assembly,BP,
18557,GO:1900029,1,0.932570392814841,0,11,positive regulation of ruffle assembly,BP,
18559,GO:1900035,1,0.993885584402155,0,1,negative regulation of cellular response to heat,BP,
18560,GO:1900036,1,0.994081600272742,0,1,positive regulation of cellular response to heat,BP,
18561,GO:1900037,1,0.928932159565614,0,12,regulation of cellular response to hypoxia,BP,
18562,GO:1900038,1,0.957378687233809,0,7,negative regulation of cellular response to hypoxia,BP,
18563,GO:1900039,1,0.988250871786128,0,2,positive regulation of cellular response to hypoxia,BP,
18564,GO:1900040,1,0.95259390780801,0,7,regulation of interleukin-2 secretion,BP,
18565,GO:1900041,1,0.975251293155695,0,4,negative regulation of interleukin-2 secretion,BP,
18566,GO:1900042,1,0.976773453191439,0,3,positive regulation of interleukin-2 secretion,BP,
18567,GO:1900044,1,0.935824915255092,0,9,regulation of protein K63-linked ubiquitination,BP,
18568,GO:1900045,1,0.963132802895063,0,5,negative regulation of protein K63-linked ubiquitination,BP,
18571,GO:1900048,1,0.865859338666858,0,23,positive regulation of hemostasis,BP,
18572,GO:1900052,1,0.994655127578734,0,1,regulation of retinoic acid biosynthetic process,BP,
18573,GO:1900053,1,0.994655127578734,0,1,negative regulation of retinoic acid biosynthetic process,BP,
18574,GO:1900060,1,0.975857209846184,0,4,negative regulation of ceramide biosynthetic process,BP,
18575,GO:1900062,1,0.993373508395355,0,1,regulation of replicative cell aging,BP,
18576,GO:1900063,1,0.976584801467779,0,3,regulation of peroxisome organization,BP,
18577,GO:1900076,1,0.643232747220243,0,66,regulation of cellular response to insulin stimulus,BP,
18578,GO:1900077,1,0.805722634144388,0,33,negative regulation of cellular response to insulin stimulus,BP,
18579,GO:1900078,1,0.833388085196354,0,26,positive regulation of cellular response to insulin stimulus,BP,
18580,GO:1900081,1,0.990713196986705,0,1,regulation of arginine catabolic process,BP,
18581,GO:1900082,1,0.990713196986705,0,1,negative regulation of arginine catabolic process,BP,
18582,GO:1900084,1,0.959029551326437,0,6,regulation of peptidyl-tyrosine autophosphorylation,BP,
18583,GO:1900085,1,0.993908726252119,0,1,negative regulation of peptidyl-tyrosine autophosphorylation,BP,
18584,GO:1900086,1,0.964909191803039,0,5,positive regulation of peptidyl-tyrosine autophosphorylation,BP,
18585,GO:1900087,1,0.836492328940292,0,27,positive regulation of G1/S transition of mitotic cell cycle,BP,
18586,GO:1900094,1,0.956961320762967,0,7,regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry,BP,
18587,GO:1900095,1,0.989809789584226,0,1,regulation of dosage compensation by inactivation of X chromosome,BP,
18588,GO:1900098,1,0.994355150667844,0,1,regulation of plasma cell differentiation,BP,
18589,GO:1900100,1,0.994355150667844,0,1,positive regulation of plasma cell differentiation,BP,
18590,GO:1900101,1,0.853238870061766,0,25,regulation of endoplasmic reticulum unfolded protein response,BP,
18591,GO:1900102,1,0.932799076073264,0,11,negative regulation of endoplasmic reticulum unfolded protein response,BP,
18592,GO:1900103,1,0.919015074454037,0,13,positive regulation of endoplasmic reticulum unfolded protein response,BP,
18593,GO:1900104,1,0.981487606881003,0,3,regulation of hyaluranon cable assembly,BP,
18594,GO:1900106,1,0.981487606881003,0,3,positive regulation of hyaluranon cable assembly,BP,
18595,GO:1900107,1,0.956370184209429,0,7,regulation of nodal signaling pathway,BP,
18596,GO:1900108,1,0.98293196009982,0,3,negative regulation of nodal signaling pathway,BP,
18597,GO:1900109,1,0.983152389692153,0,3,regulation of histone H3-K9 dimethylation,BP,
18598,GO:1900110,1,0.98908642610189,0,2,negative regulation of histone H3-K9 dimethylation,BP,
18599,GO:1900111,1,0.994001150992829,0,1,positive regulation of histone H3-K9 dimethylation,BP,
18600,GO:1900112,1,0.938748364609724,0,9,regulation of histone H3-K9 trimethylation,BP,
18601,GO:1900113,1,0.968818612900186,0,5,negative regulation of histone H3-K9 trimethylation,BP,
18602,GO:1900114,1,0.985269815404757,0,2,positive regulation of histone H3-K9 trimethylation,BP,
18603,GO:1900115,1,0.905176847572107,0,15,extracellular regulation of signal transduction,BP,
18604,GO:1900116,1,0.905176847572107,0,15,extracellular negative regulation of signal transduction,BP,
18605,GO:1900117,1,0.875099782428668,0,21,regulation of execution phase of apoptosis,BP,
18606,GO:1900118,1,0.956201683762682,0,7,negative regulation of execution phase of apoptosis,BP,
18607,GO:1900119,1,0.928397358315219,0,12,positive regulation of execution phase of apoptosis,BP,
18608,GO:1900120,1,0.882098710518842,0,20,regulation of receptor binding,BP,
18609,GO:1900121,1,0.933738946618878,0,11,negative regulation of receptor binding,BP,
18610,GO:1900122,1,0.950945650243087,0,8,positive regulation of receptor binding,BP,
18611,GO:1900125,1,0.952786767888154,0,7,regulation of hyaluronan biosynthetic process,BP,
18612,GO:1900126,1,0.978625880049143,0,3,negative regulation of hyaluronan biosynthetic process,BP,
18613,GO:1900127,1,0.973602220297419,0,4,positive regulation of hyaluronan biosynthetic process,BP,
18614,GO:1900130,1,0.993424517206004,0,1,regulation of lipid binding,BP,
18615,GO:1900131,1,0.993424517206004,0,1,negative regulation of lipid binding,BP,
18616,GO:1900133,1,0.981100397036646,0,3,regulation of renin secretion into blood stream,BP,
18617,GO:1900134,1,0.993327316611908,0,1,negative regulation of renin secretion into blood stream,BP,
18618,GO:1900135,1,0.987691773326566,0,2,positive regulation of renin secretion into blood stream,BP,
18619,GO:1900138,1,0.98728703931272,0,2,negative regulation of phospholipase A2 activity,BP,
18620,GO:1900139,1,0.992686052058233,0,1,negative regulation of arachidonic acid secretion,BP,
18621,GO:1900141,1,0.993993421089467,0,1,regulation of oligodendrocyte apoptotic process,BP,
18622,GO:1900142,1,0.993993421089467,0,1,negative regulation of oligodendrocyte apoptotic process,BP,
18623,GO:1900145,1,0.968039876349182,0,5,regulation of nodal signaling pathway involved in determination of left/right asymmetry,BP,
18624,GO:1900146,1,0.989093349785128,0,2,negative regulation of nodal signaling pathway involved in determination of left/right asymmetry,BP,
18625,GO:1900147,1,0.985448406373991,0,2,regulation of Schwann cell migration,BP,
18626,GO:1900148,1,0.993850639026861,0,1,negative regulation of Schwann cell migration,BP,
18627,GO:1900149,1,0.991546303497539,0,1,positive regulation of Schwann cell migration,BP,
18628,GO:1900150,1,0.988350028894366,0,2,regulation of defense response to fungus,BP,
18629,GO:1900151,1,0.894492367377188,0,16,regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
18630,GO:1900152,1,0.994347655690543,0,1,negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
18631,GO:1900153,1,0.894492367377188,0,16,positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
18632,GO:1900154,1,0.987611558720063,0,2,regulation of bone trabecula formation,BP,
18633,GO:1900155,1,0.987611558720063,0,2,negative regulation of bone trabecula formation,BP,
18634,GO:1900157,1,0.987263145370469,0,2,regulation of bone mineralization involved in bone maturation,BP,
18635,GO:1900158,1,0.993159917296035,0,1,negative regulation of bone mineralization involved in bone maturation,BP,
18636,GO:1900159,1,0.994063026317346,0,1,positive regulation of bone mineralization involved in bone maturation,BP,
18637,GO:1900161,1,0.993847557092416,0,1,regulation of phospholipid scramblase activity,BP,
18638,GO:1900163,1,0.993847557092416,0,1,positive regulation of phospholipid scramblase activity,BP,
18639,GO:1900164,1,0.956961320762967,0,7,nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
18640,GO:1900165,1,0.955917502672506,0,7,negative regulation of interleukin-6 secretion,BP,
18641,GO:1900166,1,0.987838595453272,0,2,regulation of glial cell-derived neurotrophic factor secretion,BP,
18642,GO:1900168,1,0.987838595453272,0,2,positive regulation of glial cell-derived neurotrophic factor secretion,BP,
18643,GO:1900169,1,0.982350915449573,0,2,regulation of glucocorticoid mediated signaling pathway,BP,
18644,GO:1900170,1,0.993850639026861,0,1,negative regulation of glucocorticoid mediated signaling pathway,BP,
18645,GO:1900175,1,0.968039876349182,0,5,regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
18646,GO:1900176,1,0.989093349785128,0,2,negative regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
18648,GO:1900181,1,0.869453094912184,0,21,negative regulation of protein localization to nucleus,BP,
18650,GO:1900186,1,0.980733978008011,0,3,negative regulation of clathrin-dependent endocytosis,BP,
18651,GO:1900190,1,0.994063026317346,0,1,regulation of single-species biofilm formation,BP,
18652,GO:1900191,1,0.994063026317346,0,1,negative regulation of single-species biofilm formation,BP,
18653,GO:1900193,1,0.959335651778281,0,7,regulation of oocyte maturation,BP,
18654,GO:1900194,1,0.982412588486848,0,3,negative regulation of oocyte maturation,BP,
18655,GO:1900195,1,0.988448952025192,0,2,positive regulation of oocyte maturation,BP,
18656,GO:1900200,1,0.986508997543432,0,2,mesenchymal cell apoptotic process involved in metanephros development,BP,
18657,GO:1900204,1,0.986508997543432,0,2,apoptotic process involved in metanephric collecting duct development,BP,
18658,GO:1900205,1,0.986508997543432,0,2,apoptotic process involved in metanephric nephron tubule development,BP,
18659,GO:1900208,1,0.988983866856904,0,2,regulation of cardiolipin metabolic process,BP,
18660,GO:1900210,1,0.988983866856904,0,2,positive regulation of cardiolipin metabolic process,BP,
18661,GO:1900211,1,0.986508997543432,0,2,regulation of mesenchymal cell apoptotic process involved in metanephros development,BP,
18662,GO:1900212,1,0.986508997543432,0,2,negative regulation of mesenchymal cell apoptotic process involved in metanephros development,BP,
18663,GO:1900214,1,0.986508997543432,0,2,regulation of apoptotic process involved in metanephric collecting duct development,BP,
18664,GO:1900215,1,0.986508997543432,0,2,negative regulation of apoptotic process involved in metanephric collecting duct development,BP,
18665,GO:1900217,1,0.986508997543432,0,2,regulation of apoptotic process involved in metanephric nephron tubule development,BP,
18666,GO:1900218,1,0.986508997543432,0,2,negative regulation of apoptotic process involved in metanephric nephron tubule development,BP,
18667,GO:1900220,1,0.984539618280162,0,2,semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis,BP,
18668,GO:1900221,1,0.927311643650281,0,10,regulation of amyloid-beta clearance,BP,
18669,GO:1900222,1,0.979436276107937,0,3,negative regulation of amyloid-beta clearance,BP,
18670,GO:1900223,1,0.952487635502995,0,6,positive regulation of amyloid-beta clearance,BP,
18671,GO:1900224,1,0.984154724505831,0,2,positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
18672,GO:1900225,1,0.928955781659941,0,11,regulation of NLRP3 inflammasome complex assembly,BP,
18673,GO:1900226,1,0.973839960622024,0,4,negative regulation of NLRP3 inflammasome complex assembly,BP,
18674,GO:1900227,1,0.959788936776583,0,6,positive regulation of NLRP3 inflammasome complex assembly,BP,
18675,GO:1900228,1,0.994063026317346,0,1,regulation of single-species biofilm formation in or on host organism,BP,
18676,GO:1900229,1,0.994063026317346,0,1,negative regulation of single-species biofilm formation in or on host organism,BP,
18677,GO:1900238,1,0.980115038480902,0,3,regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,
18678,GO:1900239,1,0.971528052622826,0,4,regulation of phenotypic switching,BP,
18679,GO:1900241,1,0.993802384256541,0,1,positive regulation of phenotypic switching,BP,
18680,GO:1900242,1,0.941153747840353,0,8,regulation of synaptic vesicle endocytosis,BP,
18681,GO:1900243,1,0.992577619341872,0,1,negative regulation of synaptic vesicle endocytosis,BP,
18682,GO:1900244,1,0.970703572526673,0,4,positive regulation of synaptic vesicle endocytosis,BP,
18683,GO:1900245,1,0.97685073747651,0,3,positive regulation of MDA-5 signaling pathway,BP,
18684,GO:1900246,1,0.961876631509259,0,5,positive regulation of RIG-I signaling pathway,BP,
18685,GO:1900247,1,0.937474686481404,0,10,regulation of cytoplasmic translational elongation,BP,
18686,GO:1900248,1,0.984722528182355,0,2,negative regulation of cytoplasmic translational elongation,BP,
18687,GO:1900259,1,0.994309922363705,0,1,regulation of RNA-directed 5'-3' RNA polymerase activity,BP,
18688,GO:1900260,1,0.994309922363705,0,1,negative regulation of RNA-directed 5'-3' RNA polymerase activity,BP,
18689,GO:1900262,1,0.965728044361992,0,6,regulation of DNA-directed DNA polymerase activity,BP,
18690,GO:1900264,1,0.965728044361992,0,6,positive regulation of DNA-directed DNA polymerase activity,BP,
18691,GO:1900271,1,0.79860669015557,0,31,regulation of long-term synaptic potentiation,BP,
18692,GO:1900272,1,0.946027578455683,0,8,negative regulation of long-term synaptic potentiation,BP,
18693,GO:1900273,1,0.884395896707106,0,16,positive regulation of long-term synaptic potentiation,BP,
18695,GO:1900275,1,0.98593702650762,0,2,negative regulation of phospholipase C activity,BP,
18696,GO:1900276,1,0.993514637734672,0,1,regulation of proteinase activated receptor activity,BP,
18697,GO:1900279,1,0.993489301443189,0,1,regulation of CD4-positive, alpha-beta T cell costimulation,BP,
18698,GO:1900281,1,0.993489301443189,0,1,positive regulation of CD4-positive, alpha-beta T cell costimulation,BP,
18699,GO:1900363,1,0.924476400946437,0,12,regulation of mRNA polyadenylation,BP,
18700,GO:1900364,1,0.94900838727608,0,8,negative regulation of mRNA polyadenylation,BP,
18701,GO:1900365,1,0.979592118055826,0,3,positive regulation of mRNA polyadenylation,BP,
18702,GO:1900368,1,0.977791271488544,0,3,regulation of RNA interference,BP,
18703,GO:1900369,1,0.985178079571157,0,2,negative regulation of RNA interference,BP,
18704,GO:1900370,1,0.99250318369924,0,1,positive regulation of RNA interference,BP,
18705,GO:1900371,1,0.433685880391491,0,127,regulation of purine nucleotide biosynthetic process,BP,
18706,GO:1900372,1,0.794301087364118,0,35,negative regulation of purine nucleotide biosynthetic process,BP,
18707,GO:1900373,1,0.698910548984307,0,56,positive regulation of purine nucleotide biosynthetic process,BP,
18708,GO:1900376,1,0.948896631149441,0,7,regulation of secondary metabolite biosynthetic process,BP,
18709,GO:1900377,1,0.98407864119253,0,2,negative regulation of secondary metabolite biosynthetic process,BP,
18710,GO:1900378,1,0.964254467977671,0,5,positive regulation of secondary metabolite biosynthetic process,BP,
18711,GO:1900383,1,0.993604949601281,0,1,regulation of synaptic plasticity by receptor localization to synapse,BP,
18712,GO:1900387,1,0.994205529033535,0,1,negative regulation of cell-cell adhesion by negative regulation of transcription from RNA polymerase II promoter,BP,
18714,GO:1900402,1,0.941639129761967,0,8,regulation of carbohydrate metabolic process by regulation of transcription from RNA polymerase II promoter,BP,
18715,GO:1900407,1,0.655580222334623,0,66,regulation of cellular response to oxidative stress,BP,
18716,GO:1900408,1,0.779002625396883,0,39,negative regulation of cellular response to oxidative stress,BP,
18717,GO:1900409,1,0.908653580160549,0,15,positive regulation of cellular response to oxidative stress,BP,
18718,GO:1900424,1,0.925758512180766,0,12,regulation of defense response to bacterium,BP,
18719,GO:1900425,1,0.967970102049533,0,5,negative regulation of defense response to bacterium,BP,
18720,GO:1900426,1,0.964178918432753,0,6,positive regulation of defense response to bacterium,BP,
18721,GO:1900449,1,0.747088544930888,0,42,regulation of glutamate receptor signaling pathway,BP,
18722,GO:1900450,1,0.992771592226114,0,1,negative regulation of glutamate receptor signaling pathway,BP,
18723,GO:1900451,1,0.935357663664451,0,9,positive regulation of glutamate receptor signaling pathway,BP,
18724,GO:1900452,1,0.918627973366462,0,12,regulation of long term synaptic depression,BP,
18725,GO:1900453,1,0.981564059983536,0,3,negative regulation of long term synaptic depression,BP,
18726,GO:1900454,1,0.965501989424904,0,5,positive regulation of long term synaptic depression,BP,
18727,GO:1900477,1,0.994214829225251,0,1,negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter,BP,
18728,GO:1900533,1,0.994497794456455,0,1,palmitic acid metabolic process,BP,
18729,GO:1900535,1,0.994497794456455,0,1,palmitic acid biosynthetic process,BP,
18731,GO:1900543,1,0.746374296239812,0,45,negative regulation of purine nucleotide metabolic process,BP,
18733,GO:1900558,1,0.994269865341732,0,1,austinol metabolic process,BP,
18734,GO:1900560,1,0.994269865341732,0,1,austinol biosynthetic process,BP,
18735,GO:1900561,1,0.994269865341732,0,1,dehydroaustinol metabolic process,BP,
18736,GO:1900563,1,0.994269865341732,0,1,dehydroaustinol biosynthetic process,BP,
18737,GO:1900619,1,0.981720673652404,0,3,acetate ester metabolic process,BP,
18738,GO:1900620,1,0.993921330858198,0,1,acetate ester biosynthetic process,BP,
18739,GO:1900623,1,0.979004809576953,0,3,regulation of monocyte aggregation,BP,
18740,GO:1900625,1,0.979004809576953,0,3,positive regulation of monocyte aggregation,BP,
18741,GO:1900673,1,0.981288814753747,0,3,olefin metabolic process,BP,
18742,GO:1900719,1,0.992701755809941,0,1,regulation of uterine smooth muscle relaxation,BP,
18743,GO:1900721,1,0.992701755809941,0,1,positive regulation of uterine smooth muscle relaxation,BP,
18744,GO:1900736,1,0.977507910010327,0,4,regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
18745,GO:1900737,1,0.993514637734672,0,1,negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
18746,GO:1900738,1,0.983889836173196,0,3,positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
18747,GO:1900739,1,0.832138887764913,0,30,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,
18748,GO:1900740,1,0.832138887764913,0,30,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,
18749,GO:1900744,1,0.816361814126554,0,31,regulation of p38MAPK cascade,BP,
18750,GO:1900745,1,0.873497048293306,0,21,positive regulation of p38MAPK cascade,BP,
18751,GO:1900746,1,0.933408422390205,0,10,regulation of vascular endothelial growth factor signaling pathway,BP,
18752,GO:1900747,1,0.979940969106297,0,3,negative regulation of vascular endothelial growth factor signaling pathway,BP,
18753,GO:1900748,1,0.968945325876994,0,4,positive regulation of vascular endothelial growth factor signaling pathway,BP,
18754,GO:1900750,1,0.932674531806479,0,12,oligopeptide binding,MF,
18755,GO:1900753,1,0.993042330895871,0,1,doxorubicin transport,BP,
18756,GO:1900756,1,0.985309272745405,0,2,protein processing in phagocytic vesicle,BP,
18757,GO:1900825,1,0.978156827801089,0,3,regulation of membrane depolarization during cardiac muscle cell action potential,BP,
18758,GO:1900827,1,0.990140555769818,0,1,positive regulation of membrane depolarization during cardiac muscle cell action potential,BP,
18759,GO:1900864,1,0.947655773630944,0,9,mitochondrial RNA modification,BP,
18760,GO:1901004,1,0.994630845244039,0,1,ubiquinone-6 metabolic process,BP,
18761,GO:1901006,1,0.994630845244039,0,1,ubiquinone-6 biosynthetic process,BP,
18762,GO:1901016,1,0.712072720595781,0,49,regulation of potassium ion transmembrane transporter activity,BP,
18763,GO:1901017,1,0.903215282146949,0,15,negative regulation of potassium ion transmembrane transporter activity,BP,
18764,GO:1901018,1,0.855772815507423,0,22,positive regulation of potassium ion transmembrane transporter activity,BP,
18766,GO:1901020,1,0.826527174198863,0,31,negative regulation of calcium ion transmembrane transporter activity,BP,
18768,GO:1901026,1,0.977652890275783,0,3,ripoptosome assembly involved in necroptotic process,BP,
18769,GO:1901028,1,0.755553223275066,0,46,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,
18770,GO:1901029,1,0.954592731481927,0,8,negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,
18771,GO:1901030,1,0.79609254822755,0,37,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,
18772,GO:1901031,1,0.801420031417075,0,35,regulation of response to reactive oxygen species,BP,
18773,GO:1901032,1,0.897045177620514,0,17,negative regulation of response to reactive oxygen species,BP,
18774,GO:1901033,1,0.95150422226474,0,8,positive regulation of response to reactive oxygen species,BP,
18775,GO:1901052,1,0.993580646328245,0,1,sarcosine metabolic process,BP,
18776,GO:1901053,1,0.993580646328245,0,1,sarcosine catabolic process,BP,
18777,GO:1901068,1,0.725280172198048,0,50,guanosine-containing compound metabolic process,BP,
18778,GO:1901069,1,0.994556443430817,0,1,guanosine-containing compound catabolic process,BP,
18779,GO:1901070,1,0.925618055132452,0,14,guanosine-containing compound biosynthetic process,BP,
18780,GO:1901071,1,0.870407918833197,0,22,glucosamine-containing compound metabolic process,BP,
18781,GO:1901072,1,0.948260850753329,0,9,glucosamine-containing compound catabolic process,BP,
18782,GO:1901073,1,0.985932487875949,0,2,glucosamine-containing compound biosynthetic process,BP,
18783,GO:1901074,1,0.985686819911754,0,2,regulation of engulfment of apoptotic cell,BP,
18784,GO:1901076,1,0.991735655035025,0,1,positive regulation of engulfment of apoptotic cell,BP,
18785,GO:1901077,1,0.932057535449196,0,11,regulation of relaxation of muscle,BP,
18786,GO:1901078,1,0.978940675260665,0,3,negative regulation of relaxation of muscle,BP,
18787,GO:1901079,1,0.981109799879843,0,3,positive regulation of relaxation of muscle,BP,
18788,GO:1901080,1,0.992701755809941,0,1,regulation of relaxation of smooth muscle,BP,
18789,GO:1901082,1,0.992701755809941,0,1,positive regulation of relaxation of smooth muscle,BP,
18790,GO:1901086,1,0.992666679637346,0,1,benzylpenicillin metabolic process,BP,
18791,GO:1901090,1,0.987975663215547,0,2,regulation of protein tetramerization,BP,
18792,GO:1901091,1,0.987975663215547,0,2,negative regulation of protein tetramerization,BP,
18793,GO:1901093,1,0.987975663215547,0,2,regulation of protein homotetramerization,BP,
18794,GO:1901094,1,0.987975663215547,0,2,negative regulation of protein homotetramerization,BP,
18795,GO:1901096,1,0.936872179190622,0,9,regulation of autophagosome maturation,BP,
18796,GO:1901097,1,0.97956244603722,0,3,negative regulation of autophagosome maturation,BP,
18797,GO:1901098,1,0.954873693770908,0,6,positive regulation of autophagosome maturation,BP,
18798,GO:1901099,1,0.821909477957759,0,32,negative regulation of signal transduction in absence of ligand,BP,
18802,GO:1901142,1,0.952429221714051,0,7,insulin metabolic process,BP,
18803,GO:1901143,1,0.986146829250411,0,2,insulin catabolic process,BP,
18804,GO:1901145,1,0.979810189188761,0,3,mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
18805,GO:1901147,1,0.986508997543432,0,2,mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
18806,GO:1901159,1,0.971588777423278,0,5,xylulose 5-phosphate biosynthetic process,BP,
18807,GO:1901160,1,0.919103368365806,0,12,primary amino compound metabolic process,BP,
18808,GO:1901162,1,0.976798687996686,0,4,primary amino compound biosynthetic process,BP,
18809,GO:1901163,1,0.940217134273138,0,10,regulation of trophoblast cell migration,BP,
18810,GO:1901164,1,0.969145220546944,0,5,negative regulation of trophoblast cell migration,BP,
18811,GO:1901165,1,0.97016023702599,0,5,positive regulation of trophoblast cell migration,BP,
18812,GO:1901166,1,0.97996632189811,0,3,neural crest cell migration involved in autonomic nervous system development,BP,
18813,GO:1901184,1,0.550561511404625,0,90,regulation of ERBB signaling pathway,BP,
18814,GO:1901185,1,0.706374436957309,0,53,negative regulation of ERBB signaling pathway,BP,
18815,GO:1901186,1,0.80214269294058,0,34,positive regulation of ERBB signaling pathway,BP,
18816,GO:1901187,1,0.986108179903501,0,2,regulation of ephrin receptor signaling pathway,BP,
18817,GO:1901189,1,0.994069990985103,0,1,positive regulation of ephrin receptor signaling pathway,BP,
18818,GO:1901193,1,0.994706273244466,0,1,regulation of formation of translation preinitiation complex,BP,
18819,GO:1901194,1,0.994706273244466,0,1,negative regulation of formation of translation preinitiation complex,BP,
18820,GO:1901201,1,0.909245298267568,0,13,regulation of extracellular matrix assembly,BP,
18821,GO:1901202,1,0.994073344588183,0,1,negative regulation of extracellular matrix assembly,BP,
18822,GO:1901203,1,0.93509551652843,0,9,positive regulation of extracellular matrix assembly,BP,
18823,GO:1901207,1,0.986828679614412,0,2,regulation of heart looping,BP,
18824,GO:1901208,1,0.993545597571315,0,1,negative regulation of heart looping,BP,
18825,GO:1901210,1,0.993545597571315,0,1,regulation of cardiac chamber formation,BP,
18826,GO:1901211,1,0.993545597571315,0,1,negative regulation of cardiac chamber formation,BP,
18827,GO:1901213,1,0.923168787860371,0,12,regulation of transcription from RNA polymerase II promoter involved in heart development,BP,
18831,GO:1901219,1,0.993545597571315,0,1,regulation of cardiac chamber morphogenesis,BP,
18832,GO:1901220,1,0.993545597571315,0,1,negative regulation of cardiac chamber morphogenesis,BP,
18833,GO:1901222,1,0.703584050924143,0,55,regulation of NIK/NF-kappaB signaling,BP,
18834,GO:1901223,1,0.944160246809235,0,9,negative regulation of NIK/NF-kappaB signaling,BP,
18835,GO:1901224,1,0.761501508543014,0,43,positive regulation of NIK/NF-kappaB signaling,BP,
18836,GO:1901228,1,0.978140063572021,0,3,positive regulation of transcription from RNA polymerase II promoter involved in heart development,BP,
18837,GO:1901229,1,0.993950154352162,0,1,regulation of non-canonical Wnt signaling pathway via JNK cascade,BP,
18838,GO:1901231,1,0.993950154352162,0,1,positive regulation of non-canonical Wnt signaling pathway via JNK cascade,BP,
18839,GO:1901232,1,0.993950154352162,0,1,regulation of convergent extension involved in axis elongation,BP,
18840,GO:1901233,1,0.993950154352162,0,1,negative regulation of convergent extension involved in axis elongation,BP,
18841,GO:1901246,1,0.988586007226797,0,2,regulation of lung ciliated cell differentiation,BP,
18842,GO:1901247,1,0.99462671200744,0,1,negative regulation of lung ciliated cell differentiation,BP,
18843,GO:1901248,1,0.993926991213386,0,1,positive regulation of lung ciliated cell differentiation,BP,
18844,GO:1901249,1,0.99462671200744,0,1,regulation of lung goblet cell differentiation,BP,
18845,GO:1901251,1,0.99462671200744,0,1,positive regulation of lung goblet cell differentiation,BP,
18846,GO:1901252,1,0.987873247422822,0,2,regulation of intracellular transport of viral material,BP,
18847,GO:1901253,1,0.994803908005211,0,1,negative regulation of intracellular transport of viral material,BP,
18848,GO:1901254,1,0.993033504495575,0,1,positive regulation of intracellular transport of viral material,BP,
18849,GO:1901255,1,0.986297671772544,0,2,nucleotide-excision repair involved in interstrand cross-link repair,BP,
18850,GO:1901256,1,0.969675561641522,0,5,regulation of macrophage colony-stimulating factor production,BP,
18851,GO:1901257,1,0.994088824750106,0,1,negative regulation of macrophage colony-stimulating factor production,BP,
18852,GO:1901258,1,0.981874347984227,0,3,positive regulation of macrophage colony-stimulating factor production,BP,
18853,GO:1901264,1,0.674895068269899,0,64,carbohydrate derivative transport,BP,
18855,GO:1901269,1,0.989925940293056,0,2,lipooligosaccharide metabolic process,BP,
18856,GO:1901271,1,0.989925940293056,0,2,lipooligosaccharide biosynthetic process,BP,
18857,GO:1901291,1,0.994299326270081,0,1,negative regulation of double-strand break repair via single-strand annealing,BP,
18858,GO:1901292,1,0.344556928407422,0,162,nucleoside phosphate catabolic process,BP,
18860,GO:1901295,1,0.988460077738153,0,2,regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
18861,GO:1901296,1,0.994356959793459,0,1,negative regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
18862,GO:1901297,1,0.994069990985103,0,1,positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
18863,GO:1901298,1,0.93772449617806,0,10,regulation of hydrogen peroxide-mediated programmed cell death,BP,
18864,GO:1901299,1,0.962875389610409,0,6,negative regulation of hydrogen peroxide-mediated programmed cell death,BP,
18865,GO:1901300,1,0.973889238652493,0,4,positive regulation of hydrogen peroxide-mediated programmed cell death,BP,
18866,GO:1901301,1,0.986840492038569,0,2,regulation of cargo loading into COPII-coated vesicle,BP,
18867,GO:1901303,1,0.993886869730289,0,1,negative regulation of cargo loading into COPII-coated vesicle,BP,
18868,GO:1901304,1,0.994411747803641,0,1,regulation of spermidine biosynthetic process,BP,
18869,GO:1901307,1,0.994411747803641,0,1,positive regulation of spermidine biosynthetic process,BP,
18870,GO:1901314,1,0.976566914684873,0,3,regulation of histone H2A K63-linked ubiquitination,BP,
18871,GO:1901315,1,0.976566914684873,0,3,negative regulation of histone H2A K63-linked ubiquitination,BP,
18872,GO:1901317,1,0.955131133149903,0,8,regulation of flagellated sperm motility,BP,
18873,GO:1901318,1,0.994292606909101,0,1,negative regulation of flagellated sperm motility,BP,
18874,GO:1901321,1,0.989077393495349,0,2,positive regulation of heart induction,BP,
18875,GO:1901328,1,0.99435385843341,0,1,response to cytochalasin B,BP,
18876,GO:1901329,1,0.981173752878912,0,3,regulation of odontoblast differentiation,BP,
18877,GO:1901331,1,0.993657144447763,0,1,positive regulation of odontoblast differentiation,BP,
18878,GO:1901337,1,0.993914642257477,0,1,thioester transport,BP,
18879,GO:1901338,1,0.918845300095547,0,14,catecholamine binding,MF,
18880,GO:1901339,1,0.954743574970306,0,7,regulation of store-operated calcium channel activity,BP,
18881,GO:1901340,1,0.993160175700081,0,1,negative regulation of store-operated calcium channel activity,BP,
18882,GO:1901341,1,0.967455722059375,0,5,positive regulation of store-operated calcium channel activity,BP,
18884,GO:1901343,1,0.531078780975691,0,93,negative regulation of vasculature development,BP,
18885,GO:1901344,1,0.994624645380928,0,1,response to leptomycin B,BP,
18886,GO:1901350,1,0.99162818630491,0,1,cell-cell signaling involved in cell-cell junction organization,BP,
18887,GO:1901355,1,0.986088942045641,0,2,response to rapamycin,BP,
18892,GO:1901373,1,0.994554376599818,0,1,lipid hydroperoxide transport,BP,
18893,GO:1901374,1,0.964398470935342,0,6,acetate ester transport,BP,
18894,GO:1901375,1,0.988065605081576,0,2,acetate ester transmembrane transporter activity,MF,
18895,GO:1901376,1,0.993874018242704,0,1,organic heteropentacyclic compound metabolic process,BP,
18896,GO:1901377,1,0.993874018242704,0,1,organic heteropentacyclic compound catabolic process,BP,
18897,GO:1901379,1,0.625421914159926,0,69,regulation of potassium ion transmembrane transport,BP,
18898,GO:1901380,1,0.886553630356872,0,18,negative regulation of potassium ion transmembrane transport,BP,
18899,GO:1901381,1,0.799394366390844,0,32,positive regulation of potassium ion transmembrane transport,BP,
18900,GO:1901382,1,0.971140581569787,0,4,regulation of chorionic trophoblast cell proliferation,BP,
18901,GO:1901383,1,0.985045495116763,0,2,negative regulation of chorionic trophoblast cell proliferation,BP,
18903,GO:1901386,1,0.930806595932252,0,12,negative regulation of voltage-gated calcium channel activity,BP,
18905,GO:1901388,1,0.993973843574546,0,1,regulation of transforming growth factor beta activation,BP,
18906,GO:1901389,1,0.993973843574546,0,1,negative regulation of transforming growth factor beta activation,BP,
18907,GO:1901401,1,0.992302408598171,0,1,regulation of tetrapyrrole metabolic process,BP,
18908,GO:1901407,1,0.945932184691303,0,9,regulation of phosphorylation of RNA polymerase II C-terminal domain,BP,
18909,GO:1901409,1,0.958591775415667,0,7,positive regulation of phosphorylation of RNA polymerase II C-terminal domain,BP,
18910,GO:1901419,1,0.993043888219735,0,1,regulation of response to alcohol,BP,
18911,GO:1901421,1,0.993043888219735,0,1,positive regulation of response to alcohol,BP,
18912,GO:1901474,1,0.957620745965584,0,7,azole transmembrane transporter activity,MF,
18913,GO:1901475,1,0.975743796764925,0,4,pyruvate transmembrane transport,BP,
18914,GO:1901490,1,0.9722277773815,0,4,regulation of lymphangiogenesis,BP,
18915,GO:1901491,1,0.985730459348747,0,2,negative regulation of lymphangiogenesis,BP,
18916,GO:1901492,1,0.986303825656899,0,2,positive regulation of lymphangiogenesis,BP,
18917,GO:1901503,1,0.967295113675667,0,5,ether biosynthetic process,BP,
18918,GO:1901505,1,0.810484176838438,0,34,carbohydrate derivative transmembrane transporter activity,MF,
18921,GO:1901523,1,0.982093183737666,0,3,icosanoid catabolic process,BP,
18922,GO:1901524,1,0.912832715465754,0,13,regulation of mitophagy,BP,
18923,GO:1901525,1,0.965584026473986,0,5,negative regulation of mitophagy,BP,
18924,GO:1901526,1,0.945387273824758,0,8,positive regulation of mitophagy,BP,
18925,GO:1901529,1,0.972163206942644,0,4,positive regulation of anion channel activity,BP,
18926,GO:1901532,1,0.591108735538406,0,88,regulation of hematopoietic progenitor cell differentiation,BP,
18927,GO:1901533,1,0.956943795230968,0,7,negative regulation of hematopoietic progenitor cell differentiation,BP,
18928,GO:1901534,1,0.986797167847966,0,2,positive regulation of hematopoietic progenitor cell differentiation,BP,
18929,GO:1901535,1,0.961052267908531,0,5,regulation of DNA demethylation,BP,
18930,GO:1901536,1,0.987499390979625,0,2,negative regulation of DNA demethylation,BP,
18931,GO:1901537,1,0.973221441231492,0,3,positive regulation of DNA demethylation,BP,
18932,GO:1901538,1,0.958353336891374,0,6,changes to DNA methylation involved in embryo development,BP,
18933,GO:1901545,1,0.99373036117976,0,1,response to raffinose,BP,
18934,GO:1901550,1,0.924425665734887,0,12,regulation of endothelial cell development,BP,
18935,GO:1901551,1,0.993123196197072,0,1,negative regulation of endothelial cell development,BP,
18936,GO:1901552,1,0.968833282304984,0,5,positive regulation of endothelial cell development,BP,
18937,GO:1901555,1,0.991688800822766,0,1,response to paclitaxel,BP,
18938,GO:1901557,1,0.993232675100923,0,1,response to fenofibrate,BP,
18939,GO:1901558,1,0.986387256910771,0,2,response to metformin,BP,
18940,GO:1901561,1,0.993349906318514,0,1,response to benomyl,BP,
18941,GO:1901563,1,0.967388574191607,0,5,response to camptothecin,BP,
18945,GO:1901567,1,0.86933678783806,0,24,fatty acid derivative binding,MF,
18947,GO:1901569,1,0.952988058957349,0,8,fatty acid derivative catabolic process,BP,
18949,GO:1901571,1,0.822901861246045,0,31,fatty acid derivative transport,BP,
18952,GO:1901580,1,0.989525691929859,0,1,regulation of telomeric RNA transcription from RNA pol II promoter,BP,
18953,GO:1901581,1,0.989525691929859,0,1,negative regulation of telomeric RNA transcription from RNA pol II promoter,BP,
18954,GO:1901582,1,0.989525691929859,0,1,positive regulation of telomeric RNA transcription from RNA pol II promoter,BP,
18955,GO:1901585,1,0.993830354210075,0,1,regulation of acid-sensing ion channel activity,BP,
18956,GO:1901588,1,0.992873696916713,0,1,dendritic microtubule,CC,
18957,GO:1901594,1,0.993156557790908,0,1,response to capsazepine,BP,
18960,GO:1901607,1,0.688947869416843,0,59,alpha-amino acid biosynthetic process,BP,
18961,GO:1901608,1,0.994600878772001,0,1,regulation of vesicle transport along microtubule,BP,
18962,GO:1901609,1,0.994600878772001,0,1,negative regulation of vesicle transport along microtubule,BP,
18963,GO:1901611,1,0.939426558783995,0,10,phosphatidylglycerol binding,MF,
18964,GO:1901612,1,0.95649251682027,0,7,cardiolipin binding,MF,
18966,GO:1901616,1,0.717815084675463,0,53,organic hydroxy compound catabolic process,BP,
18969,GO:1901620,1,0.955645518739022,0,7,regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
18970,GO:1901621,1,0.967221563697897,0,5,negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
18971,GO:1901622,1,0.993954273412238,0,1,positive regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
18972,GO:1901623,1,0.903185771632709,0,17,regulation of lymphocyte chemotaxis,BP,
18973,GO:1901624,1,0.982513358549986,0,3,negative regulation of lymphocyte chemotaxis,BP,
18974,GO:1901626,1,0.934308089441868,0,10,regulation of postsynaptic membrane organization,BP,
18975,GO:1901627,1,0.994081084265276,0,1,negative regulation of postsynaptic membrane organization,BP,
18976,GO:1901628,1,0.974571335017669,0,4,positive regulation of postsynaptic membrane organization,BP,
18977,GO:1901629,1,0.98586329849779,0,2,regulation of presynaptic membrane organization,BP,
18978,GO:1901630,1,0.994679925836776,0,1,negative regulation of presynaptic membrane organization,BP,
18979,GO:1901631,1,0.991136692060413,0,1,positive regulation of presynaptic membrane organization,BP,
18980,GO:1901639,1,0.992169153657553,0,1,XDP catabolic process,BP,
18981,GO:1901640,1,0.992169153657553,0,1,XTP binding,MF,
18982,GO:1901641,1,0.992169153657553,0,1,ITP binding,MF,
18983,GO:1901642,1,0.964896913984721,0,6,nucleoside transmembrane transport,BP,
18984,GO:1901652,1,0.0517507135874638,0,441,response to peptide,BP,
18985,GO:1901653,1,0.114478215632516,0,321,cellular response to peptide,BP,
18986,GO:1901654,1,0.327237140297956,0,172,response to ketone,BP,
18987,GO:1901655,1,0.575447745955783,0,83,cellular response to ketone,BP,
18988,GO:1901656,1,0.980255529713749,0,3,glycoside transport,BP,
18989,GO:1901657,1,0.436876706590231,0,134,glycosyl compound metabolic process,BP,
18990,GO:1901658,1,0.813721787957026,0,35,glycosyl compound catabolic process,BP,
18991,GO:1901659,1,0.775883925453724,0,43,glycosyl compound biosynthetic process,BP,
18992,GO:1901660,1,0.942890780848251,0,8,calcium ion export,BP,
18993,GO:1901661,1,0.856343967344983,0,27,quinone metabolic process,BP,
18994,GO:1901662,1,0.988391393262865,0,2,quinone catabolic process,BP,
18995,GO:1901663,1,0.922838775462358,0,14,quinone biosynthetic process,BP,
18996,GO:1901664,1,0.981191773263293,0,3,regulation of NAD+ ADP-ribosyltransferase activity,BP,
18997,GO:1901666,1,0.981191773263293,0,3,positive regulation of NAD+ ADP-ribosyltransferase activity,BP,
18998,GO:1901668,1,0.977566563856121,0,4,regulation of superoxide dismutase activity,BP,
18999,GO:1901671,1,0.983616181824306,0,3,positive regulation of superoxide dismutase activity,BP,
19000,GO:1901673,1,0.879853899679638,0,19,regulation of mitotic spindle assembly,BP,
19001,GO:1901674,1,0.979086401508582,0,3,regulation of histone H3-K27 acetylation,BP,
19002,GO:1901675,1,0.991820574444095,0,1,negative regulation of histone H3-K27 acetylation,BP,
19003,GO:1901676,1,0.993270260172184,0,1,positive regulation of histone H3-K27 acetylation,BP,
19004,GO:1901678,1,0.932812871209608,0,11,iron coordination entity transport,BP,
19005,GO:1901679,1,0.952373979367007,0,8,nucleotide transmembrane transport,BP,
19006,GO:1901680,1,0.990290622045223,0,1,sulfur-containing amino acid secondary active transmembrane transporter activity,MF,
19008,GO:1901682,1,0.835088227183316,0,27,sulfur compound transmembrane transporter activity,MF,
19009,GO:1901685,1,0.906988868792958,0,18,glutathione derivative metabolic process,BP,
19010,GO:1901687,1,0.906988868792958,0,18,glutathione derivative biosynthetic process,BP,
19012,GO:1901699,1,0.017579623893215,0,586,cellular response to nitrogen compound,BP,
19015,GO:1901702,1,0.982713379445425,0,3,salt transmembrane transporter activity,MF,
19016,GO:1901706,1,0.993951184084783,0,1,mesenchymal cell differentiation involved in bone development,BP,
19017,GO:1901707,1,0.994624645380928,0,1,leptomycin B binding,MF,
19018,GO:1901722,1,0.93419329684109,0,11,regulation of cell proliferation involved in kidney development,BP,
19019,GO:1901723,1,0.969286624624713,0,5,negative regulation of cell proliferation involved in kidney development,BP,
19020,GO:1901724,1,0.963805887517019,0,6,positive regulation of cell proliferation involved in kidney development,BP,
19021,GO:1901725,1,0.941020070918206,0,8,regulation of histone deacetylase activity,BP,
19022,GO:1901726,1,0.989651086040061,0,1,negative regulation of histone deacetylase activity,BP,
19023,GO:1901727,1,0.957421887331372,0,6,positive regulation of histone deacetylase activity,BP,
19024,GO:1901731,1,0.987771657129743,0,2,positive regulation of platelet aggregation,BP,
19025,GO:1901739,1,0.914988545964628,0,15,regulation of myoblast fusion,BP,
19026,GO:1901740,1,0.988988963879714,0,2,negative regulation of myoblast fusion,BP,
19027,GO:1901741,1,0.925183745112233,0,13,positive regulation of myoblast fusion,BP,
19028,GO:1901748,1,0.982090602941592,0,3,leukotriene D4 metabolic process,BP,
19029,GO:1901750,1,0.982090602941592,0,3,leukotriene D4 biosynthetic process,BP,
19030,GO:1901751,1,0.994066121639822,0,1,leukotriene A4 metabolic process,BP,
19032,GO:1901797,1,0.851531042412259,0,26,negative regulation of signal transduction by p53 class mediator,BP,
19033,GO:1901798,1,0.875862073428139,0,20,positive regulation of signal transduction by p53 class mediator,BP,
19035,GO:1901800,1,0.526376762758051,0,99,positive regulation of proteasomal protein catabolic process,BP,
19036,GO:1901804,1,0.994046520305129,0,1,beta-glucoside metabolic process,BP,
19037,GO:1901805,1,0.994046520305129,0,1,beta-glucoside catabolic process,BP,
19038,GO:1901810,1,0.993850639026861,0,1,beta-carotene metabolic process,BP,
19039,GO:1901825,1,0.993936769823406,0,1,zeaxanthin metabolic process,BP,
19040,GO:1901827,1,0.993936769823406,0,1,zeaxanthin biosynthetic process,BP,
19041,GO:1901834,1,0.994388489476242,0,1,regulation of deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
19042,GO:1901835,1,0.994388489476242,0,1,positive regulation of deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
19043,GO:1901836,1,0.931018178389859,0,11,regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
19044,GO:1901837,1,0.988489526993952,0,2,negative regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
19045,GO:1901838,1,0.941866026813177,0,9,positive regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
19046,GO:1901841,1,0.934923810809809,0,11,regulation of high voltage-gated calcium channel activity,BP,
19047,GO:1901842,1,0.977668601347696,0,4,negative regulation of high voltage-gated calcium channel activity,BP,
19048,GO:1901843,1,0.980411058453117,0,3,positive regulation of high voltage-gated calcium channel activity,BP,
19049,GO:1901844,1,0.942743080718388,0,9,regulation of cell communication by electrical coupling involved in cardiac conduction,BP,
19050,GO:1901846,1,0.992962801972498,0,1,positive regulation of cell communication by electrical coupling involved in cardiac conduction,BP,
19051,GO:1901856,1,0.987786958966609,0,2,negative regulation of cellular respiration,BP,
19053,GO:1901858,1,0.96110799363758,0,6,regulation of mitochondrial DNA metabolic process,BP,
19054,GO:1901859,1,0.980274825534255,0,3,negative regulation of mitochondrial DNA metabolic process,BP,
19055,GO:1901860,1,0.986684362077532,0,2,positive regulation of mitochondrial DNA metabolic process,BP,
19057,GO:1901862,1,0.749484298531646,0,44,negative regulation of muscle tissue development,BP,
19059,GO:1901873,1,0.98574328627614,0,2,regulation of post-translational protein modification,BP,
19060,GO:1901874,1,0.98574328627614,0,2,negative regulation of post-translational protein modification,BP,
19061,GO:1901876,1,0.989350214258702,0,2,regulation of calcium ion binding,BP,
19062,GO:1901877,1,0.989350214258702,0,2,negative regulation of calcium ion binding,BP,
19063,GO:1901879,1,0.59681250317863,0,73,regulation of protein depolymerization,BP,
19064,GO:1901880,1,0.672525553479398,0,56,negative regulation of protein depolymerization,BP,
19065,GO:1901881,1,0.908323072592255,0,15,positive regulation of protein depolymerization,BP,
19066,GO:1901888,1,0.573388166768024,0,80,regulation of cell junction assembly,BP,
19067,GO:1901889,1,0.870209413485994,0,20,negative regulation of cell junction assembly,BP,
19068,GO:1901890,1,0.810933380979828,0,30,positive regulation of cell junction assembly,BP,
19070,GO:1901895,1,0.979887403114652,0,3,negative regulation of calcium-transporting ATPase activity,BP,
19072,GO:1901897,1,0.954295381148561,0,7,regulation of relaxation of cardiac muscle,BP,
19073,GO:1901898,1,0.984223426923331,0,2,negative regulation of relaxation of cardiac muscle,BP,
19074,GO:1901899,1,0.988323680066956,0,2,positive regulation of relaxation of cardiac muscle,BP,
19075,GO:1901906,1,0.975932507390272,0,4,diadenosine pentaphosphate metabolic process,BP,
19076,GO:1901907,1,0.975932507390272,0,4,diadenosine pentaphosphate catabolic process,BP,
19077,GO:1901908,1,0.975932507390272,0,4,diadenosine hexaphosphate metabolic process,BP,
19078,GO:1901909,1,0.975932507390272,0,4,diadenosine hexaphosphate catabolic process,BP,
19079,GO:1901910,1,0.975932507390272,0,4,adenosine 5'-(hexahydrogen pentaphosphate) metabolic process,BP,
19080,GO:1901911,1,0.975932507390272,0,4,adenosine 5'-(hexahydrogen pentaphosphate) catabolic process,BP,
19081,GO:1901917,1,0.99386887877746,0,1,regulation of exoribonuclease activity,BP,
19082,GO:1901919,1,0.99386887877746,0,1,positive regulation of exoribonuclease activity,BP,
19083,GO:1901950,1,0.993850639026861,0,1,dense core granule transport,BP,
19084,GO:1901962,1,0.994137348650146,0,1,S-adenosyl-L-methionine transmembrane transport,BP,
19085,GO:1901963,1,0.987925477807713,0,2,regulation of cell proliferation involved in outflow tract morphogenesis,BP,
19086,GO:1901964,1,0.994367297581572,0,1,positive regulation of cell proliferation involved in outflow tract morphogenesis,BP,
19088,GO:1901976,1,0.816208698921255,0,32,regulation of cell cycle checkpoint,BP,
19089,GO:1901977,1,0.963732354260165,0,6,negative regulation of cell cycle checkpoint,BP,
19090,GO:1901978,1,0.936341156653282,0,10,positive regulation of cell cycle checkpoint,BP,
19091,GO:1901979,1,0.979002327969123,0,3,regulation of inward rectifier potassium channel activity,BP,
19092,GO:1901980,1,0.990077631515077,0,1,positive regulation of inward rectifier potassium channel activity,BP,
19093,GO:1901981,1,0.394491632979211,0,138,phosphatidylinositol phosphate binding,MF,
19094,GO:1901983,1,0.657383066253803,0,65,regulation of protein acetylation,BP,
19095,GO:1901984,1,0.864180381665164,0,23,negative regulation of protein acetylation,BP,
19096,GO:1901985,1,0.797610947326135,0,35,positive regulation of protein acetylation,BP,
19097,GO:1901986,1,0.994563160586758,0,1,response to ketamine,BP,
19104,GO:1901993,1,0.987508038083345,0,2,regulation of meiotic cell cycle phase transition,BP,
19105,GO:1901994,1,0.987508038083345,0,2,negative regulation of meiotic cell cycle phase transition,BP,
19106,GO:1901998,1,0.800868381374868,0,35,toxin transport,BP,
19107,GO:1902001,1,0.905257946361302,0,14,fatty acid transmembrane transport,BP,
19108,GO:1902003,1,0.882873696029817,0,18,regulation of amyloid-beta formation,BP,
19109,GO:1902004,1,0.935593650869759,0,10,positive regulation of amyloid-beta formation,BP,
19110,GO:1902010,1,0.993489813350026,0,1,negative regulation of translation in response to endoplasmic reticulum stress,BP,
19111,GO:1902017,1,0.767899952069636,0,39,regulation of cilium assembly,BP,
19112,GO:1902018,1,0.944234756944178,0,9,negative regulation of cilium assembly,BP,
19113,GO:1902019,1,0.969839451253232,0,5,regulation of cilium-dependent cell motility,BP,
19114,GO:1902022,1,0.968235466224072,0,5,L-lysine transport,BP,
19115,GO:1902023,1,0.960201870559495,0,6,L-arginine transport,BP,
19116,GO:1902031,1,0.964971769735062,0,6,regulation of NADP metabolic process,BP,
19117,GO:1902033,1,0.956590874529453,0,7,regulation of hematopoietic stem cell proliferation,BP,
19118,GO:1902035,1,0.968720229768958,0,5,positive regulation of hematopoietic stem cell proliferation,BP,
19119,GO:1902036,1,0.628656546224215,0,79,regulation of hematopoietic stem cell differentiation,BP,
19120,GO:1902037,1,0.981709992288837,0,3,negative regulation of hematopoietic stem cell differentiation,BP,
19121,GO:1902038,1,0.993513358261835,0,1,positive regulation of hematopoietic stem cell differentiation,BP,
19125,GO:1902044,1,0.987038372816863,0,2,regulation of Fas signaling pathway,BP,
19126,GO:1902045,1,0.994071280813827,0,1,negative regulation of Fas signaling pathway,BP,
19127,GO:1902047,1,0.964522217650272,0,6,polyamine transmembrane transport,BP,
19128,GO:1902065,1,0.929707757251351,0,11,response to L-glutamate,BP,
19129,GO:1902071,1,0.994680959082457,0,1,regulation of hypoxia-inducible factor-1alpha signaling pathway,BP,
19130,GO:1902073,1,0.994680959082457,0,1,positive regulation of hypoxia-inducible factor-1alpha signaling pathway,BP,
19131,GO:1902074,1,0.925520199185772,0,13,response to salt,BP,
19132,GO:1902075,1,0.959881129734618,0,7,cellular response to salt,BP,
19133,GO:1902076,1,0.989286060231701,0,1,regulation of lateral motor column neuron migration,BP,
19134,GO:1902078,1,0.989286060231701,0,1,positive regulation of lateral motor column neuron migration,BP,
19135,GO:1902080,1,0.994405028845343,0,1,regulation of calcium ion import into sarcoplasmic reticulum,BP,
19136,GO:1902081,1,0.994405028845343,0,1,negative regulation of calcium ion import into sarcoplasmic reticulum,BP,
19138,GO:1902093,1,0.960615967231493,0,7,positive regulation of flagellated sperm motility,BP,
19139,GO:1902098,1,0.992855173037058,0,1,calcitriol binding,MF,
19143,GO:1902102,1,0.993723958214045,0,1,regulation of metaphase/anaphase transition of meiotic cell cycle,BP,
19144,GO:1902103,1,0.993723958214045,0,1,negative regulation of metaphase/anaphase transition of meiotic cell cycle,BP,
19145,GO:1902105,1,0.233245367934376,0,223,regulation of leukocyte differentiation,BP,
19146,GO:1902106,1,0.607867849014529,0,76,negative regulation of leukocyte differentiation,BP,
19147,GO:1902107,1,0.469371237143812,0,118,positive regulation of leukocyte differentiation,BP,
19148,GO:1902108,1,0.697755931126444,0,59,regulation of mitochondrial membrane permeability involved in apoptotic process,BP,
19149,GO:1902109,1,0.98344889986596,0,3,negative regulation of mitochondrial membrane permeability involved in apoptotic process,BP,
19150,GO:1902110,1,0.715523860739503,0,55,positive regulation of mitochondrial membrane permeability involved in apoptotic process,BP,
19151,GO:1902115,1,0.357857871250573,0,149,regulation of organelle assembly,BP,
19152,GO:1902116,1,0.813621875279357,0,31,negative regulation of organelle assembly,BP,
19153,GO:1902117,1,0.664356649469496,0,58,positive regulation of organelle assembly,BP,
19154,GO:1902121,1,0.992855173037058,0,1,lithocholic acid binding,MF,
19155,GO:1902122,1,0.994178148773045,0,1,chenodeoxycholic acid binding,MF,
19156,GO:1902159,1,0.98701980856252,0,2,regulation of cyclic nucleotide-gated ion channel activity,BP,
19157,GO:1902161,1,0.992104559503058,0,1,positive regulation of cyclic nucleotide-gated ion channel activity,BP,
19158,GO:1902162,1,0.983411042715852,0,3,regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
19159,GO:1902164,1,0.983411042715852,0,3,positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
19160,GO:1902165,1,0.921716753913542,0,14,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
19161,GO:1902166,1,0.932180479089538,0,12,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
19162,GO:1902167,1,0.994988314183967,0,1,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
19163,GO:1902170,1,0.889475455905708,0,18,cellular response to reactive nitrogen species,BP,
19164,GO:1902172,1,0.970488447814717,0,5,regulation of keratinocyte apoptotic process,BP,
19165,GO:1902174,1,0.982125125450879,0,3,positive regulation of keratinocyte apoptotic process,BP,
19166,GO:1902175,1,0.852908935238198,0,26,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
19167,GO:1902176,1,0.896946809967398,0,18,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
19168,GO:1902177,1,0.97030829811852,0,5,positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
19170,GO:1902186,1,0.827563883461789,0,29,regulation of viral release from host cell,BP,
19171,GO:1902187,1,0.910172953464073,0,14,negative regulation of viral release from host cell,BP,
19172,GO:1902188,1,0.909815802440917,0,15,positive regulation of viral release from host cell,BP,
19173,GO:1902202,1,0.975187308164175,0,4,regulation of hepatocyte growth factor receptor signaling pathway,BP,
19174,GO:1902203,1,0.992721642207101,0,1,negative regulation of hepatocyte growth factor receptor signaling pathway,BP,
19175,GO:1902204,1,0.994249709560149,0,1,positive regulation of hepatocyte growth factor receptor signaling pathway,BP,
19176,GO:1902205,1,0.994408129914415,0,1,regulation of interleukin-2-mediated signaling pathway,BP,
19177,GO:1902206,1,0.994408129914415,0,1,negative regulation of interleukin-2-mediated signaling pathway,BP,
19178,GO:1902211,1,0.993850639026861,0,1,regulation of prolactin signaling pathway,BP,
19179,GO:1902213,1,0.993850639026861,0,1,positive regulation of prolactin signaling pathway,BP,
19180,GO:1902214,1,0.980203263512268,0,3,regulation of interleukin-4-mediated signaling pathway,BP,
19181,GO:1902215,1,0.994408129914415,0,1,negative regulation of interleukin-4-mediated signaling pathway,BP,
19182,GO:1902216,1,0.985716058634978,0,2,positive regulation of interleukin-4-mediated signaling pathway,BP,
19183,GO:1902217,1,0.994602428791373,0,1,erythrocyte apoptotic process,BP,
19184,GO:1902218,1,0.962976277291877,0,6,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
19185,GO:1902219,1,0.968086479440589,0,5,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
19186,GO:1902220,1,0.994723062888751,0,1,positive regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
19187,GO:1902221,1,0.944523442989561,0,10,erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process,BP,
19188,GO:1902222,1,0.944523442989561,0,10,erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process,BP,
19189,GO:1902224,1,0.929364951376785,0,12,ketone body metabolic process,BP,
19190,GO:1902226,1,0.983042765900935,0,3,regulation of macrophage colony-stimulating factor signaling pathway,BP,
19191,GO:1902227,1,0.988943834030219,0,2,negative regulation of macrophage colony-stimulating factor signaling pathway,BP,
19192,GO:1902228,1,0.994033627873654,0,1,positive regulation of macrophage colony-stimulating factor signaling pathway,BP,
19195,GO:1902231,1,0.966654395007834,0,6,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,
19196,GO:1902232,1,0.994408129914415,0,1,regulation of positive thymic T cell selection,BP,
19197,GO:1902233,1,0.994408129914415,0,1,negative regulation of positive thymic T cell selection,BP,
19198,GO:1902235,1,0.834507101232089,0,29,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,
19199,GO:1902236,1,0.897743856773669,0,17,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,
19200,GO:1902237,1,0.941418908329742,0,10,positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,
19201,GO:1902238,1,0.993126818994063,0,1,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
19202,GO:1902239,1,0.993126818994063,0,1,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
19203,GO:1902250,1,0.994602428791373,0,1,regulation of erythrocyte apoptotic process,BP,
19204,GO:1902251,1,0.994602428791373,0,1,negative regulation of erythrocyte apoptotic process,BP,
19205,GO:1902253,1,0.870546149144909,0,23,regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
19206,GO:1902254,1,0.899594034481649,0,17,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
19207,GO:1902255,1,0.979142714844804,0,4,positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
19208,GO:1902256,1,0.980664437569727,0,3,regulation of apoptotic process involved in outflow tract morphogenesis,BP,
19209,GO:1902257,1,0.9879722882434,0,2,negative regulation of apoptotic process involved in outflow tract morphogenesis,BP,
19210,GO:1902259,1,0.904995298318562,0,15,regulation of delayed rectifier potassium channel activity,BP,
19211,GO:1902260,1,0.955513433597988,0,7,negative regulation of delayed rectifier potassium channel activity,BP,
19212,GO:1902261,1,0.971290800596965,0,4,positive regulation of delayed rectifier potassium channel activity,BP,
19213,GO:1902262,1,0.970062882263385,0,5,apoptotic process involved in blood vessel morphogenesis,BP,
19214,GO:1902263,1,0.978234264794216,0,3,apoptotic process involved in embryonic digit morphogenesis,BP,
19215,GO:1902267,1,0.971103439179779,0,5,regulation of polyamine transmembrane transport,BP,
19216,GO:1902268,1,0.983921327527985,0,3,negative regulation of polyamine transmembrane transport,BP,
19217,GO:1902269,1,0.986974769360028,0,2,positive regulation of polyamine transmembrane transport,BP,
19218,GO:1902271,1,0.992855173037058,0,1,D3 vitamins binding,MF,
19220,GO:1902282,1,0.952372370502185,0,8,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,MF,
19221,GO:1902283,1,0.993216182234582,0,1,negative regulation of primary amine oxidase activity,BP,
19222,GO:1902284,1,0.783308931477774,0,32,neuron projection extension involved in neuron projection guidance,BP,
19223,GO:1902285,1,0.902085753659197,0,13,semaphorin-plexin signaling pathway involved in neuron projection guidance,BP,
19224,GO:1902287,1,0.908900916316352,0,12,semaphorin-plexin signaling pathway involved in axon guidance,BP,
19225,GO:1902292,1,0.994679409213495,0,1,cell cycle DNA replication initiation,BP,
19226,GO:1902296,1,0.993591135045223,0,1,DNA strand elongation involved in cell cycle DNA replication,BP,
19227,GO:1902298,1,0.983588911729125,0,2,cell cycle DNA replication maintenance of fidelity,BP,
19228,GO:1902299,1,0.982729455714152,0,3,pre-replicative complex assembly involved in cell cycle DNA replication,BP,
19229,GO:1902302,1,0.968121610189608,0,5,regulation of potassium ion export,BP,
19230,GO:1902303,1,0.987387187168868,0,2,negative regulation of potassium ion export,BP,
19231,GO:1902304,1,0.987705386036144,0,2,positive regulation of potassium ion export,BP,
19233,GO:1902306,1,0.918066370289706,0,12,negative regulation of sodium ion transmembrane transport,BP,
19235,GO:1902308,1,0.96811170537679,0,5,regulation of peptidyl-serine dephosphorylation,BP,
19236,GO:1902309,1,0.979345925743041,0,3,negative regulation of peptidyl-serine dephosphorylation,BP,
19237,GO:1902310,1,0.988531258317111,0,2,positive regulation of peptidyl-serine dephosphorylation,BP,
19238,GO:1902311,1,0.994372983298238,0,1,regulation of copper ion transmembrane transport,BP,
19239,GO:1902315,1,0.994679409213495,0,1,nuclear cell cycle DNA replication initiation,BP,
19240,GO:1902319,1,0.993591135045223,0,1,DNA strand elongation involved in nuclear cell cycle DNA replication,BP,
19241,GO:1902336,1,0.987517179471662,0,2,positive regulation of retinal ganglion cell axon guidance,BP,
19242,GO:1902337,1,0.942567711353515,0,9,regulation of apoptotic process involved in morphogenesis,BP,
19243,GO:1902338,1,0.968022900815712,0,5,negative regulation of apoptotic process involved in morphogenesis,BP,
19244,GO:1902339,1,0.980969023431266,0,3,positive regulation of apoptotic process involved in morphogenesis,BP,
19245,GO:1902356,1,0.994311989915189,0,1,oxaloacetate(2-) transmembrane transport,BP,
19246,GO:1902358,1,0.92931363483345,0,11,sulfate transmembrane transport,BP,
19247,GO:1902359,1,0.988141134809679,0,2,Notch signaling pathway involved in somitogenesis,BP,
19248,GO:1902362,1,0.993842677868841,0,1,melanocyte apoptotic process,BP,
19249,GO:1902363,1,0.991555657821302,0,1,regulation of protein localization to spindle pole body,BP,
19250,GO:1902365,1,0.991555657821302,0,1,positive regulation of protein localization to spindle pole body,BP,
19251,GO:1902366,1,0.988141134809679,0,2,regulation of Notch signaling pathway involved in somitogenesis,BP,
19252,GO:1902367,1,0.988141134809679,0,2,negative regulation of Notch signaling pathway involved in somitogenesis,BP,
19253,GO:1902369,1,0.744890810716874,0,44,negative regulation of RNA catabolic process,BP,
19254,GO:1902373,1,0.774570076098207,0,38,negative regulation of mRNA catabolic process,BP,
19255,GO:1902378,1,0.994004758645168,0,1,VEGF-activated neuropilin signaling pathway involved in axon guidance,BP,
19256,GO:1902379,1,0.992268880590988,0,1,chemoattractant activity involved in axon guidance,MF,
19257,GO:1902380,1,0.99403672181897,0,1,positive regulation of endoribonuclease activity,BP,
19258,GO:1902387,1,0.993850639026861,0,1,ceramide 1-phosphate binding,MF,
19259,GO:1902388,1,0.993850639026861,0,1,ceramide 1-phosphate transporter activity,MF,
19260,GO:1902389,1,0.993850639026861,0,1,ceramide 1-phosphate transport,BP,
19261,GO:1902396,1,0.993274375949279,0,1,protein localization to bicellular tight junction,BP,
19265,GO:1902410,1,0.962429991025457,0,6,mitotic cytokinetic process,BP,
19266,GO:1902412,1,0.971597642574176,0,4,regulation of mitotic cytokinesis,BP,
19267,GO:1902414,1,0.943439071130183,0,8,protein localization to cell junction,BP,
19268,GO:1902415,1,0.946181722181571,0,9,regulation of mRNA binding,BP,
19269,GO:1902416,1,0.957508630100765,0,7,positive regulation of mRNA binding,BP,
19270,GO:1902423,1,0.985977232930755,0,2,regulation of attachment of mitotic spindle microtubules to kinetochore,BP,
19271,GO:1902425,1,0.985977232930755,0,2,positive regulation of attachment of mitotic spindle microtubules to kinetochore,BP,
19272,GO:1902426,1,0.993904868414913,0,1,deactivation of mitotic spindle assembly checkpoint,BP,
19273,GO:1902430,1,0.938814374820916,0,9,negative regulation of amyloid-beta formation,BP,
19274,GO:1902442,1,0.99336119602073,0,1,regulation of ripoptosome assembly involved in necroptotic process,BP,
19275,GO:1902443,1,0.99336119602073,0,1,negative regulation of ripoptosome assembly involved in necroptotic process,BP,
19276,GO:1902444,1,0.994675534529457,0,1,riboflavin binding,MF,
19277,GO:1902445,1,0.983826426721823,0,3,regulation of mitochondrial membrane permeability involved in programmed necrotic cell death,BP,
19278,GO:1902455,1,0.962008701181436,0,6,negative regulation of stem cell population maintenance,BP,
19279,GO:1902459,1,0.951528419575561,0,7,positive regulation of stem cell population maintenance,BP,
19280,GO:1902460,1,0.992925831117803,0,1,regulation of mesenchymal stem cell proliferation,BP,
19281,GO:1902462,1,0.992925831117803,0,1,positive regulation of mesenchymal stem cell proliferation,BP,
19282,GO:1902463,1,0.989021347847279,0,2,protein localization to cell leading edge,BP,
19283,GO:1902464,1,0.993014285054507,0,1,regulation of histone H3-K27 trimethylation,BP,
19284,GO:1902466,1,0.993014285054507,0,1,positive regulation of histone H3-K27 trimethylation,BP,
19285,GO:1902473,1,0.946735419551884,0,8,regulation of protein localization to synapse,BP,
19286,GO:1902474,1,0.952596142389845,0,7,positive regulation of protein localization to synapse,BP,
19287,GO:1902475,1,0.743777194602404,0,44,L-alpha-amino acid transmembrane transport,BP,
19289,GO:1902480,1,0.994035174827267,0,1,protein localization to mitotic spindle,BP,
19290,GO:1902488,1,0.990741781317258,0,1,cholangiocyte apoptotic process,BP,
19291,GO:1902490,1,0.994264955450685,0,1,regulation of sperm capacitation,BP,
19292,GO:1902493,1,0.571835887718348,0,85,acetyltransferase complex,CC,
19295,GO:1902498,1,0.96729729095179,0,4,regulation of protein autoubiquitination,BP,
19296,GO:1902499,1,0.984365958196533,0,2,positive regulation of protein autoubiquitination,BP,
19297,GO:1902504,1,0.993747268352421,0,1,regulation of signal transduction involved in mitotic G2 DNA damage checkpoint,BP,
19298,GO:1902510,1,0.958820233259787,0,7,regulation of apoptotic DNA fragmentation,BP,
19299,GO:1902511,1,0.993886869730289,0,1,negative regulation of apoptotic DNA fragmentation,BP,
19300,GO:1902512,1,0.983828476533357,0,3,positive regulation of apoptotic DNA fragmentation,BP,
19301,GO:1902513,1,0.956708892014749,0,7,regulation of organelle transport along microtubule,BP,
19302,GO:1902514,1,0.93899071184966,0,9,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
19303,GO:1902523,1,0.980200781109601,0,3,positive regulation of protein K63-linked ubiquitination,BP,
19304,GO:1902524,1,0.987920049044764,0,2,positive regulation of protein K48-linked ubiquitination,BP,
19305,GO:1902525,1,0.971025911474673,0,5,regulation of protein monoubiquitination,BP,
19306,GO:1902527,1,0.977498261212409,0,4,positive regulation of protein monoubiquitination,BP,
19307,GO:1902528,1,0.990928958252341,0,1,regulation of protein linear polyubiquitination,BP,
19308,GO:1902530,1,0.990928958252341,0,1,positive regulation of protein linear polyubiquitination,BP,
19312,GO:1902544,1,0.988500199968374,0,2,regulation of DNA N-glycosylase activity,BP,
19313,GO:1902546,1,0.994854530693101,0,1,positive regulation of DNA N-glycosylase activity,BP,
19314,GO:1902547,1,0.926610031075196,0,11,regulation of cellular response to vascular endothelial growth factor stimulus,BP,
19315,GO:1902548,1,0.972807154156211,0,4,negative regulation of cellular response to vascular endothelial growth factor stimulus,BP,
19317,GO:1902555,1,0.837444177991665,0,29,endoribonuclease complex,CC,
19318,GO:1902559,1,0.988487964696343,0,2,3'-phospho-5'-adenylyl sulfate transmembrane transport,BP,
19319,GO:1902560,1,0.988851815798577,0,2,GMP reductase complex,CC,
19320,GO:1902562,1,0.776872820702108,0,39,H4 histone acetyltransferase complex,CC,
19321,GO:1902563,1,0.935658546586055,0,10,regulation of neutrophil activation,BP,
19322,GO:1902564,1,0.973329718242262,0,4,negative regulation of neutrophil activation,BP,
19323,GO:1902565,1,0.974070146359063,0,4,positive regulation of neutrophil activation,BP,
19324,GO:1902566,1,0.976882461107837,0,4,regulation of eosinophil activation,BP,
19325,GO:1902567,1,0.988343333813914,0,2,negative regulation of eosinophil activation,BP,
19326,GO:1902568,1,0.988405322386981,0,2,positive regulation of eosinophil activation,BP,
19327,GO:1902569,1,0.994312506803972,0,1,negative regulation of activation of Janus kinase activity,BP,
19328,GO:1902570,1,0.939003976700501,0,10,protein localization to nucleolus,BP,
19329,GO:1902571,1,0.964539461749295,0,6,regulation of serine-type peptidase activity,BP,
19330,GO:1902572,1,0.964539461749295,0,6,negative regulation of serine-type peptidase activity,BP,
19331,GO:1902573,1,0.990458391802756,0,1,positive regulation of serine-type peptidase activity,BP,
19332,GO:1902576,1,0.975580043911514,0,4,negative regulation of nuclear cell cycle DNA replication,BP,
19333,GO:1902579,1,0.638807916978419,0,69,multi-organism localization,BP,
19334,GO:1902581,1,0.969091840593509,0,5,multi-organism cellular localization,BP,
19335,GO:1902583,1,0.969091840593509,0,5,multi-organism intracellular transport,BP,
19336,GO:1902594,1,0.985367653540629,0,2,multi-organism nuclear import,BP,
19337,GO:1902595,1,0.988492873582146,0,2,regulation of DNA replication origin binding,BP,
19338,GO:1902600,1,0.512390576110586,0,110,proton transmembrane transport,BP,
19339,GO:1902603,1,0.976548364352049,0,4,carnitine transmembrane transport,BP,
19340,GO:1902605,1,0.993872476334636,0,1,heterotrimeric G-protein complex assembly,BP,
19341,GO:1902606,1,0.989533271509547,0,2,regulation of large conductance calcium-activated potassium channel activity,BP,
19342,GO:1902608,1,0.989533271509547,0,2,positive regulation of large conductance calcium-activated potassium channel activity,BP,
19343,GO:1902612,1,0.993869906618234,0,1,regulation of anti-Mullerian hormone signaling pathway,BP,
19344,GO:1902613,1,0.993869906618234,0,1,negative regulation of anti-Mullerian hormone signaling pathway,BP,
19345,GO:1902616,1,0.994321810855476,0,1,acyl carnitine transmembrane transport,BP,
19346,GO:1902617,1,0.966969279693567,0,5,response to fluoride,BP,
19347,GO:1902618,1,0.992198720087598,0,1,cellular response to fluoride,BP,
19348,GO:1902622,1,0.806086402009136,0,37,regulation of neutrophil migration,BP,
19349,GO:1902623,1,0.986611908758098,0,2,negative regulation of neutrophil migration,BP,
19350,GO:1902624,1,0.831827142046779,0,32,positive regulation of neutrophil migration,BP,
19351,GO:1902626,1,0.984338298366549,0,3,assembly of large subunit precursor of preribosome,BP,
19352,GO:1902629,1,0.994582794965587,0,1,regulation of mRNA stability involved in cellular response to UV,BP,
19353,GO:1902630,1,0.984001899479145,0,2,regulation of membrane hyperpolarization,BP,
19354,GO:1902631,1,0.991673968663183,0,1,negative regulation of membrane hyperpolarization,BP,
19355,GO:1902636,1,0.988762085796419,0,2,kinociliary basal body,CC,
19358,GO:1902656,1,0.915818440787196,0,13,calcium ion import into cytosol,BP,
19359,GO:1902659,1,0.9816918701849,0,3,regulation of glucose mediated signaling pathway,BP,
19360,GO:1902661,1,0.9816918701849,0,3,positive regulation of glucose mediated signaling pathway,BP,
19361,GO:1902667,1,0.765694041167992,0,36,regulation of axon guidance,BP,
19362,GO:1902668,1,0.859916066479799,0,21,negative regulation of axon guidance,BP,
19363,GO:1902669,1,0.937209668431396,0,8,positive regulation of axon guidance,BP,
19366,GO:1902683,1,0.98190708896512,0,3,regulation of receptor localization to synapse,BP,
19367,GO:1902684,1,0.994600878772001,0,1,negative regulation of receptor localization to synapse,BP,
19368,GO:1902685,1,0.993085385379474,0,1,positive regulation of receptor localization to synapse,BP,
19369,GO:1902686,1,0.706968625353013,0,57,mitochondrial outer membrane permeabilization involved in programmed cell death,BP,
19371,GO:1902710,1,0.889506131519555,0,17,GABA receptor complex,CC,
19372,GO:1902711,1,0.896426743673519,0,16,GABA-A receptor complex,CC,
19373,GO:1902713,1,0.950879593369439,0,8,regulation of interferon-gamma secretion,BP,
19374,GO:1902714,1,0.988099739516018,0,2,negative regulation of interferon-gamma secretion,BP,
19375,GO:1902715,1,0.962336060022555,0,6,positive regulation of interferon-gamma secretion,BP,
19376,GO:1902722,1,0.981694048188232,0,3,positive regulation of prolactin secretion,BP,
19377,GO:1902723,1,0.980407134936336,0,3,negative regulation of skeletal muscle satellite cell proliferation,BP,
19378,GO:1902724,1,0.985326719171075,0,2,positive regulation of skeletal muscle satellite cell proliferation,BP,
19379,GO:1902725,1,0.978926757129565,0,3,negative regulation of satellite cell differentiation,BP,
19380,GO:1902728,1,0.985326719171075,0,2,positive regulation of growth factor dependent skeletal muscle satellite cell proliferation,BP,
19381,GO:1902730,1,0.980732194579498,0,3,positive regulation of proteoglycan biosynthetic process,BP,
19382,GO:1902731,1,0.975609749534097,0,3,negative regulation of chondrocyte proliferation,BP,
19383,GO:1902732,1,0.982781631127384,0,3,positive regulation of chondrocyte proliferation,BP,
19384,GO:1902737,1,0.993033504495575,0,1,dendritic filopodium,CC,
19385,GO:1902739,1,0.956168491592652,0,6,regulation of interferon-alpha secretion,BP,
19386,GO:1902741,1,0.956168491592652,0,6,positive regulation of interferon-alpha secretion,BP,
19387,GO:1902742,1,0.820922363875533,0,29,apoptotic process involved in development,BP,
19389,GO:1902744,1,0.971510959156887,0,4,negative regulation of lamellipodium organization,BP,
19391,GO:1902746,1,0.978990446922609,0,3,regulation of lens fiber cell differentiation,BP,
19392,GO:1902747,1,0.994267539592801,0,1,negative regulation of lens fiber cell differentiation,BP,
19393,GO:1902748,1,0.990536994876242,0,1,positive regulation of lens fiber cell differentiation,BP,
19397,GO:1902766,1,0.98892990192235,0,2,skeletal muscle satellite cell migration,BP,
19398,GO:1902767,1,0.987575457228875,0,2,isoprenoid biosynthetic process via mevalonate,BP,
19399,GO:1902769,1,0.989620548463066,0,1,regulation of choline O-acetyltransferase activity,BP,
19400,GO:1902771,1,0.989620548463066,0,1,positive regulation of choline O-acetyltransferase activity,BP,
19401,GO:1902773,1,0.99372037283893,0,1,GTPase activator complex,CC,
19402,GO:1902774,1,0.953565573042789,0,7,late endosome to lysosome transport,BP,
19403,GO:1902775,1,0.978961414319689,0,3,mitochondrial large ribosomal subunit assembly,BP,
19404,GO:1902803,1,0.829844714665369,0,27,regulation of synaptic vesicle transport,BP,
19405,GO:1902804,1,0.975940455489219,0,4,negative regulation of synaptic vesicle transport,BP,
19406,GO:1902805,1,0.977829753171023,0,3,positive regulation of synaptic vesicle transport,BP,
19409,GO:1902808,1,0.799706790195509,0,34,positive regulation of cell cycle G1/S phase transition,BP,
19410,GO:1902809,1,0.981363157384122,0,3,regulation of skeletal muscle fiber differentiation,BP,
19411,GO:1902811,1,0.987486274093285,0,2,positive regulation of skeletal muscle fiber differentiation,BP,
19412,GO:1902816,1,0.974177153496187,0,4,regulation of protein localization to microtubule,BP,
19413,GO:1902817,1,0.974177153496187,0,4,negative regulation of protein localization to microtubule,BP,
19414,GO:1902822,1,0.973361702676847,0,4,regulation of late endosome to lysosome transport,BP,
19415,GO:1902823,1,0.984138659423316,0,2,negative regulation of late endosome to lysosome transport,BP,
19416,GO:1902824,1,0.98905110994705,0,2,positive regulation of late endosome to lysosome transport,BP,
19417,GO:1902838,1,0.992626349998796,0,1,regulation of nuclear migration along microtubule,BP,
19418,GO:1902846,1,0.991555657821302,0,1,positive regulation of mitotic spindle elongation,BP,
19419,GO:1902847,1,0.993819061108973,0,1,regulation of neuronal signal transduction,BP,
19421,GO:1902855,1,0.936321564143667,0,10,regulation of non-motile cilium assembly,BP,
19422,GO:1902856,1,0.986083037559109,0,2,negative regulation of non-motile cilium assembly,BP,
19423,GO:1902857,1,0.955281339264771,0,7,positive regulation of non-motile cilium assembly,BP,
19424,GO:1902858,1,0.994183314412697,0,1,propionyl-CoA metabolic process,BP,
19425,GO:1902860,1,0.994183314412697,0,1,propionyl-CoA biosynthetic process,BP,
19426,GO:1902866,1,0.963179236773746,0,6,regulation of retina development in camera-type eye,BP,
19427,GO:1902867,1,0.993669940119772,0,1,negative regulation of retina development in camera-type eye,BP,
19428,GO:1902868,1,0.98824584876093,0,2,positive regulation of retina development in camera-type eye,BP,
19429,GO:1902869,1,0.98198944827623,0,3,regulation of amacrine cell differentiation,BP,
19430,GO:1902870,1,0.993669940119772,0,1,negative regulation of amacrine cell differentiation,BP,
19431,GO:1902871,1,0.98824584876093,0,2,positive regulation of amacrine cell differentiation,BP,
19432,GO:1902882,1,0.623963229289046,0,74,regulation of response to oxidative stress,BP,
19433,GO:1902883,1,0.769086075878829,0,41,negative regulation of response to oxidative stress,BP,
19434,GO:1902884,1,0.903279061040892,0,16,positive regulation of response to oxidative stress,BP,
19435,GO:1902889,1,0.99175205968801,0,1,protein localization to spindle microtubule,BP,
19436,GO:1902890,1,0.994886556596673,0,1,regulation of root hair elongation,BP,
19437,GO:1902891,1,0.994886556596673,0,1,negative regulation of root hair elongation,BP,
19438,GO:1902893,1,0.807130512207611,0,31,regulation of pri-miRNA transcription by RNA polymerase II,BP,
19439,GO:1902894,1,0.922218563254218,0,11,negative regulation of pri-miRNA transcription by RNA polymerase II,BP,
19440,GO:1902895,1,0.863825453183226,0,22,positive regulation of pri-miRNA transcription by RNA polymerase II,BP,
19441,GO:1902896,1,0.981022872002796,0,3,terminal web assembly,BP,
19442,GO:1902897,1,0.980382059188774,0,3,regulation of postsynaptic density protein 95 clustering,BP,
19443,GO:1902902,1,0.931293576731014,0,11,negative regulation of autophagosome assembly,BP,
19445,GO:1902904,1,0.4538553928719,0,116,negative regulation of supramolecular fiber organization,BP,
19447,GO:1902908,1,0.98752817298973,0,2,regulation of melanosome transport,BP,
19448,GO:1902910,1,0.993079164753351,0,1,positive regulation of melanosome transport,BP,
19450,GO:1902912,1,0.993850639026861,0,1,pyruvate kinase complex,CC,
19451,GO:1902913,1,0.993657144447763,0,1,positive regulation of neuroepithelial cell differentiation,BP,
19452,GO:1902914,1,0.894008761168951,0,16,regulation of protein polyubiquitination,BP,
19453,GO:1902915,1,0.956439612553855,0,6,negative regulation of protein polyubiquitination,BP,
19454,GO:1902916,1,0.94297627899039,0,9,positive regulation of protein polyubiquitination,BP,
19456,GO:1902931,1,0.946692211772197,0,9,negative regulation of alcohol biosynthetic process,BP,
19458,GO:1902936,1,0.550268556191902,0,90,phosphatidylinositol bisphosphate binding,MF,
19459,GO:1902937,1,0.980919973730186,0,3,inward rectifier potassium channel complex,CC,
19460,GO:1902938,1,0.979015532679678,0,3,regulation of intracellular calcium activated chloride channel activity,BP,
19461,GO:1902939,1,0.9937949460586,0,1,negative regulation of intracellular calcium activated chloride channel activity,BP,
19462,GO:1902941,1,0.985312556455917,0,2,regulation of voltage-gated chloride channel activity,BP,
19463,GO:1902943,1,0.985312556455917,0,2,positive regulation of voltage-gated chloride channel activity,BP,
19464,GO:1902946,1,0.941877635163749,0,8,protein localization to early endosome,BP,
19465,GO:1902947,1,0.960266188981065,0,6,regulation of tau-protein kinase activity,BP,
19466,GO:1902948,1,0.989620548463066,0,1,negative regulation of tau-protein kinase activity,BP,
19467,GO:1902949,1,0.975953475366057,0,4,positive regulation of tau-protein kinase activity,BP,
19468,GO:1902950,1,0.944102566795349,0,9,regulation of dendritic spine maintenance,BP,
19469,GO:1902951,1,0.980430319794224,0,3,negative regulation of dendritic spine maintenance,BP,
19470,GO:1902952,1,0.980602346108068,0,3,positive regulation of dendritic spine maintenance,BP,
19471,GO:1902953,1,0.971352647362305,0,4,positive regulation of ER to Golgi vesicle-mediated transport,BP,
19472,GO:1902954,1,0.981061056416716,0,2,regulation of early endosome to recycling endosome transport,BP,
19473,GO:1902955,1,0.989620548463066,0,1,positive regulation of early endosome to recycling endosome transport,BP,
19474,GO:1902956,1,0.982475884416764,0,3,regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
19475,GO:1902957,1,0.993653817804457,0,1,negative regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
19476,GO:1902958,1,0.988751396060123,0,2,positive regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
19477,GO:1902959,1,0.94492323409692,0,8,regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19478,GO:1902960,1,0.983770624556681,0,2,negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19479,GO:1902961,1,0.960518131413396,0,6,positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19480,GO:1902962,1,0.983019480710789,0,2,regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19481,GO:1902963,1,0.983019480710789,0,2,negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19482,GO:1902965,1,0.954632513149704,0,6,regulation of protein localization to early endosome,BP,
19483,GO:1902966,1,0.954632513149704,0,6,positive regulation of protein localization to early endosome,BP,
19484,GO:1902969,1,0.941492998072112,0,9,mitotic DNA replication,BP,
19485,GO:1902975,1,0.994679409213495,0,1,mitotic DNA replication initiation,BP,
19486,GO:1902977,1,0.994294932830485,0,1,mitotic DNA replication preinitiation complex assembly,BP,
19487,GO:1902983,1,0.993591135045223,0,1,DNA strand elongation involved in mitotic DNA replication,BP,
19488,GO:1902988,1,0.97593408613758,0,3,neurofibrillary tangle assembly,BP,
19489,GO:1902990,1,0.980653544244274,0,3,mitotic telomere maintenance via semi-conservative replication,BP,
19490,GO:1902991,1,0.853920804648851,0,23,regulation of amyloid precursor protein catabolic process,BP,
19491,GO:1902992,1,0.92688103473422,0,11,negative regulation of amyloid precursor protein catabolic process,BP,
19492,GO:1902993,1,0.924465810890027,0,12,positive regulation of amyloid precursor protein catabolic process,BP,
19493,GO:1902994,1,0.986459106693052,0,2,regulation of phospholipid efflux,BP,
19494,GO:1902995,1,0.986459106693052,0,2,positive regulation of phospholipid efflux,BP,
19495,GO:1902996,1,0.983503122312632,0,2,regulation of neurofibrillary tangle assembly,BP,
19496,GO:1902997,1,0.989620548463066,0,1,negative regulation of neurofibrillary tangle assembly,BP,
19497,GO:1902998,1,0.993819061108973,0,1,positive regulation of neurofibrillary tangle assembly,BP,
19498,GO:1903000,1,0.994679925836776,0,1,regulation of lipid transport across blood brain barrier,BP,
19499,GO:1903002,1,0.994679925836776,0,1,positive regulation of lipid transport across blood brain barrier,BP,
19500,GO:1903003,1,0.962359002884406,0,6,positive regulation of protein deubiquitination,BP,
19501,GO:1903004,1,0.993293917962388,0,1,regulation of protein K63-linked deubiquitination,BP,
19502,GO:1903006,1,0.993293917962388,0,1,positive regulation of protein K63-linked deubiquitination,BP,
19503,GO:1903007,1,0.993293917962388,0,1,positive regulation of Lys63-specific deubiquitinase activity,BP,
19505,GO:1903010,1,0.884383737825514,0,18,regulation of bone development,BP,
19506,GO:1903011,1,0.951880655079115,0,7,negative regulation of bone development,BP,
19507,GO:1903012,1,0.95843801562306,0,7,positive regulation of bone development,BP,
19508,GO:1903015,1,0.988738497275814,0,2,regulation of exo-alpha-sialidase activity,BP,
19509,GO:1903016,1,0.994288730402198,0,1,negative regulation of exo-alpha-sialidase activity,BP,
19510,GO:1903017,1,0.994418208254504,0,1,positive regulation of exo-alpha-sialidase activity,BP,
19512,GO:1903019,1,0.929507952106269,0,12,negative regulation of glycoprotein metabolic process,BP,
19513,GO:1903020,1,0.870608961030438,0,21,positive regulation of glycoprotein metabolic process,BP,
19514,GO:1903025,1,0.942317955914569,0,9,regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
19515,GO:1903026,1,0.971094192702575,0,5,negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
19516,GO:1903027,1,0.985532526933639,0,2,regulation of opsonization,BP,
19517,GO:1903028,1,0.991351639056398,0,1,positive regulation of opsonization,BP,
19518,GO:1903031,1,0.988289080262179,0,2,regulation of microtubule plus-end binding,BP,
19519,GO:1903033,1,0.988289080262179,0,2,positive regulation of microtubule plus-end binding,BP,
19522,GO:1903036,1,0.724175426215078,0,50,positive regulation of response to wounding,BP,
19523,GO:1903037,1,0.191441177468557,0,261,regulation of leukocyte cell-cell adhesion,BP,
19524,GO:1903038,1,0.549766853977842,0,94,negative regulation of leukocyte cell-cell adhesion,BP,
19525,GO:1903039,1,0.292001456123706,0,196,positive regulation of leukocyte cell-cell adhesion,BP,
19526,GO:1903044,1,0.951428968668699,0,8,protein localization to membrane raft,BP,
19527,GO:1903045,1,0.992359008317099,0,1,neural crest cell migration involved in sympathetic nervous system development,BP,
19532,GO:1903052,1,0.480869797760514,0,112,positive regulation of proteolysis involved in cellular protein catabolic process,BP,
19533,GO:1903053,1,0.822125814794218,0,28,regulation of extracellular matrix organization,BP,
19534,GO:1903054,1,0.96472942829696,0,6,negative regulation of extracellular matrix organization,BP,
19535,GO:1903055,1,0.90141138380688,0,15,positive regulation of extracellular matrix organization,BP,
19536,GO:1903056,1,0.985000070452668,0,2,regulation of melanosome organization,BP,
19539,GO:1903061,1,0.973100411987206,0,4,positive regulation of protein lipidation,BP,
19540,GO:1903069,1,0.946276591787631,0,9,regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
19541,GO:1903070,1,0.981938215747079,0,3,negative regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
19542,GO:1903071,1,0.957990324372073,0,7,positive regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
19543,GO:1903072,1,0.994806490833661,0,1,regulation of death-inducing signaling complex assembly,BP,
19544,GO:1903073,1,0.994806490833661,0,1,negative regulation of death-inducing signaling complex assembly,BP,
19545,GO:1903076,1,0.588230484294669,0,80,regulation of protein localization to plasma membrane,BP,
19546,GO:1903077,1,0.867838001499455,0,22,negative regulation of protein localization to plasma membrane,BP,
19547,GO:1903078,1,0.726349193272899,0,47,positive regulation of protein localization to plasma membrane,BP,
19548,GO:1903080,1,0.994745534763665,0,1,regulation of C-C chemokine receptor CCR7 signaling pathway,BP,
19549,GO:1903082,1,0.994745534763665,0,1,positive regulation of C-C chemokine receptor CCR7 signaling pathway,BP,
19550,GO:1903093,1,0.981163288890039,0,3,regulation of protein K48-linked deubiquitination,BP,
19551,GO:1903094,1,0.989455688250091,0,2,negative regulation of protein K48-linked deubiquitination,BP,
19552,GO:1903095,1,0.986888853068321,0,2,ribonuclease III complex,CC,
19553,GO:1903096,1,0.993723958214045,0,1,protein localization to meiotic spindle midzone,BP,
19554,GO:1903108,1,0.992649397692802,0,1,regulation of mitochondrial transcription,BP,
19555,GO:1903109,1,0.992649397692802,0,1,positive regulation of mitochondrial transcription,BP,
19556,GO:1903115,1,0.754735196088604,0,38,regulation of actin filament-based movement,BP,
19557,GO:1903116,1,0.979553921453873,0,3,positive regulation of actin filament-based movement,BP,
19558,GO:1903119,1,0.978963743271495,0,3,protein localization to actin cytoskeleton,BP,
19559,GO:1903121,1,0.974160443691245,0,4,regulation of TRAIL-activated apoptotic signaling pathway,BP,
19560,GO:1903122,1,0.994806490833661,0,1,negative regulation of TRAIL-activated apoptotic signaling pathway,BP,
19561,GO:1903123,1,0.990489208522649,0,1,regulation of thioredoxin peroxidase activity,BP,
19562,GO:1903124,1,0.990489208522649,0,1,negative regulation of thioredoxin peroxidase activity,BP,
19563,GO:1903125,1,0.990489208522649,0,1,negative regulation of thioredoxin peroxidase activity by peptidyl-threonine phosphorylation,BP,
19564,GO:1903126,1,0.994186413900613,0,1,negative regulation of centriole-centriole cohesion,BP,
19565,GO:1903131,1,0.820101031438079,0,30,mononuclear cell differentiation,BP,
19566,GO:1903135,1,0.98201672443665,0,3,cupric ion binding,MF,
19567,GO:1903136,1,0.963429450393924,0,6,cuprous ion binding,MF,
19568,GO:1903140,1,0.924425665734887,0,12,regulation of establishment of endothelial barrier,BP,
19569,GO:1903141,1,0.993123196197072,0,1,negative regulation of establishment of endothelial barrier,BP,
19570,GO:1903142,1,0.968833282304984,0,5,positive regulation of establishment of endothelial barrier,BP,
19571,GO:1903143,1,0.982288250426447,0,3,adrenomedullin receptor complex,CC,
19572,GO:1903146,1,0.745312516232446,0,44,regulation of autophagy of mitochondrion,BP,
19573,GO:1903147,1,0.954805521687755,0,7,negative regulation of autophagy of mitochondrion,BP,
19574,GO:1903165,1,0.993896896634834,0,1,response to polycyclic arene,BP,
19575,GO:1903167,1,0.994806490833661,0,1,regulation of pyrroline-5-carboxylate reductase activity,BP,
19576,GO:1903168,1,0.994806490833661,0,1,positive regulation of pyrroline-5-carboxylate reductase activity,BP,
19578,GO:1903170,1,0.80777688616588,0,34,negative regulation of calcium ion transmembrane transport,BP,
19579,GO:1903173,1,0.987703210438038,0,2,fatty alcohol metabolic process,BP,
19580,GO:1903176,1,0.994806490833661,0,1,regulation of tyrosine 3-monooxygenase activity,BP,
19581,GO:1903178,1,0.994806490833661,0,1,positive regulation of tyrosine 3-monooxygenase activity,BP,
19582,GO:1903179,1,0.988428539782423,0,2,regulation of dopamine biosynthetic process,BP,
19583,GO:1903181,1,0.988428539782423,0,2,positive regulation of dopamine biosynthetic process,BP,
19584,GO:1903182,1,0.994668043425921,0,1,regulation of SUMO transferase activity,BP,
19585,GO:1903184,1,0.994806490833661,0,1,L-dopa metabolic process,BP,
19586,GO:1903185,1,0.994806490833661,0,1,L-dopa biosynthetic process,BP,
19587,GO:1903189,1,0.994806490833661,0,1,glyoxal metabolic process,BP,
19588,GO:1903195,1,0.994806490833661,0,1,regulation of L-dopa biosynthetic process,BP,
19589,GO:1903197,1,0.994806490833661,0,1,positive regulation of L-dopa biosynthetic process,BP,
19590,GO:1903198,1,0.994806490833661,0,1,regulation of L-dopa decarboxylase activity,BP,
19591,GO:1903200,1,0.994806490833661,0,1,positive regulation of L-dopa decarboxylase activity,BP,
19592,GO:1903201,1,0.692869905640694,0,57,regulation of oxidative stress-induced cell death,BP,
19593,GO:1903202,1,0.779002625396883,0,39,negative regulation of oxidative stress-induced cell death,BP,
19594,GO:1903203,1,0.873414510599193,0,20,regulation of oxidative stress-induced neuron death,BP,
19595,GO:1903204,1,0.905131045378646,0,15,negative regulation of oxidative stress-induced neuron death,BP,
19596,GO:1903205,1,0.857164822466415,0,24,regulation of hydrogen peroxide-induced cell death,BP,
19597,GO:1903206,1,0.897045177620514,0,17,negative regulation of hydrogen peroxide-induced cell death,BP,
19598,GO:1903207,1,0.975928539262051,0,4,regulation of hydrogen peroxide-induced neuron death,BP,
19599,GO:1903208,1,0.975928539262051,0,4,negative regulation of hydrogen peroxide-induced neuron death,BP,
19600,GO:1903209,1,0.918999392420414,0,13,positive regulation of oxidative stress-induced cell death,BP,
19601,GO:1903210,1,0.992013629895481,0,1,glomerular visceral epithelial cell apoptotic process,BP,
19603,GO:1903215,1,0.972841075810685,0,4,negative regulation of protein targeting to mitochondrion,BP,
19604,GO:1903216,1,0.985223831137443,0,2,regulation of protein processing involved in protein targeting to mitochondrion,BP,
19605,GO:1903217,1,0.985223831137443,0,2,negative regulation of protein processing involved in protein targeting to mitochondrion,BP,
19606,GO:1903223,1,0.971576702374671,0,4,positive regulation of oxidative stress-induced neuron death,BP,
19607,GO:1903224,1,0.966015344072689,0,5,regulation of endodermal cell differentiation,BP,
19608,GO:1903225,1,0.977416497281463,0,3,negative regulation of endodermal cell differentiation,BP,
19609,GO:1903232,1,0.971409555660836,0,5,melanosome assembly,BP,
19610,GO:1903233,1,0.983817125733698,0,2,regulation of calcium ion-dependent exocytosis of neurotransmitter,BP,
19611,GO:1903236,1,0.953867032334333,0,8,regulation of leukocyte tethering or rolling,BP,
19612,GO:1903237,1,0.978990710519592,0,4,negative regulation of leukocyte tethering or rolling,BP,
19613,GO:1903238,1,0.974342600494712,0,4,positive regulation of leukocyte tethering or rolling,BP,
19614,GO:1903242,1,0.944252060238905,0,8,regulation of cardiac muscle hypertrophy in response to stress,BP,
19615,GO:1903243,1,0.957232015703291,0,6,negative regulation of cardiac muscle hypertrophy in response to stress,BP,
19616,GO:1903244,1,0.986446057618503,0,2,positive regulation of cardiac muscle hypertrophy in response to stress,BP,
19617,GO:1903248,1,0.990713196986705,0,1,regulation of citrulline biosynthetic process,BP,
19618,GO:1903249,1,0.990713196986705,0,1,negative regulation of citrulline biosynthetic process,BP,
19619,GO:1903251,1,0.96230850234758,0,6,multi-ciliated epithelial cell differentiation,BP,
19620,GO:1903265,1,0.953473018593713,0,8,positive regulation of tumor necrosis factor-mediated signaling pathway,BP,
19623,GO:1903279,1,0.979839699780206,0,3,regulation of calcium:sodium antiporter activity,BP,
19624,GO:1903280,1,0.992459667068166,0,1,negative regulation of calcium:sodium antiporter activity,BP,
19625,GO:1903281,1,0.987285116545652,0,2,positive regulation of calcium:sodium antiporter activity,BP,
19626,GO:1903282,1,0.993653817804457,0,1,regulation of glutathione peroxidase activity,BP,
19627,GO:1903284,1,0.993653817804457,0,1,positive regulation of glutathione peroxidase activity,BP,
19628,GO:1903285,1,0.993653817804457,0,1,positive regulation of hydrogen peroxide catabolic process,BP,
19629,GO:1903286,1,0.975144955432437,0,4,regulation of potassium ion import,BP,
19630,GO:1903288,1,0.982320600673794,0,3,positive regulation of potassium ion import,BP,
19631,GO:1903292,1,0.987262647956287,0,2,protein localization to Golgi membrane,BP,
19632,GO:1903293,1,0.750154739427445,0,44,phosphatase complex,CC,
19633,GO:1903294,1,0.986054178225056,0,2,regulation of glutamate secretion, neurotransmission,BP,
19634,GO:1903296,1,0.986054178225056,0,2,positive regulation of glutamate secretion, neurotransmission,BP,
19635,GO:1903297,1,0.969842255636932,0,5,regulation of hypoxia-induced intrinsic apoptotic signaling pathway,BP,
19636,GO:1903298,1,0.969842255636932,0,5,negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway,BP,
19637,GO:1903299,1,0.943229747845346,0,9,regulation of hexokinase activity,BP,
19638,GO:1903300,1,0.97644894792023,0,4,negative regulation of hexokinase activity,BP,
19639,GO:1903301,1,0.965987633247948,0,5,positive regulation of hexokinase activity,BP,
19640,GO:1903305,1,0.464096453644017,0,116,regulation of regulated secretory pathway,BP,
19641,GO:1903306,1,0.877614351546627,0,20,negative regulation of regulated secretory pathway,BP,
19642,GO:1903307,1,0.74158529436859,0,46,positive regulation of regulated secretory pathway,BP,
19643,GO:1903311,1,0.17091218984712,0,271,regulation of mRNA metabolic process,BP,
19644,GO:1903312,1,0.640772122390753,0,68,negative regulation of mRNA metabolic process,BP,
19645,GO:1903313,1,0.655246744026584,0,62,positive regulation of mRNA metabolic process,BP,
19646,GO:1903314,1,0.994178148773045,0,1,regulation of nitrogen cycle metabolic process,BP,
19651,GO:1903321,1,0.637295405209232,0,70,negative regulation of protein modification by small protein conjugation or removal,BP,
19653,GO:1903332,1,0.957587727741384,0,7,regulation of protein folding,BP,
19654,GO:1903333,1,0.969954996945363,0,5,negative regulation of protein folding,BP,
19655,GO:1903335,1,0.973361702676847,0,4,regulation of vacuolar transport,BP,
19656,GO:1903336,1,0.984138659423316,0,2,negative regulation of vacuolar transport,BP,
19657,GO:1903337,1,0.98905110994705,0,2,positive regulation of vacuolar transport,BP,
19658,GO:1903347,1,0.971778998134853,0,4,negative regulation of bicellular tight junction assembly,BP,
19659,GO:1903348,1,0.980254861519098,0,3,positive regulation of bicellular tight junction assembly,BP,
19660,GO:1903349,1,0.96254731475251,0,6,omegasome membrane,CC,
19661,GO:1903350,1,0.914336803553251,0,13,response to dopamine,BP,
19662,GO:1903351,1,0.914336803553251,0,13,cellular response to dopamine,BP,
19663,GO:1903352,1,0.959505556273605,0,6,L-ornithine transmembrane transport,BP,
19664,GO:1903358,1,0.905067771896005,0,15,regulation of Golgi organization,BP,
19665,GO:1903361,1,0.959268575814505,0,7,protein localization to basolateral plasma membrane,BP,
19668,GO:1903364,1,0.419791677004621,0,131,positive regulation of cellular protein catabolic process,BP,
19669,GO:1903365,1,0.957290082082052,0,7,regulation of fear response,BP,
19670,GO:1903367,1,0.970290261120305,0,5,positive regulation of fear response,BP,
19671,GO:1903371,1,0.969957046980336,0,4,regulation of endoplasmic reticulum tubular network organization,BP,
19672,GO:1903373,1,0.978483065358206,0,3,positive regulation of endoplasmic reticulum tubular network organization,BP,
19673,GO:1903375,1,0.986409117076351,0,2,facioacoustic ganglion development,BP,
19674,GO:1903376,1,0.956355606209587,0,7,regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19675,GO:1903377,1,0.975862869456165,0,4,negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19676,GO:1903378,1,0.98669944307609,0,2,positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19677,GO:1903381,1,0.992936770176133,0,1,regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19678,GO:1903382,1,0.992936770176133,0,1,negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19679,GO:1903383,1,0.988751396060123,0,2,regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,BP,
19680,GO:1903384,1,0.988751396060123,0,2,negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,BP,
19681,GO:1903385,1,0.986105173172812,0,2,regulation of homophilic cell adhesion,BP,
19682,GO:1903387,1,0.992559275203521,0,1,positive regulation of homophilic cell adhesion,BP,
19683,GO:1903391,1,0.670137777595214,0,56,regulation of adherens junction organization,BP,
19684,GO:1903392,1,0.894982482469434,0,16,negative regulation of adherens junction organization,BP,
19685,GO:1903393,1,0.83573426722574,0,25,positive regulation of adherens junction organization,BP,
19686,GO:1903394,1,0.994073344588183,0,1,protein localization to kinetochore involved in kinetochore assembly,BP,
19687,GO:1903400,1,0.965475822547636,0,5,L-arginine transmembrane transport,BP,
19688,GO:1903401,1,0.968235466224072,0,5,L-lysine transmembrane transport,BP,
19689,GO:1903402,1,0.993291347376045,0,1,regulation of renal phosphate excretion,BP,
19690,GO:1903403,1,0.993291347376045,0,1,negative regulation of renal phosphate excretion,BP,
19691,GO:1903405,1,0.948258628013216,0,9,protein localization to nuclear body,BP,
19692,GO:1903406,1,0.993411193433432,0,1,regulation of sodium:potassium-exchanging ATPase activity,BP,
19693,GO:1903408,1,0.993411193433432,0,1,positive regulation of sodium:potassium-exchanging ATPase activity,BP,
19694,GO:1903409,1,0.579508722593046,0,83,reactive oxygen species biosynthetic process,BP,
19695,GO:1903412,1,0.982904877113141,0,3,response to bile acid,BP,
19696,GO:1903413,1,0.982904877113141,0,3,cellular response to bile acid,BP,
19697,GO:1903414,1,0.993557877795695,0,1,iron cation export,BP,
19698,GO:1903416,1,0.961571568342071,0,6,response to glycoside,BP,
19699,GO:1903420,1,0.99196872111255,0,1,protein localization to endoplasmic reticulum tubular network,BP,
19700,GO:1903421,1,0.897590275409218,0,15,regulation of synaptic vesicle recycling,BP,
19701,GO:1903422,1,0.985572493586936,0,2,negative regulation of synaptic vesicle recycling,BP,
19702,GO:1903423,1,0.949172143481867,0,7,positive regulation of synaptic vesicle recycling,BP,
19703,GO:1903426,1,0.656835345245594,0,65,regulation of reactive oxygen species biosynthetic process,BP,
19704,GO:1903427,1,0.876137097268683,0,21,negative regulation of reactive oxygen species biosynthetic process,BP,
19705,GO:1903428,1,0.759362154165045,0,42,positive regulation of reactive oxygen species biosynthetic process,BP,
19706,GO:1903429,1,0.874641930455429,0,20,regulation of cell maturation,BP,
19707,GO:1903430,1,0.958626511552071,0,7,negative regulation of cell maturation,BP,
19708,GO:1903431,1,0.950885782727166,0,7,positive regulation of cell maturation,BP,
19709,GO:1903432,1,0.849109797340245,0,25,regulation of TORC1 signaling,BP,
19710,GO:1903433,1,0.987182328442016,0,2,regulation of constitutive secretory pathway,BP,
19711,GO:1903434,1,0.993300086491463,0,1,negative regulation of constitutive secretory pathway,BP,
19712,GO:1903435,1,0.99384139396637,0,1,positive regulation of constitutive secretory pathway,BP,
19713,GO:1903436,1,0.985634729738397,0,2,regulation of mitotic cytokinetic process,BP,
19714,GO:1903438,1,0.985634729738397,0,2,positive regulation of mitotic cytokinetic process,BP,
19715,GO:1903439,1,0.970772212115502,0,5,calcitonin family receptor complex,CC,
19716,GO:1903440,1,0.977907239459469,0,4,amylin receptor complex,CC,
19717,GO:1903441,1,0.950424689931582,0,8,protein localization to ciliary membrane,BP,
19718,GO:1903442,1,0.99331653001693,0,1,response to lipoic acid,BP,
19719,GO:1903444,1,0.993659447561876,0,1,negative regulation of brown fat cell differentiation,BP,
19720,GO:1903445,1,0.983152862888506,0,3,protein transport from ciliary membrane to plasma membrane,BP,
19721,GO:1903450,1,0.990814956566794,0,1,regulation of G1 to G0 transition,BP,
19722,GO:1903452,1,0.990814956566794,0,1,positive regulation of G1 to G0 transition,BP,
19723,GO:1903461,1,0.993685808991134,0,1,Okazaki fragment processing involved in mitotic DNA replication,BP,
19724,GO:1903463,1,0.98028985453651,0,3,regulation of mitotic cell cycle DNA replication,BP,
19725,GO:1903464,1,0.987826850323905,0,2,negative regulation of mitotic cell cycle DNA replication,BP,
19726,GO:1903465,1,0.992371064595669,0,1,positive regulation of mitotic cell cycle DNA replication,BP,
19727,GO:1903487,1,0.987853341800358,0,2,regulation of lactation,BP,
19728,GO:1903489,1,0.994355150667844,0,1,positive regulation of lactation,BP,
19729,GO:1903490,1,0.985634729738397,0,2,positive regulation of mitotic cytokinesis,BP,
19730,GO:1903494,1,0.994783245209959,0,1,response to dehydroepiandrosterone,BP,
19731,GO:1903496,1,0.994783245209959,0,1,response to 11-deoxycorticosterone,BP,
19732,GO:1903504,1,0.91343369707999,0,14,regulation of mitotic spindle checkpoint,BP,
19736,GO:1903509,1,0.47655584695135,0,118,liposaccharide metabolic process,BP,
19737,GO:1903510,1,0.485703580104816,0,108,mucopolysaccharide metabolic process,BP,
19738,GO:1903513,1,0.846994315600245,0,26,endoplasmic reticulum to cytosol transport,BP,
19739,GO:1903514,1,0.807874717582334,0,29,release of sequestered calcium ion into cytosol by endoplasmic reticulum,BP,
19740,GO:1903515,1,0.99101623176355,0,1,calcium ion transport from cytosol to endoplasmic reticulum,BP,
19741,GO:1903516,1,0.981330567459038,0,3,regulation of single strand break repair,BP,
19742,GO:1903517,1,0.993791868572001,0,1,negative regulation of single strand break repair,BP,
19743,GO:1903518,1,0.987461638195379,0,2,positive regulation of single strand break repair,BP,
19744,GO:1903519,1,0.980969023431266,0,3,regulation of mammary gland involution,BP,
19745,GO:1903521,1,0.980969023431266,0,3,positive regulation of mammary gland involution,BP,
19748,GO:1903524,1,0.683565334142705,0,60,positive regulation of blood circulation,BP,
19749,GO:1903525,1,0.964230040655771,0,5,regulation of membrane tubulation,BP,
19750,GO:1903526,1,0.986464849101545,0,2,negative regulation of membrane tubulation,BP,
19751,GO:1903527,1,0.977463176360636,0,3,positive regulation of membrane tubulation,BP,
19753,GO:1903531,1,0.362745579845482,0,158,negative regulation of secretion by cell,BP,
19756,GO:1903537,1,0.987927082721405,0,2,meiotic cell cycle process involved in oocyte maturation,BP,
19757,GO:1903538,1,0.987927082721405,0,2,regulation of meiotic cell cycle process involved in oocyte maturation,BP,
19758,GO:1903539,1,0.92037579400084,0,12,protein localization to postsynaptic membrane,BP,
19759,GO:1903540,1,0.944718855437561,0,9,establishment of protein localization to postsynaptic membrane,BP,
19760,GO:1903541,1,0.916618712027111,0,14,regulation of exosomal secretion,BP,
19761,GO:1903542,1,0.98771682345157,0,2,negative regulation of exosomal secretion,BP,
19762,GO:1903543,1,0.916618712027111,0,14,positive regulation of exosomal secretion,BP,
19763,GO:1903544,1,0.993526152433194,0,1,response to butyrate,BP,
19764,GO:1903545,1,0.993526152433194,0,1,cellular response to butyrate,BP,
19765,GO:1903546,1,0.960765598716861,0,6,protein localization to photoreceptor outer segment,BP,
19766,GO:1903547,1,0.989424843684939,0,2,regulation of growth hormone activity,BP,
19767,GO:1903551,1,0.96293087359323,0,6,regulation of extracellular exosome assembly,BP,
19768,GO:1903553,1,0.974351905104196,0,4,positive regulation of extracellular exosome assembly,BP,
19769,GO:1903555,1,0.498418696692512,0,110,regulation of tumor necrosis factor superfamily cytokine production,BP,
19770,GO:1903556,1,0.760848716177287,0,45,negative regulation of tumor necrosis factor superfamily cytokine production,BP,
19771,GO:1903557,1,0.654036626494335,0,66,positive regulation of tumor necrosis factor superfamily cytokine production,BP,
19773,GO:1903564,1,0.969975002540597,0,4,regulation of protein localization to cilium,BP,
19774,GO:1903565,1,0.993533828399082,0,1,negative regulation of protein localization to cilium,BP,
19775,GO:1903566,1,0.976289381682442,0,3,positive regulation of protein localization to cilium,BP,
19776,GO:1903567,1,0.987636396453854,0,2,regulation of protein localization to ciliary membrane,BP,
19777,GO:1903568,1,0.993533828399082,0,1,negative regulation of protein localization to ciliary membrane,BP,
19778,GO:1903569,1,0.994064573961392,0,1,positive regulation of protein localization to ciliary membrane,BP,
19779,GO:1903570,1,0.993473686849716,0,1,regulation of protein kinase D signaling,BP,
19780,GO:1903572,1,0.993473686849716,0,1,positive regulation of protein kinase D signaling,BP,
19781,GO:1903573,1,0.775298531147102,0,40,negative regulation of response to endoplasmic reticulum stress,BP,
19782,GO:1903575,1,0.988104290590927,0,2,cornified envelope assembly,BP,
19783,GO:1903576,1,0.994219479532597,0,1,response to L-arginine,BP,
19785,GO:1903579,1,0.882550735889621,0,19,negative regulation of ATP metabolic process,BP,
19787,GO:1903584,1,0.99302883062763,0,1,regulation of histone deubiquitination,BP,
19788,GO:1903586,1,0.99302883062763,0,1,positive regulation of histone deubiquitination,BP,
19790,GO:1903588,1,0.974230905983868,0,4,negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
19792,GO:1903593,1,0.98382346656263,0,3,regulation of histamine secretion by mast cell,BP,
19793,GO:1903595,1,0.98382346656263,0,3,positive regulation of histamine secretion by mast cell,BP,
19794,GO:1903596,1,0.975125505432519,0,4,regulation of gap junction assembly,BP,
19795,GO:1903597,1,0.993554040284568,0,1,negative regulation of gap junction assembly,BP,
19796,GO:1903598,1,0.981453105361741,0,3,positive regulation of gap junction assembly,BP,
19797,GO:1903599,1,0.887656296821306,0,17,positive regulation of autophagy of mitochondrion,BP,
19798,GO:1903608,1,0.961718425540203,0,6,protein localization to cytoplasmic stress granule,BP,
19799,GO:1903609,1,0.993908726252119,0,1,negative regulation of inward rectifier potassium channel activity,BP,
19800,GO:1903610,1,0.994292606909101,0,1,regulation of calcium-dependent ATPase activity,BP,
19801,GO:1903611,1,0.994292606909101,0,1,negative regulation of calcium-dependent ATPase activity,BP,
19802,GO:1903613,1,0.992523891905727,0,1,regulation of protein tyrosine phosphatase activity,BP,
19803,GO:1903615,1,0.992523891905727,0,1,positive regulation of protein tyrosine phosphatase activity,BP,
19804,GO:1903618,1,0.993224430037506,0,1,regulation of transdifferentiation,BP,
19805,GO:1903620,1,0.993224430037506,0,1,positive regulation of transdifferentiation,BP,
19806,GO:1903621,1,0.994283303357982,0,1,protein localization to photoreceptor connecting cilium,BP,
19807,GO:1903624,1,0.943377673092825,0,9,regulation of DNA catabolic process,BP,
19808,GO:1903625,1,0.988214016111817,0,2,negative regulation of DNA catabolic process,BP,
19809,GO:1903626,1,0.973545129587953,0,4,positive regulation of DNA catabolic process,BP,
19810,GO:1903627,1,0.994292606909101,0,1,regulation of dUTP diphosphatase activity,BP,
19811,GO:1903629,1,0.994292606909101,0,1,positive regulation of dUTP diphosphatase activity,BP,
19812,GO:1903630,1,0.988982556456287,0,2,regulation of aminoacyl-tRNA ligase activity,BP,
19813,GO:1903631,1,0.994292606909101,0,1,negative regulation of aminoacyl-tRNA ligase activity,BP,
19814,GO:1903632,1,0.994659777306154,0,1,positive regulation of aminoacyl-tRNA ligase activity,BP,
19815,GO:1903633,1,0.994292606909101,0,1,regulation of leucine-tRNA ligase activity,BP,
19816,GO:1903634,1,0.994292606909101,0,1,negative regulation of leucine-tRNA ligase activity,BP,
19817,GO:1903636,1,0.994999677880221,0,1,regulation of protein import into mitochondrial outer membrane,BP,
19818,GO:1903638,1,0.994999677880221,0,1,positive regulation of protein import into mitochondrial outer membrane,BP,
19819,GO:1903639,1,0.995023438339568,0,1,regulation of gastrin-induced gastric acid secretion,BP,
19820,GO:1903640,1,0.995023438339568,0,1,negative regulation of gastrin-induced gastric acid secretion,BP,
19821,GO:1903644,1,0.988998738354799,0,2,regulation of chaperone-mediated protein folding,BP,
19822,GO:1903645,1,0.994999677880221,0,1,negative regulation of chaperone-mediated protein folding,BP,
19823,GO:1903649,1,0.872050070761014,0,20,regulation of cytoplasmic transport,BP,
19824,GO:1903650,1,0.98954273897705,0,2,negative regulation of cytoplasmic transport,BP,
19825,GO:1903651,1,0.937170565508662,0,9,positive regulation of cytoplasmic transport,BP,
19826,GO:1903659,1,0.988632610351163,0,2,regulation of complement-dependent cytotoxicity,BP,
19827,GO:1903660,1,0.988632610351163,0,2,negative regulation of complement-dependent cytotoxicity,BP,
19829,GO:1903671,1,0.852048174750707,0,23,negative regulation of sprouting angiogenesis,BP,
19831,GO:1903673,1,0.994297000326347,0,1,mitotic cleavage furrow formation,BP,
19832,GO:1903674,1,0.994300618465776,0,1,regulation of cap-dependent translational initiation,BP,
19833,GO:1903676,1,0.994300618465776,0,1,positive regulation of cap-dependent translational initiation,BP,
19834,GO:1903677,1,0.982507638914079,0,3,regulation of cap-independent translational initiation,BP,
19835,GO:1903679,1,0.982507638914079,0,3,positive regulation of cap-independent translational initiation,BP,
19836,GO:1903689,1,0.949956708380633,0,6,regulation of wound healing, spreading of epidermal cells,BP,
19837,GO:1903690,1,0.967689350018507,0,4,negative regulation of wound healing, spreading of epidermal cells,BP,
19838,GO:1903691,1,0.981681287619611,0,2,positive regulation of wound healing, spreading of epidermal cells,BP,
19839,GO:1903697,1,0.993559412787292,0,1,negative regulation of microvillus assembly,BP,
19840,GO:1903699,1,0.989199650782065,0,1,tarsal gland development,BP,
19841,GO:1903701,1,0.992604083088988,0,1,substantia propria of cornea development,BP,
19842,GO:1903704,1,0.993224430037506,0,1,negative regulation of production of siRNA involved in RNA interference,BP,
19843,GO:1903706,1,0.0816406275479173,0,387,regulation of hemopoiesis,BP,
19844,GO:1903707,1,0.481081773147583,0,114,negative regulation of hemopoiesis,BP,
19845,GO:1903708,1,0.378011625316235,0,151,positive regulation of hemopoiesis,BP,
19846,GO:1903709,1,0.989199650782065,0,1,uterine gland development,BP,
19847,GO:1903712,1,0.99336683965506,0,1,cysteine transmembrane transport,BP,
19848,GO:1903715,1,0.9611858428549,0,6,regulation of aerobic respiration,BP,
19849,GO:1903717,1,0.992312364217936,0,1,response to ammonia,BP,
19850,GO:1903718,1,0.992312364217936,0,1,cellular response to ammonia,BP,
19851,GO:1903719,1,0.982660470099646,0,3,regulation of I-kappaB phosphorylation,BP,
19852,GO:1903721,1,0.982660470099646,0,3,positive regulation of I-kappaB phosphorylation,BP,
19853,GO:1903722,1,0.988399138967371,0,2,regulation of centriole elongation,BP,
19854,GO:1903723,1,0.994821471152595,0,1,negative regulation of centriole elongation,BP,
19855,GO:1903724,1,0.993544574192048,0,1,positive regulation of centriole elongation,BP,
19857,GO:1903726,1,0.957222266422428,0,7,negative regulation of phospholipid metabolic process,BP,
19859,GO:1903729,1,0.929444423626108,0,11,regulation of plasma membrane organization,BP,
19860,GO:1903742,1,0.994600878772001,0,1,regulation of anterograde synaptic vesicle transport,BP,
19861,GO:1903743,1,0.994600878772001,0,1,negative regulation of anterograde synaptic vesicle transport,BP,
19863,GO:1903748,1,0.95368852106524,0,7,negative regulation of establishment of protein localization to mitochondrion,BP,
19865,GO:1903750,1,0.976417952563875,0,4,regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
19866,GO:1903751,1,0.976417952563875,0,4,negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
19867,GO:1903753,1,0.968036433746404,0,5,negative regulation of p38MAPK cascade,BP,
19868,GO:1903755,1,0.994668043425921,0,1,positive regulation of SUMO transferase activity,BP,
19869,GO:1903756,1,0.987019661205618,0,2,regulation of transcription from RNA polymerase II promoter by histone modification,BP,
19870,GO:1903758,1,0.987019661205618,0,2,negative regulation of transcription from RNA polymerase II promoter by histone modification,BP,
19871,GO:1903759,1,0.993659447561876,0,1,signal transduction involved in regulation of aerobic respiration,BP,
19872,GO:1903760,1,0.97906727543986,0,3,regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,BP,
19873,GO:1903762,1,0.986271489597361,0,2,positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,BP,
19874,GO:1903763,1,0.979278693250964,0,3,gap junction channel activity involved in cell communication by electrical coupling,MF,
19875,GO:1903764,1,0.981366781861244,0,3,regulation of potassium ion export across plasma membrane,BP,
19876,GO:1903765,1,0.993706289308994,0,1,negative regulation of potassium ion export across plasma membrane,BP,
19877,GO:1903766,1,0.994849365179344,0,1,positive regulation of potassium ion export across plasma membrane,BP,
19878,GO:1903767,1,0.993966632638298,0,1,sweet taste receptor complex,CC,
19879,GO:1903768,1,0.993966632638298,0,1,taste receptor complex,CC,
19880,GO:1903770,1,0.993791868572001,0,1,negative regulation of beta-galactosidase activity,BP,
19881,GO:1903772,1,0.971369445798065,0,5,regulation of viral budding via host ESCRT complex,BP,
19882,GO:1903774,1,0.982627956959091,0,3,positive regulation of viral budding via host ESCRT complex,BP,
19883,GO:1903775,1,0.987772210289945,0,2,regulation of DNA double-strand break processing,BP,
19884,GO:1903778,1,0.991986995276228,0,1,protein localization to vacuolar membrane,BP,
19886,GO:1903781,1,0.979532362723882,0,3,positive regulation of cardiac conduction,BP,
19887,GO:1903786,1,0.993874018242704,0,1,regulation of glutathione biosynthetic process,BP,
19888,GO:1903788,1,0.993874018242704,0,1,positive regulation of glutathione biosynthetic process,BP,
19889,GO:1903789,1,0.94928353273184,0,8,regulation of amino acid transmembrane transport,BP,
19890,GO:1903792,1,0.862867084395881,0,22,negative regulation of anion transport,BP,
19891,GO:1903793,1,0.802234433999298,0,34,positive regulation of anion transport,BP,
19892,GO:1903795,1,0.95569922610682,0,6,regulation of inorganic anion transmembrane transport,BP,
19893,GO:1903796,1,0.984593599779105,0,2,negative regulation of inorganic anion transmembrane transport,BP,
19894,GO:1903797,1,0.985312556455917,0,2,positive regulation of inorganic anion transmembrane transport,BP,
19895,GO:1903798,1,0.910568508213829,0,14,regulation of production of miRNAs involved in gene silencing by miRNA,BP,
19896,GO:1903799,1,0.94410328188386,0,8,negative regulation of production of miRNAs involved in gene silencing by miRNA,BP,
19897,GO:1903800,1,0.958856889399939,0,7,positive regulation of production of miRNAs involved in gene silencing by miRNA,BP,
19898,GO:1903801,1,0.994118761776139,0,1,L-leucine import across plasma membrane,BP,
19899,GO:1903803,1,0.994292865344197,0,1,L-glutamine import across plasma membrane,BP,
19900,GO:1903804,1,0.993805719061549,0,1,glycine import across plasma membrane,BP,
19901,GO:1903814,1,0.994849365179344,0,1,regulation of collecting lymphatic vessel constriction,BP,
19902,GO:1903815,1,0.994849365179344,0,1,negative regulation of collecting lymphatic vessel constriction,BP,
19903,GO:1903817,1,0.949690471379259,0,8,negative regulation of voltage-gated potassium channel activity,BP,
19904,GO:1903818,1,0.910783896924335,0,13,positive regulation of voltage-gated potassium channel activity,BP,
19905,GO:1903823,1,0.993791868572001,0,1,telomere single strand break repair,BP,
19906,GO:1903824,1,0.993791868572001,0,1,negative regulation of telomere single strand break repair,BP,
19907,GO:1903825,1,0.48461450214132,0,107,organic acid transmembrane transport,BP,
19908,GO:1903826,1,0.959983240671289,0,6,arginine transmembrane transport,BP,
19910,GO:1903828,1,0.539950597658775,0,95,negative regulation of cellular protein localization,BP,
19912,GO:1903830,1,0.8992424811011,0,16,magnesium ion transmembrane transport,BP,
19913,GO:1903831,1,0.874872091570932,0,21,signal transduction involved in cellular response to ammonium ion,BP,
19914,GO:1903837,1,0.994010428273367,0,1,regulation of mRNA 3'-UTR binding,BP,
19915,GO:1903839,1,0.994010428273367,0,1,positive regulation of mRNA 3'-UTR binding,BP,
19917,GO:1903845,1,0.625619415770051,0,68,negative regulation of cellular response to transforming growth factor beta stimulus,BP,
19918,GO:1903846,1,0.843465527964113,0,25,positive regulation of cellular response to transforming growth factor beta stimulus,BP,
19919,GO:1903847,1,0.983590070976122,0,2,regulation of aorta morphogenesis,BP,
19920,GO:1903849,1,0.983590070976122,0,2,positive regulation of aorta morphogenesis,BP,
19921,GO:1903850,1,0.993913613330413,0,1,regulation of cristae formation,BP,
19922,GO:1903852,1,0.993913613330413,0,1,positive regulation of cristae formation,BP,
19924,GO:1903860,1,0.982460584234589,0,3,negative regulation of dendrite extension,BP,
19927,GO:1903867,1,0.940838250974695,0,9,extraembryonic membrane development,BP,
19928,GO:1903874,1,0.979700910268242,0,3,ferrous iron transmembrane transport,BP,
19929,GO:1903881,1,0.993374277796434,0,1,regulation of interleukin-17-mediated signaling pathway,BP,
19930,GO:1903883,1,0.993374277796434,0,1,positive regulation of interleukin-17-mediated signaling pathway,BP,
19931,GO:1903884,1,0.993374277796434,0,1,regulation of chemokine (C-C motif) ligand 20 production,BP,
19932,GO:1903886,1,0.993374277796434,0,1,positive regulation of chemokine (C-C motif) ligand 20 production,BP,
19933,GO:1903888,1,0.994886556596673,0,1,regulation of plant epidermal cell differentiation,BP,
19934,GO:1903889,1,0.994886556596673,0,1,negative regulation of plant epidermal cell differentiation,BP,
19935,GO:1903891,1,0.974827003827137,0,4,regulation of ATF6-mediated unfolded protein response,BP,
19936,GO:1903892,1,0.987385972845769,0,2,negative regulation of ATF6-mediated unfolded protein response,BP,
19937,GO:1903893,1,0.993998058902975,0,1,positive regulation of ATF6-mediated unfolded protein response,BP,
19938,GO:1903894,1,0.920384950086271,0,13,regulation of IRE1-mediated unfolded protein response,BP,
19939,GO:1903895,1,0.974964788890291,0,4,negative regulation of IRE1-mediated unfolded protein response,BP,
19940,GO:1903896,1,0.954550946898287,0,7,positive regulation of IRE1-mediated unfolded protein response,BP,
19941,GO:1903897,1,0.942968919472397,0,9,regulation of PERK-mediated unfolded protein response,BP,
19942,GO:1903898,1,0.96898910966589,0,5,negative regulation of PERK-mediated unfolded protein response,BP,
19943,GO:1903899,1,0.979776226632756,0,3,positive regulation of PERK-mediated unfolded protein response,BP,
19945,GO:1903901,1,0.64653885255953,0,69,negative regulation of viral life cycle,BP,
19947,GO:1903903,1,0.979347146372325,0,3,regulation of establishment of T cell polarity,BP,
19948,GO:1903905,1,0.985382704903746,0,2,positive regulation of establishment of T cell polarity,BP,
19949,GO:1903906,1,0.993875817209287,0,1,regulation of plasma membrane raft polarization,BP,
19950,GO:1903909,1,0.946670354983783,0,8,regulation of receptor clustering,BP,
19951,GO:1903910,1,0.994081084265276,0,1,negative regulation of receptor clustering,BP,
19952,GO:1903911,1,0.974053280866394,0,4,positive regulation of receptor clustering,BP,
19953,GO:1903912,1,0.973627006732373,0,4,negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,BP,
19954,GO:1903916,1,0.994058899436136,0,1,regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation,BP,
19955,GO:1903917,1,0.994058899436136,0,1,positive regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation,BP,
19956,GO:1903918,1,0.991381201365226,0,1,regulation of actin filament severing,BP,
19957,GO:1903919,1,0.991381201365226,0,1,negative regulation of actin filament severing,BP,
19958,GO:1903921,1,0.985309272745405,0,2,regulation of protein processing in phagocytic vesicle,BP,
19959,GO:1903923,1,0.985309272745405,0,2,positive regulation of protein processing in phagocytic vesicle,BP,
19960,GO:1903924,1,0.994139414088738,0,1,estradiol binding,MF,
19961,GO:1903925,1,0.994323361538874,0,1,response to bisphenol A,BP,
19962,GO:1903926,1,0.994323361538874,0,1,cellular response to bisphenol A,BP,
19963,GO:1903929,1,0.987759257734487,0,2,primary palate development,BP,
19964,GO:1903935,1,0.970995629374463,0,5,response to sodium arsenite,BP,
19965,GO:1903936,1,0.970995629374463,0,5,cellular response to sodium arsenite,BP,
19966,GO:1903937,1,0.992729490465192,0,1,response to acrylamide,BP,
19967,GO:1903939,1,0.993564529379673,0,1,regulation of TORC2 signaling,BP,
19968,GO:1903943,1,0.994275809008079,0,1,regulation of hepatocyte apoptotic process,BP,
19969,GO:1903944,1,0.994275809008079,0,1,negative regulation of hepatocyte apoptotic process,BP,
19970,GO:1903946,1,0.993706289308994,0,1,negative regulation of ventricular cardiac muscle cell action potential,BP,
19971,GO:1903947,1,0.986271489597361,0,2,positive regulation of ventricular cardiac muscle cell action potential,BP,
19972,GO:1903949,1,0.986475336170964,0,2,positive regulation of atrial cardiac muscle cell action potential,BP,
19973,GO:1903952,1,0.993239887333237,0,1,regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,BP,
19974,GO:1903954,1,0.993239887333237,0,1,positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,BP,
19976,GO:1903959,1,0.851562193502869,0,23,regulation of anion transmembrane transport,BP,
19977,GO:1903960,1,0.926288291208617,0,11,negative regulation of anion transmembrane transport,BP,
19978,GO:1903961,1,0.960600684428459,0,6,positive regulation of anion transmembrane transport,BP,
19979,GO:1903963,1,0.88887647387832,0,19,arachidonate transport,BP,
19980,GO:1903964,1,0.981107656917989,0,3,monounsaturated fatty acid metabolic process,BP,
19981,GO:1903965,1,0.994577111387632,0,1,monounsaturated fatty acid catabolic process,BP,
19982,GO:1903966,1,0.98645784305705,0,2,monounsaturated fatty acid biosynthetic process,BP,
19983,GO:1903969,1,0.983042765900935,0,3,regulation of response to macrophage colony-stimulating factor,BP,
19984,GO:1903970,1,0.988943834030219,0,2,negative regulation of response to macrophage colony-stimulating factor,BP,
19985,GO:1903971,1,0.994033627873654,0,1,positive regulation of response to macrophage colony-stimulating factor,BP,
19986,GO:1903972,1,0.983042765900935,0,3,regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
19987,GO:1903973,1,0.988943834030219,0,2,negative regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
19988,GO:1903974,1,0.994033627873654,0,1,positive regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
19989,GO:1903975,1,0.946687418602511,0,9,regulation of glial cell migration,BP,
19990,GO:1903976,1,0.977127277203704,0,4,negative regulation of glial cell migration,BP,
19991,GO:1903977,1,0.979712293010403,0,3,positive regulation of glial cell migration,BP,
19992,GO:1903978,1,0.936193334990386,0,9,regulation of microglial cell activation,BP,
19993,GO:1903979,1,0.987324097346239,0,2,negative regulation of microglial cell activation,BP,
19994,GO:1903980,1,0.953177821492667,0,7,positive regulation of microglial cell activation,BP,
19995,GO:1903984,1,0.979247248463398,0,3,positive regulation of TRAIL-activated apoptotic signaling pathway,BP,
19996,GO:1903988,1,0.993557877795695,0,1,ferrous iron export across plasma membrane,BP,
19997,GO:1903995,1,0.988697894846464,0,2,regulation of non-membrane spanning protein tyrosine kinase activity,BP,
19998,GO:1903997,1,0.988697894846464,0,2,positive regulation of non-membrane spanning protein tyrosine kinase activity,BP,
19999,GO:1903998,1,0.9733868525013,0,4,regulation of eating behavior,BP,
20000,GO:1903999,1,0.987501538334285,0,2,negative regulation of eating behavior,BP,
20001,GO:1904000,1,0.985708471932473,0,2,positive regulation of eating behavior,BP,
20002,GO:1904008,1,0.994563160586758,0,1,response to monosodium glutamate,BP,
20003,GO:1904009,1,0.994563160586758,0,1,cellular response to monosodium glutamate,BP,
20004,GO:1904010,1,0.994563160586758,0,1,response to Aroclor 1254,BP,
20005,GO:1904016,1,0.971492579759972,0,4,response to Thyroglobulin triiodothyronine,BP,
20006,GO:1904017,1,0.983866538208536,0,2,cellular response to Thyroglobulin triiodothyronine,BP,
20008,GO:1904019,1,0.55909561174741,0,86,epithelial cell apoptotic process,BP,
20009,GO:1904020,1,0.981722949410394,0,3,regulation of G-protein coupled receptor internalization,BP,
20010,GO:1904021,1,0.988019906861702,0,2,negative regulation of G-protein coupled receptor internalization,BP,
20011,GO:1904022,1,0.993627463299271,0,1,positive regulation of G-protein coupled receptor internalization,BP,
20012,GO:1904026,1,0.987867311382764,0,2,regulation of collagen fibril organization,BP,
20013,GO:1904027,1,0.993980025172119,0,1,negative regulation of collagen fibril organization,BP,
20014,GO:1904028,1,0.993850639026861,0,1,positive regulation of collagen fibril organization,BP,
20015,GO:1904029,1,0.570818087857672,0,88,regulation of cyclin-dependent protein kinase activity,BP,
20016,GO:1904030,1,0.808718831080057,0,32,negative regulation of cyclin-dependent protein kinase activity,BP,
20017,GO:1904031,1,0.79583647237165,0,36,positive regulation of cyclin-dependent protein kinase activity,BP,
20018,GO:1904035,1,0.660952934111458,0,63,regulation of epithelial cell apoptotic process,BP,
20019,GO:1904036,1,0.798064964327297,0,34,negative regulation of epithelial cell apoptotic process,BP,
20020,GO:1904037,1,0.843616807819496,0,26,positive regulation of epithelial cell apoptotic process,BP,
20021,GO:1904041,1,0.993590111754218,0,1,regulation of cystathionine beta-synthase activity,BP,
20022,GO:1904042,1,0.993590111754218,0,1,negative regulation of cystathionine beta-synthase activity,BP,
20023,GO:1904044,1,0.975587887467073,0,4,response to aldosterone,BP,
20024,GO:1904045,1,0.994146127068272,0,1,cellular response to aldosterone,BP,
20025,GO:1904046,1,0.989166722998187,0,2,negative regulation of vascular endothelial growth factor production,BP,
20026,GO:1904047,1,0.982029530937096,0,3,S-adenosyl-L-methionine binding,MF,
20027,GO:1904048,1,0.983075246765142,0,2,regulation of spontaneous neurotransmitter secretion,BP,
20028,GO:1904049,1,0.990062801978125,0,1,negative regulation of spontaneous neurotransmitter secretion,BP,
20029,GO:1904050,1,0.992943019572363,0,1,positive regulation of spontaneous neurotransmitter secretion,BP,
20030,GO:1904054,1,0.990741781317258,0,1,regulation of cholangiocyte proliferation,BP,
20031,GO:1904056,1,0.990741781317258,0,1,positive regulation of cholangiocyte proliferation,BP,
20032,GO:1904057,1,0.988425183790629,0,2,negative regulation of sensory perception of pain,BP,
20033,GO:1904058,1,0.967375015582058,0,5,positive regulation of sensory perception of pain,BP,
20034,GO:1904059,1,0.981553714685742,0,2,regulation of locomotor rhythm,BP,
20036,GO:1904063,1,0.639444381828303,0,69,negative regulation of cation transmembrane transport,BP,
20038,GO:1904071,1,0.983951736321401,0,2,presynaptic active zone assembly,BP,
20039,GO:1904073,1,0.991525779307736,0,1,regulation of trophectodermal cell proliferation,BP,
20040,GO:1904075,1,0.991525779307736,0,1,positive regulation of trophectodermal cell proliferation,BP,
20041,GO:1904090,1,0.978356119070355,0,4,peptidase inhibitor complex,CC,
20042,GO:1904098,1,0.980982492609245,0,3,regulation of protein O-linked glycosylation,BP,
20043,GO:1904100,1,0.980982492609245,0,3,positive regulation of protein O-linked glycosylation,BP,
20045,GO:1904115,1,0.762529205038955,0,40,axon cytoplasm,CC,
20046,GO:1904116,1,0.979630742427342,0,3,response to vasopressin,BP,
20047,GO:1904117,1,0.979630742427342,0,3,cellular response to vasopressin,BP,
20048,GO:1904118,1,0.993683761241314,0,1,regulation of otic vesicle morphogenesis,BP,
20049,GO:1904120,1,0.993683761241314,0,1,positive regulation of otic vesicle morphogenesis,BP,
20050,GO:1904121,1,0.978802067744759,0,3,phosphatidylethanolamine transporter activity,MF,
20051,GO:1904124,1,0.983154406366271,0,3,microglial cell migration,BP,
20052,GO:1904139,1,0.983154406366271,0,3,regulation of microglial cell migration,BP,
20053,GO:1904140,1,0.994505287372902,0,1,negative regulation of microglial cell migration,BP,
20054,GO:1904141,1,0.994033627873654,0,1,positive regulation of microglial cell migration,BP,
20055,GO:1904149,1,0.994505287372902,0,1,regulation of microglial cell mediated cytotoxicity,BP,
20056,GO:1904151,1,0.994505287372902,0,1,positive regulation of microglial cell mediated cytotoxicity,BP,
20057,GO:1904152,1,0.920693997382347,0,13,regulation of retrograde protein transport, ER to cytosol,BP,
20058,GO:1904153,1,0.944690957352467,0,9,negative regulation of retrograde protein transport, ER to cytosol,BP,
20059,GO:1904154,1,0.981013368693246,0,3,positive regulation of retrograde protein transport, ER to cytosol,BP,
20060,GO:1904155,1,0.993564273551594,0,1,DN2 thymocyte differentiation,BP,
20061,GO:1904156,1,0.993564273551594,0,1,DN3 thymocyte differentiation,BP,
20062,GO:1904158,1,0.976333635316411,0,3,axonemal central apparatus assembly,BP,
20063,GO:1904167,1,0.989864112083234,0,1,regulation of thyroid hormone receptor activity,BP,
20064,GO:1904168,1,0.989864112083234,0,1,negative regulation of thyroid hormone receptor activity,BP,
20065,GO:1904170,1,0.986530777176185,0,2,regulation of bleb assembly,BP,
20066,GO:1904172,1,0.986530777176185,0,2,positive regulation of bleb assembly,BP,
20067,GO:1904177,1,0.962100104438758,0,6,regulation of adipose tissue development,BP,
20068,GO:1904179,1,0.967280075372108,0,5,positive regulation of adipose tissue development,BP,
20069,GO:1904180,1,0.963995878955237,0,6,negative regulation of membrane depolarization,BP,
20070,GO:1904181,1,0.936747592297311,0,10,positive regulation of membrane depolarization,BP,
20071,GO:1904182,1,0.994684575433119,0,1,regulation of pyruvate dehydrogenase activity,BP,
20072,GO:1904192,1,0.990741781317258,0,1,regulation of cholangiocyte apoptotic process,BP,
20073,GO:1904193,1,0.990741781317258,0,1,negative regulation of cholangiocyte apoptotic process,BP,
20074,GO:1904195,1,0.990741781317258,0,1,regulation of granulosa cell proliferation,BP,
20075,GO:1904197,1,0.990741781317258,0,1,positive regulation of granulosa cell proliferation,BP,
20076,GO:1904199,1,0.993189873360537,0,1,positive regulation of regulation of vascular smooth muscle cell membrane depolarization,BP,
20077,GO:1904200,1,0.990741781317258,0,1,iodide transmembrane transport,BP,
20078,GO:1904201,1,0.990741781317258,0,1,regulation of iodide transport,BP,
20079,GO:1904202,1,0.990741781317258,0,1,negative regulation of iodide transport,BP,
20080,GO:1904204,1,0.982874166104176,0,2,regulation of skeletal muscle hypertrophy,BP,
20081,GO:1904205,1,0.992059605957339,0,1,negative regulation of skeletal muscle hypertrophy,BP,
20082,GO:1904206,1,0.990741781317258,0,1,positive regulation of skeletal muscle hypertrophy,BP,
20085,GO:1904210,1,0.99457246115258,0,1,VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
20086,GO:1904211,1,0.987114650184943,0,2,membrane protein proteolysis involved in retrograde protein transport, ER to cytosol,BP,
20087,GO:1904212,1,0.990741781317258,0,1,regulation of iodide transmembrane transport,BP,
20088,GO:1904213,1,0.990741781317258,0,1,negative regulation of iodide transmembrane transport,BP,
20089,GO:1904217,1,0.982315813926982,0,3,regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,BP,
20090,GO:1904219,1,0.982315813926982,0,3,positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,BP,
20091,GO:1904220,1,0.976274113480083,0,4,regulation of serine C-palmitoyltransferase activity,BP,
20092,GO:1904222,1,0.982315813926982,0,3,positive regulation of serine C-palmitoyltransferase activity,BP,
20093,GO:1904226,1,0.994159554370149,0,1,regulation of glycogen synthase activity, transferring glucose-1-phosphate,BP,
20094,GO:1904227,1,0.994159554370149,0,1,negative regulation of glycogen synthase activity, transferring glucose-1-phosphate,BP,
20095,GO:1904229,1,0.991574369340807,0,1,regulation of succinate dehydrogenase activity,BP,
20096,GO:1904231,1,0.991574369340807,0,1,positive regulation of succinate dehydrogenase activity,BP,
20097,GO:1904232,1,0.991574369340807,0,1,regulation of aconitate hydratase activity,BP,
20098,GO:1904234,1,0.991574369340807,0,1,positive regulation of aconitate hydratase activity,BP,
20099,GO:1904235,1,0.990937733486572,0,1,regulation of substrate-dependent cell migration, cell attachment to substrate,BP,
20100,GO:1904237,1,0.990937733486572,0,1,positive regulation of substrate-dependent cell migration, cell attachment to substrate,BP,
20101,GO:1904238,1,0.955915229115849,0,7,pericyte cell differentiation,BP,
20102,GO:1904239,1,0.99457246115258,0,1,regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
20103,GO:1904240,1,0.99457246115258,0,1,negative regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
20104,GO:1904245,1,0.988124139845915,0,2,regulation of polynucleotide adenylyltransferase activity,BP,
20105,GO:1904246,1,0.994388489476242,0,1,negative regulation of polynucleotide adenylyltransferase activity,BP,
20106,GO:1904247,1,0.993700656683758,0,1,positive regulation of polynucleotide adenylyltransferase activity,BP,
20107,GO:1904251,1,0.939341120095914,0,10,regulation of bile acid metabolic process,BP,
20108,GO:1904252,1,0.981843368176696,0,3,negative regulation of bile acid metabolic process,BP,
20109,GO:1904253,1,0.981994128478464,0,3,positive regulation of bile acid metabolic process,BP,
20110,GO:1904259,1,0.960305493702139,0,5,regulation of basement membrane assembly involved in embryonic body morphogenesis,BP,
20111,GO:1904261,1,0.960305493702139,0,5,positive regulation of basement membrane assembly involved in embryonic body morphogenesis,BP,
20112,GO:1904262,1,0.930374659523332,0,11,negative regulation of TORC1 signaling,BP,
20113,GO:1904263,1,0.943902495477969,0,9,positive regulation of TORC1 signaling,BP,
20114,GO:1904265,1,0.992046542220221,0,1,ubiquitin-specific protease activity involved in negative regulation of retrograde protein transport, ER to cytosol,MF,
20115,GO:1904266,1,0.991546303497539,0,1,regulation of Schwann cell chemotaxis,BP,
20116,GO:1904268,1,0.991546303497539,0,1,positive regulation of Schwann cell chemotaxis,BP,
20117,GO:1904271,1,0.994013005560847,0,1,L-proline import across plasma membrane,BP,
20118,GO:1904274,1,0.994139930455338,0,1,tricellular tight junction assembly,BP,
20119,GO:1904282,1,0.994283044929331,0,1,regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
20120,GO:1904283,1,0.994283044929331,0,1,negative regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
20121,GO:1904288,1,0.972272699618787,0,4,BAT3 complex binding,MF,
20122,GO:1904289,1,0.986742249875204,0,2,regulation of mitotic DNA damage checkpoint,BP,
20123,GO:1904290,1,0.992951350380076,0,1,negative regulation of mitotic DNA damage checkpoint,BP,
20124,GO:1904292,1,0.838497533392282,0,27,regulation of ERAD pathway,BP,
20125,GO:1904293,1,0.920900465351753,0,13,negative regulation of ERAD pathway,BP,
20126,GO:1904294,1,0.917572172826965,0,13,positive regulation of ERAD pathway,BP,
20127,GO:1904298,1,0.993154490170671,0,1,regulation of transcytosis,BP,
20128,GO:1904300,1,0.993154490170671,0,1,positive regulation of transcytosis,BP,
20129,GO:1904301,1,0.993154490170671,0,1,regulation of maternal process involved in parturition,BP,
20130,GO:1904303,1,0.993154490170671,0,1,positive regulation of maternal process involved in parturition,BP,
20133,GO:1904313,1,0.993244007704684,0,1,response to methamphetamine hydrochloride,BP,
20134,GO:1904315,1,0.789049727925574,0,35,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential,MF,
20135,GO:1904316,1,0.993154490170671,0,1,response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine,BP,
20136,GO:1904317,1,0.993154490170671,0,1,cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine,BP,
20137,GO:1904321,1,0.920307728746322,0,11,response to forskolin,BP,
20138,GO:1904322,1,0.920307728746322,0,11,cellular response to forskolin,BP,
20141,GO:1904327,1,0.985710129187049,0,2,protein localization to cytosolic proteasome complex,BP,
20142,GO:1904328,1,0.993883785009252,0,1,regulation of myofibroblast contraction,BP,
20144,GO:1904339,1,0.986129376126993,0,2,negative regulation of dopaminergic neuron differentiation,BP,
20145,GO:1904340,1,0.977442694087897,0,4,positive regulation of dopaminergic neuron differentiation,BP,
20146,GO:1904341,1,0.992611156593489,0,1,regulation of colon smooth muscle contraction,BP,
20147,GO:1904343,1,0.992611156593489,0,1,positive regulation of colon smooth muscle contraction,BP,
20148,GO:1904344,1,0.994920131708846,0,1,regulation of gastric mucosal blood circulation,BP,
20149,GO:1904346,1,0.994920131708846,0,1,positive regulation of gastric mucosal blood circulation,BP,
20150,GO:1904347,1,0.987568445692715,0,2,regulation of small intestine smooth muscle contraction,BP,
20151,GO:1904349,1,0.987568445692715,0,2,positive regulation of small intestine smooth muscle contraction,BP,
20152,GO:1904350,1,0.932772303323244,0,9,regulation of protein catabolic process in the vacuole,BP,
20153,GO:1904351,1,0.981065056680548,0,3,negative regulation of protein catabolic process in the vacuole,BP,
20154,GO:1904352,1,0.956481382903557,0,5,positive regulation of protein catabolic process in the vacuole,BP,
20155,GO:1904353,1,0.836704632261152,0,26,regulation of telomere capping,BP,
20156,GO:1904354,1,0.941680620871479,0,8,negative regulation of telomere capping,BP,
20157,GO:1904355,1,0.895328597395568,0,17,positive regulation of telomere capping,BP,
20158,GO:1904356,1,0.677359951631785,0,58,regulation of telomere maintenance via telomere lengthening,BP,
20159,GO:1904357,1,0.838128139342197,0,25,negative regulation of telomere maintenance via telomere lengthening,BP,
20160,GO:1904358,1,0.791624194068856,0,36,positive regulation of telomere maintenance via telomere lengthening,BP,
20161,GO:1904373,1,0.994490301443168,0,1,response to kainic acid,BP,
20162,GO:1904375,1,0.557081180286364,0,88,regulation of protein localization to cell periphery,BP,
20163,GO:1904376,1,0.856908382688739,0,24,negative regulation of protein localization to cell periphery,BP,
20164,GO:1904377,1,0.696759990608331,0,53,positive regulation of protein localization to cell periphery,BP,
20165,GO:1904378,1,0.979367901789858,0,3,maintenance of unfolded protein involved in ERAD pathway,BP,
20166,GO:1904379,1,0.985710129187049,0,2,protein localization to cytosolic proteasome complex involved in ERAD pathway,BP,
20167,GO:1904380,1,0.875730125470561,0,20,endoplasmic reticulum mannose trimming,BP,
20168,GO:1904381,1,0.979435426605124,0,3,Golgi apparatus mannose trimming,BP,
20169,GO:1904382,1,0.972403089111753,0,4,mannose trimming involved in glycoprotein ERAD pathway,BP,
20170,GO:1904383,1,0.988012906992836,0,2,response to sodium phosphate,BP,
20171,GO:1904385,1,0.880630835435422,0,20,cellular response to angiotensin,BP,
20172,GO:1904386,1,0.967743070327591,0,5,response to L-phenylalanine derivative,BP,
20173,GO:1904387,1,0.987110389848593,0,2,cellular response to L-phenylalanine derivative,BP,
20174,GO:1904389,1,0.994490301443168,0,1,rod bipolar cell differentiation,BP,
20175,GO:1904391,1,0.994490301443168,0,1,response to ciliary neurotrophic factor,BP,
20176,GO:1904393,1,0.979840361006876,0,3,regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
20177,GO:1904394,1,0.994081084265276,0,1,negative regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
20178,GO:1904395,1,0.985675338061079,0,2,positive regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
20179,GO:1904396,1,0.951900726700118,0,7,regulation of neuromuscular junction development,BP,
20180,GO:1904397,1,0.988603669336883,0,2,negative regulation of neuromuscular junction development,BP,
20181,GO:1904398,1,0.977275980833852,0,3,positive regulation of neuromuscular junction development,BP,
20182,GO:1904399,1,0.994490301443168,0,1,heparan sulfate binding,MF,
20183,GO:1904400,1,0.993691696544535,0,1,response to Thyroid stimulating hormone,BP,
20184,GO:1904404,1,0.991469945654152,0,1,response to formaldehyde,BP,
20185,GO:1904406,1,0.925384225197067,0,12,negative regulation of nitric oxide metabolic process,BP,
20186,GO:1904407,1,0.79610933013121,0,35,positive regulation of nitric oxide metabolic process,BP,
20187,GO:1904408,1,0.994699040695356,0,1,melatonin binding,MF,
20188,GO:1904412,1,0.993421186575349,0,1,regulation of cardiac ventricle development,BP,
20189,GO:1904414,1,0.993421186575349,0,1,positive regulation of cardiac ventricle development,BP,
20190,GO:1904415,1,0.962683228580635,0,6,regulation of xenophagy,BP,
20191,GO:1904417,1,0.962683228580635,0,6,positive regulation of xenophagy,BP,
20192,GO:1904424,1,0.932838637742268,0,10,regulation of GTP binding,BP,
20193,GO:1904425,1,0.993344773528105,0,1,negative regulation of GTP binding,BP,
20194,GO:1904426,1,0.985888359403049,0,2,positive regulation of GTP binding,BP,
20196,GO:1904428,1,0.97685757652554,0,3,negative regulation of tubulin deacetylation,BP,
20197,GO:1904429,1,0.962118610023263,0,6,regulation of t-circle formation,BP,
20198,GO:1904430,1,0.980360846840906,0,3,negative regulation of t-circle formation,BP,
20199,GO:1904431,1,0.981396017410831,0,3,positive regulation of t-circle formation,BP,
20200,GO:1904432,1,0.989092218570254,0,2,regulation of ferrous iron binding,BP,
20201,GO:1904434,1,0.989092218570254,0,2,positive regulation of ferrous iron binding,BP,
20202,GO:1904435,1,0.989092218570254,0,2,regulation of transferrin receptor binding,BP,
20203,GO:1904437,1,0.989092218570254,0,2,positive regulation of transferrin receptor binding,BP,
20204,GO:1904447,1,0.979220104652971,0,2,folic acid import across plasma membrane,BP,
20205,GO:1904448,1,0.992750414346676,0,1,regulation of aspartate secretion,BP,
20206,GO:1904450,1,0.992750414346676,0,1,positive regulation of aspartate secretion,BP,
20207,GO:1904454,1,0.991170325144447,0,1,ubiquitin-specific protease activity involved in positive regulation of ERAD pathway,MF,
20208,GO:1904455,1,0.984818224586774,0,2,ubiquitin-specific protease activity involved in negative regulation of ERAD pathway,MF,
20209,GO:1904456,1,0.994321810855476,0,1,negative regulation of neuronal action potential,BP,
20210,GO:1904457,1,0.994046520305129,0,1,positive regulation of neuronal action potential,BP,
20211,GO:1904464,1,0.994392107511739,0,1,regulation of matrix metallopeptidase secretion,BP,
20212,GO:1904465,1,0.994392107511739,0,1,negative regulation of matrix metallopeptidase secretion,BP,
20213,GO:1904467,1,0.891595928604354,0,17,regulation of tumor necrosis factor secretion,BP,
20214,GO:1904468,1,0.970184137482515,0,5,negative regulation of tumor necrosis factor secretion,BP,
20215,GO:1904469,1,0.919020346292234,0,12,positive regulation of tumor necrosis factor secretion,BP,
20216,GO:1904475,1,0.983886432126705,0,2,regulation of Ras GTPase binding,BP,
20217,GO:1904477,1,0.991995872618971,0,1,positive regulation of Ras GTPase binding,BP,
20218,GO:1904478,1,0.970899734157117,0,5,regulation of intestinal absorption,BP,
20219,GO:1904479,1,0.989008638485119,0,2,negative regulation of intestinal absorption,BP,
20220,GO:1904481,1,0.994018160475625,0,1,response to tetrahydrofolate,BP,
20221,GO:1904482,1,0.994018160475625,0,1,cellular response to tetrahydrofolate,BP,
20222,GO:1904491,1,0.977534191564949,0,4,protein localization to ciliary transition zone,BP,
20223,GO:1904492,1,0.993945006015651,0,1,Ac-Asp-Glu binding,MF,
20224,GO:1904493,1,0.993945006015651,0,1,tetrahydrofolyl-poly(glutamate) polymer binding,MF,
20225,GO:1904498,1,0.978963743271495,0,3,protein localization to mitotic actomyosin contractile ring,BP,
20226,GO:1904499,1,0.993522058428007,0,1,regulation of chromatin-mediated maintenance of transcription,BP,
20227,GO:1904501,1,0.993522058428007,0,1,positive regulation of chromatin-mediated maintenance of transcription,BP,
20228,GO:1904502,1,0.962461159853913,0,5,regulation of lipophagy,BP,
20229,GO:1904504,1,0.962461159853913,0,5,positive regulation of lipophagy,BP,
20230,GO:1904505,1,0.972764514451609,0,4,regulation of telomere maintenance in response to DNA damage,BP,
20231,GO:1904506,1,0.972764514451609,0,4,negative regulation of telomere maintenance in response to DNA damage,BP,
20232,GO:1904515,1,0.993564529379673,0,1,positive regulation of TORC2 signaling,BP,
20233,GO:1904526,1,0.944137631428305,0,9,regulation of microtubule binding,BP,
20234,GO:1904527,1,0.980118750823513,0,3,negative regulation of microtubule binding,BP,
20235,GO:1904528,1,0.96359825395925,0,6,positive regulation of microtubule binding,BP,
20236,GO:1904529,1,0.986110207888842,0,2,regulation of actin filament binding,BP,
20237,GO:1904530,1,0.993689136688129,0,1,negative regulation of actin filament binding,BP,
20238,GO:1904531,1,0.992373423518007,0,1,positive regulation of actin filament binding,BP,
20239,GO:1904533,1,0.980618246782899,0,3,regulation of telomeric loop disassembly,BP,
20240,GO:1904534,1,0.987603798904906,0,2,negative regulation of telomeric loop disassembly,BP,
20241,GO:1904535,1,0.99292765452283,0,1,positive regulation of telomeric loop disassembly,BP,
20242,GO:1904542,1,0.993913613330413,0,1,regulation of free ubiquitin chain polymerization,BP,
20243,GO:1904544,1,0.993913613330413,0,1,positive regulation of free ubiquitin chain polymerization,BP,
20244,GO:1904550,1,0.994219996241772,0,1,response to arachidonic acid,BP,
20245,GO:1904555,1,0.994013005560847,0,1,L-proline transmembrane transport,BP,
20246,GO:1904556,1,0.994013005560847,0,1,L-tryptophan transmembrane transport,BP,
20247,GO:1904562,1,0.982929357287138,0,2,phosphatidylinositol 5-phosphate metabolic process,BP,
20250,GO:1904567,1,0.993734971734107,0,1,response to wortmannin,BP,
20251,GO:1904568,1,0.993734971734107,0,1,cellular response to wortmannin,BP,
20252,GO:1904569,1,0.994389523203463,0,1,regulation of selenocysteine incorporation,BP,
20253,GO:1904570,1,0.994389523203463,0,1,negative regulation of selenocysteine incorporation,BP,
20254,GO:1904572,1,0.994389523203463,0,1,negative regulation of mRNA binding,BP,
20255,GO:1904573,1,0.994389523203463,0,1,regulation of selenocysteine insertion sequence binding,BP,
20256,GO:1904574,1,0.994389523203463,0,1,negative regulation of selenocysteine insertion sequence binding,BP,
20257,GO:1904576,1,0.988287603746334,0,2,response to tunicamycin,BP,
20258,GO:1904577,1,0.988287603746334,0,2,cellular response to tunicamycin,BP,
20259,GO:1904578,1,0.981780029583177,0,3,response to thapsigargin,BP,
20260,GO:1904579,1,0.981780029583177,0,3,cellular response to thapsigargin,BP,
20261,GO:1904580,1,0.988153679318803,0,2,regulation of intracellular mRNA localization,BP,
20262,GO:1904582,1,0.988153679318803,0,2,positive regulation of intracellular mRNA localization,BP,
20263,GO:1904585,1,0.994173499887978,0,1,response to putrescine,BP,
20264,GO:1904586,1,0.994173499887978,0,1,cellular response to putrescine,BP,
20265,GO:1904587,1,0.96109079800325,0,6,response to glycoprotein,BP,
20266,GO:1904588,1,0.994644794758761,0,1,cellular response to glycoprotein,BP,
20268,GO:1904590,1,0.93988656405533,0,10,negative regulation of protein import,BP,
20270,GO:1904594,1,0.989585442732175,0,1,regulation of termination of RNA polymerase II transcription,BP,
20271,GO:1904595,1,0.989585442732175,0,1,positive regulation of termination of RNA polymerase II transcription,BP,
20272,GO:1904596,1,0.994595712016855,0,1,regulation of connective tissue replacement involved in inflammatory response wound healing,BP,
20273,GO:1904597,1,0.994595712016855,0,1,negative regulation of connective tissue replacement involved in inflammatory response wound healing,BP,
20274,GO:1904599,1,0.994595712016855,0,1,advanced glycation end-product binding,MF,
20275,GO:1904602,1,0.988512674948786,0,2,serotonin-activated cation-selective channel complex,CC,
20276,GO:1904603,1,0.994595712016855,0,1,regulation of advanced glycation end-product receptor activity,BP,
20277,GO:1904604,1,0.994595712016855,0,1,negative regulation of advanced glycation end-product receptor activity,BP,
20278,GO:1904606,1,0.993522570185009,0,1,fat cell apoptotic process,BP,
20279,GO:1904612,1,0.979010972819546,0,3,response to 2,3,7,8-tetrachlorodibenzodioxine,BP,
20280,GO:1904613,1,0.985227014968435,0,2,cellular response to 2,3,7,8-tetrachlorodibenzodioxine,BP,
20281,GO:1904616,1,0.986110207888842,0,2,regulation of actin binding,BP,
20282,GO:1904617,1,0.993689136688129,0,1,negative regulation of actin binding,BP,
20283,GO:1904618,1,0.992373423518007,0,1,positive regulation of actin binding,BP,
20284,GO:1904627,1,0.988440661974616,0,2,response to phorbol 13-acetate 12-myristate,BP,
20285,GO:1904628,1,0.988440661974616,0,2,cellular response to phorbol 13-acetate 12-myristate,BP,
20286,GO:1904631,1,0.994130894445662,0,1,response to glucoside,BP,
20287,GO:1904633,1,0.992013629895481,0,1,regulation of glomerular visceral epithelial cell apoptotic process,BP,
20288,GO:1904635,1,0.992013629895481,0,1,positive regulation of glomerular visceral epithelial cell apoptotic process,BP,
20289,GO:1904636,1,0.973258627526007,0,4,response to ionomycin,BP,
20290,GO:1904637,1,0.973258627526007,0,4,cellular response to ionomycin,BP,
20291,GO:1904638,1,0.992013629895481,0,1,response to resveratrol,BP,
20292,GO:1904639,1,0.992013629895481,0,1,cellular response to resveratrol,BP,
20293,GO:1904640,1,0.985964136866255,0,2,response to methionine,BP,
20294,GO:1904645,1,0.823844331309314,0,27,response to amyloid-beta,BP,
20295,GO:1904646,1,0.833513092318164,0,25,cellular response to amyloid-beta,BP,
20296,GO:1904647,1,0.990550101929946,0,1,response to rotenone,BP,
20297,GO:1904649,1,0.993522570185009,0,1,regulation of fat cell apoptotic process,BP,
20298,GO:1904651,1,0.993522570185009,0,1,positive regulation of fat cell apoptotic process,BP,
20301,GO:1904667,1,0.96300913959142,0,7,negative regulation of ubiquitin protein ligase activity,BP,
20303,GO:1904672,1,0.96678885634257,0,5,regulation of somatic stem cell population maintenance,BP,
20304,GO:1904673,1,0.979810189188761,0,3,negative regulation of somatic stem cell population maintenance,BP,
20305,GO:1904674,1,0.9867130705635,0,2,positive regulation of somatic stem cell population maintenance,BP,
20306,GO:1904675,1,0.993772895529134,0,1,regulation of somatic stem cell division,BP,
20307,GO:1904677,1,0.993772895529134,0,1,positive regulation of somatic stem cell division,BP,
20308,GO:1904680,1,0.874675375232839,0,22,peptide transmembrane transporter activity,MF,
20309,GO:1904681,1,0.993896896634834,0,1,response to 3-methylcholanthrene,BP,
20311,GO:1904684,1,0.968775162957525,0,4,negative regulation of metalloendopeptidase activity,BP,
20313,GO:1904688,1,0.968255389948268,0,5,regulation of cytoplasmic translational initiation,BP,
20314,GO:1904689,1,0.994706273244466,0,1,negative regulation of cytoplasmic translational initiation,BP,
20315,GO:1904690,1,0.973409755266449,0,4,positive regulation of cytoplasmic translational initiation,BP,
20316,GO:1904691,1,0.994188480268316,0,1,negative regulation of type B pancreatic cell proliferation,BP,
20317,GO:1904692,1,0.993408374504949,0,1,positive regulation of type B pancreatic cell proliferation,BP,
20318,GO:1904693,1,0.977752940900856,0,3,midbrain morphogenesis,BP,
20319,GO:1904694,1,0.976330539754057,0,3,negative regulation of vascular smooth muscle contraction,BP,
20320,GO:1904695,1,0.994297000326347,0,1,positive regulation of vascular smooth muscle contraction,BP,
20321,GO:1904700,1,0.993946035639214,0,1,granulosa cell apoptotic process,BP,
20322,GO:1904701,1,0.994356959793459,0,1,Wnt-Frizzled-LRP5/6 complex assembly,BP,
20323,GO:1904705,1,0.787482486307833,0,36,regulation of vascular smooth muscle cell proliferation,BP,
20324,GO:1904706,1,0.91600511417618,0,14,negative regulation of vascular smooth muscle cell proliferation,BP,
20325,GO:1904707,1,0.855025573586393,0,23,positive regulation of vascular smooth muscle cell proliferation,BP,
20326,GO:1904708,1,0.993946035639214,0,1,regulation of granulosa cell apoptotic process,BP,
20327,GO:1904711,1,0.994356959793459,0,1,regulation of Wnt-Frizzled-LRP5/6 complex assembly,BP,
20328,GO:1904713,1,0.984397747180089,0,2,beta-catenin destruction complex binding,MF,
20330,GO:1904715,1,0.982179431304606,0,3,negative regulation of chaperone-mediated autophagy,BP,
20331,GO:1904716,1,0.9940656057432,0,1,positive regulation of chaperone-mediated autophagy,BP,
20332,GO:1904717,1,0.977829788379347,0,3,regulation of AMPA glutamate receptor clustering,BP,
20333,GO:1904719,1,0.994024862532168,0,1,positive regulation of AMPA glutamate receptor clustering,BP,
20334,GO:1904720,1,0.98777609303798,0,2,regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
20335,GO:1904721,1,0.993702192811864,0,1,negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
20336,GO:1904722,1,0.99403672181897,0,1,positive regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
20337,GO:1904723,1,0.994356959793459,0,1,negative regulation of Wnt-Frizzled-LRP5/6 complex assembly,BP,
20338,GO:1904724,1,0.745447550093246,0,51,tertiary granule lumen,CC,
20339,GO:1904729,1,0.982359889147466,0,3,regulation of intestinal lipid absorption,BP,
20340,GO:1904730,1,0.993908469052429,0,1,negative regulation of intestinal lipid absorption,BP,
20341,GO:1904732,1,0.985997450816494,0,2,regulation of electron transfer activity,BP,
20342,GO:1904734,1,0.995070959432778,0,1,positive regulation of electron transfer activity,BP,
20343,GO:1904738,1,0.887922447519149,0,16,vascular associated smooth muscle cell migration,BP,
20344,GO:1904742,1,0.971363837864861,0,4,regulation of telomeric DNA binding,BP,
20345,GO:1904743,1,0.982170456885848,0,2,negative regulation of telomeric DNA binding,BP,
20346,GO:1904744,1,0.988999193803162,0,2,positive regulation of telomeric DNA binding,BP,
20347,GO:1904746,1,0.968022900815712,0,5,negative regulation of apoptotic process involved in development,BP,
20348,GO:1904747,1,0.980969023431266,0,3,positive regulation of apoptotic process involved in development,BP,
20349,GO:1904748,1,0.942567711353515,0,9,regulation of apoptotic process involved in development,BP,
20350,GO:1904749,1,0.968412729539196,0,5,regulation of protein localization to nucleolus,BP,
20351,GO:1904750,1,0.991836733701099,0,1,negative regulation of protein localization to nucleolus,BP,
20352,GO:1904751,1,0.976385137100122,0,4,positive regulation of protein localization to nucleolus,BP,
20353,GO:1904752,1,0.887922447519149,0,16,regulation of vascular associated smooth muscle cell migration,BP,
20354,GO:1904753,1,0.965812215097155,0,5,negative regulation of vascular associated smooth muscle cell migration,BP,
20355,GO:1904754,1,0.919380243314945,0,11,positive regulation of vascular associated smooth muscle cell migration,BP,
20356,GO:1904760,1,0.979170570163523,0,3,regulation of myofibroblast differentiation,BP,
20357,GO:1904761,1,0.985849185651808,0,2,negative regulation of myofibroblast differentiation,BP,
20358,GO:1904762,1,0.993226491557752,0,1,positive regulation of myofibroblast differentiation,BP,
20359,GO:1904764,1,0.994237565286352,0,1,chaperone-mediated autophagy translocation complex disassembly,BP,
20360,GO:1904766,1,0.991710142539669,0,1,negative regulation of macroautophagy by TORC1 signaling,BP,
20361,GO:1904768,1,0.987732177386696,0,2,all-trans-retinol binding,MF,
20362,GO:1904772,1,0.993928277755103,0,1,response to tetrachloromethane,BP,
20363,GO:1904776,1,0.959185194956017,0,6,regulation of protein localization to cell cortex,BP,
20364,GO:1904777,1,0.993850639026861,0,1,negative regulation of protein localization to cell cortex,BP,
20365,GO:1904778,1,0.965122201552072,0,5,positive regulation of protein localization to cell cortex,BP,
20366,GO:1904779,1,0.949141053550561,0,7,regulation of protein localization to centrosome,BP,
20367,GO:1904781,1,0.954835684051337,0,6,positive regulation of protein localization to centrosome,BP,
20368,GO:1904782,1,0.992771592226114,0,1,negative regulation of NMDA glutamate receptor activity,BP,
20369,GO:1904783,1,0.986728759051574,0,2,positive regulation of NMDA glutamate receptor activity,BP,
20370,GO:1904784,1,0.992450229507276,0,1,NLRP1 inflammasome complex assembly,BP,
20371,GO:1904790,1,0.99377366455181,0,1,regulation of shelterin complex assembly,BP,
20372,GO:1904792,1,0.99377366455181,0,1,positive regulation of shelterin complex assembly,BP,
20373,GO:1904793,1,0.993522058428007,0,1,regulation of euchromatin binding,BP,
20374,GO:1904796,1,0.967802604158903,0,5,regulation of core promoter binding,BP,
20375,GO:1904797,1,0.992136458591208,0,1,negative regulation of core promoter binding,BP,
20376,GO:1904798,1,0.975475209642934,0,4,positive regulation of core promoter binding,BP,
20377,GO:1904799,1,0.993249672159224,0,1,regulation of neuron remodeling,BP,
20378,GO:1904800,1,0.993249672159224,0,1,negative regulation of neuron remodeling,BP,
20379,GO:1904803,1,0.994988314183967,0,1,regulation of translation involved in cellular response to UV,BP,
20380,GO:1904806,1,0.987738712940129,0,2,regulation of protein oxidation,BP,
20381,GO:1904808,1,0.987738712940129,0,2,positive regulation of protein oxidation,BP,
20382,GO:1904812,1,0.993250444491064,0,1,rRNA acetylation involved in maturation of SSU-rRNA,BP,
20383,GO:1904813,1,0.471231159134021,0,123,ficolin-1-rich granule lumen,CC,
20384,GO:1904814,1,0.923639185066327,0,13,regulation of protein localization to chromosome, telomeric region,BP,
20385,GO:1904815,1,0.988104275860874,0,2,negative regulation of protein localization to chromosome, telomeric region,BP,
20386,GO:1904816,1,0.934766446779735,0,11,positive regulation of protein localization to chromosome, telomeric region,BP,
20387,GO:1904823,1,0.982207358423274,0,3,purine nucleobase transmembrane transport,BP,
20388,GO:1904826,1,0.991337379953931,0,1,regulation of hydrogen sulfide biosynthetic process,BP,
20389,GO:1904828,1,0.991337379953931,0,1,positive regulation of hydrogen sulfide biosynthetic process,BP,
20390,GO:1904829,1,0.994387197314057,0,1,regulation of aortic smooth muscle cell differentiation,BP,
20391,GO:1904831,1,0.994387197314057,0,1,positive regulation of aortic smooth muscle cell differentiation,BP,
20392,GO:1904833,1,0.983616181824306,0,3,positive regulation of removal of superoxide radicals,BP,
20393,GO:1904835,1,0.994004758645168,0,1,dorsal root ganglion morphogenesis,BP,
20394,GO:1904837,1,0.7958950885602,0,34,beta-catenin-TCF complex assembly,BP,
20395,GO:1904842,1,0.99417298335658,0,1,response to nitroglycerin,BP,
20396,GO:1904843,1,0.99417298335658,0,1,cellular response to nitroglycerin,BP,
20397,GO:1904844,1,0.98226885230949,0,3,response to L-glutamine,BP,
20398,GO:1904845,1,0.98226885230949,0,3,cellular response to L-glutamine,BP,
20400,GO:1904848,1,0.994668043425921,0,1,negative regulation of cell chemotaxis to fibroblast growth factor,BP,
20401,GO:1904849,1,0.978805772247494,0,3,positive regulation of cell chemotaxis to fibroblast growth factor,BP,
20402,GO:1904850,1,0.99377366455181,0,1,negative regulation of establishment of protein localization to telomere,BP,
20403,GO:1904851,1,0.948024038320587,0,9,positive regulation of establishment of protein localization to telomere,BP,
20404,GO:1904854,1,0.987743200724966,0,2,proteasome core complex binding,MF,
20405,GO:1904861,1,0.906629929134791,0,13,excitatory synapse assembly,BP,
20406,GO:1904862,1,0.97889466126018,0,3,inhibitory synapse assembly,BP,
20407,GO:1904863,1,0.993329114045753,0,1,regulation of beta-catenin-TCF complex assembly,BP,
20408,GO:1904864,1,0.993329114045753,0,1,negative regulation of beta-catenin-TCF complex assembly,BP,
20409,GO:1904867,1,0.948258628013216,0,9,protein localization to Cajal body,BP,
20410,GO:1904868,1,0.98063448583902,0,2,telomerase catalytic core complex assembly,BP,
20411,GO:1904869,1,0.953669676793125,0,8,regulation of protein localization to Cajal body,BP,
20412,GO:1904871,1,0.953669676793125,0,8,positive regulation of protein localization to Cajal body,BP,
20413,GO:1904872,1,0.897142061296119,0,18,regulation of telomerase RNA localization to Cajal body,BP,
20414,GO:1904874,1,0.916996377683917,0,15,positive regulation of telomerase RNA localization to Cajal body,BP,
20415,GO:1904875,1,0.988024276585232,0,2,regulation of DNA ligase activity,BP,
20416,GO:1904876,1,0.993792381470899,0,1,negative regulation of DNA ligase activity,BP,
20417,GO:1904877,1,0.994196229440863,0,1,positive regulation of DNA ligase activity,BP,
20418,GO:1904878,1,0.989879419975328,0,1,negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
20419,GO:1904879,1,0.987245868496801,0,2,positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
20420,GO:1904880,1,0.980188886717135,0,3,response to hydrogen sulfide,BP,
20421,GO:1904881,1,0.986103171377963,0,2,cellular response to hydrogen sulfide,BP,
20422,GO:1904882,1,0.98063448583902,0,2,regulation of telomerase catalytic core complex assembly,BP,
20423,GO:1904884,1,0.98063448583902,0,2,positive regulation of telomerase catalytic core complex assembly,BP,
20424,GO:1904885,1,0.962908184896126,0,5,beta-catenin destruction complex assembly,BP,
20425,GO:1904886,1,0.881554431425375,0,18,beta-catenin destruction complex disassembly,BP,
20426,GO:1904887,1,0.990489208522649,0,1,Wnt signalosome assembly,BP,
20428,GO:1904889,1,0.988288186539386,0,2,regulation of excitatory synapse assembly,BP,
20429,GO:1904891,1,0.988288186539386,0,2,positive regulation of excitatory synapse assembly,BP,
20431,GO:1904893,1,0.747714993580699,0,45,negative regulation of STAT cascade,BP,
20433,GO:1904895,1,0.994427769569109,0,1,ESCRT complex assembly,BP,
20434,GO:1904896,1,0.941335583465981,0,10,ESCRT complex disassembly,BP,
20435,GO:1904897,1,0.993576041518231,0,1,regulation of hepatic stellate cell proliferation,BP,
20436,GO:1904899,1,0.993576041518231,0,1,positive regulation of hepatic stellate cell proliferation,BP,
20437,GO:1904902,1,0.994427769569109,0,1,ESCRT III complex assembly,BP,
20438,GO:1904903,1,0.941335583465981,0,10,ESCRT III complex disassembly,BP,
20439,GO:1904907,1,0.979934754663598,0,2,regulation of maintenance of mitotic sister chromatid cohesion, telomeric,BP,
20440,GO:1904908,1,0.979934754663598,0,2,negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric,BP,
20441,GO:1904910,1,0.99377366455181,0,1,regulation of establishment of RNA localization to telomere,BP,
20442,GO:1904911,1,0.99377366455181,0,1,negative regulation of establishment of RNA localization to telomere,BP,
20443,GO:1904913,1,0.99377366455181,0,1,regulation of establishment of protein-containing complex localization to telomere,BP,
20444,GO:1904914,1,0.99377366455181,0,1,negative regulation of establishment of protein-containing complex localization to telomere,BP,
20445,GO:1904923,1,0.920770084288341,0,12,regulation of autophagy of mitochondrion in response to mitochondrial depolarization,BP,
20446,GO:1904924,1,0.99404523094554,0,1,negative regulation of mitophagy in response to mitochondrial depolarization,BP,
20447,GO:1904925,1,0.926290183595616,0,11,positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization,BP,
20448,GO:1904928,1,0.982768943444052,0,2,coreceptor activity involved in canonical Wnt signaling pathway,MF,
20449,GO:1904929,1,0.959608167748172,0,6,coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway,MF,
20450,GO:1904933,1,0.992268880590988,0,1,regulation of cell proliferation in midbrain,BP,
20451,GO:1904934,1,0.992268880590988,0,1,negative regulation of cell proliferation in midbrain,BP,
20453,GO:1904938,1,0.961531057713835,0,5,planar cell polarity pathway involved in axon guidance,BP,
20454,GO:1904947,1,0.993727287673251,0,1,folic acid import into mitochondrion,BP,
20457,GO:1904950,1,0.391073068958353,0,147,negative regulation of establishment of protein localization,BP,
20459,GO:1904953,1,0.935574825635236,0,10,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
20460,GO:1904954,1,0.981951710587086,0,3,canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
20461,GO:1904955,1,0.992268880590988,0,1,planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation,BP,
20463,GO:1904958,1,0.982587798082827,0,3,positive regulation of midbrain dopaminergic neuron differentiation,BP,
20464,GO:1904959,1,0.985997450816494,0,2,regulation of cytochrome-c oxidase activity,BP,
20465,GO:1904960,1,0.995070959432778,0,1,positive regulation of cytochrome-c oxidase activity,BP,
20467,GO:1904971,1,0.992902900696797,0,1,regulation of viral translation,BP,
20468,GO:1904973,1,0.992902900696797,0,1,positive regulation of viral translation,BP,
20469,GO:1904975,1,0.985928298987096,0,2,response to bleomycin,BP,
20470,GO:1904976,1,0.985928298987096,0,2,cellular response to bleomycin,BP,
20471,GO:1904977,1,0.9938021277445,0,1,lymphatic endothelial cell migration,BP,
20472,GO:1904978,1,0.978732651877148,0,3,regulation of endosome organization,BP,
20473,GO:1904979,1,0.994134766915014,0,1,negative regulation of endosome organization,BP,
20474,GO:1904980,1,0.991612843941265,0,1,positive regulation of endosome organization,BP,
20475,GO:1904983,1,0.994190030066028,0,1,glycine import into mitochondrion,BP,
20476,GO:1904990,1,0.994028213838835,0,1,regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
20477,GO:1904992,1,0.994028213838835,0,1,positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
20478,GO:1904994,1,0.929710391562362,0,12,regulation of leukocyte adhesion to vascular endothelial cell,BP,
20479,GO:1904995,1,0.972895638574117,0,5,negative regulation of leukocyte adhesion to vascular endothelial cell,BP,
20480,GO:1904996,1,0.955623685329933,0,7,positive regulation of leukocyte adhesion to vascular endothelial cell,BP,
20481,GO:1904997,1,0.988237564619208,0,2,regulation of leukocyte adhesion to arterial endothelial cell,BP,
20482,GO:1904998,1,0.993775458987486,0,1,negative regulation of leukocyte adhesion to arterial endothelial cell,BP,
20483,GO:1904999,1,0.994427769569109,0,1,positive regulation of leukocyte adhesion to arterial endothelial cell,BP,
20484,GO:1905000,1,0.990863686550615,0,1,regulation of membrane repolarization during atrial cardiac muscle cell action potential,BP,
20485,GO:1905005,1,0.959903000713891,0,6,regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
20486,GO:1905006,1,0.98695874508298,0,2,negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
20487,GO:1905007,1,0.965395128131544,0,5,positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
20488,GO:1905008,1,0.993956333071298,0,1,regulation of L-lysine import across plasma membrane,BP,
20489,GO:1905010,1,0.993956333071298,0,1,positive regulation of L-lysine import across plasma membrane,BP,
20490,GO:1905024,1,0.97290399676062,0,4,regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
20491,GO:1905025,1,0.993706289308994,0,1,negative regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
20492,GO:1905026,1,0.986271489597361,0,2,positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
20493,GO:1905030,1,0.992532541703704,0,1,voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential,MF,
20494,GO:1905031,1,0.96401278813268,0,5,regulation of membrane repolarization during cardiac muscle cell action potential,BP,
20495,GO:1905032,1,0.993706289308994,0,1,negative regulation of membrane repolarization during cardiac muscle cell action potential,BP,
20496,GO:1905033,1,0.986271489597361,0,2,positive regulation of membrane repolarization during cardiac muscle cell action potential,BP,
20497,GO:1905034,1,0.993776997130679,0,1,regulation of antifungal innate immune response,BP,
20498,GO:1905035,1,0.993776997130679,0,1,negative regulation of antifungal innate immune response,BP,
20499,GO:1905037,1,0.54888670502074,0,90,autophagosome organization,BP,
20500,GO:1905038,1,0.923579530422917,0,13,regulation of membrane lipid metabolic process,BP,
20501,GO:1905039,1,0.48461450214132,0,107,carboxylic acid transmembrane transport,BP,
20502,GO:1905040,1,0.994004758645168,0,1,otic placode development,BP,
20503,GO:1905041,1,0.994130119971222,0,1,regulation of epithelium regeneration,BP,
20504,GO:1905042,1,0.994130119971222,0,1,negative regulation of epithelium regeneration,BP,
20505,GO:1905044,1,0.993850639026861,0,1,regulation of Schwann cell proliferation involved in axon regeneration,BP,
20506,GO:1905045,1,0.993850639026861,0,1,negative regulation of Schwann cell proliferation involved in axon regeneration,BP,
20508,GO:1905049,1,0.957394194621227,0,6,negative regulation of metallopeptidase activity,BP,
20510,GO:1905051,1,0.989257204858332,0,2,regulation of base-excision repair,BP,
20511,GO:1905053,1,0.989257204858332,0,2,positive regulation of base-excision repair,BP,
20512,GO:1905062,1,0.99388995467855,0,1,positive regulation of cardioblast proliferation,BP,
20513,GO:1905063,1,0.948592185556148,0,8,regulation of vascular smooth muscle cell differentiation,BP,
20514,GO:1905064,1,0.98125148881163,0,3,negative regulation of vascular smooth muscle cell differentiation,BP,
20515,GO:1905065,1,0.966722940093749,0,5,positive regulation of vascular smooth muscle cell differentiation,BP,
20516,GO:1905066,1,0.988460077738153,0,2,regulation of canonical Wnt signaling pathway involved in heart development,BP,
20517,GO:1905067,1,0.994356959793459,0,1,negative regulation of canonical Wnt signaling pathway involved in heart development,BP,
20518,GO:1905068,1,0.994069990985103,0,1,positive regulation of canonical Wnt signaling pathway involved in heart development,BP,
20519,GO:1905069,1,0.987417015382499,0,2,allantois development,BP,
20520,GO:1905071,1,0.978496223722313,0,3,occluding junction disassembly,BP,
20521,GO:1905073,1,0.978496223722313,0,3,regulation of occluding junction disassembly,BP,
20522,GO:1905075,1,0.978496223722313,0,3,positive regulation of occluding junction disassembly,BP,
20523,GO:1905076,1,0.994264955450685,0,1,regulation of interleukin-17 secretion,BP,
20524,GO:1905077,1,0.994264955450685,0,1,negative regulation of interleukin-17 secretion,BP,
20525,GO:1905089,1,0.988953029585571,0,1,regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
20526,GO:1905090,1,0.988953029585571,0,1,negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
20527,GO:1905097,1,0.958108316682827,0,6,regulation of guanyl-nucleotide exchange factor activity,BP,
20528,GO:1905098,1,0.973803943772357,0,4,negative regulation of guanyl-nucleotide exchange factor activity,BP,
20529,GO:1905099,1,0.991995872618971,0,1,positive regulation of guanyl-nucleotide exchange factor activity,BP,
20530,GO:1905103,1,0.993224945433582,0,1,integral component of lysosomal membrane,CC,
20532,GO:1905123,1,0.986108594947771,0,2,regulation of glucosylceramidase activity,BP,
20533,GO:1905132,1,0.993723958214045,0,1,regulation of meiotic chromosome separation,BP,
20534,GO:1905133,1,0.993723958214045,0,1,negative regulation of meiotic chromosome separation,BP,
20535,GO:1905143,1,0.994485650557976,0,1,eukaryotic translation initiation factor 2 complex assembly,BP,
20536,GO:1905144,1,0.874872091570932,0,21,response to acetylcholine,BP,
20537,GO:1905145,1,0.874872091570932,0,21,cellular response to acetylcholine,BP,
20538,GO:1905146,1,0.926974699049037,0,10,lysosomal protein catabolic process,BP,
20539,GO:1905150,1,0.978972571302681,0,3,regulation of voltage-gated sodium channel activity,BP,
20540,GO:1905152,1,0.992231699272651,0,1,positive regulation of voltage-gated sodium channel activity,BP,
20541,GO:1905153,1,0.923037273925122,0,12,regulation of membrane invagination,BP,
20542,GO:1905154,1,0.986931917243184,0,2,negative regulation of membrane invagination,BP,
20543,GO:1905155,1,0.941010122155989,0,9,positive regulation of membrane invagination,BP,
20544,GO:1905161,1,0.992577619341872,0,1,protein localization to phagocytic vesicle,BP,
20545,GO:1905162,1,0.992577619341872,0,1,regulation of phagosome maturation,BP,
20546,GO:1905165,1,0.94371549920105,0,7,regulation of lysosomal protein catabolic process,BP,
20547,GO:1905166,1,0.981065056680548,0,3,negative regulation of lysosomal protein catabolic process,BP,
20548,GO:1905167,1,0.967699869066279,0,3,positive regulation of lysosomal protein catabolic process,BP,
20549,GO:1905168,1,0.993376585915367,0,1,positive regulation of double-strand break repair via homologous recombination,BP,
20550,GO:1905169,1,0.992577619341872,0,1,regulation of protein localization to phagocytic vesicle,BP,
20551,GO:1905171,1,0.992577619341872,0,1,positive regulation of protein localization to phagocytic vesicle,BP,
20552,GO:1905172,1,0.992902900696797,0,1,RISC complex binding,MF,
20553,GO:1905174,1,0.98816417001049,0,2,regulation of vascular smooth muscle cell dedifferentiation,BP,
20554,GO:1905176,1,0.993802384256541,0,1,positive regulation of vascular smooth muscle cell dedifferentiation,BP,
20555,GO:1905202,1,0.987402682592774,0,2,methylcrotonoyl-CoA carboxylase complex,CC,
20556,GO:1905203,1,0.987522061226203,0,2,regulation of connective tissue replacement,BP,
20557,GO:1905204,1,0.994595712016855,0,1,negative regulation of connective tissue replacement,BP,
20558,GO:1905205,1,0.992888301474336,0,1,positive regulation of connective tissue replacement,BP,
20559,GO:1905206,1,0.967358521199595,0,5,positive regulation of hydrogen peroxide-induced cell death,BP,
20560,GO:1905207,1,0.767191308481489,0,39,regulation of cardiocyte differentiation,BP,
20561,GO:1905208,1,0.908243921856241,0,14,negative regulation of cardiocyte differentiation,BP,
20562,GO:1905209,1,0.849878604966914,0,24,positive regulation of cardiocyte differentiation,BP,
20563,GO:1905214,1,0.931513069191615,0,11,regulation of RNA binding,BP,
20564,GO:1905215,1,0.994389523203463,0,1,negative regulation of RNA binding,BP,
20565,GO:1905216,1,0.950324214190768,0,8,positive regulation of RNA binding,BP,
20566,GO:1905217,1,0.993691696544535,0,1,response to astaxanthin,BP,
20567,GO:1905222,1,0.99367019604866,0,1,atrioventricular canal morphogenesis,BP,
20568,GO:1905223,1,0.991995350398444,0,1,epicardium morphogenesis,BP,
20569,GO:1905224,1,0.985570425883828,0,2,clathrin-coated pit assembly,BP,
20570,GO:1905225,1,0.988369934056895,0,2,response to thyrotropin-releasing hormone,BP,
20571,GO:1905226,1,0.994625162038072,0,1,regulation of adhesion of symbiont to host epithelial cell,BP,
20572,GO:1905229,1,0.994644794758761,0,1,cellular response to thyrotropin-releasing hormone,BP,
20573,GO:1905230,1,0.993232675100923,0,1,response to borneol,BP,
20574,GO:1905231,1,0.993232675100923,0,1,cellular response to borneol,BP,
20575,GO:1905232,1,0.966737330747893,0,5,cellular response to L-glutamate,BP,
20576,GO:1905233,1,0.993232675100923,0,1,response to codeine,BP,
20577,GO:1905235,1,0.993232675100923,0,1,response to quercetin,BP,
20578,GO:1905237,1,0.993232675100923,0,1,response to cyclosporin A,BP,
20579,GO:1905239,1,0.992695998159764,0,1,regulation of canonical Wnt signaling pathway involved in osteoblast differentiation,BP,
20580,GO:1905240,1,0.992695998159764,0,1,negative regulation of canonical Wnt signaling pathway involved in osteoblast differentiation,BP,
20581,GO:1905242,1,0.987485841409989,0,2,response to 3,3',5-triiodo-L-thyronine,BP,
20582,GO:1905243,1,0.993902811040913,0,1,cellular response to 3,3',5-triiodo-L-thyronine,BP,
20583,GO:1905244,1,0.945819326338135,0,8,regulation of modification of synaptic structure,BP,
20584,GO:1905245,1,0.94492323409692,0,8,regulation of aspartic-type peptidase activity,BP,
20585,GO:1905246,1,0.983770624556681,0,2,negative regulation of aspartic-type peptidase activity,BP,
20586,GO:1905247,1,0.960518131413396,0,6,positive regulation of aspartic-type peptidase activity,BP,
20587,GO:1905255,1,0.991945753067963,0,1,regulation of RNA binding transcription factor activity,BP,
20588,GO:1905258,1,0.989326661381499,0,2,regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,BP,
20589,GO:1905259,1,0.989326661381499,0,2,negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,BP,
20590,GO:1905267,1,0.987495215043761,0,2,endonucleolytic cleavage involved in tRNA processing,BP,
20591,GO:1905268,1,0.731294858768847,0,45,negative regulation of chromatin organization,BP,
20592,GO:1905269,1,0.55247765259296,0,88,positive regulation of chromatin organization,BP,
20593,GO:1905271,1,0.99496507023635,0,1,regulation of proton-transporting ATP synthase activity, rotational mechanism,BP,
20594,GO:1905273,1,0.99496507023635,0,1,positive regulation of proton-transporting ATP synthase activity, rotational mechanism,BP,
20595,GO:1905274,1,0.991546303497539,0,1,regulation of modification of postsynaptic actin cytoskeleton,BP,
20597,GO:1905277,1,0.993705521198315,0,1,negative regulation of epithelial tube formation,BP,
20598,GO:1905278,1,0.974854794319249,0,4,positive regulation of epithelial tube formation,BP,
20599,GO:1905279,1,0.984397747180089,0,2,regulation of retrograde transport, endosome to Golgi,BP,
20600,GO:1905285,1,0.993421186575349,0,1,fibrous ring of heart morphogenesis,BP,
20601,GO:1905286,1,0.981919192283198,0,3,serine-type peptidase complex,CC,
20602,GO:1905288,1,0.957652661684855,0,6,vascular associated smooth muscle cell apoptotic process,BP,
20603,GO:1905289,1,0.990489208522649,0,1,regulation of CAMKK-AMPK signaling cascade,BP,
20604,GO:1905292,1,0.98031637944055,0,3,regulation of neural crest cell differentiation,BP,
20605,GO:1905294,1,0.98031637944055,0,3,positive regulation of neural crest cell differentiation,BP,
20606,GO:1905301,1,0.992943019572363,0,1,regulation of macropinocytosis,BP,
20607,GO:1905302,1,0.992943019572363,0,1,negative regulation of macropinocytosis,BP,
20608,GO:1905304,1,0.990742296431914,0,1,regulation of cardiac myofibril assembly,BP,
20609,GO:1905305,1,0.990742296431914,0,1,negative regulation of cardiac myofibril assembly,BP,
20610,GO:1905309,1,0.990034427969389,0,1,positive regulation of cohesin loading,BP,
20611,GO:1905310,1,0.98031637944055,0,3,regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
20612,GO:1905312,1,0.98031637944055,0,3,positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
20613,GO:1905313,1,0.994151291207698,0,1,transforming growth factor beta receptor signaling pathway involved in heart development,BP,
20614,GO:1905314,1,0.898962722951537,0,15,semi-lunar valve development,BP,
20615,GO:1905317,1,0.992882043020951,0,1,inferior endocardial cushion morphogenesis,BP,
20616,GO:1905319,1,0.993850639026861,0,1,mesenchymal stem cell migration,BP,
20617,GO:1905320,1,0.993850639026861,0,1,regulation of mesenchymal stem cell migration,BP,
20618,GO:1905322,1,0.993850639026861,0,1,positive regulation of mesenchymal stem cell migration,BP,
20619,GO:1905323,1,0.957363977893696,0,6,telomerase holoenzyme complex assembly,BP,
20620,GO:1905327,1,0.994475315120246,0,1,tracheoesophageal septum formation,BP,
20622,GO:1905331,1,0.884893510510186,0,18,negative regulation of morphogenesis of an epithelium,BP,
20623,GO:1905332,1,0.81975738358024,0,30,positive regulation of morphogenesis of an epithelium,BP,
20624,GO:1905333,1,0.984300417622225,0,3,regulation of gastric motility,BP,
20625,GO:1905335,1,0.988322391623798,0,1,regulation of aggrephagy,BP,
20626,GO:1905337,1,0.988322391623798,0,1,positive regulation of aggrephagy,BP,
20627,GO:1905340,1,0.976517201730198,0,4,regulation of protein localization to kinetochore,BP,
20628,GO:1905341,1,0.993904868414913,0,1,negative regulation of protein localization to kinetochore,BP,
20629,GO:1905342,1,0.976517201730198,0,4,positive regulation of protein localization to kinetochore,BP,
20630,GO:1905344,1,0.993850639026861,0,1,prostaglandin catabolic process,BP,
20631,GO:1905348,1,0.837444177991665,0,29,endonuclease complex,CC,
20632,GO:1905349,1,0.989154270178319,0,2,ciliary transition zone assembly,BP,
20633,GO:1905354,1,0.873364543421499,0,22,exoribonuclease complex,CC,
20634,GO:1905355,1,0.992636041178951,0,1,spine apparatus assembly,BP,
20635,GO:1905359,1,0.993723958214045,0,1,protein localization to meiotic spindle,BP,
20636,GO:1905360,1,0.816044539327527,0,33,GTPase complex,CC,
20637,GO:1905365,1,0.994134766915014,0,1,regulation of intralumenal vesicle formation,BP,
20638,GO:1905366,1,0.994134766915014,0,1,negative regulation of intralumenal vesicle formation,BP,
20639,GO:1905368,1,0.613484447095235,0,83,peptidase complex,CC,
20640,GO:1905369,1,0.691922712230695,0,63,endopeptidase complex,CC,
20641,GO:1905370,1,0.99404523094554,0,1,serine-type endopeptidase complex,CC,
20642,GO:1905371,1,0.986662060013924,0,2,ceramide phosphoethanolamine metabolic process,BP,
20643,GO:1905373,1,0.986662060013924,0,2,ceramide phosphoethanolamine biosynthetic process,BP,
20644,GO:1905383,1,0.983099410145003,0,3,protein localization to presynapse,BP,
20645,GO:1905384,1,0.988212403327163,0,2,regulation of protein localization to presynapse,BP,
20646,GO:1905386,1,0.988212403327163,0,2,positive regulation of protein localization to presynapse,BP,
20647,GO:1905392,1,0.994886556596673,0,1,plant organ morphogenesis,BP,
20648,GO:1905394,1,0.98013837874597,0,3,retromer complex binding,MF,
20649,GO:1905395,1,0.981200675915483,0,3,response to flavonoid,BP,
20650,GO:1905397,1,0.988789106704922,0,2,activated CD8-positive, alpha-beta T cell apoptotic process,BP,
20651,GO:1905402,1,0.988789106704922,0,2,regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
20652,GO:1905403,1,0.994264955450685,0,1,negative regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
20653,GO:1905404,1,0.994492885251886,0,1,positive regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
20654,GO:1905405,1,0.990034427969389,0,1,regulation of mitotic cohesin loading,BP,
20655,GO:1905406,1,0.990034427969389,0,1,positive regulation of mitotic cohesin loading,BP,
20656,GO:1905407,1,0.987941242690785,0,2,regulation of creatine transmembrane transporter activity,BP,
20657,GO:1905408,1,0.987941242690785,0,2,negative regulation of creatine transmembrane transporter activity,BP,
20658,GO:1905419,1,0.994343262068184,0,1,sperm flagellum movement involved in flagellated sperm motility,BP,
20659,GO:1905421,1,0.994886556596673,0,1,regulation of plant organ morphogenesis,BP,
20660,GO:1905422,1,0.994886556596673,0,1,negative regulation of plant organ morphogenesis,BP,
20661,GO:1905424,1,0.988164720586537,0,2,regulation of Wnt-mediated midbrain dopaminergic neuron differentiation,BP,
20662,GO:1905426,1,0.988164720586537,0,2,positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation,BP,
20663,GO:1905429,1,0.987338782292371,0,2,response to glycine,BP,
20664,GO:1905430,1,0.994215345919295,0,1,cellular response to glycine,BP,
20665,GO:1905432,1,0.993179548007666,0,1,regulation of retrograde trans-synaptic signaling by neuropeptide,BP,
20666,GO:1905433,1,0.993179548007666,0,1,negative regulation of retrograde trans-synaptic signaling by neuropeptide,BP,
20667,GO:1905435,1,0.993850639026861,0,1,regulation of histone H3-K4 trimethylation,BP,
20668,GO:1905437,1,0.993850639026861,0,1,positive regulation of histone H3-K4 trimethylation,BP,
20669,GO:1905438,1,0.986843399432783,0,2,non-canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
20670,GO:1905443,1,0.992968526325195,0,1,regulation of clathrin coat assembly,BP,
20671,GO:1905445,1,0.992968526325195,0,1,positive regulation of clathrin coat assembly,BP,
20673,GO:1905447,1,0.993653817804457,0,1,negative regulation of mitochondrial ATP synthesis coupled electron transport,BP,
20675,GO:1905449,1,0.986477444248622,0,2,regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
20676,GO:1905451,1,0.986477444248622,0,2,positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
20677,GO:1905456,1,0.950645669778056,0,7,regulation of lymphoid progenitor cell differentiation,BP,
20678,GO:1905457,1,0.979745930863119,0,3,negative regulation of lymphoid progenitor cell differentiation,BP,
20679,GO:1905458,1,0.993240402415367,0,1,positive regulation of lymphoid progenitor cell differentiation,BP,
20680,GO:1905459,1,0.957652661684855,0,6,regulation of vascular associated smooth muscle cell apoptotic process,BP,
20681,GO:1905460,1,0.991525779307736,0,1,negative regulation of vascular associated smooth muscle cell apoptotic process,BP,
20682,GO:1905461,1,0.965840264294105,0,5,positive regulation of vascular associated smooth muscle cell apoptotic process,BP,
20685,GO:1905464,1,0.99317851521984,0,1,positive regulation of DNA duplex unwinding,BP,
20686,GO:1905468,1,0.992577619341872,0,1,regulation of clathrin-coated pit assembly,BP,
20687,GO:1905469,1,0.992577619341872,0,1,negative regulation of clathrin-coated pit assembly,BP,
20688,GO:1905474,1,0.994515622273784,0,1,canonical Wnt signaling pathway involved in stem cell proliferation,BP,
20689,GO:1905475,1,0.369198298314814,0,153,regulation of protein localization to membrane,BP,
20690,GO:1905476,1,0.831181167322221,0,29,negative regulation of protein localization to membrane,BP,
20691,GO:1905477,1,0.488998184576638,0,110,positive regulation of protein localization to membrane,BP,
20692,GO:1905483,1,0.989286060231701,0,1,regulation of motor neuron migration,BP,
20693,GO:1905485,1,0.989286060231701,0,1,positive regulation of motor neuron migration,BP,
20694,GO:1905502,1,0.994673209711004,0,1,acetyl-CoA binding,MF,
20695,GO:1905508,1,0.813389056551255,0,28,protein localization to microtubule organizing center,BP,
20696,GO:1905512,1,0.993963542547474,0,1,regulation of short-term synaptic potentiation,BP,
20697,GO:1905513,1,0.993963542547474,0,1,negative regulation of short-term synaptic potentiation,BP,
20698,GO:1905515,1,0.735179820588341,0,47,non-motile cilium assembly,BP,
20699,GO:1905516,1,0.947154464234145,0,8,positive regulation of fertilization,BP,
20700,GO:1905517,1,0.818386855764493,0,33,macrophage migration,BP,
20701,GO:1905518,1,0.992749368324187,0,1,regulation of presynaptic active zone assembly,BP,
20702,GO:1905520,1,0.992749368324187,0,1,positive regulation of presynaptic active zone assembly,BP,
20703,GO:1905521,1,0.88258669738376,0,20,regulation of macrophage migration,BP,
20704,GO:1905522,1,0.970249111003784,0,5,negative regulation of macrophage migration,BP,
20705,GO:1905523,1,0.932922035431361,0,11,positive regulation of macrophage migration,BP,
20706,GO:1905524,1,0.991302130619267,0,1,negative regulation of protein autoubiquitination,BP,
20707,GO:1905535,1,0.992584956360459,0,1,regulation of eukaryotic translation initiation factor 4F complex assembly,BP,
20708,GO:1905537,1,0.992584956360459,0,1,positive regulation of eukaryotic translation initiation factor 4F complex assembly,BP,
20709,GO:1905538,1,0.992902900696797,0,1,polysome binding,MF,
20710,GO:1905541,1,0.993956333071298,0,1,regulation of L-arginine import across plasma membrane,BP,
20711,GO:1905546,1,0.994109469806523,0,1,cellular response to phenylpropanoid,BP,
20712,GO:1905547,1,0.994442240407395,0,1,regulation of telomeric heterochromatin assembly,BP,
20713,GO:1905549,1,0.994442240407395,0,1,positive regulation of telomeric heterochromatin assembly,BP,
20714,GO:1905550,1,0.988699790685809,0,2,regulation of protein localization to endoplasmic reticulum,BP,
20715,GO:1905552,1,0.988699790685809,0,2,positive regulation of protein localization to endoplasmic reticulum,BP,
20716,GO:1905553,1,0.981525181093932,0,3,regulation of blood vessel branching,BP,
20717,GO:1905555,1,0.986857625247906,0,2,positive regulation blood vessel branching,BP,
20718,GO:1905562,1,0.907135202502598,0,14,regulation of vascular endothelial cell proliferation,BP,
20719,GO:1905563,1,0.979338480707925,0,3,negative regulation of vascular endothelial cell proliferation,BP,
20720,GO:1905564,1,0.926288376385795,0,11,positive regulation of vascular endothelial cell proliferation,BP,
20721,GO:1905572,1,0.993824193909186,0,1,ganglioside GM1 transport to membrane,BP,
20722,GO:1905573,1,0.988158629571692,0,2,ganglioside GM1 binding,MF,
20723,GO:1905574,1,0.993824193909186,0,1,ganglioside GM2 binding,MF,
20724,GO:1905575,1,0.993824193909186,0,1,ganglioside GM3 binding,MF,
20726,GO:1905577,1,0.993824193909186,0,1,ganglioside GP1c binding,MF,
20727,GO:1905578,1,0.994026409266231,0,1,regulation of ERBB3 signaling pathway,BP,
20728,GO:1905580,1,0.994026409266231,0,1,positive regulation of ERBB3 signaling pathway,BP,
20729,GO:1905581,1,0.994442498811555,0,1,positive regulation of low-density lipoprotein particle clearance,BP,
20730,GO:1905589,1,0.993956333071298,0,1,positive regulation of L-arginine import across plasma membrane,BP,
20731,GO:1905590,1,0.993673523183041,0,1,fibronectin fibril organization,BP,
20732,GO:1905594,1,0.994699040695356,0,1,resveratrol binding,MF,
20733,GO:1905595,1,0.987889686888921,0,2,regulation of low-density lipoprotein particle receptor binding,BP,
20734,GO:1905596,1,0.993410937173695,0,1,negative regulation of low-density lipoprotein particle receptor binding,BP,
20735,GO:1905597,1,0.994442498811555,0,1,positive regulation of low-density lipoprotein particle receptor binding,BP,
20736,GO:1905598,1,0.993410937173695,0,1,negative regulation of low-density lipoprotein receptor activity,BP,
20737,GO:1905599,1,0.994442498811555,0,1,positive regulation of low-density lipoprotein receptor activity,BP,
20738,GO:1905600,1,0.98173673303177,0,3,regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
20739,GO:1905601,1,0.993410937173695,0,1,negative regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
20740,GO:1905602,1,0.988249143885971,0,2,positive regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
20741,GO:1905603,1,0.992701755809941,0,1,regulation of maintenance of permeability of blood-brain barrier,BP,
20742,GO:1905604,1,0.992701755809941,0,1,negative regulation of maintenance of permeability of blood-brain barrier,BP,
20743,GO:1905606,1,0.972854705368811,0,4,regulation of presynapse assembly,BP,
20744,GO:1905608,1,0.992749368324187,0,1,positive regulation of presynapse assembly,BP,
20745,GO:1905610,1,0.992584956360459,0,1,regulation of mRNA cap binding,BP,
20746,GO:1905612,1,0.992584956360459,0,1,positive regulation of mRNA cap binding,BP,
20747,GO:1905616,1,0.986480735801871,0,2,regulation of miRNA mediated inhibition of translation,BP,
20748,GO:1905618,1,0.986480735801871,0,2,positive regulation of miRNA mediated inhibition of translation,BP,
20749,GO:1905634,1,0.962596048163623,0,5,regulation of protein localization to chromatin,BP,
20750,GO:1905636,1,0.994641694887482,0,1,positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
20751,GO:1905642,1,0.993850639026861,0,1,negative regulation of DNA methylation,BP,
20752,GO:1905643,1,0.992201598747689,0,1,positive regulation of DNA methylation,BP,
20753,GO:1905647,1,0.994013005560847,0,1,proline import across plasma membrane,BP,
20754,GO:1905651,1,0.977606613372353,0,3,regulation of artery morphogenesis,BP,
20755,GO:1905653,1,0.977606613372353,0,3,positive regulation of artery morphogenesis,BP,
20756,GO:1905661,1,0.987598742177124,0,2,regulation of telomerase RNA reverse transcriptase activity,BP,
20757,GO:1905663,1,0.987598742177124,0,2,positive regulation of telomerase RNA reverse transcriptase activity,BP,
20758,GO:1905664,1,0.976323062255669,0,4,regulation of calcium ion import across plasma membrane,BP,
20759,GO:1905665,1,0.988054130222232,0,2,positive regulation of calcium ion import across plasma membrane,BP,
20760,GO:1905666,1,0.937120234822368,0,9,regulation of protein localization to endosome,BP,
20761,GO:1905668,1,0.937120234822368,0,9,positive regulation of protein localization to endosome,BP,
20762,GO:1905671,1,0.981261401179136,0,3,regulation of lysosome organization,BP,
20763,GO:1905672,1,0.994177632221241,0,1,negative regulation of lysosome organization,BP,
20764,GO:1905687,1,0.992305290401354,0,1,regulation of diacylglycerol kinase activity,BP,
20765,GO:1905689,1,0.992305290401354,0,1,positive regulation of diacylglycerol kinase activity,BP,
20766,GO:1905693,1,0.994178148773045,0,1,regulation of phosphatidic acid biosynthetic process,BP,
20767,GO:1905695,1,0.994178148773045,0,1,positive regulation of phosphatidic acid biosynthetic process,BP,
20768,GO:1905696,1,0.985539954989521,0,2,regulation of polysome binding,BP,
20769,GO:1905698,1,0.992902900696797,0,1,positive regulation of polysome binding,BP,
20770,GO:1905705,1,0.991688800822766,0,1,cellular response to paclitaxel,BP,
20771,GO:1905709,1,0.970250562379733,0,5,negative regulation of membrane permeability,BP,
20772,GO:1905710,1,0.694655164106307,0,60,positive regulation of membrane permeability,BP,
20773,GO:1905711,1,0.993329627581151,0,1,response to phosphatidylethanolamine,BP,
20774,GO:1905719,1,0.987680048090503,0,2,protein localization to perinuclear region of cytoplasm,BP,
20775,GO:1905720,1,0.991555657821302,0,1,cytoplasmic microtubule bundle,CC,
20776,GO:1905747,1,0.994633428505869,0,1,negative regulation of saliva secretion,BP,
20777,GO:1905748,1,0.994633428505869,0,1,hard palate morphogenesis,BP,
20778,GO:1905764,1,0.979694683904826,0,3,regulation of protection from non-homologous end joining at telomere,BP,
20779,GO:1905765,1,0.979694683904826,0,3,negative regulation of protection from non-homologous end joining at telomere,BP,
20780,GO:1905767,1,0.991783054295074,0,1,regulation of double-stranded telomeric DNA binding,BP,
20781,GO:1905768,1,0.991783054295074,0,1,negative regulation of double-stranded telomeric DNA binding,BP,
20784,GO:1905773,1,0.978579046556947,0,3,8-hydroxy-2'-deoxyguanosine DNA binding,MF,
20785,GO:1905774,1,0.99317851521984,0,1,regulation of DNA helicase activity,BP,
20786,GO:1905776,1,0.99317851521984,0,1,positive regulation of DNA helicase activity,BP,
20787,GO:1905777,1,0.98154791943231,0,3,regulation of exonuclease activity,BP,
20788,GO:1905778,1,0.987603798904906,0,2,negative regulation of exonuclease activity,BP,
20789,GO:1905779,1,0.99386887877746,0,1,positive regulation of exonuclease activity,BP,
20790,GO:1905793,1,0.982328850988045,0,2,protein localization to pericentriolar material,BP,
20791,GO:1905794,1,0.990059222792504,0,1,response to puromycin,BP,
20792,GO:1905795,1,0.990059222792504,0,1,cellular response to puromycin,BP,
20793,GO:1905799,1,0.994940793151887,0,1,regulation of intraciliary retrograde transport,BP,
20794,GO:1905802,1,0.99381598176533,0,1,regulation of cellular response to manganese ion,BP,
20795,GO:1905809,1,0.859087278888356,0,22,negative regulation of synapse organization,BP,
20799,GO:1905832,1,0.966879757660108,0,4,positive regulation of spindle assembly,BP,
20800,GO:1905838,1,0.987603798904906,0,2,regulation of telomeric D-loop disassembly,BP,
20801,GO:1905839,1,0.987603798904906,0,2,negative regulation of telomeric D-loop disassembly,BP,
20802,GO:1905843,1,0.989549333370492,0,1,regulation of cellular response to gamma radiation,BP,
20803,GO:1905853,1,0.994679925836776,0,1,regulation of heparan sulfate binding,BP,
20804,GO:1905855,1,0.994679925836776,0,1,positive regulation of heparan sulfate binding,BP,
20805,GO:1905858,1,0.994679925836776,0,1,regulation of heparan sulfate proteoglycan binding,BP,
20806,GO:1905860,1,0.994679925836776,0,1,positive regulation of heparan sulfate proteoglycan binding,BP,
20807,GO:1905863,1,0.984164442398319,0,2,invadopodium organization,BP,
20808,GO:1905867,1,0.97703640110437,0,4,epididymis development,BP,
20809,GO:1905874,1,0.974278161798144,0,4,regulation of postsynaptic density organization,BP,
20810,GO:1905875,1,0.993775202635273,0,1,negative regulation of postsynaptic density organization,BP,
20811,GO:1905878,1,0.990221448472484,0,1,invadopodium disassembly,BP,
20812,GO:1905879,1,0.936891180501744,0,10,regulation of oogenesis,BP,
20813,GO:1905880,1,0.974085922117244,0,4,negative regulation of oogenesis,BP,
20814,GO:1905881,1,0.973582824921223,0,4,positive regulation of oogenesis,BP,
20815,GO:1905890,1,0.994679925836776,0,1,regulation of cellular response to very-low-density lipoprotein particle stimulus,BP,
20816,GO:1905891,1,0.993819061108973,0,1,regulation of cellular response to thapsigargin,BP,
20817,GO:1905892,1,0.993819061108973,0,1,negative regulation of cellular response to thapsigargin,BP,
20818,GO:1905894,1,0.993819061108973,0,1,regulation of cellular response to tunicamycin,BP,
20819,GO:1905895,1,0.993819061108973,0,1,negative regulation of cellular response to tunicamycin,BP,
20820,GO:1905897,1,0.626026905992683,0,73,regulation of response to endoplasmic reticulum stress,BP,
20822,GO:1905899,1,0.994475315120246,0,1,regulation of smooth muscle tissue development,BP,
20823,GO:1905900,1,0.994475315120246,0,1,negative regulation of smooth muscle tissue development,BP,
20824,GO:1905901,1,0.994475315120246,0,1,positive regulation of smooth muscle tissue development,BP,
20827,GO:1905906,1,0.956617620866879,0,7,regulation of amyloid fibril formation,BP,
20828,GO:1905907,1,0.981428648555918,0,3,negative regulation of amyloid fibril formation,BP,
20829,GO:1905908,1,0.974377644398753,0,4,positive regulation of amyloid fibril formation,BP,
20830,GO:1905912,1,0.994336283952402,0,1,regulation of calcium ion export across plasma membrane,BP,
20831,GO:1905913,1,0.994336283952402,0,1,negative regulation of calcium ion export across plasma membrane,BP,
20832,GO:1905918,1,0.994172466827488,0,1,regulation of CoA-transferase activity,BP,
20833,GO:1905920,1,0.994172466827488,0,1,positive regulation of CoA-transferase activity,BP,
20834,GO:1905927,1,0.990221448472484,0,1,regulation of invadopodium disassembly,BP,
20835,GO:1905929,1,0.990221448472484,0,1,positive regulation of invadopodium disassembly,BP,
20836,GO:1905936,1,0.97808003781571,0,4,regulation of germ cell proliferation,BP,
20837,GO:1905937,1,0.983210079841686,0,3,negative regulation of germ cell proliferation,BP,
20838,GO:1905938,1,0.994783245209959,0,1,positive regulation of germ cell proliferation,BP,
20839,GO:1905939,1,0.892801515613566,0,18,regulation of gonad development,BP,
20840,GO:1905940,1,0.968914850484891,0,5,negative regulation of gonad development,BP,
20841,GO:1905941,1,0.940141593873605,0,10,positive regulation of gonad development,BP,
20842,GO:1905942,1,0.994026409266231,0,1,regulation of formation of growth cone in injured axon,BP,
20843,GO:1905943,1,0.994026409266231,0,1,negative regulation of formation of growth cone in injured axon,BP,
20844,GO:1905952,1,0.487177184982512,0,109,regulation of lipid localization,BP,
20845,GO:1905953,1,0.810148417113581,0,31,negative regulation of lipid localization,BP,
20846,GO:1905954,1,0.648411226918046,0,66,positive regulation of lipid localization,BP,
20847,GO:1905957,1,0.993043888219735,0,1,regulation of cellular response to alcohol,BP,
20848,GO:1905959,1,0.993043888219735,0,1,positive regulation of cellular response to alcohol,BP,
20849,GO:1905961,1,0.9509222080327,0,8,protein-cysteine S-palmitoyltransferase complex,CC,
20850,GO:1990000,1,0.913527534216211,0,14,amyloid fibril formation,BP,
20852,GO:1990003,1,0.992169153657553,0,1,IDP phosphatase activity,MF,
20853,GO:1990005,1,0.988288700240674,0,2,granular vesicle,CC,
20854,GO:1990008,1,0.994403995151308,0,1,neurosecretory vesicle,CC,
20855,GO:1990009,1,0.98599802562534,0,2,retinal cell apoptotic process,BP,
20857,GO:1990023,1,0.916633814194521,0,12,mitotic spindle midzone,CC,
20858,GO:1990026,1,0.986210775381758,0,2,hippocampal mossy fiber expansion,CC,
20859,GO:1990030,1,0.993272060897795,0,1,pericellular basket,CC,
20860,GO:1990031,1,0.993657912147519,0,1,pinceau fiber,CC,
20861,GO:1990032,1,0.992976070568363,0,1,parallel fiber,CC,
20862,GO:1990034,1,0.964901354022544,0,5,calcium ion export across plasma membrane,BP,
20863,GO:1990036,1,0.985471020697337,0,2,calcium ion import into sarcoplasmic reticulum,BP,
20864,GO:1990037,1,0.982938890721639,0,3,Lewy body core,CC,
20865,GO:1990038,1,0.994276584277594,0,1,Lewy body corona,CC,
20866,GO:1990046,1,0.994628261973722,0,1,stress-induced mitochondrial fusion,BP,
20867,GO:1990047,1,0.994110502197272,0,1,spindle matrix,CC,
20868,GO:1990048,1,0.993850639026861,0,1,anterograde neuronal dense core vesicle transport,BP,
20869,GO:1990050,1,0.978136376964161,0,4,phosphatidic acid transporter activity,MF,
20870,GO:1990051,1,0.985944899063123,0,2,activation of protein kinase C activity,BP,
20871,GO:1990070,1,0.994892238566387,0,1,TRAPPI protein complex,CC,
20872,GO:1990071,1,0.986603907060959,0,2,TRAPPII protein complex,CC,
20873,GO:1990072,1,0.988773971252713,0,2,TRAPPIII protein complex,CC,
20874,GO:1990074,1,0.993475478836168,0,1,polyuridylation-dependent mRNA catabolic process,BP,
20875,GO:1990075,1,0.969506094107088,0,4,periciliary membrane compartment,CC,
20876,GO:1990079,1,0.994773430272166,0,1,cartilage homeostasis,BP,
20877,GO:1990086,1,0.973630179255248,0,4,lens fiber cell apoptotic process,BP,
20878,GO:1990089,1,0.697539396125234,0,52,response to nerve growth factor,BP,
20880,GO:1990108,1,0.984737397343802,0,2,protein linear deubiquitination,BP,
20881,GO:1990111,1,0.975933759842629,0,4,spermatoproteasome complex,CC,
20882,GO:1990112,1,0.987738712940129,0,2,RQC complex,CC,
20883,GO:1990116,1,0.987738712940129,0,2,ribosome-associated ubiquitin-dependent protein catabolic process,BP,
20884,GO:1990117,1,0.99487002715562,0,1,B cell receptor apoptotic signaling pathway,BP,
20885,GO:1990124,1,0.945111507938038,0,8,messenger ribonucleoprotein complex,CC,
20886,GO:1990126,1,0.899888957455056,0,16,retrograde transport, endosome to plasma membrane,BP,
20887,GO:1990127,1,0.993126818994063,0,1,intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
20888,GO:1990130,1,0.96908697728596,0,5,GATOR1 complex,CC,
20889,GO:1990131,1,0.97611432401642,0,4,Gtr1-Gtr2 GTPase complex,CC,
20890,GO:1990134,1,0.992686837324998,0,1,epithelial cell apoptotic process involved in palatal shelf morphogenesis,BP,
20891,GO:1990136,1,0.993990844694674,0,1,linoleate 9S-lipoxygenase activity,MF,
20893,GO:1990144,1,0.964502080725521,0,6,intrinsic apoptotic signaling pathway in response to hypoxia,BP,
20894,GO:1990145,1,0.987218355760982,0,2,maintenance of translational fidelity,BP,
20895,GO:1990164,1,0.987558029740006,0,2,histone H2A phosphorylation,BP,
20896,GO:1990165,1,0.994244283305648,0,1,single-strand break-containing DNA binding,MF,
20897,GO:1990166,1,0.994068443221543,0,1,protein localization to site of double-strand break,BP,
20898,GO:1990167,1,0.984027755016421,0,2,protein K27-linked deubiquitination,BP,
20899,GO:1990168,1,0.984840026736592,0,2,protein K33-linked deubiquitination,BP,
20900,GO:1990169,1,0.942764328089036,0,11,stress response to copper ion,BP,
20901,GO:1990170,1,0.994247384005406,0,1,stress response to cadmium ion,BP,
20902,GO:1990172,1,0.992248455173689,0,1,G-protein coupled receptor catabolic process,BP,
20903,GO:1990173,1,0.941292081730878,0,10,protein localization to nucleoplasm,BP,
20904,GO:1990174,1,0.993301628432331,0,1,phosphodiesterase decapping endonuclease activity,MF,
20905,GO:1990175,1,0.993263056118401,0,1,EH domain binding,MF,
20906,GO:1990179,1,0.978963743271495,0,3,protein localization to actomyosin contractile ring,BP,
20907,GO:1990180,1,0.982858306879859,0,3,mitochondrial tRNA 3'-end processing,BP,
20908,GO:1990182,1,0.900577732232833,0,17,exosomal secretion,BP,
20909,GO:1990183,1,0.994849365179344,0,1,lymphatic vascular process in circulatory system,BP,
20910,GO:1990186,1,0.994849365179344,0,1,regulation of lymphatic vessel size,BP,
20911,GO:1990188,1,0.99393239492871,0,1,euchromatin binding,MF,
20912,GO:1990189,1,0.983002055584902,0,3,peptide-serine-N-acetyltransferase activity,MF,
20913,GO:1990190,1,0.989366744417119,0,2,peptide-glutamate-N-acetyltransferase activity,MF,
20914,GO:1990192,1,0.994849365179344,0,1,collecting lymphatic vessel constriction,BP,
20916,GO:1990226,1,0.964307397974565,0,6,histone methyltransferase binding,MF,
20918,GO:1990239,1,0.960292538385651,0,6,steroid hormone binding,MF,
20919,GO:1990246,1,0.97562626446412,0,4,uniplex complex,CC,
20920,GO:1990247,1,0.952153381752548,0,7,N6-methyladenosine-containing RNA binding,MF,
20921,GO:1990253,1,0.939481077501217,0,9,cellular response to leucine starvation,BP,
20922,GO:1990254,1,0.968572343817227,0,5,keratin filament binding,MF,
20923,GO:1990256,1,0.989184455116053,0,1,signal clustering,BP,
20924,GO:1990258,1,0.994685092053482,0,1,histone glutamine methylation,BP,
20925,GO:1990259,1,0.994685092053482,0,1,histone-glutamine methyltransferase activity,MF,
20926,GO:1990261,1,0.993850639026861,0,1,pre-mRNA catabolic process,BP,
20927,GO:1990262,1,0.993869906618234,0,1,anti-Mullerian hormone signaling pathway,BP,
20928,GO:1990264,1,0.987744253675722,0,2,peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity,BP,
20929,GO:1990266,1,0.62589338365636,0,78,neutrophil migration,BP,
20930,GO:1990267,1,0.993626439905363,0,1,response to transition metal nanoparticle,BP,
20931,GO:1990268,1,0.993626439905363,0,1,response to gold nanoparticle,BP,
20932,GO:1990269,1,0.986908979678603,0,2,RNA polymerase II C-terminal domain phosphoserine binding,MF,
20933,GO:1990275,1,0.993798793234776,0,1,preribosome binding,MF,
20934,GO:1990280,1,0.99175205968801,0,1,RNA localization to chromatin,BP,
20935,GO:1990298,1,0.994175824307592,0,1,bub1-bub3 complex,CC,
20936,GO:1990314,1,0.943403976946157,0,8,cellular response to insulin-like growth factor stimulus,BP,
20937,GO:1990316,1,0.943929660024222,0,8,Atg1/ULK1 kinase complex,CC,
20938,GO:1990332,1,0.993216182234582,0,1,Ire1 complex,CC,
20939,GO:1990349,1,0.994254102342162,0,1,gap junction-mediated intercellular transport,BP,
20941,GO:1990356,1,0.994668043425921,0,1,sumoylated E2 ligase complex,CC,
20942,GO:1990357,1,0.982282151331388,0,3,terminal web,CC,
20943,GO:1990379,1,0.988867927538959,0,2,lipid transport across blood brain barrier,BP,
20944,GO:1990380,1,0.944261235595832,0,7,Lys48-specific deubiquitinase activity,MF,
20945,GO:1990381,1,0.915968883761086,0,13,ubiquitin-specific protease binding,MF,
20946,GO:1990384,1,0.994627745318633,0,1,hyaloid vascular plexus regression,BP,
20947,GO:1990386,1,0.994266505932956,0,1,mitotic cleavage furrow ingression,BP,
20948,GO:1990390,1,0.993500050914606,0,1,protein K33-linked ubiquitination,BP,
20949,GO:1990391,1,0.796836042630748,0,33,DNA repair complex,CC,
20950,GO:1990393,1,0.965823664291941,0,5,3M complex,CC,
20951,GO:1990399,1,0.994130119971222,0,1,epithelium regeneration,BP,
20952,GO:1990401,1,0.993857060510416,0,1,embryonic lung development,BP,
20953,GO:1990402,1,0.994151291207698,0,1,embryonic liver development,BP,
20954,GO:1990403,1,0.935947846663678,0,10,embryonic brain development,BP,
20955,GO:1990404,1,0.98758304019277,0,2,protein ADP-ribosylase activity,MF,
20956,GO:1990405,1,0.958223902842871,0,6,protein antigen binding,MF,
20957,GO:1990406,1,0.987563773681163,0,2,CGRP receptor complex,CC,
20958,GO:1990407,1,0.994820954592241,0,1,calcitonin gene-related peptide binding,MF,
20959,GO:1990408,1,0.987563773681163,0,2,calcitonin gene-related peptide receptor signaling pathway,BP,
20960,GO:1990409,1,0.987626850668496,0,2,adrenomedullin binding,MF,
20961,GO:1990410,1,0.976924408031006,0,4,adrenomedullin receptor signaling pathway,BP,
20962,GO:1990414,1,0.972033633944992,0,4,replication-born double-strand break repair via sister chromatid exchange,BP,
20963,GO:1990415,1,0.981274908962178,0,3,Pex17p-Pex14p docking complex,CC,
20964,GO:1990416,1,0.94564749087955,0,8,cellular response to brain-derived neurotrophic factor stimulus,BP,
20965,GO:1990418,1,0.982075112860492,0,3,response to insulin-like growth factor stimulus,BP,
20966,GO:1990421,1,0.989525691929859,0,1,subtelomeric heterochromatin,CC,
20967,GO:1990423,1,0.979206155272723,0,3,RZZ complex,CC,
20968,GO:1990425,1,0.973786912956985,0,3,ryanodine receptor complex,CC,
20969,GO:1990426,1,0.983588911729125,0,2,mitotic recombination-dependent replication fork processing,BP,
20970,GO:1990427,1,0.991462676802844,0,1,stereocilia tip-link density,CC,
20971,GO:1990428,1,0.986315740438208,0,2,miRNA transport,BP,
20972,GO:1990429,1,0.981274908962178,0,3,peroxisomal importomer complex,CC,
20973,GO:1990430,1,0.971139624807625,0,4,extracellular matrix protein binding,MF,
20974,GO:1990435,1,0.991462676802844,0,1,upper tip-link density,CC,
20975,GO:1990439,1,0.993767000104572,0,1,MAP kinase serine/threonine phosphatase activity,MF,
20976,GO:1990440,1,0.935672310424616,0,11,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,BP,
20977,GO:1990441,1,0.975898330903786,0,4,negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,BP,
20978,GO:1990442,1,0.98420080560649,0,3,intrinsic apoptotic signaling pathway in response to nitrosative stress,BP,
20979,GO:1990446,1,0.977970520658435,0,4,U1 snRNP binding,MF,
20980,GO:1990448,1,0.991859674331477,0,1,exon-exon junction complex binding,MF,
20981,GO:1990452,1,0.987027999129434,0,2,Parkin-FBXW7-Cul1 ubiquitin ligase complex,CC,
20982,GO:1990454,1,0.946214390893568,0,7,L-type voltage-gated calcium channel complex,CC,
20983,GO:1990456,1,0.993311392315829,0,1,mitochondrion-endoplasmic reticulum membrane tethering,BP,
20985,GO:1990460,1,0.97943402692946,0,3,leptin receptor binding,MF,
20986,GO:1990462,1,0.956321418710185,0,7,omegasome,CC,
20987,GO:1990478,1,0.994291314736043,0,1,response to ultrasound,BP,
20988,GO:1990481,1,0.976456696248717,0,4,mRNA pseudouridine synthesis,BP,
20989,GO:1990498,1,0.982658891524399,0,2,mitotic spindle microtubule,CC,
20990,GO:1990502,1,0.985599784505276,0,2,dense core granule maturation,BP,
20991,GO:1990504,1,0.952097420401812,0,6,dense core granule exocytosis,BP,
20992,GO:1990505,1,0.983588911729125,0,2,mitotic DNA replication maintenance of fidelity,BP,
20993,GO:1990511,1,0.973970741709335,0,4,piRNA biosynthetic process,BP,
20994,GO:1990518,1,0.992902900696797,0,1,single-stranded DNA-dependent ATP-dependent 3'-5' DNA helicase activity,MF,
20995,GO:1990519,1,0.987456090352582,0,2,pyrimidine nucleotide import into mitochondrion,BP,
20996,GO:1990523,1,0.975434511357594,0,4,bone regeneration,BP,
20997,GO:1990535,1,0.96407692053169,0,5,neuron projection maintenance,BP,
20998,GO:1990539,1,0.994089340810551,0,1,fructose import across plasma membrane,BP,
20999,GO:1990542,1,0.663704593154456,0,67,mitochondrial transmembrane transport,BP,
21000,GO:1990546,1,0.994460328392633,0,1,mitochondrial tricarboxylic acid transmembrane transport,BP,
21001,GO:1990564,1,0.971245654946099,0,5,protein polyufmylation,BP,
21002,GO:1990565,1,0.994423634968794,0,1,HSP90-CDC37 chaperone complex,CC,
21003,GO:1990569,1,0.985980092052505,0,2,UDP-N-acetylglucosamine transmembrane transport,BP,
21004,GO:1990570,1,0.993850639026861,0,1,GDP-mannose transmembrane transport,BP,
21005,GO:1990572,1,0.993224430037506,0,1,TERT-RMRP complex,CC,
21006,GO:1990573,1,0.943305580285749,0,9,potassium ion import across plasma membrane,BP,
21007,GO:1990575,1,0.987321641699258,0,2,mitochondrial L-ornithine transmembrane transport,BP,
21008,GO:1990578,1,0.992283023880083,0,1,perinuclear endoplasmic reticulum membrane,CC,
21009,GO:1990579,1,0.993216182234582,0,1,peptidyl-serine trans-autophosphorylation,BP,
21010,GO:1990583,1,0.994266505932956,0,1,phospholipase D activator activity,MF,
21011,GO:1990584,1,0.984562816079211,0,3,cardiac Troponin complex,CC,
21012,GO:1990589,1,0.984692338058456,0,2,ATF4-CREB1 transcription factor complex,CC,
21013,GO:1990590,1,0.988462209031378,0,2,ATF1-ATF4 transcription factor complex,CC,
21014,GO:1990592,1,0.971245654946099,0,5,protein K69-linked ufmylation,BP,
21015,GO:1990597,1,0.980429140101066,0,3,AIP1-IRE1 complex,CC,
21016,GO:1990599,1,0.979694683904826,0,3,3' overhang single-stranded DNA endodeoxyribonuclease activity,MF,
21017,GO:1990603,1,0.993590111754218,0,1,dark adaptation,BP,
21018,GO:1990604,1,0.980050680766119,0,3,IRE1-TRAF2-ASK1 complex,CC,
21019,GO:1990613,1,0.993471894822818,0,1,mitochondrial membrane fusion,BP,
21020,GO:1990617,1,0.989249270967548,0,2,CHOP-ATF4 complex,CC,
21021,GO:1990619,1,0.987787111474519,0,2,histone H3-K9 deacetylation,BP,
21022,GO:1990622,1,0.989080867642112,0,2,CHOP-ATF3 complex,CC,
21023,GO:1990630,1,0.993216182234582,0,1,IRE1-RACK1-PP2A complex,CC,
21024,GO:1990635,1,0.973149086901124,0,4,proximal dendrite,CC,
21025,GO:1990637,1,0.979715271876108,0,3,response to prolactin,BP,
21026,GO:1990641,1,0.982438500094328,0,3,response to iron ion starvation,BP,
21027,GO:1990646,1,0.993734971734107,0,1,cellular response to prolactin,BP,
21028,GO:1990654,1,0.992750152842796,0,1,sebum secreting cell proliferation,BP,
21029,GO:1990666,1,0.986022914023823,0,2,PCSK9-LDLR complex,CC,
21030,GO:1990667,1,0.987889686888921,0,2,PCSK9-AnxA2 complex,CC,
21031,GO:1990668,1,0.969696020752712,0,5,vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane,BP,
21032,GO:1990682,1,0.987298590034077,0,2,CSF1-CSF1R complex,CC,
21033,GO:1990696,1,0.983078794792584,0,2,USH2 complex,CC,
21034,GO:1990697,1,0.994140446824707,0,1,protein depalmitoleylation,BP,
21035,GO:1990698,1,0.987653326213448,0,2,palmitoleoyltransferase activity,MF,
21036,GO:1990699,1,0.994140446824707,0,1,palmitoleyl hydrolase activity,MF,
21037,GO:1990700,1,0.993256364963249,0,1,nucleolar chromatin organization,BP,
21038,GO:1990705,1,0.990741781317258,0,1,cholangiocyte proliferation,BP,
21039,GO:1990707,1,0.989525691929859,0,1,nuclear subtelomeric heterochromatin,CC,
21040,GO:1990708,1,0.992729490465192,0,1,conditioned place preference,BP,
21041,GO:1990709,1,0.9785519512157,0,3,presynaptic active zone organization,BP,
21043,GO:1990715,1,0.993196582358652,0,1,mRNA CDS binding,MF,
21044,GO:1990716,1,0.976415363345857,0,3,axonemal central apparatus,CC,
21045,GO:1990718,1,0.990258078366673,0,1,axonemal central pair projection,CC,
21046,GO:1990723,1,0.983022184844774,0,2,cytoplasmic periphery of the nuclear pore complex,CC,
21047,GO:1990726,1,0.973966273776332,0,5,Lsm1-7-Pat1 complex,CC,
21048,GO:1990729,1,0.994275809008079,0,1,primary miRNA modification,BP,
21049,GO:1990730,1,0.986794909007474,0,2,VCP-NSFL1C complex,CC,
21050,GO:1990736,1,0.993189873360537,0,1,regulation of vascular smooth muscle cell membrane depolarization,BP,
21051,GO:1990737,1,0.980554154294827,0,3,response to manganese-induced endoplasmic reticulum stress,BP,
21052,GO:1990739,1,0.990741781317258,0,1,granulosa cell proliferation,BP,
21053,GO:1990742,1,0.986070779575505,0,2,microvesicle,CC,
21054,GO:1990743,1,0.971907763046533,0,4,protein sialylation,BP,
21055,GO:1990744,1,0.994275809008079,0,1,primary miRNA methylation,BP,
21056,GO:1990745,1,0.979665664914508,0,3,EARP complex,CC,
21057,GO:1990748,1,0.598364490769345,0,86,cellular detoxification,BP,
21058,GO:1990751,1,0.991546303497539,0,1,Schwann cell chemotaxis,BP,
21060,GO:1990755,1,0.993850639026861,0,1,mitotic spindle microtubule depolymerization,BP,
21061,GO:1990756,1,0.981876980522265,0,3,protein binding, bridging involved in substrate recognition for ubiquitination,MF,
21062,GO:1990758,1,0.994340936030276,0,1,mitotic sister chromatid biorientation,BP,
21063,GO:1990761,1,0.977646932569277,0,3,growth cone lamellipodium,CC,
21064,GO:1990763,1,0.959801207566766,0,6,arrestin family protein binding,MF,
21065,GO:1990764,1,0.993883785009252,0,1,myofibroblast contraction,BP,
21066,GO:1990765,1,0.992611156593489,0,1,colon smooth muscle contraction,BP,
21067,GO:1990768,1,0.994920131708846,0,1,gastric mucosal blood circulation,BP,
21068,GO:1990769,1,0.982245456140446,0,3,proximal neuron projection,CC,
21069,GO:1990770,1,0.987568445692715,0,2,small intestine smooth muscle contraction,BP,
21070,GO:1990771,1,0.992132797473463,0,1,clathrin-dependent extracellular exosome endocytosis,BP,
21071,GO:1990773,1,0.994392107511739,0,1,matrix metallopeptidase secretion,BP,
21072,GO:1990774,1,0.88581446046613,0,18,tumor necrosis factor secretion,BP,
21073,GO:1990776,1,0.860993746857699,0,23,response to angiotensin,BP,
21074,GO:1990777,1,0.815586938005474,0,32,lipoprotein particle,CC,
21076,GO:1990782,1,0.634230771009189,0,67,protein tyrosine kinase binding,MF,
21077,GO:1990784,1,0.993207415872535,0,1,response to dsDNA,BP,
21078,GO:1990785,1,0.976746431503895,0,3,response to water-immersion restraint stress,BP,
21079,GO:1990786,1,0.993207415872535,0,1,cellular response to dsDNA,BP,
21080,GO:1990791,1,0.981313128880517,0,3,dorsal root ganglion development,BP,
21081,GO:1990796,1,0.993768281656602,0,1,photoreceptor cell terminal bouton,CC,
21082,GO:1990809,1,0.976072832646887,0,4,endoplasmic reticulum tubular network membrane organization,BP,
21083,GO:1990812,1,0.980580754377593,0,3,growth cone filopodium,CC,
21084,GO:1990817,1,0.994112567016873,0,1,RNA adenylyltransferase activity,MF,
21085,GO:1990822,1,0.948693592190963,0,8,basic amino acid transmembrane transport,BP,
21087,GO:1990825,1,0.945186150524611,0,9,sequence-specific mRNA binding,MF,
21088,GO:1990828,1,0.994173499887978,0,1,hepatocyte dedifferentiation,BP,
21089,GO:1990829,1,0.994277101124997,0,1,C-rich single-stranded DNA binding,MF,
21091,GO:1990832,1,0.994237565286352,0,1,slow axonal transport,BP,
21092,GO:1990833,1,0.994237565286352,0,1,clathrin-uncoating ATPase activity,MF,
21093,GO:1990834,1,0.975726897142303,0,4,response to odorant,BP,
21095,GO:1990839,1,0.987216695602288,0,2,response to endothelin,BP,
21096,GO:1990841,1,0.77077850213666,0,38,promoter-specific chromatin binding,MF,
21097,GO:1990843,1,0.992013629895481,0,1,subsarcolemmal mitochondrion,CC,
21098,GO:1990844,1,0.992013629895481,0,1,interfibrillar mitochondrion,CC,
21099,GO:1990845,1,0.919850984568722,0,13,adaptive thermogenesis,BP,
21100,GO:1990851,1,0.976524230839255,0,3,Wnt-Frizzled-LRP5/6 complex,CC,
21101,GO:1990859,1,0.99409604990986,0,1,cellular response to endothelin,BP,
21102,GO:1990868,1,0.966017102636853,0,5,response to chemokine,BP,
21103,GO:1990869,1,0.966017102636853,0,5,cellular response to chemokine,BP,
21104,GO:1990874,1,0.787482486307833,0,36,vascular smooth muscle cell proliferation,BP,
21105,GO:1990876,1,0.991853938633544,0,1,cytoplasmic side of nuclear pore,CC,
21106,GO:1990879,1,0.987738712940129,0,2,CST complex,CC,
21107,GO:1990882,1,0.993250444491064,0,1,rRNA acetylation,BP,
21108,GO:1990883,1,0.993250444491064,0,1,rRNA cytidine N-acetyltransferase activity,MF,
21109,GO:1990884,1,0.993250444491064,0,1,RNA acetylation,BP,
21110,GO:1990889,1,0.994325946015146,0,1,H4K20me3 modified histone binding,MF,
21112,GO:1990907,1,0.924005114085559,0,11,beta-catenin-TCF complex,CC,
21113,GO:1990909,1,0.925708201372642,0,10,Wnt signalosome,CC,
21114,GO:1990910,1,0.982129707374263,0,3,response to hypobaric hypoxia,BP,
21115,GO:1990911,1,0.975967711598255,0,4,response to psychosocial stress,BP,
21116,GO:1990913,1,0.993973843574546,0,1,sperm head plasma membrane,CC,
21117,GO:1990917,1,0.993973843574546,0,1,ooplasm,CC,
21118,GO:1990918,1,0.986821606487191,0,2,double-strand break repair involved in meiotic recombination,BP,
21119,GO:1990922,1,0.993576041518231,0,1,hepatic stellate cell proliferation,BP,
21120,GO:1990923,1,0.981646503772592,0,3,PET complex,CC,
21121,GO:1990926,1,0.981257765507754,0,3,short-term synaptic potentiation,BP,
21122,GO:1990927,1,0.985580763175905,0,2,calcium ion regulated lysosome exocytosis,BP,
21123,GO:1990928,1,0.985208280759628,0,2,response to amino acid starvation,BP,
21124,GO:1990930,1,0.994475315120246,0,1,RNA N1-methyladenosine dioxygenase activity,MF,
21125,GO:1990931,1,0.993075016881986,0,1,RNA N6-methyladenosine dioxygenase activity,MF,
21126,GO:1990936,1,0.98816417001049,0,2,vascular smooth muscle cell dedifferentiation,BP,
21127,GO:1990938,1,0.993224945433582,0,1,peptidyl-aspartic acid autophosphorylation,BP,
21129,GO:1990948,1,0.974068459800189,0,5,ubiquitin ligase inhibitor activity,MF,
21130,GO:1990955,1,0.99317851521984,0,1,G-rich single-stranded DNA binding,MF,
21131,GO:1990962,1,0.993232675100923,0,1,drug transport across blood-brain barrier,BP,
21132,GO:1990963,1,0.993232675100923,0,1,establishment of blood-retinal barrier,BP,
21133,GO:1990966,1,0.974565631894719,0,4,ATP generation from poly-ADP-D-ribose,BP,
21134,GO:1990967,1,0.988264555684964,0,2,multi-organism toxin transport,BP,
21135,GO:1990968,1,0.991945753067963,0,1,modulation by host of RNA binding by virus,BP,
21136,GO:1990969,1,0.991945753067963,0,1,modulation by host of viral RNA-binding transcription factor activity,BP,
21137,GO:1990971,1,0.993262026815901,0,1,EMILIN complex,CC,
21138,GO:1990983,1,0.993952728724263,0,1,tRNA demethylation,BP,
21139,GO:1990984,1,0.993952728724263,0,1,tRNA demethylase activity,MF,
21140,GO:2000001,1,0.90512689453858,0,16,regulation of DNA damage checkpoint,BP,
21141,GO:2000002,1,0.969644299440061,0,5,negative regulation of DNA damage checkpoint,BP,
21142,GO:2000003,1,0.993850639026861,0,1,positive regulation of DNA damage checkpoint,BP,
21143,GO:2000004,1,0.994367297581572,0,1,regulation of metanephric S-shaped body morphogenesis,BP,
21144,GO:2000005,1,0.994367297581572,0,1,negative regulation of metanephric S-shaped body morphogenesis,BP,
21145,GO:2000006,1,0.994367297581572,0,1,regulation of metanephric comma-shaped body morphogenesis,BP,
21146,GO:2000007,1,0.994367297581572,0,1,negative regulation of metanephric comma-shaped body morphogenesis,BP,
21147,GO:2000008,1,0.802771667792479,0,33,regulation of protein localization to cell surface,BP,
21148,GO:2000009,1,0.923815576930358,0,12,negative regulation of protein localization to cell surface,BP,
21149,GO:2000010,1,0.916140847473526,0,13,positive regulation of protein localization to cell surface,BP,
21150,GO:2000011,1,0.994149741938164,0,1,regulation of adaxial/abaxial pattern formation,BP,
21151,GO:2000015,1,0.976632222743529,0,4,regulation of determination of dorsal identity,BP,
21152,GO:2000016,1,0.989173935977086,0,2,negative regulation of determination of dorsal identity,BP,
21153,GO:2000017,1,0.987322409433175,0,2,positive regulation of determination of dorsal identity,BP,
21154,GO:2000018,1,0.950065109332896,0,8,regulation of male gonad development,BP,
21155,GO:2000019,1,0.993277462394299,0,1,negative regulation of male gonad development,BP,
21156,GO:2000020,1,0.956498083209689,0,7,positive regulation of male gonad development,BP,
21160,GO:2000036,1,0.849013196114423,0,24,regulation of stem cell population maintenance,BP,
21163,GO:2000042,1,0.93610078197076,0,9,negative regulation of double-strand break repair via homologous recombination,BP,
21164,GO:2000043,1,0.994076440360544,0,1,regulation of cardiac cell fate specification,BP,
21166,GO:2000047,1,0.94691277375009,0,9,regulation of cell-cell adhesion mediated by cadherin,BP,
21167,GO:2000048,1,0.977208554540942,0,4,negative regulation of cell-cell adhesion mediated by cadherin,BP,
21168,GO:2000049,1,0.969004740812087,0,5,positive regulation of cell-cell adhesion mediated by cadherin,BP,
21171,GO:2000052,1,0.924122348251037,0,12,positive regulation of non-canonical Wnt signaling pathway,BP,
21172,GO:2000053,1,0.983119038509568,0,2,regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
21173,GO:2000054,1,0.992986733621958,0,1,negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
21174,GO:2000055,1,0.99006331330171,0,1,positive regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
21175,GO:2000056,1,0.994317675710056,0,1,regulation of Wnt signaling pathway involved in digestive tract morphogenesis,BP,
21176,GO:2000057,1,0.994317675710056,0,1,negative regulation of Wnt signaling pathway involved in digestive tract morphogenesis,BP,
21179,GO:2000060,1,0.554596103481647,0,90,positive regulation of ubiquitin-dependent protein catabolic process,BP,
21180,GO:2000061,1,0.994475315120246,0,1,regulation of ureter smooth muscle cell differentiation,BP,
21181,GO:2000062,1,0.994475315120246,0,1,negative regulation of ureter smooth muscle cell differentiation,BP,
21182,GO:2000063,1,0.994475315120246,0,1,positive regulation of ureter smooth muscle cell differentiation,BP,
21183,GO:2000064,1,0.961882571690604,0,6,regulation of cortisol biosynthetic process,BP,
21184,GO:2000065,1,0.975332250559992,0,4,negative regulation of cortisol biosynthetic process,BP,
21185,GO:2000066,1,0.993277462394299,0,1,positive regulation of cortisol biosynthetic process,BP,
21186,GO:2000067,1,0.994886556596673,0,1,regulation of root morphogenesis,BP,
21187,GO:2000074,1,0.9503097080073,0,8,regulation of type B pancreatic cell development,BP,
21188,GO:2000077,1,0.985816238790343,0,2,negative regulation of type B pancreatic cell development,BP,
21189,GO:2000078,1,0.983204702973536,0,3,positive regulation of type B pancreatic cell development,BP,
21190,GO:2000079,1,0.992986733621958,0,1,regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,BP,
21191,GO:2000080,1,0.992986733621958,0,1,negative regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,BP,
21193,GO:2000096,1,0.949149097841936,0,8,positive regulation of Wnt signaling pathway, planar cell polarity pathway,BP,
21194,GO:2000097,1,0.982449396546311,0,3,regulation of smooth muscle cell-matrix adhesion,BP,
21195,GO:2000098,1,0.988395117480755,0,2,negative regulation of smooth muscle cell-matrix adhesion,BP,
21196,GO:2000101,1,0.993772895529134,0,1,regulation of mammary stem cell proliferation,BP,
21197,GO:2000103,1,0.993772895529134,0,1,positive regulation of mammary stem cell proliferation,BP,
21198,GO:2000104,1,0.878148280133218,0,19,negative regulation of DNA-dependent DNA replication,BP,
21199,GO:2000105,1,0.909137667587972,0,14,positive regulation of DNA-dependent DNA replication,BP,
21200,GO:2000106,1,0.622965846206199,0,75,regulation of leukocyte apoptotic process,BP,
21201,GO:2000107,1,0.762676461912334,0,43,negative regulation of leukocyte apoptotic process,BP,
21202,GO:2000108,1,0.858767760253872,0,24,positive regulation of leukocyte apoptotic process,BP,
21203,GO:2000109,1,0.955628556294554,0,7,regulation of macrophage apoptotic process,BP,
21204,GO:2000110,1,0.980828390204284,0,3,negative regulation of macrophage apoptotic process,BP,
21205,GO:2000111,1,0.980154884970093,0,3,positive regulation of macrophage apoptotic process,BP,
21208,GO:2000114,1,0.87795822798654,0,18,regulation of establishment of cell polarity,BP,
21211,GO:2000118,1,0.986951262547654,0,2,regulation of sodium-dependent phosphate transport,BP,
21212,GO:2000119,1,0.993753930174252,0,1,negative regulation of sodium-dependent phosphate transport,BP,
21213,GO:2000121,1,0.941724542484307,0,10,regulation of removal of superoxide radicals,BP,
21214,GO:2000124,1,0.987111493883785,0,2,regulation of endocannabinoid signaling pathway,BP,
21216,GO:2000136,1,0.902030685249562,0,15,regulation of cell proliferation involved in heart morphogenesis,BP,
21217,GO:2000137,1,0.983485732618645,0,2,negative regulation of cell proliferation involved in heart morphogenesis,BP,
21218,GO:2000138,1,0.966777814954612,0,5,positive regulation of cell proliferation involved in heart morphogenesis,BP,
21219,GO:2000142,1,0.788282661662984,0,36,regulation of DNA-templated transcription, initiation,BP,
21220,GO:2000143,1,0.961787786883032,0,6,negative regulation of DNA-templated transcription, initiation,BP,
21221,GO:2000144,1,0.836026984470791,0,27,positive regulation of DNA-templated transcription, initiation,BP,
21225,GO:2000152,1,0.977486924368917,0,4,regulation of ubiquitin-specific protease activity,BP,
21226,GO:2000156,1,0.987140774659452,0,2,regulation of retrograde vesicle-mediated transport, Golgi to ER,BP,
21227,GO:2000157,1,0.989455688250091,0,2,negative regulation of ubiquitin-specific protease activity,BP,
21228,GO:2000158,1,0.987904977337756,0,2,positive regulation of ubiquitin-specific protease activity,BP,
21229,GO:2000167,1,0.992502135147244,0,1,regulation of planar cell polarity pathway involved in neural tube closure,BP,
21231,GO:2000170,1,0.986583460618788,0,2,positive regulation of peptidyl-cysteine S-nitrosylation,BP,
21232,GO:2000171,1,0.830275390675324,0,26,negative regulation of dendrite development,BP,
21233,GO:2000172,1,0.971726418709111,0,4,regulation of branching morphogenesis of a nerve,BP,
21234,GO:2000173,1,0.993249672159224,0,1,negative regulation of branching morphogenesis of a nerve,BP,
21235,GO:2000174,1,0.993240402415367,0,1,regulation of pro-T cell differentiation,BP,
21236,GO:2000176,1,0.993240402415367,0,1,positive regulation of pro-T cell differentiation,BP,
21238,GO:2000178,1,0.874683019577657,0,20,negative regulation of neural precursor cell proliferation,BP,
21240,GO:2000181,1,0.551593518243291,0,87,negative regulation of blood vessel morphogenesis,BP,
21241,GO:2000182,1,0.978724894913064,0,3,regulation of progesterone biosynthetic process,BP,
21242,GO:2000184,1,0.992013629895481,0,1,positive regulation of progesterone biosynthetic process,BP,
21243,GO:2000191,1,0.898425982478635,0,16,regulation of fatty acid transport,BP,
21244,GO:2000192,1,0.963548112088704,0,5,negative regulation of fatty acid transport,BP,
21245,GO:2000193,1,0.940751035707146,0,10,positive regulation of fatty acid transport,BP,
21246,GO:2000194,1,0.92730698152271,0,12,regulation of female gonad development,BP,
21247,GO:2000195,1,0.975474151684654,0,4,negative regulation of female gonad development,BP,
21248,GO:2000196,1,0.982907229784171,0,3,positive regulation of female gonad development,BP,
21249,GO:2000197,1,0.959060012613545,0,6,regulation of ribonucleoprotein complex localization,BP,
21250,GO:2000199,1,0.993689392670227,0,1,positive regulation of ribonucleoprotein complex localization,BP,
21251,GO:2000200,1,0.993689392670227,0,1,regulation of ribosomal subunit export from nucleus,BP,
21252,GO:2000202,1,0.993689392670227,0,1,positive regulation of ribosomal subunit export from nucleus,BP,
21253,GO:2000206,1,0.993689392670227,0,1,regulation of ribosomal small subunit export from nucleus,BP,
21254,GO:2000208,1,0.993689392670227,0,1,positive regulation of ribosomal small subunit export from nucleus,BP,
21255,GO:2000209,1,0.868156071029589,0,21,regulation of anoikis,BP,
21256,GO:2000210,1,0.964614887469634,0,6,positive regulation of anoikis,BP,
21257,GO:2000211,1,0.986905833758557,0,2,regulation of glutamate metabolic process,BP,
21258,GO:2000212,1,0.992685528542536,0,1,negative regulation of glutamate metabolic process,BP,
21259,GO:2000213,1,0.994178148773045,0,1,positive regulation of glutamate metabolic process,BP,
21260,GO:2000224,1,0.982787511588649,0,3,regulation of testosterone biosynthetic process,BP,
21261,GO:2000225,1,0.988069254881676,0,2,negative regulation of testosterone biosynthetic process,BP,
21262,GO:2000226,1,0.994538358435351,0,1,regulation of pancreatic A cell differentiation,BP,
21263,GO:2000227,1,0.994538358435351,0,1,negative regulation of pancreatic A cell differentiation,BP,
21264,GO:2000229,1,0.988985667549452,0,2,regulation of pancreatic stellate cell proliferation,BP,
21265,GO:2000230,1,0.99432878894376,0,1,negative regulation of pancreatic stellate cell proliferation,BP,
21266,GO:2000231,1,0.99462671200744,0,1,positive regulation of pancreatic stellate cell proliferation,BP,
21267,GO:2000232,1,0.930100562888261,0,11,regulation of rRNA processing,BP,
21268,GO:2000233,1,0.986033075974862,0,2,negative regulation of rRNA processing,BP,
21269,GO:2000234,1,0.950339943808032,0,8,positive regulation of rRNA processing,BP,
21271,GO:2000242,1,0.760184754245872,0,44,negative regulation of reproductive process,BP,
21272,GO:2000243,1,0.73831238924372,0,47,positive regulation of reproductive process,BP,
21274,GO:2000251,1,0.897235299129701,0,18,positive regulation of actin cytoskeleton reorganization,BP,
21275,GO:2000252,1,0.960380831276863,0,7,negative regulation of feeding behavior,BP,
21276,GO:2000253,1,0.965394321199564,0,5,positive regulation of feeding behavior,BP,
21277,GO:2000254,1,0.97808003781571,0,4,regulation of male germ cell proliferation,BP,
21278,GO:2000255,1,0.983210079841686,0,3,negative regulation of male germ cell proliferation,BP,
21279,GO:2000256,1,0.994783245209959,0,1,positive regulation of male germ cell proliferation,BP,
21280,GO:2000257,1,0.796875056275719,0,36,regulation of protein activation cascade,BP,
21281,GO:2000258,1,0.957652554662054,0,6,negative regulation of protein activation cascade,BP,
21282,GO:2000259,1,0.980515398026189,0,3,positive regulation of protein activation cascade,BP,
21283,GO:2000269,1,0.903345718686524,0,15,regulation of fibroblast apoptotic process,BP,
21284,GO:2000270,1,0.952995073475787,0,7,negative regulation of fibroblast apoptotic process,BP,
21285,GO:2000271,1,0.952456047476159,0,7,positive regulation of fibroblast apoptotic process,BP,
21286,GO:2000272,1,0.829252222055792,0,28,negative regulation of signaling receptor activity,BP,
21287,GO:2000273,1,0.821405865335197,0,29,positive regulation of signaling receptor activity,BP,
21288,GO:2000275,1,0.977733496288201,0,4,regulation of oxidative phosphorylation uncoupler activity,BP,
21289,GO:2000276,1,0.988616460602852,0,2,negative regulation of oxidative phosphorylation uncoupler activity,BP,
21290,GO:2000277,1,0.994806490833661,0,1,positive regulation of oxidative phosphorylation uncoupler activity,BP,
21291,GO:2000278,1,0.533412594839485,0,96,regulation of DNA biosynthetic process,BP,
21292,GO:2000279,1,0.805607829918602,0,32,negative regulation of DNA biosynthetic process,BP,
21293,GO:2000280,1,0.994886556596673,0,1,regulation of root development,BP,
21294,GO:2000282,1,0.985567435333001,0,2,regulation of cellular amino acid biosynthetic process,BP,
21295,GO:2000283,1,0.990713196986705,0,1,negative regulation of cellular amino acid biosynthetic process,BP,
21296,GO:2000284,1,0.994806490833661,0,1,positive regulation of cellular amino acid biosynthetic process,BP,
21297,GO:2000286,1,0.981330619928222,0,3,receptor internalization involved in canonical Wnt signaling pathway,BP,
21298,GO:2000287,1,0.994129087348799,0,1,positive regulation of myotome development,BP,
21299,GO:2000288,1,0.9463846188062,0,9,positive regulation of myoblast proliferation,BP,
21300,GO:2000290,1,0.994129087348799,0,1,regulation of myotome development,BP,
21301,GO:2000291,1,0.915933972761346,0,14,regulation of myoblast proliferation,BP,
21302,GO:2000295,1,0.983328648641661,0,3,regulation of hydrogen peroxide catabolic process,BP,
21303,GO:2000296,1,0.989609552226713,0,2,negative regulation of hydrogen peroxide catabolic process,BP,
21304,GO:2000297,1,0.979550672724014,0,3,negative regulation of synapse maturation,BP,
21305,GO:2000298,1,0.987643926393331,0,2,regulation of Rho-dependent protein serine/threonine kinase activity,BP,
21306,GO:2000299,1,0.993554807790665,0,1,negative regulation of Rho-dependent protein serine/threonine kinase activity,BP,
21307,GO:2000300,1,0.839476129146443,0,25,regulation of synaptic vesicle exocytosis,BP,
21308,GO:2000301,1,0.981239296974974,0,3,negative regulation of synaptic vesicle exocytosis,BP,
21309,GO:2000302,1,0.977829753171023,0,3,positive regulation of synaptic vesicle exocytosis,BP,
21310,GO:2000303,1,0.923579530422917,0,13,regulation of ceramide biosynthetic process,BP,
21311,GO:2000304,1,0.951667190379056,0,8,positive regulation of ceramide biosynthetic process,BP,
21312,GO:2000307,1,0.987763555586207,0,2,regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,
21313,GO:2000308,1,0.994063026317346,0,1,negative regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,
21314,GO:2000309,1,0.993663286186664,0,1,positive regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,
21315,GO:2000310,1,0.88227482515879,0,18,regulation of NMDA receptor activity,BP,
21316,GO:2000311,1,0.845304332535555,0,24,regulation of AMPA receptor activity,BP,
21317,GO:2000312,1,0.979120843758928,0,3,regulation of kainate selective glutamate receptor activity,BP,
21318,GO:2000313,1,0.988773705540957,0,2,regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
21319,GO:2000314,1,0.994429320035563,0,1,negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
21320,GO:2000316,1,0.945864208895266,0,9,regulation of T-helper 17 type immune response,BP,
21321,GO:2000317,1,0.969219492202604,0,5,negative regulation of T-helper 17 type immune response,BP,
21322,GO:2000318,1,0.975910518150599,0,4,positive regulation of T-helper 17 type immune response,BP,
21323,GO:2000319,1,0.951959442508388,0,8,regulation of T-helper 17 cell differentiation,BP,
21324,GO:2000320,1,0.969219492202604,0,5,negative regulation of T-helper 17 cell differentiation,BP,
21325,GO:2000321,1,0.982197380105362,0,3,positive regulation of T-helper 17 cell differentiation,BP,
21326,GO:2000322,1,0.94889712530367,0,8,regulation of glucocorticoid receptor signaling pathway,BP,
21327,GO:2000323,1,0.960721726742929,0,6,negative regulation of glucocorticoid receptor signaling pathway,BP,
21328,GO:2000324,1,0.987696910420046,0,2,positive regulation of glucocorticoid receptor signaling pathway,BP,
21329,GO:2000325,1,0.992088352764727,0,1,regulation of ligand-dependent nuclear receptor transcription coactivator activity,BP,
21330,GO:2000327,1,0.992088352764727,0,1,positive regulation of ligand-dependent nuclear receptor transcription coactivator activity,BP,
21331,GO:2000328,1,0.976847661701502,0,4,regulation of T-helper 17 cell lineage commitment,BP,
21332,GO:2000329,1,0.987670777720616,0,2,negative regulation of T-helper 17 cell lineage commitment,BP,
21333,GO:2000330,1,0.989043144187488,0,2,positive regulation of T-helper 17 cell lineage commitment,BP,
21334,GO:2000331,1,0.986897969248633,0,2,regulation of terminal button organization,BP,
21335,GO:2000332,1,0.9886775941202,0,2,regulation of blood microparticle formation,BP,
21336,GO:2000334,1,0.9886775941202,0,2,positive regulation of blood microparticle formation,BP,
21337,GO:2000338,1,0.988061587152251,0,2,regulation of chemokine (C-X-C motif) ligand 1 production,BP,
21338,GO:2000340,1,0.988061587152251,0,2,positive regulation of chemokine (C-X-C motif) ligand 1 production,BP,
21340,GO:2000342,1,0.987878914396813,0,2,negative regulation of chemokine (C-X-C motif) ligand 2 production,BP,
21342,GO:2000344,1,0.954137270506096,0,7,positive regulation of acrosome reaction,BP,
21343,GO:2000345,1,0.931263063751216,0,11,regulation of hepatocyte proliferation,BP,
21344,GO:2000346,1,0.981168829342241,0,3,negative regulation of hepatocyte proliferation,BP,
21345,GO:2000347,1,0.962004486712927,0,6,positive regulation of hepatocyte proliferation,BP,
21346,GO:2000348,1,0.962980015373263,0,6,regulation of CD40 signaling pathway,BP,
21347,GO:2000349,1,0.987297788852737,0,2,negative regulation of CD40 signaling pathway,BP,
21348,GO:2000350,1,0.994745534763665,0,1,positive regulation of CD40 signaling pathway,BP,
21349,GO:2000351,1,0.773137587754419,0,39,regulation of endothelial cell apoptotic process,BP,
21350,GO:2000352,1,0.846894275191075,0,25,negative regulation of endothelial cell apoptotic process,BP,
21351,GO:2000353,1,0.913048787454549,0,14,positive regulation of endothelial cell apoptotic process,BP,
21352,GO:2000354,1,0.963913673394916,0,6,regulation of ovarian follicle development,BP,
21353,GO:2000355,1,0.988564013804848,0,2,negative regulation of ovarian follicle development,BP,
21354,GO:2000356,1,0.994475315120246,0,1,regulation of kidney smooth muscle cell differentiation,BP,
21355,GO:2000357,1,0.994475315120246,0,1,negative regulation of kidney smooth muscle cell differentiation,BP,
21356,GO:2000358,1,0.994475315120246,0,1,positive regulation of kidney smooth muscle cell differentiation,BP,
21357,GO:2000359,1,0.988728983707334,0,2,regulation of binding of sperm to zona pellucida,BP,
21358,GO:2000360,1,0.988728983707334,0,2,negative regulation of binding of sperm to zona pellucida,BP,
21359,GO:2000361,1,0.985852164405866,0,2,regulation of prostaglandin-E synthase activity,BP,
21360,GO:2000363,1,0.985852164405866,0,2,positive regulation of prostaglandin-E synthase activity,BP,
21361,GO:2000367,1,0.988886224617877,0,2,regulation of acrosomal vesicle exocytosis,BP,
21362,GO:2000368,1,0.988886224617877,0,2,positive regulation of acrosomal vesicle exocytosis,BP,
21363,GO:2000369,1,0.888493200012094,0,16,regulation of clathrin-dependent endocytosis,BP,
21364,GO:2000370,1,0.972851870885871,0,4,positive regulation of clathrin-dependent endocytosis,BP,
21365,GO:2000371,1,0.966394074700564,0,5,regulation of DNA topoisomerase (ATP-hydrolyzing) activity,BP,
21366,GO:2000373,1,0.966394074700564,0,5,positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity,BP,
21367,GO:2000374,1,0.984100613847411,0,3,regulation of oxygen metabolic process,BP,
21368,GO:2000376,1,0.989809776871405,0,2,positive regulation of oxygen metabolic process,BP,
21370,GO:2000378,1,0.752959870567737,0,45,negative regulation of reactive oxygen species metabolic process,BP,
21371,GO:2000379,1,0.605776660866857,0,78,positive regulation of reactive oxygen species metabolic process,BP,
21374,GO:2000382,1,0.973795994580909,0,4,positive regulation of mesoderm development,BP,
21375,GO:2000383,1,0.993306253802084,0,1,regulation of ectoderm development,BP,
21376,GO:2000384,1,0.993306253802084,0,1,negative regulation of ectoderm development,BP,
21377,GO:2000386,1,0.987805341770026,0,2,positive regulation of ovarian follicle development,BP,
21378,GO:2000387,1,0.99456987767494,0,1,regulation of antral ovarian follicle growth,BP,
21379,GO:2000388,1,0.99456987767494,0,1,positive regulation of antral ovarian follicle growth,BP,
21380,GO:2000389,1,0.980322190463141,0,3,regulation of neutrophil extravasation,BP,
21381,GO:2000391,1,0.980322190463141,0,3,positive regulation of neutrophil extravasation,BP,
21383,GO:2000393,1,0.986520055024133,0,2,negative regulation of lamellipodium morphogenesis,BP,
21385,GO:2000395,1,0.989290957022188,0,2,regulation of ubiquitin-dependent endocytosis,BP,
21386,GO:2000397,1,0.989290957022188,0,2,positive regulation of ubiquitin-dependent endocytosis,BP,
21387,GO:2000401,1,0.780813397776718,0,40,regulation of lymphocyte migration,BP,
21388,GO:2000402,1,0.957222345716009,0,7,negative regulation of lymphocyte migration,BP,
21389,GO:2000403,1,0.853020089932328,0,26,positive regulation of lymphocyte migration,BP,
21390,GO:2000404,1,0.841721663394874,0,28,regulation of T cell migration,BP,
21391,GO:2000405,1,0.987196094388815,0,2,negative regulation of T cell migration,BP,
21392,GO:2000406,1,0.873171503394598,0,22,positive regulation of T cell migration,BP,
21393,GO:2000407,1,0.982723006297383,0,3,regulation of T cell extravasation,BP,
21394,GO:2000409,1,0.988363372875552,0,2,positive regulation of T cell extravasation,BP,
21395,GO:2000410,1,0.982617904347613,0,3,regulation of thymocyte migration,BP,
21396,GO:2000412,1,0.988355022695263,0,2,positive regulation of thymocyte migration,BP,
21397,GO:2000413,1,0.993663286186664,0,1,regulation of fibronectin-dependent thymocyte migration,BP,
21398,GO:2000415,1,0.993663286186664,0,1,positive regulation of fibronectin-dependent thymocyte migration,BP,
21399,GO:2000416,1,0.975656016855217,0,4,regulation of eosinophil migration,BP,
21400,GO:2000417,1,0.98787816251406,0,2,negative regulation of eosinophil migration,BP,
21401,GO:2000418,1,0.987629396670578,0,2,positive regulation of eosinophil migration,BP,
21402,GO:2000419,1,0.993529222863612,0,1,regulation of eosinophil extravasation,BP,
21403,GO:2000420,1,0.993529222863612,0,1,negative regulation of eosinophil extravasation,BP,
21404,GO:2000422,1,0.99392802044389,0,1,regulation of eosinophil chemotaxis,BP,
21405,GO:2000424,1,0.99392802044389,0,1,positive regulation of eosinophil chemotaxis,BP,
21406,GO:2000425,1,0.941489745559506,0,9,regulation of apoptotic cell clearance,BP,
21407,GO:2000426,1,0.9879383076298,0,2,negative regulation of apoptotic cell clearance,BP,
21408,GO:2000427,1,0.953448415596382,0,7,positive regulation of apoptotic cell clearance,BP,
21409,GO:2000434,1,0.989755296095474,0,2,regulation of protein neddylation,BP,
21410,GO:2000435,1,0.989755296095474,0,2,negative regulation of protein neddylation,BP,
21411,GO:2000437,1,0.979147497085999,0,3,regulation of monocyte extravasation,BP,
21412,GO:2000438,1,0.991771332408741,0,1,negative regulation of monocyte extravasation,BP,
21413,GO:2000439,1,0.987272480346036,0,2,positive regulation of monocyte extravasation,BP,
21414,GO:2000446,1,0.993051154624465,0,1,regulation of macrophage migration inhibitory factor signaling pathway,BP,
21415,GO:2000449,1,0.982723006297383,0,3,regulation of CD8-positive, alpha-beta T cell extravasation,BP,
21416,GO:2000451,1,0.988363372875552,0,2,positive regulation of CD8-positive, alpha-beta T cell extravasation,BP,
21417,GO:2000452,1,0.988658578052625,0,2,regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
21418,GO:2000454,1,0.994332665670474,0,1,positive regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
21419,GO:2000458,1,0.988398826594949,0,2,regulation of astrocyte chemotaxis,BP,
21420,GO:2000463,1,0.83506904992859,0,25,positive regulation of excitatory postsynaptic potential,BP,
21421,GO:2000464,1,0.993997028244295,0,1,positive regulation of astrocyte chemotaxis,BP,
21422,GO:2000465,1,0.95798154006492,0,6,regulation of glycogen (starch) synthase activity,BP,
21423,GO:2000466,1,0.979533185184985,0,3,negative regulation of glycogen (starch) synthase activity,BP,
21424,GO:2000467,1,0.978385190453482,0,3,positive regulation of glycogen (starch) synthase activity,BP,
21425,GO:2000468,1,0.984202779260407,0,2,regulation of peroxidase activity,BP,
21426,GO:2000469,1,0.990489208522649,0,1,negative regulation of peroxidase activity,BP,
21427,GO:2000470,1,0.993653817804457,0,1,positive regulation of peroxidase activity,BP,
21428,GO:2000471,1,0.986725764619868,0,2,regulation of hematopoietic stem cell migration,BP,
21429,GO:2000473,1,0.986725764619868,0,2,positive regulation of hematopoietic stem cell migration,BP,
21430,GO:2000474,1,0.987271424792701,0,2,regulation of opioid receptor signaling pathway,BP,
21431,GO:2000479,1,0.913412525866353,0,14,regulation of cAMP-dependent protein kinase activity,BP,
21432,GO:2000480,1,0.952293700570301,0,8,negative regulation of cAMP-dependent protein kinase activity,BP,
21433,GO:2000481,1,0.970332633187214,0,4,positive regulation of cAMP-dependent protein kinase activity,BP,
21434,GO:2000482,1,0.872787384614118,0,22,regulation of interleukin-8 secretion,BP,
21435,GO:2000483,1,0.954849041792099,0,7,negative regulation of interleukin-8 secretion,BP,
21436,GO:2000484,1,0.919757013490602,0,14,positive regulation of interleukin-8 secretion,BP,
21437,GO:2000485,1,0.987577039753702,0,2,regulation of glutamine transport,BP,
21438,GO:2000486,1,0.993522570185009,0,1,negative regulation of glutamine transport,BP,
21439,GO:2000487,1,0.994016098455656,0,1,positive regulation of glutamine transport,BP,
21440,GO:2000489,1,0.961353809831677,0,6,regulation of hepatic stellate cell activation,BP,
21441,GO:2000490,1,0.987686391619141,0,2,negative regulation of hepatic stellate cell activation,BP,
21442,GO:2000491,1,0.973342418680707,0,4,positive regulation of hepatic stellate cell activation,BP,
21443,GO:2000492,1,0.993747268352421,0,1,regulation of interleukin-18-mediated signaling pathway,BP,
21444,GO:2000494,1,0.993747268352421,0,1,positive regulation of interleukin-18-mediated signaling pathway,BP,
21445,GO:2000501,1,0.973464088092474,0,5,regulation of natural killer cell chemotaxis,BP,
21446,GO:2000502,1,0.989405761030757,0,2,negative regulation of natural killer cell chemotaxis,BP,
21447,GO:2000503,1,0.9838893504129,0,3,positive regulation of natural killer cell chemotaxis,BP,
21448,GO:2000504,1,0.986826277518826,0,2,positive regulation of blood vessel remodeling,BP,
21449,GO:2000508,1,0.955403883112466,0,8,regulation of dendritic cell chemotaxis,BP,
21450,GO:2000510,1,0.955403883112466,0,8,positive regulation of dendritic cell chemotaxis,BP,
21451,GO:2000511,1,0.994658227399849,0,1,regulation of granzyme A production,BP,
21452,GO:2000513,1,0.994658227399849,0,1,positive regulation of granzyme A production,BP,
21453,GO:2000514,1,0.782361999546425,0,39,regulation of CD4-positive, alpha-beta T cell activation,BP,
21454,GO:2000515,1,0.889899819879252,0,18,negative regulation of CD4-positive, alpha-beta T cell activation,BP,
21455,GO:2000516,1,0.859022765834353,0,25,positive regulation of CD4-positive, alpha-beta T cell activation,BP,
21456,GO:2000517,1,0.994658227399849,0,1,regulation of T-helper 1 cell activation,BP,
21457,GO:2000518,1,0.994658227399849,0,1,negative regulation of T-helper 1 cell activation,BP,
21458,GO:2000520,1,0.982915933754471,0,3,regulation of immunological synapse formation,BP,
21459,GO:2000521,1,0.988682773005191,0,2,negative regulation of immunological synapse formation,BP,
21460,GO:2000522,1,0.994167818170529,0,1,positive regulation of immunological synapse formation,BP,
21461,GO:2000523,1,0.987694709871365,0,2,regulation of T cell costimulation,BP,
21462,GO:2000525,1,0.987694709871365,0,2,positive regulation of T cell costimulation,BP,
21463,GO:2000526,1,0.994167818170529,0,1,positive regulation of glycoprotein biosynthetic process involved in immunological synapse formation,BP,
21464,GO:2000527,1,0.994836451333021,0,1,regulation of myeloid dendritic cell chemotaxis,BP,
21465,GO:2000529,1,0.994836451333021,0,1,positive regulation of myeloid dendritic cell chemotaxis,BP,
21466,GO:2000532,1,0.993993421089467,0,1,regulation of renal albumin absorption,BP,
21467,GO:2000533,1,0.993993421089467,0,1,negative regulation of renal albumin absorption,BP,
21468,GO:2000535,1,0.960113760204231,0,6,regulation of entry of bacterium into host cell,BP,
21469,GO:2000536,1,0.991689841766479,0,1,negative regulation of entry of bacterium into host cell,BP,
21470,GO:2000537,1,0.98774148201237,0,2,regulation of B cell chemotaxis,BP,
21471,GO:2000538,1,0.98774148201237,0,2,positive regulation of B cell chemotaxis,BP,
21473,GO:2000543,1,0.976598256319749,0,4,positive regulation of gastrulation,BP,
21475,GO:2000545,1,0.994668043425921,0,1,negative regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,
21476,GO:2000546,1,0.978805772247494,0,3,positive regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,
21477,GO:2000547,1,0.984025709238415,0,3,regulation of dendritic cell dendrite assembly,BP,
21478,GO:2000548,1,0.994836451333021,0,1,negative regulation of dendritic cell dendrite assembly,BP,
21479,GO:2000549,1,0.994936660871352,0,1,positive regulation of dendritic cell dendrite assembly,BP,
21480,GO:2000551,1,0.953262499054865,0,8,regulation of T-helper 2 cell cytokine production,BP,
21481,GO:2000552,1,0.988531468276404,0,2,negative regulation of T-helper 2 cell cytokine production,BP,
21482,GO:2000553,1,0.964325939716285,0,6,positive regulation of T-helper 2 cell cytokine production,BP,
21483,GO:2000554,1,0.994658227399849,0,1,regulation of T-helper 1 cell cytokine production,BP,
21484,GO:2000556,1,0.994658227399849,0,1,positive regulation of T-helper 1 cell cytokine production,BP,
21485,GO:2000557,1,0.994658227399849,0,1,regulation of immunoglobulin production in mucosal tissue,BP,
21486,GO:2000558,1,0.994658227399849,0,1,positive regulation of immunoglobulin production in mucosal tissue,BP,
21487,GO:2000559,1,0.991771332408741,0,1,regulation of CD24 biosynthetic process,BP,
21488,GO:2000560,1,0.991771332408741,0,1,positive regulation of CD24 biosynthetic process,BP,
21489,GO:2000561,1,0.963943193581628,0,6,regulation of CD4-positive, alpha-beta T cell proliferation,BP,
21490,GO:2000562,1,0.976901620026581,0,4,negative regulation of CD4-positive, alpha-beta T cell proliferation,BP,
21491,GO:2000563,1,0.975993613999508,0,4,positive regulation of CD4-positive, alpha-beta T cell proliferation,BP,
21492,GO:2000564,1,0.982633332083647,0,3,regulation of CD8-positive, alpha-beta T cell proliferation,BP,
21493,GO:2000566,1,0.989108779962501,0,2,positive regulation of CD8-positive, alpha-beta T cell proliferation,BP,
21494,GO:2000567,1,0.994149741938164,0,1,regulation of memory T cell activation,BP,
21495,GO:2000568,1,0.994149741938164,0,1,positive regulation of memory T cell activation,BP,
21496,GO:2000569,1,0.993600344714669,0,1,regulation of T-helper 2 cell activation,BP,
21497,GO:2000570,1,0.993600344714669,0,1,positive regulation of T-helper 2 cell activation,BP,
21498,GO:2000571,1,0.993489301443189,0,1,regulation of interleukin-4-dependent isotype switching to IgE isotypes,BP,
21499,GO:2000572,1,0.993489301443189,0,1,positive regulation of interleukin-4-dependent isotype switching to IgE isotypes,BP,
21500,GO:2000573,1,0.669178156352148,0,63,positive regulation of DNA biosynthetic process,BP,
21501,GO:2000574,1,0.94663597930021,0,9,regulation of microtubule motor activity,BP,
21502,GO:2000576,1,0.965947670493102,0,6,positive regulation of microtubule motor activity,BP,
21503,GO:2000580,1,0.971926110071401,0,5,regulation of ATP-dependent microtubule motor activity, plus-end-directed,BP,
21504,GO:2000582,1,0.971926110071401,0,5,positive regulation of ATP-dependent microtubule motor activity, plus-end-directed,BP,
21505,GO:2000583,1,0.993307281570577,0,1,regulation of platelet-derived growth factor receptor-alpha signaling pathway,BP,
21506,GO:2000584,1,0.993307281570577,0,1,negative regulation of platelet-derived growth factor receptor-alpha signaling pathway,BP,
21509,GO:2000588,1,0.984551489536142,0,2,positive regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
21510,GO:2000589,1,0.980115038480902,0,3,regulation of metanephric mesenchymal cell migration,BP,
21511,GO:2000591,1,0.980115038480902,0,3,positive regulation of metanephric mesenchymal cell migration,BP,
21512,GO:2000592,1,0.986508997543432,0,2,regulation of metanephric DCT cell differentiation,BP,
21513,GO:2000594,1,0.986508997543432,0,2,positive regulation of metanephric DCT cell differentiation,BP,
21514,GO:2000595,1,0.993169734686661,0,1,regulation of optic nerve formation,BP,
21515,GO:2000597,1,0.993169734686661,0,1,positive regulation of optic nerve formation,BP,
21516,GO:2000601,1,0.9603700223537,0,6,positive regulation of Arp2/3 complex-mediated actin nucleation,BP,
21517,GO:2000606,1,0.993705521198315,0,1,regulation of cell proliferation involved in mesonephros development,BP,
21518,GO:2000607,1,0.993705521198315,0,1,negative regulation of cell proliferation involved in mesonephros development,BP,
21519,GO:2000609,1,0.975749173764878,0,4,regulation of thyroid hormone generation,BP,
21520,GO:2000611,1,0.98132848909955,0,3,positive regulation of thyroid hormone generation,BP,
21521,GO:2000612,1,0.993293917962388,0,1,regulation of thyroid-stimulating hormone secretion,BP,
21522,GO:2000615,1,0.929417838669651,0,11,regulation of histone H3-K9 acetylation,BP,
21523,GO:2000616,1,0.986971979428557,0,2,negative regulation of histone H3-K9 acetylation,BP,
21524,GO:2000617,1,0.953339940659694,0,7,positive regulation of histone H3-K9 acetylation,BP,
21525,GO:2000618,1,0.965839976533741,0,5,regulation of histone H4-K16 acetylation,BP,
21526,GO:2000619,1,0.981676885807909,0,3,negative regulation of histone H4-K16 acetylation,BP,
21527,GO:2000620,1,0.983870480515402,0,2,positive regulation of histone H4-K16 acetylation,BP,
21528,GO:2000622,1,0.972113105403208,0,4,regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
21529,GO:2000623,1,0.972113105403208,0,4,negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
21530,GO:2000625,1,0.986844643602295,0,2,regulation of miRNA catabolic process,BP,
21531,GO:2000627,1,0.986844643602295,0,2,positive regulation of miRNA catabolic process,BP,
21532,GO:2000628,1,0.956892463090781,0,7,regulation of miRNA metabolic process,BP,
21533,GO:2000630,1,0.969013783482124,0,5,positive regulation of miRNA metabolic process,BP,
21534,GO:2000631,1,0.993614671204414,0,1,regulation of pre-miRNA processing,BP,
21535,GO:2000632,1,0.993614671204414,0,1,negative regulation of pre-miRNA processing,BP,
21536,GO:2000637,1,0.877455761603485,0,20,positive regulation of gene silencing by miRNA,BP,
21537,GO:2000638,1,0.987288242245228,0,2,regulation of SREBP signaling pathway,BP,
21538,GO:2000639,1,0.987288242245228,0,2,negative regulation of SREBP signaling pathway,BP,
21539,GO:2000641,1,0.895190632322909,0,17,regulation of early endosome to late endosome transport,BP,
21540,GO:2000642,1,0.98954273897705,0,2,negative regulation of early endosome to late endosome transport,BP,
21541,GO:2000643,1,0.947005333879754,0,8,positive regulation of early endosome to late endosome transport,BP,
21542,GO:2000644,1,0.941622791541342,0,9,regulation of receptor catabolic process,BP,
21543,GO:2000645,1,0.980541954692064,0,3,negative regulation of receptor catabolic process,BP,
21544,GO:2000646,1,0.966403066925398,0,5,positive regulation of receptor catabolic process,BP,
21545,GO:2000647,1,0.934704594130599,0,10,negative regulation of stem cell proliferation,BP,
21548,GO:2000650,1,0.922756219417841,0,11,negative regulation of sodium ion transmembrane transporter activity,BP,
21549,GO:2000651,1,0.912304649276691,0,13,positive regulation of sodium ion transmembrane transporter activity,BP,
21550,GO:2000653,1,0.980310943176469,0,3,regulation of genetic imprinting,BP,
21551,GO:2000654,1,0.993308052375291,0,1,regulation of cellular response to testosterone stimulus,BP,
21552,GO:2000655,1,0.993308052375291,0,1,negative regulation of cellular response to testosterone stimulus,BP,
21553,GO:2000656,1,0.994317675710056,0,1,regulation of apolipoprotein binding,BP,
21554,GO:2000657,1,0.994317675710056,0,1,negative regulation of apolipoprotein binding,BP,
21555,GO:2000659,1,0.957182948579248,0,7,regulation of interleukin-1-mediated signaling pathway,BP,
21556,GO:2000660,1,0.969728983287178,0,5,negative regulation of interleukin-1-mediated signaling pathway,BP,
21557,GO:2000661,1,0.992753552302774,0,1,positive regulation of interleukin-1-mediated signaling pathway,BP,
21558,GO:2000662,1,0.963620049691764,0,6,regulation of interleukin-5 secretion,BP,
21559,GO:2000663,1,0.993415549653041,0,1,negative regulation of interleukin-5 secretion,BP,
21560,GO:2000664,1,0.970008984284585,0,5,positive regulation of interleukin-5 secretion,BP,
21561,GO:2000665,1,0.958509395212772,0,7,regulation of interleukin-13 secretion,BP,
21562,GO:2000666,1,0.987717887989427,0,2,negative regulation of interleukin-13 secretion,BP,
21563,GO:2000667,1,0.970431942393066,0,5,positive regulation of interleukin-13 secretion,BP,
21564,GO:2000668,1,0.940399216055471,0,10,regulation of dendritic cell apoptotic process,BP,
21565,GO:2000669,1,0.959589576560063,0,7,negative regulation of dendritic cell apoptotic process,BP,
21566,GO:2000670,1,0.980009740677892,0,3,positive regulation of dendritic cell apoptotic process,BP,
21569,GO:2000674,1,0.933647159558148,0,11,regulation of type B pancreatic cell apoptotic process,BP,
21570,GO:2000675,1,0.962032242776127,0,6,negative regulation of type B pancreatic cell apoptotic process,BP,
21571,GO:2000676,1,0.970506032077877,0,5,positive regulation of type B pancreatic cell apoptotic process,BP,
21575,GO:2000683,1,0.987572024344872,0,2,regulation of cellular response to X-ray,BP,
21576,GO:2000685,1,0.993828043976683,0,1,positive regulation of cellular response to X-ray,BP,
21577,GO:2000690,1,0.993095490841172,0,1,regulation of cardiac muscle cell myoblast differentiation,BP,
21578,GO:2000691,1,0.993095490841172,0,1,negative regulation of cardiac muscle cell myoblast differentiation,BP,
21579,GO:2000696,1,0.901452836179161,0,15,regulation of epithelial cell differentiation involved in kidney development,BP,
21580,GO:2000697,1,0.976307032666247,0,4,negative regulation of epithelial cell differentiation involved in kidney development,BP,
21581,GO:2000698,1,0.968339653875396,0,5,positive regulation of epithelial cell differentiation involved in kidney development,BP,
21582,GO:2000699,1,0.993705521198315,0,1,fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
21583,GO:2000701,1,0.993705521198315,0,1,glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
21584,GO:2000702,1,0.993705521198315,0,1,regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
21585,GO:2000703,1,0.993705521198315,0,1,negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
21586,GO:2000705,1,0.978524017773669,0,3,regulation of dense core granule biogenesis,BP,
21587,GO:2000706,1,0.993401710947692,0,1,negative regulation of dense core granule biogenesis,BP,
21588,GO:2000707,1,0.985024480923316,0,2,positive regulation of dense core granule biogenesis,BP,
21589,GO:2000718,1,0.994831285768497,0,1,regulation of maintenance of mitotic sister chromatid cohesion, centromeric,BP,
21590,GO:2000719,1,0.994831285768497,0,1,negative regulation of maintenance of mitotic sister chromatid cohesion, centromeric,BP,
21591,GO:2000721,1,0.978428474617722,0,3,positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,
21592,GO:2000722,1,0.979654840018158,0,3,regulation of cardiac vascular smooth muscle cell differentiation,BP,
21593,GO:2000723,1,0.993908983453303,0,1,negative regulation of cardiac vascular smooth muscle cell differentiation,BP,
21594,GO:2000724,1,0.985659380854543,0,2,positive regulation of cardiac vascular smooth muscle cell differentiation,BP,
21595,GO:2000725,1,0.829752162989251,0,27,regulation of cardiac muscle cell differentiation,BP,
21596,GO:2000726,1,0.925764958654872,0,11,negative regulation of cardiac muscle cell differentiation,BP,
21597,GO:2000727,1,0.896364597011851,0,16,positive regulation of cardiac muscle cell differentiation,BP,
21598,GO:2000729,1,0.98841147267427,0,2,positive regulation of mesenchymal cell proliferation involved in ureter development,BP,
21599,GO:2000733,1,0.993705521198315,0,1,regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
21600,GO:2000734,1,0.993705521198315,0,1,negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
21602,GO:2000737,1,0.881237926202836,0,18,negative regulation of stem cell differentiation,BP,
21603,GO:2000738,1,0.893176739381157,0,17,positive regulation of stem cell differentiation,BP,
21605,GO:2000740,1,0.993401710947692,0,1,negative regulation of mesenchymal stem cell differentiation,BP,
21606,GO:2000741,1,0.97023832090077,0,4,positive regulation of mesenchymal stem cell differentiation,BP,
21607,GO:2000742,1,0.994210695735449,0,1,regulation of anterior head development,BP,
21608,GO:2000744,1,0.994210695735449,0,1,positive regulation of anterior head development,BP,
21609,GO:2000752,1,0.993847557092416,0,1,regulation of glucosylceramide catabolic process,BP,
21610,GO:2000753,1,0.993847557092416,0,1,positive regulation of glucosylceramide catabolic process,BP,
21611,GO:2000754,1,0.993847557092416,0,1,regulation of sphingomyelin catabolic process,BP,
21612,GO:2000755,1,0.993847557092416,0,1,positive regulation of sphingomyelin catabolic process,BP,
21613,GO:2000756,1,0.690271016400659,0,57,regulation of peptidyl-lysine acetylation,BP,
21614,GO:2000757,1,0.873547764752318,0,21,negative regulation of peptidyl-lysine acetylation,BP,
21615,GO:2000758,1,0.828450594464471,0,29,positive regulation of peptidyl-lysine acetylation,BP,
21616,GO:2000759,1,0.992774467618625,0,1,regulation of N-terminal peptidyl-lysine acetylation,BP,
21617,GO:2000761,1,0.992774467618625,0,1,positive regulation of N-terminal peptidyl-lysine acetylation,BP,
21618,GO:2000763,1,0.994066637540254,0,1,positive regulation of transcription from RNA polymerase II promoter involved in norepinephrine biosynthetic process,BP,
21619,GO:2000764,1,0.994066637540254,0,1,positive regulation of semaphorin-plexin signaling pathway involved in outflow tract morphogenesis,BP,
21620,GO:2000765,1,0.864954442797238,0,22,regulation of cytoplasmic translation,BP,
21621,GO:2000766,1,0.951552707063743,0,7,negative regulation of cytoplasmic translation,BP,
21622,GO:2000767,1,0.954456517905333,0,7,positive regulation of cytoplasmic translation,BP,
21623,GO:2000768,1,0.993264085382676,0,1,positive regulation of nephron tubule epithelial cell differentiation,BP,
21624,GO:2000772,1,0.802003181328286,0,33,regulation of cellular senescence,BP,
21625,GO:2000773,1,0.893784169828869,0,16,negative regulation of cellular senescence,BP,
21626,GO:2000774,1,0.947880174258618,0,9,positive regulation of cellular senescence,BP,
21627,GO:2000775,1,0.994208112361827,0,1,histone H3-S10 phosphorylation involved in chromosome condensation,BP,
21628,GO:2000777,1,0.988381722571118,0,2,positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia,BP,
21631,GO:2000780,1,0.869569605618435,0,20,negative regulation of double-strand break repair,BP,
21633,GO:2000785,1,0.791213180969708,0,35,regulation of autophagosome assembly,BP,
21634,GO:2000786,1,0.93155002511532,0,10,positive regulation of autophagosome assembly,BP,
21635,GO:2000790,1,0.984425645546743,0,2,regulation of mesenchymal cell proliferation involved in lung development,BP,
21636,GO:2000791,1,0.984425645546743,0,2,negative regulation of mesenchymal cell proliferation involved in lung development,BP,
21637,GO:2000793,1,0.974441192485812,0,3,cell proliferation involved in heart valve development,BP,
21638,GO:2000794,1,0.947242279960458,0,8,regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
21639,GO:2000795,1,0.991059124353862,0,1,negative regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
21640,GO:2000797,1,0.993401710947692,0,1,regulation of amniotic stem cell differentiation,BP,
21641,GO:2000798,1,0.993401710947692,0,1,negative regulation of amniotic stem cell differentiation,BP,
21642,GO:2000800,1,0.994430353677249,0,1,regulation of endocardial cushion to mesenchymal transition involved in heart valve formation,BP,
21643,GO:2000802,1,0.994430353677249,0,1,positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation,BP,
21644,GO:2000804,1,0.989585442732175,0,1,regulation of termination of RNA polymerase II transcription, poly(A)-coupled,BP,
21645,GO:2000806,1,0.989585442732175,0,1,positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled,BP,
21646,GO:2000807,1,0.948380908405634,0,7,regulation of synaptic vesicle clustering,BP,
21647,GO:2000808,1,0.99241929572855,0,1,negative regulation of synaptic vesicle clustering,BP,
21648,GO:2000809,1,0.964175472239258,0,5,positive regulation of synaptic vesicle clustering,BP,
21649,GO:2000810,1,0.874346250313206,0,20,regulation of bicellular tight junction assembly,BP,
21650,GO:2000811,1,0.902328740259092,0,15,negative regulation of anoikis,BP,
21651,GO:2000812,1,0.993288776571703,0,1,regulation of barbed-end actin filament capping,BP,
21653,GO:2000818,1,0.988225864230529,0,2,negative regulation of myoblast proliferation,BP,
21654,GO:2000819,1,0.987290308693744,0,2,regulation of nucleotide-excision repair,BP,
21655,GO:2000820,1,0.980339653819679,0,3,negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,
21656,GO:2000821,1,0.966492282232235,0,5,regulation of grooming behavior,BP,
21657,GO:2000822,1,0.957290082082052,0,7,regulation of behavioral fear response,BP,
21658,GO:2000823,1,0.963428596841968,0,6,regulation of androgen receptor activity,BP,
21659,GO:2000824,1,0.987371344652177,0,2,negative regulation of androgen receptor activity,BP,
21660,GO:2000825,1,0.975754095949246,0,4,positive regulation of androgen receptor activity,BP,
21661,GO:2000826,1,0.807857800072047,0,32,regulation of heart morphogenesis,BP,
21662,GO:2000827,1,0.994005274042763,0,1,mitochondrial RNA surveillance,BP,
21663,GO:2000828,1,0.986724730118782,0,2,regulation of parathyroid hormone secretion,BP,
21664,GO:2000830,1,0.992371064595669,0,1,positive regulation of parathyroid hormone secretion,BP,
21665,GO:2000831,1,0.909735754613896,0,16,regulation of steroid hormone secretion,BP,
21666,GO:2000832,1,0.985685243260271,0,2,negative regulation of steroid hormone secretion,BP,
21667,GO:2000833,1,0.950321752162994,0,9,positive regulation of steroid hormone secretion,BP,
21668,GO:2000834,1,0.993598298111347,0,1,regulation of androgen secretion,BP,
21669,GO:2000836,1,0.993598298111347,0,1,positive regulation of androgen secretion,BP,
21670,GO:2000843,1,0.9853482156489,0,2,regulation of testosterone secretion,BP,
21671,GO:2000845,1,0.9853482156489,0,2,positive regulation of testosterone secretion,BP,
21672,GO:2000846,1,0.925497516076566,0,13,regulation of corticosteroid hormone secretion,BP,
21673,GO:2000847,1,0.985685243260271,0,2,negative regulation of corticosteroid hormone secretion,BP,
21674,GO:2000848,1,0.961214964769212,0,7,positive regulation of corticosteroid hormone secretion,BP,
21675,GO:2000849,1,0.948427838481917,0,9,regulation of glucocorticoid secretion,BP,
21676,GO:2000850,1,0.985685243260271,0,2,negative regulation of glucocorticoid secretion,BP,
21677,GO:2000851,1,0.973276272687834,0,5,positive regulation of glucocorticoid secretion,BP,
21678,GO:2000852,1,0.978107913987809,0,4,regulation of corticosterone secretion,BP,
21679,GO:2000854,1,0.989358317960191,0,2,positive regulation of corticosterone secretion,BP,
21680,GO:2000855,1,0.975835585506386,0,4,regulation of mineralocorticoid secretion,BP,
21681,GO:2000857,1,0.987610890609023,0,2,positive regulation of mineralocorticoid secretion,BP,
21682,GO:2000858,1,0.975835585506386,0,4,regulation of aldosterone secretion,BP,
21683,GO:2000860,1,0.987610890609023,0,2,positive regulation of aldosterone secretion,BP,
21684,GO:2000864,1,0.979568051879514,0,3,regulation of estradiol secretion,BP,
21685,GO:2000866,1,0.987496304277161,0,2,positive regulation of estradiol secretion,BP,
21686,GO:2000870,1,0.989316623344359,0,2,regulation of progesterone secretion,BP,
21687,GO:2000872,1,0.99504203350921,0,1,positive regulation of progesterone secretion,BP,
21688,GO:2000878,1,0.988377255050008,0,2,positive regulation of oligopeptide transport,BP,
21689,GO:2000880,1,0.988377255050008,0,2,positive regulation of dipeptide transport,BP,
21690,GO:2000896,1,0.993661238904075,0,1,amylopectin metabolic process,BP,
21691,GO:2000909,1,0.993850639026861,0,1,regulation of sterol import,BP,
21692,GO:2000969,1,0.962691136022738,0,5,positive regulation of AMPA receptor activity,BP,
21693,GO:2000970,1,0.994041878730589,0,1,regulation of detection of glucose,BP,
21694,GO:2000971,1,0.994041878730589,0,1,negative regulation of detection of glucose,BP,
21695,GO:2000973,1,0.957118257795763,0,6,regulation of pro-B cell differentiation,BP,
21696,GO:2000974,1,0.979745930863119,0,3,negative regulation of pro-B cell differentiation,BP,
21697,GO:2000977,1,0.976612014086745,0,4,regulation of forebrain neuron differentiation,BP,
21698,GO:2000978,1,0.989182817161195,0,2,negative regulation of forebrain neuron differentiation,BP,
21699,GO:2000979,1,0.993704753095749,0,1,positive regulation of forebrain neuron differentiation,BP,
21700,GO:2000980,1,0.955746383736951,0,7,regulation of inner ear receptor cell differentiation,BP,
21701,GO:2000981,1,0.973454046052139,0,4,negative regulation of inner ear receptor cell differentiation,BP,
21702,GO:2000983,1,0.989622177069628,0,2,regulation of ATP citrate synthase activity,BP,
21703,GO:2000984,1,0.989622177069628,0,2,negative regulation of ATP citrate synthase activity,BP,
21704,GO:2000987,1,0.970290261120305,0,5,positive regulation of behavioral fear response,BP,
21705,GO:2001012,1,0.957391856188023,0,7,mesenchymal cell differentiation involved in renal system development,BP,
21706,GO:2001013,1,0.971402347161161,0,4,epithelial cell proliferation involved in renal tubule morphogenesis,BP,
21707,GO:2001014,1,0.88653510604663,0,18,regulation of skeletal muscle cell differentiation,BP,
21708,GO:2001015,1,0.959544715722624,0,6,negative regulation of skeletal muscle cell differentiation,BP,
21709,GO:2001016,1,0.967134786357161,0,5,positive regulation of skeletal muscle cell differentiation,BP,
21713,GO:2001023,1,0.623378654648625,0,74,regulation of response to drug,BP,
21714,GO:2001024,1,0.850294264979218,0,25,negative regulation of response to drug,BP,
21715,GO:2001025,1,0.85852239311273,0,25,positive regulation of response to drug,BP,
21717,GO:2001027,1,0.977577672783866,0,3,negative regulation of endothelial cell chemotaxis,BP,
21718,GO:2001028,1,0.919408244961032,0,12,positive regulation of endothelial cell chemotaxis,BP,
21719,GO:2001029,1,0.992430305916516,0,1,regulation of cellular glucuronidation,BP,
21720,GO:2001031,1,0.992430305916516,0,1,positive regulation of cellular glucuronidation,BP,
21721,GO:2001032,1,0.924595419517645,0,12,regulation of double-strand break repair via nonhomologous end joining,BP,
21722,GO:2001033,1,0.970602827498908,0,5,negative regulation of double-strand break repair via nonhomologous end joining,BP,
21723,GO:2001034,1,0.965268603762985,0,5,positive regulation of double-strand break repair via nonhomologous end joining,BP,
21724,GO:2001035,1,0.987486274093285,0,2,regulation of tongue muscle cell differentiation,BP,
21725,GO:2001037,1,0.987486274093285,0,2,positive regulation of tongue muscle cell differentiation,BP,
21726,GO:2001038,1,0.839588769505067,0,27,regulation of cellular response to drug,BP,
21727,GO:2001039,1,0.897045177620514,0,17,negative regulation of cellular response to drug,BP,
21728,GO:2001040,1,0.961407896021434,0,6,positive regulation of cellular response to drug,BP,
21729,GO:2001044,1,0.919605848131803,0,13,regulation of integrin-mediated signaling pathway,BP,
21730,GO:2001045,1,0.985470203722734,0,2,negative regulation of integrin-mediated signaling pathway,BP,
21731,GO:2001046,1,0.96060725854763,0,6,positive regulation of integrin-mediated signaling pathway,BP,
21732,GO:2001049,1,0.994259787243675,0,1,regulation of tendon cell differentiation,BP,
21733,GO:2001051,1,0.994259787243675,0,1,positive regulation of tendon cell differentiation,BP,
21734,GO:2001053,1,0.934179450557312,0,11,regulation of mesenchymal cell apoptotic process,BP,
21735,GO:2001054,1,0.945079480821398,0,9,negative regulation of mesenchymal cell apoptotic process,BP,
21736,GO:2001055,1,0.98847309054733,0,2,positive regulation of mesenchymal cell apoptotic process,BP,
21737,GO:2001056,1,0.417706253320325,0,137,positive regulation of cysteine-type endopeptidase activity,BP,
21738,GO:2001057,1,0.656669081960613,0,64,reactive nitrogen species metabolic process,BP,
21739,GO:2001065,1,0.994594678661389,0,1,mannan binding,MF,
21740,GO:2001069,1,0.987831016476892,0,2,glycogen binding,MF,
21741,GO:2001070,1,0.986527597027221,0,2,starch binding,MF,
21742,GO:2001074,1,0.988138974260945,0,2,regulation of metanephric ureteric bud development,BP,
21743,GO:2001076,1,0.988138974260945,0,2,positive regulation of metanephric ureteric bud development,BP,
21744,GO:2001106,1,0.983886432126705,0,2,regulation of Rho guanyl-nucleotide exchange factor activity,BP,
21745,GO:2001108,1,0.991995872618971,0,1,positive regulation of Rho guanyl-nucleotide exchange factor activity,BP,
21748,GO:2001112,1,0.992721642207101,0,1,regulation of cellular response to hepatocyte growth factor stimulus,BP,
21749,GO:2001113,1,0.992721642207101,0,1,negative regulation of cellular response to hepatocyte growth factor stimulus,BP,
21750,GO:2001135,1,0.938883841495408,0,9,regulation of endocytic recycling,BP,
21751,GO:2001136,1,0.993560947772158,0,1,negative regulation of endocytic recycling,BP,
21752,GO:2001137,1,0.969851818852283,0,4,positive regulation of endocytic recycling,BP,
21753,GO:2001138,1,0.947752457072511,0,8,regulation of phospholipid transport,BP,
21754,GO:2001140,1,0.947752457072511,0,8,positive regulation of phospholipid transport,BP,
21756,GO:2001142,1,0.993963542547474,0,1,nicotinate transport,BP,
21757,GO:2001144,1,0.994161103785021,0,1,regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,BP,
21758,GO:2001145,1,0.994161103785021,0,1,negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,BP,
21759,GO:2001148,1,0.988377255050008,0,2,regulation of dipeptide transmembrane transport,BP,
21760,GO:2001150,1,0.988377255050008,0,2,positive regulation of dipeptide transmembrane transport,BP,
21761,GO:2001151,1,0.993627463299271,0,1,regulation of renal water transport,BP,
21762,GO:2001153,1,0.993627463299271,0,1,positive regulation of renal water transport,BP,
21763,GO:2001160,1,0.987765146298378,0,2,regulation of histone H3-K79 methylation,BP,
21764,GO:2001162,1,0.987765146298378,0,2,positive regulation of histone H3-K79 methylation,BP,
21765,GO:2001163,1,0.994113857554735,0,1,regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
21766,GO:2001165,1,0.994113857554735,0,1,positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
21767,GO:2001166,1,0.96801820532582,0,5,regulation of histone H2B ubiquitination,BP,
21768,GO:2001168,1,0.973680300820818,0,4,positive regulation of histone H2B ubiquitination,BP,
21769,GO:2001169,1,0.623807246174042,0,69,regulation of ATP biosynthetic process,BP,
21770,GO:2001170,1,0.915181655649169,0,13,negative regulation of ATP biosynthetic process,BP,
21771,GO:2001171,1,0.848868617067009,0,24,positive regulation of ATP biosynthetic process,BP,
21772,GO:2001173,1,0.994186413900613,0,1,regulation of histone H2B conserved C-terminal lysine ubiquitination,BP,
21773,GO:2001176,1,0.98801705095952,0,2,regulation of mediator complex assembly,BP,
21774,GO:2001178,1,0.98801705095952,0,2,positive regulation of mediator complex assembly,BP,
21775,GO:2001179,1,0.960165271906819,0,7,regulation of interleukin-10 secretion,BP,
21776,GO:2001180,1,0.981651462069393,0,3,negative regulation of interleukin-10 secretion,BP,
21777,GO:2001181,1,0.978116252772081,0,4,positive regulation of interleukin-10 secretion,BP,
21778,GO:2001182,1,0.957036090227162,0,7,regulation of interleukin-12 secretion,BP,
21779,GO:2001183,1,0.981357931998945,0,3,negative regulation of interleukin-12 secretion,BP,
21780,GO:2001184,1,0.981650665492005,0,3,positive regulation of interleukin-12 secretion,BP,
21781,GO:2001185,1,0.958085915539244,0,7,regulation of CD8-positive, alpha-beta T cell activation,BP,
21782,GO:2001186,1,0.988127902162545,0,2,negative regulation of CD8-positive, alpha-beta T cell activation,BP,
21783,GO:2001187,1,0.982451092036319,0,3,positive regulation of CD8-positive, alpha-beta T cell activation,BP,
21784,GO:2001188,1,0.971792614373658,0,5,regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
21785,GO:2001189,1,0.982561950568253,0,3,negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
21786,GO:2001190,1,0.989041473216876,0,2,positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
21787,GO:2001191,1,0.993809823819756,0,1,regulation of gamma-delta T cell activation involved in immune response,BP,
21788,GO:2001193,1,0.993809823819756,0,1,positive regulation of gamma-delta T cell activation involved in immune response,BP,
21789,GO:2001197,1,0.960305493702139,0,5,basement membrane assembly involved in embryonic body morphogenesis,BP,
21790,GO:2001198,1,0.942963881504982,0,10,regulation of dendritic cell differentiation,BP,
21791,GO:2001199,1,0.965639546149292,0,6,negative regulation of dendritic cell differentiation,BP,
21792,GO:2001200,1,0.975796201960832,0,4,positive regulation of dendritic cell differentiation,BP,
21793,GO:2001201,1,0.977537800912417,0,3,regulation of transforming growth factor-beta secretion,BP,
21794,GO:2001202,1,0.984803092426306,0,2,negative regulation of transforming growth factor-beta secretion,BP,
21795,GO:2001203,1,0.992623730601324,0,1,positive regulation of transforming growth factor-beta secretion,BP,
21796,GO:2001204,1,0.931835745056153,0,10,regulation of osteoclast development,BP,
21797,GO:2001205,1,0.963942896075648,0,5,negative regulation of osteoclast development,BP,
21798,GO:2001206,1,0.98199755295595,0,3,positive regulation of osteoclast development,BP,
21799,GO:2001207,1,0.99332577587971,0,1,regulation of transcription elongation from RNA polymerase I promoter,BP,
21800,GO:2001208,1,0.99332577587971,0,1,negative regulation of transcription elongation by RNA polymerase I,BP,
21801,GO:2001212,1,0.912245778843896,0,14,regulation of vasculogenesis,BP,
21802,GO:2001213,1,0.992315508269107,0,1,negative regulation of vasculogenesis,BP,
21803,GO:2001214,1,0.937375740966708,0,10,positive regulation of vasculogenesis,BP,
21804,GO:2001222,1,0.799710735806117,0,29,regulation of neuron migration,BP,
21805,GO:2001223,1,0.943362842398122,0,8,negative regulation of neuron migration,BP,
21806,GO:2001224,1,0.899898582965533,0,13,positive regulation of neuron migration,BP,
21807,GO:2001225,1,0.934954347594344,0,10,regulation of chloride transport,BP,
21808,GO:2001226,1,0.981139826469829,0,3,negative regulation of chloride transport,BP,
21809,GO:2001228,1,0.977990064831176,0,2,regulation of response to gamma radiation,BP,
21810,GO:2001229,1,0.988319882657755,0,1,negative regulation of response to gamma radiation,BP,
21817,GO:2001239,1,0.760225670146679,0,44,regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,
21818,GO:2001240,1,0.821909477957759,0,32,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,
21819,GO:2001241,1,0.926001368654715,0,12,positive regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,
21823,GO:2001245,1,0.981154711824811,0,3,regulation of phosphatidylcholine biosynthetic process,BP,
21824,GO:2001246,1,0.993251731661176,0,1,negative regulation of phosphatidylcholine biosynthetic process,BP,
21825,GO:2001247,1,0.993063088285647,0,1,positive regulation of phosphatidylcholine biosynthetic process,BP,
21826,GO:2001248,1,0.994178148773045,0,1,regulation of ammonia assimilation cycle,BP,
21827,GO:2001250,1,0.994178148773045,0,1,positive regulation of ammonia assimilation cycle,BP,
21830,GO:2001253,1,0.993735484040148,0,1,regulation of histone H3-K36 trimethylation,BP,
21831,GO:2001256,1,0.92766264055607,0,12,regulation of store-operated calcium entry,BP,
21833,GO:2001258,1,0.801042084243881,0,36,negative regulation of cation channel activity,BP,
21835,GO:2001260,1,0.994066637540254,0,1,regulation of semaphorin-plexin signaling pathway,BP,
21836,GO:2001262,1,0.994066637540254,0,1,positive regulation of semaphorin-plexin signaling pathway,BP,
21837,GO:2001267,1,0.869363737391133,0,23,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
21838,GO:2001268,1,0.972301214048717,0,5,negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
21839,GO:2001269,1,0.894158473549416,0,18,positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
21840,GO:2001270,1,0.97459729349179,0,4,regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
21841,GO:2001271,1,0.979639041597736,0,3,negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
21842,GO:2001272,1,0.994854530693101,0,1,positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
21843,GO:2001273,1,0.86970464879637,0,20,regulation of glucose import in response to insulin stimulus,BP,
21844,GO:2001274,1,0.980513085222779,0,3,negative regulation of glucose import in response to insulin stimulus,BP,
21845,GO:2001275,1,0.892790470091835,0,16,positive regulation of glucose import in response to insulin stimulus,BP,
21846,GO:2001279,1,0.968076534906467,0,5,regulation of unsaturated fatty acid biosynthetic process,BP,
21847,GO:2001280,1,0.980803426182787,0,3,positive regulation of unsaturated fatty acid biosynthetic process,BP,
21848,GO:2001286,1,0.972230129798376,0,4,regulation of caveolin-mediated endocytosis,BP,
21849,GO:2001287,1,0.987851016105005,0,2,negative regulation of caveolin-mediated endocytosis,BP,
21850,GO:2001288,1,0.990928958252341,0,1,positive regulation of caveolin-mediated endocytosis,BP,
21851,GO:2001293,1,0.984686383069805,0,2,malonyl-CoA metabolic process,BP,
21852,GO:2001294,1,0.994155422707334,0,1,malonyl-CoA catabolic process,BP,
21853,GO:2001295,1,0.990475853341656,0,1,malonyl-CoA biosynthetic process,BP,
21854,GO:2001300,1,0.966064110291347,0,6,lipoxin metabolic process,BP,
21855,GO:2001301,1,0.966064110291347,0,6,lipoxin biosynthetic process,BP,
21856,GO:2001302,1,0.988003215315166,0,2,lipoxin A4 metabolic process,BP,
21857,GO:2001303,1,0.988003215315166,0,2,lipoxin A4 biosynthetic process,BP,
21858,GO:2001304,1,0.994066121639822,0,1,lipoxin B4 metabolic process,BP,
21859,GO:2001306,1,0.994066121639822,0,1,lipoxin B4 biosynthetic process,BP,
21860,GO:2001311,1,0.994351790855444,0,1,lysobisphosphatidic acid metabolic process,BP,
9595,GO:0035094,1,0.760480438715602,0,42,response to nicotine,BP,
20821,GO:1905898,1,0.799664223440316,0,35,positive regulation of response to endoplasmic reticulum stress,BP,
2957,GO:0006101,1,0.815487373362612,0,33,citrate metabolic process,BP,
18920,GO:1901522,1,0.852754003383163,0,23,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus,BP,
21574,GO:2000679,1,0.875818480454386,0,21,positive regulation of transcription regulatory region DNA binding,BP,
20879,GO:1990090,1.00000000000001,0.711166490359262,0,49,cellular response to nerve growth factor stimulus,BP,
16095,GO:0071007,1.00000000000001,0.838196775241539,0,29,U2-type catalytic step 2 spliceosome,CC,
9604,GO:0035112,1.00000000000001,0.926606658867358,0,11,genitalia morphogenesis,BP,
3279,GO:0006590,1.00000000000001,0.915186276091037,0,13,thyroid hormone generation,BP,
8241,GO:0032206,1.00000000000001,0.725136498576352,0,49,positive regulation of telomere maintenance,BP,
10990,GO:0043001,1.00000000000001,0.81062494733946,0,31,Golgi to plasma membrane protein transport,BP,
12813,GO:0047496,1.00000000000001,0.76861675583639,0,38,vesicle transport along microtubule,BP,
15491,GO:0061900,1.00000000000001,0.807989690805432,0,31,glial cell activation,BP,
